PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Yokoyama, R; Ohkura, M; Wakui, T				Yokoyama, Ryohei; Ohkura, Masashi; Wakui, Tetsuya			Robust Optimal Operation of a Gas Turbine Cogeneration Plant Under Uncertain Energy Demands	JOURNAL OF ENGINEERING FOR GAS TURBINES AND POWER-TRANSACTIONS OF THE ASME			English	Article							OPTIMAL-DESIGN; SUPPLY-SYSTEMS; DECOMPOSITION; OPTIMIZATION; CRITERION; COST	Some optimal operation methods based on the mixed-integer linear programming (MILP) have been proposed to operate energy supply plants properly from the viewpoints of economics, energy saving, and CO2 emission reduction. However, most of the methods are effective only under certain energy demands. In operating an energy supply plant actually, it is necessary to determine the operational strategy properly based on predicted energy demands. In this case, realized energy demands may differ from the predicted ones. Therefore, it is necessary to determine the operational strategy so that it is robust against the uncertainty in energy demands. In this paper, an optimization method based on the MILP is proposed to conduct the robust optimal operation of energy supply plants under uncertain energy demands. The uncertainty in energy demands is expressed by their intervals. The operational strategy is determined to minimize the maximum regret in the operational cost under the uncertainty. In addition, a hierarchical relationship among operation modes and on/off states of equipment, energy demands, and energy flow rates of equipment is taken into account. First, a general formulation of a robust optimal operation problem is presented, which is followed by a general solution procedure. Then, in a numerical study, the proposed method is applied to a gas turbine cogeneration plant for district energy supply. Through the study, some features of the robust optimal operation are clarified, and the validity and effectiveness of the proposed method are ascertained.	[Yokoyama, Ryohei; Ohkura, Masashi; Wakui, Tetsuya] Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Yokoyama, R (reprint author), Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	yokoyama@me.osakafu-u.ac.jp; ohkura@me.osakafu-u.ac.jp; wakui@me.osakafu-u.ac.jp					ITO K, 1990, J ENG GAS TURB POWER, V112, P122, DOI 10.1115/1.2906466; Verderame PM, 2010, IND ENG CHEM RES, V49, P3993, DOI 10.1021/ie902009k; Iyer RR, 1997, COMPUT CHEM ENG, V21, P787, DOI 10.1016/S0098-1354(96)00317-1; Yokoyama R, 2002, ENERG CONVERS MANAGE, V43, P499, DOI 10.1016/S0196-8904(01)00027-9; VANDENBOSCH PPJ, 1985, IEEE T POWER AP SYST, V104, P1684; Yokoyama R, 2004, J ENG GAS TURB POWER, V126, P823, DOI 10.1115/1.1771688; KONNO H, 1976, MATH PROGRAM, V11, P14, DOI 10.1007/BF01580367; SHEBLE GB, 1994, IEEE T POWER SYST, V9, P128, DOI 10.1109/59.317549; Yokoyama R, 1999, J ENERG RESOUR-ASME, V121, P254, DOI 10.1115/1.2795991; Yokoyama R, 2002, ENERG CONVERS MANAGE, V43, P771, DOI 10.1016/S0196-8904(01)00075-9; Zeng Y, 2011, ENERGIES, V4, P1624, DOI 10.3390/en4101624; Biegler L.T., 1997, SYSTEMATIC METHODS C; CANDLER W, 1982, COMPUT OPER RES, V9, P59, DOI 10.1016/0305-0548(82)90006-5; Dotzauer E., 1997, THESIS LINKOPING U L; Kouvelis P., 1997, ROBUST DISCRETE OPTI; PARKINSON A, 1993, J MECH DESIGN, V115, P74, DOI 10.1115/1.2919328; Yokoyama R., 2001, 2001GT0208 ASME; Yokoyama R., 1999, 99GT128 ASME; Yokoyama R., 2013, ASME J ENG GAS TURBI, V135, P1; Yokoyama R, 2014, ENERG CONVERS MANAGE, V84, P196, DOI 10.1016/j.enconman.2014.03.045	20	1	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0742-4795	1528-8919		J ENG GAS TURB POWER	J. Eng. Gas. Turbines Power-Trans. ASME	FEB	2015	137	2							022001	10.1115/1.4028211		11	Engineering, Mechanical	Engineering	AZ2FU	WOS:000348050800010		
J	Kiyohara, K; Kitamura, T; Iwami, T; Nishiyama, C; Kawamura, T				Kiyohara, Kosuke; Kitamura, Tetsuhisa; Iwami, Taku; Nishiyama, Chika; Kawamura, Takashi			Impact of the Great East Japan earthquake on out-of-hospital cardiac arrest with cardiac origin in non-disaster reas	JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH			English	Article							HANSHIN-AWAJI EARTHQUAKE; HEART-DISEASE DEATH; STRESS; ATTACK	Background To examine changes in the incidence of out-of-hospital cardiac arrest (OHCA) with cardiac origin in the non-disaster areas of Japan before and after the Great East Japan Earthquake of 11 March 2011. Methods The 35 prefectures in Japan with no dead or missing caused directly by the earthquake were defined as the non-disaster areas. Data of adult OHCA patients in the non-disaster areas from March 4 to 24 each year from 2005 to 2011 were obtained from the All-Japan Utstein Registry. Risk ratios (RRs) of OHCA incidence and 95% CIs were estimated for three specific weeks in 2011 (1 week before and 2 weeks after the earthquake) by applying multivariable Poisson regression model. Incidence in the corresponding periods of March 4-24 from 2005 to 2010 was set as the baseline risk. Results In the analyses from a total of 17 353 OHCA patients, the incidence statistically significantly increased in the first week after the earthquake in all adults (adjusted-RR=1.13, 95% CI=1.05 to 1.22, p=0.001) and in elderly women (adjusted-RR=1.23, 95% CI=1.11 to 1.37, p<0.001). Conclusions The Great East Japan Earthquake caused the increase of OHCA among elderly women even in the non-disaster areas.	[Kiyohara, Kosuke] Tokyo Womens Med Univ, Dept Publ Hlth, Shinjuku Ku, Tokyo 1628666, Japan; [Kitamura, Tetsuhisa] Osaka Univ, Dept Social & Environm Med, Grad Sch Med, Div Environm Med & Populat Sci, Suita, Osaka, Japan; [Iwami, Taku; Kawamura, Takashi] Kyoto Univ Hlth Serv, Kyoto, Japan; [Nishiyama, Chika] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan	Kiyohara, K (reprint author), Tokyo Womens Med Univ, Dept Publ Hlth, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	kiyosuke0817@hotmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [25870391]	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (25870391) of Japan.	Aoki T, 2012, EUR HEART J, V33, P2796, DOI 10.1093/eurheartj/ehs288; Ma WJ, 2011, EUR HEART J, V32, P1006, DOI 10.1093/eurheartj/ehq495; Wilbert-Lampen U, 2008, NEW ENGL J MED, V358, P475, DOI 10.1056/NEJMoa0707427; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Kario K, 1998, J AM GERIATR SOC, V46, P537; Kario K, 1997, J AM GERIATR SOC, V45, P610; Kario K, 2003, HYPERTENS RES, V26, P355, DOI 10.1291/hypres.26.355; Kitamura T, 2013, NEW ENGL J MED, V369, P2165, DOI 10.1056/NEJMc1306058; Leor J, 1996, NEW ENGL J MED, V334, P413, DOI 10.1056/NEJM199602153340701; Nakagawa I, 2009, HEART, V95, P2009, DOI 10.1136/hrt.2009.174201; Shedd OL, 2004, J AM COLL CARDIOL, V44, P1265, DOI 10.1016/j.jacc.2004.04.058; SUZUKI S, 1995, LANCET, V345, P981, DOI 10.1016/S0140-6736(95)90727-0; TRICHOPOULOS D, 1983, LANCET, V1, P441; Watanabe H, 2005, JAMA-J AM MED ASSOC, V294, P305, DOI 10.1001/jama.294.3.305	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0143-005X	1470-2738		J EPIDEMIOL COMMUN H	J. Epidemiol. Community Health	FEB	2015	69	2					185	188		10.1136/jech-2014-204380		4	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AZ0YE	WOS:000347967000015		
J	Iida, O				Iida, Oaki			Effects of System Rotation on Vortical Structure in Wall Turbulence	JOURNAL OF FLUIDS ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							LOW-REYNOLDS-NUMBER; CHANNEL FLOW; SPANWISE ROTATION; SIMULATIONS	Direct numerical simulations (DNSs) of rotating turbulent Poiseuille flows are performed to study the effects of both cyclonic and anticyclonic system rotation on the kinematics of the quasi-streamwise vortices. By using the second invariant of the deformation tensor, a number of streamwise vortices are detected and averaged in the wall vicinity where the intense sweep motion, i.e., the inrush motion of high-speed fluid toward the wall, is related to the quasi-streamwise vortices. The effects of the system rotation on the angle of vortex axis are clearly observed as studied in longitudinal vortices of the homogeneous shear flow. Moreover, by calculating the probability of the emergence of the counterclockwise vortices (CCVs) around a clockwise vortex (CV), we find that with increase in the anticyclonic system rotation, the probability increases and decreases in the ejection and sweep sides of a CV, respectively. In contrast, cyclonic system rotation attenuates CCVs in both sides of a CV, though it increases at the top of the CV. This distribution of CCVs is found to affect sweep motion related to the quasi-streamwise vortices.	Nagoya Inst Technol, Dept Mech Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Iida, O (reprint author), Nagoya Inst Technol, Dept Mech Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	iida.oaki@nitech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [2356024]	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan through a Grant-in-Aid for Scientific Research (No. 2356024). The author is also grateful to the comments of referees.	JOHNSTON JP, 1972, J FLUID MECH, V56, P533, DOI 10.1017/S0022112072002502; Brethouwer G, 2005, J FLUID MECH, V542, P305, DOI 10.1017/S0022112005006427; KRISTOFFERSEN R, 1993, J FLUID MECH, V256, P163, DOI 10.1017/S0022112093002757; KIM J, 1987, J FLUID MECH, V177, P133, DOI 10.1017/S0022112087000892; JIMENEZ J, 1991, J FLUID MECH, V225, P213, DOI 10.1017/S0022112091002033; CHOI H, 1994, J FLUID MECH, V262, P75, DOI 10.1017/S0022112094000431; Grundestam O, 2008, J FLUID MECH, V598, P177, DOI 10.1017/S0022112007000122; Iida O, 2008, FLOW TURBUL COMBUST, V81, P17, DOI 10.1007/s10494-007-9125-z; Iida O, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3478980; Ishida T., 2014, APPL THERM IN PRESS; Jacobitz FG, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2896284; Jeong J, 1997, J FLUID MECH, V332, P185; Kuroda A., 1995, Turbulent Shear Flows 9. Selected Papers from the Ninth International Symposium on Turbulent Shear Flows; Le AT, 2000, INT J HEAT FLUID FL, V21, P480, DOI 10.1016/S0142-727X(00)00035-7; Nakabayashi K, 2005, J FLUID MECH, V528, P355, DOI 10.1017/S0022112004002939; Nakabayashi K, 1996, J FLUID MECH, V315, P1, DOI 10.1017/S0022112096002303; Robinson S. K., 1991, 103859 NASA; Uchiyama T., 2013, OPEN TRANSP PHENOM J, V5, P30; Wu HB, 2004, PHYS FLUIDS, V16, P979, DOI 10.1063/1.1649337	19	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0098-2202	1528-901X		J FLUID ENG-T ASME	J. Fluids Eng.-Trans. ASME	FEB	2015	137	2							021201	10.1115/1.4027953		10	Engineering, Mechanical	Engineering	AZ2FK	WOS:000348049800006		
J	Suzumori, N; Kumagai, K; Goto, S; Nakamura, A; Sugiura-Ogasawara, M				Suzumori, Nobuhiro; Kumagai, Kyoko; Goto, Shinobu; Nakamura, Akira; Sugiura-Ogasawara, Mayumi			Parental Decisions Following Prenatal Diagnosis of Chromosomal Abnormalities: Implications for Genetic Counseling Practice in Japan	JOURNAL OF GENETIC COUNSELING			English	Article						Prenatal diagnosis; Termination; Genetic counseling; Chromosome aneuploidy; Japan	DOWN-SYNDROME; FETAL ANEUPLOIDY; PREGNANCY; TERMINATION; ATTITUDES; LEBANON	Parental decision-making to terminate or continue a pregnancy was studied after prenatal diagnosis of a chromosome aneuploidy among a sample of patients around the city of Nagoya, Japan. A total of 1,051 amniocentesis cases at 15-18 weeks of gestation were analyzed. Of these, 60 cases of chromosomal anomalies with aneuploidies were diagnosed by conventional cytogenetic analysis. Of the 45 diagnoses of autosomal chromosome aneuploidies, pregnancy was terminated in 93.3 % of the cases. Of the 15 cases diagnosed with sex chromosome aneuploidy, pregnancy was terminated in 46.7 %. Differences in parental decisions with respect to maternal age, gestational week at diagnosis, number of pregnancies per individual and existing number of children were not significant in patients diagnosed either with autosomal or sex chromosome aneuploidy. The findings indicate that when diagnosed with a chromosome aneuploidy in which a severe prognosis was expected, most couples decided to terminate the pregnancy in Japan. Implications of these findings for expanding the profession of genetic counseling are discussed and research recommendations are provided.	[Suzumori, Nobuhiro; Kumagai, Kyoko; Goto, Shinobu; Sugiura-Ogasawara, Mayumi] Nagoya City Univ, Div Clin & Mol Genet, Dept Obstet & Gynecol, Grad Sch Med Sci,Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Nakamura, Akira] Chiba Univ Commerce, Ichikawa, Chiba 2728512, Japan	Suzumori, N (reprint author), Nagoya City Univ, Div Clin & Mol Genet, Dept Obstet & Gynecol, Grad Sch Med Sci,Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	og.n.suz@med.nagoya-cu.ac.jp					Mansfield C, 1999, PRENATAL DIAG, V19, P808, DOI 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.3.CO;2-2; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Mezei G, 2004, OBSTET GYNECOL, V104, P94, DOI 10.1097/01.AOG.000128171.14081.eb; Schechtman KB, 2002, OBSTET GYNECOL, V99, P216, DOI 10.1016/S0029-7844(01)01673-8; Balkan M, 2010, J GENET COUNS, V19, P241, DOI 10.1007/s10897-009-9275-3; Britt DW, 2000, AM J MED GENET, V93, P410, DOI 10.1002/1096-8628(20000828)93:5<410::AID-AJMG12>3.0.CO;2-F; Dzurova D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-69; Eldahdah LT, 2007, PRENATAL DIAG, V27, P525, DOI 10.1002/pd.1721; Forrester MB, 2003, AM J MED GENET A, V119A, P305, DOI 10.1002/ajmg.a.20150; Hawkins A., 2012, J GENETIC COUNSELING; Kato M, 2010, CULT HEALTH SEX, V12, P177, DOI 10.1080/13691050902993676; Murakami K, 2012, NURS HEALTH SCI, V14, P95, DOI 10.1111/j.1442-2018.2011.00670.x; Pinsker JE, 2012, J CLIN ENDOCR METAB, V97, pE994, DOI 10.1210/jc.2012-1245; Quadrelli R, 2007, PRENATAL DIAG, V27, P228, DOI 10.1002/pd.1651; R Development Core Team, 2009, R LANG ENV STAT COMP; Sasaki A, 2011, PRENATAL DIAG, V31, P1007, DOI 10.1002/pd.2816; Shaffer BL, 2006, PRENATAL DIAG, V26, P667, DOI 10.1002/pd.1462; Shojai R, 2005, Gynecol Obstet Fertil, V33, P514, DOI 10.1016/j.gyobfe.2005.05.015; Suzumori N., 2014, PRENATAL DIAGNOSIS; Zahed L, 2002, PRENATAL DIAG, V22, P880, DOI 10.1002/pd.429	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-7700	1573-3599		J GENET COUNS	J. Genet. Couns.	FEB	2015	24	1					117	121		10.1007/s10897-014-9744-1		5	Genetics & Heredity	Genetics & Heredity	AZ3MG	WOS:000348131000012		
J	Waight, JD; Takai, S; Marelli, B; Qin, GZ; Hance, KW; Zhang, D; Tighe, R; Lan, Y; Lo, KM; Sabzevari, H; Hofmeister, R; Wilson, NS				Waight, Jeremy D.; Takai, Shinji; Marelli, Bo; Qin, Guozhong; Hance, Kenneth W.; Zhang, Dong; Tighe, Robert; Lan, Yan; Lo, Kin-Ming; Sabzevari, Helen; Hofmeister, Robert; Wilson, Nicholas S.			Cutting Edge: Epigenetic Regulation of Foxp3 Defines a Stable Population of CD4(+) Regulatory T Cells in Tumors from Mice and Humans	JOURNAL OF IMMUNOLOGY			English	Article							TGF-BETA; EXPRESSION; PROGRESSION; CONTRIBUTE; TOLERANCE; CARCINOMA; BLOCKADE; MELANOMA; EFFICACY	CD4(+) regulatory T cells (Tregs) are critical for maintaining self-tolerance and function to prevent autoimmune disease. High densities of intratumoral Tregs are generally associated with poor patient prognosis, a correlation attributed to their broad immune-suppressive features. Two major populations of Tregs have been defined, thymically derived natural Tregs (nTregs) and peripherally induced Tregs (iTregs). However, the relative contribution of nTregs versus iTregs to the intratumoral Treg compartment remains controversial. Demarcating the proportion of nTregs versus iTregs has important implications in the design of therapeutic strategies to overcome their antagonistic effects on antitumor immune responses. We used epigenetic, phenotypic, and functional parameters to evaluate the composition of nTregs versus iTregs isolated from mouse tumor models and primary human tumors. Our findings failed to find evidence for extensive intratumoral iTreg induction. Rather, we identified a population of Foxp3-stable nTregs in tumors from mice and humans.	[Waight, Jeremy D.; Marelli, Bo; Qin, Guozhong; Hance, Kenneth W.; Zhang, Dong; Tighe, Robert; Lan, Yan; Lo, Kin-Ming; Sabzevari, Helen; Hofmeister, Robert; Wilson, Nicholas S.] EMD Serono Res & Dev Inst, Immunooncol Platform, Billerica, MA 01821 USA; [Takai, Shinji] Ono Pharmaceut Co Ltd, Med Affairs, Oncol Sect, Osaka 5418564, Japan	Hofmeister, R (reprint author), EMD Serono Res & Dev Inst, Immunooncol Platform, 45A Middlesex Turnpike, Billerica, MA 01821 USA.	Robert.Hofmeister@EMDSerono.com					Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Hasegawa Y, 2001, CANCER, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; Zhou G, 2007, J IMMUNOL, V178, P2155; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Selvaraj RK, 2007, J IMMUNOL, V178, P7667; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012	19	6	6	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	FEB 1	2015	194	3					878	882		10.4049/jimmunol.1402725		5	Immunology	Immunology	AZ3NK	WOS:000348134000007		
J	Watanabe, K; Terakura, S; Martens, AC; van Meerten, T; Uchiyama, S; Imai, M; Sakemura, R; Goto, T; Hanajiri, R; Imahashi, N; Shimada, K; Tomita, A; Kiyoi, H; Nishida, T; Naoe, T; Murata, M				Watanabe, Keisuke; Terakura, Seitaro; Martens, Anton C.; van Meerten, Tom; Uchiyama, Susumu; Imai, Misa; Sakemura, Reona; Goto, Tatsunori; Hanajiri, Ryo; Imahashi, Nobuhiko; Shimada, Kazuyuki; Tomita, Akihiro; Kiyoi, Hitoshi; Nishida, Tetsuya; Naoe, Tomoki; Murata, Makoto			Target Antigen Density Governs the Efficacy of Anti-CD20-CD28-CD3 zeta Chimeric Antigen Receptor-Modified Effector CD8(+) T Cells	JOURNAL OF IMMUNOLOGY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; DEPENDENT CELLULAR CYTOTOXICITY; CD20 PROTEIN EXPRESSION; TUMOR-CELLS; HYPER-CVAD; RITUXIMAB; LYMPHOMA; THERAPY; AFFINITY	The effectiveness of chimeric Ag receptor (CAR)-transduced T (CAR-T) cells has been attributed to supraphysiological signaling through CARs. Second-and later-generation CARs simultaneously transmit costimulatory signals with CD3 zeta signals upon ligation, but may lead to severe adverse effects owing to the recognition of minimal Ag expression outside the target tumor. Currently, the threshold target Ag density for CAR-T cell lysis and further activation, including cytokine production, has not yet been investigated in detail. Therefore, we determined the threshold target Ag density required to induce CAR-T cell responses using novel anti-CD20 CART cells with a CD28 intracellular domain and a CD20-transduced CEM cell model. The newly developed CD20CAR-T cells demonstrated Ag-specific lysis and cytokine secretion, which was a reasonable level as a second-generation CAR. For lytic activity, the threshold Ag density was determined to be similar to 200 molecules per target cell, whereas the Ag density required for cytokine production of CAR-T cells was similar to 10-fold higher, at a few thousand per target cell. CD20CAR-T cells responded efficiently to CD20-downregulated lymphoma and leukemia targets, including rituximab-or ofatumumab-refractory primary chronic lymphocytic leukemia cells. Despite the potential influence of the structure, localization, and binding affinity of the CAR/Ag, the threshold determined may be used for target Ag selection. An Ag density below the threshold may not result in adverse effects, whereas that above the threshold may be sufficient for practical effectiveness. CD20CAR-T cells also demonstrated significant lytic activity against CD20-downregulated tumor cells and may exhibit effectiveness for CD20-positive lymphoid malignancies.	[Watanabe, Keisuke; Terakura, Seitaro; Sakemura, Reona; Goto, Tatsunori; Hanajiri, Ryo; Imahashi, Nobuhiko; Shimada, Kazuyuki; Tomita, Akihiro; Kiyoi, Hitoshi; Nishida, Tetsuya; Naoe, Tomoki; Murata, Makoto] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4668560, Japan; [Martens, Anton C.] Vrije Univ Amsterdam, Dept Hematol, Med Ctr Amsterdam, NL-1007 MB Amsterdam, Netherlands; [Martens, Anton C.] Univ Med Ctr Utrecht, Dept Immunol, NL-3508 GA Utrecht, Netherlands; [van Meerten, Tom] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9700 RB Groningen, Netherlands; [Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Div Adv Sci & Biotechnol, Osaka 5650871, Japan; [Imai, Misa] Meijo Univ, Fac Pharm, Nagoya, Aichi 4688503, Japan; [Shimada, Kazuyuki] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Naoe, Tomoki] Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi 4600001, Japan	Terakura, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668560, Japan.	tseit@med.nagoya-u.ac.jp	Terakura, Seitaro/A-6188-2011	Terakura, Seitaro/0000-0002-1194-8046	Foundation for Promotion of Cancer Research (Tokyo, Japan); Japan Society for the Promotion of Science KAKENHI [24790969]; Program to Disseminate Tenure Tracking System (MEXT, Japan); Health Labor Science Research Grant [H25-Immunology-104];  [23659487]	This work was supported by grants from the Foundation for Promotion of Cancer Research (Tokyo, Japan; to S. T.), the Japan Society for the Promotion of Science KAKENHI (24790969 to S. T.), the Program to Disseminate Tenure Tracking System (MEXT, Japan; to K. S.), a Grant-in-Aid for Challenging Exploratory Research (23659487 to T. Naoe), and a Health Labor Science Research Grant (H25-Immunology-104 to M. M.).	Andris-Widhopf J., 2011, COLD SPRING HARB PRO, V2011; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Terakura S, 2012, BLOOD, V119, P72, DOI 10.1182/blood-2011-07-366419; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Wierda WG, 2011, BLOOD, V118, P5126, DOI 10.1182/blood-2011-04-348656; Abramson JS, 2005, BLOOD, V106, P1164, DOI 10.1182/blood-2005-02-0687; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Oki Y, 2013, BRIT J HAEMATOL, V163, P611, DOI 10.1111/bjh.12585; Thomas DA, 2010, J CLIN ONCOL, V28, P3880, DOI 10.1200/JCO.2009.26.9456; Menard S, 2004, CELL MOL LIFE SCI, V61, P2965, DOI 10.1007/s00018-004-4277-7; Turtle CJ, 2012, CURR OPIN IMMUNOL, V24, P633, DOI 10.1016/j.coi.2012.06.004; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Jensen MC, 2014, IMMUNOL REV, V257, P127, DOI 10.1111/imr.12139; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Uchiyama S, 2010, CANCER SCI, V101, P201, DOI 10.1111/j.1349-7006.2009.01392.x; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Jaglowski SM, 2010, BLOOD, V116, P3705, DOI 10.1182/blood-2010-04-001230; Hiraga J, 2009, BLOOD, V113, P4885, DOI 10.1182/blood-2008-08-175208; Jilani I, 2003, BLOOD, V102, P3514, DOI 10.1182/blood-2003-01-0055; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Purbhoo MA, 2006, J IMMUNOL, V176, P7308; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Turatti F, 2007, J IMMUNOTHER, V30, P684; Tsai PC, 2012, CLIN CANCER RES, V18, P1039, DOI 10.1158/1078-0432.CCR-11-1429; Johnson NA, 2009, HAEMATOL-HEMATOL J, V94, P423, DOI 10.3324/haematol.2008.001024; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; van Meerten T, 2006, CLIN CANCER RES, V12, P4027, DOI 10.1158/1078-0432.CCR-06-0066; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Casucci M, 2013, BLOOD, V122, P3461, DOI 10.1182/blood-2013-04-493361; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210; Jazirehi AR, 2005, ONCOGENE, V24, P2121, DOI 10.1038/sj.onc.1208349; Tang Y, 2007, J IMMUNOL, V179, P2815; Tomita A, 2007, INT J HEMATOL, V86, P49, DOI 10.1532/IJH97.07028; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Lenkei R, 1998, CYTOMETRY, V33, P188, DOI 10.1002/(SICI)1097-0320(19981001)33:2<188::AID-CYTO13>3.0.CO;2-Q; Long AH, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23621; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Prevodnik VK, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-33; Shimada K, 2014, BRIT J HAEMATOL, V166, P455, DOI 10.1111/bjh.12857; Sonoki T, 2009, INT J HEMATOL, V89, P400, DOI 10.1007/s12185-009-0295-4; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Weijtens MEM, 1998, INT J CANCER, V77, P181, DOI 10.1002/(SICI)1097-0215(19980717)77:2<181::AID-IJC2>3.0.CO;2-M	47	3	3	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	FEB 1	2015	194	3					911	920		10.4049/jimmunol.1402346		10	Immunology	Immunology	AZ3NK	WOS:000348134000011		
J	Hatano, R; Ohnuma, K; Otsuka, H; Komiya, E; Taki, I; Iwata, S; Dang, NH; Okumura, K; Morimoto, C				Hatano, Ryo; Ohnuma, Kei; Otsuka, Haruna; Komiya, Eriko; Taki, Izumi; Iwata, Satoshi; Dang, Nam H.; Okumura, Ko; Morimoto, Chikao			CD26-Mediated Induction of EGR2 and IL-10 as Potential Regulatory Mechanism for CD26 Costimulatory Pathway	JOURNAL OF IMMUNOLOGY			English	Article							T-CELL-ACTIVATION; NF-KAPPA-B; TRANSCRIPTION FACTOR; MONOCLONAL-ANTIBODY; CYTOKINE PRODUCTION; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; EXPRESSION; MICE; DIFFERENTIATION	CD26 is associated with T cell signal transduction processes as a costimulatory molecule, and CD26(+) T cells have been suggested to be involved in the pathophysiology of diverse autoimmune diseases. Although the cellular and molecular mechanisms involved in CD26-mediated T cell activation have been extensively evaluated by our group and others, potential negative feedback mechanisms to regulate CD26-mediated activation still remain to be elucidated. In the present study, we examine the expression of inhibitory molecules induced via CD26-mediated costimulation. We show that coengagement of CD3 and CD26 induces preferential production of IL-10 in human CD4(+) T cells, mediated through NFAT and Raf-MEK-ERK pathways. A high level of early growth response 2 ( EGR2) is also induced following CD26 costimulation, possibly via NFAT and AP-1-mediated signaling, and knockdown of EGR2 leads to decreased IL-10 production. Furthermore, CD3/CD26-stimulated CD4(+) T cells clearly suppress proliferative activity and effector cytokine production of bystander T cells in an IL-10-dependent manner. Taken together, our data suggest that robust CD26 costimulatory signaling induces preferential expression of EGR2 and IL-10 as a potential mechanism for regulating CD26-mediated activation.	[Hatano, Ryo; Ohnuma, Kei; Otsuka, Haruna; Komiya, Eriko; Taki, Izumi; Iwata, Satoshi; Morimoto, Chikao] Juntendo Univ, Dept Therapy Dev & Innovat Immune Disorders & Can, Grad Sch Med, Tokyo 1138421, Japan; [Hatano, Ryo; Okumura, Ko] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo 1138421, Japan; [Dang, Nam H.] Univ Florida, Div Hematol Oncol, Gainesville, FL 32610 USA	Morimoto, C (reprint author), Juntendo Univ, Dept Therapy Dev & Innovat Immune Disorders & Can, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	morimoto@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Japan; Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan [S1311011]; Japan Society for the Promotion of Science KAKENHI [26860760]; Japan Society for the Promotion of Science	This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K. Ohnuma and C.M.) and the Ministry of Health, Labor and Welfare, Japan (to C.M.), as well as Foundation of Strategic Research Projects in Private Universities Grant-in-Aid S1311011 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to C.M.). This work was also supported by Japan Society for the Promotion of Science KAKENHI Grant 26860760 (to R.H.) and Japan Society for the Promotion of Science Research Fellowships for Young Scientists (to R.H.).	Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Ohnuma K, 2007, J BIOL CHEM, V282, P10117, DOI 10.1074/jbc.M609157200; Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586; Bettelli E, 1998, J IMMUNOL, V161, P3299; TANAKA T, 1992, J IMMUNOL, V149, P481; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Groux H, 1997, NATURE, V389, P737; Iwasaki Y, 2013, EUR J IMMUNOL, V43, P1063, DOI 10.1002/eji.201242942; Shoemaker J, 2006, J IMMUNOL, V176, P3470; Ohnuma K, 2004, P NATL ACAD SCI USA, V101, P14186, DOI 10.1073/pnas.0405266101; Hutloff A, 1999, NATURE, V397, P263; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Vasanthakumar A, 2013, EUR J IMMUNOL, V43, P882, DOI 10.1002/eji.201343479; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Zheng Y, 2012, J EXP MED, V209, P2157, DOI 10.1084/jem.20120342; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Bengsch B, 2012, J IMMUNOL, V188, P5438, DOI 10.4049/jimmunol.1103801; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Hatano R, 2013, IMMUNOLOGY, V138, P165, DOI 10.1111/imm.12028; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Macon-Lemaitre L, 2005, IMMUNOLOGY, V115, P170, DOI 10.1111/j.1365-2567.2005.02145.x; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187; Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; EGUCHI K, 1989, J IMMUNOL, V142, P4233; FOX DA, 1984, J IMMUNOL, V133, P1250; Hatano R, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-30; Hatano R, 2013, BRIT J HAEMATOL, V162, P263, DOI 10.1111/bjh.12378; Huard B, 1996, EUR J IMMUNOL, V26, P1180, DOI 10.1002/eji.1830260533; Ishii T, 2001, P NATL ACAD SCI USA, V98, P12138, DOI 10.1073/pnas.211439098; Krakauer M, 2006, J NEUROIMMUNOL, V181, P157, DOI 10.1016/j.jneuroim.2006.09.006; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; MORIMOTO C, 1989, J IMMUNOL, V143, P3430; NANUS DM, 1993, P NATL ACAD SCI USA, V90, P7069, DOI 10.1073/pnas.90.15.7069; Ohnuma Kei, 2006, Mod Rheumatol, V16, P3, DOI 10.1007/s10165-005-0452-4; Okamura T, 2012, ANN RHEUM DIS, V71, P96, DOI 10.1136/annrheumdis-2011-200588; Reinhold D, 1997, IMMUNOLOGY, V91, P354, DOI 10.1046/j.1365-2567.1997.d01-2258.x; Stremenova J, 2010, INT J ONCOL, V36, P351, DOI 10.3892/ijo_00000506; To SQ, 2013, BIOCHEM BIOPH RES CO, V433, P96, DOI 10.1016/j.bbrc.2013.02.058	56	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	FEB 1	2015	194	3					960	972		10.4049/jimmunol.1402143		13	Immunology	Immunology	AZ3NK	WOS:000348134000016		
J	Harada, M; Kamimura, D; Arima, Y; Kohsaka, H; Nakatsuji, Y; Nishida, M; Atsumi, T; Meng, J; Bando, H; Singh, R; Sabharwal, L; Jiang, JJ; Kumai, N; Miyasaka, N; Sakoda, S; Yamauchi-Takihara, K; Ogura, H; Hirano, T; Murakami, M				Harada, Masaya; Kamimura, Daisuke; Arima, Yasunobu; Kohsaka, Hitoshi; Nakatsuji, Yuji; Nishida, Makoto; Atsumi, Toru; Meng, Jie; Bando, Hidenori; Singh, Rajeev; Sabharwal, Lavannya; Jiang, Jing-Jing; Kumai, Noriko; Miyasaka, Nobuyuki; Sakoda, Saburo; Yamauchi-Takihara, Keiko; Ogura, Hideki; Hirano, Toshio; Murakami, Masaaki			Temporal Expression of Growth Factors Triggered by Epiregulin Regulates Inflammation Development	JOURNAL OF IMMUNOLOGY			English	Article							T-CELLS; AUTOIMMUNE ARTHRITIS; POSITIVE-FEEDBACK; IL-6 AMPLIFIER; IN-VIVO; INTERLEUKIN-6; GP130; ACTIVATION; RESPONSES; BETA	In this study, we investigated the relationship between several growth factors and inflammation development. Serum concentrations of epiregulin, amphiregulin, betacellulin, TGF-alpha, fibroblast growth factor 2, placental growth factor (PLGF), and tenascin C were increased in rheumatoid arthritis patients. Furthermore, local blockades of these growth factors suppressed the development of cytokine-induced arthritis in mice by inhibiting chemokine and IL-6 expressions. We found that epiregulin expression was early and followed by the induction of other growth factors at different sites of the joints. The same growth factors then regulated the expression of epiregulin at later time points of the arthritis. These growth factors were increased in patients suffering from multiple sclerosis (MS) and also played a role in the development of an MS model, experimental autoimmune encephalomyelitis. The results suggest that the temporal expression of growth factors is involved in the inflammation development seen in several diseases, including rheumatoid arthritis and MS. Therefore, various growth factor pathways might be good therapeutic targets for various inflammatory diseases.	[Harada, Masaya; Kamimura, Daisuke; Arima, Yasunobu; Atsumi, Toru; Meng, Jie; Bando, Hidenori; Singh, Rajeev; Sabharwal, Lavannya; Jiang, Jing-Jing; Kumai, Noriko; Ogura, Hideki; Murakami, Masaaki] Hokkaido Univ, Div Mol Neuroimmunol, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; [Harada, Masaya; Kamimura, Daisuke; Arima, Yasunobu; Atsumi, Toru; Meng, Jie; Bando, Hidenori; Singh, Rajeev; Sabharwal, Lavannya; Jiang, Jing-Jing; Kumai, Noriko; Ogura, Hideki; Murakami, Masaaki] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0600815, Japan; [Harada, Masaya; Kamimura, Daisuke; Arima, Yasunobu; Atsumi, Toru; Meng, Jie; Bando, Hidenori; Sabharwal, Lavannya; Jiang, Jing-Jing; Kumai, Noriko; Ogura, Hideki; Murakami, Masaaki] Osaka Univ, Lab Dev Immunol, Japan Sci & Technol Agcy, Core Res Engn Sci & Technol,Grad Sch Frontier Bio, Osaka 5650871, Japan; [Harada, Masaya; Kamimura, Daisuke; Arima, Yasunobu; Atsumi, Toru; Meng, Jie; Bando, Hidenori; Sabharwal, Lavannya; Jiang, Jing-Jing; Kumai, Noriko; Ogura, Hideki; Murakami, Masaaki] Osaka Univ, Japan Sci & Technol Agcy, Core Res Engn Sci & Technol, Lab Dev Immunol,Grad Sch Med, Osaka 5650871, Japan; [Harada, Masaya; Kamimura, Daisuke; Arima, Yasunobu; Atsumi, Toru; Meng, Jie; Bando, Hidenori; Sabharwal, Lavannya; Jiang, Jing-Jing; Kumai, Noriko; Yamauchi-Takihara, Keiko; Murakami, Masaaki] Osaka Univ, Japan Sci & Technol Agcy, World Premier Int Immunol Frontier Res Ctr, Lab Dev Immunol,Core Res Engn Sci & Technol, Osaka 5650871, Japan; [Kohsaka, Hitoshi; Miyasaka, Nobuyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med & Rheumatol, Tokyo 1138519, Japan; [Nakatsuji, Yuji] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka 5650871, Japan; [Nishida, Makoto; Yamauchi-Takihara, Keiko] Osaka Univ, Hlth Care Ctr, Osaka 5600043, Japan; [Sakoda, Saburo] Toneyama Hosp, Natl Hosp Org, Dept Neurol, Osaka 5600045, Japan; [Hirano, Toshio] Osaka Univ, Core Res Engn Sci & Technol, Japan Sci & Technol Agcy, Osaka, Japan	Murakami, M (reprint author), Hokkaido Univ, Div Mol Neuroimmunol, Inst Med Genet, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	murakami@igm.hokudai.ac.jp		Harada, Masaya/0000-0002-1318-3542	Japan Society for the Promotion of Science (KAKENHI); Japan Science and Technology Agency-Core Research for Engineering, Science, and Technology program; Takeda Research Foundation; Mochida Memorial Foundation; Japan Intractable Diseases Research Foundation; Uehara Foundation; Naito Foundation; Waksman Foundation of Japan; Tokyo Biochemical Research Foundation; Osaka Cancer Research Foundation; Osaka Foundation for the Promotion of Clinical Immunology	This work was supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI; to Y.A., M. H., M. M., and T. H.) and the Japan Science and Technology Agency-Core Research for Engineering, Science, and Technology program (to T. H. and M. M.), the Takeda Research Foundation (to M. M. and Y.A.), the Mochida Memorial Foundation (to Y.A.), the Japan Intractable Diseases Research Foundation (to Y.A.), the Uehara Foundation (to M. M.), the Naito Foundation (to M. M.), the Waksman Foundation of Japan (to M. M.), the Tokyo Biochemical Research Foundation (to M. M.), the Osaka Cancer Research Foundation (to M. M.), and the Osaka Foundation for the Promotion of Clinical Immunology (to M. M.).	Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Murakami M, 2013, CELL REP, V3, P946, DOI 10.1016/j.celrep.2013.01.028; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Lee J, 2012, J IMMUNOL, V189, P1928, DOI 10.4049/jimmunol.1103613; Atsumi T, 2014, CANCER RES, V74, P8, DOI 10.1158/0008-5472.CAN-13-2322; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Sawa S, 2006, J EXP MED, V203, P1459, DOI 10.1084/jem.20052187; Murakami M, 2011, J EXP MED, V208, P103, DOI 10.1084/jem.20100900; Hirano T, 1998, Int Rev Immunol, V16, P249, DOI 10.3109/08830189809042997; Lee J, 2013, INT IMMUNOL, V25, P319, DOI 10.1093/intimm/dxs158; Sadikot Ruxana T., 2008, V477, P383, DOI 10.1007/978-1-60327-517-0_29	17	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	FEB 1	2015	194	3					1039	1046		10.4049/jimmunol.1400562		8	Immunology	Immunology	AZ3NK	WOS:000348134000024		
J	Okamoto, S; Fujiwara, H; Nishimori, H; Matsuoka, K; Fujii, N; Kondo, E; Tanaka, T; Yoshimura, A; Tanimoto, M; Maeda, Y				Okamoto, Sachiyo; Fujiwara, Hideaki; Nishimori, Hisakazu; Matsuoka, Ken-ichi; Fujii, Nobuharu; Kondo, Eisei; Tanaka, Takehiro; Yoshimura, Akihiko; Tanimoto, Mitsune; Maeda, Yoshinobu			Anti-IL-12/23 p40 Antibody Attenuates Experimental Chronic Graft-versus-Host Disease via Suppression of IFN-gamma/IL-17-Producing Cells	JOURNAL OF IMMUNOLOGY			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; BONE-MARROW-TRANSPLANTATION; HUMAN TH17 CELLS; INTERFERON-GAMMA; T-CELLS; DOUBLE-BLIND; AUTOIMMUNE INFLAMMATION; MEDIATED PATHOLOGY; T(H)17 CELLS; TGF-BETA	Chronic graft-versus-host disease (GVHD) is a major cause of late death and morbidity after allogeneic hematopoietic cell transplantation. Recently, in addition to Th2 cells, Th1 and Th17 cells have been shown to contribute to chronic GVHD progression. IL-12 induces Th1 cells and IL-23 plays a role in stabilizing and/or amplifying Th17 cells, as well as in inducing IFN-gamma/IL-17 double-producing cells. Because mAb targeting the p40 subunit common to both IL-12 and IL-23 can inhibit both IL-12R and IL-23R-mediated signaling, we investigated the effects of anti-p40 mAb on a well-defined chronic GVHD mice model. Treatment of anti-p40 mAb in allogeneic recipients significantly reduced the severity of clinical and pathological chronic GVHD. Intracellular staining revealed that IFN-gamma single-positive (IL-17(-)) and IFN-gamma/IL-17 double-positive cells were suppressed in anti-p40 mAb-treated allogeneic recipients compared with control recipients. The cytokine levels of IFN-gamma and IL-17 were also decreased in serum from anti-p40 mAb-treated allogeneic recipients. T-bet expression of donor IL-17(+) CD4(+) T cells was reduced significantly in anti-p40 mAb-treated recipients, and this reduction in T-bet expression was associated with IL-22 production by donor T cells. These results suggested that anti-p40 mAb attenuated chronic GVHD via suppression of IFN-gamma/IL-17-producing cells, and that targeting the IL-12/IL-23 pathway may represent a promising therapeutic strategy for preventing and treating chronic GVHD.	[Okamoto, Sachiyo; Fujiwara, Hideaki; Nishimori, Hisakazu; Matsuoka, Ken-ichi; Fujii, Nobuharu; Kondo, Eisei; Tanimoto, Mitsune; Maeda, Yoshinobu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama 7000914, Japan; [Tanaka, Takehiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7000914, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1088345, Japan	Maeda, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7000914, Japan.	yosmaeda@md.okayama-u.ac.jp	Yoshimura, Akihiko/K-5515-2013		Japan Society for Promotion of Science KAKENHI Grant [24591424]; Health and Labor Science Research grants	This work was supported by Japan Society for Promotion of Science KAKENHI Grant 24591424 (to Y.M.) and Health and Labor Science Research grants (to Y.M.).	Hill GR, 2010, BLOOD, V116, P819, DOI 10.1182/blood-2009-11-256495; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Becker C, 2006, J IMMUNOL, V177, P2760; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Wolff D, 2011, BIOL BLOOD MARROW TR, V17, P1, DOI 10.1016/j.bbmt.2010.05.011; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Wang Y, 2014, IMMUNITY, V40, P355, DOI 10.1016/j.immuni.2014.01.002; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Ochs LA, 1996, BONE MARROW TRANSPL, V17, P1085; Suryani S, 2007, J NEUROIMMUNOL, V183, P96, DOI 10.1016/j.jneuroim.2006.11.023; Nishimori H, 2012, BLOOD, V119, P285, DOI 10.1182/blood-2011-01-332478; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Akpek G, 2001, BLOOD, V97, P1219, DOI 10.1182/blood.V97.5.1219; Korholz D, 1997, BONE MARROW TRANSPL, V19, P691, DOI 10.1038/sj.bmt.1700718; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sugiyama H, 2014, BIOL BLOOD MARROW TR, V20, P183, DOI 10.1016/j.bbmt.2013.11.018; Dander E, 2009, TRANSPLANTATION, V88, P1261, DOI 10.1097/TP.0b013e3181bc267e; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Chen X, 2007, BLOOD, V110, P3804, DOI 10.1182/blood-2007-05-091074; Ritchie D, 2005, BIOL BLOOD MARROW TR, V11, P706, DOI 10.1016/j.bbmt.2005.05.015; Imanguli MM, 2009, BLOOD, V113, P3620, DOI 10.1182/blood-2008-07-168351; McInnes IB, 2013, LANCET, V382, P780, DOI 10.1016/S0140-6736(13)60594-2; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Zhou LX, 2007, J INVEST DERMATOL, V127, P281, DOI 10.1038/sj.jid.5700517; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Baker KS, 2004, BLOOD, V104, P1898, DOI 10.1182/blood-2004-03-1010; Loh J., 2006, J EXP MED, V203, P2785; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Teshima T, 2008, BIOL BLOOD MARROW TR, V14, P142, DOI 10.1016/j.bbmt.2007.10.023; Zhao DC, 2011, J IMMUNOL, V186, P856, DOI 10.4049/jimmunol.1002195	39	3	3	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	FEB 1	2015	194	3					1357	1363		10.4049/jimmunol.1400973		7	Immunology	Immunology	AZ3NK	WOS:000348134000055		
J	Spyrou, LA; Aravas, N				Spyrou, L. A.; Aravas, N.			Thermomechanical Modeling of Laser Spot Welded Solar Absorbers	JOURNAL OF MANUFACTURING SCIENCE AND ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						solar absorber; laser spot welding; residual stress; welding distortion; supercooling; finite element analysis	FINITE-ELEMENT SIMULATION; NUMERICAL-SIMULATION; RESIDUAL-STRESS; ALUMINUM; TEMPERATURE; PREDICTION; DISTORTION; SHEETS; JOINTS; COPPER	A finite element (FE) approach is developed to investigate the laser spot welding (LSW) of flat-plate solar absorbers and the stress and distortion fields that develop after fabrication and during operation. Numerical calculations at two different levels are carried out. At a microscopic scale, the details of a spot weld are analyzed. At a macroscopic level, a global approach is used to simulate the joining of the pipeline to the absorber plate and the "restoration" (flattening) process of the absorber. The simulated welding-induced distortion is compared with experimental measurements. The thermomechanical behavior of a solar absorber under working conditions is also studied and operational stresses and the critical locations for structural failure are reported.	[Spyrou, L. A.] Inst Res & Technol Thessaly, Ctr Res & Technol Hellas CERTH, Volos 38333, Greece; [Aravas, N.] Univ Thessaly, Dept Mech Engn, Volos 38334, Greece; [Aravas, N.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Spyrou, LA (reprint author), Inst Res & Technol Thessaly, Ctr Res & Technol Hellas CERTH, Volos 38333, Greece.	lspyrou@ireteth.certh.gr; aravas@mie.uth.gr			Greek General Secretariat for Research and Technology (GSRT) via a "Synergasia" project	This research was supported by the Greek General Secretariat for Research and Technology (GSRT) via a "Synergasia" project. The authors would like to thank Dr. Elias Hontzopoulos of Prime Laser Technology S.A. for the welding experiments and fruitful discussions. Thanks go also to Professor G. Haidemenopoulos, Dr. A. Zervaki, and Dr. E. Kamoutsi of the University of Thessaly for the metallographic data of spot welds and the thermodynamics data for the supercooling effect.	ABAQUS/Standard, 2012, ABAQUS STAND 2012 VE; Agnihotri O.P., 1981, SOLAR SELECTIVE SURF; [Anonymous], 2012, MAT PROP DAT MPDB VE; Deng D, 2009, MATER DESIGN, V30, P359, DOI 10.1016/j.matdes.2008.04.052; Schubert E, 2001, J MATER PROCESS TECH, V115, P2, DOI 10.1016/S0924-0136(01)00756-7; Andersson JO, 2002, CALPHAD, V26, P273, DOI 10.1016/S0364-5916(02)00037-8; Tan WD, 2012, J MANUF SCI E-T ASME, V134, DOI 10.1115/1.4007101; Farahmand P, 2014, OPT LASER TECHNOL, V63, P154, DOI 10.1016/j.optlastec.2014.04.016; Spina R, 2007, J MATER PROCESS TECH, V191, P215, DOI 10.1016/j.jmatprotec.2007.03.087; Darcourt C, 2004, J PHYS IV, V120, P785, DOI 10.1051/jp4:2004120091; Moraitis GA, 2008, J MATER PROCESS TECH, V198, P260, DOI 10.1016/j.jmatprotec.2007.07.013; Tsirkas SA, 2003, J MATER PROCESS TECH, V134, P59, DOI 10.1016/S0924-0136(02)00921-4; Shanmugam NS, 2010, MATER DESIGN, V31, P4528, DOI 10.1016/j.matdes.2010.03.057; Yilbas BS, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4024155; SIMO JC, 1990, INT J NUMER METH ENG, V29, P1595, DOI 10.1002/nme.1620290802; Zhang Y, 2013, OPT LASER TECHNOL, V48, P405, DOI 10.1016/j.optlastec.2012.10.039; Wang HL, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4024818; Sabbaghzadeh J, 2008, OPT LASER TECHNOL, V40, P289, DOI 10.1016/j.optlastec.2007.05.005; Tan HD, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4023270; Marimuthu S, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4023240; Kalogirou SA, 2004, PROG ENERG COMBUST, V30, P231, DOI 10.1016/j.pecs.2004.02.001; Balasubramanian K R, 2008, Advances in Production Engineering & Management, V3; Brandal G, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4025495; Chalmers B., 1964, PRINCIPLES SOLIDIFIC; Chang WS, 2001, METALL MATER TRANS B, V32, P723, DOI 10.1007/s11663-001-0126-3; De A, 2003, SCI TECHNOL WELD JOI, V8, P377, DOI 10.1179/136217103225005570; Duffie JA, 2006, SOLAR ENG THERMAL PR; Durr U., 2004, P 23 INT C APPL LAS; Frewin MR, 1999, WELD J, V78, P15; Han Q, 2012, J MATER PROCESS TECH, V212, P1116, DOI 10.1016/j.jmatprotec.2011.12.022; Kang DH, 2001, FINITE ELEM ANAL DES, V37, P749, DOI 10.1016/S0168-874X(01)00042-7; Lee D, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.3075869; Lee D, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.3006321; Ma C, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4025819; Mai TA, 2004, MAT SCI ENG A-STRUCT, V374, P224, DOI 10.1016/j.msea.2004.02.025; Martinson P, 2009, MATER DESIGN, V30, P3351, DOI 10.1016/j.matdes.2009.03.041; MATHEWSO.AG, 1972, J PHYS F MET PHYS, V2, P403, DOI 10.1088/0305-4608/2/2/030; Atabaki MM, 2014, OPT LASER TECHNOL, V59, P68, DOI 10.1016/j.optlastec.2013.12.008; PELLS GP, 1969, J PHYS PART C SOLID, V2, P1835, DOI 10.1088/0022-3719/2/10/318; Sammons PM, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4025061; Shi B, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4025832; Stevens V, 2012, J MANUF SCI E-T ASME, V134, DOI 10.1115/1.4005807; Voothaluru R., 2013, ASME J MANUF SCI ENG, V134; Xu WX, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4025579; Xue ZQ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/49/495501; Zain-ul-Abdein M, 2009, J MATER PROCESS TECH, V209, P2907, DOI 10.1016/j.jmatprotec.2008.06.051	46	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1087-1357	1528-8935		J MANUF SCI E-T ASME	J. Manuf. Sci. Eng.-Trans. ASME	FEB	2015	137	1							011016	10.1115/1.4028197		15	Engineering, Manufacturing; Engineering, Mechanical	Engineering	AZ3IS	WOS:000348121400016		
J	Maekawa, K; Ishida, T; Chijiwa, N; Fujiyama, C				Maekawa, K.; Ishida, T.; Chijiwa, N.; Fujiyama, C.			Multiscale Coupled-Hygromechanistic Approach to the Life-Cycle Performance Assessment of Structural Concrete	JOURNAL OF MATERIALS IN CIVIL ENGINEERING			English	Article						Multiscale analysis; Micropores; Prestressed concrete viaducts; RC slabs; Fatigue; Creep; Shear capacity; Self-desiccation	CRACKED CONCRETE; PERMEABILITY; SIMULATION; SHRINKAGE; STRENGTH; MODEL	Moisture and cracks are scourges of structural concrete, and understanding the multiscale interactions between the two is key to determining long-term durability performance. This paper uses three-dimensional integrated micromaterial structural modeling to address moisture migration/balance and associated volume changes of concrete with creep in prestressed concrete bridge viaducts that are experiencing excessive deflections. It is found that moisture migration-related deflections driven by the capillary surface tension and disjoining pressures in cement micropores account for 25 to 45% of the macroscopic deflections. These apparent kinematics can be approximated by adding the moisture-related time-dependent deflections to the mechanistic-induced creep by external loads. This paper also addresses water-crack interaction in cracked RC bridge decks under moving loads in view of the coupled hygromechanics. It is found that the water presence on the upper deck parts, when subjected to high-speed traffic, can shorten the fatigue life of the deck by one-and-a-half order of life span. This reduction in life is discussed in terms of high-water pressure developing over large numbers of wheel passages, in addition to the reduced shear transfer along crack planes.	[Maekawa, K.; Ishida, T.] Univ Tokyo, Dept Civil Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Chijiwa, N.] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 1520033, Japan; [Fujiyama, C.] Hosei Univ, Dept Civil & Environm Engn, Shinjuku Ku, Tokyo 1028160, Japan	Maekawa, K (reprint author), Univ Tokyo, Dept Civil Engn, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.	koichi_maekawa@civil.t.u-tokyo.ac.jp			JSPS KAKENHI [23226011]; Construction Technology Research and Development Subsidy Program	This study was financially supported by JSPS KAKENHI Grant No. 23226011 and the Construction Technology Research and Development Subsidy Program established by the Ministry of Land, Infrastructure, Transport and Tourism of Japan.	Wang KJ, 1997, CEMENT CONCRETE RES, V27, P381, DOI 10.1016/S0008-8846(97)00031-8; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Maekawa K, 2006, J ADV CONCR TECHNOL, V4, P445, DOI 10.3151/jact.4.445; Aldea CM, 1999, MATER STRUCT, V32, P370, DOI 10.1007/BF02479629; Asamoto S., 2006, J ADV CONCR TECHNOL, V4, P301, DOI 10.3151/jact.4.301; Award M. E., 1974, ACI PUBLICATION, VSP-41, P1; Bazant Z. P., 2010, CONCRETE INT, V32, P44; Biot M. A., 1962, J APPL PHYS, V33, P1483; Burdet O., 2010, P 3 FIB INT C FIB WA, V663, P108; Daly A. F., 2000, BRIDGE MANAGEMENT 4, P552; Delannoy Y., 1990, CAVITATION MULTI FED, V98, P153; Gebreyouhannes E, 2011, J ADV CONCR TECHNOL, V9, P73, DOI 10.3151/jact.9.73; Hata Y., 1993, P FIP S, P305; Kasper E. P., 1997, UCBSEMM9709 DEP CIV; Lepech M., 2005, P INT C FRACT; Li VC, 2003, J ADV CONCR TECHNOL, V1, P215, DOI DOI 10.3151/JACT.1.215; Maekawa K., 1999, MODELING CONCRETE PE; Maekawa K, 2011, CEMENT CONCRETE RES, V41, P1310, DOI 10.1016/j.cemconres.2011.03.021; Maekawa K, 2003, NONLINEAR MECH REINF; Maekawa K, 2013, ENG COMPUTATION, V30, P825, DOI 10.1108/EC-06-2012-0125; Maekawa K., 2008, MULTISCALE MODELING; Matsui S., 1987, P JCI, V9, P627; Mitamura H., 2007, DEV HIGH PERFORMANCE, V130; National Institute for Land and Infrastructure Management (NILIM), 2011, 645 NILIM, pH21; Ohno M, 2012, J ADV CONCR TECHNOL, V10, P47, DOI 10.3151/jact.10.47; Sagan M., 2012, MAT STRUCTURES ADV I, P1171; Sato R, 2008, J ADV CONCR TECHNOL, V6, P45, DOI 10.3151/jact.6.45; Sinmura A., 1997, MATER STRUCT, V30, P72; Solwik V., 2000, J STRUCT ENG, P235, DOI [10.1061/(ASCE)0733-9445(2000)126:2(235), DOI 10.1061/(ASCE)0733-9445(2000)126:2(235)]; Suryanto B, 2010, ACI MATER J, V107, P450	30	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0899-1561	1943-5533		J MATER CIVIL ENG	J. Mater. Civ. Eng.	FEB	2015	27	2							A4014003	10.1061/(ASCE)MT.1943-5533.0000984		9	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	AZ3TX	WOS:000348150600003		
J	Shrestha, J; Ueda, T; Zhang, DW				Shrestha, Justin; Ueda, Tamon; Zhang, Dawei			Durability of FRP Concrete Bonds and Its Constituent Properties under the Influence of Moisture Conditions	JOURNAL OF MATERIALS IN CIVIL ENGINEERING			English	Article						Fiber-reinforced polymer (FRP); Concrete; Bond; Moisture; Interface; Continuous immersion; Wet-dry cycles	MECHANICAL-PROPERTIES; FRACTURE ENERGY; EPOXY-RESINS; TEMPERATURE; COMPOSITES; INTERFACE; WATER; ENVIRONMENTS; DIFFUSION; BEHAVIOR	Strengthening by fiber-reinforced polymers (FRPs) is one of the most common solutions to the ageing infrastructures. However, long-term durability of such systems under different environmental conditions needs to be understood properly before widely adopting these methods in the field. This paper presents research outcomes from an experimental program carried out to determine the influence of moisture on the durability of the bond between FRP and concrete along with its constituent materials. Performance was evaluated through single lap shear bond tests and various kinds of tests on the resin samples, including water absorption, mechanical characterization, and glass transition temperature (T-g) analysis. The specimens were exposed to continuous water immersion and wet-dry cycles for a maximum period of up to 24 and 18 months, respectively. The results show some deterioration on the material and the bond properties in both exposure conditions. The bond strength decreased up to 32 and 12% for high-strength and normal-strength concrete substrates, respectively, after continuous immersion, indicating the key role of the substrate in the durability of bonds. As a result of exposure, failure propagated towards the primer-concrete interface region. The failure mode changed from concrete cohesion to primer-concrete mixed failure for normal-strength concrete and from mixed failure to complete adhesion failure in case of high-strength concrete. These shifts in failure patterns are mainly due to destruction of the adhesion bond caused by water molecules at the interface. However, it is found that the loss of the adhesion bond is somehow compensated by the good mechanical interlocking obtained by proper surface roughness condition of the substrate. Finally, the effects of water were also investigated in interfacial bond stress-slip laws and fracture energies. (c) 2014 American Society of Civil Engineers.	[Shrestha, Justin] Hokkaido Univ, Div Engn & Policy Sustainable Environm, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Ueda, Tamon] Hokkaido Univ, Div Engn & Policy Sustainable Environm, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Zhang, Dawei] Zhejiang Univ, Dept Civil Engn, Coll Civil Engn & Architecture, Hangzhou 310058, Zhejiang, Peoples R China	Zhang, DW (reprint author), Zhejiang Univ, Dept Civil Engn, Coll Civil Engn & Architecture, Hangzhou 310058, Zhejiang, Peoples R China.	justin@eng.hokudai.ac.jp; ueda@eng.hokudai.ac.jp; dwzhang@zju.edu.cn			 [22246058]	The authors would like to acknowledge contributions made by Mr. Atsuya Komori and Mr. Atushi Kitami for this research. The authors are also grateful to Nippon Steel and Materials Co., Ltd., for providing necessary epoxy resins and carbon fiber sheets for this study. This study was conducted with the financial aid provided by the Grant-in-Aid for Scientific Research (A) No. 22246058.	Al-Tamimi A., 2011, BUILT HUMAN ENV REV, V4, P33; Ouyang ZY, 2008, J COMPOS CONSTR, V12, P425, DOI 10.1061/(ASCE)1090-0268(2008)12:4(425); Au C, 2006, J COMPOS CONSTR, V10, P35, DOI 10.1061/(ASCE)1090-0268(2006)10:1(35); Leone M, 2009, COMPOS PART B-ENG, V40, P85, DOI 10.1016/j.compositesb.2008.06.004; Tuakta C, 2011, J COMPOS CONSTR, V15, P743, DOI 10.1061/(ASCE)CC.1943-5614.0000210; LEFEBVRE DR, 1991, J ADHES SCI TECHNOL, V5, P201, DOI 10.1163/156856191X00152; Benzarti K, 2011, CONSTR BUILD MATER, V25, P523, DOI 10.1016/j.conbuildmat.2010.08.003; Zhou JM, 1999, POLYMER, V40, P5505, DOI 10.1016/S0032-3861(98)00790-3; Sciolti MS, 2010, J COMPOS CONSTR, V14, P823, DOI 10.1061/(ASCE)CC.1943-5614.0000132; Tuakta C, 2011, COMPOS PART B-ENG, V42, P145, DOI 10.1016/j.compositesb.2010.11.002; [Anonymous], 2004, C39 ASTM; Toutanji H, 2001, COMPOS STRUCT, V53, P457, DOI 10.1016/S0263-8223(01)00057-5; Dai JG, 2010, J COMPOS CONSTR, V14, P834, DOI 10.1061/(ASCE)CC.1943-5614.0000142; Choi S, 2012, J COMPOS CONSTR, V16, P10, DOI 10.1061/(ASCE)CC.1943-5614.0000233; Karbhari VM, 2009, COMPOS PART A-APPL S, V40, P1353, DOI 10.1016/j.compositesa.2009.01.011; Toutanji HA, 1997, CEMENT CONCRETE COMP, V19, P351, DOI 10.1016/S0958-9465(97)00028-0; BELLENGER V, 1989, J MATER SCI, V24, P63, DOI 10.1007/BF00660933; WRIGHT WW, 1981, COMPOSITES, V12, P201, DOI 10.1016/0010-4361(81)90505-X; Yang QA, 2008, J APPL POLYM SCI, V107, P2607, DOI 10.1002/app.27287; Ueda T, 2005, PROG STRUCT ENG MAT, V7, P27, DOI 10.1002/jose.187; Abanilla MA, 2006, COMPOS PART B-ENG, V37, P200, DOI 10.1016/j.compositesb.2005.05.016; ASTM, 2004, E135603 ASTM; Au C., 2005, THESIS MIT CAMBRIDGE; BAZANT ZP, 1988, ACI MATER J, V85, P262; Choi S, 2010, ACS APPL MATER INTER, V2, P934, DOI 10.1021/am9009346; Dai J., 2003, THESIS HOKKAIDO U SA; Djouani F, 2011, CONSTR BUILD MATER, V25, P411, DOI 10.1016/j.conbuildmat.2010.02.035; Dolan C. W., 2010, DESIGN GUIDELINES DU; Frigione M, 2006, J MATER CIVIL ENG, V18, P715, DOI 10.1061/(ASCE)0899-156](2006)18:5(715); Japanese Standards Association (JSA), 1995, JISK7113 JSA; Japanese Standards Association (JSA), 1999, JISK6850 JSA; Karbhari VM, 1997, COMPOS STRUCT, V40, P293, DOI 10.1016/S0263-8223(98)00031-2; Konvalinka P., 2002, EFFECT MOISTURE CONT, V5, P59; Lau D., 2009, THESIS MIT CAMBRIDGE; Mays G., 1992, ADHESIVES CIVIL ENG; Ouyang ZY, 2009, J COMPOS CONSTR, V13, P53, DOI 10.1061/(ASCE)1090-0268(2009)13:1(53); Petrie E. M., 2006, EPOXY ADHESIVE FORMU; Saadatmanesh H, 2010, ACI MATER J, V107, P267; Shoukry SN, 2011, CONSTR BUILD MATER, V25, P688, DOI 10.1016/j.conbuildmat.2010.07.020; Subramaniam KV, 2008, ENG FRACT MECH, V75, P3924, DOI 10.1016/j.engfracmech.2007.12.016; Tu L, 1996, ACI MATER J, V93, P26	41	1	1	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0899-1561	1943-5533		J MATER CIVIL ENG	J. Mater. Civ. Eng.	FEB	2015	27	2							A4014009	10.1061/(ASCE)MT.1943-5533.0001093		14	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	AZ3TX	WOS:000348150600009		
J	Hosokawa, M; Arai, T; Masuda-Suzukake, M; Kondo, H; Matsuwaki, T; Nishihara, M; Hasegawa, M; Akiyama, H				Hosokawa, Masato; Arai, Tetsuaki; Masuda-Suzukake, Masami; Kondo, Hiromi; Matsuwaki, Takashi; Nishihara, Masugi; Hasegawa, Masato; Akiyama, Haruhiko			Progranulin Reduction Is Associated With Increased Tau Phosphorylation in P301L Tau Transgenic Mice	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Alzheimer disease; Granulin; Phosphorylation; Progranulin; Tau	FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; CORTICOBASAL SYNDROME; EPITHELIN PRECURSOR; MUTATION CARRIERS; GROWTH-FACTOR; HOST-DEFENSE; INFLAMMATION; VARIABILITY; PHENOTYPE	Granulin (GRN) mutations have been identified in familial frontotemporal lobar degeneration patients with ubiquitin pathology. GRN transcript haploinsufficiency is proposed as a disease mechanism that leads to the loss of functional progranulin (PGRN) protein. Thus, these mutations are strongly involved in frontotemporal lobar degeneration pathogenesis. Moreover, recent findings indicate that GRN mutations are associated with other neurodegenerative disorders with tau pathology, including Alzheimer disease and corticobasal degeneration. To investigate the potential influence of a decline in PGRN protein on tau accumulation, P301L tau transgenic mice were interbred with GRN-deficient mice, producing P301L tau transgenic mice harboring the GRN hemizygote. Brains were collected from 13- and 19-month old mice, and sequential extraction of proteins, immunoblotting, and immunohistochemical analyses were performed. Immunoblotting analysis revealed that tau phosphorylation was accelerated in the Tris-saline soluble fraction of 13-month-old and in the sarkosyl-insoluble fraction of 19-month-old P301L tau/GRN hemizygotes compared with those in fractions from P301L tau transgenic mice. Activity of cyclin-dependent kinases was also upregulated in the brains of P301L tau/GRN hemizygote mice. Although the mechanisms involved in these findings remain unknown, our data suggest that a reduction in PGRN protein might contribute to phosphorylation and intraneuronal accumulation of tau.	[Hosokawa, Masato; Arai, Tetsuaki; Akiyama, Haruhiko] Tokyo Metropolitan Inst Med Sci, Dementia Res Project, Setagaya Ku, Tokyo 1568506, Japan; [Masuda-Suzukake, Masami; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Neuropathol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan; [Kondo, Hiromi] Tokyo Metropolitan Inst Med Sci, Histol Ctr, Setagaya Ku, Tokyo 1568506, Japan; [Arai, Tetsuaki] Univ Tsukuba, Fac Med, Dept Neuropsychiat, Div Clin Med, Tsukuba, Ibaraki, Japan; [Matsuwaki, Takashi; Nishihara, Masugi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Physiol, Bunkyo Ku, Tokyo, Japan	Hosokawa, M (reprint author), Tokyo Metropolitan Inst Med Sci, Dept Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	hosokawa-ms@igakuken.or.jp			Japan Society for the Promotion of Science(JSPS KAKENHI) [21591536, 24591738]	This research was partially supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI grant 21591536 to Haruhiko Akiyama and 24591738 to Masato Hosokawa). Additional funding for our study was supplied by our institute.	Masellis M, 2006, BRAIN, V129, P3115, DOI 10.1093/brain/awl276; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Kelley BJ, 2009, NEUROBIOL AGING, V30, P739, DOI 10.1016/j.neurobiolaging.2007.08.022; Perry DC, 2013, JAMA NEUROL, V70, P774, DOI 10.1001/2013.jamaneurol.393; Lewis J, 2000, NAT GENET, V25, P402; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S14744422(07)70221-1; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Lee MJ, 2011, NEURODEGENER DIS, V8, P216, DOI 10.1159/000322538; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Carecchio M, 2009, J NEUROL SCI, V287, P291, DOI 10.1016/j.jns.2009.07.011; Le Ber I, 2008, BRAIN, V131, P732, DOI 10.1093/brain/awn012; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kelley BJ, 2010, ARCH NEUROL-CHICAGO, V67, P171, DOI 10.1001/archneurol.2010.113; Leverenz JB, 2007, BRAIN, V130, P1360, DOI 10.1093/brain/awm069; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Pickford F, 2011, AM J PATHOL, V178, P284, DOI 10.1016/j.ajpath.2010.11.002; Cortini F, 2008, EUR J NEUROL, V15, P1111, DOI 10.1111/j.1468-1331.2008.02266.x; Fenoglio C, 2009, J ALZHEIMERS DIS, V18, P603, DOI 10.3233/JAD-2009-1170; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Mukherjee O, 2006, ANN NEUROL, V60, P314, DOI 10.1002/ama.20963; Brouwers N, 2007, ARCH NEUROL-CHICAGO, V64, P1436, DOI 10.1001/archneur.64.10.1436; Spina S, 2007, J NEUROPATH EXP NEUR, V66, P892, DOI 10.1097/nen.0b013e3181567873	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	FEB	2015	74	2					158	165				8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AZ4IA	WOS:000348183600006		
J	Sato, M; Iizuka, T; Watanabe, A; Iwase, N; Otsuka, H; Terada, N; Fujisawa, M				Sato, M.; Iizuka, T.; Watanabe, A.; Iwase, N.; Otsuka, H.; Terada, N.; Fujisawa, M.			Electromyogram biofeedback training for daytime clenching and its effect on sleep bruxism	JOURNAL OF ORAL REHABILITATION			English	Article						awake bruxism; sleep bruxism; biofeedback; temporal muscle; electromyography; cognitive behavioural therapy	ORAL SPLINT DEVICES; TEMPOROMANDIBULAR DISORDERS; OCCLUSAL; EFFICACY; PARAFUNCTIONS; ATTRITION; STRESS; TEETH; RISK; BITE	Bruxism contributes to the development of temporomandibular disorders as well as causes dental problems. Although it is an important issue in clinical dentistry, no treatment approaches have been proven effective. This study aimed to use electromyogram (EMG) biofeedback (BF) training to improve awake bruxism (AB) and examine its effect on sleep bruxism (SB). Twelve male participants (mean age, 268 +/- 25years) with subjective symptoms of AB or a diagnosis of SB were randomly divided into BF (n=7) and control (CO, n=5) groups to undergo 5-h daytime and night-time EMG measurements for three consecutive weeks. EMG electrodes were placed over the temporalis muscle on the habitual masticatory side. Those in the BF group underwent BF training to remind them of the occurrence of undesirable clenching activity when excessive EMG activity of certain burst duration was generated in week 2. Then, EMGs were recorded at week 3 as the post-BF test. Those in the CO group underwent EMG measurement without any EMG BF training throughout the study period. Although the number of tonic EMG events did not show statistically significant differences among weeks 1-3 in the CO group, events in weeks 2 and 3 decreased significantly compared with those in week 1, both daytime and night-time, in the BF group (P<005, Scheffe's test). This study results suggest that EMG BF to improve AB tonic EMG events can also provide an effective approach to regulate SB tonic EMG events.	[Sato, M.; Iizuka, T.; Watanabe, A.; Iwase, N.; Otsuka, H.; Fujisawa, M.] Meikai Univ, Sch Dent, Div Fixed Prosthodont, Dept Restorat & Biomat Sci, Sakado, Saitama 3500283, Japan; [Terada, N.] Toyo Univ, Biomed Engn Res Ctr, Kawagoe, Saitama, Japan	Fujisawa, M (reprint author), Meikai Univ, Sch Dent, Div Fixed Prosthodont, Dept Restorat & Biomat Sci, 1-1 Keyakidai, Sakado, Saitama 3500283, Japan.	m-fujisawa@dent.meikai.ac.jp			Japan Society for the Promotion of Science [23390447]; Meikai University Miyata Research Grant (E)	This research was supported by a grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science to M.F. (No. 23390447) and by Meikai University Miyata Research Grant (E) to M.S.	Iida T, 2010, EUR J ORAL SCI, V118, P635, DOI 10.1111/j.1600-0722.2010.00784.x; Dube C, 2004, J DENT RES, V83, P398; Harada T, 2006, J ORAL REHABIL, V33, P482, DOI 10.1111/j.1365-2842.2005.01576.x; Fujisawa M, 2013, J ORAL REHABIL, V40, P731, DOI 10.1111/joor.12087; Jain V, 2012, J PROSTHODONT RES, V56, P287, DOI 10.1016/j.jpor.2012.05.002; Gallo LM, 1999, J DENT RES, V78, P1436; Manfredini D, 2009, J OROFAC PAIN, V23, P153; Dao TTT, 1998, CRIT REV ORAL BIOL M, V9, P345; Lavigne GJ, 1996, J DENT RES, V75, P546; Kreiner M, 2001, J AM DENT ASSOC, V132, P770; van der Zaag J, 2005, J OROFAC PAIN, V19, P151; Jadidi F, 2008, J ORAL REHABIL, V35, P171, DOI 10.1111/j.1365-2842.2007.01781.x; Lobbezoo F, 2013, J ORAL REHABIL, V40, P2, DOI 10.1111/joor.12011; KARDACHI BJR, 1978, J PERIODONTOL, V49, P367; Michelotti A, 2010, J ORAL REHABIL, V37, P157, DOI 10.1111/j.1365-2842.2009.02033.x; Winocur E, 2011, J ORAL REHABIL, V38, P3, DOI 10.1111/j.1365-2842.2010.02118.x; Rompre PH, 2007, J DENT RES, V86, P837; Clark Glenn T., 1997, Journal of Orofacial Pain, V11, P298; Gohdo Y, 2004, PROSTHODONT RES PRAC, V3, P46, DOI 10.2186/prp.3.46; Hauri JP, 2005, INT CLASSIFICATION S, P189; Carra Maria Clotilde, 2012, Dent Clin North Am, V56, P387, DOI 10.1016/j.cden.2012.01.003; Iida T, 2012, EXP BRAIN RES, V216, P375, DOI 10.1007/s00221-011-2941-3; Johansson Anders, 2011, J Prosthodont Res, V55, P127, DOI 10.1016/j.jpor.2011.02.004; Kato Takafumi, 2003, Alpha Omegan, V96, P24; Kato T, 2013, J PROSTHODONT RES, V57, P69, DOI 10.1016/j.jpor.2013.03.001; Nishigawa K, 2003, J PROSTHET DENT, V89, P412, DOI 10.1067/mpr.2003.82; NYQUIST H, 1928, T AIEE, V47, P617; Ogawa Y, 2005, DENT JPN, V41, P54; Ohira H, 2009, NEUROIMAGE, V47, P897, DOI 10.1016/j.neuroimage.2009.04.088; REDING GR, 1966, J DENT RES, V45, P1198, DOI 10.1177/00220345660450042701; RUGH JD, 1981, J PERIODONTOL, V52, P263; Seligman DA, 2000, J PROSTHET DENT, V83, P76, DOI 10.1016/S0022-3913(00)70091-6; Serra-Negra Júnia Maria, 2012, Braz Dent J, V23, P746, DOI 10.1590/S0103-64402012000600020; Van Selms MKA, 2008, J ORAL REHABIL, V35, P45, DOI 10.1111/j.1365-2842.2007.01795.x; Watanabe Akira, 2011, J Prosthodont Res, V55, P75, DOI 10.1016/j.jpor.2010.09.003; Wieselmann-Penkner K, 2001, J ORAL REHABIL, V28, P849, DOI 10.1046/j.1365-2842.2001.00748.x	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	FEB	2015	42	2					83	89		10.1111/joor.12233		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AZ7WN	WOS:000348425900001		
J	Mikamo, S; Kodama, N; Pan, Q; Maeda, N; Minagi, S				Mikamo, S.; Kodama, N.; Pan, Q.; Maeda, N.; Minagi, S.			Effect of nasal speaking valve on speech intelligibility under velopharyngeal incompetence: a questionnaire survey	JOURNAL OF ORAL REHABILITATION			English	Article						velopharyngeal incompetence; articulation; speech intelligibility; questionnaires; amyotrophic lateral sclerosis; cerebrovascular disease	PALATAL LIFT PROSTHESES	Velopharyngeal incompetence is known as a contributing factor to speech disorders. Suwaki etal. reported that nasal speaking valve (NSV) could improve dysarthria by regulating nasal emission utilising one-way valve. However, disease or condition which would be susceptible to treatment by NSV has not been clarified yet. This study aimed to evaluate the effect of NSV by questionnaire survey using ready-made NSV. Subjects were recruited through the internet bulletin, and NSV survey set was sent to the applicant. Sixty-six participants, who agreed to participate in this study, used NSV and mailed back the questionnaire which included self-evaluation and third-party evaluation of speech intelligibility. Statistical analysis revealed that the use of NSV resulted in significant speech intelligibility improvement in both self-evaluation and third-party evaluation (P<001). Regarding the type of underlying disease of dysarthria, significant effect of NSV on self-evaluation of speech intelligibility could be observed in cerebrovascular disease and neurodegenerative disease (P<001) and that on third-party evaluation in neurodegenerative disease (P<001). Eighty-six percent of subjects showed improvement of speech intelligibility by shutting up nostrils by fingers, and the significant effect of NSV on both self-evaluation and third-party evaluation of speech intelligibility was observed (P<0001). From the results of this study, it was suggested that NSV would be effective in cerebrovascular disease and neurodegenerative disease, as well as in subjects whose speech intelligibility was improved by closing nostrils.	[Mikamo, S.; Kodama, N.; Pan, Q.; Maeda, N.; Minagi, S.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Okayama 7008525, Japan	Kodama, N (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	naoki-k@md.okayama-u.ac.jp					Shifman A, 2000, J PROSTHET DENT, V83, P99, DOI 10.1016/S0022-3913(00)70094-1; Esposito SJ, 2000, J PROSTHET DENT, V83, P90, DOI 10.1016/S0022-3913(00)70093-X; Blakeley RW, 1964, CLEFT PALATE J, V1, P194; Bzoch KR, 1964, CLEFT PALATE J, V1, P275; Itoh M, 1993, JPN J LOGOPED PHONIA, V34, P237; Koidis P T, 2003, Orthod Craniofac Res, V6, P101, DOI 10.1034/j.1600-0854.2003. c249.x; LANG BR, 1969, PLAST RECONSTR SURG, V43, P467, DOI 10.1097/00006534-196905000-00003; Logemann J.A., 1983, EVALUATION TREATMENT; Matsui Y, 1993, Int J Oral Maxillofac Implants, V8, P316; Ono Takahiro, 2005, Gerodontology, V22, P116, DOI 10.1111/j.1741-2358.2005.00057.x; SATO Y, 1987, J PROSTHET DENT, V58, P206, DOI 10.1016/0022-3913(87)90178-8; Stewart DS, 1994, J MED SPEECH-LANG PA, V2, P149; Suwaki M, 2008, J ORAL REHABIL, V35, P73, DOI 10.1111/j.1365-2842.2007.01800.x; Suwaki M, 2008, J ORAL REHABIL, V35, P361, DOI 10.1111/j.1365-2842.2008.01846.x; TROSTCARDAMONE JE, 1989, CLEFT PALATE J, V26, P68; Ueda N, 2002, CLEFT PALATE-CRAN J, V39, P12, DOI 10.1597/1545-1569(2002)039<0012:NDOAPL>2.0.CO;2; WITT PD, 1995, CLEFT PALATE-CRAN J, V32, P469, DOI 10.1597/1545-1569(1995)032<0469:DPLPSV>2.3.CO;2; Yorkston KM, 1990, MANAGEMENT MOTOR SPE	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	FEB	2015	42	2					136	143		10.1111/joor.12237		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AZ7WN	WOS:000348425900008		
J	Koyano, K; Esaki, D				Koyano, K.; Esaki, D.			Occlusion on oral implants: current clinical guidelines	JOURNAL OF ORAL REHABILITATION			English	Review						dental implants; dental occlusion; evidence-based dentistry; clinical guideline; dental prosthesis; clinical trial	FIXED PARTIAL DENTURES; RANDOMIZED CONTROLLED-TRIAL; WELDED TITANIUM FRAMEWORKS; 4 ENDOSSEOUS IMPLANTS; BONE LEVEL CHANGE; MANDIBULAR OVERDENTURES; DENTAL IMPLANTS; FOLLOW-UP; PROSPECTIVE MULTICENTER; EXTRACTION SOCKETS	Proper implant occlusion is essential for adequate oral function and the prevention of adverse consequences, such as implant overloading. Dental implants are thought to be more prone to occlusal overloading than natural teeth because of the loss of the periodontal ligament, which provides shock absorption and periodontal mechanoreceptors, which provide tactile sensitivity and proprioceptive motion feedback. Although many guidelines and theories on implant occlusion have been proposed, few have provided strong supportive evidence. Thus, we performed a narrative literature review to ascertain the influence of implant occlusion on the occurrence of complications of implant treatment and discuss the clinical considerations focused on the overloading factors at present. The search terms were dental implant', dental implantation', dental occlusion' and dental prosthesis'. The inclusion criteria were literature published in English up to September 2013. Randomised controlled trials (RCTs), prospective cohort studies and case-control studies with at least 20 cases and 12months follow-up interval were included. Based on the selected literature, this review explores factors related to the implant prosthesis (cantilever, crown/implant ratio, premature contact, occlusal scheme, implant-abutment connection, splinting implants and tooth-implant connection) and other considerations, such as the number, diameter, length and angulation of implants. Over 700 abstracts were reviewed, from which more than 30 manuscripts were included. We found insufficient evidence to establish firm clinical guidelines for implant occlusion. To discuss the ideal occlusion for implants, further well-designed RCTs are required in the future.	[Koyano, K.; Esaki, D.] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabil Dent, Fukuoka 8128582, Japan	Koyano, K (reprint author), Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabil Dent,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	koyano@dent.kyushu-u.ac.jp					Bragger U, 2005, CLIN ORAL IMPLAN RES, V16, P326, DOI 10.1111/j.1600-0501.2005.01105.x; Romeo E, 2009, CLIN ORAL IMPLAN RES, V20, P1278, DOI 10.1111/j.1600-0501.2009.01766.x; Tawil G, 2006, INT J ORAL MAX IMPL, V21, P275; Romeo E, 2004, INT J ORAL MAX IMPL, V19, P247; Romeo E, 2006, INT J PROSTHODONT, V19, P586; Koyano K, 2012, J ORAL REHABIL, V39, P513, DOI 10.1111/j.1365-2842.2012.02303.x; Meijer HJA, 2009, CLIN ORAL IMPLAN RES, V20, P722, DOI 10.1111/j.1600-0501.2009.01710.x; Kreissl ME, 2007, CLIN ORAL IMPLAN RES, V18, P720, DOI 10.1111/j.1600-0501.2007.01414.x; Lekholm U, 1999, INT J ORAL MAX IMPL, V14, P639; Ganeles J, 2008, CLIN ORAL IMPLAN RES, V19, P1119, DOI 10.1111/j.1600-0501.2008.01626.x; Jofre J, 2010, CLIN ORAL IMPLAN RES, V21, P243, DOI 10.1111/j.1600-0501.2009.01834.x; Andersson B, 2003, INT J PROSTHODONT, V16, P640; Malo P, 2011, EUR J ORAL IMPLANTOL, V4, P227; Vigolo P, 2010, INT J ORAL MAX IMPL, V25, P1189; Sailer I, 2012, CLIN ORAL IMPLAN RES, V23, P163, DOI 10.1111/j.1600-0501.2012.02538.x; Lemmerman KJ, 2005, J PERIODONTOL, V76, P310, DOI 10.1902/jop.2005.76.2.310; Wennstrom JL, 2005, J CLIN PERIODONTOL, V32, P567, DOI 10.1111/j.1600-051X.2005.00715.x; Kronstrom M, 2010, INT J ORAL MAX IMPL, V25, P181; Prosper L, 2010, INT J ORAL MAX IMPL, V25, P607; Schincaglia GP, 2008, INT J ORAL MAX IMPL, V23, P474; Esposito M, 1999, INT J ORAL MAX IMPL, V14, P473; ADELL R, 1985, INT DENT J, V35, P259; Wennstrom J, 2004, J CLIN PERIODONTOL, V31, P1077, DOI 10.1111/j.1600-051X.2004.00603.x; Crespi R, 2008, INT J ORAL MAX IMPL, V23, P753; Visser A, 2005, CLIN ORAL IMPLAN RES, V16, P19, DOI 10.1111/j.1600-0501.2004.01085.x; Wismeijer D, 1999, CLIN ORAL IMPLAN RES, V10, P297, DOI 10.1034/j.1600-0501.1999.100406.x; Malo P, 2011, J AM DENT ASSOC, V142, P310; Ortorp A, 2009, CLIN IMPLANT DENT R, V11, P311, DOI 10.1111/j.1708-8208.2008.00119.x; Jemt T, 2002, INT J PROSTHODONT, V15, P544; Slot W, 2013, J CLIN PERIODONTOL, V40, P303, DOI 10.1111/jcpe.12051; Naert I, 2004, INT J ORAL MAX IMPL, V19, P695; Batenburg RHK, 1998, INT J ORAL MAX SURG, V27, P435, DOI 10.1016/S0901-5027(98)80032-5; Block MS, 2002, INT J ORAL MAX IMPL, V17, P473; Carlsson GE, 2009, ODONTOLOGY, V97, P8, DOI 10.1007/s10266-008-0096-x; Degidi M, 2009, J PERIODONTOL, V80, P1393, DOI 10.1902/jop.2009.090153; Eliasson A, 2000, INT J ORAL MAX IMPL, V15, P505; Eliasson A, 2008, SWED DENT J S, V197, P3; Galli F, 2008, CLIN ORAL IMPLAN RES, V19, P546, DOI 10.1111/j.1600-0501.2008.01530.x; Gracis S, 2012, CLIN ORAL IMPLAN RES, V23, P202, DOI 10.1111/j.1600-0501.2012.02556.x; Baris-Guncu M, 2008, CLIN ORAL IMPLAN RES, V19, P335, DOI 10.1111/j.1600-0501.2007.01471.x; Gunne J, 1999, INT J PROSTHODONT, V12, P216; Hall JAG, 2006, INT J PROSTHODONT, V19, P17; Lundgren D, 2000, PERIODONTOLOGY, V1994, P23; Mau J, 2002, CLIN ORAL IMPLAN RES, V13, P477, DOI 10.1034/j.1600-0501.2002.130506.x; Misch C E, 1999, Implant Dent, V8, P376, DOI 10.1097/00008505-199904000-00008; OLSSON M, 1995, CLIN ORAL IMPLAN RES, V6, P114, DOI 10.1034/j.1600-0501.1995.060207.x; Rangert BR, 1997, INT J ORAL MAX IMPL, V12, P360; Sethi A, 2000, INT J ORAL MAX IMPL, V15, P801; Stoker G, 2012, CLIN ORAL IMPLAN RES, V23, P925, DOI 10.1111/j.1600-0501.2011.02237.x; Tabrizi R, 2013, J ORAL MAXIL SURG, V71, P272, DOI 10.1016/j.joms.2012.09.027; WIE H, 1995, CLIN ORAL IMPLAN RES, V6, P47, DOI 10.1034/j.1600-0501.1995.060106.x	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	FEB	2015	42	2					153	161		10.1111/joor.12239		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AZ7WN	WOS:000348425900010		
J	Shimizu, R; Kitade, M; Kobayashi, T; Hori, SI; Watanabe, A				Shimizu, Ryosuke; Kitade, Mikiko; Kobayashi, Takashi; Hori, Shin-Ichiro; Watanabe, Ayahisa			Pharmacokinetic-pharmacodynamic modeling for reduction of hepatic apolipoprotein B mRNA and plasma total cholesterol after administration of antisense oligonucleotide in mice	JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS			English	Article						PK-PD model; Antisense oligonucleotides; Apolipoprotein B; Time-delay	NUCLEIC-ACID; LC-MS/MS; PHOSPHOROTHIOATE OLIGONUCLEOTIDE; QUANTIFICATION; HEPATOCYTES; METABOLITES; CELLS	Second-generation antisense oligonucleotides (ASOs) demonstrate excellent biological stability and in vitro/in vivo potency, and thus are considered to be attractive candidates for drugs to treat various diseases. A pharmacokinetic-pharmacodynamic (PK-PD) model of ASOs is desired for the design of appropriate PK and pharmacological studies. The objective of this study was to develop a PK-PD model to accurately simulate hepatic ASO concentration and its efficacy from plasma ASO concentration. After single subcutaneous administration of an ASO targeting hepatic apolipoprotein B (Apo-B) mRNA to mice, the ASO was absorbed rapidly and showed biphasic decline with time from the plasma and liver (t(1/2): 1-3 and 81-183 h, T-max: 0.25-0.50 and 4-8 h). After administration, hepatic Apo-B mRNA and plasma total cholesterol began decreasing at 4-8 and 8-24 h, and their T-max values were observed at 24-72 and 72 h. To develop the PK-PD model based on the mechanisms of ASOs, we described the plasma and hepatic ASO concentration with linear two-compartment models. In addition, we inserted two indirect response models for mRNA and plasma total cholesterol. Model predictions from plasma ASO concentration gave excellent fits to the observed values of hepatic ASO concentration, Apo-B mRNA and plasma total cholesterol after single or multiple subcutaneous administrations. Our PK-PD model could accurately predict hepatic ASO concentrations and their efficacies from plasma ASO concentrations. This PK-PD model could be a useful tool for suggesting PK and pharmacological study protocols for various liver-targeted second-generation ASOs.	[Shimizu, Ryosuke; Kitade, Mikiko; Watanabe, Ayahisa] Shionogi & Co Ltd, Drug Dev Res Labs, Drug Metab & Pharmacokinet, Toyonaka, Osaka, Japan; [Kobayashi, Takashi] Shionogi & Co Ltd, Discovery Res Lab Innovat Frontier Med, Shionogi Innovat Ctr Drug Discovery, Sapporo, Hokkaido, Japan; [Hori, Shin-Ichiro] Shionogi & Co Ltd, Biotechnol Based Med, Discovery Res Lab Innovat Frontier Med, Toyonaka, Osaka, Japan	Watanabe, A (reprint author), Shionogi & Co Ltd, Drug Dev Res Labs, Drug Metab & Pharmacokinet, Toyonaka, Osaka, Japan.	ayahisa.watanabe@shionogi.co.jp					Prakash TP, 2014, NUCLEIC ACIDS RES, V42, P8796, DOI 10.1093/nar/gku531; Straarup EM, 2010, NUCLEIC ACIDS RES, V38, P7100, DOI 10.1093/nar/gkq457; Yu RZ, 2013, EXPERT OPIN DRUG MET, V9, P169, DOI 10.1517/17425255.2013.737320; Geary RS, 2009, EXPERT OPIN DRUG MET, V5, P381, DOI [10.1517/17425250902877680 , 10.1517/17425250902877680]; Yu RZ, 2001, J PHARMACOL EXP THER, V296, P388; Lee RG, 2013, J CARDIOVASC TRANSL, V6, P969, DOI 10.1007/s12265-013-9495-7; Grunweller A, 2007, BIODRUGS, V21, P235; Geary RS, 2009, BIOCHEM PHARMACOL, V78, P284, DOI 10.1016/j.bcp.2009.04.013; Yu RZ, 2004, CURR OPIN DRUG DISC, V7, P195; Ewles M, 2014, BIOANALYSIS, V6, P447, DOI 10.4155/bio.13.319; Yu RZ, 2009, BIOCHEM PHARMACOL, V77, P910, DOI 10.1016/j.bcp.2008.11.005; Grunweller A, 2003, NUCLEIC ACIDS RES, V31, P3185, DOI 10.1093/nar/gkg409; Chi KN, 2008, CLIN CANCER RES, V14, P833, DOI 10.1158/1078-0432.CCR-07-1310; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Thomas GS, 2013, J AM COLL CARDIOL, V62, P2178, DOI 10.1016/j.jacc.2013.07.081; Callies S, 2011, BRIT J CLIN PHARMACO, V71, P416, DOI 10.1111/j.1365-2125.2010.03836.x; Cen YY, 2012, J PHARMACEUT BIOMED, V70, P447, DOI 10.1016/j.jpba.2012.06.022; Dandekar PK, 2003, J ANTIMICROB CHEMOTH, V52, P405, DOI 10.1093/jac/dkg337; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Kimber Wendy L, 2003, Reprod Biomed Online, V6, P318; Obika S, 2008, BIOORGAN MED CHEM, V16, P9230, DOI 10.1016/j.bmc.2008.09.013; PULLINGER CR, 1989, J LIPID RES, V30, P1065; Turnpenny P, 2011, BIOANALYSIS, V3, P1911, DOI [10.4155/bio.11.100, 10.4155/BIO.11.100]	23	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1567-567X	1573-8744		J PHARMACOKINET PHAR	J. Pharmacokinet. Pharmacodyn.	FEB	2015	42	1					67	77		10.1007/s10928-014-9398-5		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ0RL	WOS:000347952200005		
J	Shuro, I; Kobayashi, S; Nakamura, T; Tsuzaki, K				Shuro, I.; Kobayashi, S.; Nakamura, T.; Tsuzaki, K.			The Effects of Si and Al Alloying on alpha/gamma Phase Equilibria in Fe-Cr-Ni-Mn Based Ternary and Quaternary Systems	JOURNAL OF PHASE EQUILIBRIA AND DIFFUSION			English	Article						Cr equivalent; diffusion multiple; high Mn steel; phase equilibria	INDUCED PLASTICITY; STEELS; MICROSTRUCTURE; TEMPERATURE	Phase equilibria between the ferrite phase (alpha) and the austenite phase (gamma) were investigated in the iron-rich corner of the Fe-Cr-Mn-Ni-Si/Al systems at 1000 A degrees C using a diffusion multiple approach and scanning electron microscopy/energy dispersive spectroscopy (SEM/EDS) techniques. Cr equivalents of Si and Al are established as a function of Ni and Mn content in contrast to fixed values reported in other studies. The Cr equivalents of Si (Cr (eq) (Si) ) are in the range between -0.5 and 1.3 being positive at 0 wt.% Mn and with values slightly below zero at 5-15 wt.% Mn. The Cr equivalents of Al (Cr (eq) (Al) ) ranged between 0.6 and 4.8 decreasing with increase in Ni and Mn content. When compared to Cr (eq) (Al) , the Cr (eq) (Si) do not show a strong dependence on Ni and Mn content. Thermodynamic calculation using Thermo-Calc software agrees with the experimental results qualitatively.	[Shuro, I.; Kobayashi, S.; Nakamura, T.; Tsuzaki, K.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Shuro, I.] Univ Cape Town, Electron Microscope Unit, ZA-7925 Cape Town, South Africa; [Tsuzaki, K.] Kyushu Univ, Dept Mech Engn, Nishi Ku, Fukuoka 8190395, Japan	Shuro, I (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	innoshuro@gmail.com					CHEN FC, 1993, MAT SCI ENG A-STRUCT, V160, P261, DOI 10.1016/0921-5093(93)90455-N; Kobayashi S, 2009, INTERMETALLICS, V17, P1085, DOI 10.1016/j.intermet.2009.05.009; Bouaziz O, 2011, CURR OPIN SOLID ST M, V15, P141, DOI 10.1016/j.cossms.2011.04.002; TAKAKI S, 1990, ISIJ INT, V30, P632, DOI 10.2355/isijinternational.30.632; Nikulin I, 2013, MAT SCI ENG A-STRUCT, V587, P192, DOI 10.1016/j.msea.2013.08.061; Kobayashi S, 2010, SCRIPTA MATER, V63, P1104, DOI 10.1016/j.scriptamat.2010.08.015; Sawaguchi T, 2008, SCRIPTA MATER, V59, P826, DOI 10.1016/j.scriptamat.2008.06.030; Ding H, 2011, J IRON STEEL RES INT, V18, P36; Grassel O, 2000, INT J PLASTICITY, V16, P1391, DOI 10.1016/S0749-6419(00)00015-2; Charles J., 1982, J PHYS, V43, pC4, DOI 10.1051/jphyscol:1982466; De Cooman B.C., 2012, MAT SCI TECHNOL, V285, P514; Han YS, 1997, MAT SCI ENG A-STRUCT, V222, P76, DOI 10.1016/S0921-5093(96)10501-3; Kobayashi S, 2008, J ALLOY COMPD, V452, P67, DOI 10.1016/j.jallcom.2007.01.171; Ohta A, 1999, INT J FATIGUE, V21, pS113; Schneider H., 1960, FOUNDRY TRADE J, V108, P563; Shuro I, 2014, J ALLOY COMPD, V588, P284, DOI 10.1016/j.jallcom.2013.11.095	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1547-7037	1863-7345		J PHASE EQUILIB DIFF	J. Phase Equilib. Diffus.	FEB	2015	36	1					53	59		10.1007/s11669-014-0356-0		7	Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Chemistry; Materials Science; Metallurgy & Metallurgical Engineering	AZ4NE	WOS:000348197800007		
J	Oya, K; Watanabe, R; Soga, Y; Ikeda, Y; Nakamura, T; Iwamori, S				Oya, Kei; Watanabe, Ryota; Soga, Yuta; Ikeda, Yuki; Nakamura, Takaharu; Iwamori, Satoru			Effect of humidity conditions on active oxygen species generated under ultraviolet light irradiation and etching characteristics of fluorocarbon polymer	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						Active oxygen; UV light irradiation; Humidity; Electron spin resonance; Fluorocarbon thin film; X-ray photoelectron spectroscopy	RADICAL SCAVENGING CAPACITY; CRYSTAL MICROBALANCE QCM; HOLLOW-CATHODE LAMP; ABSORPTION-SPECTROSCOPY; ATMOSPHERIC CHEMISTRY; PHOTOCHEMICAL DATA; KINETIC-DATA; WATER-VAPOR; OZONE; PLASMAS	For efficient industrial application, it is necessary to understand the formation mechanisms of active oxygen species under ultraviolet (UV) light irradiation. In this study, active oxygen was generated by UV lamps (providing wavelengths of 185 and 254 nm) at two different humidity levels. The generation of excited singlet oxygen [O(D-1)] and hydroxyl radicals (OH*) in the atmosphere were detected using the electron spin resonance (ESR) method, while ozone (O-3) was detected using a gas tube. The concentrations of O(D-1) and O-3 generated under low humidity conditions were much higher than those generated at high humidity. On the other hand, the concentration of OH* generated under high humidity condition were much higher than that generated at low humidity. The amount of O(D-1) increased linearly with irradiation time, while the increase of O-3 concentration was observed to be suppressed after 5 min. Fluorocarbon thin, films r.f.-sputtered onto quartz crystal oscillators were used to investigate the etching behavior of generated active oxygen species. The etching rates were found to be higher at high humidity, which is believed to be due to the contribution of OH* whose concentration was higher in the presence of larger amounts of water in the atmosphere. (C) 2014 Elsevier B.V. All rights reserved.	[Oya, Kei; Watanabe, Ryota; Soga, Yuta; Ikeda, Yuki; Nakamura, Takaharu; Iwamori, Satoru] Tokai Univ, Sch Engn, Dept Mech Engn, Hiratsuka, Kanagawa 2591292, Japan	Oya, K (reprint author), Tokai Univ, Sch Engn, Dept Mech Engn, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	k.oya@tokai-u.jp			Japan Science and Technology Agency (JST) [AS2414101P]	This work was financially supported by a Grant-in-Aid for A-STEP (No. AS2414101P) from the Japan Science and Technology Agency (JST).	Adams SF, 2001, J PHYS CHEM A, V105, P5977, DOI 10.1021/jp0039058; Nagai H, 2003, REV SCI INSTRUM, V74, P3453, DOI 10.1063/1.1582386; Atkinson R, 2004, ATMOS CHEM PHYS, V4, P1461; ASAMI K, 1993, CORROS SCI, V35, P43, DOI 10.1016/0010-938X(93)90131-Y; ATKINSON R, 1992, J PHYS CHEM REF DATA, V21, P1125; Salvermoser M, 2008, OZONE-SCI ENG, V30, P228, DOI 10.1080/01919510802070611; Stafford DS, 2004, J APPL PHYS, V96, P2451, DOI 10.1063/1.1768615; Takashima S, 1999, APPL PHYS LETT, V75, P3929, DOI 10.1063/1.125497; Baulch DL, 2005, J PHYS CHEM REF DATA, V34, P757, DOI 10.1063/1.1748524; Han SK, 2011, CHEMOSPHERE, V84, P1095, DOI 10.1016/j.chemosphere.2011.04.051; Kamibayashi M, 2006, FREE RADICAL RES, V40, P1166, DOI 10.1080/10715760600883254; ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4; Yoshino K, 2013, VACUUM, V93, P84, DOI 10.1016/j.vacuum.2013.01.009; BURROWS JP, 1981, J PHOTOCHEM, V16, P147, DOI 10.1016/0047-2670(81)80026-3; Endo N, 2009, J CLIN BIOCHEM NUTR, V45, P193, DOI 10.3164/jcbn.08-265; Iwamori S, 2012, SENSOR ACTUAT B-CHEM, V171, P769, DOI 10.1016/j.snb.2012.05.070; Liu GM, 2000, J PHOTOCH PHOTOBIO A, V133, P83, DOI 10.1016/S1010-6030(00)00227-6; Manion J. A., 2008, NIST STANDARD REFERE; MOLINA LT, 1986, J GEOPHYS RES-ATMOS, V91, P14501, DOI 10.1029/JD091iD13p14501; Nguyen MT, 2003, COORDIN CHEM REV, V244, P93, DOI 10.1016/S0010-8545(03)00101-2; Ono R, 2005, J PHYS D APPL PHYS, V38, P2812, DOI 10.1088/0022-3727/38/16/011; Oowada S, 2012, J CLIN BIOCHEM NUTR, V51, P117, DOI 10.3164/jcbn.11-113; Teramoto Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.4722317; Yoshihara K, 2007, P JPN ACAD B-PHYS, V83, P320, DOI 10.2183/pjab/83.320	24	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	FEB 1	2015	298						33	39		10.1016/j.jphotochem.2014.09.001		7	Chemistry, Physical	Chemistry	AY5EG	WOS:000347595300005		
J	Watanabe, Y; Fukuyoshi, S; Oda, A				Watanabe, Yurie; Fukuyoshi, Shuichi; Oda, Akifumi			Comparison of photoreactions of flutamide in acetonitrile and 2-propanol solvents in the absence of cage-forming compounds	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article							PHOTO-SMILES REARRANGEMENT; ADVANCED PROSTATE-CANCER; AROMATIC NITRO-COMPOUNDS; REACTION-MECHANISM; PHOTOCHEMISTRY; PHOTOSUBSTITUTION; NITROBENZENE; PATHWAYS; VESICLES; PHOTOSENSITIVITY	Flutamide(2-methyl-N-[4-nitro-3-(trifluoromethylphenyl)]propanamide) is a widely used anti-cancer drug. It has been reported that photodermatosis is occasionally induced when an individual taking flutamide is exposed to sunlight. In this study, we found that flutamide undergoes different photoreactions in two different solvents: acetonitrile and 2-propanol. The photo-induced nitro-nitrite rearrangement was the predominant reaction when a flutamide solution in acetonitrile was irradiated with UV light, and phenoxy radicals and nitrogen monoxide were generated. The nitrogen monoxide recombined with the phenoxy radical at the ortho position and was oxidized by the oxygen dissolved in the acetonitrile. The final product was o-nitrophenol derivative. However, the photoreduction of the nitro group followed by solvolysis of the trifluoromethyl group was observed when a flutamide solution in 2-propanol was irradiated with UV light. The three fluorine atoms in the trifluoromethyl group were eliminated by being nucleophilically attacked by a solvent molecule, resulting in an ester bond with 2-propanol being formed. (C) 2014 Elsevier B.V. All rights reserved.	[Watanabe, Yurie; Fukuyoshi, Shuichi; Oda, Akifumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kanazawa, Ishikawa 9201192, Japan; [Oda, Akifumi] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Oda, A (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	oda@p.kanazawa-u.ac.jp	ODA, Akifumi/D-8405-2015; Fukuyoshi, Shuichi/D-8388-2015				LIPPERT E, 1978, HELV CHIM ACTA, V61, P279, DOI 10.1002/hlca.19780610125; He YG, 2006, CHEM-ASIAN J, V1, P56, DOI 10.1002/asia.200600107; Sortino S, 2001, PHOTOCHEM PHOTOBIOL, V73, P6, DOI 10.1562/0031-8655(2001)073<0006:TPOFAI>2.0.CO;2; Ornstein DK, 1996, UROLOGY, V48, P901, DOI 10.1016/S0090-4295(96)00315-9; Leroy D, 1996, PHOTODERMATOL PHOTO, V12, P216; HAMANOUE K, 1984, J AM CHEM SOC, V106, P5993, DOI 10.1021/ja00332a041; YOKOYAMA K, 1980, B CHEM SOC JPN, V53, P2472, DOI 10.1246/bcsj.53.2472; CHAPMAN OL, 1966, J AM CHEM SOC, V88, P5550, DOI 10.1021/ja00975a037; YOKOYAMA K, 1980, B CHEM SOC JPN, V53, P3474, DOI 10.1246/bcsj.53.3474; FINNEGAN RA, 1968, J AM CHEM SOC, V90, P1670, DOI 10.1021/ja01008a061; Nakagaki R, 1996, B CHEM SOC JPN, V69, P261, DOI 10.1246/bcsj.69.261; Vilaplana J, 1998, CONTACT DERMATITIS, V38, P68, DOI 10.1111/j.1600-0536.1998.tb05655.x; Schellhammer PF, 1997, UROLOGY, V50, P330, DOI 10.1016/S0090-4295(97)00279-3; Udagawa C, 2011, J PHOTOCH PHOTOBIO A, V226, P57, DOI 10.1016/j.jphotochem.2011.10.015; Shet MS, 1997, DRUG METAB DISPOS, V25, P1298; MUTAI K, 1985, B CHEM SOC JPN, V58, P2066, DOI 10.1246/bcsj.58.2066; HURLEY R, 1966, J AM CHEM SOC, V88, P4330, DOI 10.1021/ja00971a005; NAKAGAKI R, 1985, CHEM PHYS LETT, V121, P262, DOI 10.1016/0009-2614(85)85522-6; Tonnesen HH, 2001, INT J PHARM, V225, P1, DOI 10.1016/S0378-5173(01)00746-3; Bosca F, 2001, PHOTOCHEM PHOTOBIOL, V73, P463, DOI 10.1562/0031-8655(2001)073<0463:POHTAM>2.0.CO;2; Plaza-Medina EF, 2011, J PHYS CHEM A, V115, P577, DOI 10.1021/jp109041y; BARLTROP JA, 1968, J CHEM SOC C, P1467, DOI 10.1039/j39680001467; Chaignon P, 2005, PHOTOCHEM PHOTOBIOL, V81, P1539, DOI 10.1562/2005-08-03-RA-637; Doepp D., 1995, HDB ORGANIC PHOTOCHE, P1019; Fasani E, 2009, PHOTOCHEM PHOTOBIOL, V85, P879, DOI 10.1111/j.1751-1097.2009.00546.x; Gilbert A., 1991, NITRO COMPOUNDS ESSE, P436; GRINTER R, 1968, TETRAHEDRON LETT, P3845; James L.B., 1969, TETRAHEDRON LETT, V38, P3263; Matsuzaki Y, 2006, J GASTROENTEROL, V41, P231, DOI 10.1007/s00535-005-1749-y; MUTAI K, 1978, TETRAHEDRON LETT, P1273; SCHELLHAMMER P, 1995, UROLOGY, V45, P745, DOI 10.1016/S0090-4295(99)80077-6; Sortino S, 2003, HELV CHIM ACTA, V86, P266, DOI 10.1002/hlca.200390027; Sortino S, 2001, CHEM COMMUN, P1226, DOI 10.1039/b102359b; Sortino S, 2002, HELV CHIM ACTA, V85, P1407, DOI 10.1002/1522-2675(200205)85:5<1407::AID-HLCA1407>3.0.CO;2-E; Watanabe Y., 2013, XRAY STRUCT ANAL ONL, V29, P35	35	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	FEB 1	2015	298						55	61		10.1016/j.jphotochem.2014.10.009		7	Chemistry, Physical	Chemistry	AY5EG	WOS:000347595300008		
J	Larsson, O; Benghin, VV; Berger, T; Casolino, M; Di Fino, L; Fuglesang, C; Larosa, M; Lund-Jensen, B; Nagamatsu, A; Narici, L; Nikolaev, IV; Picozza, P; Reitz, G; De Santis, C; Zaconte, V				Larsson, O.; Benghin, V. V.; Berger, T.; Casolino, M.; Di Fino, L.; Fuglesang, C.; Larosa, M.; Lund-Jensen, B.; Nagamatsu, A.; Narici, L.; Nikolaev, I. V.; Picozza, P.; Reitz, G.; De Santis, C.; Zaconte, V.			Measurements of heavy-ion anisotropy and dose rates in the Russian section of the International Space Station with the Sileye-3/Alteino detector	JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS			English	Article						Alteino; ISS; dose; dose equivalent; LET; heavy ion	LIGHT-FLASHES; COSMIC-RAYS; RADIATION; BOARD; ISS; MIR; EYE	In this work we present data on linear energy transfer (LET), dose and dose equivalent rates from different locations of the Russian part of the International Space Station (ISS) measured by the Sileye-3/Alteino detector. Data were taken as part of the ESA ALTCRISS project from late 2005 through 2007. The LET rate data shows a heavy-ion (LET > 50 keV/mu m) anisotropy. From the heavy-ion LET rate in the Zvezda service module we find ISS (y) over cap (Starboard) and (z) over cap (Nadir) to be about 10-15 times higher than in (x) over cap (Forward). The situation is similar for dose and dose equivalent rates, ranging from 25-40 mu Gy d(-1) in (x) over cap to about 75 mu Gy d(-1) in (z) over cap, whereas for the dose equivalent the rate peaks in (y) over cap with around 470 mu Sv d(-1). The heavy-ion anisotropy confirms what has been reported by the ALTEA collaboration. Measurements using two sets of passive detectors, DLR-TLDs and PADLES (TLD+CR-39), have also been performed in conjunction with Alteino measurements, both shielded and unshielded. The passive detectors register a dose rate about 3-5 times as high as Alteino, 260-280 mu Gy d(-1) for PADLES and 200-260 mu Gy d(-1) for DLR-TLDs. For the dose equivalent PADLES measurements ranges from 560-740 mu Sv d(-1).	[Larsson, O.; Fuglesang, C.; Lund-Jensen, B.] Royal Inst Technol, Albanova Univ Ctr, SE-10691 Stockholm, Sweden; [Benghin, V. V.; Nikolaev, I. V.] Inst Biomed Problems, Moscow, Russia; [Berger, T.; Larosa, M.; Reitz, G.] German Aerosp Ctr, Cologne, Germany; [Casolino, M.; Di Fino, L.; Narici, L.; Picozza, P.; De Santis, C.; Zaconte, V.] Ist Nazl Fis Nucl, Sect Roma Tor Vergata, Rome, Italy; [Casolino, M.] RIKEN, Wako, Saitama, Japan; [Di Fino, L.; Larosa, M.; Narici, L.; Picozza, P.; De Santis, C.; Zaconte, V.] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Nagamatsu, A.] Japan Aerosp Explorat Agcy, Tokyo, Japan	Larsson, O (reprint author), Royal Inst Technol, Albanova Univ Ctr, SE-10691 Stockholm, Sweden.	OscarLar@KTH.se	De Santis, Cristian/C-1210-2011; 	De Santis, Cristian/0000-0002-7280-2446; casolino, marco/0000-0001-6067-5104; Picozza, Piergiorgio/0000-0002-7986-3321	ESA; Riken; ACCC-Riken; Russian Space Agency; Italian Space Agency [ASI 2013-034-R.0]; INFN (Instituto Nazionale di Fisica Nucleare); Swedish National Space Board (SNSB)	The ALTCRISS project was supported by ESA. We would also like to extend our gratitude towards Riken, ACCC-Riken, the Russian Space Agency, to the Italian Space Agency (ASI 2013-034-R.0 and ALTEA-MoMa contract), to INFN (Instituto Nazionale di Fisica Nucleare), and the Swedish National Space Board (SNSB) for financial support, building the detector, launching it to the Space Station, and for data handling and analysis. We thank all colleagues and friends at MARS center, Napoli, for the fundamental support and help for the whole duration of the mission.	Reitz G, 2005, RADIAT PROT DOSIM, V116, P374, DOI 10.1093/rpd/nci262; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; SULLIVAN JD, 1971, NUCL INSTRUM METHODS, V95, P5, DOI 10.1016/0029-554X(71)90033-4; Allison J, 2006, IEEE T NUCL SCI, V53, P270, DOI 10.1109/TNS.2006.869826; Benton ER, 2010, RADIAT MEAS, V45, P957, DOI 10.1016/j.radmeas.2010.05.008; Narici L, 2012, RADIAT MEAS, V47, P1030, DOI 10.1016/j.radmeas.2012.07.006; Wilson JW, 2006, ADV SPACE RES, V37, P1656, DOI 10.1016/j.asr.2005.02.038; Casolino M, 2006, ADV SPACE RES, V37, P1691, DOI 10.1016/j.asr.2005.03.136; Nagamatsu A, 2013, RADIAT MEAS, V59, P84, DOI 10.1016/j.radmeas.2013.05.008; GLEESON LJ, 1968, ASTROPHYS J, V154, P1011, DOI 10.1086/149822; La Tessa C, 2009, NUCL INSTRUM METH B, V267, P3383, DOI 10.1016/j.nimb.2009.06.107; Casolino M, 2006, ADV SPACE RES, V37, P1685, DOI 10.1016/j.asr.2006.02.050; Casolino M, 2002, NUCL PHYS B-PROC SUP, V113, P71, DOI 10.1016/S0920-5632(02)01824-8; Di Fino L, 2011, RADIAT RES, V176, P397, DOI 10.1667/RR2179.1; CARTWRIGHT BG, 1978, NUCL INSTRUM METHODS, V153, P457, DOI 10.1016/0029-554X(78)90989-8; Durante M, 2011, REV MOD PHYS, V83, P1245, DOI 10.1103/RevModPhys.83.1245; Avdeev S, 2002, ACTA ASTRONAUT, V50, P511, DOI 10.1016/S0094-5765(01)00190-4; Bidoli V, 2000, ADV SPACE RES, V25, P2075, DOI 10.1016/S0273-1177(99)01017-0; Cameron J.R, 1968, THERMOLUMINESCENT DO; Casolino M, 2003, ADV SPACE RES, V31, P135, DOI 10.1016/S0273-1177(02)00880-3; Casolino M, 2007, ADV SPACE RES, V40, P1746, DOI 10.1016/j.asr.2007.04.037; Fuglesang C, 2007, NUCL INSTRUM METH A, V580, P861, DOI 10.1016/j.nima.2007.06.095; Larsson O, 2014, J PHYS G NUCL PARTIC, V41, DOI 10.1088/0954-3899/41/1/015202; Nagamatsu A, 2006, P 20 WORKSH RAD DET, V7, P26; Narici L, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075010; Ohnishi T, 2009, BIOCHEM BIOPH RES CO, V390, P485, DOI 10.1016/j.bbrc.2009.09.114; Usoskin IG, 2005, J GEOPHYS RES-SPACE, V110, DOI [10.1029/2004JA010946, 10.1029/2005JA011250]; Usoskin IG, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016105; Valentin J, 2003, ANN ICRP, V33, P1	29	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0954-3899	1361-6471		J PHYS G NUCL PARTIC	J. Phys. G-Nucl. Part. Phys.	FEB	2015	42	2							025002	10.1088/0954-3899/42/2/025002		9	Physics, Nuclear; Physics, Particles & Fields	Physics	AZ3MA	WOS:000348130400003		
J	Toyokawa, M; Minomo, K; Kohno, M; Yahiro, M				Toyokawa, Masakazu; Minomo, Kosho; Kohno, Michio; Yahiro, Masanobu			Roles of chiral three-nucleon forces in nucleon-nucleus scattering	JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS			English	Article						nucleon elastic scattering; g-matrix folding model; three-nucleon force	PROTON ELASTIC-SCATTERING; REACTION-CROSS-SECTION; INELASTIC-SCATTERING; MATTER; MODEL; POTENTIALS; ORDER; MG-24; C-12	We investigate the effects of chiral three-nucleon force (3NF) at NNLO level on nucleon-nucleus (NA) elastic scattering, using the standard framework based on the Brueckner-Hartree-Fock method for nuclear matter and the g-matrix folding model for NA elastic scattering. The optical potential in nuclear matter calculated from chiral two-nucleon force (2NF) at (NLO)-L-3 level is found to be close to that from Bonn-B 2NF, whereas the Melbourne g-matrix is known as a practical effective nucleon-nucleon interaction constructed by localizing the g-matrices calculated from Bonn-B 2NF. As the first attempt to estimate chiral-3NF effects on NA scattering, the effects are simply introduced by multiplying the local Melbourne g-matrix by the ratio of the optical potential in nuclear matter calculated from chiral 2NF+3NF to that from chiral 2NF. For NA elastic scattering on various targets at 65 MeV, chiral 3NF makes the folding potential less attractive and more absorptive. The novel property for the imaginary part is originated in the enhancement of tensor correlations due to chiral 3NF (mainly the 2 pi-exchange diagram). The two effects are small for differential cross sections and vector analyzing powers at the forward and middle angles where the experimental data are available. If backward measurements are made, the data will reveal the effects of chiral 3NF.	[Toyokawa, Masakazu; Yahiro, Masanobu] Kyushu Univ, Dept Phys, Fukuoka 8128581, Japan; [Minomo, Kosho; Kohno, Michio] Osaka Univ, Nucl Phys Res Ctr, Ibaraki 5670047, Japan; [Kohno, Michio] Kyushu Dent Univ, Div Phys, Kitakyushu, Fukuoka 8038580, Japan	Toyokawa, M (reprint author), Kyushu Univ, Dept Phys, Fukuoka 8128581, Japan.	toyokawa@phys.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [244137, 25400266, 26400278]	This work is supported in part by by Grant-in-Aid for Scientific Research (Nos. 244137, 25400266, and 26400278) from Japan Society for the Promotion of Science (JSPS).	Holt JW, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.024002; JEUKENNE JP, 1977, PHYS REV C, V16, P80, DOI 10.1103/PhysRevC.16.80; Kohno M, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.064005; SATCHLER GR, 1979, PHYS REP, V55, P183, DOI 10.1016/0370-1573(79)90081-4; Bogner SK, 2005, NUCL PHYS A, V763, P59, DOI 10.1016/j.nuclphysa.2005.08.024; Sammarruca F, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.054317; Amos K, 2000, ADV NUCL PHYS, V25, P275; Rijken TA, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.044008; WIRINGA RB, 1988, PHYS REV C, V38, P1010, DOI 10.1103/PhysRevC.38.1010; Rijken TA, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.044007; Carbone A, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.044302; MACHLEIDT R, 1987, PHYS REP, V149, P1, DOI 10.1016/S0370-1573(87)80002-9; Nogga A, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.064002; AUSTERN N, 1987, PHYS REP, V154, P125, DOI 10.1016/0370-1573(87)90094-9; Epelbaum E, 2005, NUCL PHYS A, V747, P362, DOI 10.1016/j.nuclphysa.2004.09.107; Epelbaum E, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.064001; Dewulf Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.152501; LAGARIS IE, 1981, NUCL PHYS A, V359, P349, DOI 10.1016/0375-9474(81)90241-4; Wiringa RB, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.182501; BERTSCH G, 1977, NUCL PHYS A, V284, P399, DOI 10.1016/0375-9474(77)90392-X; RIKUS L, 1984, NUCL PHYS A, V414, P413, DOI 10.1016/0375-9474(84)90611-0; Furumoto T, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.044610; BERGER JF, 1991, COMPUT PHYS COMMUN, V63, P365, DOI 10.1016/0010-4655(91)90263-K; Pudliner BS, 1997, PHYS REV C, V56, P1720, DOI 10.1103/PhysRevC.56.1720; NEGELE JW, 1972, PHYS REV C, V5, P1472, DOI 10.1103/PhysRevC.5.1472; FRIEDMAN B, 1981, NUCL PHYS A, V361, P502, DOI 10.1016/0375-9474(81)90649-7; Muther H, 2000, PROG PART NUCL PHYS, V45, P243, DOI 10.1016/S0146-6410(00)00105-8; YAMAGUCHI N, 1983, PROG THEOR PHYS, V70, P459, DOI 10.1143/PTP.70.459; Hebeler K, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.031301; YAMAGUCHI N, 1986, PROG THEOR PHYS, V76, P1289, DOI 10.1143/PTP.76.1289; Baba M, 2002, J NUCL SCI TECHNOL S, V2, P204; BRIEVA FA, 1977, NUCL PHYS A, V291, P299, DOI 10.1016/0375-9474(77)90322-0; DAVISON NE, 1977, NUCL PHYS A, V290, P45, DOI 10.1016/0375-9474(77)90663-7; DEVRIES H, 1987, ATOM DATA NUCL DATA, V36, P495, DOI 10.1016/0092-640X(87)90013-1; Entem D. R., 2003, Physical Review C (Nuclear Physics), V68, DOI 10.1103/PhysRevC.68.041001; FUJITA J, 1957, PROG THEOR PHYS, V17, P366, DOI 10.1143/PTP.17.366; HAFTEL MI, 1970, NUCL PHYS A, VA158, P1, DOI 10.1016/0375-9474(70)90047-3; HJORT EL, 1994, PHYS REV C, V50, P275, DOI 10.1103/PhysRevC.50.275; Holt JW, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.024614; Ingemarsson A, 1999, NUCL PHYS A, V653, P341, DOI 10.1016/S0375-9474(99)00236-5; Jeukenne J. P., 1976, Physics Reports. Physics Letters Section C, V25c, DOI 10.1016/0370-1573(76)90017-X; Kalantar-Nayestanaki N, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016301; KAMIMURA M, 1986, PROG THEOR PHYS SUPP, P1; Kasahara T., 1974, PROG THEOR PHYS SUPP, V56, P96, DOI 10.1143/PTPS.56.96; KATO S, 1985, PHYS REV C, V31, P1616, DOI 10.1103/PhysRevC.31.1616; KERMAN AK, 1959, ANN PHYS-NEW YORK, V8, P551, DOI 10.1016/0003-4916(59)90076-4; LOISEAU BA, 1971, NUCL PHYS A, VA165, P601, DOI 10.1016/0375-9474(71)90474-X; MENET JJH, 1971, PHYS REV C, V4, P1114, DOI 10.1103/PhysRevC.4.1114; Minomo K, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.051601; Navratil P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.042501; Noga A, 2006, PHYS REV C, V73; Rafi S, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014003; SAKAGUCHI H, 1979, PHYS LETT B, V89, P40, DOI 10.1016/0370-2693(79)90071-6; SAKAGUCHI H, 1981, PHYS LETT B, V99, P92, DOI 10.1016/0370-2693(81)90957-6; Satchler G. R., 1983, DIRECT NUCL REACTION; Skibinski R, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.054005; Suzuki K, 2000, NUCL PHYS A, V665, P92, DOI 10.1016/S0375-9474(99)00399-1; Toyokawa M, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.054602; White L, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.044607; Yahiro M, 2008, PROG THEOR PHYS, V120, P767, DOI 10.1143/PTP.120.767	60	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0954-3899	1361-6471		J PHYS G NUCL PARTIC	J. Phys. G-Nucl. Part. Phys.	FEB	2015	42	2							025104	10.1088/0954-3899/42/2/025104		15	Physics, Nuclear; Physics, Particles & Fields	Physics	AZ3MA	WOS:000348130400009		
J	Kimura, F; Sato, M; Kato-Noguchi, H				Kimura, Fukiko; Sato, Masashi; Kato-Noguchi, Hisashi			Allelopathy of pine litter: Delivery of allelopathic substances into forest floor	JOURNAL OF PLANT BIOLOGY			English	Article						Allelopathy; Growth inhibitor; Litter; Pine forest; Phytoalexin	SECONDARY SUCCESSION; PLANTS; ALLELOCHEMICALS; HALEPENSIS; NEEDLES; DENSIFLORA; CHEMISTRY; HABITATS; GROWTH; LEAVES	Red pine (Pinus densiflora Sieb. et Zucc.) forest forms sparse forest floor where herbaceous plants do not grow well. Allelopathic chemical interaction was speculated to play an important role in the formation of the forest floor. However, only several phenolic acids and their related compounds have been isolated from the forest floor. Those compounds are universal in many plants and cannot distinguish such strong allelopathic activity of red pine from other plants. The present research investigates whether red pine litter contains some potential allelopathic substances other than phenolics. Aqueous methanol extracts of red pine litter inhibited the growth of cress (Lepidium sativum) and Digitaria sanguinalis L., and increasing the extract concentration increased the inhibition. The extract was then purified by several chromatographies and biological activities of all separated fractions were determined. Two main inhibitory substances were finally isolated and their chemical structures were determined by spectral data as 9 alpha,13 beta- epidioxyabeit-8(14)en-18-oic acid and abscisic acid-beta-Dglucopyranosyl ester. These compounds may be synthesized in pine plants and delivered into the forest floor by defoliation of the needles. Their inhibitory activity on the germination and the growth may play an important role in the formation of the sparse forest floors.	[Kimura, Fukiko; Sato, Masashi; Kato-Noguchi, Hisashi] Kagawa Univ, Dept Appl Bioresources, Fac Agr, Miki, Kagawa 7610795, Japan	Kimura, F (reprint author), Kagawa Univ, Dept Appl Bioresources, Fac Agr, Miki, Kagawa 7610795, Japan.	pinus_densiflora_sz@yahoo.co.jp					Zhao HB, 2011, J CHEM ECOL, V37, P785, DOI 10.1007/s10886-011-9970-z; Kong CH, 2004, J AGR FOOD CHEM, V52, P2861, DOI 10.1021/jf035467i; Caboun V, 2006, ALLELOPATHY J, V17, P17; Weidenhamer JD, 2010, J CHEM ECOL, V36, P59, DOI 10.1007/s10886-009-9735-0; Fernandez C, 2013, J CHEM ECOL, V39, P298, DOI 10.1007/s10886-013-0239-6; Seigler DS, 1996, AGRON J, V88, P876; Wallstedt A, 1997, J CHEM ECOL, V23, P2345, DOI 10.1023/B:JOEC.0000006678.37973.be; Reigosa MJ, 1999, CRIT REV PLANT SCI, V18, P577, DOI 10.1080/07352689991309405; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Barrero AF, 1991, PHYTOCHEMISTRY, V30, P5933; Blum U, 1999, CRIT REV PLANT SCI, V18, P6733; Bonanomi G, 2006, NEW PHYTOLGIST, V169, P5713; Chu-Chou M, 1978, ANN APPL BIOL, V90, P4073; Duke SO, 2000, WEED RES, V40, P993; Einhellig FA, 1999, PRINCIPALS PRACTICES, P4793; Fernandez C, 2006, CHEMOECOLOGY, V16, P97, DOI 10.1007/s00049-006-0334-z; GROSS D, 1994, J PLANT GROWTH REGUL, V13, P93, DOI 10.1007/BF00210953; Harris MR, 2003, AUST J BOT, V51, P93, DOI 10.1071/BT02045; Inderjit, 1996, BOT REV, V62, P186, DOI 10.1007/BF02857921; Jia L, 2003, J BEIJING FOREST U, V25, P6; Kato-Noguchi H, 2011, PLANT GROWTH REGUL, V65, P299, DOI 10.1007/s10725-011-9601-2; Kato-Noguchi H, 2009, J PLANT PHYSIOL, V166, P442, DOI 10.1016/j.jplph.2008.06.012; KIL BS, 1983, J CHEM ECOL, V9, P1135, DOI 10.1007/BF00982217; Kinouchi Y, 2000, J NAT PROD, V63, P817, DOI 10.1021/np0000217; KOSHIMIZ.K, 1968, AGR BIOL CHEM TOKYO, V32, P789; Lee I. K., 1963, Bot. Mag., V76, P400; LODHI MAK, 1982, J CHEM ECOL, V8, P275, DOI 10.1007/BF00984023; LONSDALE WM, 1988, ANN BOT-LONDON, V61, P319; LOVEYS BR, 1981, AUST J PLANT PHYSIOL, V8, P571; Navarro-Cano JA, 2010, RESTOR ECOL, V18, P165, DOI 10.1111/j.1526-100X.2009.00606.x; Nektarios PA, 2005, HORTSCIENCE, V40, P246; Node Mari, 2003, Weed Biology and Management, V3, P111, DOI 10.1046/j.1445-6664.2003.00092.x; PUTNAM AR, 1988, WEED TECHNOL, V2, P510; Rice EL, 1984, ALLELOPATHY; Schuller WH, 1959, J AM CHEM SOC, V82, P1734; Son Doo-Sik, 1996, Journal of Korean Forestry Society, V85, P372; Tanaka R, 1997, PHYTOCHEMISTRY, V46, P1051, DOI 10.1016/S0031-9422(97)84396-8	37	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1226-9239	1867-0725		J PLANT BIOL	J. Plant Biol.	FEB	2015	58	1					61	67		10.1007/s12374-014-0322-8		7	Plant Sciences	Plant Sciences	AZ0UL	WOS:000347960200008		
J	Yamaguchi, H; Nakanishi, S; Iba, H; Itoh, T				Yamaguchi, Hiroyuki; Nakanishi, Shinji; Iba, Hideki; Itoh, Takahito			Amorphous polymeric anode materials from poly(acrylic acid) and tin(II) oxide for lithium ion batteries	JOURNAL OF POWER SOURCES			English	Article						Anode material; Amorphous; Poly(acrylic acid); Tin oxide (II); Lithium ion batteries	ELECTROCHEMICAL REACTION; DEGRADATION MECHANISMS; THERMAL DECOMPOSITIONS; NEGATIVE ELECTRODES; METAL POLYACRYLATES; TIN; STABILITY; COMPOSITE; STORAGE; SNO2	The reaction of poly(acrylic acid) (FAA) and tin oxide (II) (SnO) provides an amorphous product (PSnA), which was found to be a promising precursor of an anode material for lithium ion batteries. The anode electrode composed of PSnA as the active material and polyimide as the binder showed a better cycling performance than the anode electrode using SnO as the active material. It is considered that the organic polymer chain present in PSnA might act as a buffer to the volume change in the active material during the charge discharge cycles. The X-ray diffraction (XRD) results of the electrode after delithiation revealed that nano-sized cubic tin (alpha-Sn) and tetragonal tin (beta-Sn) particles are formed in the active material. Therefore, it is concluded that these nano-sized tin particles in the polymer matrix were effective for the storage and release of Li ions. (C) 2014 Elsevier B.V. All rights reserved.	[Yamaguchi, Hiroyuki; Nakanishi, Shinji; Iba, Hideki] Toyota Motor Co Ltd, Battery Res Div, Shizuoka 4101193, Japan; [Yamaguchi, Hiroyuki; Itoh, Takahito] Mie Univ, Grad Sch Engn, Div Chem Mat, Tsu, Mie 5148507, Japan	Yamaguchi, H (reprint author), Toyota Motor Co Ltd, Battery Res Div, 1200 Mishuku, Shizuoka 4101193, Japan.	hiroyuki_yamaguchi_ac@mail.toyota.co.jp					Alcantara R, 2001, J SOLID STATE ELECTR, V6, P55, DOI 10.1007/s100080100194; Li J, 2010, ELECTROCHIM ACTA, V55, P2991, DOI 10.1016/j.electacta.2010.01.011; Kepler KD, 1999, ELECTROCHEM SOLID ST, V2, P307, DOI 10.1149/1.1390819; Idota Y, 1997, SCIENCE, V276, P1395, DOI 10.1126/science.276.5317.1395; Wang C, 2012, J PHYS CHEM C, V116, P4000, DOI 10.1021/jp300136p; Winter M, 1999, ELECTROCHIM ACTA, V45, P31, DOI 10.1016/S0013-4686(99)00191-7; Im HS, 2013, ACS NANO, V7, P11103, DOI 10.1021/nn404837d; Dahn JR, 2006, J ELECTROCHEM SOC, V153, pA361, DOI 10.1149/1.2150160; MCNEILL IC, 1990, POLYM DEGRAD STABIL, V30, P213, DOI 10.1016/0141-3910(90)90077-K; Brousse T, 1998, SOLID STATE IONICS, V113, P51, DOI 10.1016/S0167-2738(98)00366-X; Tian QH, 2014, J POWER SOURCES, V246, P587, DOI 10.1016/j.jpowsour.2013.08.009; Yamaguchi H, 2013, KOBUNSHI RONBUNSHU, V70, P87; Xiao YW, 1999, J ELECTROCHEM SOC, V146, P3623, DOI 10.1149/1.1392524; Mao O, 1998, J ELECTROCHEM SOC, V145, P4195, DOI 10.1149/1.1838936; Hochgatterer NS, 2008, ELECTROCHEM SOLID ST, V11, pA76, DOI 10.1149/1.2888173; Guo XW, 2013, J POWER SOURCES, V226, P75, DOI 10.1016/j.jpowsour.2012.10.068; Furukawa S., 1966, CHIBA DAIGAKU KOGAKU, V17, P33; Furukawa S., 1963, CHIBA DAIGAKU KOGAKU, V14, P116; Furukawa S., 1963, CHIBA DAIGAKU KOGAKU, V14, P39; GRONOWSKI A, 1983, J THERM ANAL, V26, P233, DOI 10.1007/BF01913207; HETPER J, 1981, J THERM ANAL, V20, P345, DOI 10.1007/BF01912883; Inoue H., 2008, ELECTROCHEMISTRY, V76, P358; Liu HP, 2009, ELECTROCHIM ACTA, V54, P5782, DOI 10.1016/j.electacta.2009.05.030; Matsumura T, 2003, SOLID STATE IONICS, V158, P253, DOI 10.1016/S0167-2738(02)00913-X; MCNEILL IC, 1990, POLYM DEGRAD STABIL, V30, P267, DOI 10.1016/0141-3910(90)90081-H; Nagayama M, 1998, SOLID STATE IONICS, V106, P33, DOI 10.1016/S0167-2738(97)00481-5; NICHOLSON JW, 1988, BRIT POLYM J, V20, P97, DOI 10.1002/pi.4980200203; Ren QQ, 2012, J POWER SOURCES, V199, P336, DOI 10.1016/j.jpowsour.2011.10.039; SKUPINSKA J, 1986, J THERM ANAL, V31, P1017, DOI 10.1007/BF02119255	29	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	FEB 1	2015	275						1	5		10.1016/j.jpowsour.2014.10.071		5	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AZ2UT	WOS:000348088400001		
J	Towada, J; Karouji, T; Sato, H; Kadoma, Y; Shimada, K; Ui, K				Towada, Jun; Karouji, Tomohiro; Sato, Hiroki; Kadoma, Yoshihiro; Shimada, Kazuaki; Ui, Koichi			Charge discharge characteristics of natural graphite electrode in N, N-diethyl-N-methyl-N-(2-methoxyethyl)ammonium bis(trifluoromethylsulfonyl)amide containing lithium ion for lithium-ion secondary batteries	JOURNAL OF POWER SOURCES			English	Article						Lithium-ion secondary battery; Room-temperature ionic liquid; Bis(trifluoromethylsulfonyl)amide; Negative electrode; Natural graphite	LIQUID ELECTROLYTES; NEGATIVE ELECTRODE; ELECTROCHEMICAL INTERCALATION; POLYACRYLIC-ACID; SURFACE	We investigated the electrochemical characteristics of a natural graphite electrode in room-temperature ionic liquids not containing additives. N, N-diethyl-N-methyl-N-(2-methoxyethyl)ammonium bis(trifluoromethylsulfonyl)amide (DEME-TFSA) containing lithium bis(trifluoromethylsulfonyl)amide (LiTFSA) as the electrolyte and a natural graphite electrode as the negative electrode material were employed. The charge discharge tests showed that the discharge capacity and the charge discharge efficiency of the natural graphite electrode at the 1st cycle were 318 mAh g(-1) and 75.6%, respectively. The cycle performance showed that the discharge capacity and the charge discharge efficiency were stably maintained at ca. 320 inAh g(-1) and 100%, respectively, until the initial 10th cycle. The ex-situ X-ray diffraction measurements showed that lithium graphite intercalation compounds, such as LiC12 and LiC6, were formed after the 1st charge. The structural change in the natural graphite electrode was reversible because graphite recovered to its original structure after the 1st discharge. These results clarified that the graphite electrode could operate as a negative electrode for lithium-ion secondary batteries in DEME-TFSA containing Li-TFSA without organic solvents. (C) 2014 Elsevier B.V. All rights reserved.	[Towada, Jun] Iwate Univ, Grad Sch Engn, Dept Frontier Matter & Funct Engn, Morioka, Iwate 0208551, Japan; [Karouji, Tomohiro; Sato, Hiroki; Kadoma, Yoshihiro; Ui, Koichi] Iwate Univ, Grad Sch Engn, Dept Frontier Mat & Funct Engn, Morioka, Iwate 0208551, Japan; [Shimada, Kazuaki] Iwate Univ, Grad Sch Engn, Dept Chem & Bioengn, Morioka, Iwate 0208551, Japan	Ui, K (reprint author), Iwate Univ, Grad Sch Engn, Dept Frontier Mat & Funct Engn, 4-3-5 Ueda, Morioka, Iwate 0208551, Japan.	kui@iwate-u.ac.jp			Japanese Ministry of Education, Science, Sports and Culture [25410248]; A-step (Exploratory Research) of Japan Science and Technology Agency (JST) [AS231Z04134C]	This study was partially supported by a Grant-in-Aid for Scientific Research (C) from the Japanese Ministry of Education, Science, Sports and Culture (No. 25410248) and A-step (Exploratory Research) of Japan Science and Technology Agency (JST) (AS231Z04134C).	Zheng HH, 2006, CARBON, V44, P203, DOI 10.1016/j.carbon.2005.07.038; Nguyen CC, 2010, ELECTROCHEM COMMUN, V12, P1593, DOI 10.1016/j.elecom.2010.09.003; Sato T, 2004, J POWER SOURCES, V138, P253, DOI 10.1016/j.jpowsour.2004.06.027; Seki S, 2008, J PHYS CHEM C, V112, P16708, DOI 10.1021/jp805403e; Sugimoto T, 2008, J POWER SOURCES, V183, P436, DOI 10.1016/j.jpowsour.2008.05.036; Letellier M, 2007, CARBON, V45, P1025, DOI 10.1016/j.carbon.2006.12.018; Howlett PC, 2006, J ELECTROCHEM SOC, V153, pA595, DOI 10.1149/1.2164726; Zhao L, 2007, J POWER SOURCES, V174, P352, DOI 10.1016/j.jpowsour.2007.06.131; Aurbach D, 1996, J ELECTROCHEM SOC, V143, P3809, DOI 10.1149/1.1837300; Seki S, 2005, ELECTROCHEM SOLID ST, V8, pA577, DOI 10.1149/1.2041330; Ishikawa M, 2006, J POWER SOURCES, V162, P658, DOI 10.1016/j.jpowsour.2006.02.077; Carlin RT, 1996, J APPL ELECTROCHEM, V26, P1147; Drofenik J, 2003, ELECTROCHIM ACTA, V48, P883, DOI 10.1016/S0013-4686(02)00784-3; Egashira M, 2010, ELECTROCHEMISTRY, V78, P370; Sutto TE, 2003, ELECTROCHEM SOLID ST, V6, pA50, DOI 10.1149/1.1543333; Towada J, 2013, ELECTROCHEMISTRY, V81, P432, DOI 10.5796/electrochemistry.81.432; Ui K, 2011, J POWER SOURCES, V196, P3900, DOI 10.1016/j.jpowsour.2010.12.007; Ui K, 2014, J POWER SOURCES, V247, P981, DOI 10.1016/j.jpowsour.2013.08.083; Ui K, 2007, J POWER SOURCES, V173, P518, DOI 10.1016/j.jpowsour.2007.04.078	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	FEB 1	2015	275						50	54		10.1016/j.jpowsour.2014.10.101		5	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AZ2UT	WOS:000348088400009		
J	Kuriyama, H; Saruwatari, H; Satake, H; Shima, A; Uesugi, F; Tanaka, H; Ushirogouchi, T				Kuriyama, Hiromichi; Saruwatari, Hidesato; Satake, Hideki; Shima, Amika; Uesugi, Fumihiko; Tanaka, Hiroki; Ushirogouchi, Tooru			Observation of anisotropic microstructural changes during cycling in LiNi0.5Co0.2Mn0.3O2 cathode material	JOURNAL OF POWER SOURCES			English	Article						Li ion secondary battery; Cathode; Microstructural changes; Transmission electron microscopy; Electron energy-loss spectroscopy	LITHIUM-ION BATTERIES; X-RAY-ABSORPTION; ELECTRONIC-STRUCTURE; HIGH-POWER; LONG-LIFE; SPECTROSCOPY; LI-1-XCO1/3NI1/3MN1/3O2; MICROSCOPY; PARTICLES; MECHANISM	Microstructural changes in LiNi0.5Co0.2Mn0.3O2 cathode material after charge/discharge cycles were investigated by transmission electron microscopy and electron energy loss-spectroscopy. The microstructure on the surface of the cycled primary particles of LiNi0.5Co0.2Mn0.3O2 changed from an ordered rock-salt structure into a metal monoxide-type rock-salt structure, and this was accompanied by reduction of the oxidation states of the transition metal ions, especially the Mn4+ ions. It should be noted that the (0001) surface of the primary particles remained intact after the cycling test. These results indicate that the degradation mechanism of LiNi0.5Co0.2Mn0.3O2 is different from that of other LiNiO2-based cathode materials previously reported. Tailoring the transition metal ion content ratios is expected to give LiNi1-x-yCoxMnyO2 various levels of surface stability. (C) 2014 Elsevier B.V. All rights reserved.	[Kuriyama, Hiromichi; Saruwatari, Hidesato; Satake, Hideki; Ushirogouchi, Tooru] Toshiba Co Ltd, Social Infrastruct Syst Co, Saiwai Ku, Kawasaki, Kanagawa 2120013, Japan; [Shima, Amika; Uesugi, Fumihiko] Toshiba Nanoanal Corp, Isogo Ku, Yokohama, Kanagawa 2358522, Japan; [Tanaka, Hiroki] Toshiba Co Ltd, Corp Res & Dev Ctr, Saiwai Ku, Kawasaki, Kanagawa 2128582, Japan	Kuriyama, H (reprint author), Toshiba Co Ltd, Social Infrastruct Syst Co, Saiwai Ku, 72-34 Horikawa Cho, Kawasaki, Kanagawa 2120013, Japan.	hiromichi2.kuriyama@toshiba.co.jp					Abraham DP, 2003, J ELECTROCHEM SOC, V150, pA1450, DOI 10.1149/1.1613291; Takami N, 2013, J POWER SOURCES, V244, P469, DOI 10.1016/j.jpowsour.2012.11.055; OHZUKU T, 1993, J ELECTROCHEM SOC, V140, P1862, DOI 10.1149/1.2220730; Yoon WS, 2007, J POWER SOURCES, V174, P1015, DOI 10.1016/j.jpowsour.2007.06.214; Zheng SJ, 2011, J ELECTROCHEM SOC, V158, pA357, DOI 10.1149/1.3544843; Miao S, 2005, J PHYS CHEM B, V109, P23473, DOI 10.1021/jp0542266; Weaving JS, 2001, J POWER SOURCES, V97-8, P733, DOI 10.1016/S0378-7753(01)00700-5; Sun YK, 2009, NAT MATER, V8, P320, DOI 10.1038/nmat2418; Sasaki T, 2009, J ELECTROCHEM SOC, V156, pA289, DOI 10.1149/1.3076136; Yin SC, 2006, CHEM MATER, V18, P1901, DOI 10.1021/cm0511769; Yoon WS, 2005, J AM CHEM SOC, V127, P17479, DOI 10.1021/ja0530568; Liao PY, 2007, ELECTROCHIM ACTA, V53, P1850, DOI 10.1016/j.electacta.2007.08.045; Tsai YW, 2005, CHEM MATER, V17, P3191, DOI 10.1021/cm048027v; KURATA H, 1993, PHYS REV B, V48, P2102, DOI 10.1103/PhysRevB.48.2102; Zeng YW, 2008, J POWER SOURCES, V183, P316, DOI 10.1016/j.jpowsour.2008.01.043; Deb A., 2005, J APPL PHYS, V97; DELMAS C, 1993, J POWER SOURCES, V44, P595, DOI 10.1016/0378-7753(93)80208-7; Egerton R. F., 1996, ELECT ENERGY LOSS SP; Graetz J, 2002, J PHYS CHEM B, V106, P1286, DOI 10.1021/jp0133283; Jung S.-K., 2013, ADV ENERGY MATER, V4; Kojima Y, 2011, J POWER SOURCES, V196, P7721, DOI 10.1016/j.jpowsour.2011.05.017; Lu ZH, 2001, ELECTROCHEM SOLID ST, V4, pA200, DOI 10.1149/1.1413182; Muto S., 2008, J ELECTROCHEM SOC, V156, pA371; Nonaka T, 2007, J ELECTROCHEM SOC, V154, pA353, DOI 10.1149/1.2472557; Ohzuku T, 2001, CHEM LETT, P642; Palacin MR, 1997, J ELECTROCHEM SOC, V144, P4226	26	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	FEB 1	2015	275						99	105		10.1016/j.jpowsour.2014.10.197		7	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AZ2UT	WOS:000348088400015		
J	Ishihara, T; Xie, J; Shin, TH; Ju, YW; Ida, S; Kilner, JA				Ishihara, Tatsumi; Xie, Jing; Shin, Tae Ho; Ju, Young-Wan; Ida, Shintaro; Kilner, John A.			Bi doped Pr6O11 as fluorite oxide cathode for all-fluorite solid oxide fuel cells	JOURNAL OF POWER SOURCES			English	Article						Fluorite oxide cathode; Solid oxide fuel cell; Anode; Praseodymium oxide	SURFACE EXCHANGE; LOW-TEMPERATURE; ANODE; SOFCS; ELECTROLYTES; COMPOSITE; CERIA; TECHNOLOGY; OXIDATION	Defect fluorite, Bi-doped Pr6O11, was studied as a cathode and it was found that Bi doped Pr6O11 exhibits high surface activity for the cathode reaction, and an all-fluorite concept SOFCs is successfully demonstrated by using Ce0.6Mn0.3Fe0.1O2 for anode. Diffusivity and surface activity in Bi doped Pr6O11 was further studied with O-18(2)-16O(2) gas phase exchange and a surface activity was competitively high with that of La0.6Sr0.4Fe0.8Co0.2O3 (LSFC), and this high surface activity is a result of the large oxygen vacancy in Pr6O11. The power generation property of the cell was also examined by using C3H8 and the power density of 0.4 W/cm(2) was exhibited when dry C3H8 was directly used for a fuel because of decreased IR loss. (C) 2014 Elsevier B.V. All rights reserved.	[Ishihara, Tatsumi; Xie, Jing; Shin, Tae Ho; Ju, Young-Wan; Ida, Shintaro] Kyushu Univ, Fac Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Ishihara, Tatsumi; Ida, Shintaro; Kilner, John A.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka, Japan; [Kilner, John A.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England	Ishihara, T (reprint author), Kyushu Univ, Fac Engn, Dept Appl Chem, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	ishihara@cstf.kyushu-u.ac.jp			JSPS [24226016]	Part of this work was financially supported by JSPS Grant-in-Aid for Scientific Research (S) (No. 24226016).	ISHIHARA T, 1994, J AM CHEM SOC, V116, P3801, DOI 10.1021/ja00088a016; Xia CR, 2001, SOLID STATE IONICS, V144, P249, DOI 10.1016/S0167-2738(01)00980-8; Minh NQ, 2004, SOLID STATE IONICS, V174, P271, DOI 10.1016/j.ssi.2004.07.042; Zhan ZL, 2005, SCIENCE, V308, P844, DOI 10.1126/science.1109213; Singhal SC, 2000, SOLID STATE IONICS, V135, P305, DOI 10.1016/S0167-2738(00)00452-5; Lane JA, 1999, SOLID STATE IONICS, V121, P201, DOI 10.1016/S0167-2738(99)00014-4; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; Li HJ, 2012, RSC ADV, V2, P3857, DOI 10.1039/c2ra01256a; Shin TH, 2011, J AM CHEM SOC, V133, P19399, DOI 10.1021/ja206278f; Armstrong EN, 2011, J ELECTROCHEM SOC, V158, pB492, DOI 10.1149/1.3555122; Ishihara T, 2010, ELECTROCHEM SOLID ST, V13, pB95, DOI 10.1149/1.3430667; Atkinson A, 2004, NAT MATER, V3, P17, DOI 10.1038/nmat1040; Zha SW, 2003, J POWER SOURCES, V115, P44, DOI 10.1016/S0378-7753(02)00625-0; Hsu MF, 2006, ELECTROCHEM SOLID ST, V9, pA193, DOI 10.1149/1.2167929; Skinner SJ, 2001, INT J INORG MATER, V3, P113, DOI 10.1016/S1466-6049(01)00004-6; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Stambouli AB, 2002, RENEW SUST ENERG REV, V6, P433, DOI 10.1016/S1364-0321(02)00014-X; Manning PS, 1996, SOLID STATE IONICS, V93, P125, DOI 10.1016/S0167-2738(96)00514-0; Zheng K, 1996, SOLID STATE IONICS, V86-8, P1241, DOI 10.1016/0167-2738(96)00294-9; Ishihara T, 2009, CATAL COMMUN, V10, P1722, DOI 10.1016/j.catcom.2009.05.016; Kan CC, 2010, SOLID STATE IONICS, V181, P338, DOI 10.1016/j.ssi.2009.12.011; Kuru Y, 2011, ECS TRANSACTIONS, V35, P1131, DOI 10.1149/1.3570094; Matsui T, 2005, SOLID STATE IONICS, V176, P663, DOI 10.1016/j.ssi.2004.10.010; Mohammadi A., 2006, J FUEL CELL SCI TECH, V6, P1; Shin TH, 2010, J ELECTROCHEM SOC, V157, pB1896, DOI 10.1149/1.3500979; Zhang J, 1996, J SOLID STATE CHEM, V122, P53, DOI 10.1006/jssc.1996.0081	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	FEB 1	2015	275						167	174		10.1016/j.jpowsour.2014.10.159		8	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AZ2UT	WOS:000348088400023		
J	Tanibata, N; Matsuyama, T; Hayashi, A; Tatsumisago, M				Tanibata, Naoto; Matsuyama, Takuya; Hayashi, Akitoshi; Tatsumisago, Masahiro			All-solid-state sodium batteries using amorphous TiS3 electrode with high capacity	JOURNAL OF POWER SOURCES			English	Article						All-solid-state battery; Sodium battery; Amorphous electrode; TiS3; Sulfide	LITHIUM SECONDARY BATTERIES; GLASS-CERAMIC ELECTROLYTES; BEHAVIOR	All-solid-state sodium cells (Na15Sn4/Na3PS4 glass-ceramic/a-TiS3) showed a high capacity of over 300 mAh per gram of TiS3 at the 1st dischargecharge cycle. The capacity was gradually decreased to 100 mAh g(-1) at the 10th cycle. Nyquist plots of the cell showed that the resistance of the alpha-TiS3 composite electrode became larger with the dischargecharge cycles. The XRD patterns of the alpha-TiS3 composite electrode before and after the 1st cycle indicated that the alpha-TiS3 was still amorphous during dischargecharge process. The Raman bands attributable to alpha-TiS3 were also observed after the 1st cycle. The SEM images and EDX mapping indicated that the alpha-TiS3 particles aggregated in the electrode after the 10th cycle. The all-solid-state sodium cell using alpha-TiS3 composite electrode with acetylene black as a conductive additive showed the high capacity of over 300 mAh g(-1) for 5 cycles. (C) 2014 Elsevier B.V. All rights reserved.	[Tanibata, Naoto; Matsuyama, Takuya; Hayashi, Akitoshi; Tatsumisago, Masahiro] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Sakai, Osaka 5998531, Japan	Hayashi, A (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	hayashi@chem.osakafu-u.ac.jp			JST "Advanced Low Carbon Technology Research and Development Program" and; MEXT program "Elements Strategy Initiative to Form Core Research Center"	The present work was partially supported by JST "Advanced Low Carbon Technology Research and Development Program" and MEXT program "Elements Strategy Initiative to Form Core Research Center".	Matsuyama T, 2013, J SOLID STATE ELECTR, V17, P2697, DOI 10.1007/s10008-013-2157-5; Ohta N, 2006, ADV MATER, V18, P2226, DOI 10.1002/adma.200502604; Minami T, 2006, SOLID STATE IONICS, V177, P2715, DOI 10.1016/j.ssi.2006.07.017; Yamamoto T, 2012, J POWER SOURCES, V217, P479, DOI 10.1016/j.jpowsour.2012.05.110; Hayashi A, 2012, CHEM LETT, V41, P886, DOI 10.1246/cl.2012.886; Ellis BL, 2012, CURR OPIN SOLID ST M, V16, P168, DOI 10.1016/j.cossms.2012.04.002; Hayashi A., 2014, J POWER SOURCES, V671, P102; Hayashi A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1843; HOLLECK GL, 1977, ELECTROCHIM ACTA, V22, P647, DOI 10.1016/0013-4686(77)85134-7; Lindic MH, 2005, SOLID STATE IONICS, V176, P1529, DOI 10.1016/j.ssi.2005.04.007; ONUKI Y, 1983, SOLID STATE IONICS, V11, P195; Tanibata N., 2014, CHEMELECTROCHEM, V1, P1130; Tatsumisago M, 2008, FUNCT MATER LETT, V1, P31, DOI 10.1142/S1793604708000071; ZANINI M, 1981, J ELECTROCHEM SOC, V128, P1647, DOI 10.1149/1.2127703	14	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	FEB 1	2015	275						284	287		10.1016/j.jpowsour.2014.10.193		4	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AZ2UT	WOS:000348088400036		
J	Park, YC; Kakinuma, K; Uchida, H; Watanabe, M; Uchida, M				Park, Young-Chul; Kakinuma, Katsuyoshi; Uchida, Hiroyuki; Watanabe, Masahiro; Uchida, Makoto			Effects of short-side-chain perfluorosulfonic acid ionomers as binders on the performance of low Pt loading fuel cell cathodes	JOURNAL OF POWER SOURCES			English	Article						Short-side-chain perfluorosulfonic acid ionomer; Low Pt loading; Cathode catalyst layer; Polymer electrolyte fuel cells	GAS-DIFFUSION ELECTRODES; CATALYST LAYERS; SULFONATED POLYIMIDE; MEMBRANES; PROTON; DEPENDENCE; TRANSPORT; PLATINUM; HUMIDITY; WATER	We investigated the effects of short-side-chain (SSC) perfiuorosulfonic acid ionomers on the electrochemical properties, fuel cell performance and ionomer distribution of a highly dispersed Pt/GCB catalyst with a low Pt loading, 0.05 mg cm(-2). The SSC ionomers in the cathode catalyst layers (CLs) resulted in an improvement of the Pt utilization (U-pt) and Pt effectiveness (Ef(pt)) values compared with those for the conventional long-side-chain (LSC) ionomer. Furthermore, the SSC ionomers with high ion exchange capacity (IEC), e.g., SSC-1.43 and SSC-1.80 ionomers, exhibited significantly enhanced cell performance under low to medium relative humidity (RH) conditions. This result is ascribed to the higher proton conductivity of the SSC ionomers and more effective trapping of water that is produced during the oxygen reduction reaction (ORR) than those of the [SC ionomer. It was also found that the SSC ionomers showed better continuity and uniformity on the Pt and carbon particles than the LSC ionomer, which might have led to improvement of both the mass transport and the proton-conducting network in the CLs. The application of the SSC ionomers as binders demonstrated an increase of the performance at the low Pt loading fuel cell cathode over a wide range of humidity. (C) 2014 Elsevier B.V. All rights reserved.	[Park, Young-Chul; Kakinuma, Katsuyoshi; Watanabe, Masahiro; Uchida, Makoto] Univ Yamanashi, Fuel Cell Nanomat Ctr, Kofu, Yamanashi 4000021, Japan; [Uchida, Hiroyuki] Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi 4008511, Japan	Uchida, M (reprint author), Univ Yamanashi, Fuel Cell Nanomat Ctr, 6-43 Miyamae, Kofu, Yamanashi 4000021, Japan.	m-watanabe@yamanashi.ac.jp; uchidam@yamanashi.ac.jp			"Research on Nanotechnology for High Performance Fuel Cells (HiPer-FC)" project from the New Energy and Industrial Technology Development Organization (NEDO) of Japan	This work was supported by funds for the "Research on Nanotechnology for High Performance Fuel Cells (HiPer-FC)" project from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The authors are grateful to N. Miyake, Asahi Kasei E-Materials Co., for kindly providing the experimental SSC ionomers.	Kreuer KD, 2008, J POWER SOURCES, V178, P499, DOI 10.1016/j.jpowsour.2007.11.011; Subbaraman R, 2010, CHEMPHYSCHEM, V11, P2825, DOI 10.1002/cphc.201000190; UCHIDA M, 1995, J ELECTROCHEM SOC, V142, P463, DOI 10.1149/1.2044068; Stassi A, 2011, J POWER SOURCES, V196, P8925, DOI 10.1016/j.jpowsour.2010.12.084; Ghielmi A, 2005, J POWER SOURCES, V145, P108, DOI 10.1016/j.jpowsour.2004.12.068; Yoda T, 2009, ELECTROCHIM ACTA, V54, P4328, DOI 10.1016/j.electacta.2009.02.099; Bae B, 2010, J PHYS CHEM B, V114, P10481, DOI 10.1021/jp1052908; WATANABE M, 1986, J ELECTROANAL CHEM, V197, P195, DOI 10.1016/0022-0728(86)80149-8; Lee M, 2011, ELECTROCHIM ACTA, V56, P4783, DOI 10.1016/j.electacta.2011.03.072; Yano H, 2010, PHYS CHEM CHEM PHYS, V12, P3806, DOI 10.1039/b923460h; Yang D, 2009, CARBON, V47, P145, DOI 10.1016/j.carbon.2008.09.045; Omata T, 2012, PHYS CHEM CHEM PHYS, V14, P16713, DOI 10.1039/c2cp42997g; Lee M, 2010, ELECTROCHIM ACTA, V55, P8504, DOI 10.1016/j.electacta.2010.07.071; Holdcroft S, 2014, CHEM MATER, V26, P381, DOI 10.1021/cm401445h; Uchida M, 2013, PHYS CHEM CHEM PHYS, V15, P11236, DOI 10.1039/c3cp51801a; Iden H, 2013, J ELECTROANAL CHEM, V693, P34, DOI 10.1016/j.jelechem.2013.01.026; Yue ZR, 1999, CARBON, V37, P1785, DOI 10.1016/S0008-6223(99)00047-0; Luo XY, 2011, PHYS CHEM CHEM PHYS, V13, P18055, DOI 10.1039/c1cp22559f; Omata T, 2012, ACS APPL MATER INTER, V4, P730, DOI 10.1021/am201360j; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; WILSON MS, 1992, J ELECTROCHEM SOC, V139, pL28, DOI 10.1149/1.2069277; Zhao NN, 2013, J POWER SOURCES, V242, P877, DOI 10.1016/j.jpowsour.2013.05.176; TICIANELLI EA, 1988, J ELECTROANAL CHEM, V251, P275, DOI 10.1016/0022-0728(88)85190-8; Konno M, 2014, ULTRAMICROSCOPY, V145, P28, DOI 10.1016/j.ultramic.2013.09.001; Barbir F, 2005, SUSTAIN WORLD SER, P1, DOI 10.1016/B978-012078142-3/50002-1; Carter R N, 2007, ECS T, V11, P423, DOI 10.1149/1.2780956; Higuchi E, 2006, RES CHEM INTERMEDIAT, V32, P533, DOI 10.1163/156856706777973781; Lei C, 2011, J POWER SOURCES, V196, P6168, DOI 10.1016/j.jpowsour.2011.03.024; liyama A., 2009, HDB FUEL CELLS FUNDA, V6; Moukheiber E, 2012, J MEMBRANE SCI, V389, P294, DOI 10.1016/j.memsci.2011.10.041; O'Hayre R., 2009, FUEL CELL FUNDAMENTA; Peron J, 2011, J POWER SOURCES, V196, P179, DOI 10.1016/j.jpowsour.2010.06.050	32	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	FEB 1	2015	275						384	391		10.1016/j.jpowsour.2014.10.149		8	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AZ2UT	WOS:000348088400049		
J	Nishida, K; Taniguchi, R; Ishizaki, Y; Tsushima, S; Hirai, S				Nishida, Kosuke; Taniguchi, Ryo; Ishizaki, Yugo; Tsushima, Shohji; Hirai, Shuichiro			Impacts of channel wettability and flow direction on liquid water transport in the serpentine flow field of a polymer electrolyte fuel cell	JOURNAL OF POWER SOURCES			English	Article						Polymer electrolyte fuel cell; Serpentine flow field; Liquid water transport; Channel wettability; Flow direction; Visualization	NEUTRON IMAGING TECHNIQUE; 2-PHASE FLOW; CATHODE CHANNELS; PART; QUANTIFICATION; RADIOGRAPHY; MANAGEMENT; BEHAVIOR; VISUALIZATION; MANIFOLDS	Water plugging in cathode flow field of polymer electrolyte fuel cells (PEFCs) is one of the critical issues to be solved for high power density and high durability. To alleviate performance degradation due to water plugging, it is necessary to control liquid water transport inside gas channel and promote water removal. In this study, the in-situ visualization of liquid water behavior in the serpentine flow field of a specialized transparent PEFC was performed using a high-speed camera. Furthermore, the cell voltage and the differential pressure between the cathode inlet and outlet were simultaneously measured, and the effects of channel wettability and flow direction on the water transport and cell performance were investigated under operating conditions. It was found that the horizontal arrangement of the serpentine channel enhances liquid water removal from the cell without being disturbed by gravity. Especially, highly hydrophilic coating of the horizontally oriented serpentine channel effectively suppresses water plugging and reduces the differential pressure inside the cathode flow field. (C) 2014 Elsevier B.V. All rights reserved.	[Nishida, Kosuke; Taniguchi, Ryo; Ishizaki, Yugo] Kyoto Inst Technol, Dept Mech & Syst Engn, Sakyo Ku, Kyoto 6068585, Japan; [Tsushima, Shohji] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan; [Hirai, Shuichiro] Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, Tokyo 1528552, Japan	Nishida, K (reprint author), Kyoto Inst Technol, Dept Mech & Syst Engn, Sakyo Ku, Kyoto 6068585, Japan.	knishida@kit.ac.jp					Zhang JB, 2006, ELECTROCHIM ACTA, V51, P2715, DOI 10.1016/j.electacta.2005.08.010; Yoshizawa K, 2008, J ELECTROCHEM SOC, V155, pB223, DOI 10.1149/1.2823003; Yang XG, 2004, ELECTROCHEM SOLID ST, V7, pA408, DOI 10.1149/1.1803051; Wang ZH, 2001, J POWER SOURCES, V94, P40, DOI 10.1016/S0378-7753(00)00662-5; Maier W, 2010, ELECTROCHEM COMMUN, V12, P1436, DOI 10.1016/j.elecom.2010.08.002; Boillat P, 2008, ELECTROCHEM COMMUN, V10, P546, DOI 10.1016/j.elecom.2008.01.018; Trabold TA, 2006, INT J HEAT MASS TRAN, V49, P4712, DOI 10.1016/j.ijheatmasstransfer.2006.07.003; Zhang FY, 2006, J ELECTROCHEM SOC, V153, pA225, DOI 10.1149/1.2138675; Tuber K, 2003, J POWER SOURCES, V124, P403, DOI 10.1016/S0378-7753(03)00797-3; Sasabe T, 2010, INT J HYDROGEN ENERG, V35, P11119, DOI 10.1016/j.ijhydene.2010.06.050; Kramer D, 2005, ELECTROCHIM ACTA, V50, P2603, DOI 10.1016/j.electacta.2004.11.005; Hickner MA, 2010, J ELECTROCHEM SOC, V157, pB32, DOI 10.1149/1.3250864; Ma HP, 2006, J POWER SOURCES, V162, P469, DOI 10.1016/j.jpowsour.2006.06.055; Turhan A, 2006, J POWER SOURCES, V160, P1195, DOI 10.1016/j.jpowsour.2006.03.027; Sinha PK, 2006, ELECTROCHEM SOLID ST, V9, pA344, DOI 10.1149/1.2203307; Liu X, 2007, ELECTROCHIM ACTA, V52, P3607, DOI 10.1016/j.electacta.2006.10.030; Bellows RJ, 1999, J ELECTROCHEM SOC, V146, P1099, DOI 10.1149/1.1391727; Nishida K, 2010, J POWER SOURCES, V195, P3365, DOI 10.1016/j.jpowsour.2009.12.073; Turhan A, 2010, ELECTROCHIM ACTA, V55, P2734, DOI 10.1016/j.electacta.2009.11.095; Liu X, 2008, INT J HYDROGEN ENERG, V33, P1040, DOI 10.1016/j.ijhydene.2007.11.018; Qin CZ, 2012, J ELECTROCHEM SOC, V159, pB434, DOI 10.1149/2.004205jes; Hickner MA, 2006, J ELECTROCHEM SOC, V153, pA902, DOI 10.1149/1.2184893; Kim HI, 2010, CURR APPL PHYS, V10, pS91, DOI 10.1016/j.cap.2009.11.050; Owejan JP, 2009, INT J HYDROGEN ENERG, V34, P3436, DOI 10.1016/j.ijhydene.2008.12.100; Satija R, 2004, J POWER SOURCES, V129, P238, DOI 10.1016/j.jpowsour.2003.11.068; Liu X, 2006, J POWER SOURCES, V156, P267, DOI 10.1016/j.jpowsour.2005.06.027; Cai YH, 2006, J POWER SOURCES, V161, P843, DOI 10.1016/j.jpowsour.2006.04.110; Hussaini IS, 2009, J POWER SOURCES, V187, P444, DOI 10.1016/j.jpowsour.2008.11.030; Pasaogullari U, 2005, J ELECTROCHEM SOC, V152, pA380, DOI 10.1149/1.1850339; Hartnig C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2907485; Spernjak D, 2007, J POWER SOURCES, V170, P334, DOI 10.1016/j.jpowsour.2007.04.020; Quan P, 2005, J POWER SOURCES, V152, P131, DOI 10.1016/j.jpowsour.2005.02.075; Lee SJ, 2008, J POWER SOURCES, V185, P867, DOI 10.1016/j.jpowsour.2008.08.101; Lu ZJ, 2011, INT J HYDROGEN ENERG, V36, P9864, DOI 10.1016/j.ijhydene.2011.04.226; Zhu W, 2008, ECS TRANSACTIONS, V16, P995, DOI 10.1149/1.2981939; Manke I, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2731440; Geiger AB, 2002, FUEL CELLS, V2, P92, DOI 10.1002/fuce.200290007; He GL, 2007, J POWER SOURCES, V163, P864, DOI 10.1016/j.jpowsour.2006.09.059; He GL, 2010, J POWER SOURCES, V195, P1561, DOI 10.1016/j.jpowsour.2009.09.052; Jiao K, 2006, J POWER SOURCES, V157, P226, DOI 10.1016/j.jpowsour.2005.06.041; Jiao K, 2006, J POWER SOURCES, V154, P124, DOI 10.1016/j.jpowsour.2005.04.003; Natarajan D, 2001, J ELECTROCHEM SOC, V148, pA1324, DOI 10.1149/1.1415032; Quan P, 2007, J POWER SOURCES, V164, P222, DOI 10.1016/j.jpowsour.2006.09.110; Utturkar A., 2011, P ASME 2011 9 FUEL C, P54262; Zhan ZG, 2006, J POWER SOURCES, V160, P1, DOI 10.1016/j.jpowsour.2005.12.081; Zhu X, 2007, J POWER SOURCES, V172, P287, DOI 10.1016/j.jpowsour.2007.07.024	46	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	FEB 1	2015	275						447	457		10.1016/j.jpowsour.2014.11.059		11	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AZ2UT	WOS:000348088400056		
J	Jeong, M; Yokoshima, T; Nara, H; Momma, T; Osaka, T				Jeong, Moongook; Yokoshima, Tokihiko; Nara, Hiroki; Momma, Toshiyuki; Osaka, Tetsuya			Effect of electrolyte on cycle performances of the electrodeposited Sn-O-C composite anode of lithium secondary batteries	JOURNAL OF POWER SOURCES			English	Article						Tin; Anode; Sn-O-C composite; Electrodeposition; Electrolyte; Lithium secondary batteries	ION BATTERIES; CORROSION; LIQUID; NICKEL; ALLOY; ACID	The electrodeposited Sn-O-C composite anode cycling with LiClO4 delivered stable cycle performances showing discharge capacity of 473 mA h g Risri with 95% of coulombic efficiency at 100th cycle. However, the anode showed poor cycle performances with LiPF6 delivering discharge capacity of 69 mA h g(-1) of sn at 100th cycle with 70% of coulombic efficiency. Electrochemical investigation performed by cyclic voltammetry and differential capacity plots revealed that the Sn-O-C composite cycling with LiPF86 suffered from retarded phase transition reaction between Li and Sn during charge/discharge process. X-ray photoelectron spectroscopy declared the existence of fluorinated-Sn and LiF. Moreover, energy dispersive X-ray spectroscopy found increase in their amount with repeated cycles. The morphologies of the Sn-O-C composite cycled with LiPF6 showed aggregated particles containing the chemical state of fluorinated-Sn and LiF on its surface. Furthermore, the significant pulverization and aggregation of the active material were observed from the Sn-O-C composite cycled by LiPF6 rather than that of LiClO4, which was probably promoted by the generated HF strongly corroding metallic component. (C) 2014 Elsevier B.V. All rights reserved.	[Jeong, Moongook; Momma, Toshiyuki; Osaka, Tetsuya] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Jeong, Moongook; Yokoshima, Tokihiko; Nara, Hiroki; Momma, Toshiyuki; Osaka, Tetsuya] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Osaka, T (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	osakatets@waseda.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was partly supported by a Grant-in-Aid for specially promoted research "Establishment of electrochemical device engineering" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, "Advanced Low Carbon Technology Research and Development Program, Specially Promoted Research for Innovative Next Generation Batteries (ALCA SPRING)" from Japan Science and Technology Agency (JST), Japan.	Kawamura T, 2006, J POWER SOURCES, V156, P547, DOI 10.1016/j.jpowsour.2005.05.084; Zhang SS, 2002, J POWER SOURCES, V109, P458, DOI 10.1016/S0378-7753(02)00110-6; Chou SL, 2011, DALTON T, V40, P12801, DOI 10.1039/c1dt10396b; Nishimura Y, 2007, ELECTROCHIM ACTA, V53, P111, DOI 10.1016/j.electacta.2007.06.026; Li JT, 2011, J PHYS CHEM C, V115, P7012, DOI 10.1021/jp201232n; Heider U, 1999, J POWER SOURCES, V81, P119, DOI 10.1016/S0378-7753(99)00142-1; Xu K, 2004, CHEM REV, V104, P4303, DOI 10.1021/cr030203g; Nara H, 2012, ENERG ENVIRON SCI, V5, P6500, DOI 10.1039/c2ee03278c; Al-Salman R, 2008, PHYS CHEM CHEM PHYS, V10, P6233, DOI 10.1039/b809075k; Momma T, 2011, ELECTROCHEM COMMUN, V13, P969, DOI 10.1016/j.elecom.2011.06.014; Li YP, 2014, CORROS SCI, V78, P101, DOI 10.1016/j.corsci.2013.09.004; Aurbach D., 1999, NONAQUEOUS ELECTROCH, P68; Bechelany M, 2012, THIN SOLID FILMS, V520, P1895, DOI 10.1016/j.tsf.2011.09.026; Choo MH, 2013, ELECTROCHIM ACTA, V112, P252, DOI 10.1016/j.electacta.2013.08.121; Jeong M, 2014, J ELECTROCHEM SOC, V161, pD3025, DOI 10.1149/2.004407jes; Jeong M, 2014, RSC ADV, V4, P26872, DOI 10.1039/c4ra03435j; Momma T, 2013, J POWER SOURCES, V242, P527, DOI 10.1016/j.jpowsour.2013.05.136; Nara H, 2013, ELECTROCHIM ACTA, V110, P403, DOI 10.1016/j.electacta.2013.07.143; Osaka T, 2014, J MATER CHEM A, V2, P883, DOI 10.1039/c3ta13080k	19	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-7753	1873-2755		J POWER SOURCES	J. Power Sources	FEB 1	2015	275						525	530		10.1016/j.jpowsour.2014.11.008		6	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AZ2UT	WOS:000348088400065		
J	Yokokita, T; Ooe, K; Kasamatsu, Y; Yoshimura, T; Takahashi, N; Shiohara, N; Takamiya, K; Komori, Y; Kikutani, Y; Kino, A; Shinohara, A				Yokokita, T.; Ooe, K.; Kasamatsu, Y.; Yoshimura, T.; Takahashi, N.; Shiohara, N.; Takamiya, K.; Komori, Y.; Kikutani, Y.; Kino, A.; Shinohara, A.			Solvent extraction using carrier-free radiotracers of Mo and W from HCl and HCl/LiCl solutions into Aliquat 336	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Molybdenum (Mo); Tungsten (W); Lithium chloride (LiCl); Hydrochloric acid (HCl); Aliquat 336; Seaborgium (Sg)	SEABORGIUM ELEMENT 106; SHORT-LIVED ISOTOPES; ANION-EXCHANGE; AQUEOUS CHEMISTRY; HOMOLOGS; BEHAVIOR; HF; SYSTEM; AMINES; MEDIA	We performed solvent extraction of Mo-99 and W-181 from HCl and HCl/LiCl solutions into Aliquat 336-chloroform solutions. It is found that the extracted anionic species of Mo and W have a net charge of -1 from the logD versus log[Aliquat 336] plots. At high H3O+ concentrations, the D values in HCl were lower than those in HCl/LiCl, probably because of the protonation of anionic Mo and W species in HCl. The D values of Mo were significantly higher than those of W, suggesting that the extracted Mo and W species are different from each other and/or have different stabilities in HCl.	[Yokokita, T.; Kasamatsu, Y.; Takahashi, N.; Komori, Y.; Kikutani, Y.; Kino, A.; Shinohara, A.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Ooe, K.] Niigata Univ, Fac Sci, Niigata 9502181, Japan; [Yoshimura, T.] Osaka Univ, Radioisotope Res Ctr, Suita, Osaka 5650871, Japan; [Shiohara, N.] Osaka Univ, Sch Sci, Toyonaka, Osaka 5600043, Japan; [Takamiya, K.] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan	Yokokita, T (reprint author), Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan.	yokokita@chem.sci.osaka-u.ac.jp					KRATZ JV, 1989, RADIOCHIM ACTA, V48, P121; SEELEY FG, 1966, J CHEM ENG DATA, V11, P424, DOI 10.1021/je60030a043; Fan FL, 2009, RADIOCHIM ACTA, V97, P297, DOI 10.1524/ract.2009.1624; Griffith WP, 1967, J CHEM SOC A, V9, P675; Heinter-Wirguin C, 1965, J INORG NUCL CHEM, V27, P1989; Johansson M, 2003, RADIOCHIM ACTA, V91, P351, DOI 10.1524/ract.91.6.351.20021; Kolthoff IM, 1949, TXB QUANTITATIVE INO; Kronenberg A, 2004, RADIOCHIM ACTA, V92, P395, DOI 10.1524/ract.92.7.395.35747; Liang XH, 2012, J RADIOANAL NUCL CH, V292, P917, DOI 10.1007/s10967-012-1624-2; Mishra S, 1996, RADIOCHIM ACTA, V73, P89; OMORI T, 1962, B CHEM SOC JPN, V35, P1633, DOI 10.1246/bcsj.35.1633; Ooe K, 2011, P RADIOCHIM ACTA, V1, P127; Pfrepper G, 2000, RADIOCHIM ACTA, V88, P273, DOI 10.1524/ract.2000.88.5.273; SATO T, 1995, HYDROMETALLURGY, V37, P253, DOI 10.1016/0304-386X(94)00066-C; Schadel M, 1997, RADIOCHIM ACTA, V77, P149; Schadel M, 2006, ANGEW CHEM INT EDIT, V45, P368, DOI 10.1002/anie.200461072; Schadel M, 1998, RADIOCHIM ACTA, V83, P163; Takamiya K, 2000, J NUCL RADIOCHEM SCI, V1, P81; Trubert D, 1996, ANAL CHIM ACTA, V332, P257, DOI 10.1016/0003-2670(96)00242-5	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1091	1094		10.1007/s10967-014-3449-7		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200002		
J	Aoyagi, N; Watanabe, M; Kirishima, A; Sato, N; Kimura, T				Aoyagi, Noboru; Watanabe, Masayuki; Kirishima, Akira; Sato, Nobuaki; Kimura, Takaumi			Optical properties of tetravalent uranium complexes in non-aqueous media	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Uranium(IV) complexes; UV-Vis-NIR absorption spectra; Time-resolved laser-induced fluorescence spectroscopy (TRLFS); Ionic liquids	FLUORESCENCE SPECTROSCOPY; AQUEOUS-SOLUTION; UP-CONVERSION; LUMINESCENCE; CRYSTAL; TRANSITIONS; ACTINIDES; EMISSION; U4+	We study photo-physical behaviors of tetravalent uranium halides such as UF4, UCl4, UBr4 and UI4 to understand the electronic transitions under the unexplored condition such as in non-aqueous media at cryogenic temperature. These complexes exhibit white fluorescence by UV-pulse excitation at lambda (ex) = 394 nm. The fluorescence lifetimes in organic solvents are shorter than that in ionic liquids in spite of the longer ionic radii between uranium and ligands. Chemical species and the coordination number of U-IV in water, in organic solutions, and in ionic liquids are thoroughly different, resulting in a variety of fluorescence spectra and decays.	[Aoyagi, Noboru; Watanabe, Masayuki; Kimura, Takaumi] Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Tokai, Ibaraki 3191195, Japan; [Kirishima, Akira; Sato, Nobuaki] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Aoyagi, N (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Shirakatashirane 2-4, Tokai, Ibaraki 3191195, Japan.	aoyagi.noboru@jaea.go.jp					Aoyagi N, 2011, CHEM COMMUN, V47, P4490, DOI 10.1039/c0cc05550f; Hashem E, 2013, RSC ADV, V3, P4350, DOI 10.1039/c3ra22712j; Billard I, 2008, SPRINGER SER FLUORES, V05, P465, DOI 10.1007/4243_2008_050; Collins RN, 2011, J ENVIRON QUAL, V40, P731, DOI 10.2134/jeq2010.0166; Danilo C, 2010, PHYS CHEM CHEM PHYS, V12, P1116, DOI 10.1039/b914222c; Aoyagi N, 2012, J APPL SOL CHEM MODE, V1, P148; Behrendt M, 2009, OPT MATER, V31, P514, DOI 10.1016/j.optmat.2007.10.013; COUNTRYM.R, 1971, J INORG NUCL CHEM, V33, P2213, DOI 10.1016/0022-1902(71)80583-3; Geipel G, 2006, COORDIN CHEM REV, V250, P844, DOI 10.1016/j.ccr.2005.11.007; Godbole SV, 2003, RADIAT MEAS, V37, P621, DOI 10.1016/S1350-4487(03)00066-0; HUSSONNOIS M, 1981, J CRYST GROWTH, V51, P11, DOI 10.1016/0022-0248(81)90004-X; Karbowiak M, 2004, J PHYS CHEM A, V108, P6397, DOI 10.1021/jp038024q; Kirishima A, 2004, RADIOCHIM ACTA, V92, P705, DOI 10.1524/ract.92.9.705.54971; Kirishima A, 2003, CHEM COMMUN, P910, DOI 10.1039/b300583f; Kitawaki S, 2013, J NUCL MATER, V439, P212, DOI 10.1016/j.jnucmat.2013.03.017; Lehmann S, 2010, J RADIOANAL NUCL CH, V283, P395, DOI 10.1007/s10967-009-0412-0; Lehmann S, 2009, SPECTROCHIM ACTA A, V73, P902, DOI 10.1016/j.saa.2009.04.013; Lukman S, 2012, GEOCHIM COSMOCHIM AC, V88, P199, DOI 10.1016/j.gca.2012.04.023; Mandal S, 2007, INORG CHEM, V46, P7935, DOI 10.1021/ic700866f; Martell A. E., 2004, NIST CRITICALLY SELE; Natrajan LS, 2012, COORDIN CHEM REV, V256, P1583, DOI 10.1016/j.ccr.2012.03.029; XU W, 1995, CHEM PHYS, V193, P339, DOI 10.1016/0301-0104(94)00393-O	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1095	1098		10.1007/s10967-014-3616-x		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200003		
J	Bessho, K; Oki, Y; Akimune, N; Matsumura, H; Masumoto, K; Sekimoto, S; Osada, N; Kinoshita, N; Monjushiro, H; Shibata, S				Bessho, Kotaro; Oki, Yuichi; Akimune, Naoya; Matsumura, Hiroshi; Masumoto, Kazuyoshi; Sekimoto, Shun; Osada, Naoyuki; Kinoshita, Norikazu; Monjushiro, Hideaki; Shibata, Seiichi			Corrosion of copper in water and colloid formation under intense radiation field	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radiation effect; Corrosion; Colloid; gamma-Ray; Bremsstrahlung	COOLING WATER; RADIONUCLIDES; BEHAVIOR	Radiation effects of photons on corrosion and colloid formation of copper (Cu) in water were investigated as a model for the cooling water for electromagnets at accelerator facilities. Irradiation experiments were carried out at a Co-60 gamma-ray irradiation facility and an electron linear accelerator facility; production of soluble Cu species and relatively-large particulate Cu species (> 200 nm) were promoted by gamma-ray/bremsstrahlung irradiations. The results imply that particulate Cu species are initially generated at the Cu/water interface, grow up, and are finally released into water phase as relatively-large particles. These characteristic radiation effects may be related with production of reactive species in water.	[Bessho, Kotaro; Matsumura, Hiroshi; Masumoto, Kazuyoshi; Monjushiro, Hideaki] High Energy Accelerator Res Org KEK, Tsukuba, Ibaraki 3050801, Japan; [Oki, Yuichi; Sekimoto, Shun; Shibata, Seiichi] Kyoto Univ, Inst Res Reactor, Kyoto, Japan; [Akimune, Naoya] Kyoto Univ, Grad Sch Engn, Kyoto, Japan; [Osada, Naoyuki] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Kinoshita, Norikazu] Shimizu Corp, Inst Technol, Tokyo 135, Japan	Bessho, K (reprint author), High Energy Accelerator Res Org KEK, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan.	kotaro.besho@kek.jp					CASWELL RS, 1980, RADIAT RES, V83, P217, DOI 10.2307/3575276; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Baker RW, 2004, MEMBRANE TECHNOLOGY, P72; DEGUELDRE C, 1995, NUCL SCI ENG, V120, P65; Freiser H, 1963, IONIC EQUILIBRIA ANA; Matsumura H, 2009, NUCL TECHNOL, V168, P979; Matsumura H, PROG NUCL S IN PRESS; Neeb KH, 1997, RADIOCHEMISTRY NUCL; Research Reactor Institute Kyoto University, 2008, DOS RAT MAPS 60CO G; Swanson W. P., 1979, IAEA TECHNICAL REPOR	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1117	1121		10.1007/s10967-014-3464-8		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200007		
J	Saito, T; Aoyagi, N; Kimura, T				Saito, Takumi; Aoyagi, Noboru; Kimura, Takaumi			Time-resolved laser-induced fluorescence spectroscopy combined with parallel factor analysis: a robust speciation technique for UO2 (2+)	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Uranyl; Complexation; Time-resolved laser-induced fluorescence spectroscopy; Factor analysis; Silicic acid	URANIUM SPECIATION; PARAFAC; TRLFS; ACID	Time-resolved laser-induced fluorescence spectroscopy (TRLFS) is a powerful speciation technique for fluorescent metal ions and can be further improved by combining with multi-mode factor analysis such as parallel factor analysis (PARAFAC). This study demonstrates the applicability of TRLFS combined with PARAFAC for the speciation of uranyl (UO2 (2+)) in the presence of silicic acid (Si(OH)(4)). A series of TRLFS data with varied Si(OH)(4) concentration was processed by PARAFAC, resulting in three factors corresponding to free UO2 (2+), UO2SiO(OH) (3) (+) , and UO2OH+. The stability constant of UO2SiO(OH) (3) (+) was further optimized, based on the intensity profiles of the factors.	[Saito, Takumi] Japan Atom Energy Agcy, Adv Sci Res Ctr, Nucl Sci Res Inst, Tokai, Ibaraki 3191195, Japan; [Aoyagi, Noboru; Kimura, Takaumi] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Nucl Sci Res Inst, Tokai, Ibaraki 3191195, Japan	Saito, T (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Nucl Sci Res Inst, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	saito.takumi@jaea.go.jp					Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; Ishida K, 2012, J COLLOID INTERF SCI, V374, P258, DOI 10.1016/j.jcis.2012.01.060; Collins RN, 2011, J ENVIRON QUAL, V40, P731, DOI 10.2134/jeq2010.0166; Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Bro R, 1997, CHEMOMETR INTELL LAB, V38, P149, DOI 10.1016/S0169-7439(97)00032-4; Buffle J., 1985, COMPLEXATION REACTIO; Davies C., 1962, ION ASS; ELIET V, 1995, J CHEM SOC FARADAY T, V91, P2275, DOI 10.1039/ft9959102275; Guillaumont R., 2003, UPDATE CHEM THERMODY; Jensen MP, 1996, RADIOCHIM ACTA, V72, P143; Lukman S, 2012, GEOCHIM COSMOCHIM AC, V88, P199, DOI 10.1016/j.gca.2012.04.023; Moll H, 1998, J ALLOY COMPD, V271, P765, DOI 10.1016/S0925-8388(98)00203-5; Moulin C, 1998, APPL SPECTROSC, V52, P528, DOI 10.1366/0003702981944076; MOULIN C, 1995, ANAL CHEM, V67, P348, DOI 10.1021/ac00098a019; Saito T, 2010, ENVIRON SCI TECHNOL, V44, P5055, DOI 10.1021/es9036995; Stumm W., 1996, AQUATIC CHEM	16	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1129	1132		10.1007/s10967-014-3465-7		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200009		
J	Shimada, A; Sakatani, K; Kameo, Y; Takahashi, K				Shimada, Asako; Sakatani, Keiichi; Kameo, Yutaka; Takahashi, Kuniaki			Determination of I-129 in the accumulated radioactive water and processed water of the Fukushima Daiichi Nuclear Power Plant	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						I-129; Accumulated radioactive water; Fukushima Daiichi Nuclear Power Plants; Anion SR		Accumulated radioactive water (AW) and processed water (PW) were sampled from certain locations of the accumulated radioactive water processing facility at the Fukushima Daiichi Nuclear Power Plants, in order to estimate the radioactivity of the secondary waste such as zeolite and sludge, which adsorbed radioactive material. The method to separate iodide ion (I-) from other radionuclides using the solid phase extraction sorbent, Anion SR, was optimized to measure the concentration of I-129 in the AW and PW samples. After the chemical separation, the concentration of I-129 in the sampled water was determined by inductively coupled plasma mass spectrometry with a dynamic reaction cell (DRC-ICP-MS).	[Shimada, Asako; Sakatani, Keiichi; Kameo, Yutaka; Takahashi, Kuniaki] Japan Atom Energy Agcy, Nucl Cycle Backend Directorate, Tokai, Ibaraki, Japan; [Shimada, Asako; Kameo, Yutaka] Japan Atom Energy Agcy, Fukushima Project Team, Tokai, Ibaraki, Japan	Shimada, A (reprint author), Japan Atom Energy Agcy, Nucl Cycle Backend Directorate, 2-4 Tokai Mura, Tokai, Ibaraki, Japan.	shimada.asako@jaea.go.jp					Kameo Y, 2012, BUNSEKI KAGAKU, V61, P845; Tanaka K, 2013, P 14 WORKSH ENV RAD, P17	2	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1137	1140		10.1007/s10967-014-3428-z		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200011		
J	Osawa, T				Osawa, Takahito			Development of an automatic prompt gamma-ray activation analysis system	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Prompt gamma-ray analysis; LabVIEW; Revolute joint robot; Automatic analysis; Sample exchanger		An automatic prompt gamma-ray activation analysis system was developed and installed at JRR-3M. This system is mainly composed of two personal computers, four programs, a vertical revolute joint robot, and data acquisition devices. The main control software, referred to as AutoPGA, was developed using LabVIEW 2011 and the program can control all functions of the analytical system. Up to 14 samples can be automatically measured by the system. Therefore, this system can not only dramatically increase the efficiency of routine measurements but also decrease the background level of gamma-rays for the analysis.	Japan Atom Energy Agcy, Neutron Imaging & Quantum Beam Anal Grp, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan	Osawa, T (reprint author), Japan Atom Energy Agcy, Neutron Imaging & Quantum Beam Anal Grp, Quantum Beam Sci Directorate, Shirakata Shirane 2-4, Tokai, Ibaraki 3191195, Japan.	osawa.takahito@jaea.go.jp					Osawa T, 2011, NUCL INSTRUM METH B, V269, P717, DOI 10.1016/j.nimb.2011.01.129; Ebihara M, 2004, ADV SPACE RES, V34, P2305, DOI 10.1016/j.asr.2004.06.004; Saito T, 2008, J RADIOANAL NUCL CH, V278, P409, DOI 10.1007/s10967-008-0810-8; Tanoi K, 2009, J RADIOANAL NUCL CHE, V278, P375; YONEZAWA C, 1993, NUCL INSTRUM METH A, V329, P207, DOI 10.1016/0168-9002(93)90938-E; Yoshida S, 2011, PROG NUCL SCI TECH, V1, P259	6	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1141	1146		10.1007/s10967-014-3436-z		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200012		
J	Fujimura, S; Sakuma, Y; Sato, M; Saito, T; Yoshioka, K; Yamauchi, T; Sato, N; Eguchi, S				Fujimura, Shigeto; Sakuma, Yuuki; Sato, Mutsuto; Saito, Takashi; Yoshioka, Kunio; Yamauchi, Toshimi; Sato, Norio; Eguchi, Sadao			Difference in Cs-137 concentration of brown rice between the years of 2011 and 2012 in Fukushima Prefecture	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Aging effect; Brown rice; Cs-137 concentration; Paddy field	PADDY-FIELD; SOIL	The objective of this study was to understand the effect of decrease in available radiocesium independently of the potassium and zeolite application effect on the uptake of radiocesium by rice. Brown rice produced in seven paddy fields located at four different sites of Fukushima Prefecture were sampled in 2011 and 2012. Any decontamination treatment was not conducted in these fields during the 2-year period. The Cs-137 concentrations in brown rice was 30 % lower in 2012 (1.3-160 Bq kg(-1)) compared to those in 2011 (2.8-290 Bq kg(-1)) with neither decontamination nor additional application of potassium and/or zeolite.	[Fujimura, Shigeto; Sakuma, Yuuki; Sato, Mutsuto; Saito, Takashi; Yoshioka, Kunio; Yamauchi, Toshimi] Fukushima Agr Technol Ctr, Koriyama, Fukushima 9630531, Japan; [Fujimura, Shigeto] NARO Tohoku Agr Res Ctr, Fukushima 9602156, Japan; [Eguchi, Sadao] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan	Fujimura, S (reprint author), NARO Tohoku Agr Res Ctr, 50 Harajukuminami, Fukushima 9602156, Japan.	fujimu@affrc.go.jp			ZEN-NOH (National Federation of Agricultural Cooperative Associations); Ministry of Agriculture, Forestry and Fisheries (MAFF)	The present study was partly supported by grants from ZEN-NOH (National Federation of Agricultural Cooperative Associations) and Ministry of Agriculture, Forestry and Fisheries (MAFF), "Development of decontamination technologies for radioactive substances in agricultural land and forest."	Ehlken S, 2002, J ENVIRON RADIOACTIV, V58, P97, DOI 10.1016/S0265-931X(01)00060-1; Qi Z, 2008, J EXP BOT, V59, P595, DOI 10.1093/jxb/erm330; Zhu YG, 2000, J EXP BOT, V51, P1635, DOI 10.1093/jexbot/51.351.1635; Ohmori Y, 2014, J PLANT RES, V127, P57, DOI 10.1007/s10265-013-0616-9; Endo S, 2013, J ENVIRON RADIOACTIV, V116, P59, DOI 10.1016/j.jenvrad.2012.08.018; BILO M, 1993, J ENVIRON RADIOACTIV, V19, P25, DOI 10.1016/0265-931X(93)90056-D; Saito T., 2012, P INT S ENV MON DOS, P165; Tsukada H, 2002, J ENVIRON RADIOACTIV, V59, P351, DOI 10.1016/S0265-931X(01)00083-2; Tsukada H, 2002, ENVIRON POLLUT, V117, P403, DOI 10.1016/S0269-7491(01)00199-3; Tsumura A, 1984, B NATL I AGR SCI B, V36, P57	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1147	1150		10.1007/s10967-014-3479-1		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200013		
J	Bu, WT; Zheng, J; Guo, QJ; Aono, T; Otosaka, S; Tagami, K; Uchida, S				Bu, Wenting; Zheng, Jian; Guo, Qiuju; Aono, Tatsuo; Otosaka, Shigeyoshi; Tagami, Keiko; Uchida, Shigeo			Temporal distribution of plutonium isotopes in marine sediments off Fukushima after the Fukushima Dai-ichi Nuclear Power Plant accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						FDNPP accident; Plutonium isotopes; Marine sediments; SF-ICP-MS	PACIFIC-OCEAN; NORTH PACIFIC; RADIOCESIUM; FALLOUT; PU	The characterization of Pu isotopes in a sediment core collected in the western North Pacific off Fukushima in January 2013 was determined. We compared the results with that of the marine sediments collected from July 2011 to July 2012. Both the Pu239+240 activities and the Pu-240/Pu-239 atom ratios showed no variation in the marine sediments in the last 2 years since the FDNPP accident. Pu contamination in the marine sediments in the investigated areas still originated from global fallout and the Pacific Proving Ground close-in fallout.	[Bu, Wenting; Guo, Qiuju] Peking Univ, Sch Phys, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China; [Bu, Wenting; Zheng, Jian; Aono, Tatsuo; Tagami, Keiko; Uchida, Shigeo] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 2638555, Japan; [Otosaka, Shigeyoshi] Japan Atom Energy Agcy, Res Grp Environm Sci, Tokai, Ibaraki 3191195, Japan	Guo, QJ (reprint author), Peking Univ, Sch Phys, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China.	jzheng@nirs.go.jp; qjguo@pku.edu.cn	Zheng, Jian/A-5195-2012	Zheng, Jian/0000-0003-0616-5570	Kakenhi [24110004]; Agency for Natural Resources and Energy (METI), Japan; Natural Science Foundation of China [11275015]	This work was supported by the Kakenhi Grant-in-aid for Scientific Research on Innovative Areas (24110004), and partly supported by the Agency for Natural Resources and Energy (METI), Japan and the National Natural Science Foundation of China (11275015).	Zheng J, 2012, GEOCHEM J, V46, P361; Aoyama M, 2013, J RADIOANAL NUCL CH, V296, P535, DOI 10.1007/s10967-012-2033-2; Otosaka S, 2013, ENVIRON MONIT ASSESS, V185, P5419, DOI 10.1007/s10661-012-2956-7; Perianez R, 2013, J RADIOANAL NUCL CH, V298, P635, DOI 10.1007/s10967-013-2422-1; Honda MC, 2013, BIOGEOSCIENCES, V10, P3525, DOI 10.5194/bg-10-3525-2013; Bu WT, 2014, ENVIRON SCI TECHNOL, V48, P534, DOI 10.1021/es403500e; Bu WT, 2013, BIOGEOSCIENCES, V10, P2497, DOI 10.5194/bg-10-2497-2013; Buesseler KO, 1997, J ENVIRON RADIOACTIV, V36, P69, DOI 10.1016/S0265-931X(96)00071-9; Dong W, 2010, J ENVIRON RADIOACTIV, V101, P622, DOI 10.1016/j.jenvrad.2010.03.011; Hong GH, 1999, SCI TOTAL ENVIRON, V238, P225; KALLEL N, 1988, OCEANOL ACTA, V11, P369; Lee SH, 2003, DEEP-SEA RES PT II, V50, P2727, DOI 10.1016/S0967-0645(03)00150-4; Liu ZY, 2011, J RADIOANAL NUCL CH, V288, P911, DOI 10.1007/s10967-011-1025-y; Zheng J, 2013, ENVIRON SCI TECHNOL, V47, P9584, DOI 10.1021/es402212v; Zheng J, 2004, ENVIRON SCI TECHNOL, V38, P3498, DOI 10.1021/es0351931; Zheng J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00304	16	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1151	1154		10.1007/s10967-014-3437-y		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200014		
J	Miyazaki, J; Nagatomo, T; Kobayashi, Y; Kubo, MK; Yamada, Y; Mihara, M; Sato, W; Sato, S; Kitagawa, A				Miyazaki, Jun; Nagatomo, Takashi; Kobayashi, Yoshio; Kubo, Michael Kenya; Yamada, Yasuhiro; Mihara, Mototsugu; Sato, Wataru; Sato, Shinji; Kitagawa, Atsushi			Local structure of Mn-57/Fe-57 implanted into lithium hydride	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						In-beam Mossbauer Spectroscopy; beta-Decay of Mn-57; Lithium hydride; Density functional theory calculations	IN-BEAM MOSSBAUER; SPECTROSCOPY; CONDUCTIVITY; CRYSTALS	We report the in-beam Mossbauer spectra of Mn-57 implanted into polycrystalline lithium hydride (LiH). Comparing the in-beam Mossbauer spectra data with the results of density functional theory (DFT) calculations, Fe-57 atoms were implanted into Li or H substitutional sites in the LiH crystal. By changing the sample temperature from 11 K to over 800 K, we observed a reduction of Fe-57 at a substitutional H site with a neighboring Li or H atom defect, and an addition of Fe-57 at substitutional H or Li site without neighboring atom defects. It suggests annealing effect-induced recovery.	[Miyazaki, Jun] Nihon Univ, Coll Ind Technol, Narashino, Chiba 2758576, Japan; [Nagatomo, Takashi] High Energy Accelerator Res Org, Inst Mat Struct Sci, Tokai, Ibaraki 3191106, Japan; [Kobayashi, Yoshio] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Kobayashi, Yoshio] RIKEN, Nishina Ctr Accelerator Based Sci, Adv Meson Sci Lab, Wako, Saitama 3510198, Japan; [Kubo, Michael Kenya] Int Christian Univ, Div Arts & Sci, Mitaka, Tokyo 1818585, Japan; [Yamada, Yasuhiro] Tokyo Univ Sci, Dept Chem, Shinjuku Ku, Tokyo 1628602, Japan; [Mihara, Mototsugu] Osaka Univ, Dept Phys, Toyonaka, Osakaxz 5600043, Japan; [Sato, Wataru] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Sato, Shinji; Kitagawa, Atsushi] Natl Inst Radiol Sci, Dept Accelerator & Med Phys, Inage Ku, Chiba 2638555, Japan	Miyazaki, J (reprint author), Tokyo Univ Agr & Technol, Dept Chem Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	jmiya@cc.tuat.ac.jp					PRETZEL FE, 1960, J PHYS CHEM SOLIDS, V16, P10, DOI 10.1016/0022-3697(60)90064-0; DIDISHEIM JJ, 1984, INORG CHEM, V23, P1953, DOI 10.1021/ic00181a032; IKEYA M, 1977, J PHYS SOC JPN, V42, P168, DOI 10.1143/JPSJ.42.168; Kobayashi Y, 2010, HYPERFINE INTERACT, V198, P173, DOI 10.1007/s10751-010-0255-7; Kubo MK, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4833916; Nagatomo T, 2012, HYPERFINE INTERACT, V204, P125, DOI 10.1007/s10751-011-0487-1; Nagatomo T, 2011, NUCL INSTRUM METH B, V269, P455, DOI 10.1016/j.nimb.2010.12.042; Narygina O, 2011, EARTH PLANET SC LETT, V307, P409, DOI 10.1016/j.epsl.2011.05.015; Neese F, 2008, ORCA AB INITIO DFT S; Saito T, 2003, J RADIOANAL NUCL CH, V255, P519, DOI 10.1023/A:1022584432737; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; VAROTSOS P, 1974, PHYS REV B, V9, P1866, DOI 10.1103/PhysRevB.9.1866; VAROTSOS PA, 1974, PHYS REV B, V10, P5220, DOI 10.1103/PhysRevB.10.5220; Yamada Y, 2014, HYPERFINE INTERACT, V226, P35, DOI 10.1007/s10751-013-0913-7; Yamada Y, 2013, CHEM PHYS LETT, V567, P14, DOI 10.1016/j.cplett.2013.03.033	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1155	1158		10.1007/s10967-014-3456-8		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200015		
J	Kitayama, K; Tsukada, H; Ohse, K; Kawatsu, K				Kitayama, Kyo; Tsukada, Hirofumi; Ohse, Kenji; Kawatsu, Kencho			Concentration of Cs-137 in atmospheric coarse and fine particles collected in Fukushima Prefecture	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Cs-137; Cs-134; Fine particle; Coarse particle; Fukushima	ACCIDENT	Concentration of Cs-137 in coarse and fine aerosol particles was observed in the atmosphere around Fukushima and Date Cities, Fukushima Prefecture from August 2012 to July 2013. Airborne particles were collected once every 2 weeks and separated at a 50 % cutoff diameter of 1.1 A mu m. The averages of total Cs-137 concentration in coarse and fine particles was 183 and 166 A mu Bq m(-3) for Fukushima and Date sites, respectively. The average ratio of coarse to fine particle concentrations was approximately 2:1 at both sites. The particle-size distribution of Cs-137 was different from that collected immediately after the accident.	[Kitayama, Kyo; Tsukada, Hirofumi; Ohse, Kenji; Kawatsu, Kencho] Fukushima Univ, Future Ctr Reg Revitalizat, Fukushima, Japan	Kitayama, K (reprint author), Fukushima Univ, Future Ctr Reg Revitalizat, Fukushima, Japan.	r653@ipc.fukushima-u.ac.jp					SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; Katata G, 2012, J ENVIRON RADIOACTIV, V111, P2, DOI 10.1016/j.jenvrad.2011.09.011; Kaneyasu N, 2012, ENVIRON SCI TECHNOL, V46, P5720, DOI 10.1021/es204667h; Ministry of education culture sports science and technology Japan, 2013, 6 RAD MON ACT PLAN; Morales C., 1979, SAHARAN DUST, P71; Seinfeld J. H., 2006, ATMOSPHERIC CHEM PHY; Tsukada H, 2012, 2012 FALL M AT EN SO	7	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1159	1162		10.1007/s10967-014-3512-4		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200016		
J	Toyoshima, A; Ooe, K; Miyashita, S; Asai, M; Attallah, MF; Goto, N; Gupta, NS; Haba, H; Huang, M; Kanaya, J; Kaneya, Y; Kasamatsu, Y; Kitatsuji, Y; Kitayama, Y; Koga, K; Komori, Y; Koyama, T; Kratz, JV; Lerum, HV; Oshimi, Y; Pershina, V; Sato, D; Sato, TK; Shigekawa, Y; Shinohara, A; Tanaka, A; Tsukada, K; Tsuto, S; Yokokita, T; Yokoyama, A; Omtvedt, JP; Nagame, Y; Schadel, M				Toyoshima, A.; Ooe, K.; Miyashita, S.; Asai, M.; Attallah, M. F.; Goto, N.; Gupta, N. S.; Haba, H.; Huang, M.; Kanaya, J.; Kaneya, Y.; Kasamatsu, Y.; Kitatsuji, Y.; Kitayama, Y.; Koga, K.; Komori, Y.; Koyama, T.; Kratz, J. V.; Lerum, H. V.; Oshimi, Y.; Pershina, V.; Sato, D.; Sato, T. K.; Shigekawa, Y.; Shinohara, A.; Tanaka, A.; Tsukada, K.; Tsuto, S.; Yokokita, T.; Yokoyama, A.; Omtvedt, J. P.; Nagame, Y.; Schaedel, M.			Chemical studies of Mo and W in preparation of a seaborgium (Sg) reduction experiment using MDG, FEC, and SISAK	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Seaborgium (Sg); Molybdenum (Mo); Tungsten (W); Electrolytic reduction; Solvent extraction	ELEMENTS	The extraction and reduction behavior of Mo and W, lighter homologs of Sg, was studied in continuous on-line experiments at the JAEA tandem accelerator to develop a new chemistry assembly consisting of a membrane degasser (MDG), a flow electrolytic column (FEC), and the continuous liquid-liquid extraction apparatus (SISAK). Extraction yields of Mo and W from 0.1 M HCl/0.9 M LiCl into 4-isopropyltropolone (hinokitiol, HT) in toluene were investigated. In the reduction experiment, Mo(VI) was successfully reduced to a lower oxidation state while W(VI) showed no reduction under the given conditions.	[Toyoshima, A.; Miyashita, S.; Asai, M.; Kaneya, Y.; Kitatsuji, Y.; Sato, T. K.; Tsukada, K.; Nagame, Y.; Schaedel, M.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Ooe, K.; Goto, N.; Koyama, T.; Oshimi, Y.; Sato, D.; Tanaka, A.; Tsuto, S.] Niigata Univ, Inst Sci & Technol, Niigata 9502181, Japan; [Miyashita, S.; Koga, K.] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan; [Attallah, M. F.; Gupta, N. S.; Lerum, H. V.; Omtvedt, J. P.] Univ Oslo, Dept Chem, N-0315 Oslo, Norway; [Haba, H.; Huang, M.; Kanaya, J.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Kasamatsu, Y.; Komori, Y.; Shigekawa, Y.; Shinohara, A.; Yokokita, T.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Kitayama, Y.; Yokoyama, A.] Kanazawa Univ, Coll & Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Kratz, J. V.] Johannes Gutenberg Univ Mainz, Inst Kernchem, D-55128 Mainz, Germany; [Pershina, V.; Schaedel, M.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany	Toyoshima, A (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan.	toyoshima.atsushi@jaea.go.jp					Haba H, 2012, PHYS REV C, V85; Kekesi T, 2005, HYDROMETALLURGY, V77, P81, DOI 10.1016/j.hydromet.2004.10.012; Omtvedt JP, 2007, EUR PHYS J D, V45, P91, DOI 10.1140/epjd/e2007-00214-6; Ooe K, 2014, DEV NEW CONTINUOUS D; Pershina V, 1999, J PHYS CHEM A, V103, P8463, DOI 10.1021/jp990322t; Toyoshima A, 2008, RADIOCHIM ACTA, V96, P323, DOI 10.1524/ract.2008.1498	6	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1169	1172		10.1007/s10967-014-3438-x		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200018		
J	Yamagata, T; Shozugawa, K; Okumura, R; Takamiya, K; Matsuo, M				Yamagata, T.; Shozugawa, K.; Okumura, R.; Takamiya, K.; Matsuo, M.			A study on redox sensitive elements in the sediments at dredged trenches in Tokyo Bay by instrumental neutron activation analysis	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Sediment; Tokyo Bay; Dredged trench; Hypoxia; Instrumental neutron activation analysis (INAA)		To evaluate redox conditions at dredged trenches in Tokyo Bay, the concentrations of U, Th, Ce, Fe, and Mn in sediments were measured. In the Th/U-Ce/U plots, the values of Th/U and Ce/U ratios at each site gathered in different places on a same line. Therefore, it is considered that Th/U and Ce/U ratios are reflecting the redox states in different sites. The concentrations of Fe and Mn in August 2011 decreased near the surface at dredged trenches. It is presumed that their concentrations at dredged trenches are influenced by the redox conditions of the surface of sediments.	[Yamagata, T.; Shozugawa, K.; Matsuo, M.] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Okumura, R.; Takamiya, K.] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan	Yamagata, T (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan.	0084385768@mail.ecc.u-tokyo.ac.jp			 [22310006]	This work was supported by Grant-in-Aid for Scientific Research 22310006. This study was partly conducted under the approval of KUR (Proposal No. 23075, 24049 and 25053).	FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; KLINKHAMMER GP, 1991, GEOCHIM COSMOCHIM AC, V55, P1799, DOI 10.1016/0016-7037(91)90024-Y; Yamashita Y, 2007, GEOCHIM COSMOCHIM AC, V71, P3458, DOI 10.1016/j.gca.2007.05.003; THOMSON J, 1993, GEOCHIM COSMOCHIM AC, V57, P579, DOI 10.1016/0016-7037(93)90369-8; Brookins D.G., 1988, EH PH DIAGRAMS GEOCH; Honda T, 2008, B SOC SEA WATER SCI, V62, P28; Suzuki M, 2008, J RADIOANAL NUCL CH, V278, P337, DOI 10.1007/s10967-008-0606-x	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1179	1183		10.1007/s10967-014-3503-5		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200020		
J	Rudolph, D; Forsberg, U; Golubev, P; Sarmiento, LG; Yakushev, A; Andersson, LL; Di Nitto, A; Dullmann, CE; Gates, JM; Gregorich, KE; Gross, CJ; Herzberg, RD; Hessberger, FP; Khuyagbaatar, J; Kratz, JV; Rykaczewski, K; Schadel, M; Aberg, S; Ackermann, D; Block, M; Brand, H; Carlsson, BG; Cox, D; Derkx, X; Eberhardt, K; Even, J; Fahlander, C; Gerl, J; Jager, E; Kindler, B; Krier, J; Kojouharov, I; Kurz, N; Lommel, B; Mistry, A; Mokry, C; Nitsche, H; Omtvedt, JP; Papadakis, P; Ragnarsson, I; Runke, J; Schaffner, H; Schausten, B; Thorle-Pospiech, P; Torres, T; Traut, T; Trautmann, N; Turler, A; Ward, A; Ward, DE; Wiehl, N				Rudolph, D.; Forsberg, U.; Golubev, P.; Sarmiento, L. G.; Yakushev, A.; Andersson, L-L.; Di Nitto, A.; Dullmann, Ch. E.; Gates, J. M.; Gregorich, K. E.; Gross, C. J.; Herzberg, R-D.; Hessberger, F. P.; Khuyagbaatar, J.; Kratz, J. V.; Rykaczewski, K.; Schaedel, M.; Aberg, S.; Ackermann, D.; Block, M.; Brand, H.; Carlsson, B. G.; Cox, D.; Derkx, X.; Eberhardt, K.; Even, J.; Fahlander, C.; Gerl, J.; Jaeger, E.; Kindler, B.; Krier, J.; Kojouharov, I.; Kurz, N.; Lommel, B.; Mistry, A.; Mokry, C.; Nitsche, H.; Omtvedt, J. P.; Papadakis, P.; Ragnarsson, I.; Runke, J.; Schaffner, H.; Schausten, B.; Thoerle-Pospiech, P.; Torres, T.; Traut, T.; Trautmann, N.; Tuerler, A.; Ward, A.; Ward, D. E.; Wiehl, N.			Selected spectroscopic results on element 115 decay chains	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Superheavy elements; Nuclear spectroscopy; Nuclear structure	HEAVIEST NUCLEI; CA-48-INDUCED REACTIONS; SUPERHEAVY ELEMENTS; ENERGIES; SPECTRA; MASSES; TASCA; GSI	Thirty correlated alpha-decay chains were observed in an experiment studying the fusion-evaporation reaction Ca-48 + Am-243 at the GSI Helmholtzzentrum fur Schwerionenforschung. The decay characteristics of the majority of these 30 chains are consistent with previous observations and interpretations of such chains to originate from isotopes of element Z = 115. High-resolution alpha-photon coincidence spectroscopy in conjunction with comprehensive Monte-Carlo simulations allow to propose excitation schemes of atomic nuclei of the heaviest elements, thereby probing nuclear structure models near the 'Island of Stability' with unprecedented experimental precision.	[Rudolph, D.; Forsberg, U.; Golubev, P.; Sarmiento, L. G.; Aberg, S.; Carlsson, B. G.; Fahlander, C.; Ragnarsson, I.; Ward, D. E.] Lund Univ, S-22100 Lund, Sweden; [Yakushev, A.; Dullmann, Ch. E.; Hessberger, F. P.; Schaedel, M.; Ackermann, D.; Block, M.; Brand, H.; Gerl, J.; Jaeger, E.; Kindler, B.; Krier, J.; Kojouharov, I.; Kurz, N.; Lommel, B.; Runke, J.; Schaffner, H.; Schausten, B.; Torres, T.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Andersson, L-L.; Dullmann, Ch. E.; Hessberger, F. P.; Khuyagbaatar, J.; Derkx, X.; Eberhardt, K.; Even, J.; Mokry, C.; Thoerle-Pospiech, P.; Wiehl, N.] Helmholtz Inst Mainz, D-55099 Mainz, Germany; [Di Nitto, A.; Dullmann, Ch. E.; Kratz, J. V.; Derkx, X.; Eberhardt, K.; Mokry, C.; Thoerle-Pospiech, P.; Traut, T.; Trautmann, N.; Wiehl, N.] Johannes Gutenberg Univ Mainz, D-55099 Mainz, Germany; [Gates, J. M.; Gregorich, K. E.; Nitsche, H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Gross, C. J.; Rykaczewski, K.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Herzberg, R-D.; Cox, D.; Mistry, A.; Papadakis, P.; Ward, A.] Univ Liverpool, Liverpool L69 7ZE, Merseyside, England; [Schaedel, M.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki, Japan; [Omtvedt, J. P.] Univ Oslo, N-0315 Oslo, Norway; [Tuerler, A.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Tuerler, A.] Univ Bern, CH-5232 Villigen, Switzerland	Rudolph, D (reprint author), Lund Univ, S-22100 Lund, Sweden.	Dirk.Rudolph@nuclear.lu.se	Turler, Andreas/D-3913-2014; Block, Michael/I-2782-2015; Di Nitto, Antonio/C-5069-2011	Turler, Andreas/0000-0002-4274-1056; Block, Michael/0000-0001-9282-8347; Di Nitto, Antonio/0000-0002-9319-366X	European Community FP7-Capacities ENSAR [262010]; Royal Physiographic Society in Lund; Euroball Owners Committee; Swedish Research Council; German BMBF; Office of Nuclear Physics, U.S. Department of Energy; UK Science and Technology Facilities Council	The authors would like to thank the ion-source and accelerator staff at GSI. This work is supported by the European Community FP7-Capacities ENSAR No. 262010, the Royal Physiographic Society in Lund, the Euroball Owners Committee, the Swedish Research Council, the German BMBF, the Office of Nuclear Physics, U.S. Department of Energy, and the UK Science and Technology Facilities Council.	Stavsetra L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.132502; Oganessian Y, 2011, RADIOCHIM ACTA, V99, P429, DOI 10.1524/ract.2011.1860; Goriely S, 2001, ATOM DATA NUCL DATA, V77, P311, DOI 10.1006/adnd.2000.0857; Schadel M, 2007, EUR PHYS J D, V45, P67, DOI 10.1140/epjd/e2007-00036-6; Runke J, 2014, J RADIOANAL NUCL CH, V299, P1081, DOI 10.1007/s10967-013-2616-6; Hofmann S, 2007, EUR PHYS J A, V32, P251, DOI 10.1140/epja/i2007-10373-x; Cwiok S, 2005, NATURE, V433, P705, DOI 10.1038/nature03336; Andersson LL, 2010, NUCL INSTRUM METH A, V622, P164, DOI 10.1016/j.nima.2010.06.243; Dvorak J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.242501; Bender M, 2001, PHYS LETT B, V515, P42, DOI 10.1016/S0370-2693(01)00863-2; Rudolph D, 2014, ACTA PHYS POL B, V45, P263, DOI 10.5506/APhysPolB.45.263; Gates JM, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.054618; MOLLER P, 1995, ATOM DATA NUCL DATA, V59, P185, DOI 10.1006/adnd.1995.1002; Muntian I, 2003, PHYS ATOM NUCL+, V66, P1015, DOI 10.1134/1.1586412; Herzberg RD, 2008, PROG PART NUCL PHYS, V61, P674, DOI 10.1016/j.ppnp.2008.05.003; Moseley HGJ, 1913, PHILOS MAG, V26, P1024, DOI 10.1080/14786441308635052; Barber RC, 2011, PURE APPL CHEM, V83, P1485, DOI 10.1351/PAC-REP-10-05-01; BEMIS CE, 1973, PHYS REV LETT, V31, P647, DOI 10.1103/PhysRevLett.31.647; CARLSON TA, 1969, NUCL PHYS A, VA135, P57, DOI 10.1016/0375-9474(69)90147-X; Oganessian YT, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014302; Dullmann CE, 2011, PHYS REV LETT, V104; Forsberg U, 2012, ACTA PHYS POL B, V43, P305, DOI 10.5506/APhysPolB.43.305; Forsberg U, 2014, EUR PHYS J WEB C, V66; Forsberg U, PHYS REV C UNPUB; Geng LS, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.061303; HESSBERGER FP, 1989, NUCL INSTRUM METH A, V274, P522, DOI 10.1016/0168-9002(89)90184-8; Hofmann S, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12062-1; Khuyagbaatar J, 2012, NUCL INSTRUM METH A, V689, P40, DOI 10.1016/j.nima.2012.06.007; Kibedi T, 2012, ATOM DATA NUCL DATA, V98, P313, DOI 10.1016/j.adt.2011.11.001; Muntian I, 2003, ACTA PHYS POL B, V34, P2073; NILSSON SG, 1969, NUCL PHYS A, VA131, P1, DOI 10.1016/0375-9474(69)90809-4; Oganessian YT, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.021601; Oganessian YT, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.054621; Oganessian Y, 2007, J PHYS G NUCL PARTIC, V34, pR165, DOI 10.1088/0954-3899/34/4/R01; Rudolph D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.112502; Sarmiento LG, 2012, NUCL INSTRUM METH A, V667, P26, DOI 10.1016/j.nima.2011.11.074; Sarmiento LG, P SCI UNPUB; Seaborg G. T., 1990, ELEMENTS URANIUM; Tolokonnikov SV, 2013, PHYS ATOM NUCL+, V76, P708, DOI 10.1134/S1063778813060136	39	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1185	1190		10.1007/s10967-014-3445-y		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200021		
J	Takeda, A; Tsukada, H; Takaku, Y; Hisamatsu, S				Takeda, Akira; Tsukada, Hirofumi; Takaku, Yuichi; Hisamatsu, Shun'ichi			Effect of aging on availability of iodine in grassland soil collected in Rokkasho, Japan	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Iodate; Iodide; Radioiodine; Soil-to-plant transfer	EXTRACTION; SPECIATION; WATER	Time-dependent changes in the availability of iodine in soil were investigated for 23 months. Stable iodine was added to a grassland soil collected in Rokkasho, Japan. Whether iodine was added as I- or IO3 (-), its water extractability decreased drastically for first 4 months after addition and then slightly decreased thereafter. These results indicate that most of the I- and IO3 (-) added to the soil was rapidly converted to an insoluble form. The soil-to-grass transfer factor of the added iodine showed a double exponential decline with time, similar to the decline observed for the water-extraction yield.	[Takeda, Akira; Tsukada, Hirofumi; Takaku, Yuichi; Hisamatsu, Shun'ichi] Inst Environm Sci, Dept Radioecol, Rokkasho, Aomori 0393212, Japan	Takeda, A (reprint author), Inst Environm Sci, Dept Radioecol, 1-7 Ienomae, Rokkasho, Aomori 0393212, Japan.	takeda@ies.or.jp		Hisamatsu, Shun'ichi/0000-0001-6410-5387			Hu QH, 2005, J CONTAM HYDROL, V78, P185, DOI 10.1016/j.jconhyd.2005.05.007; Gilfedder BS, 2010, GEOCHIM COSMOCHIM AC, V74, P3090, DOI 10.1016/j.gca.2010.03.008; Yamaguchi N, 2010, J ENVIRON RADIOACTIV, V101, P451, DOI 10.1016/j.jenvrad.2008.06.003; Takeda A, 2011, SOIL SCI PLANT NUTR, V57, P19, DOI 10.1080/00380768.2010.548313; Takeda A, 2013, J ENVIRON RADIOACTIV, V122, P29, DOI 10.1016/j.jenvrad.2013.02.005; IUSS Working Group WRB, 2006, WORLD SOIL RES REP; Seki M, 2012, ENVIRON SCI TECHNOL, V47, P390; Shimamoto YS, 2010, J GEOCHEM EXPLOR, V107, P117, DOI 10.1016/j.gexplo.2009.11.001; STANFORD G, 1970, SOIL SCI, V109, P190, DOI 10.1097/00010694-197003000-00008; Yamada H, 1999, SOIL SCI PLANT NUTR, V45, P563; Yamada H, 1996, SOIL SCI PLANT NUTR, V42, P367	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1191	1195		10.1007/s10967-014-3457-7		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200022		
J	Satou, Y; Sueki, K; Sasa, K; Kitagawa, J; Ikarashi, S; Kinoshita, N				Satou, Yukihiko; Sueki, Keisuke; Sasa, Kimikazu; Kitagawa, Jun-ichi; Ikarashi, Satoshi; Kinoshita, Norikazu			Vertical distribution and formation analysis of the I-131, Cs-137, Te-129m, and Ag-110m from the Fukushima Dai-ichi Nuclear Power Plant in the beach soil	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Beach soil; Vertical distribution; FDNPP accident; Hot spots	ACCIDENT; JAPAN	We have investigated vertical distributions of Ag-110m, I-131, Te-129m, and Cs-137 and existence in beach soil collected three months after the Great East Japan Earthquake. All the nuclides passed through tsunami deposit and original beach soil, then reached fine particle layer lying beneath them in the three months. Moreover, depth profiles of all the nuclides did not exhibit exponential decrease. Behavior of I-131, Te-129m, and Cs-137 were explained with distribution coefficients (K (d)) but that of Ag-110m was not explained. Particulate form was observed for the Cs-137; number of the particle was proportional to the Cs-137 concentration in the soil sample.	[Satou, Yukihiko; Sueki, Keisuke; Sasa, Kimikazu; Kitagawa, Jun-ichi; Ikarashi, Satoshi] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Kinoshita, Norikazu] Shimizu Corp, Inst Technol, Koto Ku, Tokyo 1358530, Japan	Satou, Y (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	yukihiko@ied.tsukuba.ac.jp			JSPS KAKENHI [24246156, 24110006, 256895]; reconstruction support program for eastern Japan at the University of Tsukuba	The authors should like to thank Prof. Yuichi Onda, Dr. Hiroaki Kato, and Mr. Tsutomu Takahashi, University of Tsukuba, for their assistances in the overall measurements. This work was supported by the JSPS KAKENHI Grant No. 24246156, 24110006, 256895, and the reconstruction support program for eastern Japan at the University of Tsukuba. Author Y. S. received Grant-in-Aid for JSPS Fellows.	Matsunaga T, 2013, SCI TOTAL ENVIRON, V447, P301, DOI 10.1016/j.scitotenv.2012.12.087; Tanaka K, 2012, GEOCHEM J, V46, P73; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Szczucinski W, 2012, SEDIMENT GEOL, V282, P40, DOI 10.1016/j.sedgeo.2012.07.019; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; IAEA, 2010, IAEA TECH REP SER; Japan Meteorological Agency, 2014, AUT MET DAT ACQ SYST; Kato H, 2011, J ENV RADACT, V111, P59; Komai T, 2012, P ISOPE 2012, V22, P49	9	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1197	1200		10.1007/s10967-014-3562-7		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200023		
J	Sato, W; Komatsuda, S; Yamada, Y; Ohkubo, Y				Sato, W.; Komatsuda, S.; Yamada, Y.; Ohkubo, Y.			Local structures at In impurity sites in ZnO probed by the TDPAC technique	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Zinc oxide; Perturbed angular correlation; Indium; Impurity; Local structure		Local structures in zinc oxide (ZnO) doped with In ions were investigated by means of the time-differential perturbed angular correlation (TDPAC) method with the Cd-111(a dagger In-111) probe. Indium-concentration dependence of the TDPAC spectra suggests that the local structures formed by the impurities are sensitive to their population in the system: In ions occupy defect-free Zn sites when doped with a trace amount; they locally form microscopic unique structures widely dispersed in ZnO at 0.05 at. % or higher; and other compounds are formed at the In concentration as high as 10 at. %. Their characteristic structures are discussed based on the hyperfine-interaction parameters.	[Sato, W.] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Sato, W.; Komatsuda, S.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Yamada, Y.] Tokyo Univ Sci, Dept Chem, Shinjuku Ku, Tokyo 1628602, Japan; [Ohkubo, Y.] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan	Sato, W (reprint author), Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan.	wsato@se.kanazawa-u.ac.jp			JSPS KAKENHI [23600004]	The present work was supported by JSPS KAKENHI Grant Number, 23600004, and was accomplished as part of the Visiting Researcher's Program of Kyoto University Research Reactor Institute (KURRI).	Abreu Y, 2012, SOLID STATE COMMUN, V152, P399, DOI 10.1016/j.ssc.2011.12.001; Behan AJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047206; Moriga T, 1998, J AM CERAM SOC, V81, P1310; Sharma P, 2003, NAT MATER, V2, P673, DOI 10.1038/nmat984; BAVERSTA.U, 1972, NUCL PHYS A, VA186, P500, DOI 10.1016/0375-9474(72)90980-3; Firestone R.B., 1996, TABLE ISOTOPES; Frauenfelder H., 1965, ALPHA BETA GAMMA RAY, V2, P997; He Y, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.155202; Komatsuda S, 2011, J PHYS SOC JPN, V80; Ney A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.041202; Sato W, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045319; Sato W, 2013, HYPERFINE INTERACT, V221, P79, DOI 10.1007/s10751-012-0709-1; Sato W, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235209; Schatz G., 1996, NUCL CONDENSED MATTE	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1201	1204		10.1007/s10967-014-3446-x		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200024		
J	Kawabata, M; Hashimoto, K; Saeki, H; Sato, N; Motoishi, S; Takakura, K; Konno, C; Nagai, Y				Kawabata, Masako; Hashimoto, Kazuyuki; Saeki, Hideya; Sato, Nozomi; Motoishi, Shoji; Takakura, Kosuke; Konno, Chikara; Nagai, Yasuki			Production and separation of Cu-64 and Cu-67 using 14 MeV neutrons	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Cu-64; Cu-67; Radioisotope production; 14 MeV neutrons; Nuclear medicine	NUCLEAR-MEDICINE; RADIONUCLIDES; TARGET; ZINC	Cu-64 and Cu-67, promising candidates for radioimmunotherapy, were produced by irradiating enriched (ZnO)-Zn-64 and natural ZnO with similar to 14 MeV neutrons via the Zn-64(n, p)Cu-64 and Zn-67(n, p)Cu-67 reactions. No-carrier-added Cu-64,Cu-67 were separated giving a yield of > 90 %, a low radionuclide impurity ratio of Zn-65 (Zn-65/Cu-64 < 0.01 %) and Zn decontamination factor of over 9.7 x 10(5). The labelling efficiency with Cu-64,Cu-67 for TETA was 92-97 %. The current study demonstrated that the fundamental separation and the purification procedure for Cu-64,Cu- 67 from (ZnO)-Zn-nat, 64 were established with high separation efficiency and successful labelling, together with high recovery of Zn samples.	[Kawabata, Masako; Hashimoto, Kazuyuki; Saeki, Hideya; Sato, Nozomi; Motoishi, Shoji; Nagai, Yasuki] Japan Atom Energy Agcy, Nucl Engn Res Collaborat Ctr, Tokai, Ibaraki 3191195, Japan; [Takakura, Kosuke; Konno, Chikara] Fus Res & Dev Directorate, Tokai, Ibaraki 3191195, Japan	Kawabata, M (reprint author), Japan Atom Energy Agcy, Nucl Engn Res Collaborat Ctr, 2-4 Shirane, Tokai, Ibaraki 3191195, Japan.	kawabata.masako@jaea.go.jp			Japan Society for the Promotion of Science	The current work was financially supported through the Grants-in-Aid for Scientific Research program provided by the Japan Society for the Promotion of Science. We would like to thank the members of Analysis Technology Section of JAEA for the elemental analysis by ICP-AES.	Al-Abyad M, 2006, APPL RADIAT ISOTOPES, V64, P717, DOI 10.1016/j.apradiso.2005.12.020; Mausner LF, 1998, APPL RADIAT ISOTOPES, V49, P285, DOI 10.1016/S0969-8043(97)00040-7; Novak-Hofer I, 2002, EUR J NUCL MED MOL I, V29, P821, DOI 10.1007/s00259-001-0724-y; Fadil M, 2008, NUCL INSTRUM METH B, V266, P4318, DOI 10.1016/j.nimb.2008.05.138; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Qaim SM, 2012, RADIOCHIM ACTA, V100, P635, DOI 10.1524/ract.2012.1966; Sun XK, 2003, J BIOL INORG CHEM, V8, P217, DOI 10.1007/s00775-002-0408-5; Be M-M, 2004, TABLE RADIONUCL, V2; Blower PJ, 1996, NUCL MED BIOL, V23, P957, DOI 10.1016/S0969-8051(96)00130-8; Dirks C, 2010, J RADIOANAL NUCL CH, V286, P671, DOI 10.1007/s10967-010-0744-9; Katabuchi T, 2008, J RADIOANAL NUCL CH, V277, P467, DOI 10.1007/s10967-007-7144-9; Kin T, 2013, J PHYS SOC JPN, V82; Le VS, 2008, J RADIOANAL NUCL CHE, V277, P451; Nagai Y, 2013, J PHYS SOC JPN, V82; SCHWARZBACH R, 1995, APPL RADIAT ISOTOPES, V46, P329, DOI 10.1016/0969-8043(95)00010-B; Shikata E, 1964, J NUCL SCI TECHNOL, V1, P177, DOI 10.3327/jnst.1.177; Ting G, 2010, J BIOMED BIOTECHNOL, V2010; Vimalnath KV, 2012, J RADIOANAL NUCL CH, V294, P43, DOI 10.1007/s10967-011-1548-2; ZINN KR, 1994, CANCER, V73, P774, DOI 10.1002/1097-0142(19940201)73:3+<774::AID-CNCR2820731305>3.0.CO;2-L	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1205	1209		10.1007/s10967-014-3488-0		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200025		
J	Ueda, S; Kakiuchi, H; Hasegawa, H; Akata, N; Kawamura, H; Hisamatsu, S				Ueda, Shinji; Kakiuchi, Hideki; Hasegawa, Hidenao; Akata, Naofumi; Kawamura, Hidehisa; Hisamatsu, Shun'ichi			Iodine-129 in water samples collected adjacent to a spent nuclear fuel reprocessing plant in Rokkasho, Japan	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						I-129; Environmental water; Concentration; Reprocessing plant; Rokkasho	ACCELERATOR MASS-SPECTROMETRY; ANTHROPOGENIC I-129; FALLOUT	The spent nuclear fuel reprocessing plant in Rokkasho, Japan, has been undergoing final testing since March 2006. The concentrations of I-129 in environmental water samples collected around the reprocessing plant were measured from 2005 to 2012. The I-129 concentrations in water samples of the brackish lake adjacent to a plant from 2006 to 2008 which the spent fuel rods were cut and chemically processed, was higher than the background level. The major source of I-129 in the lake was dominated by the direct deposition of I-129 from the atmosphere than that from the ocean.	[Ueda, Shinji; Kakiuchi, Hideki; Hasegawa, Hidenao; Akata, Naofumi; Hisamatsu, Shun'ichi] Inst Environm Sci, Dept Radioecol, Aomori 0393212, Japan; [Kawamura, Hidehisa] Kyushu Environm Evaluat Assoc, Fukuoka 8130004, Japan	Ueda, S (reprint author), Inst Environm Sci, Dept Radioecol, 1-7 Rokkasho, Aomori 0393212, Japan.	sueda@ies.or.jp		Hisamatsu, Shun'ichi/0000-0001-6410-5387			Schmidt A, 1998, SCI TOTAL ENVIRON, V223, P131, DOI 10.1016/S0048-9697(98)00309-X; Reithmeier H, 2010, SCI TOTAL ENVIRON, V408, P5052, DOI 10.1016/j.scitotenv.2010.07.015; Hou XL, 2013, ENVIRON SCI TECHNOL, V47, P3091, DOI 10.1021/es304460k; Sharma P, 2000, NUCL INSTRUM METH B, V172, P112, DOI 10.1016/S0168-583X(00)00132-4; Englund E, 2008, ENVIRON SCI TECHNOL, V42, P9225, DOI 10.1021/es8009953; Hanawa K., 1987, J OCEANOGR SOC JAPAN, V42, P435; International Commission on Radiological Protection, 1996, ICRP PUBL, V72; Japan Nuclear Fuel Limited, 1992, APPL DES REPR FAC RO; Raisbeck G. M., 1999, Science of the Total Environment, V237-238, P31, DOI 10.1016/S0048-9697(99)00122-9; Shima S, 2003, P INT S RAD ENV DOS, P384; Suzuki T, 2008, QUAT GEOCHRONOL, V3, P268, DOI 10.1016/j.quageo.2007.12.004; Suzuki T., 2013, BIOGEOSCI DISCUSS, V10, P1401, DOI DOI 10.5194/BGD-10-1401-2013; Toyama C, 2012, J ENVIRON RADIOACTIV, V113, P116, DOI 10.1016/j.jenvrad.2012.04.014; Ueda S, 2005, LIMNOLOGY, V6, P149, DOI 10.1007/s10201-005-0153-x	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1211	1215		10.1007/s10967-014-3451-0		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200026		
J	Akata, N; Hasegawa, H; Kawabata, H; Kakiuchi, H; Chikuchi, Y; Shima, N; Suzuki, T; Hisamatsu, S				Akata, Naofumi; Hasegawa, Hidenao; Kawabata, Hitoshi; Kakiuchi, Hideki; Chikuchi, Yuki; Shima, Nagayoshi; Suzuki, Toshitaka; Hisamatsu, Shun'ichi			Atmospheric deposition of radionuclides (Be-7, Pb-210, Cs-134, Cs-137 and K-40) during 2000-2012 at Rokkasho, Japan, and impact of the Fukushima Dai-ichi Nuclear Power Plant accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Atmospheric deposition; Rokkasho village; Fukushima Dai-ichi Nuclear Power Plant accident; Radiocesium	AOMORI	We measured the concentrations of several radionuclides in atmospheric deposition samples collected in the period from 2000 to 2012 at Rokkasho, Japan. Monthly Be-7 deposition rates were higher in winter/spring and fall, and monthly Pb-210 deposition rates were highest in winter/spring. Following the accident at the Fukushima Dai-ichi Nuclear Power Plant in March 2011, the radiocesium (Cs-134 and Cs-137) deposition rate rapidly increased until it reached the maximum in April 2011, after which the deposition rate of Cs-137 decreased with a half-time of 22 days before remaining constant throughout 2012.	[Akata, Naofumi; Hasegawa, Hidenao; Kawabata, Hitoshi; Kakiuchi, Hideki; Hisamatsu, Shun'ichi] Inst Environm Sci, Rokkasho, Aomori 0393212, Japan; [Chikuchi, Yuki] JGC Plantech Aomori, Rokkasho, Aomori 0393212, Japan; [Shima, Nagayoshi] Fukushima Univ, Fukushima 9601296, Japan; [Suzuki, Toshitaka] Yamagata Univ, Yamagata 9908560, Japan	Akata, N (reprint author), Natl Inst Fus Sci, 322-6 Oroshi, Toki, Gifu 5095292, Japan.	akata.naofumi@LHD.nifs.ac.jp		Hisamatsu, Shun'ichi/0000-0001-6410-5387			Akata N, 2007, J ENVIRON RADIOACTIV, V95, P1, DOI 10.1016/j.jenvrad.2007.01.007; Akata N, 2009, J RADIOANAL NUCL CH, V279, P493, DOI 10.1007/s10967-007-7301-9; Akata N, 2008, J RADIOANAL NUCL CH, V277, P347, DOI 10.1007/s10967-007-7095-1; Hirose K, 2008, APPL RADIAT ISOTOPES, V66, P1675, DOI 10.1016/j.apradiso.2007.09.019; Yamamoto M, 2006, J ENVIRON RADIOACTIV, V86, P110, DOI 10.1016/j.jenvrad.2005.08.001; Hasegawa H, 2007, J RADIOANAL NUCL CH, V273, P171, DOI 10.1007/s10967-007-0731-y; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; AOYAMA M, 1988, GEOPHYS RES LETT, V15, P327, DOI 10.1029/GL015i004p00327; BASKARAN M, 1995, J GEOPHYS RES-ATMOS, V100, P2833, DOI 10.1029/94JD02824; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Igarashi Y., 2005, WATER AIR SOIL POLL, V5, P51, DOI DOI 10.1007/S11267-005-0726-Z; Nagaoka M, 2013, JPN J HLTH PHYS, V48, P104; Papastefanou C, 2006, J RADIOANAL NUCL CH, V267, P315, DOI 10.1007/s10967-006-0050-8; SAKURAI H, 2006, RADIOISOTOPES, V55, P501; Ueno T, 2003, J RADIOANAL NUCL CH, V255, P335, DOI 10.1023/A:1022508921409; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD RE	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1217	1222		10.1007/s10967-014-3466-6		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200027		
J	Ono, R; Togimitsu, T; Sato, W				Ono, R.; Togimitsu, T.; Sato, W.			Evaluation of vacancy-type defects in ZnO by the positron annihilation lifetime spectroscopy	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Positron annihilation lifetime spectroscopy; ZnO; Annealing effect; Vacancy; Grain boundary		Thermal behavior of vacancy-type defects in polycrystalline ZnO was studied by the positron annihilation lifetime spectroscopy. Two-component analysis of the PALS spectra revealed that the defect-related longer-lifetime component decreases as the annealing temperature is raised, and almost disappears within 15 min when annealed at 1,273 K. We also found that the intensity of this component decreases with increasing density of the annealed ZnO pellets; however, little density dependence was seen in its lifetime. These observations evidently suggest that this component having long lifetime of about 400 ps corresponds to the positrons trapped in grain boundaries in the polycrystalline ZnO.	[Ono, R.; Togimitsu, T.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Sato, W.] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan	Sato, W (reprint author), Kanazawa Univ, Inst Sci & Engn, Kakumamachi, Kanazawa, Ishikawa 9201192, Japan.	wsato@se.kanazawa-u.ac.jp			JSPS KAKENHI [23600004]	This work was supported in part by JSPS KAKENHI Grant Number 23600004.	Dutta S, 2009, PROG MATER SCI, V54, P89, DOI 10.1016/j.pmatsci.2008.07.002; Pearton SJ, 2005, PROG MATER SCI, V50, P293, DOI 10.1016/j.pmatsci.2004.04.001; Olsen JV, 2007, PHYS STATUS SOLIDI C, V4, P4004, DOI 10.1002/pssc.200675868; Chen ZQ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245206; Chen ZQ, 2003, J APPL PHYS, V94, P4807, DOI 10.1063/1.1609050; Krause-Rehberg R., 1999, POSITRON ANNIHILATIO; McCluskey MD, 2009, J APPL PHYS, V106; Saarinen K., 1998, IDENTIFICATION DEFEC; Tumisto F, 2003, PHYS REV LETT, V91	9	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1223	1226		10.1007/s10967-014-3452-z		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200028		
J	Yamamoto, M				Yamamoto, Masayoshi			Overview of the Fukushima Dai-ichi Nuclear Power Plant (FDNPP) accident, with amounts and isotopic compositions of the released radionuclides	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						FDNPP accident; Overview of the accident; Released radionuclides	PU; CS-137; I-131	Huge amounts of radionuclides were released into the atmosphere and ocean from the Fukushima Dai-ichi Nuclear Power Plant (FDNPP), operated by the Tokyo Electric Power Company, as a result of the reactor accident after the magnitude 9.0 Great East Japan Earthquake and subsequent gigantic tsunami on March 11, 2011. Here, a brief overview of the FDNPP accident was made, together with the total amounts of released radionuclides, mainly Cs-137, I-131, Sr-90 and transuranic nuclides (Pu-238,Pu-239,Pu-240, Am-241 and Cm-242,Cm-243,Cm-244).	Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan	Yamamoto, M (reprint author), Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan.	pluto@llrl.ku-unet.ocn.ne.jp			Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan [24110008]	This work was supported by a Grant-in-Aid for Scientific Research No. 24110008 (Yamamoto 2012-2016 from the Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan).	Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Sakaguchi A, 2012, GEOCHEM J, V46, P355; Butler D, 2011, NATURE, V471, P555, DOI 10.1038/471555a; Long NQ, 2012, J ENVIRON RADIOACTIV, V111, P53, DOI 10.1016/j.jenvrad.2011.11.018; Kaneyasu N, 2012, ENVIRON SCI TECHNOL, V46, P5720, DOI 10.1021/es204667h; Miyake Y, 2012, GEOCHEM J, V46, P327; Yamamoto M, 2014, J ENVIRON RADIOACTIV, V132, P31, DOI 10.1016/j.jenvrad.2014.01.013; Paatero J, 2012, J ENVIRON RADIOACTIV, V114, P41, DOI 10.1016/j.jenvrad.2011.12.027; Bailly du Bois P, 2011, J ENVIRON RADIOACTIV, V114, P2; Bossew P, 2011, J ENVIRON RADIOACTIV, V114, P22; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Doi T, 2012, J ENVIRON RADIOACTIV, V2012, P55; Forum Chernobyl, 2005, ENV CONS CHERN ACC T; Hisamatsu S, 2012, J ENVIRON RADIOACTIV, V111, P1, DOI 10.1016/j.jenvrad.2011.12.017; Imanaka T, 2012, HEALTH PHYS, V102, P680, DOI 10.1097/HP.0b013e31824cfe18; NERH (Nuclear Emergency Response Headquarters) Government of Japan, 2011, JAP GOV IAEA MIN C N; NSC, 2011, TRIAL EST EM RAD MAT; Sakaguchi A, 2014, ENVIRON SCI TECHNOL, V48, P3691, DOI 10.1021/es405294s; Stohl A, 2012, J ENVIRON RADIOACTIV, V112, P155, DOI 10.1016/j.jenvrad.2012.06.001; Torii T, 2013, HEALTH PHYS, V105, P192, DOI 10.1097/HP.0b013e318294444e; Tsuruta H, 2013, 5 AS PAC S RAD APSOR, P5; Yamamoto M, 2012, GEOCHEM J, V46, P341; Zheng J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00304	23	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1227	1231		10.1007/s10967-014-3639-3		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200029		
J	Tadai, T; Akiyama, K; Aoshima, H; Ibuki, R; Kubuki, S				Tadai, T.; Akiyama, K.; Aoshima, H.; Ibuki, R.; Kubuki, S.			Synthesis of C-14 labeled C-60 with higher specific radioactivity	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Fullerenes; C-60; C-14; Liquid scintillation counter; Quenching effect		In this paper, we report the production of C-60[C-14] with the highest specific radioactivity to date by improving of previously reported method. To avoid the loss of C-14, the porous carbon after adsorbing C-14 labeled furan resin was sintered by "Baking" method instead of heating at 1,000 A degrees C in the electric furnace. As a result of this improvement, the specific radioactivity of the produced C-60[C-14] was found to be 0.958 MBq/mg (18.7 mCi/mmol). This is the highest specific radioactivity among those reported to date.	[Tadai, T.; Akiyama, K.; Kubuki, S.] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Aoshima, H.; Ibuki, R.] Vitamin C60 BioRes Corp, Chuo Ku, Tokyo 1030028, Japan	Akiyama, K (reprint author), Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan.	kakiyama@tmu.ac.jp			Mitsubishi Corporation	This work was carried out under the financial support from Mitsubishi Corporation, and by fruitful discussion provided by Dr. Kazunori Hirabayashi of Tokyo Metropolitan University. Some of the authors (TT and KA) express their gratitude for the supports. The other author (TT) is grateful to the international Conference Dispatch Program for Students, Program for Enhancing Systematic Education in Graduate Schools of Tokyo Metropolitan University.	KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Chan WCW, 2007, TOXICITY STUDIES FUL; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; SAITO Y, 1992, CHEM PHYS LETT, V200, P643, DOI 10.1016/0009-2614(92)80104-J; SCRIVENS WA, 1994, J AM CHEM SOC, V116, P4517, DOI 10.1021/ja00089a067	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1233	1237		10.1007/s10967-014-3453-y		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200030		
J	Komatsuda, S; Sato, W; Ohkubo, Y				Komatsuda, S.; Sato, W.; Ohkubo, Y.			Thermal stability of locally-associated Al and In impurities in zinc oxide	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Zinc oxide; Aluminum; Impurity; Local structure; Perturbed angular correlation; In-111	THIN-FILM; DOPED ZNO; TEMPERATURE; TRANSPARENT	The stability of locally-associated Al and In impurities in zinc oxide (ZnO) was investigated by means of the time-differential perturbed angular correlation (TDPAC) method with the Cd-111(a dagger In-111) probe. We found that Al and In impurities associate with each other by their thermal diffusion in air, and the association process irreversibly proceeds at high temperature. In vacuum, however, it was revealed that the rigid bonding between Al and In ions dissociates by heat treatment at temperatures higher than 873 K, and this dissociation process is enhanced with increasing annealing temperature. The contrastive atmosphere dependence of the stability of the association between Al and In in ZnO is discussed based on the variation of the TDPAC spectra against heat-treatment temperature.	[Komatsuda, S.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Sato, W.] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Ohkubo, Y.] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan	Sato, W (reprint author), Kanazawa Univ, Inst Sci & Engn, Kakumamachi, Kanazawa, Ishikawa 9201192, Japan.	wsato@se.kanazawa-u.ac.jp			JSPS [255811]	We express our gratitude to Prof. Y. Kobayashi for providing experimental apparatus for the TDPAC measurements. This work was supported in part by the Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows, 255811.	Abreu Y, 2012, SOLID STATE COMMUN, V152, P399, DOI 10.1016/j.ssc.2011.12.001; Ahn B D, 2007, APPL PHYS LETT, V91; Han JP, 2001, J EUR CERAM SOC, V21, P1883, DOI 10.1016/S0955-2219(01)00136-4; Han L, 2013, J ELECTRON MATER, V42, P1573, DOI 10.1007/s11664-012-2325-x; Bhosle V, 2006, J APPL PHYS, V100, DOI 10.1063/1.2218466; Meyer BK, 2004, PHYS STATUS SOLIDI B, V241, P231, DOI 10.1002/pssb.200301962; BAVERSTA.U, 1972, NUCL PHYS A, VA186, P500, DOI 10.1016/0375-9474(72)90980-3; Firestone R.B., 1996, TABLE ISOTOPES; Komatsuda S, 2011, J PHYS SOC JPN, V80; Munoz EL, 2012, PHYSICA B, V407, P3121, DOI 10.1016/j.physb.2011.12.041; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Sato W, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045319; Sato W, 2011, P RADIOCHIM ACTA, V1, P435; Sato W, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235209; Sato W, 2008, J PHYS SOC JPN, V77; Takeda Y, 2005, THIN SOLID FILMS, V486, P28, DOI 10.1016/j.tsf.2004.12.045	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1249	1252		10.1007/s10967-014-3460-z		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200033		
J	Sato, TK; Asai, M; Sato, N; Tsukada, K; Toyoshima, A; Ooe, K; Miyashita, S; Kaneya, Y; Osa, A; Schadel, M; Nagame, Y; Ichikawa, S; Stora, T; Kratz, JV				Sato, T. K.; Asai, M.; Sato, N.; Tsukada, K.; Toyoshima, A.; Ooe, K.; Miyashita, S.; Kaneya, Y.; Osa, A.; Schaedel, M.; Nagame, Y.; Ichikawa, S.; Stora, T.; Kratz, J. V.			Development of a He/CdI2 gas-jet system coupled to a surface-ionization type ion-source in JAEA-ISOL: towards determination of the first ionization potential of Lr (Z=103)	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						He/CdI2 gas-jet transport system; Isotope separator on-line (ISOL); Surface ionization; Lawrencium; Ionization potential; Lanthanide isotopes	TRANSITION ENERGIES; ATOMIC LAWRENCIUM	We report on development of a gas-jet transport system coupled to a surface ionization ion-source in the JAEA-ISOL (Isotope Separator On-Line) system. As a new aerosol material for the gas-jet system, CdI2, which has a low boiling point of 713 A degrees C, is exploited to prevent deposition of the aerosol material on the surface of the ion-source. An additional filament is newly installed in the previous ion-source to provide uniform heating of an ionizer. The present system is applied to the measurement of absolute efficiencies of various short-lived lanthanide isotopes produced in nuclear reactions.	[Sato, T. K.; Asai, M.; Sato, N.; Tsukada, K.; Toyoshima, A.; Kaneya, Y.; Osa, A.; Schaedel, M.; Nagame, Y.; Ichikawa, S.] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Ooe, K.] Niigata Univ, Inst Sci & Technol, Niigata 9502181, Japan; [Miyashita, S.] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan; [Kaneya, Y.; Nagame, Y.] Ibaraki Univ, Grad Sch Sci & Engn, Mito, Ibaraki 3108512, Japan; [Ichikawa, S.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Stora, T.] CERN, ISOLDE, CH-1211 Geneva 23, Switzerland; [Kratz, J. V.] Johannes Gutenberg Univ Mainz, Inst Kernchem, D-55099 Mainz, Germany	Sato, TK (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan.	sato.tetsuya@jaea.go.jp					Zou Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.183001; Borschevsky A, 2007, EUR PHYS J D, V45, P115, DOI 10.1140/epjd/e2007-00130-9; Erdmann N, 1998, J ALLOY COMPD, V271, P837, DOI 10.1016/S0925-8388(98)00229-1; Asai M, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.067301; Asai M, 2003, EUR PHYS J A, V16, P17, DOI 10.1140/epja/i2002-10112-y; Asai M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.102502; DESCLAUX JP, 1980, J PHYS-PARIS, V41, P943, DOI 10.1051/jphys:01980004109094300; DRESSER MJ, 1968, J APPL PHYS, V39, P338, DOI 10.1063/1.1655755; Haynes W.M., 2013, CRC HDB CHEM PHYS; HERTEL GR, 1967, J CHEM PHYS, V47, P335, DOI 10.1063/1.1711871; Ichikawa S, 1996, NUCL INSTRUM METH A, V374, P330, DOI 10.1016/0168-9002(96)00086-1; KAWASE Y, 1985, NUCL INSTRUM METH A, V241, P305, DOI 10.1016/0168-9002(85)90583-2; KIRCHNER R, 1990, NUCL INSTRUM METH A, V292, P203, DOI 10.1016/0168-9002(90)90377-I; Sakama M, 2000, EUR PHYS J A, V9, P303, DOI 10.1007/s100500070013; Sato N, 2014, RADIOCHIM ACTA, V102, P211, DOI 10.1515/ract-2014-2142; Sato TK, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4789772; SMITH DH, 1969, J CHEM PHYS, V51, P3105, DOI 10.1063/1.1672462; Tsukada K, 1998, PHYS REV C, V57, P2057, DOI 10.1103/PhysRevC.57.2057	18	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1253	1257		10.1007/s10967-014-3467-5		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200034		
J	Nomura, K; de Souza, P; Hirai, S; Kojima, N				Nomura, Kiyoshi; de Souza, Paulo; Hirai, Shoji; Kojima, Norimichi			Mossbauer analysis of iron ore and rapidly reduced iron ore treated by micro-discharge using carbon felt	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Iron ore; Hematite; Goethite; Mossbauer analysis; Chemical analysis; Micro discharge using carbon felt (MD/CF)		Several samples of iron ores produced in Australia and Brazil were analyzed by Mossbauer spectrometry. Almost all iron ores are composed of hematite, goethite, and fine grains of the oxides, of which the ratios are different among production area. The amount ratio of hematite and goethite, determined by Mossbauer spectrometry, were almost consistent with those obtained by a conventional chemical analysis especially for iron ore with less goethite. Iron ores were treated by a micro discharge using carbon felt (MD/CF). It is found that FeO, Fe(CO3), and Fe3O4 are produced by MD/CF. The treatment by MD/CF is efficient in rapid reduction of iron ores.	[Nomura, Kiyoshi; Kojima, Norimichi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [de Souza, Paulo] CSIRO Computat Informat, Hobart, Tas 7005, Australia; [Hirai, Shoji] Tokyo City Univ, Fac Engn, Setagaya Ku, Tokyo 1588557, Japan	Nomura, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	dqf10204@nifty.com	de Souza, Paulo/B-8961-2008; 	de Souza, Paulo/0000-0002-0091-8925; Nomura, Kiyoshi/0000-0003-0625-1778			[Anonymous], 2005, M8213 JIS JAP STAND; [Anonymous], 1995, M8211 JIS JAP STAND; Haque KE, 1999, INT J MINER PROCESS, V57, P1, DOI 10.1016/S0301-7516(99)00009-5; [Anonymous], 1995, M8212 JIS JAP STAND; Klencsar Z, MOSSWINN 3 1 PROGRAM; KOCH F, 1969, ACTA CRYSTALL B-STRU, VB 25, P275, DOI 10.1107/S0567740869002111; Kurihara H, 2009, J JPN SOC POWDER POW, V56, P116; Meisel W, 1973, P 5 INT C MOSSB SPEC, P200; ONO K, 1964, J PHYS SOC JPN, V19, P899, DOI 10.1143/JPSJ.19.899; Ujihira Y, 1996, ANAL CORROSION PRODU; Yasutaka M, 2011, JPN J IRON STEEL, V97, P70	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1259	1263		10.1007/s10967-014-3468-4		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200035		
J	Takata, H; Kusakabe, M; Oikawa, S				Takata, Hyoe; Kusakabe, Masashi; Oikawa, Shinji			Radiocesiums (Cs-134, Cs-137) in zooplankton in the waters of Miyagi, Fukushima and Ibaraki Prefectures	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Cs-134; Cs-137 Zooplankton; Taxon; Export flux	PACIFIC-OCEAN; RADIONUCLIDES; SEA; DISPERSION	Concentrations of radiocesium (Cs-134 and Cs-137) were measured in zooplankton in the waters of Miyagi, Fukushima, and Ibaraki Prefectures from May 2012 to January 2013. They varied from 0.1 to 9.1 Bq/kg-wet, and from 0.1 to 12.8 Bq/kg-wet for Cs-134 and Cs-137, respectively. The zooplankton-to-water concentration ratio (CR) of Cs-137 was calculated to be 20-1410 L/kg. Export fluxes of Cs-137 by zooplankton were estimated to be 13-165 mBq/m(2)/y. The contribution of zooplankton for the downward transport of Cs-137 was at most 18 % of the previously reported export fluxes of Cs-137 by sinking particles as obtained from sediment trap observations.	[Takata, Hyoe; Kusakabe, Masashi; Oikawa, Shinji] Marine Ecol Res Inst, Cent Lab, Onjuku, Chiba 2995105, Japan	Takata, H (reprint author), Marine Ecol Res Inst, Cent Lab, 300 Iwawada, Onjuku, Chiba 2995105, Japan.	takata@kaiseiken.or.jp					Kaeriyama H, 2008, J ENVIRON RADIOACTIV, V99, P1838, DOI 10.1016/j.jenvrad.2008.08.006; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Miyazawa Y, 2013, BIOGEOSCIENCES, V10, P2349, DOI 10.5194/bg-10-2349-2013; du Bois PB, 2012, J ENVIRON RADIOACTIV, V114, P2, DOI 10.1016/j.jenvrad.2011.11.015; Stohl A, 2012, ATMOS CHEM PHYS, V12, P2313, DOI 10.5194/acp-12-2313-2012; Oikawa S, 2013, BIOGEOSCIENCES, V10, P5031, DOI 10.5194/bg-10-5031-2013; Honda MC, 2013, BIOGEOSCIENCES, V10, P3525, DOI 10.5194/bg-10-3525-2013; Kusakabe M, 2013, BIOGEOSCIENCES, V10, P5019, DOI 10.5194/bg-10-5019-2013; BUESSELER KO, 1987, NATURE, V329, P825, DOI 10.1038/329825a0; Carroll ML, 1998, DEEP-SEA RES PT I, V45, P1303, DOI 10.1016/S0967-0637(98)00013-2; FISHER NS, 1991, DEEP-SEA RES, V38, P1261, DOI 10.1016/0198-0149(91)90026-C; FOWLER SW, 1987, NATURE, V329, P56, DOI 10.1038/329056a0; IAEA, 2004, IAEA TECHN REP SER, V422; Kitamura M, 2013, BIOGEOSCIENCES DISCU, V10, P6143; Kobari T, 2003, PROGR OCEANOGRAPHY, V57, P297; Kobari Toru, 2000, Bulletin of Plankton Society of Japan, V47, P129; KUSAKABE M, 1988, GEOPHYS RES LETT, V15, P44, DOI 10.1029/GL015i001p00044; MILLER CB, 1993, PROG OCEANOGR, V32, P295, DOI 10.1016/0079-6611(93)90018-9; Rypina I.I., 2013, BIOGEOSCIENCES DISCU, V10, P1517, DOI DOI 10.5194/BGD-10-1517-2013	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1265	1271		10.1007/s10967-014-3504-4		7	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200036		
J	Ueno, S; Toda, K; Asano, A; Takahashi, N; Kasamatsu, Y; Yokokita, T; Yokoyama, A				Ueno, S.; Toda, K.; Asano, A.; Takahashi, N.; Kasamatsu, Y.; Yokokita, T.; Yokoyama, A.			Measurement of evaporation-residue cross sections with light beams and deformed lanthanide target nuclei	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Fusion reaction; Excitation function; Deformed nucleus; HIVAP code	ELEMENTS; FUSION	To obtain a better understanding of the fusion reaction, we have focused on reactions involving deformed nuclei. Evaporation residue cross sections of the Tm-169+Ne-20 reaction were measured, from which we extracted the fusion excitation function. This is compared with literature data of the Tm-169+O-16 and Ho-165+Ne-20 systems. Irradiation with Ne-20 ion beam has been carried out at the incident energy near the Coulomb barrier, where the effect of nuclear deformation is prominent. The results are consistent with the idea that the degree of deformation has an effect on the threshold value of the excitation functions near the Coulomb barrier.	[Ueno, S.; Toda, K.; Asano, A.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Takahashi, N.; Kasamatsu, Y.; Yokokita, T.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Yokoyama, A.] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan	Ueno, S (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	coffeepudding1126@yahoo.co.jp					Hofmann S, 2000, REV MOD PHYS, V72, P733, DOI 10.1103/RevModPhys.72.733; HINDE DJ, 1995, PHYS REV LETT, V74, P1295, DOI 10.1103/PhysRevLett.74.1295; Asano A, 2009, J NUCL RAD SCI S, V10, P127; Bass R., 1980, NUCL REACTIONS HEAVY; Firestone RB, 1996, TABLE ISOTOPES, VII; Morita K, 2004, J PHYS SOC JPN, V73, P2593, DOI 10.1143/JPSJ.73.2593; Oganessian Yu. Ts., 2007, J PHYS G, V34, P165, DOI DOI 10.1088/0954-3899/34/4/R01; REISDORF W, 1992, Z PHYS A-HADRON NUCL, V343, P47, DOI 10.1007/BF01291597; Reus U, 1983, CATALOG GAMMA RAYS 2; Reus U, 1983, CATALOG GAMMA RAYS 1; Toda K, 2012, J NUCL RAD SCI S, V13, P93	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1273	1276		10.1007/s10967-014-3632-x		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200037		
J	Yoshida, G; Ninomiya, K; Ito, TU; Higemoto, W; Nagatomo, T; Strasser, P; Kawamura, N; Shimomura, K; Miyake, Y; Miura, T; Kubo, KM; Shinohara, A				Yoshida, G.; Ninomiya, K.; Ito, T. U.; Higemoto, W.; Nagatomo, T.; Strasser, P.; Kawamura, N.; Shimomura, K.; Miyake, Y.; Miura, T.; Kubo, K. M.; Shinohara, A.			Muon capture probability of carbon and oxygen for CO, CO2, and COS under low-pressure gas conditions	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Negative muon; Muonic atom; Muon capture; Muonic X-ray; EGS-5 code	MESONS; RATIOS; ATOMS	When a negatively charged muon is stopped in a substance, it is captured by an atom of the substance, and the muonic atom is formed. The muon capture process is significantly affected by the chemical environment of the atom and factors such as molecular structure (chemical effect). In this study, we performed muon irradiation for low-pressure CO, CO2, and COS molecules and measured the muonic X-rays emitted immediately after muon capture by an atom. In this paper, we quantitatively discuss the muon capture probability of each type of atom using the LMM model.	[Yoshida, G.; Ninomiya, K.; Shinohara, A.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Ito, T. U.; Higemoto, W.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Naka, Ibaraki 3191192, Japan; [Nagatomo, T.; Strasser, P.; Kawamura, N.; Shimomura, K.; Miyake, Y.] High Energy Accelerator Res Org KEK, Muon Sci Lab, Tsukuba, Ibaraki 3050801, Japan; [Miura, T.] High Energy Accelerator Res Org KEK, Radiat Sci Ctr, Tsukuba, Ibaraki 3050801, Japan; [Kubo, K. M.] Int Christian Univ, Div Nat Sci, Mitaka, Tokyo 1818585, Japan	Yoshida, G (reprint author), Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan.	yoshidag12@chem.sci.osaka-u.ac.jp			JSPS KAKENHI, Japan [24740279, 26800213]	This research was supported by the Grant-in-Aid for Young Scientists B (JSPS KAKENHI, Japan: Grant Number 24740279 and 26800213).	FERMI E, 1947, PHYS REV, V72, P399, DOI 10.1103/PhysRev.72.399; BACHER R, 1985, PHYS REV LETT, V54, P2087, DOI 10.1103/PhysRevLett.54.2087; DANIEL H, 1975, PHYS REV LETT, V35, P1649, DOI 10.1103/PhysRevLett.35.1649; Hirayama H., 2005, SLACR730; Hughes VW, 1977, MUON PHYS; Huheey J.E., 1993, INORGANIC CHEM PRINC; IMANISHI N, 1988, PHYS REV A, V37, P43, DOI 10.1103/PhysRevA.37.43; Jean Y, 1993, INTRO MOL ORBITALS; Kadono R, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/2/026302; KNIGHT JD, 1983, PHYS REV A, V27, P2936, DOI 10.1103/PhysRevA.27.2936; KUBO MK, 1989, RADIOCHIM ACTA, V47, P77; Ninomiya K, 2011, J KOREAN PHYS SOC, V59, P2917, DOI 10.3938/jkps.59.2917; PETRUKHIN VI, 1976, ZH EKSP TEOR FIZ+, V70, P1145; SCHNEUWLY H, 1978, NUCL PHYS A, V312, P419, DOI 10.1016/0375-9474(78)90601-2; SCHNEUWLY H, 1983, PHYS REV A, V27, P950, DOI 10.1103/PhysRevA.27.950; SUZUKI T, 1980, PHYS LETT B, V95, P202, DOI 10.1016/0370-2693(80)90469-4	16	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1277	1281		10.1007/s10967-014-3602-3		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200038		
J	Hatsukawa, Y; Hashimoto, K; Tsukada, K; Sato, T; Asai, M; Toyoshima, A; Nagai, Y; Tanimori, T; Sonoda, S; Kabuki, S; Saji, H; Kimura, H				Hatsukawa, Yuichi; Hashimoto, Kazuyuki; Tsukada, Kazuaki; Sato, Tetsuya; Asai, Masato; Toyoshima, Atsushi; Nagai, Yasuki; Tanimori, Toru; Sonoda, Shinya; Kabuki, Shigeto; Saji, Hideo; Kimura, Hiroyuki			Production of Tc-95m for Compton camera imaging	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Technetium-95m; Compton camera imaging; MDP labeling; Mo-95(p,n)Tc-95m reaction	MICRO PIXEL CHAMBER; PROJECTION; DETECTOR; DESIGN; TPC	With the development of the Compton camera which can realize high position resolution, technetium isotopes emitting high energy gamma-rays are required. In this study, Technetium-95m which emits some gamma rays with higher than 200 keV was produced by the Mo-95(p,n)Tc-95m reaction. Image of gamma-rays from Tc-95m was taken by a Compton gamma-ray camera.	[Hatsukawa, Yuichi; Hashimoto, Kazuyuki; Tsukada, Kazuaki; Sato, Tetsuya; Asai, Masato; Toyoshima, Atsushi; Nagai, Yasuki] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Tanimori, Toru; Sonoda, Shinya] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Kabuki, Shigeto] Tokai Univ, Sch Med, Sagamihara, Kanagawa 2591193, Japan; [Saji, Hideo; Kimura, Hiroyuki] Kyoto Univ, Fac Pharmaceut Sci, Kyoto 6068501, Japan	Hatsukawa, Y (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan.	hatsukawa.yuichi@jaea.go.jp					Eckelman WC, 2009, JACC-CARDIOVASC IMAG, V2, P364, DOI 10.1016/j.jcmg.2008.12.013; Orito R, 2003, NUCL INSTRUM METH A, V513, P408, DOI 10.1016/j.nima.2003.08.071; Banerjee S, 2001, SEMIN NUCL MED, V31, P260, DOI 10.1053/snuc.2001.26205; Wilderman SJ, 1998, IEEE T NUCL SCI, V45, P957, DOI 10.1109/23.682685; Kurosawa S, 2012, CURR APPL PHYS, V12, P364, DOI 10.1016/j.cap.2011.07.027; Pandey U, 2014, APPL RADIAT ISOTOPES, V86, P52, DOI 10.1016/j.apradiso.2013.12.036; RAMAMOORTHY N, 1986, J RADIOAN NUCL CH AR, V98, P121, DOI 10.1007/BF02060439; Dash A, 2013, NUCL MED BIOL, V40, P167, DOI 10.1016/j.nucmedbio.2012.10.005; Eggen DT, 1947, PHYS REV, V74, P57; IZUMO M, 1991, APPL RADIAT ISOTOPES, V42, P297; Kabuki S, 2010, NUCL INSTRUM METH A, V623, P606, DOI 10.1016/j.nima.2010.03.085; Kabuki S, 2007, NUCL INSTRUM METH A, V580, P1031, DOI 10.1016/j.nima.2007.06.098; Kubo H, 2003, NUCL INSTRUM METH A, V513, P94, DOI 10.1016/j.nima.2003.08.009; Mizumura Y, 2014, J INSTRUM, V9, DOI 10.1088/1748-0221/9/05/C05045; Nagayoshi T, 2005, NUCL INSTRUM METH A, V546, P457, DOI 10.1016/j.nima.2005.02.042; Ochi A, 2001, NUCL INSTRUM METH A, V471, P264, DOI 10.1016/S0168-9002(01)00996-2; Takada A, 2005, NUCL INSTRUM METH A, V546, P258, DOI 10.1016/j.nima.2005.03.050; Tanimori T, 2004, NEW ASTRON REV, V48, P236; UNIK JP, 1959, PHYS REV, V115, P1687, DOI 10.1103/PhysRev.115.1687	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1283	1285		10.1007/s10967-014-3508-0		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200039		
J	Ogawa, H; Kitajima, A; Tanaka, H; Kawamoto, T				Ogawa, Hiroshi; Kitajima, Akiko; Tanaka, Hisashi; Kawamoto, Tohru			Numerical evaluation of Cs adsorption in PB column by extended Langmuir formula and one-dimensional adsorption model	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radioactive cesium; Decontamination; Prussian blue; Adsorption; Langmuir formula; Simulation	GRANULAR ACTIVATED CARBON; RADIOACTIVE CESIUM; KINETIC-MODEL; CHLOROPHENOLS; PARAMETERS; ISOTHERMS; MIGRATION; TRANSPORT; EQUATIONS; MATRICES	Adsorption property of granulated Prussian blue adsorbent on radioactive cesium was evaluated for efficient decontamination in Fukushima area. The adsorbent was found to show an inflective adsorption isotherm, which was expressed by extended Langmuir formula with three adsorption sites. Adsorption speeds of each site were evaluated by time-dependent batch experiment. The simulation using derived parameters and one-dimensional adsorption model successfully reproduced the experimental data of cesium decontamination by small and large columns.	[Ogawa, Hiroshi; Kitajima, Akiko; Tanaka, Hisashi; Kawamoto, Tohru] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058568, Japan	Ogawa, H (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058568, Japan.	h.ogawa@aist.go.jp	Kawamoto, Tohru/B-7145-2008	Kawamoto, Tohru/0000-0002-3984-2980			Saiers JE, 1996, J CONTAM HYDROL, V22, P255, DOI 10.1016/0169-7722(95)00094-1; FUJIKAWA Y, 1991, J CONTAM HYDROL, V8, P43, DOI 10.1016/0169-7722(91)90008-O; JACKSON DR, 1984, ENVIRON SCI TECHNOL, V18, P668, DOI 10.1021/es00127a007; Kitajima A, 2014, ENVIRON SCI-PROC IMP, V16, P28, DOI 10.1039/c3em00416c; Hamdaoui O, 2007, J HAZARD MATER, V147, P381, DOI 10.1016/j.jhazmat.2007.01.021; Parajuli D, 2013, ENVIRON SCI TECHNOL, V47, P3800, DOI 10.1021/es303467n; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Kitajima A, 2012, CHEM LETT, V41, P1473, DOI 10.1246/cl.2012.1473; Hamdaoui O, 2007, J HAZARD MATER, V147, P401, DOI 10.1016/j.jhazmat.2007.01.023; CAMERON DR, 1977, WATER RESOUR RES, V13, P183, DOI 10.1029/WR013i001p00183; Lee CP, 2013, J RADIOANAL NUCL CH, V296, P1119, DOI 10.1007/s10967-012-2184-1; Macasek F, 1998, J RADIOANAL NUCL CH, V229, P79, DOI 10.1007/BF02389450; Nguyen C, 2000, LANGMUIR, V16, P1868, DOI 10.1021/la990584m; NIELSEN P, 1987, Z NATURFORSCH B, V42, P1451; REYNOLDS WD, 1982, CAN GEOTECH J, V19, P92; SELIM HM, 1988, WATER RESOUR RES, V24, P2061, DOI 10.1029/WR024i012p02061	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1287	1290		10.1007/s10967-014-3473-7		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200040		
J	Matsunaga, T; Nakanishi, T; Atarashi-Andoh, M; Takeuchi, E; Tsuduki, K; Nishimura, S; Koarashi, J; Otosaka, S; Sato, T; Nagao, S				Matsunaga, Takeshi; Nakanishi, Takahiro; Atarashi-Andoh, Mariko; Takeuchi, Erina; Tsuduki, Katsunori; Nishimura, Syusaku; Koarashi, Jun; Otosaka, Shigeyoshi; Sato, Tsutomu; Nagao, Seiya			A passive collection system for whole size fractions in river suspended solids	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Suspended solids; Passive collection; Radiocesium; Stable carbon; Fluvial transport		In order to solve difficulties in collection of river suspended solids (SS) such as frequent observations during stochastic rainfall events, a simple passive collection system of SS has been developed. It is composed of sequentially connected two large-scale filter vessels. A portion of river water flows down into the filter vessels utilizing a natural drop of streambed. The system enable us to carry out long-term, unmanned SS collection. It is also compatible with dissolved component collection. Its performance was validated in a forested catchment by applying to radiocesium and stable carbon transport.	[Matsunaga, Takeshi; Nakanishi, Takahiro; Atarashi-Andoh, Mariko; Takeuchi, Erina; Tsuduki, Katsunori; Nishimura, Syusaku; Koarashi, Jun; Otosaka, Shigeyoshi] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan; [Sato, Tsutomu] Hokkaido Univ, Grad Sch Engn, Div Sustainable Resources Engn, Sapporo, Hokkaido 0608628, Japan; [Nagao, Seiya] Kanazawa Univ, Inst Nat & Environm Technol, Low Level Radioact Lab, Kanazawa, Ishikawa 9231224, Japan	Atarashi-Andoh, M (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan.	andoh.mariko@jaea.go.jp					Nagao S, 2013, BIOGEOSCIENCES, V10, P6215, DOI 10.5194/bg-10-6215-2013; Ueda S, 2013, J ENVIRON RADIOACTIV, V118, P96, DOI 10.1016/j.jenvrad.2012.11.009; Phillips JM, 2000, HYDROL PROCESS, V14, P2589, DOI 10.1002/1099-1085(20001015)14:14<2589::AID-HYP94>3.3.CO;2-4; Kim SJ, 2010, BIOGEOSCIENCES, V7, P1323; Inshizuka S, 2006, ANN FOREST SCI, DOI [10.1051/forest:2006036, DOI 10.1051/FOREST:2006036]; MEXT, DAT MAPS RES RES DIS; Mizoguchi Y, 2002, ECOLOGICAL STUDIES, V158; Nakanishi T, 2010, J RADIOANAL NUCL CH, V283, P831, DOI 10.1007/s10967-009-0422-y; Priadi C, 2011, J ENVIRON MONITOR, V13, P1470, DOI 10.1039/c0em00713g	9	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1291	1295		10.1007/s10967-014-3491-5		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200041		
J	Yanaga, M; Oishi, A				Yanaga, M.; Oishi, A.			Decontamination of radioactive cesium in soil	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Decontamination; Radioactive cesium; Nuclear power plant accident; Soil	FUKUSHIMA	Agricultural soil containing radioactive cesium was decontaminated using an extraction method involving aqueous potassium solutions. Results demonstrated that the potassium solution could extract radioactive cesium from soil artificially contaminated with Cs-137, although extraction rate decreased as time after contamination increased. However, visual examination of radioactivity distribution in soil samples significantly contaminated by the accident at the Fukushima Daiichi nuclear power plant showed that radioactive cesium also existed as insoluble particles. Therefore, reducing the volume of radioactive wastes generated from soil decontamination requires a physical decontamination method combined with chemical treatment.	[Yanaga, M.; Oishi, A.] Shizuoka Univ, Grad Sch Sci, Dept Chem, Suruga Ku, Shizuoka 4228529, Japan; [Yanaga, M.] Shizuoka Univ, Fac Sci, Radiosci Res Lab, Suruga Ku, Shizuoka 4228529, Japan	Yanaga, M (reprint author), Shizuoka Univ, Grad Sch Sci, Dept Chem, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	srmyana@ipc.shizuoka.ac.jp			JSPS KAKENHI [25350124]; Shizuoka University, Japan	This work was supported by JSPS KAKENHI Grant Number 25350124 and by Shizuoka University, Japan. We are grateful to Dr. Hiromitsu Haba and Dr. Yoshitomo Uwamino (RIKEN) for providing the gamma standard sources.	Adachi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02554; [Anonymous], 2012, REP RES DEC MOD PROJ; Kogure T, 2012, CHEM LETT, V41, P380, DOI 10.1246/cl.2012.380; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; Nogawa Norio, 2011, Radioisotopes, V60, P311, DOI 10.3769/radioisotopes.60.311; Yanaga M, 2013, RAD SAF MANAG, V12, P16; Yanaga M, 2013, RAD SAF MANAG, V12, P37	7	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1301	1304		10.1007/s10967-014-3541-z		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200043		
J	Nagaoka, M; Yokoyama, H; Fujita, H; Nakano, M; Watanabe, H; Sumiya, S				Nagaoka, M.; Yokoyama, H.; Fujita, H.; Nakano, M.; Watanabe, H.; Sumiya, S.			Spatial distribution of radionuclides in seabed sediments off Ibaraki coast after the Fukushima Daiichi Nuclear Power Plant accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Seabed sediment; Ibaraki coast; Fukushima Daiichi Nuclear Power Plant accident; Cesium; Strontium; Plutonium isotopes	CS-137; ISOTOPES; OCEAN	Fifty-one seabed sediments were collected to estimate the influence of the Fukushima Daiichi Nuclear Power Plant accident on the area offshore from Ibaraki. The Cs-134 and Cs-137 radioactivity levels were 3.8-206.7 and 6.1-296 Bq/kg (dry wt), respectively, and the activity ratios of Cs-134/Cs-137 were 0.48-0.77. The Sr-90 and Pu-239,Pu-240 activity levels were ND-0.26 and 0.170-0.78 Bq/kg (dry wt), respectively. The ratios of Pu-238/Pu-239,Pu-240 activity were 0.014-0.019. The Sr-90 radioactivity was increased by the accident and Pu isotopes radioactivity was not changed.	[Nagaoka, M.; Yokoyama, H.; Fujita, H.; Nakano, M.; Watanabe, H.; Sumiya, S.] Japan Atom Energy Agcy, Nucl Fuel Cycle Engn Labs, Tokai, Ibaraki 3191194, Japan	Nagaoka, M (reprint author), Japan Atom Energy Agcy, Nucl Fuel Cycle Engn Labs, 4-33 Muramatsu, Tokai, Ibaraki 3191194, Japan.	nagaoka.mika@jaea.go.jp					Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Zheng J, 2012, GEOCHEM J, V46, P361; Aoyama M, 2012, GEOCHEM J, V46, P321; Bu WT, 2013, BIOGEOSCIENCES, V10, P2497, DOI 10.5194/bg-10-2497-2013; Kawamura H, 2011, J NUCL SCI TECHNOL, V48, P1349, DOI 10.3327/jnst.48.1349; MEXT (Japanese Ministry of Education Culture Sports Science and Technology), 2011, READ SEA AR MON OFFS; Otosaka S, 2012, ENVIRON MONIT ASSESS, V184, P5419; Sumiya S, 2012, JAEA REV; UNSCEAR, 1982, REP 1982 ION RAD SOU	9	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1305	1308		10.1007/s10967-014-3633-9		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200044		
J	Inoue, M; Minakawa, M; Yoshida, K; Nakano, Y; Kofuji, H; Nagao, S; Hamajima, Y; Yamamoto, M				Inoue, M.; Minakawa, M.; Yoshida, K.; Nakano, Y.; Kofuji, H.; Nagao, S.; Hamajima, Y.; Yamamoto, M.			Vertical profiles of Ra-228 and Ra-226 activities in the Sea of Japan and their implications on water circulation	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Ra-228; Ra-226; Low-background gamma-spectrometry; Deep proper water; Sea of Japan; Turn-over time	COPRECIPITATION METHOD; RA-228/RA-226 RATIO; COASTAL WATER; SPECTROMETRY; CS-137; TIME; BE-7	We analyzed a total of 25 seawater samples collected from 2 columns within the Sea of Japan for Ra-226 (half life 1,600 years) and Ra-228 (half life 5.75 years) by employing low-background gamma-spectrometry. The Ra-228 activity level in the deep proper water (DPW) similar to 0.13 mBq/L) was found to be higher than that of deep waters from the Pacific and Atlantic Oceans (< 0.1 mBq/L), indicating its continuous delivery to the DPW by active water circulation before complete radioactive decay. Using a steady state box model of Ra-226 and Ra-228, the turn-over time in the DPW was calculated to be similar to 80 years.	[Inoue, M.; Yoshida, K.; Nakano, Y.; Kofuji, H.; Nagao, S.; Hamajima, Y.; Yamamoto, M.] Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan; [Minakawa, M.] Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Kanazawa, Ishikawa 2368648, Japan; [Kofuji, H.] Japan Marine Sci Fdn, Minato Ku, Mutsu, Aomori 0350064, Japan	Inoue, M (reprint author), Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan.	mutsuo@llrl.ku-unet.ocn.ne.jp	HAMAJIMA, Yasunori/L-3802-2015	HAMAJIMA, Yasunori/0000-0002-8485-4606	Ministry of Education, Culture, Sports, Science and Technology of Japan [21510011]	We thank the researchers, captain, and crew of the R/V Soyo Maru for their assistance during sampling. This study was supported partly by a Grant-in-Aid for Scientific Research No. 21510011 (M. Inoue) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	CHEN CTA, 1995, J GEOPHYS RES-OCEANS, V100, P13737, DOI 10.1029/95JC00939; Kumamoto Y, 1998, GEOPHYS RES LETT, V25, P651, DOI 10.1029/98GL00359; TRIER RM, 1972, EARTH PLANET SC LETT, V16, P141, DOI 10.1016/0012-821X(72)90249-X; Hatta M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026537; KAUFMAN A, 1973, J GEOPHYS RES, V78, P8827, DOI 10.1029/JC078i036p08827; Hamajima Y, 2004, APPL RADIAT ISOTOPES, V61, P179, DOI 10.1016/j.apradiso.2004.03.041; HARADA K, 1986, EARTH PLANET SC LETT, V77, P236, DOI 10.1016/0012-821X(86)90164-0; Hogan P., 2006, OCEANOGRAPHY, V19, P134; Horibe Y., 1983, J OCEANOGR SOC JAPAN, V39, P220, DOI 10.1007/BF02070392; Inoue M, 2007, MAR CHEM, V107, P559, DOI 10.1016/j.marchem.2007.08.003; Inoue Mutsuo, 2007, Radioisotopes, V56, P77; Inoue M, 2012, J ENVIRON RADIOACTIV, V104, P75, DOI 10.1016/j.jenvrad.2011.09.007; Inoue M, 2013, J ENVIRON RADIOACTIV, V126, P176, DOI 10.1016/j.jenvrad.2013.08.001; Nakano Y, 2008, J OCEANOGR, V64, P713, DOI 10.1007/s10872-008-0060-y; Okubo T, 1980, J OCEANOGR SOC JPN, V36, P263, DOI 10.1007/BF02072128; Suzuki T, 2010, NUCL INSTRUM METH B, V268, P1229, DOI 10.1016/j.nimb.2009.10.140; WATANABE YW, 1991, MAR CHEM, V34, P97, DOI 10.1016/0304-4203(91)90016-P	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1309	1312		10.1007/s10967-014-3492-4		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200045		
J	Inoue, M; Yoneoka, S; Ochiai, S; Oikawa, S; Fujimoto, K; Yagi, Y; Honda, N; Nagao, S; Yamamoto, M; Hamajima, Y; Murakami, T; Kofuji, H; Misonoo, J				Inoue, M.; Yoneoka, S.; Ochiai, S.; Oikawa, S.; Fujimoto, K.; Yagi, Y.; Honda, N.; Nagao, S.; Yamamoto, M.; Hamajima, Y.; Murakami, T.; Kofuji, H.; Misonoo, J.			Lateral and temporal variations in Fukushima Dai-ichi NPP-derived Cs-134 and Cs-137 in marine sediments in/around the Sado Basin, Sea of Japan	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Cs-134; Cs-137; Marine sediment; Fukushima Dai-ichi nuclear power plant accident; Riverine particle; Sea of Japan	NUCLEAR-POWER-PLANT; ACCIDENT; SEAWATERS	Lateral and temporal profiles for concentrations of Cs-134 and Cs-137 were examined in marine sediments obtained from coastal and offshore areas on the Sea of Japan-side of central Honshu. In 2013, concentrations declined sharply from an estuarine (30 Bq/kg-dry for Cs-134) to offshore areas. In the offshore Sado Basin, the concentration of short-lived Cs-134, which was not detected (< 0.3 Bq/kg-dry) in 2010, was 1-15 Bq/kg-dry in 2011-2013. Discharged riverine materials affected by radiocesium derived from the Fukushima Dai-ichi Nuclear Power Plant have been delivered to this offshore basin.	[Inoue, M.; Yoneoka, S.; Ochiai, S.; Nagao, S.; Yamamoto, M.; Hamajima, Y.; Murakami, T.] Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan; [Oikawa, S.; Misonoo, J.] Marine Ecol Res Inst, Shinjuku Ku, Tokyo 1620801, Japan; [Fujimoto, K.] Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Kanazawa, Ishikawa 2368648, Japan; [Yagi, Y.; Honda, N.] Japan Sea Natl Fisheries Res Inst, Fisheries Res Agcy, Chuo Ku, Niigata 9518121, Japan; [Kofuji, H.] Japan Marine Sci Fdn, Mutsu, Aomori 0350064, Japan	Inoue, M (reprint author), Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan.	mutsuo@llrl.ku-unet.ocn.ne.jp	HAMAJIMA, Yasunori/L-3802-2015	HAMAJIMA, Yasunori/0000-0002-8485-4606	Ministry of Education, Culture, Sports, Science, and Technology, Japan [24510011]	We thank the researchers, captain, and crew of all the R/Vs used in this study for their assistance during sampling. This study was partly supported by a Grant-in-Aid to M. Inoue (Scientific Research No. 24510011) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Inoue M, 2012, GEOCHEM J, V46, P311; Nagao S, 2013, BIOGEOSCIENCES, V10, P6215, DOI 10.5194/bg-10-6215-2013; Ueda S, 2013, J ENVIRON RADIOACTIV, V118, P96, DOI 10.1016/j.jenvrad.2012.11.009; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Kusakabe M, 2013, BIOGEOSCIENCES, V10, P5019, DOI 10.5194/bg-10-5019-2013; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Hamajima Y, 2004, APPL RADIAT ISOTOPES, V61, P179, DOI 10.1016/j.apradiso.2004.03.041; Inoue M, 2013, APPL RADIAT ISOTOPES, V81, P340, DOI 10.1016/j.apradiso.2013.03.084; Inoue M, 2013, J ENVIRON RADIOACTIV, V126, P176, DOI 10.1016/j.jenvrad.2013.08.001; Otosaka S, 2012, MONIT ASSESS, DOI [10.1007/s10661-012-2956-7, DOI 10.1007/S10661-012-2956-7]	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1313	1316		10.1007/s10967-014-3518-y		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200046		
J	Ooe, K; Attallah, MF; Asai, M; Goto, N; Gupta, NS; Haba, H; Huang, M; Kanaya, J; Kaneya, Y; Kasamatsu, Y; Kitatsuji, Y; Kitayama, Y; Koga, K; Komori, Y; Koyama, T; Kratz, JV; Lerum, HV; Miyashita, S; Oshimi, Y; Pershina, V; Sato, D; Sato, TK; Shigekawa, Y; Shinohara, A; Tanaka, A; Toyoshima, A; Tsukada, K; Tsuto, S; Yokokita, T; Yokoyama, A; Omtvedt, JP; Nagame, Y; Schadel, M				Ooe, K.; Attallah, M. F.; Asai, M.; Goto, N.; Gupta, N. S.; Haba, H.; Huang, M.; Kanaya, J.; Kaneya, Y.; Kasamatsu, Y.; Kitatsuji, Y.; Kitayama, Y.; Koga, K.; Komori, Y.; Koyama, T.; Kratz, J. V.; Lerum, H. V.; Miyashita, S.; Oshimi, Y.; Pershina, V.; Sato, D.; Sato, T. K.; Shigekawa, Y.; Shinohara, A.; Tanaka, A.; Toyoshima, A.; Tsukada, K.; Tsuto, S.; Yokokita, T.; Yokoyama, A.; Omtvedt, J. P.; Nagame, Y.; Schaedel, M.			Development of a new continuous dissolution apparatus with a hydrophobic membrane for superheavy element chemistry	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Molybdenum; Tungsten; Gas-jet transport; Continuous dissolution; Hydrophobic membrane		A new technique for continuous dissolution of nuclear reaction products transported by a gas-jet system was developed for superheavy element (SHE) chemistry. In this technique, a hydrophobic membrane is utilized to separate an aqueous phase from the gas phase. With this technique, the dissolution efficiencies of short-lived radionuclides of Mo-91m,Mo-93m and W-176 were measured. Yields of more than 80 % were observed for short-lived radionuclides at aqueous-phase flow rates of 0.1-0.4 mL/s. The gas flow-rate had no influence on the dissolution efficiency within the studied flow range of 1.0-2.0 L/min. These results show that this technique is applicable for on-line chemical studies of SHEs in the liquid phase.	[Ooe, K.; Asai, M.; Kaneya, Y.; Kitatsuji, Y.; Miyashita, S.; Sato, T. K.; Toyoshima, A.; Tsukada, K.; Nagame, Y.; Schaedel, M.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Ooe, K.; Goto, N.; Koyama, T.; Oshimi, Y.; Sato, D.; Tanaka, A.; Tsuto, S.] Niigata Univ, Inst Sci & Technol, Niigata 9502181, Japan; [Attallah, M. F.; Gupta, N. S.; Lerum, H. V.; Omtvedt, J. P.] Univ Oslo, Dept Chem, N-0315 Oslo, Norway; [Haba, H.; Huang, M.; Kanaya, J.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Kasamatsu, Y.; Komori, Y.; Shigekawa, Y.; Shinohara, A.; Yokokita, T.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Kitayama, Y.; Yokoyama, A.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Koga, K.; Miyashita, S.] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan; [Kratz, J. V.] Johannes Gutenberg Univ Mainz, Inst Kernchem, D-55128 Mainz, Germany; [Pershina, V.; Schaedel, M.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany	Ooe, K (reprint author), Niigata Univ, Inst Sci & Technol, Niigata 9502181, Japan.	ooe@chem.sc.niigata-u.ac.jp					Attallah MF, UNPUB; Haba H, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.024611; Hild D, 2013, RADIOCHIM ACTA, V101, P681, DOI 10.1524/ract.2013.2080; Kratz JV, 2011, HDB NUCL CHEM, V2, P925; Nilsen J, 2009, THESIS U OSLO OSLO; Omtvedt J. P., 2002, J NUCL RADIOCHEM SCI, V3, P121; Omtvedt JP, 2007, EUR PHYS J D, V45, P91, DOI 10.1140/epjd/e2007-00214-6; Schadel M, 2006, ANGEW CHEM INT EDIT, V45, P368, DOI 10.1002/anie.200461072; Schadel M, 2012, RADIOCHIM ACTA, V100, P579, DOI 10.1524/ract.2012.1965; Toyoshima A, 2008, RADIOCHIM ACTA, V96, P323, DOI 10.1524/ract.2008.1498	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1317	1320		10.1007/s10967-014-3469-3		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200047		
J	Hirose, K				Hirose, Katsumi			Two-years trend of monthly Cs-137 deposition observed in Kanto and south Tohoku areas, Japan: effects of the Fukushima Dai-ichi nuclear power plant accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Fukushima; Cs-137; Deposition; Temporal variation; Radioactivity emission	RADIONUCLIDES; ATMOSPHERE	To elucidate deposition behavior of the FDNPP-derived radionuclides after the major emission in March 2011, two-years trends (March 2011 to April 2013) of the monthly Cs-137 deposition at monitoring stations of Kanto and south Tohoku regions were examined. The higher Cs-137 depositions within about 300 km of the FDNPP than pre-Fukushima level were still observed until April 2013. The monthly Cs-137 deposition showed marked winter peaks in 2012 and 2013 at the Futaba station, about 5 km of the FDNPP. The monthly Cs-137 deposition generally decreased with increasing distance from the FDNPP.	[Hirose, Katsumi] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1028554, Japan; [Hirose, Katsumi] Saitama Univ, Geosphere Res Inst, Sakura Ku, Saitama 3388570, Japan	Hirose, K (reprint author), Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioicho, Tokyo 1028554, Japan.	hirose45037@mail2.accsnet.ne.jp					Amano H, 2012, J ENVIRON RADIOACTIV, V111, P42, DOI 10.1016/j.jenvrad.2011.10.019; Hirose K, 2013, APPL RADIAT ISOTOPES, V81, P325, DOI 10.1016/j.apradiso.2013.03.076; Hirose K, 2008, APPL RADIAT ISOTOPES, V66, P1675, DOI 10.1016/j.apradiso.2007.09.019; Morino Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048689; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Doi T, 2013, J ENVIRON RADIOACTIV, V122, P55, DOI 10.1016/j.jenvrad.2013.02.001; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Stohl A, 2012, ATMOS CHEM PHYS, V11, P2313; Yoshida N, 2012, ELEMENTS, V8, P201, DOI 10.2113/gselements.8.3.201	9	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1327	1329		10.1007/s10967-014-3480-8		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200049		
J	Hayashi, H; Akabori, M; Minato, K				Hayashi, Hirokazu; Akabori, Mitsuo; Minato, Kazuo			Electrochemical behavior of americium in NaCl-2CsCl melt	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Am; Molten salt; Electrochemistry	KCL EUTECTIC MELT; CYCLIC VOLTAMMETRY; IONS; ACTINIDES; NEPTUNIUM	Electrochemical behavior of Am in NaCl-2CsCl melt at 823 K was investigated by transient electrochemical techniques such as cyclic voltammetry and differential pulse voltammetry. The results show that Am(III) ion is reduced to Am metal by a two-step mechanism via Am(II) ion. Formal standard potential of Am(III)/Am(II) and that of Am(II)/Am(0) redox couples have been determined to be -2.73 and -2.97 V versus Cl-2/Cl-, respectively.	[Hayashi, Hirokazu; Akabori, Mitsuo; Minato, Kazuo] Japan Atom Energy Agcy, Sector Nucl Sci Res, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan	Hayashi, H (reprint author), Japan Atom Energy Agcy, Sector Nucl Sci Res, Nucl Sci & Engn Ctr, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	hayashi.hirokazu55@jaea.go.jp					Nagai T, 2005, J NUCL SCI TECHNOL, V42, P1025, DOI 10.3327/jnst.42.1025; Masset P, 2005, J NUCL MATER, V344, P173, DOI 10.1016/j.jnucmat.2005.04.038; Shirai O, 2006, J ALLOY COMPD, V408, P1267, DOI 10.1016/j.jallcom.2005.04.119; Serp J, 2006, ELECTROCHIM ACTA, V51, P4024, DOI 10.1016/j.electacta.2005.11.016; Osipenko A, 2011, J ELECTROANAL CHEM, V651, P67, DOI 10.1016/j.jelechem.2010.10.027; Masset P, 2007, J ELECTROANAL CHEM, V603, P166, DOI 10.1016/j.jelechem.2007.01.028; Kuznetsov SA, 2005, J ELECTROCHEM SOC, V152, pC203, DOI 10.1149/1.1864532; Bard A.J., 2001, ELECTROCHEMICAL METH, P286; Fukasawa K, 2011, J ALLOY COMPD, V509, P5112, DOI 10.1016/j.jallcom.2011.01.192; Hayashi H, 2008, J ALLOY COMPD, V456, P243, DOI 10.1016/j.jallcom.2007.02.011; Hayashi H, 2008, NUCL TECHNOL, V162, P129; Koyama T, 2011, WOODHEAD PUBL SER EN, P269; Minato K., 2005, 2005059 JAERI; Nagai T, 2007, THESIS KYOTO U JAPAN; Osipenko A, 2010, J NUCL MATER, V396, P102, DOI 10.1016/j.jnucmat.2009.10.061; Shibata H, 2012, P 4 AS C MOLT SALT C, P257; Uehara A, 2013, J NUCL MATER, V437, P166, DOI 10.1016/j.jnucmat.2013.02.003; Vavilov S, 2004, J NUCL SCI TECHNOL, V41, P1018, DOI 10.3327/jnst.41.1018; Vavilov S, 2003, TN84002003030 JNC	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1331	1334		10.1007/s10967-014-3471-9		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200050		
J	Shimada, T; Tanaka, T				Shimada, Taro; Tanaka, Tadao			Characterization on the radioactive aerosols dispersed during plasma arc cutting of radioactive metal piping	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Decommissioning; Radioactive aerosol; Particle size distribution; Plasma arc cutting; Safety assessment; Specific radioactivity	PARTICLE-SIZE	Radioactive metal pipes activated and/or contaminated were segmented by plasma arc cutting to understand the generation and dispersion behaviors of radioactive aerosols. The specific radioactivity of the aerosols increased with decreasing particle size. Particularly for surface contaminated pipe, the specific radioactivity of Co-60 was inversely proportional to the surface area of particles smaller than about 0.3 mu m of aerodynamic diameter.	[Shimada, Taro; Tanaka, Tadao] Japan Atom Energy Agcy, Nucl Safety Res Ctr, Tokai, Ibaraki 3191195, Japan	Shimada, T (reprint author), Japan Atom Energy Agcy, Nucl Safety Res Ctr, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	shimada.taro@jaea.go.jp			Secretariat of Nuclear Regulation Authority (NRA), Japan	The authors would like to appreciate the Department of Decommissioning and Waste Management at Nuclear Science Research Institute in Tokai and FUGEN Decommissioning Engineering Center in Tsuruga for the cutting experiments. A part of this study was funded by the Secretariat of Nuclear Regulation Authority (NRA), Japan (formerly Japan Nuclear Energy Safety Organization (JNES)).	Lin CC, 2009, PROG NUCL ENERG, V51, P207, DOI 10.1016/j.pnucene.2008.05.005; DORRIAN MD, 1995, RADIAT PROT DOSIM, V60, P119; Haynes, 2013, CRC HDB CHEM PHYS; Kowalski W.J., 1999, ASHRAE T, V105, P4; Novick V. J., 1996, Proceedings of the Topical Meeting on The Best of D & D Creative, Comprehensive and Cost-Effective; OKI Y, 1994, APPL RADIAT ISOTOPES, V45, P553, DOI 10.1016/0969-8043(94)90197-X; ONODERA J, 1991, J AEROSOL SCI, V22, pS747, DOI 10.1016/S0021-8502(05)80208-3; Tanaka Manabu, 2012, Quarterly Journal of the Japan Welding Society, V30, DOI 10.2207/qjjws.30.164	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1345	1349		10.1007/s10967-014-3629-5		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200053		
J	Usuda, S; Yamanishi, K; Mimura, H; Sasaki, Y; Kirishima, A; Sato, N; Niibori, Y				Usuda, Shigekazu; Yamanishi, Kei; Mimura, Hitoshi; Sasaki, Yuji; Kirishima, Akira; Sato, Nobuaki; Niibori, Yuichi			Separation of Am and Cm by using TODGA and DOODA(C8) adsorbents with hydrophilic ligand-nitric acid solution	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Chromatographic separation; Am and Cm; TODGA and DOODA(C8) adsorbents; Hydrophilic DOODA(C2) and TEDGA ligands; Synergistic effect	EXTRACTION CHROMATOGRAPHY; MINOR ACTINIDES; RARE-EARTHS; METAL-IONS; N,N,N',N'-TETRAOCTYL-3,6-DIOXAOCTANEDIAMIDE; LANTHANIDES; DIGLYCOLAMIDE; DIAMIDES; WASTE	Extraction chromatographic separation of trivalent minor actinides (MA: Am and Cm) was investigated by using solid adsorbents impregnating the lipophilic diamide-type ligands, TODGA (N,N,N',N'-tetraoctyl-3-oxapentane-1,5-diamide) and DOODA(C8) (N,N,N',N'-tetraoctyl-3,6-dioxaoctane-1,8-diamide). In nitric acid eluents, hydrophilic diamide-type ligands, DOODA(C2) (N,N,N',N'-tetraethyl-3,6-dioxaoctanediamide) and TEDGA (N,N,N',N'-tetraethyl-diglycolamide) were included for the respective adsorbents as masking agents in order to produce a synergistic effect in mutual separation of Am and Cm. The adsorption tendency of Am and Cm for the adsorbents was opposite each other, that was similar to the case of lanthanides.	[Usuda, Shigekazu; Yamanishi, Kei; Mimura, Hitoshi; Niibori, Yuichi] Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy Engn, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Sasaki, Yuji] Japan Atom Energy Agcy, Res Grp Aqueous Separat Chem, Tokai, Ibaraki 3191195, Japan; [Yamanishi, Kei; Sato, Nobuaki] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Usuda, S (reprint author), NAIS Co Inc, Tokai, Ibaraki 3191112, Japan.	usuda@kem.biglobe.ne.jp					Usuda S, 2013, CHEM LETT, V42, P1220, DOI 10.1246/cl.130476; Sasaki Y, 2011, SOLVENT EXTR RES DEV, V18, P93; Sasaki Y, 2007, ANAL SCI, V23, P727, DOI 10.2116/analsci.23.727; Sasaki Y, 2010, SOLVENT EXTR ION EXC, V28, P335, DOI 10.1080/07366291003680723; Ansari SA, 2006, TALANTA, V68, P1273, DOI 10.1016/j.talanta.2005.07.042; Hoshi H, 2004, J ALLOY COMPD, V374, P451, DOI 10.1016/j.jallcom.2003.11.144; Sasaki Y, 2011, P GLOB 2011 MAK; Sasaki Y, 2012, PROCEDIA CHEM, V7, P380, DOI 10.1016/j.proche.2012.10.059; Sasaki Y, 2012, SOLVENT EXTR RES DEV, V19, P51; Sasaki Y, 2010, CHEM LETT, V39, P898, DOI 10.1246/cl.2010.898; Sasaki Y, 2009, CHEM LETT, V38, P630, DOI 10.1246/cl.2009.630; Sasaki Y, 2007, P GLOB 2007, P1117; Watanabe S, 2012, PROCEDIA CHEM, V7, P411, DOI 10.1016/j.proche.2012.10.064; Xu Y, 2011, THESIS TOHOKU U SEND; Yamanishi K, 2012, P IEX 2012 INT ION E; Yamanishi K, 2013, P WM2013 C ANN WAST; Zhang AY, 2007, SEPAR SCI TECHNOL, V42, P2235, DOI 10.1080/15363830701313545; Zhang AY, 2007, EUR POLYM J, V43, P529, DOI 10.1016/j.eurpolymj.2006.10.034	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1351	1355		10.1007/s10967-014-3481-7		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200054		
J	Hirose, M; Kikawada, Y; Tsukamoto, A; Oi, T; Honda, T; Hirose, K; Takahashi, H				Hirose, Masaaki; Kikawada, Yoshikazu; Tsukamoto, Atsushi; Oi, Takao; Honda, Teruyuki; Hirose, Katsumi; Takahashi, Hiroaki			Chemical forms of radioactive Cs in soils originated from Fukushima Dai-ichi nuclear power plant accident studied by extraction experiments	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radioactive cesium; Fukushima Dai-ichi nuclear power plant accident; Sequential extraction; Soil contamination	PREFECTURE; PROFILES; CESIUM	We performed three-step sequential extraction experiments, with Milli-Q water, 1 M ammonium acetate solution and 0.11 M acetic acid as extractants of Cs, on soils radiologically contaminated by Fukushima Dai-ichi Nuclear Power Plant accident. Though aqueous solutions containing ammonium salts are effective to extract Cs from soils, the obtained overall extracted fractions of radioactive Cs by the three-step sequential extraction process were less than 30 %. Thus, the most of the radioactive Cs deposited on soils is probably incorporated in the non- or hardly exchangeable site of clay minerals, components of the soils.	[Hirose, Masaaki; Kikawada, Yoshikazu; Oi, Takao; Hirose, Katsumi] Sophia Univ, Fac Sci & Technol, Chiyoda Ku, Tokyo 1028554, Japan; [Tsukamoto, Atsushi; Honda, Teruyuki] Tokyo City Univ, Grad Sch Engn, Setagaya Ku, Tokyo 1588557, Japan; [Takahashi, Hiroaki] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan	Hirose, M (reprint author), Sophia Univ, Fac Sci & Technol, Chiyoda Ku, 7-1 Kioicho, Tokyo 1028554, Japan.	macha1031@sophia.ac.jp					Ohno T, 2012, GEOCHEM J, V46, P287; Tanaka K, 2012, GEOCHEM J, V46, P73; Qin HB, 2012, GEOCHEM J, V46, P297; Kaneyasu N, 2012, ENVIRON SCI TECHNOL, V46, P5720, DOI 10.1021/es204667h; Povinec P. P., 2013, FUKUSHIMA ACCIDENT R; Tsumura A, 1984, B NATL I AGR SCI B, V36, P57; Tsuruta H., 2012, Chikyukagaku (Geochemistry), V46, P99	7	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1357	1359		10.1007/s10967-014-3592-1		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200055		
J	Shirai, N; Toktaganov, M; Takahashi, H; Yokozuka, Y; Sekimoto, S; Ebihara, M				Shirai, Naoki; Toktaganov, Meiramkhan; Takahashi, Hiroki; Yokozuka, Yuta; Sekimoto, Shun; Ebihara, Mitsuru			Multielemental analysis of Korean geological reference samples by INAA, ICP-AES and ICP-MS	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Korean geological reference samples; INAA; ICP-AES; ICP-MS; Chemical compositions	URANIUM FISSION; GSJ; NEUTRON; ROCKS	Six Korean geological reference samples (KB-1, KGB-1, KT-1, KD-1, KG-1 and KG-2) prepared by Korea Institutes of Geoscience and Mineral Resources were analyzed by using INAA, ICP-AES and ICP-MS. Some elements could be determined by both INAA and non-INAA methods (ICP-AES and ICP-MS), and these data are consistent with each other. This study confirms that a combination of ICP-AES and ICP-MS is comparable to INAA in determining a wide range of major, minor and trace elements in geological materials.	[Shirai, Naoki; Takahashi, Hiroki; Yokozuka, Yuta; Ebihara, Mitsuru] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Toktaganov, Meiramkhan] Natl Nucl Ctr Republ Kazakhstan, Inst Atom Energy, Kurchatov 071100, Kazakhstan; [Sekimoto, Shun] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan	Shirai, N (reprint author), Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan.	shirai-naoki@tmu.ac.jp					IMAI N, 1995, GEOSTANDARD NEWSLETT, V19, P135, DOI 10.1111/j.1751-908X.1995.tb00158.x; Shinotsuka K, 1996, ANAL SCI, V12, P917, DOI 10.2116/analsci.12.917; Yoon YY, 1997, ANALYST, V122, P1223, DOI 10.1039/a704782g; Ebihara M, 1985, ANAL SCI, V1, P209, DOI 10.2116/analsci.1.209; GLASCOCK MD, 1986, J RADIOAN NUCL CH AR, V99, P121, DOI 10.1007/BF02060832; Kimura J, 1996, J MINERALOGY PETROLO, V91, P102, DOI 10.2465/ganko.91.102; Kong P, 1997, GEOCHEM J, V31, P339; Ribeiro IS, 2013, J RADIOANAL NUCL CH, V296, P759, DOI 10.1007/s10967-012-2129-8; Sakamoto K, 1997, J RADIOANAL NUCL CH, V215, P69, DOI 10.1007/BF02109880	9	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1367	1374		10.1007/s10967-014-3653-5		8	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200057		
J	Shirai, N; Hidaka, Y; Yamaguchi, A; Sekimoto, S; Ebihara, M; Kojima, H				Shirai, Naoki; Hidaka, Yoshihiro; Yamaguchi, Akira; Sekimoto, Shun; Ebihara, Mitsuru; Kojima, Hideyasu			Neutron activation analysis of iron meteorites	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Iron meteorites; INAA; Self-absorption of gamma-rays; Classification of iron meteorites	CHEMICAL CLASSIFICATION; ORIGIN; TRENDS; IIIAB; CORE; IAB; IIE	A simple and effective instrumental neutron activation analysis for iron meteorites is presented in this study. In order to design the analytical procedure, self-absorption of gamma-rays on samples, interfering nuclides and their respective reactions were examined. Seventeen elements (Fe, Co, Ni, Cu, Ga, Ge, As, Mo, Ru, Rh, Sb, W, Re, Os, Ir, Pt and Au) could be nondestructively determined in Canyon Diablo and Cape York iron meteorites. Our data of these two iron meteorites are consistent with the corresponding literature values. This study confirms that our analytical procedure with INAA is simple and effective in classification of iron meteorites.	[Shirai, Naoki; Hidaka, Yoshihiro; Ebihara, Mitsuru] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Yamaguchi, Akira; Kojima, Hideyasu] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Sekimoto, Shun] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan	Shirai, N (reprint author), Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan.	shirai-naoki@tmu.ac.jp					Wasson JT, 2006, GEOCHIM COSMOCHIM AC, V70, P6153, DOI 10.1016/j.gca.2006.01.032; Wasson JT, 2007, GEOCHIM COSMOCHIM AC, V71, P760, DOI 10.1016/j.gca.2006.09.032; WASSON JT, 1989, GEOCHIM COSMOCHIM AC, V53, P735, DOI 10.1016/0016-7037(89)90016-1; D'Orazio M, 2003, GEOSTANDARD NEWSLETT, V27, P215, DOI 10.1111/j.1751-908X.2003.tb00723.x; Wasson JT, 2001, GEOCHIM COSMOCHIM AC, V65, P951, DOI 10.1016/S0016-7037(00)00597-4; Birck JL, 1998, METEORIT PLANET SCI, V33, P647; CHOI BG, 1995, GEOCHIM COSMOCHIM AC, V59, P593, DOI 10.1016/0016-7037(94)00384-X; Goldstein JI, 2009, CHEM ERDE-GEOCHEM, V69, P293, DOI 10.1016/j.chemer.2009.01.002; Kong P, 1996, ANAL CHEM, V68, P4130, DOI 10.1021/ac960477m; MALVIN DJ, 1984, GEOCHIM COSMOCHIM AC, V48, P785, DOI 10.1016/0016-7037(84)90101-7; PERNICKA E, 1987, GEOCHIM COSMOCHIM AC, V51, P1717, DOI 10.1016/0016-7037(87)90350-4; SCOTT ERD, 1976, GEOCHIM COSMOCHIM AC, V40, P103, DOI 10.1016/0016-7037(76)90198-8; Wasson JT, 2009, GEOCHIM COSMOCHIM AC, V73, P4879, DOI 10.1016/j.gca.2009.05.062; Wasson JT, 2011, GEOCHIM COSMOCHIM AC, V75, P1757, DOI 10.1016/j.gca.2010.12.017; Wasson JT, 2002, GEOCHIM COSMOCHIM AC, V66, P2445, DOI 10.1016/S0016-7037(02)00848-7; WASSON JT, 1986, GEOCHIM COSMOCHIM AC, V50, P725, DOI 10.1016/0016-7037(86)90348-0; WASSON JT, 1970, GEOCHIM COSMOCHIM AC, V34, P957, DOI 10.1016/0016-7037(70)90078-5; WASSON JT, 1988, METEORITICS, V23, P365; Wasson JT, 1998, GEOCHIM COSMOCHIM AC, V62, P715, DOI 10.1016/S0016-7037(97)00379-7; WILLIS J, 1981, RADIOCHIM ACTA, V29, P45	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1375	1380		10.1007/s10967-014-3654-4		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200058		
J	Sugo, Y; Sasaki, Y; Taguchi, M; Ishioka, NS				Sugo, Yumi; Sasaki, Yuji; Taguchi, Mitsumasa; Ishioka, Noriko S.			alpha-Radiation effect on solvent extraction of minor actinide	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Solvent extraction; Minor actinide; alpha-Radiolysis; Organic extractant; Am-241	RADIOLYSIS; AMIDES	alpha-Radiation effect on the solvent extraction of Am-241 using the solution of N,N,N',N'-tetraoctyldiglycolamide was investigated by means of the external and internal irradiation systems. In contrast to the internal irradiation system using an actinide radionuclide as an alpha-particles emitter, the external irradiation with He-4(2+) ions provided by an accelerator can be carried out in a reasonable timescale and without contamination with radionuclides. No significant decrease in distribution ratio was observed even after irradiation over 200 kGy in both systems. It was also confirmed that the external irradiation system could be a useful alternative to the internal irradiation.	[Sugo, Yumi; Taguchi, Mitsumasa; Ishioka, Noriko S.] Sector Nucl Sci Res, Quantum Beam Sci Ctr, Takasaki, Gumma, Japan; [Sasaki, Yuji] Sector Nucl Sci Res, Nucl Sci & Engn Ctr, Takasaki, Gumma, Japan; [Sugo, Yumi; Taguchi, Mitsumasa; Ishioka, Noriko S.] Japan Atom Energy Agcy, Sect Nucl Sci Res, Quantum Beam Sci Ctr, Takasaki, Gunma 3701292, Japan; [Sasaki, Yuji] Japan Atom Energy Agcy, Sector Nucl Sci Res, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan	Sugo, Y (reprint author), Japan Atom Energy Agcy, Sect Nucl Sci Res, Quantum Beam Sci Ctr, Takasaki, Gunma 3701292, Japan.	sugo.yumi@jaea.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [20760599]	The authors would like to express their appreciation to Dr. T. Kimura and Dr. Y. Morita of JAEA for their helpful discussions. Acknowledgement is also due to the staff of TIARA facility in JAEA for their help with the irradiation. This work was supported in part by a Grant-in-Aid for Young Scientist (B) (No. 20760599) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	GASPARINI GM, 1986, SOLVENT EXTR ION EXC, V4, P1233, DOI 10.1080/07366298608917921; Sugo Y, 2007, RADIAT PHYS CHEM, V76, P794, DOI 10.1016/j.radphyschem.2006.05.008; Sasaki Y, 2001, SOLVENT EXTR ION EXC, V19, P91, DOI 10.1081/SEI-100001376; Sugo Y, 2009, RADIAT PHYS CHEM, V78, P1140, DOI 10.1016/j.radphyschem.2009.06.031; Buchholz BA, 1996, SEPAR SCI TECHNOL, V31, P2231, DOI 10.1080/01496399608001043; Mezyk SP, 2013, J RADIOANAL NUCL CH, V296, P711, DOI 10.1007/s10967-012-2036-z; Nuclear Science and Nuclear Development, 2012, ACT FISS PROD PART T	7	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1381	1384		10.1007/s10967-014-3494-2		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200059		
J	Komori, Y; Yokokita, T; Kasamatsu, Y; Haba, H; Toyoshima, A; Toyomura, K; Nakamura, K; Kanaya, J; Huang, M; Kudou, Y; Takahashi, N; Shinohara, A				Komori, Y.; Yokokita, T.; Kasamatsu, Y.; Haba, H.; Toyoshima, A.; Toyomura, K.; Nakamura, K.; Kanaya, J.; Huang, M.; Kudou, Y.; Takahashi, N.; Shinohara, A.			Solid-liquid extraction of Mo and W by Aliquat 336 from HCl solutions toward extraction chromatography experiments of Sg	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Superheavy elements; Seaborgium; Molybdenum; Tungsten; Reversed-phase extraction chromatography; Aliquat 336	HYDROCHLORIC-ACID; AQUEOUS CHEMISTRY; ELEMENT-106; BEHAVIOR	We studied solid-liquid extraction behavior of carrier-free Mo and W radiotracers onto an Aliquat 336-loaded resin from HCl solutions toward extraction chromatography experiments of element 106, seaborgium (Sg). Distribution coefficients (K (d)) of Mo and W on the resin were determined as a function of HCl concentration by a batch method. On-line extraction chromatography of Mo and W was also carried out in 2-8 M HCl solutions with an automated rapid chemistry apparatus. The order of extraction probability from 2 to 8 M HCl was Mo > W, which reflected the order of the K (d) values in the batch experiment.	[Komori, Y.; Yokokita, T.; Kasamatsu, Y.; Toyomura, K.; Nakamura, K.; Takahashi, N.; Shinohara, A.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Haba, H.; Kanaya, J.; Huang, M.; Kudou, Y.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Toyoshima, A.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan	Komori, Y (reprint author), Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan.	yukiko.komori@riken.jp					Turler A, 2013, CHEM REV, V113, P1237, DOI 10.1021/cr3002438; SCHADEL M, 1989, RADIOCHIM ACTA, V48, P171; Haba H, 2007, RADIOCHIM ACTA, V95, P1, DOI 10.1524/ract.2007.95.1.1; Haba H, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.024611; Heinter-Wirguin C, 1965, J INORG NUCL CHEM, V27, P1989; Kronenberg A, 2004, RADIOCHIM ACTA, V92, P395, DOI 10.1524/ract.92.7.395.35747; Ooe K, 2011, P RADIOCHIM ACTA, V1, P127; Pershina V, 2001, INORG CHEM, V40, P776, DOI 10.1021/ic0003731; SATO T, 1995, HYDROMETALLURGY, V37, P253, DOI 10.1016/0304-386X(94)00066-C; Schadel M, 1997, RADIOCHIM ACTA, V77, P149; Schadel M, 2006, ANGEW CHEM INT EDIT, V45, P368, DOI 10.1002/anie.200461072; Schadel M, 1998, RADIOCHIM ACTA, V83, P163; Yokokita T, 2014, APSORC13 P, DOI [10.1007/s10967-014-3449-7, DOI 10.1007/S10967-014-3449-7]	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1385	1388		10.1007/s10967-014-3476-4		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200060		
J	Ishii, N; Tagami, K; Uchida, S				Ishii, Nobuyoshi; Tagami, Keiko; Uchida, Shigeo			The C-14 partitioning of [1,2-C-14] sodium acetate in three phases (solid, liquid, and gas) in Japanese agricultural soils	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Transuranic (TRU) waste; Radiocarbon; Agricultural fields; Partitioning	BEHAVIOR	Radiocarbon (C-14) partitioning ratios in the soil solid, liquid, and gas phases was determined by batch sorption experiments using 63 paddy soil and 79 upland soil samples to understand the behavior of C-14 in agricultural fields. The mean C-14 partitioning ratios for all agricultural soil samples were 35 % for the soil solid phase, 5 % for the liquid phase, and 60 % for the gas phase. A comparison of the C-14 partitioning between paddy and upland samples showed significant differences. This difference was caused by soil solution pH. Land use would affect the behavior of the C-14 as the sodium acetate form.	[Ishii, Nobuyoshi; Tagami, Keiko; Uchida, Shigeo] Natl Inst Radiol Sci, Off Biospher Assessment Waste Disposal, Inage Ku, Chiba 2638555, Japan	Ishii, N (reprint author), Natl Inst Radiol Sci, Off Biospher Assessment Waste Disposal, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	nobu@nirs.go.jp			Agency for Natural Resources and Energy, the Ministry of Economy, Trade and Industry (METI), Japan	This work has been supported by the Agency for Natural Resources and Energy, the Ministry of Economy, Trade and Industry (METI), Japan.	Ishii N, 2011, RADIAT PROT DOSIM, V146, P151, DOI 10.1093/rpd/ncr125; Ishii N, 2010, J NUCL SCI TECHNOL, V47, P238, DOI 10.3327/jnst.47.238; Japan Atomic Energy Agency The Federation of Electric Power Companies of Japan, 2007, JAEA REV; Kaneko S, 2003, MATER RES SOC SYMP P, V757, P621; Ogiyama S, 2010, APPL RADIAT ISOTOPES, V68, P256, DOI 10.1016/j.apradiso.2009.11.030	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1389	1392		10.1007/s10967-014-3536-9		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200061		
J	Kanai, Y				Kanai, Y.			Geochemical behavior and activity ratios of Fukushima-derived radionuclides in aerosols at the Geological Survey of Japan, Tsukuba, Japan	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Activity ratio; Aerosol; Fukushima Dai-ichi accident; Geological Survey of Japan; Tsukuba	POWER-PLANT ACCIDENT; NUCLEAR; GSJ	Aerosols from the Fukushima Dai-ichi Nuclear Power Plant accident were collected at the Geological Survey of Japan. The temporal patterns of the Cs-134/Cs-137, Cs-136/Cs-137, and Te-132/Cs-137 activity ratios were consistent with expectations based on their half-lives. Those for I-131 and Te-129m decreased with some fluctuations. Ag-110m/Cs-137 declined more rapidly than expected and Nb-95/Cs-137 increased with time. The results suggest that the temporal patterns depended not only on their half-lives but also on many factors such as chemical speciation, the diversity of sources, changes in the temperature and discharge rate from the reactors, and the processes of transport.	Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan	Kanai, Y (reprint author), Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058567, Japan.	y.kanai@aist.go.jp					Amano H, 2012, J ENVIRON RADIOACTIV, V111, P42, DOI 10.1016/j.jenvrad.2011.10.019; Kanai Y, 2012, J ENVIRON RADIOACTIV, V111, P33, DOI 10.1016/j.jenvrad.2011.10.011; Momoshima N, 2012, J ENVIRON RADIOACTIV, V111, P28, DOI 10.1016/j.jenvrad.2011.09.001; Doi T, 2013, J ENVIRON RADIOACTIV, V122, P55, DOI 10.1016/j.jenvrad.2013.02.001; Haba H, 2012, GEOCHEM J, V46, P271; Kanai Y., 2012, B GEOL SURV JAPAN, V63, P107; Kanai Y., 2011, B GEOL SURV JPN, V62, P357; KANAI Y, 2013, BULL GEOL SURV JPN, V64, P139	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1405	1408		10.1007/s10967-014-3495-1		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200064		
J	Hasegawa, H; Tsukada, H; Kawabata, H; Takaku, Y; Hisamatsu, S				Hasegawa, Hidenao; Tsukada, Hirofumi; Kawabata, Hitoshi; Takaku, Yuichi; Hisamatsu, Shun'ichi			Foliar uptake and translocation of stable Cs and I in radish plants	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Foliar uptake; Translocation; Cs; I-; IO3-	EDIBLE PARTS; IODINE; CESIUM; WHEAT	We studied the foliar uptake of Cs and I in radish plants by applying droplets of a solution of Cs (as CsCl or CsNO3) or I (as NaI or NaIO3) on upper leaf surfaces. Approximately 60 to 80 % of Cs applied as CsCl was absorbed regardless of the initial concentration of CsCl solution. The foliar uptake of Cs applied as CsNO3 decreased with increasing CsNO3 concentration in the solution. The foliar uptake of I was independent of I concentration in the applied solution. Approximately 80 % of applied I- was absorbed, whereas 90 % of applied IO3 (-) remained on the leaf surface.	[Hasegawa, Hidenao; Tsukada, Hirofumi; Kawabata, Hitoshi; Takaku, Yuichi; Hisamatsu, Shun'ichi] Inst Environm Sci, Aomori 0393212, Japan	Hasegawa, H (reprint author), Inst Environm Sci, 1-7 Ienomae, Aomori 0393212, Japan.	hhidenao@ies.or.jp		Hisamatsu, Shun'ichi/0000-0001-6410-5387	Aomori Prefectural Government, Japan	We are grateful to Ms. Y. Chikuchi and Ms. M. Koshita (JGC PLANTECH AOMORI) for their technical assistance. This work was performed under contract with the Aomori Prefectural Government, Japan.	SHAW G, 1989, J ENVIRON RADIOACTIV, V10, P213, DOI 10.1016/0265-931X(89)90026-X; Hurtevent P, 2013, J ENVIRON RADIOACTIV, V121, P43, DOI 10.1016/j.jenvrad.2012.04.013; Shaw G, 2007, ENVIRON EXP BOT, V59, P361, DOI 10.1016/j.envexpbot.2006.04.008; AMIRO BD, 1989, ATMOS ENVIRON, V23, P533, DOI 10.1016/0004-6981(89)90002-4; Budavari S., 1996, MERCK INDEX; Bystrzejewska-Piotrowska G, 2004, ENVIRON EXP BOT, V51, P3, DOI 10.1016/S0098-8472(03)00039-X; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Hasegawa H, 2009, J ENVIRON RADIOACTIV, V100, P54, DOI 10.1016/j.jenvrad.2008.10.011; International Atomic Energy Agency (IAEA), 1994, IAEA TECHN REP SER, V364; OESTLING O, 1989, RADIAT PHYS CHEM, V33, P551; Schonherr J, 2001, PLANT SOIL, V236, P117, DOI 10.1023/A:1011976727078; Wildung RE, 1985, SPECIATION FISSION A	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1409	1412		10.1007/s10967-014-3496-0		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200065		
J	Seike, M; Eguchi, M; Shinohara, A; Yoshimura, T				Seike, Moe; Eguchi, Mai; Shinohara, Atsushi; Yoshimura, Takashi			Solvent extraction behaviors of Americium(III) and Europium(III) using 2-hydroxy-2-methyloctanoic acid and 2-hydroxy-2-trifluoromethyloctanoic acid	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Actinides; Lanthanides; Americium; Europium; Solvent extraction	CAPILLARY-ELECTROPHORESIS; CHROMATOGRAPHY; LANTHANIDES; SEPARATIONS; SPECIATION; ACTINIDES; COMPLEXES; THORIUM	Solvent extraction behaviors of Am(III) and Eu(III) using 2-hydroxy-2-methyloctanoic acid (Hhmo) and 2-hydroxy-2-trifluoromethyloctanoic acid (Hhfo) were investigated in aqueous acetic acid/1-octanol at 20 A degrees C. In both cases, distribution ratios (D) of the organic/aqueous phases increased with increasing pH of the aqueous solution. The D (Am(Hhfo)) and D (Eu(Hhfo)) values were found to be much higher than those for D (Am(Hhmo)) and D (Eu(Hhmo)), respectively, under similar pH conditions. The maximum separation factor of D (Eu(Hhfo))/D (Am(Hhfo)) was 2.31 +/- A (0.70) (0.80) at pH 4.29. The differences between D (Am(Hhmo)) and D (Eu(Hhmo)) values were relatively small in the pH region under consideration.	[Seike, Moe; Eguchi, Mai; Shinohara, Atsushi] Osaka Univ, Dept Chem, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Yoshimura, Takashi] Osaka Univ, Radioisotope Res Ctr, Suita, Osaka 5650871, Japan	Yoshimura, T (reprint author), Osaka Univ, Radioisotope Res Ctr, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tyoshi@rirc.osaka-u.ac.jp					Modolo G, 2012, RADIOCHIM ACTA, V100, P715, DOI 10.1524/ract.2012.1962; Blay G, 2002, TETRAHEDRON, V58, P8565, DOI 10.1016/S0040-4020(02)00947-X; Datta A, 2013, RADIOCHIM ACTA, V101, P81, DOI 10.1524/ract.2013.2005; Janos P, 2003, ELECTROPHORESIS, V24, P1982, DOI 10.1002/elps.200305470; Raut NM, 2004, J CHROMATOGR A, V1052, P131, DOI 10.1016/j.chroma.2004.08.054; KNIGHT CH, 1984, ANAL CHEM, V56, P474, DOI 10.1021/ac00267a041; Ambard C, 2005, RADIOCHIM ACTA, V93, P665, DOI 10.1524/ract.2005.93.11.665; Chen XY, 2012, INORG CHEM, V51, P13254, DOI 10.1021/ic301775d; Choppin GR, 2000, J RADIOANAL NUCL CH, V243, P45, DOI 10.1023/A:1006754927614; Kikunaga H, 2011, P RADIOCHIM ACTA, V1, P167; Yabuuchi T, 1999, CHEM PHARM BULL, V47, P684	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1413	1416		10.1007/s10967-014-3482-6		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200066		
J	Miura, T; Okumura, R; Iinuma, Y; Sekimoto, S; Takamiya, K; Ohata, M; Hioki, A				Miura, Tsutomu; Okumura, Ryo; Iinuma, Yuto; Sekimoto, Shun; Takamiya, Koichi; Ohata, Masaki; Hioki, Akiharu			Precise determination of bromine in PP resin pellet by instrumental neutron activation analysis using internal standardization	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Neutron activation analysis; Bromine; Internal standard method; RoHS directive; Measurement uncertainty; Certified reference material	ACCURATE DETERMINATION	Instrumental neutron activation analysis with the internal standardization was applied to the precise determination of Br in polypropylene resin of candidate certified reference material. The known amount of Au-197 was used as an internal standard to compensate for neutron flux inhomogeneity, to improve the gamma ray measurement uncertainty and the linearity of the calibration curves. The reliability of the proposed method validated using analytical results of BCR-681. The analytical result of Br in the sample was consistent with that obtained by ID-ICPMS. The relative expanded uncertainty (k = 2) was 1.5 %, and it was equivalent to that of ID-ICPMS.	[Miura, Tsutomu; Ohata, Masaki; Hioki, Akiharu] AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan; [Okumura, Ryo; Iinuma, Yuto; Sekimoto, Shun; Takamiya, Koichi] Kyoto Univ, Inst Res Reactor, Kyoto, Japan	Miura, T (reprint author), AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan.	t.miura@aist.go.jp					Ohata M, 2014, ANAL CHIM ACTA, V837, P23, DOI 10.1016/j.aca.2014.06.023; De Corte F, 2003, ATOM DATA NUCL DATA, V85, P47, DOI 10.1016/S0092-640X(03)00036-6; [Anonymous], 2000, CERT AN CERT REF MAT; Greenberg RR, 2011, SPECTROCHIM ACTA B, V66, P193, DOI 10.1016/j.sab.2010.12.011; Fazekas B, 1997, J RADIOANAL NUCL CH, V215, P271, DOI 10.1007/BF02034477; CURRIE LA, 1994, PURE APPL CHEM, V66, P595, DOI 10.1351/pac199466030595; Miura T, 2010, TALANTA, V82, P1143, DOI 10.1016/j.talanta.2010.06.024; Miura T, 2009, J RADIOANAL NUCL CH, V282, P49, DOI 10.1007/s10967-009-0314-1; Miura T, 2009, ANAL SCI, V25, P881; Ohata M, 2008, BUNSEKI KAGAKU, V57, P417, DOI 10.2116/bunsekikagaku.57.417; Ozeki T, 2001, BUNSEKI, P56	11	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1417	1420		10.1007/s10967-014-3619-7		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200067		
J	Shibahara, Y; Kubota, T; Fujii, T; Fukutani, S; Ohta, T; Takamiya, K; Okumura, R; Mizuno, S; Yamana, H				Shibahara, Y.; Kubota, T.; Fujii, T.; Fukutani, S.; Ohta, T.; Takamiya, K.; Okumura, R.; Mizuno, S.; Yamana, H.			U-235/U-238 Isotopic ratio in plant samples from Fukushima Prefecture	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Isotopic ratio; Uranium; Thermal ionization mass spectrometry; Plant sample	ENVIRONMENTAL-SAMPLES; MASS-SPECTROMETRY; PU	Uranium was recovered from plant samples obtained from Fukushima Prefecture, and the U-235/U-238 isotopic ratio was analyzed using thermal ionization mass spectrometry. The possibility of soil and biosphere contamination with U by the nuclear accident at Fukushima Daiichi nuclear power plant was evaluated. The isotopic ratio of U in the plant samples was the same as the natural abundance, which suggests that no significant contamination with U occurred.	[Shibahara, Y.; Kubota, T.; Fujii, T.; Fukutani, S.; Takamiya, K.; Okumura, R.; Yamana, H.] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan; [Ohta, T.] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Mizuno, S.] Fukushima Prefectural Govt, Nucl Power Safety Div, Fukushima 9608043, Japan	Shibahara, Y (reprint author), Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan.	y-shibahara@rri.kyoto-u.ac.jp			KUR Research Program for Scientific Basis of Nuclear Safety	The authors thank T. Takahashi, N. Sato, M. Tanigaki, Y. Kobayashi, A. Uehara, H. Yoshino, H. Yoshinaga of Kyoto University Research Reactor Institute, L. Belkacemi of University Pierre and Marie Curie, M. Kowatari of Japan Atomic Energy Agency, M. Konno, and S. Matsuzaki of Fukushima Prefecture for their support of this study. This work was supported by the KUR Research Program for Scientific Basis of Nuclear Safety.	Sakaguchi A, 2012, GEOCHEM J, V46, P355; [Anonymous], 2011, RES NUCL AN CES SOIL; Richter S, 2003, INT J MASS SPECTROM, V229, P181, DOI [10.1016/S1387-3806(03)00338-5, 10.1016/S1387-3806(03)000338-5]; Bohlke JK, 2005, J PHYS CHEM REF DATA, V34, P57, DOI 10.1063/1.1836764; Haraguchi H, 2003, J ANAL ATOM SPECTROM, V19, P5; IGARASHI Y, 1990, ANAL SCI, V6, P157, DOI 10.2116/analsci.6.157; Lee MH, 2011, TALANTA, V86, P99, DOI 10.1016/j.talanta.2011.08.019; Neuhoff J, 2008, NAT BUR STAND US SPE, P267; Platzner I. T., 1997, MODERN ISOTOPE RATIO; Shibahara Y, 2014, J NUCL SCI TECHNOL, V51, P575, DOI 10.1080/00223131.2014.891954; Strachnov V, 1991, IAEAAL035; Takagai Y, 2011, BUNSEKI KAGAKU; Yoshida S, 2000, J ENVIRON RADIOACTIV, V50, P161, DOI 10.1016/S0265-931X(00)00075-8	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1421	1424		10.1007/s10967-014-3542-y		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200068		
J	Tomobuchi, Y; Tachibana, Y; Nomura, M; Suzuki, T				Tomobuchi, Yusuke; Tachibana, Yu; Nomura, Masao; Suzuki, Tatsuya			Effect of alcohols on separation behavior of rare earth elements using benzimidazole-type anion-exchange resin in nitric acid solutions	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Minor actinides; Rare earth elements; Anion-exchange resin; Nitric acid/alcohol mixed solvent	PYRIDINE TYPE RESIN; ACTINIDES	The mutual separation of rare earth elements based on the ion exchange chromatography has been studied. The effect of alcohols on separation behavior of rare earth elements using the benzimidazole-type anion-exchange resin embedded in high-porous silica beads was investigated in nitric acid/alcohol mixed solvent systems. It was confirmed that the mutual separation of rare earth elements is possible by using our proposed methods. It was found that the distribution coefficients of rare earth elements depend on the corresponding alcoholic relative permittivity and on the steric hindrance due to the hydrophobic interaction among each alcoholic molecule.	[Tomobuchi, Yusuke; Tachibana, Yu; Suzuki, Tatsuya] Nagaoka Univ Technol, Grad Sch Engn, Dept Nucl Syst Safety Engn, Nagaoka, Niigata 9402188, Japan; [Nomura, Masao] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan	Suzuki, T (reprint author), Nagaoka Univ Technol, Grad Sch Engn, Dept Nucl Syst Safety Engn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	tasuzuki@vos.nagaokaut.ac.jp			KAKENHI [23360423]	This work was partially supported by the Grant-in-Aid for Scientific Research (B) (KAKENHI No. 23360423).	Aneheim E, 2010, SOLVENT EXTR ION EXC, V48, P437; Madic C, 2002, PROG NUCL ENERG, V40, P523, DOI 10.1016/S0149-1970(02)00046-X; SILBER HB, 1990, INORG CHEM, V29, P4473, DOI 10.1021/ic00347a028; Ikeda A, 2007, ANAL CHEM, V79, P8016, DOI 10.1021/ac070700n; Suzuki T, 2006, J ALLOY COMPD, V408, P1013, DOI 10.1016/j.jallcom.2004.12.130; Modolo G, 2010, RADIOCHIM ACTA, V98, P193, DOI 10.1524/ract.2010.1708; Salvatores M, 2011, PROG PART NUCL PHYS, V66, P144, DOI 10.1016/j.ppnp.2010.10.001; Geng YX, 2011, J RADIOANAL NUCL CH, V289, P83, DOI 10.1007/s10967-011-1052-8; Ikeda A, 2005, J RADIOANAL NUCL CH, V263, P605, DOI 10.1007/s10967-005-0631-y; Bhattacharyya A, 2011, J RADIOANAL NUCL CH, V288, P709, DOI 10.1007/s10967-011-1027-9; Iwasa S, 2001, J ION EXCH, V12, P40; Salvatores A, 2005, NUCL ENG DES, V235, P805, DOI 10.1016/j.nucengdes.2004.10.009; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Suzuki T, 2010, J ION EXCH, V21, P328; Suzuki T, 2007, J RADIOANAL NUCL CH, V272, P257, DOI 10.1007/s10967-007-0511-8; Wohlfarth C, 2008, HDB CHEM PHYS	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1425	1428		10.1007/s10967-014-3509-z		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200069		
J	Tachibana, Y; Yamazaki, Y; Nomura, M; Suzuki, T				Tachibana, Yu; Yamazaki, Yuki; Nomura, Masao; Suzuki, Tatsuya			Molybdenum isotope fractionation in ion exchange reaction by using anion exchange chromatography	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Molybdenum; Adsorption mechanism; Isotope fractionation; Anion-exchange chromatography; Benzimidazole-type anion-exchange resin	DISPLACEMENT CHROMATOGRAPHY; ADSORPTION; SEPARATION; CHEMISTRY; OXIDES; COPPER; SYSTEM; RESIN	The isotope fractionation of Mo(VI) species using benzimidazole-type anion-exchange resins embedded in high-porous silica beads was investigated in various HCl solutions ranging in concentration from 0.1 to 11.2 M (M = mol/dm(3)) at 298 K. As a result, the plots of the slope coefficients of Mo(VI) species against the corresponding b values, which are parameter of the adsorbent-adsorbate relative affinity in the adsorption process, were found to be a good linear relationship and the isotope fractionation coefficients of Mo(VI) species were also obtained by using the isotope fractionation curve of Mo(VI) species.	[Tachibana, Yu; Yamazaki, Yuki; Suzuki, Tatsuya] Nagaoka Univ Technol, Grad Sch Engn, Dept Nucl Syst Safety Engn, Nagaoka, Niigata 9402188, Japan; [Nomura, Masao] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan	Suzuki, T (reprint author), Nagaoka Univ Technol, Grad Sch Engn, Dept Nucl Syst Safety Engn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	tasuzuki@vos.nagaokaut.ac.jp			KAKENHI [24656567]	This work was partially supported by the Grant-in-Aid for Challenging Exploratory Research (KAKENHI No. 24656567).	BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; Hayasaka K, 2008, PROG NUCL ENERG, V50, P510, DOI 10.1016/j.pnucene.2007.11.086; Bigeleisen J, 1996, J AM CHEM SOC, V118, P3676, DOI 10.1021/ja954076k; Marechal C, 2002, GEOCHIM COSMOCHIM AC, V66, P1499, DOI 10.1016/S0016-7037(01)00815-8; Nomura M, 1996, J AM CHEM SOC, V118, P9127, DOI 10.1021/ja954075s; OLAZABAL MA, 1992, SOLVENT EXTR ION EXC, V10, P623, DOI 10.1080/07366299208918125; Barling J, 2004, EARTH PLANET SC LETT, V217, P315, DOI 10.1016/S0012-821X(03)00608-3; Wang JN, 2010, J HAZARD MATER, V176, P1018, DOI 10.1016/j.jhazmat.2009.11.142; Gagnon K, 2011, NUCL MED BIOL, V38, P907, DOI 10.1016/j.nucmedbio.2011.02.010; Ban Y, 2002, J ION EXCHANGE, V13, P46; Ding XC, 2010, PROG NUCL ENERG, V52, P164, DOI 10.1016/j.pnucene.2009.06.003; Ding XC, 2006, J CHROMATOGR A, V1113, P182, DOI 10.1016/j.chroma.2006.02.015; Golgberg T, 2009, GEOCHIM COSMOCHIM AC, V73, P6502; Heeg MJ, 1999, ACCOUNTS CHEM RES, V32, P1053, DOI 10.1021/ar980002c; Hogfeldt E., 1982, STABILITY CONSTANT A; Ismail IM, 2000, ANAL CHEM, V72, P2841, DOI 10.1021/ac991187j; Ismail IM, 2011, J CHROMATOGR A, V1218, P2923, DOI 10.1016/j.chroma.2011.03.009; Ismail IM, 1998, J CHROMATOGR A, V808, P185, DOI 10.1016/S0021-9673(98)00116-2; Kashiwabara T, 2009, GEOCHEM J, V43, pE31; Kim SH, 2000, J ION EXCHANGE, V11, P26; Kimura A, 2011, IOP C SER MAT SCI EN, V18, P1; Matin MA, 1998, SEPAR SCI TECHNOL, V33, P1075, DOI 10.1080/01496399808545241; Nagai Y., 2009, J PHYS SOC JPN, V78, P1; Slejko F, 1985, ADSORPTION TECHNOLOG; Suzuki T, 2010, J ION EXCH, V21, P328; Suzuki T, 2004, REV SCI INSTRUM, V75, P1931, DOI 10.1063/1.1702105; Tachibana Y, MOLYBDENUM ISO UNPUB	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1429	1434		10.1007/s10967-014-3510-6		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200070		
J	Ohtsuka, Y; Takaku, Y; Hisamatsu, S				Ohtsuka, Yoshihito; Takaku, Yuichi; Hisamatsu, Shun'ichi			Background internal dose rates of earthworm and arthropod species in the forests of Aomori, Japan	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Environmental protection; Non-human species; Background radiation; Natural radionuclides; Forest ecosystem	SR-90	In this study, we measured the concentrations of several natural radionuclides in samples of one earthworm species and 11 arthropod species collected from four coniferous forests in Rokkasho, Aomori Prefecture, Japan, and we assessed the background internal radiation dose rate for each species. Dose rates were calculated by using the radionuclide concentrations in the samples and dose conversion coefficients obtained from the literature. The mean internal dose rate in the earthworm species was 0.28 mu Gy h(-1), and the mean internal dose rates in the arthropod species ranged between 0.036 and 0.69 mu Gy h(-1).	[Ohtsuka, Yoshihito; Takaku, Yuichi; Hisamatsu, Shun'ichi] Inst Environm Sci, Dept Radioecol, Aomori 0393212, Japan	Ohtsuka, Y (reprint author), Inst Environm Sci, Dept Radioecol, Aomori 0393212, Japan.	ohtsuka@ies.or.jp					Mietelski JW, 2008, J RADIOANAL NUCL CH, V275, P571, DOI 10.1007/s10967-007-7062-x; Framework for Assessment of Environmental Impact, 2003, EC 5 FRAM PROGR; Fukuda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054312; Hasegawa M, 2013, J ENVIRON RADIOACTIV, V126, P8, DOI 10.1016/j.jenvrad.2013.06.006; ICRP, 2007, ICRP PUBL, V103; ICRP, 2012, ICRP PUBL, V114; Mietelski JW, 2004, J RADIOANAL NUCL CH, V262, P645, DOI 10.1007/s10967-004-0488-5; Ministry of the Environment, 2003, 6 7 NAT SURV NAT ENV; Ohtsuka Y, 2006, J RADIOANAL NUCL CH, V268, P397, DOI 10.1556/JRNC.268.2006.2.30	9	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1441	1445		10.1007/s10967-014-3498-y		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200072		
J	Muramatsu, H; Kawasumi, K; Kondo, T; Matsuo, K; Itoh, S				Muramatsu, H.; Kawasumi, K.; Kondo, T.; Matsuo, K.; Itoh, S.			Size-distribution of airborne radioactive particles from the Fukushima accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Particle size distribution; Radioactive aerosols; Airborne radionuclide; Nuclear power plant accident; Activity median aerodynamic diameter	NUCLEAR ACCIDENT; AEROSOLS; RADIONUCLIDES; JAPAN; AIR	The particle size distribution of radioactive aerosols, which originated from the released radioactive materials from the Fukushima Daiichi nuclear power plant accident, has been observed using the Andersen-type classifier combined with a high volume air sampler. Estimated activity median aerodynamic diameters (AMADs) of I-131-, Cs-134- and Cs-137-aerosols were ranging from 0.56 to 0.60 mu m, which were larger than that of Be-7-aerosols existing as an aerosol including cosmogenic radionuclide, about 0.2 mu m.	[Muramatsu, H.; Kawasumi, K.; Kondo, T.] Shinshu Univ, Fac Educ, Dept Chem, Nagano 3808544, Japan; [Matsuo, K.] Shinshu Univ, Grad Sch Educ, Nagano 3808544, Japan; [Itoh, S.] Natl Agr & Food Res Org, Tsukuba, Ibaraki 3058517, Japan	Muramatsu, H (reprint author), Shinshu Univ, Fac Educ, Dept Chem, Nagano 3808544, Japan.	hmurama@shinshu-u.ac.jp					Masson O, 2013, ENVIRON SCI TECHNOL, V47, P10995, DOI 10.1021/es401973c; WHITBY KT, 1978, ATMOS ENVIRON, V12, P135, DOI 10.1016/0004-6981(78)90196-8; Kaneyasu N, 2012, ENVIRON SCI TECHNOL, V46, P5720, DOI 10.1021/es204667h; Doi T, 2013, J ENVIRON RADIOACTIV, V122, P55, DOI 10.1016/j.jenvrad.2013.02.001; Aoyama M, 1992, PRECIPITATION SCAVEN, V3, P1581; Baklanov A, 2001, PHYS CHEM EARTH PT B, V26, P787, DOI 10.1016/S1464-1909(01)00087-9; BONDIETTI EA, 1986, NATURE, V322, P313, DOI 10.1038/322313b0; JOST DT, 1986, NATURE, V324, P22, DOI 10.1038/324022a0; KAUPPINEN EI, 1986, ENVIRON SCI TECHNOL, V20, P1257, DOI 10.1021/es00154a011; Koizumi Akio, 2012, Environmental Health and Preventive Medicine, V17, P292, DOI 10.1007/s12199-011-0251-9; Mala H, 2013, J ENVIRON RADIOACTIV, V126, P92, DOI 10.1016/j.jenvrad.2013.07.016; Miyamoto Y, 2014, J ENVIRON RADIOACTIV, V132, P1, DOI 10.1016/j.jenvrad.2014.01.010; Muramatsu H, 2008, J RADIOANAL NUCL CH, V275, P299, DOI 10.1007/s10967-007-7056-8; REINEKING A, 1987, RADIAT PROT DOSIM, V19, P159	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1459	1463		10.1007/s10967-014-3690-0		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200075		
J	Maeda, E; Yokoyama, A; Taniguchi, T; Washiyama, K; Nishinaka, I				Maeda, E.; Yokoyama, A.; Taniguchi, T.; Washiyama, K.; Nishinaka, I.			Extraction of astatine isotopes for development of radiopharmaceuticals using a Rn-211-At-211 generator	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radionuclide therapy; Astatine; Liquid-liquid extraction; Rn-211-At-211 generator		In order to utilize a At-211 isotope, a promising alpha-emitter for radionuclide therapy, the chemical properties of astatine isotopes are studied. We have examined wet chemistry methods through the distribution ratios of astatine in liquid-liquid extraction. The astatine isotopes have been found to be well extracted into DIPE and MIBK. We observed that the distribution ratio of astatine isotopes increases with concentrations of HCl greater than 3 M, while it decreases with the HCl concentration less than 2 M. The results will be useful for development of the Rn-211-At-211 generator.	[Maeda, E.; Taniguchi, T.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Yokoyama, A.] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa, Japan; [Washiyama, K.] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Nishinaka, I.] Japan Atom Energy Agcy, ASRC, Tokai, Ibaraki, Japan	Yokoyama, A (reprint author), Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa, Japan.	yokoyama@se.kanazawa-u.ac.jp					Alliot C, 2009, RADIOCHIM ACTA, V97, P161, DOI 10.1524/ract.2009.1590; Champion J, 2013, J PHYS CHEM A, V117, P1983, DOI 10.1021/jp3099413; Nayak D, 2003, RADIOCHIM ACTA, V91, P159, DOI 10.1524/ract.91.3.159.19982; Neumann H M, 1957, INORG NUCL CHEM, V4, P349	4	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1465	1468		10.1007/s10967-014-3586-z		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200076		
J	Kimura, H; Uesugi, M; Muneda, A; Watanabe, R; Yokoyama, A; Nakanishi, T				Kimura, H.; Uesugi, M.; Muneda, A.; Watanabe, R.; Yokoyama, A.; Nakanishi, T.			The situation of Ag and Pu radioisotopes in soil released from Fukushima Daiichi nuclear power plants	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Pu; Ag-110m; Hot particle; Soil; Fukusima Daiichi; alpha-ray spectrometry		Massive radionuclides were released into the environment due to the Fukushima Daiichi nuclear power plant (FDNPP) accident in March 2011. The concentrations of Pu and Ag-110m in a soil sample that was collected in Futaba-machi located at 4 km north-west of FDNPP were measured by alpha-spectrometry and gamma-spectrometry, respectively. The analytical result suggests that Pu isotopes are deposited in the soil as particles with high radioactivity (hot particles), although the Ag-110m isotope is deposited uniformly like as Cs isotopes in a soil sample.	[Kimura, H.; Watanabe, R.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Uesugi, M.; Yokoyama, A.] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa, Japan; [Muneda, A.] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa, Japan; [Nakanishi, T.] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan	Yokoyama, A (reprint author), Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa, Japan.	yokoyama@se.kanazawa-u.ac.jp					[Anonymous], 1991, THE PU AN; Kimura H, 2013, P 14 WORKSH ENV RAD, P344; Vajda N, 2011, ANAL CHEM, V83, P4688, DOI 10.1021/ac2008288; Yamamoto M, 2012, GEOCHEM J, V46, P341	4	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1469	1471		10.1007/s10967-014-3587-y		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200077		
J	Shimizu, R; Yamada, Y; Kobayashi, Y				Shimizu, R.; Yamada, Y.; Kobayashi, Y.			Liquid phase synthesis of iron sulfide particles	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Iron sulfide; Trivalent iron; Particles; Mossbauer spectroscopy; Polyol method		Iron sulfide particles were prepared using a polyol method; a mixture of ferrocene, 1,2-hexadecanediol (HD), and 1-octadecanethiol in oleylamine were heated to obtain particles. The particles were investigated using Mossbauer spectroscopy, scanning electron microscopy, and powder X-ray diffraction. Hexagonal plate shaped Fe1-x S particles with sizes of 2-3 mu m were obtained in the solvent without HD, whereas 100-200 nm Fe2S3 particles were obtained in the presence of HD. The Fe2S3 particles were transformed to Fe3S4 (greigite) by heating at 100 A degrees C.	[Shimizu, R.; Yamada, Y.] Tokyo Univ Sci, Dept Chem, Shijuku Ku, Tokyo 1628602, Japan; [Kobayashi, Y.] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Kobayashi, Y.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan	Yamada, Y (reprint author), Tokyo Univ Sci, Dept Chem, Shijuku Ku, 1-3 Kagurazaka, Tokyo 1628602, Japan.	yyasu@rs.kagu.tus.ac.jp					Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; FIEVET F, 1989, SOLID STATE IONICS, V32-3, P198, DOI 10.1016/0167-2738(89)90222-1; BOEHM HP, 1966, ANGEW CHEM INT EDIT, V5, P963, DOI 10.1002/anie.196609631; Lyubutin IS, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-012-1397-0; STILLER AH, 1978, J AM CHEM SOC, V100, P2553, DOI 10.1021/ja00476a051; TEMPERLE.AA, 1966, J PHYS CHEM SOLIDS, V27, P85, DOI 10.1016/0022-3697(66)90168-5; TOWNSEND MG, 1979, J PHYS CHEM SOLIDS, V40, P183, DOI 10.1016/0022-3697(79)90013-1	7	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1473	1476		10.1007/s10967-014-3506-2		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200078		
J	Shiga, K; Yamada, Y; Kobayashi, Y				Shiga, K.; Yamada, Y.; Kobayashi, Y.			Mossbauer study of iron fluoride films produced by pulsed laser deposition	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Iron fluoride; Film; Pulsed laser deposition; Mossbauer spectroscopy	THIN-FILMS	Iron fluoride thin films were produced by the reaction of laser-evaporated iron atoms with sulfur hexafluoride (SF6) gas. The iron fluoride films were investigated using Mossbauer spectroscopy, powder X-ray diffraction, and scanning electron microscopy. The composition of the iron fluoride films changed according to the pressure of ambient SF6 gas: FeF3 was obtained at high pressure, while FeF2 was obtained at low pressure. In addition, the size of FeF3 crystallites produced in the film was controlled by the substrate temperature during pulsed laser deposition.	[Shiga, K.; Yamada, Y.] Tokyo Univ Sci, Dept Chem, Shinjuku Ku, Tokyo 1628602, Japan; [Kobayashi, Y.] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Kobayashi, Y.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan	Shiga, K (reprint author), Tokyo Univ Sci, Dept Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628602, Japan.	jb113673@ed.tus.ac.jp					Yamakawa N, 2009, J AM CHEM SOC, V131, P10525, DOI 10.1021/ja902639w; Yokoyama D, 2007, J RADIOANAL NUCL CH, V272, P631, DOI 10.1007/s10967-007-0637-8; KARRAKER DG, 1992, INORG CHEM, V31, P1118, DOI 10.1021/ic00032a042; LACHTER A, 1980, PHYS STATUS SOLIDI A, V61, P619, DOI 10.1002/pssa.2210610236; Makimura Y, 2006, APPL SURF SCI, V252, P4587, DOI 10.1016/j.apsusc.2005.06.043; Usui R, 2012, HYPERFINE INTERACT, V205, P13, DOI 10.1007/s10751-011-0473-7; Yamada Y, 2010, J PHYS CONF SER, V217, DOI 10.1088/1742-6596/217/1/012096; Yamada Y, 2010, HYPERFINE INTERACT, V198, P55, DOI 10.1007/s10751-010-0236-x; Yamada Y, 2000, CHEM LETT, P746, DOI 10.1246/cl.2000.746	9	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1477	1480		10.1007/s10967-014-3523-1		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200079		
J	Awaludin, R; Gunawan, A; Lubis, H; Sriyono; Herlina; Mutalib, A; Kimura, A; Tsuchiya, K; Tanase, M; Ishihara, M				Awaludin, Rohadi; Gunawan, AdangHardi; Lubis, Hotman; Sriyono; Herlina; Mutalib, Abdul; Kimura, Akihiro; Tsuchiya, Kunihiko; Tanase, Masakazu; Ishihara, Masahiro			Mechanism of Mo-99 adsorption and Tc-99m elution from zirconium-based material in Mo-99/Tc-99m generator column using neutron-irradiated natural molybdenum	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Adsorption mechanism; Mo-99/Tc-99m radionuclide generator; Neutron-irradiated natural molybdenum; Oxidizing agent		The Mo-99 adsorption and Tc-99m elution mechanism were investigated using SEM-EDS to analyze the elemental composition of the adsorbent surfaces. From the changes of element composition, it was found that molybdate ions were adsorbed into the adsorbent by ion exchange with Cl- ion in the material. It was also revealed that Tc-99m can be eluted in high oxidation state since the Tc-99m in lower oxidation state easily made coordination bonds with other elements in the adsorbent.	[Awaludin, Rohadi; Gunawan, AdangHardi; Lubis, Hotman; Sriyono; Herlina; Mutalib, Abdul] Natl Nucl Energy Agcy Indonesia, Ctr Radioisotope & Radiopharmaceut, Serpong, Indonesia; [Kimura, Akihiro; Tsuchiya, Kunihiko; Ishihara, Masahiro] Japan Atom Energy Agcy, Oarai Res & Dev Ctr, Neutron Irradiat & Testing Reactor Ctr, Ibaraki, Japan; [Tanase, Masakazu] Chiyoda Technol Corp, Shizuoka, Japan	Awaludin, R (reprint author), Natl Nucl Energy Agcy Indonesia, Ctr Radioisotope & Radiopharmaceut, Serpong, Indonesia.	rohadi_a@batan.go.id					Chattopadhyay S, 2008, APPL RADIAT ISOTOPES, V66, P1295, DOI 10.1016/j.apradiso.2008.02.085; *INT AT EN AG, 2003, MAN REACT PROD RAD I; *INT AT EN AG, 2009, TECHN 99M RAD STAT T; LEE JS, 2010, Patent No. 20100248955; MUTALIB A, 2001, P 2001 WORKSH UT RES; Tanase M, 1997, APPL RADIAT ISOTOPES, V48, P607, DOI 10.1016/S0969-8043(96)00320-X	6	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1481	1483		10.1007/s10967-014-3606-z		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200080		
J	Maekawa, A; Momoshima, N; Sugihara, S; Ohzawa, R; Nakama, A				Maekawa, A.; Momoshima, N.; Sugihara, S.; Ohzawa, R.; Nakama, A.			Analysis of Cs-134 and Cs-137 distribution in soil of Fukushima prefecture and their specific adsorption on clay minerals	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radiocesium interception potential; Fukushima daiichi nuclear power plant accident; Vertical distribution; Clay minerals	RADIOCESIUM; ACCIDENT; SORPTION; JAPAN	We collected surface soil samples within 60 km from the Fukushima Daiichi Nuclear Power Plants (FDNPP) and analyzed spatial and temporal radiocesium distributions. No large change in vertical distribution pattern of radiocesium has been observed on the samples collected in April 2011 and April 2012 at the same sampling points, suggesting strong adsorption of Cs-134 and Cs-137 on soil. Cesium is known to be adsorbed specifically on clay minerals in soil. To confirm the specific adsorption of Cs on clay minerals in these samples, we divided the soil into different particle sizes and measured the activity in each size fraction. The activity was highest in the clay fraction (< 2 mu m) and tended to decrease as the particle size increases. The radiocesium interception potential (RIP), which is defined by the product of the frayed edge sites (FES) capacity and Cs-K selectivity coefficient, was measured using carrier-free Cs-137. No correlation between the value of RIP and the penetration depth of radiocesium was observed, probably suggesting other important physicochemical factors.	[Maekawa, A.; Ohzawa, R.; Nakama, A.] Kyushu Univ, Grad Sch Sci, Higashi Ku, Fukuoka 8128581, Japan; [Momoshima, N.; Sugihara, S.] Kyushu Univ, Radioisotope Ctr, Higashi Ku, Fukuoka 8128581, Japan	Maekawa, A (reprint author), Kyushu Univ, Grad Sch Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	maekawa_akihiro_01@pref.fukushima.lg.jp					SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; Matsunaga T, 2013, SCI TOTAL ENVIRON, V447, P301, DOI 10.1016/j.scitotenv.2012.12.087; CREMERS A, 1988, NATURE, V335, P247, DOI 10.1038/335247a0; Koarashi J, 2012, SCI TOTAL ENVIRON, V431, P392, DOI 10.1016/j.scitotenv.2012.05.041; Ishikawa Nao, 2007, Radioisotopes, V56, P519; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Nakao A, 2008, SOIL SCI PLANT NUTR, V54, P479, DOI 10.1111/j.1747-0765.2008.00262.x; Nakao A, 2009, EUR J SOIL SCI, V60, P127, DOI 10.1111/j.1365-2389.2008.01097.x; Saitoh K, 2013, HEADQUARTERS FUKUSHI; Stautnton S, 2002, J ENVIRON RADIOACTIV, V58, P163, DOI 10.1016/S0265-931X(01)00064-9; Tamura K, 2013, HEADQUARTERS FUKUSHI; Wauters J, 1996, APPL GEOCHEM, V11, P589, DOI 10.1016/0883-2927(96)00027-3	12	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1485	1489		10.1007/s10967-014-3575-2		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200081		
J	Chen, RZ; Asai, M; Fukushima, C; Ishizaki, M; Kurihara, M; Arisaka, M; Nankawa, T; Watanabe, M; Kawamoto, T; Tanaka, H				Chen, Rongzhi; Asai, Miyuki; Fukushima, Chikako; Ishizaki, Manabu; Kurihara, Masato; Arisaka, Makoto; Nankawa, Takuya; Watanabe, Masayuki; Kawamoto, Tohru; Tanaka, Hisashi			Column study on electrochemical separation of cesium ions from wastewater using copper hexacyanoferrate film	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Metal hexacyanoferrate complex; Electrochemical separation; Cesium; Radioactive waste; Column removal	EXCHANGE; FERROCYANIDES	Nanoparticle film of copper hexacyanoferrate (CuHCFIII) was developed and coated on the rolled sheet electrodes for column cesium separation from wastewater. Results indicated well balance of Cs adsorption and desorption can be achieved switching the potentials between anodes and cathodes. XPS and isotherm studies indicated the electrochemical oxidation-reduction of Fe(II/III) on the monolayer of the CuHCFIII film made contributions to reversible Cs separation. Minimization of secondary waste, simple regeneration and uniformly coating for any size, suggest a promising column technology for sequential removal of Cs from actual wastewater.	[Chen, Rongzhi; Asai, Miyuki; Fukushima, Chikako; Kurihara, Masato; Kawamoto, Tohru; Tanaka, Hisashi] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Ishizaki, Manabu; Kurihara, Masato] Yamagata Univ, Dept Mat & Biol Chem, Fac Sci, Yamagata 9908560, Japan; [Arisaka, Makoto; Nankawa, Takuya; Watanabe, Masayuki] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Tanaka, H (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	crz0718@hotmail.com; tohru.kawamoto@aist.go.jp; hisashi.tanaka@aist.go.jp	Kawamoto, Tohru/B-7145-2008	Kawamoto, Tohru/0000-0002-3984-2980			Chan KY, 2007, MICROELECTRON J, V38, P60, DOI 10.1016/j.mejo.2006.09.011; LEVAN MD, 1981, J PHYS CHEM-US, V85, P3247, DOI 10.1021/j150622a009; PEKAREK V, 1972, TALANTA, V19, P1245, DOI 10.1016/0039-9140(72)80124-3; Sun B, 2012, J HAZARD MATER, V233, P177, DOI 10.1016/j.jhazmat.2012.07.010; Chen RZ, 2013, ELECTROCHIM ACTA, V87, P119, DOI 10.1016/j.electacta.2012.08.124; Nilchi A, 2003, J RADIOANAL NUCL CH, V258, P457, DOI 10.1023/B:JRNC.0000011738.46843.ff; BOCARSLY AB, 1982, J ELECTROANAL CHEM, V140, P167, DOI 10.1016/0368-1874(82)85310-0; Coughtrey PJ, 1983, RADIONUCLIDE DISTRIB, V2; Hao XG, 2008, SEP PURIF TECHNOL, V63, P407, DOI 10.1016/j.seppur.2008.06.001; Keggin J., 1936, NATURE, V137, P577, DOI DOI 10.1038/137577A0; Lilga MA, 2001, SEP PURIF TECHNOL, V24, P451, DOI 10.1016/S1383-5866(01)00145-9; Elizalde-Gonzalez MP, 2001, MICROPOR MESOPOR MAT, V46, P277, DOI 10.1016/S1387-1811(01)00308-0	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1491	1495		10.1007/s10967-014-3588-x		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200082		
J	Ochiai, S; Yamamoto, M; Nagao, S; Itono, T; Kashiwaya, K				Ochiai, Shinya; Yamamoto, Masayoshi; Nagao, Seiya; Itono, Taeko; Kashiwaya, Kenji			Sediment transport processes in a reservoir-catchment system inferred from sediment trap observations and fallout radionuclides	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Reservoir sediment; Sediment trap; Pb-210; Cs-137; Cs-134	POWER-PLANT ACCIDENT; INDUCED EROSION; DEPOSITION; PB-210; CS-137; BE-7; LAKE	Sediment transport processes and their responses to hydrological conditions were investigated based on sediment trap observations in a reservoir-catchment system in Japan. The annual discharge rate of Cs-134 from the catchment was much higher than that of Cs-137. This difference suggests that Cs-134 freshly derived from the Fukushima Dai-ichi Nuclear Power Plant accident accumulated in the surface soil, which acted as a major sediment source. The seasonal changes in the Cs-137/Pb-210(ex) ratio in the trap samples corresponded well to the precipitation changes. This suggests that the precipitation intensity affects the source of eroded sediment in the catchment.	[Ochiai, Shinya; Yamamoto, Masayoshi; Nagao, Seiya] Kanazawa Univ, Low Level Radioact Lab, Inst Nat & Environm Technol, Nomi, Ishikawa 9231224, Japan; [Itono, Taeko] Kanazawa Univ, Grad Sch Nat Sci Technol, Kanazawa, Ishikawa 9201192, Japan; [Kashiwaya, Kenji] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan	Ochiai, S (reprint author), Kanazawa Univ, Low Level Radioact Lab, Inst Nat & Environm Technol, O 24 Wake, Nomi, Ishikawa 9231224, Japan.	sochiai@ies.or.jp					Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Katata G, 2012, J ENVIRON RADIOACTIV, V111, P2, DOI 10.1016/j.jenvrad.2011.09.011; Shotbolt LA, 2005, PROG PHYS GEOG, V29, P337, DOI 10.1191/0309133305pp452ra; Yamamoto M, 2006, J ENVIRON RADIOACTIV, V86, P110, DOI 10.1016/j.jenvrad.2005.08.001; Peng YJ, 2005, EARTH PLANET SC LETT, V233, P467, DOI 10.1016/j.epsl.2005.02.022; Kashiwaya K, 1997, EARTH SURF PROC LAND, V22, P913; Page MJ, 1994, J PALEOLIMNOL, V11, P333, DOI 10.1007/BF00677993; Lamoureux S, 2000, WATER RESOUR RES, V36, P309, DOI 10.1029/1999WR900271; Kashiwaya K, 2012, T JPN GEOMORPHOL UNI, V33, P219; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Le Cloarec MF, 2007, SCI TOTAL ENVIRON, V375, P125, DOI 10.1016/j.scitotenv.2006.12.020; Richie JC, 1990, J ENVIRON QUAL, V19, P215; The Ministry of Education Culture Sports Science and Technology (MEXT), 2011, SUMM VERS RES RES DI; The Ministry of Education Culture Sports Science and Technology (MEXT), 2011, RES 4 AIRB MON SURV	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1497	1501		10.1007/s10967-014-3577-0		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200083		
J	Miyatani, R; Yamada, Y; Kobayashi, Y				Miyatani, R.; Yamada, Y.; Kobayashi, Y.			Mossbauer study of iron carbide nanoparticles produced by sonochemical synthesis	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Sonochemistry; Iron carbide; Ferrocene; Nanoparticles	AMORPHOUS IRON; PARTICLES	Iron carbide nanoparticles were produced by ultrasonication of ferrocene in diphenylmethane and their properties were investigated using Mossbauer spectroscopy, Transmission electron microscopy and X-ray diffraction. The as-prepared particles were amorphous paramagnetic iron carbides, and the particles obtained after annealing exhibited magnetic components. The particles obtained after annealing at 873 K under argon flow for 2 h consisted of Fe3C, alpha-Fe, and paramagnetic iron carbide, while Mossbauer spectra indicated that no iron oxides were present.	[Miyatani, R.; Yamada, Y.] Tokyo Univ Sci, Dept Chem, Shinjuku Ku, Tokyo 1628602, Japan; [Kobayashi, Y.] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Kobayashi, Y.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan	Miyatani, R (reprint author), Tokyo Univ Sci, Dept Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628602, Japan.	r-miyatani@hotmail.co.jp					SUSLICK KS, 1991, NATURE, V353, P414, DOI 10.1038/353414a0; SATO T, 1987, J MAGN MAGN MATER, V65, P252, DOI 10.1016/0304-8853(87)90044-8; Bang JH, 2007, J AM CHEM SOC, V129, P2242, DOI 10.1021/ja0676657; Nikitenko SI, 2004, J PHYS CHEM B, V108, P7620, DOI 10.1021/jp036376r; Burke NAD, 2002, CHEM MATER, V14, P4752, DOI 10.1021/cm020126q; Kumar RV, 2000, J MATER CHEM, V10, P1125, DOI 10.1039/b000440p; NOMURA K, 1990, HYPERFINE INTERACT, V56, P1711, DOI 10.1007/BF02405500; Pinkas J, 2008, ULTRASON SONOCHEM, V15, P257, DOI 10.1016/j.ultsonch.2007.03.009; RON M, 1966, PHYS LETT, V20, P481, DOI 10.1016/0031-9163(66)90962-0; TANAKA T, 1991, J LESS-COMMON MET, V171, P237, DOI 10.1016/0022-5088(91)90147-V; Yamada Y, 2010, J PHYS CONF SER, V217, DOI 10.1088/1742-6596/217/1/012096	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1503	1506		10.1007/s10967-014-3507-1		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200084		
J	Oikawa, S; Watabe, T; Takata, H; Misonoo, J; Kusakabe, M				Oikawa, S.; Watabe, T.; Takata, H.; Misonoo, J.; Kusakabe, M.			Plutonium isotopes and Am-241 in surface sediments off the coast of the Japanese islands before and soon after the Fukushima Dai-ichi nuclear power plant accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Pu isotopes; Am-241; Sediment; Fukushima Dai-ichi nuclear power plant accident	PU ISOTOPES; RADIONUCLIDES; DISTRIBUTIONS; ENVIRONMENT; PACIFIC	The concentrations of Pu239+240, Pu-241 and Am-241 in the sediments at the coast of Japanese islands from 2008 to 2011 varied widely from one sampling site to another and were generally lower in sandy sediments at shallower sites, and higher in clayey sediments at deeper sites. In contrast, there seemed to be no temporal variation in the concentrations during the survey period. The Am-241/Pu239+240 activity ratio was relatively higher than the global fallout presumably owing to the ingrowth of Am-241 from the ancestor, Pu-241 originating mainly from the hydrogen bomb explosion tests in the Marshall Islands in the 1950s.	[Oikawa, S.; Takata, H.] Marine Ecol Res Inst, Cent Lab, Onjuku, Chiba 2995105, Japan; [Watabe, T.; Misonoo, J.; Kusakabe, M.] Marine Ecol Res Inst, Shinjuku Ku, Tokyo 1620801, Japan	Oikawa, S (reprint author), Marine Ecol Res Inst, Cent Lab, 300 Iwawada, Onjuku, Chiba 2995105, Japan.	neptunium.237@gmail.com					LIVINGSTON HD, 1975, EARTH PLANET SC LETT, V25, P361, DOI 10.1016/0012-821X(75)90254-X; Zheng J, 2012, GEOCHEM J, V46, P361; Sakaguchi A, 2012, GEOCHEM J, V46, P355; Muramatsu Y, 2001, SCI TOTAL ENVIRON, V278, P151, DOI 10.1016/S0048-9697(01)00644-1; Tsumune D, 2013, BIOGEOSCIENCES, V10, P5601, DOI 10.5194/bg-10-5601-2013; Oikawa S, 2013, BIOGEOSCIENCES, V10, P5031, DOI 10.5194/bg-10-5031-2013; Kusakabe M, 2013, BIOGEOSCIENCES, V10, P5019, DOI 10.5194/bg-10-5019-2013; Bu WT, 2013, BIOGEOSCIENCES, V10, P2497, DOI 10.5194/bg-10-2497-2013; Krey PW, 1976, IAEASM1993967167; Oikawa S, 2011, J ENVIRON RADIOACTIV, V102, P302, DOI 10.1016/j.jenvrad.2010.12.007; YAMAMOTO M, 1990, RADIOCHIM ACTA, V51, P85; Zheng J, 2013, ENVIRON SCI TECHNOL, V47, P9584, DOI 10.1021/es402212v; Zheng J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00304	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1513	1518		10.1007/s10967-014-3530-2		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200086		
J	Watanabe, S; Hashimoto, K; Ishioka, NS				Watanabe, Satoshi; Hashimoto, Kazuyuki; Ishioka, Noriko S.			Lutetium-177 complexation of DOTA and DTPA in the presence of competing metals	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Lu-177; Complexation; DOTA; DTPA; Competing metals	RADIOLABELED SOMATOSTATIN ANALOG; TUMORS; RADIOIMMUNOTHERAPY; THERAPY	As part of basic studies on bifunctional chelating agents for Lu-177-labeled antibodies, Lu-177 complexation of 1,4,7,10-tetraazacyclododecan-N,NA ',NA ' A ',NA ' A ' A '-tetraacetic acid (DOTA) and diethylenetriamine-N,N,NA ',NA ' A ',NA ' A '-pentaacetic acid (DTPA) was investigated in the presence of competing metals, including Ca(II), Fe(II), and Zn(II). It was found that DTPA is a better Lu-177 complexation agent than DOTA in the presence of Ca(II), Fe(II), and Zn(II). Moreover, the elimination of Fe from the Lu-177 solution proved especially effective because the DTPA comlexation of Lu-177 was highly inhibited by Fe(II).	[Watanabe, Satoshi; Ishioka, Noriko S.] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Takasaki, Gumma 3701292, Japan; [Hashimoto, Kazuyuki] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki 3191195, Japan	Watanabe, S (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Takasaki, Gumma 3701292, Japan.	watanabe.satoshi@jaea.go.jp					Koppe MJ, 2004, J NUCL MED, V45, P1224; Kwekkeboom DJ, 2005, J CLIN ONCOL, V23, P2754, DOI 10.1200/JCO.2005.08.066; Grunberg J, 2005, CLIN CANCER RES, V11, P5112, DOI 10.1158/1078-0432.CCR-05-0227; [Anonymous], NIST STANDARD REFERE, V46; Kwekkeboom DJ, 2001, EUR J NUCL MED, V28, P1319, DOI 10.1007/s002590100574; Vera DRB, 2012, NUCL MED BIOL, V39, P3, DOI 10.1016/j.nucmedbio.2011.07.001; Brouwers AH, 2004, J NUCL MED, V45, P327; De Leon-Rodriguez LM, 2008, BIOCONJUGATE CHEM, V19, P391, DOI 10.1021/bc700328s; de Keizer B, 2008, EUR J NUCL MED MOL I, V35, P749, DOI 10.1007/s00259-007-0691-z; Kam B L R, 2012, Eur J Nucl Med Mol Imaging, V39 Suppl 1, pS103, DOI 10.1007/s00259-011-2039-y; Lie S, 2001, BIOCONJUG CHEM, V12, P7; Persson M, 2007, CANCER RES, V67, P326, DOI 10.1158/0008-5472.CAN-06-2363; Smith CJ, 2003, NUCL MED BIOL, V30, P101, DOI 10.1016/S0969-8051(02)00391-8; Watanabe S, 2015, J RADIOANAL NUCL CH, V303, P935, DOI 10.1007/s10967-014-3534-y	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1519	1521		10.1007/s10967-014-3590-3		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200087		
J	Kaji, D; Morimoto, K; Haba, H; Wakabayashi, Y; Kudou, Y; Huang, M; Goto, S; Murakami, M; Goto, N; Koyama, T; Tamura, N; Tsuto, S; Sumita, T; Tanaka, K; Takeyama, M; Yamaki, S; Morita, K				Kaji, D.; Morimoto, K.; Haba, H.; Wakabayashi, Y.; Kudou, Y.; Huang, M.; Goto, S.; Murakami, M.; Goto, N.; Koyama, T.; Tamura, N.; Tsuto, S.; Sumita, T.; Tanaka, K.; Takeyama, M.; Yamaki, S.; Morita, K.			Startup of a new gas-filled recoil separator GARIS-II	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Superheavy; GARIS-II; Gas-filled recoil ion separator; Transmission		A new gas-filled recoil ion separator GARIS-II was on-line tested by using two Ar-40-induced fusion reactions of Tm-169(Ar-40,4n)Fr-205 and Pb-208(Ar-40,3n)Fm-245, respectively. The products were collected to a focal plane with high efficiency of 47 +/- A 1 and 63 +/- A 9 % for Fr-205 and Fm-245 under low background condition.	[Kaji, D.; Morimoto, K.; Haba, H.; Wakabayashi, Y.; Kudou, Y.; Huang, M.; Morita, K.] RIKEN, Nishina Ctr Accelerator Based Sci, Saitama 3500198, Japan; [Goto, S.; Murakami, M.; Goto, N.; Koyama, T.; Tamura, N.; Tsuto, S.] Niigata Univ, Fac Sci, Niigata 9502181, Japan; [Sumita, T.; Tanaka, K.] Tokyo Univ Sci, Fac Sci & Technol, Chiba 2788510, Japan; [Takeyama, M.] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 9908560, Japan; [Yamaki, S.] Saitama Univ, Dept Phys, Saitama 3388570, Japan	Kaji, D (reprint author), RIKEN, Nishina Ctr Accelerator Based Sci, Saitama 3500198, Japan.	daiya@riken.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [19002005]	The experiment was performed at the RI Beam Factory operated by the RIKEN Nishina Center and CNS, University of Tokyo. The authors are grateful to the accelerator staff members for their cooperation and assistance during the experiment. This research was partially supported by a Grant-in-Aid for specially promoted research, 19002005, 2007, from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	VERMEULEN D, 1984, Z PHYS A-HADRON NUCL, V318, P157, DOI 10.1007/BF01413464; Kaji D, 2011, PROC RADIOCHIM ACTA, V1, P105; Kaji D, 2014, JPS C P, V1; Kaji D, 2013, NUCL INSTRUM METH B, V317, P311, DOI 10.1016/j.nimb.2013.05.085; MUNZENBERG G, 1981, Z PHYS A-HADRON NUCL, V302, P7, DOI 10.1007/BF01425097	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1523	1525		10.1007/s10967-014-3706-9		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200088		
J	Zhang, ZJ; Ninomiya, K; Takahashi, N; Shinohara, A				Zhang, Zijian; Ninomiya, Kazuhiko; Takahashi, Naruto; Shinohara, Atsushi			Daily variation of I-131, Cs-134 and Cs-137 activity concentrations in the atmosphere in Osaka during the early phase after the FDNPP accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radioactive iodine; Radioactive cesium; Time variation; Air-mass transportation	NUCLEAR-POWER-PLANT; AIRBORNE RADIONUCLIDES; FUKUSHIMA; DISPERSION; JAPAN	To investigate the time variations of radionuclides discharged from the Fukushima Daiichi nuclear power plants accident, we started collecting aerosol samples in Osaka, Japan, using a high-volume sampler from March 15 to May 1, 2011. Atmospheric radioactivity concentrations of I-131, Cs-134 and Cs-137 were measured with germanium semi-conductor detectors. Only I-131 was detected in the early phase and two Cs-134.137 peaks were found in Osaka in April. Using the HYSPLIT model, we concluded that direct transportation of the air mass from the Fukushima area was responsible for such events.	[Zhang, Zijian; Ninomiya, Kazuhiko; Takahashi, Naruto; Shinohara, Atsushi] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Zhang, ZJ (reprint author), Osaka Univ, Grad Sch Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	chous11@chem.sci.osaka-u.ac.jp					Manolopoulou M, 2011, J ENVIRON RADIOACTIV, V102, P796, DOI 10.1016/j.jenvrad.2011.04.010; Povinec PP, 2012, J ENVIRON RADIOACTIV, V114, P81, DOI 10.1016/j.jenvrad.2012.05.008; Momoshima N, 2012, J ENVIRON RADIOACTIV, V111, P28, DOI 10.1016/j.jenvrad.2011.09.001; Masson O, 2011, ENVIRON SCI TECHNOL, V45, P7670, DOI 10.1021/es2017158; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Haba H, 2012, GEOCHEM J, V46, P271; Katata G, 2012, J ENVIRON RADIOACTIV, V109, P103, DOI 10.1016/j.jenvrad.2012.02.006; Kinoshita N, PNAS, V108, P19526	9	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1527	1531		10.1007/s10967-014-3752-3		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200089		
J	Ohse, K; Kitayama, K; Suenaga, S; Matsumoto, K; Kanno, A; Suzuki, C; Kawatsu, K; Tsukada, H				Ohse, Kenji; Kitayama, Kyo; Suenaga, Seiichi; Matsumoto, Kiyoyuki; Kanno, Akira; Suzuki, Chika; Kawatsu, Kencho; Tsukada, Hirofumi			Concentration of radiocesium in rice, vegetables, and fruits cultivated in the evacuation area in Okuma Town, Fukushima	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Evacuation area; Test cultivation; Radiocesium; Transfer factor; Fukushima Daiichi nuclear power plant accident	SOIL; CS-137; JAPAN	Radiocesium concentration in the crops cultivated in contaminated and decontaminated soils in the evacuation area were measured. The radiocesium concentration in the decontaminated soil decreased approximately one-quarter to that in the contaminated soil. The radiocesium concentration in the rice and vegetables cultivated in the decontaminated soil decreased to one-half to tenth of that in the contaminated soil. Except for eggplant and pumpkin cultivated in the decontaminated field, the radiocesium concentration in crops was higher than the standard limit in foods in Japan. The obtained transfer factors of most crops were within the reported values.	[Ohse, Kenji; Kitayama, Kyo; Kanno, Akira; Suzuki, Chika; Kawatsu, Kencho; Tsukada, Hirofumi] Fukushima Univ, Fukushima Future Ctr Reg Revitalizat, Fukushima, Japan; [Suenaga, Seiichi; Matsumoto, Kiyoyuki] Okuma Govt Off, Okuma, Fukushima, Japan	Ohse, K (reprint author), Fukushima Univ, Fukushima Future Ctr Reg Revitalizat, Fukushima, Japan.	r644@ipc.fukushima-u.ac.jp					COMANS RNJ, 1992, GEOCHIM COSMOCHIM AC, V56, P1157, DOI 10.1016/0016-7037(92)90053-L; Fukuyama T, 2004, SCI TOTAL ENVIRON, V318, P187, DOI 10.1016/S0048-9697(03)00366-8; IAEA, 2010, IAEA TECHN REP SER, V472; Kamei-Ishikawa N., 2008, J NUCL SCI TECHNOL, V6, P146; Komamura M, 2005, MISCELLANEOUS PUBLIC, V28, P1; Rosen K, 1999, J ENVIRON RADIOACTIV, V46, P45, DOI 10.1016/S0265-931X(99)00040-5; Tsukada H, 2002, J ENVIRON RADIOACTIV, V59, P351, DOI 10.1016/S0265-931X(01)00083-2; Tsukada H, 2002, J RADIOANAL NUCL CH, V252, P219, DOI 10.1023/A:1015789500124	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1533	1537		10.1007/s10967-014-3685-x		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200090		
J	Oya, Y; Uchimura, H; Toda, K; Ikka, T; Morita, A; Okuno, K				Oya, Yasuhisa; Uchimura, Hiromichi; Toda, Kensuke; Ikka, Takashi; Morita, Akio; Okuno, Kenji			Dissolution behavior of Cs-137 absorbed on the green tea leaves	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Cesium-137; Tea leaves; Dissolution		The green tea leaf was dipped in the (CsCl)-Cs-137 solution to elucidate the dissolution behavior of Cs-137. The IP observation showed that Cs-137 was not uniformly adsorbed on the tea leaf, even if the tea leaf was dipped in the homogeneous solution. The activation energy of Cs-137 dissolution was estimated to be 0.045 eV, indicating that most of Cs-137 would exist as the adsorbed state. The dissolution behaviors as a function of cesium and potassium concentrations and pH, were also studied.	[Oya, Yasuhisa; Uchimura, Hiromichi; Toda, Kensuke; Okuno, Kenji] Shizuoka Univ, Grad Sch Sci, Suruga Ku, Shizuoka 4228529, Japan; [Ikka, Takashi; Morita, Akio] Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan	Oya, Y (reprint author), Shizuoka Univ, Grad Sch Sci, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	syoya@ipc.shizuoka.ac.jp			Chubu Electric Co. Ltd.	This study has been supported by Chubu Electric Co. Ltd.	Tagami K, 2012, J ENVIRON RADIOACTIV, V111, P65, DOI 10.1016/j.jenvrad.2011.09.017; Furuta E, 2013, J RADIOANAL NUCL CH, V297, P337, DOI 10.1007/s10967-012-2343-4; Makoto Yanaga, 2013, RAD SAF MANAG, V12, P16; Tagami K, 2012, J RADIOANAL NUCL CH, V292, P243, DOI 10.1007/s10967-011-1398-y; Tatsuya Tsuboi, 2012, RADIAT SAF MANAG, V11, P11	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1539	1542		10.1007/s10967-014-3549-4		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200091		
J	Arisaka, M; Watanabe, M; Ishizaki, M; Kurihara, M; Chen, RZ; Tanaka, H				Arisaka, Makoto; Watanabe, Masayuki; Ishizaki, Manabu; Kurihara, Masato; Chen, Rongzhi; Tanaka, Hisashi			Cesium adsorption ability and stability of metal hexacyanoferrates irradiated with gamma rays	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Cesium; Metal hexacyanoferrate; Gamma-ray irradiation; Adsorption ability; Stability	WASTE-WATER; NANOPARTICLES; REMOVAL	The cesium (Cs) adsorption ability and stability of metal hexacyanoferrates (MHCFs: M = Fe, Cu, Ni) in HNO3 solutions were investigated as a function of the absorbed dose resulting from irradiation with gamma rays.	[Arisaka, Makoto; Watanabe, Masayuki] Japan Atom Energy Agcy, Res Grp Radiochem, Nucl Sci & Engn Directorate, Tokai, Ibaraki, Japan; [Ishizaki, Manabu; Kurihara, Masato] Yamagata Univ, Fac Sci, Dept Mat & Biol Chem, Yamagata 990, Japan; [Chen, Rongzhi; Tanaka, Hisashi] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki, Japan	Arisaka, M (reprint author), Japan Atom Energy Agcy, Res Grp Radiochem, Nucl Sci & Engn Directorate, Tokai, Ibaraki, Japan.	arisaka.makoto@jaea.go.jp					Chen RZ, 2012, ELECTROCHEM COMMUN, V25, P23, DOI 10.1016/j.elecom.2012.09.012; Ishizaki M, 2013, DALTON T, V42, P16049, DOI 10.1039/c3dt51637g; Ishizaki M, 2011, MOL CRYST LIQ CRYST, V539, P18, DOI 10.1080/15421406.2011.566024; Chen RZ, 2013, ELECTROCHIM ACTA, V87, P119, DOI 10.1016/j.electacta.2012.08.124; CROFF AG, 1983, NUCL TECHNOL, V62, P335; Gotoh A, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345609; International Atomic Energy Agency, 1992, INT AT EN AG TECHN R, V337; International Atomic Energy Agency, 1985, INT AT EN AG TECHN R, V257	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1543	1547		10.1007/s10967-014-3710-0		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200092		
J	Nogami, M; Haratani, T; Tachibana, Y; Kaneshiki, T; Nomura, M; Suzuki, T				Nogami, Masanobu; Haratani, Tomohiro; Tachibana, Yu; Kaneshiki, Toshitaka; Nomura, Masao; Suzuki, Tatsuya			Adsorptivity of various metal ions onto benzo-18-crown-6 and dibenzo-18-crown-6 resins	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Benzo-18-crown-6; Dibenzo-18-crown-6; Resin; Nuclide separation	ZINC ISOTOPE-SEPARATION; SELECTIVE EXTRACTION	Adsorptivity of metal ions onto silica-supported benzo-18-crown-6 (B18C6) and dibenzo-18-crown-6 (DB18C6) resins was investigated in nitric acid and hydrochloric acid media to evaluate the applicability of these resins for selective separation of nuclides from radioactive waste solutions. Both resins adsorbed Pd(II) and Ag(I) from HNO3, and Fe(III) and Ba(II) from HCl. It was also found that the B18C6 and DB18C6 resins adsorbed Sr(II) from HCl and Ca(II) from HNO3, respectively. This indicates that the two resins adsorb metal ions with smaller cationic diameters with different selectivity. This behavior is different from other impregnated adsorbents and extractants containing the 18-crown-6 moiety.	[Nogami, Masanobu; Haratani, Tomohiro] Kinki Univ, Dept Elect & Elect Engn, Higashiosaka, Osaka 577, Japan; [Tachibana, Yu; Suzuki, Tatsuya] Nagaoka Univ Technol, Dept Nucl Syst Safety Engn, Nagaoka, Niigata 94021, Japan; [Kaneshiki, Toshitaka; Nomura, Masao] Tokyo Inst Technol, Res Labs Nucl Reactors, Tokyo 152, Japan	Nogami, M (reprint author), Kinki Univ, Dept Elect & Elect Engn, Higashiosaka, Osaka 577, Japan.	mnogami@ele.kindai.ac.jp			KAKENHI [23360423]	This work was partially supported by a Grant-in-Aid for Scientific Research (B) (KAKENHI No. 23360423).	Agrawal YK, 2001, SEP PURIF TECHNOL, V24, P197, DOI 10.1016/S1383-5866(00)00231-8; Hayasaka K, 2008, PROG NUCL ENERG, V50, P510, DOI 10.1016/j.pnucene.2007.11.086; Yaftian MR, 2005, SEP PURIF TECHNOL, V42, P175, DOI 10.1016/j.seppur.2004.07.011; HORWITZ EP, 1992, SOLVENT EXTR ION EXC, V10, P313, DOI 10.1080/07366299208918107; Ding X, 2007, J RADIOANAL NUCL CH, V273, P79, DOI 10.1007/s10967-007-0714-z; Ding XC, 2006, J CHROMATOGR A, V1113, P182, DOI 10.1016/j.chroma.2006.02.015; El-Hefny NE, 2011, INT J MINER PROCESS, V101, P58, DOI 10.1016/j.minpro.2011.07.013; Gupta KK, 2003, SOLVENT EXTR ION EXC, V21, P53, DOI 10.1081/SEI-120017547; KINARD WF, 1980, SEPAR SCI TECHNOL, V15, P1013, DOI 10.1080/01496398008076284; Nogami M, 2010, J RADIOANAL NUCL CH, V284, P195, DOI 10.1007/s10967-010-0465-0; SEKO M, 1980, NUCL TECHNOL, V50, P178; WANG WJ, 1983, J RADIOANAL CHEM, V76, P49; Wu Y, 2012, J NUCL SCI TECHNOL, V49, P320, DOI 10.1080/00223131.2012.660022	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1549	1553		10.1007/s10967-014-3555-6		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200093		
J	Oura, Y; Ebihara, M; Tsuruta, H; Nakajima, T; Ohara, T; Ishimoto, M; Katsumura, Y				Oura, Yasuji; Ebihara, Mitsuru; Tsuruta, Haruo; Nakajima, Teruyuki; Ohara, Toshimasa; Ishimoto, Mitsunori; Katsumura, Yosuke			Determination of atmospheric radiocesium on filter tapes used at automated SPM monitoring stations for estimation of transport pathways of radionuclides from Fukushima Dai-ichi Nuclear Power Plant	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Fukushima Dai-ichi Nuclear Power Plant accident; Cs-137; Automated air pollution monitoring station; Filter tape; Suspended particulate matter	ACCIDENT; JAPAN	Suspended particulate matters (SPM) collected hourly at that time of Fukushima Dai-ichi Nuclear Plant accident in 2011 on a filter tape at many automated SPM monitoring stations located widely in eastern Japan was analyzed in order to determine atmospheric radiocesium concentration. Precise time series of Cs-137 concentrations in wide areas of eastern Japan were revealed. Analysis of radioactivity of SPM collected on filter tapes by automated SPM monitoring stations even at 1-2 years after the accident is concluded to give very valuable information to resolve the matter of radioactive contamination by Fukushima accident.	[Oura, Yasuji; Ebihara, Mitsuru] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Tsuruta, Haruo; Nakajima, Teruyuki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Ohara, Toshimasa] Natl Inst Environm Studies, Fukushima Project Off, Tsukuba, Ibaraki 3058506, Japan; [Ishimoto, Mitsunori; Katsumura, Yosuke] Univ Tokyo, Nucl Profess Sch, Tokai, Ibaraki 3191195, Japan	Oura, Y (reprint author), Tokyo Metropolitan Univ, Dept Chem, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	oura-yasuji@tmu.ac.jp	Nakajima, Teruyuki/H-2370-2013	Nakajima, Teruyuki/0000-0002-9042-504X			Amano H, 2011, J ENVIRON RADIOACTIV, V111, P42; Furuta S, 2011, JAEA REV, P2011; Haba H, 2012, GEOCHEM J, V46, P271; Nagaoka K, 2012, HEALTH PHYS, V102, P437, DOI 10.1097/HP.0b013e31823bc2d3; Nakagawa Y, 2011, RADIOISOTOPES, V60, P467, DOI 10.379/Radioisotopes.60.467	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1555	1559		10.1007/s10967-014-3662-4		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200094		
J	Kofuji, H				Kofuji, Hisaki			In situ measurement of Cs-134 and Cs-137 in seabed using underwater gamma-spectrometry systems: application in surveys following the Fukushima Dai-ichi Nuclear Power Plant accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						In situ gamma-spectrometry; Radiocesium; Marine sediment; Fukushima Dai-ichi Nuclear Power Plant accident	RADIONUCLIDES	Two underwater gamma-spectrometric systems incorporating NaI(Tl) detectors (the seabed mooring system and the towing system) were used to measure radiocesium in seabed that was released due to the Fukushima Dai-ichi Nuclear Power Plant (FDNPP) accident and assess the accuracy of in situ measurements on seabed. We also applied a simple calculating method for seabed radiocesium by separating the gamma-spectra based on four contributions (Cs-134 + Cs-137, K-40, U-series, and Th-series radionuclides). The concentration of Cs-134 + Cs-137 in sediments at two sites in Sendai Bay were calculated to be between 10-250 Bq/kg-dry through our method with a short integration time (1-5 min).	Japan Marine Sci Fdn, Mutsu, Aomori 0350064, Japan	Kofuji, H (reprint author), Japan Marine Sci Fdn, Minato Machi, Mutsu, Aomori 0350064, Japan.	kofuji@jmsfmml.or.jp			Watanabe Memorial Foundation for the Advancement of Technology	We thank Dr. M. Okano for his advice regarding procedures for field-testing of underwater systems and our data analysis methods. We also thank Prof. S. Nagao for the suggestion to conduct field tests of the seabed mooring system. This work was supported by a Grant-in-Aid from the Watanabe Memorial Foundation for the Advancement of Technology.	Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Oikawa S, 2013, BIOGEOSCIENCES, V10, P5031, DOI 10.5194/bg-10-5031-2013; Kusakabe M, 2013, BIOGEOSCIENCES, V10, P5019, DOI 10.5194/bg-10-5019-2013; Hirayama H., 2005, SLACR730 KEK; Kofuji H, 2005, KEK P 2005 4 TSUK 8; Thornton B, 2013, MAR POLLUT BULL, V74, P344, DOI 10.1016/j.marpolbul.2013.06.031; Thornton B, 2013, DEEP-SEA RES PT I, V79, P10, DOI 10.1016/j.dsr.2013.05.001	7	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1575	1579		10.1007/s10967-014-3702-0		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200098		
J	Kikunaga, H; Takamiya, K; Hirose, K; Ohtsuki, T				Kikunaga, H.; Takamiya, K.; Hirose, K.; Ohtsuki, T.			Comparison of the decay constants of Cr-51 with metal, oxide, and chromate chemical states	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Half-life; Decay constant; Chemical effect; Radionuclide Cr-51		Chromium-51 decays through electron capture, the probability ofwhich is perturbed by its electronic state. We have precisely measured the decay constants (lambda) of Cr-51 with metal (Cr-0), oxide (Cr3+), and chromate (Cr6+) to investigate the effects of chemical states on the decay constants of Cr-51. The value of {lambda(Cr6+) - lambda(Cr-0)}/lambda(Cr-0) was determined to be (6.4 +/- 3.7) x 10(-4), whereas the difference less than 1.4 x 10(-4) was observed for {lambda(Cr3+) -lambda(Cr-0)}/lambda(Cr-0).	[Kikunaga, H.; Hirose, K.; Ohtsuki, T.] Tohoku Univ, Res Ctr Elect Photon Sci, Sendai, Miyagi 980, Japan	Kikunaga, H (reprint author), Tohoku Univ, Res Ctr Elect Photon Sci, Sendai, Miyagi 980, Japan.	kikunaga@lns.tohoku.ac.jp			JSPS KAKENHI [24740136]	The authors would like to thank the technical staff of Research Center for Electron Photon Science, Tohoku University for their excellent operation of the accelerators. This work was supported by JSPS KAKENHI Grant Number 24740136.	EMERY GT, 1972, ANNU REV NUCL PART S, V22, P165, DOI 10.1146/annurev.ns.22.120172.001121; Firestone R.B., 1996, TABLE ISOTOPES; Kakiuchi S., 1981, Bulletin of the Institute for Chemical Research, Kyoto University, V59; Kikunaga H, 2011, P RADIOCHIM ACTA, V1, P113; Ohtsuki T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.112501	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1581	1583		10.1007/s10967-014-3570-7		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200099		
J	Saito, T; Takahashi, K; Makino, T; Tsukada, H; Sato, M; Yoshioka, K				Saito, Takashi; Takahashi, Kazuhira; Makino, Tomoyuki; Tsukada, Hirofumi; Sato, Mutsuto; Yoshioka, Kunio			Effect of application timing of potassium fertilizer on root uptake of Cs-137 in brown rice	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Cs-137; Brown rice; Potassium fertilizer; Soil-to-brown rice transfer factor; Exchangeable K; Exchangeable Cs-137	SOIL	We investigated the optimal timing and quantity of K to reduce radiocesium in brown rice. The concentration of Cs-137 in brown rice was reduced from 32 Bq kg(-1) without K fertilizer to 2.0 Bq kg(-1) with 16 g m(-2) of basal K. The concentration of exchangeable Cs-137 in the soil decreased from 234 to 25 Bq kg(-1) with increasing application of K fertilizer from 0 to 57 g m(-2). Hence, heavy application of K fertilizer in the early growing period can decrease the uptake of Cs-137 by rice plants and the concentration of exchangeable Cs-137 in the soil.	[Saito, Takashi; Takahashi, Kazuhira; Sato, Mutsuto; Yoshioka, Kunio] Fukushima Agr Technol Ctr, Agroenvironm Div, Koriyama, Fukushima 9630531, Japan; [Makino, Tomoyuki] Natl Inst Agroenvironm Sci, Soil Environm Div, Tsukuba, Ibaraki 3058604, Japan; [Tsukada, Hirofumi] Fukushima Univ, Fukushima Future Ctr Reg Revitalizat, Fukushima 9601296, Japan	Saito, T (reprint author), Fukushima Agr Technol Ctr, Agroenvironm Div, 116 Shimonakamichi,Hiwada Machi, Koriyama, Fukushima 9630531, Japan.	saito_takashi_01@pref.fukushima.lg.jp					Tanaka K, 2012, GEOCHEM J, V46, P73; Kato N, 2012, INT SCI S COMB RAD C, P317; Saito T, 2012, EFFECT POTASSIUM APP, P165; Takata Y, 2012, INT SCI S COMB RAD C, P362; Tsukada H., 2012, PEDOLOGIST, V55, P435; Tsukada H, 2002, J ENVIRON RADIOACTIV, V59, P351, DOI 10.1016/S0265-931X(01)00083-2; VANBERGEIJK KE, 1992, J ENVIRON RADIOACTIV, V15, P265, DOI 10.1016/0265-931X(92)90062-X; Wang CJ, 1997, APPL RADIAT ISOTOPES, V48, P301, DOI 10.1016/S0969-8043(96)00178-9	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1585	1587		10.1007/s10967-014-3609-9		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200100		
J	Dote, H; Yasuhara, H; Nakashima, S				Dote, Haruka; Yasuhara, Hiroki; Nakashima, Satoru			Crystal structure and spin state of mixed-crystals of iron with NCS and NCBH3 for the assembled complexes bridged by 1,3-bis(4-pyridyl)propanes	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Mossbauer spectroscopy; Mixed crystals; Spin-crossover; Assembled complexes	COORDINATION POLYMER; NETWORK; SOLIDS	New mixed crystals, Fe(NCS) (x) (NCBH3)((2-x))(bpp)(2), (bpp = 1,3-bis(4-pyridyl)propane) were synthesized. The formation of mixed crystals was confirmed by powder X-ray diffraction patterns and single crystal X-ray structural analysis. Elemental analyses showed that all Fe(NCS) (x) (NCBH3)((2-x))(bpp)(2) samples had more Fe(NCS)(2) unit than the preparation fraction. Fe-57 Mossbauer spectroscopy revealed that all the spectra consist of only Fe(NCS)(2) unit and Fe(NCBH3)(2) unit. And the fraction of low-spin state in the Fe(NCBH3)(2) unit changed with the change of x. The results suggested that the high spin site of Fe(NCS)(2) unit affects the spin state of Fe(NCBH3)(2) unit.	[Dote, Haruka; Yasuhara, Hiroki] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398530, Japan; [Nakashima, Satoru] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev N BARD, Higashihiroshima 7398530, Japan	Dote, H (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Chem, 1-3-1 Kagamiyama, Higashihiroshima 7398530, Japan.	d110135@hiroshima-u.ac.jp; snaka@hiroshima-u.ac.jp					SUBRAMANIAN S, 1995, ANGEW CHEM INT EDIT, V34, P2127, DOI 10.1002/anie.199521271; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; Biradha K, 1999, ANGEW CHEM INT EDIT, V38, P492, DOI 10.1002/(SICI)1521-3773(19990215)38:4<492::AID-ANIE492>3.0.CO;2-#; Atsuchi M, 2011, INORG CHIM ACTA, V370, P82, DOI 10.1016/j.ica.2011.01.028; Atsuchi M, 2007, CHEM LETT, V36, P1064, DOI 10.1246/cl.2007.1064; Carlucci L, 1999, CHEM COMMUN, P449, DOI 10.1039/a809361j; CARLUCCI L, 1994, J CHEM SOC CHEM COMM, P2755, DOI 10.1039/c39940002755; GARDNER GB, 1995, NATURE, V374, P792, DOI 10.1038/374792a0; Gudbjartson H, 1999, J AM CHEM SOC, V121, P2599, DOI 10.1021/ja982577a; Nakashima S, 2010, J PHYS CONF SER, V217, DOI 10.1088/1742-6596/217/1/012035; Zheng L-M, 1999, J CHEM SOC DA, V14, P2311, DOI 10.1039/A809738K	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1589	1593		10.1007/s10967-014-3676-y		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200101		
J	Nomura, R; Inoue, M; Kofuji, H				Nomura, Ritsuo; Inoue, Mutsuo; Kofuji, Hisaki			Inspection of residual flow using Ra-224/Ra-228 ratios in the semi-closed water body of Nakaumi, a coastal lagoon in southwest Japan	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Brackish water; Lake Nakaumi; Ra-224/Ra-228 ratio; Ra-228/Ra-226 ratio; Anticlockwise eddy circulation	GROUNDWATER INPUT; RADIUM ISOTOPES	In order to investigate the water circulation, we examined Ra-228/Ra-226 and Ra-224/Ra-228 activity ratios of a man-made semi-closed brackish water body in Lake Nakaumi, southwest Japan. The Ra-224/Ra-228 ratios in the surface water were observed to be the lowest (0.02) in the central area, while those in the surrounding waters were higher (similar to 0.1), thus suggesting the occurrence of an anticlockwise eddy circulation. The Ra-224/Ra-228 ratios in the deep waters were relatively uniform, but a basin-wide anticlockwise flow of water was also indicated.	[Nomura, Ritsuo] Shimane Univ, Foraminiferal Lab, Fac Educ, Matsue, Shimane 6908504, Japan; [Inoue, Mutsuo] Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan; [Kofuji, Hisaki] Japan Marine Sci Fdn, Mutsu Marine Lab, Mutsu, Aomori 0350064, Japan	Nomura, R (reprint author), Shimane Univ, Foraminiferal Lab, Fac Educ, Matsue, Shimane 6908504, Japan.	nomura@edu.shimane-u.ac.jp			 [21340147];  [25287138]	One of authors (R.N.) appreciates Mr. S. Ikeda for kind help in both field and laboratory works. This work was supported by the Japanese Grant-in Aid for Scientific Research (B) (R. Nomura, Nos. 21340147, 25287138).	Moore WS, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003041; Swarzenski PW, 2007, MAR CHEM, V104, P69, DOI 10.1016/j.marchem.2006.08.001; Krest JM, 1999, MAR CHEM, V64, P129, DOI 10.1016/S0304-4203(98)00070-X; Moore WS, 2000, CONT SHELF RES, V20, P1993, DOI 10.1016/S0278-4343(00)00054-6; Kelly RP, 2002, LIMNOL OCEANOGR, V47, P1796; BOLLINGER MS, 1993, GEOCHIM COSMOCHIM AC, V57, P2203, DOI 10.1016/0016-7037(93)90562-B; Katsuki K, 2008, J PALEOLIMNOL, V40, P1115, DOI 10.1007/s10933-008-9217-3; Nomura R, 2013, APPL RADIAT ISOTOPES, V81, P310, DOI 10.1016/j.apradiso.2013.03.069; Nomura Ritsuo, 2002, Journal of the Geological Society of Japan, V108, P394; Nomura Ritsuo, 2003, Journal of the Geological Society of Japan, V109, P197; Ohta Tomoko, 2004, Radioisotopes, V53, P1; The Oceanography Course Team, 1999, WAV TID SHALL WAT PR	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1595	1599		10.1007/s10967-014-3680-2		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200102		
J	Minowa, H				Minowa, Haruka			Image analysis of radiocesium distribution in coniferous trees two years after the Fukushima Daiichi Nuclear Power Plant accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radiocesium; Autoradiography; Coniferous trees; Tree leaves; Fukushima Daiichi Nuclear Power Plant	RADIONUCLIDES; JAPAN	For the investigation of the characteristics and behavior of fallout deposits of the accident at the Fukushima Daiichi Nuclear Power Plant (NPP) in March 2011, autoradiographic imaging was used to examine tree leaves, branches, and barks from locations at 10-60 km south of the Fukushima Daiichi NPP. The autoradiographs revealed particulate contamination in many old leaf samples; few contaminations were present in current-year leaves. Although no particulate contamination was observed on leaves that had grown after the accident, a relatively small amount of radiocesium had become incorporated in the upper leaves of the sampled branches.	Jikei Univ, Sch Med, Radioisotope Res Facil, Minato Ku, Tokyo 1058461, Japan	Minowa, H (reprint author), Jikei Univ, Sch Med, Radioisotope Res Facil, Minato Ku, 3-25-8,Nishi shinbashi, Tokyo 1058461, Japan.	minowa@jikei.ac.jp					Tanaka K, 2013, J RADIOANAL NUCL CH, V295, P2007, DOI 10.1007/s10967-012-2192-1; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Haba H, 2012, GEOCHEM J, V46, P271; Katata G, 2012, J ENVIRON RADIOACTIV, V109, P103, DOI 10.1016/j.jenvrad.2012.02.006; Sakamoto F, 2013, AT ENERGY SOC JPN, V12, P257	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1601	1605		10.1007/s10967-014-3817-3		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200103		
J	Saito, T; Kurihara, Y; Koike, Y; Tanihata, I; Fujiwara, M; Sakaguchi, H; Shinohara, A; Yamamoto, H				Saito, T.; Kurihara, Y.; Koike, Y.; Tanihata, I.; Fujiwara, M.; Sakaguchi, H.; Shinohara, A.; Yamamoto, H.			Altitude distribution of radioactive cesium at Fuji volcano caused by Fukushima Daiichi Nuclear Power Station accident	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Fukushima Daiichi Nuclear Power Station accident; Radioactive cesium; Altitude distribution; Mt. Fuji; Global fallout		Altitude distributions of radioactive cesium (Cs-134 and Cs-137) fallout at Mt. Fuji due to Fukushima Daiichi Nuclear Power Station accident have been investigated. Radioactive cesium from Fukushima Daiichi Nuclear Power Station is found to reach the height of 2,700 m. It is inferred that some amounts of radioactive cesium are attributable to the global fallout due to the nuclear weapons tests in the atmosphere.	[Saito, T.] Shokei Gakuin Univ, Fac Comprehens Human Sci, Natori, Miyagi 9811295, Japan; [Kurihara, Y.; Koike, Y.] Meiji Univ, Sch Sci & Technol, Tama Ku, Kawasaki, Kanagawa 2148571, Japan; [Tanihata, I.; Fujiwara, M.; Sakaguchi, H.] Osaka Univ, Nucl Phys Res Ctr, Osaka, Ibaraki 5670047, Japan; [Shinohara, A.] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Yamamoto, H.] Osaka Univ, Dept Adm Safety & Hyg, Suita, Osaka 5650871, Japan	Saito, T (reprint author), Shokei Gakuin Univ, Fac Comprehens Human Sci, 4-10-1 Yurigaoka, Natori, Miyagi 9811295, Japan.	t_saito@shokei.ac.jp			MEXT KAKENHI [24110009]; JSPS KAKENHI [24510074]	This work was supported by MEXT KAKENHI Grant Number 24110009, and JSPS KAKENHI Grant Number 24510074.	Abe S, 1989, RADIOL SCI, V34, P109; KURIHARA Y, 2007, RADIOISOTOPES, V56, P795; Kurihara Y, 2011, P RADIOCHIM ACTA, V1, P335; Nakamura T, 1986, VOLCANOL SOC JPN, V31, P253; SATO J, 1977, GEOCHEM J, V11, P49; UNSCEAR, 2000, 2000 REP GEN ASS SCI	6	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1613	1615		10.1007/s10967-014-3753-2		3	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200105		
J	Nagao, S; Kanamori, M; Ochiai, S; Inoue, M; Yamamoto, M				Nagao, Seiya; Kanamori, Masaki; Ochiai, Shinya; Inoue, Mutsuo; Yamamoto, Masayoshi			Migration behavior of Cs-134 and Cs-137 in the Niida River water in Fukushima Prefecture, Japan during 2011-2012	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radiocesium; Dissolved; Particulate; Rain events	NUCLEAR-POWER-PLANT; RADIOCESIUM; ACCIDENT; CHERNOBYL; SYSTEMS; CS	Total radioactivity of Cs-137 in water samples from the Niida River was 0.025-4.18 Bq/L during May 2011-November 2012. Higher radioactivity was found during May-September 2011 and after a high flow condition caused by a rain event in 2012. The particulate phase of Cs-134 and Cs-137 was 47-48 % for May-September 2011, 75-93 % in normal flow conditions and 86-91 % in high flow conditions after December 2011. These results indicate that the supply of Cs-134 and Cs-137 from the watershed differs from the early stage up to September 2011 and from the last stage.	[Nagao, Seiya; Ochiai, Shinya; Inoue, Mutsuo; Yamamoto, Masayoshi] Kanazawa Univ, Inst Nat & Environm Technol, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan; [Kanamori, Masaki] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Nagao, S (reprint author), Kanazawa Univ, Inst Nat & Environm Technol, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan.	nagao37@staff.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24310009, 24110008]	This study was partly funded by a Grant-in-Aid for Scientific Research No. 24310009 and 24110008 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Sakaguchi A, 2012, GEOCHEM J, V46, P355; MATSUNAGA T, 1991, APPL GEOCHEM, V6, P159, DOI 10.1016/0883-2927(91)90026-L; Nagao S, 2013, BIOGEOSCIENCES, V10, P6215, DOI 10.5194/bg-10-6215-2013; Kaneyasu N, 2012, ENVIRON SCI TECHNOL, V46, P5720, DOI 10.1021/es204667h; Tanaka K, 2013, J RADIOANAL NUCL CH, V295, P1927, DOI 10.1007/s10967-012-2160-9; Ueda S, 2013, J ENVIRON RADIOACTIV, V118, P96, DOI 10.1016/j.jenvrad.2012.11.009; Chartin C., 2013, ANTHROPOCENE, V1, P23; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Fukushima Prefectural Government, 2012, REP INF WAT AR RIV P, P211; Fukushima Prefectural Government, 2012, DAT WAT DISCH NIID R; Madruga MJ, 1997, WATER AIR SOIL POLL, V99, P201, DOI 10.1023/A:1018361121952; Matsunaga T, 1998, J CONTAM HYDROL, V35, P101, DOI 10.1016/S0169-7722(98)00119-3; Nagao S, 2013, PROG NUCL SCI TECHNO, V4, P9; Nuclear Emergency Response Headquarters (NERH) Government of Japan, 2011, REP JAP GOV IAEA MIN; Nuclear Regulation Agency in Japan, 2013, MON INF ENV RAD LEV; Roig M, 2007, J ENVIRON QUAL, V36, P943, DOI 10.2134/jeq2006.0402; Sansone U, 1996, SCI TOTAL ENVIRON, V186, P257, DOI 10.1016/0048-9697(96)05120-0; Voitsekhovitch O, 1997, STUD ENVIRON SCI, V68, P75	18	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	2015	303	2					1617	1621		10.1007/s10967-014-3686-9		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AZ4LJ	WOS:000348192200106		
J	Mishra, S; Arae, H; Sorimachi, A; Hosoda, M; Tokonami, S; Ishikawa, T; Sahoo, SK				Mishra, Suchismita; Arae, Hideki; Sorimachi, Atsuyuki; Hosoda, Masahiro; Tokonami, Shinji; Ishikawa, Tetsuo; Sahoo, Sarata Kumar			Distribution and retention of Cs radioisotopes in soil affected by Fukushima nuclear plant accident	JOURNAL OF SOILS AND SEDIMENTS			English	Article						Cs radioisotopes; Distribution coefficient; FDNPP; Retention; Soil characteristics; Sorption	RADIONUCLIDES; CESIUM; SORPTION; CS-137; ACCUMULATION; SPECIATION; STRONTIUM	There was a large release of radio-cesium (Cs-134 and Cs-137) to the atmosphere during the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident, and contaminated the soil, over a vast area, due to fallout activity. Therefore, studies on the behaviour of radio-cesium especially migration in soil and its retention on soil particles is very important for external dose assessment and root uptake. We have determined the sorption coefficient (K (d)) for Cs using the laboratory batch method in soil samples collected from a contaminated area affected by the FDNPP accident, and the effect of various soil parameters on the K (d) value has been studied. We have noticed that Cs sorption is mostly influenced by cation exchange process and Cs is sorbed on the surface of clay particles. From vertical depth profile of Cs in soil, it is found that most of it is retained on the top layer within a 5-cm thickness. Sequential extraction of soil using various reagents may be helpful to understand better the mechanism of Cs retention.	[Mishra, Suchismita; Arae, Hideki; Sahoo, Sarata Kumar] Natl Inst Radiol Sci, Project Environm Dynam & Radiat Effects, Inage Ku, Chiba 2638555, Japan; [Mishra, Suchismita] Bhabha Atom Res Ctr, Environm Monitoring & Assessment Sect, Bombay 400085, Maharashtra, India; [Sorimachi, Atsuyuki; Ishikawa, Tetsuo] Fukushima Med Univ, Fukushima 9601295, Japan; [Hosoda, Masahiro] Hirosaki Univ, Grad Sch Hlth Sci, Aomori 0368564, Japan; [Tokonami, Shinji] Hirosaki Univ, Inst Radiat Emergency Med, Aomori 0368564, Japan	Sahoo, SK (reprint author), Natl Inst Radiol Sci, Project Environm Dynam & Radiat Effects, Inage Ku, Anagawa 4-9-1, Chiba 2638555, Japan.	sahoo@nirs.go.jp			Japan Society for the Promotion of Science [P11503]; Japan Society for the Promotion of Science	This research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (P11503). SM is thankful to the Japan Society for the Promotion of Science for the award of postdoctoral fellowship.	Tamponnet C, 2008, J ENVIRON RADIOACTIV, V99, P820, DOI 10.1016/j.jenvrad.2007.10.011; Kim Y, 1996, GEOCHIM COSMOCHIM AC, V60, P1041, DOI 10.1016/0016-7037(95)00452-1; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Bondar YI, 2001, RADIOCHEMISTRY, V43, P643, DOI 10.1023/A:1014828429276; Cha HJ, 2006, J RADIOANAL NUCL CH, V267, P349, DOI 10.1007/s10967-006-0054-4; Giannakopoulou F, 2007, J HAZARD MATER, V149, P553, DOI 10.1016/j.jhazmat.2007.06.109; Hakem NL, 2000, J RADIOANAL NUCL CH, V246, P275, DOI 10.1023/A:1006701902891; Hosoda Masahiro, 2013, Sci Rep, V3, P2283, DOI 10.1038/srep02283; Kakiuchi H, 2002, J RADIOANAL NUCL CH, V252, P437, DOI 10.1023/A:1015703430592; Kamel NHM, 2002, J RADIOANAL NUCL CH, V254, P421, DOI 10.1023/A:1021669500684; Konya J, 2005, J COLLOID INTERF SCI, V290, P350; Lee CP, 2008, J RADIOANAL NUCL CH, V275, P115, DOI 10.1007/s10967-007-6988-3; Li RY, 2004, SOIL SCI, V169, P374, DOI 10.1097/01.ss.0000128012.07644.a8; Lujaniene G., 2006, Lithuanian Journal of Physics, V46; Mishra S, 2012, RADIAT PROT DOSIM, V152, P238, DOI 10.1093/rpd/ncs230; Nikolova I, 2000, J ENVIRON RADIOACTIV, V47, P319, DOI 10.1016/S0265-931X(99)00048-X; Vandenhove H, 2009, J ENVIRON RADIOACTIV, V100, P697, DOI 10.1016/j.jenvrad.2009.03.014; Watanabe T, 2012, GEOCHEM J, V46, P279; Yoshida N, 2012, ELEMENTS, V8, P201, DOI 10.2113/gselements.8.3.201	19	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1439-0108	1614-7480		J SOIL SEDIMENT	J. Soils Sediments	FEB	2015	15	2					374	380		10.1007/s11368-014-0985-2		7	Geosciences, Multidisciplinary; Soil Science	Geology; Agriculture	AZ3MN	WOS:000348131800012		
J	Alkhair, M; Sulaiman, MY; Sopian, K; Lim, CH; Salleh, E; Mat, S; Saha, BB				Alkhair, M.; Sulaiman, M. Y.; Sopian, K.; Lim, C. H.; Salleh, E.; Mat, S.; Saha, B. B.			Design and Modeling of One Refrigeration Ton Solar Assisted Adsorption Air Conditioning System	JOURNAL OF SOLAR ENERGY ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						solar energy; adsorption air conditioning; activated carbon fiber/ethanol; cooling load	PERFORMANCE; CHILLER; COLLECTOR; PREDICTION; SIMULATION; STORAGE; DRIVEN; BED	The modeling of the performance of a one refrigeration ton (RT) solar assisted adsorption air-conditioning refrigeration system using activated carbon fiber/ethanol as the adsorbent/adsorbate pair has been undertaken in this study. The effects of hot water, cooling water, chilled water inlet temperatures, and hot water and chilled water flow rates were taken into consideration in the optimization of the system and in the design of the condenser, evaporator, and hot water storage tank. The study includes analysis of the weather data and its effect on both the adsorption system and the cooling load. This is then followed by estimation of the cooling capacity and coefficient of performance (COP) of the adsorption system as a function of the input parameters. The results of the model will be compared to experimental data in a next step.	[Alkhair, M.; Sulaiman, M. Y.; Sopian, K.; Lim, C. H.; Salleh, E.; Mat, S.] Univ Kebangsaan Malaysia, SERI, Bangi 43600, Selangor, Malaysia; [Saha, B. B.] Kyushu Univ, Program Leading Grad Sch, Green Asia Educ Ctr, Kasuga, Fukuoka 8168580, Japan	Alkhair, M (reprint author), Univ Kebangsaan Malaysia, SERI, Bangi 43600, Selangor, Malaysia.	dr.alkhair@yahoo.com	Sopian, Kamaruzzaman/A-3850-2009; 	Sopian, Kamaruzzaman/0000-0002-4675-3927	Government of Malaysia; Universiti Kebangsaan Malaysia (UKM)	This work was carried out under the Prototype Development Research Grant Scheme 2011, and we would like to thank the Government of Malaysia and Universiti Kebangsaan Malaysia (UKM) for the financial support.	Aghbalou F, 2004, APPL THERM ENG, V24, P2537, DOI 10.1016/j.applthermaleng.2004.04.009; Aktacir MA, 2010, APPL ENERG, V87, P599, DOI 10.1016/j.apenergy.2009.05.008; Anyanwu EE, 2007, APPL THERM ENG, V27, P2514, DOI 10.1016/j.applthermaleng.2007.02.002; Luo HL, 2007, SOL ENERGY, V81, P607, DOI 10.1016/j.solener.2006.09.001; Sumathy K, 2003, PROG ENERG COMBUST, V29, P301, DOI 10.1016/S0360-1285(03)00028-5; El-Sharkawy II, 2008, INT J REFRIG, V31, P1407, DOI 10.1016/j.ijrefrig.2008.03.012; Khattab NM, 2006, SOL ENERGY, V80, P823, DOI 10.1016/j.solener.2005.05.018; Luo HL, 2006, APPL THERM ENG, V26, P1218, DOI 10.1016/j.applthermaleng.2005.10.036; Gonzalez MI, 2007, ENERG CONVERS MANAGE, V48, P2587, DOI 10.1016/j.enconman.2007.03.016; Hildbrand C, 2004, SOL ENERGY, V77, P311, DOI 10.1016/j.solener.2004.05.007; Lemmini F, 2005, RENEW ENERG, V30, P1989, DOI 10.1016/j.renene.2005.03.003; Saha BB, 2007, INT J REFRIG, V30, P86, DOI 10.1016/j.ijrefrig.2006.08.004; Li DHW, 2003, ENERG CONVERS MANAGE, V44, P1831, DOI 10.1016/S0196-8904(02)00189-9; Ogueke NV, 2008, RENEW ENERG, V33, P2428, DOI 10.1016/j.renene.2008.02.007; Saha BB, 2007, INT J REFRIG, V30, P96, DOI 10.1016/j.ijrefrig.2006.08.005; Dassler I, 2012, ENRGY PROCED, V30, P921, DOI 10.1016/j.egypro.2012.11.104; El-sharkawy I. I. A., 2006, INT J ENG TECHNOL AD, V3, P382; Khan MZI, 2007, RENEW ENERG, V32, P365, DOI 10.1016/j.renene.2006.02.003; Laidi M, 2013, INT J REFRIG, V36, P247, DOI 10.1016/j.ijrefrig.2012.09.016; Li C, 2013, RENEW ENERG, V57, P223, DOI 10.1016/j.renene.2013.01.040; Qi R., 2012, INT J LOW CARBON TEC, V7, P303; Yong L, 2004, ENERG CONVERS MANAGE, V45, P2761, DOI 10.1016/j.enconman.2003.12.004; Zhai XQ, 2010, APPL ENERG, V87, P824, DOI 10.1016/j.apenergy.2009.10.002	23	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0199-6231	1528-8986		J SOL ENERG-T ASME	J. Sol. Energy Eng. Trans.-ASME	FEB	2015	137	1							011005	10.1115/1.4027964		9	Energy & Fuels; Engineering, Mechanical	Energy & Fuels; Engineering	AZ3RZ	WOS:000348145600005		
J	Jo, B; Banerjee, D				Jo, Byeongnam; Banerjee, Debjyoti			Effect of Dispersion Homogeneity on Specific Heat Capacity Enhancement of Molten Salt Nanomaterials Using Carbon Nanotubes	JOURNAL OF SOLAR ENERGY ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							THERMAL-ENERGY STORAGE; NANO-FLUIDS; NANOFLUIDS; TRANSPORT; PLANTS	The specific heat capacity of a carbonate salt eutectic-based carbon nanotube nanomaterial was measured in present study. Differential scanning calorimeter (DSC) was used to measure the specific heat capacity of the nanomaterials. The specific heat capacity value in liquid phase was compared with that of a pure eutectic. A carbonate salt eutectic was used as a base material, which consists of lithium carbonate and potassium carbonate by 62:38 molar ratio. Multiwalled carbon nanotubes (CNT) at 1% mass concentration were dispersed in the molten salt eutectic. In order to find an appropriate surfactant for synthesizing molten salt nanomaterials, three surfactants, sodium dodecyl benzene sulfonate (SDBS), sodium dodecyl sulfate (SDS), and gum arabic (GA), at 1% mass concentration with respect to the salt eutectic were added. In preparation of dehydrated nanomaterials, water was evaporated by heating vials on a hot plate. Three different temperature conditions (120, 140, and 160 degrees C) were employed to investigate the effect of dispersion homogeneity of the nanotubes in the base material on the specific heat capacity of the nanomaterials. It is expected that the amount of agglomerated nanotubes decreases with increase of evaporation temperature (shorter elapsed time for evaporation). The results showed that the specific heat capacity of the nanomaterials was enhanced up to 21% in liquid phase. Additionally, it was found that the specific heat capacity enhancement of the nanomaterials, which contained SDS, was more sensitive to the evaporation time. Also, it can be decided that GA is the most appropriate to disperse CNT into the aqueous salt solution. Finally, CNT dispersion was confirmed with scanning electron microscope (SEM) images for pre-DSC and post-DSC samples. Furthermore, theoretical predictions of the specific heat capacity were compared with the experimental results obtained in present study.	[Jo, Byeongnam] Univ Tokyo, Nucl Profess Sch, Tokai, Ibaraki 3191188, Japan; [Jo, Byeongnam; Banerjee, Debjyoti] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA	Jo, B (reprint author), Univ Tokyo, Nucl Profess Sch, Shirakata 2-22, Tokai, Ibaraki 3191188, Japan.	jo@vis.t.u-tokyo.ac.jp			Department of Energy (DOE) solar Energy Program (Golden, CO) [DE-FG36-08GO18154];  [Amd. M001]	For this study, the authors acknowledge the support of the Department of Energy (DOE) solar Energy Program (Golden, CO) under Grant No. DE-FG36-08GO18154; Amd. M001 (Title: "Molten Salt-Carbon Nanotube Thermal Energy Storage for Concentrating Solar Power Systems").	Hilding J, 2003, J DISPER SCI TECHNOL, V24, P1, DOI 10.1081/DIS-120017941; Shin DH, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4002600; Kim SH, 2009, CARBON, V47, P1297, DOI 10.1016/j.carbon.2009.01.011; Wang XQ, 2007, INT J THERM SCI, V46, P1, DOI 10.1016/j.ijthermalsci.2006.06.010; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Dudda B, 2013, INT J THERM SCI, V69, P37, DOI 10.1016/j.ijthermalsci.2013.02.003; Tiznobaik H, 2013, INT J HEAT MASS TRAN, V57, P542, DOI 10.1016/j.ijheatmasstransfer.2012.10.062; Hasnain SM, 1998, ENERG CONVERS MANAGE, V39, P1127, DOI 10.1016/S0196-8904(98)00025-9; [Anonymous], 2005, E126905 ASTM; Nelson IC, 2009, J THERMOPHYS HEAT TR, V23, P752, DOI 10.2514/1.31033; Oh SH, 2005, SCIENCE, V310, P661, DOI 10.1126/science.1118611; Kim HD, 2007, INT J MULTIPHAS FLOW, V33, P691, DOI 10.1016/j.ijmultiphaseflow.2007.02.007; Zhou SQ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2890431; Herrmann U, 2002, J SOL ENERG-T ASME, V124, P145, DOI 10.1115/1.1467601; Shin D, 2011, INT J HEAT MASS TRAN, V54, P1064, DOI 10.1016/j.ijheatmasstransfer.2010.11.017; Keblinski P, 2005, MATER TODAY, V8, P36, DOI 10.1016/S1369-7021(05)70936-6; Vajjha RS, 2009, J HEAT TRANS-T ASME, V131, DOI 10.1115/1.3090813; You SM, 2003, APPL PHYS LETT, V83, P3374, DOI 10.1063/1.1619206; Zhou LP, 2010, ADV MECH ENG, DOI 10.1155/2010/172085; Jo B, 2009, J VISUAL-JAPAN, V12, P37; ARAKI N, 1988, INT J THERMOPHYS, V9, P1071, DOI 10.1007/BF01133274; Billings B. H., 1972, AM I PHYS HDB; Choi S.U.S., 1995, FED, V231, P99; Duffle J. A., 1974, SOLAR ENERGY THERMAL; Janz G. J., 1979, NAT STAND REF DATA S, V61, P1; Jo B., 2010, ES201090299 ASME; Kearney D, 2003, J SOL ENERG-T ASME, V125, P170, DOI 10.1115/1.1565087; Kim SJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2360892; Kline S. J., 1953, MECH ENG, V75, P3; Li Y, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/15/155405; Malik D., 2010, THESIS TEXAS A M U C; Masuda H., 1993, NETSU BUSSEI, V4, P227; Pacheco JE, 2002, J SOL ENERG-T ASME, V124, P153, DOI 10.1115/1.1464123; Rodriguez-Aseguinolaza J, 2014, J THERM ANAL CALORIM, V117, P93, DOI 10.1007/s10973-014-3639-0; Sathyamurthi V, 2009, J HEAT TRANS-T ASME, V131, DOI 10.1115/1.3000595; Shin D., 2010, INT J STRUC IN PRESS, V3, P25; Singh N., 2010, THESIS TEXAS A M U C; Smith J. M., 1987, CHEM ENG SERIES; Solutia Inc., 1999, SOL INC TECHN B	39	3	3	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0199-6231	1528-8986		J SOL ENERG-T ASME	J. Sol. Energy Eng. Trans.-ASME	FEB	2015	137	1							011011	10.1115/1.4028144		9	Energy & Fuels; Engineering, Mechanical	Energy & Fuels; Engineering	AZ3RZ	WOS:000348145600011		
J	Azuma, H; Inamoto, T; Takahara, K; Nomi, H; Hirano, H; Ibuki, N; Uehara, H; Komura, K; Minami, K; Uchimoto, T; Saito, K; Takai, T; Tanda, N; Yamamoto, K; Narumi, Y; Kiyama, S				Azuma, Haruhito; Inamoto, Teruo; Takahara, Kiyoshi; Nomi, Hayahito; Hirano, Hajime; Ibuki, Naokazu; Uehara, Hiroshi; Komura, Kazumasa; Minami, Koichiro; Uchimoto, Taizo; Saito, Kenkichi; Takai, Tomoaki; Tanda, Naoki; Yamamoto, Kazuhiro; Narumi, Yoshihumi; Kiyama, Satoshi			Novel Bladder Preservation Therapy with Osaka Medical College Regimen	JOURNAL OF UROLOGY			English	Article						balloon occlusion; infusions; intra-arterial; hemodialysis solutions; urinary bladder neoplasms	TRANSITIONAL-CELL CARCINOMA; OCCLUDED-ARTERIAL-INFUSION; LYMPH-NODE INVOLVEMENT; RADICAL CYSTECTOMY; PELVIC LYMPHADENECTOMY; NEOADJUVANT CHEMOTHERAPY; CANCER; IMPACT; METAANALYSIS; METASTASES	Purpose: We investigated the effect of balloon occluded arterial infusion of an anticancer agent (cisplatin/gemcitabine), used concomitantly with hemodialysis, which delivers an extremely high concentration of anticancer agent to the tumor site without systemic adverse effects, along with concurrent radiation (referred to as the Osaka Medical College regimen) in patients with advanced bladder cancer. Materials and Methods: A total of 329 patients (TisN0 16, T2N0 174, T3N0 77, T4N0 22 and TxN+ 40) were assigned to receive the Osaka Medical College regimen. Patients who did not achieve complete response underwent total cystectomy or secondary balloon occluded arterial infusion with an increased amount of cisplatin and/or gemcitabine. Results: The Osaka Medical College regimen allowed 83.6% (276 of 329) of patients in total and 93.6% (250 of 267) of patients with organ confined disease (including T3b) to achieve complete response. Of the patients with a complete response 96% (240 of 250) survived with a functional bladder without evidence of recurrent disease within a mean followup of 159 weeks. Although lymph node involvement, especially N2 stage, was selected as a significant risk factor for treatment failure and survival, it was noteworthy that 61.9% of patients with N1 disease achieved complete response and that the 5-year overall survival rate was 72.2%. No patients had grade III or more severe toxicities. Conclusions: The Osaka Medical College regimen, a new bladder preservation strategy, can be curative not only in patients for whom cystectomy is indicated, but also in patients whose condition is not amenable to curative treatment because of disease stage, age or other factors, and for whom merely palliative therapy would otherwise seem the only option.	[Azuma, Haruhito; Inamoto, Teruo; Takahara, Kiyoshi; Nomi, Hayahito; Hirano, Hajime; Ibuki, Naokazu; Uehara, Hiroshi; Komura, Kazumasa; Minami, Koichiro; Uchimoto, Taizo; Saito, Kenkichi; Takai, Tomoaki; Tanda, Naoki; Kiyama, Satoshi] Osaka Med Coll, Dept Urol, Takatsuki, Osaka 5698686, Japan; [Yamamoto, Kazuhiro; Narumi, Yoshihumi] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan	Azuma, H (reprint author), Osaka Med Coll, Dept Urol, 2-7 Daigaku Cho, Takatsuki, Osaka 5698686, Japan.	uro004@poh.osaka-med.ac.jp					Abol-Enein H, 2003, LANCET, V361, P1927; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Efstathiou JA, 2012, EUR UROL, V61, P705, DOI 10.1016/j.eururo.2011.11.010; Herr HW, 2003, J UROLOGY, V169, P943, DOI 10.1097/01.ju.0000032474.22093.06; Winquist E, 2004, J UROLOGY, V171, P561, DOI 10.1097/01.ju.0000090967.08622.33; Abol-Enein H, 2004, J UROLOGY, V172, P1818, DOI 10.1097/01.ju.0000140457.83695.a7; Stein JP, 2003, J UROLOGY, V170, P35, DOI 10.1097/01.ju.0000072422.69286.0e; Shariat SF, 2006, J UROLOGY, V176, P2414, DOI 10.1016/j.juro.2006.08.004; [Anonymous], 1999, LANCET, V354, P533; Madersbacher S, 2003, J CLIN ONCOL, V21, P690, DOI 10.1200/JCO.2003.05.101; Dhar NB, 2008, J UROLOGY, V179, P873, DOI 10.1016/j.juro.2007.10.076; Kassouf W, 2009, UROLOGY, V73, P147, DOI 10.1016/j.urology.2008.07.035; Koppie TM, 2006, CANCER, V107, P2368, DOI 10.1002/cncr.22250; CVITKOVIC E, 1977, CANCER, V39, P1357, DOI 10.1002/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C; Kassouf W, 2008, J CLIN ONCOL, V26, P121, DOI 10.1200/JCO.2007.12.9247; Leissner J, 2004, J UROLOGY, V171, P139, DOI 10.1097/01.ju.0000102302.26806.fb; Bassi P, 1999, J UROLOGY, V161, P1494, DOI 10.1016/S0022-5347(05)68936-7; Stockle M, 1996, UROLOGY, V48, P868, DOI 10.1016/S0090-4295(96)00299-3; Azuma H, 2009, AM J CLIN ONCOL-CANC, V32, P592, DOI 10.1097/COC.0b013e318199fb42; Azuma H, 2013, INT J ONCOL, V43, P79, DOI 10.3892/ijo.2013.1923; Azuma H, 2008, AM J CLIN ONCOL-CANC, V31, P11, DOI 10.1097/COC.0b013e318136e27a; BELT RJ, 1979, CANCER TREAT REP, V63, P1515; Collins JM, 1989, CANC CHEMOTHERAPY CH, V4; Herr HW, 2002, J UROLOGY, V167, P1295, DOI 10.1016/S0022-5347(05)65284-6; Konety BR, 2003, J UROLOGY, V169, P946, DOI 10.1097/01.0000052721.61645.a3; Mills RD, 2001, J UROLOGY, V166, P19, DOI 10.1016/S0022-5347(05)66067-3; Mitsuzane K, 1990, Gan To Kagaku Ryoho, V17, P1701; Stein JP, 2001, J CLIN ONCOL, V19, P666; TALLEY RW, 1973, CANCER CHEMOTH REP 1, V57, P465; Vazina A, 2004, J UROLOGY, V171, P1830, DOI 10.1097/01.ju.0000121604.58067.95	30	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	FEB	2015	193	2					443	450		10.1016/j.juro.2014.08.094		8	Urology & Nephrology	Urology & Nephrology	AY6YZ	WOS:000347709800015		
J	Moriya, K; Mitsui, T; Kitta, T; Nakamura, M; Kanno, Y; Kon, M; Nishimura, Y; Shinohara, N; Nonomura, K				Moriya, Kimihiko; Mitsui, Takahiko; Kitta, Takeya; Nakamura, Michiko; Kanno, Yukiko; Kon, Masafumi; Nishimura, Yoko; Shinohara, Nobuo; Nonomura, Katsuya			Early Discontinuation of Antibiotic Prophylaxis in Patients with Persistent Primary Vesicoureteral Reflux Initially Detected during Infancy: Outcome Analysis and Risk Factors for Febrile Urinary Tract Infection	JOURNAL OF UROLOGY			English	Article						risk factors; urinary tract infections; vesico-ureteral reflux; watchful waiting	INTERNATIONAL REFLUX; ACUTE PYELONEPHRITIS; RENAL SCARS; CHILDREN; MULTICENTER; TRIAL; MANAGEMENT	Purpose: We retrospectively assessed the incidence of and risk factors for febrile urinary tract infection in children during active surveillance after early discontinuation of antibiotic prophylaxis. Materials and Methods: We retrospectively evaluated 9 females and 61 uncircumcised males diagnosed with primary vesicoureteral reflux before age 1 year who had persistent reflux on followup voiding cystourethrogram and were subsequently followed under active surveillance without continuous antibiotic prophylaxis. Patients with secondary vesicoureteral reflux or associated urological abnormality were excluded. Clinical outcomes, including incidence of febrile urinary tract infection and new scar formation, were evaluated. Risk factors for febrile urinary tract infection were also analyzed. Results: Mean age at stopping continuous antibiotic prophylaxis was 21 months, and mean followup was 61 months. During active surveillance 21 patients had febrile urinary tract infection, and the 5-year infection-free rate under active surveillance was 67.5%. One or 2 foci of minimal new scarring developed in 4 of 16 patients who underwent followup dimercapto-succinic acid scan after febrile urinary tract infection. On multivariate analysis dilated vesicoureteral reflux on followup voiding cystourethrogram was the only significant risk factor for febrile urinary tract infection. Conclusions: This study revealed that about two-thirds of patients with persistent vesicoureteral reflux were free of febrile urinary tract infection during 5 years of active surveillance. Those with dilated vesicoureteral reflux on followup voiding cystourethrogram are at significantly greater risk for febrile urinary tract infection. Accordingly active surveillance, especially in patients with nondilated vesicoureteral reflux on followup voiding cystourethrogram, seems to be a safe option even in children who have not yet been toilet trained.	[Moriya, Kimihiko; Mitsui, Takahiko; Kitta, Takeya; Nakamura, Michiko; Kanno, Yukiko; Kon, Masafumi; Nishimura, Yoko; Shinohara, Nobuo; Nonomura, Katsuya] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido 0600824, Japan	Moriya, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0600824, Japan.	k-moriya@med.hokudai.ac.jp					Alconcher LF, 2009, J PEDIATR UROL, V5, P383, DOI 10.1016/j.jpurol.2009.02.207; Al-Sayyad AJ, 2005, J UROLOGY, V174, P1587, DOI 10.1097/01.ju.0000176336.67905.c7; Peters CA, 2010, J UROLOGY, V184, P1134, DOI 10.1016/j.juro.2010.05.065; Montini G, 2008, PEDIATRICS, V122, P1064, DOI 10.1542/peds.2007-3770; Knudson MJ, 2007, J UROLOGY, V178, P1684, DOI 10.1016/j.juro.2007.03.161; Elder JS, 1997, J UROLOGY, V157, P1846, DOI 10.1016/S0022-5347(01)64882-1; Cooper CS, 2000, J UROLOGY, V163, P269, DOI 10.1016/S0022-5347(05)68034-2; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; Brandstrom P, 2010, J UROLOGY, V184, P286, DOI 10.1016/j.juro.2010.01.061; Leslie B, 2010, J UROLOGY, V184, P1093, DOI 10.1016/j.juro.2010.05.013; Garin EH, 2006, PEDIATRICS, V117, P626, DOI 10.1542/peds.2005-1362; Roussey-Kesler G, 2008, J UROLOGY, V179, P674, DOI 10.1016/j.juro.2007.09.090; Arant BS, 2001, J PEDIATR-US, V139, P620, DOI 10.1067/mpd.2001.119451; Cheng CH, 2008, PEDIATRICS, V122, P1212, DOI 10.1542/peds.2007-2926; Drzewiecki BA, 2012, J UROLOGY, V188, P1480, DOI 10.1016/j.juro.2012.02.033; Hoberman A, 2014, NEW ENGL J MED, V370, P2367, DOI 10.1056/NEJMoa1401811; Kitchens DM, 2010, J UROLOGY, V184, P1594, DOI 10.1016/j.juro.2010.04.020; Nakai H, 2003, J UROLOGY, V169, P309, DOI 10.1097/01.ju.0000042766.09295.72; OLBING H, 1992, J UROLOGY, V148, P1653; Pennesi M, 2008, PEDIATRICS, V121, pE1489, DOI 10.1542/peds.2007-2652; Report of the International Reflux Study Committee, 1981, J UROL, V125, P277; Thompson RH, 2001, J UROLOGY, V166, P1465, DOI 10.1016/S0022-5347(05)65811-9	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	FEB	2015	193	2					637	642		10.1016/j.juro.2014.08.007		6	Urology & Nephrology	Urology & Nephrology	AY6YZ	WOS:000347709800082		
J	Minagawa, T; Ogawa, T; Ishizuka, O; Nishizawa, O				Minagawa, Tomonori; Ogawa, Teruyuki; Ishizuka, Osamu; Nishizawa, Osamu			Impact of Dynamic Transrectal Ultrasonography on Pelvic Organ Prolapse	JOURNAL OF UROLOGY			English	Article						pelvic organ prolapse; diagnosis; ultrasonography	URINARY-INCONTINENCE; STRESS-INCONTINENCE; VAGINAL PROLAPSE; BLADDER NECK; ULTRASOUND; FLOOR	Purpose: We developed a new method to evaluate pelvic organ prolapse dynamically in patients in supine and standing positions using transrectal ultrasonography. We visualized the descent and prolapse of pelvic organs in real time using dynamic transrectal ultrasonography. The dynamic transrectal ultrasonography findings were compared with intraoperative findings. Materials and Methods: A prospective analysis was performed including 31 women with symptomatic pelvic organ prolapse. Before surgical repair for pelvic organ prolapse, transrectal ultrasonography was performed by an operator separate from the surgeon, and the transrectal ultrasonography findings were compared with the intraoperative findings, focused on the diagnosis of pelvic organ prolapse. The patients were put on the fluoroscopic tilting table for passive postural change from supine to standing position. After injection of sonographic jelly into the vaginal lumen, the ultrasound probe was inserted into the rectum. With passive postural change from supine to standing position using the fluoroscopic tilting table, descent and prolapse of pelvic organs were dynamically evaluated in real time. Results: Cystocele, uterine prolapse and rectocele were dynamically observed in this procedure. Morphological details of pelvic organ prolapse such as movement, sliding, eversion, descent, and looseness of vaginal wall and bladder wall were successfully demonstrated in most cases. Dynamic transrectal ultrasonography demonstrated a high sensitivity (85.0%), specificity (81.1%), and positive (77.3%) and negative (87.8%) predictive value. Conclusions: We successfully demonstrated morphological conditions and dynamic changes of pelvic organs during passive postural change using dynamic transrectal ultrasonography in real time. Dynamic transrectal ultrasonography can be a useful modality to visualize pelvic organ prolapse preoperatively.	[Minagawa, Tomonori; Ogawa, Teruyuki; Ishizuka, Osamu; Nishizawa, Osamu] Shinshu Univ, Sch Med, Dept Urol, Nagano, Japan	Minagawa, T (reprint author), 3-1-1 Asahi, Matsumoto, Nagano, Japan.	minagaaa2006@yahoo.co.jp					Adisuroso T, 2012, ULTRASOUND OBST GYN, V39, P698, DOI 10.1002/uog.10124; Bjelic-Radisic V, 2014, INT UROGYNECOL J, V25, P1047, DOI 10.1007/s00192-014-2333-x; Dietz HP, 2001, ULTRASOUND OBST GYN, V18, P511, DOI 10.1046/j.0960-7692.2001.00494.x; DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717; Comiter CV, 1999, UROLOGY, V54, P454, DOI 10.1016/S0090-4295(99)00165-X; Jinkins JR, 2005, EUR RADIOL, V15, P1815, DOI 10.1007/s00330-005-2666-4; SCHAER GN, 1995, OBSTET GYNECOL, V85, P220, DOI 10.1016/0029-7844(94)00369-O; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Tunn R, 2005, INT UROGYNECOL J, V16, P236, DOI 10.1007/s00192-004-1228-7; KLUTKE C, 1990, J UROLOGY, V143, P563; Jelovsek JE, 2007, LANCET, V369, P1027, DOI 10.1016/S0140-6736(07)60462-0; Hagen S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003882.pub3; CREIGHTON SM, 1992, BRIT J OBSTET GYNAEC, V99, P310, DOI 10.1111/j.1471-0528.1992.tb13729.x; Dietz H P, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P365, DOI 10.1007/BF02199565; Dietz HP, 2006, ULTRASOUND OBST GYN, V28, P629, DOI 10.1002/uog.3828; KIRSCHNERHERMANNS R, 1993, BRIT J UROL, V72, P715, DOI 10.1111/j.1464-410X.1993.tb16254.x; KOHORN EI, 1986, OBSTET GYNECOL, V68, P269; Tunn R, 2003, ULTRASOUND OBST GYN, V22, P205, DOI 10.1002/uog.189	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	FEB	2015	193	2					670	676		10.1016/j.juro.2014.06.094		7	Urology & Nephrology	Urology & Nephrology	AY6YZ	WOS:000347709800096		
J	Akaihata, H; Nomiya, M; Hata, J; Yabe, M; Takahashi, N; Haga, N; Kushida, N; Ishibashi, K; Aikawa, K; Yamaguchi, O; Kojima, Y				Akaihata, Hidenori; Nomiya, Masanori; Hata, Junya; Yabe, Michihiro; Takahashi, Norio; Haga, Nobuhiro; Kushida, Nobuhiro; Ishibashi, Kei; Aikawa, Ken; Yamaguchi, Osamu; Kojima, Yoshiyuki			Pelvic Arterial Occlusive Disease Affects the RhoA/Rho-Kinase Pathway in Bladder Smooth Muscle	JOURNAL OF UROLOGY			English	Article						urinary bladder, overactive; arterial occlusive diseases; rho-associated kinases; muscle contraction; muscle, smooth	URINARY-TRACT SYMPTOMS; RHO-KINASE; RAT MODEL; CHRONIC ISCHEMIA; OBSTRUCTION; CONTRACTION; PHOSPHORYLATION; OVERACTIVITY; ASSOCIATION; INHIBITION	Purpose: We investigated the effect of pelvic arterial occlusive disease on the RhoA/Rho-kinase pathway in a rat model of chronic bladder ischemia. Materials and Methods: Male adult Sprague Dawley(R) rats at age 16 weeks were divided into arterial endothelial injury and control groups. The injury group underwent balloon endothelial injury of the bilateral iliac arteries and received a 2% cholesterol diet to induce pelvic arterial occlusive disease. The control group received a regular diet. At 8 weeks cystometrograms were performed. Bladder tissue was harvested for pharmacological studies and Western blot. Results: Cystometrograms showed significantly lower bladder capacity in the arterial endothelial injury group than in controls. Organ bath studies revealed significantly decreased phasic contractions induced by carbachol in bladder strips from the injury group than from controls. In controls bladder strip tonic contractions induced by carbachol were significantly decreased compared with phasic contractions. However, no significant difference was observed between phasic and tonic contractions in the injury group. The Rho-kinase inhibitor Y-27632 produced a concentration dependent decrease in tonic contractions, which was more pronounced in the injury group. Western blot showed significantly increased RhoA and Rho-kinase beta expression in the injury group. Conclusions: Our results suggest that pelvic arterial occlusive disease can affect the RhoA/Rho-kinase pathway in the bladder. This pathway might possibly be involved in the maintenance of tonic contraction and contribute to the bladder hyperactivity caused by pelvic arterial occlusive disease.	[Akaihata, Hidenori; Nomiya, Masanori; Yamaguchi, Osamu] Fukushima Med Univ, Sch Med, Dept Urol, Fukushima 9601295, Japan; [Nomiya, Masanori; Yamaguchi, Osamu] Nihon Univ, Sch Engn, Div Bioengn, Koriyama, Fukushima, Japan; [Nomiya, Masanori; Yamaguchi, Osamu] Nihon Univ, Sch Engn, LUTD Res, Koriyama, Fukushima, Japan	Nomiya, M (reprint author), Fukushima Med Univ, Sch Med, Dept Urol, 1 Hikarigaoka, Fukushima 9601295, Japan.	hidenoriakaihata@yahoo.co.jp					Pinggera GM, 2008, BJU INT, V102, P470, DOI 10.1111/j.1464-410X.2008.07587.x; Ponholzer A, 2006, EUR UROL, V50, P581, DOI 10.1016/j.eururo.2006.01.031; Rembold CM, 2004, AM J PHYSIOL-CELL PH, V287, pC594, DOI 10.1152/ajpcell.00082.2004; Andersson KE, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.09.030; Shiomi H, 2013, NEUROUROL URODYNAM, V32, P1019, DOI 10.1002/nau.22360; Andersson KE, 2011, NEUROUROL URODYNAM, V30, P292, DOI 10.1002/nau.20999; Bing W, 2003, AM J PHYSIOL-RENAL, V285, pF990, DOI 10.1152/ajprenal.00378.2002; Nomiya M, 2013, J UROLOGY, V189, P754, DOI 10.1016/j.juro.2012.07.141; Goi Y, 2013, J UROLOGY, V190, P1116, DOI 10.1016/j.juro.2013.03.110; Hamid SA, 2007, AM J PHYSIOL-HEART C, V292, pH2598, DOI 10.1152/ajpheart.01393.2006; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Wendt IR, 2003, CLIN EXP PHARMACOL P, V30, P565, DOI 10.1046/j.1440-1681.2003.03882.x; Yamaguchi O, 2014, NEUROUROL URODYNAM, V33, P54, DOI 10.1002/nau.22517; Azadzoi KM, 1999, J UROLOGY, V162, P1768, DOI 10.1016/S0022-5347(05)68236-5; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P195, DOI 10.1002/nau.21073; Azadzoi KM, 2010, J UROLOGY, V183, P362, DOI 10.1016/j.juro.2009.08.103; Azadzoi KM, 1999, J UROLOGY, V161, P1626, DOI 10.1016/S0022-5347(05)68995-1; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Marx JO, 2014, INT J UROL, V21, P319, DOI 10.1111/iju.12247; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P185, DOI 10.1002/nau.21191; Poley RN, 2008, EUR J PHARMACOL, V599, P137, DOI 10.1016/j.ejphar.2008.09.045; Rajasekaran M, 2005, NEUROUROL URODYNAM, V24, P295, DOI 10.1002/nau.20122; Sagawa K, 2013, UROLOGY, V81; Shahab N, 2012, UROLOGY, P79; Soler R, 2013, EUR UROL, V64, P610, DOI 10.1016/j.eururo.2013.04.042; Takahashi N, 2009, NEUROUROL URODYNAM, V28, P257, DOI 10.1002/nau.20625; Yada T, 2005, J AM COLL CARDIOL, V45, P599, DOI 10.1016/j.jacc.2004.10.053; Yamaguchi O, 2009, WORLD J UROL, V27, P722, DOI 10.1007/s00345-009-0470-5	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	FEB	2015	193	2					706	713		10.1016/j.juro.2014.09.102		8	Urology & Nephrology	Urology & Nephrology	AY6YZ	WOS:000347709800102		
J	Solonenko, OP; Nishiyama, H; Smirnov, AV; Takana, H; Jang, J				Solonenko, O. P.; Nishiyama, H.; Smirnov, A. V.; Takana, H.; Jang, J.			Visualization of arc and plasma flow patterns for advanced material processing	JOURNAL OF VISUALIZATION			English	Review						Visualization; Transfer arc torch; Twin torch; Nontransfer DC torch; DC-RF hybrid plasma flow system; Plasma jet; Reynolds number; Optimization	HYBRID PLASMA; THERMAL PLASMA; ATMOSPHERIC-PRESSURE; PARTICLE; JET; LAMINAR; POWDERS; SYSTEM; SPHEROIDIZATION; DECOMPOSITION	Results are presented for physical experiments that illustrate the possibilities and efficiency of visualization for studying the effect of operating conditions (backward-facing stepped forming nozzle, exit diameter of anode, mass flow, and composition of working gas) on plasma flows at low Reynolds numbers for advanced coating and powder processing. In particular, the shadow method, based on adaptive visualization transparency, is used for imaging electric arc and plasma jet flow patterns for different operating conditions. Because of visualization, the optimal geometrical characteristics of the backward-facing stepped forming nozzle, mass flow rate of the working gas, and its composition were found. These provide: (1) the absence of micro-shunting of the arc inside the backward-facing stepped nozzle for a transfer arc and twin arcs; and (2) compared to transient and turbulent jets, a higher density for the heat flux from a quasi-laminar flow to the surface of a flat substrate and the powder material to be treated, for nontransfer arc DC (direct current) torches and DC-RF (direct current and radio frequency) hybrid plasma flow system.	[Solonenko, O. P.; Smirnov, A. V.] Khristianovich Inst Theoret & Appl Mech SB RAS, Novosibirsk, Russia; [Nishiyama, H.; Takana, H.; Jang, J.] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan	Solonenko, OP (reprint author), Khristianovich Inst Theoret & Appl Mech SB RAS, Novosibirsk, Russia.	solo@itam.nsc.ru			Siberian Branch of the Russian Academy of Sciences [2, 98]; Institute of Fluid Science, Tohoku University, Japan [J13060, J14012]	This work was supported in part within the framework of Interdisciplinary Integration Projects No. 2 and 98, of the Siberian Branch of the Russian Academy of Sciences for 2012-2014. Part of the work was also carried out under International Collaborative Research Project J13060, J14012 at the Institute of Fluid Science, Tohoku University, Japan.	PFENDER E, 1994, THIN SOLID FILMS, V238, P228, DOI 10.1016/0040-6090(94)90060-4; PROULX P, 1987, PLASMA CHEM PLASMA P, V7, P29, DOI 10.1007/BF01015998; Duan Z, 2002, J THERM SPRAY TECHN, V11, P44, DOI 10.1361/105996302770348961; Ye R, 2007, THIN SOLID FILMS, V515, P4251, DOI 10.1016/j.tsf.2006.02.050; Tanaka M, 2003, PLASMA CHEM PLASMA P, V23, P585, DOI 10.1023/A:1023272007864; Solonenko OP, 2011, J THERM SCI TECH-JPN, V6, P219, DOI 10.1299/jtst.6.219; Karoly Z, 2003, POWDER TECHNOL, V132, P211, DOI 10.1016/S0032-5910(03)00077-9; Fauchais P, 2000, PLASMA PHYS CONTR F, V42, pB365, DOI 10.1088/0741-3335/42/12B/327; Ando Y, 2009, J THERM SPRAY TECHN, V18, P483, DOI 10.1007/s11666-009-9400-8; Bernecki T, 1988, US Patent, Patent No. 4780591; Bica I, 2005, PLASMA CHEM PLASMA P, V25, P121, DOI 10.1007/s11090-004-8838-1; Bini R, 2007, PLASMA CHEM PLASMA P, V27, P359, DOI 10.1007/s11090-007-9083-1; Chen D, 2014, P ITSC 2014 MAY 2014, P48; Cheng K, 2006, PLASMA CHEM PLASMA P, V26, P211, DOI 10.1007/s11090-006-9006-6; Choi HK, 1982, PLASMA CHEM PLASMA P, V2, P361, DOI 10.1007/BF00567563; Fauchais P., 2004, J PHYS D, V37, P86; Frolov V, 2011, ROM J PHYS, V56, P36; Gauvin W. H., 1989, Plasma Chemistry and Plasma Processing, V9, DOI 10.1007/BF01015874; Goutier S, 2008, J THERM SPRAY TECHN, V17, P895, DOI 10.1007/s11666-008-9270-5; Hamatani H, 2012, P 9 INT PIP C IPC201; Han YS, 2006, ADV MATER RES-SWITZ, V11-12, P673; Hawley D, 2010, P ITSC 2010 MAY 2010; Hsu K. C., 1984, Plasma Chemistry and Plasma Processing, V4, DOI 10.1007/BF00566842; Iwao T, 2009, VACUUM, V83, P34; Jang J, 2011, J FLUID SCI TECHNOL, V6, P729; Kawajiri K, 2005, INT J HEAT MASS TRAN, V48, P183, DOI 10.1016/j.ijheatmasstransfer.2004.07.037; Kawajiri K, 2003, SURF COAT TECH, V171, P134, DOI 10.1016/S0257-8972(03)00256-1; Kawajiri K, 2006, THIN SOLID FILMS, V506, P660, DOI 10.1016/j.tsf.2005.08.360; Kim KS, 2005, IEEE T PLASMA SCI, V33, P813, DOI 10.1109/TPS.2005.844526; Kittaka S, 2005, 92 NIPP STEEL, P1; Kozlov VV, 2013, J FLOW CONTROL MEAS, V1, P94; Kozlov VV, 2013, J FLOW CONTROL MEAS, V1, P108; Kuz'min VI, 1995, P 8 NAT THERM SPRAY, P83; Leblanc L, 2000, P ITSC 00 MAY 2000 M; Lemanov VV, 2013, TECH PHYS LETT, V39, P34; MCKELLIGET JW, 1990, METALL TRANS B, V21, P589, DOI 10.1007/BF02667872; Nishiyama H, 2009, J THERM SPRAY TECHN, V18, P593, DOI 10.1007/s11666-009-9358-6; Outcalt D, 2006, P ITSC 06 MAY 2006 S; Pan WX, 2002, PLASMA CHEM PLASMA P, V22, P271, DOI 10.1023/A:1014899510362; Pan WX, 2006, PLASMA CHEM PLASMA P, V26, P335, DOI 10.1007/s11090-006-9000-z; Seo JH, 2008, PLASMA SOURCES SCI T, V17; Shevchenko A, 2006, P 12 INT S FLOW VIS, P1; Solonenko O P, 1995, THERMAL PLASMA NEW M, V2, P7; Solonenko O P, 2001, P 15 INT S PLASM CHE, V5, P2079; Solonenko OP, 2007, COMPL SYST 5 INT WOR, P561; Solonenko OP, 2005, P 17 INT S PLASM CHE, P8; Solonenko OP, 2000, HIGH ENERGY PROCESSE; Takana H, 2011, J THERM SPRAY TECHN, V20, P432, DOI 10.1007/s11666-010-9547-3; Tang KM, 2010, J PHYS D, V43, P1; Wang HX, 2007, PLASMA CHEM PLASMA P, V27, P141, DOI 10.1007/s11090-006-9047-x; Williams JK, 1995, DEV TWIN DC PLASMA A, P1; Wu XF, 2007, SOL ST PHEN, V121-123, P187; Yamamoto T, 2005, P 17 INT S PLASM CHE; Ye R, 2004, PLASMA CHEM PLASMA P, V24, P555, DOI 10.1007/s11090-004-7932-8; YOSHIDA T, 1983, J APPL PHYS, V54, P640, DOI 10.1063/1.332070; Zhukov MF, 1990, HIGH TEMPERATURE DUS; Zhukov MF, 1985, ELECT ARC GENERATORS; Zhukov MF, 1994, THERMAL PLASMA NEW M, V1, P5; ZhZh Zheenbaev, 1983, 2 JET PLASMA TORCH	59	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	FEB	2015	18	1					1	15		10.1007/s12650-014-0221-6		15	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	AZ3NR	WOS:000348134800001		
J	Kong, F; Kim, HD; Setoguchi, T				Kong, Fanshi; Kim, Heuy Dong; Setoguchi, Toshiaki			An investigation of the effective pressure ratio effects on the ejector-diffuser system	JOURNAL OF VISUALIZATION			English	Article							CHEVRON NOZZLE; AIR EJECTOR; VISUALIZATION; FLOW		[Kong, Fanshi; Kim, Heuy Dong] Andong Natl Univ, Dept Mech Engn, Andong, South Korea; [Setoguchi, Toshiaki] Saga Univ, Inst Ocean Energy, Saga, Japan	Kim, HD (reprint author), Andong Natl Univ, Dept Mech Engn, Andong, South Korea.	kimhd@andong.ac.kr			Advanced Research Center Program through the National Research Foundation of Korea (NRF) - Korea government (MSIP) through Next Generation Space Propulsion Research Center at Seoul National University [2013073861]	This work was supported by Advanced Research Center Program (No. 2013073861) through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) contracted through Next Generation Space Propulsion Research Center at Seoul National University.	Desevaux P, 2004, J VISUAL-JAPAN, V7, P249; Desevaux P, 2001, J VISUAL-JAPAN, V4, P311; Katanoda H, 2000, SHOCK WAVES, V10, P95, DOI 10.1007/s001930050182; Kong FS, 2013, PROCEDIA ENGINEER, V56, P193, DOI 10.1016/j.proeng.2013.03.107; Kong FS, 2013, J THERM SCI, V22, P459, DOI 10.1007/s11630-013-0648-4; Mitchell DM, 2012, J VISUAL-JAPAN, V15, P333, DOI 10.1007/s12650-012-0139-9; Thiagarajan V, 2006, J VISUAL-JAPAN, V9, P91; Vishwanathappa MD, 2005, DESALINATION SEAWATE; Werle MJ, 2009, J PROPUL POWER, V25, P228, DOI 10.2514/1.36042	9	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	FEB	2015	18	1					31	34		10.1007/s12650-014-0235-0		4	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	AZ3NR	WOS:000348134800005		
J	Zheng, Y; Rinoshika, A				Zheng, Yan; Rinoshika, Akira			Multi-scale vortical structure analysis on large eddy simulation of dune wake flow	JOURNAL OF VISUALIZATION			English	Article						Wake; Dune; Large eddy simulation; Multi-scale; Wavelet analysis; Vortical structure; PIV	WAVELET ANALYSIS; FIXED DUNE; TURBULENCE; SURFACE	The three-dimensional dune wake flow is evaluated by large eddy simulation at a Reynolds number of 5,534, and validated by time-averaged results of particle image velocimetry measurement at a central streamwise plane. To reveal multi-scale characteristics of vortical structure, the instantaneous velocity, vorticity, and pressure were decomposed into the large-, intermediate-and small-scale components by three-dimensional wavelet multi-resolution technique, the scale of each wavelet component is quantified by two-point autocorrelation function with the central scale of 43, 20 and 9.6 mm, respectively. It is found that large-scale structure determines the formation of separation bubble and makes the most significance to the vorticity. Some intermediate-scale and small-scale streamwise vortices cause the upwelling of vortical structures, and they tend to be more active at the downstream. By visualization of pressure distribution, we can find that pressure distribution is mainly characterized by large-scale structure, and the distribution of small-scale structure can be interfered as a reason why large-scale vortical structure breaks into small vortices at the near outlet region.	[Zheng, Yan; Rinoshika, Akira] Yamagata Univ, Grad Sch Sci & Engn, Dept Mech Syst Engn, Yonezawa, Yamagata 9928510, Japan	Rinoshika, A (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Mech Syst Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	rinosika@yz.yamagata-u.ac.jp					Parsons DR, 2004, GEOMORPHOLOGY, V59, P149, DOI 10.1016/j.gcomorph.2003.09.012; FARGE M, 1992, ANNU REV FLUID MECH, V24, P395, DOI 10.1146/annurev.fluid.24.1.395; Grigoriadis DGE, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001014; Hersen P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.264301; Venditti JG, 2000, J GEOPHYS RES-OCEANS, V105, P22035, DOI 10.1029/2000JC900094; Walker IJ, 2003, EARTH SURF PROC LAND, V28, P1111, DOI 10.1002/esp.520; MENEVEAU C, 1991, J FLUID MECH, V232, P469, DOI 10.1017/S0022112091003786; Broglia R, 2003, J FLUID MECH, V484, P223, DOI 10.1017/S0022112003004257; Bagnold R.A., 1941, PHYS BLOWN SAND DESE; Balachandar R, 2007, CAN J CIVIL ENG, V34, P1587, DOI 10.1139/L07-068; Best J, 2002, J GEOPHYS RES, V107, pC9; Camussi R, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2185684; Farge M, 2001, Phys Rev Lett, V87, P054501, DOI 10.1103/PhysRevLett.87.054501; Farge M, 1999, PHYS FLUIDS, V11, P2187, DOI 10.1063/1.870080; Fluent Inc, 2006, FLUENT 6 3 US GUID; Hersen P, 2005, J GEOPHYS RES, V110, pF4; Lancaster N., 1995, GEOMORPHOLOGY DESERT; Mohammad O, 2013, J FLUID MECH, V721, P454, DOI [10.1017/jfm.2013.36, DOI 10.1017/JFM.2013.36]; Palmer JA, 2012, EXP FLUIDS, V52, P809, DOI 10.1007/s00348-011-1104-4; Patel VC, 2004, P 6 INT C HYDR SCI E; Rinoshika A, 2005, J FLUID MECH, V524, P229, DOI 10.1017/S0022112004002319; Rinoshika A, 2011, EXP THERM FLUID SCI, V35, P1231, DOI 10.1016/j.expthermflusci.2011.04.010; Rinoshika A, 2005, PHYS REV E, V71, P1; Rinoshika A, 2009, PHYS REV E, V79, P1; YAMADA M, 1991, PROG THEOR PHYS, V86, P799, DOI 10.1143/PTP.86.799; Yue WS, 2005, J FLUID ENG-T ASME, V127, P858, DOI 10.1115/1.1988345	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	FEB	2015	18	1					95	109		10.1007/s12650-014-0227-0		15	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	AZ3NR	WOS:000348134800011		
J	Zheng, YZ; Suematsu, H; Itoh, T; Fujimaki, R; Morinaga, S; Kawahara, Y				Zheng, Yunzhu; Suematsu, Haruka; Itoh, Takayuki; Fujimaki, Ryohei; Morinaga, Satoshi; Kawahara, Yoshinobu			Scatterplot layout for high-dimensional data visualization	JOURNAL OF VISUALIZATION			English	Article						Visualization; Scatterplot; Isomap; Force-directed graph layout; Rectangle packing		Multi-dimensional data visualization is an important research topic that has been receiving increasing attention. Several techniques that apply scatterplot matrices have been proposed to represent multi-dimensional data as a collection of two-dimensional data visualization spaces. Typically, when using the scatterplot-based approach it is easier to understand relations between particular pairs of dimensions, but it often requires too large display spaces to display all possible scatterplots. This paper presents a technique to display meaningful sets of scatterplots generated from high-dimensional datasets. Our technique first evaluates all possible scatterplots generated from high-dimensional datasets, and selects meaningful sets. It then calculates the similarity between arbitrary pairs of the selected scatterplots, and places relevant scatterplots closer together in the display space while they never overlap each other. This design policy makes users easier to visually compare relevant sets of scatterplots. This paper presents algorithms to place the scatterplots by the combination of ideal position calculation and rectangle packing algorithms, and two examples demonstrating the effectiveness of the presented technique.	[Zheng, Yunzhu; Suematsu, Haruka; Itoh, Takayuki] Ochanomizu Univ, Dept Informat Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Fujimaki, Ryohei] NEC Labs Amer, Cupertino, CA USA; [Morinaga, Satoshi] Osaka Univ, Osaka, Japan; [Kawahara, Yoshinobu] NEC Corp Ltd, Kawasaki, Kanagawa, Japan	Itoh, T (reprint author), Ochanomizu Univ, Dept Informat Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	yunzhu@itolab.is.ocha.ac.jp; haruka@itolab.is.ocha.ac.jp; itot@computer.org					Correa CD, 2012, IEEE T VIS COMPUT GR, V18, P106, DOI 10.1109/TVCG.2010.260; Elmqvist N, 2008, IEEE T VIS COMPUT GR, V14, P1141, DOI 10.1109/TVCG.2008.153; Sips M, 2009, COMPUT GRAPH FORUM, V28, P831; Itoh T, 2006, IEEE COMPUT GRAPH, V26, P40, DOI 10.1109/MCG.2006.34; KEIM DA, 1994, IEEE COMPUT GRAPH, V14, P40, DOI 10.1109/38.310723; Feiner S., 1990, ACM S US INT SOFTW T, P76; Grinstein G, 2001, KDD WORKSH VIS DAT M; Harel D, 2002, ADV VIS INTERFACES A, V157-166, P2002; Inselberg A., 1990, IEEE VISUALIZATION, P361; Itoh T, 2009, IEEE PAC VIS SYMP, P121; Leban G, 2005, BIOINFORMATICS, V21, P413, DOI 10.1093/bioinformatics/bti016; Lin CC, 2009, J VISUAL LANG COMPUT, V20, P385, DOI 10.1016/j.jvlc.2009.04.006; Mihalisin T, 1990, IEEE VISUALIZATION, P255; Ward M., 1994, IEEE VISUALIZATION, V1994, P326; Wilkinson L, 2005, INFOVIS 05: IEEE Symposium on Information Visualization, Proceedings, P157, DOI 10.1109/INFVIS.2005.1532142; Wong PC, 1997, 30 YEARS MULTIDIMENS, P3	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1343-8875	1875-8975		J VISUAL-JAPAN	J. Vis.	FEB	2015	18	1					111	119		10.1007/s12650-014-0230-5		9	Computer Science, Interdisciplinary Applications; Imaging Science & Photographic Technology	Computer Science; Imaging Science & Photographic Technology	AZ3NR	WOS:000348134800012		
J	Jayawardena, AW				Jayawardena, A. W.			Climate change - Is it the cause or the effect?	KSCE JOURNAL OF CIVIL ENGINEERING			English	Article						climate change; global warming; population; IPCC; projection uncertainties; scenarios; paleoclimatology; water and food security	FOOD SECURITY; MECHANISM	Climate change and global warming are currently hot topics. There is no doubt that warming is taking place in some parts of the globe as evidenced by melting of ice caps and glaciers, sea level rises, temperature rises, among other changes. At the same time, skeptics are of the view that the issue is blown out of proportion, and that warming exists locally and that it is premature to conclude that it is a global phenomenon. Projections made into the future climate have many uncertainties. These include model uncertainties, data length and their representativeness, calibration and validation issues, and the logic of projecting into 100 years or more into the future with a relatively short window of observations. What is not made known to the public at large is a balanced view that highlights the real scientific evidence and limitations and uncertainties of their findings. As a result the general public do not get a balanced view of the issues and get to know only a partial truth and not the whole truth. In this paper, an attempt is made to revisit the issues in the light of available information, and to highlight the important role of increasing population, with the objective of giving a reasonably balanced view since opinions about the issues are either biased or divided.	[Jayawardena, A. W.] Univ Hong Kong, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China; [Jayawardena, A. W.] Nippon Koei Co Ltd Engn Consultants, Ctr Res & Dev, Tsukuba, Ibaraki 3001259, Japan	Jayawardena, AW (reprint author), Univ Hong Kong, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China.	hrecjaw@hkucc.hku.hk					Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Gregory PJ, 2005, PHILOS T ROY SOC B, V360, P2139, DOI 10.1098/rstb.2005.1745; Elsner JB, 2000, J CLIMATE, V13, P2293, DOI 10.1175/1520-0442(2000)013<2293:SVIMUS>2.0.CO;2; Karhu K, 2014, NATURE, V513, P81, DOI 10.1038/nature13604; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Aggarwal PK, 2004, ENVIRON SCI POLICY, V7, P487, DOI 10.1016/j.envsci.2004.07.006; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Avery D. T, 2008, LEADERSHIP MANAGE EN, V8, P153, DOI DOI 10.1061/(ASCE)1532-6748(2008)8:3(153); EOS, 2008, T AGU, V89; Food and Agricultural Organization of the United Nations, 2008, CLIM CHANG FOOD SEC; ILO, 2007, EMPL SECT KEY IND LA; Pachauri R. K., 2007, CLIMATE CHANGE 2007; Rundt K., 2008, GLOBAL WARMING MAN M; Yim W. S. S., 2009, QUATERNARY SCI, V29, P190	14	1	1	KOREAN SOCIETY OF CIVIL ENGINEERS-KSCE	SEOUL	50-7 OGUM-DONG, SONGPA-KU, SEOUL, 138-857, SOUTH KOREA	1226-7988	1976-3808		KSCE J CIV ENG	KSCE J. Civ. Eng.	FEB	2015	19	2					359	365		10.1007/s12205-015-0524-8		7	Engineering, Civil	Engineering	AZ3NZ	WOS:000348135500001		
J	Roychowdhury, A; Pati, SP; Kumar, S; Das, D				Roychowdhury, Anirban; Pati, Satya Prakash; Kumar, Sanjay; Das, Dipankar			Tunable properties of magneto-optical Fe3O4/CdS nanocomposites on size variation of the magnetic component	MATERIALS CHEMISTRY AND PHYSICS			English	Article						Composite materials; Nanostructured materials; Optical materials; Magnetization; Luminescence; Mossbauer spectroscopy	CDS QUANTUM DOTS; OPTICAL-PROPERTIES; NANOPARTICLES; SULFIDE	Magnetic-fluorescent Fe3O4/CdS nanocomposites (NCs) with size of Fe3O4 varying between 5 and 12 nm have been synthesized by a two-step facile chemical route. XRD, TEM and Raman studies confirmed the phase purity and crystallinity of all the NCs. Photoluminescence peaks at 605 and 677 nm are assigned to sulfur and Cd vacancies respectively in CdS structure. Dc magnetization measurements indicate presence of superparamagnetic (SPM) relaxation in the NC having magnetite of size upto 7 nm whereas the NC containing magnetite of size 12 nm is ferrimagnetic. Ac susceptibility and Fe-57 Mossbauer measurements corroborate SPM relaxation in the samples. (C) 2014 Elsevier B.V. All rights reserved.	[Roychowdhury, Anirban; Das, Dipankar] UGC DAE Consortium Sci Res, Kolkata 700098, India; [Pati, Satya Prakash] Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 9808579, Japan; [Kumar, Sanjay] Jadavpur Univ, Dept Phys, Kolkata 700032, India	Das, D (reprint author), UGC DAE Consortium Sci Res, 3-LB-8, Kolkata 700098, India.	ddas@alpha.iuc.res.in			University Grants Commission, New Delhi	A. Roychowdhury acknowledges University Grants Commission, New Delhi for providing support in the form of fellowship. The authors thank Dr. A. Saha and Dr. A. Chakraborty, UGC-DAE CSR, Kolkata for UV, PL, Raman and fluorescence microscopy measurements facilities, respectively.	Chen YF, 2002, ANAL CHEM, V74, P5132, DOI 10.1021/ac0258251; Li H, 2007, IND ENG CHEM RES, V46, P2013, DOI 10.1021/ie060963s; Berry FJ, 1998, J PHYS-CONDENS MAT, V10, P215, DOI 10.1088/0953-8984/10/1/024; Roychowdhury A, 2014, POWDER TECHNOL, V254, P583, DOI 10.1016/j.powtec.2014.01.076; SCHMITTRINK S, 1989, ADV PHYS, V38, P89, DOI 10.1080/00018738900101102; Wang L, 2007, J PHYS CHEM C, V111, P9538, DOI 10.1021/jp0715777; Rao BS, 2011, CHALCOGENIDE LETT, V8, P177; Roychowdhury A, 2013, J PHYS CHEM SOLIDS, V74, P811, DOI 10.1016/j.jpcs.2013.01.012; Goya GF, 2003, J APPL PHYS, V94, P3520, DOI 10.1063/1.1599959; Corr SA, 2008, NANOSCALE RES LETT, V3, P87, DOI 10.1007/s11671-008-9122-8; Zheng YG, 2007, ADV MATER, V19, P1475, DOI 10.1002/adma.200601939; Jonsson T, 1997, J MAGN MAGN MATER, V168, P269, DOI 10.1016/S0304-8853(96)00710-X; Bala H, 2008, MATER CHEM PHYS, V111, P50, DOI 10.1016/j.matchemphys.2008.03.015; Chauksey P., 2009, INDIAN J ENG MATER S, V16, P157; Ichimura M, 1999, J APPL PHYS, V85, P7411, DOI 10.1063/1.369371; Jonathan D.G., 2006, P SOC PHOTO-OPT INS, V6337, pA1; Kachkachi H, 2000, J PHYS-CONDENS MAT, V12, P3077, DOI 10.1088/0953-8984/12/13/316; KRISHNA MVR, 1991, PHYS REV LETT, V67, P629; Kumar RV, 2000, J MATER CHEM, V10, P1125, DOI 10.1039/b000440p; Mirzaie RA, 2012, MATER CHEM PHYS, V133, P311, DOI 10.1016/j.matchemphys.2012.01.029; Mondal S.P., 2007, J APPL PHYS, V102; Pati S.P., 2013, J APPL PHYS, V113; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Tiwari S., 2008, APPL PHYS LETT, V93; Zhang Y, 2009, CHINESE CHEM LETT, V20, P969, DOI 10.1016/j.cclet.2009.03.038; Zhong Y.Q., 2002, J LUMIN, V99, P29	26	6	6	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0254-0584	1879-3312		MATER CHEM PHYS	Mater. Chem. Phys.	FEB 1	2015	151						105	111		10.1016/j.matchemphys.2014.11.043		7	Materials Science, Multidisciplinary	Materials Science	AZ5LY	WOS:000348263600017		
J	Fukuda, K; Higuchi, T; Aita, T				Fukuda, Kozue; Higuchi, Takeshi; Aita, Tadahiro			Fabrication of anisotropic microparticles by laser ablation and laser heating	MATERIALS CHEMISTRY AND PHYSICS			English	Article						Microstructure; Composite material; Magnetic properties	ONE-POT SYNTHESIS; JANUS PARTICLES; AU-FE3O4 NANOPARTICLES; MAGNETIC NANOPARTICLES; SULFIDE NANOPARTICLES; COMPOSITE-PARTICLES; GOLD NANOPARTICLES; NANOCRYSTALS; SURFACE; HETERODIMERS	Laser ablation and laser heating were used as micro-cutting and micro-bonding tools for fabrication of anisotropic microparticles. By using the techniques, two kinds of anisotropic microparticles to which a polymer film or magnetic particles was attached on their one hemisphere were fabricated from transparent spherical acrylic polymer particles of about 10 gm. In the fabrication of the anisotropic particles to which a polymer film attached, a mono-particle layer of the acrylic polymer particles formed on water surface was transferred on to a target plate coated with a polymer film and the plate was heated so that the particles strongly adhered to the polymer film. The plate was irradiated by 1064 nm or 532 nm pulse light from a Q-switched YAG laser to cause the ablation of the target. The ablation blew off the polymer film together with the acrylic polymer particles from the target plate, which gave the anisotropic particles. Anisotropic particles to which magnetic particles attached on their one hemisphere were fabricated by laser heating. A magnetic particle layer formed on water surface was transferred onto a quartz plate and then the monoparticle layer of the acrylic polymer particles was transferred onto the magnetic particle layer. The magnetic particles were heated by irradiation of 808 nm light from a CW diode laser, which caused the adhesion of the magnetic particles to the polymer particles. Rotation of the obtained magnetically anisotropic particles under rotating magnetic field was demonstrated. (C) 2014 Published by Elsevier B.V.	[Fukuda, Kozue; Higuchi, Takeshi; Aita, Tadahiro] Yamagata Univ, Dept Chem & Chem Engn, Yonezawa, Yamagata, Japan	Aita, T (reprint author), Yamagata Univ, Dept Chem & Chem Engn, 3-16 Jounan 4-Choume, Yonezawa, Yamagata, Japan.	aita@yz.yamagata-u.ac.jp					Adams DJ, 2008, COLLOID SURFACE A, V317, P360, DOI 10.1016/j.colsurfa.2007.11.004; Figuerola A, 2008, J AM CHEM SOC, V130, P1477, DOI 10.1021/ja078034v; Kwon KW, 2005, J AM CHEM SOC, V127, P10269, DOI 10.1021/ja051713q; Teo BM, 2011, LANGMUIR, V27, P30, DOI 10.1021/la104284v; Ohnuma A, 2009, J AM CHEM SOC, V131, P1352, DOI 10.1021/ja8079934; Choi JS, 2006, J AM CHEM SOC, V128, P15982, DOI 10.1021/ja066547g; Jiang S, 2010, ADV MATER, V22, P1060, DOI 10.1002/adma.200904094; Chen T, 2008, J AM CHEM SOC, V130, P11858, DOI 10.1021/ja8040288; Nisisako T, 2006, ADV MATER, V18, P1152, DOI 10.1002/adma.200502431; Zerrouki D, 2008, NATURE, V455, P380, DOI 10.1038/nature07237; Torrisi L, 2007, NUCL INSTRUM METH B, V255, P373, DOI 10.1016/j.nimb.2006.12.144; Chaubey GS, 2008, CHEM MATER, V20, P475, DOI 10.1021/cm7028068; Seo D, 2008, J AM CHEM SOC, V130, P2940, DOI [10.1021/ja711093j, 10.1021/ja711093i]; Teranishi T, 2008, J AM CHEM SOC, V130, P4210, DOI 10.1021/ja077921v; Lattuada M, 2011, NANO TODAY, V6, P286, DOI 10.1016/j.nantod.2011.04.008; Teranishi T, 2004, J AM CHEM SOC, V126, P9914, DOI 10.1021/ja047606y; Arshad M, 2009, J THERM ANAL CALORIM, V96, P873, DOI 10.1007/s10973-009-0063-y; Paunov VN, 2004, ADV MATER, V16, P788, DOI 10.1002/adma.200306476; Behrend CJ, 2005, J MAGN MAGN MATER, V293, P663, DOI 10.1016/j.jmmm.2005.02.072; Talapin DV, 2007, NANO LETT, V7, P2951, DOI 10.1021/nl072003g; Xu CJ, 2009, J AM CHEM SOC, V131, P4216, DOI 10.1021/ja900790v; Teng XW, 2003, J AM CHEM SOC, V125, P14559, DOI 10.1021/ja0376700; Pavlick RA, 2011, ANGEW CHEM INT EDIT, V50, P9374, DOI [10.1002/anie.201103565, 10.1002/ange.201103565]; Yuet KP, 2010, LANGMUIR, V26, P4281, DOI 10.1021/la903348s; Nie ZH, 2006, J AM CHEM SOC, V128, P9408, DOI 10.1021/ja060882n; Xu C, 2008, ANGEW CHEM INT EDIT, V47, P173, DOI 10.1002/anie.200704392; Yu H, 2005, NANO LETT, V5, P379, DOI 10.1021/nl047955q; Wang BB, 2008, J AM CHEM SOC, V130, P11594, DOI 10.1021/ja804192e; Koo HY, 2004, ADV MATER, V16, P274, DOI 10.1002/adma.200305617; Pellegrino T, 2006, J AM CHEM SOC, V128, P6690, DOI 10.1021/ja0607741; Takei H, 1997, LANGMUIR, V13, P1865, DOI 10.1021/la9621067; Saito N, 2006, LANGMUIR, V22, P9397, DOI 10.1021/la061298v; Casavola M, 2008, EUR J INORG CHEM, P837, DOI 10.1002/ejic.200701047; Chen QH, 2011, MATER CHEM PHYS, V128, P377, DOI 10.1016/j.matchemphys.2011.03.009; Choi SH, 2006, J AM CHEM SOC, V128, P2520, DOI 10.1021/ja0577342; Ding PJ, 2012, NUCL INSTRUM METH B, V286, P40, DOI 10.1016/j.nimb.2011.12.027; Grangwal S., 2008, LANGMUIR, V24, P13312; Gu HW, 2004, J AM CHEM SOC, V126, P5664, DOI 10.1021/ja0496423; Hugonnot E, 2003, LANGMUIR, V19, P226, DOI 10.1021/la0261085; Lattuada M, 2007, J AM CHEM SOC, V129, P12878, DOI 10.1021/ja0740521; Liu B, 2012, J COLLOID INTERF SCI, V385, P34, DOI 10.1016/j.jcis.2012.06.032; Paradhan S., 2007, ADV FUNCT MATER, V17, P2385; Prasad N, 2009, ADV FUNCT MATER, V19, P1656, DOI 10.1002/adfm.200801181; Rhutesh R., 2009, ADV MATER, V21, P1949; Suzuki D, 2006, COLLOID POLYM SCI, V284, P1471, DOI 10.1007/s00396-006-1524-5; Teranishi T, 2007, ANGEW CHEM INT EDIT, V46, P1713, DOI 10.1002/anie.200603865; Teranishi T, 2009, CHEM LETT, V38, P194, DOI 10.1246/cl.2009.194; Wang YL, 2011, LANGMUIR, V27, P7207, DOI 10.1021/la200749w	48	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0254-0584	1879-3312		MATER CHEM PHYS	Mater. Chem. Phys.	FEB 1	2015	151						215	221		10.1016/j.matchemphys.2014.11.057		7	Materials Science, Multidisciplinary	Materials Science	AZ5LY	WOS:000348263600030		
J	Benelmekki, M; Vernieres, J; Kim, JH; Diaz, RE; Grammatikopoulos, P; Sowwan, M				Benelmekki, Maria; Vernieres, Jerome; Kim, Jeong-Hwan; Diaz, Rosa-E.; Grammatikopoulos, Panagiotis; Sowwan, Mukhles			On the formation of ternary metallic-dielectric multicore-shell nanoparticles by inert-gas condensation method	MATERIALS CHEMISTRY AND PHYSICS			English	Article						Biomaterials; Sputtering; Optical properties; Magnetic properties	SURFACE; SPECTRA; FE	Magneto-plasmonic hybrid nanoparticles (HNPs) are promising for a large number for dual magneto-optical bioapplications. Gas-phase techniques offer a good alternative to chemical routes for the generation of tailored HNPs. Here, we present a novel method to synthesize ternary HNPs composed of multiple dumbbell-like FeAg cores encapsulated by an amorphous Si shell. The method involves a simultaneous sputtering of Fe, Ag and Si targets under controlled conditions. We demonstrate that the morphology and the size of the HNPs can be modulated by tuning experimental parameters such as the energy and the cooling rate, or the collision and coalescence processes experienced by the HNPs during their formation. We find that by increasing the residence time of the HNPs in the aggregation zone, we increase both the size of the HNPs, and the thickness of the Si shell. HNPs exhibit ferromagnetic behavior and show an enhanced, red-shifted, light absorption band due to the strong near-field coupling between the Ag cores and the Si shell. A mechanism of formation of these HNPs is suggested, combining the physico-chemical properties of the materials (Fe, Ag, Si) with the experimental conditions. (C) 2014 Elsevier B.V. All rights reserved.	[Benelmekki, Maria; Vernieres, Jerome; Kim, Jeong-Hwan; Diaz, Rosa-E.; Grammatikopoulos, Panagiotis; Sowwan, Mukhles] Technol Grad Univ, Onna Son, Okinawa, Japan; [Benelmekki, Maria; Vernieres, Jerome; Kim, Jeong-Hwan; Diaz, Rosa-E.; Grammatikopoulos, Panagiotis; Sowwan, Mukhles] Okinawa Inst Sci, Nanoparticles Design Unit, Onna Son, Okinawa, Japan; [Sowwan, Mukhles] Al Quds Uni, Nanotechnol Res Lab, Jerusalem, Israel	Benelmekki, M (reprint author), Technol Grad Univ, 1919-1 Tancha, Onna Son, Okinawa, Japan.	maria.benelmekki@oist.jp	vernieres, jerome/G-2504-2015; Grammatikopoulos, Panagiotis/G-2511-2015				Jensen TR, 2000, J PHYS CHEM B, V104, P10549, DOI 10.1021/jp002435e; Kaur M, 2012, J PHYS CHEM C, V116, P12875, DOI 10.1021/jp301453w; Xu YH, 2008, ADV MATER, V20, P994, DOI 10.1002/adma.200602895; Gu HW, 2005, J AM CHEM SOC, V127, P34, DOI 10.1021/ja045220h; Lu Y, 2003, J AM CHEM SOC, V125, P12724, DOI 10.1021/ja0373014; Alonso J, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/2/025705; Perro A, 2005, J MATER CHEM, V15, P3745, DOI 10.1039/b505099e; Zeng H, 2008, ADV FUNCT MATER, V18, P391, DOI 10.1002/adfm.200701211; Elsukova A, 2011, PHYS STATUS SOLIDI A, V208, P2437, DOI 10.1002/pssa.201127104; Zhang L, 2006, J COLLOID INTERF SCI, V297, P660, DOI 10.1016/j.jcis.2005.11.009; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; Parsina I, 2012, NANOSCALE, V4, P1160, DOI 10.1039/c1nr11171j; Skumryev V, 2003, NATURE, V423, P850, DOI 10.1038/nature01687; Benelmekki M, 2014, NANOSCALE, V6, P3532, DOI 10.1039/c3nr06114k; Hara S, 2005, SURF SCI, V585, P17, DOI 10.1016/j.susc.2005.03.061; Yu H, 2005, NANO LETT, V5, P379, DOI 10.1021/nl047955q; Meng XT, 2011, NANOSCALE, V3, P977, DOI 10.1039/c0nr00846j; Wang C, 2009, ADV MATER, V21, P3045, DOI 10.1002/adma.200900320; Bai JM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/6/065701; Chen YJ, 2013, SMALL, V9, P3242, DOI 10.1002/smll.201300543; Ido S, 1999, JPN J APPL PHYS 1, V38, P4450, DOI 10.1143/JJAP.38.4450; Moulder J. F., 1992, HDB XRAY PHOTOELECTR; Nanbu K, 1997, JPN J APPL PHYS 1, V36, P4808, DOI 10.1143/JJAP.36.4808; Sumiyama K., 2012, J NANOPART RES, V12, P2589; Tanaka N, 2010, MATER TRANS, V51, P1990, DOI 10.2320/matertrans.M2010177	25	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0254-0584	1879-3312		MATER CHEM PHYS	Mater. Chem. Phys.	FEB 1	2015	151						275	281		10.1016/j.matchemphys.2014.11.066		7	Materials Science, Multidisciplinary	Materials Science	AZ5LY	WOS:000348263600037		
J	Priya, SL; Kumar, V; Kurokawa, F; Kanno, I				Priya, S. Laxmi; Kumar, V.; Kurokawa, Fumiya; Kanno, Isaku			Transverse piezoelectric properties of {100} - Oriented PLZT[x/65/35] thin films	MATERIALS CHEMISTRY AND PHYSICS			English	Article						Thin films; Sol-gel growth; Crystal symmetry; Piezoelectricity	SOL-GEL TECHNIQUE; FABRICATION; DEPOSITION; ACTUATORS; BEHAVIOR; MEMS	Preferentially {100}-oriented thin films of lead lanthanum zirconate titanate, (Pb1-xLax) (Zr0.65Ti0.35)(1-x/4)O-3[PLZT(x/65/35)] with compositions near the morphotropic phase boundary (MPB) were prepared on silicon substrates (111)Pt/Ti/SiO2/Si by sol-gel spin coating technique. The structural, micro structural and electrical characteristics have been studied as a function of thin film composition. Crystalline orientation and microstructure of the thin films have been determined by X-ray diffraction, Scanning electron microscopy, respectively. The transverse piezoelectric coefficient, e(31)* of the PLZT thin films have been evaluated by tip deflection of unimorph cantilevers. The influence of thin film composition on e(31)* have been determined. PLZT (7/65/35) thin film exhibited the optimum dielectric and piezoelectric characteristics with a dielectric permittivity, epsilon(r) = 917; dielectric loss, tan delta = 0.03 and average e(31)* = -4.2 C/m(2). (C) 2014 Elsevier B.V. All rights reserved.	[Priya, S. Laxmi; Kumar, V.] Govt India, C MET, Dept Informat Technol, Minist Commun & Informat Technol,Sci Soc, Trichur 680581, Kerala, India; [Kurokawa, Fumiya; Kanno, Isaku] Kobe Univ, Kobe, Hyogo 6578501, Japan	Kumar, V (reprint author), Govt India, C MET, Dept Informat Technol, Minist Commun & Informat Technol,Sci Soc, Athani PO, Trichur 680581, Kerala, India.	vkumar@cmet.gov.in	Kanno, Isaku/B-3959-2010		UGC	One of the authors, Laxmi Priya S would like to acknowledge UGC for the Junior Research Fellowship.	Ambika D, 2009, APPL PHYS B-LASERS O, V97, P661, DOI 10.1007/s00340-009-3633-6; Ambika D, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/6/065401; Kanno I, 2003, SENSOR ACTUAT A-PHYS, V107, P68, DOI 10.1016/S0924-4247(03)00234-6; Narayanan M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4792529; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Ma CR, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4872375; Thomas R, 2003, THIN SOLID FILMS, V443, P14, DOI 10.1016/S0040-6090(03)00926-X; Wolf RA, 2004, J APPL PHYS, V95, P1397, DOI 10.1063/1.1636530; Jain M, 2002, MATER LETT, V56, P692, DOI 10.1016/S0167-577X(02)00597-9; Kanda K, 2009, J MICROELECTROMECH S, V18, P610, DOI 10.1109/JMEMS.2009.2015478; Frantti J, 1997, PHYS REV B, V56, P221, DOI 10.1103/PhysRevB.56.221; Muralt P, 2000, J MICROMECH MICROENG, V10, P136, DOI 10.1088/0960-1317/10/2/307; Hu ZQ, 2014, CERAM INT, V40, P557, DOI 10.1016/j.ceramint.2013.05.139; Camargo ER, 2001, J MATER CHEM, V11, P1875, DOI 10.1039/b009096o; Chen LL, 2007, J SOL-GEL SCI TECHN, V42, P299, DOI 10.1007/s10971-006-0649-9; Chen SY, 2001, J APPL PHYS, V90, P2970, DOI 10.1063/1.1394159; Deluca M., 2010, J RAMAN SPECTROSC, V42, P488; Frantti J, 1996, J APPL PHYS, V79, P1065, DOI 10.1063/1.360895; Haertling G., 1993, ANN REPORT; Kanda K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD12; Mckinstry Trolier, 2004, J ELECTROCERAM, V12, P7; Muralt P, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337362; Pandey SK, 2010, INTEGR FERROELECTR, V121, P65, DOI 10.1080/10584587.2010.504132; Poyato R, 2005, J APPL PHYS, V98, DOI 10.1063/1.1994936; Sivanandan K, 2008, SENSOR ACTUAT A-PHYS, V148, P134, DOI 10.1016/j.sna.2008.06.031; SMITS JG, 1991, IEEE T ULTRASON FERR, V38, P256, DOI 10.1109/58.79611	26	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0254-0584	1879-3312		MATER CHEM PHYS	Mater. Chem. Phys.	FEB 1	2015	151						308	311		10.1016/j.matchemphys.2014.11.071		4	Materials Science, Multidisciplinary	Materials Science	AZ5LY	WOS:000348263600042		
J	Krieger, J; Nakanishi, K; Schlag, W				Krieger, Joachim; Nakanishi, Kenji; Schlag, Wilhelm			Center-stable manifold of the ground state in the energy space for the critical wave equation	MATHEMATISCHE ANNALEN			English	Article						Nonlinear wave equation; Sobolev critical exponent; Hamiltonian; Blowup; Scattering; Ground state; Stability; Invariant manifold	KLEIN-GORDON EQUATION; GLOBAL DYNAMICS; BLOW-UP; INSTABILITY	We construct a center-stable manifold of the ground state solitons in the energy space for the critical wave equation without imposing any symmetry, as the dynamical threshold between scattering and blow-up, and also as a collection of solutions which stay close to the ground states. Up to energy slightly above the ground state, this completes the 9-set classification of the global dynamics in our previous paper (DCDS 33:6, 2013). We can also extend the manifold to arbitrary energy size by adding large radiation. The manifold contains all the solutions scattering to the ground state solitons, and also some of those blowing up in finite time by concentration of the ground states.	[Krieger, Joachim] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Nakanishi, Kenji] Kyoto Univ, Dept Math, Kyoto 6068502, Japan; [Schlag, Wilhelm] Univ Chicago, Dept Math, Chicago, IL 60615 USA	Krieger, J (reprint author), Ecole Polytech Fed Lausanne, Batiment Math,Stn 8, CH-1015 Lausanne, Switzerland.	joachim.krieger@epfl.ch			Swiss National Science foundation; National Science Foundation [DMS-0617854, DMS-1160817]	Support by the Swiss National Science foundation for the first author is acknowledged.; Support of the National Science Foundation DMS-0617854, DMS-1160817 for the third author is gratefully acknowledged.	Bizon P, 2004, NONLINEARITY, V17, P2187, DOI 10.1088/0951-7715/17/6/009; Krieger J, 2009, DUKE MATH J, V147, P1, DOI 10.1215/00127094-2009-005; Duyckaerts T, 2011, J EUR MATH SOC, V13, P533, DOI 10.4171/JEMS/261; PAYNE LE, 1975, ISRAEL J MATH, V22, P273, DOI 10.1007/BF02761595; Nakanishi K, 2012, CALC VAR PARTIAL DIF, V44, P1, DOI 10.1007/s00526-011-0424-9; LEVINE HA, 1974, T AM MATH SOC, V192, P1, DOI 10.2307/1996814; Krieger J, 2013, AM J MATH, V135, P935; Beceanu M., ARXIV12122285; Donninger R., ARXIV12013258V1; Donninger R., ARXIV12124718; Duyckaerts T., 2008, INT MATH RES PAP IMR, V2007, P67; Duyckaerts T., GAFA IN PRESS; Duyckaerts T., ARXIV12040031; Duyckaerts T., JEMS IN PRESS; Hillairet M., ARXIV10101768; Kenig C, 2008, ACTA MATH-DJURSHOLM, V201, P147, DOI 10.1007/s11511-008-0031-6; Krieger J, 2007, AM J MATH, V129, P843; Krieger J., ARXIV12124628; Krieger J., 2013, DCDS, V33, P6; Krieger J., ARXIV12090347; Nakanishi K, 2012, ARCH RATION MECH AN, V203, P809, DOI 10.1007/s00205-011-0462-7; Nakanishi K., 2011, J DIFFER EQUATIONS, V250, P2233; Nakanishi K, 2012, SIAM J MATH ANAL, V44, P1175, DOI 10.1137/11082720X; Szpak N, 2001, THEOR MATH PHYS+, V127, P817, DOI 10.1023/A:1010460004007	24	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	FEB	2015	361	1-2					1	50		10.1007/s00208-014-1059-x		50	Mathematics	Mathematics	AZ6CM	WOS:000348306200001		
J	Onodera, M				Onodera, Michiaki			Geometric flows for quadrature identities	MATHEMATISCHE ANNALEN			English	Article							FREE-BOUNDARY PROBLEM; HELE SHAW FLOWS; VARIATIONAL-INEQUALITIES; EXISTENCE; SURFACES	A new geometric flow describing the motion of quadrature surfaces is introduced. This characterization enables us to study quadrature surfaces through the investigation of the flow. It is proved that the flow is uniquely solvable under the geometric condition that the initial surface has positive mean curvature. As a consequence, a bifurcation criterion for quadrature surfaces is obtained. In fact, we study a generalized flow which includes the geometric flow and the Hele-Shaw flow as special cases.	Kyushu Univ, Inst Math Ind, Fukuoka 8190395, Japan	Onodera, M (reprint author), Kyushu Univ, Inst Math Ind, Fukuoka 8190395, Japan.	onodera@imi.kyushu-u.ac.jp			Mittag-Leffler Institute	The author would like to thank Professor Bjorn Gustafsson, Professor Piotr Boguslaw Mucha and Professor Henrik Shahgholian for constructive discussions and encouragement. He is also grateful for the generous support and kind hospitality of the Mittag-Leffler Institute, where this work was initiated in the autumn of 2011. His sincere thanks also go to the anonymous referees for their valuable comments and suggestions.	AHARONOV D, 1981, ISRAEL J MATH, V40, P331, DOI 10.1007/BF02761373; Amann H., 1995, MONOGRAPHS MATH, V89; GUSTAFSSON B, 1985, SIAM J MATH ANAL, V16, P279, DOI 10.1137/0516021; ALT HW, 1981, J REINE ANGEW MATH, V325, P105; ANGENENT SB, 1990, P ROY SOC EDINB A, V115, P91; Escher J, 1997, SIAM J MATH ANAL, V28, P1028, DOI 10.1137/S0036141095291919; NI WM, 1991, COMMUN PUR APPL MATH, V44, P819, DOI 10.1002/cpa.3160440705; BEURLING A., 1957, SEMINARS ANAL FUNCTI, V1, P248; Escher J., 1995, NONLINEAR DIFFERENTI, V2, P463, DOI 10.1007/BF01210620; Escher J., 1997, ADV DIFFERENTIAL EQU, V2, P619; Gilbarg D., 2001, CLASSICS MATH; Grisvard P., 1979, ANN MAT PUR APPL, V120, P329; Gustafsson B, 1996, J REINE ANGEW MATH, V473, P137; HENROT A, 1994, ARK MAT, V32, P79, DOI 10.1007/BF02559524; Lunardi A., 1995, PROGR NONLINEAR DIFF, V16; RICHARDS.S, 1972, J FLUID MECH, V56, P609, DOI 10.1017/S0022112072002551; Sakai M., 1982, LECT NOTES MATH, V934; SAKAI M, 1983, T AM MATH SOC, V276, P267; SHAHGHOLIAN H, 1994, POTENTIAL ANAL, V3, P245, DOI 10.1007/BF01053435; SHAHGHOLIAN H, 1994, ARK MAT, V32, P475, DOI 10.1007/BF02559582	20	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	FEB	2015	361	1-2					77	106		10.1007/s00208-014-1062-2		30	Mathematics	Mathematics	AZ6CM	WOS:000348306200004		
J	Cornelissen, G; Kato, F; Kool, J				Cornelissen, Gunther; Kato, Fumiharu; Kool, Janne			A combinatorial Li-Yau inequality and rational points on curves	MATHEMATISCHE ANNALEN			English	Article							UNIFORM BOUNDEDNESS CONJECTURE; DRINFELD MODULES; FUNCTION-FIELDS; FUNDAMENTAL DOMAINS; CHARACTERISTIC-P; ELLIPTIC-CURVES; FINITE COVERS; GRAPHS; TORSION; REDUCTION	We present a method to control gonality of nonarchimedean curves based on graph theory. Let denote a complete nonarchimedean valued field. We first prove a lower bound for the gonality of a curve over the algebraic closure of in terms of the minimal degree of a class of graph maps, namely: one should minimize over all so-called finite harmonic graph morphisms to trees, that originate from any refinement of the dual graph of the stable model of the curve. Next comes our main result: we prove a lower bound for the degree of such a graph morphism in terms of the first eigenvalue of the Laplacian and some "volume" of the original graph; this can be seen as a substitute for graphs of the Li-Yau inequality from differential geometry, although we also prove that the strict analogue of the original inequality fails for general graphs. Finally, we apply the results to give a lower bound for the gonality of arbitrary Drinfeld modular curves over finite fields and for general congruence subgroups of that is linear in the index , with a constant that only depends on the residue field degree and the degree of the chosen "infinite" place. This is a function field analogue of a theorem of Abramovich for classical modular curves. We present applications to uniform boundedness of torsion of rank two Drinfeld modules that improve upon existing results, and to lower bounds on the modular degree of certain elliptic curves over function fields that solve a problem of Papikian.	[Cornelissen, Gunther] Univ Utrecht, Math Inst, NL-3508 TA Utrecht, Netherlands; [Kato, Fumiharu] Kumamoto Univ, Dept Math, Kumamoto 8608555, Japan; [Kool, Janne] Max Planck Inst Math, D-53072 Bonn, Germany	Cornelissen, G (reprint author), Univ Utrecht, Math Inst, Postbus 80-010, NL-3508 TA Utrecht, Netherlands.	g.cornelissen@uu.nl; kato@sci.kumamoto-u.ac.jp; kool79@mpim-bonn.mpg.de					ABRAMOVICH D, 1991, COMPOS MATH, V78, P227; Abramovich D., 1996, INT MATH RES NOTICES, V20, P1005, DOI DOI 10.1155/S1073792896000621.MR1422373; Amini O., 2014, PREPRINT; Amini O., 2013, PREPRINT; Anand CK, 2000, CH CRC RES NOTES, V413, P109; GEKELER EU, 1995, INT J MATH, V6, P689, DOI 10.1142/S0129167X95000286; Ellenberg JS, 2012, DUKE MATH J, V161, P1233, DOI 10.1215/00127094-1593272; Pink R, 2009, J NUMBER THEORY, V129, P882, DOI 10.1016/j.jnt.2008.12.002; LI P, 1982, INVENT MATH, V69, P269, DOI 10.1007/BF01399507; Baker M, 2009, INT MATH RES NOTICES, P2914, DOI 10.1093/imrn/rnp037; Bodlaender HL, 2011, INFORM COMPUT, V209, P1103, DOI 10.1016/j.ic.2011.04.003; EICHINGER BE, 1978, J CHEM PHYS, V69, P4595, DOI 10.1063/1.436410; ABHYANKAR S, 1955, AM J MATH, V77, P575, DOI 10.2307/2372643; NAKAJIMA S, 1987, T AM MATH SOC, V303, P595, DOI 10.2307/2000686; Breuer F, 2010, J NUMBER THEORY, V130, P1241, DOI 10.1016/j.jnt.2009.11.009; MUMFORD D, 1972, COMPOS MATH, V24, P129; Urakawa H, 2000, GLASGOW MATH J, V42, P319, DOI 10.1017/S0017089500030019; Baker M, 2008, ALGEBR NUMBER THEORY, V2, P613; Gekeler EU, 1996, J REINE ANGEW MATH, V476, P27; FIEDLER M, 1973, CZECH MATH J, V23, P298; Armana C, 2012, ALGEBR NUMBER THEORY, V6, P1239, DOI 10.2140/ant.2012.6.1239; Bollobas B, 2001, CAMBRIDGE STUDIES AD, V73; Cadoret A., 2014, POINTS BOUNDED UNPUB; Caporaso L., 2014, SPRINGER P MATH STAT, V71, P73; Caporaso L, 2012, CONTEMP MATH, V564, P69, DOI 10.1090/conm/564/11150; Carbone L, 2011, J ALGEBRA, V325, P431, DOI 10.1016/j.jalgebra.2010.08.028; Chung F., 2004, INTERNET MATH, V1, P257, DOI 10.1080/15427951.2004.10129089; Chung F. R. K., 1997, CBMS REGIONAL C SERI; Clark PL, 2009, ISR J MATH, V171, P349, DOI 10.1007/s11856-009-0053-6; Cojocaru AC, 2004, ACTA ARITH, V114, P159, DOI 10.4064/aa114-2-5; Coleman RF., 2003, DOC MATH, P217; Cornelissen G, 2010, ISR J MATH, V180, P345, DOI 10.1007/s11856-010-0107-9; Cvetkovic D. M., 1980, PURE APPL MATH, V87; DRINFELD VG, 1988, FUNCT ANAL APPL+, V22, P28, DOI 10.1007/BF01077720; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290; FREY G, 1994, ISRAEL J MATH, V85, P79, DOI 10.1007/BF02758637; Gekeler E.-U., 1995, J TH NOMB BORDEAUX, V7, P27; Gekeler E.-U., 1986, LECT NOTES MATH, V1231; KAMIENNY S, 1995, ASTERISQUE, P81; Kim HH, 2003, J AM MATH SOC, V16, P139, DOI 10.1090/S0894-0347-02-00410-1; KLEIMAN SL, 1972, AM J MATH, V94, P431, DOI 10.2307/2374630; Liu Q, 1999, COMPOS MATH, V118, P61, DOI 10.1023/A:1001141725199; Liu Q, 2006, COMPOS MATH, V142, P101, DOI 10.1112/S0010437X05001557; Lorscheid O, 2013, ALGEBR NUMBER THEORY, V7, P19, DOI 10.2140/ant.2013.7.19; Mikhalkin G., 2006, P INT C MATH MADR 20, VII, P827; MORGENSTERN M, 1995, COMBINATORICA, V15, P111, DOI 10.1007/BF01294463; MORGENSTERN M, 1994, SIAM J DISCRETE MATH, V7, P560, DOI 10.1137/S0895480192235325; Pal A, 2010, ALGEBR NUMBER THEORY, V4, P509; Papikian M, 2002, J NUMBER THEORY, V97, P317, DOI 10.1016/S0022-314X(02)00016-1; Papikian M, 2007, MATH ANN, V337, P139, DOI 10.1007/s00208-006-0029-3; Papikian M, 2007, T AM MATH SOC, V359, P3483, DOI 10.1090/S0002-9947-07-04147-5; Poonen B, 2007, MATH RES LETT, V14, P691; Poonen B, 1997, MATH ANN, V308, P571, DOI 10.1007/s002080050090; Rust I., 1998, Finite Fields and their Applications, V4, DOI 10.1006/ffta.1998.0220; Saidi M, 1996, MANUSCRIPTA MATH, V89, P245, DOI 10.1007/BF02567516; Schweizer A, 2004, FORUM MATH, V16, P925, DOI 10.1515/form.2004.16.6.925; Schweizer A, 2003, MATH Z, V244, P601, DOI 10.1007/s00209-003-0514-2; Serre J.-P., 2003, SPRINGER MONOGRAPHS; Chandran LS, 2003, INFORM PROCESS LETT, V87, P195, DOI 10.1016/S0020-0190(03)00286-2; van Dobben de Bruyn J., 2012, THESIS LEIDEN U	60	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	FEB	2015	361	1-2					211	258		10.1007/s00208-014-1067-x		48	Mathematics	Mathematics	AZ6CM	WOS:000348306200010		
J	Katayama, S; Matoba, T; Sunagawa, H				Katayama, Soichiro; Matoba, Toshiaki; Sunagawa, Hideaki			Semilinear hyperbolic systems violating the null condition	MATHEMATISCHE ANNALEN			English	Article							NONLINEAR SCHRODINGER-EQUATIONS; KLEIN-GORDON SYSTEMS; 3 SPACE DIMENSIONS; LINEAR WAVE-EQUATIONS; SMALL INITIAL DATA; GLOBAL-SOLUTIONS; ASYMPTOTIC-BEHAVIOR; 2D; EXISTENCE; INFINITY	We consider systems of semilinear wave equations in three space dimensions with quadratic nonlinear terms not satisfying the null condition. We prove small data global existence of the classical solution under a new structural condition related to the weak null condition. For two-component systems satisfying this condition, we also observe a new kind of asymptotic behavior: Only one component is dissipated and the other one behaves like a non-trivial free solution in the large time.	[Katayama, Soichiro] Wakayama Univ, Dept Math, Wakayama 6408510, Japan; [Matoba, Toshiaki] Osaka Prefectural Tennoji High Sch, Abeno Ku, Osaka 5450005, Japan; [Sunagawa, Hideaki] Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan	Katayama, S (reprint author), Wakayama Univ, Dept Math, 930 Sakaedani, Wakayama 6408510, Japan.	katayama@center.wakayama-u.ac.jp; sunagawa@math.sci.osaka-u.ac.jp			JSPS [23540241, 22740089, 25400161]	The authors would like to express their sincere gratitude to Prof. Akitaka Matsumura for his comments on the earlier version of this work. The work of S. K. is supported by Grant-in-Aid for Scientific Research (C) (No. 23540241), JSPS. The work of H. S. is supported by Grant-in-Aid for Young Scientists (B) (No. 22740089) and Grant-in-Aid for Scientific Research (C) (No. 25400161), JSPS.	Alinhac S, 2006, INDIANA U MATH J, V55, P1209, DOI 10.1512/iumj.2006.55.2671; Alinhac S, 2003, ASTERISQUE, P1; Lindblad H, 2005, COMMUN MATH PHYS, V256, P43, DOI 10.1007/s00220-004-1281-6; Hayashi N, 2012, COMMUN PART DIFF EQ, V37, P947, DOI 10.1080/03605302.2012.668256; Hayashi N, 2011, DIFFER INTEGRAL EQU, V24, P417; Lindblad H, 2008, AM J MATH, V130, P115, DOI 10.1353/ajm.2008.0009; LINDBLAD H, 1990, COMMUN PUR APPL MATH, V43, P445, DOI 10.1002/cpa.3160430403; Lindblad H, 2010, ANN MATH, V171, P1401; CHRISTODOULOU D, 1986, COMMUN PUR APPL MATH, V39, P267, DOI 10.1002/cpa.3160390205; Delort JM, 2004, J FUNCT ANAL, V211, P288, DOI 10.1016/j.jfa.2004.01.008; Hormander L., 1997, LECT NONLINEAR HYPER; Hormander L., 1988, ANAL MATH APPL, P211; JOHN F, 1981, COMMUN PUR APPL MATH, V34, P29, DOI 10.1002/cpa.3160340103; Katayama S, 2012, COMMUN PUR APPL MATH, V65, P1285, DOI 10.1002/cpa.21392; Katayama S, 2014, DIFFER INTEGRAL EQU, V27, P301; Katayama S, 2013, J DIFFER EQUATIONS, V255, P120, DOI 10.1016/j.jde.2013.04.003; Katayama S, 2012, J HYPERBOL DIFFER EQ, V9, P263, DOI 10.1142/S0219891612500099; Katayama S, 2008, INDIANA U MATH J, V57, P377, DOI 10.1512/iumj.2008.57.3166; Kawahara Y, 2011, J DIFFER EQUATIONS, V251, P2549, DOI 10.1016/j.jde.2011.04.001; Klainerman S., 1986, LECTURES APPL MATH, V23, P293; Li CH, 2012, DISCRETE CONT DYN-A, V32, P4265, DOI 10.3934/dcds.2012.32.4265; Lindblad H, 2003, CR MATH, V336, P901, DOI 10.1016/S1631-073X(03)00231-0; LINDBLAD H, 1992, COMMUN PUR APPL MATH, V45, P1063, DOI 10.1002/cpa.3160450902; Phillips R. S., 1989, SCATTERING THEORY; Sogge C. D., 1995, LECT NONLINEAR WAVE; Sunagawa H., 2004, HOKKAIDO MATH J, V33, P457	26	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	FEB	2015	361	1-2					275	312		10.1007/s00208-014-1071-1		38	Mathematics	Mathematics	AZ6CM	WOS:000348306200012		
J	Metafune, G; Sobajima, M; Spina, C				Metafune, Giorgio; Sobajima, Motohiro; Spina, Chiara			Weighted Caldern-Zygmund and Rellich inequalities in L-p	MATHEMATISCHE ANNALEN			English	Article							UNBOUNDED DIFFUSION-COEFFICIENTS; ELLIPTIC-OPERATORS; SPACES; CONSTANTS	We find necessary and sufficient conditions for the validity of weighted Rellich and Caldern-Zygmund inequalities with respect to -norm, , for functions in the whole space and in the half-space with Dirichlet boundary conditions. General operators like are considered. We compute best constants in some situations.	[Metafune, Giorgio; Sobajima, Motohiro; Spina, Chiara] Univ Salento, Dipartimento Matemat Ennio De Giorgi, I-73100 Lecce, Italy; [Sobajima, Motohiro] Tokyo Univ Sci, Dept Math, Tokyo 162, Japan	Metafune, G (reprint author), Univ Salento, Dipartimento Matemat Ennio De Giorgi, CP 193, I-73100 Lecce, Italy.	giorgio.metafune@unisalento.it; msobajima1984@gmail.com; chiara.spina@unisalento.it		Metafune, Giorgio/0000-0002-1137-0715			Metafune G, 2012, ANN SCUOLA NORM-SCI, V11, P303; Musina R, 2014, DIFFER INTEGRAL EQU, V27, P579; Metafune G, 2014, REND LINCEI-MAT APPL, V25, P109, DOI 10.4171/RLM/670; Caldiroli P, 2012, CALC VAR PARTIAL DIF, V45, P147, DOI 10.1007/s00526-011-0454-3; Mitidieri E, 2000, MATH NOTES+, V67, P479, DOI 10.1007/BF02676404; Davies EB, 1998, MATH Z, V227, P511, DOI 10.1007/PL00004389; Ghoussoub N, 2011, MATH ANN, V349, P1, DOI 10.1007/s00208-010-0510-x; ARENDT W, 1994, Q J MATH, V45, P133, DOI 10.1093/qmath/45.2.133; Arendt W., 1994, DIFFERENTIAL INTEGRA, V5, P1153; Davies E.B., 1989, HEAT KERNELS SPECTRA; Engel K.-J., 2000, ONE PARAMETER SEMIGR; Fornaro S, 2007, DISCRETE CONT DYN-A, V18, P747; Fornaro S, 2007, J MATH PURE APPL, V87, P367, DOI 10.1016/j.matpur.2007.02.001; Kato T., 1984, DIFF EQUAT, V92, P341, DOI 10.1016/S0304-0208(08)73713-7; KOVALENKO VF, 1981, J MATH PHYS, V22, P1033, DOI 10.1063/1.525009; KREE P, 1966, ANN I FOURIER, V16, P91; Metafune G, 2002, STUD MATH, V153, P179, DOI 10.4064/sm153-2-5; Metafune G, 2014, ADV DIFFERENTIAL EQU, V19, P473; Metafune G, 2008, MEDITERR J MATH, V5, P357, DOI 10.1007/s00009-008-0155-0; MUCKENHO.B, 1971, T AM MATH SOC, V161, P249, DOI 10.2307/1995940; Musina R, 2014, ANN MAT PUR APPL, V193, P1629, DOI 10.1007/s10231-013-0348-4; Nagel R., 1980, LECT NOTES MATH, V1184, P1; Okazawa N., 1996, JAPAN J MATH, V22, P199; Ouhabaz EM, 2005, LOND MATH SOC MONOGR, V31, P1; Rellich F., 1956, P INT C MATH 1954, VIII, P243; Stein E. M., 1957, P AM MATH SOC, V8, P250, DOI 10.2307/2033721; Stein Elias M., 1971, PRINCETON MATH SERIE, V32; Vilenkin N.Ja., 1969, T MATH MONOGRAPHS, V22; Voigt J., 1992, B SOC ROY SC LIEGE, V61, P465	29	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	FEB	2015	361	1-2					313	366		10.1007/s00208-014-1075-x		54	Mathematics	Mathematics	AZ6CM	WOS:000348306200013		
J	Kikuta, S				Kikuta, Shin			The limits on boundary of orbifold Kahler-Einstein metrics and Kahler-Ricci flows over quasi-projective manifolds	MATHEMATISCHE ANNALEN			English	Article							ASYMPTOTICS	In this paper, we consider a sequence of orbifold Kahler-Einstein metrics and normalized Kahler-Ricci flows on a quasi-projective manifold for a projective manifold and a divisor of with simple normal crossings such that is ample. For sufficiently large or is the orbifold Kahler-Einstein metric or orbifold normalized Kahler-Ricci flow on equipped with the orbifold structure with respect to the divisor , respectively. The main theorem of this paper is that the limit on the boundary or the inside of the sequence as is exactly the complete normalized Kahler-Ricci flow on or , respectively. Moreover our method of the proof also leads to a result that on the boundary the sequence converges to the complete Kahler-Einstein metric on (D) over bar as m -> infinity.	Tokyo Denki Univ, Sch Engn, Dept Math, Tokyo 1208551, Japan	Kikuta, S (reprint author), Tokyo Denki Univ, Sch Engn, Dept Math, Tokyo 1208551, Japan.	skikuta@mail.dendai.ac.jp			KAKENHI [24-4805]	The author wishes to express his deep gratitude to Professor Hajime Tsuji for introducing Schumacher's result [11] and this problem to him. Professor Tsuji gave a great deal of his kind and valuable advice as well throughout the author's preparation for this paper. He would also like to thank the referee for careful reading of the manuscript and several helpful comments. He is supported by the Grant-in-Aid for Scientific Research (KAKENHI No. 24-4805) and the Grant-in-Aid for JSPS fellows.	Coman D, 2013, J REINE ANGEW MATH, V676, P33, DOI 10.1515/CRELLE.2011.185; Chau A, 2004, J DIFFER GEOM, V66, P211; KOBAYASHI R, 1984, OSAKA J MATH, V21, P399; Schumacher G, 1998, MATH ANN, V311, P631, DOI 10.1007/s002080050203; Rochon F, 2012, ADV MATH, V231, P2892, DOI 10.1016/j.aim.2012.08.005; CAO HD, 1985, INVENT MATH, V81, P359, DOI 10.1007/BF01389058; Bando S., 1990, ADV STUDIES PURE MAT, V18; CARLSON J, 1972, ANN MATH, V95, P557, DOI 10.2307/1970871; Krylov N.V., 1996, GRADUATE STUDIES MAT, V12; Ladyzenskaja O. A., 1968, TRANSLATIONS MATH MO, V23; Lott J, 2011, DUKE MATH J, V156, P87, DOI 10.1215/00127094-2010-067; Song J., 2013, ARXIVMATH12123653; Tian G., 1987, ADV SERIES MATH PHYS, V1; TSUJI H, 1988, DUKE MATH J, V57, P537, DOI 10.1215/S0012-7094-88-05724-9; Wu DM, 2006, COMMUN ANAL GEOM, V14, P795	15	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	FEB	2015	361	1-2					477	510		10.1007/s00208-014-1080-0		34	Mathematics	Mathematics	AZ6CM	WOS:000348306200018		
J	Matsumoto, Y				Matsumoto, Yuya			Good reduction criterion for K3 surfaces	MATHEMATISCHE ZEITSCHRIFT			English	Article						K3 surfaces; Good reduction; Galois representations; Period map; Complex multiplication	WEIGHT SPECTRAL SEQUENCES; SEMI-STABLE REDUCTION; ABELIAN-VARIETIES; ARTIN STACKS; CRYSTALLINE COHOMOLOGY; 6 OPERATIONS; CURVES; RAMIFICATION; COEFFICIENTS; MODULES	We prove a N,ron-Ogg-Shafarevich type criterion for good reduction of K3 surfaces, which states that a K3 surface over a complete discrete valuation field has potential good reduction if its -adic cohomology group is unramified. We also prove a -adic version of the criterion. (These are analogues of the criteria for good reduction of abelian varieties.) The model of the surface will be in general not a scheme but an algebraic space. As a corollary of the criterion we obtain the surjectivity of the period map of K3 surfaces in positive characteristic.	Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan	Matsumoto, Y (reprint author), Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan.	ymatsu@ms.u-tokyo.ac.jp			 [12J08397]	The author expresses his sincere gratitude to his advisor Atsushi Shiho for supporting him in many ways. The author also thanks Takuma Hayashi, Tetsushi Ito, Teruhisa Koshikawa, Keerthi Madapusi Pera, Yukiyoshi Nakkajima, Takeshi Saito, Naoya Umezaki, and Kohei Yahiro for giving him helpful comments. This work was supported by Grant-in-Aid for JSPS Fellows Grant Number 12J08397.	Andreatta F., 2013, P ADIC NONABELIAN CR; SAINTDONAT B, 1974, AM J MATH, V96, P602, DOI 10.2307/2373709; Laszlo Y, 2008, PUBL MATH-PARIS, P169, DOI 10.1007/s10240-008-0012-5; Laszlo YS, 2008, PUBL MATH-PARIS, P109, DOI 10.1007/s10240-008-0011-6; Laszlo Y, 2009, MATH Z, V261, P737, DOI 10.1007/s00209-008-0348-z; ABHYANKAR S, 1956, AM J MATH, V78, P321, DOI 10.2307/2372519; RAPOPORT M, 1982, INVENT MATH, V68, P21, DOI 10.1007/BF01394268; Nakayama C, 1998, COMPOS MATH, V112, P45, DOI 10.1023/A:1000327225021; OGG AP, 1967, AM J MATH, V89, P1, DOI 10.2307/2373092; ODA T, 1995, J NUMBER THEORY, V53, P342, DOI 10.1006/jnth.1995.1095; Coleman R, 1999, DUKE MATH J, V97, P171, DOI 10.1215/S0012-7094-99-09708-9; SAITO M, 1988, PUBL RES I MATH SCI, V24, P849, DOI 10.2977/prims/1195173930; MATSUSAKA T, 1964, AM J MATH, V86, P668, DOI 10.2307/2373030; Artin M., 1973, SEMINAIRE MATH SUPER, V44; ARTIN M, 1974, J ALGEBRA, V29, P330, DOI 10.1016/0021-8693(74)90102-1; Luce A, 2000, ANN MATH, V152, P489; Elsenhans AS, 2011, MATH PROC CAMBRIDGE, V151, P263, DOI 10.1017/S0305004111000326; Grothendieck A., 1961, I HAUTES ETUDES SCI, V11; HYODO O, 1994, ASTERISQUE, P221; Illusie L., 1988, ASTERISQUE, V223, P9; ITO T., 2001, THESIS U TOKYO; KAWAMATA Y., 1994, J ALGEBRAIC GEOM, V3, P463; KNUTSON D., 1971, LECT NOTES MATH, V203; KOLLAR J, 1985, COMPOS MATH, V56, P369; Kulikov V. S., 1977, IZV AKAD NAUK SSSR M, V41, P1008; Kulikov Vik. S., 1977, USP MAT NAUK, V32, P257; Liu Y., 2012, ENHANCED 6 OPERATION; Madapusi Pera K, 2014, INTEGRAL CANONICAL M; Madapusi Pera K, 2014, TATE CONJECTURE K3 S; Matsumoto Y, TOHOKU MATH J; Maulik D., 2012, SUPERSINGULAR K3 SUR; MOKRANE A, 1993, DUKE MATH J, V72, P301, DOI 10.1215/S0012-7094-93-07211-0; Nakayama C, 2000, AM J MATH, V122, P721, DOI 10.1353/ajm.2000.0030; Nakkajima Y., 2005, J MATH SCI-U TOKYO, V12, P513; Nakkajima Y, 2006, REND SEMIN MAT U PAD, V116, P71; Nakkajima Y, 2000, J ALGEBRAIC GEOM, V9, P355; Nakkajima Y., PREPRINT; Neron A., 1964, I HAUTES ETUDES SCI, V21, P128; Olsson M.C., 2008, ASTERISQUE, V316; Pjateckii-Shapiro I.I., 1971, IZV AKAD NAUK SSSR M, V35, P530; Rizov J., 2006, MODULI STACKS POLARI; Rizov J, 2010, J REINE ANGEW MATH, V648, P13, DOI 10.1515/CRELLE.2010.078; Saito T, 2003, J INST MATH JUSSIEU, V2, P583, DOI 10.1017/S1474748003000173; Saito T, 2004, J ALGEBRAIC GEOM, V13, P287; SERRE JP, 1968, ANN MATH, V88, P492, DOI 10.2307/1970722; Tsuji T, 1999, COMPOS MATH, V118, P11, DOI 10.1023/A:1001020809306; van Luijk R, 2007, ALGEBR NUMBER THEORY, V1, P1; ZARHIN YG, 1983, J REINE ANGEW MATH, V341, P193	48	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	FEB	2015	279	1-2					241	266		10.1007/s00209-014-1365-8		26	Mathematics	Mathematics	AY8WJ	WOS:000347831200011		
J	Yamana, S				Yamana, Shunsuke			On poles of the exterior cube L-functions for GL(6)	MATHEMATISCHE ZEITSCHRIFT			English	Article						Exterior cube L-functions; Poles of L-functions; Base change; Automorphic induction	SPIN L-FUNCTIONS	We determine the irreducible cuspidal automorphic representations of whose twisted exterior cube -functions have poles.	Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan	Yamana, S (reprint author), Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan.	yamana@math.kyushu-u.ac.jp			European Research Council under the European Community [290766]; JSPS [24840033]	The author would like to thank Michael Harris for inviting him as a postdoctoral fellow at the Institut de mathematiques de Jussieu, where this paper was written. The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 290766 (AAMOT). The author is partially supported by JSPS Grant-in-Aid for Research Activity Start-up 24840033.	Arthur J., 1989, ANN MATH STUDIES, V120; Bump D., 1992, INT MATH RES NOTICES, V8, P153; Bump D., 1999, T AM MATH SOC, V352, P875; Ginzburg D, 2000, COMPOS MATH, V123, P243, DOI 10.1023/A:1002461508749; GINZBURG D, 1995, J REINE ANGEW MATH, V465, P101; GINZBURG D, 1995, DUKE MATH J, V77, P753, DOI 10.1215/S0012-7094-95-07723-0; Hundley J, 2008, ISR J MATH, V165, P103, DOI 10.1007/s11856-008-1006-1; IKEDA T, 1992, COMPOS MATH, V83, P187; Kim HH, 2005, CAN J MATH, V57, P535, DOI 10.4153/CJM-2005-023-x; SHAHIDI F, 1981, AM J MATH, V103, P297, DOI 10.2307/2374219	10	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	FEB	2015	279	1-2					267	270		10.1007/s00209-014-1366-7		4	Mathematics	Mathematics	AY8WJ	WOS:000347831200012		
J	Kawakami, Y; Maruo, YY; Nakagawa, T; Saito, H				Kawakami, Yoshiyuki; Maruo, Yasuko Y.; Nakagawa, Taro; Saito, Hiroyuki			A screening method for detecting formaldehyde emitted from textile products	MEASUREMENT			English	Article						Formaldehyde; Screening; Textile; Acetylacetone method	ELEMENT; SENSOR	Formaldehyde is widely used to improve textile quality, but it is categorized as a potential carcinogen in humans. The concentration of formaldehyde emitted from textile products therefore has implications for public health. The standard method uses acetylacetone for determining formaldehyde extracted from textile products, but requires a water solution and the use of an analyzer. In this study, we present a method for screening textile-emitted formaldehyde via a porous glass sensor that we previously developed. Our method is suitable for on-site screening, whereas the commonly used method is not. The glass sensor was used to measure formaldehyde concentrations emitted from several kinds of textile products. The results showed good agreement (coefficient 0.92) with those of the acetylacetone method. Moreover, we estimate the effects of temperature, and suggest a formula to calculate concentration including temperature correction. (C) 2014 Elsevier Ltd. All rights reserved.	[Kawakami, Yoshiyuki; Saito, Hiroyuki] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Elect Engn & Comp Sci, Adv Mat Energy & Environm Syst, Kanazawa, Ishikawa 9201192, Japan; [Maruo, Yasuko Y.] Tohoku Inst Technol, Taihaku Ku, Sendai, Miyagi 9828577, Japan; [Kawakami, Yoshiyuki; Nakagawa, Taro] Shinyei Technol Co Ltd, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Saito, Hiroyuki] Nippon Telegraph & Tel Corp, Energy & Environm Syst Labs, Musashino, Tokyo 1808585, Japan	Kawakami, Y (reprint author), Shinyei Technol Co Ltd, Chuo Ku, 6-5-2 Minamimachi, Kobe, Hyogo 6500047, Japan.	y-kawakami@stc.shinyei.co.jp; maruo-yasuko@tohtech.ac.jp; t-nakagawa@stc.shinyei.co.jp; saitou.hiroyuki@lab.ntt.co.jp					Chen LG, 2008, J CHROMATOGR A, V1192, P89, DOI 10.1016/j.chroma.2008.03.037; Saenz M, 2011, ANAL CHIM ACTA, V687, P50, DOI 10.1016/j.aca.2010.12.006; Maruo YY, 2008, TALANTA, V74, P1141, DOI 10.1016/j.talanta.2007.08.017; International Organization for Standardization, 2011, 141841 ISO; Japanese Industrial Standard, 2011, L1041 JIS; Kanwal S, 2010, SPECTROSC LETT, V43, P84, DOI 10.1080/00387010903278275; Maruo YY, 2011, ANAL CHIM ACTA, V702, P247, DOI 10.1016/j.aca.2011.06.050; Maruo YY, 2010, INDOOR AIR, V20, P486, DOI 10.1111/j.1600-0668.2010.00670.x; NARUSE M, 1995, B ENVIRON CONTAM TOX, V55, P810; Salerno-Kochan R., 2012, FIBRES TEXT E EUR, V20	10	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-2241	1873-412X		MEASUREMENT	Measurement	FEB	2015	62						41	46		10.1016/j.measurement.2014.11.005		6	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AY5OX	WOS:000347622900005		
J	Cheng, C; Kawaguchi, K				Cheng, Chun; Kawaguchi, Ken'ichi			A preliminary study on the response of steel structures using surveillance camera image with vision-based method during the Great East Japan Earthquake	MEASUREMENT			English	Article						The Great East Japan Earthquake; Steel structures; High-rise buildings; Seismic response; Vision based method	DISPLACEMENT MEASUREMENT; BRIDGE	Steel structures had experienced an intense and long transient response caused by the great earthquake motion during the Great East Japan Earthquake on 11th March 2011. Lots of non-structural damages such as ceiling fallen and glass broken are the main damage characteristics of steel structures although there were rarely structural damages. Some opened earthquake records and videos were adopted in this study in order to investigate the seismic behavior of the steel structures. An application of vision-based method has been carried out on a video of surveillance camera provided by Japan Broadcasting Corporation (Nippon Housou Kyoukai) to obtain the displacement response and natural period of the high-rise steel buildings in Tokyo. (C) 2014 Elsevier Ltd. All rights reserved.	[Cheng, Chun; Kawaguchi, Ken'ichi] IIS, Meguro Ku, Tokyo 1538505, Japan	Kawaguchi, K (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo 1138654, Japan.	chengchun603@gmail.com; kawaken@iis.u-tokyo.ac.jp					Park JW, 2010, NDT&E INT, V43, P642, DOI 10.1016/j.ndteint.2010.06.009; [Anonymous], 2012, DAM INV REP GREAT E; Lee JJ, 2006, EXP MECH, V46, P105, DOI [10.1007/s11340-006-6124-2, 10.1007/s11340-006-3124-2]; STEPHEN GA, 1993, ENG STRUCT, V15, P197, DOI 10.1016/0141-0296(93)90054-8; Park KT, 2005, ENG STRUCT, V27, P371, DOI 10.1016/j.engstruct.2004.10.013; Architectural Institute of Japan, 2011, DAM INV QUICK REP GR; Architectural Institute of Japan, 2012, P RES SEM DEP SOC NE; Channel NHK, 2012, NHK CHANNEL     0304; Chen CH, 2012, ACTIVATION AND DETOXIFICATION ENZYMES: FUNCTIONS AND IMPLICATIONS, P25, DOI 10.1007/978-1-4614-1049-2_4; Hosozawa N., 2011, S STEEL STRUCT GREAT; Japan Meteorological Agency, 2011, GREAT E JAP EARTHQ; Kojima H., 2011, SEISMIC RECORDS OB 2, P337; Mulono T., 2011, OUTL MONTHL SEM RAIL; Olaszek P., 1999, Measurement, V25, DOI 10.1016/S0263-2241(99)00006-8; Tokyo Local Finance Bureau, 2011, SEISM STRAT 1 2 METR; Wahheh A.M., 2003, SMART MATER STRUCT, V12, P785; Yamamoto K., 2011, STUDY DYNAMIC RESPON, P327; Yano K., 1972, ANN M ARCH I JAP, P1527	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-2241	1873-412X		MEASUREMENT	Measurement	FEB	2015	62						142	148		10.1016/j.measurement.2014.10.039		7	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AY5OX	WOS:000347622900015		
J	Fujii, T; Ohfuji, H				Fujii, Taku; Ohfuji, Hiroaki			Pressure estimation using the 'diamond Raman scale' at low pressures in diamond anvil cell experiments using a highly confocal Raman system	MEASUREMENT SCIENCE & TECHNOLOGY			English	Article						diamond anvil cell; diamond Raman; high pressure; pressure estimation	COMPLETE MISCIBILITY; CALIBRATION; TEMPERATURE; GAUGE; MBAR	Pressure estimation using the frequency shift of the diamond Raman peak from the anvil culet is readily and widely used in diamond anvil cell experiments along with the conventional ruby fluorescence method. Here, we propose a modified diamond Raman scale particularly designed for pressure measurement below similar to 10 GPa. A series of experiments were conducted using a highly confocal Raman system and H2O, ethanol/methanol mixture and NaCl samples loaded in a rhenium gasket which was pre-indented to 40-60 or 100-110 mu m thick. The result showed that the frequency of the diamond Raman peak from the anvil culet increases linearly with pressure between 1 and 13 GPa, when using a sufficiently pre-indented (40-60 mu m thick) gasket. The frequency shifts are calibrated against the pressure determined by the ruby fluorescence method, which is an alternative pressure scale. In addition, a preliminary measurement at high temperature up to 575 K suggests the potential application of this method for high temperature experiments.	[Fujii, Taku; Ohfuji, Hiroaki] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan	Fujii, T (reprint author), Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan.	fujii@sci.ehime-u.ac.jp			Japan Society for the Promotion of Sciences [20740255]	The authors thank Professors T Yagi, H Hirai and T Irifune for their technical support and suggestions. This study was partly supported by Grant-in-Aid for Young Scientists (B) (#20740255) to HO from the Japan Society for the Promotion of Sciences.	Akahama Y, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012195; Akawama Y, 2004, J APPL PHYS, V96, P3748; Datchi F, 2007, HIGH PRESSURE RES, V27, P447, DOI 10.1080/08957950701659593; Ohfuji H, 2010, HIGH PRESSURE RES, V30, P142, DOI 10.1080/08957951003600764; Shen AH, 1997, NATURE, V385, P710, DOI 10.1038/385710a0; PIERMARINI GJ, 1975, J APPL PHYS, V46, P2774, DOI 10.1063/1.321957; MAO HK, 1978, J APPL PHYS, V49, P3276, DOI 10.1063/1.325277; KUHS WF, 1984, J CHEM PHYS, V81, P3612, DOI 10.1063/1.448109; Bureau H, 1999, EARTH PLANET SC LETT, V165, P187, DOI 10.1016/S0012-821X(98)00266-0; WANG CZ, 1990, PHYS REV B, V42, P11276, DOI 10.1103/PhysRevB.42.11276; BASSETT WA, 1993, REV SCI INSTRUM, V64, P2340, DOI 10.1063/1.1143931; HERCHEN H, 1991, PHYS REV B, V43, P11740, DOI 10.1103/PhysRevB.43.11740; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; Dubrovinsky L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2160; Eremets MI, 2003, J RAMAN SPECTROSC, V34, P515, DOI 10.1002/jrs.1044; HANFLAND M, 1985, J APPL PHYS, V57, P2752, DOI 10.1063/1.335417; RAGAN DD, 1992, J APPL PHYS, V72, P5539, DOI 10.1063/1.351951; Vohra Y K, 1994, AIP C P, V309, P515	18	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	FEB	2015	26	2							025501	10.1088/0957-0233/26/2/025501		5	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AZ3NU	WOS:000348135100018		
J	Kikuchi, K; Mochizuki, O				Kikuchi, K.; Mochizuki, O.			Velocity profile of thin film flows measured using a confocal microscopy particle image velocimetry system with simultaneous multi depth position	MEASUREMENT SCIENCE & TECHNOLOGY			English	Article						near wall flow; confocal micro-PIV; tilted microscopic observation; wall shear stress	RED-BLOOD-CELLS; PIV MEASUREMENTS; MICROCHANNEL; MICROFLUIDICS; VISUALIZATION; FLUORESCENCE; WALLS	In this paper, we report a technique for simultaneously visualizing flows near walls at nanodepth positions. To achieve such a high interval of depth gradient, we developed a tilted observation technique in a particle image velocimetry (PIV) system based on confocal microscopy. The focal plane along the bottom of the flow channel was tilted by tilting the micro-channel, enabling depth scanning in the microscopic field of view. Our system is suitable for measuring 3D two-component flow fields. The depth interval was approximately 220 nm over a depth range of 10 mu m, depending on the tilt angle of the micro-channel. Applying the proposed system, we visualized the near-wall flow in a drainage film flow under laminar conditions to the depth of approximately 30 mu m via vertical scanning from the bottom to the free surface. The velocity gradient was proportional to the distance from the wall, consistent with theoretical predictions. From the measured near-wall velocity gradient, we calculated the wall shear stress. The measurement accuracy was approximately 1.3 times higher in our proposed method than in the conventional confocal micro-PIV method.	[Kikuchi, K.] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan; [Mochizuki, O.] Toyo Univ, Dept Bio Med Engn, Saitama, Japan	Kikuchi, K (reprint author), Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan.	kenji@pfsl.mech.tohoku.ac.jp			 [25820050]	This work was supported by a Grant-in-Aid for Young Scientists (B) Number 25820050.	Meinhart CD, 1999, EXP FLUIDS, V27, P414, DOI 10.1007/s003480050366; Park JS, 2004, EXP FLUIDS, V37, P105, DOI 10.1007/s00348-004-0790-6; BENJAMIN TB, 1957, J FLUID MECH, V2, P554, DOI 10.1017/S0022112057000373; Kahler CJ, 2012, EXP FLUIDS, V52, P1629, DOI 10.1007/s00348-012-1280-x; Tretheway DC, 2002, PHYS FLUIDS, V14, pL9, DOI 10.1063/1.1432696; Shinohara K, 2004, MEAS SCI TECHNOL, V15, P1965, DOI 10.1088/0957-0233/15/10/003; Kim KC, 2012, J MECH SCI TECHNOL, V26, P3769, DOI 10.1007/s12206-012-1003-5; Benard N, 2003, J BIOMECH, V36, P991, DOI 10.1016/S0021-9290(03)00068-X; Kinoshita H, 2007, LAB CHIP, V7, P338, DOI 10.1039/b617391h; Kahler CJ, 2012, EXP FLUIDS, V52, P1641, DOI 10.1007/s00348-012-1307-3; Santiago JG, 1998, EXP FLUIDS, V25, P316, DOI 10.1007/s003480050235; Anoop K, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-284; Born M., 1999, PRINCIPLES OPTICS EL; Isigai S, 1971, T JAPAN SOC MECH ENG, V37, P1708; Kazoe Y, 2007, ANAL CHEM, V79, P6727, DOI 10.1021/ac070547x; Kikuchi K, 2008, J FLUID SCI TECHNOL, V3, P975, DOI 10.1299/jfst.3.975; Kim MJ, 2002, EXP FLUIDS, V33, P170, DOI [10.1007/s00348-002-0449-0, 10.1007/s0048-002-0449-0]; Lima R, 2008, J BIOMECH, V41, P2188, DOI 10.1016/j.jbiomech.2008.04.033; Nusselt W., 1916, VDI Zeitschrift, V60; PAWLEY J.B., 2006, HDB BIOL CONFOCAL MI; Sato Y, 2003, MEAS SCI TECHNOL, V14, P114, DOI 10.1088/0957-0233/14/1/317; Sugii Y, 2005, MEAS SCI TECHNOL, V16, P1126, DOI 10.1088/0957-0233/16/5/011; Tokgoz S, 2012, EXP FLUIDS, V53, P561, DOI 10.1007/s00348-012-1311-7; Zerai B, 2005, TRANSPORT POROUS MED, V60, P159, DOI 10.1007/s11242-004-4796-6	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	FEB	2015	26	2							025301	10.1088/0957-0233/26/2/025301		8	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AZ3NU	WOS:000348135100014		
J	Tanaka, Y; Kudo, Y; Hirasakura, T; Kurokawa, T				Tanaka, Yosuke; Kudo, Yoshimi; Hirasakura, Taiki; Kurokawa, Takashi			Wide range distance measurement over 50 km based on highly sensitive detection of the two-photon absorption photocurrent from a Si-APD	MEASUREMENT SCIENCE & TECHNOLOGY			English	Article						distance measurement; two-photon absorption; fiber sensors; optical sensors	FREQUENCY-DOMAIN REFLECTOMETRY; AVALANCHE PHOTODIODE; LASER; FIBER; PHOTODETECTOR; RESOLUTION; RADAR	We studied a wide range distance measurement system based on highly sensitive detection of the two-photon absorption photocurrent from a Si-APD. The measurable distance was investigated theoretically and experimentally in detail. The experimental results agreed well with the theory. We demonstrated fiber fault location over a 50 km fiber. Breakpoints from 20 m to 50 km away in the optical fiber were successfully detected.	[Tanaka, Yosuke; Kudo, Yoshimi; Hirasakura, Taiki; Kurokawa, Takashi] Tokyo Univ Agr & Technol, Div Adv Elect & Elect Engn, Inst Engn, Fuchu, Tokyo 183, Japan	Tanaka, Y (reprint author), Tokyo Univ Agr & Technol, Div Adv Elect & Elect Engn, Inst Engn, Fuchu, Tokyo 183, Japan.	tyosuke@cc.tuat.ac.jp	Tanaka, Yosuke/C-8806-2013		Japan Society for the Promotion of Science [25630170]	This study was partially supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (25630170).	Aizawa K, 2005, OPT REV, V12, P122, DOI 10.1007/s10043-004-0122-3; Koshikiya Y, 2008, J LIGHTWAVE TECHNOL, V26, P3287, DOI 10.1109/JLT.2008.928916; Minoshima K, 2000, APPL OPTICS, V39, P5512, DOI 10.1364/AO.39.005512; Tanaka Y, 2005, IEEE PHOTONIC TECH L, V17, P2682, DOI 10.1109/LPT.2005.859120; BARNOSKI MK, 1976, APPL OPTICS, V15, P2112, DOI 10.1364/AO.15.002112; Tanaka Y, 2003, OPT LETT, V28, P402, DOI 10.1364/OL.28.000402; Tanaka Y, 2007, JPN J APPL PHYS 1, V46, P5331, DOI 10.1143/JJAP.46.5331; EARNSHAW KB, 1972, APPL OPTICS, V11, P749, DOI 10.1364/AO.11.000749; EICKHOFF W, 1981, APPL PHYS LETT, V39, P693, DOI 10.1063/1.92872; FORRESTER PA, 1981, OPT QUANT ELECTRON, V13, P259, DOI 10.1007/BF00619793; HUGHES AJ, 1972, IEEE J QUANTUM ELECT, VQE 8, P909, DOI 10.1109/JQE.1972.1076885; Kikuchi K, 1998, ELECTRON LETT, V34, P1354, DOI 10.1049/el:19980936; KOBAYASI T, 1970, PR INST ELECTR ELECT, V58, P1568, DOI 10.1109/PROC.1970.7981; MATSUMOTO H, 1984, APPL OPTICS, V23, P3388	14	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	FEB	2015	26	2							025205	10.1088/0957-0233/26/2/025205		7	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AZ3NU	WOS:000348135100013		
J	Albrecht, E; Kuzinski, J; Komolka, K; Gotoh, T; Maak, S				Albrecht, Elke; Kuzinski, Judith; Komolka, Katrin; Gotoh, Takafumi; Maak, Steffen			Localization and abundance of early markers of fat cell differentiation in the skeletal muscle of cattle during growth - Are DLK1-positive cells the origin of marbling flecks?	MEAT SCIENCE			English	Article						Intramuscular fat; CEBPB; DLK1; Holstein; Japanese Black; Preadipocyte	BOVINE ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; JAPANESE BLACK; HOLSTEIN STEERS; PREF-1; ADIPOGENESIS; CELLULARITY; PREADIPOCYTES; DEPOSITION	Localization and abundance of early markers of adipogenic differentiation were investigated in bovine muscle tissue to verify their association with marbling development. Bovine skeletal muscle samples were used for immunohistochemical localization and measurement of mRNA and protein abundance of delta-like homolog 1 (DLK1) and CCAAT/enhancer-binding protein beta (CEBPB). The localization of DLK1-positive cells confirmed the position of small clusters of adipocytes which can be considered as the origin of marbling flecks. The results indicated higher DLK1 expression in the less marbled muscle of Holstein (HS) steers (P < 0.05) and a trend to higher CEBPB expression in Japanese Black (JB) steers (P < 0.1) at slaughter. The number of DLK1-positive cells and fat content were negatively correlated. The lower expression of DLK1 together with higher CEBPB abundance during fattening in JB may have contributed to the development of more adipocytes in the skeletal muscle of JB. (C) 2014 Elsevier Ltd. All rights reserved.	[Albrecht, Elke; Kuzinski, Judith; Komolka, Katrin; Maak, Steffen] Leibniz Inst Farm Anim Biol, Inst Muscle Biol & Growth, D-18196 Dummerstorf, Germany; [Gotoh, Takafumi] Kyushu Univ, Kuju Agr Res Ctr, Kuju, Oita 8780201, Japan	Albrecht, E (reprint author), Leibniz Inst Farm Anim Biol, Inst Muscle Biol & Growth, Wilhelm Stahl Allee 2, D-18196 Dummerstorf, Germany.	elke.albrecht@fbn-dummerstorf.de			Pfizer Animal Health	The authors wish to thank Karola Marquardt, Elke Schwitulla, Tetsuji Etoh, and Yuji Shiotsuka for excellent technical assistance and Pfizer Animal Health for financial support of parts of this study.	Albrecht E, 2013, J ANIM SCI, V91, P3666, DOI 10.2527/jas.2013-6258; Bi P, 2012, J ANIM SCI, V90, P924, DOI 10.2527/jas.2011-4594; Pickworth CL, 2011, J ANIM SCI, V89, P355, DOI 10.2527/jas.2010-3229; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI200315924; Albrecht E, 2011, MEAT SCI, V89, P13, DOI 10.1016/j.meatsci.2011.03.012; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Steinhoff-Wagner J, 2011, J NUTR, V141, P48, DOI 10.3945/jn.110.128652; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; Hausman GJ, 2004, J ANIM SCI, V82, P925; Wang YH, 2006, J NUTR, V136, P2953; Gotoh T, 2009, MEAT SCI, V82, P300, DOI 10.1016/j.meatsci.2009.01.026; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Gregoire FM, 1998, PHYSIOL REV, V78, P783; Yang XJ, 2006, J ANIM SCI, V84, P3251, DOI 10.2527/jas.2006-187; Platter WJ, 2005, J ANIM SCI, V83, P890; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Albrecht E, 2006, J ANIM SCI, V84, P1067; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Bellmann O, 2004, LIVEST PROD SCI, V85, P45, DOI 10.1016/S0301-6226(03)00121-0; CIANZIO DS, 1985, J ANIM SCI, V60, P970; Fernhough ME, 2007, DOMEST ANIM ENDOCRIN, V33, P367, DOI 10.1016/j.domaniend.2007.05.001; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1046/j.1432-0436.1999.6420103.x; HOOD RL, 1973, J LIPID RES, V14, P605; MAY SG, 1994, J ANIM SCI, V72, P3110; Ozutsumi K, 1996, MEAT SCI, V43, P61, DOI 10.1016/0309-1740(95)00042-9; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; SCHOBERLEIN L, 1989, ARCH TIERZUCHT, V32, P235; Shirouchi B, 2014, MEAT SCI, V96, P157, DOI 10.1016/j.meatsci.2013.06.027; Sul HS, 2000, INT J OBESITY, V24, pS15; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Vuocolo T, 2005, AUST J EXP AGR, V45, P879, DOI 10.1071/EA05049; Vuocolo T, 2003, COMP BIOCHEM PHYS B, V134, P315, DOI 10.1016/S1096-4959(02)00265-8; WEGNER J, 1984, MONATSH VETERINARMED, V39, P665; Xu JX, 2009, MEAT SCI, V83, P120, DOI 10.1016/j.meatsci.2009.04.009; Yamada T, 2014, BIOCHEM BIOPH RES CO, V445, P310, DOI 10.1016/j.bbrc.2014.01.177; ZEMBAYASHI M, 1994, MEAT SCI, V38, P367, DOI 10.1016/0309-1740(94)90063-9	40	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740	1873-4138		MEAT SCI	Meat Sci.	FEB	2015	100						237	245		10.1016/j.meatsci.2014.10.012		9	Food Science & Technology	Food Science & Technology	AY7WC	WOS:000347765700034		
J	Kamihiro, S; Stergiadis, S; Leifert, C; Eyre, MD; Butler, G				Kamihiro, S.; Stergiadis, S.; Leifert, C.; Eyre, M. D.; Butler, G.			Meat quality and health implications of organic and conventional beef production	MEAT SCIENCE			English	Article						Beef quality; Fatty acid intake; Organic; Conventional	FATTY-ACID-COMPOSITION; CONJUGATED LINOLEIC-ACID; GRASS-SILAGE; RETAIL BEEF; TRANS-18/1 ISOMERS; PRODUCTION SYSTEMS; INTRAMUSCULAR FAT; N-3 PUFA; MILK; CONCENTRATE	Recommendation to reduce fat consumption from ruminant meat does not consider the contribution of nutritionally beneficial fatty acids in lean beef. Here we report effects of production system (organic vs conventional) and finishing season on meat and fat quality of sirloin steaks from retail outlets and simulated fatty add intakes by consumers. There was little difference in meat quality (pH, shear force and colour), but the fat profiles varied considerably between production systems and season. Meat fat from organic and summer finished cattle contained higher concentrations of conjugated linoleic acid, its precursor vaccenic add and individual omega-3 fatty acids and had a lower ratio of omega-6 to omega-3 fatty acids compared with non-organic and winter finished cattle respectively. The fat profile from summer finished organic beef aligns better to recommended dietary guideline including those for long chain omega-3 fatty acids compared with that from winter finished, non-organic steak. (C) 2014 Elsevier Ltd. All rights reserved.	[Kamihiro, S.; Stergiadis, S.; Leifert, C.; Eyre, M. D.; Butler, G.] Newcastle Univ, Sch Agr Food & Rural Dev, Nafferton Ecol Farming Grp, Stocksfield NE43 7XD, Northd, England; [Kamihiro, S.] Minist Agr Forestry & Fisheries Japan, Food Safety & Consumers Affairs Bur, Div Anim Hlth, Tokyo 1008950, Japan	Butler, G (reprint author), Newcastle Univ, Sch Agr Food & Rural Dev, Nafferton Ecol Farming Grp, Stocksfield NE43 7XD, Northd, England.	gillian.butler@ncl.ac.uk			National Personnel Authority; Ministry of Agriculture, Forestry and Fisheries of Japan	One of us (SK) was in receipt of funding from the National Personnel Authority and Ministry of Agriculture, Forestry and Fisheries of Japan (18-03-1982) in the framework of the Japanese Government Long-Term Fellowship Program.	Alfaia CMM, 2006, MEAT SCI, V72, P425, DOI 10.1016/j.meatsci.2005.08.012; Alfaia CMM, 2006, J SCI FOOD AGR, V86, P2196, DOI 10.1002/jsfa.2596; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Williams CM, 2006, P NUTR SOC, V65, P42, DOI 10.1079/PNS2005473; McAfee AJ, 2010, MEAT SCI, V84, P1, DOI 10.1016/j.meatsci.2009.08.029; Ellis KA, 2006, J DAIRY SCI, V89, P1938; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; McAfee AJ, 2011, BRIT J NUTR, V105, P80, DOI 10.1017/S0007114510003090; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; Pestana JM, 2012, J SCI FOOD AGR, V92, P2428, DOI 10.1002/jsfa.5648; Butler G, 2008, J SCI FOOD AGR, V88, P1431, DOI 10.1002/jsfa.3235; Steinshamn H, 2008, LIVEST SCI, V119, P202, DOI 10.1016/j.livsci.2008.04.004; Butler G, 2011, J DAIRY SCI, V94, P24, DOI 10.3168/jds.2010-3331; Calder PC, 2004, CLIN SCI, V107, P1; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; NgehNgwainbi J, 1997, J AOAC INT, V80, P359; Warren HE, 2008, MEAT SCI, V78, P256, DOI 10.1016/j.meatsci.2007.06.008; Scollan N, 2006, MEAT SCI, V74, P17, DOI 10.1016/j.meatsci.2006.05.002; Raes K, 2003, MEAT SCI, V65, P1237, DOI 10.1016/S0309-1740(03)00031-7; Cho YM, 2006, J ANIM SCI, V84, P1481; PURCHAS RW, 1990, MEAT SCI, V27, P129, DOI 10.1016/0309-1740(90)90061-A; MAY SG, 1993, MEAT SCI, V35, P289, DOI 10.1016/0309-1740(93)90034-F; Kraft J, 2008, J AGR FOOD CHEM, V56, P4775, DOI 10.1021/jf8001813; Ruxton CHS, 2007, J HUM NUTR DIET, V20, P275, DOI 10.1111/j.1365-277X.2007.00770.x; Raes K, 2004, ANIM FEED SCI TECH, V113, P199, DOI 10.1016/j.anifeedsci.2003.09.001; Howe P, 2006, NUTRITION, V22, P47, DOI 10.1016/j.nut.2005.05.009; Razminowicz RH, 2006, MEAT SCI, V73, P351, DOI 10.1016/j.meatsci.2005.12.013; French P, 2000, MEAT SCI, V56, P173, DOI 10.1016/S0309-1740(00)00037-1; Page JK, 2001, J ANIM SCI, V79, P678; Bhattacharya A, 2006, J NUTR BIOCHEM, V17, P789, DOI 10.1016/j.jnutbio.2006.02.009; Angood KM, 2008, MEAT SCI, V78, P176, DOI 10.1016/j.meatsci.2007.06.002; Bates B., 2008, NAT DIET NUTR SURV; Committee on Medical Aspects of Food Policy, 1984, DIET CARD DIS, V28; Crawley M. J., 2007, R BOOK; Daley CA, 2010, NUTR J, V9; European Food Safety Authority, 2010, EFSA J, V8; Food and Agriculture Organisation of the United Nations, 2010, FAO FOOD NUTR, V91; Food and agriculture organization of the United Nations: Fisheries and aquaculture department, 2012, STAT WORLD FISH AQ, V2012; Food Standards Agency, 2002, MCCANC WIDD COMP FOO; Eriksson SF, 2007, MEAT SCI, V76, P746, DOI 10.1016/j.meatsci.2007.02.021; Greenfield H., 2003, FOOD COMP DAT PROD M, P170; Jones S.J., 2004, BOVINE MYOLOGY MUSCL; Kramer JKG, 2004, AM J CLIN NUTR, V79, p1137S; Palmquist D.L., 2005, BIOSYNTHESIS CONJUGA, V50, P179; Penney N, 1998, FOOD RES INT, V31, P521, DOI 10.1016/S0963-9969(99)00027-7; R Development Core Team, 2009, R LANG ENV STAT COMP; Scollan N. D., 2008, Health benefits of organic food: effects of the environment, P50, DOI 10.1079/9781845934590.0050; Soil Association, 2012, ORG MARK REP 2012; Yang A, 1999, LIPIDS, V34, P971, DOI 10.1007/s11745-999-0447-8	50	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740	1873-4138		MEAT SCI	Meat Sci.	FEB	2015	100						306	318		10.1016/j.meatsci.2014.10.015		13	Food Science & Technology	Food Science & Technology	AY7WC	WOS:000347765700043		
J	Wakabayashi, I				Wakabayashi, Ichiro			Associations of Blood Lipid-Related Indices with Blood Pressure and Pulse Pressure in Middle-Aged Men	METABOLIC SYNDROME AND RELATED DISORDERS			English	Article							POLYCYSTIC-OVARY-SYNDROME; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; ACCUMULATION PRODUCT; METABOLIC SYNDROME; INSULIN-RESISTANCE; ALCOHOL INTAKE; FOLLOW-UP; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK	Introduction: Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LDL-C/HDL-C) ratio is known as a classical atherogenic index. In addition, triglycerides to HDL-C (TGs/HDL-C) ratio and lipid accumulation product (LAP) have been proposed to be good discriminators for cardiometabolic risk. The aim of this study was to determine which lipid index is most strongly associated with blood pressure and pulse pressure. Methods: The subjects were 36,536 Japanese men aged 35-60 years who were not receiving drug therapy for dyslipidemia. Relationships of each lipid index with blood pressure and pulse pressure were investigated by using linear and logistic regression analyses. Results: There were significant positive correlations of systolic and diastolic blood pressure and pulse pressure with the lipid-related indices such as LDL-C/HDL-C ratio, TGs/HDL-C ratio, and LAP. The correlations with LAP were significantly stronger than those with the LDL-C/HDL-C ratio and the TGs/HDL-C ratio. Odds ratios (ORs) for hypertension and high pulse pressure in subjects with versus subjects without high levels of each lipid-related index were significantly higher than the reference level of 1.00. The ORs of subjects with versus subjects without high LAP tended to be higher than the ORs of subjects with versus subjects without high LDL-C/HDL-C ratio or high TGs/HDL-C ratio. In the linear and logistic regression analyses, the associations of the lipid-related indices with pulse pressure were weaker than the corresponding associations with blood pressure. Conclusion: LAP shows stronger associations with blood pressure and pulse pressure than the other lipid-related indices and is suggested to be better for discriminating the risk of hypertension.	Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan	Wakabayashi, I (reprint author), Hyogo Coll Med, Dept Environm & Prevent Med, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	wakabaya@hyo-med.ac.jp			Japan Society for the Promotion of Science [24390171]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (no. 24390171). The author thanks Dr. Takashi Daimon for his helpful suggestions on statistical analysis.	Taverna MJ, 2011, EUR J ENDOCRINOL, V164, P559, DOI 10.1530/EJE-10-1039; Jeppesen J, 1997, ARTERIOSCL THROM VAS, V17, P1114; Xiang S, 2013, EXP CLIN ENDOCR DIAB, V121, P115, DOI 10.1055/s-0032-1333261; Benetos A, 1997, HYPERTENSION, V30, P1410; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Safar ME, 2000, J HYPERTENS, V18, P1527, DOI 10.1097/00004872-200018110-00001; Cicero AFG, 2013, METAB SYNDR RELAT D, V11, P412, DOI 10.1089/met.2012.0147; SAFAR ME, 1987, J HYPERTENS, V5, P213, DOI 10.1097/00004872-198704000-00013; Wiltgen D, 2009, HUM REPROD, V24, P1726, DOI 10.1093/humrep/dep072; Wehr E, 2011, J CLIN ENDOCR METAB, V96, pE986, DOI 10.1210/jc.2011-0031; Kahn HS, 2006, DIABETES CARE, V29, P151, DOI 10.2337/diacare.29.01.06.dc05-1805; Xia C, 2012, EUR J CLIN NUTR, V66, P1035, DOI 10.1038/ejcn.2012.83; [Anonymous], 2005, J JPN SOC INT MED, V94, P794; MADHAVAN S, 1994, HYPERTENSION, V23, P395; Gaziano JM, 1997, CIRCULATION, V96, P2520; O'Rourke M, 1999, HYPERTENSION, V34, P372; KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Ioachimescu AG, 2010, OBESITY, V18, P1836, DOI 10.1038/oby.2009.453; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Onat A, 2010, J CLIN LIPIDOL, V4, P89, DOI 10.1016/j.jacl.2010.02.005; Bozorgmanesh M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-100; Bozorgmanesh M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-45; Brisson D, 2013, J WOMENS HEALTH, V22, P362, DOI 10.1089/jwh.2012.3807; Chiang JK, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-78; CHOWIENCZYK PJ, 1992, LANCET, V340, P1430, DOI 10.1016/0140-6736(92)92621-L; Ferrario CM, 2002, AM J MED SCI, V323, P17, DOI 10.1097/00000441-200201000-00004; Godinjak Amina, 2012, Med Arch, V66, P409, DOI 10.5455/medarh.2012.66.409-411; Hosseinpanah F, 2014, CLIN ENDOCRINOL, V81, P52, DOI 10.1111/cen.12287; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Kahn HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050428; Klatsky AL, 1996, CLIN CHIM ACTA, V246, P91, DOI 10.1016/0009-8981(96)06230-4; LANGER RD, 1992, CIRCULATION, V85, P910; National Cholesterol Education Program (NCEP); Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, CIRCULATION, V106, P3143, DOI DOI 10.1001/ARCHINTE.1991.00400060019005; Omvik Per, 1996, Blood Pressure, V5, P71, DOI 10.3109/08037059609062111; Shimomura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-104; Wakabayashi I, 2012, J STUD ALCOHOL DRUGS, V73, P998; Wakabayashi I, 2014, DIABETIC MED, V31, P868, DOI 10.1111/dme.12430; Wakabayashi I, 2014, J ATHEROSCLER THROMB, V21, P282; Wakabayashi I, 2013, ALCOHOL ALCOHOLISM, V48, P535, DOI 10.1093/alcalc/agt032; Wakabayashi I, 2012, EUR J CLIN INVEST, V42, P179, DOI 10.1111/j.1365-2362.2011.02568.x; Wehr E, 2011, OBESITY, V19, P1873, DOI 10.1038/oby.2011.42	42	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-4196	1557-8518		METAB SYNDR RELAT D	Metab. Syndr. Relat. Disord.	FEB 1	2015	13	1					22	28		10.1089/met.2014.0093		7	Medicine, Research & Experimental	Research & Experimental Medicine	AZ6IW	WOS:000348324400002		
J	Kado, Y; Kishimoto, A; Uda, T				Kado, Yuya; Kishimoto, Akihiro; Uda, Tetsuya			New Smelting Process for Titanium: Magnesiothermic Reduction of TiCl4 into Liquid Bi and Subsequent Refining by Vacuum Distillation	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							SYSTEM	We demonstrate a new continuous smelting process for Ti that combines magnesiothermic reduction of TiCl4 into liquid Bi and refining by vacuum distillation. TiCl4 is reduced by Mg into liquid Bi to form Bi-Ti liquid alloys, and subsequently refined by vacuum distillation. The Bi-Ti liquid alloys can be easily transferred from a reduction vessel to a refining vessel; consequently, the reduction and refining steps can be performed continuously. Bi-Ti alloys with various compositions were confirmed to form, and the compositions were controllable via adjustment of the nominal composition of TiCl4, Mg, and Bi. After reduction, the alloys were efficiently separated from MgCl2 by differences in their densities. In addition, vacuum distillation of the alloys purified Ti to be greater than 99.6 at pct. Moreover, consideration of the heat balance in the reduction step indicated that the proposed process has the potential to unlimitedly improve the feed rate of TiCl4 when the concentration of Ti in the alloy is 6 to 7 at pct.	[Kado, Yuya; Kishimoto, Akihiro; Uda, Tetsuya] Kyoto Univ, Grad Sch Engn, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; [Kado, Yuya] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058569, Japan	Kado, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan.	y.kado@aist.go.jp			Advanced Low Carbon Technology Research and Development Program (Japan Science and Technology Agency)	This study was financially supported by the Advanced Low Carbon Technology Research and Development Program (Japan Science and Technology Agency). The authors would like to acknowledge Kamioka Mining & Smelting Co., Ltd. for supplying the Bi metal used in this study.	CHASE MW, 1985, J PHYS CHEM REF DATA, V14, P1; Chase Jr M., 1998, MONOHGRAPH, V9, P1963; Gleave W.W., 1956, US Patent, Patent No. 2757135; Kado Y, 2013, J ELECTROCHEM SOC, V160, pE139, DOI 10.1149/2.102310jes; Maruyama S, 2013, J PHASE EQUILIB DIFF, V34, P289, DOI 10.1007/s11669-013-0243-0; Moriya A., 1993, SHIGEN TO SOZAI, V109, P1164; Murray J.L., 1987, PHASE DIAGRAMS BINAR, P282; Sato K., 1989, SHIGEN TO SOZAI, V105, P623; Tomonari T., 2001, CHITAN KOGYO SONO TE; Vassilev GP, 2004, Z METALLKD, V95, P813	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	FEB	2015	46	1					57	61		10.1007/s11663-014-0164-2		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AZ4NS	WOS:000348199900009		
J	Liu, ZQ; Li, LM; Qi, FS; Li, BK; Jiang, MF; Tsukihashi, F				Liu, Zhongqiu; Li, Linmin; Qi, Fengsheng; Li, Baokuan; Jiang, Maofa; Tsukihashi, Fumitaka			Population Balance Modeling of Polydispersed Bubbly Flow in Continuous-Casting Using Multiple-Size-Group Approach	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							INTERFACIAL AREA TRANSPORT; LARGE-EDDY SIMULATION; 2-PHASE FLOW; WATER MODEL; BREAK-UP; MOLD; COALESCENCE; ENTRAPMENT; DYNAMICS; NOZZLES	A population balance model based on the multiple-size-group (MUSIG) approach has been developed to investigate the polydispersed bubbly flow inside the slab continuous-casting mold and bubble behavior including volume fraction, breakup, coalescence, and size distribution. The Eulerian-Eulerian approach is used to describe the equations of motion of the two-phase flow. All the non-drag forces (lift force, virtual mass force, wall lubrication force, and turbulent dispersion force) and drag force are incorporated in this model. Sato and Sekiguchi model is used to account for the bubble-induced turbulence. Luo and Svendsen model and Prince and Blanch model are used to describe the bubbles breakup and coalescence behavior, respectively. A 1/4th water model of the slab continuous-casting mold was applied to investigate the distribution and size of bubbles by injecting air through a circumferential inlet chamber which was made of the specially-coated samples of mullite porous brick, which is used for the actual upper nozzle. Against experimental data, numerical results showed good agreement for the gas volume fraction and local bubble Sauter mean diameter. The bubble Sauter mean diameter in the upper recirculation zone decreases with increasing water flow rate and increases with increasing gas flow rate. The distribution of bubble Sauter mean diameter along the width direction of the upper mold increases first, and then gradually decreases from the SEN to the narrow wall. Close agreements between the predictions and measurements demonstrate the capability of the MUSIG model in modeling bubbly flow inside the continuous-casting mold. (C) The Minerals, Metals & Materials Society and ASM International 2014	[Liu, Zhongqiu; Li, Linmin; Qi, Fengsheng; Li, Baokuan; Jiang, Maofa] Northeastern Univ, Shenyang 110819, Peoples R China; [Tsukihashi, Fumitaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat, Kashiwa, Chiba 2778561, Japan	Li, BK (reprint author), Northeastern Univ, Shenyang 110819, Peoples R China.	libk@smm.neu.edu.cn			National Natural Science Foundation of China [51210007]	Authors are grateful to the National Natural Science Foundation of China for support of this research, Grant No. 51210007.	Abbel G., 1996, ISIJ INT, V36, P219; Li B, 2005, ISIJ INT, V45, P30, DOI 10.2355/isijinternational.45.30; Liu ZQ, 2013, ISIJ INT, V53, P484, DOI 10.2355/isijinternational.53.484; Yao W, 2004, INT J HEAT MASS TRAN, V47, P307, DOI 10.1016/j.ijheatmasstransfer.2003.06.004; Krepper E, 2005, NUCL ENG DES, V235, P597, DOI 10.1016/j.nucengdes.2004.09.006; Ramos-Banderas A, 2005, INT J MULTIPHAS FLOW, V31, P643, DOI 10.1016/j.ijmultiphaseflow.2005.01.010; Bai H, 2001, METALL MATER TRANS B, V32, P1143, DOI 10.1007/s11663-001-0102-y; Igathinathane C, 2008, COMPUT ELECTRON AGR, V63, P168, DOI 10.1016/j.compag.2008.02.007; Kasai N, 1997, TETSU TO HAGANE, V83, P24; PRINCE MJ, 1990, AICHE J, V36, P1485, DOI 10.1002/aic.690361004; Luo H, 1996, AICHE J, V42, P1225, DOI 10.1002/aic.690420505; Hibiki T, 2002, INT J HEAT MASS TRAN, V45, P2351, DOI 10.1016/S0017-9310(01)00327-1; THOMAS BG, 1994, METALL MATER TRANS B, V25, P527, DOI 10.1007/BF02650074; Cheung SCP, 2007, CHEM ENG PROCESS, V46, P742, DOI 10.1016/j.cep.2006.10.004; Lee GG, 2010, MET MATER INT, V16, P501, DOI 10.1007/s12540-010-0601-y; [Anonymous], 2012, ANSYS CFX 14 0 US MA; Cheung SCP, 2007, CHEM ENG SCI, V62, P4659, DOI 10.1016/j.ces.2007.05.030; Miki Y, 2011, TETSU TO HAGANE, V97, P423, DOI 10.2355/tetsutohagane.97.423; ANTAL SP, 1991, INT J MULTIPHAS FLOW, V17, P635, DOI 10.1016/0301-9322(91)90029-3; DREW DA, 1987, INT J MULTIPHAS FLOW, V13, P113, DOI 10.1016/0301-9322(87)90011-5; Zhang LF, 2007, METALL MATER TRANS B, V38, P63, DOI 10.1007/s11663-006-9007-0; Kwon Y, 2006, ISIJ INT, V46, P257, DOI 10.2355/isijinternational.46.257; CHESTERS AK, 1982, APPL SCI RES, V38, P353, DOI 10.1007/BF00385965; Wu Q, 1998, INT J HEAT MASS TRAN, V41, P1103, DOI 10.1016/S0017-9310(97)00167-1; Deen NG, 2001, CHEM ENG SCI, V56, P6341, DOI 10.1016/S0009-2509(01)00249-4; Sanchez-Perez R, 2004, METALL MATER TRANS B, V35, P85, DOI 10.1007/s11663-004-0099-0; Kumar S, 1996, CHEM ENG SCI, V51, P1311, DOI 10.1016/0009-2509(96)88489-2; Burns A.D., 2004, P 5 INT C MULT FLOW; Creech D., 1999, THESIS U ILLINOIS UR; Duan XY, 2011, CHEM ENG SCI, V66, P872, DOI 10.1016/j.ces.2010.11.031; Jakobsen HA, 1997, IND ENG CHEM RES, V36, P4052, DOI 10.1021/ie970276o; Kubo N., 1997, CAMP ISIJ, V10, P758; Liu ZQ, 2014, ISIJ INT, V54, P1314, DOI 10.2355/isijinternational.54.1314; Martin-Valdepenas JM, 2007, HEAT MASS TRANSFER, V43, P787, DOI 10.1007/s00231-006-0160-4; RIZK MA, 1989, INT J MULTIPHAS FLOW, V15, P119, DOI 10.1016/0301-9322(89)90089-X; Sato Y., 1975, International Journal of Multiphase Flow, V2, DOI 10.1016/0301-9322(75)90030-0; Xiang K, 2013, COMPUT BIOL MED, V43, P847, DOI 10.1016/j.compbiomed.2013.04.005; Yuan Q, 2001, COMPUTATIONAL MODELING OF MATERIALS, MINERALS AND METALS PROCESSING, P491	38	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	FEB	2015	46	1					406	420		10.1007/s11663-014-0192-y		15	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AZ4NS	WOS:000348199900044		
J	El-Mahdy, AFM; Ejupi, V; Shibata, T; Kabashima, T; Lu, JZ; Kai, M				El-Mahdy, Ahmed F. M.; Ejupi, Valon; Shibata, Takayuki; Kabashima, Tsutomu; Lu, Jianzhong; Kai, Masaaki			Facile preparation of streptavidin-coated sephadex beads and their application to chemiluminescence detection of a target DNA	MICROCHIMICA ACTA			English	Article						Streptavidin-coated sephadex beads; Immobilization; Chemiluminescence detection; Hybridization; Target DNA	SUSPENSION ARRAY TECHNOLOGY; TELOMERASE ACTIVITY; GENE; ADSORPTION; ASSAYS; IDENTIFICATION; MICROCARRIERS; IMMUNOASSAYS; PROBES; LABELS	We report on an efficient strategy for the preparation of streptavidin (SA)-coated sephadex beads by the reductive amination of the aldehyde groups on the oxidized sephadex beads that were coupled to the free amino groups of SA. The resulting beads have a stable spherical shape with an average diameter of 20-100 mu m. The capacity of SA conjugated to 1 mg of these beads is, respectively, similar to 24 and similar to 5 times higher than that of commercially available SA-coated polystyrene and sepharose beads. The new beads were successfully applied to the chemiluminescence (CL) detection of telomer DNA via a sandwich-type hybridization assay that involves the following steps: (a) Target DNA is first hybridized with biotinylated capture cDNA immobilized on the SA-coated sephadex beads; (b) the hybrid is then sandwiched with a guanine-rich polymeric probe which (c), is sensitively detected by CL after mixing with a 3,4,5-trimethoxy-phenylglyoxal reagent at room temperature for 10 s. The entire assay can be completed within 2-3 h and has a linear range that extends from 5 to 200 nM concentrations of the target DNA. The lower detection limit is approximately 0.75 nM (1.3 ng center dot 100 mu L-1) in a test tube. Compared to other methods, this one has a wider linear range, a lower detection limit, and is faster. We presume that the new method and materials will be readily applicable to the sensitive detection of target DNA, and also in bead-based CL immunoassays.	[El-Mahdy, Ahmed F. M.; Ejupi, Valon; Shibata, Takayuki; Kabashima, Tsutomu; Kai, Masaaki] Nagasaki Univ, Grad Sch Biomed Sci, Fac Pharmaceut Sci, Nagasaki 8528521, Japan; [Lu, Jianzhong] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China	Kai, M (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Fac Pharmaceut Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	ms-kai@nagasaki-u.ac.jp		EL-Mahdy, Ahmed/0000-0002-5237-750X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Global Center of Excellence Program at Nagasaki University	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and also supported partially by the Global Center of Excellence Program at Nagasaki University.	Kai M, 1999, ANAL CHIM ACTA, V381, P155, DOI 10.1016/S0003-2670(98)00724-7; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Peng QW, 2011, ANALYST, V136, P140, DOI 10.1039/c0an00448k; Wilson R, 2006, ANGEW CHEM INT EDIT, V45, P6104, DOI 10.1002/anie.200600288; Kellar KL, 2002, EXP HEMATOL, V30, P1227, DOI 10.1016/S0301-472X(02)00922-0; Huhtinen P, 2004, J IMMUNOL METHODS, V294, P111, DOI 10.1016/j.jim.2004.09.002; Pavlov V, 2004, ANAL CHEM, V76, P2152, DOI 10.1021/ac0352191; Braeckmans K, 2002, NAT REV DRUG DISCOV, V1, P447, DOI 10.1038/nrd817; Xiao Y, 2007, J AM CHEM SOC, V129, P11896, DOI 10.1021/ja074218y; Kerman K, 2006, ANAL CHEM, V78, P2182, DOI 10.1021/ac051526a; Butler JE, 2000, METHODS, V22, P4, DOI 10.1006/meth.2000.1031; Nelson BP, 2001, ANAL CHEM, V73, P1, DOI 10.1021/ac0010431; Zhang ZF, 2007, SCI CHINA SER B, V50, P127, DOI 10.1007/s11426-007-2031-3; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Yamasuji M, 2011, ANAL BIOCHEM, V413, P50, DOI 10.1016/j.ab.2011.01.047; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; BAYER EA, 1990, METHOD ENZYMOL, V184, P80; BERENSON RJ, 1987, BLOOD, V69, P1363; DAVIES J, 1994, J IMMUNOL METHODS, V167, P263, DOI 10.1016/0022-1759(94)90095-7; Dudin G, 1988, HUM GENET, V80; El-Mahdy AFM, 2014, CHEM COMMUN, V50, P859, DOI 10.1039/c3cc47454b; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hermanson GT, 1992, IMMOBILIZED AFFINITY; Jani IV, 2002, LANCET INFECT DIS, V2, P243, DOI 10.1016/S1473-3099(02)00242-6; Li T, 2007, CHEM COMMUN, P4209, DOI 10.1039/b712165b; Lu JZ, 2003, CHEM COMMUN, P2888, DOI 10.1039/b306895a; Nolan JP, 2001, CELL MOL BIOL, V47, P1241; PETERMAN JH, 1988, J IMMUNOL METHODS, V111, P271, DOI 10.1016/0022-1759(88)90136-6; Richard MC, 2002, NUCLEIC ACIDS RES, V30, P10; Sun CF, 2008, GENE, V420, P90, DOI 10.1016/j.gene.2008.05.013; Sun YR, 2000, HIGH TECH LETT, V10, P95; Trau M, 2001, ADV MATER, V13, P975, DOI 10.1002/1521-4095(200107)13:12/13<975::AID-ADMA975>3.0.CO;2-#; Ugozzoli LA, 2004, CLIN CHEM, V50, P1963, DOI 10.1073/clinchem.2004.039784; Valimaa L, 2004, ANAL BIOCHEM, V331, P376, DOI 10.1016/j.ab.2004.04.003; Wilchek M, 1998, ANAL BIOCHEM, V171, P1; Xie X, 2004, CHINESE SCI BULL, V49, P886, DOI 10.1360/03wb0166; Xin-Chun G, 2010, ANAL CHIM ACTA, V668, P208; Yingying Qi, 2009, Spectrochimica Acta, Part A (Molecular and Biomolecular Spectroscopy), V74, DOI 10.1016/j.saa.2009.05.023; Zheng YL, 2009, CANCER RES, V69, P1604, DOI 10.1158/0008-5472.CAN-08-3028	40	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-3672	1436-5073		MICROCHIM ACTA	Microchim. Acta	FEB	2015	182	3-4					495	503		10.1007/s00604-014-1348-9		9	Chemistry, Analytical	Chemistry	AZ4TL	WOS:000348215900005		
J	Webb, JD; Seki, T; Goldston, JF; Pruski, M; Crudden, CM				Webb, Jonathan D.; Seki, Tomohiro; Goldston, Jennifer F.; Pruski, Marek; Crudden, Cathleen M.			Selective functionalization of the mesopores of SBA-15	MICROPOROUS AND MESOPOROUS MATERIALS			English	Article						Mesoporous silica; SBA-15; Silylation; Surface functionalization; Selective grafting; Solid state NMR	SOLID-STATE NMR; DRUG-DELIVERY; SILICA NANOPARTICLES; ORGANOMETALLIC CATALYSTS; ELECTROLESS DEPOSITION; INTERFACIAL REACTIONS; CARRIER SYSTEM; MCM-41; ENANTIOSELECTIVITY; MOLECULES	A method has been developed that permits the highly selective functionalization of the interior and exterior surfaces of the ubiquitous mesoporous material, SBA-15. The key step is reloading the as-synthesized material with structure-directing agent, Pluronic (R) P123, prior to selective functionalization of the external surface with a silylating agent. This new approach represents a significant improvement over literature procedures. Results from physisorption analyses as well as solid-state NMR permit a detailed, quantitative assessment of functionalized SBA-15. This work also provides insight into the stability of the silyl layer during extraction procedures - an issue often neglected in other studies but of significant importance as decomposition of this layer could result in the introduction of new silanols and reduce the effectiveness of any selective grafting procedure. (C) 2014 Elsevier Inc. All rights reserved.	[Webb, Jonathan D.; Seki, Tomohiro; Crudden, Cathleen M.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Goldston, Jennifer F.; Pruski, Marek] Iowa State Univ, US DOE, Ames Lab, Ames, IA 50011 USA; [Goldston, Jennifer F.; Pruski, Marek] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Crudden, Cathleen M.] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648601, Japan	Crudden, CM (reprint author), Iowa State Univ, US DOE, Ames Lab, Ames, IA 50011 USA.	mpruski@iastate.edu; cathleen.crudden@chem.queensu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); NSERC; U. E. Carmichael and Queen's University; Queen's University; U.S. Department of Energy, Office of Basic Energy Sciences (BES), Division of Chemical Sciences, Geosciences, and Biosciences through the Ames Laboratory; Iowa State University [DE-AC02-07CH11358]	CMC thanks the Natural Sciences and Engineering Research Council of Canada (NSERC) for funding in terms of Discovery, Discovery Accelerator and RTI grants. CMC also acknowledges the Canada Foundation for Innovation (CFI) for infrastructure funding. JDW acknowledges NSERC for a Canada PGSD fellowship. TS acknowledges U. E. Carmichael and Queen's University for a Duncan and Urlla Carmichael Fellowship. JDW and TS acknowledge Queen's University for Queen's Graduate Awards. This research was also supported by the U.S. Department of Energy, Office of Basic Energy Sciences (BES), Division of Chemical Sciences, Geosciences, and Biosciences through the Ames Laboratory (JFG and MP). The Ames Laboratory is operated for the U.S. Department of Energy by Iowa State University under Contract No. DE-AC02-07CH11358.	Bui TX, 2011, J HAZARD MATER, V193, P156, DOI 10.1016/j.jhazmat.2011.07.043; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Jones MD, 2003, ANGEW CHEM INT EDIT, V42, P4326, DOI 10.1002/anie.200250861; Kruk M, 2000, CHEM MATER, V12, P1961, DOI 10.1021/cm000164e; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Liong M, 2009, J MATER CHEM, V19, P6251, DOI 10.1039/b902462j; Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488; Raja R, 2003, J AM CHEM SOC, V125, P14982, DOI 10.1021/ja030381r; Ambrogio MW, 2011, ACCOUNTS CHEM RES, V44, P903, DOI 10.1021/ar200018x; Casasus R, 2004, J AM CHEM SOC, V126, P8612, DOI 10.1021/ja048095i; Nguyen TD, 2007, J AM CHEM SOC, V129, P626, DOI 10.1021/ja065485r; Yang Q, 2005, CHEM MATER, V17, P5999, DOI 10.1021/cm051198v; Kang T, 2004, IND ENG CHEM RES, V43, P1478, DOI 10.1021/ie030590k; Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362; Lu AH, 2004, J AM CHEM SOC, V126, P8616, DOI 10.1021/ja0486521; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Wan Y, 2007, CHEM REV, V107, P2821, DOI 10.1021/cr068020s; Liu YH, 2004, LANGMUIR, V20, P3231, DOI 10.1021/la0358421; Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075; Shenderovich IG, 2003, J PHYS CHEM B, V107, P11924, DOI 10.1021/jp0349740; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l; Trebosc J, 2005, J AM CHEM SOC, V127, P3057, DOI 10.1021/ja043567e; Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i; Yang PP, 2012, CHEM SOC REV, V41, P3679, DOI 10.1039/c2cs15308d; Gartmann N, 2009, ANGEW CHEM INT EDIT, V48, P6354, DOI 10.1002/anie.200902436; YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P1535, DOI 10.1246/bcsj.63.1535; Park M, 1998, MICROPOR MESOPOR MAT, V25, P75, DOI 10.1016/S1387-1811(98)00173-5; de Juan F, 2000, ADV MATER, V12, P430, DOI 10.1002/(SICI)1521-4095(200003)12:6<430::AID-ADMA430>3.0.CO;2-3; Sierra I, 2013, CHEM SOC REV, V42, P3792, DOI 10.1039/c2cs35221d; Kageyama K, 1999, SCIENCE, V285, P2113, DOI 10.1126/science.285.5436.2113; Linares N, 2011, CHEM COMMUN, V47, P9024, DOI 10.1039/c1cc11016k; Zhang ZT, 2002, CHEM MATER, V14, P965, DOI 10.1021/cm0115517; Sun JM, 2006, J AM CHEM SOC, V128, P15756, DOI 10.1021/ja064884j; Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191; Cheng K, 2007, J AM CHEM SOC, V129, P9674, DOI 10.1021/ja070598b; Asefa T, 2005, CHEM MATER, V17, P2481, DOI 10.1021/cm047800j; Antochshuk V, 2000, J PHYS CHEM B, V104, P9713, DOI 10.1021/jp0021648; Antochshuk V, 1999, CHEM COMMUN, P2373, DOI 10.1039/a905242i; Antochshuk V, 2000, CHEM MATER, V12, P2496, DOI 10.1021/cm000268p; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Bourlinos AB, 2003, J PHYS CHEM B, V107, P920, DOI 10.1021/jp0205113; Cauda V., 2009, J AM CHEM SOC, V131, P11361; Hara K, 2012, J PHYS CHEM C, V116, P7083, DOI 10.1021/jp300580f; Inagaki S., 1993, CHEM COMMUN, P680; Johnson BFG, 1999, CHEM COMMUN, P1167, DOI 10.1039/a902441g; Kubo W., 2012, PHYS CHEM CHEM PHYS, V14, P1418; Lunn JD, 2010, CHEM COMMUN, V46, P2926, DOI 10.1039/b927487a; Nelson TD, 1996, SYNTHESIS-STUTTGART, P1031; Raynor SA, 2000, CHEM COMMUN, P1925, DOI 10.1039/b005689h; Shephard DS, 1998, ANGEW CHEM INT EDIT, V37, P2719, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2719::AID-ANIE2719>3.0.CO;2-6; Song CE, 2006, EUR J INORG CHEM, P2927, DOI 10.1002/ejic.200600344; Taguchi A, 2005, MICROPOR MESOPOR MAT, V77, P1, DOI 10.1016/j.micromeso.2004.06.030; Wiench JW, 2008, J MAGN RESON, V193, P233, DOI 10.1016/j.jmr.2008.05.007; Xie Y., 2008, J PHYS CHEM C, P9996	56	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-1811	1873-3093		MICROPOR MESOPOR MAT	Microporous Mesoporous Mat.	FEB	2015	203						123	131		10.1016/j.micromeso.2014.10.032		9	Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	AY5DI	WOS:000347593000015		
J	Kohno, Y; Kato, Y; Shibata, M; Fukuhara, C; Maeda, Y; Tomita, Y; Kobayashi, K				Kohno, Yoshiumi; Kato, Yasushi; Shibata, Masashi; Fukuhara, Choji; Maeda, Yasuhisa; Tomita, Yasumasa; Kobayashi, Kenkichiro			Enhanced stability of natural anthocyanin incorporated in Fe-containing mesoporous silica	MICROPOROUS AND MESOPOROUS MATERIALS			English	Article						Naturally occurring dye; Adsorption; Photostability; Mesoporous silica; HMS	NEUTRAL TEMPLATING ROUTE; MAYA BLUE; SPECTROSCOPIC CHARACTERIZATION; CATALYTIC-PROPERTIES; MOLECULAR-SIEVES; LIGHT FASTNESS; PIGMENT; COLOR; DYE; SURFACE	Anthocyanin is known as a safe coloring material although its poor stability often limits more extended use. In this study, we tried the enhancement of the photostability of the anthocyanin by the incorporation into the pore of HMS type mesoporous silica containing various metal ions. The anthocyanin was adsorbed on the HMS by pouring a highly concentrated anthocyanin solution to the dried HMS, urging the incorporation of the dye into the mesopore by a capillary condensation. Improved stability of the anthocyanin against visible irradiation was achieved by the adsorption onto the HMS containing Fe3+, although other metal ions in the HMS showed less effect on the stabilization. From the UV-vis spectroscopy, the Fe3+ species effective for the stabilization of the anthocyanin was found to be the tetrahedral one highly dispersed in the silica framework. The decrease in the absorptivity of the anthocyanin on the Fe-HMS compared to other metal-containing HMS suggested that the Fe-HMS promoted the aggregate formation of the anthocyanin molecules. The highly dispersed Fe3+ species had an ability to gather the anthocyanin molecule close to itself, resulting in tight incorporation of the dye inside the mesopore. The incorporation and aggregate formation of the anthocyanin was expected to contribute to the improvement of the stability against irradiation. (C) 2014 Elsevier Inc. All rights reserved.	[Kohno, Yoshiumi; Kato, Yasushi; Fukuhara, Choji; Maeda, Yasuhisa; Tomita, Yasumasa; Kobayashi, Kenkichiro] Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Shibata, Masashi] Tokyo Univ Technol, Sch Biosci & Biotechnol, Hachioji, Tokyo 1920982, Japan	Kohno, Y (reprint author), Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	tykouno@ipc.shizuoka.ac.jp			JSPS [24700787, 25289279]; Suga Weathering Technology Foundation	Part of this work was financially supported by JSPS KAKENHI Grant Numbers 24700787 and 25289279, and Suga Weathering Technology Foundation.	TANEV PT, 1995, SCIENCE, V267, P865, DOI 10.1126/science.267.5199.865; Gabelica Z, 2001, MICROPOR MESOPOR MAT, V44, P645, DOI 10.1016/S1387-1811(01)00245-1; Cavalcanti RN, 2011, FOOD RES INT, V44, P499, DOI 10.1016/j.foodres.2010.12.007; Cheng P, 2014, J SPECTROSC, P1, DOI 10.1155/2014/751458; Rodriguez-Saona LE, 2001, J FOOD PROCESS PRES, V25, P165, DOI 10.1111/j.1745-4549.2001.tb00452.x; Itoh T, 2002, J AM CHEM SOC, V124, P13437, DOI 10.1021/ja0203059; Kohno Y, 2008, MICROPOR MESOPOR MAT, V116, P70, DOI 10.1016/j.micromeso.2008.03.014; Kumar MS, 2004, J CATAL, V227, P384, DOI 10.1016/j.jcat.2004.08.003; Calzaferri G, 2000, SOLID STATE SCI, V2, P421, DOI 10.1016/S1293-2558(00)00129-1; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k; Kondo T, 1998, TETRAHEDRON LETT, V39, P8307, DOI 10.1016/S0040-4039(98)01858-9; Kohno Y, 2014, J PHYS CHEM SOLIDS, V75, P48, DOI 10.1016/j.jpcs.2013.08.007; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; CHU CTW, 1985, J PHYS CHEM-US, V89, P1569, DOI 10.1021/j100255a005; Moncada MC, 2003, INORG CHIM ACTA, V356, P51, DOI 10.1016/S0020-1693(03)00394-3; Del Rio MS, 2006, ARCHAEOMETRY, V48, P115; Wang Y, 2002, J CATAL, V209, P186, DOI 10.1006/jcat.2002.3607; BAUBLIS A, 1994, J FOOD SCI, V59, P1219, DOI 10.1111/j.1365-2621.1994.tb14681.x; Kohno Y, 2011, MICROPOR MESOPOR MAT, V141, P77, DOI 10.1016/j.micromeso.2010.11.004; Samuels M, 2013, J PHOTOCH PHOTOBIO B, V121, P23, DOI 10.1016/j.jphotobiol.2013.02.004; Leitao IMV, 2013, J CHEM EDUC, V90, P1493, DOI 10.1021/ed300425c; Lima E, 2012, J PHYS CHEM C, V116, P4556, DOI 10.1021/jp207602m; Ogawa M, 2011, CHEM COMMUN, V47, P8602, DOI 10.1039/c1cc12392k; Kohno Y, 2009, APPL CLAY SCI, V42, P519, DOI 10.1016/j.clay.2008.06.012; Dangles O, 2000, J CHEM SOC PERK T 2, P1653, DOI 10.1039/b003260n; Buchweitz M, 2012, FOOD CHEM, V132, P1971, DOI 10.1016/j.foodchem.2011.12.034; MAZZA G, 1987, FOOD CHEM, V25, P207, DOI 10.1016/0308-8146(87)90147-6; Giustetto R, 2012, MICROPOR MESOPOR MAT, V155, P167, DOI 10.1016/j.micromeso.2012.01.024; Bordiga S, 1996, J CATAL, V158, P486, DOI 10.1006/jcat.1996.0048; Nozaki C, 2002, J AM CHEM SOC, V124, P13194, DOI 10.1021/ja020388t; Bujdak J, 2002, COLLOID SURFACE A, V207, P207, DOI 10.1016/S0927-7757(02)00094-8; Schulz-Ekloff G, 2002, MICROPOR MESOPOR MAT, V51, P91, DOI 10.1016/S1387-1811(01)00455-3; Fois E, 2003, MICROPOR MESOPOR MAT, V57, P263, DOI 10.1016/S1387-1811(02)00596-6; Frick D., 2003, REV PROG COLOR, V33, P15, DOI DOI 10.1111/J.1478-4408.2003.TB00141.X; Gago S, 2013, MICROPOR MESOPOR MAT, V180, P40, DOI 10.1016/j.micromeso.2013.06.001; Gomes R, 2010, PHOTOCH PHOTOBIO SCI, V9, P991, DOI 10.1039/c0pp00022a; GOTO T, 1991, ANGEW CHEM INT EDIT, V30, P17, DOI 10.1002/anie.199100171; Holderich WF, 2000, PHYS CHEM CHEM PHYS, V2, P3919, DOI 10.1039/b003425h; Lin YH, 2014, DYES PIGMENTS, V100, P97, DOI 10.1016/j.dyepig.2013.08.022; Lin Y.-H., 2013, J JPN SOC COLOUR MAT, V86, P397; Liu H, 2008, MICROPOR MESOPOR MAT, V108, P56, DOI 10.1016/j.micromeso.2007.03.027; Oda H., 2003, J HOME EC JPN, V54, P1007; Oda H, 2001, COLOR TECHNOL, V117, P204; On DT, 2003, MICROPOR MESOPOR MAT, V57, P169; Santhosh Kumar M., 2006, APPL CATAL B-ENVIRON, V62, P244, DOI 10.1016/j.apcatb.2005.07.012; Shibata M, 1999, CHEM LETT, P1291, DOI 10.1246/cl.1999.1291; STARR MS, 1973, J FOOD SCI, V38, P1043, DOI 10.1111/j.1365-2621.1973.tb02144.x; Taylor G. W., 1986, REV PROG COLORATION, V16, P53; TIMBERLA.CF, 1966, NATURE, V212, P158, DOI 10.1038/212158a0; Tuel A, 1996, CHEM MATER, V8, P114, DOI 10.1021/cm950276j; Umamaheswari V, 2006, MICROPOR MESOPOR MAT, V89, P47, DOI 10.1016/j.micromeso.2005.05.045; YOSHIDA K, 1995, NATURE, V373, P291, DOI 10.1038/373291a0	52	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-1811	1873-3093		MICROPOR MESOPOR MAT	Microporous Mesoporous Mat.	FEB	2015	203						232	237		10.1016/j.micromeso.2014.10.042		6	Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	AY5DI	WOS:000347593000028		
J	Tanaka, M; Suh, I; Takada, H; Iwamoto, M				Tanaka, Masashi; Suh, Insuhk; Takada, Hitoshi; Iwamoto, Masakazu			Preparation of porous MTiOx (M = Cr, Mo, or W) composite oxides from a mesostructured material of titanium oxysulfate and surfactant micelles based on a wall ion exchange-calcination method	MICROPOROUS AND MESOPOROUS MATERIALS			English	Article						Titanium; Porous composite oxides; Chromium; Wormhole pore structure; Wall ion exchange	ENHANCED PHOTOCATALYTIC ACTIVITY; MESOPOROUS TIO2; ANION-EXCHANGE; OXIDATIVE DEHYDROGENATION; CATALYTIC-PROPERTIES; VISIBLE-LIGHT; ACTIVE-SITES; MIXED OXIDES; CHROMIUM; BEHAVIOR	Wall ion exchange (WIE) and subsequent calcination were applied to prepare porous TiO2-based composite oxides using a composite of TiOSO4 center dot xH(2)SO(4)center dot xH(2)O and cetyltrimethylammonium bromide (TS). Chromium oxyanion HCrO4- in an aqueous solution was ion-exchanged stoichiometrically with HCrO4- in TS at pH values in the range of 2.2-5.5. Calcination of the HCrai-introduced TS (Cr-TS) at 673 K for 2 h in air produced Cr-Ti oxide with surface areas of 296-430 m(2) g(-1), pore diameters of 1.7-2.5 nm, and a wormhole-like pore structure. These high surface areas could be achieved at ratios of Cr and Ti in the Cr-Ti oxide of 0.30-0.39 or above. XAFS, FT-IR, and UV-vis diffuse reflectance spectra indicated the occurrence of dimerization of HCrO4- to Cr2O3- during drying of the Cr-TS. The Cr2O7- species was then reduced to Cr(III) species upon calcination at 473-573 K. The Cr(III) species located on the surfaces of the pore walls were reoxidized to Cr(VI) upon calcination at 673 K, whereas those inside the pore walls remained unchanged. The present WIE-calcination method was applied to oxyanions of Mo, W, and V but did not produce the stoichiometric exchange that occurred in the Cr-TS system. Porous Mo- and W-Ti oxides with surface areas of 197-258 and 218-273 m(2) g(-1), respectively, were obtained upon treatment at approximately pH 10 and subsequent calcination at 673 K, although the reaction mechanisms were unknown. No porous V-Ti oxides with a high surface area could be obtained. (C) 2014 Elsevier Inc. All rights reserved.	[Tanaka, Masashi; Iwamoto, Masakazu] Chuo Univ, Res & Dev Initiat, Bunkyo Ku, Tokyo 1128551, Japan; [Suh, Insuhk; Takada, Hitoshi] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Iwamoto, M (reprint author), Chuo Univ, Res & Dev Initiat, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	iwamotom@tamacc.chuo-u.ac.jp			Japan Society for Promotion of Science (JSPS); Japan Science and Technology Agency (ALCA, JST)	The authors thank Dr. Daling Lu of Tokyo Institute of Technology for the TEM measurements. The measurements of the XAFS spectra were performed under proposal numbers of 2009G661 of the Photon Factory Program Advisory Committee. This work was supported by Grants-in-Aid from the Japan Society for Promotion of Science (JSPS) and the Advanced Low Carbon Technology Research and Development Program of Japan Science and Technology Agency (ALCA, JST).	Wang Y, 2003, J CATAL, V220, P347, DOI 10.1016/S0021-9517(03)00278-1; Pan JH, 2006, CHEM MATER, V18, P847, DOI 10.1021/cm0522782; Mutin PH, 2006, APPL CATAL B-ENVIRON, V69, P49, DOI 10.1016/j.apcatb.2006.05.021; Li LC, 2012, CATAL LETT, V142, P480, DOI 10.1007/s10562-012-0768-6; Yu JG, 2003, J CATAL, V217, P69, DOI 10.1016/S0021-9517(03)00034-4; Iwamoto M, 2002, CHEM LETT, P814, DOI 10.1246/cl.2002.814; ANTONELLI DM, 1995, ANGEW CHEM INT EDIT, V34, P2014, DOI 10.1002/anie.199520141; Peterson ML, 1997, GEOCHIM COSMOCHIM AC, V61, P3399, DOI 10.1016/S0016-7037(97)00165-8; Kondo JN, 2005, J MATER CHEM, V15, P2035, DOI 10.1039/b418331b; ZECCHINA A, 1971, J PHYS CHEM-US, V75, P2783; Ma F, 2012, APPL CATAL A-GEN, V427, P145, DOI 10.1016/j.apcata.2012.03.043; Davydov L, 2001, J CATAL, V203, P157, DOI 10.1006/jcat.2001.3334; Sakthivel S, 2006, APPL CATAL B-ENVIRON, V63, P31, DOI 10.1016/j.apcatb.2005.08.011; Hou YD, 2008, CHEMOSPHERE, V72, P414, DOI 10.1016/j.chemosphere.2008.02.035; Takehira K, 2004, J CATAL, V224, P404, DOI 10.1016/j.jcat.2004.03.014; Ballav N, 2012, CHEM ENG J, V198, P536, DOI 10.1016/j.cej.2012.05.110; Wang CH, 2006, J COLLOID INTERF SCI, V301, P236, DOI 10.1016/j.jcis.2006.05.002; Liu JW, 2009, J COLLOID INTERF SCI, V335, P216, DOI 10.1016/j.jcis.2009.03.027; Mimura N, 2006, J PHYS CHEM B, V110, P21764, DOI 10.1021/jp0619661; Baes Jr C.F., 1976, HYDROLYSIS CATIONS; Chan MH, 2007, SURF COAT TECH, V202, P962, DOI 10.1016/j.surfcoat.2007.05.045; Delouis W, 2006, INORG CHEM COMMUN, V9, P1136, DOI 10.1016/j.inoche.2006.07.031; Editorial Committee qof a Handbook of Inorganic Chemistry, 1965, HDB IN CHEM; Hayashi F., 2010, EUR J INORG CHEM, V15, P2235; House J., 2008, INORG CHEM, P235; Joint Committee for Powder Diffraction Standard, 1974, POWD DIFFR FIL; Khaleel A, 2010, J NON-CRYST SOLIDS, V356, P1282, DOI 10.1016/j.jnoncrysol.2010.04.031; Linden M, 1999, CHEM MATER, V11, P3002, DOI 10.1021/cm991082x; Mustafa S, 1997, REACT FUNCT POLYM, V34, P135, DOI 10.1016/S1381-5148(97)00079-5; Pak C, 2001, MICROPOR MESOPOR MAT, V48, P165, DOI 10.1016/S1387-1811(01)00340-7; Rao TVM, 2009, J MOL CATAL A-CHEM, V301, P159, DOI 10.1016/j.molcata.2008.12.027; Robinson J.W., 1974, HDB SPECTROSCOPY, V2, P97; Schattka JH, 2002, CHEM MATER, V14, P5103, DOI 10.1021/cm021238k; Segura Y, 2006, J PHYS CHEM B, V110, P948, DOI 10.1021/jp053576p; Sohn JR, 1998, J MOL CATAL A-CHEM, V135, P99, DOI 10.1016/S1381-1169(97)00295-1; SOHN JR, 1993, J MATER SCI, V28, P4651, DOI 10.1007/BF00414254; Suh I., 2013, EUR J INORG CHEM, V28, P4970; Takada H, 2004, CHEM LETT, V33, P62, DOI 10.1246/cl.2004.62; Waddington T., 1959, ADV INORG CHEM RAD, V1, P180; Wang Y, 2006, MAT SCI ENG B-SOLID, V128, P229, DOI 10.1016/j.mseb.2005.12.004; Wu P, 2005, CHEM MATER, V17, P3921, DOI 10.1021/cm0482277; Wu P, 1998, CHEM LETT, P1213, DOI 10.1246/cl.1998.1213; ZAKI MI, 1986, J THERM ANAL, V31, P825, DOI 10.1007/BF01913553	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-1811	1873-3093		MICROPOR MESOPOR MAT	Microporous Mesoporous Mat.	FEB	2015	203						274	281		10.1016/j.micromeso.2014.10.044		8	Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	AY5DI	WOS:000347593000032		
J	Kato, T; Otsuki, T; Yoshimoto, M; Itagaki, K; Kohsaka, T; Matsumoto, Y; Ike, K; Park, EY				Kato, Tatsuya; Otsuki, Takahiro; Yoshimoto, Mai; Itagaki, Kohei; Kohsaka, Tetsuya; Matsumoto, Yumino; Ike, Kazunori; Park, Enoch Y.			Bombyx mori Nucleopolyhedrovirus Displaying Neospora caninum Antigens as a Vaccine Candidate Against N-caninum Infection in Mice	MOLECULAR BIOTECHNOLOGY			English	Article						Bombyx mori nucleopolyhedrovirus (BmNPV) bacmid; Antigen-displaying baculovirus; Silkworm; Neospora caninum; Vaccine	IMMUNE-RESPONSES; SILKWORM LARVAE; SURFACE PROTEIN; IN-VITRO; CATTLE; CELLS; NCSRS2; HOST; EXPRESSION; PROTECTION	Baculovirus display systems have been utilized for cell-specific gene transfer, regenerative medicine, and as vaccine vectors. In particular, baculovirus particles displaying surface antigens have been used as vaccines against some parasites and viruses. In this study, Bombyx mori nucleopolyhedrovirus (BmNPV) particles displaying Neospora caninum antigens (NcSAG1, NcSRS2, and NcMIC3) purified from the hemolymph or fat body of silkworm larvae were prepared to vaccinate mice against N. caninum. Each antigen was expressed on the surface of BmNPV particles through glycoprotein 64 transmembrane and cytoplasmic domains. Antigen-specific antibody production was induced in mice by immunization with each recombinant BmNPV particle. NcMIC3-displaying BmNPV particles purified from the fat body induced a lower antibody titer than particles purified from the hemolymph. Antigen-specific IgG2a was predominantly produced in mice by immunization with NcSAG1-displaying BmNPV particles compared to IgG1, and induction of IFN-gamma was dominant, indicating that antigen-displaying BmNPV particles can elicit a Th1 immune response in mice. Semi-quantitative PCR analysis revealed that immunization with each antigen-displaying BmNPV particle partially protected mice from cerebral N. caninum infection. These results suggest that antigen-displaying BmNPV particles can provide an alternative method of controlling neosporosis in cattle and represent a new generation of N. caninum vaccines.	[Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Biotechnol Lab, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Kato, Tatsuya; Otsuki, Takahiro; Yoshimoto, Mai; Itagaki, Kohei; Park, Enoch Y.] Shizuoka Univ, Biotechnol Lab, Dept Appl Biol Chem, Fac Agr,Suruga Ku, Shizuoka 4228529, Japan; [Kohsaka, Tetsuya] Shizuoka Univ, Dept Appl Biol Chem, Lab Anim Reprod & Physiol, Fac Agr,Suruga Ku, Shizuoka 4228529, Japan; [Matsumoto, Yumino; Ike, Kazunori] Nippon Vet & Life Univ, Lab Vet Parasitol, Musashino, Tokyo 1808602, Japan	Park, EY (reprint author), Shizuoka Univ, Biotechnol Lab, Res Inst Green Sci & Technol, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	atkato@ipc.shizuoka.ac.jo; su_ta12highland_ene@yahoo.co.jp; maiyoshimoto18@gmail.com; pixy_007bc@yahoo.co.jp; t-kohsaka@agr.shizuoka.ac.jp; v09082@nvlu.ac.jp; ike-k@nvlu.ac.jp; acypark@ipc.shizuoka.ac.jp	Kato, Tatsuya/E-3095-2010; 	Park, Enoch Y./0000-0002-7840-1424	Ministry of Education, Culture, Sports, Science and Technology, Japan [22248009]	This work was supported by Grant-in-Aid for Scientific Research (A) Grant No. 22248009 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abe T, 2009, J VIROL, V83, P7629, DOI 10.1128/JVI.00679-09; Alaeddine F, 2005, J PARASITOL, V91, P657, DOI 10.1645/GE-401R; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Reichel MP, 2009, INT J PARASITOL, V39, P1173, DOI 10.1016/j.ijpara.2009.05.007; Nishikawa Y, 2000, INT J PARASITOL, V30, P51, DOI 10.1016/S0020-7519(99)00162-9; Cowper B, 2012, MOL BIOCHEM PARASIT, V186, P1, DOI 10.1016/j.molbiopara.2012.08.007; Goodswen SJ, 2013, INFECT GENET EVOL, V13, P133, DOI 10.1016/j.meegid.2012.08.012; Cannas A, 2003, J PARASITOL, V89, P44, DOI 10.1645/0022-3395(2003)089[0044:RCIONC]2.0.CO;2; Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060; Weston JF, 2012, PREV VET MED, V103, P136, DOI 10.1016/j.prevetmed.2011.08.010; Staska LM, 2005, INFECT IMMUN, V73, P1321, DOI 10.1128/IAI.73.3.1321-1329.2005; Gronowski AM, 1999, J VIROL, V73, P9944; Otsuki T, 2013, VET PARASITOL, V192, P284, DOI 10.1016/j.vetpar.2012.09.038; Vonlaufen N, 2004, INFECT IMMUN, V72, P576, DOI 10.1128/IAI.72.1.576-583.2004; Alvarez-Garcia G, 2007, PARASITOLOGY, V134, P41, DOI 10.1017/S0031182006001284; Nishikawa Y, 2002, VET PARASITOL, V109, P191, DOI 10.1016/S0304-4017(02)00256-X; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; Chen CY, 2011, BIOTECHNOL ADV, V29, P618, DOI 10.1016/j.biotechadv.2011.04.004; Baszler TV, 2008, CLIN VACCINE IMMUNOL, V15, P659, DOI 10.1128/CVI.00436-07; Dubey J. P., 2010, VET PARASITOL, V180, P90; Fang R, 2010, VACCINE, V28, P1803, DOI 10.1016/j.vaccine.2009.12.005; Haldorson GJ, 2006, EXP PARASITOL, V112, P172, DOI 10.1016/j.exppara.2005.11.004; Hervas-Stubbs S, 2007, J IMMUNOL, V178, P2361; Kato T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-55; Lei Y, 2005, PARASITOLOGY, V131, P467, DOI 10.1017/S003118200500805X; Nishikawa Y, 2009, CLIN VACCINE IMMUNOL, V16, P792, DOI 10.1128/CVI.00032-09; Nishimura M, 2013, VACCINE, V31, P3528, DOI 10.1016/j.vaccine.2013.05.083; Tang XC, 2010, VACCINE, V28, P6821, DOI 10.1016/j.vaccine.2010.08.040; Wilson S, 2008, VACCINE, V26, P2451, DOI 10.1016/j.vaccine.2008.03.027; Yoshida S, 2010, INFECT IMMUN, V78, P595, DOI 10.1128/IAI.00877-09	30	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1073-6085	1559-0305		MOL BIOTECHNOL	Mol. Biotechnol.	FEB	2015	57	2					145	154		10.1007/s12033-014-9810-9		10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	AZ3OH	WOS:000348136300005		
J	Sakurai, M; Kurokawa, H; Shimada, A; Nakamura, K; Miyata, H; Morita, T				Sakurai, Masashi; Kurokawa, Haruna; Shimada, Akinori; Nakamura, Kazuhiro; Miyata, Hajime; Morita, Takehito			Excitatory amino acid transporter 2 downregulation correlates with thalamic neuronal death following kainic acid-induced status epilepticus in rat	NEUROPATHOLOGY			English	Article						epilepsy; excitatory amino acid transporter 2; neuronal death; status epilepticus; thalamus	TEMPORAL-LOBE EPILEPSY; IDIOPATHIC GENERALIZED EPILEPSY; MICROGLIAL ACTIVATION; GLUTAMATE TRANSPORT; REFRACTORY EPILEPSY; HIPPOCAMPAL; ISCHEMIA; SEIZURES; CORTEX; DAMAGE	Recurrent seizures without interictal resumption (status epilepticus) have been reported to induce neuronal death in the midline thalamic region that has functional roles in memory and decision-making; however, the pathogenesis underlying status epilepticus-induced thalamic neuronal death is yet to be determined. We performed histological and immunohistochemical studies as well as cerebral blood flow measurement using 4.7 tesla magnetic resonance imaging spectrometer on midline thalamic region in Sprague-Dawley rats (n=75, male, 7 weeks after birth, body weight 250-300g) treated with intraperitoneal injection of kainic acid (10mg/kg) to induce status epilepticus (n=55) or normal saline solution (n=20). Histological study using paraffin-embedded specimens revealed neuronal death showing ischemic-like changes and Fluoro-Jade C positivity with calcium deposition in the midline thalamic region of epileptic rats. The distribution of neuronal death was associated with focal loss of immunoreactivity for excitatory amino acid transporter 2 (EAAT2), stronger immunoreaction for glutamate and increase in number of Iba-1-positive microglial cells showing swollen cytoplasm and long processes. Double immunofluorescence study demonstrated co-expression of interleukin-1 beta (IL-1) and inducible nitric oxide synthase (iNOS) within microglial cells, and loss of EAAT2 immunoreactivity in reactive astrocytes. These microglial alterations and astrocytic EAAT2 downregulation were also observed in tissue without obvious neuronal death in kainic acid-treated rats. These results suggest the possible role of glutamate excitotoxicity in neuronal death in the midline thalamic region following kainic acid-induced status epilepticus due to astrocytic EAAT2 downregulation following microglial activation showing upregulation of IL-1 and iNOS.	[Sakurai, Masashi; Kurokawa, Haruna; Morita, Takehito] Tottori Univ, Dept Vet Pathol, Tottori 6808553, Japan; [Shimada, Akinori] Azabu Univ, Dept Pathol, Sagamihara, Kanagawa, Japan; [Nakamura, Kazuhiro] Res Inst Brain & Blood Vessels, Dept Radiol & Nucl Med, Akita 0100874, Japan; [Miyata, Hajime] Res Inst Brain & Blood Vessels, Dept Neuropathol, Akita 0100874, Japan	Morita, T (reprint author), Tottori Univ, Dept Vet Pathol, Tottori 6808553, Japan.	morita@muses.tottori-u.ac.jp		Miyata, Hajime/0000-0003-2551-5978			Alessio A, 2006, EPILEPSY BEHAV, V8, P593, DOI 10.1016/j.yebeh.2006.01.007; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; PETITO CK, 1987, NEUROLOGY, V37, P1281; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; McKenna JT, 2004, J COMP NEUROL, V480, P115, DOI 10.1002/cne.20342; Vertes RP, 2002, J COMP NEUROL, V442, P163, DOI 10.1002/cne.10083; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474; Rodriguez MJ, 2000, INT J DEV NEUROSCI, V18, P299, DOI 10.1016/S0736-5748(99)00098-2; Kanner AM, 2011, EPILEPSIA, V52, P21, DOI 10.1111/j.1528-1167.2010.02907.x; Natsume J, 2003, NEUROLOGY, V60, P1296; Tham WWP, 2009, BRAIN RES REV, V62, P109, DOI 10.1016/j.brainresrev.2009.09.007; Anderson CM, 2000, GLIA, V32, P1; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/01.wco.0000063766.15877.8e; Rao VLR, 2001, J NEUROSCI, V21, P1876; Zhang XA, 1997, EUR J NEUROSCI, V9, P760, DOI 10.1111/j.1460-9568.1997.tb01424.x; Rijkers K, 2009, EXP NEUROL, V216, P258, DOI 10.1016/j.expneurol.2008.12.014; Gayoso MJ, 2003, HISTOL HISTOPATHOL, V18, P855; Proper EA, 2002, BRAIN, V125, P32, DOI 10.1093/brain/awf001; Jacek S, 2007, EPILEPSY BEHAV, V11, P466, DOI 10.1016/j.yebeh.2007.05.016; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; INGVAR M, 1988, ACTA NEUROPATHOL, V75, P362; Swanson RA, 1997, J NEUROSCI, V17, P932; Bertram EH., 2012, EXP NEUROL, V244, P67; Blume Warren T., 2001, Epilepsia, V42, P1212, DOI 10.1046/j.1528-1157.2001.22001.x; Fujikawa Denson G., 2000, Epilepsia, V41, P981, DOI 10.1111/j.1528-1157.2000.tb00283.x; Helms G, 2006, J NEUROL NEUROSUR PS, V77, P489, DOI 10.1136/jnnp.2005.074682; Meldrum BS, 1992, GREENFIELDS NEUROPAT, P1246; MELDRUM BS, 1993, BRAIN PATHOL, V3, P405, DOI 10.1111/j.1750-3639.1993.tb00768.x; Najjar S, 2011, NEUROLOGIST, V17, P249, DOI 10.1097/NRL.0b013e31822aad04; Nakamura K, 2008, IEEE ENG MED BIO, P839; Paxinos G., 1986, RAT BRAIN STEREOTAXI; Prow NA, 2008, J NEUROCHEM, V105, P1276, DOI 10.1111/j.1471-4159.2008.05230.x; Tanaka M, 2003, IEICE TECH REP, V103, P5; Ueda Y, 2001, J NEUROCHEM, V76, P892, DOI 10.1046/j.1471-4159.2001.00087.x; Yamada T, 2006, NEUROCHEM RES, V31, P49, DOI 10.1007/s11064-005-9077-4	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	FEB	2015	35	1					1	+		10.1111/neup.12141		9	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AZ2JU	WOS:000348060900001		
J	Kuninaka, N; Kawaguchi, M; Ogawa, M; Sato, A; Arima, K; Murayama, S; Saito, Y				Kuninaka, Nobuo; Kawaguchi, Minato; Ogawa, Masaru; Sato, Ayako; Arima, Kunimasa; Murayama, Shigeo; Saito, Yuko			Simplification of the modified Gallyas method	NEUROPATHOLOGY			English	Article						argyrophilic grains; glial cytoplasmic inclusion; lanthanum nitrate hexahydrate; neurofibrillary tangles; simplification technique	CAMPBELL-SWITZER METHODS; NEUROFIBRILLARY CHANGES; ALZHEIMER-TYPE; SILVER; PIGMENT; DISEASE; BODIES; BRAAK	The Gallyas method is a silver impregnation technique that is essential in the field of neuropathology because of its high sensitivity for the detection of argentophilic inclusion bodies in the central nervous system. In Japan, the Gallyas method has improved and is widely used as the modified Gallyas method. However, this method is not popularly used in general pathology laboratories because of the need for special reagents, several staining processes, and skilled techniques. The objective of the current study was to provide a simplified Gallyas method. We omitted the lanthanum nitrate step from the staining process and verified the adequacy in comparison with the original method as well as immunohistochemistry, using specimens from patients of Alzheimer's disease, argyrophilic grain disease, multiple system atrophy, Pick's disease, and Lewy body disease. The simplified method provided good staining to all the structures in archival tissues, compared with the modified Gallyas method in a significantly shorter staining time. The lanthanum nitrate step can be omitted from the modified Gallyas method, resulting in reduction in the number of reagents required and shortening of the staining time.	[Kuninaka, Nobuo; Kawaguchi, Minato; Ogawa, Masaru; Sato, Ayako; Arima, Kunimasa; Saito, Yuko] Natl Ctr Hosp Neurol & Psychiat, Dept Pathol & Lab Med, Kodaira, Tokyo 1878551, Japan; [Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan	Saito, Y (reprint author), Natl Ctr Hosp Neurol & Psychiat, Dept Pathol & Lab Med, Ogawahigashi Cho 4-1-1, Kodaira, Tokyo 1878551, Japan.	yukosm@ncnp.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; NCNP [22-7]	This research was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and an Intramural Research Grant (22-7) for Neurological and Psychiatric Disorders of NCNP. We thank Drs. H. Hatsuta, T. Adachi, S. Funabe, and M. Sugiyama for helpful discussions and Mr. N. Aikyo, Ms. Y. Kimura, Ms. M. Harada, Ms. N. Naoi, and Ms. Saishoji for technical support.	Adachi T, 2010, J NEUROPATH EXP NEUR, V69, P737, DOI 10.1097/NEN.0b013e3181e5ae5c; Uchihara T, 2005, ACTA NEUROPATHOL, V110, P255, DOI 10.1007/s00401-005-1044-2; Uchihara T, 2001, ACTA NEUROPATHOL, V102, P462; BRAAK H, 1988, STAIN TECHNOL, V63, P197; Arai N, 1996, NEUROPATHOLOGY, V16, P133, DOI 10.1111/j.1440-1789.1996.tb00168.x; Arima K, 2010, NEUROPATHOLOGY, V30, P309; Gallyas F, 2008, BIOTECH HISTOCHEM, V83, P221, DOI 10.1080/10520290802538543; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; KITOH T, 1980, ACTA NEUROPATHOL, V49, P67; LILLIE RD, 1957, J HISTOCHEM CYTOCHEM, V5, P346; Matsumoto A, 1982, MARKER INTRO METHOD, P123; Namimatsu S, 2010, NICHIIDAI IGAKU ZASS, V6, P178, DOI 10.1272/manms.6.178; Perdrau JR, 1921, J PATHOL BACTERIOL, V24, P117, DOI 10.1002/path.1700240109; Uchihara T, 1994, PATHOL CLIN MED, V12, P163; UCHIHARA T, 1995, J NEUROL, V242, P485, DOI 10.1007/BF00867417; Uchihara T, 2005, ACTA NEUROPATHOL, V109, P483, DOI 10.1007/s00401-005-0988-6; UCHIHARA T, 1992, ACTA NEUROPATHOL, V83, P271	17	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	FEB	2015	35	1					10	15		10.1111/neup.12144		6	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AZ2JU	WOS:000348060900002		
J	Honda, H; Hamasaki, H; Wakamiya, T; Koyama, S; Suzuki, SO; Fujii, N; Iwaki, T				Honda, Hiroyuki; Hamasaki, Hideomi; Wakamiya, Tomihiro; Koyama, Sachiko; Suzuki, Satoshi O.; Fujii, Naoki; Iwaki, Toru			Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions	NEUROPATHOLOGY			English	Article						amyotrophic lateral sclerosis; hnRNP; hnRNPA1; motor neuron; TDP-43	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PRION-LIKE DOMAINS; NEUROLOGICAL DISEASE; TARDBP MUTATIONS; TDP-43; PROTEIN; A1; AUTOANTIBODIES; A/B	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by loss of motor neurons and appearance of skein-like inclusions. The inclusions are composed of trans-activation response (TAR) DNA-binding protein 43 (TDP-43), a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) family. hnRNPA1 and hnRNPA2/B1 are hnRNPs that interact with the C-terminus of TDP-43. Using immunohistochemistry, we investigated the association between TDP-43 and hnRNPA1 in ALS spinal motor neurons. We examined spinal cords of seven ALS cases and six muscular dystrophy cases (used as controls) for the presence of TDP-43 and hnRNPA1 protein. In the control cases, hnRNPA1 immunoreactivity in motor neurons was intense in the nucleus and weak in the cytoplasm where it showed a fine granular appearance. In the ALS cases, hnRNPA1 immunoreactivity in motor neurons was reduced in the nuclei of neurons with skein-like inclusions but was not detected in the skein-like inclusions. The marked loss of hnRNPA1 in motor neurons with concomitant cytoplasmic aggregation of TDP-43 may represent a severe disturbance of mRNA processing, suggesting a key role in progressive neuronal death in ALS.	[Honda, Hiroyuki; Hamasaki, Hideomi; Wakamiya, Tomihiro; Koyama, Sachiko; Suzuki, Satoshi O.; Iwaki, Toru] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Neuropathol, Fukuoka 8128582, Japan; [Fujii, Naoki] Natl Omuta Hosp, Dept Neurol, Neuromuscular Ctr, Fukuoka, Japan	Iwaki, T (reprint author), Kyushu Univ, Dept Neuropathol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	iwaki@np.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26290017]	This study was supported in part by a Grant-in-Aid for Scientific Research (B) (No. 26290017) from the Japan Society for the Promotion of Science (JSPS).	Bekenstein U, 2013, MOL CELL NEUROSCI, V56, P436, DOI 10.1016/j.mcn.2012.12.002; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Lee S, 2011, J NEUROIMMUNOL, V235, P56, DOI 10.1016/j.jneuroim.2011.02.007; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Donev R, 2007, MOL PSYCHIATR, V12, P681, DOI 10.1038/sj.mp.4001971; Neumann M, 2007, ACTA NEUROPATHOL, V113, P543, DOI 10.1007/s00401-007-0221-x; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Mayeda A, 1998, RNA, V4, P1111, DOI 10.1017/S135583829898089X; Berson A, 2012, EMBO MOL MED, V4, P730, DOI 10.1002/emmm.201100995; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Lee SM, 2006, NEUROSCI LETT, V401, P188, DOI 10.1016/j.neulet.2006.03.016; Seelen M, 2014, NEUROBIOL AGING, V35; Sueoka E, 2004, ANN NEUROL, V56, P778, DOI 10.1002/ana.20276	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	FEB	2015	35	1					37	43		10.1111/neup.12153		7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AZ2JU	WOS:000348060900005		
J	Itoh, K; Yagita, K; Nozaki, T; Katano, H; Hasegawa, H; Matsuo, K; Hosokawa, Y; Tando, S; Fushiki, S				Itoh, Kyoko; Yagita, Kenji; Nozaki, Tomoyoshi; Katano, Harutaka; Hasegawa, Hideki; Matsuo, Koushun; Hosokawa, Youhei; Tando, So; Fushiki, Shinji			An autopsy case of Balamuthia mandrillaris amoebic encephalitis, a rare emerging infectious disease, with a brief review of the cases reported in Japan	NEUROPATHOLOGY			English	Article						Balamuthia mandrillaris; granulomatous amoebic encephalitis; MRI; necrotizing vasculitis; PCR	LEPTOMYXID-AMEBA; MENINGOENCEPHALITIS	Balamuthia mandrillaris is an amoeba found in fresh water and soil that causes granulomatous amoebic encephalitis. We report herein an autopsy case of B. mandrillaris amoebic encephalitis, which was definitely diagnosed by PCR. An 81-year-old man, who had Sjogren's syndrome, manifested drowsiness 2 months before his death with progressive deterioration. Neuroimaging demonstrated foci of T2- and fluid-attenuated inversion recovery high and T1 low-intensity with irregular post-contrast ring enhancement in the cerebral hemisphere, thalamus and midbrain. Pathologically, multiple hemorrhagic and necrotic lesions were found in the cerebrum, thalamus, midbrain, pons, medulla and cerebellum, which were characterized by liquefactive necrosis, marked edema, hemorrhage and necrotizing vasculitis associated with the perivascular accumulation of amoebic trophozoites, a few cysts, and the infiltration of numerous neutrophils and microglia/macrophages. The trophozoites were ovoid or round, 10-60m in diameter, and they showed foamy cytoplasm and a round nucleus with small karyosome in the center. The PCR and immunohistochemistry from paraffin-embedded brain specimens revealed angioinvasive encephalitis due to B. mandrillaris. Human cases of B. mandrillaris brain infection are rare in Japan, with only a few brief reports in the literature.	[Itoh, Kyoko; Tando, So; Fushiki, Shinji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto 6028566, Japan; [Yagita, Kenji; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan; [Katano, Harutaka; Hasegawa, Hideki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Matsuo, Koushun] Ohmihachiman Community Med Ctr, Div Neurol, Ohmihachiman, Japan; [Hosokawa, Youhei] Ohmihachiman Community Med Ctr, Div Pathol, Ohmihachiman, Japan	Itoh, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	kxi14@koto.kpu-m.ac.jp					VISVESVARA GS, 1990, J CLIN MICROBIOL, V28, P2750; Lorenzo-Morales J, 2013, TRENDS PARASITOL, V29, P483, DOI 10.1016/j.pt.2013.07.009; Gupte AA, 2014, AM J TRANSPLANT, V14, P1417, DOI 10.1111/ajt.12726; Schuster FL, 2003, J CLIN MICROBIOL, V41, P3175, DOI 10.1128/JCM.41.7.3175-3180.2003; ANZIL AP, 1991, ARCH PATHOL LAB MED, V115, P21; Bando Y, 2012, PATHOL INT, V62, P418, DOI 10.1111/j.1440-1827.2012.02816.x; Bravo FG, 2012, CURR INFECT DIS REP, V14, P391, DOI 10.1007/s11908-012-0266-4; Combs FJ, 2011, RADIOGRAPHICS, V31, P31, DOI 10.1148/rg.311105067; Deol I, 2000, SURG NEUROL, V53, P611, DOI 10.1016/S0090-3019(00)00232-9; LaFleur M, 2013, RADIOL CASE, V7, P9; Lobo SA, 2013, PARASITOL RES, V112, P4015, DOI 10.1007/s00436-013-3592-z; PEREZ MT, 2001, ANN DIAGN PATHOL, V11, P440; Phillips BC, 2013, CLIN NEUROL NEUROSUR, V115, P1102, DOI 10.1016/j.clineuro.2012.08.015; Shirabe T, 2002, NEUROPATHOLOGY, V22, P213, DOI 10.1046/j.1440-1789.2002.00444.x; Siddiqui R, 2008, MICROB PATHOGENESIS, V44, P89, DOI 10.1016/j.micpath.2007.06.008; TARATUTO AL, 1991, T ROY SOC TROP MED H, V85, P77, DOI 10.1016/0035-9203(91)90164-T; Yamasaki K, 2011, NEUROL MED-CHIR, V51, P667	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	FEB	2015	35	1					64	69		10.1111/neup.12151		6	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AZ2JU	WOS:000348060900009		
J	Ishida, C; Kobayashi, K; Kitamura, T; Ujike, H; Iwasa, K; Yamada, M				Ishida, Chiho; Kobayashi, Katsuji; Kitamura, Tatsuru; Ujike, Hiroshi; Iwasa, Kazuo; Yamada, Masahito			Frontotemporal dementia with parkinsonism linked to chromosome 17 with the MAPT R406W mutation presenting with a broad distribution of abundant senile plaques	NEUROPATHOLOGY			English	Article						Alzheimer disease; frontotemporal dementia; MAPT protein; senile plaque; tau	ALZHEIMERS-DISEASE; TAU MUTATIONS; NEUROPATHOLOGIC ASSESSMENT; CEREBROSPINAL-FLUID; LOBAR DEGENERATION; FRONTAL-VARIANT; TAUOPATHY; PHENOTYPE; FAMILY	We report the autopsy results of a patient with familial dementia who was diagnosed as having frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) with an R406W mutation in the microtubule-associated protein tau (MAPT) gene. This patient showed Alzheimer's disease (AD)-like clinical manifestations from the age of 59, with reduced -amyloid1-42 (A(42)) and elevated total and phosphorylated tau levels in the cerebrospinal fluid. He did not present with any apparent parkinsonism throughout the disease course. His autopsy at age 73 showed atrophy and neurodegeneration in many brain regions, particularly in the antero-medial temporal cortex and hippocampus, followed by the frontal lobes, with abundant neurofibrillary tangles. In addition, a diffuse distribution of A-positive senile plaques, including many neuritic plaques, was observed and classified as stage C according to the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) criteria. These results suggest that analyzing of the MAPT gene is essential for diagnosing familial dementia, even if amyloid markers such as A(42) in the cerebrospinal fluid and amyloid imaging are positive, or if neuropathological findings indicate a diagnosis of AD.	[Ishida, Chiho] Natl Hosp Org Iou Hosp, Dept Neurol, Komatsu, Japan; [Kobayashi, Katsuji] Awazu Neuropsychiat Sanat, Dept Psychiat, Komatsu, Japan; [Kitamura, Tatsuru] Ishikawa Prefectual Takamatsu Hosp, Dept Psychiat, Kahoku, Ishikawa, Japan; [Ujike, Hiroshi] Ujike Nishiguchi Clin, Okayama, Japan; [Iwasa, Kazuo; Yamada, Masahito] Kanazawa Univ Grad Sch Med Sci, Dept Neurol, Kanazawa, Ishikawa, Japan	Ishida, C (reprint author), Natl Hosp Org Iou Hosp, Dept Neurol, Iwade Machi Ni73-1, Kanazawa, Ishikawa 9200192, Japan.	cishida@ioudom.hosp.go.jp					Lindquist SG, 2008, EUR J NEUROL, V15, P377, DOI 10.1111/j.1468-1331.2008.02069.x; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; van Swieten JC, 1999, ANN NEUROL, V46, P617, DOI 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I; Hogg M, 2003, ACTA NEUROPATHOL, V106, P323, DOI 10.1007/s00401-003-0734-x; MIRRA SS, 1991, NEUROLOGY, V41, P479; Rosso SM, 2003, ARCH NEUROL-CHICAGO, V60, P1209, DOI 10.1001/archneur.60.9.1209; Tolboom N, 2010, ALZ DIS ASSOC DIS, V24, P303, DOI 10.1097/WAD.0b013e3181cf35ec; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Mann DMA, 2001, NEUROSCI LETT, V304, P161, DOI 10.1016/S0304-3940(01)01785-2; Saito Y, 2002, NEUROLOGY, V58, P811; Taylor KI, 2008, NAT CLIN PRACT NEURO, V4, P226, DOI 10.1038/ncpneuro0746; Johnson JK, 1999, ARCH NEUROL-CHICAGO, V56, P1233, DOI 10.1001/archneur.56.10.1233; Goedert M, 1998, NEURON, V21, P955, DOI 10.1016/S0896-6273(00)80615-7; Ikeuchi Takeshi, 2011, Dement Geriatr Cogn Dis Extra, V1, P267, DOI 10.1159/000331243; Kobayashi K, 2003, J NEUROL, V250, P990, DOI 10.1007/s00415-003-1137-6; Komatsu J, 2011, ACTA NEUROL BELG, V111, P374; Morinaga A, 2010, DEMENT GERIATR COGN, V30, P285, DOI 10.1159/000320265; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Rosso SM, 2000, ANN NY ACAD SCI, V920, P115; Ujike H, 2001, ARCH NEUROL-CHICAGO, V58, P1004, DOI 10.1001/archneur.58.6.1004	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	FEB	2015	35	1					75	82		10.1111/neup.12154		8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AZ2JU	WOS:000348060900011		
J	Miyajima, H				Miyajima, Hiroaki			Symposium: Neurodegeneration with Brain Iron Accumulation	NEUROPATHOLOGY			English	Article						ceruloplasmin; iron; ferroxidase; ferroportin; hepcidin; neurodegeneration; iron metabolic cycle	CERULOPLASMIN-DEFICIENT MICE; FERROXIDASE ACTIVITY; LIPID-PEROXIDATION; ACERULOPLASMINEMIA; FERROPORTIN; OVERLOAD; HEPCIDIN; INTERNALIZATION; HOMEOSTASIS; METABOLISM	Aceruloplasminemia is characterized by progressive neurodegeneration with brain iron accumulation due to the complete lack of ceruloplasmin ferroxidase activity caused by mutations in the ceruloplasmin gene. Redox-active iron accumulation was found to be more prominent in the astrocytes than in the neurons. The most characteristic findings were abnormal or deformed astrocytes and globular structures of astrocytes. The lack of ceruloplasmin may primarily damage astrocytes in the aceruloplasminemic brains as a result of lipid peroxidation due to massive iron deposition. In the normal brain, iron may be continuously recycled between astrocytes and neurons, with transferrin acting as a shuttle. The glycosylphosphatidylinositol (GPI)-linked ceruloplasmin on astrocytes functions as a ferroxidase, mediating the oxidation of ferrous iron transported from the cytosol by ferroportin and its subsequent transfer to transferrin. In cases with aceruloplasminemia, neurons take up the iron from alternative sources of non-transferrin-bound iron, because astrocytes without GPI-linked ceruloplasmin cannot transport iron to transferrin. The excess iron in astrocytes could result in oxidative damage to these cells, and the neuronal cell protection offered by astrocytes would thus be disrupted. Neuronal cell loss may result from iron starvation in the early stage and from iron-mediated oxidation in the late stage. Ceruloplasmin may therefore play an essential role in neuronal survival in the central nervous system.	[Miyajima, Hiroaki] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan	Miyajima, H (reprint author), Hamamatsu Univ Sch Med, Dept Med 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	miyajima@hama-med.ac.jp					Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Kaneko Y, 2010, J GASTROENTEROL, V45, P1163, DOI 10.1007/s00535-010-0259-8; MIYAJIMA H, 1987, NEUROLOGY, V37, P761; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; McNeill A, 2008, NEUROLOGY, V70, P1614, DOI 10.1212/01.wnl.0000310985.40011.d6; Patel BN, 2002, J NEUROSCI, V22, P6578; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Miyajima H, 1997, ANN NEUROL, V41, P404, DOI 10.1002/ana.410410318; McNeill A, 2008, EUR NEUROL, V60, P200, DOI 10.1159/000148691; Kuhn J, 2007, BRAIN DEV-JPN, V29, P450, DOI 10.1016/j.braindev.2007.01.001; Kaneko K, 2002, FREE RADICAL RES, V36, P303, DOI 10.1080/10715760290019327; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Jeong SY, 2006, J NEUROSCI, V26, P9810, DOI 10.1523/JNEUROSCI.2922-06.2006; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Mitsumori F, 2009, MAGN RESON MED, V62, P1326, DOI 10.1002/mrm.22097; Daimon M, 1997, DIABETES CARE, V20, P678; Gonzalez-Cuyar LF, 2008, NEUROPATHOLOGY, V28, P466, DOI 10.1111/j.1440-1789.2008.00901.x; Guo P, 2009, PEPTIDES, V30, P262, DOI 10.1016/j.peptides.2008.09.017; Hellman NE, 2000, GUT, V47, P858, DOI 10.1136/gut.47.6.858; Kaneko K, 2002, J NEUROPATH EXP NEUR, V61, P1069; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Kono S, 2012, CURR DRUG TARGETS, V13, P1190; Mitsumori F, 2013, 54 EXP NUCL MAGN RES; Miyajima H, 1999, NEUROLOGY, V53, P617; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Miyajima H, 2002, BLOOD CELL MOL DIS, V29, P433, DOI 10.1006/bcmd.2002.0561; MORITA H, 1995, ANN NEUROL, V37, P646, DOI 10.1002/ana.410370515; Oide T, 2006, NEUROPATH APPL NEURO, V32, P170, DOI 10.1111/j.1365-2990.2006.00710.x; SAMOKYSZYN VM, 1989, J BIOL CHEM, V264, P21; Skidmore FM, 2008, J NEUROL NEUROSUR PS, V79, P467, DOI 10.1136/jnnp.2007.120568	34	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	FEB	2015	35	1					83	90		10.1111/neup.12149		8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AZ2JU	WOS:000348060900012		
J	Tanboon, J; Hayashi, YK; Nishino, I; Sangruchi, T				Tanboon, Jantima; Hayashi, Yukiko K.; Nishino, Ichizo; Sangruchi, Tumtip			Kyphoscoliosis and easy fatigability in a 14-year-old boy	NEUROPATHOLOGY			English	Article							TROPOMYOSIN GENE TPM2; CAP DISEASE; NEMALINE RODS; MYOPATHY; MUTATION; FAMILY		[Tanboon, Jantima; Sangruchi, Tumtip] Mahidol Univ, Siriraj Hosp, Dept Pathol, Fac Med, Bangkok 10700, Thailand; [Hayashi, Yukiko K.] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan; [Hayashi, Yukiko K.; Nishino, Ichizo] Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Hayashi, Yukiko K.; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Clin Dev, Translat Med Ctr, Tokyo, Japan	Tanboon, J (reprint author), Mahidol Univ, Siriraj Hosp, Dept Pathol, Fac Med, Bangkok 10700, Thailand.	jtanboon@gmail.com			Ministry of Health Labour and Welfare; National Center of Neurology and Psychiatry [23-5]	The authors thank Ms. Rangsima Nguenvattana for her secretarial work on the preparation of this manuscript. This work was supported partly by Research on Intractable Diseases, Comprehensive Research on Disability Health and Welfare, and Applying Health Technology from the Ministry of Health Labour and Welfare; partly by Intramural Research Grant 23-5 for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry.	Tasca G, 2013, ACTA NEUROPATHOL, V125, P169, DOI 10.1007/s00401-012-1049-6; Lehtokari VL, 2007, NEUROMUSCULAR DISORD, V17, P433, DOI 10.1016/j.nmd.2007.02.015; Tajsharghi H, 2007, ARCH NEUROL-CHICAGO, V64, P1334, DOI 10.1001/archneur.64.9.1334; Marttila M, 2014, HUM MUTAT, V35, P779, DOI 10.1002/humu.22554; Clarke NF, 2009, NEUROMUSCULAR DISORD, V19, P348, DOI 10.1016/j.nmd.2009.03.003; Cuisset JM, 2006, NEUROMUSCULAR DISORD, V16, P277, DOI 10.1016/j.nmd.2006.01.014; Fidzianska A, 2002, J NEUROL SCI, V201, P27, DOI 10.1016/S0022-510X(02)00156-9; Ohlsson M, 2008, NEUROLOGY, V71, P1896, DOI 10.1212/01.wnl.0000336654.44814.b8; Schreckenbach T, 2014, NEUROMUSCULAR DISORD, V24, P117, DOI 10.1016/j.nmd.2013.10.002	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	FEB	2015	35	1					91	93		10.1111/neup.12147		3	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AZ2JU	WOS:000348060900013		
J	Ishida, Y; Kawashima, H; Morichi, S; Yamanaka, G; Okumura, A; Nakagawa, S; Morishima, T				Ishida, Yu; Kawashima, Hisashi; Morichi, Shinichiro; Yamanaka, Gaku; Okumura, Akihisa; Nakagawa, Satoshi; Morishima, Tsuneo			Brain Magnetic Resonance Imaging in Acute Phase of Pandemic Influenza A (H1N1) 2009-Associated Encephalopathy in Children	NEUROPEDIATRICS			English	Article						brain MRI; pandemic influenza A (H1N1) 2009-associated encephalopathy; diffusion-weighted imaging	NEUROLOGIC COMPLICATIONS; SPLENIAL LESION; INFECTION; ENCEPHALITIS/ENCEPHALOPATHY; FEATURES	Pandemic influenza A (H1N1) 2009 has been shown to be associated more with neurological complications than the seasonal influenza virus. In this study, we focused on the clinical usefulness of magnetic resonance imaging (MRI) in the acute phase of influenza A (H1N1) 2009-associated encephalopathy. A questionnaire was distributed to pediatric and general hospitals in Japan that treat children with encephalopathy. We conducted a questionnaire-based study involving the collection of information regarding 207 patients with encephalopathy. Brain MRI was performed in 97 of these 207 patients in the age group of 9 months to 15 years (mean, 7.5 years) within 48 hours after the development of encephalopathy symptoms. Sixty-six patients (68%) showed normal imaging. Diffuse brain edema was visible in five patients and an abnormal signal in the deep gray matter in two patients which is consistent with acute necrotizing encephalopathy. Abnormal signals of the splenial lesion, subcortical white matter (bright tree appearance), and cortical area were observed in 15, 1, and 8 patients, respectively. From our findings based on the questionnaire results, we suggest that MRI is useful for determining fatal cases of pandemic influenza A (H1N1) 2009 infection when performed in the acute phase. However, MRI is not useful in predicting the development of sequelae.	[Ishida, Yu; Kawashima, Hisashi; Morichi, Shinichiro; Yamanaka, Gaku] Tokyo Med Univ, Dept Paediat, Shinjuku Ku, Tokyo 1600023, Japan; [Okumura, Akihisa] Juntendo Univ, Sch Med, Dept Pediat, Bunkyo Ku, Tokyo 113, Japan; [Nakagawa, Satoshi] Natl Ctr Child Hlth & Dev, Dept Intens Care, Setagaya Ku, Tokyo, Japan; [Morishima, Tsuneo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pediat, Okayama, Japan	Ishida, Y (reprint author), Tokyo Med Univ, Dept Paediat, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	ishiyu@tokyo-med.ac.jp			Health Labor Sciences Research Grant, the Study Group of Influenza-Associated Encephalopathy	The authors thank the physicians who participated in the survey. The research groups were funded by the Health Labor Sciences Research Grant, the Study Group of Influenza-Associated Encephalopathy.	Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Takanashi JI, 2009, BRAIN DEV-JPN, V31, P217, DOI 10.1016/j.braindev.2008.04.002; Zeng HW, 2013, PEDIATR RADIOL, V43, P1182, DOI 10.1007/s00247-013-2682-5; Bulakbasi N, 2006, AM J NEURORADIOL, V27, P1983; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Ekstrand JJ, 2010, ANN NEUROL, V68, P762, DOI 10.1002/ana.22184; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Evans A. S., 2009, Morbidity and Mortality Weekly Report, V58, P773; Fluss J, 2010, EUR J PAEDIATR NEURO, V14, P97, DOI 10.1016/j.ejpn.2009.09.007; Kawashima Hisashi, 2005, J Infect, V51, pE53, DOI 10.1016/j.jinf.2004.08.017; Kawashima H, 2012, J MED VIROL, V84, P1151, DOI 10.1002/jmv.23317; Kitcharoen S, 2010, EMERG INFECT DIS, V16, P569, DOI 10.3201/eid1603.091699; Kumakura A, 2011, PEDIATR NEUROL, V45, P344, DOI 10.1016/j.pediatrneurol.2011.08.004; Ministry of Health Labour and Welfare Japan, 2011, REP INFL A H1N1; Morishima Tsuneo, 2006, Nihon Rinsho, V64, P1897; Okumura A, 2005, BRAIN DEV-JPN, V27, P271, DOI 10.1016/j.brainres.2004.07.005; Yoshikawa H, 2001, J CHILD NEUROL, V16, P885, DOI 10.1177/088307380101601204; Zheng YJ, 2011, PEDIATR PULM, V46, P246, DOI 10.1002/ppul.21359	19	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0174-304X	1439-1899		NEUROPEDIATRICS	Neuropediatrics	FEB	2015	46	1					20	25		10.1055/s-0034-1393708		6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	AZ3OK	WOS:000348136600005		
J	Hida, H; Mouri, A; Mori, K; Matsumoto, Y; Seki, T; Taniguchi, M; Yamada, K; Iwamoto, K; Ozaki, N; Nabeshima, T; Noda, Y				Hida, Hirotake; Mouri, Akihiro; Mori, Kentaro; Matsumoto, Yurie; Seki, Takeshi; Taniguchi, Masayuki; Yamada, Kiyofumi; Iwamoto, Kunihiro; Ozaki, Norio; Nabeshima, Toshitaka; Noda, Yukihiro			Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action Involving D-3-5-HT2A and D-I-NMDA Receptors in the mPFC	NEUROPSYCHOPHARMACOLOGY			English	Article							DOPAMINE D-3 RECEPTOR; PREFRONTAL CORTEX; MEDIATED NEUROTRANSMISSION; GLUTAMATE INTERACTIONS; SEROTONIN RECEPTORS; OBJECT RECOGNITION; ANTIPSYCHOTIC-DRUG; COGNITIVE FUNCTION; INDUCED IMPAIRMENT; WORKING-MEMORY	Blonanserin differs from currently used serotonin 5-HT2A/dopamine-D-2 receptor antagonists in that it exhibits higher affinity for dopamine-D-2/3 receptors than for serotonin 5-HT2A receptors. We investigated the involvement of dopamine-D-3 receptors in the effects of blonanserin on cognitive impairment in an animal model of schizophrenia. We also sought to elucidate the molecular mechanism underlying this involvement. Blonanserin, as well as olanzapine, significantly ameliorated phencyclidine (PCP)-induced impairment of visual-recognition memory, as demonstrated by the novel-object recognition test (NORT) and increased extracellular dopamine levels in the medial prefrontal cortex (mPFC). With blonanserin, both of these effects were antagonized by DOI (a serotonin 5-HT2A receptor agonist) and 7-OH-DPAT (a dopamine-D-3 receptor agonist), whereas the effects of olanzapine were antagonized by DOI but not by 7-OH-DPAT. The ameliorating effect was also antagonized by SCH23390 (a dopamine-D-I, receptor antagonist) and H-89 (a protein kinase A (PKA) inhibitor). Blonanserin significantly remediated the decrease in phosphorylation levels of PICA at Thr(192) and of NRI (an essential subunit of N-methyl-D-aspartate (NMDA) receptors) at Ser(897) by PKA in the mPFC after a NORT training session in the PCP-administered mice. There were no differences in the levels of NRI phosphorylated at Ser(896) by PKC in any group. These results suggest that the ameliorating effect of blonanserin on PCP-induced cognitive impairment is associated with indirect functional stimulation of the dopamine-D-I-PKA-NMDA receptor pathway following augmentation of dopaminergic neurotransmission due to inhibition of both dopamine-D-3 and serotonin 5-HT2A receptors in the mPFC.	[Hida, Hirotake; Mouri, Akihiro; Mori, Kentaro; Matsumoto, Yurie; Taniguchi, Masayuki; Noda, Yukihiro] Meijo Univ, Grad Sch Pharm, Div Clin Sci & Neuropsychopharmacol, Nagoya, Aichi 4688503, Japan; [Matsumoto, Yurie; Iwamoto, Kunihiro; Ozaki, Norio] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Seki, Takeshi; Nabeshima, Toshitaka] Meijo Univ, Dept Reg Pharmaceut Care & Sci, Fac Pharm, Nagoya, Aichi 4688503, Japan; [Yamada, Kiyofumi] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4648601, Japan	Noda, Y (reprint author), Meijo Univ, Grad Sch Pharm, Div Clin Sci & Neuropsychopharmacol, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	ynoda@meijo-u.ac.jp	Ozaki, Norio/M-8908-2014; 清文, 山田/I-7487-2014; IWAMOTO, Kunihiro/M-8857-2014	Ozaki, Norio/0000-0002-7360-4898; 清文, 山田/0000-0002-5280-5180; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [26460240, 24590219]; Ministry of Health, Labor and Welfare (MHLW); Meijo University Research Institute grant; Smoking Research Foundation Grant for Biomedical Research (SRF); Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency [AS251Z02986P, AS251Z03018Q]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Dainippon Sumitomo; Abbvie; Asahi Kasei Pharma; Astellas; Eisai; Eli Lilly; GlaxoSmithKline; Janssen; Meiji Seika Pharma; Mochida; MSD; Novartis Pharma; Ono; Otsuka; Pfizer; Shionogi; Takeda; Tanabe Mitsubishi; Sanofi; Yoshitomi	This study was supported by the 'Academic Frontier' Project for Private Universities (2007-2011) and Grants-in-Aid for Scientific Research C (24590219 and 26460240) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Research on Risk of Chemical Substances (2008-2010), Health and Labor Science Research Grants supported by the Ministry of Health, Labor and Welfare (MHLW); a Meijo University Research Institute grant; a Smoking Research Foundation Grant for Biomedical Research (SRF); the Joint Research Project under the Japan-Korea basic scientific cooperation program (2010-2012) from the Japan Society for the Promotion of Science (JSPS); the Adaptable and Seamless Technology Transfer Program Through Target-driven R&D (AS251Z02986P, AS251Z03018Q), Japan Science and Technology Agency; a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows; and a Grant-in-Aid for Scientific Research on Innovative Areas, 'Glial Assembly: A New Regulatory Machinery of Brain Function And Disorders', and a Grant-in-Aid for 'Integrated Research on Neuropsychiatric Disorders' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Dr Y Noda has received research support and speakers' honoraria from Dainippon Sumitomo. Dr N Ozaki has received research support or speakers' honoraria from, or has served as a consultant to, Abbvie, Asahi Kasei Pharma, Astellas, Dainippon Sumitomo, Eisai, Eli Lilly, GlaxoSmithKline, Janssen, Meiji Seika Pharma, Mochida, MSD, Novartis Pharma, Ono, Otsuka, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi, Sanofi, and Yoshitomi. Dr K Iwamoto has received speakers' honoraria from Dainippon Sumitomo, Eisai, Eli Lilly, GlaxoSmithKline, Meiji Seika Pharma, Mochida, Otsuka, and Tanabe Mitsubishi. The other authors declare no conflict of interest.	Abekawa T, 2006, N-S ARCH PHARMACOL, V374, P177, DOI 10.1007/s00210-006-0115-9; AHLENIUS S, 1994, EUR J PHARMACOL, V260, P177, DOI 10.1016/0014-2999(94)90335-2; Nakajima S, 2013, EUR NEUROPSYCHOPHARM, V23, P799, DOI 10.1016/j.euroneuro.2013.05.006; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; GOBERT A, 1995, J PHARMACOL EXP THER, V275, P899; Wang DY, 2007, NEUROPHARMACOLOGY, V53, P379, DOI 10.1016/j.neuropharm.2007.05.026; DeLeon A, 2004, CLIN THER, V26, P649, DOI 10.1016/S0149-2918(04)90066-5; Ohno Y, 2010, PHARMACOL BIOCHEM BE, V96, P175, DOI 10.1016/j.pbb.2010.04.027; Gyertyan I, 2008, N-S ARCH PHARMACOL, V378, P529, DOI 10.1007/s00210-008-0311-x; Freedman R, 2003, NEW ENGL J MED, V349, P1738; Brown VJ, 2002, TRENDS NEUROSCI, V25, P340, DOI 10.1016/S0166-2236(02)02164-1; HOYER D, 1986, BRAIN RES, V376, P97, DOI 10.1016/0006-8993(86)90903-0; Meltzer HY, 1999, SCHIZOPHRENIA BULL, V25, P233; Kruse MS, 2009, EUR NEUROPSYCHOPHARM, V19, P296, DOI 10.1016/j.euroneuro.2008.12.006; Nagai T, 2003, NEUROREPORT, V14, P269, DOI 10.1097/01.wnr.0000053063.88427.9e; Meltzer HY, 2003, PROG NEURO-PSYCHOPH, V27, P1159, DOI 10.1016/j.pnpbp.2003.09.010; Dias R, 1996, BEHAV NEUROSCI, V110, P872, DOI 10.1037/0735-7044.110.5.872; Gurevich EV, 1999, NEUROPSYCHOPHARMACOL, V20, P60, DOI 10.1016/S0893-133X(98)00066-9; Garcia E, 2009, CNS DRUGS, V23, P615, DOI 10.2165/00023210-200923070-00006; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Watson DJG, 2012, NEUROPSYCHOPHARMACOL, V37, P770, DOI 10.1038/npp.2011.254; Noda Y, 2010, INT J NEUROPSYCHOPH, V13, P1343, DOI 10.1017/S1461145710000222; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Castner SA, 2004, PSYCHOPHARMACOLOGY, V174, P111, DOI 10.1007/s00213-003-1710-9; Tenjin T, 2013, NEUROPSYCH DIS TREAT, V9, P587, DOI 10.2147/NDT.S34433; DIAZ J, 1995, NEUROSCIENCE, V65, P731, DOI 10.1016/0306-4522(94)00527-C; Gyertyan I, 2007, EUR J PHARMACOL, V572, P171, DOI 10.1016/j.ejphar.2007.06.035; LEVESQUE D, 1992, P NATL ACAD SCI USA, V89, P8155, DOI 10.1073/pnas.89.17.8155; Takahashi S, 2013, ASIA-PAC PSYCHIAT, V5, P164, DOI 10.1111/j.1758-5872.2012.00232.x; NODA Y, 1995, BRIT J PHARMACOL, V116, P2531; Marek GJ, 2007, INT REV NEUROBIOL, V78, P165, DOI 10.1016/S0074-7742(06)78006-0; Pritchard LM, 2003, NEUROPSYCHOPHARMACOL, V28, P100, DOI 10.1038/sj.npp.1300018; Morris BJ, 2005, CURR OPIN PHARMACOL, V5, P101, DOI 10.1016/j.coph.2004.08.008; Diaz J, 2000, J NEUROSCI, V20, P8677; Perrault G, 1997, J PHARMACOL EXP THER, V280, P73; Nagai T, 2009, PSYCHOPHARMACOLOGY, V202, P315, DOI 10.1007/s00213-008-1240-6; Horiguchi M, 2013, BEHAV BRAIN RES, V247, P158, DOI 10.1016/j.bbr.2013.03.027; BISCHOFF S, 1986, EUR J PHARMACOL, V129, P367, DOI 10.1016/0014-2999(86)90449-8; DALY SA, 1993, NEUROPHARMACOLOGY, V32, P509, DOI 10.1016/0028-3908(93)90177-5; Enomoto T, 2005, MOL PHARMACOL, V68, P1765; Gross G, 2012, HDB EXP PHARM, V213, P167, DOI DOI 10.1007/978-3-642-25758-2_7; Hida H, 2014, BEHAV BRAIN RES, V258, P34, DOI 10.1016/j.bbr.2013.09.026; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Levant B, 1996, SYNAPSE, V24, P60; MADDOX VH, 1965, J MED CHEM, V8, P230, DOI 10.1021/jm00326a019; Millan MJ, 1997, EUR J PHARMACOL, V321, pR7; Mori T, 1997, JPN J PHARMACOL, V73, P251, DOI 10.1254/jjp.73.251; Mouri A, 2007, MOL PHARMACOL, V71, P1598, DOI 10.1124/mol.106.032961; Noda A, 2001, NEUROPSYCHOPHARMACOL, V24, P451, DOI 10.1016/S0893-133X(00)00192-5; Paxinos G., 1997, MOUSE BRAIN STEREOTA; SPAULDING WD, 1994, ACTA PSYCHIAT SCAND, V90, P116, DOI 10.1111/j.1600-0447.1994.tb05900.x; Tenjin T, 2012, HUM PSYCHOPHARM CLIN, V27, P90, DOI 10.1002/hup.1276; Watson DJG, 2012, INT J NEUROPSYCHOPH, V15, P471, DOI 10.1017/S1461145711000435	54	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	FEB	2015	40	3					601	613		10.1038/npp.2014.207		13	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AY6ET	WOS:000347660900008		
J	Makino, K; Okuda, K; Sugino, E; Nishiya, T; Toyama, T; Iwawaki, T; Fujimura, M; Kumagai, Y; Uehara, T				Makino, Kento; Okuda, Kosaku; Sugino, Eisuke; Nishiya, Tadashi; Toyama, Takashi; Iwawaki, Takao; Fujimura, Masatake; Kumagai, Yoshito; Uehara, Takashi			Correlation Between Attenuation of Protein Disulfide Isomerase Activity Through S-Mercuration and Neurotoxicity Induced by Methylmercury	NEUROTOXICITY RESEARCH			English	Article						Methylmercury; Neurotoxicity; Endoplasmic reticulum stress; Protein disulfide isomerase; S-mercuration	CELL-DEATH; INDUCED APOPTOSIS; NITRIC-OXIDE; RAT-BRAIN; IN-VITRO; PHOSPHATASE; ASTROCYTES; MECHANISM; OXIDATION; PATHWAYS	Methylmercury (MeHg), an environmental pollutant, causes neuronal death via endoplasmic reticulum (ER) stress; however, the precise mechanism is not fully understood. The aim of this study was to elucidate the possible mechanism of MeHg-induced neurotoxicity. Treatment with MeHg resulted in a loss of cell viability in a concentration-dependent manner accompanying the expression of ER stress marker genes in human neuroblastoma SH-SY5Y cells. We next attempted to identify a target protein for MeHg in the ER. MeHg covalently modified protein disulfide isomerase (PDI), which is important for disulfide bond formation in nascent proteins in the ER lumen. S-Nitrosylation of the catalytic domains of PDI by nitric oxide was attenuated up to 50 % by a MeHg challenge in cells. The MeHg-modified C-terminal catalytic domain in PDI was detected by MALDI-TOF/MS. Furthermore, treatment with MeHg significantly attenuated the enzymatic activity of PDI. Taken together, these observations suggest that MeHg results in ER stress and following the unfolded protein response pathway via ER dysfunction due to S-mercuration of the C-terminus of PDI.	[Makino, Kento; Okuda, Kosaku; Sugino, Eisuke; Nishiya, Tadashi; Uehara, Takashi] Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Toyama, Takashi; Kumagai, Yoshito] Univ Tsukuba, Doctoral Program Biomed Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Iwawaki, Takao] Gunma Univ, Adv Sci Res Leaders Dev Unit, Iwawaki Lab, Maebashi, Gumma 371, Japan; [Fujimura, Masatake] Natl Inst Minamata Dis, Dept Basic Med Sci, Minamata, Japan	Uehara, T (reprint author), Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	uehara@pharm.okayama-u.ac.jp			Japan Ministry of Education, Culture, Sports and Technology (MEXT) [25670029, 22310093]; Takeda Science Foundation; Smoking Research Foundation; Okayama Medical Foundation	We thank Aki Tsuboi and Yoko Okamoto for providing technical assistance. This work was supported in part by Grants-in Aid for Scientific Research on Challenging Exploratory Research 25670029 and Scientific Research B 22310093 from the Japan Ministry of Education, Culture, Sports and Technology (MEXT), by the Takeda Science Foundation, the Smoking Research Foundation, and the Okayama Medical Foundation.	Toyama T, 2007, BIOCHEM BIOPH RES CO, V363, P645, DOI 10.1016/j.bbrc.2007.09.017; Kanda H, 2012, ARCH TOXICOL, V86, P1693, DOI 10.1007/s00204-012-0893-4; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Shinyashiki M, 1998, BRAIN RES, V798, P147, DOI 10.1016/S0006-8993(98)00400-4; Calderon J, 2003, ECOTOX ENVIRON SAFE, V56, P93, DOI 10.1016/S0147-6513(03)00053-8; Uehara T, 2007, ANTIOXID REDOX SIGN, V9, P597, DOI 10.1089/ars.2006.1517; Wagner C, 2010, BIOMETALS, V23, P1171, DOI 10.1007/s10534-010-9367-4; Kanda H, 2008, ARCH TOXICOL, V82, P803, DOI 10.1007/s00204-008-0307-9; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Shiraishi M, 2014, ENVIRON TOXICOL PHAR, V37, P1256, DOI 10.1016/j.etap.2014.04.025; Usuki F, 2011, J BIOL CHEM, V286, P6641, DOI 10.1074/jbc.M110.168872; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Miura T, 2011, CHEM RES TOXICOL, V24, P559, DOI 10.1021/tx100427p; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; CLARKSON TW, 1972, ANNU REV PHARMACOLOG, V12, P375, DOI 10.1146/annurev.pa.12.040172.002111; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Kumagai Y., 2013, OXID MED CELL LONGEV, V2013; Kumagai Y, 1997, APPL ORGANOMET CHEM, V11, P635; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Miura K, 1999, TOXICOL APPL PHARM, V160, P279, DOI 10.1006/taap.1999.8781; Numajiri N, 2011, P NATL ACAD SCI USA, V108, P10349, DOI 10.1073/pnas.1103503108; Posser T, 2010, TOXICOL IN VITRO, V24, P1498, DOI 10.1016/j.tiv.2010.07.015; Sanfeliu Coral, 2001, Neurotoxicology (Little Rock), V22, P317, DOI 10.1016/S0161-813X(01)00015-8; Shanker G, 2004, MOL BRAIN RES, V128, P48, DOI 10.1016/j.molbrainres.2004.05.022; Shanker G, 2005, MOL BRAIN RES, V137, P11, DOI 10.1016/j.molbrainres.2005.02.006; Tsuruma K, 2006, J BIOL CHEM, V281, P11397, DOI 10.1074/jbc.M510597200; Uehara T, 2011, NITRIC OXIDE-BIOL CH, V25, P108, DOI 10.1016/j.niox.2010.11.002; Usuki F, 2008, NEUROTOXICOLOGY, V29, P22, DOI 10.1016/j.neuro.2007.08.011	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	FEB	2015	27	2					99	105		10.1007/s12640-014-9494-8		7	Neurosciences	Neurosciences & Neurology	AZ4OC	WOS:000348200900001		
J	Okui, S; Kawai, G				Okui, Saya; Kawai, Gota			In NMR Tube Transcription for Rapid Screening of RNA Conformation	NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS			English	Article						RNA; NMR; screening; structure	SPECTROSCOPY; POLYMERASE	A simple method for rapid structure screening for RNA by NMR is proposed. Target RNA is transcribed in a NMR tube and its spectra are measured without purification. The proposed method, in NMR tube transcription or INTT, was applied for three RNAs for which NMR spectra have been measured by using the conventionally purified samples. By the real-time measuring, increase of imino proton signals and decrease of NTP signals can be observed. It was confirmed that INTT spectra are in general similar to those obtained by the conventional method. INTT can be used for the first-step screening of RNA folding.	[Okui, Saya; Kawai, Gota] Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, Narashino, Chiba 2750016, Japan	Kawai, G (reprint author), Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, Narashino, Chiba 2750016, Japan.	gota.kawai@p.chibakoudai.jp			Ministry of Education, Culture, Sports, Science, and Technology [21200039, 24310147]	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (21200039) and Scientific Research (B) (24310147) from the Ministry of Education, Culture, Sports, Science, and Technology.	Nameki N, 1999, NUCLEIC ACIDS RES, V27, P3667, DOI 10.1093/nar/27.18.3667; Takahashi KI, 2000, RNA, V6, P96, DOI 10.1017/S1355838200991635; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; McGettigan PA, 2013, CURR OPIN CHEM BIOL, V17, P4, DOI 10.1016/j.cbpa.2012.12.008; Arai H, 2009, BIOINFORMATICS, V25, P948, DOI 10.1093/bioinformatics/btn345; Baba S, 2004, RNA, V10, P1380, DOI 10.1261/rna.7460104; KEARNS DR, 1971, NATURE, V229, P338, DOI 10.1038/229338a0; NIKONOWICZ EP, 1992, NUCLEIC ACIDS RES, V20, P4507, DOI 10.1093/nar/20.17.4507; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Reckel S, 2005, CHEMBIOCHEM, V6, P1601, DOI 10.1002/cbic.200500076; REID BR, 1981, ANNU REV BIOCHEM, V50, P969, DOI 10.1146/annurev.bi.50.070181.004541; SCHIMMEL PR, 1980, ANNU REV BIOPHYS BIO, V9, P181, DOI 10.1146/annurev.bb.09.060180.001145; Zhou LL, 2011, J GENET GENOMICS, V38, P505, DOI 10.1016/j.jgg.2011.08.006	21	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1525-7770	1532-2335		NUCLEOS NUCLEOT NUCL	Nucleosides Nucleotides Nucleic Acids	FEB 1	2015	34	2					103	113		10.1080/15257770.2014.964412		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ9GW	WOS:000348522800004		
J	Matsumoto, T; Hashimura, M; Takayama, K; Ishida, K; Kawakami, Y; Matsuzaki, T; Nakano, N; Matsushita, T; Kuroda, R; Kurosaka, M				Matsumoto, T.; Hashimura, M.; Takayama, K.; Ishida, K.; Kawakami, Y.; Matsuzaki, T.; Nakano, N.; Matsushita, T.; Kuroda, R.; Kurosaka, M.			A radiographic analysis of alignment of the lower extremities - initiation and progression of varus-type knee osteoarthritis	OSTEOARTHRITIS AND CARTILAGE			English	Article						Osteoarthritis; Initiation; Progression	AXIAL ALIGNMENT; LOWER-LIMB; DISEASE PROGRESSION; BASE-LINE; MALALIGNMENT; RISK; COMPARTMENT; PREVALENCE; VALGUS; LOAD	Objective: This study aimed to investigate alignment based on age in normal knees and alignment based on deformity in osteoarthritis (OA) knees using detailed radiographic parameters. Design: Various parameters were measured from weight-bearing long leg radiographs of 1251 legs (797 normal and 454 OA knees) as a cross-sectional study. Normal knees were classified by age (young, middle aged, aged, and elderly) and symptomatic OA knees on the basis of the alignment (femorotibial angle (FTA): mild, moderate, severe and profound). The mean measurements in each group were calculated and compared within each group. Results: The femoral shaft showed medially bowed curvature (femoral bowing) of approximately 2 degrees in the young normal group, which shifted to lateral bowing with age. However, OA knees showed larger lateral bowing with OA grade, which might reduce the condylar-shaft angle and subsequently shifted the mechanical axis medially. Progression of mild to moderate OA might be associated with a decreasing condylar-shaft angle (femoral condylar orientation) and widening condylar-plateau angle (joint space narrowing) rather than decreasing tibial plateau flattering. Steeping of the tibial plateau inclination due to increasing tibial plateau shift (tibial plateau compression) rather than medial tibial bowing might be the main contributor to worsening of varus deformity in knees with severe and profound OA. Conclusions: This cross-sectional study might provide the possibility of OA initiation and progression. The lateral curvature of the femoral shaft associated with aging may contribute to the initiation of varus-type OA of the knee. These changes in the femur may be followed by secondary signs of OA progression including varus femoral condylar orientation, medial joint space narrowing, and tibial plateau compression. (C) 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Matsumoto, T.; Takayama, K.; Kawakami, Y.; Matsuzaki, T.; Nakano, N.; Matsushita, T.; Kuroda, R.; Kurosaka, M.] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 6500017, Japan; [Hashimura, M.] Yasue Orthopaed Clin, Dept Orthopaed Surg, Kobe, Hyogo, Japan; [Ishida, K.] Kobe Kaisei Hosp, Dept Orthopaed Surg, Kobe, Hyogo, Japan	Matsumoto, T (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	matsun@m4.dion.ne.jp; m-hasshi@gaia.eonet.ne.jp; kojitakayama78@yahoo.co.jp; wavedreamer17@yahoo.co.jp; yohei_kawakami@hotmail.com; tokiomatsuzaki@yahoo.co.jp; naokix1981@yahoo.co.jp; matsushi@med.kobe-u.ac.jp; kurodar@med.kobe-u.ac.jp; kurosaka@med.kobe-u.ac.jp					Sharma L, 2008, ARTHRITIS RHEUM, V58, P1716, DOI 10.1002/art.23462; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Skytta ET, 2011, ACTA ORTHOP BELG, V77, P329; Cooke TDV, 2002, RHEUMATOL INT, V22, P160, DOI 10.1007/s00296-002-0218-7; Lasam MPG, 2013, CLIN ORTHOP RELAT R, V471, P1472, DOI 10.1007/s11999-012-2618-7; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; COOKE TDV, 1991, J BONE JOINT SURG BR, V73, P715; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745; Cicuttini F, 2004, RHEUMATOLOGY, V43, P321, DOI 10.1093/rheumatology/keh017; Brouwer GM, 2007, ARTHRITIS RHEUM, V56, P1204, DOI 10.1002/art.22515; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Cerejo R, 2002, ARTHRITIS RHEUM, V46, P2632, DOI 10.1002/art.10530; Chang CB, 2010, OSTEOARTHR CARTILAGE, V18, P530, DOI 10.1016/j.joca.2009.12.004; Tanamas S, 2009, ARTHRIT RHEUM-ARTHR, V61, P459, DOI 10.1002/art.24336; Mullaji AB, 2009, J ARTHROPLASTY, V24, P861, DOI 10.1016/j.arth.2008.05.025; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Tang WM, 2000, J BONE JOINT SURG AM, V82A, P1603; Chang A, 2004, ARTHRITIS RHEUM, V50, P3897, DOI 10.1002/art.20657; Cooke D, 1997, OSTEOARTHR CARTILAGE, V5, P39, DOI 10.1016/S1063-4584(97)80030-1; COVENTRY MB, 1987, J BONE JOINT SURG AM, V69A, P32; Dearborn J T, 1996, Am J Orthop (Belle Mead NJ), V25, P18; Felson DT, 2005, RHEUMATOLOGY, V44, P100, DOI 10.1093/rheumatology/keh411; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; HSU RWW, 1990, CLIN ORTHOP RELAT R, P215; Khattak Mujahid Jamil, 2010, J Orthop Surg (Hong Kong), V18, P22; Nagamine R, 2000, J Orthop Sci, V5, P232, DOI 10.1007/s007760050157; Sharma L, 2010, ANN RHEUM DIS, V69, P1940, DOI 10.1136/ard.2010.129742; SIU D, 1991, INVEST RADIOL, V26, P71, DOI 10.1097/00004424-199101000-00013; WEVERS HW, 1982, J BIOMED ENG, V4, P319, DOI 10.1016/0141-5425(82)90050-4; Yau W P, 2007, J Orthop Surg (Hong Kong), V15, P32	30	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	FEB	2015	23	2					217	223		10.1016/j.joca.2014.11.015		7	Orthopedics; Rheumatology	Orthopedics; Rheumatology	AZ3LI	WOS:000348128400006		
J	Endo, J; Watanabe, A; Sasho, T; Yamaguchi, S; Saito, M; Akagi, R; Muramatsu, Y; Mukoyama, S; Katsuragi, J; Akatsu, Y; Fukawa, T; Okubo, T; Osone, F; Takahashi, K				Endo, J.; Watanabe, A.; Sasho, T.; Yamaguchi, S.; Saito, M.; Akagi, R.; Muramatsu, Y.; Mukoyama, S.; Katsuragi, J.; Akatsu, Y.; Fukawa, T.; Okubo, T.; Osone, F.; Takahashi, K.			Utility of T2 mapping and dGEMRIC for evaluation of cartilage repair after allograft chondrocyte implantation in a rabbit model	OSTEOARTHRITIS AND CARTILAGE			English	Article						Magnetic resonance imaging; T2 mapping; dGEMRIC; Osteochondral defect; Allograft chondrocyte implantation; Cartilage repair	GADOLINIUM-ENHANCED MRI; FULL-THICKNESS DEFECTS; ARTICULAR-CARTILAGE; REPARATIVE CARTILAGE; GLYCOSAMINOGLYCAN CONCENTRATION; OSTEOCHONDRITIS-DISSECANS; KNEE; TRANSPLANTATION; RELAXATION; CONTRAST	Objective: To investigate the effectiveness of quantitative Magnetic resonance imaging (MRI) for evaluating the quality of cartilage repair over time following allograft chondrocyte implantation using a threedimensional scaffold for osteochondral lesions. Design: Thirty knees from 15 rabbits were analyzed. An osteochondral defect (diameter, 4 mm; depth, 1 mm) was created on the patellar groove of the femur in both legs. The defects were filled with a chondrocyte-seeded scaffold in the right knee and an empty scaffold in the left knee. Five rabbits each were euthanized at 4, 8, and 12 weeks and their knees were examined via macroscopic inspection, histological and biochemical analysis, and quantitative MRI (T2 mapping and dGEMRIC) to assess the state of tissue repair following allograft chondrocyte implantation with a three-dimensional scaffold for osteochondral lesions. Results: Comparatively good regenerative cartilage was observed both macroscopically and histologically. In both chondrocyte-seeded and control knees, the T2 values of repair tissues were highest at 4 weeks and showed a tendency to decrease with time. Delta R1 values of dGEMRIC also tended to decrease with time in both groups, and the mean Delta R1 was significantly lower in the CS-scaffold group than in the control group at all time points. Delta R1 - 1/r (R1post -R1pre), where r is the relaxivity of Gd-DTPA(2-), R1 -1/T1 (longitudinal relaxation time). Conclusion: T2 mapping and dGEMRIC were both effective for evaluating tissue repair after allograft chondrocyte implantation. DR1 values of dGEMRIC represented good correlation with histologically and biochemically even at early stages after the implantation. (C) 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Endo, J.; Watanabe, A.; Sasho, T.; Saito, M.; Akagi, R.; Muramatsu, Y.; Mukoyama, S.; Katsuragi, J.; Akatsu, Y.; Fukawa, T.; Takahashi, K.] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Chiba 2608670, Japan; [Okubo, T.; Osone, F.] Teikyo Univ, Chiba Med Ctr, Dept Med Imaging, Ichihara, Chiba 2990111, Japan	Endo, J (reprint author), Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	orthopaedics@hotmail.co.jp					Almqvist KF, 2001, ANN RHEUM DIS, V60, P781, DOI 10.1136/ard.60.8.781; Gikas PD, 2009, J BONE JOINT SURG BR, V91B, P1172, DOI 10.1302/0301-620X.91B9.22490; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Watanabe A, 2007, J MAGN RESON IMAGING, V26, P109, DOI 10.1002/jmri.20962; Pai A, 2008, MAGN RESON IMAGING, V26, P1215, DOI 10.1016/j.mri.2008.02.017; Tanaka T, 2005, TISSUE ENG, V11, P331, DOI 10.1089/ten.2005.11.331; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579; Revell CM, 2009, TISSUE ENG PART B-RE, V15, P1, DOI 10.1089/ten.teb.2008.0189; Tiderius CJ, 2003, MAGNET RESON MED, V49, P488, DOI 10.1002/mrm.10389; Loeuille D, 2012, OSTEOPOROSIS INT, V23, pS867, DOI 10.1007/s00198-012-2166-8; Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25; GUERNE PA, 1995, ARTHRITIS RHEUM, V38, P960, DOI 10.1002/art.1780380712; Zhang KL, 2013, MAGN RESON IMAGING, V31, P1731, DOI 10.1016/j.mri.2013.06.005; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Duvvuri U, 1997, MAGNET RESON MED, V38, P863, DOI 10.1002/mrm.1910380602; Burstein D, 2001, MAGNET RESON MED, V45, P36, DOI 10.1002/1522-2594(200101)45:1<36::AID-MRM1006>3.0.CO;2-W; Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367; Borthakur A, 2006, NMR BIOMED, V19, P781, DOI 10.1002/nbm.1102; Holtzman DJ, 2010, J MAGN RESON IMAGING, V32, P914, DOI 10.1002/jmri.22300; Watanabe A, 2009, OSTEOARTHR CARTILAGE, V17, P1341, DOI 10.1016/j.joca.2009.03.022; Friedrich KM, 2010, EUR J RADIOL, V73, P622, DOI 10.1016/j.ejrad.2008.12.017; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Nieminen MT, 2012, J MAGN RESON IMAGING, V36, P1287, DOI 10.1002/jmri.23644; Du J, 2009, J MAGN RESON IMAGING, V29, P412, DOI 10.1002/jmri.21465; Bashir A, 1997, RADIOLOGY, V205, P551; Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112; Trattnig S, 2007, J MAGN RESON IMAGING, V26, P974, DOI 10.1002/jmri.21091; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Williams A, 2004, AM J ROENTGENOL, V182, P167; Gold GE, 2006, OSTEOARTHR CARTILAGE, V14, pA76, DOI 10.1016/j.joca.2006.03.010; Watanabe A, 2006, RADIOLOGY, V239, P201, DOI 10.1148/radiol.2383050173; Bashir A, 1999, MAGNET RESON MED, V41, P857, DOI 10.1002/(SICI)1522-2594(199905)41:5<857::AID-MRM1>3.0.CO;2-E; Bieri O, 2011, MAGN RESON MED, V66, P410, DOI 10.1002/mrm.22807; DZIOBA R B, 1988, Arthroscopy, V4, P72, DOI 10.1016/S0749-8063(88)80067-7; Emmerson BC, 2007, AM J SPORT MED, V35, P907, DOI 10.1177/0363546507299932; Frazier SB, 2008, OPEN GLYCOSCI, V1, P31, DOI 10.2174/1875398100801010031; GREEN WT, 1977, CLIN ORTHOP RELAT R, P237; Insko EK, 1999, MAGNET RESON MED, V41, P30; Jamali AA, 2005, CLIN ORTHOP RELAT R, P176, DOI 10.1097/01.blo.0000165854.15579.85; KNEELAND JB, 1986, RADIOLOGY, V158, P819; Masuoka K, 2005, J BIOMED MATER RES B, V75B, P177, DOI 10.1002/jbm.b.30284; Matzat Stephen J, 2013, Quant Imaging Med Surg, V3, P162, DOI 10.3978/j.issn.2223-4292.2013.06.04; Moriya T, 2007, J ORTHOP SCI, V12, P265, DOI 10.1007/s00776-007-1111-8; Peterson L, 2000, CLIN ORTHOP RELAT R, P212	44	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	FEB	2015	23	2					280	288		10.1016/j.joca.2014.10.012		9	Orthopedics; Rheumatology	Orthopedics; Rheumatology	AZ3LI	WOS:000348128400015		
J	Ochi, T; Seo, S; Yazaki, Y; Okawada, M; Doi, T; Miyano, G; Koga, H; Lane, GJ; Yamataka, A				Ochi, Takanori; Seo, Shogo; Yazaki, Yuta; Okawada, Manabu; Doi, Takashi; Miyano, Go; Koga, Hiroyuki; Lane, Geoffrey J.; Yamataka, Atsuyuki			Traction-assisted dissection with soft tissue coverage is effective for repairing recurrent urethrocutaneous fistula following hypospadias surgery	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Hypospadias; Urethrocutaneous fistula; Recurrent; External spermatic fascia	INCISED PLATE URETHROPLASTY; SURGICAL-TREATMENT; URETHRAL FISTULAS; DARTOS FLAP; CLOSURE; MANAGEMENT	Urethrocutaneous fistula (UCF) complicating hypospadias surgery is associated with compromised tissue and perfusion at the UCF site, especially if recurrent. We report our technique for UCF repair. Between 1997 and 2014, we treated 35 UCF in 26 postoperative hypospadias patients; 12 UCF were recurrent (mean 2.5; range 1-5). Mean age at UCF repair was 9.3 years (range 2-22). Our repair involves making a superficial incision 3-5 mm around the fistula orifice, placing multiple stay sutures in the outer edge of this incision and dissecting only the epidermis under traction for 7-10 mm. This technique does not compromise underlying connective tissue or tissue perfusion. The skin layer of the inner edge of the circumferential incision is trimmed completely and the fistula closed using 7/0 absorbable interrupted sutures. A pedicled external spermatic fascia, or tunica vaginalis flap is then mobilized to cover the repair site through a subcutaneous tunnel and the skin closed. A urethral catheter is placed and removed the next day. Duration of follow-up was calculated as the period from discharge home until the last outpatient clinic attendance. Repair was successful in all cases. Penile cosmesis was acceptable to good without any testicular complications or scrotal deformity. At mean follow-up of 7.4 years (range 0.4-17.3) there have been no recurrences. Our technique allows UCF to be repaired effectively and is also indicated for recurrences.	[Ochi, Takanori; Seo, Shogo; Yazaki, Yuta; Okawada, Manabu; Doi, Takashi; Miyano, Go; Koga, Hiroyuki; Lane, Geoffrey J.; Yamataka, Atsuyuki] Juntendo Univ, Sch Med, Dept Pediat Gen & Urogenital Surg, Bunkyo Ku, Tokyo 1138421, Japan	Yamataka, A (reprint author), Juntendo Univ, Sch Med, Dept Pediat Gen & Urogenital Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	tochi@juntendo.ac.jp; yama@juntendo.ac.jp					Richter F, 2003, UROLOGY, V61, P448, DOI 10.1016/S0090-4295(02)02146-5; Muruganandham K, 2010, PEDIATR SURG INT, V26, P305, DOI 10.1007/s00383-009-2490-z; Borer JG, 2001, J UROLOGY, V165, P581, DOI 10.1097/00005392-200102000-00075; Shankar KR, 2002, BJU INT, V89, P103, DOI 10.1046/j.1464-4096.2001.01705.x; Latifoglu O, 2000, ANN PLAS SURG, V44, P381, DOI 10.1097/00000637-200044040-00005; Routh JC, 2006, J UROLOGY, V176, P1578, DOI 10.1016/j.juro.2006.06.032; Elbakry A, 2001, BJU INT, V88, P590, DOI 10.1046/j.1464-4096.2001.02390.x; Cimador M, 2003, BJU INT, V92, P621, DOI 10.1046/j.1464-410X.2003.04437.x; Santangelo K, 2003, J UROLOGY, V170, P1589, DOI 10.1097/01.ju.0000084624.17496.29; Churchill BM, 1996, J UROLOGY, V156, P2047, DOI 10.1016/S0022-5347(01)65432-6; Jozsa T, 2011, UROL INT, V87, P380, DOI 10.1159/000329776; Routh JC, 2008, ADV UROL, V2008, P1, DOI 10.1155/2008/615928; Waterman BJ, 2002, J UROLOGY, V168, P726, DOI 10.1016/S0022-5347(05)64734-9; Yamataka A, 2012, PEDIATR SURG INT, V28, P919, DOI 10.1007/s00383-012-3143-1; Yamataka A, 1998, J PEDIATR SURG, V33, P1788, DOI 10.1016/S0022-3468(98)90285-8; Yang SSD, 2001, J UROLOGY, V166, P2342, DOI 10.1016/S0022-5347(05)65585-1	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	FEB	2015	31	2					203	207		10.1007/s00383-014-3652-1		5	Pediatrics; Surgery	Pediatrics; Surgery	AZ8DR	WOS:000348445500015		
J	Arimitsu, K; Hofmann, SG				Arimitsu, Kohki; Hofmann, Stefan G.			Cognitions as mediators in the relationship between self-compassion and affect	PERSONALITY AND INDIVIDUAL DIFFERENCES			English	Article						Self-compassion; Self-esteem; Automatic thoughts; Anxiety; Depression; Life satisfaction	AUTOMATIC THOUGHTS QUESTIONNAIRE; LOVING-KINDNESS MEDITATION; RANDOMIZED CONTROLLED-TRIAL; PSYCHOMETRIC PROPERTIES; DEPRESSIVE SYMPTOMS; NEGATIVE SYMPTOMS; COMMUNITY ADULTS; ATQ-P; RUMINATION; ESTEEM	Previous studies suggest that self-compassion is related to numerous facets of mental health, but the role of cognitions in this relationship remains unknown. To examine the mediating role of cognitions in the relationship between self-compassion and anxiety, depression, and life satisfaction when controlling for self-esteem in Japanese people, we conducted two studies. Study 1 (N= 231) examined the relationship between self-compassion and affect by modeling negative automatic thoughts as a mediator; Study 2 (N = 233) tested whether positive and negative automatic thoughts meditate this relationship. Results suggested that both self-compassion and self-esteem increased positive automatic thoughts and decreased trait anxiety, whereas only self-esteem increased life satisfaction and decreased depression directly. Positive automatic thoughts increased life satisfaction and decreased depression and trait anxiety, and positive automatic thoughts mediated the relationship between self-compassion and negative affect. These findings suggest that both positive and negative automatic thoughts mediate the relationship between self-compassion and affect in Japanese people. (C) 2014 Elsevier Ltd. All rights reserved.	[Arimitsu, Kohki] Komazawa Univ, Dept Psychol, Setagaya Ku, Tokyo 1548525, Japan; [Hofmann, Stefan G.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA	Arimitsu, K (reprint author), Komazawa Univ, Dept Psychol, Setagaya Ku, 1-23-1 Komazawa, Tokyo 1548525, Japan.	arimitsu@komazawa-u.ac.jp					Allen AB, 2012, SELF IDENTITY, V11, P428, DOI 10.1080/15298868.2011.595082; Allen AB, 2010, SOCIAL PERSONALITY P, V4, P107, DOI DOI 10.1111/J.1751-9004.2009.00246.X; Johnson DP, 2009, J CLIN PSYCHOL, V65, P499, DOI 10.1002/jclp.20591; Irons C, 2006, BRIT J CLIN PSYCHOL, V45, P297, DOI 10.1348/014466505X68230; Hofmann SG, 2012, DEPRESS ANXIETY, V29, P409, DOI 10.1002/da.21888; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Jazaieri H, 2013, J HAPPINESS STUD, V14, P1113, DOI 10.1007/s10902-012-9373-z; Wei MF, 2011, J PERS, V79, P191, DOI 10.1111/j.1467-6494.2010.00677.x; Neff KD, 2009, J PERS, V77, P23, DOI 10.1111/j.1467-6494.2008.00537.x; Kojima M, 2002, PSYCHIAT RES, V110, P291, DOI 10.1016/S0165-1781(02)00106-3; Breines JG, 2013, J EXP SOC PSYCHOL, V49, P58, DOI 10.1016/j.jesp.2012.07.015; Barnard LK, 2011, REV GEN PSYCHOL, V15, P289, DOI 10.1037/a0025754; [Anonymous], 2005, SELF IDENTITY, DOI DOI 10.1080/13576500444000317; Terry ML, 2013, SELF IDENTITY, V12, P278, DOI 10.1080/15298868.2012.667913; Lyubomirsky S, 1999, J PERS SOC PSYCHOL, V77, P1041, DOI 10.1037/0022-3514.77.5.1041; Alden LE, 2013, EMOTION, V13, P64, DOI 10.1037/a0027761; Kitayama S, 1997, PERS SOC PSYCHOL B, V23, P736, DOI 10.1177/0146167297237006; Krieger T, 2013, BEHAV THER, V44, P501, DOI 10.1016/j.beth.2013.04.004; Besser A, 2003, PERS INDIV DIFFER, V35, P1735, DOI 10.1016/S0191-8869(02)00403-8; Neff KD, 2007, J RES PERS, V41, P139, DOI 10.1016/j.jrp.2006.03.004; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; Diedrich A, 2014, BEHAV RES THER, V58, P43, DOI 10.1016/j.brat.2014.05.006; Gilbert P, 2004, BRIT J CLIN PSYCHOL, V43, P31, DOI 10.1348/014466504772812959; Raes F, 2010, PERS INDIV DIFFER, V48, P757, DOI 10.1016/j.paid.2010.01.023; Kernis MH, 2005, J PERS, V73, P1569, DOI 10.1111/j.1467-6494.2005.00359.x; Johnson DP, 2011, SCHIZOPHR RES, V129, P137, DOI 10.1016/j.schres.2011.02.015; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Neff KD, 2007, J RES PERS, V41, P908, DOI 10.1016/j.jrp.2006.08.002; Neff KD, 2013, SELF IDENTITY, V12, P160, DOI 10.1080/15298868.2011.649546; Hofmann SG, 2011, CLIN PSYCHOL REV, V31, P1126, DOI 10.1016/j.cpr.2011.07.003; Johnson EA, 2013, J SOC CLIN PSYCHOL, V32, P939; INGRAM RE, 1988, J CONSULT CLIN PSYCH, V56, P898, DOI 10.1037//0022-006X.56.6.898; Laithwaite H, 2009, BEHAV COGN PSYCHOTH, V37, P511, DOI 10.1017/S1352465809990233; Neff KD, 2010, SELF IDENTITY, V9, P225, DOI 10.1080/15298860902979307; [Anonymous], 2003, SELF IDENTITY, DOI DOI 10.1080/15298860309027; Braehler C, 2013, BRIT J CLIN PSYCHOL, V52, P199, DOI 10.1111/bjc.12009; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Leary MR, 2007, J PERS SOC PSYCHOL, V92, P887, DOI 10.1037/0022-3514.92.5.887; Kearney DJ, 2013, J TRAUMA STRESS, V26, P426, DOI 10.1002/jts.21832; Arimitsu K., 2014, JAPANESE J PSYCHOL, V85, P50; Beck A. T., 1996, MANUAL BECK DEPRESSI; Boelen Paul A., 2007, Cognitive Behaviour Therapy, V36, P23, DOI 10.1080/16506070600874315; BURGESS E, 1994, COGNITIVE THER RES, V18, P15, DOI 10.1007/BF02359392; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIENER E, 1995, J PERS SOC PSYCHOL, V68, P653, DOI 10.1037/0022-3514.69.1.120; Fukui I., 1998, JAPANESE J BEHAV THE, V24, P57; Fukui I., 2005, B CTR CLIN PSYCHOL, V5, P71; Gilbert P., 2005, COMPASSION CONCEPTUA, P263; Hallion L. S., 2011, PSYCHOL BULL, V137, P940; Hitokoto H., 2014, J HAPPINESS STUDIES; Ingram RE, 1995, PSYCHOL ASSESSMENT, V7, P495, DOI 10.1037/1040-3590.7.4.495; Jolly JB, 1996, COGNITIVE THER RES, V20, P481, DOI 10.1007/BF02227909; Koga A., 1980, JAPANESE PSYCHOL REV, V23, P269; Kuster F, 2012, PERS SOC PSYCHOL B, V38, P747, DOI 10.1177/0146167212437250; Miyamoto Y, 2011, COGNITION EMOTION, V25, P22, DOI 10.1080/02699931003612114; Neff K., 2011, SELF COMPASSION STOP; Nishikawa D., 2014, JAPANESE J PSYCHOL, V84, P451; Nolen-Hoeksema S, 2004, DEPRESSIVE RUMINATIO, P107; Petersen LE, 2014, PERS INDIV DIFFER, V56, P133, DOI 10.1016/j.paid.2013.08.036; Phillips WJ, 2013, J GERONTOL B-PSYCHOL, V68, P529, DOI 10.1093/geronb/gbs091; Pyszczynski T, 2003, HANDBOOK OF SELF AND IDENTITY, P314; Rosenberg M., 1965, SOC ADOLESCENT SELF; Salzberg S., 1995, LOVING KINDNESS REVO; Spielberger CD, 1970, STAI MANUAL STATETRA; Takano K, 2009, BEHAV RES THER, V47, P260, DOI 10.1016/j.brat.2008.12.008; Yamaguchi A, 2014, PERS INDIV DIFFER, V68, P65, DOI 10.1016/j.paid.2014.03.013; Yamamoto M., 1982, JAPANESE J ED PSYCHO, V30, P64	68	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0191-8869			PERS INDIV DIFFER	Pers. Individ. Differ.	FEB	2015	74						41	48		10.1016/j.paid.2014.10.008		8	Psychology, Social	Psychology	AY5EQ	WOS:000347596300008		
J	Ruffle, JK; Farmer, AD; Kano, M; Giampietro, V; Aziz, Q; Coen, SJ				Ruffle, James K.; Farmer, Adam D.; Kano, Michiko; Giampietro, Vincent; Aziz, Qasim; Coen, Steven J.			The influence of extraversion on brain activity at baseline and during the experience and expectation of visceral pain	PERSONALITY AND INDIVIDUAL DIFFERENCES			English	Article						Extraversion; Visceral pain; fMRI; Human brain; Pain anticipation; Personality	PSYCHOPHYSIOLOGICAL RESPONSES; SENSATION; ACTIVATION; CLUSTERS	Eysenck proposed a 'trait theory' of personality, the dimensions of which encompass numerous individual qualities. Whilst the influence of neuroticism on the brain processing of pain is well described, the role of extraversion, to date, has not been systematically investigated. Our aim was to address this knowledge gap using functional magnetic resonance imaging (fMRI). Extraversion was measured in 33 healthy volunteers (17 males, mean age 29 years [range 20-53]) using the Eysenck Personality Questionnaire. fMRI data were acquired using a 3T MRI scanner during rest, pain anticipation, and painful oesophageal balloon distention. The effect of extraversion on flVIRI responses was determined. Extraversion scores varied (range 6-22) and did not influence pain threshold or rating. High extraversion was associated with significantly greater activity in the left cuneus during rest (p <= 0.001), and the right insula during both anticipation (p <= 0.0002) and pain (p <= 0.0008). Low extraversion was associated with significantly greater brain activity in the bilateral precuneus, bilateral lingual gyrus, right inferior temporal gyrus, left fusiform gyrus and left superior parietal lobule during pain anticipation (all p <= 0.0001). These results suggest that extraversion is associated with differences in the brain processing of visceral pain. Future studies of visceral pain, using fMRI, should control for extraversion. (C) 2014 Elsevier Ltd. All rights reserved.	[Ruffle, James K.; Farmer, Adam D.; Kano, Michiko; Aziz, Qasim] Queen Mary Univ London, Ctr Digest Dis, Blizard Inst, Wingate Inst Neurogastroenterol,Barts & London Sc, London, England; [Kano, Michiko] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Giampietro, Vincent] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England; [Coen, Steven J.] UCL, Res Dept Clin Educ & Hlth Psychol, London, England	Aziz, Q (reprint author), Barts & London Queen Marys Sch Med & Dent, Wingate Inst Neurogastroenterol, 26 Ashfield St, London E1 2AJ, England.	q.aziz@qmul.ac.uk					Drabant EM, 2011, NEUROIMAGE, V55, P401, DOI 10.1016/j.neuroimage.2010.11.040; Vassend O, 2013, PAIN, V154, P722, DOI 10.1016/j.pain.2013.01.010; Ramirez-Maestre C, 2004, J BEHAV MED, V27, P147, DOI 10.1023/B:JOBM.0000019849.21524.70; Van Oudenhove L, 2007, WORLD J GASTROENTERO, V13, P3438; Coen SJ, 2011, GASTROENTEROLOGY, V141, P909, DOI 10.1053/j.gastro.2011.06.008; O'Gorman RL, 2006, NEUROIMAGE, V31, P489, DOI 10.1016/j.neuroimage.2005.12.048; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; Coen SJ, 2009, GASTROENTEROLOGY, V137, P253, DOI 10.1053/j.gastro.2009.02.052; Seifert F, 2013, HUM BRAIN MAPP, V34, P1768, DOI 10.1002/hbm.22035; Yaguez L, 2005, GASTROENTEROLOGY, V128, P1819, DOI 10.1053/j.gastro.2005.02.068; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; Kumari V, 2004, J NEUROSCI, V24, P10636, DOI 10.1523/JNEUROSCI.3206-04.2004; Lee JE, 2010, J PAIN, V11, P681, DOI 10.1016/j.jpain.2009.10.013; Aziz Q, 1997, GASTROENTEROLOGY, V113, P50, DOI 10.1016/S0016-5085(97)70079-9; BARNES GE, 1975, BRIT J SOC CLIN PSYC, V14, P303; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Eysenck H. J., 1973, EYSENCK EXTRAVERSION; Eysenck H. J., 1947, DIMENSIONS PERSONALI; Eysenck Jr H, 1991, MANUAL EYSENCK PERSO; Farmer AD, 2013, PAIN, V154, P2266, DOI 10.1016/j.pain.2013.05.016; Farmer AD, 2014, NEUROGASTROENT MOTIL, V26, P139, DOI 10.1111/nmo.12245; Ferracuti S, 2005, PERCEPT MOTOR SKILL, V100, P237, DOI 10.2466/PMS.100.1.237-248; IASP, 1994, PAIN TERMS CURR LI 3; Kehoe EG, 2012, SOC COGN AFFECT NEUR, V7, P858, DOI 10.1093/scan/nsr059; Ramirez-Maestre C, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-012-0312-9; Spielberger CD, 1970, MANUAL STATE TRAIT A; Tamura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039527; Walter S., 2011, PSYCHOSOCIAL MED, V8	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0191-8869			PERS INDIV DIFFER	Pers. Individ. Differ.	FEB	2015	74						248	253		10.1016/j.paid.2014.10.024		6	Psychology, Social	Psychology	AY5EQ	WOS:000347596300044		
J	Tanaka, H; Maruta, T; Tamoi, M; Yabuta, Y; Yoshimura, K; Ishikawa, T; Shigeoka, S				Tanaka, Hiroyuki; Maruta, Takanori; Tamoi, Masahiro; Yabuta, Yukinori; Yoshimura, Kazuya; Ishikawa, Takahiro; Shigeoka, Shigeru			Transcriptional control of vitamin C defective 2 and tocopherol cyclase genes by light and plastid-derived signals: The partial involvement of GENOMES UNCOUPLED 1	PLANT SCIENCE			English	Article						Plastid signaling; Chloroplast; Ascorbate; Tocopherol; Arabidopsis; GENOMES UNCOUPLED 1	L-GALACTOSE PHOSPHORYLASE; ELECTRON-TRANSPORT CHAIN; VITAMIN-C BIOSYNTHESIS; ASCORBIC-ACID; ARABIDOPSIS-THALIANA; HOMOGENTISATE PHYTYLTRANSFERASE; OXIDATIVE STRESS; ALPHA-TOCOPHEROL; OVER-EXPRESSION; PLANTS	Previous findings have-suggested-that-light and plastid-derived signals are involved in the regulation of biosynthetic pathways for L-ascorbic acid (AsA) and tocopherols (Toc). Photosynthetic electron transport (PET) activity, plastid gene expression (PGE), and the tetrapyrrole metabolism have been identified as signals that regulate nuclear gene expression through the GENOMES UNCOUPLED 1 (GUN1) protein. Here, we examined the effects of disrupting GUN1 on these pathways. The expression of vitamin C defective 2 (VTC2) and tocopherol cyclase (TC) genes, which encode key enzymes in the AsA and Toc biosynthetic pathways, respectively, was affected by illumination and darkness in parallel with the levels of both these antioxidants. However, the GUN1 disruption had no effect on these biosynthetic pathways under light-dark conditions. All treatments that inhibited PET, PGE, and the tetrapyrrole metabolism interrupted both biosynthetic pathways; however, this was partially mitigated by the GUN1 disruption. The expression patterns of VTC2 and TC reflected the levels of both antioxidants under most of the conditions examined. Our results suggest that the transcriptional control of VTC2 and TC by light and plastid-derived signals is important for the regulation of the biosynthetic pathways, and that GUN1 is at least partially involved in the plastid-derived signals-dependent regulation. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Tanaka, Hiroyuki; Tamoi, Masahiro; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan; [Maruta, Takanori; Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane 6908504, Japan; [Yabuta, Yukinori] Tottori Univ, Fac Agr, Sch Agr Biol & Environm Sci, Tottori 6808550, Japan; [Yoshimura, Kazuya] Chubu Univ, Coll Biosci & Biotechnol, Dept Food & Nutr Sci, Kasugai, Aichi 4878501, Japan	Shigeoka, S (reprint author), Kinki Univ, Fac Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	shigeoka@nara.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22248042]; MEXT [S1101035]	This work was supported by a Grant-in-Aid for Scientific Research (A) (S.S.: 22248042) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and in part by the Strategic Project to Support the Formation of Research Bases at Private Universities: Matching Fund Subsidy from MEXT, 2011-2015 (S1101035). We are grateful to Dr. Takehito Inaba (Miyazaki University) for donating the gun1-101 seeds.	Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Kerchev PI, 2011, PLANT CELL, V23, P3319, DOI 10.1105/tpc.111.090100; Gray JC, 2003, PHILOS T R SOC B, V358, P135, DOI 10.1098/rstb.2002.1180; Kobayashi N, 2008, PLANT J, V55, P607, DOI 10.1111/j.1365-313X.2008.03539.x; Yabuta Y, 2013, TRANSGENIC RES, V22, P391, DOI 10.1007/s11248-012-9656-5; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Laing WA, 2004, P NATL ACAD SCI USA, V101, P16976, DOI 10.1073/pnas.0407453101; Oswald O, 2001, P NATL ACAD SCI USA, V98, P2047, DOI 10.1073/pnas.021449998; Maruta T, 2008, J BIOL CHEM, V283, P28842, DOI 10.1074/jbc.M805538200; Bulley S, 2012, PLANT BIOTECHNOL J, V10, P390, DOI 10.1111/j.1467-7652.2011.00668.x; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.127.3.1113; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Wang J, 2013, PLANT CELL, V25, P625, DOI 10.1105/tpc.112.106880; Cela J, 2011, PLANT CELL PHYSIOL, V52, P1389, DOI 10.1093/pcp/pcr085; Conklin PL, 2006, J BIOL CHEM, V281, P15662, DOI 10.1074/jbc.M601409200; Yabuta Y, 2007, J EXP BOT, V58, P2661, DOI 10.1093/jxb/erm124; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Cottage A, 2010, J EXP BOT, V61, P3773, DOI 10.1093/jxb/erq186; Yoshimura K, 2014, BIOSCI BIOTECH BIOCH, V78, P60, DOI 10.1080/09168451.2014.877831; Smirnoff N, 2000, CRIT REV BIOCHEM MOL, V35, P291, DOI 10.1080/10409230008984166; Kakizaki T, 2009, PLANT PHYSIOL, V151, P1339, DOI 10.1104/pp.109.145987; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Munne-Bosch S, 2007, PLANTA, V225, P681, DOI 10.1007/s00425-006-0375-0; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Vinti G, 2005, PLANT MOL BIOL, V57, P343, DOI 10.1007/s11103-004-7867-8; Zhang ZW, 2011, PLANT CELL ENVIRON, V34, P1031, DOI 10.1111/j.1365-3040.2011.02302.x; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Page M, 2012, PLANT CELL ENVIRON, V35, P388, DOI 10.1111/j.1365-3040.2011.02369.x; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Munne-Bosch S, 2004, PLANTA, V218, P323, DOI 10.1007/s00425-003-1126-0; Kanwischer M, 2005, PLANT PHYSIOL, V137, P713, DOI 10.1104/pp.104.054908; Asensi-Fabado M.A., 2010, TRENDS PLANT SCI, V15, P582; Conklin PL, 2013, J EXP BOT, V64, P2793, DOI 10.1093/jxb/ert140; Cottage A.J., 2008, PHOTOSYNTHESIS ENERG, P1201; Krieger-Liszkay A, 2006, J EXP BOT, V57, P1677, DOI 10.1093/jxb/erl002; Lee K, 2007, MOL CELLS, V24, P301; Li MJ, 2010, PHYSIOL PLANTARUM, V140, P225, DOI 10.1111/j.1399-3054.2010.01395.x; Maruta T, 2010, PLANT CELL PHYSIOL, V51, P190, DOI 10.1093/pcp/pcp177; Massot C, 2012, PLANTA, V235, P153, DOI 10.1007/s00425-011-1493-x; Munne-Bosch S, 2002, FEBS LETT, V524, P145, DOI 10.1016/S0014-5793(02)03041-7; Porfirova S, 2002, P NATL ACAD SCI USA, V99, P12495, DOI 10.1073/pnas.182330899; Szymanska R, 2010, PLANT CELL PHYSIOL, V51, P537, DOI 10.1093/pcp/pcq017; Zhang Da-Peng, 2007, Science, V316, P700, DOI 10.1126/science.1142703	50	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	FEB	2015	231						20	29		10.1016/j.plantsci.2014.11.007		10	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	AZ5KZ	WOS:000348261200003		
J	Babu, AN; Jogaiah, S; Ito, S; Nagaraj, AK; Tran, LSP				Babu, Anupama Narendra; Jogaiah, Sudisha; Ito, Shin-Ichi; Nagaraj, Amruthesh Kestur; Lam-Son Phan Tran			Improvement of growth, fruit weight and early blight disease protection of tomato plants by rhizosphere bacteria is correlated with their beneficial traits and induced biosynthesis of antioxidant peroxidase and polyphenol oxidase	PLANT SCIENCE			English	Article						Plant growth promoting rhizobacteria; Tomato early blight; Induced systemic protection; Defense-related enzyme; Nutrients uptake; Plant growth promotion	INDUCED SYSTEMIC RESISTANCE; PROMOTING RHIZOBACTERIA; DEFENSE ENZYMES; DOWNY MILDEW; HOT PEPPER; INDUCTION; BACILLUS; EXPRESSION; RESPONSES; PROTEINS	Five plant growth promoting rhizobacteria (PGPRs) of different genera, newly isolated from healthy tomato rhizosphere, were characterized with phosphate solubilizing and root colonizing ability. Treatment with these isolates recorded a significant increase in seed germination and seedling vigor as well as tomato growth and fruit weight which might be partly attributed to the ability of the PGPRs to produce IAA and enhance nutrient uptake and chlorophyll content in treated plants. More importantly, a strong protection against early blight disease was observed in PGPR-pretreated tomato plants infected with Alternaria solani which is in accordance with the presence of siderophores, HCN, chitinase and glucanase in the isolated PGPRs. Additionally, a significantly enhanced accumulation of antioxidant peroxidase (POX) and polyphenol oxidase (PPO) enzymes was observed in the PGPR-pretreated plants with or without pathogen infection in comparison with water or pathogen control. Notably, the highest increase in POX and PPO accumulations was recorded in tomato plants raised from seeds primed with TN_Vel-35 strain. A significant upregulation of POX and PPO in tomato plants subjected to similar treatment with TN_Vel-35 versus respective control was also noticed, further strengthening that the PGPR-induced POX and PPO biosyntheses also contribute to PGPR-mediated protection against early blight disease in tomato plants. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Babu, Anupama Narendra; Nagaraj, Amruthesh Kestur] Univ Mysore, Dept Studies Bot, Appl Plant Pathol Lab, Mysore 570006, Karnataka, India; [Jogaiah, Sudisha] Karnatak Univ, Dept Studies Biotechnol & Microbiol, Lab Plant & Microbe Interact, Dharwad 580003, Karnataka, India; [Ito, Shin-Ichi] Yamaguchi Univ, Fac Agr, Dept Biol & Environm Sci, Lab Mol Plant Pathol, Yamaguchi 753, Japan; [Lam-Son Phan Tran] RIKEN, Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa 2300045, Japan	Nagaraj, AK (reprint author), Univ Mysore, Dept Studies Bot, Appl Plant Pathol Lab, Mysore 570006, Karnataka, India.	dr.knamruthesh@botany.uni-mysore.ac.in; son.tran@riken.jp	Tran, Lam-Son/A-1346-2009	Tran, Lam-Son/0000-0001-9883-9768	University of Mysore, India; JSPS, Japan	The first author thanks University of Mysore, India, for awarding a Research Fellowship in Sciences under University post graduate fellowship program (Special cell for SC/ST). SJ would like to thank JSPS, Japan for financial support under post-doc researcher fellowship to conduct the molecular work. Thanks to University of Mysore and Yamaguchi University, Japan for providing laboratory facilities.	Adesemoye AO, 2010, APPL SOIL ECOL, V46, P54, DOI 10.1016/j.apsoil.2010.06.010; Alikhani HA, 2006, PLANT SOIL, V287, P35, DOI 10.1007/s11104-006-9059-6; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Yasmin F, 2009, AFR J MICROBIOL RES, V3, P815; Zhang SA, 2010, BIOL CONTROL, V53, P129, DOI 10.1016/j.biocontrol.2009.10.015; ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P73, DOI 10.1016/0048-4059(82)90025-X; Ramamoorthy V, 2002, PLANT SOIL, V239, P55, DOI 10.1023/A:1014904815352; Richter C, 2012, MOL PLANT MICROBE IN, V25, P200, DOI 10.1094/MPMI-04-11-0082; Nakkeeran S, 2006, BIOCONTROL SCI TECHN, V16, P403, DOI 10.1080/09583150500532196; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Ramamoorthy V, 2001, CROP PROT, V20, P1, DOI 10.1016/S0261-2194(00)00056-9; Harrach BD, 2013, MOL PLANT MICROBE IN, V26, P599, DOI 10.1094/MPMI-09-12-0216-R; Vanitha SC, 2011, BIOL PLANTARUM, V55, P317, DOI 10.1007/s10535-011-0045-3; Tan HL, 2010, CANCER METAST REV, V29, P553, DOI 10.1007/s10555-010-9246-z; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; Van der Ent S, 2009, PHYTOCHEMISTRY, V70, P1581, DOI 10.1016/j.phytochem.2009.06.009; HIRAISHI A, 1992, LETT APPL MICROBIOL, V15, P210, DOI 10.1111/j.1472-765X.1992.tb00765.x; Ahemad Munees, 2014, Journal of King Saud University Science, V26, P1, DOI 10.1016/j.jksus.2013.05.001; Chowdappa P, 2013, BIOL CONTROL, V65, P109, DOI 10.1016/j.biocontrol.2012.11.009; Khalid A, 2004, J APPL MICROBIOL, V96, P473, DOI 10.1046/j.1365-2672.2003.02161.x; Hariprasad P, 2009, PLANT SOIL, V316, P13, DOI 10.1007/s11104-008-9754-6; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793; Rana A, 2011, ANN MICROBIOL, V61, P893, DOI 10.1007/s13213-011-0211-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; ARORA YK, 1985, PHYTOPATHOL Z, V114, P325; Ashrafuzzaman M., 2009, AFR J MICROBIOL RES, V3, P815; CASTRIC PA, 1977, J BACTERIOL, V130, P826; Chaerani Reni, 2007, Journal of General Plant Pathology, V73, P96, DOI 10.1007/s10327-006-0337-1; Chithrashree A., 2011, BIOL CONTROL, V59, P114; Cuppuccino J.G., 2004, MICROBIOLOGY LAB MAN; Egamberdieva D., 2010, BIOL FERT SOILS, V47, P197; Glick B.R., 2012, PLANT GROWTH PROMOTI, DOI DOI 10.6064/2012/963401; Grigolli JFJ, 2011, CROP BREED APPL BIOT, V11, P174, DOI 10.1590/S1984-70332011000200010; Hammerschmidt R, 1995, INDUCED RESISTANCE D; Han HS, 2005, RES J AGR BIOL SCI, V1, P176; Hariprasad P, 2014, BIOL CONTROL, V72, P9, DOI 10.1016/j.biocontrol.2014.01.012; Hariprasad P, 2009, BIOL CONTROL, V50, P307, DOI 10.1016/j.biocontrol.2009.04.002; HISCOX JD, 1979, CAN J BOT, V57, P1332; Jackson M. L., 1973, SOIL CHEM ANAL; Jackson M.L., 1962, SOIL CHEM ANAL; Latha P, 2009, BIOL CONTROL, V50, P85, DOI 10.1016/j.biocontrol.2009.03.002; Liu YH, 2010, BIOL PLANTARUM, V54, P697, DOI 10.1007/s10535-010-0123-y; Malleswari D., 2013, Journal of Microbiology and Biotechnology Research, V3, P84; Manivannan M., 2012, International Journal of Pharmaceutical and Biological Archives, V3, P179; Mathur S.B., 2003, COMMON LAB SEED HLTH, P357; Ng L. C., 2012, Australian Journal of Crop Science, V6, P170; Pieterse CMJ, 2003, SYMBIOSIS, V35, P39; Raj S. Niranjan, 2004, International Journal of Pest Management, V50, P41, DOI 10.1080/09670870310001626365; Raj SN, 2003, PLANT DIS, V87, P380, DOI 10.1094/PDIS.2003.87.4.380; Ramamoorthy V, 2002, EUR J PLANT PATHOL, V108, P429, DOI 10.1023/A:1016062702102; Ramiro DA, 2006, J CHEM ECOL, V32, P1977, DOI 10.1007/s10886-006-9122-z; RENWICK A, 1991, PLANT PATHOL, V40, P524, DOI 10.1111/j.1365-3059.1991.tb02415.x; Sandeep C., 2011, Journal of Phytology, V3, P19; Senthilraja G, 2013, PHYSIOL MOL PLANT P, V82, P10, DOI 10.1016/j.pmpp.2012.12.002; Silva H.S.A., 2003, PHYTOPATHOLOGY, V150, P42; Sudisha J., 2010, ARCH PHYTOPATHOLOGY, V43, P368; Sudisha J, 2006, BIOL CONTROL, V37, P196, DOI 10.1016/j.biocontrol.2005.11.018; Sudisha J, 2010, J PEST SCI, V83, P461, DOI 10.1007/s10340-010-0316-3; Sudisha J., 2013, J EXP BOT, V64, P3829, DOI DOI 10.1093/JXB/ERT212; Thakker J.N., 2013, ISRN BIOTECH, V13, P1; Volkalounakis D.J. D.J., 1983, ANN APPL BIOL S, V102, P138	65	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	FEB	2015	231						62	73		10.1016/j.plantsci.2014.11.006		12	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	AZ5KZ	WOS:000348261200007		
J	Higashi, H; Ikeda, H; Setoguchi, H				Higashi, Hiroyuki; Ikeda, Hajime; Setoguchi, Hiroaki			Molecular phylogeny of Shortia sensu lato (Diapensiaceae) based on multiple nuclear sequences	PLANT SYSTEMATICS AND EVOLUTION			English	Article						Diapensiaceae; Multiple nuclear sequences; Schizocodon; Shortia; Molecular phylogeny	FLOWERING PLANTS; GROUP CLASSIFICATION; PLEISTOCENE; INTROGRESSION; MITOCHONDRIAL; CHLOROPLAST; MIGRATION; FAMILIES; MARKERS; UPDATE	Molecular phylogenetics is commonly used to perform accurate taxonomic classification. Furthermore, nuclear multilocus sequences have been applied to resolve ambiguous phylogenetic relationships based on conventional markers such as chloroplast and nuclear ribosomal DNA. Here, we reconstructed the phylogenetic tree of Diapensiaceae to revise the traditional classification of the genus Shortia sensu lato (s.l.), which includes Shortia sensu stricto (s.s.) and Schizocodon; whether the latter taxon is treated as an independent genus or includes Shortia s.l. has been disputed since its first description. The phylogeny based on eight nuclear markers developed for this study indicated that Shortia s.l. is not a monophyletic group and that Schizocodon and Shortia s.s. are reciprocally monophyletic. In addition, Schizocodon would be sister to other genus Diapensia despite their morphological differentiation. Thus, our data suggest that Schizocodon represents an independent genus. Our study demonstrated that multiple nuclear loci can resolve obscure phylogenetic relationships determined using conventional markers.	[Higashi, Hiroyuki; Setoguchi, Hiroaki] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Ikeda, Hajime] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	Higashi, H (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.	higashi.hiroyuki.27s@st.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21370032, 22405013]	We thank T. Ohtsuki, N. Ishibashi, H. Oh, N. Ohki, S. Yamada, H. Yagi, T. Wakabayashi, H. Imogawa, S. Nozoe, Q. Han, D. Takahashi and Y. Umetsu (Kyoto University) for helpful advice regarding the experiments. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (21370032 and 22405013 to HS) and a Grant-in-Aid for JSPS Fellows (HH).	Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Wang J, 2014, HEREDITY, V112, P156, DOI 10.1038/hdy.2013.87; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Carstens BC, 2007, SYSTEMATIC BIOL, V56, P400, DOI 10.1080/10635150701405560; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Gibbard P, 2009, QUATERNAIRE, V20, P125; Anderberg AA, 2002, AM J BOT, V89, P677, DOI 10.3732/ajb.89.4.677; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73; Nielsen R, 2001, GENETICS, V158, P885; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Ikeda H, 2012, NEW PHYTOL, V194, P583, DOI 10.1111/j.1469-8137.2012.04061.x; Bremer B, 2003, BOT J LINN SOC, V141, P399; APG I, 1998, ANN MISSOURI BOT GAR, V85, P531, DOI DOI 10.2307/2992015; Bremer B, 2009, BOT J LINN SOC, V161, P105; Doyle JJ, 1990, FOCUS, V12, P13; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Gray A, 1878, ANN SCI NATURELLES B, V7, P173; Hara H, 1948, ENUMERATIO SPERMATOP, V1, P72; Higashi H, 2013, BOT J LINN SOC, V173, P46, DOI 10.1111/boj.12074; Makino T, 1901, BOT MAG TOKYO, V15, P141; Makino T, 1907, BOT MAG TOKYO, V21, P29; Masamune G, 1930, BOT MAG TOKYO, V44, P221; Ohwi J, 1965, FLORA JAPAN, P1008; Qin H, 2005, FLORA CHINA, V14, P235; Rambaut A., 2007, TRACER V1 4, V4; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Ronblom K, 2002, SYST BOT, V27, P383; Rowland LJ, 2003, HORTSCIENCE, V38, P1428; Sequeira F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-264; SETOGUCHI H, 1995, J PLANT RES, V108, P87, DOI 10.1007/BF02344310; von Siebold PF, 1843, ABHANDELUNGEN MATH P, V3, P723; Wei H, 2005, THEOR APPL GENET, V111, P1347, DOI 10.1007/s00122-005-0064-6; Xiang J, 2004, EVOLUTION, V58, P2175; YAMAZAKI T, 1990, Journal of Japanese Botany, V65, P309; Yamazaki T, 1993, FLORA JAPAN, P1; Yamazaki T, 1968, J JAP BOT, V43, P81; Yu Y, 2012, RASP RECONSTRUCT ANC	47	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0378-2697	1615-6110		PLANT SYST EVOL	Plant Syst. Evol.	FEB	2015	301	2					523	529		10.1007/s00606-014-1088-7		7	Plant Sciences; Evolutionary Biology	Plant Sciences; Evolutionary Biology	AZ3ID	WOS:000348119800002		
J	Sharma, SK; Yamamoto, M; Mukai, Y				Sharma, Santosh Kumar; Yamamoto, Maki; Mukai, Yasuhiko			Immuno-cytogenetic manifestation of epigenetic chromatin modification marks in plants	PLANTA			English	Review						DNA methylation; Histone modification; CENH3; Immuno-FISH; Plants	HISTONE H4 ACETYLATION; DNA METHYLATION; FUNCTIONAL CENTROMERES; ARABIDOPSIS-THALIANA; POLLEN DEVELOPMENT; B-CHROMOSOMES; H3 LYSINE-9; MODIFICATION PATTERNS; CYTOSINE METHYLATION; FLOWERING-TIME	Histone proteins and the nucleosomes along with DNA are the essential components of eukaryotic chromatin. Post-translational histone-DNA interactions and modifications eventually offer significant alteration in the chromatin environment and potentially influence diverse fundamental biological processes, some of which are known to be epigenetically inherited and constitute the "epigenetic code". Such chromatin modifications evidently uncover remarkable diversity and biological specificity associated with distinct patterns of covalent histone marks. The past few years have witnessed major breakthroughs in plant biology research by utilizing chromatin modification-specific antibodies through molecular cytogenetic tools to ascertain hallmark signatures of chromatin domains on the chromosomes. Here, we survey current information on chromosomal distribution patterns of chromatin modifications with special emphasis on histone methylation, acetylation, phosphorylation, and centromere-specific histone 3 (CENH3) marks in plants using immuno-FISH as a basic tool. Major available information has been classified under typical and comparative cytogenetic detection of chromatin modifications in plants. Further, spatial distribution of chromatin environment that exists between different cell types such as angiosperm/gymnosperm, monocot/dicot, diploid/polyploids, vegetative/generative cells, as well as different stages, i.e., mitosis versus meiosis has also been discussed in detail. Several challenges and future perspectives of molecular cytogenetics in the grooming field of plant chromatin dynamics have also been addressed.	[Sharma, Santosh Kumar; Mukai, Yasuhiko] Osaka Kyoiku Univ, Plant Mol Genet Lab, Div Nat Sci, Kashiwara, Osaka 5828582, Japan; [Yamamoto, Maki] Kansai Univ Welf Sci, Dept Rehabil Sci, Kashiwara, Osaka 5820026, Japan	Sharma, SK (reprint author), Osaka Kyoiku Univ, Plant Mol Genet Lab, Div Nat Sci, 4-698-1 Asahigaoka, Kashiwara, Osaka 5828582, Japan.	sksshillong@gmail.com			Japan Society for the Promotion of Science (JSPS), Japan [P13399/2013]	We thank Japan Society for the Promotion of Science (JSPS), Japan for providing postdoctoral fellowship and research grant (SKS, no. P13399/2013). Sincere thanks are also due to Dr. Go Suzuki and all members of Plant Molecular Genetics Laboratory, Osaka Kyoiku University, Osaka, Japan for their constant encouragement and help. We apologize to those authors whose works we could not cite because of space limitations.	Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Ravi M, 2013, PLANT CENTROMERE BIOLOGY, P169; Houben A, 2005, CYTOGENET GENOME RES, V109, P148, DOI 10.1159/000082394; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Houben A, 1999, PLANT J, V18, P675, DOI 10.1046/j.1365-313x.1999.00496.x; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Xu DZ, 2009, CELL CYCLE, V8, P3688; Iwata A, 2013, PLANT J, V76, P47, DOI 10.1111/tpj.12269; Tek AL, 2010, CHROMOSOME RES, V18, P337, DOI 10.1007/s10577-010-9119-x; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106; Houben A, 2011, CHROMOSOME RES, V19, P471, DOI 10.1007/s10577-011-9207-6; Fuchs J, 2008, CHROMOSOME RES, V16, P891, DOI 10.1007/s10577-008-1252-4; Strahl BD, 2000, NATURE, V403, P41; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Earley KW, 2007, PLANT J, V52, P615, DOI 10.1111/j.1365-313X.2007.03264.x; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Dong QH, 2012, PLANT J, V71, P800, DOI 10.1111/j.1365-313X.2012.05029.x; Hirsch CD, 2009, MOL BIOL EVOL, V26, P2877, DOI 10.1093/molbev/msp208; Houben A, 1996, CHROMOSOME RES, V4, P191, DOI 10.1007/BF02254958; Caperta AD, 2008, CYTOGENET GENOME RES, V122, P73, DOI 10.1159/000151319; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Fu SL, 2013, P NATL ACAD SCI USA, V110, P6033, DOI 10.1073/pnas.1303944110; Oliver C, 2013, PLANTA, V238, P23, DOI 10.1007/s00425-013-1885-1; Jin WW, 2008, CHROMOSOME RES, V16, P1203, DOI 10.1007/s10577-008-1269-8; Zhang WL, 2008, PLANT CELL, V20, P25, DOI 10.1105/tpc.107.057083; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Koo DH, 2009, PLANT J, V59, P509, DOI 10.1111/j.1365-313X.2009.03881.x; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Probst AV, 2003, PLANT J, V33, P743, DOI 10.1046/j.1365-313X.2003.01667.x; TURNER BM, 1989, FEBS LETT, V253, P141, DOI 10.1016/0014-5793(89)80947-0; Nagaki K, 2009, CHROMOSOMA, V118, P249, DOI 10.1007/s00412-008-0193-1; Koo DH, 2011, GENOME RES, V21, P908, DOI 10.1101/gr.116202.110; Lavania UC, 2012, PLANT J, V71, P539, DOI 10.1111/j.1365-313X.2012.05006.x; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Carchilan M, 2007, PLANT CELL, V19, P1738, DOI 10.1105/tpc.106.046946; Houben A, 2007, BBA-GENE STRUCT EXPR, V1769, P308, DOI 10.1016/j.bbaexp.2007.01.002; Shaked H, 2001, PLANT CELL, V13, P1749; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Wang GX, 2011, CHROMOSOMA, V120, P353, DOI 10.1007/s00412-011-0315-z; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Nagaki K, 2005, CHROMOSOME RES, V13, P195, DOI 10.1007/s10577-005-0847-2; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Servet C, 2008, BBA-GENE REGUL MECH, V1779, P376, DOI 10.1016/j.bbagrm.2008.04.007; Belyaev ND, 1998, CHROMOSOME RES, V6, P59, DOI 10.1023/A:1009222609581; Braszewska-Zalewska A, 2010, GENOME, V53, P203, DOI [10.1139/g09-088, 10.1139/G09-088]; Demidov D, 2014, CYTOGENET GENOME RES, V143, P150, DOI 10.1159/000360018; Dunemann F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098504; Granot G, 2009, PLANTA, V231, P27, DOI 10.1007/s00425-009-1026-z; He SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097364; Houben A, 1997, CHROMOSOME RES, V5, P233, DOI 10.1023/B:CHRO.0000032297.10876.86; Janousek B, 2000, PROTOPLASMA, V211, P116, DOI 10.1007/BF01279904; Jasencakova Z, 2003, PLANT J, V33, P471, DOI 10.1046/j.1365-313X.2003.01638.x; Liu B, 2003, P NATL ACAD SCI USA, V93, P8449; Nagaki K, 2012, PLANT CELL REP, V31, P771, DOI 10.1007/s00299-011-1198-4; Nagaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051315; Nagaki K, 2011, CHROMOSOME RES, V19, P591, DOI 10.1007/s10577-011-9219-2; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Pandey P, 2013, CYTOGENET GENOME RES, V141, P50, DOI 10.1159/000351211; Ribeiro T, 2009, SEX PLANT REPROD, V22, P1, DOI 10.1007/s00497-008-0083-y; Sanei M, 2011, P NATL ACAD SCI USA, V108, pE498, DOI 10.1073/pnas.1103190108; Sano Y, 2010, CELL BIOL INT, V34, P253, DOI 10.1042/CBI20090124; Shiio Yuzuru, 2003, Proceedings of the National Academy of Sciences of the United States of America, V100, P13225, DOI 10.1073/pnas.1735528100; Suzuki G, 2010, GENES GENET SYST, V85, P377, DOI 10.1266/ggs.85.377; Tek AL, 2014, GENE, V538, P8, DOI 10.1016/j.gene.2014.01.034; Tek AL, 2011, CHROMOSOME RES, V19, P969, DOI 10.1007/s10577-011-9247-y; Vyskot B, 1999, GENOME, V42, P343, DOI 10.1139/gen-42-2-343; Yue MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083258; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhou DX, 2009, EPIGENETICS, V4, P15	75	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	FEB	2015	241	2					291	301		10.1007/s00425-014-2233-9		11	Plant Sciences	Plant Sciences	AZ6DX	WOS:000348309800001		
J	Takahashi, M; Yamamoto, R; Sakurai, N; Nakano, Y; Takeda, T				Takahashi, Machiko; Yamamoto, Ryoichi; Sakurai, Naoki; Nakano, Yuki; Takeda, Takumi			Fungal hemicellulose-degrading enzymes cause physical property changes concomitant with solubilization of cell wall polysaccharides	PLANTA			English	Article						Xylanase; 1,3-1,4-beta-Glucanase; Viscoelastic properties; Hemicellulosic tethers; Polysaccharide solubilization	PEA STEM SEGMENTS; MAGNAPORTHE-ORYZAE; COLEOPTILE SEGMENTS; BINDING DOMAINS; GROWTH; ELONGATION; MAIZE; ENDOGLUCANASE; XYLOGLUCANS; EXPRESSION	Physical properties of wheat coleoptile segments decreased after treatment with hemicellulose-degrading enzymes, indicating that hemicellulosic polysaccharides function to control the strength of primary cell walls. Changes in the physical properties of plant cell walls, a viscoelastic structure, are thought to be one of the growth-limiting factors for plants and one of the infection-affecting factors for fungi. To study the significance of hemicellulosic polysaccharides that form cross-bridges between cellulose microfibrils in controlling cell wall strength in monocot plants, the effects of hemicellulose degradation by recombinant Magnaporthe oryzae xylanase and 1,3-1,4-beta-glucanase, and recombinant Aspergillus oryzae xyloglucanase on the physical properties and polysaccharide solubilization were investigated using wheat (Triticum aestivum L.) coleoptiles. Treatments with xylanase or 1,3-1,4-beta-glucanase significantly decreased the viscosity and elasticity of wheat coleoptile segments. In addition, xyloglucanase treatment slightly decreased the viscoelasticity. Furthermore, 1,3-1,4-beta-glucan polymer was solubilized during hydrolysis with xylanase and xyloglucanase, even though neither enzyme had hydrolytic activity towards 1,3-1,4-beta-glucan. These results suggest that xylan and xyloglucan interact with 1,3-1,4-beta-glucan and that the composites and hemicellulosic polysaccharides form inter-molecular bridges. Degradation of these bridges causes decreases in the physical properties, resulting in increased extensibility of the cell walls. These findings provide a testable model in which wheat coleoptile cell walls are loosened by the degradation of hemicellulosic polysaccharides and hemicellulose-degrading enzymes play a significant role in loosening the walls during fungal infection.	[Takahashi, Machiko; Nakano, Yuki; Takeda, Takumi] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Yamamoto, Ryoichi] Tezukayama Gakuin Univ, Inst Human & Environm Sci, Nara 6318585, Japan; [Sakurai, Naoki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan	Takeda, T (reprint author), Iwate Biotechnol Res Ctr, 22-174-4 Narita, Kitakami, Iwate 0240003, Japan.	takumitakeda27@gmail.com			Iwate Prefecture	This work was supported by Iwate Prefecture.	FRY SC, 1989, PHYSIOL PLANTARUM, V75, P532, DOI 10.1111/j.1399-3054.1989.tb05620.x; Fincher GB, 2009, CURR OPIN PLANT BIOL, V12, P140, DOI 10.1016/j.pbi.2009.01.002; Takahashi M, 2013, J BIOL CHEM, V288, P13821, DOI 10.1074/jbc.M112.448902; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Nguyen QB, 2011, MOL MICROBIOL, V81, P1008, DOI 10.1111/j.1365-2958.2011.07746.x; [Anonymous], 1983, CARBOHYD POLYM, DOI 10.1016/0144-8617(83)90019-X; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103; Roulin S, 2002, PLANTA, V215, P51, DOI 10.1007/s00425-001-0721-1; Takeda T, 2002, P NATL ACAD SCI USA, V99, P9055, DOI 10.1073/pnas.132080299; Takahashi M, 2010, APPL ENVIRON MICROB, V76, P6583, DOI 10.1128/AEM.00618-10; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Ito J, 2004, BIOTECHNOL PROGR, V20, P688, DOI 10.1021/bp034332u; SCALBERT A, 1985, PHYTOCHEMISTRY, V24, P1359, DOI 10.1016/S0031-9422(00)81133-4; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Park YW, 2003, PLANT J, V33, P1099, DOI 10.1046/j.1365-313X.2003.01696.x; CARPITA NC, 1983, PLANT PHYSIOL, V72, P515, DOI 10.1104/pp.72.2.515; Darvill A, 1980, BIOCH PLANTS, V1, P91; Gibeaut DM, 2005, PLANTA, V221, P729, DOI 10.1007/s00425-005-1481-0; HAYASHI T, 1984, PLANT PHYSIOL, V75, P605, DOI 10.1104/pp.75.3.605; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139; HOSON T, 1989, PLANT PHYSIOL, V90, P1353, DOI 10.1104/pp.90.4.1353; INOUHE M, 1991, PLANT PHYSIOL, V96, P426, DOI 10.1104/pp.96.2.426; KAMATA Y, 1988, J FOOD SCI, V53, P589, DOI 10.1111/j.1365-2621.1988.tb07764.x; KATO Y, 1985, PLANT PHYSIOL, V78, P20, DOI 10.1104/pp.78.1.20; LABAVITC.JM, 1974, PLANT PHYSIOL, V53, P669, DOI 10.1104/pp.53.5.669; Miller M., 1972, ANAL BIOCHEM, V47, P273; SAKURAI N, 1979, PLANT CELL PHYSIOL, V20, P1349; SHERWOOD RT, 1980, PHYTOPATHOLOGY, V70, P273, DOI 10.1094/Phyto-70-273; Tabuchi A, 2011, PLANT J, V68, P546, DOI 10.1111/j.1365-313X.2011.04705.x; TAIZ L, 1984, ANNU REV PLANT PHYS, V35, P585; Takeda H, 2010, PHYSIOL PLANTARUM, V139, P413, DOI 10.1111/j.1399-3054.2010.01372.x; Takeda T, 2010, APPL MICROBIOL BIOT, V88, P1113, DOI 10.1007/s00253-010-2781-2; Tanimoto E, 2000, PLANT SOIL, V226, P21, DOI 10.1023/A:1026460308158; Yuan S, 2001, PLANT PHYSIOL, V127, P324, DOI 10.1104/pp.127.1.324	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	FEB	2015	241	2					359	370		10.1007/s00425-014-2176-1		12	Plant Sciences	Plant Sciences	AZ6DX	WOS:000348309800006		
J	Mameda, T; Misaki, T; Okamoto, Y; Sugimura, T				Mameda, Takuya; Misaki, Tomonori; Okamoto, Yasuaki; Sugimura, Takashi			Induction period for the enantioselective hydrogenation of alpha,beta-unsaturated acids over a cinchonidine-modified palladium catalyst	REACTION KINETICS MECHANISMS AND CATALYSIS			English	Article						Enantioselective hydrogenation; Pd/C catalyst; Induction period	ASYMMETRIC HETEROGENEOUS CATALYSIS; UNSATURATED CARBOXYLIC-ACIDS; MODIFIED PD/TIO2 CATALYST; (E)-ALPHA-PHENYLCINNAMIC ACID; MODIFIED PLATINUM; MODIFIED PD/C; PHENYLCINNAMIC ACID; AMINE ADDITION; DEPENDENCE; SUBSTRATE	The enantioselective hydrogenation of alpha-phenylcinnamic acid (PCA) was performed using a cinchonidine (CD)-modified Pd/C catalyst, and the conversion and enantiomeric excess (ee) of the product were monitored during the reaction. Low ee values were observed only during the initial stages of the reaction (< 20 % conversion) in the presence of benzylamine as reported, and the use of the 3-ethyl-analogue instead of 3-vinyl natural CD as a modifier resulted in no decline in ee despite the presence of amine. Because the 3-ethyl moiety was generated in situ during the modification process prior to the reaction of PCA, the role of the 3-substituent was unclear, as is the case with Pt/ketone hydrogenation systems. To determine the reasons for the induction, the initial stage of the reaction was mimicked using a very small amount of substrate (stoichiometric catalysis). During this study, a minimum quantity of benzylamine additive was found to be necessary to increase the ee and the reaction rate, indicating that benzylamine functioned during the induction period.	[Mameda, Takuya; Misaki, Tomonori; Okamoto, Yasuaki; Sugimura, Takashi] Univ Hyogo, Grad Sch Mat Sci, Kobe, Hyogo 6781297, Japan	Sugimura, T (reprint author), Univ Hyogo, Grad Sch Mat Sci, 3-2-1 Kohto, Kobe, Hyogo 6781297, Japan.	sugimura@sci.u-hyogo.ac.jp					Nitta Y, 2005, J CATAL, V236, P164, DOI 10.1016/j.jcat.2005.09.006; Mallat T, 2007, CHEM REV, V107, P4863, DOI 10.1021/cr0683663; Kim TY, 2010, J MOL CATAL A-CHEM, V327, P58, DOI 10.1016/j.molcata.2010.05.013; Murzin DY, 2005, CATAL REV, V47, P175, DOI 10.1081/CR-200057461; Kim TY, 2009, CATAL LETT, V131, P279, DOI 10.1007/s10562-009-0067-z; Heitbaum M, 2006, ANGEW CHEM INT EDIT, V45, P4732, DOI 10.1002/anie.200504212; Sugimura T, 2009, J CATAL, V262, P57, DOI 10.1016/j.jcat.2008.11.022; Meemken F, 2012, ACS CATAL, V2, P464, DOI 10.1021/cs2006923; Szollosi G, 2010, J CATAL, V276, P259, DOI 10.1016/j.jcat.2010.09.020; Blaser HU, 2000, J AM CHEM SOC, V122, P12675, DOI 10.1021/ja003259q; BLASER HU, 1991, STUD SURF SCI CATAL, V67, P147, DOI 10.1016/S0167-2991(08)61934-5; BLASER HU, 1991, J MOL CATAL, V68, P215, DOI 10.1016/0304-5102(91)80076-F; Burgi T, 1999, J CATAL, V183, P405, DOI 10.1006/jcat.1999.2411; Klabunovskii E, 2006, CATAL MET COMPLEXES, V31, P1; Kubota T, 2012, APPL CATAL A-GEN, V437, P18, DOI 10.1016/j.apcata.2012.06.008; Makra Z, 2014, CATAL COMMUN, V46, P113, DOI 10.1016/j.catcom.2013.11.029; MEHEUX PA, 1991, J CATAL, V128, P387, DOI 10.1016/0021-9517(91)90297-H; Nitta Y, 2000, TOP CATAL, V13, P179, DOI 10.1023/A:1009013828819; Nitta Y, 1999, CHEM LETT, P635; Nitta Y, 1996, CHEM LETT, P897, DOI 10.1246/cl.1996.897; Ogawa H, 2013, CHEM LETT, V42, P813, DOI 10.1246/cl.130245; Sugimura T, 2005, TETRAHEDRON-ASYMMETR, V16, P1573, DOI 10.1016/j.tetasy.2005.03.020; Szollosi G, 2011, ACS CATAL, V1, P1316, DOI 10.1021/cs2001994; Szollosi G, 2005, J CATAL, V231, P480, DOI 10.1016/j.jcat.2005.01.023	24	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1878-5190	1878-5204		REACT KINET MECH CAT	React. Kinet. Mech. Catal.	FEB	2015	114	1					55	61		10.1007/s11144-014-0769-0		7	Chemistry, Physical	Chemistry	AZ3IR	WOS:000348121300004		
J	Oyama, Y; Matsushita, B; Fukushima, T				Oyama, Yoichi; Matsushita, Bunkei; Fukushima, Takehiko			Distinguishing surface cyanobacterial blooms and aquatic macrophytes using Landsat/TM and ETM plus shortwave infrared bands	REMOTE SENSING OF ENVIRONMENT			English	Article						Landsat; Inland water; Cyanobacteria; Aquatic macrophytes; SWIR bands	DIFFERENCE WATER INDEX; CHLOROPHYLL-A; IMAGING SPECTROMETER; SPECTRAL REFLECTANCE; VEGETATION; LAKE; EUTROPHICATION; IMAGERY; NDWI; FLUORESCENCE	Satellite remote sensing can be considered a suitable approach to monitor the extent of cyanobacterial blooms compared with conventional ship surveys because of the patchiness and high spatial and temporal variability of the blooms. However, most of the existing algorithms are not capable of distinguishing cyanobacterial blooms and aquatic macrophytes due to their similar spectral characteristics in the red and near infrared (NIR) wavelengths. In this study, we conducted in situ spectral measurements and satellite data analyses for cyanobacterial blooms and aquatic macrophytes to find an effective method to distinguish them using medium-resolution Landsat satellite images. The reflectance spectra were measured for lake waters and cyanobacterial blooms with 13 different chlorophyll-a concentration levels (from 54 to 21,736 mu g L-1) and four types of aquatic macrophytes (two emerged and two floating-leaved macrophytes) in the wavelength range from 350 to 2500 nm. In addition, seven Landsat images were collected for nine lakes in Japan or Indonesia. We calculated several selected indices, i.e., the normalized difference vegetation index (NDVI), five types of normalized difference water index (NDWI), and the floating algal index (FAI) to find an appropriate index for distinguishing cyanobacterial blooms and aquatic macrophytes. The results showed that the spectral characteristics of cyanobacterial blooms were significantly different from those of aquatic macrophytes in the short-wave infrared (SWIR) region, indicating that the SWIR bands are important for distinguishing cyanobacterial blooms and aquatic macrophytes. The results also showed that the combination of FAI and NDWI4,5 was an effective method for classifying lake areas. We first used the FAI for extracting lake waters, and we then used the NDWI4,5 to classify the remaining areas as cyanobacterial blooms or aquatic macrophytes. The results also showed that the threshold of NDWI4,5 was less sensitive to the effects of both the atmosphere and mixed pixels compared to the other indices. Our application of the FAI threshold of 0.05 and the NDWI4,5 threshold of 0.63 to six lakes in Japan and Indonesia showed that the proposed method could successfully distinguish lake water, cyanobacterial blooms, and aquatic macrophytes. (C) 2014 Elsevier Inc. All rights reserved.	[Oyama, Yoichi; Matsushita, Bunkei; Fukushima, Takehiko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Oyama, Y (reprint author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan.	y-oyama@ies.life.tsulcuba.ac.jp	fukushima, takehiko/G-6790-2012	fukushima, takehiko/0000-0002-0095-4926	Global Environment Research Fund of Japan's Ministry of the Environment [S-9]; Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [23404015, 25420555]	We sincerely thank Dr. Hiroya Yamano and Dr. Akihide Kamei of Japan's National Institute for Environmental Studies (NIES) for the use of the FieldSpec FR spectroradiometer, and the three anonymous reviewers for their helpful comments and suggestions. This research was supported in part by the Global Environment Research Fund (S-9) of Japan's Ministry of the Environment, and by Grants-in-Aid for Scientific Research from Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (Nos. 23404015 and 25420555).	PALMER KF, 1974, J OPT SOC AM, V64, P1107, DOI 10.1364/JOSA.64.001107; Codd GA, 2000, ECOL ENG, V16, P51, DOI 10.1016/S0925-8574(00)00089-6; Tyler AN, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S11; Matthews MW, 2012, REMOTE SENS ENVIRON, V124, P637, DOI 10.1016/j.rse.2012.05.032; Letelier RM, 1996, REMOTE SENS ENVIRON, V58, P215, DOI 10.1016/S0034-4257(96)00073-9; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Hu CM, 2009, REMOTE SENS ENVIRON, V113, P2118, DOI 10.1016/j.rse.2009.05.012; Mobley CD, 1999, APPL OPTICS, V38, P7442, DOI 10.1364/AO.38.007442; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425; Simis SGH, 2005, LIMNOL OCEANOGR, V50, P237; Jakubauskas M, 2000, INT J REMOTE SENS, V21, P3533, DOI 10.1080/014311600750037543; Ma M, 2007, INT J REMOTE SENS, V28, P5523, DOI 10.1080/01431160601009698; Vermote EF, 1997, IEEE T GEOSCI REMOTE, V35, P675, DOI 10.1109/36.581987; Gower J, 2005, INT J REMOTE SENS, V26, P2005, DOI 10.1080/01431160500075857; Kutser T, 2006, ESTUAR COAST SHELF S, V67, P303, DOI 10.1016/j.ecss.2005.11.024; Janse JH, 1998, ENVIRON POLLUT, V102, P547, DOI 10.1016/S0269-7491(98)80082-1; KAHRU M, 1993, MAR ECOL PROG SER, V101, P1, DOI 10.3354/meps101001; Rogers AS, 2004, INT J REMOTE SENS, V25, P2317, DOI 10.1080/01431160310001618103; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.2307/2641247; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Scheffer M, 2007, HYDROBIOLOGIA, V584, P455, DOI 10.1007/s10750-007-0616-7; Wynne TT, 2008, INT J REMOTE SENS, V29, P3665, DOI 10.1080/01431160802007640; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025; Dash P, 2011, REMOTE SENS ENVIRON, V115, P3409, DOI 10.1016/j.rse.2011.08.004; PENUELAS J, 1993, REMOTE SENS ENVIRON, V46, P110, DOI 10.1016/0034-4257(93)90088-F; Kahru M, 2007, MAR ECOL PROG SER, V343, P15, DOI 10.3354/meps06943; Antoine D, 1998, APPL OPTICS, V37, P2245, DOI 10.1364/AO.37.002245; Codd G. A., 2005, IHP 6 TECHNICAL DOCU, V76; Dekker A. G., 1992, P 6 AUSTR REM SENS C, V1, P204; Dekker AG, 2001, RE S D I PR, V4, P307; El-Alem A, 2012, REMOTE SENS-BASEL, V4, P2373, DOI 10.3390/rs4082373; Fukui Prefecture, 2013, IMPL PLANN SHEET NAT, P1; GALAT DL, 1989, J PLANKTON RES, V11, P925, DOI 10.1093/plankt/11.5.925; Gopal B, 1987, WATER HYACINTH; GOWER JFR, 1980, BOUND-LAY METEOROL, V18, P235, DOI 10.1007/BF00122022; Havens K. E., 2007, P INT INT S CYAN HAR, P733; Hoffer R. M., 1978, REMOTE SENSING QUANT, P227; Hu CM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005511; Igarashi S., 2009, 55 ANN M JAP SOC LIM, V62; Klapper H., 1991, CONTROL EUTROPHICATI; Kutser T, 2004, LIMNOL OCEANOGR, V49, P2179; Mehra A., 1999, Resource and Environmental Biotechnology, V2, P255; Park H., 2003, FATE MICROCYSTIN LAK, V1, P79; Rouse J.W., 1973, 3 ERTS S, P309; SCOR-UNESCO, 1966, MON OC METH, V1, P11; Sridhar BBM, 2007, J GREAT LAKES RES, V33, P279; Subramaniam A, 2002, DEEP-SEA RES PT II, V49, P107; Takei K., 2004, B NAGANO PREFECTUAL, P8; Trisakti B., 2012, P SEM NAT LIMN, V4, P342	49	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	FEB	2015	157				SI		35	47		10.1016/j.rse.2014.04.031		13	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	AZ5JI	WOS:000348257100004		
J	Yagi, M; Takeda, K; Machida, M; Asazuma, T				Yagi, Mitsuru; Takeda, Kotaro; Machida, Masafumi; Asazuma, Takashi			Discordance of gravity line and C7PL in patient with adult spinal deformity-factors affecting the occiput-trunk sagittal discordance	SPINE JOURNAL			English	Article						Adult spinal deformity; Sagittal alignment; Scoliosis; Balance; Ground reaction force	RADIOGRAPHIC PARAMETERS; SCOLIOSIS; VOLUNTEERS; ALIGNMENT; OSTEOTOMY; QUALITY; FUSION; PELVIS; LUMBAR	BACKGROUND CONTEXT: During quiet standing, the gravity line (GL) can be located according to the sum of the ground reaction forces (GRFs) measured with a force platform. C7 plumb line (C7PL) is an easy method to estimate sagittal trunk balance, but discordance between C7PL and the GL is widely recognized. However, the prevalence of occiput-trunk (O-T) discordance (GL-C7PLO3 cm) and the factors affecting this type of discordance have not yet been determined. PURPOSE: The purpose of this study was to report the prevalence of O-T discordance in adult spinal deformity (ASD) patients and identify the factors affecting this type of discordance. STUDY DESIGN: This was a retrospective consecutive case series of ASD. PATIENT SAMPLE: This retrospective case series included 300 consecutive ASD patients. The inclusion criteria were age more than 50 years, Cobb angle of the main curve more than 20 degrees, and C7PL more than 5 cm. The exclusion criteria consisted of inappropriate radiography; syndromic, neuromuscular, or other pathologic conditions; and previous joint replacement. OUTCOME MEASURES: The outcome measures included self-reported (Scoliosis Research Society 22 and Oswestry disability index [ODI]) and radiographic measures. METHODS: In a retrospective consecutive case series, demographic and radiographic patient data were reviewed. Demographic data included age, gender, curve type, SRS22, and ODI. Radiographic data included GL, C7PL, C2-C7, T2-T5, T5-T12, T10-L2, T2 tilt, lumbar lordosis (LL), sacrum slope (SS), pelvic tilt (PT), and pelvic incidence (PI). Global sagittal and spinopelvic alignments were also reviewed. Patients were categorized in either a O-T concordance (C group, GL-C7PL<3 cm) or a O-T discordance (D group, GL-C7PL more than +3 cm) group, and the demographic, radiographic, and clinical outcome data were compared between these groups. One-way analysis of variance, correlation coefficient tests, and multiple regression and logistic regression analyses were performed for statistical analysis. p Value less than.01 was considered statistically significant. Force platform analysis was performed to assess the relationship among GRF, GL, and C7PL. RESULTS: Among 300 consecutive ASD patients, 72 (24%) were categorized in the D group. There was no significant difference in terms of demographic data between the C and D groups. The SRS and ODI of patients with GL more than 10 cm were significantly lower than those of patients with GL less than 10 cm. Comparisons of regional sagittal alignment showed significantly higher T5-T12 values in the D group, and multiple regression analysis revealed significant correlations among T2-T5, T5-T12, and GL-C7PL. In contrast, the analysis of global sagittal alignment revealed a significantly large T2 sagittal tilt in the D group compared with the C group. Force platform analysis showed concordance between GRF and GL, whereas discordance was observed between GRF and C7PL. The D group could be classified into 2 groups based on the global sagittal alignment: 10 patients were classified as the hypo-compensation type (small SVA, small CL, small TK, and normal-to-small LL), whereas 62 were classified as the forward-leaning type (large sagittal vertical axis, large cervical lordosis, large thoracic kyphosis, and small LL). CONCLUSIONS: The prevalence of discordance between GL and C7PL in ASD patients was 24%, and thoracic kyphosis and global sagittal alignment were significantly correlated with this discordance. The concordance of GRF and GL and the discordance of GRF and C7PL highlight the importance and necessity of accounting for GL when considering surgical treatment. (C) 2015 Elsevier Inc. All rights reserved.	[Yagi, Mitsuru; Asazuma, Takashi] Natl Hosp Org, Dept Orthoped Surg, Murayama Med Ctr, Gakuen, Tokyo 2080011, Japan; [Takeda, Kotaro; Machida, Masafumi] Natl Hosp Org, Clin Res Ctr, Murayama Med Ctr, Gakuen, Tokyo 2080011, Japan; [Takeda, Kotaro] Fujita Hlth Univ, Fujita Mem Nanakuri Inst, Tsu, Mie 5141296, Japan	Yagi, M (reprint author), Natl Hosp Org, Dept Orthoped Surg, Murayama Med Ctr, 2-37-1 Musashimurayama, Gakuen, Tokyo 2080011, Japan.	yagiman@gmail.com			K2M, Inc.; Surgical Spine, Inc.	Author disclosures: MY: Speaking/Teaching Arrangements: Depuy Synthes, Inc. (A, Paid directly to institution); Research Support (Staff/Materials): K2M, Inc. (Staff/Materials); Research Support (Staff/Materials): K2M, Inc. (Staff/Materials); Grants: Surgical Spine, Inc. (B, Paid directly to institution). KT: Nothing to disclose. MM: Nothing to disclose. TA: Nothing to disclose.	DeWald CJ, 2006, SPINE, V31, pS144, DOI 10.1097/01.brs.0000236893.65878.39; Schwab F, 2006, SPINE, V31, pE959, DOI 10.1097/01.brs.0000248126.96737.0f; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; Vaz G, 2002, EUR SPINE J, V11, P80, DOI 10.1007/s005860000224; Vedantam R, 1998, SPINE, V23, P211, DOI 10.1097/00007632-199801150-00012; KOSTUIK JP, 1988, ORTHOP CLIN N AM, V19, P371; Rose PS, 2009, SPINE, V34, P785, DOI 10.1097/BRS.0b013e31819d0c86; Kuntz C, 2007, J NEUROSURG-SPINE, V6, P104, DOI 10.3171/spi.2007.6.2.104; Lafage V, 2009, SPINE, V34, pE599, DOI 10.1097/BRS.0b013e3181aad219; Kim YJ, 2007, SPINE, V32, P2653; GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005; Hammerberg EM, 2003, J SPINAL DISORD TECH, V16, P44; Bridwell KH, 2009, SPINE, V34, P2171, DOI 10.1097/BRS.0b013e3181a8fdc8; Blondel B, 2013, SPINE, V38, pE394, DOI 10.1097/BRS.0b013e3182872415; Ploumis A, 2009, SPINE, V34, P1581, DOI 10.1097/BRS.0b013e31819c94cc; Basmajian JV, 1985, MUSCLES ALIVE THEIR, P361; Cohen J., 1998, STAT POWER ANAL BEHA; El Fegoun AB, 2005, SPINE, V30, P1535; Good CR, 2010, SPINE, V35, P210, DOI 10.1097/BRS.0b013e3181c91163; Heary Robert F, 2008, Neurosurgery, V63, P69, DOI 10.1227/01.NEU.0000320426.59061.79; Kuntz Charles 4th, 2008, Neurosurgery, V63, P25, DOI 10.1227/01.NEU.0000313120.81565.D7; Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P558, DOI 10.1007/s00586-011-1939-7; Lowe T, 2006, SPINE, V31, pS119, DOI 10.1097/01.brs.0000232709.48446.be; Neal CJ, 2011, J NEUROSURG-SPINE, V15, P82, DOI 10.3171/2011.2.SPINE1018; Roussouly P, 2006, SPINE, V31, pE320, DOI 10.1097/01.brs.0000218263.58642.ff; Schwab F, 2006, SPINE, V31, P1; WINTER RB, 1989, SPINE, V14, P1287, DOI 10.1097/00007632-198912000-00003; Yagi M, 2013, SPINE DEFORMITY; Yagi M, 2013, SPINE DEFORMITY, V1, P123	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	FEB 1	2015	15	2					213	221		10.1016/j.spinee.2014.08.010		9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AZ2DX	WOS:000348045900004		
J	Yoshihara, H; Yoneoka, D				Yoshihara, Hiroyuki; Yoneoka, Daisuke			National trends in the surgical treatment for lumbar degenerative disc disease: United States, 2000 to 2009	SPINE JOURNAL			English	Article						Lumbar degenerative disc disease; Surgical treatment; Trend; Spinal fusion; Total disc replacement; Nationwide Inpatient Sample	LOW-BACK-PAIN; SPINE SURGERY; REGIONAL-VARIATIONS; INTERBODY FUSION; ARTHROPLASTY; PREFERENCES; MANAGEMENT; FIXATION; RATES	BACKGROUND CONTEXT: Surgical treatment for lumbar degenerative disc disease (DDD) remains controversial. Options include anterior lumbar interbody fusion, posterior approach fusion procedures such as posterior lumbar interbody fusion (PLIF) and posterolateral lumbar fusion (PLF), anterior and posterior lumbar fusion (APLF), and total disc replacement (TDR). However, the trends during the last decade are uncertain. PURPOSE: To examine the trends in the surgical treatment for lumbar DDD on a national level. STUDY DESIGN: A retrospective analysis of population-based national hospital discharge data collected for the Nationwide Inpatient Sample (NIS). PATIENT SAMPLE: In the NIS from 2000 to 2009, patients aged 18 years or older with primary diagnosis of lumbar/lumbosacral DDD who underwent surgical treatment were included. OUTCOME MEASURES: Trends in the surgical treatment for lumbar DDD. METHODS: Clinical data were derived from the NIS between 2000 and 2009. Patients aged 18 years or older with a primary diagnosis of lumbar/lumbosacral DDD who underwent spinal fusion or TDR were identified. Data regarding patient-and health care system-related characteristics were retrieved and analyzed. RESULTS: A total of 380,305 patients underwent surgical treatment for lumbar DDD between 2000 and 2009. Population adjusted incidence increased 2.4-fold from 2000 to 2009. Among the procedures, APLF increased 3.0-fold and PLIF/PLF increased 2.8-fold. Total disc replacement did not increase significantly. Anterior lumbar interbody fusion was performed in 16.8% of patients, PLIF/PLF in 67.9%, APLF in 13.6%, and TDR in 1.8%. Surgical treatment for lumbar DDD was 1.8 times more common in the Midwest region and 1.7 times more common in the South region than in the Northeast region. Total disc replacement was more common in younger patients and in the Northeast region. Poterior lumbar interbody fusion/PLF was more common in older patients and in the South region. CONCLUSIONS: During the last decade, surgical treatment for lumbar DDD has increased 2.4-fold in the United States. Although all fusion procedures significantly increased, TDR did not increase. Surgical treatment for lumbar DDD was more common in the Midwest and South regions. Trends in the procedures were different depending on the age group and hospital region. (C) 2015 Elsevier Inc. All rights reserved.	[Yoshihara, Hiroyuki] Suny Downstate Med Ctr, Dept Orthopaed Surg, Brooklyn, NY 11203 USA; [Yoshihara, Hiroyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Yoshihara, Hiroyuki] Nassau Univ, Med Ctr, Dept Orthopaed Surg, E Meadow, NY 11554 USA; [Yoneoka, Daisuke] Grad Univ Adv Studies, Sch Adv Sci, Dept Stat Sci, Tachikawa, Tokyo 1908562, Japan	Yoshihara, H (reprint author), Suny Downstate Med Ctr, Dept Orthopaed Surg, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	hiroyoshihara55@yahoo.co.jp		Yoneoka, Daisuke/0000-0002-3525-5092			Deyo Richard A, 2006, Clin Orthop Relat Res, V443, P139, DOI 10.1097/01.blo.0000198726.62514.75; Carragee EJ, 2006, SPINE, V31, P2115, DOI 10.1097/01.brs.0000231436.30262.dd; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Alosh H, 2009, SPINE, V34, P1956, DOI 10.1097/BRS.0b013e3181ab930e; Anderson DG, 2011, EUR SPINE J, V20, P1323, DOI 10.1007/s00586-011-1782-x; Jacobs WCH, 2013, SPINE, V38, P24, DOI 10.1097/BRS.0b013e3182741b21; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Cain CMJ, 2005, SPINE, V30, P2631, DOI 10.1097/01.brs.0000187897.25889.54; Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002; TAYLOR VM, 1994, SPINE, V19, P1207; Weinstein JN, 2006, SPINE, V31, P2707; Awe Olatilewa O, 2011, Surg Neurol Int, V2, P139, DOI 10.4103/2152-7806.85980; DAVIS H, 1994, SPINE, V19, P1117, DOI 10.1097/00007632-199405001-00003; KNOX BD, 1993, J SPINAL DISORD, V6, P242; Lin EL, 2006, J AM ACAD ORTHOP SUR, V14, P705; Madigan L, 2009, J AM ACAD ORTHOP SUR, V17, P102; Ozgur Burak M, 2006, Spine J, V6, P435, DOI 10.1016/j.spinee.2005.08.012; Pannell WC, 2013, SPINE J; RA Deyo, 2005, SPINE, V30, P1446; Smith DS, 2002, J UROLOGY, V167, P2117, DOI 10.1016/S0022-5347(05)65099-9; U.S. Census Bureau, POP EST 2000S; van den Eerenbeemt KD, 2010, EUR SPINE J, V19, P1262, DOI 10.1007/s00586-010-1445-3	23	11	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	FEB 1	2015	15	2					265	271		10.1016/j.spinee.2014.09.026		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AZ2DX	WOS:000348045900011		
J	Sugiura, T; Kashii, M; Matsuo, Y; Morimoto, T; Honda, H; Kaito, T; Iwasaki, M; Yoshikawa, H				Sugiura, Tsuyoshi; Kashii, Masafumi; Matsuo, Yohei; Morimoto, Tokimitsu; Honda, Hirotsugu; Kaito, Takashi; Iwasaki, Motoki; Yoshikawa, Hideki			Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis	SPINE JOURNAL			English	Article						Teriparatide; Glucocorticoid-induced osteoporosis; Bone graft; Bone remodeling; Spinal fusion; Adjacent vertebrae	PARATHYROID-HORMONE 1-34; POSTMENOPAUSAL WOMEN; LUMBAR FUSION; FRACTURE; OSTEOBLASTS; PREVENTION; APOPTOSIS; THERAPY; UPDATE; MICROARCHITECTURE	BACKGROUND CONTEXT: There has been no study regarding the effect of intermittent administration of teriparatide (TPTD [recombinant human parathyroid hormone (1-34)]) on spinal fusion in patients with glucocorticoid-induced osteoporosis (GIOP). PURPOSE: To elucidate the effect of intermittent administration of TPTD on spinal fusion in rats with GIOP. STUDY DESIGN: An experimental animal study of rats under continuous glucocorticoid (GC) exposure undergoing spinal fusion surgery and administration of TPTD or saline. METHODS: Male 8-week-old rats (n=18) were administered 5 mg/kg methylprednisolone (MP) for 12 weeks. After 6 weeks of MP administration, the rats underwent posterolateral spinal fusion (L4-L5) with iliac crest autograft. Then, five times a week, they were given either saline or 40 mu g/kg TPTD for 6 weeks. The following assessments were performed: time-course bone microstructural analysis of the fusion mass and adjacent vertebrae (L6), with in vivo microcomputed tomography (mu CT); fusion assessment, with manual palpation testing and three-dimensional CT images; and bone histomorphometrical analysis of the fusion mass. RESULTS: In the TPTD group, values for bone volume and other bone microstructural parameters at the fusion mass increased and peaked 4 weeks after surgery, and these values were significantly greater than those for the control (CNT) group at 4 and 6 weeks after surgery. Fusion assessment showed that fusion rate was higher in the TPTD group than in the CNT group (CNT group: 56%, TPTD group: 89%). Bone histomorphometry revealed that values for bone formation parameters were significantly higher in the TPTD group than in the CNT group. CONCLUSIONS: Under continuous GC exposure in a rat model of spinal fusion, intermittent TPTD administration accelerated bone modeling and remodeling predominantly by stimulating bone formation at the fusion mass and increasing the fusion rate. Intermittent TPTD administration also improved bone microarchitecture of adjacent vertebrae. (C) 2015 Elsevier Inc. All rights reserved.	[Sugiura, Tsuyoshi; Kashii, Masafumi; Matsuo, Yohei; Morimoto, Tokimitsu; Honda, Hirotsugu; Kaito, Takashi; Iwasaki, Motoki; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Fac Med, Dept Orthoped Surg, Suita, Osaka 5650871, Japan	Kashii, M (reprint author), Osaka Univ, Grad Sch Med, Fac Med, Dept Orthoped Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mkashii-osk@umin.ac.jp					DeWald CJ, 2006, SPINE, V31, pS144, DOI 10.1097/01.brs.0000236893.65878.39; Bostrom MPG, 2000, BONE, V26, P437, DOI 10.1016/S8756-3282(00)00251-9; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Carbonare LD, 2001, J BONE MINER RES, V16, P97, DOI 10.1359/jbmr.2001.16.1.97; Abe Y, 2007, BONE, V41, P775, DOI 10.1016/j.bone.2007.06.025; BRIDWELL KH, 1993, J SPINAL DISORD, V6, P461; Karras D, 2012, J RHEUMATOL, V39, P600, DOI 10.3899/jrheum.110947; Nakajima A, 2002, J BONE MINER RES, V17, P2038, DOI 10.1359/jbmr.2002.17.11.2038; Hulley PA, 2002, BONE, V31, P220, DOI 10.1016/S8756-3282(02)00807-4; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Van Staa TP, 2003, ARTHRITIS RHEUM, V48, P3224, DOI 10.1002/art.11283; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; Grauer JN, 2001, SPINE, V26, P127, DOI 10.1097/00007632-200101150-00004; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; D'Amelio P, 2012, OSTEOPOROSIS INT, V23, P1245, DOI 10.1007/s00198-011-1666-2; MCGUIRE RA, 1993, SPINE, V18, P1662, DOI 10.1097/00007632-199309000-00015; Ming N, 2012, SPINE, V37, P1275, DOI 10.1097/BRS.0b013e31824ac089; Dempster DW, 2001, J BONE MINER RES, V16, P1846, DOI 10.1359/jbmr.2001.16.10.1846; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Toyone T, 2010, SPINE, V35, P1915, DOI 10.1097/BRS.0b013e3181dc846c; Tseng YY, 2012, OSTEOPOROSIS INT, V23, P1613, DOI 10.1007/s00198-011-1730-y; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Liu Y, 2004, J BONE MINER RES, V19, P479, DOI 10.1359/JBMR.0301242; Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8; Bultink IEM, 2013, EXPERT OPIN PHARMACO, V14, P185, DOI 10.1517/14656566.2013.761975; Datta Nabanita S, 2011, World J Orthop, V2, P67, DOI 10.5312/wjo.v2.i8.67; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; FINKELSTEIN JS, 1994, NEW ENGL J MED, V331, P1618, DOI 10.1056/NEJM199412153312404; Ito M, 2004, LUMBAR SPINE, P683; Jahng JS, 2000, ORTHOPEDICS, V23, P1089; Lane NE, 1998, ENDOCRIN METAB CLIN, V27, P465, DOI 10.1016/S0889-8529(05)70017-7; Lawrence James P, 2006, Spine J, V6, P385, DOI 10.1016/j.spinee.2005.10.010; NEUGEBAUER BM, 1995, J BONE MINER RES, V10, P157; Ohtori S, 2012, SPINE, V37, pE1464, DOI 10.1097/BRS.0b013e31826ca2a8; Qiu Z, 2013, OSTEOPOROSIS INT, V24, P2693, DOI 10.1007/s00198-013-2385-7; WEST JL, 1991, J BONE JOINT SURG AM, V73A, P1179; Yao W, 2008, ARTHRITIS RHEUM, V58, P3485, DOI 10.1002/art.23954; ZDEBLICK TA, 1993, SPINE, V18, P983, DOI 10.1097/00007632-199306150-00006	41	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	FEB 1	2015	15	2					298	306		10.1016/j.spinee.2014.08.001		9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AZ2DX	WOS:000348045900016		
J	Tofuku, K; Murakami, N; Naruo, S				Tofuku, Katsuhiro; Murakami, Naoya; Naruo, Seiichiro			Swelling of a lumbar spinal nerve root mimicking an intraspinal mass lesion on preoperative magnetic resonance imaging	SPINE JOURNAL			English	Editorial Material									[Tofuku, Katsuhiro; Murakami, Naoya; Naruo, Seiichiro] Naruo Orthoped Hosp, Dept Orthoped Surg, Chuo Ku, Kumamoto 8620958, Japan	Tofuku, K (reprint author), Naruo Orthoped Hosp, Dept Orthoped Surg, Chuo Ku, 12-24 Okadamachi, Kumamoto 8620958, Japan.						EPSTEIN JA, 1981, J NEUROSURG, V55, P585, DOI 10.3171/jns.1981.55.4.0585; Kim Yu Yil, 2010, Korean J Pain, V23, P51, DOI 10.3344/kjp.2010.23.1.51; Roser F, 2005, J NEUROSURG-SPINE, V2, P472, DOI 10.3171/spi.2005.2.4.0472	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	FEB 1	2015	15	2					363	364		10.1016/j.spinee.2014.09.025		2	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AZ2DX	WOS:000348045900024		
J	Mitsuyama, T; Kubota, M; Nakamura, Y; Yuzurihara, M; Hoshi, K; Okada, Y				Mitsuyama, Tetsuryu; Kubota, Motoo; Nakamura, Yoshiaki; Yuzurihara, Masahito; Hoshi, Kazuei; Okada, Yoshikazu			Neuroendocrine tumor arising from tailgut cyst with spinal cord tethering: case report and literature review	SPINE JOURNAL			English	Article						Embryologic failure; Malignant transformation; Neuroendocrine tumor; Somatostatine analogue; Spinal cord tethering; Tailgut cyst	OF-THE-LITERATURE; CARCINOID-TUMOR	BACKGROUND CONTEXT: Neuroendocrine tumors (NETs) from tailgut cysts are rare; only 15 cases have been reported until now. A tailgut cyst with spinal cord tethering has not been previously reported, although both diseases are congenital anomalies in the early stage of gestation. PURPOSE: To report a rare case of NET from tailgut cyst associated with spinal cord tethering and review the literature. STUDY DESIGN: Case report and literature review. METHODS: We describe the clinical course of a 53-year-old man, who presented with gluteal pain and bladder dysfunction. Magnetic resonance images showed that a tumor of the sacral spinal canal extended into the retrorectal space and connected to a thickened fatty filum terminale, which was tethering the spinal cord. RESULTS: Because of tumor malignancy on a computed tomography-guided biopsy and the imaging data of involvement of presacral lymph nodes, we performed total removal of the tumor. Pathologic examination revealed NET (Grade 2) arising from a tailgut cyst. The patient received somatostatin analog therapy after surgery, followed by local radiation because of the further enlargement of the lymph nodes. Later, we started everolimus therapy for the metastases to the retroperitoneal lymph nodes. He presented with no local recurrence or further disease progression at 28 months after surgery. The review indicated that tumors in Grade 2 or 3 showed progressive clinical course after surgery and three of seven patients with biopsy were misdiagnosed. CONCLUSIONS: The correct preoperative diagnosis of NETs from tailgut cysts is difficult, but extremely important because Grade 2 or 3 tumors show disease progression even after surgery. Presacral congenital tumors, such as tailgut cysts, have the potential of malignant transformation into neuroendcrine tumors or adenocarcinomas. Comorbidity of spinal cord tethering and tailgut cyst suggests some relationship to common developmental errors in embryogenesis. (C) 2015 Elsevier Inc. All rights reserved.	[Mitsuyama, Tetsuryu; Okada, Yoshikazu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1628666, Japan; [Mitsuyama, Tetsuryu; Kubota, Motoo; Yuzurihara, Masahito] Kameda Med Ctr, Dept Spinal Surg, Kamogawa, Chiba 2968602, Japan; [Nakamura, Yoshiaki] Kameda Med Ctr, Dept Oncol, Kamogawa, Chiba 2968602, Japan; [Hoshi, Kazuei] Kameda Med Ctr, Dept Pathol, Kamogawa, Chiba 2968602, Japan	Mitsuyama, T (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, 8-1 Kawada Chou, Tokyo 1628666, Japan.	tmitsuyama@nij.twmu.ac.jp					Prasad AR, 2000, ARCH PATHOL LAB MED, V124, P725; Volante M, 2007, MODERN PATHOL, V20, P1172, DOI 10.1038/modpathol.3800954; Mathis KL, 2010, BRIT J SURG, V97, P575, DOI 10.1002/bjs.6915; Klimstra DS, 2010, PANCREAS, V39, P707, DOI 10.1097/MPA.0b013e3181ec124e; Culler MD, 2011, CANCER METAST REV, V30, P9, DOI 10.1007/s10555-011-9293-0; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Dahan H, 2001, RADIOGRAPHICS, V21, P575; HJERMSTAD BM, 1988, AM J CLIN PATHOL, V89, P139; Oberg K, 2011, CANCER METAST REV, V30, P3, DOI 10.1007/s10555-011-9292-1; Chan JA, 2011, CURR TREAT OPTION ON, V12, P136, DOI 10.1007/s11864-011-0148-2; Furuta M, 1998, LUNG CANCER-J IASLC, V22, P55, DOI 10.1016/S0169-5002(98)00067-1; GonuL II, 2007, INT J COLORECTAL DIS, V22, P1283, DOI 10.1007/s00384-006-0153-2; Horenstein MG, 1998, AM J SURG PATHOL, V22, P251, DOI 10.1097/00000478-199802000-00015; Jacob Sunitha, 2004, Indian J Pathol Microbiol, V47, P32; La Rosa S, 2010, ENDOCR PATHOL, V21, P190, DOI 10.1007/s12022-010-9127-6; Larsen WJ, 2001, HUMAN EMBRYOLOGY, P86; Lee CM, 2007, J KOREAN SOC COLOPRO, V23, P65; Liang JJ, 2008, INT J CLIN EXP PATHO, V1, P539; Lin S L, 1992, Zhonghua Yi Xue Za Zhi (Taipei), V49, P57; Mathieu A, 2005, HISTOL HISTOPATHOL, V20, P1065; Mourra N, 2003, DIS COLON RECTUM, V46, P411, DOI 10.1097/01.DCR.0000054696.40479.42; Niazi TN, 2011, J NEUROSURG-SPINE, V14, P382, DOI 10.3171/2010.11.SPINE09763; Oyama K, 2000, DIAGN CYTOPATHOL, V22, P376, DOI 10.1002/(SICI)1097-0339(200006)22:6<376::AID-DC9>3.0.CO;2-6; Rindi G, 2010, WHO CLASSIFICATION T, V3, P13; Skandalakis JE, 1994, EMBRYOLOGY SURG, P242; Song DE, 2004, ARCH PATHOL LAB MED, V128, P578; Spada F, 2011, Ecancermedicalscience, V5, P201, DOI 10.3332/ecancer.2011.201; Wohlke M, 2011, PATHOLOGE, V32, P165, DOI 10.1007/s00292-010-1390-2; Zoccali M, 2012, ARCH SURG-CHICAGO, V147, P93, DOI 10.1001/archsurg.2011.702a	29	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	FEB 1	2015	15	2					E1	E8		10.1016/j.spinee.2014.09.027		8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AZ2DX	WOS:000348045900001		
J	Sakamoto, H; Takeda, N; Arai, F; Hosokawa, K; Garcia, P; Suda, T; Frampton, J; Ogawa, M				Sakamoto, Hiroshi; Takeda, Naoki; Arai, Fumio; Hosokawa, Kentaro; Garcia, Paloma; Suda, Toshio; Frampton, Jon; Ogawa, Minetaro			Determining c-Myb Protein Levels Can Isolate Functional Hematopoietic Stem Cell Subtypes	STEM CELLS			English	Article						Hematopoietic stem cells; Proto-oncogene proteins c-myb; Animals; Genetically modified; Hematopoietic stem cell transplantation; Cell proliferation; Hematopoiesis	SELF-RENEWAL; DIFFERENTIATION; RECONSTITUTION; PROLIFERATION; COMPARTMENT; PROGENITORS; HIERARCHY; CAPACITY; KNOCKOUT; PROGRAMS	The transcription factor c-Myb was originally identified as a transforming oncoprotein encoded by two avian leukemia viruses. Subsequently, through the generation of mouse models that affect its expression, c-Myb has been shown to be a key regulator of hematopoiesis, including having critical roles in hematopoietic stem cells (HSCs). The precise function of c-Myb in HSCs although remains unclear. We have generated a novel c-myb allele in mice that allows direct observation of c-Myb protein levels in single cells. Using this reporter line we demonstrate that subtypes of HSCs can be isolated based upon their respective c-Myb protein expression levels. HSCs expressing low levels of c-Myb protein (c-Myb(low)HSC) appear to represent the most immature, dormant HSCs and they are a predominant component of HSCs that retain bromodeoxyuridine labeling. Hematopoietic stress, induced by 5-fluorouracil ablation, revealed that in this circumstance c-Myb-expressing cells become critical for multilineage repopulation. The discrimination of HSC subpopulations based on c-Myb protein levels is not reflected in the levels of c-myb mRNA, there being no more than a 1.3-fold difference comparing c-Myb(low) and c-Myb(high)HSCs. This illustrates how essential it is to include protein studies when aiming to understand the regulatory networks that control stem cell behavior.	[Sakamoto, Hiroshi; Ogawa, Minetaro] Kumamoto Univ, Dept Cell Differentiat, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Takeda, Naoki] Kumamoto Univ, Div Transgen Technol, Inst Resource Dev & Anal, Kumamoto 8600811, Japan; [Arai, Fumio; Hosokawa, Kentaro; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Shinjuku Ku, Tokyo, Japan; [Garcia, Paloma; Frampton, Jon] Univ Birmingham, Coll Med, Birmingham, W Midlands, England; [Garcia, Paloma; Frampton, Jon] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Ogawa, Minetaro] Japan Sci & Technol Agcy, CREST, Kumamoto, Japan	Sakamoto, H (reprint author), Kumamoto Univ, Dept Cell Differentiat, Inst Mol Embryol & Genet, 2-2-1 Honjo, Kumamoto 8600811, Japan.	hisaka@kumamoto-u.ac.jp			KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [19591120, 21591208, 24591400]; Japan Science and Technology Agency, CREST; JSPS; Leukemia and Lymphoma Research	We thank Dr. Okada for useful discussions and M. Aoki and S. Tsunoda for technical assistance. This work was partially supported by KAKENHI, Grants-in-Aid for scientific research (C), (19591120, 21591208, and 24591400) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Japan Science and Technology Agency, CREST, and by the JSPS Institutional Program for Young Researcher Overseas Visits. J.F. and P.G. were supported by a Specialist Programme Grant from Leukemia and Lymphoma Research. F.A. and K.H. are currently affiliated with the Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8581, Japan.	Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Garcia P, 2009, EMBO J, V28, P1492, DOI 10.1038/emboj.2009.97; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Lieu YK, 2009, P NATL ACAD SCI USA, V106, P21689, DOI 10.1073/pnas.0907623106; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Greig KT, 2008, SEMIN IMMUNOL, V20, P247, DOI 10.1016/j.smim.2008.05.003; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Carpinelli MR, 2004, P NATL ACAD SCI USA, V101, P6553, DOI 10.1073/pnas.0401496101; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Muller-Sieburg CE, 2002, BLOOD, V100, P1302; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	FEB	2015	33	2					479	490		10.1002/stem.1855		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	AZ4RW	WOS:000348211300016		
J	Matsui, H; Matsui, F; Maejima, N; Matsushita, T; Okamoto, T; Hattori, AN; Sano, Y; Yamauchi, K; Daimon, H				Matsui, Hirosuke; Matsui, Fumihiko; Maejima, Naoyuki; Matsushita, Tomohiro; Okamoto, Takeshi; Hattori, Azusa N.; Sano, Yasuhisa; Yamauchi, Kazuto; Daimon, Hiroshi			Local atomic configuration of graphene, buffer layer, and precursor layer on SiC(0001) by photoelectron diffraction	SURFACE SCIENCE			English	Article						Graphene; Interface structure; Photoelectron diffraction; Photoelectron spectroscopy; Synchrotron radiation	CIRCULAR-DICHROISM; FREE PLANARIZATION; HELICAL UNDULATOR; BORON-NITRIDE; GRAPHITE; 6H-SIC(0001); ARRANGEMENT; ANALYZER; CATALYST; SPRING-8	The layer-specific atomic structure of the 4H-SiC(0001) surface at each stage of single-layer graphene formation was studied using photoelectron diffraction. The 2 pi-sr C 1s photoelectron intensity angular distributions (PIADs) excited by circularly-polarized soft X-ray were measured. Taking the photoelectron inelastic mean free path into account, we have separated C 1s PIADs of the graphene overlayer together with the interface buffer layer beneath it and the precursor layer, (6 root 3 x 6 root 3)-R30 degrees, from that of the SIC substrate. Clear diffraction rings due to the intra-layer C-C bond scattering of graphene were observed. The forward focusing peaks indicating the directions of the neighboring atoms seen from the C atoms directly bonded to the SiC substrate were observed for the precursor and interface buffer layers. This result suggests that the structures of both layers have a common local atomic configuration. (C) 2014 Elsevier B.V. All rights reserved.	[Matsui, Hirosuke; Matsui, Fumihiko; Maejima, Naoyuki; Daimon, Hiroshi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan; [Matsushita, Tomohiro] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan; [Okamoto, Takeshi; Sano, Yasuhisa; Yamauchi, Kazuto] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Hattori, Azusa N.] Osaka Univ, Grad Sch Engn, Res Ctr Ultra Precis Sci & Technol, Suita, Osaka 5650871, Japan	Matsui, H (reprint author), Nagoya Univ, RCMS, Nagoya, Aichi 4648602, Japan.	h-matsui@chemmagoya-u.ac.jp			 [11J09374]	This work was performed with the approval of the Japan Synchrotron Radiation Institute, Proposal No. 2009B1769, 2010A1469, and 2011A1471. The authors express deepest gratitude to Dr. Tetsuya Nakamura and Dr. Takayuki Muro for their experimental supports. This study was also supported by a Grant-in-Aid for JSPS Fellows, No. 11J09374.	Fadley CS, 1997, PROG SURF SCI, V54, P341, DOI 10.1016/S0079-6816(97)00013-0; Roth S, 2013, NANO LETT, V13, P2668, DOI 10.1021/nl400815w; Hara H, 2006, J ELECTRON MATER, V35, pL11, DOI 10.1007/s11664-006-0218-6; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Saitoh Y, 2000, REV SCI INSTRUM, V71, P3254, DOI 10.1063/1.1287626; Tanuma S, 2011, SURF INTERFACE ANAL, V43, P689, DOI 10.1002/sia.3522; [Anonymous], 1985, AT DATA NUCL DATA TA, V32, P1; Kotsugi M, 2001, NUCL INSTRUM METH A, V467, P1493, DOI 10.1016/S0168-9002(01)00733-1; Zhou SY, 2007, NAT MATER, V6, P770, DOI 10.1038/nmat2003; Riedl C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.246804; Emtsev KV, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155303; Forbeaux I, 1998, PHYS REV B, V58, P16396, DOI 10.1103/PhysRevB.58.16396; Varchon F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.126805; Powell CJ, 2010, J ELECTRON SPECTROSC, V178, P331, DOI 10.1016/j.elspec.2009.05.004; DAIMON H, 1988, REV SCI INSTRUM, V59, P545, DOI 10.1063/1.1139884; Auwarter W, 1999, SURF SCI, V429, P229, DOI 10.1016/S0039-6028(99)00381-7; Johansson LI, 1996, PHYS REV B, V53, P13793, DOI 10.1103/PhysRevB.53.13793; TRUCANO P, 1975, NATURE, V258, P136, DOI 10.1038/258136a0; Borovikov V, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.121406; DAIMON H, 1990, REV SCI INSTRUM, V61, P57, DOI 10.1063/1.1141923; Daimon H, 2001, PHYS REV LETT, V86, P2034, DOI 10.1103/PhysRevLett.86.2034; de Lima LH, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.081403; Hattori AN, 2011, SURF SCI, V605, P597, DOI 10.1016/j.susc.2010.12.025; Inaji K, 2008, APPL SURF SCI, V254, P7549, DOI 10.1016/j.apsusc.2008.01.025; Kato Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2824844; Langer T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3100776; Maejima N, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.044604; Matsui F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.207201; Matsui F, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.013601; Matsui F, 2004, APPL PHYS LETT, V85, P3737, DOI 10.1063/1.1810214; Matsui F, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.114604; Matsui F, 2010, J ELECTRON SPECTROSC, V181, P150, DOI 10.1016/j.elspec.2010.02.015; Matsui F, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.013705; Matsui F, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.110110; Matsushita T, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085419; Muro T, 2005, J ELECTRON SPECTROSC, V144, P1101, DOI 10.1016/j.elspec.2005.01.140; Okamoto T, 2009, MATER SCI FORUM, V600-603, P835, DOI 10.4028/www.scientific.net/MSF.600-603.835; Sdauzero G., 2012, PHYS REV B, V85; Starke U, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/13/134016; Tromp RM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.106104; Xie XN, 2001, SURF SCI, V478, P57, DOI 10.1016/S0039-6028(00)01064-5	41	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	FEB	2015	632						98	102		10.1016/j.susc.2014.09.021		5	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	AY5IJ	WOS:000347605600015		
J	Matsushita, SY; Kawamoto, E; Haga, K; Yamada, T; Suto, S				Matsushita, Stephane Yu; Kawamoto, Erina; Haga, Kenya; Yamada, Taro; Suto, Shozo			Morphology and atomic structure of hydrogen-terminated Si(110)-(1 x 1) surfaces prepared by a wet chemical process	SURFACE SCIENCE			English	Article						Si(110); Etching; STM; LEED; HREELS; Anisotropy	SCANNING-TUNNELING-MICROSCOPY; REFLECTANCE ANISOTROPY; AQUEOUS NH4F; SILICON; PHONONS; SI(111); CMOS	We have measured the macroscopic and microscopic surface morphology of hydrogen-terminated Si(110)-(1 x 1) [H:Si(110)-(1 x 1)] surfaces prepared by an improved wet chemical process. The observations were performed by high-resolution electron-energy-loss spectroscopy (HREELS), low-energy-electron diffraction (LEED), and scanning tunneling microscopy (STM). At macroscopic scale, it was found that the surface is a mono-hydride terminated surface with a two-dimensional p2mg space group, thus, being a well-defined H:Si(110)-(1 x 1) surface. At microscopic scale, elongated terraces were observed along the [1 (1) over bar0] direction reflecting surface anisotropy. The terraces extend in frames with sizes up to a few micrometers. We discussed the macroscopic and microscopic surface morphology by combining our LEED and STM results. (C) 2014 Elsevier B.V. All rights reserved.	[Matsushita, Stephane Yu; Kawamoto, Erina; Haga, Kenya; Suto, Shozo] Tohoku Univ, Grad Sch Sci, Dept Phys, Sendai, Miyagi 980857, Japan; [Yamada, Taro] RIKEN, Wako, Saitama 3510198, Japan	Suto, S (reprint author), Tohoku Univ, Grad Sch Sci, Dept Phys, Sendai, Miyagi 980857, Japan.	suto@surface.phys.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Tohoku University Institute for International Advanced Research and Education	We would like to thank T. Matsuda, T. Taoka, and H. Kato for useful discussion. This work was partially supported by the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and by Global COE Program "Weaving Science Web beyond Particle-Matter Hierarchy" from MEXT. S.Y.M. and E.K. also thank the Tohoku University Institute for International Advanced Research and Education for their financial support.	Seifert N, 2012, IEEE T NUCL SCI, V59, P2666, DOI 10.1109/TNS.2012.2218128; Arima K, 2004, APPL PHYS LETT, V85, P6254, DOI 10.1063/1.1840108; Arima K., 2005, J APPL PHYS, V98; BEHM RJ, 1985, SURF SCI, V160, P387, DOI 10.1016/0039-6028(85)90782-4; CHABAL YJ, 1983, PHYS REV LETT, V50, P1850, DOI 10.1103/PhysRevLett.50.1850; Clark I.T., 2008, J CHEM PHYS, V128; Clark IT, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.08JB04; DELSOLE R, 1991, PHYS REV B, V43, P2136, DOI 10.1103/PhysRevB.43.2136; Eremtchenko M, 2005, SURF SCI, V582, P159, DOI 10.1016/j.susc.2005.03.013; Fritsch J, 2001, J PHYS-CONDENS MAT, V13, P7611, DOI 10.1088/0953-8984/13/34/309; Fukidome H, 1999, JPN J APPL PHYS 2, V38, pL1085, DOI 10.1143/JJAP.38.L1085; Fukidome H, 1998, APPL SURF SCI, V130, P146, DOI 10.1016/S0169-4332(98)00041-5; JAKOB P, 1994, SURF SCI, V302, P49, DOI 10.1016/0039-6028(94)91095-2; Kato H, 2007, JPN J APPL PHYS 1, V46, P5701, DOI 10.1143/JJAP.46.5701; LAMBERT RM, 1975, SURF SCI, V49, P325, DOI 10.1016/0039-6028(75)90348-9; Matsushita S.Y., 2014, J CHEM PHYS, V140; Mendoza BS, 1998, PHYS REV B, V57, P12709; Pendry J.B., 1974, LOW ENERGY ELECT DIF; Sugawa S., 2001, P IEDM; Suto S, 2013, APPL SURF SCI, V267, P90, DOI 10.1016/j.apsusc.2012.07.153; Teramoto A, 2007, IEEE T ELECTRON DEV, V54, P1438, DOI 10.1109/TED.2007.896372; Watanabe S, 1996, SURF SCI, V351, P149, DOI 10.1016/0039-6028(95)01273-7; Yang M, 2003, IEEE ELECTR DEVICE L, V24, P339, DOI 10.1109/LED.2003.812565; Ye JH, 1996, J ELECTROCHEM SOC, V143, P4012, DOI 10.1149/1.1837329	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	FEB	2015	632						135	141		10.1016/j.susc.2014.10.003		7	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	AY5IJ	WOS:000347605600020		
J	Kanazawa, K; Nakamura, M; Huang, H; Taninaka, A; Shigekawa, H				Kanazawa, Ken; Nakamura, Miki; Huang, Hui; Taninaka, Atsushi; Shigekawa, Hidemi			Variation in anisotropic dispersion relations of self-assembled monolayer on Cu(001) induced by modulation of molecular structures	SURFACE SCIENCE			English	Article						Scanning tunneling microscopy; Anisotropic dispersion relation; beta-Alanine; Amino acid; 2DEG; Cu(001)	CU(100); GLYCINE	The two-dimensional electron gas (2DEG) states formed by self-assembled monolayers (SAM) of beta-alanine molecules on a Cu(001) surface showed anisotropic dispersion relations different from those formed by glycine SAM. beta-Alanine has a structure with an additional methylene group compared with glycine, and enantiomeric isomers were formed through adsorption, similarly to glycine. The anisotropic ratio of the effective masses was changed from 10 for glycine to 3.6 for beta-alanine, suggesting the possibility of manipulating electronic structures by modification of the molecular structures. Although the growth modes were different for beta-alanine and glycine, 2DEG states with standing waves were observed only for the p(2 x 4) phase in both cases, suggesting a key role of the interactions in the arrangement of this phase, together with the importance of the enantiomeric isomers formed through adsorption, which is also a characteristic of both molecules. (C) 2014 Elsevier B.V. All rights reserved.	[Kanazawa, Ken; Nakamura, Miki; Taninaka, Atsushi; Shigekawa, Hidemi] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Huang, Hui] Hefei Univ, Hefei, Peoples R China	Shigekawa, H (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	hidemi@ims.tsukuba.ac.jp			Japan Society for the Promotion of Science	Support from Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research) is acknowledged.	Efstathiou V, 2003, SURF SCI, V531, P304, DOI 10.1016/S0039-6028(03)00541-7; Lobo-Checa J, 2009, SCIENCE, V325, P300, DOI 10.1126/science.1175141; Gonzalez-Lakunza N, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.156805; Pennec Y, 2007, NAT NANOTECHNOL, V2, P99, DOI 10.1038/nnano.2006.212; Kanazawa K, 2011, CHEM COMMUN, V47, P11312, DOI 10.1039/c1cc11829c; Klappenberger F, 2009, NANO LETT, V9, P3509, DOI 10.1021/nl901700b; TERSOFF J, 1983, PHYS REV LETT, V50, P1998, DOI 10.1103/PhysRevLett.50.1998; Gonze X, 2005, Z KRISTALLOGR, V220, P558, DOI 10.1524/zkri.220.5.558.65066; Gonze X, 2002, COMP MATER SCI, V25, P478, DOI 10.1016/S0927-0256(02)00325-7; Klappenberger F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.026802; Heinrich BW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.216801; Kanazawa K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216102; Temirov R, 2006, NATURE, V444, P350, DOI 10.1038/nature05270; Iwai H, 2010, LANGMUIR, V26, P2294, DOI 10.1021/la902716a; Chen L, 2009, NANO LETT, V9, P4292, DOI 10.1021/nl902527d; Kanazawa K, 2007, J AM CHEM SOC, V129, P740, DOI 10.1021/ja066318u; Moon CR, 2009, NAT NANOTECHNOL, V4, P167, DOI [10.1038/nnano.2008.415, 10.1038/NNANO.2008.415]; Yang W., 1999, SURF SCI, V442, pL995	18	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	FEB	2015	632						L1	L4		10.1016/j.susc.2014.07.022		4	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	AY5IJ	WOS:000347605600030		
J	Yap, TL; Kawai, H; Neucheva, OA; Wee, ATS; Troadec, C; Saeys, M; Joachim, C				Yap, T. L.; Kawai, H.; Neucheva, O. A.; Wee, A. T. S.; Troadec, C.; Saeys, M.; Joachim, C.			Si(100)-2 x 1-H dimer rows contrast inversion in low-temperature scanning tunneling microscope images	SURFACE SCIENCE			English	Article						LT-STM; Quantum transport; Si(100)-2 x 1-H; Contrast inversion; Atomic scale devices	STM IMAGES; SURFACE; HYDROGEN; MOS2; ATOM; X-1	Detailed low temperature scanning tunneling microscope images of the Si(100)-2 x 1-H surface show a remarkable contrast inversion between filled- and empty-state images where the hydrogen dimer rows appear bright for filled-state images and dark for empty-state images. This contrast inversion originates from the change in the dominant surface states and their coupling to the tip apex and the bulk silicon channels as a function of the bias voltage: dimer Si-Si bonding states dominate the filled-state images and valley states associated with Si-Si anti-bonding states dominate the empty-state images. Care is required when constructing and interpreting the atomic structure of dangling-bond structures on the Si(100)-2 x 1-H surface. (C) 2014 Elsevier B.V. All rights reserved.	[Yap, T. L.; Kawai, H.; Neucheva, O. A.; Wee, A. T. S.; Troadec, C.; Saeys, M.; Joachim, C.] ASTAR, Inst Mat Res & Engn, Singapore 117602, Singapore; [Yap, T. L.; Wee, A. T. S.] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Yap, T. L.] GLOBALFOUNDRIES Singapore Pte Ltd, Singapore 738406, Singapore; [Saeys, M.] Univ Ghent, Chem Technol Lab, B-9052 Ghent, Belgium; [Joachim, C.] CEMES CNRS, GNS, F-31055 Toulouse, France; [Joachim, C.] CEMES CNRS, MANA Satellite, F-31055 Toulouse, France; [Joachim, C.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan	Saeys, M (reprint author), ASTAR, Inst Mat Res & Engn, 3 Res Link, Singapore 117602, Singapore.	neuchevaoa@imre.a-star.edu.sg; mark.saeys@ugent.be	Wee, Andrew/B-6624-2009	Wee, Andrew/0000-0002-5828-4312	A*STAR's VIP Atom Technology project [1021100972]; A*STAR Computational Resource Centre (A*CRC); EU ATMOL project [270028]	We acknowledge the A*STAR Computational Resource Centre (A*CRC) for the computational resources and support. We also acknowledge financial support under the A*STAR's VIP Atom Technology project 1021100972 and EU ATMOL project contract number 270028 financial support. T.LY. and H.K. contributed equally to this work.	Altibelli A, 1996, SURF SCI, V367, P209, DOI 10.1016/S0039-6028(96)00864-3; Bellec A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245434; Kolmer M, 2014, APPL SURF SCI, V288, P83, DOI 10.1016/j.apsusc.2013.09.124; Piva PG, 2005, NATURE, V435, P658, DOI 10.1038/nature03563; Kawai H, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/9/095011; Haider MB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046805; Moussa JE, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4722993; Woolcot T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.156105; Hersam MC, 2001, APPL PHYS LETT, V78, P886, DOI 10.1063/1.1348322; Fuechsle M, 2012, NAT NANOTECHNOL, V7, P242, DOI [10.1038/nnano.2012.21, 10.1038/NNANO.2012.21]; Ample F, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/12/125303; MCELLISTREM M, 1993, PHYS REV LETT, V70, P2471, DOI 10.1103/PhysRevLett.70.2471; Joachim C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/8/084025; Bellec A., 2008, PHYS REV B, V78; BOLAND JJ, 1993, ADV PHYS, V42, P129, DOI 10.1080/00018739300101474; Buehler EJ, 2000, SCIENCE, V290, P506, DOI 10.1126/science.290.5491.506; Cerda J, 1997, PHYS REV B, V56, P15885, DOI 10.1103/PhysRevB.56.15885; Hata K, 1999, PHYS REV B, V60, P8164, DOI 10.1103/PhysRevB.60.8164; Kienle D, 2006, J APPL PHYS, V100, DOI 10.1063/1.2259820; Klust A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2172397; Kolmer M., 2012, PHYS REV B, V86; Labidi H, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.165441; Manzano C, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.201302; Neucheva O.A., 2012, ATOMIC SCALE INTERCO, P23; Qin XR, 1999, PHYS REV B, V59, P7293, DOI 10.1103/PhysRevB.59.7293; Schofield SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2679; Takeuchi O, 2004, APPL PHYS LETT, V84, P3645, DOI 10.1063/1.1737063; Thirstrup C, 1998, SURF SCI, V411, P203, DOI 10.1016/S0039-6028(98)00364-1; Tiwari RK, 2008, SURF SCI, V602, P2628, DOI 10.1016/j.susc.2008.06.006; Yoshida S., 2006, SURF SCI NANOTECHNOL, V4, P192	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	FEB	2015	632						L13	L17		10.1016/j.susc.2014.10.016		5	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	AY5IJ	WOS:000347605600033		
J	Tokairin, Y; Maita, K; Takeda, S; Konno, H				Tokairin, Yoshinori; Maita, Kakeru; Takeda, Sho; Konno, Hiroyuki			Synthesis of Orthogonally Protected (2R, 3R, 4S)-4-Amino-2,3-dihydroxyheptane-1,7-dioic Acid	SYNTHESIS-STUTTGART			English	Article						unusual amino acid; dihydroxylation of Z-olefin; glutamic acid derivative; cyclic depsipeptide; JBCA method	WADSWORTH-EMMONS REACTION; Z-UNSATURATED ESTERS; STEREOSELECTIVE-SYNTHESIS; CALLIPELTIN-A; ETHYL (DIARYLPHOSPHONO)ACETATES; (2R,3R,4S)-4,7-DIAMINO-2,3-DIHYDROXYHEPTANOIC ACID; ENANTIOSPECIFIC SYNTHESIS; EFFICIENT SYNTHESIS; NATURAL-PRODUCTS; D-ALLOTHREONINE	(2R, 3R, 4S)-4-Amino-2,3-dihydroxyheptane-1,7-dioic acid, a common component of cyclic depsipeptide homophymines with anti-HIV activity, was synthesized as its orthogonally protected derivative from Fmoc-Glu(t-Bu)-OH in 6 steps. Osmium-catalyzed dihydroxylation of.-amino-Z-alpha, beta-unsaturated esters gave the dihydroxy esters with moderate diastereoselectivity. The stereochemistries of the amino acids were determined by comparison of H-1 NMR spectra.	[Tokairin, Yoshinori; Maita, Kakeru; Takeda, Sho; Konno, Hiroyuki] Yamagata Univ, Grad Sch Sci & Technol, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan	Konno, H (reprint author), Yamagata Univ, Grad Sch Sci & Technol, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan.	konno@yz.yamagata-u.ac.jp			Japan Society for the Promotion of Science [25450145]	This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (25450145) to H.K.	Ando K, 1999, J ORG CHEM, V64, P8406, DOI 10.1021/jo9907181; Ando K, 2000, J SYN ORG CHEM JPN, V58, P869; Ando K, 2000, J ORG CHEM, V65, P4745, DOI 10.1021/jo000068x; Ando K, 2010, ORG LETT, V12, P1460, DOI 10.1021/ol100071d; Oba M, 2004, TETRAHEDRON, V60, P8089, DOI 10.1016/j.tet.2004.06.109; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; Zampella A, 1996, J AM CHEM SOC, V118, P6202, DOI 10.1021/ja954287p; Hoye AT, 2011, ORG LETT, V13, P2634, DOI 10.1021/ol200743u; ANDO K, 1995, TETRAHEDRON LETT, V36, P4105, DOI 10.1016/0040-4039(95)00726-S; Bifulco G, 2007, CHEM REV, V107, P3744, DOI 10.1021/cr030733c; Ando K, 1998, J ORG CHEM, V63, P8411, DOI 10.1021/jo981337a; Bassarello C, 2001, TETRAHEDRON LETT, V42, P8611, DOI 10.1016/S0040-4039(01)01815-9; Zampella A, 2008, J ORG CHEM, V73, P5319, DOI 10.1021/jo800583b; Ando K, 1997, J ORG CHEM, V62, P1934, DOI 10.1021/jo970057c; Azuma H, 2000, J ORG CHEM, V65, P3538, DOI 10.1021/jo991447x; Kikuchi M, 2011, TETRAHEDRON LETT, V52, P3872, DOI 10.1016/j.tetlet.2011.05.062; Cahandrasekhar S., 2003, CHEM COMMUN, P1716; Dauban P, 2000, BIOORG MED CHEM LETT, V10, P129, DOI 10.1016/S0960-894X(99)00641-1; Dauban P, 1999, TETRAHEDRON, V55, P7589, DOI 10.1016/S0040-4020(99)00405-6; Dondoni A., 2000, ORG SYNTH, V77, P64; DONDONI A, 1993, TETRAHEDRON, V49, P2939, DOI 10.1016/S0040-4020(01)80389-6; Han YL, 1999, J ORG CHEM, V64, P1972, DOI 10.1021/jo982125g; Hulme AN, 2003, TETRAHEDRON LETT, V44, P7649, DOI 10.1016/j.tetlet.2003.08.030; Jeon J, 2006, J ORG CHEM, V71, P3310, DOI 10.1021/jo052676o; Kikuchi M, 2013, TETRAHEDRON, V69, P7098, DOI 10.1016/j.tet.2013.06.027; Kikuchi M, 2014, HETEROCYCLES, V89, P1620, DOI 10.3987/COM-14-13003; Kikuchi M, 2014, ORG LETT, V16, P4324, DOI 10.1021/ol5020619; Konno H, 2007, SYNTHESIS-STUTTGART, P3666, DOI 10.1055/s-2007-990848; Konno H, 2010, HETEROCYCLES, V81, P79, DOI 10.3987/COM-09-11834; KRYSAN DJ, 1994, TETRAHEDRON-ASYMMETR, V5, P625, DOI 10.1016/0957-4166(94)80024-3; Kumar AR, 2003, TETRAHEDRON LETT, V44, P5645, DOI 10.1016/S0040-4039(03)01368-6; Langlois N, 1999, TETRAHEDRON LETT, V40, P8801, DOI 10.1016/S0040-4039(99)01873-0; Oh JS, 2005, CHEM COMMUN, P770, DOI 10.1039/b414846k; Passiniemi M, 2010, SYNTHESIS-STUTTGART, P2816, DOI 10.1055/s-0029-1218843; Pelay-Gimeno M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3352; Pihko PM, 2003, TETRAHEDRON LETT, V44, P4361, DOI 10.1016/S0040-4039(03)00935-3; Reetz M., 1996, TETRAHEDRON LETT, V52, P9293; Ribes C, 2008, J ORG CHEM, V73, P7779, DOI 10.1021/jo8012989; Thoen JC, 2002, ORG LETT, V4, P4455, DOI 10.1021/ol0269852; Tokuyama H, 2002, SYNTHESIS-STUTTGART, P1121; Upadhyay PK, 2010, SYNTHESIS-STUTTGART, P3063, DOI 10.1055/s-0030-1258185; WANG L, 1992, J AM CHEM SOC, V114, P7568, DOI 10.1021/ja00045a042; Yoshimitsu Y, 2010, J ORG CHEM, V75, P3843, DOI 10.1021/jo1005284; Zampella A, 2009, ORG BIOMOL CHEM, V7, P4037, DOI 10.1039/b910015f	44	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	FEB	2015	47	3					351	358		10.1055/s-0034-1378902		8	Chemistry, Organic	Chemistry	AZ4BR	WOS:000348167800010		
J	Vieider, FM; Chmura, T; Fisher, T; Kusakawa, T; Martinsson, P; Thompson, FM; Sunday, A				Vieider, Ferdinand M.; Chmura, Thorsten; Fisher, Tyler; Kusakawa, Takao; Martinsson, Peter; Thompson, Frauke Mattison; Sunday, Adewara			Within- versus between-country differences in risk attitudes: implications for cultural comparisons	THEORY AND DECISION			English	Article						Risk attitudes; Cultural comparison; Experimental economics	PROSPECT-THEORY; UNCERTAINTY; CHOICE	Cultural comparisons enjoy increasing popularity in economics. Since cultural comparison must abandon random allocation to treatments, it is unclear whether differences found between countries can be attributed to country characteristics or are merely driven by differences in subject pools. In experiments in two Chinese cities and at two campuses in Ethiopia, we show that within-country differences are negligible. Differences between the two countries, on the other hand, are large.	[Vieider, Ferdinand M.] WZB Berlin, D-10675 Berlin, Germany; [Chmura, Thorsten] Univ Nottingham, Sch Business, Nottingham NG7 2RD, England; [Fisher, Tyler] Univ Michigan, Ann Arbor, MI 48109 USA; [Kusakawa, Takao] Hiroshima Shudo Univ, Hiroshima, Japan; [Martinsson, Peter] Univ Gothenburg, Gothenburg, Sweden; [Thompson, Frauke Mattison] Kings Coll London, London WC2R 2LS, England; [Sunday, Adewara] Univ Cape Town, ZA-7925 Cape Town, South Africa	Vieider, FM (reprint author), WZB Berlin, Reichpietschufer 50, D-10675 Berlin, Germany.	fvieider@gmail.com					Loomes G, 2002, J RISK UNCERTAINTY, V24, P103, DOI 10.1023/A:1014094209265; Conte A, 2011, J ECONOMETRICS, V162, P79, DOI 10.1016/j.jeconom.2009.10.011; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Weber EU, 1998, MANAGE SCI, V44, P1205, DOI 10.1287/mnsc.44.9.1205; Abdellaoui M, 2011, AM ECON REV, V101, P695, DOI 10.1257/aer.101.2.695; Starmer C, 2000, J ECON LIT, V38, P332, DOI 10.1257/jel.38.2.332; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Barberis NC, 2013, J ECON PERSPECT, V27, P173, DOI 10.1257/jep.27.1.173; Bruhin A, 2010, ECONOMETRICA, V78, P1375, DOI 10.3982/ECTA7139; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Prelec D, 1998, ECONOMETRICA, V66, P497, DOI 10.2307/2998573; Etchart-Vincent N, 2011, J RISK UNCERTAINTY, V42, P61, DOI 10.1007/s11166-010-9110-0; Baltussen G, 2012, EXP ECON, V15, P418, DOI 10.1007/s10683-011-9306-4; Bohnet B. I., 2008, AM ECON REV, V98, P294; Dohmen T., 2011, REV ECON STUD, V79, P645; Henrich J., 2010, BEHAV BRAIN SCI, V33, P2; Rieger M. O., 2011, WORKING PAPER; Sutter M., 2012, AM ECON REV, V103, P510; Vieider Ferdinand M., 2013, WORKING PAPER; Vieider Ferdinand M., 2012, WORKING PAPER	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0040-5833	1573-7187		THEOR DECIS	Theory Decis.	FEB	2015	78	2					209	218		10.1007/s11238-014-9418-3		10	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	AZ3JU	WOS:000348124200003		
J	Suzuki, H				Suzuki, Hidenori			What is Early Brain Injury?	TRANSLATIONAL STROKE RESEARCH			English	Letter							ANEURYSMAL SUBARACHNOID HEMORRHAGE; DELAYED CEREBRAL-ISCHEMIA; ENDOVASCULAR COILING; PROSPECTIVE REGISTRY; TREATMENT PRESAT; CLINICAL-TRIALS; SMOOTH-MUSCLE; MODEL; VASOSPASM; PERFORATION		Mie Univ, Grad Sch Med, Dept Neurosurg, Tsu, Mie 5148507, Japan	Suzuki, H (reprint author), Mie Univ, Grad Sch Med, Dept Neurosurg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	mie1192suzuki@gmail.com					Zanaty M, 2014, TRANSL STROKE RES, V5, P199, DOI 10.1007/s12975-013-0311-0; Suzuki H, 2009, STROKE, V40, P3872, DOI 10.1161/STROKEAHA.109.566109; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Edvinsson L, 2014, TRANSL STROKE RES, V5, P365, DOI 10.1007/s12975-014-0331-4; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Tso MK, 2014, TRANSL STROKE RES, V5, P174, DOI 10.1007/s12975-014-0323-4; Shimamura N, 2014, TRANSL STROKE RES, V5, P357, DOI 10.1007/s12975-013-0310-1; Naraoka M, 2013, TRANSL STROKE RES, V4, P368, DOI 10.1007/s12975-012-0247-9; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916; Taki W, 2011, WORLD NEUROSURG, V76, P437, DOI 10.1016/j.wneu.2011.04.026; Zhang JH, 2014, TRANSL STROKE RES, V5, P423, DOI 10.1007/s12975-014-0355-9; Ko SB, 2011, STROKE, V42, P669, DOI 10.1161/STROKEAHA.110.600775; Crowley RW, 2011, STROKE, V42, P919, DOI 10.1161/STROKEAHA.110.597005; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169; Brathwaite S, 2014, TRANSL STROKE RES, V5, P207, DOI 10.1007/s12975-013-0316-8; Buhler D, 2014, TRANSL STROKE RES, V5, P653, DOI 10.1007/s12975-014-0366-6; Fu C, 2013, CURR NEUROVASC RES, V10, P316; Hamada K, 2014, TRANSL STROKE RES, V5, P595, DOI 10.1007/s12975-014-0352-z; Kikkawa Y, 2015, TRANSL STROKE RES, V6, P88, DOI 10.1007/s12975-014-0375-5; Marbacher S, 2014, TRANSL STROKE RES, V5, P669, DOI 10.1007/s12975-014-0369-3; Mori K, 2014, TRANSL STROKE RES, V5, P647, DOI 10.1007/s12975-014-0356-8; Pluta RM, 2014, TRANSL STROKE RES, V5, P681, DOI 10.1007/s12975-014-0371-9; Qureshi AI, 2011, J NEUROSURG, V114, P834, DOI 10.3171/2010.6.JNS091486; Radolf S, 2014, TRANSL STROKE RES, V5, P278, DOI 10.1007/s12975-013-0292-z; Sehba FA, 2014, TRANSL STROKE RES, V5, P660, DOI 10.1007/s12975-014-0368-4; Shiba M, 2014, TRANSL STROKE RES, V5, P238, DOI 10.1007/s12975-014-0333-2; Suzuki Hidenori, 2015, Acta Neurochir Suppl, V120, P117, DOI 10.1007/978-3-319-04981-6_20; Suzuki H, 2010, EUR J EMERG MED, V17, P42, DOI 10.1097/MEJ.0b013e32832d3bde; Taki W, 2012, NEURORADIOLOGY, V54, P597, DOI 10.1007/s00234-011-0945-0	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	FEB	2015	6	1					1	3		10.1007/s12975-014-0380-8		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AZ3IT	WOS:000348121500001		
J	Kikkawa, Y; Kurogi, R; Sasaki, T				Kikkawa, Yuichiro; Kurogi, Ryota; Sasaki, Tomio			The Single and Double Blood Injection Rabbit Subarachnoid Hemorrhage Model	TRANSLATIONAL STROKE RESEARCH			English	Review						Rabbit; Subarachnoid hemorrhage; Cerebral vasospasm; Animal model; Cisterna magna	ATTENUATES CEREBRAL VASOSPASM; RECOMBINANT-HUMAN-ERYTHROPOIETIN; NITRIC-OXIDE DONOR; EARLY BRAIN-INJURY; BASILAR ARTERY; IN-VIVO; SYMPTOMATIC VASOSPASM; CEREBROSPINAL-FLUID; TIME-COURSE; RECEPTOR ANTAGONIST	Over the past 30 years, the rabbit subarachnoid hemorrhage model (SAH) has been used for investigating the post-hemorrhage pathology, especially with respect to understanding of the mechanisms of cerebral vasospasm. However, the molecular mechanisms of cerebral vasospasm remain to be elucidated. Furthermore, it is not clear whether the rabbit SAH model is suitable for the investigation of pathological conditions other than cerebral vasospasm, such as early brain injury. Therefore, the properties of the rabbit SAH model need to be validated, and the reasons for using the rabbit should be clarified. This review explores the settings and technical issues of establishing a rabbit cisterna magna single and double blood injection SAH model and discusses the characteristics and feasibilities of the models.	[Kikkawa, Yuichiro; Kurogi, Ryota; Sasaki, Tomio] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, Fukuoka 8128582, Japan; [Kikkawa, Yuichiro] Saitama Med Univ, Dept Cerebrovasc Surg, Int Med Ctr, Hidaka City, Saitama 3501298, Japan	Kikkawa, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ykikkawa@ns.med.kyushu-u.ac.jp			JSPS KAKENHI Grant [24791510, 25670624, 26462164]	This research was supported by JSPS KAKENHI Grant Numbers 24791510, 25670624, and 26462164).	Ahmad I, 1996, ACTA NEUROCHIR, V138, P1230, DOI 10.1007/BF01809753; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Kikkawa Y, 2010, J CEREBR BLOOD F MET, V30, P1637, DOI 10.1038/jcbfm.2010.35; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; McGirt MJ, 2006, NEUROSURGERY, V58, P945, DOI 10.1227/0.NEU.0000210262.67628.7E; Zhou CM, 2004, J CEREBR BLOOD F MET, V24, P419, DOI 10.1097/WCB.0000113843.39061.A1; Kertmen H, 2012, ACTA NEUROCHIR, V154, P1431, DOI 10.1007/s00701-012-1420-3; Seckin H, 2009, NEUROL RES, V31, P490, DOI 10.1179/016164108X339369; Marbacher S, 2010, BRIT J NEUROSURG, V24, P415, DOI 10.3109/02688691003746274; Naraoka M, 2013, TRANSL STROKE RES, V4, P368, DOI 10.1007/s12975-012-0247-9; Neuschmelting V, 2009, ACTA NEUROCHIR, V151, P795, DOI 10.1007/s00701-009-0350-1; Koide M, 2011, J CEREBR BLOOD F MET, V31, P3, DOI 10.1038/jcbfm.2010.143; Cosar M, 2009, SURG NEUROL, V71, P54, DOI 10.1016/j.surneu.2007.08.020; JOHSHITA H, 1990, J NEUROSURG, V73, P410, DOI 10.3171/jns.1990.73.3.0410; Ishiguro M, 2002, AM J PHYSIOL-HEART C, V283, pH2217, DOI 10.1152/ajpheart.00629.2002; Zhou ML, 2007, J NEUROSCI METH, V159, P318, DOI 10.1016/j.neumeth.2006.07.026; Aydin MD, 2011, EXP NEUROL, V230, P90, DOI 10.1016/j.expneurol.2010.09.018; Aydin MV, 2005, NEUROL RES, V27, P77, DOI 10.1179/016164105X18331; BAKER KF, 1987, SURG NEUROL, V27, P107, DOI 10.1016/0090-3019(87)90280-1; Barbosa MD, 2001, NEUROSURGERY, V49, P1205, DOI 10.1097/00006123-200111000-00032; Bavbek M, 1998, STROKE, V29, P1930; Bilginer B, 2009, TURK NEUROSURG, V19, P374; BLACK PM, 1985, NEUROSURGERY, V17, P57; Buemi M, 2000, EUR J PHARMACOL, V392, P31, DOI 10.1016/S0014-2999(00)00081-9; Bunc G, 2003, AUTON NEUROSCI-BASIC, V105, P71, DOI 10.1016/S1566-0702(03)00003-1; Bunc G, 2001, AUTON NEUROSCI-BASIC, V93, P41, DOI 10.1016/S1566-0702(01)00327-7; Cengiz SL, 2010, BRAIN INJURY, V24, P877, DOI 10.3109/02699051003789260; CHAN RC, 1984, J NEUROSURG, V61, P1120, DOI 10.3171/jns.1984.61.6.1120; Chen G, 2009, CYTOKINE, V45, P162, DOI 10.1016/j.cyto.2008.11.015; Cheng Gao, 2010, Vascul Pharmacol, V52, P77, DOI 10.1016/j.vph.2009.12.001; DEBDI M, 1992, STROKE, V23, P1154; Dinh YRT, 2001, NEUROSURGERY, V48, P33; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; EDVINSSON L, 1982, BRAIN RES BULL, V9, P799, DOI 10.1016/0361-9230(82)90187-3; ENDO S, 1988, STROKE, V19, P1420; OTSUJI T, 1994, STROKE, V25, P657; Erdi MF, 2011, TURK NEUROSURG, V21, P527, DOI [10.5137/1019-5149.JTN .4431-11.1, 10.5137/1019-5149.JTN.4431-11.1]; Fang Q, 2009, MEDIAT INFLAMM, V2009, DOI [10.1155/2009/426346, DOI 10.1155/2009/426346]; Fathi AR, 2011, ACTA NEUROCHIR, V153, P1669, DOI 10.1007/s00701-011-1049-7; Firat MM, 2005, AM J NEURORADIOL, V26, P1357; FOLEY PL, 1994, NEUROSURGERY, V34, P108; FOLEY PL, 1993, ACTA NEUROCHIR, V123, P82, DOI 10.1007/BF01476290; FUKAMI M, 1995, STROKE, V26, P2321; Gabikian P, 2002, STROKE, V33, P2681, DOI 10.1161/01.STR.0000033931.62992.B1; Gomis P, 2005, J NEUROSURG, V102, P715, DOI 10.3171/jns.2005.102.4.0715; Grasso G, 2002, J NEUROSURG, V96, P565, DOI 10.3171/jns.2002.96.3.0565; Grieb P, 1997, ACTA NEUROPATHOL, V94, P363; Guney O, 2010, WORLD NEUROSURG, V73, P42, DOI 10.1016/j.surneu.2009.06.003; Gurelik M, 2005, NEUROSCIENCE, V134, P827, DOI 10.1016/j.neuroscience.2005.04.062; HIRASHIMA Y, 1993, J NEUROSURG, V78, P592, DOI 10.3171/jns.1993.78.4.0592; Hong T, 2008, J NEUROSURG, V108, P551, DOI 10.3171/JNS/2008/108/3/0551; Iseda K, 2007, J NEUROSURG, V107, P128, DOI 10.3171/JNS-07/07/0128; Dinh YRT, 2001, NEUROSURGERY, V48, P626; Kaneko A, 2005, NEUROL RES, V27, P446, DOI 10.1179/016164105X49201; Kawada S, 1999, ACTA NEUROCHIR, V141, P1331, DOI 10.1007/s007010050438; Kawanabe Y, 2006, J NEUROSURG, V105, P288, DOI 10.3171/jns.2006.105.2.288; Kim CY, 2003, ACTA NEUROCHIR, V145, P571, DOI 10.1007/s00701-003-0024-3; Kiris T, 1999, ACTA NEUROCHIR, V141, P1323, DOI 10.1007/s007010050437; Kovacic S, 2006, AUTON NEUROSCI-BASIC, V130, P28, DOI 10.1016/j.autneu.2006.05.002; Kubota Y, 2007, VASC PHARMACOL, V47, P90, DOI 10.1016/j.vph.2007.04.004; Kusaka G, 2003, J NEUROSURG, V99, P383, DOI 10.3171/jns.2003.99.2.0383; Kwan AL, 1998, NEUROSURGERY, V42, P347, DOI 10.1097/00006123-199802000-00085; Kwan AL, 2001, NEUROSURGERY, V49, P422, DOI 10.1097/00006123-200108000-00029; Laslo AM, 2006, AM J NEURORADIOL, V27, P624; Laslo AM, 2008, AM J NEURORADIOL, V29, P79, DOI 10.3174/ajnr.A0747; Li SC, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-77; Lin CL, 2001, SURG NEUROL, V55, P297, DOI 10.1016/S0090-3019(01)00438-4; LISZCZAK TM, 1984, J NEUROSURG, V61, P486, DOI 10.3171/jns.1984.61.3.0486; Liu P, 2011, NEUROL INDIA, V59, P161, DOI 10.4103/0028-3886.79127; Mapara Manjeet, 2012, Dent Res J (Isfahan), V9, P111, DOI 10.4103/1735-3327.92960; Marbacher S, 2012, J NEUROSCI METH, V208, P138, DOI 10.1016/j.jneumeth.2012.05.010; Marbacher S, 2008, INTENS CARE MED, V34, P932, DOI 10.1007/s00134-008-0995-x; McGirt MJ, 2006, NEUROSURGERY, V58, P51, DOI [10.1227/01.NEU.0000210262.67628.7E, DOI 10.1227/01.NEU.0000210262.67628.7E.-51]; Miller CA, 2006, NEUROCRIT CARE, V5, P215, DOI 10.1385/Neurocrit.Care2006;05:215-221; Mizuno Y, 2008, VASC PHARMACOL, V48, P21, DOI 10.1016/j.vph.2007.11.002; Murphy AM, 2008, J NEUROSURG, V109, P1155, DOI 10.3171/JNS.2008.109.12.1155; NAKAGOMI T, 1989, ACTA NEUROCHIR, V98, P176, DOI 10.1007/BF01407345; Nakajima M, 2001, STROKE, V32, P620; Nakano Y, 1983, Radiat Med, V1, P299; NELSON RJ, 1991, J CEREBR BLOOD F MET, V11, P661; NIHEI H, 1991, STROKE, V22, P1419; OFFERHAUS L, 1969, Cardiovascular Research, V3, P433, DOI 10.1093/cvr/3.4.433; Pan YX, 2013, J CLIN NEUROSCI, V20, P726, DOI 10.1016/j.jocn.2012.09.012; PASQUALIN A, 1992, NEUROSURGERY, V31, P697; ROUX S, 1995, J NEUROSCI METH, V59, P245, DOI 10.1016/0165-0270(94)00210-8; Satoh M, 2001, STROKE, V32, P225; Sen O, 2006, NEUROL RES, V28, P859, DOI 10.1179/016164106X115099; Song JN, 2013, METAB BRAIN DIS, V28, P33, DOI 10.1007/s11011-012-9369-8; SPALLONE A, 1989, SURG NEUROL, V32, P408, DOI 10.1016/0090-3019(89)90002-5; STRONG MJ, 1991, NEUROTOXICOLOGY, V12, P9; Svendgaard N A, 1977, Acta Physiol Scand Suppl, V452, P73; SVENDGAARD NA, 1977, SURG NEUROL, V8, P191; TAKAHASHI S, 1993, NEUROSURGERY, V32, P281; TANAKA Y, 1991, NEUROSURGERY, V28, P387; Tang WH, 2008, NEUROL RES, V30, P571, DOI 10.1179/174313208X297986; Taplu A, 2003, EUR J ANAESTH, V20, P690; Tsurutani H, 2003, STROKE, V34, P1497, DOI 10.1161/01.STR.0000070424.38138.30; TUNCER R, 1993, ACTA NEUROCHIR, V121, P72, DOI 10.1007/BF01405186; Visocchi M, 2006, J Neurosurg Sci, V50, P89; VOLLMER DG, 1989, J NEUROSURG, V70, P599, DOI 10.3171/jns.1989.70.4.0599; VORKAPIC P, 1991, NEUROSURG REV, V14, P215, DOI 10.1007/BF00310660; Wanebo JE, 1998, NEUROSURGERY, V43, P1409, DOI 10.1097/00006123-199812000-00086; YANAMOTO H, 1992, NEUROSURGERY, V30, P351; Yurt A, 2010, NEUROSCIENCES, V15, P15; Zhang Z, 2001, STROKE, V32, P1665; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47; ZUCCARELLO M, 1989, J NEUROSURG, V71, P98, DOI 10.3171/jns.1989.71.1.0098	107	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	FEB	2015	6	1					88	97		10.1007/s12975-014-0375-5		10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AZ3IT	WOS:000348121500011		
J	Masuko, M; Ono, T; Aoki, S; Suzuki, A; Ito, H				Masuko, Masabumi; Ono, Takuya; Aoki, Saiko; Suzuki, Akihito; Ito, Hirotaka			Friction and wear characteristics of DLC coatings with different hydrogen content lubricated with several Mo-containing compounds and their related compounds	TRIBOLOGY INTERNATIONAL			English	Article						DLC; MoDTC; Wear	MOLYBDENUM DITHIOCARBAMATE; MODTC; PERFORMANCE; IMPROVEMENT; FILMS	Although the molybdenum dithiocarbamate (MoDTC) additive results in superior friction-reducing performance for both steel and diamond-like carbon (DLC) surfaces, it sometimes causes wear acceleration of DLC surfaces. This study confirmed the wear acceleration of a DLC surface lubricated with MoDTC-formulated oil. Three types of DLCs with different hydrogen contents were used. The nominal hydrogen contents of DLCs were hydrogen-free (ta-C), 10 at% (a-C:10H) and 30 at% (a-C:30H). The DLC coatings were deposited on a tool steel substrate. It was confirmed that MoDTC accelerated the wear of hydrogenated DLCs, although the formulation of MoDTC showed good friction-reducing performance for every specimen. To confirm the tribological characteristics of the other Mo-containing compounds for DLC lubrication, friction tests were carried out with several types of Mo-containing additives and their related Mo-free organic compounds. When the hydrogenated DLCs were lubricated with Mo-containing additives, the wear of the hydrogenated DLCs was accelerated. However, the hydrogenated DLCs did not show wear acceleration when lubricated with the related Mo-free organic compounds. The DLC surfaces after the friction test with Mo-containing additives were analyzed by X-ray photoelectron spectroscopy, and the MoO3 formation was confirmed on every specimen. Although the wear behavior was considered in relation to MoO3 formation on the worn surface to determine whether MoO3 plays a key role in accelerating the wear of DLC, apparent relationship between the wear acceleration and the MoO3 formation was not obtained. (C) 2014 Elsevier Ltd. All rights reserved.	[Masuko, Masabumi; Ono, Takuya; Aoki, Saiko; Suzuki, Akihito] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem Engn, Meguro Ku, Tokyo 1528552, Japan; [Ito, Hirotaka] Kobe Steel Ltd, Mat Res Lab, Kobe, Hyogo 6512271, Japan	Masuko, M (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem Engn, Meguro Ku, 12-1 O Okayama 2 Chome, Tokyo 1528552, Japan.	mmasuko@chemeng.titech.ac.jp					MITCHELL PCH, 1984, WEAR, V100, P281, DOI 10.1016/0043-1648(84)90017-6; Kano M, 2005, TRIBOL LETT, V18, P245, DOI 10.1007/s11249-004-2749-4; Bouchet MID, 2005, WEAR, V258, P1643, DOI 10.1016/j.wear.2004.11.019; YAMAMOTO Y, 1989, TRIBOL T, V32, P251, DOI 10.1080/10402008908981886; Ito H, 2008, THIN SOLID FILMS, V517, P1115, DOI 10.1016/j.tsf.2008.08.163; Vengudusamy B, 2012, TRIBOL INT, V54, P68, DOI 10.1016/j.triboint.2012.04.028; Grossiord C, 1998, TRIBOL INT, V31, P737, DOI 10.1016/S0301-679X(98)00094-2; Muraki M, 1997, TRIBOL INT, V30, P69, DOI 10.1016/0301-679X(96)00025-4; Aoki S, 2013, TRIBOL INT, V59, P57, DOI 10.1016/j.triboint.2012.06.001; de Barros' Bouchet M, 2005, TRIBOL INT, V38, P257, DOI DOI 10.1016/J.TRIBOINT.2004.08.009; Isoyama H, 1974, TRIBOL INT, V7, P151, DOI 10.1016/0041-2678(74)90022-0; Iwasaki Y, 2006, VACUUM, V80, P1266, DOI 10.1016/j.vacuum.2006.01.060; Kano M., 2004, LUBR SCI, V17, P95, DOI 10.1002/ls.3010170108; Kosarieh S, 2013, WEAR, V302, P890, DOI 10.1016/j.wear.2012.12.052; Miyake S, 2004, TRIBOL INT, V37, P751, DOI 10.1016/j.triboint.2004.01.014; Roshan R, 2011, TRIBOL ONLINE, V6, P301; Sugimito I, 2012, JSME INT J A, V78, P213; Takatoshi Shinyoshi T, 20077103 JSAE; Tokoro M, 2009, WEAR, V267, P2167, DOI 10.1016/j.wear.2009.04.009; Topolovec-Miklozic K, 2007, WEAR, V265, P1893; YAMAMOTO Y, 1994, TRIBOL T, V37, P182, DOI 10.1080/10402009408983282	21	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-679X	1879-2464		TRIBOL INT	Tribol. Int.	FEB	2015	82		B		SI		350	357		10.1016/j.triboint.2014.04.037		8	Engineering, Mechanical	Engineering	AY7QD	WOS:000347753300012		
J	Kosukegawa, H; Fridrici, V; Laurenceau, E; Kapsa, P; Ohta, M				Kosukegawa, Hiroyuki; Fridrici, Vincent; Laurenceau, Emmanuelle; Kapsa, Philippe; Ohta, Makoto			Friction of 316L stainless steel on soft-tissue-like poly(vinyl alcohol) hydrogel in physiological liquid	TRIBOLOGY INTERNATIONAL			English	Article						Poly(vinyl alcohol) hydrogel; 316L stainless steel; Elastic friction; Plasma protein	SURFACE WETTABILITY; GEL FRICTION; ADSORPTION; PROTEINS; ADHESION; FIBRINOGEN; ALBUMIN	The tribological behavior of medical SUS316L stainless steel on soft-tissue-like poly(vinyl alcohol) (PVA) hydrogel with and without dimethyl sulfoxide (DMSO) was investigated in physiological condition. In lower sliding velocity region, the maximum friction coefficient (mu(max)) is observed at certain velocity due to the adsorption of polymer chains on SUS316L. The presence of plasma proteins into liquid largely reduced mu(max) of SUS316L. Among plasma proteins tested, we found that mostly Human Serum Albumin was adsorbed on SUS316L, inhibiting the adsorption of PVA chains onto SUS316L. (C) 2014 Elsevier Ltd. All rights reserved.	[Kosukegawa, Hiroyuki; Ohta, Makoto] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kosukegawa, Hiroyuki; Fridrici, Vincent; Kapsa, Philippe] Ecole Cent Lyon, Lab Tribol & Dynam Syst, UMR CNRS ECL ENISE 5513, F-69134 Ecully, France; [Laurenceau, Emmanuelle] Ecole Cent Lyon, Inst Nanotechnol Lyon, UMR CNRS 5270, F-69134 Ecully, France	Kosukegawa, H (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	kosukegawa@wertifs.tohoku.ac.jp			Tohoku University Global COE program "World Center of Education and Research for Transdisciplinary Flow Dynamics"; JSPS Core-to-Core Program; French Government Scholarship "Promotion 2011 Francois Leonce Verny"; "LabEx MANUTECH-SISE" of Universite de Lyon (France); Program "Investissements d'Avenie" - labelled; French Government	The authors express their gratitude to Mr. Gaetan Bouvard in Ecole Centrale de Lyon for his helpful discussion. In addition, this work was financially supported by Tohoku University Global COE program "World Center of Education and Research for Transdisciplinary Flow Dynamics", the JSPS Core-to-Core Program, A. Advanced Research Networks, "International research core on smart layered materials and structures for energy saving", the French Government Scholarship "Promotion 2011 Francois Leonce Verny", the "LabEx MANUTECH-SISE" of Universite de Lyon (France) which is part of the Program "Investissements d'Avenie - labelled by the French Government and operated by the National Research Agency (ANR), - and the International Associated Laboratory (LIA CNRS) "Engineering and Science Lyon Tohoku Laboratory (ELyT)".	Allen HC, 1999, J PHYS CHEM B, V103, P660, DOI 10.1021/jp9820323; Catalan J, 2001, J ORG CHEM, V66, P5846, DOI 10.1021/jo010415i; Gong JP, 2006, SOFT MATTER, V2, P544, DOI 10.1039/b603209p; Tominaga T, 2008, SOFT MATTER, V4, P1033, DOI 10.1039/b716465c; STEINBERG D, 1995, BIOMATERIALS, V16, P1339, DOI 10.1016/0142-9612(95)91050-9; Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032; Gong J, 1998, J CHEM PHYS, V109, P8062, DOI 10.1063/1.477453; Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l; Liu L, 2010, J APPL POLYM SCI, V116, P2242, DOI 10.1002/app.31687; Jamadagni SN, 2009, LANGMUIR, V25, P13092, DOI 10.1021/la9011839; Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q; Kurokawa T, 2005, LANGMUIR, V21, P8643, DOI 10.1021/la050635h; BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326; Chida T, 2007, JAEA TECHNOL, P1; Dunn AC, 2007, TRIBOL LETT, V27, P233, DOI 10.1007/s11249-007-9230-0; Hyon S, 1990, KOBUNSHI KAKO, V39, P44; Israelachvili J. N., 1985, INTERMOLECULAR SURFA; Kagata G, 2002, J PHYS CHEM B, V106, P4596, DOI 10.1021/jp012380w; Kosukegawa H, 2013, TRIBOL LETT; Kosukegawa H, 2010, P ASME 2010 3 JOINT, P1; Kosukegawa H, 2008, J FLUID SCI TECHNOL, V3, P533, DOI 10.1299/jfst.3.533; Mamada K, 2011, TRIBOL INT, V44, P757, DOI 10.1016/j.triboint.2010.12.014; Mamada K, 2011, TRIBOL LETT, V42, P241, DOI 10.1007/s11249-011-9768-8; MORRISSEY BW, 1977, ANN NY ACAD SCI, V283, P50, DOI 10.1111/j.1749-6632.1977.tb41752.x; Ohta Makoto, 2004, Technol Health Care, V12, P225; Steinberg D, 2004, J ORAL REHABIL, V31, P1041, DOI 10.1111/j.1365-2842.2004.01350.x; Stoimenov B, 2013, TRIBOL ONLINE, V8, P140; WARKENTIN P, 1994, BIOMATERIALS, V15, P786, DOI 10.1016/0142-9612(94)90033-7	28	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-679X	1879-2464		TRIBOL INT	Tribol. Int.	FEB	2015	82		B		SI		407	414		10.1016/j.triboint.2014.05.029		8	Engineering, Mechanical	Engineering	AY7QD	WOS:000347753300017		
J	Shimono, Y; Shimono, A; Oguma, H; Konuma, A; Tominaga, T				Shimono, Y.; Shimono, A.; Oguma, H.; Konuma, A.; Tominaga, T.			Establishment of Lolium species resistant to acetolactate synthase-inhibiting herbicide in and around grain-importation ports in Japan	WEED RESEARCH			English	Article						herbicide resistance; exotic weed seeds; wheat; dispersal; spread; grain imports	RIGIDUM POPULATIONS; ANNUAL RYEGRASS; ACETOHYDROXYACID SYNTHASE; MOLECULAR-BASIS; PLANT-GROWTH; MULTIFLORUM; DNA; MUTATIONS; ALLELES; WEEDS	Compared with natural seed dispersal, human-mediated seed dispersal could spread herbicide resistance genes on a much larger scale. Herbicide-resistant weed seeds have been reported as contaminants in commercial grain. We investigated the contamination of seeds of Lolium species with target-site mutations conferring resistance to acetolactate synthase (ALS)-inhibiting herbicides in wheat imported from the USA, Canada and Australia into Japan. We also investigated the establishment of ALS-inhibiting herbicide-resistant Lolium species in 12 seaports in Japan that are major entry points for international commodities. We found herbicide-resistant Lolium spp. seeds from all classes of wheat samples. Resistant individuals became established at six of eight ports where more than 50kt of imported wheat is unloaded every year. The establishment of resistant Lolium spp. individuals was common at major grain landing ports. Monitoring over 3years at one port revealed that the frequency of resistant individuals did not fluctuate between years. Many resistant individuals were distributed in front of the entrance of a fodder company, but a few resistant individuals were found in areas 2km away from the port. The results indicate that gene flow is rare through pollen or seed movement from resistant plants to peripheral populations. Further extensive and long-term monitoring is necessary to perform a comprehensive risk assessment of herbicide-resistant plants entering Japan through major commercial ports.	[Shimono, Y.; Tominaga, T.] Kyoto Univ, Kyoto 6068502, Japan; [Shimono, A.] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Oguma, H.] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Konuma, A.] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan	Shimono, Y (reprint author), Kyoto Univ, Sakyo Ku, Kyoto 6068502, Japan.	yotti@kais.kyoto-u.ac.jp			Nippon Seimei Financial Group; JSPS KAKENHI [24780011]	We thank A. Mizuguti, T. Imaizumi and H. Hayakawa for their helping with our field work, M. Asai for useful advice and members of the Experimental Farm Management Division, NIAES for assistance with wheat sorting. This study was partly supported by the research grant for environmental problems by Nippon Seimei Financial Group and JSPS KAKENHI Grant Number 24780011 awarded to Y. Shimono.	ALCOCERRUTHLING M, 1992, WEED TECHNOL, V6, P303; Anderson RL, 2007, WEED TECHNOL, V21, P131, DOI 10.1614/WT-06-011.1; Barroso J, 2006, WEED RES, V46, P118, DOI 10.1111/j.1365-3180.2006.00500.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Tan MK, 2007, WEED RES, V47, P534, DOI 10.1111/j.1365-3180.2007.00591.x; Yu Q, 2010, J EXP BOT, V61, P3925, DOI 10.1093/jxb/erq205; Delye C, 2009, WEED RES, V49, P326, DOI 10.1111/j.1365-3180.2009.00700.x; McCourt JA, 2006, AMINO ACIDS, V31, P173, DOI 10.1007/s00726-005-0297-3; Tardif FJ, 2006, NEW PHYTOL, V169, P251, DOI 10.1111/j.1469-8137.2005.01596.x; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Owen MJ, 2014, WEED RES, V54, P314, DOI 10.1111/wre.12068; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; CHRISTOPHER JT, 1992, PLANT PHYSIOL, V100, P1909, DOI 10.1104/pp.100.4.1909; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Corbett CAL, 2006, PEST MANAG SCI, V62, P584, DOI 10.1002/ps.1219; Yu Q, 2008, PEST MANAG SCI, V64, P1229, DOI 10.1002/ps.1624; Asai M., 2009, Journal of Weed Science and Technology, V54, P219, DOI 10.3719/weed.54.219; BURNET MWM, 1994, WEED SCI, V42, P369; Busi R, 2011, AGR ECOSYST ENVIRON, V142, P403, DOI 10.1016/j.agee.2011.06.012; CHRISTOPHER JT, 1991, PLANT PHYSIOL, V95, P1036, DOI 10.1104/pp.95.4.1036; Heap I, 2014, INT SURVEY HERBICIDE; Kaloumenos NS, 2012, CROP PROT, V38, P35, DOI 10.1016/j.cropro.2012.03.002; Kaundun SS, 2012, WEED SCI, V60, P172, DOI 10.1614/WS-D-11-00147.1; Kuk YI, 2008, WEED SCI, V56, P614, DOI 10.1614/WS-08-003.1; Kurokawa S, 2004, HEREDITY, V93, P603, DOI 10.1038/sj.hdy.6800569; Leeson J. Y., 2005, PRAIRIE WEED SURVEYS; Michael PJ, 2010, WEED SCI, V58, P466, DOI 10.1614/WS-D-09-00082.1; Ministry of Finance, 2014, TRAD STAT JAP; NAYLOR BERYL, 1960, HEREDITY, V15, P219, DOI 10.1038/hdy.1960.78; Niinomi Y, 2013, WEED BIOL MANAG, V13, P31, DOI 10.1111/wbm.12007; R Development Core Team, 2011, R LANG ENV STAT COMP; Shimono Y, 2010, WEED BIOL MANAG, V10, P219, DOI 10.1111/j.1445-6664.2010.00387.x; Shimono Y, 2008, WEED RES, V48, P10; Terrell EE, 1968, TECHNICAL B USDA, V1392, P1; Thill DC, 1997, WEED SCI, V45, P337; Tranel P.J., 2014, MUTATIONS HERBICIDE; Yoshioka A, 2011, ENVIRON ENTOMOL, V40, P1027, DOI 10.1603/EN11032	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0043-1737	1365-3180		WEED RES	Weed Res.	FEB	2015	55	1					101	111		10.1111/wre.12120		11	Agronomy; Plant Sciences	Agriculture; Plant Sciences	AZ3RI	WOS:000348144000011		
J	Kyuragi, R; Matsumoto, T; Harada, Y; Saito, S; Onimaru, M; Nakatsu, Y; Tsuzuki, T; Nomura, M; Yonemitsu, Y; Maehara, Y				Kyuragi, Ryoichi; Matsumoto, Takuya; Harada, Yui; Saito, Satoru; Onimaru, Mitsuho; Nakatsu, Yoshimichi; Tsuzuki, Teruhisa; Nomura, Masatoshi; Yonemitsu, Yoshikazu; Maehara, Yoshihiko			BubR1 Insufficiency Inhibits Neointimal Hyperplasia Through Impaired Vascular Smooth Muscle Cell Proliferation in Mice	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						cell cycle; neointima; vascular smooth muscle	KINETOCHORE LOCALIZATION; MOLECULAR-MECHANISMS; GROWTH-FACTOR; ATHEROSCLEROSIS; ACTIVATION	Objective-BubR1, a cell cycle-related protein, is an essential component of the spindle checkpoint that regulates cell division. Mice with BubR1 expression reduced to 10% of the normal level display a phenotype characterized by progeria; however, the involvement of BubR1 in vascular diseases is still unknown. We generated mice in which BubR1 expression was reduced to 20% (BubR1(L/L) mice) of that in wild-type mice (BubR1(+/+)) to investigate the effects of BubR1 on arterial intimal hyperplasia. Approach and Results-Ten-week-old male BubR1(L/L) and age-matched wild-type littermates (BubR1(+/+)) were used in this study. The left common carotid artery was ligated, and histopathologic examinations were conducted 4 weeks later. Bone marrow transplantation was also performed. Vascular smooth muscle cells (VSMCs) were isolated from the thoracic aorta to examine cell proliferation, migration, and cell cycle progression. Severe neointimal hyperplasia was observed after artery ligation in BubR1(+/+) mice, whereas BubR1(L/L) mice displayed nearly complete inhibition of neointimal hyperplasia. Bone marrow transplantation from all donors did not affect the reconstitution of 3 hematopoietic lineages, and neointimal hyperplasia was still suppressed after bone marrow transplantation from BubR1(+/+) mice to BubR1(L/L) mice. VSMC proliferation was impaired in BubR1(L/L) mice because of delayed entry into the S phase. VSMC migration was unaffected in these BubR1(L/L) mice. p38 mitogen-activated protein kinase-inhibited VSMCs showed low expression of BubR1, and BubR1-inhibited VSMCs showed low expression of p38. Conclusions-BubR1 may represent a new target molecule for treating pathological states of vascular remodeling, such as restenosis after angioplasty.	[Kyuragi, Ryoichi; Matsumoto, Takuya; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Harada, Yui; Saito, Satoru; Yonemitsu, Yoshikazu] Kyushu Univ, Grad Sch Pharmaceut Sci, R&D Lab Innovat Biotherapeut, Fukuoka 8128582, Japan; [Onimaru, Mitsuho] Kyushu Univ, Grad Sch Med Sci, Dept Pathol, Fukuoka 8128582, Japan; [Nakatsu, Yoshimichi; Tsuzuki, Teruhisa] Kyushu Univ, Grad Sch Med Sci, Dept Med Biophys & Radiat Biol, Fukuoka 8128582, Japan; [Nomura, Masatoshi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan	Matsumoto, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takum@surg2.med.kyushu-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported in part by a grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology to T. Matsumoto, Y. Maehara, and Y. Yonemitsu.	Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Brady DM, 2000, CURR BIOL, V10, P675, DOI 10.1016/S0960-9822(00)00515-7; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Matsumoto T, 2007, STROKE, V38, P1050, DOI 10.1161/01.STR.0000257967.86132.01; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; CizmeciSmith G, 1997, ARTERIOSCL THROM VAS, V17, P172; Braun-Dullaeus RC, 2004, ARTERIOSCL THROM VAS, V24, P845, DOI 10.1161/01.ATV.0000125704.28058.a2; Gizard F, 2008, CIRC RES, V103, P1155, DOI 10.1161/CIRCRESAHA.108.186205; Goda AE, 2013, BIOCHEM PHARMACOL, V85, P1741, DOI 10.1016/j.bcp.2013.04.011; Guntani A, 2011, J SURG RES, V170, P143, DOI 10.1016/j.jss.2011.03.024; Kato T, 2010, ARTERIOSCLER THROMB, V30, P60; MIYAGAWA J, 1995, J CLIN INVEST, V95, P404, DOI 10.1172/JCI117669	21	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	FEB	2015	35	2					341	347		10.1161/ATVBAHA.114.304737		7	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AZ4TE	WOS:000348215100016		
J	Ooto, S; Hangai, M; Yoshimura, N				Ooto, Sotaro; Hangai, Masanori; Yoshimura, Nagahisa			Effects of Sex and Age on the Normal Retinal and Choroidal Structures on Optical Coherence Tomography	CURRENT EYE RESEARCH			English	Review						Age; choroid; optical coherence tomography; retina; sex	NERVE-FIBER LAYER; MACULAR THICKNESS MEASUREMENTS; CENTRAL SEROUS CHORIORETINOPATHY; SCANNING LASER OPHTHALMOSCOPY; AXIAL LENGTH; HIGH-SPEED; STRATUS OCT; GLAUCOMATOUS EYES; SWEPT-SOURCE; HEALTHY-SUBJECTS	Optical coherence tomography (OCT) has become an essential tool in ophthalmology. Advances in OCT technology have made it possible to measure the thickness of the retina, specific retinal layers, and the choroid. In the present study, the body of the literature documenting the normal retinal and choroidal thickness are reviewed and the effects of sex, age, and axial length on retinal/choroidal thickness are discussed. Macular, retinal layer, and choroidal thickness measured on OCT images in normal eyes showed significant variations by sex and age. Macular retinal thickness was greater in men than in women, especially in the center, inner ring, and outer temporal ring areas as defined by the Early Treatment Diabetic Retinopathy Study (ETDRS). Moreover, inner retinal thickness decreased with increasing age and choroidal thickness was greater in men than in women and was negatively correlated with age and axial length. These findings provide information that should be considered in analyses of retinal or choroidal thickness in OCT studies of retinal diseases and glaucoma.	[Ooto, Sotaro; Hangai, Masanori; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan; [Hangai, Masanori] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan	Ooto, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	ohoto@kuhp.kyoto-u.ac.jp					Adhi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037638; Paunescu LA, 2004, INVEST OPHTH VIS SCI, V45, P1716, DOI 10.1167/iovs.03-0514; MIKELBERG FS, 1989, OPHTHALMOLOGY, V96, P1325; Nassif NA, 2004, OPT EXPRESS, V12, P367, DOI 10.1364/OPEX.12.000367; Nagai-Kusuhara A, 2008, BRIT J OPHTHALMOL, V92, P186, DOI 10.1136/bjo.2007.127480; El-Ashry M, 2008, CURR EYE RES, V33, P693, DOI 10.1080/02713680802323140; Gurses-Ozden R, 2004, J GLAUCOMA, V13, P238; Kanamori A, 2003, AM J OPHTHALMOL, V135, P513, DOI 10.1016/S0002-9394(02)02003-2; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4893, DOI 10.1167/iovs.07-1326; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; DeLeon-Ortega JE, 2006, INVEST OPHTH VIS SCI, V47, P3374, DOI 10.1167/iovs.05-1239; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Leung CKS, 2005, OPHTHALMOLOGY, V112, P391, DOI 10.1016/j.ophtha.2004.10.020; Esmaeelpour M, 2010, INVEST OPHTH VIS SCI, V51, P5260, DOI 10.1167/iovs.10-5196; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Lim MCC, 2005, INVEST OPHTH VIS SCI, V46, P974, DOI 10.1167/iovs.04-0828; Budenz DL, 2005, INVEST OPHTH VIS SCI, V46, P2440, DOI 10.1167/iovs.04-1174; Bendschneider D, 2010, J GLAUCOMA, V19, P475, DOI 10.1097/IJG.0b013e3181c4b0c7; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jones AL, 2001, BRIT J OPHTHALMOL, V85, P673, DOI 10.1136/bjo.85.6.673; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Legarreta JE, 2008, OPHTHAL SURG LAS IM, V39, pS43; Unterhuber A, 2005, OPT EXPRESS, V13, P3252, DOI 10.1364/OPEX.13.003252; Li XQ, 2011, INVEST OPHTH VIS SCI, V52, P8438, DOI 10.1167/iovs.11-8108; Jirarattanasopa P, 2012, OPHTHALMOLOGY, V119, P1666, DOI 10.1016/j.ophtha.2012.02.021; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Wu PC, 2008, EYE, V22, P551, DOI 10.1038/sj.eye.6702789; Deschenes MC, 2010, INVEST OPHTH VIS SCI, V51, P2587, DOI 10.1167/iovs.09-3710; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Schuman JS, 1996, OPHTHALMOLOGY, V103, P1889; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maruko I, 2011, AM J OPHTHALMOL, V151, P594, DOI 10.1016/j.ajo.2010.10.030; Cense B, 2004, OPT EXPRESS, V12, P2435, DOI 10.1364/OPEX.12.002435; de Bruin DM, 2008, INVEST OPHTH VIS SCI, V49, P4545, DOI 10.1167/iovs.07-1553; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Alamouti B, 2003, BRIT J OPHTHALMOL, V87, P899, DOI 10.1136/bjo.87.7.899; Hoh ST, 2000, AM J OPHTHALMOL, V129, P129, DOI 10.1016/S0002-9394(99)00294-9; Leitgeb RA, 2004, OPT EXPRESS, V12, P2156, DOI 10.1364/OPEX.12.002156; Rao HL, 2011, INVEST OPHTH VIS SCI, V52, P1103, DOI 10.1167/iovs.10-5997; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Ajtony C, 2007, INVEST OPHTH VIS SCI, V48, P258, DOI 10.1167/iovs.06-0410; Schmidt-Erfurth U, 2005, INVEST OPHTH VIS SCI, V46, P3393, DOI 10.1167/iovs.05-0370; Gabriele ML, 2007, INVEST OPHTH VIS SCI, V48, P3154, DOI 10.1167/iovs.06-1416; Jirarattanasopa P, 2012, INVEST OPHTH VIS SCI, V53, P3663, DOI 10.1167/iovs.12-9619; Wojtkowski M, 2002, J BIOMED OPT, V7, P457, DOI 10.1117/1.1482379; Potsaid B, 2010, OPT EXPRESS, V18, P20029, DOI 10.1364/OE.18.020029; Li XQ, 2014, INVEST OPHTH VIS SCI, V55, P550, DOI 10.1167/iovs.13-13476; Hsu SY, 2008, J GLAUCOMA, V17, P30, DOI 10.1097/IJG.0b013e31811243b4; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Yasuno Y, 2007, OPT EXPRESS, V15, P6121, DOI 10.1364/OE.15.006121; Hangai M, 2007, OPHTHALMOLOGY, V114, P763, DOI 10.1016/j.ophtha.2006.07.055; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; Wong ACM, 2005, EYE, V19, P292, DOI 10.1038/sj.eye.6701466; Eriksson U, 2009, BRIT J OPHTHALMOL, V93, P1448, DOI 10.1136/bjo.2007.131094; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Huber R, 2007, OPT LETT, V32, P2049, DOI 10.1364/OL.32.002049; Savini G, 2005, BRIT J OPHTHALMOL, V89, P489, DOI 10.1136/bjo.2004.052498; Loduca AL, 2010, AM J OPHTHALMOL, V150, P849, DOI 10.1016/j.ajo.2010.06.034; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Varma R, 2003, INVEST OPHTH VIS SCI, V44, P3369, DOI 10.1167/iovs.02-0975; Kavroulaki D, 2010, ACTA OPHTHALMOL, V88, P850, DOI 10.1111/j.1755-3768.2009.01607.x; Lam DSC, 2007, INVEST OPHTH VIS SCI, V48, P376, DOI 10.1167/iovs.06-0426; Bourne RRA, 2005, INVEST OPHTH VIS SCI, V46, P1280, DOI 10.1167/iovs.041000; Guedes V, 2003, OPHTHALMOLOGY, V110, P177, DOI 10.1016/S0161-6420(02)01564-6; Varma R, 1996, OPHTHALMOLOGY, V103, P2114; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Bowd C, 2000, ARCH OPHTHALMOL-CHIC, V118, P22; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Polito A, 2005, ARCH OPHTHALMOL-CHIC, V123, P1330, DOI 10.1001/archopht.123.10.1330; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Bowd C, 2001, INVEST OPHTH VIS SCI, V42, P1993; Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836; Ho J, 2011, OPHTHALMOLOGY, V118, P2001, DOI 10.1016/j.ophtha.2011.02.049; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Kakinoki M, 2009, OPHTHAL SURG LAS IM, V40, P135; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P807; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P510, DOI 10.1097/IAE.0b013e3181eef053; Centofanti M, 2000, BRIT J OPHTHALMOL, V84, P786, DOI 10.1136/bjo.84.7.786; Rahman W, 2011, INVEST OPHTH VIS SCI, V52, P2267, DOI 10.1167/iovs.10-6024; Povazay B, 2003, OPT EXPRESS, V11, P1980, DOI 10.1364/OE.11.001980; Hoh ST, 2006, OPHTHALMOLOGY, V113, P773, DOI 10.1016/j.ophtha.2006.01.058; Alasil T, 2013, J GLAUCOMA, V22, P532, DOI 10.1097/IJG.0b013e318255bb4a; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Bowd C, 2006, INVEST OPHTH VIS SCI, V47, P2889, DOI 10.1167/iovs.05-1489; Sull AC, 2010, RETINA-J RET VIT DIS, V30, P235, DOI 10.1097/IAE.0b013e3181bd2c3b; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Maruko I, 2010, OPHTHALMOLOGY, V117, P1792, DOI 10.1016/j.ophtha.2010.01.023; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Ooto S, 2010, INVEST OPHTH VIS SCI, V51, P465, DOI 10.1167/iovs.09-4047; Srinivasan VJ, 2007, OPT LETT, V32, P361, DOI 10.1364/OL.32.000361; Wakitani Y, 2003, RETINA-J RET VIT DIS, V23, P177, DOI 10.1097/00006982-200304000-00007; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Delori FC, 2006, J OPT SOC AM A, V23, P521, DOI 10.1364/JOSAA.23.000521; Eisner A, 2009, BREAST CANCER RES TR, V117, P9, DOI 10.1007/s10549-008-0156-5; Hirasawa H, 2010, ARCH OPHTHALMOL-CHIC, V128, P1420, DOI 10.1001/archophthalmol.2010.244; Ishikawa H, 2006, INVEST OPHTH VIS SCI, V47, P964, DOI 10.1167/iovs.05-0748; JONAS JB, 1990, INVEST OPHTH VIS SCI, V31, P736; KNIGHT OJ, 2010, ARCH OPHTHALMOL-CHIC, V130, P312; Konno S, 2001, RETINA-J RET VIT DIS, V21, P57, DOI 10.1097/00006982-200102000-00010; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4886, DOI 10.1167/iovs.07-1187; Mansouri K, 2014, AM J OPHTHALMOL, V157, P1022, DOI 10.1016/j.ajo.2014.02.008; Massin P, 2002, EUR J OPHTHALMOL, V12, P102; Melo GB, 2006, AM J OPHTHALMOL, V142, P858, DOI 10.1016/j.ajo.2006.05.022; MIGLIOR S, 1994, CURR EYE RES, V13, P119, DOI 10.3109/02713689409042406; Mok KH, 2003, J GLAUCOMA, V12, P45, DOI 10.1097/00061198-200302000-00009; Neubauer AS, 2001, RETINA-J RET VIT DIS, V21, P596, DOI 10.1097/00006982-200112000-00006; Pons ME, 2000, ARCH OPHTHALMOL-CHIC, V118, P1044; Savini G, 2007, ARCH OPHTHALMOL-CHIC, V125, P901, DOI 10.1001/archopht.125.7.901; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586; Soliman MAE, 2002, AM J OPHTHALMOL, V133, P187, DOI 10.1016/S0002-9394(01)01340-X; Ulas F, 2013, CURR EYE RES, V38, P1172, DOI 10.3109/02713683.2013.811258; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970	118	4	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0271-3683	1460-2202		CURR EYE RES	Curr. Eye Res.	FEB	2015	40	2					213	225		10.3109/02713683.2014.952828		13	Ophthalmology	Ophthalmology	AZ4TB	WOS:000348214800011		
J	Kitamoto, E; Chikui, T; Kawano, S; Ohga, M; Kobayashi, K; Matsuo, Y; Yoshiura, T; Obara, M; Honda, H; Yoshiura, K				Kitamoto, Erina; Chikui, Toru; Kawano, Shintaro; Ohga, Masahiro; Kobayashi, Kouji; Matsuo, Yoshio; Yoshiura, Takashi; Obara, Makoto; Honda, Hiroshi; Yoshiura, Kazunori			The Application of Dynamic Contrast-Enhanced MRI and Diffusion-Weighted MRI in Patients with Maxillofacial Tumors	ACADEMIC RADIOLOGY			English	Article						DCE-MRI; TIC; ADC; pharmacokinetic analyses; TK model; head and neck tumor	SALIVARY-GLAND TUMORS; SQUAMOUS-CELL CARCINOMA; DIAGNOSTIC-VALUE; DCE-MRI; MALIGNANT-LYMPHOMA; KINETIC-PARAMETERS; NECK; HEAD; CANCER; ANGIOGENESIS	Rationale and Objectives: To elucidate the characteristics of four types of tumors, including squamous cell carcinoma (SCC), malignant lymphoma (ML), malignant salivary gland tumors (MSGTs), and pleomorphic adenoma (Pleo), in the maxillofacial region using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted MRI (DW-MRI) data. Materials and Methods: A total of 59 tumors were included in this research. DCE-MRI and DW-MRI were performed. We applied the Toffs and Kermode model (TK model) for the DCE-MRI data and obtained three dependent parameters: the influx forward volume transfer constant into the extravascular extracellular space from the plasma (K-trans), the fractional volume of extravascular extracellular space per unit volume of tissue (v(e)), and the fractional volume of plasma (v(p)). Results: Among the K-trans values, there were no significant differences between the three types of malignant tumors; however, there was a significant difference between the SCC and Pleo (P =.0099). The ve values of the Pleo were highest, with significant differences compared to the other categories (SCC, P = .0012; ML, P = .0017; and MSGT, P = .041). The ML had the lowest ve values, and there were significant differences between ML and the other two types of malignant tumors (SCC, P = .0278 and MSGT, P = .0062). In 14 (24%) cases, apparent diffusion coefficient (ADC) could not be measured because of poor image quality. The ADC values of the ML. were lowest, whereas those of Pleo were highest, similar to that observed for V-e. Conclusions: The Pleo tumors had lower K-trans values and higher v(e) values, which are useful for differentiating them from the malignant tumors. Moreover, the v(e) was also useful for establishing a diagnosis of ML.	[Kitamoto, Erina; Chikui, Toru; Yoshiura, Kazunori] Kyushu Univ, Fac Dent Sci, Dept Oral & Maxillofacial Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Kawano, Shintaro] Kyushu Univ, Fac Dent Sci, Sect Oral & Maxillofacial Oncol, Div Maxillofacial Diagnost & Surg Sci, Fukuoka 8128582, Japan; [Kobayashi, Kouji] Kyushu Univ Hosp, Dept Med Technol, Fukuoka 812, Japan; [Matsuo, Yoshio; Yoshiura, Takashi; Honda, Hiroshi] Kyushu Univ, Dept Clin Radiol, Grad Sch Med Sci, Fukuoka 8128582, Japan; Philips Elect Japan Ltd 2 13 37, Tokyo, Japan	Kitamoto, E (reprint author), Kyushu Univ, Fac Dent Sci, Dept Oral & Maxillofacial Radiol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	kitamoto@rad.dent.kyushu-u.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology) [2 4 5 9 2 8 3 4]	This work was supported by an MEXT (Ministry of Education, Culture, Sports, Science and Technology) Grant-in-Aid for Scientific Research (C) 2 4 5 9 2 8 3 4.	Habermann CR, 2009, AM J NEURORADIOL, V30, P591, DOI 10.3174/ajnr.A1412; Chikui T, 2012, J MAGN RESON IMAGING, V36, P589, DOI 10.1002/jmri.23704; Eida S, 2010, J MAGN RESON IMAGING, V31, P673, DOI 10.1002/jmri.22091; TOFTS PS, 1995, MAGN RESON MED, V33, P564, DOI 10.1002/mrm.1910330416; Asaumi J, 2004, ORAL ONCOL, V40, P579, DOI 10.1016/j.oraloncology.2003.12.002; Eida S, 2008, J MAGN RESON IMAGING, V27, P1256, DOI 10.1002/jmri.21349; Li X, 2014, MAGN RESON MED, V71, P1592, DOI 10.1002/mrm.24782; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Chikui T, 2011, EUR RADIOL, V21, P1699, DOI 10.1007/s00330-011-2102-x; Oto A, 2011, AM J ROENTGENOL, V197, P1382, DOI 10.2214/AJR.11.6861; Hisatomi M, 2007, ORAL ONCOL, V43, P940, DOI 10.1016/j.oratoncotogy.2006.11.009; Harrer JU, 2004, J MAGN RESON IMAGING, V20, P748, DOI 10.1002/jmri.20182; Jansen JFA, 2010, ANGIOGENESIS, V13, P149, DOI 10.1007/s10456-010-9167-z; WANG HZ, 1987, MAGNET RESON MED, V5, P399, DOI 10.1002/mrm.1910050502; Yabuuchi H, 2008, RADIOLOGY, V249, P909, DOI 10.1148/radiol.2493072045; Thoeny HC, 2012, RADIOLOGY, V263, P19, DOI 10.1148/radiol.11101821; Jansen JFA, 2012, ORAL ONCOL, V48, P717, DOI 10.1016/j.oraloncology.2012.02.001; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Lee FKH, 2012, EUR J RADIOL, V81, P784, DOI 10.1016/j.ejrad.2011.01.089; Yabuuchi H, 2003, RADIOLOGY, V226, P345, DOI 10.1148/radiol.2262011486; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Asaumi J, 2003, EUR J RADIOL, V48, P183, DOI 10.1016/S0720-048X(02)00347-9; Barnes L., 2005, PATHOLOGY GENETICS H; Chikui T, 2012, INT J DENT, V2012; Hermans R, 2012, HEAD NECK CANC IMAGI; Hisatomi M, 2003, ORAL ONCOL, V39, P574, DOI 10.1016/S1368-8375(03)00040-X; Matsuzaki H, 2012, EUR J RADIOL, V81, P2684, DOI 10.1016/j.ejrad.2011.11.005; Murase K, 2004, MAGNET RESON MED, V51, P858, DOI 10.1002/mrm.20022; Parker GJM, 1997, JMRI-J MAGN RESON IM, V7, P564, DOI 10.1002/jmri.1880070318; Van Cann EM, 2008, ORAL ONCOL, V44, P1147, DOI 10.1016/j.oraloncology.2008.02.009	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	FEB	2015	22	2					210	216		10.1016/j.acra.2014.08.016		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ1MK	WOS:000348002900011		
J	Oubel, E; Bonnard, E; Sueoka-Aragane, N; Kobayashi, N; Charbonnier, C; Yannamichi, J; Mizobe, H; Kimura, S				Oubel, Estanislao; Bonnard, Eric; Sueoka-Aragane, Naoko; Kobayashi, Naomi; Charbonnier, Colette; Yannamichi, Junta; Mizobe, Hideaki; Kimura, Shinya			Volume-based Response Evaluation with Consensual Lesion Selection: A Pilot Study by Using Cloud Solutions and Comparison to RECIST 1.1	ACADEMIC RADIOLOGY			English	Article						Clinical trials; RECIST; cloud computing; consensus; lesion volume; biomarkers; volume thresholds	GUIDELINE VERSION 1.1; LUNG-CANCER; CLINICAL-TRIALS; SOLID TUMORS; RECIST; VARIABILITY; CRITERIA; RADIOLOGISTS; PROGRESSION; AGREEMENT	Rationale and Objectives: Lesion volume is considered as a promising alternative to Response Evaluation Criteria in Solid Tumors (RECIST) to make tumor measurements more accurate and consistent, which would enable an earlier detection of temporal changes. In this article, we report the results of a pilot study aiming at evaluating the effects of a consensual lesion selection on volume-based response (VBR) assessments. Materials and Methods: Eleven patients with lung computed tomography scans acquired at three time points were selected from Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) and proprietary databases. Images were analyzed according to RECIST 1.1 and VBR criteria by three readers working in different geographic locations. Cloud solutions were used to connect readers and carry out a consensus process on the selection of lesions used for computing response. Because there are not currently accepted thresholds for computing VBR, we have applied a set of thresholds based on measurement variability (-35% and +55%). The benefit of this consensus was measured in terms of multiobserver agreement by using Fleiss kappa (k(fleiss))and corresponding standard errors (SE). Results: VBR after consensual selection of target lesions allowed to obtain K-fleiss = 0.85 (SE = 0.091), which increases up to 0.95 (SE = 0.092), if an extra consensus on new lesions is added. As a reference, the agreement when applying RECIST without consensus was K-fielss = 0.72 (SE = 0.088). These differences were found to be statistically significant according to a z-test. Conclusions: An agreement on the selection of lesions allows reducing the inter-reader variability when computing VBR. Cloud solutions showed to be an interesting and feasible strategy for standardizing response evaluations, reducing variability, and increasing consistency of results in multicenter clinical trials.	[Oubel, Estanislao; Charbonnier, Colette] MEDIAN Technol, R&D Dept, Deux Arcs B, F-06560 Valbonne, France; [Bonnard, Eric; Kimura, Shinya] Nice Univ Hosp, Dept Radiol, Nice, France; [Sueoka-Aragane, Naoko; Kobayashi, Naomi] Saga Univ, Dept Internal Med, Fac Med, Div Hematol Resp Med & Oncol, Saga 840, Japan; [Yannamichi, Junta; Mizobe, Hideaki] Canon Inc, Med Equipment Grp, Global Healthcare IT Project, Tokyo, Japan	Oubel, E (reprint author), MEDIAN Technol, R&D Dept, Deux Arcs B, 1800 Route Cretes, F-06560 Valbonne, France.	estanislao.oubel@mediantechnologies.com					Skougaard K, 2012, ACTA ONCOL, V51, P774, DOI 10.3109/0284186X.2012.667149; Nishino M, 2010, AM J ROENTGENOL, V195, P281, DOI 10.2214/AJR.09.4110; [Anonymous], 1982, J R STAT SOC C-APPL; Barnhart HX, 2007, J BIOPHARM STAT, V17, P529, DOI 10.1080/10543400701376480; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Dodd LE, 2008, J CLIN ONCOL, V26, P3791, DOI 10.1200/JCO.2008.16.1711; Erasmus JJ, 2003, J CLIN ONCOL, V21, P2574, DOI 10.1200/JCO.2003.01.144; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Dodd LE, 2011, BIOMETRICS, V67, P1092, DOI 10.1111/j.1541-0420.2010.01539.x; Ford R, 2009, EUR J CANCER, V45, P268, DOI 10.1016/j.ejca.2008.10.031; Amit O, 2011, EUR J CANCER, V47, P1772, DOI 10.1016/j.ejca.2011.02.013; Buckler AJ, 2010, ACAD RADIOL, V17, P107, DOI 10.1016/j.acra.2009.06.019; Mozley PD, 2012, TRANSL ONCOL, V5, P19, DOI 10.1593/tlo.11232; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Armato SG, 2008, CLIN PHARMACOL THER, V84, P448, DOI 10.1038/clpt.2008.161; Beaumont H, 2013, ASCO M ABSTR S, V31; Buckler AJ, 2010, ACAD RADIOL, V17, P100, DOI 10.1016/j.acra.2009.07.030; Darkeh MHSE, 2009, BRIT J RADIOL, V82, P681, DOI 10.1259/bjr/72829563; Gamer M., 2012, PACKAGE IRR; Herman GT, 1992, IEEE COMPUT GRAPH AP, P12; International Agency for Research on Cancer, 2012, GLOB 2012 EST INC MO; Khul CK, 2013, J CLIN ONCOL S, V5; Moskowitz CS, 2009, EUR J CANCER, V45, P300, DOI 10.1016/j.ejca.2008.11.010; Padhani AR, 2001, BRIT J RADIOL, V74, P983; R Development Core Team, 2013, R LANG ENV STAT COMP; Schuetze SM, 2008, ONCOLOGIST, V13, P32, DOI 10.1634/theoncologist.13-S2-32; Seyal AR, 2014, ACAD RADIOL; Shamsi K, 2009, J CLIN ONCOL, V27, P2103, DOI 10.1200/JCO.2008.21.3447; Suzuki C, 2013, RADIOGRAPHICS, V28, P329; Zhang JJ, 2012, THER INNOV REGUL SCI, V47, P167; Zhao BS, 2014, CLIN CANCER RES, V20, P3560, DOI 10.1158/1078-0432.CCR-14-0245	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	FEB	2015	22	2					217	225		10.1016/j.acra.2014.09.008		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ1MK	WOS:000348002900012		
J	Saika, F; Kiguchi, N; Kobayashi, Y; Kishioka, S				Saika, F.; Kiguchi, N.; Kobayashi, Y.; Kishioka, S.			Peripheral alpha4beta2 nicotinic acetylcholine receptor signalling attenuates tactile allodynia and thermal hyperalgesia after nerve injury in mice	ACTA PHYSIOLOGICA			English	Article						alpha 4 beta 2 nAChR; macrophage; nicotine; tactile allodynia; thermal hyperalgesia	SPINAL DORSAL-HORN; NEUROPATHIC PAIN; SYNAPTIC-TRANSMISSION; UP-REGULATION; IN-VIVO; MACROPHAGES; IMMUNE; MECHANISMS; NEUROINFLAMMATION; SUBTYPE	AimNeuropathic pain is often refractory to conventional analgesics including opioids and non-steroidal anti-inflammatory drugs. Evidence suggests nicotinic acetylcholine receptor ligands regulate pain transmission. Effects of 42 nicotinic acetylcholine receptor activation on pain behaviours after nerve injury were studied. MethodsMice were subjected to partial sciatic nerve ligation (PSL). Nicotinic acetylcholine receptor 4 and 2 subunits localization in injured nerves were evaluated by immunohistochemistry. Neuropathic pain, assessed by tactile allodynia and thermal hyperalgesia, was examined by von Frey test and Hargreaves test respectively. ResultsNicotinic acetylcholine receptor 4 and 2 subunits were up-regulated in injured nerves and were expressed on F4/80-positive macrophages. When nicotine was perineurally administered daily for 4days (day 7-10; maintenance phase) after nerve injury, pain behaviours were significantly alleviated. The inhibitory effects of nicotine were reversed by co-administration of mecamylamine (non-selective nicotinic acetylcholine receptor antagonist) and dihydro--erythroidine (selective 42 nicotinic acetylcholine receptor antagonist). Likewise, when 42 nicotinic acetylcholine receptor agonists (TC2559 or ABT418) were administered daily for 4days (day 7-10) after nerve injury, pain behaviours were significantly attenuated. On the other hand, nicotine administered daily for 4days (day 0-3; initiation phase) after nerve injury alleviated pain behaviours, which were antagonized by co-administration of dihydro--erythroidine. TC2559 administered daily for 4days (day 0-3) also attenuated nerve injury-induced pain behaviours. ConclusionThe activation of 42 nicotinic acetylcholine receptor expressed on infiltrating macrophages in injured nerves may participate in the relief of PSL-induced neuropathic pain during maintenance and initiation phases.	[Saika, F.; Kiguchi, N.; Kobayashi, Y.; Kishioka, S.] Wakayama Med Univ, Dept Pharmacol, Wakayama 6410012, Japan	Kishioka, S (reprint author), Wakayama Med Univ, Dept Pharmacol, Sch Med, 811-1 Kimiidera, Wakayama 6410012, Japan.	kishioka@wakayama-med.ac.jp			Smoking Research Foundation	This study was supported by a grant from the Smoking Research Foundation.	Liu T, 2000, PAIN, V86, P25, DOI 10.1016/S0304-3959(99)00306-1; Genzen JR, 2005, BRAIN RES, V1031, P229, DOI 10.1016/j.brainres.2004.10.042; Matsunaga K, 2001, J IMMUNOL, V167, P6518; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Ma WY, 2006, J NEUROCHEM, V98, P180, DOI 10.1111/j.1471-4159.2006.03856.x; Kesingland AC, 2000, PAIN, V86, P113, DOI 10.1016/S0304-3959(00)00233-5; Kim CF, 2011, BRAIN RES, V1405, P95, DOI 10.1016/j.brainres.2011.06.022; Darsow T, 2005, J BIOL CHEM, V280, P18311, DOI 10.1074/jbc.M501157200; Bridges D, 2001, BRIT J ANAESTH, V87, P12, DOI 10.1093/bja/87.1.12; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; Kiyosawa A, 2001, J PHYSIOL-LONDON, V536, P101, DOI 10.1111/j.1469-7793.2001.t01-1-00101.x; Takeda D, 2003, PAIN, V101, P13, DOI 10.1016/S0304-3959(02)00074-X; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Rashid MH, 2006, PAIN, V125, P125, DOI 10.1016/j.pain.2006.05.011; Kiguchi N, 2012, J PHARMACOL EXP THER, V340, P577, DOI 10.1124/jpet.111.187724; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Ke L, 1998, J PHARMACOL EXP THER, V286, P825; Tofaris GK, 2002, J NEUROSCI, V22, P6696; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Cucchiaro G, 2005, J PHARMACOL EXP THER, V313, P389, DOI 10.1124/jpet.104.079368; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Loram LC, 2012, J PAIN, V13, P1162, DOI 10.1016/j.jpain.2012.08.009; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Kawashima K, 2012, LIFE SCI, V91, P1027, DOI [10.1016/j.lfs.2012.05.006, 10.1016/j.lfs2012.05.006]; Freitas K, 2013, NEUROPHARMACOLOGY, V65, P156, DOI 10.1016/j.neuropharm.2012.08.022; Maeda T, 2009, P NATL ACAD SCI USA, V106, P13076, DOI 10.1073/pnas.0903524106; van der Zanden EP, 2009, GASTROENTEROLOGY, V137, P1029, DOI 10.1053/j.gastro.2009.04.057; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Bannon AW, 1998, J PHARMACOL EXP THER, V285, P787; Blanchet MR, 2004, AM J RESP CRIT CARE, V169, P903, DOI 10.1164/rccm.200210-1154OC; Cheng LZ, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-56; Costa R, 2012, NEUROPHARMACOLOGY, V63, P798, DOI 10.1016/j.neuropharm.2012.06.004; desJonge WJ, 2005, NAT IMMUNOL, V6, P844; Han ZY, 2014, J NEUROCHEM, V131, P498, DOI 10.1111/jnc.12817; Kiguchi N, 2012, NEUROCHEM INT, V61, P1212, DOI 10.1016/j.neuint.2012.09.001; LesNovere N., 1995, J MOL EVOL, V40, P155; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035	54	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	FEB	2015	213	2					462	471		10.1111/apha.12437		10	Physiology	Physiology	AY7FF	WOS:000347726000020		
J	Usui, T; Nijima, R; Sakatsume, T; Otani, K; Kameshima, S; Okada, M; Yamawaki, H				Usui, T.; Nijima, R.; Sakatsume, T.; Otani, K.; Kameshima, S.; Okada, M.; Yamawaki, H.			Eukaryotic elongation factor 2 kinase controls proliferation and migration of vascular smooth muscle cells	ACTA PHYSIOLOGICA			English	Article						growth factors; hypertension; signal transduction; vascular smooth muscle	FACTOR-II; HYPERTENSIVE-RATS; PROTEIN-KINASES; EEF2 KINASE; PHOSPHORYLATION; IDENTIFICATION; INFLAMMATION; ADIPOCYTOKINE; GLIOBLASTOMA; INHIBITION	AimEukaryotic elongation factor 2 kinase (eEF2K), also known as calmodulin (CaM)-dependent protein kinase (CaMK) III, is a unique member of CaMK family protein. We have recently found that expression of eEF2K protein increased in mesenteric artery from spontaneously hypertensive rats. As pathogenesis of hypertension is in part regulated by vascular structural remodelling via proliferation and migration of vascular smooth muscle cells (SMCs), we tested the hypothesis that eEF2K controls SMCs proliferation and migration. Methodsand resultsIn rat mesenteric arterial SMCs, an eEF2K inhibitor, A-484954 (10m), significantly inhibited platelet-derived growth factor (PDGF)-BB (10ngmL(-1))-induced SMCs proliferation as determined by a cell counting and bromodeoxyuridine incorporation assay. PDGF-BB (10ngmL(-1))-induced SMCs migration was significantly inhibited by A-484954 (10m) as determined by a Boyden chamber assay. A-484954 (10m) significantly inhibited PDGF-BB (10ngmL(-1))-induced phosphorylation of eEF2K, extracellular signal-regulated kinase (ERK), Akt, p38 and heat-shock protein (HSP) 27 as determined by Western blotting. It was confirmed that a CaM inhibitor, W-7 (50m), inhibited PDGF-BB (10ngmL(-1))-induced phosphorylation of eEF2K. In an ex vivo mesenteric arterial ring assay, 10% foetal bovine serum-induced SMCs outgrowth was significantly inhibited by A-484954 (10m). ConclusionWe for the first time revealed that eEF2K mediates PDGF-BB-induced SMCs proliferation and migration through activating ERK, Akt, p38 and HSP27 signals in a CaM-dependent manner. Our results suggest eEF2K as a novel pharmaceutical target for the prevention of hypertensive cardiovascular diseases.	[Usui, T.; Nijima, R.; Sakatsume, T.; Otani, K.; Kameshima, S.; Okada, M.; Yamawaki, H.] Kitasato Univ, Sch Vet Med, Lab Vet Pharmacol, Towada, Aomori 0348628, Japan	Yamawaki, H (reprint author), Kitasato Univ, Sch Vet Med, Lab Vet Pharmacol, Higashi 23 Bancho 35-1, Towada, Aomori 0348628, Japan.	yamawaki@vmas.kitasato-u.ac.jp			Japan Society for the Promotion of Science	We thank Dr Morita T, Dr Kazama K, Hayabe Y, and Yamada K for the technical assistance. This study was supported in part by a Grant for Scientific Research from the Japan Society for the Promotion of Science.	Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Egan CG, 2005, CARDIOVASC RES, V67, P308, DOI 10.1016/j.cardiores.2005.03.019; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Usui T, 2013, AM J PHYSIOL-HEART C, V305, pH756, DOI 10.1152/ajpheart.00373.2013; Farrer RG, 2013, J BIOL CHEM, V288, P11066, DOI 10.1074/jbc.M112.442244; Okada M, 2013, EUR J PHARMACOL, V718, P332, DOI [10.1016/j.ejphar.2013.08.013, 10.1016/j.ejphar:2013.08.013]; Usui T, 2012, HYPERTENSION, V60, P1031, DOI 10.1161/HYPERTENSIONAHA.112.200337; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; Pigott CR, 2012, BIOCHEM J, V442, P105, DOI 10.1042/BJ20111536; Kazama K, 2012, EUR J PHARMACOL, V686, P116, DOI 10.1016/j.ejphar.2012.04.033; Kazama K, 2014, AM J PHYSIOL-HEART C, V306, pH1714, DOI 10.1152/ajpheart.00048.2014; Usui T, 2012, AM J PHYSIOL-HEART C, V302, pH1894, DOI 10.1152/ajpheart.01039.2011; Phalitakul S, 2012, BIOCHEM BIOPH RES CO, V423, P844, DOI 10.1016/j.bbrc.2012.06.052; Usui T, 2014, HYPERTENSION, V63, P397, DOI 10.1161/HYPERTENSIONAHA.113.01843; Calberg U, 1991, Biochem Biophys Res Commun, V180, P1372; Chen ZH, 2011, J BIOL CHEM, V286, P43951, DOI 10.1074/jbc.M111.301291; CHENG EHC, 1995, CELL GROWTH DIFFER, V6, P615; Coen M, 2013, AM J PATHOL, V183, P996, DOI 10.1016/j.ajpath.2013.06.006; Hait WN, 2006, AUTOPHAGY, V2, P294; Hizli AA, 2013, MOL CELL BIOL, V33, P596, DOI 10.1128/MCB.01270-12; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; PRICE NT, 1991, FEBS LETT, V282, P253, DOI 10.1016/0014-5793(91)80489-P; Ruys SPD, 2012, BIOCHEM J, V442, P681, DOI 10.1042/BJ20111530; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Tada T, 2008, CARDIOVASC RES, V80, P346, DOI 10.1093/cvr/cvn211; Usui T, 2011, BIOCHEM BIOPH RES CO, V405, P47, DOI 10.1016/j.bbrc.2010.12.120; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554	28	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	FEB	2015	213	2					472	480		10.1111/apha.12354		9	Physiology	Physiology	AY7FF	WOS:000347726000021		
J	Basurra, SS; De Vos, M; Padget, J; Ji, YS; Lewis, T; Armour, S				Basurra, Shadi S.; De Vos, Marina; Padget, Julian; Ji, Yusheng; Lewis, Tim; Armour, Simon			Energy efficient zone based routing protocol for MANETs	AD HOC NETWORKS			English	Article						Mobile ad hoc networks; MANET; AODV; DSR; ZCG; Zone based routing	AD HOC NETWORKS; SENSOR NETWORKS; ALGORITHM	Mobile Ad Hoc Networks (MANET) are self-configuring infrastructureless networks of mobile devices connected via wireless links. Each device can send and receive data, but it should also forward traffic unrelated to its own use. All need to maintain their autonomy, and effectively preserve their resources (e.g. battery power). Moreover, they can leave the network at any time. Their intrinsic dynamicity and fault tolerance makes them suitable for applications, such as emergency response and disaster relief, when infrastructure is nonexistent or damaged due to natural disasters, such as earthquakes and flooding, as well as more mundane, day-to-day, uses where their flexibility would be advantageous. Routing is the fundamental research issue for such networks and refers to finding and maintaining routes between nodes. Moreover, it involves selecting the best route where many may be available. However, due to the freedom of movement of nodes, new routes need to be constantly recalculated. Most routing protocols use pure broadcasting to discover new routes, which takes up a substantial amount of bandwidth. Intelligent rebroadcasting reduces these overheads by calculating the usefulness of a rebroadcast, and the likelihood of message collisions. Unfortunately, this introduces latency and parts of the network may become unreachable. This paper discusses the Zone based Routing with Parallel Collision Guided Broadcasting Protocol (ZCG) that uses parallel and distributed broadcasting technique (Basurra et al., 2010) [81 to reduce redundant broadcasting and to accelerate the path discovery process, while maintaining a high reachability ratio as well as keeping node energy consumption low. ZCG uses a one hop clustering algorithm that splits the network into zones led by reliable leaders that are mostly static and have plentiful battery resources. The performance characteristics of the ZCG protocol are established through simulations by comparing it to other well-known routing protocols, namely the: AODV and DSR. It emerges that ZCG performs well under many circumstances. (C) 2014 Elsevier B.V. All rights reserved.	[Basurra, Shadi S.; De Vos, Marina; Padget, Julian] Univ Bath, Dept Comp Sci, Bath BA2 7AY, Avon, England; [Ji, Yusheng] Natl Inst Informat, Informat Syst Architecture Sci Res Div, Tokyo, Japan; [Lewis, Tim] Toshiba Res Europe Ltd, Bristol, Avon, England; [Armour, Simon] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1TH, Avon, England	Basurra, SS (reprint author), Univ Bath, Dept Comp Sci, Bath BA2 7AY, Avon, England.	shadi.basurra@bath.edu; mdv@cs.bath.ac.uk; jap@cs.bath.ac.uk; kei@nii.ac.jp; Tim.Lewis@toshiba-trel.com; Simon.Armour@bristol.ac.uk			Toshiba Research Europe Ltd; Yemen Ministry of Higher Education and Scientific Research (MoHESR); Great Western Research (UK); National Institute of Informatics (Nil) Japan	This work is partially supported by Toshiba Research Europe Ltd, the Yemen Ministry of Higher Education and Scientific Research (MoHESR), Great Western Research (UK) and the National Institute of Informatics (Nil) Japan.	Abdelmalek YM, 2009, IEEE SARNOFF SYMPOS, P386; Abolhasan M., 2004, AD HOC NETW, V2, P1, DOI DOI 10.1016/S1570-8705(03)00043-X; Allard G, 2006, LECT NOTES COMPUT SC, V4104, P170; Haas ZJ, 2001, IEEE ACM T NETWORK, V9, P427, DOI 10.1109/90.944341; Basu P, 2001, 21ST INTERNATIONAL CONFERENCE ON DISTRIBUTED COMPUTING SYSTEMS WORKSHOPS, PROCEEDINGS, P413; Yang CC, 2007, COMPUT COMMUN, V30, P261, DOI 10.1016/j.comcom.2006.08.014; Haas ZJ, 1997, 1997 IEEE 6TH INTERNATIONAL CONFERENCE ON UNIVERSAL PERSONAL COMMUNICATIONS RECORD, CONFERENCE RECORD, VOLS 1 AND 2, P562, DOI 10.1109/ICUPC.1997.627227; Royer EM, 1999, IEEE PERS COMMUN, V6, P46, DOI 10.1109/98.760423; Balakrishnan K, 2005, IEEE WCNC, P2137; Li F, 2007, IEEE VEH TECHNOL MAG, V2, P12, DOI 10.1109/MVT.2007.912927; Manvi SS, 2008, INFORM SCIENCES, V178, P1611, DOI 10.1016/j.ins.2007.11.005; Ko YB, 2000, WIREL NETW, V6, P307, DOI 10.1023/A:1019106118419; Di Caro G, 2005, EUR T TELECOMMUN, V16, P443, DOI 10.1002/ett.1062; Arora D, 2011, 2011 IEEE 22ND INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P1145, DOI 10.1109/PIMRC.2011.6139677; Barolli Leonard, 2004, DEXA 15 INT WORKSH P, P326; Basurra Shadi Saleh, 2010, 2010 12th IEEE International Conference on Communication Technology (ICCT 2010), DOI 10.1109/ICCT.2010.5689125; Bharghavan V., 1994, COMPUT COMMUN REV, V24, P212; Chakeres I.D., 2002, 5 INT S WIR PERS MUL, V2, P504, DOI 10.1109/WPMC.2002.1088225; Chatterjee M., 2002, J CLUSTER COMPUTING, V5, P193; Chatterjee Mainak, 2000, P 7 INT C HIGH PERF, P511; Chiang C.-C., 1997, P IEEE SING INT C NE, P197; Clausen T., 2008, 5148 RFC; Di Caro G., 2005, SWARM INT S SIS 2005, P76; Feeney LM., 2001, INFOCOM 2001 20 ANN, V3, P1548, DOI DOI 10.1109/1NEC0M.2001.916651; Funke S, 2006, LECT NOTES COMPUT SC, V4026, P234; GUNTHER A, 2005, P 4 IFIP TC6 INT C N, V3462, P768; Haas Z. J., 2002, INTRAZONE ROUTING PR; Haas Z.J., 2002, ZONE ROUTING PROTOCO; Johnson D., 2001, AD HOC NETWORKING, P139; Johnson David B., 1996, IEEE T MOBILE COMPUT; Kumar Chander, 2011, INT J APPL GRAPH THE, V3, P13; Lee Seungjoon, 2005, MOBIHOC 05, P230; Lee YJ, 2005, IEEE WCNC, P1995; Mamun-Or-Rashid Md., 2007, P JOINT C COMM INF J; Padhye J., 2004, ACM MOBICOM, P114, DOI DOI 10.1145/1023720.1023732; Parekh A. K., 1994, P SBT IEEE INT TEL S; Perkins C. E., 1999, 2 IEEE WORKSH MOB CO; Perkins C.E., 1994, P SIGCOMM 94 C COMM, P234, DOI 10.1145/190314.190336; Schillings A, 2009, LECT NOTES COMPUT SC, V5659, P51, DOI 10.1007/978-3-642-02903-5_6; SparkNotes Editors, 2012, HASH TABL C LANG; Williams B., 2002, MOBIHOC 2002. Proceedings of the Third ACM International Symposium on Mobile Ad Hoc Networking and Computing; Xu K., 2002, GLOB TEL C 17 21 NOV, V1, P72	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-8705	1570-8713		AD HOC NETW	Ad Hoc Netw.	FEB	2015	25		A				16	37		10.1016/j.adhoc.2014.09.010		22	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AY7RJ	WOS:000347756400002		
J	Chen, SL; Gwee, KA; Lee, JS; Miwa, H; Suzuki, H; Guo, P; Hao, YT; Chen, MH				Chen, S. L.; Gwee, K. A.; Lee, J. S.; Miwa, H.; Suzuki, H.; Guo, P.; Hao, Y. T.; Chen, M. H.			Systematic review with meta-analysis: prompt endoscopy as the initial management strategy for uninvestigated dyspepsia in Asia	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Review							UPPER GASTROINTESTINAL MALIGNANCY; HIGH BACKGROUND PREVALENCE; GASTRIC-CANCER; ALARM FEATURES; POPULATION; GUIDELINES; DIAGNOSIS; TREAT; CHINA; JAPAN	BackgroundPrompt endoscopy should be considered as an initial strategy for uninvestigated dyspepsia in the background of high prevalence of Helicobacter pylori infection and malignancy. However, with changes of disease patterns and dyspepsia definition, the prevalence of organic lesions at endoscopy in dyspepsia patients and the predictive values of alarm features and age for in malignancy remain unclear in Asian population. AimsTo evaluate the appropriateness of prompt endoscopy as an initial dyspepsia management strategy, we investigated the organic lesion detection rates in Asian dyspepsia patients as well as the diagnostic accuracies of alarm features and age thresholds for malignancy. MethodsLiterature was retrieved from MEDLINE, PubMed, Embase, Cochrane Library and CINAHL Plus. The prevalence rates of organic lesions and young cancer patients among dyspeptic patients and the sensitivities, specificities, likelihood ratios and diagnostic odds ratio (DOR) of alarm features and ages were estimated. The summary receiver operating characteristic curve was constructed and the area under the curve (AUC) calculated. Subgroup, sensitivity and meta-regression analyses were performed. ResultsOf the 18 included studies, 15 reported organic lesion detection rates, and six and five analysed the predictive values of alarm features and ages respectively. The overall malignancy detection rate was 1.3% (95% CI: 0.80-2.10). Among cancer patients, 17.8% (95% CI: 10.90-29.00) were younger than 45years and 3.0% (95% CI: 2.50-3.50) were younger than 35years. The diagnostic accuracy of alarm features for predicting malignancy was moderate (DOR: 4.87, 95% CI: 2.72-8.71; AUC=0.74). The diagnostic accuracy at age >35years (DOR: 9.41, 95% CI: 7.89-11.21; AUC=0.82) was better than that at age >45years (DOR: 3.50, 95% CI: 2.32-5.27; AUC=0.70). ConclusionsThe malignancy detection rate and proportion of young cancer patients were high among Asian dyspepsia patients. Alarm features and age were of limited value for predicting malignancy, and prompt endoscopy should be considered as the initial strategy for dyspepsia in Asian populations. The optimal age threshold for endoscopy screening in Asia might be 35years.	[Chen, S. L.; Chen, M. H.] Sun Yat Sen Univ, Div Gastroenterol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Gwee, K. A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Lee, J. S.] Soonchunhyang Univ Hosp, Inst Digest Res, Ctr Digest Dis, Seoul, South Korea; [Miwa, H.] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo 6638501, Japan; [Suzuki, H.] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Guo, P.; Hao, Y. T.] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Sch Publ Hlth, Guangzhou 510080, Guangdong, Peoples R China	Chen, MH (reprint author), Sun Yat Sen Univ, Div Gastroenterol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China.	chenminhu@vip.163.com	Suzuki, Hidekazu/J-4396-2013		Program of National Key Clinical Specialties [303004269002]	Declaration of funding interests: This work was supported by the Program of National Key Clinical Specialties (No. 303004269002). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	KNILLJONES RP, 1991, SCAND J GASTROENTERO, V26, P17, DOI 10.3109/00365529109109532; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Ho KY, 1998, AM J GASTROENTEROL, V93, P1816; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x; Liou JM, 2005, GASTROINTEST ENDOSC, V61, P819, DOI 10.1016/S0016-5107(05)00366-4; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Ford AC, 2010, CLIN GASTROENTEROL H, V8, P830, DOI 10.1016/j.cgh.2010.05.031; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Egger M, 1997, BRIT MED J, V315, P629; Hongo M, 2012, J GASTROEN HEPATOL, V27, P62, DOI 10.1111/j.1440-1746.2011.06949.x; Wang Yong-chuan, 2012, Cancer Biology Medicine, V9, P128, DOI 10.3969/j.issn.2095-3941.2012.02.009; [Anonymous], 2003, CANC REG ANN REP, P30; Chen WQ, 2013, CHINESE J CANCER RES, V25, P10, DOI 10.3978/j.issn.1000-9604.2012.12.04; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; Bai Y, 2010, GUT, V59, P722, DOI 10.1136/gut.2009.192401; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Ford AC, 2008, DIGEST DIS, V26, P225, DOI 10.1159/000121351; Hsu YC, 2012, DIGEST LIVER DIS, V44, P218, DOI 10.1016/j.dld.2011.10.012; Hu WHC, 2006, WORLD J GASTROENTERO, V12, P5010; Kinoshita Y, 2011, INTERNAL MED, V50, P2269, DOI 10.2169/internalmedicine.50.5678; Kiyota K, 1992, Nihon Shokakibyo Gakkai Zasshi, V89, P1973; Li XB, 2005, SCAND J GASTROENTERO, V40, P1028, DOI 10.1080/00365520510023206; Li Xiao Bo, 2005, Chin J Dig Dis, V6, P62, DOI 10.1111/j.1443-9573.2005.00200.x; Mahadeva S, 2012, DIGEST DIS SCI, V57, P3205, DOI 10.1007/s10620-012-2256-7; Malaty HM, 1997, SCAND J GASTROENTERO, V32, P751, DOI 10.3109/00365529708996529; Moayyedi P, 1999, AM J GASTROENTEROL, V94, P3122; National Institute for Health and Clinical Excellence, 2004, DYSP MAN DYSP AD PRI; Shiota S, 2009, J GASTROENTEROL, V44, P930, DOI 10.1007/s00535-009-0095-x; Sumathi B, 2008, SINGAP MED J, V49, P970; Sung JJY, 2001, GASTROINTEST ENDOSC, V54, P454, DOI 10.1067/mge.2001.118254; Talley Nicholas J, 2005, Gastroenterology, V129, P1756, DOI 10.1053/j.gastro.2005.09.020; Tally NJ, 1998, GASTROENTEROLOGY, V114, P579; THOMPSON WG, 1984, CAN MED ASSOC J, V130, P565; Wai CT, 2002, GASTROINTEST ENDOSC, V56, P548, DOI 10.1067/mge.2002.128493; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WILLIAMS B, 1988, LANCET, V2, P1349; Wu GL, 2003, CHIN J DIGITAL, V9, P533	38	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	FEB	2015	41	3					239	252		10.1111/apt.13028		14	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	AY8XZ	WOS:000347835300001		
J	Bellingrath-Kimura, SD; Kishimoto-Mo, AW; Oura, N; Sekikawa, S; Yonemura, S; Sudo, S; Hayakawa, A; Minamikawa, K; Takata, Y; Hara, H				Bellingrath-Kimura, Sonoko Dorothea; Kishimoto-Mo, Ayaka Wenhong; Oura, Noriko; Sekikawa, Seiko; Yonemura, Seichiro; Sudo, Shigeto; Hayakawa, Atsushi; Minamikawa, Kazunori; Takata, Yusuke; Hara, Hiroshi			Differences in the Spatial Variability Among CO2, CH4, and N2O Gas Fluxes from an Urban Forest Soil in Japan	AMBIO			English	Article						Carbon dioxide; Methane; Nitrous oxide; Rolling hill; Spatial variability; Urban forest	NITROUS-OXIDE EMISSIONS; METHANE UPTAKE; RESPIRATION; CONSUMPTION; VARIOGRAMS; ECOSYSTEM; SPRUCE; CEDAR	The spatial variability of carbon dioxide (CO2), methane (CH4), and nitrous oxide (N2O) fluxes from forest soil with high nitrogen (N) deposition was investigated at a rolling hill region in Japan. Gas fluxes were measured on July 25th and December 5th, 2008 at 100 points within a 100 x 100 m grid. Slope direction and position influenced soil characteristics and site-specific emissions were found. The CO2 flux showed no topological difference in July, but was significantly lower in December for north-slope with coniferous trees. Spatial dependency of CH4 fluxes was stronger than that of CO2 or N2O and showed a significantly higher uptake in hill top, and emissions in the valley indicating strong influence of water status. N2O fluxes showed no spatial dependency and exhibited high hot spots at different topology in July and December. The high N deposition led to high N2O fluxes and emphasized the spatial variability.	[Bellingrath-Kimura, Sonoko Dorothea] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Int Environm & Agr Sci, Fuchu, Tokyo 1838509, Japan; [Kishimoto-Mo, Ayaka Wenhong; Oura, Noriko; Sudo, Shigeto; Minamikawa, Kazunori] Natl Inst Agroenvironm Sci, Carbon & Nutr Cycles Div, Tsukuba, Ibaraki 3058604, Japan; [Sekikawa, Seiko] Tamagawa Univ, Coll Agr, Machida, Tokyo 1948610, Japan; [Yonemura, Seichiro] Natl Inst Agroenvironm Sci, Agrometeorol Div, Tsukuba, Ibaraki 3058604, Japan; [Hayakawa, Atsushi] Akita Prefectural Univ, Fac Bioresource Sci, Akita 0100195, Japan; [Takata, Yusuke] Natl Inst Agroenvironm Sci, Nat Resources Inventory Ctr, Tsukuba, Ibaraki 3058604, Japan; [Hara, Hiroshi] Tokyo Univ Agr & Technol, Dept Agr, Fuchu, Tokyo 1838509, Japan	Bellingrath-Kimura, SD (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Int Environm & Agr Sci, Saiwaicho 3-5-8, Fuchu, Tokyo 1838509, Japan.	skimura@cc.tuat.ac.jp; mow@affrc.go.jp; nori@affrc.go.jp; sekisei@agr.tamagawa.ac.jp; yone@affrc.go.jp; ssudo@affrc.go.jp; hayakawa@akita-pu.ac.jp; minakazu@affrc.go.jp; takatay@affrc.go.jp; harahrs@cc.tuat.ac.jp			Tokyo Foundation for Better Environment	This study was supported by the Tokyo Foundation for Better Environment. Special thanks are also due to members of Oze High School and all other people who participated in the two sampling events in 2008.	Rover M, 1999, SOIL BIOL BIOCHEM, V31, P167, DOI 10.1016/S0038-0717(97)00271-X; Hutyra LR, 2011, GLOBAL CHANGE BIOL, V17, P783, DOI 10.1111/j.1365-2486.2010.02238.x; BEKKU Y, 1995, ECOL RES, V10, P369, DOI 10.1007/BF02347863; WEBSTER R, 1992, J SOIL SCI, V43, P177; Whalen SC, 1996, SOIL BIOL BIOCHEM, V28, P1271, DOI 10.1016/S0038-0717(96)00139-3; Conrad R, 2007, ADV AGRON, V96, P1, DOI 10.1016/S0065-2113(07)96005-8; Jiang CM, 2010, ATMOS ENVIRON, V44, P2920, DOI 10.1016/j.atmosenv.2010.03.030; Ekblad A, 2001, OECOLOGIA, V127, P305, DOI 10.1007/s004420100667; Jungkunst HF, 2008, SOIL BIOL BIOCHEM, V40, P2047, DOI 10.1016/j.soilbio.2008.04.015; Morishita T, 2007, SOIL SCI PLANT NUTR, V53, P678, DOI 10.1111/j.1747-0765.2007.00181.x; Konda R, 2008, SOIL BIOL BIOCHEM, V40, P3021, DOI 10.1016/j.soilbio.2008.08.022; DORR H, 1993, CHEMOSPHERE, V26, P697, DOI 10.1016/0045-6535(93)90454-D; Fang YT, 2009, PLANT SOIL, V319, P37, DOI 10.1007/s11104-008-9847-2; Florinsky IV, 2002, ENVIRON MODELL SOFTW, V17, P295, DOI 10.1016/S1364-8152(01)00067-6; Lark RM, 2000, EUR J SOIL SCI, V51, P717, DOI 10.1046/j.1365-2389.2000.00345.x; Borken W, 2005, BIOGEOCHEMISTRY, V76, P141, DOI 10.1007/s10533-005-2901-8; Davidson E.A., 2000, BIOSCIENCE, V50, P67; Detto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076296; Economic Planning Agency, 1969, 1:1,160,000 slope map, Patent No. [2006275844, 2006-275844]; FAO/UNESCO, 1990, WORLD SOIL MAP REV L; Florinsky IV, 2004, GEODERMA, V119, P33, DOI 10.1016/S0016-7061(03)00224-6; Gulledge J, 1997, SOIL BIOL BIOCHEM, V29, P13, DOI 10.1016/S0038-0717(96)00265-9; Hatano R., 2007, Eurasian Journal of Forest Research, V10-1, P71; Japan Meteorological Agency, 2010, MET DAT; Jia Shugang, 2003, Japanese Journal of Ecology (Otsu), V53, P13; Kimura SD, 2009, WATER AIR SOIL POLL, V202, P369, DOI 10.1007/s11270-009-9983-1; Lark RM, 2004, EUR J SOIL SCI, V55, P611, DOI 10.1111/j.1365-2389.2004.00620.x; Meijide A, 2010, EUR J SOIL SCI, V61, P364, DOI 10.1111/j.1365-2389.2010.01233.x; Ministry of Environment, 2009, REP LONG TERM AC RAI; Nishina K, 2009, BIOGEOCHEMISTRY, V96, P163, DOI 10.1007/s10533-009-9356-2; Nishina K, 2009, SOIL SCI PLANT NUTR, V55, P179, DOI 10.1111/j.1747-0765.2007.00315.x; Osaka K, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000026; Papen H, 2001, J APPL BOT-ANGEW BOT, V75, P159; Rolston D.E., 1986, METHODS SOIL ANAL 1, P383; Sakata Tadashi, 2004, Bulletin of the Forestry and Forest Products Research Institute, V3, P259; Yanai J., 2000, JSSSPN, V71, P726; Yonemura S., 2000, J GEOPHYS RES, V105, P347	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0044-7447	1654-7209		AMBIO	Ambio	FEB	2015	44	1					55	66		10.1007/s13280-014-0521-z		12	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AY9EK	WOS:000347852400007		
J	Tatsumi, Y; Morimoto, A; Miyamatsu, N; Noda, M; Ohno, Y; Deura, K				Tatsumi, Yukako; Morimoto, Akiko; Miyamatsu, Naomi; Noda, Mitsuhiko; Ohno, Yuko; Deura, Kijyo			Effect of Body Mass Index on Insulin Secretion or Sensitivity and Diabetes	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; FASTING PLASMA-GLUCOSE; SUSCEPTIBILITY GENE; BETA-CELLS; RESISTANCE; MELLITUS; OBESITY; METAANALYSIS; UNDERWEIGHT; STRATEGIES	Background: Although the association between obesity and diabetes is well known, the factors predisposing to diabetes in non-obese Asians are less clearly characterized. Purpose: To investigate the effects of impaired insulin secretion (IIS) and insulin resistance (IR) according to BMI on the incidence of diabetes in the Saku Study. Methods: This 4-year cohort study involved 3,083 participants aged 30-69 years without diabetes at baseline (2006-2007). Participants were stratified by BMI (< 23.0, 23.0-24.9, and >= 25). Based on insulinogenic index and homeostasis model of IR values, participants were classified into four categories: normal; isolated IIS (i-IIS); isolated IR (i-IR); and ITS plus IR. All data were collected in 2006-2011 and analyzed in 2013-2014. Results: For participants with BMI < 23.0, the risk of developing diabetes was higher in the i-IIS (adjusted hazard ratio=6.6; 95% CI=3.7, 11.6) and IIS plus IR groups (9.4; 3.1, 28.4) than in the normal group. For participants with BMI 23.0-24.9, risk was higher in the i-IIS (9.9; 4.4, 22.1); i-IR (3.4; 1.2, 9.5); and IIS plus IR (23.4; 9.3, 58.9) groups. Among participants with BMI >= 25, risk was higher in the i-IIS (16.9; 6.0, 47.7); i-IR (7.9; 2.8, 22.6); and IIS plus IR (26.9; 9.0, 80.8) groups. BMI was negatively associated with incidence of ITS but positively associated with IR incidence. Conclusions: Individuals with normal BMI may develop diabetes mainly through IIS, whereas individuals with high BMI may develop diabetes primarily through IR. (C) 2015 American Journal of Preventive Medicine	[Tatsumi, Yukako; Ohno, Yuko] Osaka Univ, Grad Sch Med, Dept Math Hlth Sci, Suita, Osaka 5650871, Japan; [Morimoto, Akiko; Miyamatsu, Naomi] Shiga Univ Med Sci, Dept Clin Nursing, Shiga, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Deura, Kijyo] Saku Cent Hosp, Complete Hlth Check Ctr, Nagano, Japan	Tatsumi, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Math Hlth Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	y-tatumi@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science Fellowship [25-1053]	We sincerely thank all the researchers and co-medical staff of Saku Central Hospital for their excellent medical examinations and follow-up surveys. This study was funded by Grant-in-Aid from the Japan Society for the Promotion of Science Fellowship (No. 25-1053).	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morimoto A, 2013, DIABETOLOGIA, V56, P1671, DOI 10.1007/s00125-013-2932-y; Tripathy D, 2004, DIABETES CARE, V27, P2204, DOI 10.2337/diacare.27.9.2204; Jonsson A, 2009, DIABETES, V58, P2409, DOI 10.2337/db09-0246; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; Fukushima M, 2004, METABOLISM, V53, P831, DOI 10.1016/j.metabol.2004.02.012; Sairenchi T, 2008, DIABETES CARE, V31, P583, DOI 10.2337/dc07-1390; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Kosaka K, 1996, DIABETIC MED, V13, pS120; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Yoshiike N, 2002, ASIA PAC J CLIN NUTR, V11, pS727, DOI 10.1046/j.1440-6047.11.s8.18.x; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Barba C, 2004, LANCET, V363, P157; CERASI E, 1972, DIABETES, V21, P224; Duval S, 2007, OBES REV, V8, P263, DOI 10.1111/j.1467-789X.2006.00263.x; Edderkaoui M, 2013, J CANC THER, V4, P34, DOI [10.4236/jct.2013.410A005, DOI 10.4236/JCT.2013.410A005]; Japanese Ministry of Health Labour and Welfare, 2005, NAT HLTH NUTR SURV; Mneilly GS, 1996, DIABETES CARE, V19, P1320; Morimoto A, 2013, J DIABETES INVEST, V4, P274, DOI 10.1111/jdi.12019; Nakai Y, 2002, DIABETIC MED, V19, P346, DOI 10.1046/j.1464-5491.2002.00712_3.x; Okamoto K, 2012, DIABETES, V61, P1734, DOI 10.2337/db11-1201; Okamoto K, 2010, AM J HUM GENET, V86, P54, DOI 10.1016/j.ajhg.2009.12.009; Sato Y, 2002, DIABETIC MED, V19, P566, DOI 10.1046/j.1464-5491.2002.00746.x; Tatsumi Y, 2012, DIABETOL INT, V3, P92; Tayek JA, 1997, METABOLISM, V46, P140, DOI 10.1016/S0026-0495(97)90291-2; The Japan Diabetes Society, 2010, EV BAS PRACT GUID TR; The Japan Diabetes Society, 2010, TREATM GUID DIAB 201; Tripathy D, 2000, DIABETES, V49, P975, DOI 10.2337/diabetes.49.6.975; van Vliet-Ostaptchouk JV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032148; World Health Organization, 1999, REP WHO CONS DEF D 1; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	FEB	2015	48	2					128	135		10.1016/j.amepre.2014.09.009		8	Public, Environmental & Occupational Health; Medicine, General & Internal	Public, Environmental & Occupational Health; General & Internal Medicine	AZ2YY	WOS:000348096300002		
J	Aida, J; Vieth, M; Shepherd, NA; Ell, C; May, A; Neuhaus, H; Ishizaki, T; Nishimura, M; Fujiwara, M; Arai, T; Takubo, K				Aida, Junko; Vieth, Michael; Shepherd, Neil A.; Ell, Christian; May, Andrea; Neuhaus, Horst; Ishizaki, Tatsuro; Nishimura, Makoto; Fujiwara, Mutsunori; Arai, Tomio; Takubo, Kaiyo			Is Carcinoma in Columnar-lined Esophagus Always Located Adjacent to Intestinal Metaplasia? A Histopathologic Assessment	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						Barrett carcinoma; columnar-lined esophagus; cardiac-type mucosa; intestinal-type mucosa; endoscopic resection	BARRETTS-ESOPHAGUS; ESOPHAGOGASTRIC JUNCTION; ADENOCARCINOMA; SPECIMENS; HISTOGENESIS; ASSOCIATION; EXPRESSION; EPITHELIUM; DYSPLASIA; PATHOLOGY	Diagnostic criteria for Barrett esophagus in the United States and elsewhere, except the United Kingdom and Japan, include the presence of intestinal metaplasia with goblet cells. We analyzed high-grade dysplasia and adenocarcinoma in a complete series of sections of all interfaces between carcinoma in columnar-lined esophagus (CLE) and the adjacent mucosa, assessed them for the mucosal types present, and calculated the proportion of each mucosal type in each case. The materials were a consecutive series of 100 endoscopic resection cases, comprising a total of 1251 microscopic sections. After excluding cases in which intestinal-type or cardiac-type mucosa was not adjacent to CLE carcinoma, 70 cases remained, for which 885 sections were available. Whether the adjacent mucosa was primarily cardiac or intestinal in type was assessed, as were the patterns of immunostaining for HGM, MUC-2, and MUC-6. Twenty-four (34.3%) of the 70 CLE carcinomas were completely surrounded by cardiac-type mucosa, and 10 (14.3%) were completely surrounded by intestinal-type mucosa. In 13 (18.6%), the entire non-neoplastic mucosa of the endoscopic resection specimen comprised the cardiac type alone without any intestinal type, and only 3 (4.3%) comprised the intestinal type only, without any cardiac type. From these findings, we consider it unproven histogenetically that the background mucosa of CLE carcinoma is predominantly of the intestinal type. CLE carcinoma was not demonstrated to have a close relationship with CLE mucosa with intestinal metaplasia.	[Aida, Junko; Takubo, Kaiyo] Tokyo Metropolitan Geriatr Hosp, Res Team Geriatr Pathol, Sakaecho, Japan; [Ishizaki, Tatsuro] Tokyo Metropolitan Geriatr Hosp, Human Care Res Team, Sakaecho, Japan; [Nishimura, Makoto] Tokyo Metropolitan Geriatr Hosp, Dept Endoscop Surg, Sakaecho, Japan; [Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Diagnost Pathol, Sakaecho, Japan; [Fujiwara, Mutsunori] Japanese Red Cross Med Ctr, Dept Clin Med, Tokyo, Japan; [Vieth, Michael] Bayreuth Klinikum, Inst Pathol, Bayreuth, Germany; [Ell, Christian; May, Andrea] Dr Horst Schmidt Clin, Dept Gastroenterol, Wiesbaden, Germany; [Neuhaus, Horst] Evangel Krankenhaus, Dusseldorf, Germany; [Shepherd, Neil A.] Cheltenham Gen Hosp, Gloucestershire Cellular Pathol Lab, Cheltenham, Glos, England	Aida, J (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	aidajs@tmig.or.jp; takubo@tmig.or.jp			Tokyo Metropolitan Institute of Gerontology	Supported by Tokyo Metropolitan Institute of Gerontology. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Aida J, 2011, AM J SURG PATHOL, V35, P1140, DOI 10.1097/PAS.0b013e3182206c0e; Takubo K, 2009, HUM PATHOL, V40, P65, DOI 10.1016/j.humpath.2008.06.008; Chandrasoma P, 2012, AM J SURG PATHOL, V36, P1, DOI 10.1097/PAS.0b013e31822a5a2c; [Anonymous], 2011, GASTROENTEROLOGY, V140, P1084; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Spechler SJ, 1996, GASTROENTEROLOGY, V110, P614, DOI 10.1053/gast.1996.v110.agast960614; TAKUBO K, 1991, HUM PATHOL, V22, P1158, DOI 10.1016/0046-8177(91)90270-Y; Zemler B, 2010, VIRCHOWS ARCH, V456, P609, DOI 10.1007/s00428-010-0925-5; Tsukashita S, 2001, INT J CANCER, V94, P166, DOI 10.1002/ijc.1460; van Sandick JW, 2000, CANCER, V88, P2429, DOI 10.1002/1097-0142(20000601)88:11<2429::AID-CNCR1>3.0.CO;2-H; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Shiroshita H, 2004, PATHOL INT, V54, P311, DOI 10.1111/j.1440-1827.2004.01625.x; CAMERON AJ, 1995, GASTROENTEROLOGY, V109, P1541, DOI 10.1016/0016-5085(95)90642-8; Cameron AJ, 2002, AM J GASTROENTEROL, V97, P1375, DOI 10.1016/S0002-9270(02)04025-X; CLARK GWB, 1994, ARCH SURG-CHICAGO, V129, P609; Coad RA, 2005, J PATHOL, V206, P388, DOI 10.1002/path.1804; HAGGITT RC, 1978, AM J CLIN PATHOL, V70, P1; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Khor TS, 2012, AM J SURG PATHOL, V36, P331, DOI 10.1097/PAS.0b013e31823d08d6; Nunobe S, 2007, PATHOL INT, V57, P315, DOI 10.1111/j.1440-1827.2007.02102.x; PAULL A, 1976, NEW ENGL J MED, V295, P476, DOI 10.1056/NEJM197608262950904; Riddell RH, 2009, AM J GASTROENTEROL, V104, P2588, DOI 10.1038/ajg.2009.390; Ruol A, 2000, CANCER, V88, P2520, DOI 10.1002/1097-0142(20000601)88:11<2520::AID-CNCR13>3.0.CO;2-L; Takubo K, 2005, HUM PATHOL, V36, P269, DOI 10.1016/j.humpath.2005.01.012; Takubo K, 1995, PATHOLOGY, V27, P315; Tsuji Naoko, 2004, Gastric Cancer, V7, P97; Vieth M, 2006, ESOPHAGUS, V3, P171, DOI 10.1007/s10388-006-0088-2; Vieth M, 2005, BEST PRACT RES CL GA, V19, P857, DOI 10.1016/j.bpg.2005.02.008; Westerhoff M, 2012, CLIN GASTROENTEROL H, V10, P1232, DOI 10.1016/j.cgh.2012.05.013	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	FEB	2015	39	2					188	196				9	Pathology; Surgery	Pathology; Surgery	AZ0SP	WOS:000347955200005		
J	Satou, A; Asano, N; Nakazawa, A; Osumi, T; Tsurusawa, M; Ishiguro, A; Elsayed, AA; Nakamura, N; Ohshima, K; Kinoshita, T; Nakamura, S				Satou, Akira; Asano, Naoko; Nakazawa, Atsuko; Osumi, Tomoo; Tsurusawa, Masahito; Ishiguro, Atsushi; Elsayed, Ahmed Ali; Nakamura, Naoya; Ohshima, Koichi; Kinoshita, Tomohiro; Nakamura, Shigeo			Epstein-Barr Virus (EBV)-positive Sporadic Burkitt Lymphoma An Age-related Lymphoproliferative Disorder?	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						Burkitt lymphoma; sporadic; Epstein-Barr virus; age-related EBV-associated lymphoproliferative disorder; immunodeficiency	B-CELL LYMPHOMA; GERMINAL CENTER; GRANULOMATOUS REACTION; HODGKIN-LYMPHOMA; EXPRESSION; ACTIVATION; INFECTION; PATTERNS; BIOLOGY; IMPACT	Epstein-Barr virus (EBV) is detected in 20% to 30% of sporadic Burkitt lymphoma (sBL). However, only a few studies of EBV-positive (EBV+) sBL have been reported, and its characteristics still remain controversial. To highlight the features of EBV+ sBL, we compared the clinicopathologic characteristics of 33 cases of EBV+ and 117 cases of EBV-negative (EBV-) sBL in Japan. EBV+ sBL showed significantly higher age distribution (median, 42 vs. 13 y; P < 0.0001) and higher frequency of patients older than 50 years (48% vs. 16%, P< 0.0001). We also revealed the difference of the involved sites. The EBV+ group showed significantly higher incidence of involvement of tonsil (P = 0.027), adrenal gland (P = 0.011), and cervical lymph node (P = 0.040). In addition, the EBV+ group tended to have higher incidence of nodal involvement (P = 0.078) and involvement of para-aorta lymph node (P = 0.084) and heart (P = 0.050). In contrast, the gastrointestinal tract was less frequently affected in EBV+ sBL (P = 0.024). In addition, the less positivity for MUM1 (P - 0.020) of EBV+ sBL was highlighted. These results indicate that biological behavior and pathogenesis of EBV+ sBL might be different from those of EBV- sBL. Our results demonstrate that EBV+ sBL has an aspect of age-related disease and is a distinct clinicopathologic subtype, which should be distinguished from EBV- sBL.	[Satou, Akira; Elsayed, Ahmed Ali; Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi 4668550, Japan; [Satou, Akira; Elsayed, Ahmed Ali; Nakamura, Shigeo] Nagoya Univ Hosp, Clin Labs, Nagoya, Aichi 4668550, Japan; [Asano, Naoko] Nagano Prefectural Suzaka Hosp, Dept Clin Lab, Nagano, Japan; [Nakazawa, Atsuko] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Dept Pathol, Tokyo, Japan; [Osumi, Tomoo] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan; [Nakamura, Naoya] Tokai Univ, Sch Med, Dept Pathol, Tokyo 151, Japan; [Nakazawa, Atsuko; Osumi, Tomoo; Tsurusawa, Masahito] Aichi Med Univ, Japanese Pediat Leukemia Lymphoma Study Grp, Nagoya, Aichi, Japan; [Tsurusawa, Masahito] Aichi Med Univ, Dept Pediat, Nagoya, Aichi, Japan; [Kinoshita, Tomohiro] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi, Japan; [Ishiguro, Atsushi] Teine Keijinkai Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan; [Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Fukuoka, Japan	Nakamura, S (reprint author), Nagoya Univ Hosp, Dept Pathol & Lab Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	snakamur@med.nagoya-u.ac.jp	Nakamura, Shigeo/I-1571-2012				Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758; Kuze T, 2000, JPN J CANCER RES, V91, P1233; Asano N, 2005, AM J SURG PATHOL, V29, P1284, DOI 10.1097/01.pas.0000173238.17331.6b; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Tsurusawa M, 2014, PEDIATR BLOOD CANCER, V61, P1215, DOI [10.1002/pbc.24975, 10.1002/pbc.24968]; ROONEY CM, 1985, NATURE, V317, P629, DOI 10.1038/317629a0; Asano N, 2013, BEST PRACT RES CL HA, V26, P15, DOI 10.1016/j.beha.2013.04.002; Park S, 2007, BLOOD, V110, P972, DOI 10.1182/blood-2007-01-067769; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Asano N, 2009, BLOOD, V113, P2629, DOI 10.1182/blood-2008-06-164806; Dojcinov SD, 2010, AM J SURG PATHOL, V34, P405, DOI 10.1097/PAS.0b013e3181cf8622; Montes-Moreno S, 2012, MODERN PATHOL, V25, P968, DOI 10.1038/modpathol.2012.52; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Magrath I, 2012, BRIT J HAEMATOL, V156, P744, DOI 10.1111/j.1365-2141.2011.09013.x; Dojcinov SD, 2011, BLOOD, V117, P4726, DOI 10.1182/blood-2010-12-323238; Oyama T, 2003, AM J SURG PATHOL, V27, P16, DOI 10.1097/00000478-200301000-00003; Falini B, 2000, BLOOD, V95, P2084; Chang CC, 2004, AM J SURG PATHOL, V28, P464, DOI 10.1097/00000478-200404000-00005; Liu F, 2012, HISTOPATHOLOGY, V61, P1183, DOI 10.1111/j.1365-2559.2012.04339.x; Chadburn A, 2013, ARCH PATHOL LAB MED, V137, P360, DOI 10.5858/arpa.2012-0095-RA; Gualco G, 2009, HUM PATHOL, V40, P565, DOI 10.1016/j.humpath.2008.07.021; Guech-Ongey M, 2010, BLOOD, V116, P5600, DOI 10.1182/blood-2010-03-275917; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Haralambieva E, 2004, AM J SURG PATHOL, V28, P379, DOI 10.1097/00000478-200403000-00011; Leoncini L, 2008, WHO CLASSIFICATION T, P262; Little RF, 2003, BLOOD, V101, P4653, DOI 10.1182/blood-2002-11-3589; Nakamura S, 2008, WHO CLASSIFICATION T, P243; Schrager JA, 2005, AM J SURG PATHOL, V29, P1115; Swinnen LJ, 1999, SEMIN ONCOL, V26, P21; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015	30	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	FEB	2015	39	2					227	235				9	Pathology; Surgery	Pathology; Surgery	AZ0SP	WOS:000347955200010		
J	Aoyama, T; Fujikawa, H; Cho, H; Ogata, T; Shirai, J; Hayashi, T; Rino, Y; Masuda, M; Oba, MS; Morita, S; Yoshikawa, T				Aoyama, Toru; Fujikawa, Hirohito; Cho, Haruhiko; Ogata, Takashi; Shirai, Junya; Hayashi, Tsutomu; Rino, Yasushi; Masuda, Munetaka; Oba, Mari S.; Morita, Satoshi; Yoshikawa, Takaki			A Methylene Blue-assisted Technique for Harvesting Lymph Nodes After Radical Surgery for Gastric Cancer A Prospective, Randomized, Controlled Study	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						gastric cancer; methylene blue; lymph node dissection	CHEMOTHERAPY; CHEMORADIOTHERAPY	Harvesting lymph nodes (LNs) after gastrectomy is essential for accurate staging. This trial evaluated the efficiency and quality of a conventional method and a methylene blue-assisted method in a randomized manner. The key eligibility criteria were as follows: (i) histologically proven adenocarcinoma of the stomach; (ii) clinical stage I-III; (iii) R0 resection planned by gastrectomy with D1 + or D2 lymphadenectomy. The primary endpoint was the ratio of the pathologic number of harvested LNs per time (minutes) as an efficacy measure. The secondary endpoint was the number of harvested LNs, as a quality measure. Between August 2012 and December 2012, 60 patients were assigned to undergo treatment using the conventional method (n = 29) and the methylene blue dye method (n = 31). The baseline demographics were mostly well balanced between the 2 groups. The number of harvested LNs (mean +/- SD) was 33.6 +/- 11.9 in the conventional arm and 43.4 +/- 13.9 in the methylene blue arm (P = 0.005). The ratio of the number of the harvested LNs per time was 1.12 + 0.46 LNs/min in the conventional arm and 1.49 +/- 0.59 LNs/min in the methylene blue arm (P - 0.010). In the subgroup analyses, the quality and efficacy were both superior for the methylene blue dye method compared with the conventional method. The methylene blue technique is recommended for harvesting LNs during gastric cancer surgery on the basis of both the quality and efficacy.	[Aoyama, Toru; Fujikawa, Hirohito; Cho, Haruhiko; Ogata, Takashi; Shirai, Junya; Hayashi, Tsutomu; Yoshikawa, Takaki] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan; [Aoyama, Toru; Fujikawa, Hirohito; Shirai, Junya; Hayashi, Tsutomu; Rino, Yasushi; Masuda, Munetaka; Yoshikawa, Takaki] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan; [Oba, Mari S.; Morita, Satoshi] Yokohama City Univ, Med Ctr, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan	Yoshikawa, T (reprint author), Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Asahi Ku, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	yoshikawat@kcch.jp			Non-Governmental Organizations Kanagawa Standard Anti-cancer Therapy Support System	Supported, in part, by the Non-Governmental Organizations Kanagawa Standard Anti-cancer Therapy Support System. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Mekenkamp LJM, 2009, AM J SURG PATHOL, V33, P1547, DOI 10.1097/PAS.0b013e3181b2e01f; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; [Anonymous], 2011, NCCN CLIN PRACT GUID; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Markl B, 2008, AM J CLIN PATHOL, V130, P913, DOI 10.1309/AJCPVAPB5APABJNX; Neuman H, 2006, AM J SURG, V191, P827, DOI 10.1016/j.amjsurg.2005.08.041; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Rullier A, 2008, AM J SURG PATHOL, V32, P45; Isozaki E, 1986, RINSHO SHINKEIGAKU, V26, P710; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kurosu Y, 1987, J NIHON U MED ASS, V46, P1057; Okines A, 2010, ANN ONCOL, V21, pv50, DOI 10.1093/annonc/mdq164; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sobin LH, 2010, TNM CLASSIFICATION M	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	FEB	2015	39	2					266	273				8	Pathology; Surgery	Pathology; Surgery	AZ0SP	WOS:000347955200015		
J	Sugawara, K; Kadoya, T; Kuramitz, H				Sugawara, Kazuharu; Kadoya, Toshihiko; Kuramitz, Hideki			Construction of a peptide with an electroactive daunomycin like a pendant arm to detect ovalbumin	ANALYTICA CHIMICA ACTA			English	Article						Peptide probe; Binding constant; Ovalbumin; Alkyl chain	PROTEINS; ASSAY; IMMUNOSENSOR; LYSOZYME; MODEL	In this study, a peptide-1 (RNRCKGTDVQAW) constructing lysozyme was conjugated with an electroactive daunomycin in order to voltammetrically detect ovalbumin (OVA). Hetero-bifunctional cross-linking agents with four kinds of ethylene chains in differing lengths were used to bind the peptide-1 and daunomycin. After a cross-linking agent had reacted with an amino group of daunomycin, the compound was introduced into the peptide to the cysteine residue in the peptide using a pendant arm. The OVA was sensed via a change in the electrode response of the daunomycin moiety, based on the binding between the peptide and the OVA. The adsorption of the peptide probe on the electrode increased with increases in the ethylene chain. The binding constants between the peptide probes and the OVA, however, did not depend on the length of the chain. This was because the ethylene chain influenced the binding. When the peptide and the daunomycin were bound using N-(6-maleimidocaproyloxy)sulfosuccinimide, the electrode response of the peptide probe was the most sensitive from among the four cross-linking agents. The calibration curve of the OVA using the peptide probe was linear and ranged from 1.5 x 10(-11) to 3.0 x 10(-10) M. Furthermore, this method could be applied to the electrochemical sensing of the OVA in egg whites and in fetal bovine serum. (C) 2014 Elsevier B.V. All rights reserved.	[Sugawara, Kazuharu; Kadoya, Toshihiko] Maebashi Inst Technol, Gunma 3710816, Japan; [Kuramitz, Hideki] Toyama Univ, Grad Sch Sci & Engn Res, Dept Environm Biol & Chem, Toyama 9308555, Japan	Sugawara, K (reprint author), Maebashi Inst Technol, Gunma 3710816, Japan.	kzsuga@maebashi-it.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22550078]	The authors thank the Ministry of Education, Culture, Sports, Science, and Technology of Japan for the financial support of this work in the form of a Grant-in-Aid for Scientific Research (No. 22550078).	Kato M, 2009, J CHROMATOGR B, V877, P3059, DOI 10.1016/j.jchromb.2009.07.027; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Yang PL, 2007, ANAL CHEM, V79, P1690, DOI 10.1021/ac061936e; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Herzog G, 2007, ANALYST, V132, P615, DOI 10.1039/b701472d; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/bse0520023, 10.1042/BSE0520023]; Eissa S, 2013, ANALYST, V138, P4378, DOI 10.1039/c3an36883a; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Geoghegan KF, 2000, BIOCONJUGATE CHEM, V11, P71, DOI 10.1021/bc9900845; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Gerasimov JY, 2010, CHEM COMMUN, V46, P395, DOI 10.1039/b919070h; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Liu HY, 2010, ANAL CHEM, V82, P5865, DOI 10.1021/ac101110q; Wengerter BC, 2014, MOL THER, V22, P1375, DOI 10.1038/mt.2014.51; ARCAMONE F, 1964, J AM CHEM SOC, V86, P5335, DOI 10.1021/ja01077a060; Borland LM, 2008, J CHROMATOGR B, V875, P451, DOI 10.1016/j.jchromb.2008.09.026; CHANEY EN, 1982, ANAL CHEM, V54, P2556, DOI 10.1021/ac00251a034; Cherif B, 2006, CLIN CHEM, V52, P255, DOI 10.1373/clinchem.2005.085727; Feng XL, 2014, ANAL BIOCHEM, V459, P12, DOI 10.1016/j.ab.2014.04.016; Han KQ, 2013, MOL INFORM, V32, P783, DOI 10.1002/minf.201300064; HOWLETT GJ, 1973, J BIOL CHEM, V248, P619; Klingstrom T, 2011, BRIEF BIOINFORM, V12, P702, DOI 10.1093/bib/bbq064; Lee SJ, 2004, ANAL BIOCHEM, V330, P311, DOI 10.1016/j.ab.2004.04.008; Lehrach WP, 2006, BIOINFORMATICS, V22, P532, DOI 10.1093/bioinformatics/bti804; Mantzila AG, 2007, BIOSENS BIOELECTRON, V23, P362, DOI 10.1016/j.bios.2007.04.017; Pin SS, 1999, ANAL BIOCHEM, V275, P156, DOI 10.1006/abio.1999.4331; Purushothama S, 2001, ANALYST, V126, P337, DOI 10.1039/b006798i; Rolland JM, 2008, J AGR FOOD CHEM, V56, P349, DOI 10.1021/jf073330c; Sartic S., 2011, ANALYST, V136, P107; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; Sugawara K, 2014, ANAL CHIM ACTA, V834, P37, DOI 10.1016/j.aca.2014.05.003; Sugimoto Y, 2011, BIOCHEM CELL BIOL, V89, P533, DOI [10.1139/o11-041, 10.1139/O11-041]; YANNAKOPOULOS AL, 1986, BRIT POULTRY SCI, V27, P171, DOI 10.1080/00071660120048401	36	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670	1873-4324		ANAL CHIM ACTA	Anal. Chim. Acta	FEB 1	2015	857						71	78		10.1016/j.aca.2014.12.001		8	Chemistry, Analytical	Chemistry	AZ2AY	WOS:000348038100007		
J	Homma, S; Kato, K; Hayashi, J; Yamamoto, M				Homma, Satoki; Kato, Kiyoe; Hayashi, Junichi; Yamamoto, Minoru			Negative Associations Between Arterial Stiffness Parameter Evaluated by Cardio-Ankle Vascular Index and Serum Low-Density Lipoprotein Cholesterol Concentration in Early-Stage Atherosclerosis	ANGIOLOGY			English	Article						arterial stiffness; low-density lipoprotein cholesterol; atherosclerosis; risk factors; cardio-ankle vascular index	INTIMA-MEDIA THICKNESS; ASYMPTOMATIC JAPANESE SUBJECTS; GLOMERULAR-FILTRATION-RATE; TYPE-2 DIABETES-MELLITUS; PULSE-WAVE VELOCITY; C-REACTIVE PROTEIN; CORONARY ATHEROSCLEROSIS; RISK-FACTORS; CARDIOVASCULAR EVENTS; NAGASAKI ISLANDS	The cardio-ankle vascular index (CAVI), calculated values from cardio-ankle pulse wave velocity and blood pressure, corresponds predominantly to the stiffness of the aorta and peripheral arteries of the lower limbs. However, the reported associations between CAVI and serum low-density lipoprotein cholesterol (LDL-C) levels remain inconsistent. A cross-sectional study of 1878 consecutive patients (mean age: 59.2 years) who underwent general health checkup showed a negative association between CAVI and serum LDL-C or non-high-density lipoprotein cholesterol (non-HDL-C) concentrations with age-adjusted correlation and multiple regression analysis. Using the similar analyses divided by the status of risk factors and degree of maximum carotid intima-media thickness (maxIMT), negative correlations between CAVI and LDL-C or non-HDL-C levels were observed only in nonrisk groups including nondiabetics patients or patients with maxIMT <1.0 mm, in those with expected low extent of advanced atherosclerotic lesions. In contrast, such a correlation was not found in each comparable risk-loaded group.	[Homma, Satoki; Hayashi, Junichi; Yamamoto, Minoru] Kyorin Univ, Dept Gen Med, Sch Med, Mitaka, Tokyo 1818611, Japan; [Kato, Kiyoe] Saiseikai Cent Hosp, Ctr Gen Hlth Check Up, Tokyo, Japan	Homma, S (reprint author), Kyorin Univ, Dept Gen Med, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	satoki.homma@nifty.com					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Satoh N, 2008, HYPERTENS RES, V31, P1921, DOI 10.1291/hypres.31.1921; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Izuhara M, 2008, CIRC J, V72, P1762, DOI 10.1253/circj.CJ-08-0152; Kim KJ, 2011, J ATHEROSCLER THROMB, V18, P328; Hayashida H, 2013, ATHEROSCLEROSIS, V229, P186, DOI 10.1016/j.atherosclerosis.2013.04.002; Takaki A, 2008, HYPERTENS RES, V31, P1347, DOI 10.1291/hypres.31.1347; Homma S, 2001, STROKE, V32, P830; Horinaka S, 2009, ANGIOLOGY, V60, P468, DOI 10.1177/0003319708325443; Kubozono T, 2009, J ATHEROSCLER THROMB, V16, P840; Miyashita Y, 2009, J ATHEROSCLER THROMB, V16, P539; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483; Okura T, 2007, HYPERTENS RES, V30, P335, DOI 10.1291/hypres.30.335; Shimizu Y, 2013, ATHEROSCLEROSIS, V228, P491, DOI 10.1016/j.atherosclerosis.2013.03.021; Kadota K, 2008, CIRC J, V72, P304, DOI 10.1253/circj.72.304; Miyoshi T, 2010, J ATHEROSCLER THROMB, V17, P249; Nakamura K, 2008, CIRC J, V72, P598; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Zieske AW, 2005, ATHEROSCLEROSIS, V180, P87, DOI 10.1016/j.athersclerosis.2004.10.039; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101; Takaki A, 2007, CIRC J, V71, P1710, DOI 10.1253/circj.71.1710; Belcaro G, 1996, ARTERIOSCL THROM VAS, V16, P851; Higashiyama A, 2012, J ATHEROSCLER THROMB, V19, P1027; Hirasada K, 2012, J ATHEROSCLER THROMB, V19, P69; Homma Satoki, 2008, Atherosclerosis, V197, P791, DOI 10.1016/j.atherosclerosis.2007.07.027; Homma S, 1997, ATHEROSCLEROSIS, V128, P85, DOI 10.1016/S0021-9150(96)05970-9; Homma S, 2011, ATHEROSCLEROSIS, V219, P184, DOI 10.1016/j.atherosclerosis.2011.07.022; Homma S, 2001, ATHEROSCLEROSIS, V156, P389, DOI 10.1016/S0021-9150(00)00669-9; Horinaka S, 2011, ANGIOLOGY, V62, P401, DOI 10.1177/0003319710395561; Kotani K, 2012, HEART VESSELS, V27, P499, DOI 10.1007/s00380-011-0182-9; Kubozono T, 2011, CIRC J, V75, P698, DOI 10.1253/circj.CJ-10-0552; Ibata Junko, 2008, Diabetes Res Clin Pract, V80, P265, DOI 10.1016/j.diabres.2007.12.016; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Masugata H, 2012, J ATHEROSCLER THROMB, V19, P255; Namekata T, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-51; Ohashi N, 2009, METABOLISM, V58, P1023, DOI 10.1016/j.metabol.2009.03.005; Rabkin SW, 2012, ANGIOLOGY, V63, P150, DOI 10.1177/0003319711410307; Sheen YJ, 2012, ANGIOLOGY, V63, P55, DOI 10.1177/0003319711406709; Soska V, 2012, J ATHEROSCLER THROMB, V19, P453; Wakabayashi I, 2008, ANGIOLOGY, V59, P567, DOI 10.1177/0003319707312517; Zieske AW, 2005, ARTERIOSCL THROM VAS, V25, P1237, DOI 10.1161/01.ATV.0000164625.93129.64	41	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	FEB	2015	66	2					143	149		10.1177/0003319713516853		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AZ1DL	WOS:000347980400008		
J	Hioki, H; Miyashita, Y; Miura, T; Ebisawa, S; Motoki, H; Izawa, A; Tomita, T; Koyama, J; Ikeda, U				Hioki, Hirofumi; Miyashita, Yusuke; Miura, Takashi; Ebisawa, Souichirou; Motoki, Hirohiko; Izawa, Atsushi; Tomita, Takeshi; Koyama, Jun; Ikeda, Uichi			Prognostic Improvement by Multidisciplinary Therapy in Patients With Critical Limb Ischemia	ANGIOLOGY			English	Article						critical limb ischemia; multidisciplinary therapy	PERIPHERAL ARTERIAL-DISEASE; ENDOVASCULAR TREATMENT; DIABETIC-PATIENTS; RENAL-FUNCTION; FOLLOW-UP; OUTCOMES; FOOT; LESIONS	Although limb salvage rate has improved in critical limb ischemia (CLI), an improvement in CLI prognosis has been scarcely reported. Multidisciplinary therapy (MT) including revascularization, wound bed preparation, treatment of comorbidity, and education of patients with CLI may improve prognosis. The aim of this study was to investigate the effectiveness of MT in prognostic improvement. We retrospectively analyzed 72 patients with CLI and assessed whether MT improved prognosis. The incidence of amputation-free survival (freedom from major amputation [MA] and death) was significantly different between the MT and conventional groups at 2 years (0% vs 33%; P = .024). After multivariate analysis, transfusion (hazard ratio [HR] 5.778; 95% confidence interval [CI], 2.372-14.073; P < .001), multivessel coronary disease (HR 3.353; 95% CI, 1.309-8.590; P = .012), and C-reactive protein >5 mg/dL (HR 3.958; 95% CI, 1.359-11.531; P = .012) were independent predictors for MA or death. We concluded that MT was effective in improved mortality and limb salvage rate.	[Hioki, Hirofumi; Miyashita, Yusuke; Miura, Takashi; Ebisawa, Souichirou; Motoki, Hirohiko; Izawa, Atsushi; Tomita, Takeshi; Koyama, Jun; Ikeda, Uichi] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 3900802, Japan	Hioki, H (reprint author), Shinshu Univ, Sch Med, Dept Cardiovasc Med, 3-1-1 Asahi, Matsumoto, Nagano 3900802, Japan.	hhioki@shinshu-u.ac.jp					Desrosiers J, 2002, DISABIL REHABIL, V24, P774, DOI 10.1080/09638280210125814; Alnaeb ME, 2006, ANGIOLOGY, V57, P65, DOI 10.1177/000331970605700109; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318; Aiello FA, 2012, J VASC SURG, V55, P371, DOI 10.1016/j.jvs.2011.08.044; LARSSON J, 1995, DIABETIC MED, V12, P770; Castronuovo JJ, 1997, J VASC SURG, V26, P629, DOI 10.1016/S0741-5214(97)70062-4; Alexandrescu VA, 2008, J ENDOVASC THER, V15, P580, DOI 10.1583/08-2460.1; Fernandez N, 2011, J VASC SURG, V54, P722, DOI 10.1016/j.jvs.2011.03.232; Cacoub PP, 2009, ATHEROSCLEROSIS, V204, P86; Dohi S, 2012, J CARDIOL, V59, P195, DOI 10.1016/j.jjcc.2011.10.004; Iida O, 2012, EUR J VASC ENDOVASC, V43, P313, DOI 10.1016/j.ejvs.2011.11.025; Nabuurs-Ranssen MH, 2005, DIABETES CARE, V28, P243, DOI 10.2337/diacare.28.2.243; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS1, DOI DOI 10.1016/S1078-5884(07)00246-8.PUBMED:17161778; Schultz Gregory S., 2003, Wound Repair and Regeneration, V11, P1; van Kuijk JP, 2010, EUR HEART J, V31, P992, DOI 10.1093/eurheartj/ehp553; Vig S, 2011, J TISSUE VIABILITY, V20, P1; Willenberg T, J VASC SURG, V53, P1589; Youssef F, 2004, ANGIOLOGY, V55, P53, DOI 10.1177/000331970405500108	19	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	FEB	2015	66	2					187	194		10.1177/0003319714523113		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AZ1DL	WOS:000347980400015		
J	Nagata, N; Niikura, R; Shimbo, T; Ishizuka, N; Yamano, K; Mizuguchi, K; Akiyama, J; Yanase, M; Mizokami, M; Uemura, N				Nagata, Naoyoshi; Niikura, Ryota; Shimbo, Takuro; Ishizuka, Naoki; Yamano, Kazuyoshi; Mizuguchi, Kyoko; Akiyama, Junichi; Yanase, Mikio; Mizokami, Masashi; Uemura, Naomi			High-Dose Barium Impaction Therapy for the Recurrence of Colonic Diverticular Bleeding A Randomized Controlled Trial	ANNALS OF SURGERY			English	Article						barium solution; colonic diverticular hemorrhage; long-term follow up; natural history; preventive therapy	LOWER GASTROINTESTINAL HEMORRHAGE; RISK-FACTORS; URGENT COLONOSCOPY; NATURAL-HISTORY; HOSPITAL STAY; SINGLE-CENTER; ENEMA; MANAGEMENT; DIAGNOSIS; ANGIOGRAPHY	Objective: We compared the clinical efficacy of barium therapy and conservative therapy in preventing recurrence in patients with diverticular bleeding. Background: Previous case reports have indicated that barium impaction therapy provides initial hemostasis for diverticular bleeding and prevention against rebleeding. Methods: After spontaneous cessation of bleeding, patients were randomly assigned to conservative treatment (n = 27) or high-dose barium impaction therapy (n = 27). Patients were followed up for 1 year after enrollment of the last patient. The main outcome measure was rebleeding. Results: Median follow-up period was 584.5 days. The probability of rebleeding at 30-day, 180-day, 1-year, and 2-year follow-up in all patients was 3.7%, 14.8%, 28.4%, and 32.7%, respectively. By group, probability at 1 year was 42.5% in the conservative group and 14.8% in the barium group (log-rank test, P = 0.04). After adjustment for a history of hypertension, the hazard ratio of rebleeding in the barium group was 0.34 (95% confidence interval, 0.12-0.98). No complications or laboratory abnormalities due to barium therapy were observed. Compared with the conservative group, the barium group had significantly (P < 0.05) fewer hospitalizations per patient (1.7 vs 1.2), units of blood transfused (1.9 vs 0.7), colonoscopies (1.4 times vs 1.1 times), and hospital stay days (15 days vs 11 days) during the follow-up period. No patients died and none required angiographic or surgical procedures in either group. Conclusions: High-dose barium impaction therapy was effective in the long-term prevention of recurrent bleeding, and reduced the frequency of rehospitalization and need for blood transfusion and colonoscopic examination.	[Nagata, Naoyoshi; Niikura, Ryota; Akiyama, Junichi; Yanase, Mikio] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo 1628655, Japan; [Shimbo, Takuro; Ishizuka, Naoki] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Res Inst, Tokyo 1628655, Japan; [Yamano, Kazuyoshi] Natl Ctr Global Hlth & Med, Dept Radiol, Tokyo 1628655, Japan; [Mizuguchi, Kyoko] Natl Ctr Global Hlth & Med, Dept Nursing, Tokyo 1628655, Japan; [Mizokami, Masashi; Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			Ministry of Health Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [271000]; Grant of National Center for Global Health and Medicine [22-302]	Supported by a grant-in-aid from the Ministry of Health Labor and Welfare of Japan and a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (271000) and the Grant of National Center for Global Health and Medicine (22-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.	ADAMS JT, 1970, ARCH SURG-CHICAGO, V101, P457; Angtuaco TL, 2001, AM J GASTROENTEROL, V96, P1782, DOI 10.1016/S0002-9270(01)02434-0; Niikura R, 2012, COLORECTAL DIS, V14, P302, DOI 10.1111/j.1463-1318.2011.02611.x; Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x; Kaltenbach T, 2012, CLIN GASTROENTEROL H, V10, P131, DOI 10.1016/j.cgh.2011.10.029; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Fujino Y, 2013, COLORECTAL DIS, V15, P982, DOI 10.1111/codi.12232; Loffeld RJLF, 2011, ENDOSCOPY, V43, P240, DOI 10.1055/s-0030-1255939; Zuckerman GR, 1999, GASTROINTEST ENDOSC, V49, P228, DOI 10.1016/S0016-5107(99)70491-8; Jansen A, 2009, WORLD J GASTROENTERO, V15, P457, DOI 10.3748/wjg.15.457; Ishii N, 2012, GASTROINTEST ENDOSC, V75, P382, DOI 10.1016/j.gie.2011.07.030; Okamoto T, 2012, INT J COLORECTAL DIS, V27, P1161, DOI 10.1007/s00384-012-1491-x; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; Nishikawa H, 2013, ACTA GASTRO-ENT BELG, V76, P20; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Strate LL, 2012, DIGEST DIS, V30, P35, DOI 10.1159/000335707; Poncet G, 2010, ALIMENT PHARM THER, V32, P466, DOI 10.1111/j.1365-2036.2010.04362.x; Niikura R, 2012, INT J COLORECTAL DIS, V27, P1137, DOI 10.1007/s00384-012-1422-x; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Bloomfeld RS, 2001, AM J GASTROENTEROL, V96, P2367, DOI 10.1111/j.1572-0241.2001.04048.x; Yamada A, 2008, DIS COLON RECTUM, V51, P116, DOI 10.1007/s10350-007-9137-8; Strate LL, 2003, AM J GASTROENTEROL, V98, P317, DOI 10.1016/S0002-9270(02)05900-2; Tsuruoka N, 2011, J GASTROEN HEPATOL, V26, P1047, DOI 10.1111/j.1440-1746.2010.06610.x; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Lhewa DY, 2012, WORLD J GASTROENTERO, V18, P1185, DOI 10.3748/wjg.v18.i11.1185; BROWDER W, 1986, ANN SURG, V204, P530, DOI 10.1097/00000658-198611000-00004; Chait Maxwell M, 2010, World J Gastrointest Endosc, V2, P147, DOI 10.4253/wjge.v2.i5.147; Chorost MI, 2001, CLIN RADIOL, V56, P856, DOI 10.1053/crad.2001.0805; FIORITO JJ, 1989, AM J GASTROENTEROL, V84, P878; Fujimoto A, 2011, COLORECTAL DIS, V13, P896, DOI 10.1111/j.1463-1318.2010.02350.x; GUBLER J A, 1954, J Int Coll Surg, V21, P379; Iwamoto J, 2008, WORLD J GASTROENTERO, V14, P6413, DOI 10.3748/wjg.14.6413; Koperna T, 2001, HEPATO-GASTROENTEROL, V48, P702; MAGLINTE DDT, 1981, AM J ROENTGENOL, V137, P529; Matrana Marc R, 2009, Clin Colon Rectal Surg, V22, P141, DOI 10.1055/s-0029-1236157; Matsuhashi N, 2003, AM J ROENTGENOL, V180, P490; MCGUIRE HH, 1972, ANN SURG, V175, P847, DOI 10.1097/00000658-197206010-00004; MCGUIRE HH, 1994, ANN SURG, V220, P653, DOI 10.1097/00000658-199411000-00008; MILLER RE, 1975, RADIOLOGY, V117, P527; Miura S, 1996, INT J COLORECTAL DIS, V11, P71; NOVEROSKE RJ, 1964, AMER J ROENTGENOL RA, V91, P852; Pausawasdi Nonthalee, 2011, Case Rep Gastroenterol, V5, P88, DOI 10.1159/000322911; Schmulewitz N, 2003, GASTROINTEST ENDOSC, V58, P841, DOI 10.1016/S0016-5107(03)02304-6; Williams S M, 1991, Curr Probl Diagn Radiol, V20, P123	44	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	FEB	2015	261	2					269	275		10.1097/SLA.0000000000000658		7	Surgery	Surgery	AY8AP	WOS:000347777100035		
J	Fujita, T				Fujita, Tetsuji			Interpreting Postoperative CRP Response and HLA-DR Depression	ANNALS OF SURGERY			English	Letter							C-REACTIVE PROTEIN; FAST-TRACK; EXPRESSION; SURGERY; LAPAROSCOPY; INFECTION; MONOCYTES; TRIAL		Jikei Univ, Dept Surg, Sch Med, Tokyo, Japan	Fujita, T (reprint author), Jikei Univ, Dept Surg, Sch Med, Tokyo, Japan.						Veenhof AAFA, 2012, ANN SURG, V255, P216, DOI 10.1097/SLA.0b013e31824336e2; MacKay GJ, 2011, COLORECTAL DIS, V13, P583, DOI 10.1111/j.1463-1318.2010.02236.x; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; WAKEFIELD CH, 1993, BRIT J SURG, V80, P205, DOI 10.1002/bjs.1800800224; CHEADLE WG, 1991, AM J SURG, V161, P639, DOI 10.1016/0002-9610(91)91247-G; Handy JM, 2010, ANAESTHESIA, V65, P27, DOI 10.1111/j.1365-2044.2009.06161.x; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Vlug MS, 2011, ANN SURG, V254, P868, DOI 10.1097/SLA.0b013e31821fd1ce; GEWURZ H, 1995, CURR OPIN IMMUNOL, V7, P54, DOI 10.1016/0952-7915(95)80029-8; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Hoffman J A, 2004, Transpl Infect Dis, V6, P147, DOI 10.1111/j.1399-3062.2004.00069.x	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	FEB	2015	261	2					E39	E39		10.1097/SLA.0000000000000876		1	Surgery	Surgery	AY8AP	WOS:000347777100008		
J	Matsuda, A; Miyashita, M; Matsumoto, S; Matsutani, T; Sakurazawa, N; Takahashi, G; Kishi, T; Uchida, E				Matsuda, Akihisa; Miyashita, Masao; Matsumoto, Satoshi; Matsutani, Takeshi; Sakurazawa, Nobuyuki; Takahashi, Goro; Kishi, Taro; Uchida, Eiji			Comparison of Long-Term Outcomes of Colonic Stent as "Bridge to Surgery" and Emergency Surgery for Malignant Large-Bowel Obstruction: A Meta-Analysis	ANNALS OF SURGICAL ONCOLOGY			English	Article							EXPANDING METALLIC STENTS; COLORECTAL-CANCER SURGERY; TUMOR-CELL DISSEMINATION; CLINICAL-TRIALS; MANAGEMENT; INSERTION; RESECTION; COMPLICATIONS; ASSOCIATION; COLONOSCOPY	The short-term safety and efficacy of insertion of a self-expandable metallic colonic stent followed by elective surgery, bridge to surgery (BTS), for malignant large-bowel obstruction (MLBO) have been well described. However, long-term oncological outcomes are still debated. Hence, this study is conducted to evaluate long-term outcomes of colonic stent insertion followed by surgery for MLBO. A comprehensive electronic literature search through May 2014 was performed to identify studies comparing long-term outcomes between BTS and emergency surgery for MLBO. The main outcome measures were overall survival (OS), disease-free survival (DFS), and recurrence. A meta-analysis was performed using random-effects models to calculate risk ratios (RRs) with 95 % confidence intervals (95 % CIs). There were 11 studies that matched the criteria for inclusion, yielding a total of 1136 patients, of whom 432 (38.0 %) underwent BTS and 704 (62.0 %) underwent emergency surgery. In OS analyses of all patients and patients who underwent curative resection, BTS was similar to emergency surgery [(RR = 0.95; 95 % CI 0.75-1.21; P = 0.66) (RR = 0.96; 95 % CI 0.67-1.37; P = 0.82), respectively]. DFS (RR = 1.06; 95 % CI 0.91-1.24; P = 0.43) and recurrence (RR = 1.13; 95 % CI 0.82-1.54; P = 0.46) did not differ significantly between the BTS and emergency surgery groups. Results of this meta-analysis on long-term as well as well-described short-term outcomes suggest that BTS could be a promising alternative strategy for MLBO patients.	[Matsuda, Akihisa; Miyashita, Masao; Matsumoto, Satoshi; Sakurazawa, Nobuyuki; Takahashi, Goro] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, Chiba, Japan; [Matsutani, Takeshi; Uchida, Eiji] Nippon Med Sch, Dept Surg Gastroenterol, Tokyo 113, Japan; [Kishi, Taro] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi, Japan	Matsuda, A (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, Chiba, Japan.	a-matsu@nms.ac.jp					Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Kim HJ, 2013, INT J COLORECTAL DIS, V28, P407, DOI 10.1007/s00384-012-1556-x; Saida Y, 1996, DIS COLON RECTUM, V39, P552, DOI 10.1007/BF02058710; Zhang Y, 2012, SURG ENDOSC, V26, P110, DOI 10.1007/s00464-011-1835-6; Saida Y, 2003, DIS COLON RECTUM, V46, pS44, DOI 10.1097/01.DCR.0000087483.63718.A2; Alcantara M, 2011, WORLD J SURG, V35, P1904, DOI 10.1007/s00268-011-1139-y; Tekkis PP, 2004, ANN SURG, V240, P76, DOI 10.1097/01.sla.0000130723.81866.75; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Cirocchi R, 2013, SURG ONCOL, V22, P14, DOI 10.1016/j.suronc.2012.10.003; Khot UP, 2002, BRIT J SURG, V89, P1096, DOI 10.1046/j.1365-2168.2002.02148.x; Matsuda A, 2009, J SURG RES, V157, P227, DOI 10.1016/j.jss.2008.09.007; RUNKEL NS, 1991, BRIT J SURG, V78, P183, DOI 10.1002/bjs.1800780216; Egger M, 1997, BRIT MED J, V315, P629; Pirlet IA, 2011, SURG ENDOSC, V25, P1814, DOI 10.1007/s00464-010-1471-6; van Hooft JE, 2011, LANCET ONCOL, V12, P344, DOI 10.1016/S1470-2045(11)70035-3; Koch M, 2004, SURG ENDOSC, V18, P587, DOI 10.1007/s00464-003-9066-0; Gianotti L, 2013, SURG ENDOSC, V27, P832, DOI 10.1007/s00464-012-2520-0; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Platt JJ, 2012, ANN SURG ONCOL, V19, P4168, DOI 10.1245/s10434-012-2498-9; Dastur JK, 2008, TECH COLOPROCTOL, V12, P51, DOI 10.1007/s10151-008-0399-5; Tan CJ, 2012, BRIT J SURG, V99, P469, DOI 10.1002/bjs.8689; Choi JM, 2014, SURG ENDOSC, V28, P2649, DOI 10.1007/s00464-014-3517-7; DEANS GT, 1994, BRIT J SURG, V81, P1270, DOI 10.1002/bjs.1800810905; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dohmoto M., 1991, ENDOSCOPIA DIGESTIVA, V3, P1507; Dohmoto M, 1996, EUR J CANCER, V32A, P25, DOI 10.1016/0959-8049(95)00486-6; Gorissen KJ, 2013, BRIT J SURG, V100, P1805, DOI 10.1002/bjs.9297; Huang X, 2014, J GASTROINTEST SURG, V18, P584, DOI 10.1007/s11605-013-2344-9; KORENAGA D, 1991, J SURG ONCOL, V47, P188, DOI 10.1002/jso.2930470310; LUNDY J, 1983, ANN SURG, V197, P434, DOI 10.1097/00000658-198304000-00010; Marudiachalam K, 2007, BRIT J SURG, V94, P1151, DOI 10.1002/bjs.5790; Matsuda A, 2013, ANN SURG ONCOL, V20, P2485, DOI 10.1245/s10434-013-2972-z; Matsuda A, 2007, J SURG RES, V139, P15, DOI 10.1016/j.jss.2006.10.029; Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535; Quereshy FA, 2014, COLORECTAL DIS, V16, P788, DOI 10.1111/codi.12666; Sabbagh C, 2013, SURG ENDOSC, V27, P3622, DOI 10.1007/s00464-013-2934-3; Sabbagh C, 2013, ANN SURG, V258, P107, DOI 10.1097/SLA.0b013e31827e30ce; Tung Karen Lok Man, 2013, Asian J Endosc Surg, V6, P78, DOI 10.1111/ases.12030; Vitale MA, 2006, GASTROINTEST ENDOSC, V63, P814, DOI 10.1016/j.gie.2005.12.032; Xu K, 2010, SHIJIE HUAREN XIAOHU, V18, P736; Yeo HL, 2013, J GASTROINTEST SURG, V17, P2007, DOI 10.1007/s11605-013-2343-x	42	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	FEB	2015	22	2					497	504		10.1245/s10434-014-3997-7		8	Oncology; Surgery	Oncology; Surgery	AY8QH	WOS:000347817900024		
J	Kim, HJ; Choi, GS; Park, JS; Park, S; Kawai, K; Watanabe, T				Kim, Hye Jin; Choi, Gyu-Seog; Park, Jun Seok; Park, SooYeun; Kawai, Kazushige; Watanabe, Toshiaki			Clinical Significance of Thrombocytosis Before Preoperative Chemoradiotherapy in Rectal Cancer: Predicting Pathologic Tumor Response and Oncologic Outcome	ANNALS OF SURGICAL ONCOLOGY			English	Article							CARCINOMA DLD1 CELLS; POOR-PROGNOSIS; CHEMORADIATION; RADIOCHEMOTHERAPY; RADIOTHERAPY; PLATELETS; SURVIVAL; THERAPY; CEA	Thrombocytosis is considered an adverse prognostic factor in various malignancies. However, the clinical significance of thrombocytosis in rectal cancer patients is unknown. We investigated the predictive value of thrombocytosis for pathologic tumor response to preoperative chemoradiotherapy (CRT) and oncologic outcomes in patients with rectal cancer. A total of 314 patients who underwent preoperative CRT and subsequent rectal resection for rectal cancer were retrospectively evaluated at two tertiary institutions. Univariate and multivariate analyses of the clinical parameters were performed to identify markers predictive of a pathologic complete response (pCR). The Kaplan-Meier method was used to estimate 3-year disease-free and overall survival rates. Sixty-nine patients (22 %) had thrombocytosis before CRT, which significantly correlated with a large tumor size and advanced tumor depth. Thirty-nine patients (12.4 %) achieved a pCR. In the multivariate analyses, a platelet count of < 370,000/mu l (odds ratio 5.483; 95 % confidence interval, 1.271-23.653; P = 0.023) and a carcinoembryonic antigen (CEA) level of < 5 ng/dl (odds ratio, 3.084; 95 % confidence interval, 1.291-7.368; P = 0.011) were identified as independent predictive factors for a pCR. Patients with pretreatment thrombocytosis had lower 3-year disease-free (P = 0.037) and overall survival (P = 0.001) rates than patients with normal pretreatment platelet counts. Thrombocytosis is a negative predictive factor for a pCR and has an adverse impact on survival in rectal cancer. The predictive value of this easily available clinical factor should not be underestimated, and better therapeutic strategies for these tumors are required.	[Kim, Hye Jin; Choi, Gyu-Seog; Park, Jun Seok; Park, SooYeun] Kyungpook Natl Univ, Med Ctr, Sch Med, Colorectal Canc Ctr, Taegu, South Korea; [Kawai, Kazushige; Watanabe, Toshiaki] Univ Tokyo, Fac Med, Dept Surg Oncol, Tokyo 113, Japan	Choi, GS (reprint author), Kyungpook Natl Univ, Med Ctr, Sch Med, Colorectal Canc Ctr, Taegu, South Korea.	kyuschoi@mail.knu.ac.kr; toshwatanabe@yahoo.co.jp					Restivo A, 2013, ANN SURG ONCOL, V20, P864, DOI 10.1245/s10434-012-2669-8; Nieswandt B, 1999, CANCER RES, V59, P1295; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Negri FV, 2008, BRIT J CANCER, V98, P143, DOI 10.1038/sj.bjc.6604131; Huh JW, 2013, DIS COLON RECTUM, V56, P698, DOI 10.1097/DCR.0b013e3182837e5b; Shimada H, 2004, J AM COLL SURGEONS, V198, P737, DOI 10.1016/j.jamcollsurg.2004.01.022; Shida D, 2003, CANCER RES, V63, P1706; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Buergy D, 2012, INT J CANCER, V130, P2747, DOI 10.1002/ijc.27441; Verheul HMW, 2000, BLOOD, V96, P4216; Jurasz P, 2004, BRIT J PHARMACOL, V143, P819, DOI 10.1038/sj.bjp.0706013; Wallin U, 2013, DIS COLON RECTUM, V56, P859, DOI 10.1097/DCR.0b013e31828e5a72; Kawai K, 2013, INT J COLORECTAL DIS, V28, P527, DOI 10.1007/s00384-012-1594-4; Watanabe T, 2006, CANCER RES, V66, P3370, DOI 10.1158/0008-5472.CAN-05-3834; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Kuremsky JG, 2009, INT J RADIAT ONCOL, V74, P673, DOI 10.1016/j.ijrobp.2009.03.003; Park JS, 2011, ANN SURG, V254, P941, DOI 10.1097/SLA.0b013e318236c448; Das P, 2007, CANCER, V109, P1750, DOI 10.1002/cncr.22625; Ikeda M, 2002, ANN SURG ONCOL, V9, P287, DOI 10.1245/aso.2002.9.3.287; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Ishizuka M, 2012, J SURG ONCOL, V106, P887, DOI 10.1002/jso.23163; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Mori K, 2006, J SURG RES, V132, P56, DOI 10.1016/j.jss.2005.07.040; Placke T, 2011, J INNATE IMMUN, V3, P374, DOI 10.1159/000323936; Sasaki K, 2012, WORLD J SURG, V36, P192, DOI 10.1007/s00268-011-1329-7; Song SS, 2012, ANN SURG ONCOL, V19, P2471, DOI 10.1245/s10434-012-2266-x; Tomita Masaki, 2008, Interact Cardiovasc Thorac Surg, V7, P613, DOI 10.1510/icvts.2007.174391; Troxler M, 2007, BRIT J SURG, V94, P674, DOI 10.1002/bjs.5852	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	FEB	2015	22	2					513	519		10.1245/s10434-014-3988-8		7	Oncology; Surgery	Oncology; Surgery	AY8QH	WOS:000347817900026		
J	Sugimoto, K; Sakamoto, K; Tomiki, Y; Goto, M; Kotake, K; Sugihara, K				Sugimoto, Kiichi; Sakamoto, Kazuhiro; Tomiki, Yuichi; Goto, Michitoshi; Kotake, Kenjiro; Sugihara, Kenichi			Proposal of New Classification for Stage III Colon Cancer Based on the Lymph Node Ratio: Analysis of 4,172 Patients from Multi-Institutional Database in Japan	ANNALS OF SURGICAL ONCOLOGY			English	Article							COLORECTAL-CANCER; RECTAL-CANCER; PROGNOSIS; SURVIVAL; NUMBER; CATEGORIZATION; RESECTION; OUTCOMES; QUALITY; SYSTEM	We retrospectively examined the optimal lymph node ratio (LNR) cutoff value and attempted to construct a new classification using the LNR in stage III colon cancer. The clinical and pathological data of 4,172 patients with histologically proven lymph node metastasis who underwent curative surgery for primary colon cancer at multiple institutions between 1995 and 2004 were derived from the multi-institutional database of the Japanese Society for Cancer of the Colon and Rectum (JSCCR). We determined independent prognostic factors and constructed a new classification using these factors. Finally, we compared the discriminatory ability between the new classification and the TNM seventh edition (TNM 7th) classification. The optimal LNR cutoff value was 0.18. Multivariate analysis revealed that year of surgery, age, gender, histological type, TNM 7th T category, lymphatic invasion, venous invasion, TNM 7th N category, and LNR were found to be significant independent prognostic factors. We attempted to construct a new classification based on the combination of TNM 7th T category and LNR. As a result, the cancer-specific survivals were well stratified (P < .0001). According to the Akaike's information criteria value, the new classification was judged to be superior to the TNM 7th classification with respect to both a better fit and lower complexity. The optimal LNR cutoff value that was found using the Japanese multi-institutional database and the new classification using LNR are considered to be extremely significant. Therefore, these findings strongly support the application of LNR in the stage classification in stage III colon cancer.	[Sugimoto, Kiichi; Sakamoto, Kazuhiro; Tomiki, Yuichi; Goto, Michitoshi] Juntendo Univ, Fac Med, Dept Coloproctol Surg, Tokyo, Japan; [Kotake, Kenjiro] Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan; [Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Grad Sch, Tokyo, Japan	Sugimoto, K (reprint author), Juntendo Univ, Fac Med, Dept Coloproctol Surg, Tokyo, Japan.	ksugimo@juntendo.co.jp					Akaike H., 1973, 2 INT S INF THEOR, P267; Zhang JZ, 2013, J CANCER RES CLIN, V139, P1947, DOI 10.1007/s00432-013-1525-y; George S, 2006, BRIT J CANCER, V95, P841, DOI 10.1038/sjbjc.6603352; Gunderson LL, 2010, J CLIN ONCOL, V28, P256, DOI 10.1200/JCO.2009.23.9194; West NP, 2012, J CLIN ONCOL, V30, P1763, DOI 10.1200/JCO.2011.38.3992; Ceelen W, 2010, ANN SURG ONCOL, V17, P2847, DOI 10.1245/s10434-010-1158-1; Wang JP, 2008, ANN SURG ONCOL, V15, P1600, DOI 10.1245/s10434-007-9716-x; Kotake K, 2012, JPN J CLIN ONCOL, V42, P29, DOI 10.1093/jjco/hyr164; DUKES CE, 1958, BRIT J CANCER, V12, P309, DOI 10.1038/bjc.1958.37; Gunderson LL, 2010, J CLIN ONCOL, V28, P264, DOI 10.1200/JCO.2009.24.0952; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Resch A, 2013, WORLD J GASTROENTERO, V19, P8515, DOI 10.3748/wjg.v19.i46.8515; Moug SJ, 2009, BRIT J CANCER, V100, P1530, DOI 10.1038/sj.bjc.6605049; Chapuis PH, 2004, BRIT J SURG, V91, P349, DOI 10.1002/bjs.4389; Govindarajan A, 2013, ANN SURG ONCOL, V20, P3357, DOI 10.1245/s10434-013-3012-8; Kobayashi H, 2011, INT J COLORECTAL DIS, V26, P891, DOI 10.1007/s00384-011-1173-0; Kobayashi Hirotoshi, 2014, Ann Surg Oncol, V21 Suppl 3, pS398, DOI 10.1245/s10434-014-3578-9; Mori T, 2010, CANCER INVEST, V28, P387, DOI 10.3109/07357900903287055; Namm J, 2008, J AM COLL SURGEONS, V207, P882, DOI 10.1016/j.jamcollsurg.2008.08.019; Petrelli F, 2011, EJSO-EUR J SURG ONC, V37, P836, DOI 10.1016/j.ejso.2011.07.008; Priolli DG, 2009, TECH COLOPROCTOL, V13, P113, DOI 10.1007/s10151-009-0467-5; Schiffmann L, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-79; Schumacher P, 2007, AM J SURG, V194, P827, DOI 10.1016/j.amjsurg.2007.08.030; Sobin LH, 2009, TNM CLASSIFICATION M; Sugimoto K, 2013, DIGEST SURG, V30, P368, DOI 10.1159/000355444; Vaccaro CA, 2009, DIS COLON RECTUM, V52, P1244, DOI 10.1007/DCR.0b013e3181a65f0b; Wang JP, 2009, ANN SURG, V249, P559, DOI 10.1097/SLA.0b013e318197f2c8; Wang LP, 2013, WORLD J SURG, V37, P1094, DOI 10.1007/s00268-013-1940-x	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	FEB	2015	22	2					528	534		10.1245/s10434-014-4015-9		7	Oncology; Surgery	Oncology; Surgery	AY8QH	WOS:000347817900028		
J	Matsuda, S; Tsubosa, Y; Niihara, M; Sato, H; Takebayashi, K; Kawamorita, K; Mori, K; Tsushima, T; Yasui, H; Takeuchi, H; Kitagawa, Y				Matsuda, Satoru; Tsubosa, Yasuhiro; Niihara, Masahiro; Sato, Hiroshi; Takebayashi, Katsushi; Kawamorita, Keisuke; Mori, Keita; Tsushima, Takahiro; Yasui, Hirofumi; Takeuchi, Hiroya; Kitagawa, Yuko			Distribution of Lymph Node Metastasis and Clinical Validity of Gastric Tube Reconstruction in Lower Thoracic Esophageal Squamous Cell Carcinoma with Gastric Invasion	ANNALS OF SURGICAL ONCOLOGY			English	Article							ESOPHAGOGASTRIC JUNCTION; SURGICAL-TREATMENT; CANCER; ADENOCARCINOMA; STOMACH; CLASSIFICATION; INVOLVEMENT	The distribution of lymph node (LN) metastases of esophageal squamous cell carcinoma (SCC) with gastric invasion remains unclear. The purpose of this study was to clarify the relationship between gastric invasion and abdominal LN metastasis in patients with esophageal SCC. Furthermore, the clinical validity of gastric tube reconstruction for those with gastric invasion was investigated. Patients who underwent subtotal esophagectomy at our institution were reviewed. Gastric invasion was evaluated with pretreatment upper gastrointestinal endoscopy and classified into 3 groups: no invasion, Gr 0; slight invasion (0-19 mm), Gr 1; and massive invasion (20 mm or longer), Gr 2. The correlations between gastric invasion, the number of abdominal LN metastases, and postoperative recurrence were investigated. Of 79 patients, the distribution of pretreatment gastric invasion was Gr 0, 1, and 2 in 57, 15, and 7 patients, respectively. All patients underwent subtotal esophagectomy with gastric tube reconstruction. There was no significant difference in the number of abdominal LN metastases among groups. In survival analysis, the location of the distal end of the tumor was not a predictive factor for postoperative recurrence. Regarding patterns of recurrence, in patients with gastric invasion, there was no remarkable increase in the frequency of recurrence in the abdominal LNs or the regional LNs around the gastric tube. Pretreatment gastric invasion did not significantly influence abdominal LN metastasis and postoperative recurrence. In patients with esophageal SCC at the lower thoracic esophagus with gastric invasion, subtotal esophagectomy with gastric tube reconstruction might be a valid surgical procedure.	[Matsuda, Satoru; Tsubosa, Yasuhiro; Niihara, Masahiro; Takebayashi, Katsushi; Kawamorita, Keisuke] Shizuoka Canc Ctr Hosp, Div Esophageal Surg, Shizuoka, Japan; [Sato, Hiroshi] Saitama Univ, Int Med Ctr, Dept Surg, Div Upper Gastrointestinal Tract, Saitama 3388570, Japan; [Mori, Keita] Shizuoka Canc Ctr Hosp, Clin Trial Coordinat Off, Shizuoka, Japan; [Tsushima, Takahiro; Yasui, Hirofumi] Shizuoka Canc Ctr Hosp, Div Gastrointestinal Oncol, Shizuoka, Japan; [Takeuchi, Hiroya; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan	Tsubosa, Y (reprint author), Shizuoka Canc Ctr Hosp, Div Esophageal Surg, Shizuoka, Japan.	y.tsubosa@scchr.jp					Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Kakeji Y, 2012, SURG TODAY, V42, P351, DOI 10.1007/s00595-011-0114-4; Lorenzen S, 2013, BRIT J CANCER, V108, P519, DOI 10.1038/bjc.2012.588; Siewert JR, 1998, BRIT J SURG, V85, P1457; Kesler KA, 2013, ANN THORAC SURG, V95, P1162, DOI 10.1016/j.athoracsur.2013.01.006; Doki Y, 2003, SURGERY, V133, P479, DOI 10.1067/msy.2003.134; Hu H, 2012, EUR J CARDIO-THORAC, V42, P359, DOI 10.1093/ejcts/ezs015; KUWANO H, 1992, BRIT J SURG, V79, P328, DOI 10.1002/bjs.1800790415; MAETA M, 1988, J SURG ONCOL, V38, P143, DOI 10.1002/jso.2930380303; Mine S, 2014, ANN SURG ONCOL, V21, P1596, DOI 10.1245/s10434-014-3548-2; Okumura Y, 2014, SURG TODAY, V44, P395, DOI 10.1007/s00595-013-0797-9; Ozawa S, 2002, ESOPHAGUS, V7, P7; Siewert JR, 2000, ANN SURG, V232, P353; SAITO T, 1985, CANCER, V56, P2235, DOI 10.1002/1097-0142(19851101)56:9<2235::AID-CNCR2820560917>3.0.CO;2-0; Yabusaki H, 2014, SURG TODAY, V44, P1522, DOI 10.1007/s00595-013-0773-4	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	FEB	2015	22	2					617	623		10.1245/s10434-014-4017-7		7	Oncology; Surgery	Oncology; Surgery	AY8QH	WOS:000347817900041		
J	Yamamoto, T; Sugiura, T; Mizuno, T; Okamura, Y; Aramaki, T; Endo, M; Uesaka, K				Yamamoto, Tatsuma; Sugiura, Teiichi; Mizuno, Takashi; Okamura, Yukiyasu; Aramaki, Takeshi; Endo, Masahiro; Uesaka, Katsuhiko			Preoperative FDG-PET Predicts Early Recurrence and a Poor Prognosis After Resection of Pancreatic Adenocarcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; LYMPH-NODE RATIO; NEOADJUVANT CHEMOTHERAPY; CHEMORADIATION THERAPY; SERUM CA19-9; CANCER; SURVIVAL; CARCINOMA; GEMCITABINE	The aim of this study was to evaluate the clinical utility of preoperative 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) as a prognostic predictor of resectable pancreatic adenocarcinoma. A total of 128 patients with resected pancreatic adenocarcinoma who preoperatively underwent FDG-PET examinations were studied. The maximum standard uptake value (SUVmax) was calculated for each primary lesion. A receiver operating characteristics (ROC) curve was constructed to estimate the optimal cutoff value of the SUVmax. In order to determine which outcomes of interest were appropriately demonstrated, ROC curve analyses were conducted for six outcomes: 6-, 12-, and 24-month disease-free survival (DFS), and 6-, 12-, and 24-month overall survival (OS). A multivariate analysis was conducted to identify prognostic factors. The ROC curves revealed that the SUVmax predicted the 6-month DFS most optimally (area under the curve 0.757), with a cutoff value of 6.0. Of the 69 patients with an SUVmax a parts per thousand yen 6.0, 34 (49 %) developed recurrence within 6 months. In contrast, only 3 of 59 (5 %) patients with an SUVmax < 6.0 exhibited early recurrence (p < 0.001). The median OS time was 37 months in patients with an SUVmax < 6.0 and 18 months in patients with an SUVmax a parts per thousand yen 6.0 (p < 0.001). The multivariate analysis revealed lymph node metastasis (hazard ratio [HR] 2.31; p = 0.001) and an SUVmax a parts per thousand yen 6.0 (HR 2.05; p = 0.002) to be significantly correlated with a poor survival. An SUVmax a parts per thousand yen 6.0 was a significant predictor of early postoperative recurrence and subsequent poor survival following resection of pancreatic adenocarcinoma.	[Yamamoto, Tatsuma; Sugiura, Teiichi; Mizuno, Takashi; Okamura, Yukiyasu; Uesaka, Katsuhiko] Shizuoka Canc Ctr, Div Hepatobiliary Pancreat Surg, Shizuoka, Japan; [Aramaki, Takeshi; Endo, Masahiro] Shizuoka Canc Ctr, Div Diagnost Radiol, Shizuoka, Japan	Sugiura, T (reprint author), Shizuoka Canc Ctr, Div Hepatobiliary Pancreat Surg, Shizuoka, Japan.	t.sugiura@scchr.jp					American College of Radiology, 2007, ACR PRACT GUID PERF; Diederichs CG, 1998, J NUCL MED, V39, P1030; Nakata B, 2001, INT J ONCOL, V19, P53; Furukawa H, 2009, J SURG ONCOL, V100, P494, DOI 10.1002/jso.21356; Heinrich S, 2005, ANN SURG, V242, P235, DOI 10.1097/01.sla.0000172095.97787.84; Schellenberg D, 2010, INT J RADIAT ONCOL, V77, P1420, DOI 10.1016/j.ijrobp.2009.06.049; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201; Ruf J, 2005, PANCREATOLOGY, V5, P266, DOI 10.1159/000085281; Maemura K, 2006, J HEPATO-BILIARY-PAN, V13, P435, DOI 10.1007/s00534-006-1102-8; Slidell MB, 2008, ANN SURG ONCOL, V15, P165, DOI 10.1245/s10434-007-9587-1; Pedrazzoli S, 2011, ANN SURG, V254, P971, DOI 10.1097/SLA.0b013e3182383137; Motoi F, 2013, ANN SURG ONCOL, V20, P3794, DOI 10.1245/s10434-013-3129-9; Riediger H, 2009, J GASTROINTEST SURG, V13, P1337, DOI 10.1007/s11605-009-0919-2; Pawlik TM, 2007, SURGERY, V141, P610, DOI 10.1016/j.surg.2006.12.013; Takahashi H, 2010, ANN SURG, V251, P461, DOI 10.1097/SLA.0b013e3181cc90a3; Heinrich S, 2008, ANN SURG, V248, P1014, DOI 10.1097/SLA.0b013e318190a6da; Shimada K, 2011, PANCREAS, V40, P464, DOI 10.1097/MPA.0b013e31820b5d37; Sugiura T, 2012, J GASTROINTEST SURG, V16, P977, DOI 10.1007/s11605-012-1859-9; Massucco P, 2009, ANN SURG ONCOL, V16, P3323, DOI 10.1245/s10434-009-0672-5; Takahashi H, 2013, ANN SURG, V258, P1040, DOI 10.1097/SLA.0b013e31829b3ce4; Oshida M, 1998, CANCER, V82, P2227, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W; Higashi K, 2000, NUCL MED COMMUN, V21, P707, DOI 10.1097/00006231-200008000-00002; Hatano E, 2006, WORLD J SURG, V30, P1736, DOI 10.1007/s00268-005-0791-5; Hallemeier Christopher L, 2011, Am J Clin Oncol, V34, P567, DOI 10.1097/COC.0b013e3181f946fc; Kato K, 2009, PANCREAS, V38, P605, DOI 10.1097/MPA.0b013e3181a4891d; Murakami Y, 2010, J AM COLL SURGEONS, V211, P196, DOI 10.1016/j.jamcollsurg.2010.03.037; Nakata B, 1997, CANCER, V79, P695, DOI 10.1002/(SICI)1097-0142(19970215)79:4<695::AID-CNCR6>3.0.CO;2-D; Okamoto K, 2011, INT J CLIN ONCOL, V16, P39, DOI 10.1007/s10147-010-0124-z; Sobin LH, 2009, TNM CLASSIFICATION M; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; van Westreenen HL, 2005, AM J ROENTGENOL, V185, P436; Waraya M, 2009, ANN SURG ONCOL, V16, P1231, DOI 10.1245/s10434-009-0415-7; Yamazoe Y, 1992, Surg Oncol, V1, P237, DOI 10.1016/0960-7404(92)90070-2; Zimny M, 2000, SCAND J GASTROENTERO, V35, P883	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	FEB	2015	22	2					677	684		10.1245/s10434-014-4046-2		8	Oncology; Surgery	Oncology; Surgery	AY8QH	WOS:000347817900050		
J	Tanaka, Y; Hirata, S; Kubo, S; Fukuyo, S; Hanami, K; Sawamukai, N; Nakano, K; Nakayamada, S; Yamaoka, K; Sawamura, F; Saito, K				Tanaka, Yoshiya; Hirata, Shintaro; Kubo, Satoshi; Fukuyo, Shunsuke; Hanami, Kentaro; Sawamukai, Norifumi; Nakano, Kazuhisa; Nakayamada, Shingo; Yamaoka, Kunihiro; Sawamura, Fusae; Saito, Kazuyoshi			Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study	ANNALS OF THE RHEUMATIC DISEASES			English	Article							CONTROLLED-TRIAL; DISEASE-ACTIVITY; METHOTREXATE; MECHANISMS; INFLIXIMAB; INDUCTION; THERAPY; RISK	Objectives To investigate the possibility of discontinuing adalimumab (ADA) for 1 year without flaring (DAS28-erythrocyte sedimentation rate (ESR) >= 3.2), and to identify factors enabling established patients with rheumatoid arthritis (RA) to remain ADA-free. Methods Of 197 RA patients treated with ADA +methotrexate (MTX), 75 patients who met the ADA-free criteria (steroid-free and sustained DAS28-ESR remission for 6 months with stable MTX doses) were studied for 1 year. Results The mean disease duration and DAS28-ESR score in 75 patients was 7.5 years and 5.1 at baseline, respectively. The proportion of patients who sustained DAS28-ESR <2.6 (48%) and DAS28-ESR <3.2 (62%) for 1 year were significantly lower in the ADA discontinuation group than in the ADA continuation group; however, in patients with deep remission (DAS28-ESR <= 1.98) identified by receiver operating characteristics analysis following logistic analysis, these rates increased to 68% and 79%, respectively, with no significant difference between both groups. Remarkably, ADA readministration to patients with flare was effective in returning DAS28-ESR to <3.2 within 6 months in 90% and 9 months in 100% patients; among the patients who sustained DAS28-ESR <3.2 during ADA discontinuation, 100% remained in structural remission and 94% in functional remission. Conclusions The possibility of remaining ADA-free for 1 year was demonstrated in established patients with RA with outcomes that ADA can be discontinued without flaring in 79% patients with deep remission, with similar rates in the ADA continuation group, and showed no functional or structural damage in patients with DAS28-ESR <3.2. ADA readministration to patients with flare during ADA discontinuation was effective.	[Tanaka, Yoshiya; Hirata, Shintaro; Kubo, Satoshi; Fukuyo, Shunsuke; Hanami, Kentaro; Sawamukai, Norifumi; Nakano, Kazuhisa; Nakayamada, Shingo; Yamaoka, Kunihiro; Saito, Kazuyoshi] Univ Occupat & Environm Hlth, Dept Internal Med 1, Sch Med, Kitakyushu, Fukuoka 8078555, Japan; [Sawamura, Fusae] AbbVie GK, Dept Med, Tokyo, Japan	Tanaka, Y (reprint author), Univ Occupat & Environm Hlth, Dept Internal Med 1, Sch Med, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; University of Occupational and Environmental Health, Japan	The series of studies were supported in part by a Research Grant-In-Aid for Scientific Research by the Ministry of Health, Labour and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the University of Occupational and Environmental Health, Japan. Although F Sawamura is an AbbVie employee, AbbVie had no role in funding this study or in the data collection or analysis. Other than F Sawamura's contributions to meet the International Committee of Medical Journal Editors (ICMJE) authorship criteria, no other AbbVie employee had input to the content of the publication.	Aaltonen KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030275; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Tanaka Y, 2010, ANN RHEUM DIS, V69, P1286, DOI 10.1136/ard.2009.121491; Pope RM, 2002, NAT REV IMMUNOL, V2, P527, DOI 10.1038/nri846; Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Tanaka Y, 2012, CURR OPIN RHEUMATOL, V24, P319, DOI 10.1097/BOR.0b013e3283524e4c; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Mitoma H, 2008, ARTHRITIS RHEUM, V58, P1248, DOI 10.1002/art.23447; van der Heijde D, 2000, J RHEUMATOL, V27, P261; Quinn MA, 2005, ARTHRITIS RHEUM, V52, P27, DOI 10.1002/art.20712; Detert J, 2013, ANN RHEUM DIS, V72, P844, DOI 10.1136/annrheumdis-2012-201612; Arnett FC, 1987, ARTHRITIS RHEUM; Choy EHS, 2001, NEW ENGL J MED, V344, P907; Clark DA, 2013, INFLAMMOPHARMACOLOGY, V21, P125, DOI 10.1007/s10787-012-0158-0; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM, V52, P3381, DOI 10.1002/art.21405; Japan College of Rheumatology, 2012, OFF GUID US ANT AG R; Koike Ryuji, 2007, Mod Rheumatol, V17, P451, DOI 10.1007/s10165-007-0626-3; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Takeuchi T, 2012, MOD RHEUMATOL, V22, P327, DOI 10.1007/s10165-011-0516-6; Wong AK, 2012, CLIN RHEUMATOL, V31, P631, DOI 10.1007/s10067-011-1895-y	22	11	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	FEB	2015	74	2					389	395		10.1136/annrheumdis-2013-204016		7	Rheumatology	Rheumatology	AY3BA	WOS:000347458300012		
J	Kawato, Y; Yasuike, M; Nakamura, Y; Shigenobu, Y; Fujiwara, A; Sano, M; Nakai, T				Kawato, Yasuhiko; Yasuike, Motoshige; Nakamura, Yoji; Shigenobu, Yuya; Fujiwara, Atushi; Sano, Motohiko; Nakai, Toshihiro			Complete Genome Sequence Analysis of Two Pseudomonas plecoglossicida Phages, Potential Therapeutic Agents	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							BACTERIAL HEMORRHAGIC ASCITES; VIBRIO-HARVEYI BACTERIOPHAGE; COMPLETE NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI DIARRHEA; AYU; ALTIVELIS; VIRULENCE; CALVES; TOXIN; INFECTIONS	Pseudomonas plecoglossicida is a lethal pathogen of ayu (Plecoglossus altivelis) in Japan and is responsible for substantial economic costs to ayu culture. Previously, we demonstrated the efficacy of phage therapy against P. plecoglossicida infection using two lytic phages (PPpW-3 and PPpW-4) (S. C. Park, I. Shimamura, M. Fukunaga, K. Mori, and T. Nakai, Appl Environ Microbiol 66:1416-1422, 2000, http://dx.doi.org/10.1128/AEM.66.4.1416-1422.2000; S. C. Park and T. Nakai, Dis Aquat Org 53:33-39, 2003, http://dx.doi.org/10.3354/dao053033). In the present study, the complete genome sequences of these therapeutic P. plecoglossicida phages were determined and analyzed for deleterious factors as therapeutic agents. The genome of PPpW-3 (myovirus) consisted of 43,564 bp with a GC content of 61.1% and 66 predicted open reading frames (ORFs). Approximately half of the genes were similar to the genes of the Escherichia coli phage vB_EcoM_ECO1230-10 (myovirus). The genome of PPpW-4 (podovirus) consisted of 41,386 bp with a GC content of 56.8% and 50 predicted ORFs. More than 70% of the genes were similar to the genes of Pseudomonas fluorescens phage phi IBB-PF7A and Pseudomonas putida phage phi 15 (podoviruses). The whole-genome analysis revealed that no known virulence genes were present in PPpW-3 and PPpW-4. An integrase gene was found in PPpW-3, but other factors used for lysogeny were not confirmed. The PCR detection of phage genes in phage-resistant variants provided no evidence of lysogenic activity in PPpW-3 and PPpW-4. We conclude that these two lytic phages qualify as therapeutic agents.	[Kawato, Yasuhiko; Nakai, Toshihiro] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan; [Yasuike, Motoshige; Nakamura, Yoji; Fujiwara, Atushi; Sano, Motohiko] Fisheries Res Agcy, Res Ctr Aquat Genom, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Shigenobu, Yuya] Fisheries Res Agcy, Res Ctr Fisheries Oceanog & Marine Ecosyst, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan	Kawato, Y (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan.	ykawato@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This study was partly supported by a special grant from the Ministry of Agriculture, Forestry and Fisheries of Japan.	OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; YOUNG RY, 1992, MICROBIOL REV, V56, P430; Park SC, 2003, DIS AQUAT ORGAN, V53, P33, DOI 10.3354/dao053033; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Nakai T, 1999, DIS AQUAT ORGAN, V37, P33, DOI 10.3354/dao037033; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; Park SC, 2000, APPL ENVIRON MICROB, V66, P1416, DOI 10.1128/AEM.66.4.1416-1422.2000; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Koskella B, 2013, VIRUSES-BASEL, V5, P806, DOI 10.3390/v5030806; SMITH HW, 1987, J GEN MICROBIOL, V133, P1127; Karunasagar I, 2007, AQUACULTURE, V268, P288, DOI 10.1016/j.aquaculture.2007.04.049; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Vinod MG, 2006, AQUACULTURE, V255, P117, DOI 10.1016/j.aquaculture.2005.12.003; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Oakey HJ, 2002, J APPL MICROBIOL, V93, P1089, DOI 10.1046/j.1365-2672.2002.01776.x; Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69; Nishimori E, 2000, INT J SYST EVOL MICR, V50, P83; Verner-Jeffreys DW, 2007, AQUACULTURE, V270, P475, DOI 10.1016/j.aquaculture.2007.05.023; Barrow PA, 1997, TRENDS MICROBIOL, V5, P268, DOI 10.1016/S0966-842X(97)01054-8; Carlson K, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P437; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; Delcher AL, 2007, BIOINFORMATICS; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Izumi S, 2007, J FISH DIS, V30, P391, DOI 10.1111/j.1365-2761.2007.00820.x; Kawato Y, 2012, FISH PATHOL, V47, P1; Khemayan K, 2006, APPL ENVIRON MICROB, V72, P1355, DOI 10.1128/AEM.72.2.1355-1363.2006; Khemayan K, 2012, APPL ENVIRON MICROB, V78, P2790, DOI 10.1128/AEM.05929-11; Laanto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053157; Lavigne R, 2012, VIRUS TAXONOMY CLASS, P46; Matsuoka S, 2007, FISH PATHOL, V42, P181, DOI 10.3147/jsfp.42.181; MEADEN S, 2013, FRONT MICROBIOL, V4, DOI DOI 10.3389/FMICB; Munro J, 2003, DIS AQUAT ORGAN, V54, P187, DOI 10.3354/dao054187; Nakai T., 2010, Bacteriophages in the control of food- and waterborne pathogens, P257; Nakatsugawa T, 1996, FISH PATHOL, V31, P221; Oakey HJ, 2000, J APPL MICROBIOL, V89, P702, DOI 10.1046/j.1365-2672.2000.01169.x; Rozen S, 2000, BIOINFORMATICS METHO, V132, P365; Ruangpan L, 1999, DIS AQUAT ORGAN, V35, P195, DOI 10.3354/dao035195; Sambrook J, 2001, MOL CLONING LAB MANU; Santos TMA, 2011, VET MICROBIOL, V148, P267, DOI 10.1016/j.vetmic.2010.08.034; Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-80; Sillankorva S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-142; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Wakabayashi H, 1996, FISH PATHOL, V31, P239	52	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	FEB	2015	81	3					874	881		10.1128/AEM.03038-14		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AZ0CU	WOS:000347914800008		
J	Tajima, Y; Yamamoto, Y; Fukui, K; Nishio, Y; Hashiguchi, K; Usuda, Y; Sode, K				Tajima, Yoshinori; Yamamoto, Yoko; Fukui, Keita; Nishio, Yousuke; Hashiguchi, Kenichi; Usuda, Yoshihiro; Sode, Koji			Effects of Eliminating Pyruvate Node Pathways and of Coexpression of Heterogeneous Carboxylation Enzymes on Succinate Production by Enterobacter aerogenes	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							ESCHERICHIA-COLI STRAINS; ACID PRODUCTION; CORYNEBACTERIUM-GLUTAMICUM; ANAEROBIC METABOLISM; OVEREXPRESSION; GLUCOSE; SUCCINICIPRODUCENS; DEHYDROGENASE; FERMENTATION; EXPRESSION	Lowering the pH in bacterium-based succinate fermentation is considered a feasible approach to reduce total production costs. Newly isolated Enterobacter aerogenes strain AJ110637, a rapid carbon source assimilator under weakly acidic (pH 5.0) conditions, was selected as a platform for succinate production. Our previous work showed that the Delta adhE/PCK strain, developed from AJ110637 with inactivated ethanol dehydrogenase and introduced Actinobacillus succinogenes phosphoenolpyruvate carboxykinase (PCK), generated succinate as a major product of anaerobic mixed-acid fermentation from glucose under weakly acidic conditions (pH <6.2). To further improve the production of succinate by the Delta adhE/PCK strain, metabolically engineered strains were designed based on the elimination of pathways that produced undesirable products and the introduction of two carboxylation pathways from phosphoenolpyruvate and pyruvate to oxaloacetate. The highest production of succinate was observed with strain ES04/PCK+PYC, which had inactivated ethanol, lactate, acetate, and 2,3-butanediol pathways and coexpressed PCK and Corynebacterium glutamicum pyruvate carboxylase (PYC). This strain produced succinate from glucose with over 70% yield (gram per gram) without any measurable formation of ethanol, lactate, or 2,3-butanediol under weakly acidic conditions. The impact of lowering the pH from 7.0 to 5.5 on succinate production in this strain was evaluated under pH-controlled batch culture conditions and showed that the lower pH decreased the succinate titer but increased its yield. These findings can be applied to identify additional engineering targets to increase succinate production.	[Tajima, Yoshinori; Yamamoto, Yoko; Fukui, Keita; Nishio, Yousuke; Usuda, Yoshihiro] Ajinomoto Co Inc, Inst Innovat, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Hashiguchi, Kenichi] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Sode, Koji] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol, Koganei, Tokyo, Japan	Tajima, Y (reprint author), Ajinomoto Co Inc, Inst Innovat, Kawasaki Ku, Kawasaki, Kanagawa, Japan.	yoshinori_tajima@ajinomoto.com	Sode, Koji/F-6914-2013		Ajinomoto Co., Inc.	This study was funded by Ajinomoto Co., Inc. No external funds were used.	Lin H, 2005, APPL MICROBIOL BIOT, V67, P515, DOI 10.1007/s00253-004-1789-x; Shin SH, 2012, J BACTERIOL, V194, P2373, DOI 10.1128/JB.00028-12; Buschke N, 2013, BIORESOURCE TECHNOL, V135, P544, DOI 10.1016/j.biortech.2012.11.047; Martinez I, 2011, BIOTECHNOL PROGR, V27, P1225, DOI 10.1002/btpr.641; Warnecke T, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-25; Cheng KK, 2012, APPL MICROBIOL BIOT, V95, P841, DOI 10.1007/s00253-012-4214-x; VanderWerf MJ, 1997, ARCH MICROBIOL, V167, P332; Sanchez AM, 2006, METAB ENG, V8, P209, DOI 10.1016/j.ymben.2005.11.004; Zhang XL, 2009, P NATL ACAD SCI USA, V106, P20180, DOI 10.1073/pnas.0905396106; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Wendisch VF, 2006, CURR OPIN MICROBIOL, V9, P268, DOI 10.1016/j.mib.2006.03.001; Lee SJ, 2006, APPL ENVIRON MICROB, V72, P1939, DOI 10.1128/AEM.72.3.1939-1948.2006; Thakker C, 2012, BIOTECHNOL J, V7, P213, DOI 10.1002/biot.201100061; McKinlay JB, 2007, APPL MICROBIOL BIOT, V76, P727, DOI 10.1007/s00253-007-1057-y; Gokarn RR, 2001, APPL MICROBIOL BIOT, V56, P188, DOI 10.1007/s002530100661; Zhang C, 2011, BIORESOURCE TECHNOL, V102, P8344, DOI 10.1016/j.biortech.2011.06.018; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Kim P, 2004, APPL ENVIRON MICROB, V70, P1238, DOI 10.1128/AEM.70.2.1238-1241.2004; Jang YS, 2012, BIOTECHNOL BIOENG, V109, P2437, DOI 10.1002/bit.24599; Tseng CP, 1996, J BACTERIOL, V178, P1094; Sanchez AM, 2005, METAB ENG, V7, P229, DOI 10.1016/j.ymben.2005.03.001; Zeikus JG, 1999, APPL MICROBIOL BIOT, V51, P545, DOI 10.1007/s002530051431; Li Q, 2010, SEP PURIF TECHNOL, V72, P294, DOI 10.1016/j.seppur.2010.02.021; Jung MY, 2012, APPL MICROBIOL BIOT, V95, P461, DOI 10.1007/s00253-012-3883-9; Jantama K, 2008, BIOTECHNOL BIOENG, V101, P881, DOI 10.1002/bit.22005; Fukui K, 2011, J BIOTECHNOL, V154, P25, DOI 10.1016/j.jbiotec.2011.03.010; SAMUELOV NS, 1991, APPL ENVIRON MICROB, V57, P3013; Katashkina JI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-34; Converti A, 2002, APPL MICROBIOL BIOT, V59, P303, DOI 10.1007/s00253-002-1009-5; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Sanchez AM, 2005, BIOTECHNOL PROGR, V21, P358, DOI 10.1021/bp049676e; Singh A, 2011, METAB ENG, V13, P76, DOI 10.1016/j.ymben.2010.10.006; Zhang X, 2009, APPL ENVIRON MICROB, V75, P7807, DOI 10.1128/AEM.01758-09; Lee Sang Yup, 2002, Genome Inform, V13, P214; Liang LY, 2011, BIOTECHNOL LETT, V33, P2439, DOI 10.1007/s10529-011-0707-4; Lu SY, 2009, J IND MICROBIOL BIOT, V36, P1101, DOI 10.1007/s10295-009-0594-z; Minaeva NI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-63; Nwachukwu RES, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-20; Peredelchuk MY, 1997, GENE, V187, P231, DOI 10.1016/S0378-1119(96)00760-3; Tajima Y, 2014, APPL MICROBIOL BIOT, V98, P7803, DOI 10.1007/s00253-014-5884-3; Tajima Y, 2012, US patent, Patent No. [8247201 B2, 8247201]; Tang JL, 2013, APPL MICROBIOL BIOT, V97, P2513, DOI 10.1007/s00253-012-4344-1; Tsuji A, 2013, ENZYME MICROB TECH, V53, P97, DOI 10.1016/j.enzmictec.2013.04.008; Wang J, 2011, METAB ENG, V13, P328, DOI 10.1016/j.ymben.2011.03.004	45	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	FEB	2015	81	3					929	937		10.1128/AEM.03213-14		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AZ0CU	WOS:000347914800014		
J	Kato, M; Watanabe-Takahashi, M; Shimizu, E; Nishikawa, K				Kato, Mihoko; Watanabe-Takahashi, Miho; Shimizu, Eiko; Nishikawa, Kiyotaka			Identification of a Wide Range of Motifs Inhibitory to Shiga Toxin by Affinity-Driven Screening of Customized Divalent Peptides Synthesized on a Membrane	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI O157-H7; SPOT-SYNTHESIS; INFECTIONS; BINDING; GLOBOTRIAOSYLCERAMIDE; NEUTRALIZER; RISK	Shiga toxin (Stx), a major virulence factor of enterohemorrhagic Escherichia coli, binds to target cells through a multivalent interaction between its B-subunit pentamer and the cell surface receptor globotriaosylceramide, resulting in a remarkable increase in its binding affinity. This phenomenon is referred to as the "clustering effect." Previously, we developed a multivalent peptide library that can exert the clustering effect and identified Stx neutralizers with tetravalent peptides by screening this library for high-affinity binding to the specific receptor-binding site of the B subunit. However, this technique yielded only a limited number of binding motifs, with some redundancy in amino acid selectivity. In this study, we established a novel technique to synthesize up to 384 divalent peptides whose structures were customized to exert the clustering effect on the B subunit on a single cellulose membrane. By targeting Stx1a, a major Stx subtype, the customized divalent peptides were screened to identify high-affinity binding motifs. The sequences of the peptides were designed based on information obtained from the multivalent peptide library technique. A total of 64 candidate motifs were successfully identified, and 11 of these were selected to synthesize tetravalent forms of the peptides. All of the synthesized tetravalent peptides bound to the B subunit with high affinities and effectively inhibited the cytotoxicity of Stx1a in Vero cells. Thus, the combination of the two techniques results in greatly improved efficiency in identifying biologically active neutralizers of Stx.	[Kato, Mihoko; Watanabe-Takahashi, Miho; Shimizu, Eiko; Nishikawa, Kiyotaka] Doshisha Univ, Fac Life & Med Sci, Kyoto 602, Japan	Nishikawa, K (reprint author), Doshisha Univ, Fac Life & Med Sci, Kyoto 602, Japan.	knishika@mail.doshisha.ac.jp			National Center for Global Health and Medicine, Japan; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Japan	This work was supported by a grant from the National Center for Global Health and Medicine, Japan; a grant from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities; grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and a grant from the Ministry of Health, Labor and Welfare, Japan.	Yosief HO, 2013, INFECT IMMUN, V81, P2753, DOI 10.1128/IAI.00274-13; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Nishikawa K, 2005, J INFECT DIS, V191, P2097, DOI 10.1086/430388; Flagler MJ, 2010, BIOCHEMISTRY-US, V49, P1649, DOI 10.1021/bi902084y; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; KARMALI MA, 1983, LANCET, V1, P619; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; TESH VL, 1993, INFECT IMMUN, V61, P3392; KARMALI MA, 1985, J INFECT DIS, V151, P775; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; Ikeda K, 1999, CLIN NEPHROL, V52, P357; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Wong CS, 2012, CLIN INFECT DIS, V55, P33, DOI 10.1093/cid/cis299; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450; Nishikawa K, 2002, P NATL ACAD SCI USA, V99, P7669, DOI 10.1073/pnas.112058999; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Kitov PI, 2000, NATURE, V403, P669; Stearns-Kurosawa DJ, 2011, PEDIATR NEPHROL, V26, P2031, DOI 10.1007/s00467-011-1913-y; Nishikawa K, 2006, FASEB J, V20, P2597, DOI 10.1096/fj.06-6572fje; OSTROFF SM, 1989, J INFECT DIS, V160, P994; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; OBRIEN AD, 1987, MICROBIOL REV, V51, P206; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hauswaldt S, 2013, CURR INFECT DIS REP, V15, P4, DOI 10.1007/s11908-012-0302-4; Melton-Celsa A.R., 1998, ESCHERICHIA COLI O15, P121; Soltyk AM, 2002, J BIOL CHEM, V277, P5351, DOI 10.1074/jbc.M107472200; Tsutsuki K, 2013, INFECT IMMUN, V81, P2133, DOI 10.1128/IAI.01256-12; Watanabe-Takahashi M, 2010, INFECT IMMUN, V78, P177, DOI 10.1128/IAI.01022-09; Wolski VM, 2001, INFECT IMMUN, V69, P579, DOI 10.1128/IAI.69.1.579-583.2001	34	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	FEB	2015	81	3					1092	1100		10.1128/AEM.03517-14		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AZ0CU	WOS:000347914800031		
J	Kimura, K; Tomarua, Y				Kimura, Kei; Tomarua, Yuji			Discovery of Two Novel Viruses Expands the Diversity of Single-Stranded DNA and Single-Stranded RNA Viruses Infecting a Cosmopolitan Marine Diatom	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; CHAETOCEROS-TENUISSIMUS; BLOOM; EPIFLUORESCENCE; RAPHIDOPHYCEAE; ENUMERATION; ABUNDANCE; WATERS	Recent studies have suggested that diatom viruses are an important factor affecting diatom population dynamics, which in turn are important in considering marine primary productivity. The marine planktonic diatom Chaetoceros tenuissimus Meunier is a cosmopolitan species and often causes blooms off the western coast of Japan. To date, two viruses, C. tenuissimus DNA virus (CtenDNAV) type I and CtenRNAV type I, have been identified that potentially affect C. tenuissimus population dynamics in the natural environment. In this study, we successfully isolated and characterized two additional novel viruses (CtenDNAV type II and CtenRNAV type II). This paper reports the basic characteristics of these new viruses isolated from surface water or sediment from the Hiroshima Bay, Japan. The physiological and morphological characteristics of the two new viruses were similar to those of the previously isolated viruses. However, the amino acid sequences of the structural proteins of CtenDNAV type II and CtenRNAV type II were clearly distinct from those of both type I viruses, with identity scores of 38.3% and 27.6%, respectively. Our results suggest that at least four genetically distinct viruses sharing the same diatom host are present in western Japan and affect the population dynamics of C. tenuissimus. Moreover, the result that CtenRNAV type II lysed multiple diatom species indicates that RNA viruses may affect various diatom populations in the natural environment.	[Kimura, Kei; Tomarua, Yuji] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima, Japan; [Kimura, Kei] Japan Soc Promot Sci, Tokyo, Japan	Tomarua, Y (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima, Japan.	tomaruy@affrc.go.jp			KAKENHI Japan Society for the Promotion of Science [26292101]	This study was supported by Research Fellowships for Young Scientists and KAKENHI grant number 26292101 from the Japan Society for the Promotion of Science.	Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Tomaru Y, 2009, APPL ENVIRON MICROB, V75, P2375, DOI 10.1128/AEM.02580-08; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Tomaru Y, 2014, AQUAT MICROB ECOL, V73, P171, DOI 10.3354/ame01713; Tomaru Y, 2007, J OCEANOGR, V63, P215, DOI 10.1007/s10872-007-0023-8; Tomaru Y, 2004, AQUAT MICROB ECOL, V34, P227, DOI 10.3354/ame034227; Tomaru Y, 2008, AQUAT MICROB ECOL, V50, P103, DOI 10.3354/ame01170; HARA S, 1991, APPL ENVIRON MICROB, V57, P2731; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Tomaru Y, 2012, ISME J, V6, P1445, DOI 10.1038/ismej.2011.207; Baudoux AC, 2005, VIROLOGY, V341, P80, DOI 10.1016/j.virol.2005.07.002; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Nagasaki K, 2004, APPL ENVIRON MICROB, V70, P704, DOI 10.1128/AEM.70.2.704-711.2004; Imai I, 1996, FISHERIES SCI, V62, P834; Shirai Y, 2008, APPL ENVIRON MICROB, V74, P4022, DOI 10.1128/AEM.00509-08; Holmfeldt K, 2012, APPL ENVIRON MICROB, V78, P892, DOI 10.1128/AEM.06580-11; Tomaru Y, 2011, APPL ENVIRON MICROB, V77, P5285, DOI 10.1128/AEM.00202-11; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P3528, DOI 10.1128/AEM.71.7.3528-3535.2005; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Baudoux AC, 2008, J PHYCOL, V44, P902, DOI 10.1111/j.1529-8817.2008.00543.x; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ball LA, 1998, TOPLEY WILSONS MICRO, V9, P115; Bettarel Y, 2005, AQUAT MICROB ECOL, V40, P103, DOI 10.3354/ame040103; Brussaard C. P. D., 2008, PLANT VIRUSES, V2, P1; Kimura Kei, 2012, Plankton & Benthos Research, V7, P126; Kimura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082013; NISHIHARA T, 1986, EISEI KAGAKU, V32, P226; Shukla DD, 1994, POTYVIRIDAE; Suttle CA, 1993, HDB METHODS AQUATIC, P121; Suttle C.A., 2010, MANUAL AQUATIC VIRAL, P145, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7; Todd D, 2000, VIRUS TAXONOMY CLASS, P299; Tomaru Yuji, 2005, Plankton Biology and Ecology, V52, P1; Tomaru Y, 2011, AQUAT MICROB ECOL, V63, P223, DOI 10.3354/ame01496; Tomaru Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03337; Tomaru Y, 2013, PHYCOL RES, V61, P27, DOI 10.1111/j.1440-1835.2012.00670.x; Tomaru Y, 2011, AQUAT MICROB ECOL, V64, P175, DOI 10.3354/ame01517; Toyoda Kensuke, 2012, Plankton & Benthos Research, V7, P20; Weinbauer MG, 1997, AQUAT MICROB ECOL, V13, P225, DOI 10.3354/ame013225; Yokoyama Hisashi, 1997, Benthos Research, V52, P119	43	1	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	FEB	2015	81	3					1120	1131		10.1128/AEM.02380-14		12	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AZ0CU	WOS:000347914800034		
J	Uchiyama, R; Tsutsui, H				Uchiyama, Ryosuke; Tsutsui, Hiroko			Caspases as the Key Effectors of Inflammatory Responses Against Bacterial Infection	ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS			English	Review						Caspase; Inflammasome; IL-1 beta/IL-18; Fas	NF-KAPPA-B; TOLL-LIKE RECEPTORS; INTERLEUKIN-1-BETA CONVERTING-ENZYME; NLRP3 INFLAMMASOME; LISTERIA-MONOCYTOGENES; CUTTING EDGE; MYCOBACTERIUM-TUBERCULOSIS; CANDIDA-ALBICANS; MATURE IL-1-BETA; IMMUNE-RESPONSES	Caspase cysteine proteases are factors widely recognized for their role in the induction of apoptotic cell death. Caspases induce apoptosis during the inflammatory response to pathogen infection; in addition, caspases such as caspase-1 and caspase-11 are known to be involved in the production of inflammatory cytokines in response to bacterial infections. Caspase-1 is activated in the inflammasome, an intracellular protein complex that is formed by the recognition of intracellular ligands or cellular stresses by sensor molecules such as NOD-like receptors. Under certain conditions, caspase-11 is required for the activation of the caspase-1 inflammasome, referred to as the non-canonical inflammasome. In addition to these caspases, accumulating evidence indicates that caspase-8 also contributes to the production of inflammatory cytokines. In contrast to caspase-1, caspase-8 is activated by receptors located on the plasma membrane including dectin-1, TLR-3/4, and Fas. Recently, Fas-mediated caspase-8 activation and inflammatory cytokine production have been shown to play a significant role in the regulation of bacterial infections. This review highlights the functional roles and activation mechanisms of caspase-1/-11 in innate immune responses against bacterial infection. In addition, we discuss the novel aspects of caspase-8 function in comparison with caspase-1/-11 during innate inflammatory responses.	[Uchiyama, Ryosuke; Tsutsui, Hiroko] Hyogo Coll Med, Dept Microbiol, Nishinomiya, Hyogo 6638501, Japan	Uchiyama, R (reprint author), Hyogo Coll Med, Dept Microbiol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	uchiyama@hyo-med.ac.jp			Japan Society for the Promotion of Science KAKENHI [20790334]; Hyogo College of Medicine	The authors thank Prof. Shin Yonehara (Kyoto University) and Prof. Kenji Nakanishi (Hyogo College of Medicine) for helpful discussions. This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant 20790334 and by a Grant-in-Aid for Researchers, Hyogo College of Medicine, 2010.	Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; BLACK RA, 1989, FEBS LETT, V247, P386, DOI 10.1016/0014-5793(89)81376-6; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Uchiyama R, 2013, J IMMUNOL, V190, P4245, DOI 10.4049/jimmunol.1203059; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Erener S, 2012, MOL CELL, V46, P200, DOI 10.1016/j.molcel.2012.02.016; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Tsuchiya K, 2014, CRIT REV IMMUNOL, V34, P41; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Maher BM, 2013, INFECT IMMUN, V81, P4478, DOI 10.1128/IAI.01026-13; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Maksimow M, 2006, J LEUKOCYTE BIOL, V79, P369, DOI 10.1189/jlb.0505238; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Lamkanfi M, 2004, CELL DEATH DIFFER, V11, P365, DOI 10.1038/sj.cdd.4401364; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1180/blood-2006-05-024406; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Takahashi K, 2006, J IMMUNOL, V176, P4520; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Kebaier C, 2012, J INFECT DIS, V205, P807, DOI 10.1093/infdis/jir846; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; Carvalho A, 2012, CELL MOL IMMUNOL, V9, P276, DOI 10.1038/cmi.2012.1; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Koizumi Y, 2012, CELL MICROBIOL, V14, P149, DOI 10.1111/j.1462-5822.2011.01707.x; Matsumoto M, 2003, J IMMUNOL, V171, P3154; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Bian ZM, 2011, INVEST OPHTH VIS SCI, V52, P8646, DOI 10.1167/iovs.11-7570; BLACK RA, 1989, J BIOL CHEM, V264, P5323; Buskiewicz IA, 2012, FUTURE VIROL, V7, P1221, DOI 10.2217/FVL.12.115; Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Denecker G, 2008, J CELL BIOL, V180, P451, DOI [10.1083/jcb.200709098, 10.1083/icb.200709098]; Hernandez-Cuellar E, 2012, J IMMUNOL, V189, P5113, DOI 10.4049/jimmunol.1202479; Jun HK, 2012, IMMUNITY, V36, P755, DOI 10.1016/j.immuni.2012.05.002; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; McGilligan VE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074010; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Parrish A.B., 2013, COLD SPRING HARB PER, V5; Reimer T, 2007, J IMMUNOL, V179, P1166; Reutterer B, 2008, CELL MICROBIOL, V10, P1116, DOI 10.1111/j.1462-5822.2007.01114.x; Uchiyama R, 2007, INFECT IMMUN, V75, P2894, DOI 10.1128/IAI.01639-06; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026	94	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0004-069X	1661-4917		ARCH IMMUNOL THER EX	Arch. Immunol. Ther. Exp.	FEB	2015	63	1					1	13		10.1007/s00005-014-0301-2		13	Immunology	Immunology	AY7EC	WOS:000347723100001		
J	Guo, YJ; Fukuda, T; Nakamura, S; Bai, LL; Xu, J; Kuroda, K; Tomioka, R; Yoneyama, H; Isogai, E				Guo, Yijie; Fukuda, Tomokazu; Nakamura, Shuichi; Bai, Lanlan; Xu, Jun; Kuroda, Kengo; Tomioka, Rintaro; Yoneyama, Hiroshi; Isogai, Emiko			Interaction between Leptospiral Lipopolysaccharide and Toll-like Receptor 2 in Pig Fibroblast Cell Line, and Inhibitory Effect of Antibody against Leptospiral Lipopolysaccharide on Interaction	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Antibody Against Leptospiral Lipopolysaccharide; Cytokines; Leptospiral Lipopolysaccharide; Pig Fibroblast Cell Line; Toll-like Receptor 2	INTERROGANS; EXPRESSION; LPS	Leptospiral lipopolysaccharide (L-LPS) has shown potency in activating toll-like receptor 2 (TLR2) in pig fibroblasts (PEFs_NCC1), and causes the expression of proinflammatory cytokines. However, the stimulation by L-LPS was weak eliciting the function of TLR2 sufficiently in pig innate immunity responses during Leptospira infection. In this study, the immune response of pig embryonic fibroblast cell line (PEFs_SV40) was investigated and was found to be the high immune response, thus TLR2 is the predominate receptor of L-LPS in pig cells. Further, we found a strategy using the antibody against L-LPS, to prevent L-LPS interaction with TLR2 in pig cells which could impact on immune activation.	[Guo, Yijie; Bai, Lanlan; Xu, Jun; Kuroda, Kengo; Tomioka, Rintaro; Yoneyama, Hiroshi; Isogai, Emiko] Tohoku Univ, Grad Sch Agr Sci, Labs Anim Microbiol, Sendai, Miyagi 9818555, Japan; [Guo, Yijie] Xi An Jiao Tong Univ, Sch Med, Dept Immunobiol & Pathogen Biol, Xian 710061, Peoples R China; [Fukuda, Tomokazu] Tohoku Univ, Lab Anim Breeding & Genet, Sendai, Miyagi 9818555, Japan; [Nakamura, Shuichi] Tohoku Univ, Grad Sch Engn, Appl Phys Lab, Sendai, Miyagi 9808579, Japan	Isogai, E (reprint author), Tohoku Univ, Grad Sch Agr Sci, Labs Anim Microbiol, Sendai, Miyagi 9818555, Japan.	emiko@bios.tohoku.ac.jp					Fukuda T, 2012, BIOSCI BIOTECH BIOCH, V76, P1372, DOI 10.1271/bbb.120155; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; Pollack M, 1997, J IMMUNOL, V159, P3519; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Priya CG, 2008, INVEST OPHTH VIS SCI, V49, P5419, DOI 10.1167/iovs.08-2174; ISOGAI E, 1989, ZBL BAKT-INT J MED M, V271, P186; de Fost M, 2003, CLIN DIAGN LAB IMMUN, V10, P332, DOI 10.1128/CDLI.10.2.332-335.2003; Lowanitchapat A, 2010, COMP IMMUNOL MICROB, V33, P423, DOI 10.1016/j.cimid.2009.05.001; Murray GL, 2010, MOL MICROBIOL, V78, P701, DOI 10.1111/j.1365-2958.2010.07360.x; Fukuda T, 2000, ANAL BIOCHEM, V285, P274, DOI 10.1006/abio.2000.4787; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839; de Haas CJC, 1999, INFECT IMMUN, V67, P2790; Faine S, 1994, LEPTOSPIRA LEPTOSPIR; Guo Y., 2014, ANIM SCI J IN PRESS; ISOGAI E, 1986, ZBL BAKT-INT J MED M, V261, P53; ISOGAI E, 1990, ZBL BAKT-INT J MED M, V273, P200; Isogai E, 1998, J VET MED B, V45, P529; Kemenes F, 1967, Monatsh Veterinarmed, V22, P224; Rathi AV, 2010, VIROLOGY, V406, P202, DOI 10.1016/j.virol.2010.07.018; Uddin MJ, 2012, VET IMMUNOL IMMUNOP, V147, P211, DOI 10.1016/j.vetimm.2012.04.020; VAUGHAN C, 1994, POSTGRAD MED J, V70, P118; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453; Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008	23	0	0	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	FEB	2015	28	2					273	279		10.5713/ajas.14.0440		7	Agriculture, Dairy & Animal Science	Agriculture	AY9LB	WOS:000347870200017		
J	Tanaka, H; Heg, D; Takeshima, H; Takeyama, T; Awata, S; Nishida, M; Kohda, M				Tanaka, Hirokazu; Heg, Dik; Takeshima, Hirohiko; Takeyama, Tomohiro; Awata, Satoshi; Nishida, Mutsumi; Kohda, Masanori			Group composition, relatedness, and dispersal in the cooperatively breeding cichlid Neolamprologus obscurus	BEHAVIORAL ECOLOGY AND SOCIOBIOLOGY			English	Article						Cooperative breeding; Social system; Related helper; Delayed dispersal; Fish	LAKE TANGANYIKA; JULIDOCHROMIS-ORNATUS; PSEUDOTROPHEUS-ZEBRA; INBREEDING AVOIDANCE; BROODCARE HELPERS; GENETIC-MARKERS; FISH; EVOLUTION; BIRDS; BENEFITS	Cooperative breeding has been studied intensively in many species of birds and mammals but remain less well studied in fish. We report a remarkable new example of a cooperatively breeding cichlid from Lake Tanganyika, Neolamprologus obscurus. Using field observations and microsatellite DNA analyses, we studied group structure, helping behavior, relatedness, and dispersal of this species. We present four major observations. First, large territorial breeding males mated with one to eight breeding females, each of which was territorial and unrelated to another. Second, one to ten smaller fish ("subordinates") of both sexes were allowed to stay inside the breeding females' territories. Subordinates were often highly related to both the respective breeding male and female and performed territory defense and shelter maintenance, which is regarded as helping behaviors. Third, one to three subordinate males, similar in size to breeding females, were allowed to stay inside a breeding male's territory but were not tolerated in the breeding females' territories. Pairwise relatedness suggests these individuals are usually sons of the respective breeding male. Fourth, pairwise relatedness estimates suggest that juveniles delay dispersal and assist their mothers in raising offspring. As female subordinates grow up, they leave the father's territory and disperse into other groups. In contrast, male subordinates leave their mother's territory but remain within the territory of their father. The described social system makes N. obscurus a promising new model species to study the evolution of cooperative breeding.	[Tanaka, Hirokazu; Takeyama, Tomohiro; Kohda, Masanori] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Lab Anim Sociol, Osaka 5588585, Japan; [Heg, Dik] Univ Bern, Dept Clin Res, Clin Trials Unit, CH-3012 Bern, Switzerland; [Takeshima, Hirohiko; Nishida, Mutsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Awata, Satoshi] Niigata Univ, Sado Marine Biol Stn, Fac Sci, Sado 9522135, Japan	Tanaka, H (reprint author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Lab Anim Sociol, Osaka 5588585, Japan.	hirok.tanak@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Tetsumi Takahashi, Kazutaka Ota, Haruki Ochi, Hiroki Hata, Michio Hori, and the staff of the Lake Tanganyika Research Unit, Mpulungu, Zambia, especially Harris Phiri, Danny Syniynza, Ruben Shapola, and Henry Simpembwa for supporting our studies at the field. We are grateful to Satoshi Nanami and Sho Furuichi for statistical discussions and Joachim Frommen and three anonymous referees for helpful comments on early versions of this manuscript. This work was financially supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, to MK.	Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Heg D, 2005, ETHOLOGY, V111, P1017, DOI 10.1111/j.1439-0310.2005.01135.x; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187; Bergmuller R, 2005, P ROY SOC B-BIOL SCI, V272, P325, DOI 10.1098/rspb.2004.2960; Schradin C, 2002, ETHOLOGY, V108, P237, DOI 10.1046/j.1439-0310.2002.00775.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Zardoya R, 1996, P ROY SOC B-BIOL SCI, V263, P1589, DOI 10.1098/rspb.1996.0233; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; TABORSKY M, 1981, BEHAV ECOL SOCIOBIOL, V8, P143, DOI 10.1007/BF00300826; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Sturmbauer C, 2010, MOL PHYLOGENET EVOL, V57, P266, DOI 10.1016/j.ympev.2010.06.018; Wisenden BD, 1999, REV FISH BIOL FISHER, V9, P45, DOI 10.1023/A:1008865801329; TABORSKY M, 1984, ANIM BEHAV, V32, P1236, DOI 10.1016/S0003-3472(84)80241-9; Balshine-Earn S, 1998, BEHAV ECOL, V9, P432, DOI 10.1093/beheco/9.5.432; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Brouwer L, 2005, BEHAV ECOL, V16, P667, DOI 10.1093/beheco/ari042; Grantner A, 1998, J COMP PHYSIOL B, V168, P427, DOI 10.1007/s003600050162; Cockburn A, 2006, P R SOC B, V273, P1375, DOI 10.1098/rspb.2005.3458; Heg D, 2006, ENVIRON BIOL FISH, V76, P265, DOI 10.1007/s10641-006-9032-5; Stiver KA, 2007, MOL ECOL, V16, P2974, DOI 10.1111/j.1365-294X.2007.03350.x; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Feeney WE, 2013, SCIENCE, V342, P1506, DOI 10.1126/science.1240039; Desjardins JK, 2008, ANIM BEHAV, V75, P1771, DOI 10.1016/j.anbehav.2007.09.037; Duftner N, 2007, MOL PHYLOGENET EVOL, V45, P706, DOI 10.1016/j.ympev.2007.08.001; CREEL SR, 1994, BEHAV ECOL, V5, P339, DOI 10.1093/beheco/5.3.339; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Lukas D, 2012, P ROY SOC B-BIOL SCI, V279, P2151, DOI 10.1098/rspb.2011.2468; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1; TABORSKY M, 1985, BEHAVIOUR, V95, P45, DOI 10.1163/156853985X00046; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Awata S, 2006, BEHAV ECOL, V17, P372, DOI 10.1093/beheco/arj043; Awata S, 2005, BEHAV ECOL SOCIOBIOL, V58, P506, DOI 10.1007/s00265-005-0934-6; Awata S, 2004, BEHAVIOUR, V141, P1135, DOI 10.1163/1568539042664623; Bates Douglas, 2011, LME4 LINEAR MIXED EF; Eikenaar C, 2008, J AVIAN BIOL, V39, P73, DOI 10.1111/j.2008.0908-8857.04124.x; Eikenaar C, 2007, BEHAV ECOL, V18, P874, DOI 10.1093/beheco/arm047; Ekman J, 2000, BEHAV ECOL, V11, P416, DOI 10.1093/beheco/11.4.416; Fitzpatrick JL, 2008, P R SOC B, V275, P929, DOI 10.1098/rspb.2007.1449; Fitzpatrick JL, 2006, BEHAV ECOL, V17, P25, DOI 10.1093/beheco/ari090; Greenwood P.J., 1983, P116; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; Koenig W. D., 2004, ECOLOGY EVOLUTION CO; Kohler U., 1998, STRUKTUR EVOLUTION S; Komdeur J, 2001, BEHAV ECOL, V12, P706, DOI 10.1093/beheco/12.6.706; Konings A, 1998, TANGANYIKA CICHLIDS; Konovalov DA, 2008, MOL ECOL RESOUR, V8, P256, DOI 10.1111/j.1471-8286.2007.01940.x; Munehara Hiroyuki, 2001, Bulletin of Fisheries Sciences Hokkaido University, V52, P131; Parker A, 1996, ENVIRON BIOL FISH, V47, P345, DOI 10.1007/BF00005049; POLL M, 1978, B CL SCI AC ROY BELG, V64, P725; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; R Development Core Team, 2011, R LANG ENV STAT COMP; Rossiter A., 1993, ECOLOGICAL LIMNOLOGI, P32; Sato T, 1997, FISH COMMUNITIES LAK, P221; Schliewen U, 2001, MOL ECOL, V10, P1471, DOI 10.1046/j.1365-294X.2001.01276.x; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; Stiver KA, 2004, J FISH BIOL, V65, P91, DOI 10.1111/j.1095-8649.2004.00427.x; Sunobe T, 2003, J ETHOL, V21, P87, DOI 10.1007/s10164-002-0086-3; Taborsky M, 2001, J HERED, V92, P100, DOI 10.1093/jhered/92.2.100; Tommkins JL, 2002, ANIM BEHAV, V63, P1009; VanOppen MJH, 1997, MOL ECOL, V6, P387, DOI 10.1046/j.1365-294X.1997.00188.x; Wong M, 2010, BIOL REV, V86, P511; Woolfenden G.E., 1990, P241; Yamagishi S, 1996, ICHTHYOL RES, V43, P469, DOI 10.1007/BF02347645	68	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-5443	1432-0762		BEHAV ECOL SOCIOBIOL	Behav. Ecol. Sociobiol.	FEB	2015	69	2					169	181		10.1007/s00265-014-1830-8		13	Behavioral Sciences; Ecology; Zoology	Behavioral Sciences; Environmental Sciences & Ecology; Zoology	AY8QM	WOS:000347818500001		
J	Morino, L				Morino, Luca			Social correlates of androgen levels in a facultatively monogamous ape (Symphalangus syndactylus): a test of the challenge hypothesis	BEHAVIORAL ECOLOGY AND SOCIOBIOLOGY			English	Article						Challenge hypothesis; Primate; Siamang; Monogamy; Polyandry; Paternal care; Testosterone; Dominance; Social instability	FECAL TESTOSTERONE LEVELS; CHIMPANZEES PAN-TROGLODYTES; EULEMUR-FULVUS-RUFUS; MEDIATED TRADE-OFF; DOMINANCE RANK; SEASONAL-VARIATION; PROPITHECUS-VERREAUXI; CORTISOL-LEVELS; HORMONE LEVELS; MALE MARMOSETS	The challenge hypothesis posits a correlation between male androgen levels and mating system, male-male aggression in a sexual context, and parental effort. This model has received support across a variety of taxa, including primates. Most primate studies have focused on multi-male societies characterized by relatively high levels of male-male aggression and limited paternal care. To expand this dataset, predictions of the challenge hypothesis were tested in a population of wild siamangs (Symphalangus syndactylus), small apes characterized by intense territoriality, monogamous/polyandrous grouping patterns, and varying amounts of paternal behavior. Behavioral data were collected on 11 study groups (five two-male groups and six one-male groups). Seven hundred thirty-four fecal samples were collected from 18 adult males to quantify concentrations of fecal immunoreactive androgens (fiA) by radioimmunoassay. As predicted by the challenge hypothesis, males involved in the aggressive replacement of a resident male had significantly higher fiA concentrations than control males, while males displaying active parental care had significantly lower fiA concentrations than average. Results showed no association between male androgen concentration and group composition, male rank, or rate of intragroup male-male aggression. These latter findings, seemingly inconsistent with the hypothesis, could be explained by the clear and stable dominance relationships between co-resident males: given the very low rates of physical aggression, a low baseline testosterone is to be expected. Furthermore, the effects of increased intragroup conflict experienced by males in two-male groups might be offset by the higher frequency of intergroup aggression experienced by males in one-male groups.	[Morino, Luca] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08901 USA; [Morino, Luca] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan	Morino, L (reprint author), Rutgers State Univ, Dept Anthropol, 131 George St, New Brunswick, NJ 08901 USA.	lmorino@gmail.com			National Science Foundation [0726022]; Wenner-Gren Foundation [7766]	I am grateful to Laji, Tarmin, Usman, Maryadi, Mislan, Budi, and Opo for their commitment, skill, and positive attitude in the forest; to my parents, Ignacia Perugorria, Jacqueline Hicks, Alice Elder, Flor Gragera de Leon, and Susana Galan for their support at different stages of this project; to Marc Shur for inspiring conversations; to Ryne Palombit, Susan Lappan, Jacinta Beehner, and Carola Borries for professional, wise, and supportive advising; to Guang Dong, Erin Vogel, and Andrew MacIntosh for statistical advice; to Susana Galan for her patience and perception; to Larry Katz and Susan Becker (Animal Sciences Lab, Rutgers University) for introducing me to the beauty and rigor of labwork; and to three anonymous reviewers for their meticulous and constructive comments. I gratefully acknowledge the National Science Foundation (Grant ID 0726022) and Wenner-Gren Foundation (Grant 7766) for funding my research project and the State Ministry of Research and Technology and Forestry Department of Indonesia for permission to conduct research in Sumatra.	Altmann J., 1974, BEHAVIOUR, V49, P229; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Marshall AJ, 2005, AM J PRIMATOL, V65, P87, DOI 10.1002/ajp.20099; van Anders SM, 2012, HORM BEHAV, V61, P31, DOI 10.1016/j.yhbeh.2011.09.012; Teichroeb JA, 2008, HORM BEHAV, V54, P417, DOI 10.1016/j.yhbeh.2008.04.006; Ostner J, 2002, BEHAV ECOL SOCIOBIOL, V52, P485, DOI 10.1007/s00265-002-0532-9; Muehlenbein MP, 2004, AM J PRIMATOL, V64, P71, DOI 10.1002/ajp.20062; Beehner JC, 2009, HORM BEHAV, V56, P472, DOI 10.1016/j.yhbeh.2009.08.005; Kraus C, 1999, PHYSIOL BEHAV, V66, P855, DOI 10.1016/S0031-9384(99)00024-4; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; Ostner J, 2008, BEHAV ECOL SOCIOBIOL, V62, P627, DOI 10.1007/s00265-007-0487-y; Muroyama Y, 2007, AM J PRIMATOL, V69, P603, DOI 10.1002/ajp.20366; PALOMBIT RA, 1994, ANIM BEHAV, V47, P721, DOI 10.1006/anbe.1994.1097; SAPOLSKY RM, 1982, HORM BEHAV, V16, P279, DOI 10.1016/0018-506X(82)90027-7; Storey AE, 2000, EVOL HUM BEHAV, V21, P79, DOI 10.1016/S1090-5138(99)00042-2; Lynch JW, 2002, HORM BEHAV, V41, P275, DOI 10.1006/hbeh.2002.1772; Gray PB, 2002, EVOL HUM BEHAV, V23, P193, DOI 10.1016/S1090-5138(01)00101-5; Nunes S, 2000, ANIM BEHAV, V60, P857, DOI 10.1006/anbe.2000.1524; Reburn CJ, 1999, HORM BEHAV, V35, P163, DOI 10.1006/hbeh.1998.1509; Beehner JC, 2004, PHYSIOL BEHAV, V82, P269, DOI 10.1016/j.physbeh.2004.03.012; Trainor BC, 2001, HORM BEHAV, V40, P32, DOI 10.1006/hbeh.2001.1652; Bercovitch FB, 2002, ANNU REV ANTHROPOL, V31, P45, DOI 10.1146/annurev.anthro.31.040202.105553; Whitten PL, 1998, YEARB PHYS ANTHROPOL, V41, P1; Beehner JC, 2006, BEHAV ECOL SOCIOBIOL, V59, P469, DOI 10.1007/s00265-005-0071-2; Higley JD, 1996, BIOL PSYCHIAT, V40, P1067, DOI 10.1016/S0006-3223(95)00675-3; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Cavigelli SA, 2000, HORM BEHAV, V37, P246, DOI 10.1006/hbeh.2000.1585; Klinkova E, 2004, HORM BEHAV, V46, P474, DOI 10.1016/j.yhbeh.2004.05.005; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Girard-Buttoz C, 2009, PHYSIOL BEHAV, V98, P168, DOI 10.1016/j.physbeh.2009.05.005; Ross CN, 2004, PHYSIOL BEHAV, V83, P437, DOI 10.1016/j.physbeh.2004.08.036; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; Van Belle S, 2009, AM J PRIMATOL, V71, P153, DOI 10.1002/ajp.20635; DIXSON AF, 1982, NATURE, V299, P551, DOI 10.1038/299551a0; Crockford C, 2008, HORM BEHAV, V53, P254, DOI 10.1016/j.yhbeh.2007.10.007; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Bales KL, 2006, HORM BEHAV, V49, P88, DOI 10.1016/j.yhbeh.2005.05.006; Setchell JM, 2008, HORM BEHAV, V54, P365, DOI 10.1016/j.yhbeh.2008.05.004; ALBERTS SC, 1992, HORM BEHAV, V26, P167, DOI 10.1016/0018-506X(92)90040-3; Oliveira RF, 2002, COMP BIOCHEM PHYS B, V132, P203, DOI 10.1016/S1096-4959(01)00523-1; Barelli C, 2012, INT J PRIMATOL, V33, P784, DOI 10.1007/s10764-012-9606-3; Barton K., 2013, MUMIN MULTIMODEL INF; Bates D. M., 2014, LME4 LINEAR MIXED EF; BERCOVITCH FB, 1993, J REPROD FERTIL, V99, P113; Borries C, 2011, BEHAV ECOL SOCIOBIOL, V65, P685, DOI 10.1007/s00265-010-1070-5; BOUISSOU MF, 1983, HORM RES, V18, P43, DOI 10.1159/000179778; Brockman DK, 1998, AM J PHYS ANTHROPOL, V105, P137, DOI 10.1002/(SICI)1096-8644(199802)105:2<137::AID-AJPA3>3.0.CO;2-S; Chivers DJ, 1974, CONTRIBUTIONS PRIMAT, P1; Clark MM, 1999, J COMP PSYCHOL, V113, P388, DOI 10.1037/0735-7036.113.4.388; CZEKALA NM, 1994, AM J PRIMATOL, V34, P29, DOI 10.1002/ajp.1350340107; Delignette-Muller M. L., 2014, FITDISTRPLUS HELP FI; Fox J, 2011, R COMPANION APPL REG; Gaetano TJ, 2012, THESIS U WISCONSIN M; Gittins SP, 1980, MALAYAN FOREST PRIMA, P63; Goymann W, 2003, PHYSIOL BIOCHEM ZOOL, V76, P586, DOI 10.1086/375659; HARDING CF, 1981, AM ZOOL, V21, P223; HART BL, 1974, PSYCHOL BULL, V81, P383, DOI 10.1037/h0036568; Huck M, 2005, INT J PRIMATOL, V26, P159, DOI 10.1007/s10764-005-0728-8; Klukowski M, 1998, HORM BEHAV, V33, P197, DOI 10.1006/hbeh.1998.1449; Lappan S, 2007, AM J PRIMATOL, V69, P1; Lappan S, 2005, THESIS NYU; Lappan S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1307, DOI 10.1007/s00265-008-0559-7; Morino L, 2012, THESIS RUTGERS U; Morino L, 2014, AM J PRIMAT IN PRESS; O'Brien TG, 2003, ANIM CONSERV, V6, P115, DOI 10.1017/S136794300300159; PALOMBIT R, 1994, BEHAVIOUR, V128, P65, DOI 10.1163/156853994X00055; Palombit RA, 1996, BEHAVIOUR, V133, P321, DOI 10.1163/156853996X00486; R Core Team, 2013, R LANG ENV STAT COMP; Rangel-Negrin A, 2011, HORM BEHAV, V59, P149; ROSE RM, 1971, NATURE, V231, P366, DOI 10.1038/231366a0; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; Sapolsky R.M., 1993, PRIMATE SOCIAL CONFL, P171; Shur MD, 2008, AM J PHYS ANTHROPOL, P193; Whitten PL, 2004, BEHAV ECOL SOCIOBIOL, V56, P565, DOI 10.1007/s00265-004-0817-2; WICKINGS EJ, 1992, PHYSIOL BEHAV, V52, P909, DOI 10.1016/0031-9384(92)90370-H; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.1007/BF00379630; Ziegler TE, 2000, HORM BEHAV, V38, P159, DOI 10.1006/hbeh.2000.1617; Ziegler TE, 2005, AM J PRIMATOL, V67, P159, DOI 10.1002/ajp.20175	78	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-5443	1432-0762		BEHAV ECOL SOCIOBIOL	Behav. Ecol. Sociobiol.	FEB	2015	69	2					243	251		10.1007/s00265-014-1837-1		9	Behavioral Sciences; Ecology; Zoology	Behavioral Sciences; Environmental Sciences & Ecology; Zoology	AY8QM	WOS:000347818500008		
J	Maeda, Y; Sekiguchi, F; Yamanaka, R; Sugimoto, R; Yamasoba, D; Tomita, S; Nishikawa, H; Kawabata, A				Maeda, Yuma; Sekiguchi, Fumiko; Yamanaka, Rumi; Sugimoto, Ryo; Yamasoba, Daichi; Tomita, Shiori; Nishikawa, Hiroyuki; Kawabata, Atsufumi			Mechanisms for proteinase-activated receptor 1-triggered prostaglandin E-2 generation in mouse osteoblastic MC3T3-E1 cells	BIOLOGICAL CHEMISTRY			English	Article						cyclooxygenase-2 (COX-2); EP receptor; mouse osteoblastic MC3T3-E1 cell; prostaglandin E-2; proteinase-activated receptor-1 (PAR1)	CYTOSOLIC PHOSPHOLIPASE A(2); EPITHELIAL-CELLS; GENE-EXPRESSION; THROMBIN; CYCLOOXYGENASE-2; CALCIUM; SYSTEM; PROSTANOIDS; MODULATION; DISEASE	We analyzed signaling mechanisms for prostaglandin E-2 (PGE(2)) production following activation of proteinase-activated receptor-1 (PAR1), a thrombin receptor, in preosteoblastic MC3T3-E1 cells. PAR1 stimulation caused PGE(2) release, an effect suppressed by inhibitors ;of COX-1, COX-2, iPLA(2), cPLA(2), MAP kinases (MAPKs), Src, EGF receptor (EGFR) tyrosine kinase (EGFR-TK) and matrix metalloproteinase (MMP), but not by an intracellular Ca2+ chelator or inhibitors of PI3 kinase, protein kinase C (PKC) and NF-kappa B. PAR1 activation induced phosphorylation of MAPKs and upregulation of COX-2. The phosphorylation of p38 MAPK was suppressed by inhibitors of Src and EGFR-TK. The COX-2 upregulation was dependent on ERK, p38, EGFR-TK, Src, and COX-2 itself. PAR1 activation also induced MEK-dependent phosphorylation of cAMP response element binding protein (CREB). All inhibitors of EP1, EP2, EP3 and EP4 receptors suppressed the PAR1-triggered PGE(2) release. Exogenously applied PGE(2) facilitated PAR1-triggered COX-2 upregulation, but it alone had no effect. Together, the PAR1-mediated PGE(2) production in MC3T3-E1 cells appears to involve iPLA(2) and cPLA(2) for arachidonic acid release, and the MEK/ERK/CREB and Src/MMP/EGFR/p38 pathways for COX-2 upregulation, which is facilitated by endogenous PGE(2) formed by COX-2. These signaling mechanisms might underlie the role of the thrombin/PAR1/PGE(2) system in the early stage of the bone healing.	[Maeda, Yuma; Sekiguchi, Fumiko; Yamanaka, Rumi; Sugimoto, Ryo; Yamasoba, Daichi; Tomita, Shiori; Nishikawa, Hiroyuki; Kawabata, Atsufumi] Kinki Univ, Sch Pharm, Div Pharmacol & Pathophysiol, Higashiosaka, Osaka 5778502, Japan	Kawabata, A (reprint author), Kinki Univ, Sch Pharm, Div Pharmacol & Pathophysiol, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	kawabata@phar.kindai.ac.jp			Japan Society for the Promotion of Science; "Antiaging Center Project" for Private Universities from Ministry of Education, Culture, Sports, Science and Technology	This research was supported in part by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science and by "Antiaging Center Project" for Private Universities from Ministry of Education, Culture, Sports, Science and Technology, 2008-2012.	Abraham LA, 1999, J BONE MINER RES, V14, P1320, DOI 10.1359/jbmr.1999.14.8.1320; Murakami M, 2002, J BIOCHEM, V131, P285; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Bluteau G, 2006, BIOMATERIALS, V27, P2934, DOI 10.1016/j.biomaterials.2006.01.004; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Nakanishi-Matsui M, 2000, NATURE, V404, P609; Moriyuki K, 2009, J PHARMACOL SCI, V111, P269, DOI 10.1254/jphs.09155FP; Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Kawao N, 2005, J PHARMACOL EXP THER, V315, P576, DOI 10.1124/jpet.105.089490; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Sekiguchi F, 2007, BIOCHEM PHARMACOL, V73, P103, DOI 10.1016/j.bcp.2006.09.016; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; Cummings BS, 2007, BIOCHEM PHARMACOL, V74, P949, DOI 10.1016/j.bcp.2007.04.021; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P1169, DOI 10.1016/j.biocel.2007.12.003; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Song SJ, 2005, AM J PATHOL, V166, P857, DOI 10.1016/S0002-9440(10)62306-1; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Dessen A, 2000, BBA-MOL CELL BIOL L, V1488, P40, DOI 10.1016/S1388-1981(00)00108-6; Graham Simon, 2009, Expert Opin Investig Drugs, V18, P746, DOI 10.1517/13543780902893051 ; Hatae N, 2002, BIOCHEM BIOPH RES CO, V290, P162, DOI 10.1006/bbrc.2001.6169; Kawabata A, 2002, EXPERT REV MOL MED, V4, P1; Kawabata A, 2008, BRIT J PHARMACOL, V153, pS230, DOI 10.1038/sj.bjp.0707491; Lin C.C., 2014, MOL NEUROBIOL; Ljunggren O., 1991, BONE; O'Neill KR, 2012, J ORTHOP RES, V30, P1271, DOI 10.1002/jor.22071; Pagel CN, 2009, BONE, V44, P813, DOI 10.1016/j.bone.2008.12.031; Pham H, 2006, J CELL BIOCHEM, V98, P1653, DOI 10.1002/jcb.20899; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Sekiguchi F., 2007, Inflammopharmacology, V15, P246, DOI 10.1007/s10787-007-1591-3; Song SJ, 2005, INT J BIOCHEM CELL B, V37, P206, DOI 10.1016/j.biocel.2004.04.026	32	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1431-6730	1437-4315		BIOL CHEM	Biol. Chem.	FEB	2015	396	2					153	162		10.1515/hsz-2014-0148		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AY8FE	WOS:000347788900005		
J	Ohtsu, Y; Takanuki, F; Fukunaga, Y; Noguchi, K				Ohtsu, Yoshiaki; Takanuki, Fumiyo; Fukunaga, Yasuhisa; Noguchi, Kiyoshi			Determination of ASP3258, a novel phosphodiesterase type 4 inhibitor, in rat plasma by high-performance liquid chromatography with fluorescence detection and its application to pharmacokinetic study	BIOMEDICAL CHROMATOGRAPHY			English	Article						ASP3258; pharmacokinetics; rat plasma; HPLC; fluorescence detection		The potent phosphodiesterase 4 inhibitor ASP3258 contains a carboxylic acid moiety and a naphthyridine ring and is a novel therapeutic agent for asthma and chronic obstructive pulmonary disease. To support the drug development of ASP3258, we developed and validated a simple method for its determination in rat plasma. Following the addition of the analog AS1406604-00 as an internal standard, plasma samples were processed using C-18-bonded solid-phase extraction cartridges under acidic conditions and injected into a high-performance liquid chromatography system with fluorescence detection. Chromatographic separation was achieved on a Shiseido Capcell Pak C-18 UG120 column (3.0x150mm, 5 mu m) with a mobile phase consisting of acetonitrile-0.5% acetic acid (50:50, v/v). HPLC eluent was monitored with a fluorescence detector set at a wavelength of 315nm for excitation and 365nm for emission. The calibration curve was linear over a range of 2.5-250ng/mL. Validation data demonstrated that the method is selective, sensitive and accurate. In addition, the present method was successfully applied to rat plasma samples from a pharmacokinetic study. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ohtsu, Yoshiaki; Noguchi, Kiyoshi] Astellas Pharma Inc, Drug Metab Res Labs, Osaka, Japan; [Takanuki, Fumiyo] Astellas Res Technol Co Ltd, Anal & Pharmacokinet Res Div, Tsukuba, Ibaraki, Japan; [Fukunaga, Yasuhisa] Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Tsukuba, Ibaraki, Japan	Ohtsu, Y (reprint author), Astellas Pharma Inc, Drug Metab Res Labs, Osaka, Japan.	yoshiaki.ohtsu@zoho.com		Otsu, Yoshiaki/0000-0003-0494-5717			Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Kobayashi M, 2011, INT IMMUNOPHARMACOL, V11, P732, DOI 10.1016/j.intimp.2011.01.023; Kubo S, 2011, EUR J PHARMACOL, V659, P79, DOI 10.1016/j.ejphar.2011.02.042; Kobayashi M, 2012, INT IMMUNOPHARMACOL, V12, P50, DOI 10.1016/j.intimp.2011.10.008; DADGAR D, 1995, J PHARMACEUT BIOMED, V13, P89, DOI 10.1016/0731-7085(94)00106-C; Global Initiative for Asthma, 2012, GLOB STRAT ASTHM MAN; Kobayashi M, 2012, PHARMACOLOGY, V90, P223, DOI 10.1159/000342380; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; U.S. Food and Drug Administration (FDA), 2001, GUID IND BIOAN METH	9	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-3879	1099-0801		BIOMED CHROMATOGR	Biomed. Chromatogr.	FEB	2015	29	2					161	163		10.1002/bmc.3262		3	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	AY8LJ	WOS:000347804700002		
J	Belkacem, AN; Shin, D; Kambara, H; Yoshimura, N; Koike, Y				Belkacem, Abdelkader Nasreddine; Shin, Duk; Kambara, Hiroyuki; Yoshimura, Natsue; Koike, Yasuharu			Online classification algorithm for eye-movement-based communication systems using two temporal EEG sensors	BIOMEDICAL SIGNAL PROCESSING AND CONTROL			English	Article						Brain computer interface (BCI); EGG-related applications; Eye movements; Electroencephalogram (EEG); Electrooculography (EGG); Wearable sensors; Online classification	HUMAN-COMPUTER INTERFACE; EOG; TRACKING; DEVICE; GUIDANCE	Real-time classification of eye movements offers an effective mode for human-machine interaction, and many eye-based interfaces have been presented in the literature. However, such systems often require that sensors be attached around the eyes, which can be obtrusive and cause discomfort. Here, we used two electroencephalography sensors positioned over the temporal areas to perform real-time classification of eye-blink and five classes of eye movement direction. We applied a continuous wavelet transform for online detection then extracted some discriminable time-series features. Using linear classification, we obtained an average accuracy of 85.2% and sensitivity of 77.6% over all classes. The results showed that the proposed algorithm was efficient in the detection and classification of eye movements, providing high accuracy and low-latency for single trials. This work demonstrates the promise of portable eyemovement-based communication systems and the sensor positions, features extraction, and classification methods used. (C) 2014 Elsevier Ltd. All rights reserved.	[Belkacem, Abdelkader Nasreddine] Tokyo Inst Technol, Dept Informat Proc, Yokohama, Kanagawa 2268503, Japan; [Shin, Duk; Kambara, Hiroyuki; Yoshimura, Natsue; Koike, Yasuharu] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan; [Koike, Yasuharu] Tokyo Inst Technol, Solut Sci Res Lab, Yokohama, Kanagawa 2268503, Japan	Belkacem, AN (reprint author), Tokyo Inst Technol, Dept Informat Proc, Yokohama, Kanagawa 2268503, Japan.	belkacem011@hotmail.com	Belkacem, Abdelkader Nasreddin/E-4569-2014	Belkacem, Abdelkader Nasreddin/0000-0002-3024-4167	Japan Intentional Cooperation Agency (JICA); Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Japan Intentional Cooperation Agency (JICA) and the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. We would like to thank the experimental participants for their time and patience.	Ahmadibakhsh F., 2012, IEEE EMBS C BIOM ENG; Hwang CS, 2014, J MOTOR BEHAV, V46, P233, DOI 10.1080/00222895.2014.891970; Bulling A, 2011, IEEE T PATTERN ANAL, V33, P741, DOI 10.1109/TPAMI.2010.86; Barea R, 2002, IEEE T NEUR SYS REH, V10, P209, DOI 10.1109/TNSRE.2002.806829; Usakli AB, 2010, IEEE T INSTRUM MEAS, V59, P2099, DOI 10.1109/TIM.2009.2030923; Barea R, 2000, INT C PATT RECOG, P668; Pfurtscheller G, 2005, FRON NEUROS, P367; Kumar D, 2002, P ANN INT IEEE EMBS, P64; Kawato S, 2004, IMAGE VISION COMPUT, V22, P1031, DOI 10.1016/j.imavis.2004.03.013; Arimitsu S, 2007, IEEE-ASME T MECH, V12, P511, DOI 10.1109/TMECH.2007.905704; Barea R, 2012, EXPERT SYST APPL, V39, P2677, DOI 10.1016/j.eswa.2011.08.123; Zhu ZW, 2005, COMPUT VIS IMAGE UND, V98, P124, DOI 10.1016/j.cviu.2004.07.012; Aungsakun S, 2011, COMM COM INF SC, V180, P714; Aungsakun S., 2012, INT J PHYS SCI, V7, P2196; Barea R, 2002, J INTELL ROBOT SYST, V34, P279, DOI 10.1023/A:1016359503796; Belkacem A. N., 2013, J MED BIOL ENG; Belov D P, 2010, Neurosci Behav Physiol, V40, P583, DOI 10.1007/s11055-010-9299-z; Cannon JA, 2010, BIOMED SIGNAL PROCES, V5, P229, DOI 10.1016/j.bspc.2010.03.005; Deng LY, 2010, EXPERT SYST APPL, V37, P3337, DOI 10.1016/j.eswa.2009.10.017; Hashimoto M, 2009, IEEE ASME INT C ADV, P1205; IGUCHI H, 1994, MED BIOL ENG COMPUT, V32, P459, DOI 10.1007/BF02524703; James A, 2007, LECT NOTES COMPUT SC, V4792, P110; Kim J, 2004, J NEUROSCI METH, V138, P165, DOI 10.1016/j.jneumeth.2004.04.016; Lv Z, 2010, PATTERN RECOGN LETT, V31, P1041, DOI 10.1016/j.patrec.2009.12.017; Mahmud M, 2010, P IEEE RAS-EMBS INT, P168; Punsawad Y, 2010, IEEE ENG MED BIO, P1360, DOI 10.1109/IEMBS.2010.5626745; Tsui CSL, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P1266; Usakli AB, 2009, IEEE ENG MED BIO, P543, DOI 10.1109/IEMBS.2009.5333742; Yamagishi Kenji, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P2574; Yathunanthan S, 2008, 2008 4TH INTERNATIONAL CONFERENCE ON INFORMATION AND AUTOMATION FOR SUSTAINABILITY (ICIAFS), P390; Yu J.-H., 2012, P IEEE EMBS INT C BI, P305	31	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1746-8094	1746-8108		BIOMED SIGNAL PROCES	Biomed. Signal Process. Control	FEB	2015	16						40	47		10.1016/j.bspc.2014.10.005		8	Engineering, Biomedical; Medical Laboratory Technology	Engineering; Medical Laboratory Technology	AZ1QT	WOS:000348013800006		
J	Kojima, A; Ito, Y; Kitagawa, H; Matsuura, H				Kojima, Akiko; Ito, Yuki; Kitagawa, Hirotoshi; Matsuura, Hiroshi			Ionic mechanisms underlying the negative chronotropic action of propofol on sinoatrial node automaticity in guinea pig heart	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							HISTAMINE H-4 RECEPTOR; PROTEIN-COUPLED RECEPTORS; CONSTITUTIVE ACTIVITY; HUMAN EOSINOPHILS; PHARMACOLOGICAL CHARACTERIZATION; H-4-RECEPTOR AGONIST; BINDING SITE; 1ST POTENT; LIGANDS; CLONING	BACKGROUND AND PURPOSE Propofol is a widely used intravenous anaesthetic agent, but has undesirable cardiac side effects, including bradyarrhythmia and its severe form asystole. This study examined the ionic and cellular mechanisms underlying propofol-induced bradycardia. EXPERIMENTAL APPROACH Sinoatrial node cells, isolated from guinea pig hearts, were current-and voltage-clamped to record action potentials and major ionic currents involved in their spontaneous activity, such as the hyperpolarization-activated cation current (I-f), T-type and L-type Ca2+ currents (I-Ca,I-T and I-Ca,I-L, respectively) and the rapidly and slowly activating delayed rectifier K+ currents (I-Kr and I-Ks, respectively). ECGs were recorded from Langendorff-perfused, isolated guinea pig hearts. KEY RESULTS Propofol (>= 5 mu M) reversibly decreased the firing rate of spontaneous action potentials and their diastolic depolarization rate. Propofol impaired I-f activation by shifting the voltage-dependent activation to more hyperpolarized potentials (>= 1 mu M), slowing the activation kinetics (>= 3 mu M) and decreasing the maximal conductance (>= 10 mu M). Propofol decreased I-Ca,I-T (>= 3 mu M) and I-Ca,I-L (>= 1 mu M). Propofol suppressed I-Ks (>= 3 mu M), but had a minimal effect on I-Kr. Furthermore, propofol (>= 5 mu M) decreased heart rates in Langendorff-perfused hearts. The sinoatrial node cell model reasonably well reproduced the negative chronotropic action of propofol. CONCLUSIONS AND IMPLICATIONS Micromolar concentrations of propofol suppressed the slow diastolic depolarization and firing rate of sinoatrial node action potentials by impairing If activation and reducing I-Ca,I-T, I-Ca,I-L and I-Ks. These observations suggest that the direct inhibitory effect of propofol on sinoatrial node automaticity, mediated via multiple channel inhibition, underlies the propofol-induced bradycardia observed in clinical settings.	[Kojima, Akiko; Ito, Yuki; Kitagawa, Hirotoshi] Shiga Univ Med Sci, Dept Anesthesiol, Otsu, Shiga 5202192, Japan; [Matsuura, Hiroshi] Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 5202192, Japan	Kojima, A (reprint author), Shiga Univ Med Sci, Dept Anesthesiol, Otsu, Shiga 5202192, Japan.	akiko77@belle.shiga-med.ac.jp; matuurah@belle.shiga-med.ac.jp			Japan Society for the Promotion of Science (Tokyo, Japan) [24791590, 24592335, 24591086, 25460287]	This study was supported by a Grant-in-Aid for Young Scientists (B) (No. 24791590 to Akiko Kojima) and a Grant-in-Aid for Scientific Research (C) (No. 24592335 to Hirotoshi Kitagawa and Nos. 24591086 and 25460287 to Hiroshi Matsuura) from the Japan Society for the Promotion of Science (Tokyo, Japan).	Ambrosio C, 2000, MOL PHARMACOL, V57, P198; Nguyen T, 2001, MOL PHARMACOL, V59, P427; Marson CM, 2011, CHEM REV, V111, P7121, DOI 10.1021/cr900166w; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Zampeli E, 2009, BRIT J PHARMACOL, V157, P24, DOI 10.1111/j.1476-5381.2009.00151.x; Liu CL, 2001, J PHARMACOL EXP THER, V299, P121; Morse KL, 2001, J PHARMACOL EXP THER, V296, P1058; Dunford PJ, 2006, J IMMUNOL, V176, P7062; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Igel P, 2009, J MED CHEM, V52, P6297, DOI 10.1021/jm900526h; Smits RA, 2006, J MED CHEM, V49, P4512, DOI 10.1021/jm051008s; Leurs R, 2009, BRIT J PHARMACOL, V157, P14, DOI 10.1111/j.1476-5381.2009.00250.x; Ling P, 2004, BRIT J PHARMACOL, V142, P161, DOI 10.1038/sj.bjp.0705729; Reher TM, 2012, BIOCHEM PHARMACOL, V84, P192, DOI 10.1016/j.bcp.2012.04.004; Jablonowski JA, 2003, J MED CHEM, V46, P3957, DOI 10.1021/jm0341047; Buckland KF, 2003, BRIT J PHARMACOL, V140, P1117, DOI 10.1038/sj.bjp.0705530; Strasser A, 2013, TRENDS PHARMACOL SCI, V34, P13, DOI 10.1016/j.tips.2012.10.004; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Liu CL, 2001, MOL PHARMACOL, V59, P420; Nijmeijer S, 2012, MOL PHARMACOL, V82, P1174, DOI 10.1124/mol.112.080911; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; GETHER U, 1995, J BIOL CHEM, V270, P28268; Zhu Y, 2001, MOL PHARMACOL, V59, P434; Shin N, 2002, MOL PHARMACOL, V62, P38, DOI 10.1124/mol.62.1.38; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Nakamura T, 2000, BIOCHEM BIOPH RES CO, V279, P615, DOI 10.1006/bbrc.2000.4008; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; Seifert R, 2013, TRENDS PHARMACOL SCI, V34, P33, DOI 10.1016/j.tips.2012.11.001; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Ballesteros J. A., 1995, METH NEUROSCI, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Brunskole I, 2011, N-S ARCH PHARMACOL, V384, P301, DOI 10.1007/s00210-011-0673-3; desEsch I J, 2005, TRENDS PHARMACOL SCI, V26, P462; Dunford Paul J, 2011, Adv Exp Med Biol, V709, P53, DOI 10.1007/978-1-4419-8056-4_6; Geyer R, 2011, ARCH PHARM, V344, P775, DOI 10.1002/ardp.201100144; Geyer R, 2014, ARCH PHARM, V347, P77, DOI 10.1002/ardp.201300316; Igel P, 2010, BIOORG MED CHEM LETT, V20, P7191, DOI 10.1016/j.bmcl.2010.10.041; Igel P, 2009, J MED CHEM, V52, P2623, DOI 10.1021/jm9000693; Kooistra AJ, 2013, BRIT J PHARMACOL, V170, P101, DOI 10.1111/bph.12248; LANGE JHM, 1995, TETRAHEDRON, V51, P13447, DOI 10.1016/0040-4020(95)00881-8; Lim HD, 2005, J PHARMACOL EXP THER, V314, P1310, DOI 10.1124/jpet.105.087965; Lim HD, 2008, J PHARMACOL EXP THER, V327, P88, DOI 10.1124/jpet.108.140343; Lim HD, 2010, MOL PHARMACOL, V77, P734, DOI 10.1124/mol.109.063040; Lim HD, 2006, J MED CHEM, V49, P6650, DOI 10.1021/jm060880d; Nordemann U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073961; Oda T, 2001, Nihon Yakurigaku Zasshi, V118, P36; O'Reilly M, 2002, J RECEPT SIGNAL TR R, V22, P431, DOI 10.1081/RRS-120014612; Rossbach K, 2009, EXP DERMATOL, V18, P57, DOI 10.1111/j.1600-0625.2008.00762.x; SCHMUTZ J, 1967, HELV CHIM ACTA, V50, P245, DOI 10.1002/hlca.19670500131; Schneider EH, 2009, BIOCHEMISTRY-US, V48, P1424, DOI 10.1021/bi802050d; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Schnell D, 2011, N-S ARCH PHARMACOL, V383, P457, DOI 10.1007/s00210-011-0612-3; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Strasser A, 2013, J MOL MODEL, V19, P4443, DOI 10.1007/s00894-013-1923-8	58	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	FEB	2015	172	3					799	814		10.1111/bph.12936		16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY8EP	WOS:000347787500006		
J	Aramaki, T; Moriguchi, M; Bekku, E; Endo, M; Asakura, K; Boku, N; Yoshimura, K				Aramaki, Takeshi; Moriguchi, Michihisa; Bekku, Emima; Endo, Masahiro; Asakura, Koiku; Boku, Narikazu; Yoshimura, Kenichi			Prospective Evaluation of the Optimal Duration of Bed Rest After Vascular Interventions Using a 3-French Introducer Sheath	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Bed rest duration; 3-French introducer sheath; Non-coronary intervention	PROSPECTIVE RANDOMIZED TRIAL; EARLY AMBULATION; CARDIAC-CATHETERIZATION	To assess optimal bed-rest duration after vascular intervention by way of the common femoral artery using 3F introducer sheaths. Eligibility criteria for this single-center, prospective study included clinically necessary angiography, no coagulopathy or anticoagulant therapy, no hypersensitivity to contrast medium, age > 20 years, and written, informed consent. Enrolled patients were assigned to one of three groups (105/group) with the duration of bed rest deceased sequentially. A sheath was inserted by way of the common femoral artery using the Seldinger technique. The first group (level 1) received 3 h of bed rest after the vascular intervention. If no bleeding or hematomas developed, the next group (level 2) received 2.5 h of bed rest. If still no bleeding or hematomas developed, the final group (level 3) received 2 h of bed rest. If any patient had bleeding or hematomas after bed rest, the study was terminated, and the bed rest of the preceding level was considered the optimal duration. A total of 105 patients were enrolled at level 1 between November 2010 and September 2011. Eight patients were excluded from analysis because cessation of bed rest was delayed. None of the remaining subjects experienced postoperative bleeding; therefore, patient enrollment at level 2 began in September 2011. However, puncture site bleeding occurred in the 52nd patient immediately after cessation of bed rest, necessitating study termination. To prevent bleeding, at least 3 h of postoperative bed rest is recommended for patients undergoing angiography using 3F sheaths.	[Aramaki, Takeshi; Moriguchi, Michihisa; Bekku, Emima] Shizuoka Canc Ctr, Div Intervent Radiol, Nagaizumi, Shizuoka 4118777, Japan; [Endo, Masahiro; Asakura, Koiku] Shizuoka Canc Ctr, Div Diagnost Radiol, Nagaizumi, Shizuoka 4118777, Japan; [Boku, Narikazu] Shizuoka Canc Ctr, Div Med Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Boku, Narikazu] St Marianna Univ, Sch Med, Dept Med Oncol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Yoshimura, Kenichi] Kobe Univ Hosp, Clin Res Ctr, Chuo Ku, Kobe, Hyogo 6500017, Japan	Aramaki, T (reprint author), Shizuoka Canc Ctr, Div Intervent Radiol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	t.aramaki@scchr.jp; m.moriguchi@scchr.jp; e.bekku@scchr.jp; m.endo@scchr.jp; k.asakura@scchr.jp; n.boku@marianna-u.ac.jp; keyoshim@med.kobe-u.ac.jp					Ishiyama Koichi, 2002, Nippon Acta Radiologica, V62, P362; KERN MJ, 1990, J AM COLL CARDIOL, V15, P1475; LAU KW, 1993, CATHETER CARDIO DIAG, V28, P34, DOI 10.1002/ccd.1810280107; Mohammady M, 2014, INT J NURS STUD, V51, P39, DOI 10.1016/j.ijnurstu.2012.12.018; Tagney Jenny, 2005, Nurs Crit Care, V10, P167; Wood RA, 1997, CATHETER CARDIO DIAG, V42, P8, DOI 10.1002/(SICI)1097-0304(199709)42:1<8::AID-CCD3>3.0.CO;2-8	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	FEB	2015	38	1					40	44		10.1007/s00270-014-0892-3		5	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AY8RH	WOS:000347820600005		
J	Okada, T; Pellerin, O; Savard, S; Curis, E; Monge, M; Frank, M; Bobrie, G; Yamaguchi, M; Sugimoto, K; Plouin, PF; Azizi, M; Sapoval, M				Okada, Takuya; Pellerin, Olivier; Savard, Sebastien; Curis, Emmanuel; Monge, Matthieu; Frank, Michael; Bobrie, Guillaume; Yamaguchi, Masato; Sugimoto, Koji; Plouin, Pierre-Francois; Azizi, Michel; Sapoval, Marc			Eligibility for Renal Denervation: Anatomical Classification and Results in Essential Resistant Hypertension	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Arterial intervention; Hypertension; Radiofrequency ablation; Kidney/renal	BLOOD-PRESSURE CHANGES; SYMPATHETIC DENERVATION; CT-ANGIOGRAPHY; ARTERY STENOSIS; TRIAL; VARIANTS; DIAMETER; INDICATE; ABLATION; EFFICACY	To classify the renal artery (RA) anatomy based on specific requirements for endovascular renal artery denervation (RDN) in patients with drug-resistant hypertension (RH). The RA anatomy of 122 consecutive RH patients was evaluated by computed tomography angiography and classified as two types: A (main RA a parts per thousand yen20 mm in length and a parts per thousand yen4.0 mm in diameter) or B (main RA < 20 mm in length or main RA < 4.0 mm in diameter). The A type included three subtypes: A1 (without accessory RAs), A2 (with accessory RAs < 3.0 mm in diameter), and A3 (with accessory RAs a parts per thousand yen3.0 mm in diameter]. A1 and A2 types were eligible for RDN with the Simplicity Flex catheter. Type B included twi subtypes based on the main RA length and diameter. Patients were accordingly classified into three eligibility categories: complete (CE; both RAs were eligible), partial (PE; one eligible RA), and noneligibility (NE; no eligible RA). Bilateral A1 type was the most prevalent and was observed in 48.4 % of the patients followed by the A1/A2 type (18 %). CE, PE, and NE were observed in 69.7, 22.9, and 7.4 % of patients, respectively. The prevalence of accessory RAs was 41 %. Of RH patients, 30.3 % were not eligible for bilateral RDN with the current Simplicity Flex catheter. This classification provides the basis for standardized reporting to allow for pooling of results of larger patient cohorts in the future.	[Okada, Takuya; Pellerin, Olivier; Sapoval, Marc] Georges Pompidou European Hosp, AP HP, Dept Cardiovasc & Intervent Radiol, F-75015 Paris, France; [Okada, Takuya; Yamaguchi, Masato; Sugimoto, Koji] Kobe Univ Hosp, Dept Radiol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Okada, Takuya; Yamaguchi, Masato; Sugimoto, Koji] Kobe Univ Hosp, Ctr Endovasc Therapy, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Pellerin, Olivier; Plouin, Pierre-Francois; Azizi, Michel; Sapoval, Marc] Paris Descartes Univ, F-75005 Paris, France; [Savard, Sebastien; Frank, Michael; Bobrie, Guillaume; Plouin, Pierre-Francois; Azizi, Michel] Georges Pompidou European Hosp, AP HP, Dept Hypertens, F-75015 Paris, France; [Curis, Emmanuel; Monge, Matthieu; Azizi, Michel] INSERM, Clin Invest Ctr 9201, F-75015 Paris, France; [Curis, Emmanuel] Univ Paris 05, Lab Biomath, Fac Pharm, UMR U1144, F-75006 Paris, France	Okada, T (reprint author), Georges Pompidou European Hosp, AP HP, Dept Cardiovasc & Intervent Radiol, F-75015 Paris, France.	okabone@gmail.com		Curis, Emmanuel/0000-0001-8382-1493			Atherton DS, 2012, CLIN ANAT, V25, P628, DOI 10.1002/ca.21280; Glodny B, 2000, J HYPERTENS, V18, P1437, DOI 10.1097/00004872-200018100-00011; NOMURA G, 1971, AM HEART J, V81, P274, DOI 10.1016/0002-8703(71)90140-2; Mahfoud F, 2013, CIRCULATION, V128, P132, DOI 10.1161/CIRCULATIONAHA.112.000949; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Id D, 2013, JACC-CARDIOVASC INTE, V6, P1085, DOI 10.1016/j.jcin.2013.06.007; Villablanca JP, 2007, AM J ROENTGENOL, V188, P593, DOI 10.2214/AJR.05.2143; Urban BA, 2001, RADIOGRAPHICS, V21, P373; Davis MI, 2013, J AM COLL CARDIOL, V62, P231, DOI 10.1016/j.jacc.2013.04.010; Persu A, 2014, J HUM HYPERTENS, V28, P150, DOI 10.1038/jhh.2013.88; Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Kandzari DE, 2012, CLIN CARDIOL, V35, P528, DOI 10.1002/clc.22008; Ormiston JA, 2013, EUROINTERVENTION, V9, P70, DOI 10.4244/EIJV9I1A11; Worthley SG, 2013, EUR HEART J, V34, P2132, DOI 10.1093/eurheartj/eht197; Mabin T, 2012, EUROINTERVENTION, V8, P57, DOI 10.4244/EIJV8I1A10; Aytac SK, 2003, J ULTRAS MED, V22, P433; Azizi M, 2012, EUR J VASC ENDOVASC, V43, P293, DOI 10.1016/j.ejvs.2011.11.022; Beregi JP, 1999, EUR RADIOL, V9, P1330, DOI 10.1007/s003300050843; Garovic VD, 2010, J MAGN RESON IMAGING, V31, P390, DOI 10.1002/jmri.22032; Gumus H, 2012, RENAL FAILURE, V34, P286, DOI 10.3109/0886022X.2011.647295; Himmel F, 2012, J CLIN HYPERTENS, V14, P187, DOI 10.1111/j.1751-7176.2011.00585.x; Hoppe UC, 2012, 2012 ANN SCI SESS EU; Hutchinson BD, 2013, AM J ROENTGENOL, V201, pW342, DOI 10.2214/AJR.12.8560; Kawamoto S, 2003, AM J ROENTGENOL, V180, P1633; Manea CN, 2011, ROM J MORPHOL EMBRYO, V52, P855; Neri E, 1999, CARDIOVASC INTER RAD, V22, P1, DOI 10.1007/s002709900320; Ozkan Uğur, 2006, Diagn Interv Radiol, V12, P183; Palmieri Breno José, 2011, Rev Col Bras Cir, V38, P116, DOI 10.1590/S0100-69912011000200009; Ramadan SU, 2011, DIAGN INTERV RADIOL, V17, P266, DOI 10.4261/1305-3825.DIR.3507-10.0; Saba L, 2008, ACTA RADIOL, V49, P278, DOI 10.1080/02841850701777408; Sapoval M, 2012, CARDIOVASC INTER RAD, V35, P463, DOI 10.1007/s00270-011-0306-8; SAUNDERS HS, 1995, RADIOGRAPHICS, V15, P1069; Savard S, 2012, J AM COLL CARDIOL, V60, P2422, DOI 10.1016/j.jacc.2012.08.1002; Schmid A, 2013, CARDIOVASC INTER RAD, V36, P987, DOI 10.1007/s00270-013-0652-9; Standring S, 2008, GRAYS ANATOMY ANATOM; Verloop WL, 2013, J HYPERTENS, V31, P1662, DOI 10.1097/HJH.0b013e328362152e	37	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	FEB	2015	38	1					79	87		10.1007/s00270-014-0865-6		9	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AY8RH	WOS:000347820600011		
J	Iguchi, T; Hiraki, T; Gobara, H; Fujiwara, H; Matsui, Y; Sugimoto, S; Toyooka, S; Oto, T; Miyoshi, S; Kanazawa, S				Iguchi, Toshihiro; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Sugimoto, Seiichiro; Toyooka, Shinichi; Oto, Takahiro; Miyoshi, Shinichiro; Kanazawa, Susumu			Transfissural Route Used for Preoperative Localization of Small Pulmonary Lesions with a Short Hook Wire and Suture System	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Non-vascular interventions; Lung/pulmonary; Cancer	ASSISTED THORACOSCOPIC SURGERY; NEEDLE-BIOPSY; NODULES; RESECTION; EXPERIENCE; MARKING	We retrospectively evaluated the results of the transfissural route for preoperative localization with a short hook wire and suture system for video-assisted thoracoscopic surgery (VATS). Eleven patients with 11 tumors underwent CT-guided transfissural placement of a hook wire before VATS. This route was selected for all patients, because the distance between the tumor and interlobar fissure was much shorter than the required distance traversed using the conventional approach. Complications were evaluated using the National Cancer Institute Common Terminology Criteria for Adverse Events Version 4.0. The hook wire was successfully placed using the transfissural route in all but one case. Of these ten successful placements, two tumors needed a second puncture for optimal placement, because the CT scan showed that the first hook wire was not properly placed in the lung. In one patient, we did not attempt replacement after the first placement was incorrect. In ten successful procedures, the mean distance traversed in the parenchyma of the unaffected lung lobe was 27.9 mm. The distance between the pleura and placed hook wire was significantly shorter than the estimated distance between the pleura and hook wire using the conventional route (mean 16.3 vs. 40.9 mm; P = 0.0002). Grade 1 adverse events occurred (11 pneumothoraxes and 4 pulmonary hemorrhages). No grade 2 or higher adverse event was observed. The transfissural route used for preoperative localization before VATS is useful for selected patients because this route may allow for more limited lung parenchyma resection.	[Iguchi, Toshihiro; Hiraki, Takao; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Kanazawa, Susumu] Okayama Univ, Sch Med, Dept Radiol, Kita Ku, Okayama 7008558, Japan; [Sugimoto, Seiichiro; Toyooka, Shinichi; Oto, Takahiro; Miyoshi, Shinichiro] Okayama Univ, Dept Gen Thorac Surg, Sch Med, Kita Ku, Okayama 7008558, Japan; [Toyooka, Shinichi] Okayama Univ, Dept Clin Genom Med, Sch Med, Kita Ku, Okayama 7008558, Japan	Iguchi, T (reprint author), Okayama Univ, Sch Med, Dept Radiol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	iguchi@ba2.so-net.ne.jp; takaoh@tc4.so-net.ne.jp; gobara@cc.okayama-u.ac.jp; hirofujiwar@gmail.com; wckyh140@yahoo.co.jp; sei1675sugi@yahoo.co.jp; shintoyooka@gmail.com; yellowpeachoto@hotmail.com; smiyoshi@md.okayama-u.ac.jp; susumu@cc.okayama-u.ac.jp					Suzuki K, 1999, CHEST, V115, P563, DOI 10.1378/chest.115.2.563; Ciriaco P, 2004, EUR J CARDIO-THORAC, V25, P429, DOI 10.1016/j.ejcts.2003.11.036; Tomiyama N, 2006, EUR J RADIOL, V59, P60, DOI 10.1016/j.ejrad.2006.02.001; Ichinose J, 2013, ANN THORAC SURG, V96, P1203, DOI 10.1016/j.athoracsur.2013.05.026; Miyoshi K, 2009, EUR J CARDIO-THORAC, V36, P378, DOI 10.1016/j.ejcts.2009.03.039; Dendo S, 2002, RADIOLOGY, V225, P511, DOI 10.1148/radiol.2252011025; KANAZAWA S, 1995, CARDIOVASC INTER RAD, V18, P122, DOI 10.1007/BF02807237; Seo JM, 2012, J THORAC CARDIOV SUR, V143, P809, DOI 10.1016/j.jtcvs.2011.10.038; Hiraki T, 2010, AM J ROENTGENOL, V194, P809, DOI 10.2214/AJR.09.3224; Chen SF, 2011, SURG ENDOSC, V25, P1723, DOI 10.1007/s00464-010-1502-3; Gonflotti A, 2007, EUR J CARDIO-THORAC, V32, P843, DOI 10.1016/j.ejcts.2007.09.002; Huang W, 2013, THORAC CARDIOVASC SU, DOI [10.1007/978-1-4614-8217-8, DOI 10.1007/978-1-4614-8217-8]; Kanazawa S, 1998, AM J ROENTGENOL, V170, P332; NOPPEN MMP, 1995, CHEST, V107, P1615, DOI 10.1378/chest.107.6.1615	14	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	FEB	2015	38	1					222	226		10.1007/s00270-014-0862-9		5	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AY8RH	WOS:000347820600028		
J	Yabu, T; Shiba, H; Shibasaki, Y; Nakanishi, T; Imamura, S; Touhata, K; Yamashita, M				Yabu, T.; Shiba, H.; Shibasaki, Y.; Nakanishi, T.; Imamura, S.; Touhata, K.; Yamashita, M.			Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling	CELL DEATH AND DIFFERENTIATION			English	Article							BAX-DEPENDENT APOPTOSIS; FAS-INDUCED APOPTOSIS; CELL-FREE SYSTEM; NEUTRAL SPHINGOMYELINASE; PROTEIN-KINASE; C-JUN; PHOSPHOLIPASE A(2); HL-60 CELLS; MAP KINASE; PATHWAY	Neutral sphingomyelinase (nSMase) activation in response to environmental stress or inflammatory cytokine stimuli generates the second messenger ceramide, which mediates the stress-induced apoptosis. However, the signaling pathways and activation mechanism underlying this process have yet to be elucidated. Here we show that the phosphorylation of nSMase1 (sphingomyelin phosphodiesterase 2, SMPD2) by c-Jun N-terminal kinase (JNK) signaling stimulates ceramide generation and apoptosis and provide evidence for a signaling mechanism that integrates stress-and cytokine-activated apoptosis in vertebrate cells. An nSMase1 was identified as a JNK substrate, and the phosphorylation site responsible for its effects on stress and cytokine induction was Ser-270. In zebrafish cells, the substitution of Ser-270 for alanine blocked the phosphorylation and activation of nSMase1, whereas the substitution of Ser-270 for negatively charged glutamic acid mimicked the effect of phosphorylation. The JNK inhibitor SP600125 blocked the phosphorylation and activation of nSMase1, which in turn blocked ceramide signaling and apoptosis. A variety of stress conditions, including heat shock, UV exposure, hydrogen peroxide treatment, and anti-Fas antibody stimulation, led to the phosphorylation of nSMase1, activated nSMase1, and induced ceramide generation and apoptosis in zebrafish embryonic ZE and human Jurkat T cells. In addition, the depletion of MAPK8/9 or SMPD2 by RNAi knockdown decreased ceramide generation and stress-and cytokine-induced apoptosis in Jurkat cells. Therefore the phosphorylation of nSMase1 is a pivotal step in JNK signaling, which leads to ceramide generation and apoptosis under stress conditions and in response to cytokine stimulation. nSMase1 has a common central role in ceramide signaling during the stress and cytokine responses and apoptosis.	[Yabu, T.; Shiba, H.; Shibasaki, Y.; Nakanishi, T.] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan; [Imamura, S.; Touhata, K.; Yamashita, M.] Natl Res Inst Fisheries Sci, Food Safety Assessment Res Grp, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan	Yamashita, M (reprint author), Natl Res Inst Fisheries Sci, Food Safety Assessment Res Grp, Kanazawa Ku, 12-4 Fukuura 2, Yokohama, Kanagawa 2368648, Japan.	mic@affrc.go.jp			Japan Science and Technology Corporation [22780193]; Japan Society for the Promotion of Science; Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported by grants-in-aid for scientific research 22780193 (to TY) from the Japan Science and Technology Corporation; the Japan Society for the Promotion of Science, and the Ministry of Agriculture, Forestry and Fisheries of Japan.	DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Sawai H, 1999, J BIOL CHEM, V274, P38131, DOI 10.1074/jbc.274.53.38131; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; TEPPER CG, 1995, P NATL ACAD SCI USA, V92, P8443, DOI 10.1073/pnas.92.18.8443; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Dbaibo GS, 1997, J EXP MED, V185, P481, DOI 10.1084/jem.185.3.481; Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Oorni K, 1998, J BIOL CHEM, V273, P29127, DOI 10.1074/jbc.273.44.29127; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; Huwiler A, 2001, FASEB J, V15, P7; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Veiga MP, 1999, BIOPHYS J, V76, P342; AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Watanabe M, 2004, CANCER RES, V64, P1000, DOI 10.1158/0008-5472.CAN-03-1383; MACHLEIDT T, 1994, J BIOL CHEM, V269, P13760; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Zumbansen M, 2002, MOL CELL BIOL, V22, P3633, DOI 10.1128/MCB.22.11.3633-3638.2002; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; Jaffrezou JP, 1996, EMBO J, V15, P2417; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Gupta S, 1996, EMBO J, V15, P2760; Clarke CJ, 2011, BIOCHEM J, V435, P381, DOI 10.1042/BJ20101752; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Caricchio R, 2002, CELL DEATH DIFFER, V9, P574, DOI 10.1038/sj.cdd.4400996; Chang Y, 1995, P NATL ACAD SCI USA, V92, P12275, DOI 10.1073/pnas.92.26.12275; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Jana A, 2004, J BIOL CHEM, V279, P51451, DOI 10.1074/jbc.M404635200; Khelifi AF, 2005, CELL DEATH DIFFER, V12, P724, DOI 10.1038/sj.cdd.4401559; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Mizutani Y, 2001, J CELL SCI, V114, P3727; SANCHEZ I, 1994, NATURE, V372, P794; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376; Sparagna G C, 2000, AM J PHYSIOL-HEART C, V279, P2124; Tepper AD, 2001, BIOCHEM BIOPH RES CO, V280, P634, DOI 10.1006/bbrc.2000.4166; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tonnetti L, 1999, J EXP MED, V189, P1581, DOI 10.1084/jem.189.10.1581; Trajkovic K, 2008, SCIENCE, V319, P244; Watts JD, 1997, P NATL ACAD SCI USA, V94, P7292, DOI 10.1073/pnas.94.14.7292; Wei Y, 2006, AM J PHYSIOL-ENDOC M, V291, P275; Wilsbacher JL, 2006, BIOCHEMISTRY-US, V45, P13175, DOI 10.1021/bi061041w; Yabu T, 2009, J BIOL CHEM, V284, P20349, DOI 10.1074/jbc.M109.004580; Yabu T, 2001, BIOCHEM J, V360, P39, DOI 10.1042/0264-6021:3600039; YAN MH, 1994, NATURE, V372, P798; YANG ZH, 1993, J BIOL CHEM, V268, P20520	63	5	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	FEB	2015	22	2			SI		258	273		10.1038/cdd.2014.128		16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AY9AR	WOS:000347842500009		
J	Kumari, A; Iwasaki, T; Pyndiah, S; Cassimere, EK; Palani, CD; Sakamuro, D				Kumari, A.; Iwasaki, T.; Pyndiah, S.; Cassimere, E. K.; Palani, C. D.; Sakamuro, D.			Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation	CELL DEATH AND DIFFERENTIATION			English	Article							TUMOR-SUPPRESSOR BIN1; C-MYC; TRANSCRIPTIONAL TARGET; CELL-PROLIFERATION; CANCER SUPPRESSION; PARP INHIBITORS; POLYMERASE 1; GENE-CONTROL; PROTEIN; DEATH	The transcription factor adenovirus E2 promoter-binding factor (E2F)-1 normally enhances cell-cycle progression, but it also induces apoptosis under certain conditions, including DNA damage and serum deprivation. Although DNA damage facilitates the phosphorylation and stabilization of E2F1 to trigger apoptosis, how serum starvation renders cells vulnerable to E2F1-induced apoptosis remains unclear. Because poly(ADP-ribose) polymerase 1 (PARP1), a nuclear enzyme essential for genomic stability and chromatin remodeling, interacts directly with E2F1, we investigated the effects of PARP1 on E2F1-mediated functions in the presence and absence of serum. PARP1 attenuation, which increased E2F1 transactivation, induced G(2)/M cell-cycle arrest under normal growth conditions, but enhanced E2F1-induced apoptosis in serum-starved cells. Interestingly, basal PARP1 activity was sufficient to modify E2F1 by poly(ADP-ribosyl)ation, which stabilized the interaction between E2F1 and the BIN1 tumor suppressor in the nucleus. Accordingly, BIN1 acted as an RB1-independent E2F1 corepressor. Because E2F1 directly activates the BIN1 gene promoter, BIN1 curbed E2F1 activity through a negative-feedback mechanism. Conversely, when the BIN1-E2F1 interaction was abolished by PARP1 suppression, E2F1 continuously increased BIN1 levels. This is functionally germane, as PARP1-depletion-associated G(2)/M arrest was reversed by the transfection of BIN1 siRNA. Moreover, PARP-inhibitor-associated anti-transformation activity was compromised by the coexpression of dominant-negative BIN1. Because serum starvation massively reduced the E2F1 poly(ADP-ribosyl) ation, we conclude that the release of BIN1 from hypo-poly(ADP-ribosyl)ated E2F1 is a mechanism by which serum starvation promotes E2F1-induced apoptosis.	[Kumari, A.; Iwasaki, T.; Palani, C. D.; Sakamuro, D.] Georgia Regents Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Ctr Canc, Augusta, GA 30912 USA; [Kumari, A.; Pyndiah, S.; Cassimere, E. K.; Sakamuro, D.] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Mol Signaling Program, New Orleans, LA 70112 USA; [Iwasaki, T.] Kobe Univ, Res Ctr Environm Genom, Lab Mol Biol, Kobe, Hyogo 657, Japan	Sakamuro, D (reprint author), Georgia Regents Univ, Dept Biochem & Mol Biol, Ctr Canc, 1410 Laney Walker Blvd, Augusta, GA 30912 USA.	dsakamuro@gru.edu			US National Institutes of Health (NIH) [R01CA140379]; US Army Department of Defense Prostate Cancer Research Program (DAMD) [17-02-1-0131]; Kobe University Presidential Award for International Education and Research; Ruth L. Kirschstein National Research Service Award for Predoctoral Training (NIH) [F31]	We thank F Dantzer, M Weitzman, and K Munger for the reagents; W King for technical assistance with flow cytometry; GC Prendergast for helpful discussion; and M Herlyn for critical reading of the manuscript. This work was supported in part by grants from the US National Institutes of Health (NIH) (R01CA140379) and the US Army Department of Defense Prostate Cancer Research Program (DAMD 17-02-1-0131) (to DS). TI was the recipient of the 2013-2014 Kobe University Presidential Award for International Education and Research. EKC was the recipient of the Ruth L. Kirschstein National Research Service Award for Predoctoral Training (NIH F31).	Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Johnson DG, 2006, CURR MOL MED, V6, P731; Prokic I, 2014, J MOL MED, V92, P453, DOI 10.1007/s00109-014-1138-1; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Stanelle J, 2006, TRENDS MOL MED, V12, P177, DOI 10.1016/j.molmed.2006.02.002; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; del Arroyo AG, 2007, CELL CYCLE, V6, P2697; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Chiou SH, 2013, J EXP MED, V210, P85, DOI 10.1084/jem.20121044; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CANT-07-1100; Hong TT, 2014, NAT MED, V20, P624, DOI 10.1038/nm.3543; Ge K, 2000, INT J CANCER, V85, P376; Tan MS, 2013, TRENDS MOL MED, V19, P594, DOI 10.1016/j.molmed.2013.06.004; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Hong TT, 2012, HEART RHYTHM, V9, P812, DOI 10.1016/j.hrthm.2011.11.055; Yelamos J, 2011, AM J CANCER RES, V1, P328; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Cassimere EK, 2009, CELL DEATH DIFFER, V16, P1641, DOI 10.1038/cdd.2009.98; Chang MY, 2007, CANCER RES, V67, P100, DOI 10.1158/0008-5472.CAN-06-2742; DuHadaway JB, 2001, CANCER RES, V61, P3151; Elliott K, 2000, ONCOGENE, V19, P4669, DOI 10.1038/sj.onc.1203681; Elliott K, 1999, ONCOGENE, V18, P3564, DOI 10.1038/sj.onc.1202670; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Ge K, 2000, INT J CANCER, V86, P155, DOI 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M; Ghaneie A, 2007, CANCER BIOL THER, V6, P192; Guo XE, 2014, CURR DRUG TARGETS, V15, P2, DOI 10.2174/1389450114666140106095151; Hong TT, 2012, HEART RHYTHM, V9, P961, DOI 10.1016/j.hrthm.2012.01.024; Kingwell Katie, 2013, Nat Rev Neurol, V9, P184, DOI 10.1038/nrneurol.2013.34; Kinney EL, 2008, J CELL PHYSIOL, V216, P621, DOI 10.1002/jcp.21437; Kummar S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-25; Lundgaard GL, 2011, J CELL BIOCHEM, V112, P2992, DOI 10.1002/jcb.23222; MUNGER K, 1991, J VIROL, V65, P3943; Orr Bernardo, 2013, Front Oncol, V3, P164, DOI 10.3389/fonc.2013.00164; Prendergast GC, 2009, BBA-REV CANCER, V1795, P25, DOI 10.1016/j.bbcan.2008.09.001; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; Stiewe T, 2000, NAT GENET, V26, P464; Szanto M, 2012, CELL MOL LIFE SCI, V69, P4079; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453	55	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	FEB	2015	22	2			SI		311	322		10.1038/cdd.2014.146		12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AY9AR	WOS:000347842500013		
J	Hoshi-Watanabe, M; Musatti, T; Rayna, S; Vandenbroeck, M				Hoshi-Watanabe, Miwako; Musatti, Tullia; Rayna, Sylvie; Vandenbroeck, Michel			Origins and rationale of centres for parents and young children together	CHILD & FAMILY SOCIAL WORK			English	Article						child care planning; child care policy and practice; child welfare; family policy; family social work; parenting; parenthood	SOCIAL SUPPORT; SERVICES; CONTEXT; POLICY	The range of centres where parents and children come together has mushroomed in different parts of the world, as new social work practices address the emerging non-material needs of parents in changing demographic contexts. In this paper, we explore the origins and modi operandi of these centres in Belgium, France, Italy and Japan. Analysis of previous studies and policy documents reveal diverse political rationales, including addressing declining birth rates, preventing psychosocial problems and social isolation of mothers and promoting social cohesion and equality of educational opportunities. Remarkably, despite the diverse cultural and socio-political contexts and rationales, these centres also share very similar ways of functioning and provide an informal type of social support to parents with young children. As these recently emerged centres are seldom studied, further research is welcomed to explore parents' and professionals' perspectives.	[Hoshi-Watanabe, Miwako] Nagoya Univ Arts, Nagoya, Aichi, Japan; [Musatti, Tullia] Natl Res Council Italy, Inst Cognit Sci & Technol, Rome, Italy; [Rayna, Sylvie] Univ Paris 13, Ctr Experice, Paris, France; [Rayna, Sylvie] Ecole Normale Super Lyon, F-69364 Lyon, France; [Vandenbroeck, Michel] Univ Ghent, Dept Social Welf Studies, B-9000 Ghent, Belgium	Vandenbroeck, M (reprint author), Univ Ghent, Dept Social Welf Studies, B-9000 Ghent, Belgium.	Michel.Vandenbroeck@UGent.be		MUSATTI, TULLIA/0000-0003-0473-5250			Andreoli S., 1996, GIFT MAGGIO, P3; [Anonymous], 2003, GIFT SELLEMBRE, P9; Winkworth G, 2010, CHILD FAM SOC WORK, V15, P206, DOI 10.1111/j.1365-2206.2009.00660.x; Gillies V, 2005, CRIT SOC POLICY, V25, P70, DOI 10.1177/0261018305048968; Baudelot O., 1997, BEBES CULTURE; Cambi I., 2008, CTR BAMBINI GENITORI; Cameron C., 2007, CARE WORK EUROPE CUR; Cunningham H., 1995, CHILDREN CHILDHOOD W; Dolto F., 1985, LA CAUSE DES ENFANTS; DOLTO Francoise, 1981, ENFANTS SOUFFRANCE, P137; Eme B., 1993, STRUCTURES INTERMEDI; Featherstone B, 2006, BRIT J SOC WORK, V36, P5, DOI 10.1093/bjsw/bch226; Feret G., 2009, ACCUEIL QUALITE PETI, P311; Fram MS, 2005, AM J ORTHOPSYCHIAT, V75, P507, DOI 10.1037/0002-9432.75.4.507; Geens N., EUROPEAN EARLY CHILD, V21; Hardy F, 2008, CHILD FAM SOC WORK, V13, P252, DOI 10.1111/j.1365-2206.2008.00545.x; Institut de Recherche Appliquee pour l'Enfant et le Couple, 1992, ENTR DONC PSYCH ACC; Leprince F., 2004, ACCUEIL JEUNES ENFAN; Malandrin M. H., 2009, F DOLTO PSYCHANALYST; Mantovani S, 1996, EUR J PSYCHOL EDUC, V11, P119; Mantovani S., 1999, BAMBINI ADULTI INSIE; Martin C., SUSTAINABILITY TRANS; Musatti T., 2009, 19 EECERA C STRASB 2; Musatti T., 2005, LUOGO BAMBINI GENITO; Nakaya N., 2006, J SOCIAL SECURITY, V42, P165; Neyrand G., 1995, PAS MAISON VERTE; Neyrand G., 2011, SOUTENIR CONTROLER P; Novy A, 2012, URBAN STUD, V49, P1873, DOI 10.1177/0042098012444878; Organisation for Economic Co-operation and Development, 2011, DIV WE STAND; Rullo G, 2005, EUR J PSYCHOL EDUC, V20, P107; Scheu H., 2011, LIEUX ACCUEIL ENFANT; Scheu H., 2010, PARENTS PROFESSIONNE; Shiomi T., 2008, KOSODATE SHIENNO CHO; Shirai C., 2009, KOSODATE SHIEN SEIDO; This B., 2007, MAISON VERTE CREER L; Tuchida M., 2011, B RYUKOKU U FACULTY, V39, P21; Vandenbroeck M., 2009, CONT ISSUES EARLY CH, V10, P66, DOI DOI 10.2304/CIEC.2009.10.1.66; Vandeurzen J., 2010, BELEIDSBRIEF WELZIJN; Vandeurzen J., 2011, BELEIDSBRIEFWELZIJN; Walker L, 2010, CHILD FAM SOC WORK, V15, P238, DOI 10.1111/j.1365-2206.2009.00664.x	40	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-7500	1365-2206		CHILD FAM SOC WORK	Child Fam. Soc. Work	FEB	2015	20	1					62	71		10.1111/cfs.12056		10	Family Studies; Social Work	Family Studies; Social Work	AY6ZS	WOS:000347711700007		
J	Liu, XY; Hayashi, F; Yang, D				Liu, Xingyue; Hayashi, Fumio; Yang, Ding			Phylogeny of the family Sialidae (Insecta: Megaloptera) inferred from morphological data, with implications for generic classification and historical biogeography	CLADISTICS			English	Article							ESBEN-PETERSEN MEGALOPTERA; NEUROPTERIDA INSECTA; ALDERFLY GENUS; CLADISTIC-ANALYSIS; SOUTH-AFRICA; REVISION; HOLOMETABOLA; CORYDALIDAE; VICARIANCE; DISPERSAL	Sialidae (alderflies) is a family of the holometabolous insect order Megaloptera, with ca. 75 extant species in eight genera distributed worldwide. Alderflies are a group of living fossils with a long evolutionary history. The oldest fossil attributed to Sialidae dates back to the Early Jurassic period. Further, the global distribution of modern-day species shows a remarkably disjunctive pattern. However, due to the rareness of most species and scarcity of comprehensive taxonomic revisions, the phylogeny of Sialidae remains largely unexplored, and the present classification system is in great need of renewal. Here we reconstruct the first phylogeny for Sialidae worldwide based on the most comprehensive sampling and broadest morphological data ever presented for this group of insects. All Cenozoic alderflies belong to a monophyletic clade, which may also include the Early Jurassic genus dagger Dobbertinia, and the Late Jurassic genus dagger Sharasialis is their putative sister taxon. Two subfamilies of Sialidae are proposed, namely dagger Sharasialinae subfam. nov. and Sialidinae. Austrosialis is the sister of all other extant genera, an assemblage which comprises three monophyletic lineages: the Stenosialis lineage, the Ilyobius lineage, and the Sialis lineage. The revised classification of Sialidae is composed of 12 valid genera and 87 valid species. Ilyobius and Protosialis are recognized as valid generic names, while Nipponosialis is treated as a synonym of Sialis. Reconstruction of the ancestral area proposes a global distribution of alderflies in Pangaea before their diversification. The generic diversification of alderflies might have occurred before the breakup of Pangaea, but the divergence of some lineages or genera was probably promoted by the splitting of this supercontinent. (C) The Willi Hennig Society 2014.	[Liu, Xingyue; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China; [Hayashi, Fumio] Tokyo Metropolitan Univ, Dept Biol, Hachioji, Tokyo 1920397, Japan	Liu, XY (reprint author), China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China.	xingyue_liu@yahoo.com; dyangcau@126.com	Liu, Xingyue/A-3019-2013		National Natural Science Foundation of China [31320103902, 31322501]; National Key Basic Research Program of China (973 Program) [2013CB127600]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201178]; Japan Society for the Promotion of Science (JSPS) [20-08417]	We thank the following curators who kindly loaned or supplied specimens for this study: Dr L. Abraham (Kaposvar), Dr U. Aspock (NHMW, Vienna), Dr D. Britton (AMS, Sydney), Ms. M. Cochrane (SAMC, Cape Town), J. Constant (IRSB, Brussels), Dr E. DeWalt and Dr P. P. Tinerella (INHS, Champaign), Dr O. S. Flint, Jr (USNM, Washington D.C.), Mr. D. Goodger and Dr B. W. Price (BMNH, London), Dr F. de Moor (AMGS, Grahamstown), Dr A. Nel (MNHN, Paris), Dr M. Ohl (MFN, Berlin), Dr M. Owada (NSMT, Tokyo), G. Sziraki (HNHM, Budapest), Dr M. Sartori (MZL, Lausanne), A. Taeger (SDEI, Muncheberg), Dr K. Yoshizawa (SEHU, Sapporo). Thanks are due to Dr John Plant (Vienna) for help with the English. We also appreciate two anonymous reviewers who provided valuable comments on this manuscript. This research was supported by the National Natural Science Foundation of China (Nos. 31320103902 and 31322501), the National Key Basic Research Program of China (973 Program) (No. 2013CB127600), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 201178), and a grant-in-aid for fellows of the Japan Society for the Promotion of Science (JSPS) relating to the JSPS Postdoctoral Fellowship for Foreign Researchers (No. 20-08417).	Beutel RG, 2013, CLADISTICS, V29, P147, DOI 10.1111/j.1096-0031.2012.00420.x; WOOTTON RJ, 1979, SYST ENTOMOL, V4, P81, DOI 10.1111/j.1365-3113.1979.tb00614.x; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; Aspock U, 2008, SYST ENTOMOL, V33, P97; Ansorge J, 2001, NEUES JAHRB GEOL P-M, P553; WHITING MF, 1994, SYST ENTOMOL, V19, P77, DOI 10.1111/j.1365-3113.1994.tb00580.x; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; Liu XY, 2006, ZOOTAXA, P23; HAYASHI F, 1995, AQUAT INSECT, V17, P1, DOI 10.1080/01650429509361564; Beutel RG, 2008, EUR J ENTOMOL, V105, P917; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3587[1:TNFODA]2.0.CO;2; Liu XY, 2006, ENTOMOL FENNICA, V17, P394; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Wichard W, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3513[1:ANAIBA]2.0.CO;2; Nel A, 2002, GEOBIOS-LYON, V35, P313, DOI 10.1016/S0016-6995(02)00029-3; Aspock H, 1980, NEUROPTEREN EUROPAS; Aspoeck Horst, 2001, Denisia, V2, P1; AZAM KM, 1969, ANN ENTOMOL SOC AM, V62, P549; Banks N., 1920, Bulletin of the Museum of Comparative Zoology, V64; BARNARD K. H., 1931, TRANS ROY SOC S AFRICA, V19, P169; Contreras-Ramos A, 2005, AMAZONIANA, V18, P267; Contreras-Ramos A, 2006, P ENTOMOL SOC WASH, V108, P977; Contreras-Ramos A., 2004, Denisia, V13, P135; Contreras-Ramos A, 2008, ANN ENTOMOL SOC AM, V101, P808, DOI 10.1603/0013-8746(2008)101[808:NOSNAS]2.0.CO;2; Davis K. C., 1903, B NEW YORK STATE MUS, V68, P442; Elliott J. M., 1996, SCI PUBLICATION FRES, V54; Enderlein G xFCnther, 1910, Stettiner Entomologische Zeitung, V71; Esben-Petersen P., 1920, ANN S AFR MUS, V17, P499; Flint Jr O. S., 2008, INTRO AQUATIC INSECT, P425; Flint O. S. jr., 1964, Entomological News Lancaster, V75, P9; Geigy R., 1935, Revue Suisse de Zoologie, V42, P447; Grimaldi David, 2005, pi; Handlirsch A., 1920, HDB ENTOMOLOGIE, P117; Hennig W., 1953, Beitraege zur Entomologie Berlin, V3, P1; Kaiser E. W., 1961, FLORA FAUNA ARHUS, V67, P74; KUWAYAMA SATORU, 1962, PACIFIC INSECTS, V4, P325; Lambkin K.J., 1992, Queensland Naturalist, V31, P84; Latreille P. A., 1802, HIST NATURELLE GEN P, V3; LESTAGE J. A., 1927, BULL ET ANN SOC ENT BELGIQUE, V67, P71; Lestage J. A., 1927, B ANN SOC ROYAL ENTO, V67, P93; Liu X. Y., 2012, DTSCH ENTOMOLOGISCHE, V59, P235, DOI DOI 10.1002/MMND.200900029; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040345; Liu XY, 2008, ZOOTAXA, P47; Liu XY, 2011, ZOOTAXA, P1; Navas L., 1927, Broteria Serie Zoologica, V24, P5; Nel A., 1988, Neuroptera International, V5, P39; New Timothy R., 1993, Handbuch der Zoologie (Berlin), V4, P1; Nixon KC, 2002, WINCLADA VER 1 00 08; Oswald J. D., 2012, NEUROPTERIDA SPECIES; PENNY N D, 1981, Acta Amazonica, V11, P843; PENNY ND, 1993, ENTOMOL NEWS, V104, P17; Ponomarenko A.G., 1977, Paleontologicheskii Zhurnal, V1977, P78; Ponomarenko AG, 2012, PALEONTOL J+, V46, P378, DOI 10.1134/S0031030112040090; Price BW, 2012, ZOOKEYS, P27, DOI 10.3897/zookeys.201.2623; Ross HH, 1937, B ILLINOIS NATURAL H, V21, P57; Selman R. J, 1960, J INSECT PHYSL, V4, P235; STYS P, 1990, BIOL REV, V65, P401, DOI 10.1111/j.1469-185X.1990.tb01232.x; Theischinger G., 2000, AUSTR ALDERFLY LARVA; Tillyard R. J., 1919, Proceedings of the Linnean Society of New South Wales, V43; TJEDER BO, 1954, ENT MEDDEL, V27, P23; van der Weele H.W., 1909, NOTES LEYDEN MUSEUM, V30, P249; van der Weele H.W., 1910, COLLECTIONS ZOOLOGIQ, V5, P1; VSHIVKOVA T S, 1985, Entomologicheskoe Obozrenie, V64, P146; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; WHITING MF, 1991, GREAT BASIN NAT, V51, P411; Wichard Wilfried, 2002, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V86, P253; Wichard Wilfried, 1997, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V80, P197; Yang D., 2010, FAUNA SINICA INSECTA, V51; Yu Y, 2011, RASP RECONSTRUCT ANC	72	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0748-3007	1096-0031		CLADISTICS	Cladistics	FEB	2015	31	1					18	49		10.1111/cla.12071		32	Evolutionary Biology	Evolutionary Biology	AY8YJ	WOS:000347836300002		
J	Jiao, QB; Ke, Q; Li, WW; Jin, MH; Luo, Y; Zhang, LN; Yang, D; Zhang, XW				Jiao, Qibin; Ke, Qiang; Li, Weiwei; Jin, Meihua; Luo, Yan; Zhang, Linan; Yang, Dong; Zhang, Xingwei			Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						C-reactive protein; cyclo-oxygenase; inflammation; no-reflow phenomenon	C-REACTIVE-PROTEIN; ENDOTHELIUM-DEPENDENT CONTRACTIONS; CORONARY-ARTERY-DISEASE; PROSTACYCLIN SYNTHESIS; DIABETIC MICE; HYPERTENSION; DYSFUNCTION; ACTIVATION; ACETYLCHOLINE; INTERVENTION	No reflow after reperfusion therapy for myocardial infarction is a strong predictor of clinical outcome. Increased levels of inflammatory factors, including C-reactive protein (CRP), in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI) may affect myocardial perfusion. However, why the no-reflow phenomenon increases in inflammation stress after PCI is not clear. The aim of the present study was to determine the effects and molecular mechanisms underlying the effects of CRP on the expression of cyclo-oxygenase (COX) on the development of the no-reflow phenomenon. There was a significant increase in plasma levels of CRP and interleukin (IL)-6 in no-reflow patients, suggesting that inflammatory factors play an important role in the development of the no-reflow phenomenon. The mechanisms involved were further evaluated after reperfusion in a rat model mimicking the no-reflow phenomenon. Compared with normal reflow rats, there were significant increases in both COX-1 and COX-2 in cardiac tissue from no-reflow rats. The COX inhibitor indomethacin (5mg/kg, i.p.) significantly reduced the no-reflow area. In another series of experiments, human coronary artery endothelial cells (HCAEC) were treated with CRP at clinically relevant concentrations (5-25g/mL). C-Reactive protein significantly increased COX-1 and COX-2 levels in a time- and concentration-dependent manner. In addition, extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) were activated in CRP (5, 10, 25g/mL)-treated HCAEC cultures. Furthermore, the ERK inhibitor pd98059 (30mol/L) and the JNK inhibitor sp600125 (10mol/L) blocked CRP-induced COX-1 and COX-2 expression for 12h. Together, the findings of the present study suggest that CRP can promote the development of the no-reflow phenomenon by increasing COX-1 and COX-2 expression, which is regulated, in part, via ERK and JNK activity.	[Jiao, Qibin; Ke, Qiang; Li, Weiwei; Luo, Yan; Zhang, Linan; Yang, Dong; Zhang, Xingwei] Hangzhou Normal Univ, Sch Med, Affiliated Hosp, Dept Cardiol, Hangzhou 310015, Zhejiang, Peoples R China; [Jin, Meihua] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cardiac Physiol, Suita, Osaka, Japan	Zhang, XW (reprint author), Hangzhou Normal Univ, Sch Med, Affiliated Hosp, Dept Cardiol, 126 Wenzhou Rd, Hangzhou 310015, Zhejiang, Peoples R China.	hsdzxw@126.com			Department of Science and Technology of Zhejiang Province [2008C30039]; Hangzhou City Science and Technology Commission [20090833Q08, 20130733Q39]; Natural Science Foundation of Zhejiang Province [Y2111051]; Bureau of Health of Hangzhou City [2012A028]; Startup Scientific Research Funds of Hangzhou Normal University [2013QDL022]; Medical Science and Technology Project of Department of Health of Zhejiang Province [201478262]; Scientific Research Foundation of Department of Education of Zhejiang Province [Y201431002]; Ministry of Health Ministry of Scientific Research Fund Project [WKJ2010-2-021]; Bureau of Hangzhou City Science and Technology Project [20100633B12]; Hangzhou City Health Bureau Project [2011Z005]	This study was supported by grants from the Department of Science and Technology of Zhejiang Province (2008C30039), Hangzhou City Science and Technology Commission (20090833Q08, 20130733Q39), Natural Science Foundation of Zhejiang Province (Y2111051), Bureau of Health of Hangzhou City (2012A028), the Startup Scientific Research Funds of Hangzhou Normal University (2013QDL022), Medical Science and Technology Project of Department of Health of Zhejiang Province (201478262), Scientific Research Foundation of Department of Education of Zhejiang Province (Y201431002), the Ministry of Health Ministry of Scientific Research Fund Project (WKJ2010-2-021), Bureau of Hangzhou City Science and Technology Project (20100633B12) and Hangzhou City Health Bureau Project (2011Z005).	Alvarez Y, 2005, J HYPERTENS, V23, P767, DOI 10.1097/01.hjh.0000163145.12707.63; Amico C, 2004, TISSUE CELL, V36, P1, DOI 10.1016/j.tice.2003.08.001; PEPYS MB, 1981, LANCET, V1, P653; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1610, DOI 10.1161/01.ATV.0000172688.26838.9f; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Zhu NX, 2014, AM J PHYSIOL-HEART C, V307, pH319, DOI 10.1152/ajpheart.00022.2014; Tomai F, 2005, EUR HEART J, V26, P2099, DOI 10.1093/eurheartj/ehi356; Jiao QB, 2009, AM J PHYSIOL-HEART C, V297, pH576, DOI 10.1152/ajpheart.00946.2008; Bisoendial RJ, 2005, CIRC RES, V96, P714, DOI 10.1161/01.RES.0000163015.37711.AB; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669; Liu B, 2012, EXP PHYSIOL, V97, P895, DOI 10.1113/expphysiol.2011.063784; Tomoda H, 2000, AM HEART J, V140, P324, DOI 10.1067/mhj.2000.108244; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Rodrigo R, 2013, DIS MARKERS, P773, DOI 10.1155/2013/974358; Kuwano T, 2004, FASEB J, V18, P300, DOI 10.1096/fj.03-0473com; Adderley SR, 1999, J BIOL CHEM, V274, P5038, DOI 10.1074/jbc.274.8.5038; Gibson CM, 2000, CIRCULATION, V101, P125; Jiao QB, 2012, CELL CALCIUM, V51, P31, DOI 10.1016/j.ceca.2011.10.003; Bratz IN, 2004, AM J PHYSIOL-HEART C, V287, pH2394, DOI 10.1152/ajpheart.00628.2004; Burke AP, 2002, CIRCULATION, V105, P2019, DOI 10.1161/01.CIR.0000015507.29953.38; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959; LUSCHER TF, 1986, HYPERTENSION, V8, P344; MAZZONE A, 1993, CIRCULATION, V88, P358; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; Gibson CM, 2004, CIRCULATION, V109, P3096, DOI 10.1161/01.CIR.0000134278.50359.CB; Chan W, 2012, AM J CARDIOL, V109, P478, DOI 10.1016/j.amjcard.2011.09.037; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; Reffelmann T, 2002, HEART, V87, P162, DOI 10.1136/heart.87.2.162; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Theroux P, 2005, EUR HEART J, V26, P1964, DOI 10.1093/eurheartj/ehi292; Kearney PM, 2006, BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Botto N, 2007, INT J CARDIOL, V117, P123, DOI 10.1016/j.ijcard.2006.04.060; Camitta MGW, 2001, CIRCULATION, V104, P2453, DOI 10.1161/hc4401.098429; Celik T, 2005, CORONARY ARTERY DIS, V16, P293, DOI 10.1097/00019501-200508000-00006; Gabay C, 1999, NEW ENGL J MED, V340, P448; Grim TW, 2014, PHARMACOL BIOCHEM BE, V124, P405, DOI 10.1016/j.pbb.2014.07.008; Hattori Y, 2003, CARDIOVASC RES, V58, P186, DOI 10.1016/S0008-6363(02)00855-6; Heymes C, 2000, BRIT J PHARMACOL, V131, P804, DOI 10.1038/sj.bjp.0703632; Jiao QB, 2014, CLIN EXP PHARMACOL P, V41, P589, DOI 10.1111/1440-1681.12253; Lagrand WK, 1997, CIRCULATION, V95, P97; Li XD, 2010, AM J PHYSIOL-HEART C, V299, pH1255, DOI 10.1152/ajpheart.00459.2010; Miller JD, 2010, AM J PHYSIOL-HEART C, V298, pH1600, DOI 10.1152/ajpheart.01108.2009; Pradhan AD, 2002, EUR HEART J, V23, P831, DOI 10.1053/euhj.2001.3052; Schindler TH, 2004, CIRCULATION, V110, P1069, DOI 10.1161/01.CIR.0000140264.56496.76; St-Louis I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-103; Verma S, 2003, J MOL CELL CARDIOL, V35, P417, DOI 10.1016/S0022-2828(03)00042-7; Wu KK, 2005, PROSTAG LEUKOTR ESS, V72, P89, DOI 10.1016/j.plefa.2004.11.001; Yang D, 2003, HYPERTENSION, V41, P143, DOI 10.1161/01.HYP.0000047651.45322.16; Yip HK, 2005, CHEST, V127, P803, DOI 10.1378/chest.127.3.803; Yu Y, 2012, SCI TRANSL MED, V4; Zhang RX, 2006, EUR J IMMUNOL, V36, P2993, DOI 10.1002/eji.200635207; Zhao XM, 2007, J CHIN MICROCIRC, V11, P206	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	FEB	2015	42	2					162	170		10.1111/1440-1681.12339		9	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	AY8PE	WOS:000347814900006		
J	Dang, DK; Duong, CX; Nam, Y; Shin, EJ; Lim, YK; Jeong, JH; Jang, CG; Nah, SY; Nabeshima, T; Kim, HC				Duy-Khanh Dang; Duong, Chu X.; Nam, Yunsung; Shin, Eun-Joo; Lim, Yong Kwang; Jeong, Ji Hoon; Jang, Choon-Gon; Nah, Seung-Yeol; Nabeshima, Toshitaka; Kim, Hyoung-Chun			Inhibition of protein kinase (PK) C delta attenuates methamphetamine-induced dopaminergic toxicity via upregulation of phosphorylation of tyrosine hydroxylase at Ser(40) by modulation of protein phosphatase 2A and PKA	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						dopaminergic toxicity; methamphetamine; phosphorylated tyrosine hydroxylase; PKC; -mice; protein kinase A; protein kinase C; protein phosphatase 2A; striatum	SIGNALING PATHWAY; CHROMAFFIN CELLS; PARKINSON DISEASE; OXIDATIVE STRESS; NERVE-TERMINALS; MAP-KINASE; RAT-BRAIN; ACTIVATION; GENE; ROTTLERIN	Recently, we proposed that inhibition of protein kinase (PK) C may be a useful target for protection against methamphetamine (MA)-induced dopaminergic toxicity. We demonstrated that treatment with MA resulted in a significant decrease in phosphorylation of tyrosine hydroxylase (TH) at Ser(40) in the striatum, but not in the phosphorylation of TH at Ser(31). In the present study, treatment with rottlerin (1.5 or 3.0 g, i.c.v, once a day for 5 days), a PKC inhibitor, or a PKC antisense oligonucleotide (ASO; 2.5 g/l, i.c.v., 3 times) significantly attenuated MA-induced reductions in the phosphorylation of TH at Ser(40) and in the expression of PKA in the striatum of mice. This attenuation was significantly counteracted by H89 (10 or 30 ng, i.c.v., 1 h after the last MA administration), a PKA inhibitor. Treatment with rottlerin or ASO significantly attenuated the MA-induced increase in protein phosphatase (PP) 2A activity. FTY720 (1 or 5 mg/kg, i.p., 1 h after the last MA administration), a PP2A activator, significantly reversed the recovery in TH phosphorylation mediated by inhibition of PKC after MA treatment. Both H89 and FTY720 counteracted the recovery of MA-induced behavioural impairments induced by PKC inhibition. The effects, mediated by rottlerin or ASO in MA-treated wild-type mice were comparable with those in MA-treated PKC-/- mice. However, neither inhibition of the mitogen-activated protein kinase subfamily (extracellular signal-regulated kinase, c-Jun N-terminal kinase, p38) nor inhibition of calcium calmodulin kinase II significantly altered PKC inhibition-mediated attenuation of MA-induced impairment of TH phosphorylation. The results suggest that genetic or pharmacological inhibition of PKC requires modulation of PKA expression and/or PP2A activity to attenuate the impairment of TH phosphorylation at Ser(40) and behavioural activity induced by MA.	[Duy-Khanh Dang; Duong, Chu X.; Nam, Yunsung; Shin, Eun-Joo; Lim, Yong Kwang; Kim, Hyoung-Chun] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 200701, South Korea; [Duong, Chu X.] Cantho Univ Med & Pharm, Cantho City, Vietnam; [Jeong, Ji Hoon] Chung Ang Univ, Coll Med, Dept Pharmacol, Seoul 156756, South Korea; [Jang, Choon-Gon] Sungkyunkwan Univ, Sch Pharm, Dept Pharmacol, Suwon, South Korea; [Nah, Seung-Yeol] Konkuk Univ, Dept Physiol, Ginseng Res Lab, Coll Vet Med, Seoul, South Korea; [Nah, Seung-Yeol] Konkuk Univ, Bio Mol Informat Ctr, Seoul, South Korea; [Nabeshima, Toshitaka] Meijo Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi, Japan	Kim, HC (reprint author), Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 200701, South Korea.	shinej@kangwon.ac.kr; kimhc@kangwon.ac.kr			Korea Food and Drug Administration [14182MFDS979]; BK PLUS 21 program	This study was supported by a grant from the Korea Food and Drug Administration (14182MFDS979). YN and D-KD were supported by the BK PLUS 21 program. Equipment at the Institute of Pharmaceutical Science (Kangwon National University) was used for this study. The authors thank Beverly Hills English for help with English language expression.	Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Haavik J, 1998, MOL NEUROBIOL, V16, P285, DOI 10.1007/BF02741387; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; Shin EJ, 2012, BEHAV BRAIN RES, V232, P98, DOI 10.1016/j.bbr.2012.04.001; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.2797.x; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Shin EJ, 2014, MOL NEUROBIOL, V49, P1400, DOI 10.1007/s12035-013-8617-1; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Weng Z, 2007, J BIOL CHEM, V282, P34479, DOI 10.1074/jbc.M705426200; Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Kumer SC, 1996, J NEUROCHEM, V67, P443; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; HAYCOCK JW, 1991, J BIOL CHEM, V266, P5650; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; HAAVIK J, 1989, FEBS LETT, V251, P36, DOI 10.1016/0014-5793(89)81424-3; Bademci G, 2010, HUM MUTAT, V31, pE1767, DOI 10.1002/humu.21351; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; CAMPBELL DG, 1986, J BIOL CHEM, V261, P489; Ditlevsen DK, 2007, EUR J NEUROSCI, V25, P1678, DOI 10.1111/j.1460-9568.2007.05436.x; GOLDSTEIN M, 1995, J NEUROCHEM, V64, P2281; Hamelink C, 2002, J NEUROSCI, V22, P5310; HAYCOCK JW, 1993, NEUROCHEM RES, V18, P15, DOI 10.1007/BF00966919; Leal RB, 2002, NEUROCHEM RES, V27, P207, DOI 10.1023/A:1014880403970; LEE KY, 1989, J NEUROCHEM, V53, P1238, DOI 10.1111/j.1471-4159.1989.tb07420.x; Lindgren N, 2002, EUR J NEUROSCI, V15, P769, DOI 10.1046/j.1460-9568.2002.01901.x; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nakashima A, 2009, J NEURAL TRANSM, V116, P1355, DOI 10.1007/s00702-009-0227-8; Nankova B B, 1998, Stress, V2, P289; Paxinos G, 2008, MOUSE BRAIN STEREOTA; Shin EJ, 2011, NEUROCHEM INT, V59, P39, DOI 10.1016/j.neuint.2011.03.022; SMITH SJ, 1987, TRENDS NEUROSCI, V10, P142, DOI 10.1016/0166-2236(87)90039-7; Sumi-Ichinose C, 2010, J PHARMACOL SCI, V114, P17, DOI 10.1254/jphs.09R28FM; Tapia JA, 2006, BBA-MOL CELL RES, V1763, P25, DOI 10.1016/j.bbamcr.2005.10.007; Thomas G, 1997, EUR J BIOCHEM, V247, P1180, DOI 10.1111/j.1432-1033.1997.01180.x; WOOD JG, 1980, J CELL BIOL, V84, P66, DOI 10.1083/jcb.84.1.66; WU J, 1992, J BIOL CHEM, V267, P25754; Yokoyama G, 2005, BIOCHEM BIOPH RES CO, V327, P720, DOI 10.1016/j.bbrc.2004.12.070; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	FEB	2015	42	2					192	201		10.1111/1440-1681.12341		10	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	AY8PE	WOS:000347814900010		
J	Kai, M; Kogawa, T; Liu, DD; Fouad, TM; Kai, K; Niikura, N; Hsu, L; Willey, JS; Theriault, RL; Valero, V; Ueno, NT				Kai, Megumi; Kogawa, Takahiro; Liu, Diane D.; Fouad, Tamer M.; Kai, Kazuharu; Niikura, Naoki; Hsu, Limin; Willey, Jie S.; Theriault, Richard L.; Valero, Vicente; Ueno, Naoto T.			Clinical Characteristics and Outcome of Bone-Only Metastasis in Inflammatory and Noninflammatory Breast Cancers	CLINICAL BREAST CANCER			English	Article						Advanced breast cancer; Bone metastasis; Hormone receptor positivity; Overall survival; Progression-free survival	PROGNOSTIC-FACTORS; RECEPTOR STATUS; HORMONAL RECEPTOR; CARCINOMA; SUBTYPES; DISEASE; RECURRENCE; TUMOR; IBC	The clinical course of bone metastasis in inflammatory breast cancer (IBC) has not been well studied. This retrospective study analyzed 50 IBC and 147 non-IBC patients who had stage III disease on diagnosis of primary breast cancer and then developed bone-only metastasis at first recurrence. We found that the IBC group had a worse prognosis than did the non-IBC group. Background: Inflammatory breast cancer is a rare and aggressive presentation of breast cancer. Bone is a common metastatic site in breast cancer, and bone-only metastatic disease is clinically considered to have a better prognosis than visceral metastasis. However, bone-only metastasis in IBC (bone-only IBC) has not been compared with bone-only metastasis in non-IBC (bone-only non-IBC) in terms of clinical features and outcome. Because of the intrinsically aggressive nature of IBC, we hypothesized that bone-only IBC has a poorer prognosis than does bone-only non-IBC. Patients and Methods: We retrospectively identified patients with stage III primary diagnosed breast cancer who, between January 1997 and December 2012, had a first recurrence located only in the bone. Among the 197 patients that we defined as a study cohort, 50 patients had IBC and 147 patients had non-IBC. Progression-free survival (PFS) and overall survival (OS) from the date of recurrence were estimated using the Kaplan-Meier method, and patient characteristic groups were compared using the log-rank test. Results: OS did not differ significantly between the 2 groups (P = .2467), but a shorter PFS was seen in patients with bone-only IBC than in patients with bone-only non-IBC (P = .0357). Among patients with estrogen receptor (ER)-positive disease, a much shorter PFS was seen in bone-only IBC than in bone-only non-IBC (P = .0159). Conclusion: Bone-only IBC has a poorer prognosis than does bone-only non-IBC, particularly in those with ER-positive tumors. We might need to consider more aggressive intervention (eg, chemotherapy) for IBC patients with ER-positive bone-only metastatic disease.	[Kai, Megumi; Kogawa, Takahiro; Fouad, Tamer M.; Kai, Kazuharu; Hsu, Limin; Willey, Jie S.; Theriault, Richard L.; Valero, Vicente; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Kai, Megumi; Kogawa, Takahiro; Fouad, Tamer M.; Kai, Kazuharu; Hsu, Limin; Willey, Jie S.; Theriault, Richard L.; Valero, Vicente; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Liu, Diane D.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Niikura, Naoki] Tokai Univ, Sch Med, Dept Breast & Endocrine Surg, Kanagawa 2591100, Japan	Ueno, NT (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354,1515 Holcombe Blvd, Houston, TX 77030 USA.	nueno@mdanderson.org		Fouad, Tamer/0000-0002-4168-5275	Morgan Welch Inflammatory Breast Cancer Research Program; State of Texas Rare and Aggressive Breast Cancer Research Program Grant	This research was supported by Morgan Welch Inflammatory Breast Cancer Research Program, and State of Texas Rare and Aggressive Breast Cancer Research Program Grant. The authors thank Sunita Patterson of the Department of Scientific Publications for editing assistance.	Parton M, 2004, BREAST, V13, P97, DOI 10.1016/j.breast.2003.08.004; BLACK MM, 1957, SURG GYNECOL OBSTET, V105, P97; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Cristofanilli M, 2007, CANCER, V110, P1436, DOI 10.1002/cncr.22927; Coleman RE, 1998, BRIT J CANCER, V77, P336, DOI 10.1038/bjc.1998.52; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; SHERRY MM, 1986, AM J MED, V81, P381, DOI 10.1016/0002-9343(86)90286-X; Khoshnoud MR, 2011, BREAST CANCER RES TR, V126, P421, DOI 10.1007/s10549-010-1202-7; Dawood S, 2011, ANN ONCOL, V22, P515, DOI 10.1093/annonc/mdq345; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Masuda H, 2014, ANN ONCOL, V25, P384, DOI 10.1093/annonc/mdt525; Lee SJ, 2011, CANCER RES TREAT, V43, P89, DOI 10.4143/crt.2011.43.2.89; Ahn SG, 2013, YONSEI MED J, V54, P1168, DOI 10.3349/ymj.2013.54.5.1168; Kim HS, 2012, J BREAST CANCER, V15, P401, DOI 10.4048/jbc.2012.15.4.401; Nguyen DM, 2006, CLIN CANCER RES, V12, P5047, DOI 10.1158/1078-0432.CCR-05-2248; Chang J, 2003, CANCER, V97, P545, DOI 10.1002/cncr.11083; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; HARVEY HA, 1982, J SURG ONCOL, V21, P42, DOI 10.1002/jso.2930210111; Koizumi M, 2003, ANN ONCOL, V14, P1234, DOI 10.1093/annonc/mdg348; Niikura N, 2011, ONCOLOGIST, V16, P155, DOI 10.1634/theoncologist.2010-0350; PARADISO A, 1989, CANCER, V64, P1922, DOI 10.1002/1097-0142(19891101)64:9<1922::AID-CNCR2820640927>3.0.CO;2-I; SCHEID V, 1986, CANCER, V58, P2589, DOI 10.1002/1097-0142(19861215)58:12<2589::AID-CNCR2820581206>3.0.CO;2-O; Solomayer EF, 2000, BREAST CANCER RES TR, V59, P271, DOI 10.1023/A:1006308619659; TUBIANAHULIN M, 1991, BONE, V12, pS9, DOI 10.1016/8756-3282(91)90059-R; Van Laere SJ, 2006, BREAST CANCER RES TR, V95, P243, DOI 10.1007/s10549-005-9015-9; YAMASHITA K, 1991, CANCER, V68, P634, DOI 10.1002/1097-0142(19910801)68:3<634::AID-CNCR2820680332>3.0.CO;2-B; Zell JA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2225	28	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	FEB	2015	15	1					37	42		10.1016/j.clbc.2014.06.007		6	Oncology	Oncology	AZ1QF	WOS:000348012400006		
J	Akashi-Tanaka, S; Watanabe, C; Takamaru, T; Kuwayama, T; Ikeda, M; Ohyama, H; Mori, M; Yoshida, R; Hashimoto, R; Terumasa, S; Enokido, K; Hirota, Y; Okuyama, H; Nakamura, S				Akashi-Tanaka, Sadako; Watanabe, Chie; Takamaru, Tomoko; Kuwayama, Takashi; Ikeda, Murasaki; Ohyama, Hiroto; Mori, Miki; Yoshida, Reiko; Hashimoto, Rikako; Terumasa, Sawada; Enokido, Katsutoshi; Hirota, Yuko; Okuyama, Hiromi; Nakamura, Seigo			BRCAness Predicts Resistance to Taxane-Containing Regimens in Triple Negative Breast Cancer During Neoadjuvant Chemotherapy	CLINICAL BREAST CANCER			English	Article							PLATINUM-BASED CHEMOTHERAPY; TUMORS; METAANALYSIS; AGENTS; LEADS	We investigated BRCAness in the biopsy and surgical specimens from 73 patients with breast cancer, taken before and after taxane-containing neoadjuvant chemotherapy. All tumors that progressed on taxanecontaining regimens had a poor prognosis; all had BRCAness and most were triple negative. Identifying BRCAness can help predict the response to taxane-containing regimens. Background: To provide optimal treatment of heterogeneous triple negative breast cancer (TNBC), we need biomarkers that can predict the chemotherapy response. Patients and Methods: We retrospectively investigated BRCAness in 73 patients with breast cancer who had been treated with taxane- and/or anthracycline-based neoadjuvant chemotherapy (NAC). Using multiplex, ligation-dependent probe amplification on formalin-fixed core needle biopsy (CNB) specimens before NAC and surgical specimens after NAC. BRCAness status was assessed with the assessor unaware of the clinical information. Results: We obtained 45 CNB and 60 surgical specimens from the 73 patients. Of the 45 CNB specimens, 17 had BRCAness (38.6% of all subtypes). Of the 23 TNBC CNB specimens, 14 had BRCAness (61% of TNBC cases). The clinical response rates were significantly lower for BRCAness than for non-BRCAness tumors, both for all tumors (58.8% vs. 89.3%, P =.03) and for TNBC (50% vs. 100%, P =.02). All tumors that progressed with taxane therapy had BRCAness. Of the patients with TNBC, those with non-BRCAness cancer had pathologic complete responses significantly more often than did those with BRCAness tumors (77.8% vs. 14.3%, P =.007). After NAC, the clinical response rates were significant lower for BRCAness than for non-BRCAness tumors in all subtypes (P =.002) and in TNBC cases (P =.008). After a median follow-up of 26.4 months, 6 patients all with BRCAness had developed recurrence. Patients with BRCAness had shorter progression-free survival than did those with non- BRCAness (P =.049). Conclusion: Identifying BRCAness can help predict the response to taxane, and changing regimens for BRCAness TNBC might improve patient survival. A larger prospective study is needed to further clarify this issue.	[Akashi-Tanaka, Sadako; Watanabe, Chie; Takamaru, Tomoko; Kuwayama, Takashi; Ikeda, Murasaki; Ohyama, Hiroto; Mori, Miki; Yoshida, Reiko; Hashimoto, Rikako; Terumasa, Sawada; Enokido, Katsutoshi; Nakamura, Seigo] Showa Univ, Sch Med, Dept Breast Surg Oncol, Tokyo 1428666, Japan; [Hirota, Yuko] Showa Univ, Sch Med, Dept Pathol, Tokyo 1428666, Japan; [Okuyama, Hiromi] Showa Univ, Sch Med, Dept Pharm, Tokyo 1428666, Japan	Akashi-Tanaka, S (reprint author), Showa Univ, Sch Med, Dept Breast Surg Oncol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	sakashi@med.showa-u.ac.jp					Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; Lee JM, 2014, ANN ONCOL, V25, P32, DOI 10.1093/annonc/mdt384; Lips EH, 2013, BRIT J CANCER, V108, P2172, DOI 10.1038/bjc.2013.144; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Petrelli F, 2014, BREAST CANCER RES TR, V144, P223, DOI 10.1007/s10549-014-2876-z; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Vollebergh MA, 2011, ANN ONCOL, V22, P1561, DOI 10.1093/annonc/mdq624; Iwata H, 2011, JPN J CLIN ONCOL, V41, P867, DOI 10.1093/jjco/hyr081; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1452; Chalasani P, 2013, ONCOLOGIST, V18, P909, DOI 10.1634/theoncologist.2013-0039; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kriege M, 2012, CANCER-AM CANCER SOC, V118, P899, DOI 10.1002/cncr.26351; Kurebayashi J, 2006, ANTICANCER RES, V26, P695; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Liu M, 2013, ONCOL LETT, V5, P983, DOI 10.3892/ol.2012.1093; Oonk AMM, 2012, ANN ONCOL, V23, P2301, DOI 10.1093/annonc/mdr621; Paluch-Shimon S, 2014, J CLIN ONCOL S, V32, p5s; Rummel S, 2013, BREAST CANCER RES TR, V137, P119, DOI 10.1007/s10549-012-2348-2; Shien T, 2008, JPN J BREAST CANC, V23, P49; Shigenaga Rena, 2012, Nihon Rinsho, V70 Suppl 7, P191; Sikov WN, 2014, J CLIN ONCOL, V4; Sung M, 2014, ONCOGENE, V33, P1418, DOI 10.1038/onc.2013.85; Telli M, 2013, PRECOG 0105 FINAL EF; Von Minckwitz G, 2014, J CLIN ONCOL P ASCO, P1004	27	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	FEB	2015	15	1					80	85		10.1016/j.clbc.2014.08.003		6	Oncology	Oncology	AZ1QF	WOS:000348012400013		
J	Tabe, Y; Yamamoto, T; Maenou, I; Nakai, R; Idei, M; Horii, T; Miida, T; Ohsaka, A				Tabe, Yoko; Yamamoto, Takemasa; Maenou, Imiko; Nakai, Rie; Idei, Mayumi; Horii, Takashi; Miida, Takashi; Ohsaka, Akimichi			Performance evaluation of the digital cell imaging analyzer DI-60 integrated into the fully automated Sysmex XN hematology analyzer system	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						automated digital imaging; DI-60; hematology analyzer; integrated slide processing system; white blood cell differential; XN-Series	CELLAVISION DM96; DISEASES; XE-2100	Background: The XN-Series (Sysmex, Kobe, Japan) have been equipped with the automated digital cell imaging analyzer DI-60, which provides complete automation of the sample processing with automated complete blood counts (CBC), slide making/staining, and digital scanning with cell pre-classification. The aim of this study was to evaluate the efficacy of the XN-Series as an integrated blood cell analysis system. Methods: White blood cell (WBC) morphological analysis by the DI-60 was evaluated using 232 blood samples from patients. Routine analysis of a total of 2000 blood samples has been performed to evaluate the processing ability of the XN-Series connected to the DI-60. Results: The overall analysis accuracy of pre-classification of WBC by the DI-60 was 88.4%. Good correlation was observed between final results of the DI-60 analysis and manual differentiation with high sensitivity and specificity for blasts and immature granulocytes. The sample processing time of the XN-Series, from automated CBC to cell pre-classification, was 38 +/- 1 min/single run and 165 +/- 12 min/500 CBC samples run (slide preparation rate 15.6%) with no sample hold-up at the DI-60. Conclusions: The automated morphological analysis capability of the DI-60 has potential usefulness in the integrated automated hematology analysis system of XN-Series.	[Tabe, Yoko; Idei, Mayumi; Miida, Takashi] Juntendo Univ, Sch Med, Dept Clin Lab Med, Bunkyo Ku, Tokyo 1138421, Japan; [Yamamoto, Takemasa; Maenou, Imiko; Horii, Takashi; Ohsaka, Akimichi] Juntendo Univ Hosp, Div Clin Lab, Bunkyo Ku, Tokyo, Japan; [Nakai, Rie] Sysmex Corp, Sci Affairs, Kobe, Hyogo, Japan	Tabe, Y (reprint author), Juntendo Univ, Sch Med, Dept Clin Lab Med, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	tabe@juntendo.ac.jp	Miida, Takashi/A-5589-2012	Miida, Takashi/0000-0002-4294-8030	Sysmex Corporation	This study was supported by a grant from Sysmex Corporation.	Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Billard M, 2010, INT J LAB HEMATOL, V32, P530, DOI 10.1111/j.1751-553X.2009.01219.x; Briggs CJ, 2011, AM J CLIN PATHOL, V136, P309, DOI 10.1309/AJCPDLR4KGKAFW4W; Briggs C, 2012, J CLIN PATHOL, V65, P1024, DOI 10.1136/jclinpath-2012-200930; RUMKE CL, 1985, BLOOD CELLS, V11, P311; Kratz A, 2005, AM J CLIN PATHOL, V124, P770, DOI 10.1039/XMB9K0J41LHLATAY; Briggs C, 2009, INT J LAB HEMATOL, V31, P48, DOI 10.1111/j.1751-553X.2007.01002.x; Ceelie H, 2007, J CLIN PATHOL, V60, P72, DOI 10.1136/jcp.2005.035402; Bitencourt ED, 2013, REV BRAS HEMATOL HEM, V35, P404; CLSI, 2007, H20A2 CLSI; Cornet E, 2008, INT J LAB HEMATOL, V30, P536, DOI 10.1111/j.1751-553X.2007.00996.x; HILBORNE LH, 1990, JAMA-J AM MED ASSOC, V264, P382, DOI 10.1001/jama.264.3.382; Honnma H, 2009, J JAP SOC LAB HEMATO, V10, P367; Hur M, 2011, INT J LAB HEMATOL, V33, P434, DOI 10.1111/j.1751-553X.2011.01306.x; Lin MY, 2008, ANTIMICROB AGENTS CH, V52, P3188, DOI 10.1128/AAC.01553-07; PEREL ID, 1980, PATHOLOGY, V12, P449; Satoh M, 2012, J JAP SOC LAB HEMATO, V13, P304; Simson E, 2009, INT J LAB HEMATOL, V32, pe64; Yamamoto Takemasa, 2010, Rinsho Byori, V58, P884	19	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	FEB	2015	53	2					281	289		10.1515/cclm-2014-0445		9	Medical Laboratory Technology	Medical Laboratory Technology	AY6BA	WOS:000347651500024		
J	Duyck, J; Roesems, R; Cardoso, MV; Ogawa, T; Camargos, GD; Vandamme, K				Duyck, Joke; Roesems, Rutger; Cardoso, Marcio V.; Ogawa, Toru; Camargos, Germana De Villa; Vandamme, Katleen			Effect of insertion torque on titanium implant osseointegration: an animal experimental study	CLINICAL ORAL IMPLANTS RESEARCH			English	Article						animal experiments; bone implant interactions; insertion torque; surgical techniques	SURGICAL TECHNIQUES; PRIMARY STABILITY; DENTAL IMPLANTS; BONE-FORMATION; IMMEDIATE; MICROMOTION; DENSITY; INTERFACE; DESIGN; RABBIT	ObjectiveTo evaluate the effect of implant insertion torque on the peri-implant bone healing and implant osseointegration. Material and methodsBilaterally in the tibia of five adult New Zealand white rabbits, 20 implants were installed, subdivided into four groups, corresponding to two insertion torque conditions (low, < 10 Ncm vs. high > 50 Ncm) and 2 experimental periods (2weeks vs. 4weeks of healing). The implant insertion torque was determined by the surgical drill diameter relative to the implant diameter. Implant osseointegration was evaluated by quantitative histology (bone-to-implant contact with host bone [BIC-host], with neoformed bone [BIC-de novo], with both bone types [BIC-total], and peri-implant bone [BA/TA]). Every response was modelled over time using GEE (general estimation equation) with an unstructured variance-covariance matrix to correct for dependency between the measurements from one animal. The statistical significance level of =0.05 was applied. ResultsSignificantly, more BIC-host and BIC-total were recorded for H implants compared with L implants after 2week of healing (P=0.010 and P=0.0001, respectively). However, this result was no longer found for the extended healing period. Furthermore, BIC-total significantly increased over time for L implants (P<0.00001). In contrast, the significant increase in BA/TA over time was found for H implants (P<0.01). Finally, H insertion torque led to an increased BA/TA after 4week of healing (P<0.02) compared with the L insertion protocol. ConclusionL insertion torque implants installed in the rabbit tibial bone osseointegrate with considerable de novo bone formation. This bone neoformation enables L implants to catch up, already during the early osseointegration stage, the initial inferior amount BIC contact compared with that of H implants. A negative impact of the created strain environment accompanying H insertion torque implant installation on the biological process of osseointegration could not be observed, at least not at tissue level.	[Duyck, Joke; Roesems, Rutger; Cardoso, Marcio V.; Camargos, Germana De Villa; Vandamme, Katleen] Katholieke Univ Leuven, Dept Oral Hlth Sci, BE-3000 Leuven, Belgium; [Duyck, Joke; Roesems, Rutger; Cardoso, Marcio V.; Camargos, Germana De Villa; Vandamme, Katleen] Katholieke Univ Leuven, Dent Clin, BE-3000 Leuven, Belgium; [Duyck, Joke; Roesems, Rutger; Cardoso, Marcio V.; Camargos, Germana De Villa; Vandamme, Katleen] BIOMAT KU Leuven, Univ Hosp Leuven, BE-3000 Leuven, Belgium; [Duyck, Joke; Roesems, Rutger; Cardoso, Marcio V.; Camargos, Germana De Villa; Vandamme, Katleen] Prosthet Unit, BE-3000 Leuven, Belgium; [Camargos, Germana De Villa] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Prosthodont & Periodontol, Piracicaba, SP, Brazil; [Ogawa, Toru] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan	Duyck, J (reprint author), Katholieke Univ Leuven, Dept Oral Hlth Sci, Kapucijnenvoer 7 Blok Box 7001, BE-3000 Leuven, Belgium.	joke.duyck@uzleuven.be			GC Tech. Europe N.V. (Leuven, Belgium); Fund for Scientific Research Flanders (FWO Vlaanderen)	The author would like to acknowledge GC Tech. Europe N.V. (Leuven, Belgium) for providing financial support and Dr. A. Ivanova for the help with the statistical analysis. This work was further supported by the Fund for Scientific Research Flanders (FWO Vlaanderen - Postdoctoral researcher K. Vandamme).	Vandamme K, 2007, J CLIN PERIODONTOL, V34, P172, DOI 10.1111/j.1600-051X.2006.01014.x; Coelho PG, 2010, CLIN IMPLANT DENT R, V12, P202, DOI 10.1111/j.1708-8208.2009.00153.x; Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013; Turkyilmaz I, 2009, CLIN IMPLANT DENT R, V11, P113, DOI 10.1111/j.1708-8208.2008.00097.x; Turkyilmaz I, 2008, CLIN IMPLANT DENT R, V10, P231, DOI 10.1111/j.1708-8208.2008.00084.x; Tabassum A, 2010, CLIN ORAL IMPLAN RES, V21, P213, DOI 10.1111/j.1600-0501.2009.01823.x; Nkenke E, 2003, CLIN ORAL IMPLAN RES, V14, P312, DOI 10.1034/j.1600-0501.2003.120906.x; Freitas AC, 2012, CLIN ORAL IMPLAN RES, V23, P113, DOI 10.1111/j.1600-0501.2010.02142.x; Trisi P, 2009, CLIN ORAL IMPLAN RES, V20, P467, DOI 10.1111/j.1600-0501.2008.01679.x; Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x; Beer A, 2003, CLIN ORAL IMPLAN RES, V14, P616, DOI 10.1034/j.1600-0501.2003.00932.x; Tabassum A, 2010, J DENT RES, V89, P581, DOI 10.1177/0022034510363263; Vandamme K, 2007, EUR J ORAL SCI, V115, P21, DOI 10.1111/j.1600-0722.2007.00416.x; Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K; Nkenke E, 2006, CLIN ORAL IMPLAN RES, V17, P19, DOI 10.1111/j.1600-0501.2006.01348.x; Szmukler-Moncler S, 2000, CLIN ORAL IMPLAN RES, V11, P12, DOI 10.1034/j.1600-0501.2000.011001012.x; Branemark PI, 1985, TISSUE INTEGRATED PR, P202; Campos F. E., 2012, J ORAL MAXILLOFACIAL, V70, P43; Coelho P. G., 2013, J ORAL MAXILLOFACIAL, V71, P69; Dhore CR, 2008, CLIN ORAL IMPLAN RES, V19, P606, DOI 10.1111/j.1600-0501.2007.01519.x; Esposito M, 2013, COCHRANE DB SYST REV, V28, P3; Lioubavina-Hack N, 2006, CLIN ORAL IMPLAN RES, V17, P244, DOI 10.1111/j.1600-0501.2005.01201.x; Nkenke E, 2005, INT J ORAL MAX IMPL, V20, P39; Romanos GE, 2003, J PERIODONTOL, V74, P1483, DOI 10.1902/jop.2003.74.10.1483; Slaets E, 2009, CLIN ORAL IMPLAN RES, V20, P126, DOI 10.1111/j.1600-0501.2008.01623.x; Sotto-Maior Bruno Salles, 2010, Braz Dent J, V21, P508, DOI 10.1590/S0103-64402010000600005; Tabassum A., 2013, CLIN ORAL IMPLAN RES, P1	27	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7161	1600-0501		CLIN ORAL IMPLAN RES	Clin. Oral Implant. Res.	FEB	2015	26	2					191	196		10.1111/clr.12316		6	Dentistry, Oral Surgery & Medicine; Engineering, Biomedical	Dentistry, Oral Surgery & Medicine; Engineering	AY6ZA	WOS:000347709900010		
J	Luo, XB; Wan, Y; He, XJ; Mori, K				Luo, Xiongbiao; Wan, Ying; He, Xiangjian; Mori, Kensaku			Adaptive marker-free registration using a multiple point strategy for real-time and robust endoscope electromagnetic navigation	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Marker-free registration; Endoscope 3-D motion tracking; Electromagnetically navigated endoscopy; Bronchoscope navigation; Electromagnetic tracker	PERIPHERAL LUNG LESIONS; MOTION TRACKING; BRONCHOSCOPY; VALIDATION; PHANTOM; IMAGES	Registration of pre-clinical images to physical space is indispensable for computer-assisted endoscopic interventions in operating rooms. Electromagnetically navigated endoscopic interventions are increasingly performed at current diagnoses and treatments. Such interventions use an electromagnetic tracker with a miniature sensor that is usually attached at an endoscope distal tip to real time track endoscope movements in a pre-clinical image space. Spatial alignment between the electromagnetic tracker (or sensor) and pre-clinical images must be performed to navigate the endoscope to target regions. This paper proposes an adaptive marker-free registration method that uses a multiple point selection strategy. This method seeks to address an assumption that the endoscope is operated along the centerline of an intraluminal organ which is easily violated during interventions. We introduce an adaptive strategy that generates multiple points in terms of sensor measurements and endoscope tip center calibration. From these generated points, we adaptively choose the optimal point, which is the closest to its assigned the centerline of the hollow organ, to perform registration. The experimental results demonstrate that our proposed adaptive strategy significantly reduced the target registration error from 5.32 to 2.59 mm in static phantoms validation, as well as from at least 7.58 mm to 4.71 mm in dynamic phantom validation compared to current available methods. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Luo, Xiongbiao; Mori, Kensaku] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Wan, Ying; He, Xiangjian] Univ Technol Sydney, Sch Comp & Commun, Sydney, NSW 2007, Australia	Luo, XB (reprint author), Nagoya Univ, Nagoya, Aichi 4648601, Japan.	Xiongbiao.Luo@gmail.com; Joyee.Wan@gmail.com; Xiangjian.He@uts.edu.au; kensaku@is.nagoya-u.ac.jp			JSPS Kakenhi "Modality-seamless navigation for endoscopic diagnosis and surgery assistance based on multi-modality image fusion" [25242047]; JSPS Bilateral International Collaboration Grant	This work was funded by JSPS Kakenhi "Modality-seamless navigation for endoscopic diagnosis and surgery assistance based on multi-modality image fusion" (25242047) and JSPS Bilateral International Collaboration Grant.	Schwarz Y, 2006, CHEST, V129, P988, DOI 10.1378/chest.129.4.988; Seijo LM, 2010, CHEST, V138, P1316, DOI [10.1378/chest.09-2708, 10.1378/chest.09.2708]; Luo XB, 2014, IEEE T MED IMAGING, V33, P1248, DOI 10.1109/TMI.2014.2307052; Deguchi D, 2012, INT J COMPUT ASS RAD, V7, P359, DOI 10.1007/s11548-011-0626-9; Makris D, 2007, EUR RESPIR J, V29, P1187, DOI 10.1183/09031936.00165306; Becker HC, 2005, J BRONCHOL, V12, P9, DOI 10.1097/01.laboratory.0000147032.67754.22; Berghen F. V., 2005, J COMPUTATIONAL APPL, V181, P157; Bricault I, 1998, IEEE T MED IMAGING, V17, P703, DOI 10.1109/42.736022; Deligianni F, 2006, IEEE T MED IMAGING, V25, P1462, DOI 10.1109/TMI.2006.883452; Feuerstein M., 2009, 2 INT WORKSH PULM IM, P273; Gergel I., 2010, P SPIE MI 10, V7625; Khan I., 2011, CLIN PULMONARY MED, V18, P42, DOI 10.1097/CPM.0b013e318203657e; Klein T, 2007, LECT NOTES COMPUT SC, V4791, P475; Luo XB, 2010, PROC SPIE, V7625, DOI 10.1117/12.844139; Luo X., 2014, P SPIE MI 14 IM GUID, V9036; Luo XB, 2012, INT J COMPUT ASS RAD, V7, P371, DOI 10.1007/s11548-011-0645-6; Luo XB, 2012, MED IMAGE ANAL, V16, P577, DOI 10.1016/j.media.2010.11.001; Merritt SA, 2013, IEEE T MED IMAGING, V32, P1376, DOI 10.1109/TMI.2013.2252361; Peters T, 2008, IMAGE GUIDED INTERVE; Soper TD, 2010, IEEE T BIO-MED ENG, V57, P736, DOI 10.1109/TBME.2009.2034733	20	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	FEB	2015	118	2					147	157		10.1016/j.cmpb.2014.11.008		11	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Computer Science; Engineering; Medical Informatics	AZ2DN	WOS:000348045000005		
J	Araki, T; Ikeda, N; Dey, N; Chakraborty, S; Saba, L; Kumar, D; Godia, EC; Jiang, XY; Gupta, A; Radeva, P; Laird, JR; Nicolaides, A; Suri, JS				Araki, Tadashi; Ikeda, Nobutaka; Dey, Nilanjan; Chakraborty, Sayan; Saba, Luca; Kumar, Dinesh; Cuadrado Godia, Elisa; Jiang, Xiaoyi; Gupta, Ajay; Radeva, Petia; Laird, John R.; Nicolaides, Andrew; Suri, Jasjit S.			A comparative approach of four different image registration techniques for quantitative assessment of coronary artery calcium lesions using intravascular ultrasound	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						IVUS; Motion; Registration	VIRTUAL HISTOLOGY; MUTUAL-INFORMATION; ATHEROSCLEROSIS; ANGIOGRAPHY	In IVUS imaging, constant linear velocity and a constant angular velocity of 1800 rev/min causes displacement of the calcium in subsequent image frames. To overcome this error in intravascular ultrasound video, IVUS image frames must be registered prior to the lesion quantification. This paper presents a comprehensive comparison of four registration methods, namely: Rigid, Affine, B-Splines and Demons on five set of calcium lesion quantification parameters namely: (i) the mean lesion area, (ii) mean lesion arc, (iii) mean lesion span, (iv) mean lesion length, and (v) mean lesion distance from catheter. Using our IRB approved data of 100 patient volumes, our results shows that all four registrations showed a decrease in five calcium lesion parameters as follows: for Rigid registration, the values were: 4.92%, 5.84%, 5.89%, 5.27%, and 4.57%, respectively, for Affine registration the values were: 6.06%, 6.51%, 7.28%, 6.50%, and 5.94%, respectively, for B-Splines registration the values were: 7.35%, 8.03%, 9.54%, 8.18%, and 7.62%, respectively, and for Demons registration the five parameters were 7.32%, 8.02%, 10.11%, 7.94%, and 8.92% respectively. The relative overlap of identified lesions decreased by 5.91% in case of Rigid registration, 6.23% in case of Affine registration, 4.48% for Demons registration, whereas it increased by 3.05% in case of B-Splines registration. Rigid and Affine transformation-based registration took only 0.1936 and 0.2893 s per frame, respectively. Demons and B-Splines framework took only 0.5705 and 0.9405 s per frame, respectively, which were significantly slower than Rigid and Affine transformation based image registration. Published by Elsevier Ireland Ltd.	[Araki, Tadashi] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Meguro Ku, Tokyo, Japan; [Ikeda, Nobutaka] Ctr Global Hlth & Med NCGM, Div Cardiovasc Med, Shinjuku Ku, Tokyo, Japan; [Dey, Nilanjan; Chakraborty, Sayan; Suri, Jasjit S.] Global Biomed Technol Inc, Point Care Devices, Roseville, CA USA; [Saba, Luca] Univ Cagliari, AOU, I-09054 Cagliari, Italy; [Kumar, Dinesh; Suri, Jasjit S.] AtheroPoint LLC, Stoke Screening & Monitoring Div, Roseville, CA 95661 USA; [Cuadrado Godia, Elisa] Hosp Mar, IMIM, Barcelona, Spain; [Jiang, Xiaoyi] Univ Munster, Dept Comp Sci, D-48149 Munster, Germany; [Gupta, Ajay] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Radeva, Petia] Univ Barcelona, CVC, MILab, Barcelona, Spain; [Radeva, Petia] Univ Barcelona, Appl Math & Anal Dept, Barcelona, Spain; [Laird, John R.] Univ Calif Davis, Vasc Ctr, Davis, CA 95616 USA; [Nicolaides, Andrew] Vasc Screening & Diagnost Ctr, London, England; [Nicolaides, Andrew] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Suri, Jasjit S.] Idaho State Univ, Elect Engn Dept Affl, Pocatello, ID 83209 USA	Suri, JS (reprint author), AtheroPoint LLC, Stoke Screening & Monitoring Div, Roseville, CA 95661 USA.	jasjit.suri@atheropoint.com					Amores J., 2003, PATTERN RECOGN, V2652, P45, DOI 10.1007/978-3-540-44871-6_6; Gatta C, 2009, IEEE T INF TECHNOL B, V13, P1006, DOI 10.1109/TITB.2009.2027230; Guo YJ, 2006, MED BIOL ENG COMPUT, V44, P15, DOI 10.1007/s11517-005-0016-y; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Makni N, 2012, COMPUT METH PROG BIO, V108, P213, DOI 10.1016/j.cmpb.2012.04.001; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Choi Y, 2000, GRAPH MODELS, V62, P411, DOI 10.1006/gmod.2000.0531; de Graaf MA, 2013, INT J CARDIOVAS IMAG, V29, P1177, DOI 10.1007/s10554-013-0194-x; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Rivaz H, 2014, MED IMAGE ANAL, V18, P343, DOI 10.1016/j.media.2013.12.003; Lindsey JB, 2009, CIRC-CARDIOVASC INTE, V2, P543, DOI 10.1161/CIRCINTERVENTIONS.109.876672; Araki T, 2014, INT ANGIOL, V33, P392; Araki T, 2014, J MED IMAG HEALTH IN, V4, P255, DOI 10.1166/jmihi.2014.1251; Arbab-Zadeh A., 1999, AM HEART J, V138, P865; Balocco S, 2011, LECT NOTES COMPUT SC, V6669, P556; Branson K., 2004, PRACTICAL REV UNIFOR; Denton E. R., 1999, J COMPUTER ASSISTED, V5, P800; Garcia-Garcia H. M., 2010, EUR HEART J, V3, P2456; Gu S., 2014, COMPUT MED IMAGING G; Gupta A, 2013, MED BIOL ENG COMPUT, V51, P1043, DOI 10.1007/s11517-013-1086-x; Hanb D., 2014, COMPUT METH PROG BIO, V117, P179; Honda Y., 2014, CARDIOVASC INTERV TH; Katouzian A, 2012, IEEE T BIO-MED ENG, V59, P3039, DOI 10.1109/TBME.2012.2213338; Khalifa F, 2011, MULTI MODALITY STATE-OF-THE-ART MEDICAL IMAGE SEGMENTATION AND REGISTRATION METHODOLOGIES, VOL 1, P235, DOI 10.1007/978-1-4419-8195-0_9; Liang Y., 2006, ANN INT C IEEE ENG M, V1, P3218; Loizou CP, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.018; Oakeson K.D., 2004, P INT SOC OPT PHOTON, V1, P119; Rotger D., 2002, P 20 C AN SOC ESP IN, P137; Schwarz L., 2007, THESIS TU MUNCHEN, P27; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Veress I., 2002, J BIOMECH ENG, V124, P734; Wang P, 2013, IEEE T MED IMAGING, V32, P2238, DOI 10.1109/TMI.2013.2279754; Wua T.-H., 2013, COMPUT METH PROG BIO, V111, P693	34	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	FEB	2015	118	2					158	172		10.1016/j.cmpb.2014.11.006		15	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Computer Science; Engineering; Medical Informatics	AZ2DN	WOS:000348045000006		
J	Weiss, JS; Moller, HU; Aldave, AJ; Seitz, B; Bredrup, C; Kivela, T; Munier, FL; Rapuano, CJ; Nischal, KK; Kim, EK; Sutphin, J; Busin, M; Labbe, A; Kenyon, KR; Kinoshita, S; Lisch, W				Weiss, Jayne S.; Moller, Hans Ulrik; Aldave, Anthony J.; Seitz, Berthold; Bredrup, Cecilie; Kivela, Tero; Munier, Francis L.; Rapuano, Christopher J.; Nischal, Kanwal K.; Kim, Eung Kweon; Sutphin, John; Busin, Massimo; Labbe, Antoine; Kenyon, Kenneth R.; Kinoshita, Shigeru; Lisch, Walter			IC3D Classification of Corneal Dystrophies-Edition 2	CORNEA			English	Article						cornea; cornea dystrophy; cornea pathology; cornea; genetics; genetic disease; hereditary disease; confocal microscopy; histopathology; epithelium; Bowman membrane; stroma; Descemet membrane; endothelium; TGFBI; epithelial and subepithelial dystrophies; epithelial-stromal TGFBI dystrophies; stromal dystrophies; endothelial dystrophies; keratoconus; epithelial basement membrane dystrophy; epithelial recurrent erosion dystrophies; subepithelial mucinous corneal dystrophy; Meesmann dystrophy; gelatinous drop-like corneal dystrophy; Reis-Bucklers corneal dystrophy; Thiel-Behnke corneal dystrophy; Lisch epithelial corneal dystrophy; lattice corneal dystrophy; granular corneal dystrophy type 1; granular corneal dystrophy type 2; macular corneal dystrophy; Schnyder corneal dystrophy; congenital stromal corneal dystrophy; fleck corneal dystrophy; posterior amorphous corneal dystrophy; central cloudy dystrophy of Francois; pre-Descemet corneal dystrophy; Fuchs endothelial corneal dystrophy; posteror polymorphous corneal dystrophy; congenital corneal endothelial dystrophy and X-linked endothelial dystrophy; histology; confocal microscopy	INDIVIDUAL PHENOTYPIC VARIANCES; ENDOTHELIAL DYSTROPHIES; UBIAD1 GENE; KERATOCONUS; MUTATIONS; FRANCOIS; DISEASE; FAMILY; LINKAGE; EDEMA	Purpose: To update the 2008 International Classification of Corneal Dystrophies (IC3D) incorporating new clinical, histopathologic, and genetic information. Methods: The IC3D reviewed worldwide peer-reviewed articles for new information on corneal dystrophies published between 2008 and 2014. Using this information, corneal dystrophy templates and anatomic classification were updated. New clinical, histopathologic, and confocal photographs were added. Results: On the basis of revisiting the cellular origin of corneal dystrophy, a modified anatomic classification is proposed consisting of (1) epithelial and subepithelial dystrophies, (2) epithelial-stromal TGFBI dystrophies, (3) stromal dystrophies, and (4) endothelial dystrophies. Most of the dystrophy templates are updated. The entity "Epithelial recurrent erosion dystrophies" actually includes a number of potentially distinct epithelial dystrophies (Franceschetti corneal dystrophy, Dystrophia Smolandiensis, and Dystrophia Helsinglandica) but must be differentiated from dystrophies such as TGFBI-induced dystrophies, which are also often associated with recurrent epithelial erosions. The chromosome locus of Thiel-Behnke corneal dystrophy is only located on 5q31. The entity previously designated as a variant of Thiel-Behnke corneal dystrophy on chromosome 10q24 may represent a novel corneal dystrophy. Congenital hereditary endothelial dystrophy (CHED, formerly CHED2) is most likely only an autosomal recessive disorder. The so-called autosomal dominant inherited CHED (formerly CHED1) is insufficiently distinct to continue to be considered a unique corneal dystrophy. On review of almost all of the published cases, the description appeared most similar to a type of posterior polymorphous corneal dystrophy linked to the same chromosome 20 locus (PPCD1). Confocal microscopy also has emerged as a helpful tool to reveal in vivo features of several corneal dystrophies that previously required histopathologic examination to definitively diagnose. Conclusions: This revision of the IC3D classification includes an updated anatomic classification of corneal dystrophies more accurately classifying TGFBI dystrophies that affect multiple layers rather than are confined to one corneal layer. Typical histopathologic and confocal images have been added to the corneal dystrophy templates.	[Weiss, Jayne S.] Louisiana State Univ, Hlth Sci Ctr, Eye Ctr Excellence, Dept Ophthalmol Pathol & Pharmacol, New Orleans, LA 70112 USA; [Moller, Hans Ulrik] Viborg Hosp, Dept Pediat Ophthalmol, Aarhus, Denmark; [Moller, Hans Ulrik] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Aldave, Anthony J.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Seitz, Berthold] Univ Saarland, Med Ctr, Dept Ophthalmol, Homburg, Germany; [Bredrup, Cecilie] Haukeland Hosp, Dept Ophthalmol, N-5021 Bergen, Norway; [Kivela, Tero] Univ Helsinki, Cent Hosp, Dept Ophthalmol, Helsinki, Finland; [Munier, Francis L.] Jules Gonin Eye Hosp, Lausanne, Switzerland; [Rapuano, Christopher J.] Thomas Jefferson Univ, Wills Eye Hosp, Cornea Serv, Philadelphia, PA 19107 USA; [Nischal, Kanwal K.] Univ Pittsburgh, Med Ctr, Childrens Eye Ctr, Pittsburgh, PA USA; [Kim, Eung Kweon] Yonsei Univ, Coll Med, Dept Ophthalmol, Cornea Dystrophy Res Inst, Seoul, South Korea; [Sutphin, John] Univ Kansas, Med Ctr, Dept Ophthalmol, Kansas City, KS 66103 USA; [Busin, Massimo] Maitre Conf Univ Praticien Hosp, Villa Igea Hosp, Dept Ophthalmol, Forli, Italy; [Labbe, Antoine] Ctr Hosp Natl Ophtalmol Quinze Vingts, Inst Vis, Paris, France; [Kenyon, Kenneth R.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Kenyon, Kenneth R.] Harvard Univ, Sch Med, Schepens Eye Res Inst, New England Eye Ctr, Boston, MA USA; [Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Lisch, Walter] Johannes Gutenberg Univ Mainz, Dept Ophthalmol, D-55122 Mainz, Germany	Weiss, JS (reprint author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Ophthalmol, 2020 Gravier St,Suite B, New Orleans, LA 70112 USA.	jweiss@lsuhsc.edu			Cornea Society; Louisiana Lions Eye Foundation; Research to Prevent Blindness	Supported by The Cornea Society, Louisiana Lions Eye Foundation, and Research to Prevent Blindness.	Afshari NA, 2014, 2014 2015 BASIC CLIN, P253; Aldave AJ, 2002, CORNEA, V21, P739, DOI 10.1097/00003226-200211000-00001; Wang Y, 2000, AM J MED GENET, V93, P403, DOI 10.1002/1096-8628(20000828)93:5<403::AID-AJMG11>3.0.CO;2-A; [Anonymous], 1915, KLIN MONATSBL AUGENH, V54, P377; Lisch W, 2012, AM J OPHTHALMOL, V153, P1073, DOI 10.1016/j.ajo.2011.12.011; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Edwards M, 2001, CLIN EXP OPHTHALMOL, V29, P345, DOI 10.1046/j.1442-9071.2001.00448.x; Goetz KE, 2012, CURR OPIN OPHTHALMOL, V23, P355, DOI 10.1097/ICU.0b013e32835715c9; FRANCESCHETTI A., 1928, ZEITSCHR AUGENHEILK, V66, P309; KANAI A, 1971, INVEST OPHTH VISUAL, V10, P545; Aldave AJ, 2006, INVEST OPHTH VIS SCI, V47, P2820, DOI 10.1167/iovs.05-1530; Hammar B, 2009, ACTA OPHTHALMOL, V87, P659, DOI 10.1111/j.1755-3768.2008.01308.x; WEISS JS, 1992, CORNEA, V11, P93, DOI 10.1097/00003226-199203000-00001; FRANCOIS JULES, 1956, JOUR GENET HUMAINE, V5, P189; Weiss JS, 2008, CORNEA, V27, pS1, DOI 10.1097/ICO.0b013e31817780fb; Tyynismaa H, 2002, INVEST OPHTH VIS SCI, V43, P3160; Weiss JS, 1996, OPHTHALMOLOGY, V103, P465; Aldave AJ, 2013, CLIN GENET, V84, P109, DOI 10.1111/cge.12191; Biber H, 1890, THESIS; Bouchard CS, 2010, 2010 2011 BASIC CLIN, P267; BRAMSEN T, 1976, ACTA OPHTHALMOL, V54, P221; Dash DP, 2010, EYE, V24, P1085, DOI 10.1038/eye.2009.217; Fuchs E, 1910, ALBRECHT GRAEFES ARC, V76, P478, DOI 10.1007/BF01986362; GRAYSON M, 1966, AM J OPHTHALMOL, V61, P345; Groenouw A., 1890, ARCH AUGENHEILKD, V21, P281; Hamill CE, 2013, SEMIN OPHTHALMOL, V28, P281, DOI 10.3109/08820538.2013.825283; Hammar B, 2008, ACTA OPHTHALMOL, V86, P758, DOI 10.1111/j.1600-0420.2007.01123.x; Hoyt C, 2012, PAEDIAT OPHTHALMOLOG, V4th, P323; Hu Møller, 2010, Cornea, V29, P1469, DOI 10.1097/ICO.0b013e3181e9b540; KANAI A, 1971, INVEST OPHTH VISUAL, V10, P89; Karp CL, 1997, ARCH OPHTHALMOL-CHIC, V115, P1058; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036; LEVENSON JE, 1973, AM J OPHTHALMOL, V76, P967; Lisch W, 2013, CORNEA, V32, pE192, DOI 10.1097/ICO.0b013e3182a73865; Lisch W, 2012, CORNEA, V31, P55, DOI 10.1097/ICO.0b013e31821ddd0c; LOHSE E, 1989, CORNEA, V8, P200; Nakamura H, 2012, CORNEA, V31, P1217, DOI 10.1097/ICO.0b013e3181c32efd; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Rabinowitz Yaron S, 2003, Ophthalmol Clin North Am, V16, P607, DOI 10.1016/S0896-1549(03)00099-3; STRACHAN IM, 1969, BRIT J OPHTHALMOL, V53, P192, DOI 10.1136/bjo.53.3.192; WARING GO, 1978, SURV OPHTHALMOL, V23, P71, DOI 10.1016/0039-6257(78)90090-5; WARING GO, 1978, SURV OPHTHALMOL, V23, P147, DOI 10.1016/0039-6257(78)90151-0; Weiss JS, 1994, OPHTHALMOLOGY, V101, P895; Weiss JS, 2010, CORNEA, V29, P777, DOI 10.1097/ICO.0b013e3181c84bcf; Yee RW, 1997, GENOMICS, V46, P152, DOI 10.1006/geno.1997.5028; Yoshida Y, 1924, A VONGRAEFES ARCH CL, V114, P91, DOI 10.1007/BF01944086	46	10	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	FEB	2015	34	2					117	159				43	Ophthalmology	Ophthalmology	AY9ZU	WOS:000347907100005		
J	Kobayashi, A; Murata, N; Yokogawa, H; Yamazaki, N; Masaki, T; Sugiyama, K				Kobayashi, Akira; Murata, Noriaki; Yokogawa, Hideaki; Yamazaki, Natsuko; Masaki, Toshinori; Sugiyama, Kazuhisa			Evaluation of Internationally Shipped Prestripped Donor Tissue for Descemet Membrane Endothelial Keratoplasty by Vital Dye Staining	CORNEA			English	Article						Descemet stripping automated endothelial keratoplasty; Descemet membrane endothelial keratoplasty; endothelial damage; trypan blue	POSTERIOR LAMELLAR KERATOPLASTY; DMEK; TRANSPLANTATION; INCISION; GRAFTS; PRECUT; DLEK; EYES	Purpose: The aim of this study was to evaluate endothelial cell damage of internationally shipped prestripped donor tissue for Descemet membrane endothelial keratoplasty (DMEK) using vital dye staining. Methods: Six internationally shipped prestripped DMEK donors were stained with trypan blue and were subsequently photographed before they were cut with a trephine. Quantitative analysis assessment of endothelial damage of the donor graft area (8.0 mm in diameter) was performed using Adobe Photoshop CS6 Extended software. Seven internationally shipped precut Descemet stripping automated endothelial keratoplasty (DSAEK) donors were used as controls. Results: No statistical differences were noted between prestripped DMEK donors and precut DSAEK donors in mean donor age (67.7 vs. 56.4 years, P = 0.222), mean donor endothelial cell density (2687.3 vs. 2894.6 cells, P = 0.353), and death-to-preservation time (405.3 vs. 558.4 minutes, P = 0.173). However, the mean time of death-to-experiment time in DMEK donors was significantly longer than that of DSAEK donors (8.7 vs. 6.6 days, P = 0.031). Mean endothelial cell damage of prestripped DMEK donors was as low as 0.3%. However, DMEK donor endothelial damage (0.3%) was significantly higher compared with that of precut DSAEK donor tissue (0.01%, P = 0.029). Conclusions: Although endothelial damage of internationally shipped prestripped donor tissue for DMEK was higher than that of precut DSAEK donor, it was extremely low. Further evaluation using another vital dye and clinical studies may be needed to confirm this study.	[Kobayashi, Akira; Murata, Noriaki; Yokogawa, Hideaki; Yamazaki, Natsuko; Masaki, Toshinori; Sugiyama, Kazuhisa] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa 9208641, Japan	Kobayashi, A (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	kobaya@kenroku.kanazawa-u.ac.jp			KAKENHI, Japan [22591934]	Supported by a Grant-in-Aid for Scientific Research (C) KAKENHI, Japan (No. 22591934).	Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021; Dupps WJ, 2008, J CATARACT REFR SURG, V34, P578, DOI 10.1016/j.jcrs.2007.11.045; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Price MO, 2008, J CATARACT REFR SURG, V34, P1423, DOI 10.1016/j.jcrs.2008.05.044; Chen ES, 2008, CORNEA, V27, P514, DOI 10.1097/ICO.0b013e3181611c50; Terry MA, 2005, OPHTHALMOLOGY, V112, P1541, DOI 10.1016/j.ophtha.2005.03.026; Melles GRJ, 2002, CORNEA, V21, P415, DOI 10.1097/00003226-200205000-00016; Terry MA, 2005, CORNEA, V24, P59, DOI 10.1097/01.ico.0000133990.19027.a2; Melles GRJ, 2006, CORNEA, V25, P879, DOI 10.1097/01.ico.0000243962.60392.4f; Kobayashi A, 2008, CORNEA, V27, pS62, DOI 10.1097/ICO.0b013e31817f38e9; Melles GRJ, 2006, CORNEA, V25, P987; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Price MO, 2008, AM J OPHTHALMOL, V146, P36, DOI 10.1016/j.ajo.2008.02.024; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Bahar I, 2009, CORNEA, V28, P485, DOI 10.1097/ICO.0b013e3181901df4; Price MO, 2006, OPHTHALMOLOGY, V113, P1936, DOI 10.1016/j.ophtha.2006.05.034; Ham L, 2009, ARCH OPHTHALMOL-CHIC, V127, P252, DOI 10.1001/archophthalmol.2008.619; Kobayashi A, 2013, OPHTHALMOLOGY, V120, P923, DOI 10.1016/j.ophtha.2012.11.006; Dapena I, 2011, ARCH OPHTHALMOL-CHIC, V129, P88, DOI 10.1001/archophthalmol.2010.334; Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078; Ham L, 2009, EYE, V23, P1990, DOI 10.1038/eye.2008.393; Saad HA, 2008, CORNEA, V27, P818, DOI 10.1097/ICO.0b013e3181705ca2	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	FEB	2015	34	2					225	227				3	Ophthalmology	Ophthalmology	AY9ZU	WOS:000347907100017		
J	Ahuja, V; Kadowaki, T; Evans, RW; Kadota, A; Okamura, T; El Khoudary, SR; Fujiyoshi, A; Barinas-Mitchell, EJM; Hisamatsu, T; Vishnu, A; Miura, K; Maegawa, H; El-Saed, A; Kashiwagi, A; Kuller, LH; Ueshima, H; Sekikawa, A				Ahuja, Vasudha; Kadowaki, Takashi; Evans, Rhobert W.; Kadota, Aya; Okamura, Tomonori; El Khoudary, Samar R.; Fujiyoshi, Akira; Barinas-Mitchell, Emma J. M.; Hisamatsu, Takashi; Vishnu, Abhishek; Miura, Katsuyuki; Maegawa, Hiroshi; El-Saed, Aiman; Kashiwagi, Atsunori; Kuller, Lewis H.; Ueshima, Hirotsugu; Sekikawa, Akira		ERA Jump Study Grp	Comparison of HOMA-IR, HOMA-beta% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study	DIABETOLOGIA			English	Article						Cross-sectional analysis; Epidemiology; Humans; Insulin resistance; Japanese; Pathophysiology; Race; Type 2 diabetes; Visceral adipose tissue; White race	HOMEOSTASIS MODEL ASSESSMENT; VISCERAL ADIPOSE-TISSUE; INSULIN-RESISTANCE; CELL FUNCTION; MULTIETHNIC COHORT; ETHNIC-DIFFERENCES; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; WOMENS HEALTH; SENSITIVITY	At the same level of BMI, white people have less visceral adipose tissue (VAT) and are less susceptible to developing type 2 diabetes than Japanese people. No previous population-based studies have compared insulin resistance and insulin secretion between these two races in a standardised manner that accounts for VAT. We compared HOMA-IR, HOMA of beta cell function (HOMA-beta%) and disposition index (DI) in US white men and Japanese men in Japan. We conducted a population-based, cross-sectional study, comprising 298 white men and 294 Japanese men aged 40-49 years without diabetes. Insulin, glucose, VAT and other measurements were performed at the University of Pittsburgh. We used ANCOVA to compare geometric means of HOMA-IR, HOMA-beta% and DI, adjusting for VAT and other covariates. White men had higher HOMA-IR, HOMA-beta% and DI than Japanese men, and the difference remained significant (p < 0.01) after adjusting for VAT (geometric mean [95% CI]): 3.1 (2.9, 3.2) vs 2.5 (2.4, 2.6), 130.8 (124.6, 137.3) vs 86.7 (82.5, 91.0), and 42.4 (41.0, 44.0) vs 34.8 (33.6, 36.0), respectively. Moreover, HOMA-IR, HOMA-beta% and DI were significantly higher in white men even after further adjustment for BMI, impaired fasting glucose and other risk factors. The higher VAT-adjusted DI in white men than Japanese men may partly explain lower susceptibility of white people than Japanese people to developing type 2 diabetes. The results, however, should be interpreted with caution because the assessment of insulin indices was made using fasting samples and adjustment was not made for baseline glucose tolerance. Further studies using formal methods to evaluate insulin indices are warranted.	[Ahuja, Vasudha; Evans, Rhobert W.; El Khoudary, Samar R.; Barinas-Mitchell, Emma J. M.; Vishnu, Abhishek; El-Saed, Aiman; Kuller, Lewis H.; Sekikawa, Akira] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA; [Kadowaki, Takashi; Kadota, Aya; Okamura, Tomonori; Fujiyoshi, Akira; Hisamatsu, Takashi; Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga 52021, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [El-Saed, Aiman] King Abdul Aziz Med City, Infect Prevent & Control Dept, Riyadh, Saudi Arabia	Sekikawa, A (reprint author), Univ Pittsburgh, Dept Epidemiol, 130 N Bellefield Ave,Suite 546, Pittsburgh, PA 15213 USA.	akira@pitt.edu	Okamura, Tomonori/L-1693-2013				ADA (American Diabetes Association), 2013, DIABETES CARE S1, V36, pS11; Boyko EJ, 2007, DIABETES CARE, V30, P2725, DOI 10.2337/dc07-1248; Jensen CC, 2002, DIABETES, V51, P2170, DOI 10.2337/diabetes.51.7.2170; FUJIMOTO WY, 1987, DIABETES, V36, P721, DOI 10.2337/diabetes.36.6.721; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Yokoyama H, 2011, DIABETIC MED, V28, P1221, DOI 10.1111/j.1464-5491.2011.03347.x; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Moller JB, 2014, DIABETES CARE, V37, P796, DOI 10.2337/dc13-0598; Lee S, 2004, J APPL PHYSIOL, V97, P948, DOI 10.1152/japplphysiol.01200.2003; Takeda H, 2002, DIABETES CARE, V25, P995, DOI 10.2337/diacare.25.6.995; Festa A, 2013, J CLIN ENDOCR METAB, V98, P4152, DOI 10.1210/jc.2013-1937; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; Sekikawa A, 2007, AM J EPIDEMIOL, V165, P617, DOI 10.1093/aje/kwk053; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Matsuda M, 2010, NUTR METAB CARDIOVAS, V20, P79, DOI 10.1016/j.numecd.2009.07.007; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Chiu KC, 2000, DIABETES CARE, V23, P1353, DOI 10.2337/diacare.23.9.1353; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Torrens JI, 2004, DIABETES CARE, V27, P354, DOI 10.2337/diacare.27.2.354; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Fu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055727; Guglielmi C, 2012, DIABETES-METAB RES, V28, P40, DOI 10.1002/dmrr.2345; Howard G, 1998, ANN EPIDEMIOL, V8, P358, DOI 10.1016/S1047-2797(98)00002-7; Kim SH, 2004, DIABETES CARE, V27, P1998, DOI 10.2337/diacare.27.8.1998; Lee ET, 2001, DIABETOLOGIA, V44, pS3, DOI 10.1007/PL00002936; Mari A, 2005, CURR OPIN CLIN NUTR, V8, P529, DOI 10.1097/01.mco.0000171130.23441.59; Meng YX, 2007, CLIN CHEM, V53, P2152, DOI 10.1373/clinchem.2007.088930; Morimoto A, 2013, J DIABETES INVEST, V4, P274, DOI 10.1111/jdi.12019; Nakanishi S, 2004, BIOMED PHARMACOTHER, V58, P571, DOI 10.1016/j.biopha.2004.10.001; Ning F, 2010, DIABETES-METAB RES, V26, P245, DOI 10.1002/dmrr.1078; Steinbrecher A, 2011, ANN EPIDEMIOL, V21, P526, DOI 10.1016/j.annepidem.2011.03.009; Zafrir B, 2014, CARDIOVASC DRUG THER, V28, P361, DOI 10.1007/s10557-014-6534-9	37	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	FEB	2015	58	2					265	271		10.1007/s00125-014-3414-6		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AY6SY	WOS:000347697000007		
J	Urabe, H; Terashima, T; Lin, F; Kojima, H; Chan, L				Urabe, Hiroshi; Terashima, Tomoya; Lin, Fan; Kojima, Hideto; Chan, Lawrence			Bone marrow-derived TNF-alpha causes diabetic neuropathy in mice	DIABETOLOGIA			English	Article						Apoptosis; Bone marrow; Cell fusion; Diabetic complications; Diabetic neuropathy; Dorsal root ganglia; Hyperglycaemia; Peripheral nervous system; Proinsulin-producing bone marrow-derived cells; TNF-alpha	PERIPHERAL NEUROPATHY; CELL-FUSION; PATHWAY; TRANSPLANTATION; IDENTIFICATION; COMPLICATIONS; PATHOGENESIS; INHIBITION; MECHANISMS; GLYCATION	Dysregulation of biochemical pathways in response to hyperglycaemia in cells intrinsic to the nervous system (Schwann cells, neurons, vasa nervorum) are thought to underlie diabetic peripheral neuropathy (DPN). TNF-alpha is a known aetiological factor; Tnf-knockout mice are protected against DPN. We hypothesised that TNF-alpha produced by a small but specific bone marrow (BM) subpopulation marked by proinsulin production (proinsulin-producing BM-derived cells, PI-BMDCs) is essential for DPN development. We produced mice deficient in TNF-alpha, globally in BM and selectively in PI-BMDCs only, by gene targeting and BM transplantation, and induced diabetes by streptozotocin. Motor and sensory nerve conduction velocities were used to gauge nerve dysfunction. Immunocytochemistry, fluorescence in situ hybridisation (FISH) and PCR analysis of dorsal root ganglia (DRG) were employed to monitor outcome. We found that loss of TNF-alpha in BM only protected mice from DPN. We developed a strategy to delete TNF-alpha specifically in PI-BMDCs, and found that PI-BMDC-specific loss of TNF-alpha protected against DPN as robustly as loss of total BM TNF-alpha. Selective loss of PI-BMDC-derived TNF-alpha downregulated TUNEL-positive DRG neurons. FISH revealed PI-BMDC-neuron fusion cells in the DRG in mice with DPN; fusion cells were undetectable in non-diabetic mice or diabetic mice that had lost TNF-alpha expression selectively in the PI-BMDC subpopulation. BMDC-specific TNF-alpha is essential for DPN development; its selective removal from a small PI-BMDC subpopulation protects against DPN. The pathogenicity of PI-BMDC-derived TNF-alpha may have important therapeutic implications.	[Urabe, Hiroshi; Terashima, Tomoya; Lin, Fan; Kojima, Hideto; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kojima, Hideto; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Urabe, Hiroshi; Terashima, Tomoya; Kojima, Hideto] Shiga Univ Med Sci, Dept Stem Cell Biol & Regenerat Med, Otsu, Shiga 52021, Japan	Chan, L (reprint author), Baylor Coll Med, Dept Med, One Baylor Plaza MS BCM185, Houston, TX 77030 USA.	lchan@bcm.edu					Thornalley PJ, 2002, INT REV NEUROBIOL, V50, P37; Poungvarin N, 2012, DIABETOLOGIA, V55, P1783, DOI 10.1007/s00125-012-2506-4; Oates PJ, 2002, INT REV NEUROBIOL, V50, P325; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chan L, 2011, ANN NY ACAD SCI, V1240, P70, DOI 10.1111/j.1749-6632.2011.06309.x; Liu Y, 2010, DIABETOLOGIA, V53, P2600, DOI 10.1007/s00125-010-1882-x; Toth C, 2008, DIABETES, V57, P1002; Bryson JS, 1997, BONE MARROW TRANSPL, V19, P721, DOI 10.1038/sj.bmt.1700719; Hartemann A, 2011, DIABETES METAB, V37, P377, DOI 10.1016/j.diabet.2011.06.003; Schmeichel AM, 2003, DIABETES, V52, P165, DOI 10.2337/diabetes.52.1.165; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; LOW PA, 1989, INT REV NEUROBIOL, V31, P355, DOI 10.1016/S0074-7742(08)60283-4; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Yagihashi S, 2001, BRAIN, V124, P2448, DOI 10.1093/brain/124.12.2448; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Cooke KR, 1996, BLOOD, V88, P3230; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Spinetti G, 2013, CIRC RES, V112, P510, DOI 10.1161/CIRCRESAHA.112.300598; Oikawa A, 2010, ARTERIOSCL THROM VAS, V30, P498, DOI 10.1161/ATVBAHA.109.200154; Cameron NE, 2008, CURR DRUG TARGETS, V9, P60, DOI 10.2174/138945008783431718; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Fujimiya M, 2007, P NATL ACAD SCI USA, V104, P4030, DOI 10.1073/pnas.0700220104; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Leinninger GM, 2004, J PERIPHER NERV SYST, V9, P26, DOI 10.1111/j.1085-9489.2004.09105.x; Nguyen Dung V, 2012, Front Endocrinol (Lausanne), V3, P170, DOI 10.3389/fendo.2012.00170; Peters SO, 2002, J IMMUNOL METHODS, V260, P109, DOI 10.1016/S0022-1759(01)00525-7; Pugatsch T, 1996, BONE MARROW TRANSPL, V17, P273; Satoh Jo, 2003, Exp Diabesity Res, V4, P65, DOI 10.1155/EDR.2003.65; Shi XH, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-69; Skundric Dusanka S, 2003, Exp Diabesity Res, V4, P303, DOI 10.1155/EDR.2003.303; Terashima T, 2012, FASEB J, V26, P295, DOI 10.1096/fj.11-186262; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; XIA P, 1995, J CLIN INVEST, V96, P733, DOI 10.1172/JCI118117; Yamakawa I, 2011, AM J PHYSIOL-ENDOC M, V301, pE844, DOI 10.1152/ajpendo.00029.2011	36	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	FEB	2015	58	2					402	410		10.1007/s00125-014-3440-4		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AY6SY	WOS:000347697000022		
J	Suzuki, A; Hirokawa, M; Higuchi, M; Yamao, N; Kuma, S; Nakamura, H; Amino, N; Miyauchi, A				Suzuki, Ayana; Hirokawa, Mitsuyoshi; Higuchi, Miyoko; Yamao, Naoki; Kuma, Seiji; Nakamura, Hirotoshi; Amino, Nobuyuki; Miyauchi, Akira			Cytological Characteristics of Papillary Thyroid Carcinoma on LBC Specimens, Compared with Conventional Specimens	DIAGNOSTIC CYTOPATHOLOGY			English	Article						thyroid; papillary carcinoma; cytology; liquid-based cytology; convoluted nuclei	FINE-NEEDLE-ASPIRATION; LIQUID-BASED CYTOLOGY; CERVICAL-CANCER; SAMPLES; SMEARS	BackgroundThe cytological findings in conventional specimens (C-S) and liquid-based cytology specimens (LBC-S) are not quite same. The aim of this article is to clarify the cytological findings of papillary thyroid carcinoma (PTC) characteristic of LBC-S. MethodsOut of 5,971 cases diagnosed in a single institution from March to September in 2012, 161 PTC cases with both C-S and LBC-S were reviewed. Additionally, we compared the findings with those in LBC-S of 55 adenomatous or hyperplastic nodule (AN) and 21 follicular neoplasm (FN) cases. ResultsCompared to C-S, the incidences of trabecular and hobnail patterns, collagenous stroma, naked capillaries, intercellular spaces, convoluted nuclei, eosinophilic nucleoli, and perinucleolar halo were increased. Pale nuclei were observed in only one of 161 PTC cases. Specificity of convoluted nuclei and perinucleolar halo were 97.4% and 96.1%, respectively. ConclusionConvoluted nuclei and perinucleolar halo might become a new indicator of PTC in LBC-S. Contrarily, we should be aware that pale nuclei are rarely observed in LBC-S. Diagn. Cytopathol. 2015;43:108-113. (c) 2014 Wiley Periodicals, Inc.	[Suzuki, Ayana; Higuchi, Miyoko; Yamao, Naoki] Kuma Hosp, Dept Lab, Kobe, Hyogo, Japan; [Hirokawa, Mitsuyoshi; Kuma, Seiji] Kuma Hosp, Dept Diagnost Pathol, Kobe, Hyogo, Japan; [Nakamura, Hirotoshi; Amino, Nobuyuki] Kuma Hosp, Dept Internal Med, Kobe, Hyogo, Japan; [Miyauchi, Akira] Kuma Hosp, Dept Surg, Kobe, Hyogo, Japan	Suzuki, A (reprint author), JSC, CT, Chuo Ku, 8-2-35 Shimoyamate Dori, Kobe, Hyogo 6500011, Japan.	suzuki01@kuma-h.or.jp					Akamatsu S, 2012, ACTA CYTOL, V56, P370, DOI 10.1159/000337641; Ali SZ, 2010, BETHESDA SYSTEM REPO; Afify AM, 2001, CANCER CYTOPATHOL, V93, P179, DOI 10.1002/cncr.9027; Nandini NM, 2012, ASIAN PAC J CANCER P, V13, P3645, DOI 10.7314/APJCP.2012.13.8.3645; Argona A, 2013, ACTA CYTOL, V57, P266, DOI 10.1159/000346716; Fadda G, 2011, ACTA CYTOL, V55, P389, DOI 10.1159/000329029; Fischer AH, 2013, ARCH PATHOL LAB MED, V137, P26, DOI 10.5858/arpa.2012-0009-CP; Geers C, 2011, CANCER CYTOPATHOL, V119, P58, DOI 10.1002/cncy.20125; Hirokawa M, 2000, DIAGN CYTOPATHOL, V23, P351, DOI 10.1002/1097-0339(200011)23:5<351::AID-DC14>3.0.CO;2-J; Jung CK, 2008, ACTA CYTOL, V52, P313, DOI 10.1159/000325513; Kim DH, 2007, KOREAN J CYTOPATHOL, V18, P143; Lee Sung Hak, 2014, Diagn Cytopathol, V42, P11, DOI 10.1002/dc.23007; Malle D, 2006, ACTA CYTOL, V50, P23, DOI 10.1159/000325890; Mygdakos N, 2009, ROM J MORPHOL EMBRYO, V50, P245; Rossi ED, 2009, ACTA CYTOL, V53, P59; Rossi ED, 2010, CYTOPATHOLOGY, V21, P97, DOI 10.1111/j.1365-2303.2009.00659.x; Rossi ED, 2012, FRONT ENDOCRINOL, V3, P1	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	FEB	2015	43	2					108	113		10.1002/dc.23191		6	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	AZ0WY	WOS:000347963900004		
J	Kuwabara, H; Ishizaki, S; Akashi, S; Yuki, M; Shibayama, Y				Kuwabara, Hiroko; Ishizaki, Sachie; Akashi, Shizuka; Yuki, Masako; Shibayama, Yuro			alpha-Amylase Crystalloid Granuloma in the Parotid Gland	DIAGNOSTIC CYTOPATHOLOGY			English	Article						-amylase; crystalloid granuloma; parotid gland	OF-THE-LITERATURE; NONTYROSINE CRYSTALLOIDS; LESIONS		[Kuwabara, Hiroko; Ishizaki, Sachie; Akashi, Shizuka; Shibayama, Yuro] Osaka Med Coll, Dept Pathol, Takatsuki, Osaka 5698686, Japan; [Yuki, Masako] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan	Kuwabara, H (reprint author), Osaka Med Coll, Dept Pathol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	pa2020@art.osaka-med.ac.jp					Nasuti JF, 2000, DIAGN CYTOPATHOL, V22, P167, DOI 10.1002/(SICI)1097-0339(20000301)22:3<167::AID-DC7>3.0.CO;2-P; Ho C, 2013, INT J SURG PATHOL, V21, P282, DOI 10.1177/1066896912462128; TAKEDA Y, 1983, VIRCHOWS ARCH A, V399, P41; Bellizzi AM, 2008, AM J CLIN PATHOL, V130, P355, DOI 10.1309/J3YVV58V22AKXHWR; Gerhard R, 2005, DIAGN CYTOPATHOL, V32, P378, DOI 10.1002/dc.20262; Granter SR, 1999, DIAGN CYTOPATHOL, V20, P44, DOI 10.1002/(SICI)1097-0339(199901)20:1<44::AID-DC10>3.0.CO;2-K; HORIE Y, 1994, PATHOL INT, V44, P535, DOI 10.1111/j.1440-1827.1994.tb02604.x; Lopez-Rios F, 2001, DIAGN CYTOPATHOL, V25, P59, DOI 10.1002/dc.2003; Pantanowitz L, 2006, DIAGN CYTOPATHOL, V34, P749, DOI 10.1002/dc.20539; RAUBENHEIMER EJ, 1990, ORAL SURG ORAL MED O, V70, P480, DOI 10.1016/0030-4220(90)90215-E; Saenz-Santamaria J, 2003, ACTA CYTOL, V47, P1, DOI 10.1159/000326467; Sas R, 1997, ARCH ORAL BIOL, V42, P469, DOI 10.1016/S0003-9969(97)00045-9; TAKEDA Y, 1991, J ORAL PATHOL MED, V20, P234, DOI 10.1111/j.1600-0714.1991.tb00425.x; Yada N, 2012, OR SURG OR MED OR PA, V114, pE43, DOI 10.1016/j.oooo.2012.02.011	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	FEB	2015	43	2					114	116		10.1002/dc.23119		3	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	AZ0WY	WOS:000347963900005		
J	Hayashi, T; Haba, R; Kushida, Y; Katsuki, N; Shibuya, S; Kadota, K; Matsunaga, T; Miyake, K; Tamiya, T				Hayashi, Toshitetsu; Haba, Reiji; Kushida, Yoshio; Katsuki, Naomi; Shibuya, Shinsuke; Kadota, Kyuichi; Matsunaga, Toru; Miyake, Keisuke; Tamiya, Takashi			Pilomyxoid Astrocytoma of the Pineal Region: Cytopathological Features and Differential Diagnostic Considerations by Intraoperative Smear Preparation	DIAGNOSTIC CYTOPATHOLOGY			English	Article						pilomyxoid astrocytoma; pilocytic astrocytoma; pineal region; cytology; immunohistochemistry	TUMORS; EXPERIENCE; CYTOLOGY	Pilomyxoid astrocytoma (PMA) is a recently identified type of pilocytic astrocytoma (PA) with shorter progression-free and overall survival, higher rate of recurrence, and higher risk of leptomeningeal spread compared to pilocytic tumors (WHO grade 2 designation). A case is presented here in which intraoperative imprint smears of a pineal region tumor in a 14-year-old girl revealed cytologic monomorphism, elongated cells with bland nuclei embedded in a myxoid background. The tumor cells possessed uniformly round nuclei with a smooth nuclear outline, fine granular chromatin, and small nucleoli. Slender cytoplasmic fibrillary processes and angiocentric arrangement were observed but Rosenthal fibers or eosinophilic granular bodies were absent. A cytologic diagnosis of PMA of the pineal region was suggested by intraoperative smear preparation. Histology and immunohistochemical results confirmed the final diagnosis. This report shows that smear preparation can be trustworthy for the intraoperative diagnosis of PMA, helping to determine the appropriate neurosurgical procedure and therapeutic implications. Diagn. Cytopathol. 2015;43:121-124. (c) 2014 Wiley Periodicals, Inc.	[Hayashi, Toshitetsu; Haba, Reiji; Kushida, Yoshio; Katsuki, Naomi; Shibuya, Shinsuke; Kadota, Kyuichi; Matsunaga, Toru] Kagawa Univ, Dept Diagnost Pathol, Fac Med, Miki, Kagawa, Japan; [Miyake, Keisuke; Tamiya, Takashi] Kagawa Univ, Dept Neurosurg, Fac Med, Miki, Kagawa, Japan	Hayashi, T (reprint author), Kagawa Univ, Dept Diagnost Pathol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa, Japan.	htoshi@med.kagawa-u.ac.jp					Johnson MW, 2010, AM J SURG PATHOL, V34, P1783, DOI 10.1097/PAS.0b013e3181fd66c3; Brat DJ, 2007, BRAIN PATHOL, V17, P319, DOI 10.1111/j.1750-3639.2007.00082.x; Cho HY, 2009, APPL IMMUNOHISTO M M, V17, P131, DOI 10.1097/PAI.0b013e3181866a13; Ceppa EP, 2007, J NEURO-ONCOL, V81, P191, DOI 10.1007/s11060-006-9216-z; YANG GCH, 1995, ACTA CYTOL, V39, P55; Komotar RJ, 2006, NEUROPATHOLOGY, V26, P89, DOI 10.1111/j.1440-1789.2006.00641.x; Barton VN, 2013, J NEUROPATH EXP NEUR, V72, P442, DOI 10.1097/NEN.0b013e31829023dd; Khanani MF, 2006, PEDIATR BLOOD CANCER, V46, P377, DOI 10.1002/pbc.20391; Komotar Ricardo J, 2004, MedGenMed, V6, P42; Komotar RJ, 2005, NEUROSURG FOCUS, V15, P18; MOURIQUAND C, 1987, ACTA CYTOL, V31, P756; Nagaishi M, 2011, NEUROPATHOLOGY, V31, P152, DOI 10.1111/j.1440-1789.2010.01143.x; Tsugu H, 2009, ANTICANCER RES, V29, P919	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	FEB	2015	43	2					121	124		10.1002/dc.23133		4	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	AZ0WY	WOS:000347963900007		
J	Takeda, M; Kasai, T; Morita, K; Takeuchi, M; Nishikawa, T; Yamashita, A; Mikami, S; Hosoi, H; Ohbayashi, C				Takeda, Maiko; Kasai, Takahiko; Morita, Kohei; Takeuchi, Mao; Nishikawa, Takeshi; Yamashita, Akinori; Mikami, Shinji; Hosoi, Hiroshi; Ohbayashi, Chiho			Cytopathological Features of Mammary Analogue Secretory Carcinoma-Review of Literature	DIAGNOSTIC CYTOPATHOLOGY			English	Article						Mammary analogue secretory carcinoma; salivary gland; fine-needle aspiration; ETV6-NTRK3 fusion transcript	SALIVARY-GLAND; PAROTID-GLAND; DIAGNOSIS; ENTITY	Mammary analogue secretory carcinoma (MASC) is a recently described salivary gland tumor that morphologically resembles mammary secretory carcinoma and carries the identical ETV6-NTRK3 fusion gene. We report a surgical resected case of MASC in the parotid gland of a 41-year-old man. The cytological smears of a preoperative fine-needle aspiration showed many sheets and crowded clusters of monotonous epithelioid cells with mild atypia, suggestive of monomorphic tumor. Histologically, the tumor was composed of cuboidal cells with follicular, tubular, and solid structures, reminiscent of acinic cell carcinoma of follicular variant, which had been previously classified. This case had ETV6-NTRK3 fusion gene transcript confirmed by fluorescence in situ hybridization and reverse transcription polymerase chain reaction. In the cytological and histopathological diagnosis of monomorphic tumor of salivary gland, MASC needs to be taken into consideration as a differential diagnosis. Further immunohistochemical and gene analyses are needed in diagnosis of MASC. Diagn. Cytopathol. 2015;43:131-137. (c) 2014 Wiley Periodicals, Inc.	[Takeda, Maiko; Kasai, Takahiko; Morita, Kohei; Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 634, Japan; [Kasai, Takahiko] Univ Occupat & Environm Hlth, Dept Pathol & Oncol, Kitakyushu, Fukuoka 807, Japan; [Takeuchi, Mao; Nishikawa, Takeshi] Nara Med Univ Hosp, Kashihara, Nara, Japan; [Yamashita, Akinori; Mikami, Shinji; Hosoi, Hiroshi] Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Kashihara, Nara 634, Japan	Ohbayashi, C (reprint author), Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 634, Japan.	ohbayashi@naramed-u.ac.jp					Griffith CC, 2013, CANCER CYTOPATHOL, V121, P234, DOI 10.1002/cncy.21249; Rastatter JC, 2012, OTOLARYNG HEAD NECK, V146, P514, DOI 10.1177/0194599811419044; Bishop JA, 2013, CANCER CYTOPATHOL, V121, P228, DOI 10.1002/cncy.21245; Chenevert J, 2012, MODERN PATHOL, V25, P919, DOI 10.1038/modpathol.2012.57; Chiosea SI, 2012, HISTOPATHOLOGY, V61, P387, DOI 10.1111/j.1365-2559.2012.04232.x; Kratochvil FJ, 2012, OR SURG OR MED OR PA, V114, P630, DOI 10.1016/j.oooo.2012.07.480; Jung MJ, 2013, KOREAN J PATHOL, V47, P36, DOI 10.4132/KoreanJPathol.2013.47.1.36; Levine P, 2014, DIAGN CYTOPATHOL, V42, P49, DOI 10.1002/dc.22886; Sethi R, 2014, LARYNGOSCOPE, V124, P188, DOI 10.1002/lary.24254; Connor A, 2012, AM J SURG PATHOL, V36, P27, DOI 10.1097/PAS.0b013e318231542a; Griffith C, 2011, VIRCHOWS ARCH, V459, P117, DOI 10.1007/s00428-011-1098-6; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Bishop JA, 2013, AM J SURG PATHOL, V37, P1053, DOI 10.1097/PAS.0b013e3182841554; Fehr A, 2011, AM J SURG PATHOL, V35, P1600, DOI 10.1097/PAS.0b013e31822832c7; Bames L, 2005, PATHOLOGY GENETICS H, P209; Bishop Justin A, 2013, Head Neck Pathol, V7, P35, DOI 10.1007/s12105-013-0429-0; Ito S, 2012, PATHOL INT, V62, P149, DOI 10.1111/j.1440-1827.2011.02759.x; Lei Yu, 2012, Head Neck Pathol, V6, P166, DOI 10.1007/s12105-011-0312-9; Petersson Fredrik, 2012, Head Neck Pathol, V6, P135, DOI 10.1007/s12105-011-0283-x; Pinto A, 2014, MODERN PATHOL, V27, P30, DOI 10.1038/modpathol.2013.84; Pisharodi L, 2013, DIAGN CYTOPATHOL, V41, P239, DOI 10.1002/dc.21766; Williams Lindsay, 2013, Head Neck Pathol, V7, P316, DOI 10.1007/s12105-013-0443-2	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	FEB	2015	43	2					131	137		10.1002/dc.23146		7	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	AZ0WY	WOS:000347963900009		
J	Shirota, K; Kaneko, M; Sasaki, M; Minato, K; Fujikata, A; Ohta, S; Hisaka, A; Suzuki, H				Shirota, Kazuhiko; Kaneko, Makoto; Sasaki, Makoto; Minato, Kouichi; Fujikata, Akira; Ohta, Shuji; Hisaka, Akihiro; Suzuki, Hiroshi			Analysis of the Disposition of a Novel p38 MAPK Inhibitor, AKP-001, and Its Metabolites in Rats with a Simple Physiologically Based Pharmacokinetic Model	DRUG METABOLISM AND DISPOSITION			English	Article							ACTIVATED PROTEIN-KINASE; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL BACTERIA; LABORATORY-ANIMALS; DOUBLE-BLIND; SAFER DRUGS; CARBOXYLESTERASE; RIFAXIMIN; PATHWAYS; ANTEDRUG	5-[(2-Chloro-6-fluorophenyl) acetylamino]-3-(4-fluorophenyl)-4-( 4-pyrimidinyl)isoxazole (AKP-001) is a potent p38 mitogen-activated protein kinase inhibitor that is being developed to specifically target the intestines for the treatment of inflammatory bowel disease. According to the ante-drug concept, AKP-001 was designed to be metabolized to inactive forms via the first-pass metabolism to avoid undesirable systemic exposure. The purpose of this study is to investigate the pharmacokinetic characteristics of AKP-001 and its metabolites (M1 and M2) in rats, utilizing a simple physiologically based pharmacokinetic (PBPK) model. In vitro metabolic activity of AKP-001 in the S9 fraction of rat liver was examined, and plasma concentration-time profiles were developed following intravenous and/or oral administration of AKP-001 and its metabolites. AKP-001 was primarily metabolized to M1; however, M2 was not detected in liver S9 fractions. In accordance with this observation in vitro, M2 was detected in plasma after oral dosing of AKP-001 with a lag time of 1.5 hours, but not after intravenous dosing. To analyze pharmacokinetics in rats in vivo, a simple PBPK model was developed by simultaneous fitting of the plasma concentrations after treatment with AKP-001 and its metabolites. The observed plasma concentration-time profiles of AKP-001 and metabolites were described by the model adequately. Intestinal and systemic exposures of AKP-001 were simulated using the model to assess the relationship between pharmacokinetics and efficacy/safety. Model analysis suggested that oral bioavailability of intestine-targeting ante-drugs should be low to avoid systemic side effects. The pharmacokinetic properties of AKP-001 meet this criterion owing to extensive first-pass metabolism.	[Shirota, Kazuhiko; Kaneko, Makoto; Sasaki, Makoto; Minato, Kouichi; Fujikata, Akira] ASKA Pharmaceut Co Ltd, Dept Pharmaceut Res, Res Dev Ctr, Minato, Kanagawa, Japan; [Ohta, Shuji] ASKA Pharmaceut Co Ltd, Synthet Res Dept, Med Res Ctr, Minato, Kanagawa, Japan; [Hisaka, Akihiro] Univ Tokyo, Fac Med, Tokyo Univ Hosp, Tokyo 113, Japan; [Suzuki, Hiroshi] Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Pharm, Tokyo 113, Japan	Hisaka, A (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chou Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	hisaka@chiba-u.jp					KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Watanabe T, 2009, J PHARMACOL EXP THER, V328, P652, DOI 10.1124/jpet.108.146647; Mocsai A, 2000, J IMMUNOL, V164, P4321; DESCOMBE JJ, 1994, INT J CLIN PHARM RES, V14, P51; Rizzello F, 1998, EUR J CLIN PHARMACOL, V54, P91, DOI 10.1007/s002280050426; Thoreson R, 2007, SURG CLIN N AM, V87, P575, DOI 10.1016/j.suc.2007.03.001; Lee HJ, 2002, ARCH PHARM RES, V25, P111, DOI 10.1007/BF02976552; Branger J, 2002, J IMMUNOL, V168, P4070; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Genovese MC, 2009, ARTHRITIS RHEUM, V60, P317, DOI 10.1002/art.24264; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Chourasia MK, 2003, J PHARM PHARM SCI, V6, P33; Dahan A, 2009, AM J PHYSIOL-GASTR L, V297, pG371, DOI 10.1152/ajpgi.00102.2009; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Giuliano C, 2005, DRUG METAB DISPOS, V33, P1319, DOI 10.1124/dmd.105.005033; PEPPERCO.MA, 1972, J PHARMACOL EXP THER, V181, P555; Hasumi K, 2014, BIOORGAN MED CHEM, V22, P4162, DOI 10.1016/j.bmc.2014.05.045; Hisaka A, 1998, J PHARMACOKINET BIOP, V26, P495, DOI 10.1023/A:1023294632129; Khan MOF, 2005, CURR MED CHEM, V12, P2227, DOI 10.2174/0929867054864840; Kitamura S, 1997, J PHARM PHARMACOL, V49, P253; Masaki K, 2007, DRUG METAB DISPOS, V35, P1089, DOI 10.1124/dmd.106.013862; O'Donnell Sarah, 2010, Ther Adv Chronic Dis, V1, P177, DOI 10.1177/2040622310379293; Wadsworth SA, 1999, J PHARMACOL EXP THER, V291, P680; Ward KW, 2001, XENOBIOTICA, V31, P783; Yan GZ, 2012, DRUG METAB DISPOS, V40, P6, DOI [10.1124/dmd.111.040063, 10.1124/dmd.111.04006]	30	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	FEB	2015	43	2					217	226		10.1124/dmd.114.060046		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY8PX	WOS:000347816800005		
J	Izumi, S; Nozaki, Y; Maeda, K; Komori, T; Takenaka, O; Kusuhara, H; Sugiyama, Y				Izumi, Saki; Nozaki, Yoshitane; Maeda, Kazuya; Komori, Takafumi; Takenaka, Osamu; Kusuhara, Hiroyuki; Sugiyama, Yuichi			Investigation of the Impact of Substrate Selection on In Vitro Organic Anion Transporting Polypeptide 1B1 Inhibition Profiles for the Prediction of Drug-Drug Interactions	DRUG METABOLISM AND DISPOSITION			English	Article							HEPATIC-UPTAKE; CYCLOSPORINE-A; HEPATOBILIARY TRANSPORT; TRANSPLANT RECIPIENTS; HEALTHY-SUBJECTS; PHARMACOKINETICS; OATP1B1; GEMFIBROZIL; ROSUVASTATIN; MECHANISM	The risk assessment of organic anion transporting polypeptide (OATP) 1B1-mediated drug-drug interactions (DDIs) is an indispensable part of drug development. We previously reported that in vitro inhibitory potencies of several inhibitors on OATP1B1 depend on the substrates when prototypical substrates, estradiol-17 beta-glucuronide (E(2)G), estrone-3-sulfate, and sulfobromophthalein were used as test substrates. The purpose of this study was to comprehensively investigate this substrate-dependent inhibition of OATP1B1 using clinically relevant OATP1B1 inhibitors and substrate drugs. Effects of cyclosporine A (CsA), rifampin, and gemfibrozil on OATP1B1-mediated uptake of 12 substrate drugs were examined in OATP1B1-expressing human embryonic kidney 293 cells. The K-i values (mu M) for CsA varied from 0.0771 to 0.486 (6.3-fold), for rifampin from 0.358 to 1.23 (3.4-fold), and for gemfibrozil from 9.65 to 252 (26-fold). Except for the inhibition of torasemide uptake by CsA and that of nateglinide uptake by gemfibrozil, the K-i values were within 2.8-fold of those obtained using E2G as a substrate. Preincubation potentiated the inhibitory effect of CsA on OATP1B1 with similar magnitude regardless of the substrates. R values calculated based on a static model showed some variation depending on the K-i values determined with various substrates, and such variability could have an impact on the DDI predictions particularly for a weak-to-moderate inhibitor (gemfibrozil). OATP1B1 substrate drugs except for torasemide and nateglinide, or E2G as a surrogate, is recommended as an in vitro probe in the inhibition experiments, which will help mitigate the risk of false-negative DDI predictions potentially caused by substrate-dependent K-i variation.	[Izumi, Saki; Nozaki, Yoshitane; Komori, Takafumi] Tsukuba Res Labs, Drug Metab & Pharmacokinet Japan, Ibaraki, Japan; [Takenaka, Osamu] Morphotek Inc, Pharmacokinet & Pharmacodynam, Exton, PA USA; [Maeda, Kazuya; Kusuhara, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Tokyo, Japan; [Sugiyama, Yuichi] RIKEN, RIKEN Res Cluster Innovat, RIKEN Innovat Ctr, Sugiyama Lab, Yokohama, Kanagawa 2300045, Japan	Sugiyama, Y (reprint author), RIKEN, RIKEN Res Cluster Innovat, RIKEN Innovat Ctr, Sugiyama Lab,Tsurumi Ku, 1-6 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	ychi.sugiyama@riken.jp			Ministry of Health, Labour and Welfare of Japan	This study was partly supported by Grants-in-Aid for Research on Publicly Essential Drugs and Medical Devices from the Ministry of Health, Labour and Welfare of Japan.	Izumi S, 2013, DRUG METAB DISPOS, V41, P1859, DOI 10.1124/dmd.113.052290; Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615; Link E, 2008, NEW ENGL J MED, V359, P789; Ito K, 1998, PHARMACOL REV, V50, P387; Kameyama Y, 2005, PHARMACOGENET GENOM, V15, P513, DOI 10.1097/01.fpc.0000170913.73780.5f; Noe J, 2007, DRUG METAB DISPOS, V35, P1308, DOI 10.1124/dmd.106.012930; Amundsen R, 2010, DRUG METAB DISPOS, V38, P1499, DOI 10.1124/dmd.110.032268; Ho RH, 2006, GASTROENTEROLOGY, V130, P1793, DOI 10.1053/j.gastro.2006.02.034; Kusuhara H, 2013, DRUG METAB DISPOS, V41, P206, DOI 10.1124/dmd.112.048330; Imamura Y, 2011, CLIN PHARMACOL THER, V89, P81, DOI 10.1038/clpt.2010.232; Yamashiro W, 2006, DRUG METAB DISPOS, V34, P1247, DOI 10.1124/dmd.105.008938; Shitara Y, 2003, J PHARMACOL EXP THER, V304, P610, DOI 10.1124/jpet.102.041921; Muck W, 1999, CLIN PHARMACOL THER, V65, P251, DOI 10.1016/S0009-9236(99)70104-9; Poirier A, 2009, J PHARMACOKINET PHAR, V36, P585, DOI 10.1007/s10928-009-9139-3; Mizuno N, 2003, PHARMACOL REV, V55, P425, DOI 10.1124/pr.55.3.1; Maeda K, 2011, CLIN PHARMACOL THER, V90, P575, DOI 10.1038/clpt.2011.142; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Yoshida K, 2012, CLIN PHARMACOL THER, V91, P1053, DOI 10.1038/clpt.2011.351; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Kitamura S, 2008, DRUG METAB DISPOS, V36, P2014, DOI 10.1124/dmd.108.021410; Niemi M, 2011, PHARMACOL REV, V63, P157, DOI 10.1124/pr.110.002857; Burman WJ, 2001, CLIN PHARMACOKINET, V40, P327, DOI 10.2165/00003088-200140050-00002; Karlgren M, 2012, PHARM RES-DORDR, V29, P411, DOI 10.1007/s11095-011-0564-9; Binet I, 2000, KIDNEY INT, V57, P224, DOI 10.1046/j.1523-1755.2000.00838.x; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Yoshida K, 2013, ANNU REV PHARMACOL, V53, P581, DOI 10.1146/annurev-pharmtox-011112-140309; Shitara Y, 2004, J PHARMACOL EXP THER, V311, P228, DOI 10.1124/jpet.104.068536; Shitara Y, 2013, BIOPHARM DRUG DISPOS, V34, P45, DOI 10.1002/bdd.1823; Shitara Y, 2005, ANNU REV PHARMACOL, V45, P689, DOI 10.1146/annurev.pharmtox.44.101802.121444; Prueksaritanont T, 2014, BRIT J CLIN PHARMACO, V78, P587, DOI 10.1111/bcp.12377; Simonson SG, 2004, CLIN PHARMACOL THER, V76, P167, DOI 10.1016/j.clpt.2004.03.010; Hirano M, 2004, J PHARMACOL EXP THER, V311, P139, DOI 10.1124/jpet.104.068056; Sharma P, 2012, EUR J PHARM SCI, V47, P244, DOI 10.1016/j.ejps.2012.04.003; Lau YY, 2007, CLIN PHARMACOL THER, V81, P194, DOI 10.1038/sj.clpt.6100038; Center for Drug Evaluation and Research, 2012, DRUG INT STUD STUD D, DOI Silver Spring; Committee for Human Medicinal Products, 2012, GUID INV DRUG INT; Kudo T, 2013, DRUG METAB DISPOS, V41, P362, DOI 10.1124/dmd.112.049460; LEMAIRE M, 1982, J PHARM PHARMACOL, V34, P715; Ministry of Health Labour and Welfare, 2014, DRUG INT GU IN PRESS; OKERHOLM RA, 1976, P ROY SOC MED, V69, P11; Shen H, 2013, J PHARMACOL EXP THER, V344, P673, DOI 10.1124/jpet.112.200691; Shitara Y, 2013, J PHARM SCI-US, V102, P3427, DOI 10.1002/jps.23477; Soars MG, 2012, DRUG METAB DISPOS, V40, P1641, DOI 10.1124/dmd.111.042382; Takanohashi T, 2012, J PHARM PHARMACOL, V64, P199, DOI 10.1111/j.2042-7158.2011.01389.x; Takashima T, 2012, J NUCL MED, V53, P741, DOI 10.2967/jnumed.111.098681; Tornio A, 2008, CLIN PHARMACOL THER, V84, P403, DOI 10.1038/clpt.2008.34; van de Steeg E, 2013, DRUG METAB DISPOS, V41, P592, DOI 10.1124/dmd.112.049023; van Giersbergen PLM, 2007, CLIN PHARMACOL THER, V81, P414, DOI 10.1038/sj.clpt.6100075; Werner U, 2010, J CLIN PHARMACOL, V50, P160, DOI 10.1177/0091270009337514; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	50	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	FEB	2015	43	2					235	247		10.1124/dmd.114.059105		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY8PX	WOS:000347816800008		
J	Nakadai, R; Murakami, M				Nakadai, Ryosuke; Murakami, Masashi			Patterns of host utilisation by herbivore assemblages of the genus Caloptilia (Lepidoptera; Gracillariidae) on congeneric maple tree (Acer) species	ECOLOGICAL ENTOMOLOGY			English	Article						Acer; Caloptilia; community assembly; congeneric species; herbivore; host range; host suitability; plant phylogeny	PHYTOPHAGOUS INSECTS; TROPICAL FOREST; SPECIALIZATION; SPECIFICITY; STIMULANTS; SIMILARITY; PHYLOGENY; DIVERSITY; EVOLUTION; TRAITS	1. The pattern of host utilisation by congeneric Caloptilia caterpillars on 14 different species of Acer (maple) was investigated in temperate mixed forests of central Japan. A multi-filtering model of host plant utilisation was proposed to address how phylogenetically related herbivore assemblages are constructed on phylogenetically related host plant species. 2. Two hypotheses were examined. The first questioned whether a negative relationship exists between the phylogenetic distance of plants from the most suitable host species and the abundance of herbivorous insects on the host. Regarding the second, it was investigated whether the assemblage dissimilarity of herbivorous insects among host plant species increases with increasing distance of plant phylogeny and traits. 3. Mantel and partial Mantel tests were used to measure the relationship between assemblage dissimilarity of Caloptilia species and the distance of plant phylogeny and leaf traits. 4. Both hypotheses were confirmed, clearly suggesting that the utilisation and suitability of hosts for Caloptilia caterpillars were strongly influenced by phylogenetic relatedness and leaf trait similarity among Acer species. This implies that phylogenetic distance is an integrated measure of phenotypic and ecological attributes of congeneric Acer species that can be used to explain specialisation and constraints of host utilisation of congeneric herbivore species even on a short evolutionary timescale.	[Nakadai, Ryosuke; Murakami, Masashi] Chiba Univ, Community Ecol Lab, Fac Sci, Chiba, Japan	Murakami, M (reprint author), Chiba Univ, Fac Sci, Inage Ku, Yayoi 1-33, Chiba 2638522, Japan.	muramasa@faculty.chiba-u.jp			Japanese Society for the Promotion of Science [24310170]	We thank K. Watanabe, S. Saito and Y. Igarashi for their help with the fieldwork and T. Hirao, N. Kamata, and technical staff of the University of Tokyo Chichibu Forest for their support. This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science to M.M. (no. 24310170).	Hembry DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0361; Agrawal AA, 2006, ECOLOGY, V87, pS132; Pearse IS, 2013, OIKOS, V122, P1554, DOI 10.1111/j.1600-0706.2013.00527.x; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Rasmann S, 2011, AM NAT, V177, P728, DOI 10.1086/659948; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Tuomisto H, 2006, ECOLOGY, V87, P2697, DOI 10.1890/0012-9658(2006)87[2697:AOEBDU]2.0.CO;2; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Nakadai R, 2014, OECOLOGIA, V175, P1237, DOI 10.1007/s00442-014-2964-0; Singer MS, 2005, ECOL LETT, V8, P1247, DOI 10.1111/j.1461-0248.2005.00835.x; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Pearse IS, 2012, EVOLUTION, V66, P2272, DOI 10.1111/j.1558-5646.2012.01591.x; Renner SS, 2007, EVOLUTION, V61, P2701, DOI 10.1111/j.1558-5646.2007.00221.x; Okamoto T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2280; Weiblen GD, 2006, ECOLOGY, V87, pS62; BROWN JM, 1995, OECOLOGIA, V104, P52, DOI 10.1007/BF00365562; D'Costa L, 2013, ECOL ENTOMOL, V38, P456, DOI 10.1111/een.12037; Barber NA, 2011, ECOLOGY, V92, P699, DOI 10.1890/10-0125.1; Kumata T., 1982, Insecta Matsumurana, V26, P1; Kumata T., 2013, STANDARD MOTHS JAPAN, P91; Murakami M, 2007, ECOL ENTOMOL, V32, P613, DOI 10.1111/j.1365-2311.2007.00917.x; Murata T, 2011, J CHEM ECOL, V37, P1099, DOI 10.1007/s10886-011-0022-5; NISHIDA R, 1989, J CHEM ECOL, V15, P2565, DOI 10.1007/BF01014732; Ohshima I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00506; Oksanen J., 2011, VEGAN COMMUNITY ECOL; R Development Core Team, 2007, R LANG ENV STAT COMP; Reich P. B., 2011, ANN BOT, V107, P455; The University of Tokyo Chichibu Forest Graduate School of Agricultural and Life Sciences The University of Tokyo, 2012, 10 ED RES PLAN U TOK; vansGelderen D. M., 1994, MAPLES WORLD; Watanabe K, 2014, ECOL RES, V29, P299, DOI 10.1007/s11284-013-1123-0; Yonekura K., 2003, BG PLANTS YLIST ONLI	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6946	1365-2311		ECOL ENTOMOL	Ecol. Entomol.	FEB	2015	40	1					14	21		10.1111/een.12148		8	Entomology	Entomology	AY7BU	WOS:000347717200002		
J	Suzuki, K; Asahi, K; Watanabe, A				Suzuki, Kousuke; Asahi, Kensaku; Watanabe, Akira			Basic Study on Receiving Light Signal by LED for Bidirectional Visible Light Communications	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						visible light communications; bidirectional communication; LED; photo detector		Light emitting diodes (LEDs) are now used for lighting and illumination because of features such as low power consumption and long life. Lighting equipment has only LEDs, therefore it is necessary to install a photodetector to allow bidirectional communication. In this paper, we propose reception of a light signal by means of an LED for bidirectional visible light communications. We evaluate the characteristics of the LED used as a photodetector for bidirectional visible light communications through experiments. Further, we describe the newly developed experimental system that uses LEDs as a photodetector. Experiments show that an LED can be used not only as a light source but also as a photodetector for bidirectional visible light communications.	[Suzuki, Kousuke; Asahi, Kensaku] Meijo Univ, Nagoya, Aichi, Japan; [Watanabe, Akira] Meijo Univ, Fac Sci & Engn, Nagoya, Aichi, Japan	Suzuki, K (reprint author), Meijo Univ, Nagoya, Aichi, Japan.						[Anonymous], 2005, OPTOSUPPLY 3 MM DELU; Haruyama S., 2003, IEICE T A, V86-A, P1294; Ishii M, 2007, J ILLUMINAT ENG I JP, V91, P78, DOI 10.2150/jieij.91.78; Kamiya Y., 2008, DIGITAL WIRELESS COM; Suzuki K, 2010, IEICE TECHN REP, V110, P5; Tani Z., 2000, OPTICAL DEVICE APPL; Toishi K, 2005, J ARCHITECT I JPN D, VD-1, P395	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	FEB	2015	98	2					1	9		10.1002/ecj.11608		9	Engineering, Electrical & Electronic	Engineering	AZ0NP	WOS:000347942300001		
J	Ogata, M; Komoda, N				Ogata, Mikito; Komoda, Norihisa			Optimized Assignment Algorithm to Maximize the Reduction for Backup System with Multiple Deduplication Methods Installed	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						data center; deduplication; backup; capacity optimization; enterprise storage; integer programming		Deduplication backup technology removes redundant data segments in a system in order to reduce the capacity usage in the target backup storage. This technique also provides better performance, less resource utilization, less energy consumption, and TCO. This paper describes an optimization method for deduplication backup in an IT system in which multiple deduplication processes are simultaneously installed and activated. The method provides an algorithm for assignment of backup target files to installed deduplication processes to maximize the aggregate deduplication ratio while maintaining the predefined system requirements, such as backup-windows limitation and resource utilization limitation. In a real-world system, the time used to perform deduplication in each process is not constant, but variable due to operational resources contention, waiting time in queues, and data characteristics. The proposed method points out that these time parameters can be simulated as following a normal distribution, formularizes discrete assignment programming, then defines combinatory approaches of integer linear programming to incorporate the maximum deduplication ratio and the binary adjustment of parameters so as to ensure that the variance is not exceeded. By utilizing this method, the system can achieve the maximal deduplication ratio while respecting time requirements within a predefined tolerance. The effectiveness of the method is demonstrated through simulations.	[Ogata, Mikito] Hitachi Comp Peripherals Co Ltd, Nakai, Kanagawa, Japan; [Komoda, Norihisa] Osaka Univ, Dept Informat Syst Engn, Suita, Osaka 565, Japan; [Komoda, Norihisa] Osaka Univ, Grad Sch Informat Sci, Suita, Osaka 565, Japan	Ogata, M (reprint author), Hitachi Comp Peripherals Co Ltd, Nakai, Kanagawa, Japan.						[Anonymous], 2010, BRIEFS 10 DAT PROT T; [Anonymous], 2010, SURV STAT STOR US BU; Dewalker M., 2010, NEXT GENERATION DATA, V7; Ogata M, 2011, P 4 JAP CHIN JOINT S, P105; Rao G, 2010, US Patent, Patent No. [US2010/0088277 A1, 20100088277]	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	FEB	2015	98	2					10	19		10.1002/ecj.11614		10	Engineering, Electrical & Electronic	Engineering	AZ0NP	WOS:000347942300002		
J	Ohno, T; Murata, M; Matsubara, S				Ohno, Tomohiro; Murata, Masaki; Matsubara, Shigeki			Sequential Linefeed Insertion into Lecture Transcriptions for Real-Time Captioning	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						spoken language; clause boundary; dependency structure; speech corpus; information support		To generate readable captions for Japanese spoken monologues such as lectures in real time, it is necessary to sequentially display captions that have proper linefeeds inserted. This paper proposes a technique for sequentially inserting proper linefeeds into a lecture transcript whenever a bunsetsu, which is a linguistic unit shorter than a sentence in Japanese and that roughly corresponds to a basic phrase in English, is identified. Under the assumption that linefeeds are inserted at bunsetsu boundaries, this technique can reduce the delay time of captioning to the utmost possible. This technique statistically judges whether or not a linefeed should be inserted into each bunsetsu boundary by using the information that is available at the time. We conducted experiments on linefeed insertion using a Japanese lecture corpus. The experimental results confirmed that our method, which is a bunsetsu-based linefeed insertion method, was almost as accurate as the sentence-based linefeed insertion method. In addition, we conducted comparative evaluations using four baseline methods. The results confirmed that our method could insert linefeeds more accurately than the simple methods that are thought to have the same delay time as our method.	[Ohno, Tomohiro] Nagoya Univ, Grad Sch Int Dev & Res, Nagoya, Aichi 4648601, Japan; [Murata, Masaki; Matsubara, Shigeki] Nagoya Univ, Nagoya, Aichi 4648601, Japan	Ohno, T (reprint author), Nagoya Univ, Grad Sch Int Dev & Res, Nagoya, Aichi 4648601, Japan.				 [22300051]	This research was supported in part by a Scientific Grant-in-Aid (Basic Research (B)) (No. 22300051).	[Anonymous], 2008, REP CURR SIT CURR RE; Bouliane G, 2006, P 9 INT C SPOK LANG, P273; Ekioka T, 1992, BASIC JAPANESE GRAMM; Imai T, 2007, IEICE T INF SYST, VE90D, P1286, DOI 10.1093/ietisy/e90-d.8.1286; Kawahara Tatsuya, 2005, J JAPANESE SOC ARTIF, V20, P41; Maruyama T, 2004, J NATURAL LANGUAGE P, V11, P39; Matsubara Shigeki, 2002, P 3 LREC, P153; Monma T, 2001, IEICE T INF SYST, VJ84-D-II, P888; Munteanu C, 2007, P 8 ANN C INT SPEECH, P2353; Murata M, 2000, INF PROCESS SOC JPN, V41, P59; Murata Masaki, 2009, IEICE Transactions on Information and Systems, VJ92-D; Nakano S, 2007, IEICE T INF SYST, VJ90-D, P808; Ohno T, 2007, LANG RESOUR EVAL, V40, P263, DOI 10.1007/s10579-007-9023-y; Ohno T, 2007, IEICE T INF SYST, VJ90-D, P556; XUE J, 2006, P ICSLP 2006, P1630; Zhang L, 2007, MAXIMUM ENTROPY MODE	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	FEB	2015	98	2					20	31		10.1002/ecj.11616		12	Engineering, Electrical & Electronic	Engineering	AZ0NP	WOS:000347942300003		
J	Kato, S; Watanabe, S				Kato, Sho; Watanabe, Shigeyoshi			Design Technology of Stacked-Type Chain PRAM	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						nonvolatile memory; PRAM; phase-change material; chain structure; stacked memory	TRANSISTOR; IMPACT	A stacked-type chain PRAM that can result in lower cost than flash memory has been proposed. The newly proposed memory cell uses a PCM for data storage and an MOS transistor connected in parallel. This memory cell is connected in series to realize the chain structure. The cell structure, the design method for realizing stable read and write operation, and the core circuit for the stacked-type chain PRAM are described. The newly proposed memory cell has been designed to use BiCS (Bit Cost Scalable) process technology in order to achieve low-cost memory. The design of the resistance of the PCM and the pass transistor is a key issue for realizing stable operation. To design the row decoder, the circuit concept of stacked ferroelectric RAM (FeRAM) with an NAND structure cell has been successfully adopted with SGT. The newly proposed stacked-type chain PRAM is a promising candidate for realizing high-speed and low-power future nonvolatile semiconductor memory.	[Kato, Sho] Shonan Inst Technol, Fujisawa, Kanagawa, Japan; [Watanabe, Shigeyoshi] Shonan Inst Technol, Fac Engn, Fujisawa, Kanagawa, Japan	Kato, S (reprint author), Shonan Inst Technol, Fujisawa, Kanagawa, Japan.						[Anonymous], 2008, EE TIMES JAPAN  1005, Patent No. 165956; [Anonymous], 2008, EE Times Japan, Patent No. 165956; Cho WY, 2005, IEEE J SOLID-ST CIRC, V40, P293; Choi J, 2011, S VLSI TECHN; Fukuzumi Y, 2007, BIT COST SCALABLE FL; Hudgens S., 2004, MRS BULL, P1; Jang J, 2009, 2009 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P192; Kan S, 2007, IEEE J SOLID-ST CIRC, V42, P210; Pellizzer F, 2003, S VLSI TECHN; Sasago Y., 2011, S VLSI TECHN, P96; Sugano K, 2010, T IEEJ C, V130C, P226; Sugano K, 2011, T IEEJ C, V131C, P810; Sugano K, 2011, T IEEJ C, V131C, P1327; Takashima D, 1998, IEEE J SOLID-ST CIRC, V33, P787, DOI 10.1109/4.668994; Takashima D, 1997, 1997 SYMPOSIUM ON VLSI CIRCUITS, P83; TAKATO H, 1991, IEEE T ELECTRON DEV, V38, P573, DOI 10.1109/16.75168; Tamai Shoto, 2008, Transactions of the Institute of Electronics, Information and Communication Engineers C, VJ91-C; Tamai S, 2009, IEEJ C, V129C, P2091; Tanaka T, 2007, S VLSI TECHN; Usami K, 1997, IEEE J SOLID-ST CIRC, V33, P473; Watanabe S, 2003, IEEE T ELECTRON DEV, V50, P2073, DOI 10.1109/TED.2003.816556; WATANABE S, 1995, IEEE J SOLID-ST CIRC, V30, P960, DOI 10.1109/4.406391	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	FEB	2015	98	2					32	42		10.1002/ecj.11641		11	Engineering, Electrical & Electronic	Engineering	AZ0NP	WOS:000347942300004		
J	Yoshida, L; Kotani, K; Jimbo, Y				Yoshida, Lui; Kotani, Kiyoshi; Jimbo, Yasuhiko			Device Fabrication for Creating Multiscale Miniature Neuronal Networks and Spatiotemporal Pattern Analysis of Spontaneous Electrical Activities	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						miniature neuronal network; photolithography; soft lithography; spatiotemporal pattern; rat hippocampal neuron	HIPPOCAMPAL-NEURONS; AVALANCHES; CULTURES	To investigate the dynamics of neuronal networks, a device which is capable of multipoint simultaneous measurement and multiscale miniature neuronal network construction was fabricated. The results of culturing rat embryo hippocampal neurons showed that the device is biocompatible and can be successfully used in long-term culture. Analysis of the electrical data obtained with the device suggested that, in miniature neuronal networks consisting of about 2000 neurons, there occurred spatiotemporal activity patterns of neurons, which were considered to be very important to the process of storing and transforming information of a brain.	[Yoshida, Lui; Kotani, Kiyoshi] Univ Tokyo, Tokyo 1138654, Japan; [Jimbo, Yasuhiko] Univ Tokyo, Grad Sch Engn, Tokyo 1138654, Japan; [Jimbo, Yasuhiko] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138654, Japan	Yoshida, L (reprint author), Univ Tokyo, Tokyo 1138654, Japan.				 [DC1]	This study was supported in part by a Grant-in-Aid for JSPS Fellows (DC1).	Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Cohen D, 2011, J NEUROPHYSIOL, V106, P2314, DOI 10.1152/jn.00969.2010; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Rolston JD, 2007, NEUROSCIENCE, V148, P294, DOI 10.1016/j.neuroscience.2007.05.025; Bi GQ, 1998, J NEUROSCI, V18, P10464; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Beggs JM, 2003, J NEUROSCI, V23, P11167; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Xia Y.N., 1998, ANGEW CHEM INT EDIT, V37, P551, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	FEB	2015	98	2					43	51		10.1002/ecj.11642		9	Engineering, Electrical & Electronic	Engineering	AZ0NP	WOS:000347942300005		
J	Seto, Y				Seto, Yoichi			Application of Privacy Impact Assessment in the Smart City	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						personal information protection law; smart grid; privacy; privacy impact assessment; risk management		The smart city project is currently being promoted in various countries around the world. It is intended to take advantage of personal information and more appropriate utilization of energy. Therefore, the existence of privacy issues has been noted. Since a specific discussion of privacy risks in the smart city project is premature, we discuss the privacy risks associated with advances in the standardization of the smart grid, whose technology is the core of the smart city. In this paper we verify the effectiveness of Privacy Impact Assessment, with reference to privacy risks in the smart city.	Adv Inst Ind Technol, Tokyo, Japan	Seto, Y (reprint author), Adv Inst Ind Technol, Tokyo, Japan.						[Anonymous], 2009, NIST SMART GRID HIGH; [Anonymous], 2010, 7628 NISTIR, VII; [Anonymous], 2010, 7628 NISTIR, V2, P2010; [Anonymous], 2009, SMART PRIVACY SMART; Arai H, 2011, SMART GRID POLICIES; Fujii H, 2010, 201040 IEICE SITE, P35; Ito S, 2011, IEE JPN, V1, P5; Ito Satoshi, 2011, Toshiba Leading Innovation, V66; Seto Y, 2010, PRIVACY IMPACT ASSES; Seto Y, 2011, PRIVACY IMPACT ASSES, P62; Seto Y, 2009, IMPLEMENTATION ASSUR; Takasaka S, 2011, JIDO NINSHIKI, V10, P57; Takasaka S, 2012, BYOIN, V71, P532	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	FEB	2015	98	2					52	61		10.1002/ecj.11661		10	Engineering, Electrical & Electronic	Engineering	AZ0NP	WOS:000347942300006		
J	Ochiai, Y				Ochiai, Yoshihiro			Three-dimensional heat conduction analysis of inhomogeneous materials by triple-reciprocity boundary element method	ENGINEERING ANALYSIS WITH BOUNDARY ELEMENTS			English	Article						Boundary element method; Heat conduction; Computational mechanics; Functionally gradient materials; Composite	ELASTOPLASTIC ANALYSIS; DOMAIN INTEGRALS; INTERNAL CELLS; MESHLESS BEM	Homogeneous heat conduction can be easily analyzed by the boundary element method. However, domain integrals are generally necessary to solve the heat conduction problem in non-homogeneous and functionally gradient materials. This paper shows that the three-dimensional heat conduction problem in non-homogeneous and functionally gradient materials can be solved approximately without the use of a domain integral by the triple-reciprocity boundary element method. In this method, the distribution of domain effects is interpolated using integral equations. A new computer program is developed and applied to several problems. (C) 2014 Elsevier Ltd. All rights reserved.	Kinki Univ, Dept Mech Engn, Higashiosaka, Osaka 5778502, Japan	Ochiai, Y (reprint author), Kinki Univ, Dept Mech Engn, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	ochiai@mech.kindai.ac.jp					NEVES AC, 1991, INT J NUMER METH ENG, V31, P709, DOI 10.1002/nme.1620310406; Gao XW, 2007, ENG ANAL BOUND ELEM, V31, P974, DOI 10.1016/j.enganabound.2007.05.002; Gao XW, 2009, ENG ANAL BOUND ELEM, V33, P539, DOI 10.1016/j.enganabound.2008.08.009; Sutradhar A, 2002, ENG ANAL BOUND ELEM, V26, P119, DOI 10.1016/S0955-7997(01)00090-X; Brebbia C.A., 1984, BOUNDARY ELEMENT TEC, P47; Carslaw HS, 1959, CONDUCTION HEAT SOLI, P8; Gao XW, 2006, INT J NUMER METH ENG, V66, P1411, DOI 10.1002/nme.1602; Kassab AJ, 1996, ENG ANAL BOUND ELEM, V18, P273, DOI 10.1016/S0955-7997(96)00057-4; Nowak AJ, 1994, MULTIPLE RECIPROCITY, P25; Ochiai Y, 2003, ENG ANAL BOUND ELEM, V27, P241, DOI 10.1016/S0955-7997(02)00112-1; Ochiai Y, 2004, ENG ANAL BOUND ELEM, V28, P1445, DOI 10.1016/j.enganabound.2004.08.005; Ochiai Y, 2000, COMPUT AIDED GEOM D, V17, P233, DOI 10.1016/S0167-8396(99)00047-3; Ochiai Y, 2004, CMES-COMP MODEL ENG, V6, P525; Ochiai Y, 2006, ENG ANAL BOUND ELEM, V30, P194, DOI 10.1016/j.enganabound.2005.07.010; Ochiai Y, 2011, CMES-COMP MODEL ENG, V79, P83; Ochiai Y, 2011, MESHLESS HEAT CONDUC, P325; Ochiai Y, 2001, INT J NUMER METH ENG, V50, P1877, DOI 10.1002/nme.100; Partridge PW, 1992, DUAL RECIPROCITY BOU, P223; Stolarski T, 2006, ENG ANAL ANSYS SOFTW, P263; Tanaka M, 2001, ADV BOUNDARY ELEMENT, P173	20	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-7997	1873-197X		ENG ANAL BOUND ELEM	Eng. Anal. Bound. Elem.	FEB	2015	51						101	108		10.1016/j.enganabound.2014.10.014		8	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Engineering; Mathematics	AY9JB	WOS:000347865200009		
J	Noguchi, A; Akiyama, H; Nakamura, K; Sakata, K; Minegishi, Y; Mano, J; Takabatake, R; Futo, S; Kitta, K; Teshima, R; Kondo, K; Nishimaki-Mogami, T				Noguchi, Akio; Akiyama, Hiroshi; Nakamura, Kosuke; Sakata, Kozue; Minegishi, Yasutaka; Mano, Junichi; Takabatake, Reona; Futo, Satoshi; Kitta, Kazumi; Teshima, Reiko; Kondo, Kazunari; Nishimaki-Mogami, Tomoko			A novel trait-specific real-time PCR method enables quantification of genetically modified (GM) maize content in ground grain samples containing stacked GM maize	EUROPEAN FOOD RESEARCH AND TECHNOLOGY			English	Article						Genetically modified maize; qPCR; Trait-specific method; Stacked GM maize	EVENT-SPECIFIC-DETECTION; KERNEL DETECTION SYSTEM; REFERENCE MOLECULES; QUANTITATIVE DETECTION; MODIFIED ORGANISMS; MULTIPLEX; PROPORTION; FRAGMENTS; ASSAY; FOOD	Stacked genetically modified (GM) maize is increasingly produced; thereby, current event-specific quantitative real-time polymerase chain reaction (qPCR) methods have led to the overestimation of GM organism (GMO) content compared with the actual weight/weight percentage of GM organism in maize samples. We developed a feasible qPCR method in which the GMO content is calculated based on the quantification of two herbicide-tolerant trait genes, 5-enolpyruvylshikimate-3-phosphate synthase from Agrobacterium sp. strain CP4 (cp4epsps) and phosphinothricin N-acetyl-transferase from Streptomyces viridochromogenes (pat) to quantify the GMO content in ground grain samples containing stacked GM maize. The GMO contents of two genes were quantified using a plasmid calibrant and summed for quantification of total GMO content. The trait-specific method revealed lower biases for examination of test samples containing stacked GM maize compared with the event-specific method. Our results clearly show that the trait-specific method is not only simple and cost-effective, but also useful in quantifying the GMO content in ground grain samples containing stacked GM maize, which are expected to be major events in the near future. The developed method would be the only feasible way to conduct the quantification of GMO content in the ground maize samples containing stacked GM maize for the verification of the labeling regulation.	[Noguchi, Akio; Akiyama, Hiroshi; Nakamura, Kosuke; Sakata, Kozue; Teshima, Reiko; Kondo, Kazunari; Nishimaki-Mogami, Tomoko] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Minegishi, Yasutaka] Nippon Gene Co Ltd, Chiyoda Ku, Tokyo 1010054, Japan; [Mano, Junichi; Takabatake, Reona; Kitta, Kazumi] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Futo, Satoshi] Fasmac Co Ltd, Atsugi, Kanagawa 2430041, Japan	Kondo, K (reprint author), Natl Inst Hlth Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	noguchi@nihs.go.jp; kondo@nihs.go.jp			Ministry of Health, Labour and Welfare of Japan	We are very grateful to Monsanto Co. and Pioneer Hi-Bred International for providing the reference materials. This study was supported in part by a Grant from the Ministry of Health, Labour and Welfare of Japan.	Akiyama H, 2005, ANAL CHEM, V77, P7421, DOI 10.1021/ac051236u; Akiyama H, 2011, J AOAC INT, V94, P1539, DOI 10.5740/jaoac.10-447; Akiyama H, 2012, FOOD HYG SAFE SCI, V53, P157, DOI 10.3358/shokueishi.53.157; Permingeat HR, 2002, J AGR FOOD CHEM, V50, P4431, DOI 10.1021/jf020081d; Yang LT, 2005, TRANSGENIC RES, V14, P817, DOI 10.1007/s11248-005-0010-z; Shindo Y, 2002, J AOAC INT, V85, P1119; Onishi M, 2005, J AGR FOOD CHEM, V53, P9713, DOI 10.1021/jf0515476; Collonnier C, 2005, J AOAC INT, V88, P536; Yamamura K, 2007, COMMUN STAT-SIMUL C, V36, P949, DOI 10.1080/03610910701539278; Berdal KG, 2001, EUR FOOD RES TECHNOL, V213, P432, DOI 10.1007/s002170100403; Yoshimura T, 2005, J AGR FOOD CHEM, V53, P2052, DOI 10.1021/jf048327x; Kuribara H, 2002, J AOAC INT, V85, P1077; Bilder CR, 2009, J STAT COMPUT SIM, V79, P67, DOI 10.1080/00949650701608990; CHEN CL, 1990, BIOMETRICS, V46, P1035, DOI 10.2307/2532446; Akiyama H, 2008, J AGR FOOD CHEM, V56, P1977, DOI 10.1021/jf0727239; Hernandez M, 2004, J AGR FOOD CHEM, V52, P4632, DOI 10.1021/jf049789d; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baeumler S, 2006, J AGR FOOD CHEM, V54, P6527, DOI 10.1021/jf0610357; Davison J, 2008, CEREAL FOOD WORLD, V53, P186, DOI 10.1094/CFW-53-4-0186; Heck GR, 2005, CROP SCI, V45, P329; James C, 2012, GLOBAL STATUS COMMER; Joint Research Centre-European Commission, 2007, EV SPEC METH QUANT M; Joint Research Centre-European Commission, 2006, EV SPEC METH QUANT M; Joint Research Centre-European Commission, 2005, EV SPEC METH QUANT M; Joint Research Centre-European Commission, 2006, CRL ASS VAL EV SPEC; Joint Research Centre-European Commission, 2005, Event-specific method for the quantitation of maize line NK 603 using real-time PCR Protocol, Patent No. [20060095986, US 20060095986]; Joint Research Centre-European Commission, 2010, EV SPEC METH QUANT M; Kodama T, 2009, J AOAC INT, V92, P223; La Paz JL, 2006, J AOAC INT, V89, P1347; Li X, 2009, J AOAC INT, V92, P1472; Mano J, 2009, J AGR FOOD CHEM, V57, P26, DOI 10.1021/jf802551h; Mano J, 2011, J AGR FOOD CHEM, V59, P6856, DOI 10.1021/jf200212v; Oguchi T, 2010, FOOD HYG SAFE SCI, V51, P92, DOI 10.3358/shokueishi.51.92; Taverniers I, 2001, EUR FOOD RES TECHNOL, V213, P417, DOI 10.1007/s002170100405; Trifa Y, 2004, J AGR FOOD CHEM, V52, P1044, DOI 10.1021/jf034574+; United States Department of Agriculture, 2013, GEN ENG VAR CORN UPL; Wu G, 2008, J AOAC INT, V91, P143	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1438-2377	1438-2385		EUR FOOD RES TECHNOL	Eur. Food Res. Technol.	FEB	2015	240	2					413	422		10.1007/s00217-014-2340-7		10	Food Science & Technology	Food Science & Technology	AY8SW	WOS:000347824600016		
J	Wakahara, T; Ema, R; Miyamoto, N; Kawakami, Y				Wakahara, Taku; Ema, Ryoichi; Miyamoto, Naokazu; Kawakami, Yasuo			Increase in vastus lateralis aponeurosis width induced by resistance training: implications for a hypertrophic model of pennate muscle	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Pennation angle; Anatomical cross-sectional area; Muscle hypertrophy; Transverse plane	CROSS-SECTIONAL AREA; IN-VIVO; MECHANICAL-PROPERTIES; SKELETAL-MUSCLES; ARCHITECTURAL CHARACTERISTICS; JUMP PERFORMANCE; FFM ACCUMULATION; PATELLAR TENDON; FASCICLE LENGTH; LOWER-LIMB	This study aimed to ascertain whether training-induced muscle hypertrophy is accompanied by an increase in the aponeurosis width, and to infer its impact on the training-induced increase in the pennation angle. Eleven young men completed a resistance training program of unilateral knee extensions for 12 weeks. Before and after training, anatomical cross-sectional area (ACSA) of the vastus lateralis and its distal aponeurosis width in the transverse plane were measured with magnetic resonance imaging. The pennation angle and fascicle length were also determined with ultrasonography at the midbelly of the muscle. The effect of change in aponeurosis width on the magnitude of training-induced increase in pennation angle was estimated by using a parallelepipedon model. After the training, there were significant increases in ACSA (10.7 +/- A 7.6 %), pennation angle (10.8 +/- A 7.3 %) and aponeurosis width (1.9 +/- A 3.1 %), whereas no significant change was found in the fascicle length. The model simulation shows that the increase in aponeurosis width by 1.9 % reduces the magnitude of increase in pennation angle by only 0.4A degrees. These results indicate that (1) the aponeurosis width of the vastus lateralis increases after 12 weeks of resistance training and (2) the increase in the aponeurosis width accompanying muscle hypertrophy by the amount of similar to 10 % does not substantially affect the increase in pennation angle.	[Wakahara, Taku] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto 6100394, Japan; [Ema, Ryoichi] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama 3591192, Japan; [Ema, Ryoichi] Japan Soc Promot Sci, Tokyo, Japan; [Miyamoto, Naokazu] Natl Inst Fitness & Sports Kanoya, Kanoya, Kagoshima 8912311, Japan; [Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan	Wakahara, T (reprint author), Doshisha Univ, Fac Hlth & Sports Sci, 1-3 Tatara Miyakodani, Kyoto 6100394, Japan.	twakahar@mail.doshisha.ac.jp			Japan Society for Promotion of Science [23700745]	This work was supported by Grant-in-Aid for Young Scientists (B, 23700745) from the Japan Society for Promotion of Science.	Abe T, 1998, MED SCI SPORT EXER, V30, P1066, DOI 10.1097/00005768-199807000-00007; Abe T, 2012, J TRAINOL, V1, P23; Abe T, 1999, MED SCI SPORT EXER, V31, P1448, DOI 10.1097/00005768-199910000-00014; Alexander R.M., 1975, J HUMAN MOVEMENT STU, V1, P115; SPECTOR SA, 1980, J NEUROPHYSIOL, V44, P951; POWELL PL, 1984, J APPL PHYSIOL, V57, P1715; GANS C, 1991, J BIOMECH, V24, P53, DOI 10.1016/0021-9290(91)90377-Y; Kubo K, 2010, J STRENGTH COND RES, V24, P322, DOI 10.1519/JSC.0b013e3181c865e2; Brechue WF, 2002, EUR J APPL PHYSIOL, V86, P327, DOI 10.1007/s00421-001-0543-7; KAWAKAMI Y, 1993, J APPL PHYSIOL, V74, P2740; Erskine RM, 2010, EUR J APPL PHYSIOL, V110, P1117, DOI 10.1007/s00421-010-1601-9; BERG HE, 1993, ACTA PHYSIOL SCAND, V148, P379, DOI 10.1111/j.1748-1716.1993.tb09573.x; Kubo K, 2007, MED SCI SPORT EXER, V39, P1801, DOI 10.1249/mss.0b013e31813e630a; Hansen P, 2003, J APPL PHYSIOL, V95, P2375, DOI 10.1152/japplphysiol.00503.2003; Seynnes OR, 2009, J APPL PHYSIOL, V107, P523, DOI 10.1152/japplphysiol.00213.2009; Morse CI, 2007, EUR J APPL PHYSIOL, V100, P267, DOI 10.1007/s00421-007-0429-4; Reeves ND, 2003, J PHYSIOL-LONDON, V548, P971, DOI 10.1113/jphysiol.2002.035576; GOLLNICK PD, 1981, J APPL PHYSIOL, V50, P936; BODINE SC, 1982, J NEUROPHYSIOL, V48, P192; Kongsgaard M, 2007, ACTA PHYSIOL, V191, P111, DOI 10.1111/j.1748-1716.2007.01714.x; Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x; Blazevich AJ, 2003, MED SCI SPORT EXER, V35, P2013, DOI 10.1249/01.MSS.0000099092.083611.20; Ema R, 2013, EUR J APPL PHYSIOL, V113, P2691, DOI 10.1007/s00421-013-2700-1; Aagaard P, 2001, J PHYSIOL-LONDON, V534, P613, DOI 10.1111/j.1469-7793.2001.t01-1-00613.x; Iwanuma S, 2011, J APPL PHYSIOL, V110, P1615, DOI 10.1152/japplphysiol.00776.2010; Reeves ND, 2004, EXP PHYSIOL, V89, P675, DOI 10.1113/expphysiol.2004.027797; Kanehisa H, 2002, EUR J APPL PHYSIOL, V87, P112, DOI 10.1007/s00421-002-0604-6; Alegre LM, 2006, J SPORT SCI, V24, P501, DOI 10.1080/02640410500189322; Erskine RM, 2010, ACTA PHYSIOL, V199, P83, DOI 10.1111/j.1748-1716.2010.02085.x; Kubo K, 2006, J APPL BIOMECH, V22, P112; Blazevich AJ, 2007, J APPL PHYSIOL, V103, P1565, DOI 10.1152/japplphysiol.00578.2007; Gans C., 1965, Ergebnisse der Anatomie und Entwicklungsgeschichte, V38, P115; HENRIKSSONLARSEN K, 1992, EUR J APPL PHYSIOL O, V64, P68, DOI 10.1007/BF00376443; KARDEL T, 1990, J BIOMECH, V23, P953, DOI 10.1016/0021-9290(90)90310-Y; Kawakami Y, 1995, EUR J APPL PHYSIOL O, V72, P37, DOI 10.1007/BF00964112; Kawakami Y, 2005, INT J SPORT HLTH SCI, V3, P208, DOI 10.5432/ijshs.3.208; Kearns CF, 2000, EUR J APPL PHYSIOL, V83, P289, DOI 10.1007/s004210000298; Kubo K, 2009, J APPL PHYSIOL, V106, P412, DOI 10.1152/japplphysiol.91381.2008; Kubo K, 2002, J PHYSIOL-LONDON, V538, P219, DOI 10.1113/jphysiol.2001.012703; Kubo K, 2006, EUR J APPL PHYSIOL, V96, P305, DOI 10.1007/s00421-005-0087-3; Maganaris CN, 2001, J ANAT, V199, P449, DOI 10.1046/j.1469-7580.2001.19940449.x; MAXWELL LC, 1974, J APPL PHYSIOL, V37, P259; MULLER W, 1975, CELL TISSUE RES, V161, P225; Muramatsu T, 2002, J APPL PHYSIOL, V92, P129; Muraoka T, 2003, J APPL BIOMECH, V19, P39; Noorkoiv M, 2014, MED SCI SPORT EXER, V46, P1525, DOI 10.1249/MSS.0000000000000269; Seynnes OR, 2007, J APPL PHYSIOL, V102, P368, DOI 10.1152/japplphysiol.00789.2006; SPOOR CW, 1991, EUR J MORPHOL, V29, P137; WICKIEWICZ TL, 1983, CLIN ORTHOP RELAT R, P275	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	FEB	2015	115	2					309	316		10.1007/s00421-014-3012-9		8	Physiology; Sport Sciences	Physiology; Sport Sciences	AY7FD	WOS:000347725800009		
J	Koga, S; Poole, DC; Kondo, N; Oue, A; Ohmae, E; Barstow, TJ				Koga, Shunsaku; Poole, David C.; Kondo, Narihiko; Oue, Anna; Ohmae, Etsuko; Barstow, Thomas J.			Effects of increased skin blood flow on muscle oxygenation/deoxygenation: comparison of time-resolved and continuous-wave near-infrared spectroscopy signals	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Near-infrared spectroscopy; Skin blood flow; Muscle deoxygenation; Muscle oxygenation	OXYGEN-UPTAKE KINETICS; HUMAN SKELETAL-MUSCLE; CYCLE EXERCISE; DYNAMIC HETEROGENEITY; TISSUE OXYGENATION; HEAT-STRESS; DEOXYGENATION; HUMANS; HEMOGLOBIN; QUADRICEPS	We quantified the contribution of skin blood flow (SkBF) to tissue oxygenation/deoxygenation of the flexor digitorum profundus muscle during cutaneous vasodilation. Time-resolved near-infrared spectroscopy (TRS-NIRS) was utilized to measure the potential influence of optical factors [mean optical pathlength (PL) and coefficients of absorption (mu(a)) and reduced scattering ()] on the NIRS-derived signals of eight male subjects. The approximately threefold elevation of SkBF during 1 h whole-body heating (increased internal temperature similar to 0.9 A degrees C) increased both mu(a) and without changing PL. Assuming that the coefficient remained constant, i.e., as with continuous-wave (CW) NIRS, resulted in a significant increase in the apparent oxygenation [oxy(Hb + Mb), from 113 +/- A 13 mu M (mean +/- A SD) for control to 126 +/- A 13 for the increased SkBF condition, P < 0.01]: this was in marked contrast to the unchanged TRS-derived values. The deoxygenation [deoxy(Hb + Mb)] also increased from control to elevated SkBF (CW-NIRS, from 39 +/- A 8 to 45 +/- A 7; TRS, from 38 +/- A 6 to 44 +/- A 7 mu M; P < 0.01 for both), but less than that seen for oxy(Hb + Mb) and not different between TRS- and CW-NIRS. Further, and in contrast to oxy(Hb + Mb), temporal profiles of deoxy(Hb + Mb) measured by the two NIRS methods were not different. These findings support use of either NIRS method to estimate local muscle fractional O-2 extraction, but not oxygenation, when SkBF is increased at rest.	[Koga, Shunsaku] Kobe Design Univ, Appl Physiol Lab, Nishi Ku, Kobe, Hyogo 6512196, Japan; [Poole, David C.; Barstow, Thomas J.] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Poole, David C.; Barstow, Thomas J.] Kansas State Univ, Dept Kinesiol, Manhattan, KS 66506 USA; [Kondo, Narihiko] Kobe Univ, Kobe, Hyogo 6570011, Japan; [Oue, Anna] Toyo Univ, Itakura 3740193, Japan; [Ohmae, Etsuko] Hamamatsu Photon KK, Hamamatsu, Shizuoka 4348601, Japan	Koga, S (reprint author), Kobe Design Univ, Appl Physiol Lab, Nishi Ku, 8-1-1 Gakuennishi Machi, Kobe, Hyogo 6512196, Japan.	s-koga@kobe-du.ac.jp			Japan Society for the Promotion of Science [18207019]	Grants: This investigation was supported by a grant for scientific research from the Japan Society for the Promotion of Science (Grant-in-Aid 18207019) to S. Koga.	Koga S, 2011, AM J PHYSIOL-REG I, V301, pR534, DOI 10.1152/ajpregu.00101.2011; Murias JM, 2012, AM J PHYSIOL-REG I, V303, pR815, DOI 10.1152/ajpregu.00306.2012; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; Buono MJ, 2005, JPN J PHYSIOL, V55, P241, DOI 10.2170/jjphysiol.T649; Smith CJ, 2013, AM J PHYSIOL-REG I, V304, pR566, DOI 10.1152/ajpregu.00514.2012; Grassi B, 2003, J APPL PHYSIOL, V95, P149, DOI 10.1152/japplphysiol.00695.2002; Koga S, 2014, MED SCI SPORT EXER, V46, P860, DOI 10.1249/MSS.0000000000000178; Behnke BJ, 2001, RESP PHYSIOL, V126, P53, DOI 10.1016/S0034-5687(01)00195-5; Hardy JD, 1938, J NUTR, V15, P461; Burnley M, 2002, J APPL PHYSIOL, V93, P167, DOI 10.1152/japplphysiol.01217.2001; Davis SL, 2006, J APPL PHYSIOL, V100, P221, DOI 10.1152/japplphysiol.00867.2005; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511; Bangsbo J, 2000, AM J PHYSIOL-REG I, V279, pR899; Davis ML, 2013, RESP PHYSIOL NEUROBI, V186, P180, DOI 10.1016/j.resp.2013.01.012; Bowen TS, 2013, EXP PHYSIOL, V98, P1585, DOI 10.1113/expphysiol.2013.073270; Boone J, 2009, EUR J APPL PHYSIOL, V105, P851, DOI 10.1007/s00421-008-0969-2; Tew GA, 2010, EUR J APPL PHYSIOL, V110, P1083, DOI 10.1007/s00421-010-1596-2; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Koga S, 2012, J APPL PHYSIOL, V112, P26, DOI 10.1152/japplphysiol.00925.2011; Koga S, 2007, J APPL PHYSIOL, V103, P2049, DOI 10.1152/japplphysiol.00627.2007; Sato C, 2007, APPL OPTICS, V46, P2785, DOI 10.1364/AO.46.002785; Heinonen I, 2011, J APPL PHYSIOL, V111, P818, DOI 10.1152/japplphysiol.00269.2011; Grassi B, 1998, J APPL PHYSIOL, V85, P1394; Ryan TE, 2012, J APPL PHYSIOL, V113, P175, DOI 10.1152/japplphysiol.00319.2012; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Bopp CM, 2014, MICROVASC RES, V91, P37, DOI 10.1016/j.mvr.2013.10.004; Boushel R, 2000, ACTA PHYSIOL SCAND, V168, P615, DOI 10.1046/j.1365-201x.2000.00713.x; Chuang ML, 2002, MED SCI SPORT EXER, V34, P1614, DOI 10.1249/01.MSS.0000035992.08625.78; Ferreira LF, 2007, J APPL PHYSIOL, V102, P358, DOI 10.1152/japplphysiol.00920.2005; Hamaoka T, 2011, PHILOS T R SOC A, V369, P4591, DOI 10.1098/rsta.2011.0298; JOHNSON JM, 1976, J APPL PHYSIOL, V41, P826; Jones AM, 2009, J APPL PHYSIOL, V107, P372, DOI 10.1152/japplphysiol.00314.2009; Kime R, 2013, ADV EXP MED BIOL, V789, P163, DOI 10.1007/978-1-4614-7411-1_23; Koga S, 2005, AM J PHYSIOL-REG I, V288, pR212, DOI 10.1152/ajpregu.00147.2004; Kounalakis SN, 2008, EUR J APPL PHYSIOL, V103, P99, DOI 10.1007/s00421-007-0662-x; Mancini DM, 1994, J APPL PHYSIOL, V77, P2477; McCully K K, 2000, Exerc Sport Sci Rev, V28, P123; Messere A, 2013, PHYSL REP, V1, P1; Oda M, 1999, P SOC PHOTO-OPT INS, V3597, P611, DOI 10.1117/12.356809; Ooue A, 2007, EUR J APPL PHYSIOL, V101, P97, DOI 10.1007/s00421-007-0478-8; Paunescu L. A., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4250, DOI 10.1117/12.434505; Pearson J, 2011, AM J PHYSIOL-REG I, V300, pR663, DOI 10.1152/ajpregu.00662.2010; Shibasaki M, 1999, ACTA PHYSIOL SCAND, V167, P105; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106	45	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	FEB	2015	115	2					335	343		10.1007/s00421-014-3019-2		9	Physiology; Sport Sciences	Physiology; Sport Sciences	AY7FD	WOS:000347725800012		
J	Muto, M; Mori, M; Sato, Y; Uzawa, A; Masuda, S; Uchida, T; Kuwabara, S				Muto, M.; Mori, M.; Sato, Y.; Uzawa, A.; Masuda, S.; Uchida, T.; Kuwabara, S.			Current symptomatology in multiple sclerosis and neuromyelitis optica	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						multiple sclerosis; neuromyelitis optica; paroxysmal symptoms; symptomatology	DIAGNOSTIC-CRITERIA; CLINICAL-FEATURES; LHERMITTES SIGN; TONIC SPASMS; JAPAN; ATTACKS; MYELOPATHY; SYMPTOMS; PAIN	Background and objectivesSeveral symptoms and signs are characteristic of multiple sclerosis (MS) such as Lhermitte's sign, Uhthoff's phenomenon and painful tonic seizure. Neuromyelitis optica (NMO) is another inflammatory disease of the central nervous system, and most of the opticospinal form of MS is thought to be NMO. This study aimed to investigate the frequencies of symptoms and signs, previously regarded as characteristic of MS, in NMO and MS patients. MethodsConsecutive Japanese NMO-plus patients [NMO (n=30) or partial NMO (n=18)] and MS patients (n=128) seen at Chiba University Hospital between 2011 and 2012 were investigated for the frequencies of symptoms and signs characteristic of MS. Logistic regression analyses were used to identify factors that distinguished NMO-plus from MS. ResultsUnivariate analyses revealed that tonic seizures, Lhermitte's sign, persistent pain, fatigue and girdle sensation were more frequent in NMO-plus patients than in MS patients. Multivariate logistic regression analysis showed that paroxysmal itching, Uhthoff's phenomenon, Lhermitte's sign and girdle sensation were more characteristic of NMO-plus than of MS. ConclusionsSeveral classical MS symptoms and signs are more frequent in NMO patients than MS patients, which may be caused by the differences in the severity of inflammation, and localization and extensiveness of demyelinated lesions.	[Muto, M.; Mori, M.; Uzawa, A.; Masuda, S.; Uchida, T.; Kuwabara, S.] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba 2608670, Japan; [Sato, Y.] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan	Mori, M (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	morim@faculty.chiba-u.jp					Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.206703; Al-Araji AH, 2005, MULT SCLER, V11, P398, DOI 10.1191/1352458505ms1177oa; TWOMEY JA, 1980, J NEUROL NEUROSUR PS, V43, P296, DOI 10.1136/jnnp.43.4.296; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Araki M, 2013, MOD RHEUMATOL, V23, P827, DOI 10.1007/s10165-012-0715-9; Kim SM, 2012, ARCH NEUROL-CHICAGO, V69, P1026, DOI 10.1001/archneurol.2012.112; Kanamori Y, 2011, NEUROLOGY, V77, P652, DOI 10.1212/WNL.0b013e318229e694; Hayakawa S, 2008, J NEUROIMMUNOL, V196, P181, DOI 10.1016/j.jneuroim.2008.03.009; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; KANCHANDANI R, 1982, J NEUROL NEUROSUR PS, V45, P308, DOI 10.1136/jnnp.45.4.308; Vercoulen JHMM, 1996, ARCH NEUROL-CHICAGO, V53, P642; Uzawa A, 2013, CLIN CHIM ACTA, V421, P181, DOI 10.1016/j.cca.2013.03.020; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Mandler RN, 2006, AUTOIMMUN REV, V5, P537, DOI 10.1016/j.autrev.2006.02.008; SHIBASAKI H, 1981, J NEUROL SCI, V49, P253, DOI 10.1016/0022-510X(81)90083-6; Solaro C, 2004, NEUROLOGY, V63, P919; Apiwattanakul M, 2010, ANN NEUROL, V68, P757, DOI 10.1002/ana.22121; BRUCK W, 1994, ANN NEUROL, V35, P65, DOI 10.1002/ana.410350111; FUKAZAWA T, 1990, J NEUROL SCI, V100, P217, DOI 10.1016/0022-510X(90)90036-M; FUKAZAWA T, 1992, INTERNAL MED, V31, P349, DOI 10.2169/internalmedicine.31.349; Iorio R, 2011, NEUROLOGY, V77, P1644, DOI 10.1212/WNL.0b013e3182343377; Kira Jun-Ichi, 2011, Pathophysiology, V18, P69, DOI 10.1016/j.pathophys.2010.04.008; Kira J, 2011, J NEUROL SCI, V311, P69, DOI 10.1016/j.jns.2011.08.043; KUROIWA Y, 1975, NEUROLOGY, V25, P845; Matthews WB, 1985, MCALPINES MULTIPLE S; MILEY CE, 1974, NEUROLOGY, V24, P458; Nakashima I, 2007, J NEUROL, V254, P488, DOI 10.1007/s00415-006-0400-z; Ochiai H, 2002, J NEUROL, V249, P549, DOI 10.1007/s004150200063; PRINEAS JW, 1978, NEUROLOGY, V28, P68; Schmidt FR, 2012, ARQ NEURO-PSIQUIAT, V70, P271; SELHORST JB, 1995, J NEURO-OPHTHALMOL, V15, P63; SHIBASAK.H, 1974, J NEUROL SCI, V23, P215, DOI 10.1016/0022-510X(74)90224-X; SOZZI G, 1987, J NEUROL NEUROSUR PS, V50, P490, DOI 10.1136/jnnp.50.4.490; Spissu A, 1999, MOVEMENT DISORD, V14, P331, DOI 10.1002/1531-8257(199903)14:2<331::AID-MDS1020>3.0.CO;2-H; Usmani N, 2012, ARCH NEUROL-CHICAGO, V69, P121, DOI 10.1001/archneurol.2011.832; Uzawa A, 2013, J NEUROL NEUROSUR PS, V84, P517, DOI 10.1136/jnnp-2012-304039; OSTERMAN PO, 1975, BRAIN, V98, P189, DOI 10.1093/brain/98.2.189	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	FEB	2015	22	2					299	304		10.1111/ene.12566		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AY6UP	WOS:000347701300013		
J	Hishikawa, N; Yamashita, T; Deguchi, K; Wada, J; Shikata, K; Makino, H; Abe, K				Hishikawa, N.; Yamashita, T.; Deguchi, K.; Wada, J.; Shikata, K.; Makino, H.; Abe, K.			Cognitive and affective functions in diabetic patients associated with diabetes-related factors, white matter abnormality and aging	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						cognitive and affective functions; diabetes mellitus; HbA1c; insulin resistance; MRI	RISK-FACTORS; TYPE-2; DEMENTIA; MELLITUS; DECLINE; COHORT; POPULATION; DEPRESSION; PEOPLE	Background and purposeDiabetes mellitus (DM) is associated with a decline in cognitive and affective functions. MethodsIn all, 182 outpatients with DM were investigated for associations of cognitive and affective functions with diabetes-related factors and cerebral white matter abnormalities. In addition, the difference in cognitive decline of age-matched late elderly normal subjects and DM patients was investigated. ResultsThe present study revealed that cognitive and affective functions declined in some DM patients. Furthermore, the decline in these functions was unrelated to fasting blood sugar level but was related to glycosylated hemoglobin (HbA1c) and insulin resistance. Poor HbA1c control was associated with a significant decline in the calculation' subscale and insulin resistance for naming', read list of letters' and delayed recall' Montreal Cognitive Assessment (MoCA) subscale scores. Magnetic resonance imaging scans showed that both periventricular hyperintensity (PVH) and deep white matter hyperintensity were associated with Mini Mental State Examination (MMSE) and MoCA scores, but only PVH was related to homeostasis model assessment of insulin resistance scores. Compared with age-matched late elderly normal subjects, orientation to time' and registration' MMSE subscales declined in late elderly DM patients. ConclusionsThese results suggest that cognitive and affective decline in DM patients was mostly related to glucose control and insulin resistance, whilst amongst late elderly subjects the impairment of attention' and orientation' were characteristic features of DM patients.	[Hishikawa, N.; Yamashita, T.; Deguchi, K.; Abe, K.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama 7008558, Japan; [Wada, J.; Shikata, K.; Makino, H.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan	Abe, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	nozomi-hishikawa@okayama-u.ac.jp	Wada, Jun/B-2023-2011	Wada, Jun/0000-0003-1468-5170	Ministry of Health, Labour and Welfare of Japan	This work was partly supported by Grants-in-Aid from the Research Committees (Mizusawa H, Nakano I, Nishizawa M, Sasaki H and Aoki M) of the Ministry of Health, Labour and Welfare of Japan.	Exalto LG, 2013, LANCET DIABETES ENDO, V1, P183, DOI 10.1016/S2213-8587(13)70048-2; Abbatecola AM, 2006, NEUROLOGY, V67, P235, DOI 10.1212/01.wnl.0000224760.22802.e8; Rizzo MR, 2010, DIABETES CARE, V33, P2169, DOI 10.2337/dc10-0389; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; Yaffe K, 2012, ARCH NEUROL-CHICAGO, V69, P1170, DOI 10.1001/archneurol.2012.1117; Logroscino G, 2004, BRIT MED J, V328, P548, DOI 10.1136/bmj.37977.495729.EE; Deschaintre Y, 2009, NEUROLOGY, V73, P674, DOI 10.1212/WNL.0b013e3181b59bf3; FAZEKAS F, 1991, AM J NEURORADIOL, V12, P915; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chen RH, 2012, ANN ENDOCRINOL-PARIS, V73, P208, DOI 10.1016/j.ando.2012.04.009; densHeijer T, 2003, DIABETOLOGIA, V46, P1604; Gao L, 2008, BMC PUBLIC HEALTH, V11, P54; Li J, 2006, NEUROLOGY, V76, P1485; Palizgir M, 2013, IRAN RED CRESCENT ME, V15, P644, DOI 10.5812/ircmj.12107; Peila R, 2004, NEUROLOGY, V63, P228; Sweileh WM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-163; VansHarten B, 2007, AGE AGEING, V36, P164; Wu JH, 2003, ANN EPIDEMIOL, V13, P369, DOI 10.1016/S1047-2797(02)00464-7; Young SE, 2006, DIABETES CARE, V29, P2688, DOI 10.2337/dc06-0915	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	FEB	2015	22	2					313	321		10.1111/ene.12568		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AY6UP	WOS:000347701300015		
J	Li, J; Kawashirna, K; Kagawa, T				Li, Jun; Kawashirna, Kenji; Kagawa, Toshiharu			A method to suppress temperature increase in pneumatic artificial rubber muscles	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Fluidic muscle; Temperature increase; Pneumatic		In the present paper, a method by which to suppress the temperature increase in pneumatic artificial rubber muscles is proposed. The pneumatic artificial rubber muscle (PARM) is a flexible actuator. The use of PARMs in industrial and scientific applications has increased significantly as a result of their advantages. Usually, compressed air is charged or discharged from one end of the PARM as it is inflated or deflated. The PARM expands radially and contracts axially when inflated. The closed end is referred to herein as the end part. Since the fluidity of air at the end part of the PARM is low, when a PARM is pressurized repeatedly, the temperature at the end part increases significantly. This temperature increase shortens the operating life of the PARM and limits the characteristics of continuous drive. A method of addressing this temperature increase is proposed herein. A pipeline is installed in the PARM, and compressed air is charged or discharged through the pipeline in order to promote the convection of air at the end part of the PARM. As a result, the temperature increase in the PARM is suppressed. We confirmed experimentally that the proposed method can effectively suppress the temperature increase in the PARM. (C) 2014 Elsevier Inc. All rights reserved.	[Li, Jun; Kagawa, Toshiharu] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Kawashirna, Kenji] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138510, Japan	Kawashirna, K (reprint author), Tokyo Med & Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kawabmc@tmd.ac.jp					Andrikopoulos G, 2014, IEEE T IND ELECTRON, V61, P904, DOI 10.1109/TIE.2013.2254094; Li HB, 2013, IEEE-ASME T MECH, V18, P74, DOI 10.1109/TMECH.2011.2163415; Chou CP, 1996, IEEE T ROBOTIC AUTOM, V12, P90, DOI 10.1109/70.481753; Zhu XC, 2008, AUTOMATICA, V44, P2248, DOI 10.1016/j.automatica.2008.01.015; CALDWELL DG, 1995, IEEE CONTR SYST MAG, V15, P40, DOI 10.1109/37.341863; Kawashima K., 2004, J ROBOTICS MECHATRON, V16, P8; Klute G.K., 1998, IEEE RSJ 1998 INT C, V3, P1776; Noritsugu T., 1999, SICE ANN C SICE, V1, P420; Noritsugu T., 2009, J ROBOTICS MECHATRON, V21, P607; Noritsugu T., 1999, IEEE SYST MAN CYBERN, V4, P788, DOI 10.1109/ICSMC.1999.812505; References J, 2014, ROBOT CIM-INT MANUF, V30, P244; Schulte R.A., 1962, APPL EXTERNAL POWER, V874, P94; The Japan Fluid Power System Society, 1989, HYDR PEN HDB, pP429	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	FEB	2015	61						59	65		10.1016/j.expthermflusci.2014.10.004		7	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	AY5HU	WOS:000347604200006		
J	Parchim, NF; Wang, W; Iriyama, T; Ashimi, OA; Siddiqui, AH; Blackwell, S; Sibai, B; Kellems, RE; Xia, Y				Parchim, Nicholas F.; Wang, Wei; Iriyama, Takayuki; Ashimi, Olaide A.; Siddiqui, Athar H.; Blackwell, Sean; Sibai, Baha; Kellems, Rodney E.; Xia, Yang			Neurokinin 3 Receptor and Phosphocholine Transferase Missing Factors for Pathogenesis of C-Reactive Protein in Preeclampsia	HYPERTENSION			English	Article						C-reactive protein; inflammation; neurokinin B; phosphocholine transferase	NECROSIS-FACTOR-ALPHA; ACTIVATION CONTRIBUTES; SFLT-1 PRODUCTION; 3RD TRIMESTER; B LEVELS; HYPERTENSION; CELLS; ATHEROSCLEROSIS; ANGIOGENESIS; BIOMARKERS	C-reactive protein (CRP), an innate immune mediator, is elevated in the circulation before symptoms in patients with preeclampsia, a severe hypertensive pregnancy disorder with high mortality and morbidity. However, the specific sources underlying increased CRP and the role of elevated CRP in preeclampsia are undefined. Here, we report that circulating CRP levels are significantly increased in a large cohort of normotensive pregnant individuals when compared with nulligravid women and is further increased in patients with preeclampsia. These findings led us to discover further that placental syncytiotrophoblasts are previously unrecognized cellular sources of CRP and underlie elevated CRP in normotensive pregnant women and the additional increase in patients with preeclampsia. Next, we demonstrated that injection of CRP induces preeclampsia features, including hypertension (157 mm Hg CRP treated versus 119 mm Hg control), proteinuria (35.0 mg/g CRP treated versus 14.1 mg/g control), kidney, and placental damage and increased levels of sFlt-1 in pregnant mice but not in nonpregnant mice. Our study implicates that phosphocholine transferase, a placental-specific enzyme post-translationally modifying neurokinin B, is essential for the pathogenic role of CRP in preeclampsia through activation of the neurokinin 3 receptor. Overall, our studies have provided significant new insight on the pathogenic role of CRP in preeclampsia and highlighted innovative therapeutic strategies.	[Parchim, Nicholas F.; Wang, Wei; Iriyama, Takayuki; Siddiqui, Athar H.; Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ashimi, Olaide A.; Blackwell, Sean; Sibai, Baha] Univ Texas Houston, Dept Obstet Gynecol & Reprod Sci, Houston, TX 77030 USA; [Parchim, Nicholas F.; Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Wang, Wei; Xia, Yang] Cent S Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Iriyama, Takayuki] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Siddiqui, Athar H.] Univ Hyderabad, Sch Med Sci, Hyderabad 500134, Andhra Pradesh, India	Xia, Y (reprint author), Univ Texas Houston, Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu			National Institute of Health [HL119549, TL1 TR000369, RC4HD067977, HD34130]; China National Science Foundation [81228004]	This work was supported by National Institute of Health Grants HL119549 (to Y. Xia), TL1 TR000369 (to N.F. Parchim), RC4HD067977 and HD34130 (to Y. Xia and R.E. Kellems) and by China National Science Foundation 81228004 (to Y. Xia).	Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Cebesoy FB, 2009, HYPERTENS PREGNANCY, V28, P201, DOI 10.1080/10641950802601187; Boij R, 2012, AM J REPROD IMMUNOL, V68, P258, DOI 10.1111/j.1600-0897.2012.01158.x; Cetin I, 2009, ACTA OBSTET GYN SCAN, V88, P846, DOI 10.1080/00016340902971441; Wang W, 2012, HYPERTENSION, V60, P712, DOI 10.1161/HYPERTENSIONAHA.112.191817; Irani RA, 2010, HYPERTENSION, V55, P1246, DOI 10.1161/HYPERTENSIONAHA.110.150540; Kim H, 2011, EUR J CLIN NUTR, V65, P878, DOI [10.1038/ejcn.2010.267, 10.1038/ejcn.2011.42]; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Nakada E, 2009, PLACENTA, V30, P774, DOI 10.1016/j.placenta.2009.07.001; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Gadonski G, 2006, HYPERTENSION, V48, P711, DOI 10.1161/01.HYP.0000238442.33463.94; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Derzsy Z, 2010, MOL IMMUNOL, V47, P1500, DOI 10.1016/j.molimm.2010.01.021; Murphy SR, 2013, AM J PHYSIOL-REG I, V304, pR130, DOI 10.1152/ajpregu.00069.2012; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Grad E, 2013, BLOOD REV, V27, P23, DOI 10.1016/j.blre.2012.12.001; Dhillion P, 2012, AM J PHYSIOL-REG I, V303, pR353, DOI 10.1152/ajpregu.00051.2012; Zhang WR, 2013, CIRC RES, V112, P1466, DOI 10.1161/CIRCRESAHA.111.300166; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; LaMarca BBD, 2005, HYPERTENSION, V46, P82, DOI 10.1161/01.HYP.0000169152.59854.36; Castellano G, 2010, ATHEROSCLEROSIS, V209, P241, DOI 10.1016/j.atherosclerosis.2009.08.044; Catarino C, 2012, J PREGNANCY, V2012; Ertas IE, 2010, J OBSTET GYNAECOL RE, V36, P970, DOI 10.1111/j.1447-0756.2010.01279.x; Geissbuehler Verena, 2007, Archives of Gynecology and Obstetrics, V276, P151, DOI 10.1007/s00404-006-0316-y; Grad E, 2012, ARTERIOSCL THROM VAS, V32, P2468, DOI 10.1161/ATVBAHA.112.256073; Guo F, 2012, INFLAMM RES, V61, P127, DOI 10.1007/s00011-011-0396-4; Irani RA, 2009, J EXP MED, V206, P2809, DOI 10.1084/jem.20090872; Labarrere CA, 2004, AM J MED, V117, P499, DOI 10.1016/j.amjmed.2004.03.039; Lowry P, 2011, BIOPOLYMERS, V96, P189, DOI 10.1002/bip.21407; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; Nillawar Anup N, 2013, J Clin Diagn Res, V7, P801, DOI 10.7860/JCDR/2013/5187.2943; Page NM, 2000, NATURE, V405, P797; Page NM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-4; Porter K, 2014, CYTOKINE; Rampersad R, 2008, PLACENTA, V29, P855, DOI 10.1016/j.placenta.2008.07.008; Verma S, 2003, J THORAC CARDIOV SUR, V126, P1886, DOI 10.1016/j.jtcvs.2003.07.026; Wang W, 2014, HYPERTENSION, V63, P595, DOI 10.1161/HYPERTENSIONAHA.113.02458; Zulfikaroglu E, 2007, J PERINAT MED, V35, P200, DOI 10.1515/JPM.2007.050	38	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	FEB	2015	65	2					430	U425		10.1161/HYPERTENSIONAHA.114.04439		18	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AY3HC	WOS:000347474100032		
J	Ma, JX; Thakor, NV; Matsuno, F				Ma, Jiaxin; Thakor, Nitish V.; Matsuno, Fumitoshi			Hand and Wrist Movement Control of Myoelectric Prosthesis Based on Synergy	IEEE TRANSACTIONS ON HUMAN-MACHINE SYSTEMS			English	Article						Degrees of freedom (DOF); electromyogram (EMG); nonnegative matrix factorization (NMF); prosthesis; synergy	MUSCLE SYNERGIES; MATRIX FACTORIZATION; POWERED PROSTHESES; COMBINATIONS; ALGORITHMS; SIGNALS; MODELS	This study proposes a method to control a prosthetic hand by EMG signals based on muscle synergies. The muscle synergy model suggests a framework to transform commands of the central nervous system to a set of complex muscular movements. Using this method, we have tried to realize the proportional control of multiple degrees of freedom (DOF). This study focuses on controlling four kinds of hand/wrist movements of the prosthesis: open, close, pronate, and supinate. The nonnegative matrix factorization (NMF) algorithm is used to map muscle activities into these four movements through the calculation of a muscle synergy matrix. An EMG feature selection process along with a control scheme has been added, which smooths the output thereby stabilizing the movements. Ten healthy subjects performed an online experiment comprised of two tests: 1) proportional control on single DOF, and 2) simultaneous control of multiple DOFs. The results indicate that fluid hand/wrist movements could be estimated from EMG. The average R-2 values achieved by all subjects for the single-DOF test and the multiple-DOF test are 0.97 and 0.93, respectively.	[Ma, Jiaxin; Matsuno, Fumitoshi] Kyoto Univ, Sch Engn, Dept Mech Engn & Sci, Kyoto 6158530, Japan; [Thakor, Nitish V.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Ma, JX (reprint author), Kyoto Univ, Sch Engn, Dept Mech Engn & Sci, Kyoto 6158530, Japan.	ma.jiaxin.62c@st.kyoto-u.ac.jp; thakorjhu@gmail.com; matsuno@me.kyoto-u.ac.jp	Thakor, Nitish/G-9110-2015	Thakor, Nitish/0000-0002-9981-9395			Ajiboye AB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/036004; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Tenore FVG, 2009, IEEE T BIO-MED ENG, V56, P1427, DOI 10.1109/TBME.2008.2005485; Choi C, 2011, MED ENG PHYS, V33, P916, DOI 10.1016/j.medengphy.2011.02.006; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Sanger TD, 2007, J NEUROPHYSIOL, V97, P1839, DOI 10.1152/jn.00936.2006; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; Chan ADC, 2005, IEEE T BIO-MED ENG, V52, P121, DOI 10.1109/TBME.2004.836492; Bitzer S, 2006, IEEE INT CONF ROBOT, P2819; Smith RJ, 2008, IEEE ENG MED BIO, P197, DOI 10.1109/IEMBS.2008.4649124; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Huang YH, 2005, IEEE T BIO-MED ENG, V52, P1801, DOI 10.1109/TBME.2005.856295; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Overduin SA, 2008, J NEUROSCI, V28, P880, DOI 10.1523/JNEUROSCI.2869-07.2008; Cipriani C, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-29; Davoodi R, 2002, J APPL BIOMECH, V18, P357; James C., 2004, PHYSIOL MEAS, V26, pR15; Karlik B, 2003, IEEE T BIO-MED ENG, V50, P1255, DOI [10.1109/TBME.2003.818469, 10.1109/TMBE.2003.818469]; Phinyomark A, 2009, J COMPUTING, V1, P71; Seung D., 2001, ADV NEURAL INFORM PR, V13, P556; Smith R., 2009, P 31 ANN INT C IEEE, P2376; Tkach D., 2010, J NEUROENG REHABIL, V7; Zecca M, 2002, Crit Rev Biomed Eng, V30, P459, DOI 10.1615/CritRevBiomedEng.v30.i456.80	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2291	2168-2305		IEEE T HUM-MACH SYST	IEEE T. Hum.-Mach. Syst.	FEB	2015	45	1					74	83		10.1109/THMS.2014.2358634		10	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	AZ2ON	WOS:000348072800007		
J	Ugurlu, B; Nishimura, M; Hyodo, K; Kawanishi, M; Narikiyo, T				Ugurlu, Barkan; Nishimura, Masayoshi; Hyodo, Kazuyuki; Kawanishi, Michihiro; Narikiyo, Tatsuo			Proof of Concept for Robot-Aided Upper Limb Rehabilitation Using Disturbance Observers	IEEE TRANSACTIONS ON HUMAN-MACHINE SYSTEMS			English	Letter						Disturbance observer (DOB); exoskeleton; power assistance; robot-aided rehabilitation; user torque estimation	ARM EXOSKELETON; BICEPS-BRACHII; MOTION CONTROL; DESIGN; STROKE; THERAPY	This paper presents a wearable upper body exoskeleton system with a model-based compensation control framework to support robot-aided shoulder-elbow rehabilitation and power assistance tasks. To eliminate the need for EMG and force sensors, we exploit off-the-shelf compensation techniques developed for robot manipulators. Thus, target rehabilitation tasks are addressed by using only encoder readings. A proof-of-concept evaluation was conducted with five able-bodied participants. The patient-active rehabilitation task was realized via observer-based user torque estimation, in which resistive forces were adjusted using virtual impedance. In the patient-passive rehabilitation task, the proposed controller enabled precise joint tracking with a maximum positioning error of 0.25 degrees. In the power assistance task, the users' muscular activities were reduced up to 85% while exercising with a 5 kg dumbbell. Therefore, the exoskeleton system was regarded as being useful for the target tasks, indicating that it has a potential to promote robot-aided therapy protocols.	[Ugurlu, Barkan] Ozyegin Univ, Dept Mech Engn, TR-34794 Istanbul, Turkey; [Ugurlu, Barkan] Adv Telecommun Res Inst, Computat Neurosci Labs, Kyoto 6190288, Japan; [Nishimura, Masayoshi; Kawanishi, Michihiro; Narikiyo, Tatsuo] Toyota Technol Inst, Control Syst Lab, Dept Adv Sci & Technol, Nagoya, Aichi 4688511, Japan; [Hyodo, Kazuyuki] Fukuoka Inst Technol, Dept Comp Sci & Engn, Fukuoka 8110295, Japan	Ugurlu, B (reprint author), Ozyegin Univ, Dept Mech Engn, TR-34794 Istanbul, Turkey.	barkanu@ieee.org; nishimuram@hhq.suzuki.co.jp; hyodo@fit.ac.jp; kawa@toyota-ti.ac.jp; n-tatsuo@toyota-ti.ac.jp	Ugurlu, Barkan/A-4793-2015	Ugurlu, Barkan/0000-0002-9124-7441			Zinn M, 2004, IEEE ROBOT AUTOM MAG, V11, P12, DOI 10.1109/MRA.2004.1310938; Perry JC, 2007, IEEE-ASME T MECH, V12, P408, DOI 10.1109/TMECH.2007.901934; Ajoudani A, 2012, INT J ROBOT RES, V31, P1642, DOI 10.1177/0278364912464668; Vanholder R, 2000, J AM SOC NEPHROL, V11, P1553; Jarrasse N, 2012, IEEE T ROBOT, V28, P697, DOI 10.1109/TRO.2011.2178151; [Anonymous], 2014, ACCOMPANYING YOUTUBE; Rosati G, 2007, IEEE T NEUR SYS REH, V15, P560, DOI 10.1109/TNSRE.2007.908560; Mao Y, 2012, IEEE T ROBOT, V28, P922, DOI 10.1109/TRO.2012.2189496; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Ohnishi K, 1996, IEEE-ASME T MECH, V1, P56, DOI 10.1109/3516.491410; Sanchez RJ, 2006, IEEE T NEUR SYS REH, V14, P378, DOI 10.1109/TNSRE.2006.881553; Ayusawa K, 2014, INT J ROBOT RES, V33, P446, DOI 10.1177/0278364913495932; ERGIN MA, 2012, P IEEE INT C ROB AUT, P2479; Frisoli A., 2012, J NEUROENG REHABIL, V9, P1; Gupta A, 2006, IEEE-ASME T MECH, V11, P280, DOI 10.1109/TMECH.2006.875558; GUPTA AK, 2010, PROB STAT MOD, P1; Kahn LE, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-12; Khalil W, 2007, IEEE INT CONF ROBOT, P4943, DOI 10.1109/ROBOT.2007.364241; Krebs H I, 1998, IEEE Trans Rehabil Eng, V6, P75, DOI 10.1109/86.662623; Landin D, 2008, J ELECTROMYOGR KINES, V18, P270, DOI 10.1016/j.jelekin.2006.09.012; Mistry M., 2005, P IEEE RSJ INT C INT, P4071; MURAKAMI T, 1993, IEEE T IND ELECTRON, V40, P259, DOI 10.1109/41.222648; Nef Tobias, 2009, Applied Bionics and Biomechanics, V6, DOI 10.1080/11762320902840179; Salvucci Valerio, 2010, Proceedings of the 11th IEEE International Workshop on Advanced Motion Control (AMC 2010), DOI 10.1109/AMC.2010.5464120; Tsagarakis NG, 2013, IEEE T HUM-MACH SYST, V43, P177, DOI 10.1109/TSMCC.2012.2204872; Ugurlu B., 2012, P 12 IEEE INT WORKSH, P1; Ugurlu B., 2014, P IEEE C ROB AUT HON, P1354; Wade D, 1999, LANCET, V354, P176, DOI 10.1016/S0140-6736(99)90064-8; Weinstein DM, 2008, J SHOULDER ELB SURG, V17, p82S, DOI 10.1016/j.jse.2007.07.006	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2291	2168-2305		IEEE T HUM-MACH SYST	IEEE T. Hum.-Mach. Syst.	FEB	2015	45	1					110	118		10.1109/THMS.2014.2362816		9	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	AZ2ON	WOS:000348072800010		
J	Xing, J				Xing, Jian			Characteristics of wrong-way driving on motorways in Japan	IET INTELLIGENT TRANSPORT SYSTEMS			English	Article						road accidents; road traffic; intelligent transportation systems; traffic engineering computing; behavioural sciences computing; wrong-way driving characteristics; motorway network; Japan; wrong-way incident characteristics; wrong-way crashes; ITS technologies; wrong entries; suspected dementia		Characteristics of wrong-way incidents and crashes that occurred on the entire motorway network in Japan are analysed in this study with an emphasis on wrong-way crashes. Nearly 40% of vehicles in wrong-way crashes took U-turns on the main carriageway, followed by 20% entering the wrong way at interchanges after passing the tollgate, 18% before passing the tollgate and 12% at rest areas. Wrong entries and suspected dementia were the two main contributing factors for wrong-way crashes, each accounting for nearly 30% of the total number of wrong-way crashes, followed by each 8-10% for confusion with ordinary road, taking U-turns on the main carriageway and driving under the influence of alcohol. Most wrong-way crashes because of wrong entries were caused by older drivers over the age of 60 (61%) and young drivers (22%) and most of those because of confusion with ordinary road were also caused by older drivers (86%). All the wrong-way crashes caused by suspected dementia were by older drivers over the age of 65 and occurred between 4-10 p.m. Finally some applications of recent ITS technologies to prevent wrong-way driving that have been implemented recently on motorways in Japan are briefly introduced.	Nippon Expressway Res Inst Co Ltd, Machida, Tokyo 1948508, Japan	Xing, J (reprint author), Nippon Expressway Res Inst Co Ltd, 1-4-1 Tadao, Machida, Tokyo 1948508, Japan.	xing@ri-nexco.co.jp					Lathrop SL, 2010, J FORENSIC SCI, V55, P432, DOI 10.1111/j.1556-4029.2009.01305.x; Brown LB, 2004, J GERIATR PSYCH NEUR, V17, P232, DOI 10.1177/0891988704269825; Olivier F., 2012, REV GEN ROUTES, V812, P82; Topolsek D, 2007, PROMET, V19, P311; Vaswani H., 1977, TRB TRANSP RES REC, V644, P87	5	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-956X	1751-9578		IET INTELL TRANSP SY	IET Intell. Transp. Syst.	FEB	2015	9	1					3	11		10.1049/iet-its.2014.0017		9	Transportation Science & Technology	Transportation	AZ0QN	WOS:000347949900002		
J	Denis, N; Dubois, MR; Desrochers, A				Denis, Nicolas; Dubois, Maxime R.; Desrochers, Alain			Fuzzy-based blended control for the energy management of a parallel plug-in hybrid electric vehicle	IET INTELLIGENT TRANSPORT SYSTEMS			English	Article						fuzzy control; energy management systems; hybrid electric vehicles; intelligent control; fuel economy; optimal control; control system synthesis; driving condition information; fuzzy logic; vehicle state; total driving cycle; optimal control; fuel economy; energy management systems; power distribution; intelligent controller; embedded power sources; automotive industry; gas emission reduction; fuel consumption reduction; PHEV; parallel plug-in hybrid electric vehicle; fuzzy-based blended control	CONTROL STRATEGIES; LOGIC	The growing interest in reducing fuel consumption and gas emissions provides an incentive for the automotive industry to innovate in the field of hybrid electric vehicles (HEV) and plug-in hybrid electric vehicles (PHEV). The two embedded power sources in these vehicles require an intelligent controller in order to make the best decision on the power distribution. Actually these controllers, often called energy management systems, are very important and greatly influence the achievable fuel economy. Compared with an HEV, a PHEV allows battery discharge over a complete trip. As a consequence the optimal control of a PHEV implies a stronger dependence on the total driving cycle. Many authors have studied the possibility of fuzzy-based systems for both HEV and PHEV as they have proved to be robust, reliable and simple. However, classical fuzzy rule-based strategies demonstrate a lack of optimality because their design is focused on the actual vehicle state rather than the driving conditions. This study proposes a blended control strategy based on fuzzy logic for a PHEV. The proposed controller is fed with driving condition information in order to increase the controller effectiveness in every situation. The efficiency of the proposed controller is demonstrated through simulations.	[Denis, Nicolas] Toyota Technol Inst, Smart Vehicle Res Ctr Lab, Tenpaku Ward, Nagoya, Aichi 468, Japan; [Dubois, Maxime R.] Univ Sherbrooke, Elect & Comp Engn Dept, Sherbrooke, PQ J1K 2R1, Canada; [Desrochers, Alain] Univ Sherbrooke, Dept Mech Engn, Sherbrooke, PQ J1K 2R1, Canada	Denis, N (reprint author), Toyota Technol Inst, Smart Vehicle Res Ctr Lab, Tenpaku Ward, 2-12-1 Hisakata, Nagoya, Aichi 468, Japan.	nicolas.denis@toyota-ti.ac.jp			BRP Corporation; Automotive Partnership Canada (APC)	The authors wish to thank the BRP Corporation and Automotive Partnership Canada (APC) for supporting and funding this work.	Amiri M, 2009, MATH COMP MODEL DYN, V15, P191, DOI 10.1080/13873950802532294; Angarita Gil K. P., 2012, MODELISATION ELECT A; Zhou ML, 2013, APPL MECH MATER, V274, P345, DOI 10.4028/www.scientific.net/AMM.274.345; Hu XS, 2012, J POWER SOURCES, V198, P359, DOI 10.1016/j.jpowsour.2011.10.013; Zhang C, 2012, IEEE T CONTR SYST T, V20, P546, DOI 10.1109/TCST.2011.2115242; Kim N, 2011, IEEE T CONTR SYST T, V19, P1279, DOI 10.1109/TCST.2010.2061232; Salmasi FR, 2007, IEEE T VEH TECHNOL, V56, P2393, DOI 10.1109/TVT.2007.899933; Montazeri-Gh M, 2011, INT J SYST SCI, V42, P287, DOI 10.1080/00207720902957228; Langari R, 2005, IEEE T VEH TECHNOL, V54, P925, DOI 10.1109/TVT.2005.844685; Li SG, 2011, IEEE T VEH TECHNOL, V60, P3571, DOI 10.1109/TVT.2011.2165571; Li Q, 2012, INT J ELEC POWER, V43, P514, DOI 10.1016/j.ijepes.2012.06.026; Gao LJ, 2002, IEEE T COMPON PACK T, V25, P495, DOI 10.1109/TCAPT.2002.803653; Wirasingha SG, 2011, IEEE T VEH TECHNOL, V60, P111, DOI 10.1109/TVT.2010.2090178; Hu XS, 2013, APPL ENERG, V111, P1001, DOI 10.1016/j.apenergy.2013.06.056; Ehsani M., 2010, MODERN ELECT HYBRID, P283; Lewis F. L., 1995, OPTIMAL CONTROL, P315; Ravey A, 2012, IEEE T VEH TECHNOL, V61, P2452, DOI 10.1109/TVT.2012.2198680; Tulpule Pinak, 2010, International Journal of Electric and Hybrid Vehicles, V2, DOI 10.1504/IJEHV.2010.034985; Yang S., 2011, WORLD ELECT VEH J, V4, P224	19	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-956X	1751-9578		IET INTELL TRANSP SY	IET Intell. Transp. Syst.	FEB	2015	9	1					30	37		10.1049/iet-its.2014.0075		8	Transportation Science & Technology	Transportation	AZ0QN	WOS:000347949900005		
J	Yamagata, Y; Seya, H				Yamagata, Yoshiki; Seya, Hajime			Proposal for a local electricity-sharing system: a case study of Yokohama city, Japan	IET INTELLIGENT TRANSPORT SYSTEMS			English	Article						solar cells; electric vehicles; power grids; digital simulation; power engineering computing; demand side management; secondary cells; air pollution; Yokohama city; Japan; local electricity-sharing system; feed-in tariff; CO2-neutral transportation; solar photovoltaic panels; PV; central Tokyo metropolitan area; storage depot; electric vehicles; storage batteries; vehicle-to-grid system; agent-based transportation simulator; MATSim; power demandaEuro"supply; CO2-neutral EV trips; average solar irradiance	ENERGY-CONSUMPTION; DEMAND RESPONSE; VEHICLES; HYBRID; IMPACT	Here, the authors propose the concept of a local electricity-sharing system as a complement or alternative to a feed-in tariff to achieve CO2-neutral transportation in cities. In the authors' proposed system, electricity generated from widely introduced solar photovoltaic panels (PVs) is stored in the cars not in use' in a city. In Japan, almost half of the cars in the central Tokyo metropolitan area are used only on weekends and thus are kept parked during weekdays. These cars represent a huge new potential storage depot if they were replaced by electric vehicles (EVs), that is, they could be used as storage batteries in a vehicle-to-grid system. Using an agent-based transportation simulator (MATSim), the authors modelled the effects of a large-scale introduction of EVs and PVs on the hourly regional power demand-supply for Yokohama city, Japan. The results of our simulation suggest that CO2-neutral EV trips can be achieved only during periods with current average solar irradiance.	[Yamagata, Yoshiki; Seya, Hajime] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan	Yamagata, Y (reprint author), Natl Inst Environm Studies, Ctr Global Environm Res, Onogawa 16-2, Tsukuba, Ibaraki 3058506, Japan.	yamagata@nies.go.jp	Seya, Hajime/O-3987-2014	Seya, Hajime/0000-0002-6472-6885	Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was funded by the 'Research Program on Climate Change Adaptation' of the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank Dr. Simon Benger (Flinders University) and Ms. Kanae Matsui (Keio University) for their valuable comments on this paper.	Almeshaiei E., 2011, ENG J, V19, P153; Green RC, 2011, RENEW SUST ENERG REV, V15, P544, DOI 10.1016/j.rser.2010.08.015; Doucette RT, 2011, APPL ENERG, V88, P2315, DOI 10.1016/j.apenergy.2011.01.045; Faria R, 2012, ENERG CONVERS MANAGE, V61, P19, DOI 10.1016/j.enconman.2012.02.023; Darby SJ, 2012, ENERG POLICY, V49, P759, DOI 10.1016/j.enpol.2012.07.026; Swan LG, 2009, RENEW SUST ENERG REV, V13, P1819, DOI 10.1016/j.rser.2008.09.033; Wu Y, 2012, ENERG POLICY, V48, P537, DOI 10.1016/j.enpol.2012.05.060; Foley AM, 2010, ENERGY, V35, P4522, DOI 10.1016/j.energy.2010.03.057; Alfares HK, 2002, INT J SYST SCI, V33, P23, DOI 10.1080/00207720110067421; Kim JH, 2011, ENERGY, V36, P873, DOI 10.1016/j.energy.2010.12.027; Thomson M, 2007, IET RENEW POWER GEN, V1, P33, DOI 10.1049/iet-rpg:20060009; Peterson SB, 2010, J POWER SOURCES, V195, P2377, DOI 10.1016/j.jpowsour.2009.09.070; Yamagata Y, 2013, APPL ENERG, V112, P1466, DOI 10.1016/j.apenergy.2013.01.061; van Vliet O, 2011, J POWER SOURCES, V196, P2298, DOI 10.1016/j.jpowsour.2010.09.119; Perujo A, 2010, ENERG POLICY, V38, P4549, DOI 10.1016/j.enpol.2010.04.010; Albadi MH, 2008, ELECTR POW SYST RES, V78, P1989, DOI 10.1016/j.epsr.2008.04.002; Hein R, 2012, TECHNOL FORECAST SOC, V79, P1654, DOI 10.1016/j.techfore.2012.06.002; Hedegaard K, 2012, ENERGY, V48, P356, DOI 10.1016/j.energy.2012.06.012; Grandjean A, 2012, RENEW SUST ENERG REV, V16, P6539, DOI 10.1016/j.rser.2012.08.013; Richardson DB, 2013, RENEW SUST ENERG REV, V19, P247, DOI 10.1016/j.rser.2012.11.042; Denholm P, 2013, J POWER SOURCES, V236, P350, DOI 10.1016/j.jpowsour.2012.10.007; Giannouli M, 2012, SOL ENERGY, V86, P441, DOI 10.1016/j.solener.2011.10.019; Jenks M, 1996, COMPACT CITY SUSTAIN; Newman P., 1989, CITIES AUTOMOBILE DE; OECD, 2011, TOW GREEN GROWTH; Roo G, 2000, COMPACT CITIES URBAN; Schaffers H., 2013, J KNOWLEDGE EC, V3, P119, DOI DOI 10.1007/S13132-012-0083-X; The Japan Institute of Energy, 2008, COG PLAN DES MAN 200; Yamagata Yoshiki, 2013, Annals of GIS, V19, DOI 10.1080/19475683.2013.806358; Yokoi T., 2010, J INFRASTRUCT PLAN G, V66, P17; Zygiaris S., 2013, J KNOWLEDGE EC, V4, P217, DOI DOI 10.1007/S13132-012-0089-4	31	1	1	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-956X	1751-9578		IET INTELL TRANSP SY	IET Intell. Transp. Syst.	FEB	2015	9	1					38	49		10.1049/iet-its.2013.0018		12	Transportation Science & Technology	Transportation	AZ0QN	WOS:000347949900006		
J	Katsuta, K				Katsuta, Keiichi			Cost effective railway signalling by wireless communication among onboard controllers and switch controllers	IET INTELLIGENT TRANSPORT SYSTEMS			English	Article						railway communication; telecommunication signalling; locomotives; cost effective railway signalling; wireless communication; onboard controllers; switch controllers; signalling system; railway infrastructure; trackside controllers; field equipment; token block mechanism; virtual blocks; automatic train protection; interlocking function; train operation density; telegram circulation time; radio technology; train control system communication		The signalling system is one of the most costly systems in the railway infrastructure. The cost of the trackside controllers is particularly high because high-performance failsafe hardware and software are needed to supervise and control the many pieces of the field equipment. A signalling system is described that has a lower projected cost because of the application of the traditional token block mechanism to the virtual blocks dividing each controlled section. Its basic mechanism is the sharing by the wireless communication of the information about the exclusive rights with the virtual blocks, the status of the switches and the instructions for controlling the switches in the controlled section among the onboard controllers and the switch controllers, respectively. A telegram for each controlled section is circulated in turn among these controllers for the sharing. This mechanism provides an automatic train protection and an interlocking function without using the trackside controllers. Its application to a very high-density line might reduce the train operation density because of the telegram circulation time, but the reduction would be no greater than 20% on the highest density line if the current radio technology was used. A cost evaluation based on a 20-km double-track line showed that this system is about three times more cost effective than the communication-based train control system.	Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3191292, Japan	Katsuta, K (reprint author), Hitachi Ltd, Hitachi Res Lab, 7-1-1 Omika Cho, Hitachi, Ibaraki 3191292, Japan.	keiichi.katsuta.nz@hitachi.com					Emery D., 2010, ADV TRAIN CONTROL SY, P113; Jansen D. N., 2010, ADV TRAIN CONTROL SY, P143; Lindqvist L., 2010, ADV TRAIN CONTROL SY, P55; Sevestre C., 2006, REDUCTION COST SIGNA	4	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-956X	1751-9578		IET INTELL TRANSP SY	IET Intell. Transp. Syst.	FEB	2015	9	1					67	74		10.1049/iet-its.2013.0169		8	Transportation Science & Technology	Transportation	AZ0QN	WOS:000347949900009		
J	Kumar, A; Prasad, M; Srivastav, SK; Suzuki, N; Srivastav, AK				Kumar, A.; Prasad, M.; Srivastav, S. K.; Suzuki, N.; Srivastav, A. K.			Toxicological impacts of a botanical pesticide, azadirachtin on corpuscles of Stannius of stinging catfish, Heteropneustes fossilis	INTERNATIONAL JOURNAL OF ENVIRONMENTAL SCIENCE AND TECHNOLOGY			English	Article						Botanical pesticide; Corpuscles of Stannius; Calcium; Heteropneustes fossilis	LARVICIDAL ACTIVITY; AEDES-AEGYPTI; STANNIOCALCIN; FISH; NEEM; EXTRACT; CALCIUM; CELLS; ACETYLCHOLINESTERASE; VEPACIDE	Heteropneustes fossilis were subjected to 41.89 mg L-1 of azadirachtin for short-term exposure (96 h) and 10.47 mg L-1 of azadirachtin for long-term exposure (28 days). The fish were killed on 24, 48, 72 and 96 h in short-term and 7, 14, 21 and 28 days in long-term experiment. Corpuscles of Stannius (CS) were fixed on these time intervals. CS remain unchanged till 72 h in short-termazadirachtin exposure. Accumulation of granules has been noticed in the aldehyde fuchsin (AF)-positive cells at 96 h. The nuclear volume of these cells remains unchanged. The AF-negative cells of CS of azadirachtin-exposed fish exhibit a slight increase in their nuclear volume after 96 h. In long-term exposure, the CS remain unchanged up to day 14. Increased granulation in the AF-positive cells has been noticed following 21-day exposure. Moreover, the nuclear volumes of these cells show a significant decrease. Heavy accumulation of AF-positive granules and few degenerating cells are also noticed at 28 day in azadirachtin-exposed H. fossilis.	[Kumar, A.; Prasad, M.; Srivastav, S. K.; Srivastav, A. K.] DDU Gorakhpur Univ, Dept Zool, Gorakhpur 273009, Uttar Pradesh, India; [Suzuki, N.] Kanazawa Univ, Inst Nat & Environm Technol, Noto Marine Lab, Noto, Ishikawa 9270553, Japan	Srivastav, AK (reprint author), DDU Gorakhpur Univ, Dept Zool, Gorakhpur 273009, Uttar Pradesh, India.	ajaiksrivastav@hotmail.com	SUZUKI, Nobuo/J-8420-2015; Kumar, Dr. Abhishek/I-6636-2013	SUZUKI, Nobuo/0000-0003-0283-9910; Kumar, Dr. Abhishek/0000-0001-9868-5076			Agbozu IE, 2007, INT J ENVIRON SCI TE, V4, P93; SRIVASTAV AK, 1982, EXPERIENTIA, V38, P869, DOI 10.1007/BF01972324; Sazonova O, 2008, AM J PHYSIOL-RENAL, V294, pF788, DOI 10.1152/ajprenal.00553.2007; EVANS DH, 1987, ENVIRON HEALTH PERSP, V71, P47, DOI 10.2307/3430412; Rahman MF, 2001, HUM EXP TOXICOL, V20, P243, DOI 10.1191/096032701678227730; Winkaler EU, 2007, COMP BIOCHEM PHYS C, V145, P236, DOI 10.1016/j.cbpc.2006.12.009; BIDDULPH DM, 1972, ANAT REC, V173, P25, DOI 10.1002/ar.1091730103; BONGA SEW, 1992, NETH J ZOOL, V42, P478; Chandra P, 2004, ECOTOX ENVIRON SAFE, V58, P194, DOI 10.1016/j.ecoenv.2004.01.010; Chitra G, 2008, ECOLOGY ENV CONSERVA, V14, P559; Dubey NK, 2010, CURR SCI INDIA, V98, P479; HASAN N, 1987, ZOOL SCI, V4, P391; Ishibashi K, 2002, AM J PHYSIOL-RENAL, V282, pF367; James D. B., 2009, International Journal of Animal and Veterinary Advances, V1, P1; Komalamisra N, 2005, SE ASIAN J TROP MED, V361, P412; Kumar A, 2010, ACTA SCI-BIOL SCI, V34, P213; Kumar A, 2011, PESTIC BIOCHEM PHYS, V99, P170, DOI 10.1016/j.pestbp.2010.11.014; Mishra D, 2009, J APP SCI MANAG, V13, P69; Mishra D, 2010, NORTH-WEST J ZOOL, V6, P203; Mondal D, 2007, J ENVIRON BIOL, V28, P119; Parveen M, 2004, ASIAN J MICROBIOL BI, V6, P567; Punzo F, 2005, J ENVIRON BIOL, V26, P687; Rahman MF, 1999, J ENVIRON SCI HEAL B, V34, P873, DOI 10.1080/03601239909373232; Rahuman AA, 2008, PARASITOL RES, V102, P867, DOI 10.1007/s00436-007-0839-6; Roch GJ, 2010, INTEGR COMP BIOL, V50, P86, DOI 10.1093/icb/icq010; BONGA SEW, 1991, INT REV CYTOL, V128, P139, DOI 10.1016/S0074-7696(08)60499-4; Nathan SS, 2008, ECOTOX ENVIRON SAFE, V70, P244, DOI 10.1016/j.ecoenv.2007.07.005; Shanmugasundaram R, 2008, J ENVIRON BIOL, V29, P43; Sheikh-Hamad D, 2010, AM J PHYSIOL-RENAL, V298, pF248, DOI 10.1152/ajprenal.00260.2009; Sileshi GW, 2009, ECOL SOC, V14; Singh Sarita, 1996, Okajimas Folia Anatomica Japonica, V73, P75; Song G, 2006, BIOL REPROD, V74, P913, DOI 10.1095/biolreprod.106.050807; Srivastav A. K., 2009, Toxicological and Environmental Chemistry, V91, P761, DOI 10.1080/02772240802542633; Srivastav Ajai K, 2010, INT J ENV HLTH, V4, P323; SWARUP K, 1980, ACTA ANAT, V106, P180; Tiwari PR, 1993, THESIS U GORAKHPUR G; Trindade DM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-57; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; Wagner Graham F., 1994, P273	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1735-1472	1735-2630		INT J ENVIRON SCI TE	Int. J. Environ. Sci. Technol.	FEB	2015	12	2					507	512		10.1007/s13762-013-0422-x		6	Environmental Sciences	Environmental Sciences & Ecology	AY6NB	WOS:000347681800010		
J	Safarik, I; Filip, J; Horska, K; Nowakova, M; Tucek, J; Safarikova, M; Hashimoto, H; Takada, J; Zboril, R				Safarik, I.; Filip, J.; Horska, K.; Nowakova, M.; Tucek, J.; Safarikova, M.; Hashimoto, H.; Takada, J.; Zboril, R.			Magnetically-modified natural biogenic iron oxides for organic xenobiotics removal	INTERNATIONAL JOURNAL OF ENVIRONMENTAL SCIENCE AND TECHNOLOGY			English	Article						Biogenic iron oxides; Leptothrix ochracea; Magnetic fluid; Magnetic adsorbents; Xenobiotics	WATER-SOLUBLE DYES; ARSENIC REMOVAL; ADSORPTION; ADSORBENTS; PHOSPHORUS; NANOPARTICLES; BIOSORPTION; OXIDATION; BACTERIA; WASTE	Biogenic iron oxides have been collected from a water stream and subsequently magnetically modified using water-based magnetic fluid. Both natural and magnetically modified materials have been characterized in detail using wavelength dispersive X-ray fluorescence spectrometry, X-ray powder diffraction, Mossbauer spectroscopy, electron microscopy and BET surface area measurements. The natural material is composed of 2-line ferrihydrite, forming hollow microtubules-sheaths of Leptothrix ochracea, and detrital components. As a result of the ferrofluid modification, maghemite nanoparticles were identified on the surface of the treated material. The active surface area of the bulk, magnetically-modified sample was 148 m(2) g(-1). The magnetically modified material was tested as inexpensive magnetically responsive adsorbent for the removal of selected organic xenobiotics, namely organic dyes, from aqueous solutions. The observed maximum adsorption capacities ranged between 34.3 and 97.8 mg of dye per 1 g of adsorbent.	[Safarik, I.; Horska, K.; Safarikova, M.] Acad Sci, Inst Nanobiol & Struct Biol GCRC, Dept Nanobiotechnol, Ceske Budejovice 37005, Czech Republic; [Safarik, I.; Filip, J.; Nowakova, M.; Tucek, J.; Zboril, R.] Palacky Univ, Dept Expt Phys, Reg Ctr Adv Technol & Mat, Olomouc 77146, Czech Republic; [Safarik, I.; Filip, J.; Nowakova, M.; Tucek, J.; Zboril, R.] Palacky Univ, Dept Phys Chem, Reg Ctr Adv Technol & Mat, Olomouc 77146, Czech Republic; [Hashimoto, H.; Takada, J.] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Appl Chem, Okayama 7008530, Japan	Safarik, I (reprint author), Acad Sci, Inst Nanobiol & Struct Biol GCRC, Dept Nanobiotechnol, Na Sadkach 7, Ceske Budejovice 37005, Czech Republic.	ivosaf@yahoo.com	Safarikova, Mirka/H-3072-2014; Zboril, Radek/F-5153-2015		Ministry of Education of the Czech Republic [LH11111, LH12190]; Grant Agency of the Czech Republic [13-13709S]; Technology Agency of the Czech Republic "Competence Centres" [TE01020218]; Operational Program Research and Development for Innovations-European Social Fund [CZ.1.05/2.1.00/03.0058]; JSPS Bilateral Programs - Ministry of Education, Culture, Sports, Science and Technology of Japan; JST, CREST; Japanese Society for the Promotion of Science	The authors thank to Klara Safarova for electron microscope characterization of the studied samples and Jiri Pechousek for surface area measurement. This work was supported by the research Projects LH11111 and LH12190 (Ministry of Education of the Czech Republic), 13-13709S (Grant Agency of the Czech Republic), Grant from the Technology Agency of the Czech Republic "Competence Centres" (Project TE01020218), by the Operational Program Research and Development for Innovations-European Social Fund (CZ.1.05/2.1.00/03.0058) and by the Joint Research Project FY2011 in the JSPS Bilateral Programs, supported by Ministry of Education, Culture, Sports, Science and Technology of Japan. This study was also supported by JST, CREST. Ivo Safarik thanks the Japanese Society for the Promotion of Science for the financial support of his study stay in Japan in 2010.	Filip J, 2007, ENVIRON SCI TECHNOL, V41, P4367, DOI 10.1021/es062312t; Qiao RR, 2009, J MATER CHEM, V19, P6274, DOI 10.1039/b902394a; Safarik I, 2002, WATER RES, V36, P196, DOI 10.1016/S0043-1354(01)00243-3; Safarik I, 2002, MONATSH CHEM, V133, P737, DOI 10.1007/s007060200047; Kang SK, 2003, SEPAR SCI TECHNOL, V38, P3853, DOI 10.1081/SS-120024236; Safarikova M, 2005, CHEMOSPHERE, V59, P831, DOI 10.1016/j.chemosphere.2004.10.062; Bazylinski DA, 2007, GEOMICROBIOL J, V24, P465, DOI 10.1080/01490450701572259; James RE, 2004, CHEM GEOL, V212, P301, DOI 10.1016/j.chemgeo.2004.08.020; MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188; Hartley W, 2008, SCI TOTAL ENVIRON, V390, P35, DOI 10.1016/j.scitotenv.2007.09.021; GHIORSE WC, 1984, ANNU REV MICROBIOL, V38, P515; Safarik I, 2007, ENZYME MICROB TECH, V40, P1551, DOI 10.1016/j.enzmictec.2006.10.034; Safarik I, 2009, CHEM PAP, V63, P497, DOI 10.2478/s11696-009-0054-2; Safarik I, 2012, EUR FOOD RES TECHNOL, V234, P345, DOI 10.1007/s00217-011-1641-3; Rentz JA, 2009, WATER RES, V43, P2029, DOI 10.1016/j.watres.2009.02.021; Sabbatini P, 2009, DESALINATION, V248, P184, DOI 10.1016/j.desal.2008.05.104; Hashimoto H, 2007, J MAGN MAGN MATER, V310, P2405, DOI 10.1016/j.jmmm.2006.10.793; GU BH, 1994, ENVIRON SCI TECHNOL, V28, P38, DOI 10.1021/es00050a007; Mayer TD, 2000, WATER RES, V34, P3949, DOI 10.1016/S0043-1354(00)00158-5; Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003; Katsoyiannis IA, 2004, WATER RES, V38, P17, DOI 10.1016/j.watres.2003.09.011; Hanna K, 2007, APPL GEOCHEM, V22, P2045, DOI 10.1016/j.apgeochem.2007.05.005; Chitrakar R, 2006, J COLLOID INTERF SCI, V298, P602, DOI 10.1016/j.jcis.2005.12.054; Bolto BA, 1996, DESALINATION, V106, P137; Emerson E, 2010, ANNU REV MICROBIOL, V64, P561, DOI DOI 10.1146/ANNUREV.MICRO.112408.134208; KIWADA H, 1986, CHEM PHARM BULL, V34, P4253; Ko L, 2007, J ENVIRON ENG-ASCE, V133, P891, DOI 10.1061/(ASCE)0733-9372; Pirillo S, 2009, QUIM NOVA, V32, P1239, DOI 10.1590/S0100-40422009000500030; Pokhrel D, 2009, J ENVIRON MANAGE, V90, P1956, DOI 10.1016/j.jenvman.2009.01.004; Safarik I, 2011, J CEREAL SCI, V53, P78, DOI 10.1016/j.jcs2010.09.010; Safarik I, 2005, J MAGN MAGN MATER, V293, P371, DOI 10.1016/j.jmmm.2005.02.033; Safarik I, 2010, ENT MAGAZINE     JAN, P85; Safarik I, 2010, PHYSCS PROC, V9, P274, DOI 10.1016/j.phpro.2010.11.061; Safarik I., 2002, EUR CELLS MATER, V3, P52; Safarikova M, 2008, FRESEN ENVIRON BULL, V17, P486; Safarikova M., 2001, MAGN ELECT SEP, V10, P223, DOI 10.1155/2001/57434; Safariks I, 2011, MICROBIAL BIOSORPTIO, P301, DOI 10.1007/978-94-007-0443-5_13; Tien VN, 2009, WATER SCI TECHNOL, V60, P2301, DOI 10.2166/wst.2009.667; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; Jeong Y, 2007, CHEM ENG PROCESS, V46, P1030, DOI 10.1016/j.cep.2007.05.004; Zak T, 2006, SURF INTERFACE ANAL, V38, P710, DOI 10.1002/sia.2285	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1735-1472	1735-2630		INT J ENVIRON SCI TE	Int. J. Environ. Sci. Technol.	FEB	2015	12	2					673	682		10.1007/s13762-013-0455-1		10	Environmental Sciences	Environmental Sciences & Ecology	AY6NB	WOS:000347681800025		
J	Miyake, Y; Tanaka, K; Arakawa, M				Miyake, Y.; Tanaka, K.; Arakawa, M.			IL5RA polymorphisms, smoking and eczema in Japanese women: the Kyushu Okinawa Maternal and Child Health Study	INTERNATIONAL JOURNAL OF IMMUNOGENETICS			English	Article							ATOPIC-DERMATITIS; IL-5 RECEPTOR; ASTHMA; INTERLEUKIN-5; PREVALENCE; RHINOCONJUNCTIVITIS; SYMPTOMS; DISEASE	The present case-control study examined the relationship between IL5RASNPs and eczema in young adult Japanese women. Cases and control subjects were selected from pregnant women who participated in the baseline survey of the Kyushu Okinawa Maternal and Child Health Study, which is an ongoing prebirth cohort study. Cases comprised 188 women with eczema in the previous 12months as defined according to the criteria of the International Study of Asthma and Allergies in Childhood (ISAAC), regardless of the presence of a doctor's diagnosis of atopic eczema. Control subjects comprised 1130 women without eczema as defined according to the ISAAC criteria who also had not been diagnosed with atopic eczema by a doctor. Compared with the AA genotype of IL5RASNP rs17881144, the AT genotype, but not the TT genotype, was significantly associated with a decreased risk of eczema. The ATTAGA haplotype and the GTAGCA haplotype of rs17882210, rs3804797, rs334809, rs9831572, rs6771148 and rs17881144 were significantly associated with an increased risk of eczema. In contrast, the GCTGCA haplotype was significantly related to a decreased risk of eczema. Multiplicative interactions between IL5RASNPs rs334809 and rs17881144 and smoking with respect to eczema were marginally significant (P=0.07 and 0.07, respectively). This is the first study to show significant associations between IL5RASNP rs17881144, the ATTAGA haplotype, the GTAGCA haplotype, and the GCTGCA haplotype and eczema. Smoking may modify the relationships between SNPs rs334809 and rs17881144 and eczema.	[Miyake, Y.] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsue, Shimane 7910295, Japan; [Tanaka, K.] Kagawa Univ, Fac Med, Dept Hyg, Kagawa, Japan; [Arakawa, M.] Univ Ryukyus, Hlth Tourism Res Ctr, Grad Sch Tourism Sci, Okinawa, Japan	Miyake, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsue, Shimane 7910295, Japan.	miyake.yoshihiro.ls@ehime-u.ac.jp			JSPS [19590606, 20791654, 21590673, 22592355, 22119507, 24390158, 25463275, 25670305]; Health and Labour Sciences Research Grants for Research on Allergic Disease and Immunology and Health Research on Children, Youth and Families from the Ministry of Health, Labour, and Welfare of Japan; Central Research Institute of Fukuoka University; Takeda Science Foundation	This study was supported by JSPS KAKENHI Grant Numbers 19590606, 20791654, 21590673, 22592355, 22119507, 24390158, 25463275 and 25670305, by Health and Labour Sciences Research Grants for Research on Allergic Disease and Immunology and Health Research on Children, Youth and Families from the Ministry of Health, Labour, and Welfare of Japan, by the Central Research Institute of Fukuoka University and by the Takeda Science Foundation. The authors would like to thank the Kyushu Branch of the Japan Allergy Foundation, the Fukuoka Association of Obstetricians & Gynecologists, the Okinawa Association of Obstetricians & Gynecologists, the Miyazaki Association of Obstetricians & Gynecologists, the Oita Association of Obstetricians & Gynecologists, the Kumamoto Association of Obstetricians & Gynecologists, the Nagasaki Association of Obstetricians & Gynecologists, the Kagoshima Association of Obstetricians & Gynecologists, the Saga Association of Obstetricians & Gynecologists, the Fukuoka Society of Obstetrics and Gynecology, the Okinawa Society of Obstetrics and Gynecology, the Fukuoka City Government and the Fukuoka City Medical Association for their valuable support, as well as Mrs. Yukari Hayashi for her technical assistance.	Park BL, 2004, J HUM GENET, V49, P517, DOI 10.1007/s10038-004-0184-x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Strachan DP, 1997, PEDIATR ALLERGY IMMU, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Gauvreau GM, 2009, CLIN EXP ALLERGY, V39, P1297, DOI 10.1111/j.1365-2222.2009.03325.x; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Kim MJ, 2010, J KOREAN MED SCI, V25, P1828, DOI 10.3346/jkms.2010.25.12.1828; Cheong HS, 2005, J HUM GENET, V50, P628, DOI 10.1007/s10038-005-0304-2; Kabesch M, 2007, ALLERGY, V62, P423, DOI 10.1111/j.1398-9995.2006.01300.x; Losol P, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.24; Miyake Y, 2013, J PSYCHIATR RES, V47, P572, DOI 10.1016/j.jpsychires.2013.01.012; Miyake Y, 2014, CYTOKINE, V65, P138, DOI 10.1016/j.cyto.2013.11.006; Namkung JH, 2007, ALLERGY, V62, P934, DOI 10.1111/j.1398-9995.2007.01445.x; Semic-Jusufagic A, 2010, PEDIAT ALLERG IMM-UK, V21, P1052, DOI 10.1111/j.1399-3038.2010.01077.x; Statistics Bureau Ministry of Public Management Home Affairs Posts and Telecommunications, 2002, 2000 POP CENS JAP; Takatsu K, 2011, P JPN ACAD B-PHYS, V87, P463, DOI 10.2183/pjab.87.463	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3121	1744-313X		INT J IMMUNOGENET	Int. J. Immunogenet.	FEB	2015	42	1					52	57		10.1111/iji.12172		6	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	AY8XM	WOS:000347834100010		
J	Tonicelli, R; Nascimento, ACA; Dowsley, R; Muller-Quade, J; Imai, H; Hanaoka, G; Otsuka, A				Tonicelli, Rafael; Nascimento, Anderson C. A.; Dowsley, Rafael; Mueller-Quade, Joern; Imai, Hideki; Hanaoka, Goichiro; Otsuka, Akira			Information-theoretically secure oblivious polynomial evaluation in the commodity-based model	INTERNATIONAL JOURNAL OF INFORMATION SECURITY			English	Article						Information-theoretic cryptography; Cryptographic primitives; Oblivious polynomial evaluation; Commodity-based model	MCELIECE ASSUMPTIONS; TRANSFER CAPACITY; CONSTRUCTIONS; EFFICIENT; SCHEMES; BOUNDS	Oblivious polynomial evaluation (OPE) consists of a two-party protocol where a sender inputs a polynomial and a receiver inputs a single value . At the end of the protocol, the sender learns nothing and the receiver learns . This paper deals with the problem of oblivious polynomial evaluation under an information-theoretic perspective, which is based on the definitions of unconditional security developed by Cr,peau et al. (Information-theoretic conditions for two-party secure function evaluation. EUROCRYPT 2006, LNCS 4004. Springer, Berlin, Heidelberg, pp 538-554, 2006). In this paper, we propose an information-theoretic model for oblivious polynomial evaluation relying on pre-distributed data and prove very general lower bounds on the size of the pre-distributed data, as well as the size of the communications in any protocol. It is demonstrated that these bounds are tight by obtaining a round-optimal OPE protocol, which meets the lower bounds simultaneously. We present a natural generalization to OPE called oblivious linear functional evaluation.	[Tonicelli, Rafael; Nascimento, Anderson C. A.] Univ Brasilia, Dept Elect Engn, BR-70910900 Brasilia, DF, Brazil; [Dowsley, Rafael; Mueller-Quade, Joern] Karlsruhe Inst Technol, Inst Theoret Informat, D-76128 Karlsruhe, Germany; [Imai, Hideki; Hanaoka, Goichiro; Otsuka, Akira] Natl Inst Adv Ind Sci & Technol, Chyioda Ku, Tokyo 1010021, Japan	Dowsley, R (reprint author), Karlsruhe Inst Technol, Inst Theoret Informat, Fasanengarten 5, D-76128 Karlsruhe, Germany.	tonicelli@redes.unb.br; andclay@ene.unb.br; rafael.dowsley@kit.edu; mueller-quade@kit.edu; h-imai@aist.go.jp; hanaoka-goichiro@aist.go.jp; a-otsuka@aist.go.jp					AHLSWEDE R, 2007, ISIT 2007, P2061; Nascimento ACA, 2008, IEEE T INFORM THEORY, V54, P2572, DOI 10.1109/TIT.2008.921856; Dowsley R, 2008, LECT NOTES COMPUT SC, V5155, P107; Naor M, 2001, SIAM PROC S, P448; Lindell Y, 2002, J CRYPTOL, V15, P177, DOI 10.1007/s00145-001-0019-2; Peikert C, 2008, LECT NOTES COMPUT SC, V5157, P554, DOI 10.1007/978-3-540-85174-5_31; Beaver D, 1997, STOC 1997, P446; Bellare M., 1990, LNCS, V435, P547; Bleichenbacher D., 2000, LNCS; Blundo C, 2002, DESIGN CODE CRYPTOGR, V26, P97, DOI 10.1023/A:1016501125022; Chang Yan-Cheng, 2001, LNCS; Crepeau C, 2004, LNCS, V3352, P47; Crepeau C, 2006, LECT NOTES COMPUT SC, V4004, P538; Crepeau C, 2008, LECT NOTES COMPUT SC, V5155, P86; Dowsley R, 2012, IEICE T FUND ELECTR, VE95A, P567, DOI 10.1587/transfun.E95.A.567; Even S., 1983, CRYPTO 82, V82, P205; Freedman M.J., 2005, LNCS, V3378, P303; Fumy W., 1997, LECT NOTES COMPUTER, V1233, P306; Gilboa N, 1999, CRYPTO 99, P116; Haitner I, 2004, LECT NOTES COMPUT SC, V2951, P394; Hanaoka G, 2004, LECT NOTES COMPUT SC, V3108, P62; Hanaoka G, 2000, LECT NOTES COMPUT SC, V1976, P130; Imai H., 2006, ISIT 2006, P1428; Kalai YT, 2005, LECT NOTES COMPUT SC, V3494, P78; Kilian J., 1988, STOC, P20; MATSUMOTO T, 1988, LECT NOTES COMPUT SC, V293, P185; Naor M., 1999, STOC 1999, P245, DOI 10.1145/301250.301312; Nascimento A.C.A., 2007, ICITS; Pinto ACB, 2011, IEEE T INFORM THEORY, V57, P5566, DOI 10.1109/TIT.2011.2158898; Rabin M.O., 1981, TR81; Rivest R, UNCONDITIONALLY SECU	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1615-5262	1615-5270		INT J INF SECUR	Int. J. Inf. Secur.	FEB	2015	14	1					73	84		10.1007/s10207-014-0247-8		12	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	AY7GP	WOS:000347729500006		
J	Quiros-Ramirez, MA; Onisawa, T				Quiros-Ramirez, Maria Alejandra; Onisawa, Takehisa			Considering cross-cultural context in the automatic recognition of emotions	INTERNATIONAL JOURNAL OF MACHINE LEARNING AND CYBERNETICS			English	Article						Affect; Culture; Universality; Specificity; Emotional corpus	FACIAL EXPRESSION; SPEECH	Automatic recognition of emotions remains an ongoing challenge and much effort is being invested towards developing a system to solve this problem. Although several systems have been proposed, there is still none that considers the cultural context for emotion recognition. It remains unclear whether emotions are universal or culturally specific. A study on how culture influences the recognition of emotions is presented. For this purpose, a multicultural corpus for cross-cultural emotion analysis is constructed. Subjects from three different cultures-American, Asian and European-are recruited. The corpus is segmented and annotated. To avoid language artifacts, the emotion recognition model considers facial expressions, head movements, body motions and dimensional emotions. Three training and testing paradigms are carried out to compare cultural effects: intra-cultural, cross-cultural and multicultural emotion recognition. Intra-cultural and multicultural emotion recognition paradigms raised the best recognition results; cross-cultural emotion recognition rates were lower. These results suggest that emotion expression varies by culture, representing a hint of emotion specificity.	[Quiros-Ramirez, Maria Alejandra; Onisawa, Takehisa] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan	Quiros-Ramirez, MA (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	alejandra@fhuman.esys.tsukuba.ac.jp					Anacleto JC, 2008, ADV HUMAN COMPUTER I, P1; Scherer KR, 2011, INT J PSYCHOL, V46, P401, DOI 10.1080/00207594.2011.626049; Dan-Glauser ES, 2011, BEHAV RES METHODS, V43, P468, DOI 10.3758/s13428-011-0064-1; Kleinsmith A, 2006, INTERACT COMPUT, V18, P1371, DOI 10.1016/j.intcom.2006.04.003; Kamaruddin N, 2012, EXPERT SYST APPL, V39, P5115, DOI 10.1016/j.eswa.2011.11.028; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; EKMAN P, 1994, PSYCHOL BULL, V115, P268, DOI 10.1037//0033-2909.115.2.268; Haidt J, 1999, COGNITION EMOTION, V13, P225; Canu S, 2005, PERCEPT SYST INF, V2, P2; Caridakis G, 2013, J MULTIMODAL USER IN, V7, P121, DOI 10.1007/s12193-012-0112-x; Cho J, 2009, IEEE SYS MAN CYBERN, P2866, DOI 10.1109/ICSMC.2009.5346125; Darwin C., 1872, EXPRESSION EMOTIONS; Gunes H, 2013, IMAGE VISION COMPUT, V31, P120, DOI 10.1016/j.imavis.2012.06.016; Harper R., 2008, BEING HUMAN HUMAN CO; Heimgartner R, 2012, LECT NOTES COMPUTER, P572; Hoque M, 2011, IEEE INT C AUT FAC G, DOI [10.1109/FG.2011.5771425, DOI 10.1109/FG.2011.5771425]; KAMPPURI M., 2006, P 4 NORD C HUM COMP, P405, DOI 10.1145/1182475.1182523; Picard R. W., 1997, AFFECTIVE COMPUTING; Quiros-Ramirez MA, 2012, IEEE SYS MAN CYBERN, P2967; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Soleimani-damaneh M, 2011, INT J COMPUT MATH, V88, P1103, DOI 10.1080/00207160.2010.493582; Wilting J, 2006, 9 INT C SPOK LANG PR, P17	24	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-8071	1868-808X		INT J MACH LEARN CYB	Int. J. Mach. Learn. Cybern.	FEB	2015	6	1					119	127		10.1007/s13042-013-0192-2		9	Computer Science, Artificial Intelligence	Computer Science	AZ2CD	WOS:000348041300011		
J	Sawada, Y				Sawada, Yasuji			Subjectivity and awareness	INTERNATIONAL JOURNAL OF MACHINE LEARNING AND CYBERNETICS			English	Article						Subjectivity; Awareness; Decision making; Faster time signal processing; Proactive motion	TEMPORAL-ORDER	The concept of awareness was discussed from a scientific viewpoint, based on the related experimental results of visual hand tracking and temporal order judgement of successive stimuli, in order to contribute to obtaining a possible design principle of the aware machines. It was proposed that a clock which drives the internal simulator by a faster time than the development of the external world is necessary for an aware machine to make an useful decision for future like higher biological organisms.	Tohoku Inst Technol, Taihaku Ku, Sendai, Miyagi 9828577, Japan	Sawada, Y (reprint author), Tohoku Inst Technol, Taihaku Ku, 35-1 Yagiyama Kasumi, Sendai, Miyagi 9828577, Japan.	sawada@tohtech.ac.jp					LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Takahashi T, 2013, CEREB CORTEX, V23, P1952, DOI 10.1093/cercor/bhs179; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559; Chalmer DJ, 1996, CONSCIOUS MIND; Chalmers D., 1995, J CONSCIOUSNESS STUD, V2, P200, DOI DOI 10.1093/ACPR0F:0S0/978019531; Hayashi Yoshikatsu, 2010, Transactions of the Society of Instrument and Control Engineers, V46; Ishida F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.168105; Kitazawa S, 2007, ATTENTION PERFORM, P73; Kitazawa S, 2010, INT I ADV STUDIES, P26; Libet B., 2004, MIND TIME TEMPORAL F; Nakamura Y, 1998, INT C EARL WARN SYST; Sawada Y, 2012, APPL COMPUT INTELL S, V2012; Sawada Y, 2010, INT I ADV STUDIES 20	13	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-8071	1868-808X		INT J MACH LEARN CYB	Int. J. Mach. Learn. Cybern.	FEB	2015	6	1					137	144		10.1007/s13042-013-0193-1		8	Computer Science, Artificial Intelligence	Computer Science	AZ2CD	WOS:000348041300013		
J	Moriya, S; Komatsu, S; Yamasaki, K; Kawai, Y; Kokuba, H; Hirota, A; Che, XF; Inazu, M; Gotoh, A; Hiramoto, M; Miyazawa, K				Moriya, Shota; Komatsu, Seiichiro; Yamasaki, Kaho; Kawai, Yusuke; Kokuba, Hiroko; Hirota, Ayako; Che, Xiao-Fang; Inazu, Masato; Gotoh, Akihiko; Hiramoto, Masaki; Miyazawa, Keisuke			Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress-mediated cell death in multiple myeloma cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						multiple myeloma; aggresome; proteasome; autophagy; ER stress	ENDOPLASMIC-RETICULUM STRESS; BREAST-CANCER CELLS; BORTEZOMIB; INDUCTION; UBIQUITIN; HDAC6; CLARITHROMYCIN; DEACETYLASE; VORINOSTAT; LYSOSOMES	The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)-proteasome and autophagy-lysosome pathways leads to enhanced multiple myeloma (MM) cell apoptosis induction via stress overloading of the endoplasmic reticulum (ER). As misfolded protein cargo is recruited by histone deacetylase 6 (HDAC6) to dynein motors for aggresome transport, serving to sequester misfolded proteins, we further investigated the cellular effects of targeting proteolytic pathways and aggresome formation concomitantly in MM cells. Pronounced apoptosis was induced by the combination of vorinostat [suberoylanilide hydroxamic acid (SAHA); potently inhibits HDAC6] with CAM and BZ compared with each reagent or a 2-reagent combination. CAM/BZ treatment induced vimentin positive-aggresome formation along with the accumulation of autolysosomes in the perinuclear region, whereas they were inhibited in the presence of SAHA. The SAHA/CAM/BZ combination treatment maximally upregulated genes related to ER stress including C/EBP homologous protein (CHOP). Similarly to MM cell-lines, enhanced cytotoxicity with CHOP upregulation following SAHA/CAM/BZ treatment was shown by a wild-type murine embryonic fibroblast (MEF) cell line; however, a CHOP-deficient MEF cell line almost completely canceled this pronounced cytotoxicity. Knockdown of HDAC6 with siRNA exhibited further enhanced CAM/BZ-induced cytotoxicity and CHOP induction along with the cancellation of aggresome formation. Targeting the integrated networks of aggresome, proteasome, and autophagy is suggested to induce efficient ER stress-mediated apoptosis in MM cells.	[Moriya, Shota; Yamasaki, Kaho; Kawai, Yusuke; Hirota, Ayako; Che, Xiao-Fang; Hiramoto, Masaki; Miyazawa, Keisuke] Tokyo Med Univ, Dept Biochem, Tokyo 1608402, Japan; [Komatsu, Seiichiro] Tokyo Med Univ, Dept Breast Oncol, Tokyo 1608402, Japan; [Kokuba, Hiroko] Tokyo Med Univ, Dept Lab Electron Microscopy, Tokyo 1608402, Japan; [Inazu, Masato] Tokyo Med Univ, Inst Med Sci, Tokyo 1608402, Japan; [Gotoh, Akihiko] Juntendo Univ, Dept Hematol, Tokyo, Japan	Miyazawa, K (reprint author), Tokyo Med Univ, Dept Biochem, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	miyazawa@tokyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26460478, 25860398]; MEXT from the Ministry of Education, Culture, Sports, Science and Technology of Japan [S1411011]; Tokyo Medical University Cancer Research; Taisho Toyama Pharmaceutical Co., Ltd. (Tokyo, Japan); Tokyo Medical University	The authors are indebted to Dr Edward F. Barroga, Associate Professor and Senior Medical Editor of the Department of International Medical Communications of Tokyo Medical University for the editorial review of the report. This study was supported by funds of a Grant-in-Aid for Scientific Research (C) (no. 26460478) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411011, 2014-2018) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid from Tokyo Medical University Cancer Research, and a Grant-in-Aid from Taisho Toyama Pharmaceutical Co., Ltd. (Tokyo, Japan) to K.M.; and a Grant-in-Aid for Young Scientist (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 25860398) and a Research Grant from Tokyo Medical University to S.M.	Kawaguchi T, 2011, INT J ONCOL, V38, P643, DOI 10.3892/ijo.2010.882; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; Richardson PG, 2014, BLOOD, V123, P1461, DOI 10.1182/blood-2013-07-517276; Hol EM, 2006, EXPERT REV NEUROTHER, V6, P1337, DOI 10.1586/14737175.6.9.1337; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Orlowski RZ, 2013, SEMIN ONCOL, V40, P634, DOI 10.1053/j.seminoncol.2013.07.007; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moriya S, 2013, INT J ONCOL, V42, P1541, DOI 10.3892/ijo.2013.1870; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Nawrocki ST, 2008, BLOOD, V112, P2917, DOI 10.1182/blood-2007-12-130823; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Martinon F, 2012, ACTA ONCOL, V51, P822, DOI 10.3109/0284186X.2012.689113; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Dimopoulos M, 2013, LANCET ONCOL, V14, P1129, DOI 10.1016/S1470-2045(13)70398-X; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Komatsu S, 2013, BIOCHEM BIOPH RES CO, V437, P41, DOI 10.1016/j.bbrc.2013.06.032; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Nakamura M, 2010, INT J ONCOL, V37, P815, DOI 10.3892/ijo_00000731; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Fusco C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040440; Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111; Kavanaugh SA, 2010, AM J HEALTH-SYST PH, V67, P793, DOI 10.2146/ajhp090247; Komatsu S, 2012, INT J ONCOL, V40, P1029, DOI 10.3892/ijo.2011.1317; Mizushima N, 2011, Cold Spring Harb Symp Quant Biol, V76, P397, DOI 10.1101/sqb.2011.76.011023; Richter-Landsberg C, 2013, ACTA NEUROPATHOL, V126, P793, DOI 10.1007/s00401-013-1158-x; Simms-Waldrip T, 2008, MOL GENET METAB, V94, P283, DOI 10.1016/j.ymgme.2008.03.012; Verfaillie T, 2010, INT J CELL BIOL, V2010, DOI DOI 10.1155/2010/930509; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076016; Zaarur N, 2014, MOL CELL BIOL, V34, P1336, DOI 10.1128/MCB.00103-14	39	4	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					474	486		10.3892/ijo.2014.2773		13	Oncology	Oncology	AY6IX	WOS:000347671200005		
J	Chiyomaru, T; Seki, N; Inoguchi, S; Ishihara, T; Mataki, H; Matsushita, R; Goto, Y; Nishikawa, R; Tatarano, S; Itesako, T; Nakagawa, M; Enokida, H				Chiyomaru, Takeshi; Seki, Naohiko; Inoguchi, Satoru; Ishihara, Tomoaki; Mataki, Hiroko; Matsushita, Ryosuke; Goto, Yusuke; Nishikawa, Rika; Tatarano, Shuichi; Itesako, Toshihiko; Nakagawa, Masayuki; Enokida, Hideki			Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						bladder cancer; microRNA; miR-23b; miR-27b; tumor suppressor; EGFR; c-Met	EPIDERMAL-GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER; FUNCTIONAL-SIGNIFICANCE; URINARY-BLADDER; LUNG-CANCER; EXPRESSION; MICRORNAS; MIR-133A; INVASION	Recent clinical trials of chemotherapeutics for advanced bladder cancer (BC) have shown limited benefits. Therefore, new prognostic markers and more effective treatment strategies are required. One approach to achieve these goals is through the analysis of RNA networks. Our recent studies of microRNA (miRNA) expression signatures revealed that the microRNA-23b/27b (miR-23b/27b) cluster is frequently downregulated in various types of human cancers. However, the functional role of the miR-23b/27b cluster in BC cells is still unknown. Thus, the aim of the present study was to investigate the functional significance of the miR-23b/27b cluster and its regulated molecular targets, with an emphasis on its contributions to BC oncogenesis and metastasis. The expression levels of the miR-23b/27b cluster were significantly reduced in BC clinical specimens. Restoration of mature miR-23b or miR-27b miRNAs significantly inhibited cancer cell migration and invasion, suggesting that these clustered miRNAs function as tumor suppressors. Gene expression data and in silico analysis demonstrated that the genes coding for the epidermal growth factor receptor (EGFR) and hepatocyte growth factor receptor (c-Met) were potential targets of the miR-23b/27b cluster. Luciferase reporter assays and, western blotting demonstrated that EGFR and c-Met receptor trypsine kinases were directly regulated by these clustered miRNAs. We conclude that the decreased expression of the tumor-suppressive miR-23b/27b cluster enhanced cancer cell proliferation, migration and invasion in BC through direct regulation of EGFR and c-Met signaling pathways. Our data on RNA networks regulated by tumor-suppressive miR-23b/27b provide new insights into the potential mechanisms of BC oncogenesis and metastasis.	[Chiyomaru, Takeshi; Inoguchi, Satoru; Ishihara, Tomoaki; Matsushita, Ryosuke; Tatarano, Shuichi; Itesako, Toshihiko; Nakagawa, Masayuki; Enokida, Hideki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 8908520, Japan; [Mataki, Hiroko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima 8908520, Japan; [Seki, Naohiko; Goto, Yusuke; Nishikawa, Rika] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba 2608670, Japan	Enokida, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	henokida@m2.kufm.kagoshima-u.ac.jp			KAKENHI [26293354, 25462490]	The present study was supported by the KAKENHI (B), 26293354; and (C), 25462490.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Hidaka H, 2012, ONCOTARGET, V3, P44; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Yamasaki T, 2012, INT J ONCOL, V40, P1821, DOI 10.3892/ijo.2012.1391; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Kojima S, 2014, J HUM GENET, V59, P78, DOI 10.1038/jhg.2013.121; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Nohata N, 2011, BRIT J CANCER, V105, P833, DOI 10.1038/bjc.2011.311; Nohata N, 2011, INT J ONCOL, V39, P1099, DOI 10.3892/ijo.2011.1096; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; Jin LJ, 2013, CANCER RES, V73, P2884, DOI 10.1158/0008-5472.CAN-12-2162; Nishikawa R, 2014, INT J ONCOL, V45, P401, DOI 10.3892/ijo.2014.2437; Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Kinoshita T, 2013, BRIT J CANCER, V109, P2636, DOI 10.1038/bjc.2013.607; Luke C, 2010, INTERN MED J, V40, P357, DOI 10.1111/j.1445-5994.2009.01980.x; Shaw AT, 2013, NAT REV CANCER, V13, P772, DOI 10.1038/nrc3612; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; Zuiverloon TCM, 2012, EUR UROL, V61, P128, DOI 10.1016/j.eururo.2011.09.026; Kawakami K, 2012, EUR J CANCER, V48, P827, DOI 10.1016/j.ejca.2011.06.030; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Nohata N, 2012, ONCOTARGET, V3, P9; MELLON K, 1995, J UROLOGY, V153, P919, DOI 10.1016/S0022-5347(01)67604-3; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Chow NH, 1997, ANTICANCER RES, V17, P1293; Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Fuse M, 2012, J HUM GENET, V57, P691, DOI 10.1038/jhg.2012.95; Inoguchi S, 2014, FEBS LETT, V588, P3170, DOI 10.1016/j.febslet.2014.06.058; Yoshino H, 2013, CANCER SCI, V104, P1567, DOI 10.1111/cas.12280; Husted S, 2011, MOL PHARMACEUT, V8, P2055, DOI 10.1021/mp200255d; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Monga SPS, 2002, CANCER RES, V62, P2064; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Miyata Y, 2009, HUM PATHOL, V40, P496, DOI 10.1016/j.humpath.2008.09.011; Bue P, 1998, INT J CANCER, V76, P189, DOI 10.1002/(SICI)1097-0215(19980413)76:2<189::AID-IJC4>3.0.CO;2-T; Cheng HL, 2002, J CLIN ONCOL, V20, P1544, DOI 10.1200/JCO.20.6.1544; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058929; Goldman JW, 2012, CANCER-AM CANCER SOC, V118, P5903, DOI 10.1002/cncr.27575; Ishteiwy RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052106; Itesako T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084311; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Park YT, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-18	48	7	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					487	496		10.3892/ijo.2014.2752		10	Oncology	Oncology	AY6IX	WOS:000347671200006		
J	Ofuji, K; Tada, Y; Yoshikawa, T; Shimomura, M; Yoshimura, M; Saito, K; Nakamoto, Y; Nakatsura, T				Ofuji, Kazuya; Tada, Yoshitaka; Yoshikawa, Toshiaki; Shimomura, Manami; Yoshimura, Mayuko; Saito, Keigo; Nakamoto, Yasunari; Nakatsura, Tetsuya			A peptide antigen derived from EGFR T790M is immunogenic in non-small cell lung cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						acquired resistance; CTL epitope; EGFR T790M; immunotherapy; non-small cell lung cancer	MHC CLASS-I; T-CELLS; 1ST-LINE TREATMENT; MELANOMA ANTIGEN; KINASE DOMAIN; REACTIVE CTL; OPEN-LABEL; MUTATION; IDENTIFICATION; GEFITINIB	Lung cancer is the leading cause of cancer-related deaths worldwide. Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib and erlotinib, have demonstrated marked clinical activity against non-small cell lung cancer (NSCLC) harboring activating epidermal growth factor receptor (EGFR) mutations. However, in most cases, patients develop acquired resistance to EGFR-TKI therapy. The threonine to methionine change at codon 790 of EGFR (EGFR T790M) mutation is the most common acquired resistance mutation, and is present in 50% cases of TKI resistance. New treatment strategies for NSCLC patients harboring the EGFR T790M mutation are required. We evaluated the immunogenicity of an antigen derived from EGFR with the T790M mutation. Using BIMAS we selected several EGFR T790M-derived peptides bound to human leukocyte antigen (HLA)-A*02:01. T790M-A peptide (789-797) (IMQLMPFGC)-specific cytotoxic T lymphocytes (CTLs) were induced from peripheral blood mononuclear cells (PBMCs) of HLA-A2(+) healthy donors. An established T790M-A-specific CTL line showed reactivity against the NCSLC cell line, H1975-A2 (HLA-A2(+), T790M(+)), but not H1975 (HLA-A2(-), T790M(+)), and the corresponding wild-type peptide (ITQLMPFGC)-pulsed T2 cells using an interferon-gamma (IFN-gamma) enzyme-linked immuno spot (ELISPOT) assay. This CTL line also demonstrated peptide-specific cytotoxicity against H1975-A2 cells. This finding suggests that the EGFR T790M mutation-derived antigen could be a new target for cancer immunotherapy.	[Ofuji, Kazuya; Tada, Yoshitaka; Yoshikawa, Toshiaki; Shimomura, Manami; Yoshimura, Mayuko; Saito, Keigo; Nakatsura, Tetsuya] Natl Canc Ctr, Div Canc Immunotherapy, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan; [Ofuji, Kazuya; Nakamoto, Yasunari] Univ Fukui, Fac Med Sci, Dept Internal Med 2, Fukui 910, Japan; [Tada, Yoshitaka] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan	Nakatsura, T (reprint author), Natl Canc Ctr, Div Canc Immunotherapy, Exploratory Oncol Res & Clin Trial Ctr, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tnakatsu@east.ncc.go.jp			National Cancer Center Research and Development Fund [25-A-7]; Ministry of Health, Labour, and Welfare, Tokyo, Japan	We thank Professor Seiji Yano for providing the NSCLC cell line H1975, Dr Tetsuro Sasada for providing the NSCLC cell line H1975-A2, and Professor Naoto Hirano for providing aAPC-A2. This study was supported in part by the National Cancer Center Research and Development Fund (25-A-7), as well as Research for the Promotion of Cancer Control Programmes, Research on Applying Health Technology, and Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour, and Welfare, Tokyo, Japan.	Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Kawakami Y, 2001, J IMMUNOL, V166, P2871; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Parkhurst MR, 2004, CLIN CANCER RES, V10, P4688, DOI 10.1158/1078-0432.CCR-04-0325; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Hirano N, 2006, BLOOD, V107, P1528, DOI 10.1182/blood-2005-05-2073; Normanno N, 2003, J CELL PHYSIOL, V194, P13, DOI 10.1002/jcp.10194; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Fong L, 2001, P NATL ACAD SCI USA, V98, P8809, DOI 10.1073/pnas.141226398; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Pollack BP, 2011, CLIN CANCER RES, V17, P4400, DOI 10.1158/1078-0432.CCR-10-3283; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Yoshikawa T, 2011, CANCER SCI, V102, P918, DOI 10.1111/j.1349-7006.2011.01896.x; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Valmori D, 1998, J IMMUNOL, V160, P1750; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; Schirle M, 2000, EUR J IMMUNOL, V30, P2216, DOI 10.1002/1521-4141(2000)30:8<2216::AID-IMMU2216>3.0.CO;2-7; Fujita Y, 2012, J THORAC ONCOL, V7, P1640, DOI 10.1097/JTO.0b013e3182653d7f; Shepherd FA, 2011, J THORAC ONCOL, V6, P1763, DOI 10.1097/JTO.0b013e31822e28fc; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Jemal A, 2007, CA-CANCER J CLIN, V57, P43; Cai A, 2012, CLIN CANCER RES, V18, P5761, DOI 10.1158/1078-0432.CCR-12-1182; Chen WS, 1999, J EXP MED, V189, P1757, DOI 10.1084/jem.189.11.1757; He SS, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-186; Matar P, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-30; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Shomura H, 2004, BRIT J CANCER, V90, P1563, DOI 10.1038/sj.bjc.6601728; Shomura H, 2004, EUR J CANCER, V40, P1776, DOI 10.1016/j.ejca.2004.04.003; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Warren RL, 2010, HUM IMMUNOL, V71, P245, DOI 10.1016/j.humimm.2009.12.007; Yamada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078389; Yamshchikov GV, 2001, INT J CANCER, V92, P703, DOI 10.1002/1097-0215(20010601)92:5<703::AID-IJC1250>3.0.CO;2-5; Yoshimura M, 2014, ONCOL REP, V32, P33, DOI 10.3892/or.2014.3198	44	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					497	504		10.3892/ijo.2014.2787		8	Oncology	Oncology	AY6IX	WOS:000347671200007		
J	Iijima, Y; Seike, M; Noro, R; Ibi, T; Takeuchi, S; Mikami, I; Koizumi, K; Usuda, J; Gemma, A				Iijima, Yoshihito; Seike, Masahiro; Noro, Rintaro; Ibi, Takayuki; Takeuchi, Shingo; Mikami, Iwao; Koizumi, Kiyoshi; Usuda, Jitsuo; Gemma, Akihiko			Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						PIK3CA; SOX2; lung squamous cell carcinoma; prognosis	VINORELBINE PLUS CISPLATIN; NONSMALL CELL; HUMAN CANCERS; MUTATIONS; GENE; CHEMOTHERAPY; ONCOGENE; EXPRESSION; GEFITINIB; GROWTH	The recent development of human genome studies has demonstrated the possibility of alteration of several genes as oncogenic driver mutations of lung squamous cell carcinoma (SQCC). FGFR1, PIK3CA and SOX2 genes have been recognized as candidate driver genes of SQCC. The aim of the present study was to evaluate FGFR1, PIK3CA and SOX2 protein expression in SQCC and determine whether the expression of these can be used as prognostic biomarkers. We evaluated the relationships between FGFR1, PIK3CA and SOX2 expression by immunohistochemical analysis and overall survival in lung SQCC patients with stage I-Ill that originated from China, United States and Japan. FGFR1-positive, PIK3CA-negative and SOX2-positive staining each showed trends toward better survival, although the differences were not statistically significant in a Chinese cohort of 57 patients. Patients with PIK3CA-negative and SOX2-positive staining (PIK3CA/SOX2(+)) showed better prognosis compared with those with PIK3CA-positive or SOX2-negative staining in the Chinese cohort (P=0.04). The robustness of PIK3CAT/SOX2(+) classification as having prognostic significance was validated in an independent set of 66 Japanese cohort patients (P=0.007). Japanese SQCC patients with stage I were evaluated separately and PIK3CA(-)/SOX2(+) cases had significantly better survival than the group with PIK3CA-positive or SOX2-negative status (P=0.03). In univariate and multivariable Cox proportional hazards models of Asian stage I patients, the PIK3CA(-)/SOX2(+) classification was statistically significantly associated with survival and was an independent prognostic factor. Classification by PIK3CA and SOX2 protein expression is useful for predicting the prognosis of Asian patients with lung SQCC with stage I.	[Iijima, Yoshihito; Ibi, Takayuki; Takeuchi, Shingo; Mikami, Iwao; Usuda, Jitsuo] Nippon Med Sch, Grad Sch Med, Dept Thorac Surg, Tokyo 1138603, Japan; [Seike, Masahiro; Noro, Rintaro; Gemma, Akihiko] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 1138603, Japan; [Koizumi, Kiyoshi] Aizu Chuo Hosp, Dept Thorac Surg, Fukushima 9658611, Japan	Seike, M (reprint author), Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	mseike@nms.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591179, 25461172]; Clinical Rebiopy Bank Project for Comprehensive Cancer Therapy Development in Nippon Medical School	The present study was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant no. 24591179 to M.S; grant no. 25461172 to A.G), and the Clinical Rebiopy Bank Project for Comprehensive Cancer Therapy Development in Nippon Medical School.	MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Olaussen KA, 2007, NEW ENGL J MED, V357, P1559, DOI 10.1056/NEJMc072007; Drilon A, 2012, LANCET ONCOL, V13, pE418, DOI 10.1016/S1470-2045(12)70291-7; Friboulet L, 2013, NEW ENGL J MED, V368, P1101, DOI [10.1056/NEJMoa1214271, 10.1056/oa1214271]; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sholl LM, 2010, APPL IMMUNOHISTO M M, V18, P55, DOI 10.1097/PAI.0b013e3181b16b88; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Toyooka S, 2007, CLIN CANCER RES, V13, P5763, DOI 10.1158/1078-0432.CCR-07-0216; Massion PP, 2002, CANCER RES, V62, P3636; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Kim TJ, 2006, BRIT J CANCER, V94, P1678, DOI 10.1038/sj.bjc.6603180; Brcic L, 2012, AM J CLIN PATHOL, V138, P712, DOI 10.1309/AJCP05TTWQTWNLTN; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Hussenet T, 2010, CELL CYCLE, V9, P1480, DOI 10.4161/cc.9.8.11203; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351; Chen SF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031864, 10.1371/journal.pone.0049275]; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Ji MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-147; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Paul KP, 2012, J CLIN ONCOL S, V30, P7505; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Velcheti V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061427	39	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					505	512		10.3892/ijo.2014.2742		8	Oncology	Oncology	AY6IX	WOS:000347671200008		
J	Abue, M; Yokoyama, M; Shibuya, R; Tamai, K; Yamaguchi, K; Sato, I; Tanaka, N; Hamada, S; Shimosegawa, T; Sugamura, K; Satoh, K				Abue, Makoto; Yokoyama, Misa; Shibuya, Rie; Tamai, Keiichi; Yamaguchi, Kazunori; Sato, Ikuro; Tanaka, Nobuyuki; Hamada, Shin; Shimosegawa, Tooru; Sugamura, Kazuo; Satoh, Kennichi			Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						plasma; miR-483-3p; miR-21; pancreatic cancer; biomarker	MICRORNA EXPRESSION; DUCTAL ADENOCARCINOMA; FOLLOW-UP; CELLS; SERUM; CARCINOMA; INVASION; PROLIFERATION; PROGRESSION; MECHANISMS	Several recent studies have revealed that microRNAs (miRNAs) have a role in carcinogenesis and cancer development, and that it is stably detectable in plasma/serum. The aim of this study was to test whether miR-483-3p as well as miR-21 could be plasma biomarkers for PDAC. The plasma samples were obtained from three groups including 32 pancreatic ductal adenocarcinoma (PDAC) patients, 12 patients with intraductal papillary mucinous neoplasm (IPMN) patients and 30 healthy controls (HC). We evaluated the plasma miR-483-3p and miR-21 expression level by quantitative RT-PCR. We compared the differences in the plasma level of these miRNAs among the three groups, and investigated the relevance of their plasma expression level to the clinical factors in PDAC. The expressions of miR-483-3p and miR-21 were detected in all examined plasma samples. The plasma expression levels of these miRNAs were significantly higher in PDAC compared to HC (P<0.01). The plasma miR-483-3p expression was significantly higher in PDAC patients than IPMN patients (P<0.05). The plasma miR-21 level was associated with advanced stage (P<0.05), metastasis to lymph node and liver (P<0.01), and shorter survival (P<0.01) of the PDAC patients. Together, these findings suggest that measurement of the plasma miR-483-3p level is useful for discriminating PDAC from IPMN, and that the plasma miR-21 level predicts outcome of PDAC patients.	[Abue, Makoto; Yokoyama, Misa; Shibuya, Rie; Satoh, Kennichi] Miyagi Canc Ctr, Res Inst, Div Canc Stem Cell, Natori, Miyagi 9811293, Japan; [Tamai, Keiichi; Tanaka, Nobuyuki] Miyagi Canc Ctr, Res Inst, Div Canc Biol & Therapeut, Natori, Miyagi 9811293, Japan; [Yamaguchi, Kazunori; Sugamura, Kazuo] Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Oncol, Natori, Miyagi 9811293, Japan; [Sato, Ikuro] Miyagi Canc Ctr, Dept Pathol, Natori, Miyagi 9811293, Japan; [Hamada, Shin; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan	Satoh, K (reprint author), Miyagi Canc Ctr, Res Inst, Div Canc Stem Cell, 47-1 Nodayama, Natori, Miyagi 9811293, Japan.	ksatoh-gi@umin.ac.jp			KAKENHI [24591022]; Pancreas Research Foundation of Japan; Naito Foundation	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) (24591022) to K.S., Pancreas Research Foundation of Japan to M.A. and The Naito Foundation to K.S.	Ali S, 2010, AM J TRANSL RES, V28, P28; Kent OA, 2009, CANCER BIOL THER, V8, P2013, DOI 10.4161/cbt.8.21.9685; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Li AG, 2013, CLIN CANCER RES, V19, P3600, DOI 10.1158/1078-0432.CCR-12-3092; Kanno A, 2010, J GASTROENTEROL, V45, P952, DOI 10.1007/s00535-010-0238-0; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Liu JQ, 2012, INT J CANCER, V131, P683, DOI 10.1002/ijc.26422; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hao J, 2011, FEBS LETT, V585, P207, DOI 10.1016/j.febslet.2010.11.039; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Hirata K, 2007, DIGEST SURG, V24, P137, DOI 10.1159/000102067; Kong XY, 2011, DIGEST DIS SCI, V56, P602, DOI 10.1007/s10620-010-1285-3; Hasselmann DO, 2001, CLIN CHEM, V47, P1488; SATAKE K, 1985, J SURG ONCOL, V29, P15, DOI 10.1002/jso.2930290106; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wilentz RE, 2000, CANCER RES, V60, P2002; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Yamaguchi K, 2002, PANCREATOLOGY, V2, P484, DOI 10.1159/000064716; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Ryu JK, 2010, PANCREATOLOGY, V10, P66, DOI 10.1159/000231984; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Biankin AV, 2002, GUT, V50, P861, DOI 10.1136/gut.50.6.861; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Tanno S, 2010, PANCREAS, V39, P36, DOI 10.1097/MPA.0b013e3181b91cd0; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Hamada S, 2013, J CELL PHYSIOL, V228, P1255, DOI 10.1002/jcp.24280; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Ingkakul T1, 2010, ANN SURG, V25, P70; Kadera BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071978; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sobin LH, 2009, TNM CASSIFICATION MA; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169	53	6	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					539	547		10.3892/ijo.2014.2743		9	Oncology	Oncology	AY6IX	WOS:000347671200012		
J	Minami, Y; Sasaki, T; Bochimoto, H; Kawabe, J; Endo, S; Hira, Y; Watanabe, T; Okumura, S; Hasebe, N; Ohsaki, Y				Minami, Yoshinori; Sasaki, Takaaki; Bochimoto, Hiroki; Kawabe, Jun-ichi; Endo, Satoshi; Hira, Yoshiki; Watanabe, Tsuyoshi; Okumura, Shunsuke; Hasebe, Naoyuki; Ohsaki, Yoshinobu			Prostaglandin 12 analog suppresses lung metastasis by recruiting pericytes in tumor angiogenesis	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						prostaglandin I-2; metastasis; maturation; pericytes; hypoxia	ENDOTHELIAL-CELL RETRACTION; INDUCED PLATELET-AGGREGATION; PROSTACYCLIN ANALOG; PROGENITOR CELLS; NUDE-MOUSE; INHIBITION; CANCER; THROMBOXANES; 12(S)-HETE; ADHESION	Prostaglandin I-2 (PGI(2)) agonist has been reported to reduce tumor metastasis by modifying tumor angiogenesis; however, the mechanisms of how PGI(2), affects the endothelial cells or pericytes in tumor vessel maturation are still unclear. The purpose of this study was to clarify the effects of PGI(2), on tumor metastasis in a mouse lung metastasis model using Lewis lung carcinoma (LLC) cells. The mice were treated continuously with beraprost sodium (BPS), a PGI(2), analog, for 3 weeks and then examined for lung metastases. The number and size of lung metastases were decreased significantly by BPS treatment. In addition, scanning electron microscopy and immunohistochemistry revealed that BPS increased the number of tumor-associated pericytes and improved intratumor hypoxia. Collectively, this study suggests that BPS attenuated vascular functional maturation in metastatic tumors.	[Minami, Yoshinori; Sasaki, Takaaki; Endo, Satoshi; Okumura, Shunsuke; Ohsaki, Yoshinobu] Asahikawa Med Univ, Resp Ctr, Asahikawa, Hokkaido 0788510, Japan; [Bochimoto, Hiroki; Hira, Yoshiki; Watanabe, Tsuyoshi] Asahikawa Med Univ, Dept Microscop Anat & Cell Biol, Asahikawa, Hokkaido 0788510, Japan; [Kawabe, Jun-ichi] Asahikawa Med Univ, Dept Cardiovasc Regenerat & Innovat, Asahikawa, Hokkaido 0788510, Japan; [Hasebe, Naoyuki] Asahikawa Med Univ, Cardiovasc Resp & Neurol Div, Dept Med, Asahikawa, Hokkaido 0788510, Japan	Sasaki, T (reprint author), Asahikawa Med Univ, Resp Ctr, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	takaaki6@asahikawa-med.ac.jp			JSPS [20590910]	The authors thank Dr Fumitaka Ushikubi for advice and kindly providing experimental equipment. This study was partially supported by funding from the JSPS Grant-in-Aid for Scientific Research (C) (KAKENHI) Grant no. 20590910.	Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Yonenaga Y, 2005, ONCOLOGY-BASEL, V69, P159, DOI 10.1159/000087840; Stefansson IM, 2006, CANCER RES, V66, P3303, DOI 10.1158/0008-5472.CAN-05-1163; Pasqualini R, 2002, TRENDS MOL MED, V8, P563, DOI 10.1016/S1471-4914(02)02429-2; Kawabe J, 2010, ARTERIOSCL THROM VAS, V30, P464, DOI 10.1161/ATVBAHA.109.193730; O'Keeffe MB, 2008, ONCOL RES, V17, P93; HONN KV, 1994, EXP CELL RES, V210, P1, DOI 10.1006/excr.1994.1001; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079; HONN KV, 1994, CANCER RES, V54, P565; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705; Cipriani P, 2013, ANGIOGENESIS, V16, P595, DOI 10.1007/s10456-013-9338-9; HONN KV, 1989, FASEB J, V3, P2285; Tennis M, 2010, NEOPLASIA, V12, P244, DOI 10.1593/neo.91690; Aburakawa Y, 2013, CIRC J, V77, P1053, DOI 10.1253/circj.CJ-12-0897; COSTANTINI V, 1990, PROSTAGLANDINS, V39, P581, DOI 10.1016/0090-6980(90)90020-V; GORELIK E, 1984, INT J CANCER, V33, P87, DOI 10.1002/ijc.2910330115; HONN KV, 1983, CLIN EXP METASTAS, V1, P103; HONN KV, 1983, BIOCHEM PHARMACOL, V32, P1, DOI 10.1016/0006-2952(83)90644-5; HONN KV, 1981, SCIENCE, V212, P1270, DOI 10.1126/science.7015512; HONN KV, 1981, BIOCHEM BIOPH RES CO, V102, P1122, DOI 10.1016/S0006-291X(81)80128-3; KARPATKIN S, 1984, CANCER RES, V44, P3880; Kato S, 1989, Nihon Geka Gakkai Zasshi, V90, P745; LAPIS K, 1990, Archiv fuer Geschwulstforschung, V60, P97; MAHALINGAM M, 1988, CANCER RES, V48, P1460; MENTER DG, 1984, CANCER RES, V44, P450; MENTER DG, 1987, INVAS METAST, V7, P109; MENTER DG, 1987, J NATL CANCER I, V78, P961; Minami Y., 2013, RES DIRECTIONS TUMOR, P73; NIITSU Y, 1988, INVAS METAST, V8, P57; SAVA G, 1989, CLIN EXP METASTAS, V7, P671, DOI 10.1007/BF01753677; SCHWALKE MA, 1990, J SURG RES, V49, P164; TANG DG, 1993, INT J CANCER, V54, P102, DOI 10.1002/ijc.2910540117; Turner EC, 2011, MOL BIOL CELL, V22, P2664, DOI 10.1091/mbc.E11-04-0374; TZANAKAKIS GN, 1990, CANCER, V65, P446, DOI 10.1002/1097-0142(19900201)65:3<446::AID-CNCR2820650312>3.0.CO;2-0; USHIKI T, 1991, ARCH HISTOL CYTOL, V54, P427, DOI 10.1679/aohc.54.427	35	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					548	554		10.3892/ijo.2014.2783		7	Oncology	Oncology	AY6IX	WOS:000347671200013		
J	Morito, K; Nakamura, J; Kitajima, Y; Kai, K; Tanaka, T; Kubo, H; Miyake, S; Noshiro, H				Morito, Kiyoto; Nakamura, Jun; Kitajima, Yoshihiko; Kai, Keita; Tanaka, Tomokazu; Kubo, Hiroshi; Miyake, Shuusuke; Noshiro, Hirokazu			The value of trefoil factor 3 expression in predicting the long-term outcome and early recurrence of colorectal cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						trefoil factor; colorectal cancer; metastasis; survival; recurrence	TUMOR-DEVELOPMENT; GASTRIC-CANCER; TFF PEPTIDES; CELLS; MICE; PROGRESSION; METASTASIS; METHYLATION; ACTIVATION; ESTROGEN	The trefoil factor (TFF) family comprises three thermo-stable and protease-resistant proteins (TFF1, TFF2 and TFF3) and plays an essential role in gastrointestinal mucosa protection and regeneration, and TFFs have recently been found to be involved in the development and progression of various types of cancer. However, the clinical significance of TFFs in colorectal cancer (CRC) patients remains unclear. The present study determined the relationship between TFF expression and clinicopathological findings, as well as long-term outcome in CRC patients. The mRNA expression levels of TFFs were examined in the excised CRC specimens obtained from 154 consecutive CRC patients who underwent surgical resection between 2005 and 2007 at our institution. TFF3 expression was significantly associated with the presence of distant metastasis (P=0.017), although neither TFF1 nor TFF2 expression was associated with the dinicopathological features. Survival rate of the patients with positive TFF3 was significantly worse compared to those with negative TFF3 (P=0.011). A multivariate analysis revealed that the expression of TFF3, lymph node metastasis, and vascular invasion were independent prognostic factors for disease-specific survival. Furthermore, among 134 patients with no clinical findings of metastasis at surgery, the patients with positive TFF3 experienced recurrence within one year more frequently than those with negative TFF3 (P=0.039). In conclusion, TFF3 is not only a useful biomarker for A long-term surgical result in CRC patient, but also may be a risk factor of early recurrence.	[Morito, Kiyoto; Nakamura, Jun; Kitajima, Yoshihiko; Tanaka, Tomokazu; Kubo, Hiroshi; Miyake, Shuusuke; Noshiro, Hirokazu] Saga Univ, Fac Med, Dept Surg, Saga 8498501, Japan; [Kitajima, Yoshihiko] Natl Hosp Org Higashisaga, Dept Surg, Saga 8490101, Japan; [Kai, Keita] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga 8498501, Japan	Noshiro, H (reprint author), Saga Univ, Fac Med, Dept Surg, Nabesima 5-1-1, Saga 8498501, Japan.	noshiro@cc.saga-u.ac.jp					Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Kosriwong K, 2011, WORLD J GASTROENTERO, V17, P1631, DOI 10.3748/wjg.v17.i12.1631; Kirikoshi H, 2002, INT J ONCOL, V21, P655; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Poulsom R, 1997, J PATHOL, V183, P30, DOI 10.1002/(SICI)1096-9896(199709)183:1<30::AID-PATH1085>3.0.CO;2-K; Rodrigues S, 2006, ONCOGENE, V25, P6628, DOI 10.1038/sj.onc.1209665; Qu YQ, 2012, ONCOL REP, V27, P1277, DOI 10.3892/or.2012.1627; Wong WM, 1999, GUT, V44, P890; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Babyatsky M, 2009, CLIN EXP METASTAS, V26, P143, DOI 10.1007/s10585-008-9224-9; Buache E, 2011, ONCOGENE, V30, P3261, DOI 10.1038/onc.2011.41; Leung WK, 2002, J PATHOL, V197, P582, DOI 10.1002/path.1147; Ferlay J, 2010, Eur J Cancer, V46, P765, DOI 10.1016/j.ejca.2009.12.014; May FEB, 1997, J PATHOL, V182, P404; Peterson AJ, 2010, GASTROENTEROLOGY, V139, P2005, DOI 10.1053/j.gastro.2010.08.043; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin D, 1996, LAB INVEST, V75, P25; Dhar DK, 2005, CLIN CANCER RES, V11, P6472, DOI 10.1158/1078-0432.CCR-05-0671; Tanaka T, 2013, INT J ONCOL, V42, P894, DOI 10.3892/ijo.2013.1759; Efstathiou JA, 1998, P NATL ACAD SCI USA, V95, P3122, DOI 10.1073/pnas.95.6.3122; Chan VYW, 2005, REGUL PEPTIDES, V127, P87, DOI 10.1016/j.regpep.2004.10.016; Bacolod MD, 2011, ANN SURG ONCOL, V18, P3694, DOI 10.1245/s10434-011-1615-5; Bougen NM, 2013, CANCER LETT, V332, P19, DOI 10.1016/j.canlet.2012.12.012; HENRY JA, 1991, BRIT J CANCER, V64, P677, DOI 10.1038/bjc.1991.380; Hoffmann W, 2002, INT REV CYTOL, V213, P147; Huang YG, 2013, J CANCER RES THER, V9, P376, DOI 10.4103/0973-1482.119308; Rivat Christine, 2005, Cancer Res, V65, P195; Sobin LH, 2009, TNM CLASSIFICATION M; Vizoso FJ, 2003, INT J BIOL MARKER, V18, P301; Yio XY, 2005, CLIN EXP METASTAS, V22, P157, DOI 10.1007/s10585-005-6615-z	33	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					563	568		10.3892/ijo.2014.2755		6	Oncology	Oncology	AY6IX	WOS:000347671200015		
J	Matsuoka, H; Kondo, K; Takizawa, H; Fujino, H; Sakamoto, E; Uchida, J; Uyama, K; Toba, H; Kenzaki, K; Sakiyama, S; Tangoku, A				Matsuoka, Hisashi; Kondo, Kazuya; Takizawa, Hiromitsu; Fujino, Haruhiko; Sakamoto, Etsuko; Uchida, Junji; Uyama, Koh; Toba, Hiroaki; Kenzaki, Koichiro; Sakiyama, Shoji; Tangoku, Akira			Comprehensive evaluation of the response of genes to the administration of the antitumor drug S-1 using a low density array	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						anticancer drug S-1; non-small cell lung cancer; orthotopic animal model; low density array; dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine; drug resistance	MULTIDRUG-RESISTANCE PROTEIN; HUMAN CANCER XENOGRAFTS; HUMAN-LUNG-CANCER; SCID MOUSE MODEL; CELL-LINES; VINCRISTINE TRANSPORT; EXPRESSION PROFILES; ANTICANCER DRUGS; CDNA MICROARRAY; BREAST-CANCER	S-1 is a newly developed dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine that exhibits high clinical efficacy against non-small cell lung cancers. To identify genes that may be associated with chemosensitivity to the antitumor drug S-1, we used a low density array representing 93 genes to analyze expression profiles in 4 orthotopically implanted lung cancers derived from human lung cancer cell lines (Lu99,Lu130, LC6 and A549). The tumor growth inhibition (TGI) rates of S-1 in orthotopically implanted tumors of the Lu99, Lu130, LC6 and A549 cell lines were 34.6, 37.5, 32.1 and 3.6%, respectively. The expression of the PRSS3, ABCC4, TXN, SHMT1 and CMPK genes was significantly promoted in the orthotopically implanted SCID mouse Model of the 4 lung cancer cell lines by the administration of S-1, while the expression of the LMO7 and FOLH1 genes was significantly suppressed. The expression of the ABCC1, 2 and TST genes was negatively correlated with TGI. The expression of the TK1 and ERCC2 genes was positively correlated with TGI. The results of the present study suggest that the expression of the ABCC1, 2, TST, TK1 and ERCC2 genes is related to resistance to the antitumor drug S-1.	[Matsuoka, Hisashi; Takizawa, Hiromitsu; Fujino, Haruhiko; Uyama, Koh; Toba, Hiroaki; Kenzaki, Koichiro; Sakiyama, Shoji; Tangoku, Akira] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Thorac Endocrine Surg & Oncol, Tokushima 7708509, Japan; [Kondo, Kazuya] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oncol Med Serv, Tokushima 7708509, Japan; [Sakamoto, Etsuko] Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Tsukuba, Ibaraki, Japan; [Uchida, Junji] Taiho Pharmaceut Co Ltd, Tokushima Res Ctr, Tokushima, Japan	Kondo, K (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oncol Med Serv, 18-15 Kuramoto Cho 3, Tokushima 7708509, Japan.	kondo@clin.med.tokushima-u.ac.jp	Kondo, Kazuya/J-9163-2012		Taiho Pharmaceutical Co., Ltd.	Kazuya Kondo and Akira Tangoku have received research funding from Taiho Pharmaceutical Co., Ltd. Etsuko Sakamoto and Junji Uchida are employees of Taiho Pharmaceutical Co., Ltd.	Hegedus T, 2002, BBA-MOL BASIS DIS, V1587, P318, DOI 10.1016/S0925-4439(02)00095-9; Nooter K, 1995, CLIN CANCER RES, V1, P1301; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Loe DW, 1996, J BIOL CHEM, V271, P9675; Zembutsu H, 2002, CANCER RES, V62, P518; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Borst P, 2000, J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Cui YH, 1999, MOL PHARMACOL, V55, P929; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Dan S, 2002, CANCER RES, V62, P1139; Huisman MT, 2005, INT J CANCER, V116, P824, DOI 10.1002/ijc.21013; Yin M, 2011, CLIN CANCER RES, V17, P1632, DOI 10.1158/1078-0432.CCR-10-2169; Fujino H, 2005, MOL CANCER THER, V4, P1409, DOI 10.1158/1535-7163.MCT-05-0031; Sandusky GE, 2002, HISTOPATHOLOGY, V41, P65, DOI 10.1046/j.1365-2559.2002.01403.x; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Kondo K, 2004, ONCOL REP, V12, P991; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; Ishikura H, 2000, ANN THORAC SURG, V69, P1691, DOI 10.1016/S0003-4975(00)01144-9; Korita PV, 2010, ONCOL REP, V23, P965, DOI 10.3892/or_00000721; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Chu XY, 1997, J PHARMACOL EXP THER, V281, P304; Fujino H, 2003, ONCOL REP, V10, P1709; Fukushima M, 2001, EUR J CANCER, V37, P1681, DOI 10.1016/S0959-8049(01)00174-5; Golub TR, 2001, NEW ENGL J MED, V344, P601, DOI 10.1056/NEJM200102223440809; Kiyohara Chikako, 2007, Int J Med Sci, V4, P59; Loe DW, 1998, CANCER RES, V58, P5130; Mayer F, 2002, ANN ONCOL, V13, P755, DOI 10.1093/annonc/mdf129; Nagahara N, 1996, J BIOL CHEM, V271, P27395; Nooter K, 1997, LANCET, V349, P1885, DOI 10.1016/S0140-6736(05)63876-7; Nukatsuka M, 2004, INT J ONCOL, V25, P1531; Ooyama A, 2006, CANCER SCI, V97, P510, DOI 10.1111/j.1349-7006.2006.00204.x; Ott K, 2011, ANN SURG ONCOL, V18, P2688, DOI 10.1245/s10434-011-1601-y; Paget S., 1889, LANCET, V133, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Park JS, 2004, CANCER LETT, V214, P19, DOI 10.1016/j.canlet.2004.04.012; Takechi T, 2005, ONCOL REP, V14, P33; TASHIRO T, 1989, CANCER CHEMOTH PHARM, V24, P187, DOI 10.1007/BF00300241; van der Kolk DM, 1998, CLIN CANCER RES, V4, P1727	38	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					569	577		10.3892/ijo.2014.2754		9	Oncology	Oncology	AY6IX	WOS:000347671200016		
J	Kanda, M; Sugimoto, H; Nomoto, S; Oya, H; Hibino, S; Shimizu, D; Takami, H; Hashimoto, R; Okamura, Y; Yamada, S; Fujii, T; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y				Kanda, Mitsuro; Sugimoto, Hiroyuki; Nomoto, Shuji; Oya, Hisaharu; Hibino, Soki; Shimizu, Dai; Takami, Hideki; Hashimoto, Ryoji; Okamura, Yukiyasu; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro			B-cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						B-cell translocation gene 1; hepatocellular carcinoma; tumor suppressor; expression; prognosis	ACUTE LYMPHOBLASTIC-LEUKEMIA; PROMOTER HYPERMETHYLATION; PANCREATIC-JUICE; BTG1; EXPRESSION; IDENTIFICATION; PATHOGENESIS; PROGRESSION; PROTEIN; LOCALIZATION	Although the B-cell translocation gene 1 (BTG1) plays an important role in apoptosis and negatively regulates cell proliferation, BTG1 expression in hepatocellular carcinoma (HCC) has not been evaluated. In this study expression analysis of BTG1 was conducted to clarify the role of BTG1 in the initiation of HCC carcinogenesis and progression. BTG1 mRNA expression levels were determined for HCC cell lines and 151 surgical specimen pairs using quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR) assay. The mutational and methylation status of HCC cell lines were analyzed via high resolution melting (HRM) analysis and direct sequencing analysis to elucidate the regulatory mechanisms of BTG1 expression. The expression and distribution of the BTG1 protein in liver tissues were evaluated using immunohistochemistry (IHC). Decreased expression of BTG1 mRNA was confirmed in the majority of HCC cell lines (89%) and clinical HCC tissues (85%) compared with non-cancerous liver tissues. Mutations or promoter hypermethylation were not identified in HCC cell lines. BTG1 mRNA expression levels were not influenced by background liver status. The pattern of BTG1 protein expression was consistent with that of BTG1 mRNA. Downregulation of BTG1 mRNA in HCC was significantly associated with shorter disease-specific and recurrence-free survival rates. Multivariate analysis of disease-specific survival rates identified BTG1 mRNA downregulation as an independent prognostic factor for HCC (hazard ratio 2.12, 95% confidence interval 1.12-4.04, P=0.022). Our results indicate that altered BTG1 expression might affect hepatocarcinogenesis and may represent a novel biomarker for HCC carcinogenesis and progression.	[Kanda, Mitsuro; Sugimoto, Hiroyuki; Nomoto, Shuji; Oya, Hisaharu; Hibino, Soki; Shimizu, Dai; Takami, Hideki; Hashimoto, Ryoji; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4668550, Japan; [Okamura, Yukiyasu] Shizuoka Canc Ctr, Div Hepatobiliary Pancreat Surg, Shizuoka 4118777, Japan	Kanda, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	m-kanda@med.nagoya-u.ac.jp					Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Kanda M, 2013, GUT, V62, P1024, DOI 10.1136/gutjnl-2012-302823; Minguez B, 2011, DIS MARKERS, V31, P181, DOI 10.3233/DMA-2011-0841; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; Kanda M, 2013, CLIN GASTROENTEROL H, V11, P719, DOI 10.1016/j.cgh.2012.11.016; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Miki D, 2012, CANCER SCI, V103, P846, DOI 10.1111/j.1349-7006.2012.02242.x; ROUAULT JP, 1992, EMBO J, V11, P1663; Shiraha H, 2013, INT J ONCOL, V42, P1133, DOI 10.3892/ijo.2013.1829; Kanda M, 2009, INT J ONCOL, V35, P477, DOI 10.3892/ijo_00000359; Nomoto S, 2010, ANN SURG ONCOL, V17, P923, DOI 10.1245/s10434-009-0790-0; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Lee H, 2003, J IMMUNOL, V171, P5802; Lin WJ, 1996, J BIOL CHEM, V271, P15034; Kanda M, 2014, INT J ONCOL, V44, P44, DOI 10.3892/ijo.2013.2165; Rodier A, 2001, ONCOGENE, V20, P2691, DOI 10.1038/sj.onc.1204398; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Zhao Y, 2013, INT J MOL SCI, V14, P19670, DOI 10.3390/ijms141019670; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Kanda M, 2008, J SURG ONCOL, V98, P190, DOI 10.1002/jso.21095; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Hibino S, 2014, ONCOL REP, V31, P693, DOI 10.3892/or.2013.2901; Khare S, 2013, WORLD J GASTROENTERO, V19, P5439, DOI 10.3748/wjg.v19.i33.5439; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; van Galen JC, 2010, BLOOD, V115, P4810, DOI 10.1182/blood-2009-05-223081; Sheng SH, 2014, TUMOR BIOL, V35, P3317, DOI 10.1007/s13277-013-1437-0; Buitenkamp TD, 2013, LEUKEMIA, V27, P251, DOI 10.1038/leu.2012.199; Cho JW, 2004, PROTEOMICS, V4, P3456, DOI 10.1002/pmic.200400968; Kanda M, 2014, GASTRIC CANC; Kawamura-Tsuzuku J, 2004, ONCOGENE, V23, P6630, DOI 10.1038/sj.onc.1207890; Okamura Y, 2011, ANN SURG ONCOL, V18, P572, DOI 10.1245/s10434-010-1273-z; Shimizu D, 2014, ONCOL REP, V31, P1305, DOI 10.3892/or.2013.2939; Takami H, 2013, J SURG ONCOL, V108, P557, DOI 10.1002/jso.23440; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533	40	5	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					641	648		10.3892/ijo.2014.2762		8	Oncology	Oncology	AY6IX	WOS:000347671200023		
J	Maehara, S; Usuda, J; Ishizumi, T; Ichinose, S; Ohtani, K; Inoue, T; Imai, K; Furumoto, H; Kudo, Y; Kajiwara, N; Ohira, T; Ikeda, N				Maehara, Sachio; Usuda, Jitsuo; Ishizumi, Taichiro; Ichinose, Shuji; Ohtani, Keishi; Inoue, Tatsuya; Imai, Kentaro; Furumoto, Hideyuki; Kudo, Yujin; Kajiwara, Naohiro; Ohira, Tatsuya; Ikeda, Norihiko			Combination effect of photodynamic therapy using NPe6 with pemetrexed for human malignant pleural mesothelioma cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						malignant pleural mesothelioma; photodynamic therapy; pemetrexed; combination therapy	EXTRAPLEURAL PNEUMONECTOMY; LUNG-CANCER; THYMIDYLATE SYNTHASE; DRUG-DELIVERY; PHASE-III; IN-VIVO; SURGERY; EXPRESSION; MANAGEMENT; CARCINOMA	To identify a possible new treatment modality for malignant pleural mesothelioma (MPM), we examined whether combination treatment consisting of pemetrexed chemotherapy and photodynamic therapy (PDT) using the photosensitizer NPe6, enhanced the antitumor effect in both in vitro and in vivo models. We also investigated preclinical treatment schedules. Four human malignant mesothelioma cell lines (MSTO-211H, H2052, H2452 and H28) were assayed using the WST assay after treatment with pemetrexed and NPe6-PDT. The treatment schedule for the combination treatment was examined using nude mice. Pemetrexed pre-treatment enhanced the lethal effect of NPe6-PDT in the four malignant mesothelioma cell lines, but NPe6-PDT followed by pemetrexed treatment did not enhance cell lethality in the in vitro assay. Pemetrexed pre-treatment did not enhance the intracellular accumulation of NPe6, which is one of the determinants of the antitumor effect of PDT. In nude mice injected with MSTO-211H cells and then treated using a combination of pemetrexed and NPe6-PDT (10 mg/kg NPe6, 10 J/cm(2) laser irradiation), the tumor volume decreased by 50% but subsequently increased, reaching the pre-treatment value after 14 days. Pemetrexed treatment followed by NPe6-PDT resulted in an 80% reduction in the tumor size and inhibited re-growth. NPe6:PDT followed by pemetrexed treatment resulted in a 60% reduction in tumor size but did not inhibit re-growth. NPe6-PDT induced the expression of thymidylate synthase (TS), which confers resistance to pemetrexed, and NPe6-PDT followed by pemetrexed treatment did not enhance the treatment outcome in vivo. In conclusion, combination treatment, consisting of pemetrexed followed by NPe6-PDT, should be further investigated as a new treatment modality for MPM. In the future, this combination treatment may contribute to a reduction in local recurrence and a prolonged survival period in patients with MPM.	[Maehara, Sachio; Ishizumi, Taichiro; Ichinose, Shuji; Ohtani, Keishi; Inoue, Tatsuya; Imai, Kentaro; Furumoto, Hideyuki; Kudo, Yujin; Kajiwara, Naohiro; Ohira, Tatsuya; Ikeda, Norihiko] Tokyo Med Univ, Dept Surg, Tokyo 1600023, Japan; [Usuda, Jitsuo] Nippon Med Sch, Dept Thorac Surg, Tokyo 1138603, Japan	Usuda, J (reprint author), Nippon Med Sch, Dept Thorac Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	jusuda@nms.ac.jp			Japan Society for the Promotion of Science (JSPS) (KAKENHI) [21591826]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (JSPS) (to J.U.) (KAKENHI 21591826).	Adjei AA, 2004, CLIN CANCER RES, V10, p4276S, DOI 10.1158/1078-0432.CCR-040010; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; Usuda J, 2010, CLIN CANCER RES, V16, P2198, DOI 10.1158/1078-0432.CCR-09-2520; Ozasa H, 2010, CANCER SCI, V101, P161, DOI 10.1111/j.1349-7006.2009.01358.x; Pass HI, 1997, ANN SURG ONCOL, V4, P628, DOI 10.1007/BF02303746; Sitnik TM, 1998, BRIT J CANCER, V77, P1386, DOI 10.1038/bjc.1998.231; Pass HI, 1997, ANN SURG ONCOL, V4, P215, DOI 10.1007/BF02306613; EDELL ES, 1992, CHEST, V102, P1319, DOI 10.1378/chest.102.5.1319; Kennedy TC, 2007, CHEST, V132, p221S, DOI 10.1378/chest.07-1377; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Robey RW, 2005, CANCER BIOL THER, V4, P187; Hodgson JT, 2005, BRIT J CANCER, V92, P587, DOI 10.1038/sj.bjc.6602307; Krug LM, 2009, J CLIN ONCOL, V27, P3007, DOI 10.1200/JCO.2008.20.3943; Xue LY, 2001, EXP CELL RES, V263, P145, DOI 10.1006/excr.2000.5108; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Kato H, 2006, LASER SURG MED, V38, P371, DOI 10.1002/lsm.20346; Debefve E, 2011, LASER SURG MED, V43, P696, DOI 10.1002/lsm.21115; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Sinha AK, 2006, BRIT J CANCER, V95, P485, DOI 10.1038/sj.bjc.6603273; Usuda J, 2003, J BIOL CHEM, V278, P2021, DOI 10.1074/jbc.M205219200; Snyder JW, 2003, CANCER RES, V63, P8126; Anand S, 2009, CLIN CANCER RES, V15, P3333, DOI 10.1158/1078-0432.CCR-08-3054; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; Usuda J, 2010, LUNG CANCER, V67, P198, DOI 10.1016/j.lungcan.2009.04.002; Rea F, 2007, LUNG CANCER, V57, P89, DOI 10.1016/j.lungcan.2007.02.004; Krueger T, 2003, LASER SURG MED, V32, P61, DOI 10.1002/lsm.10113; Righi L, 2010, J CLIN ONCOL, V28, P1534, DOI 10.1200/JCO.2009.25.9275; Ohtani K, 2008, INT J ONCOL, V32, P397; Cappia S, 2008, AM J CLIN PATHOL, V130, P58, DOI 10.1309/TWCQV536WWRNEU51; Flores RM, 2008, J THORAC CARDIOV SUR, V135, P620, DOI 10.1016/j.jtcvs.2007.10.054; Friedberg JS, 2003, ANN THORAC SURG, V75, P952, DOI 10.1016/S0003-4975(02)04474-0; Dougherty TJ, 2002, J CLIN LASER MED SUR, V20, P3, DOI 10.1089/104454702753474931; Dougherty TJ, 1998, J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Kato H, 2003, LUNG CANCER-J IASLC, V42, P103, DOI 10.1016/S0169-5002(03)0242-3; McCormack V, 2012, BRIT J CANCER, V106, P575, DOI 10.1038/bjc.2011.563; O'Kane SL, 2010, LUNG CANCER, V67, P160, DOI 10.1016/j.lungcan.2009.04.008; Price B, 1997, AM J EPIDEMIOL, V145, P211; Ris HB, 2005, LUNG CANCER-J IASLC, V49, pS65, DOI 10.1016/j.lungcan.2005.03.024; Usuda J, 2008, INT J ONCOL, V33, P689, DOI 10.3892/ijo_00000054; Van TT, 2011, CANCER CHEMOTH PHARM, V68, P497, DOI 10.1007/s00280-010-1503-x; van Ruth S, 2003, CHEST, V123, P551, DOI 10.1378/chest.123.2.551; Vogelzang NJ, 2005, SEMIN ONCOL, V32, P336, DOI 10.1053/j.seminoncol.2005.02.010; Wang YB, 2012, EUR J CARDIO-THORAC, V42, P348, DOI 10.1093/ejcts/ezr294	43	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					741	749		10.3892/ijo.2014.2746		9	Oncology	Oncology	AY6IX	WOS:000347671200034		
J	Kasukabe, T; Okabe-Kado, J; Kato, N; Honma, Y; Kumakura, S				Kasukabe, Takashi; Okabe-Kado, Junko; Kato, Nobuo; Honma, Yoshio; Kumakura, Shunichi			Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						cotylenin A; arsenic trioxide; proliferation; invasion activity; breast cancer cells	MYELOID-LEUKEMIA CELLS; PLANT-GROWTH REGULATOR; PHASE-II TRIAL; DIFFERENTIATION-INDUCING AGENT; HEPATOCELLULAR-CARCINOMA; ANTICANCER ACTIVITY; MCF-7 CELLS; INDUCTION; APOPTOSIS; RAPAMYCIN	Arsenic trioxide (ATO) is an approved treatment for acute promyelocytic leukemia (APL). It has also shown potential for treatment of multiple myeloma and various solid tumors including breast cancer. The requirement of high, toxic concentrations for the induction of apoptosis in non-APL and solid tumor cells is a major limitation for its use in other hematological malignancies and solid tumors. We have examined whether inducers of differentiation of leukemia cells can control the growth of solid tumor cells. In the present study, we found that cotylenin A, a plant growth regulator and a potent inducer of differentiation in myeloid leukemia cells, significantly potentiated both ATO-induced inhibition of cell growth in a liquid culture, and ATO-induced inhibition of anchorage-independent growth in a semi-solid culture in human breast cancer MCF-7 and MDA-MB-231 cells. ISIR-005 (a synthetic cotylenin A-derivative) was also able to enhance ATO-induced growth inhibition. The combined treatment with cotylenin A and ATO induced cleaved caspase-7 in MCF-7 cells at the concentrations which ATO alone scarcely induced and cotylenin A alone only weakly induced. Expression of survivin in MCF-7 cells was Markedly decreased with the presence of both cotylenin A and ATO, although the expression of survivin was only slightly decreased by cotylenin A or ATO alone. The pretreatment with N:acetylcysteine significantly reduced the combination treatment-induced cell growth inhibition. These data suggest that induction of cleaved caspase-7, inhibition of survivin and oxidative responses are important events in the corporative inhibition in the growth of MCF-7 cells induced by both cotylenin A and ATO. Furthermore, we found that the combined treatment with cotylenin A and ATO also could be effective in suppressing the invasive capacity of MDA-MB-231 cells determined with the impedance-based xCELLigence Real-Time Cell Analysis technology. These results suggest that cotylenin A is an attractive enhancer for the ATO-induced anticancer activities in human breast cancer.	[Kasukabe, Takashi; Kumakura, Shunichi] Shimane Univ, Dept Med Educ & Res, Fac Med, Izumo, Shimane 6938501, Japan; [Kasukabe, Takashi; Okabe-Kado, Junko] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama 3620806, Japan; [Kato, Nobuo] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Honma, Yoshio] Shimane Univ, Ctr Canc, Fac Med, Izumo, Shimane 6938501, Japan	Kasukabe, T (reprint author), Shimane Univ, Dept Med Educ & Res, Fac Med, Izumo, Shimane 6938501, Japan.	kasukabe@med.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	The present study was supported partly by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Takahashi S, 2010, ANTI-CANCER AGENT ME, V10, P504; Kasukabe T, 2005, BREAST CANCER RES, V7, pR1097, DOI 10.1186/bcr1344; Nakaoka T, 2014, CELL ONCOL, V37, P119, DOI 10.1007/s13402-014-0167-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Hagiwara Y, 2010, INT J HEMATOL, V92, P136, DOI 10.1007/s12185-010-0627-4; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Feng Y, 2014, CANCER DISCOV, V4, P790, DOI 10.1158/2159-8290.CD-13-0548; Nakamaki T, 2002, EXP HEMATOL, V30, P421, DOI 10.1016/S0301-472X(02)00779-8; Zhang XY, 2012, CANCER LETT, V318, P93, DOI 10.1016/j.canlet.2011.12.005; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; Liu WL, 2012, CANCER BIOTHER RADIO, V27, P504, DOI 10.1089/cbr.2012.1162; Lin CC, 2007, INVEST NEW DRUG, V25, P77, DOI 10.1007/s10637-006-9004-9; Kryeziu K, 2013, MOL CANCER THER, V12, P1073, DOI 10.1158/1535-7163.MCT-13-0065; Shen ZX, 1997, BLOOD, V89, P3354; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Kim KB, 2005, CANCER, V104, P1687, DOI 10.1002/cncr.21386; Emadi A, 2010, BLOOD REV, V24, P191, DOI 10.1016/j.blre.2010.04.001; Hurvitz SA, 2013, CANCER TREAT REV, V39, P219, DOI 10.1016/j.ctrv.2012.04.008; Kasukabe T, 2008, CANCER SCI, V99, P1693, DOI 10.1111/j.1349-7006.2008.00867.x; Asahi K, 1997, BIOCHEM BIOPH RES CO, V238, P758, DOI 10.1006/bbrc.1997.7385; Aziz MYA, 2014, ONCOL LETT, V7, P1479, DOI 10.3892/ol.2014.1898; Deuer D, 2005, J CLIN ONCOL, V23, P2396; Abe O, 2005, LANCET, V365, P1687; Gianni M, 1998, BLOOD, V91, P4300; Honma Y, 2002, LEUKEMIA LYMPHOMA, V43, P1169, DOI 10.1080/1042819020026222; Kasukabe T, 2013, INT J ONCOL, V42, P767, DOI 10.3892/ijo.2012.1745; Kawakami K, 2012, ANTI-CANCER AGENT ME, V12, P791; Li W, 2014, CELL BIOCHEM BIOPHYS, V68, P427, DOI 10.1007/s12013-013-9724-3; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; SASSA T, 1970, NATURE, V227, P379, DOI 10.1038/227379a0; Si L, 2015, MOL CARCINOGEN, V54, P859, DOI 10.1002/mc.22157; Vuky J, 2002, INVEST NEW DRUG, V20, P327, DOI 10.1023/A:1016270206374; Yamada K, 2001, BRIT J HAEMATOL, V114, P814, DOI 10.1046/j.1365-2141.2001.03029.x; Yamamoto-Yamaguchi Y, 2001, BRIT J HAEMATOL, V112, P697, DOI 10.1046/j.1365-2141.2001.02601.x; Yamamoto-Yamaguchi Y, 2001, EXP HEMATOL, V29, P582, DOI 10.1016/S0301-472X(01)00626-9; Zhao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098925; Zhou CX, 2007, GYNECOL ONCOL, V105, P218, DOI 10.1016/j.ygyno.2006.11.027	40	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	FEB	2015	46	2					841	848		10.3892/ijo.2014.2760		8	Oncology	Oncology	AY6IX	WOS:000347671200046		
J	Wu, W; Liu, Z; Chen, M; Liu, ZM; Wu, X; He, XH				Wu, Wei; Liu, Zheng; Chen, Mo; Liu, Zhiming; Wu, Xi; He, Xiaohai			A New Framework for Container Code Recognition by Using Segmentation-Based and HMM-Based Approaches	INTERNATIONAL JOURNAL OF PATTERN RECOGNITION AND ARTIFICIAL INTELLIGENCE			English	Article						Container code recognition; character recognition; hidden Markov model; sliding window	LICENSE PLATE RECOGNITION; HIDDEN-MARKOV-MODELS; EXTRACTION; SYSTEM; IMAGES	Traditional methods for automatic recognition of container code in visual images are based on segmentation and recognition of isolated characters. However, when the segment fails to separate each character from the others, those methods will not function properly. Sometimes the container code characters are printed or arranged very closely, which makes it a challenge to isolate each character. To address this issue, a new framework for automatic container code recognition (ACCR) in visual images is proposed in this paper. In this framework, code-character regions are first located by applying a horizontal high-pass filter and scan line analysis. Then, character blocks are extracted from the code-character regions and further classified into two categories, i.e. single-character block and multi-character block. Finally, a segmentation-based approach is implemented for recognition of the characters in single-character blocks, and a hidden Markov model (HMM)-based method is proposed for the multi-character blocks. The experimental results demonstrate the effectiveness of the proposed method, which can successfully recognize the container code with closely arranged characters.	[Wu, Wei; He, Xiaohai] Sichuan Univ, Sch Elect & Informat Engn, Chengdu 610064, Peoples R China; [Liu, Zheng] Toyota Technol Inst, Intelligent Informat Proc Lab, Nagoya, Aichi 4688511, Japan; [Chen, Mo] Southwest Res Inst Elect Equipment, Chengdu 610036, Peoples R China; [Liu, Zhiming] Univ Nevada, Dept Elect & Biomed Engn, Reno, NV 89557 USA; [Wu, Xi] Chengdu Univ Informat Technol, Dept Elect Engn, Chengdu 610225, Peoples R China	Wu, W (reprint author), Sichuan Univ, Sch Elect & Informat Engn, Chengdu 610064, Peoples R China.	wuwei@scu.edu.cn			National Natural Science Foundation of China [61271330]; Science and Technology Plan of Sichuan Province [2014GZ0005]; National Science Foundation for Post-doctoral Scientists of China [2014M552357]; Scientific Research Foundation of State Education Ministry for the Returned Overseas Chinese Scholars; Open Research Fund of Jiangsu Province Key Laboratory of Image processing and Image communication, Nanjing University of Posts and Telecommunications [LBEK2013001]	The work was supported by the National Natural Science Foundation of China (No. 61271330), the Science and Technology Plan of Sichuan Province (No. 2014GZ0005), the National Science Foundation for Post-doctoral Scientists of China (No. 2014M552357), the Scientific Research Foundation of State Education Ministry for the Returned Overseas Chinese Scholars, and Open Research Fund of Jiangsu Province Key Laboratory of Image processing and Image communication, Nanjing University of Posts and Telecommunications (No. LBEK2013001).	Abolghasemi V, 2009, IMAGE VISION COMPUT, V27, P1134, DOI 10.1016/j.imavis.2008.10.012; Al-Muhtaseb HA, 2008, SIGNAL PROCESS, V88, P2902, DOI 10.1016/j.sigpro.2008.06.013; Llorens D, 2005, LECT NOTES COMPUT SC, V3522, P571; Wu W, 2012, EXPERT SYST APPL, V39, P2842, DOI 10.1016/j.eswa.2011.08.143; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Anagnostopoulos CNE, 2008, IEEE T INTELL TRANSP, V9, P377, DOI 10.1109/TITS.2008.922938; Fan X, 2009, IEEE SIGNAL PROC LET, V16, P10, DOI 10.1109/LSP.2008.2008486; He ZW, 2005, IEEE T INTELL TRANSP, V6, P72, DOI 10.1109/TITS.2004.838509; Huang YP, 2009, EXPERT SYST APPL, V36, P9260, DOI 10.1016/j.eswa.2008.12.006; Huang YP, 2008, INT J PATTERN RECOGN, V22, P233, DOI 10.1142/S021800140800620X; KAMEL M, 1993, CVGIP-GRAPH MODEL IM, V55, P203; Kim KB, 2007, LECT NOTES COMPUT SC, V4432, P572; Marzal A, 2007, LECT NOTES COMPUT SC, V4477, P282; Su TH, 2009, PATTERN RECOGN, V42, P167, DOI 10.1016/j.patcog.2008.05.012; Wang C. L. X., 2005, PATTERN RECOGN, V38, P369	15	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-0014	1793-6381		INT J PATTERN RECOGN	Int. J. Pattern Recognit. Artif. Intell.	FEB	2015	29	1							1550004	10.1142/S0218001415500044		19	Computer Science, Artificial Intelligence	Computer Science	AZ0XW	WOS:000347966200004		
J	Mukai, H; Saeki, T; Shimada, K; Naito, Y; Matsubara, N; Nakanishi, T; Obaishi, H; Namiki, M; Sasaki, Y				Mukai, Hirofumi; Saeki, Toshiaki; Shimada, Ken; Naito, Yoichi; Matsubara, Nobuaki; Nakanishi, Tadashi; Obaishi, Hiroshi; Namiki, Masayuki; Sasaki, Yasutsuna			Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer	INVESTIGATIONAL NEW DRUGS			English	Article						Eribulin mesylate; HER2 positive breast cancer; Japanese patients; Phase 1 study; Trastuzumab	ANTI-HER2 MONOCLONAL-ANTIBODY; HALICHONDRIN B ANALOG; EFFICACY; SAFETY; TAXANE; PHARMACOKINETICS; ANTHRACYCLINE; CHEMOTHERAPY; MONOTHERAPY; ONCOGENE	Eribulin mesylate (HalavenA (R)) is a novel inhibitor of microtubule dynamics that has demonstrated a survival benefit in patients with locally recurrent or metastatic breast cancer who previously received at least two chemotherapeutic regimens including an anthracycline and a taxane. Although trastuzumab is indicated for patients with human epidermal growth factor receptor 2 positive (HER2+) breast cancer, a phase 1 study to evaluate tolerability/safety of eribulin mesylate with trastuzumab has not been conducted. Therefore, a study of eribulin mesylate in combination with trastuzumab was conducted to evaluate dose limiting toxicity (DLT), tolerability/safety, pharmacokinetics (PK), and efficacy and to estimate the recommended dose in Japanese patients with advanced or recurrent HER2+ breast cancer. Eribulin mesylate (1.4 mg/m(2)) was administered on days 1 and 8 of every 3 week cycle. Trastuzumab was administered with a 4 mg/kg loading dose followed by 2 mg/kg weekly doses or with an 8 mg/kg loading dose followed by 6 mg/kg tri-weekly doses. A total of 12 patients (six for each regimen) received eribulin mesylate and trastuzumab. No DLT was observed and the recommended dose of eribulin mesylate in combination with trastuzumab was estimated as 1.4 mg/m(2). Common adverse events were neutropenia, leukopenia, anaemia and alopecia. This combination therapy was well tolerated and the neutropenia observed was manageable. No PK drug-drug interaction between eribulin and trastuzumab was observed. Since a transient ejection fraction decreased was observed in two patients, cardiac function should be routinely assessed in patients receiving the combination therapy of eribulin mesylate with trastuzumab (ClinicalTrials.gov Identifier: NCT01432886).	[Mukai, Hirofumi; Naito, Yoichi; Matsubara, Nobuaki] Natl Canc Ctr Hosp East, Dept Breast & Med Oncol, Kashiwa, Chiba 2778577, Japan; [Saeki, Toshiaki] Saitama Med Univ, Int Med Ctr, Dept Breast Oncol, Ctr Canc, Hidaka, Saitama 3501298, Japan; [Shimada, Ken] Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Tsuzuki Ku, Yokohama, Kanagawa 2248503, Japan; [Nakanishi, Tadashi; Obaishi, Hiroshi; Namiki, Masayuki] Eisai & Co Ltd, Bunkyo Ku, Tokyo 1128088, Japan; [Sasaki, Yasutsuna] Showa Univ, Sch Med, Dept Med, Div Med Oncol,Shinagawa Ku, Tokyo 1428666, Japan	Mukai, H (reprint author), Natl Canc Ctr Hosp East, Dept Breast & Med Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	hrmukai@east.ncc.go.jp			Eisai Co., Ltd.; AstraZeneca K.K.; Chugai Pharmaceutical Co., Ltd.; Daiichi Sankyo Co., Ltd.; Sanofi K.K.; Taiho Pharmaceutical Co., Ltd.; Bayer Yakuhin, Ltd.; Fuji Pharma Co., Ltd.; Kyowa Hakko Kirin Co., Ltd.; Mochida Pharmaceutical Co., Ltd.; Novartis Pharma K.K.; Ono Pharmaceutical Co., Ltd.; Pfizer Japan Inc.; Glaxo SmithKline K.K.; Nippon Boehringer Ingelheim Co., Ltd.; Nippon Kayaku Co., Ltd.; Phizer Japan Inc.; Public Health Research Foundation; Takeda Pharmaceutical Company Limited	Hirofumi Mukai received lecture fees from Eisai Co., Ltd., AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Sanofi K.K., and Taiho Pharmaceutical Co., Ltd. Toshiaki Saeki received lecture fees from Eisai Co., Ltd., AstraZeneca K.K., Bayer Yakuhin, Ltd., Chugai Pharmaceutical Co., Ltd., Fuji Pharma Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Mochida Pharmaceutical Co., Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sanofi K.K. and Taiho Pharmaceutical Co., Ltd. Yasutsuna Sasaki received lecture fees from Eisai Co., Ltd. and Chugai Pharmaceutical Co., Ltd. Hirofumi Mukai, Yoichi Naito and Nobuaki Matsubara received research funding from Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Glaxo SmithKline K.K., Nippon Boehringer Ingelheim Co., Ltd., Nippon Kayaku Co., Ltd., Novartis Pharma K.K., Phizer Japan Inc. and the Public Health Research Foundation. Toshiaki Saeki received research funding from Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited. Yasutsuna Sasaki received research funding from Eisai Co., Ltd. and Chugai Pharmaceutical Co., Ltd. Tadashi Nakanishi and Hiroshi Obaishi are employees and own stock of Eisai Co., Ltd. Masayuki Namiki is an employee of Eisai Co., Ltd. Ken Shimada has no disclosures. The study was designed under the responsibility of Eisai Co., Ltd.; The study was funded by Eisai Co., Ltd.; Eribulin mesylate was provided by Eisai Co., Ltd.; Eisai Co., Ltd. collected and analyzed the data and contributed to the interpretation of the study. All authors had full access to all of the data in the study and had final responsibility for the decision to submit for publication.	Aogi K, 2012, ANN ONCOL, V23, P1441, DOI 10.1093/annonc/mdr444; Leyland-Jones B, 2003, J CLIN ONCOL, V21, P3965, DOI 10.1200/JCO.2003.12.109; Kuznetsov G, 2004, CANCER RES, V64, P5760, DOI 10.1158/0008-5472.CAN-04-1169; Towle MJ, 2001, CANCER RES, V61, P1013; Mukohara T, 2012, INVEST NEW DRUG, V30, P1926, DOI 10.1007/s10637-011-9741-2; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639; Cortes J, 2010, J CLIN ONCOL, V28, P3922, DOI 10.1200/JCO.2009.25.8467; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Seidman A, 2002, J CLIN ONCOL, V20, P1215, DOI 10.1200/JCO.20.5.1215; Vahdat LT, 2009, J CLIN ONCOL, V27, P2954, DOI 10.1200/JCO.2008.17.7618; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Baselga J, 2005, J CLIN ONCOL, V23, P2162, DOI 10.1200/JCO.2005.01.014; Bullock K, 2008, ONCOLOGIST, V13, P515, DOI 10.1634/theoncologist.2007-0204; Markman Maurie, 2003, Expert Opin Drug Saf, V2, P141, DOI 10.1517/14740338.2.2.141; Redana S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-28; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tokuda Y, 1999, BRIT J CANCER, V81, P1419, DOI 10.1038/sj.bjc.6690343; Wilks S, 2014, CLIN BREAST CANCER, V14, P405, DOI 10.1016/j.clbc.2014.04.004	21	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	FEB	2015	33	1					119	127		10.1007/s10637-014-0161-y		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AZ0QI	WOS:000347949400013		
J	Iguchi, H; Nishina, T; Nogami, N; Kozuki, T; Yamagiwa, Y; Yagawa, K				Iguchi, Haruo; Nishina, Tomohiro; Nogami, Naoyuki; Kozuki, Toshiyuki; Yamagiwa, Yumiko; Yagawa, Katsuro			Phase I dose-escalation study evaluating safety, tolerability and pharmacokinetics of MEDI-573, a dual IGF-I/II neutralizing antibody, in Japanese patients with advanced solid tumours	INVESTIGATIONAL NEW DRUGS			English	Article						Novel antitumour agent; IGF-II/I inhibitor; MEDI-573; Monoclonal antibody; Phase I; Solid tumours	GROWTH-FACTOR RECEPTOR; CANCER; PATHWAY; TARGET	Purpose This Phase I, open-label, single-arm, dose-escalation study aimed to evaluate the safety and tolerability of the insulin-like growth factor (IGF-I/II) neutralizing antibody, MEDI-573, in Japanese patients with advanced solid tumours refractory to standard therapy or for which no standard therapy exists. The pharmacokinetics, pharmacodynamics and antitumour activity of MEDI-573 were also evaluated. Methods Three cohorts of patients received MEDI-573 in escalating order: cohort 1, 5 mg/kg on Day 1, 8 and 15; cohort 2, 15 mg/kg on Day 1, 8 and 15; cohort 3, 45 mg/kg on Day 1, of 21-day cycles. Results Ten patients who received at least one dose of MEDI-573 were evaluated. The median number of treatment cycles was 2.0 (range 1-6) and the median number of MEDI-573 doses received was 4.0 (range 1-17). The most commonly reported drug-related adverse events were fatigue (n = 2 patients), pyrexia (n = 2), diarrhoea (n = 2) and electrocardiogram QT prolongation (n = 2). No patients experienced a dose-limiting toxicity. Pharmacokinetics of MEDI-573 were linear with a dose-dependent increase. There were no complete or partial responses; four patients had an overall best response of stable disease. Conclusions MEDI-573 is well tolerated at the doses investigated.	[Iguchi, Haruo; Nishina, Tomohiro; Nogami, Naoyuki; Kozuki, Toshiyuki; Yamagiwa, Yumiko] Natl Hosp Org, Shikoku Canc Ctr, Clin Res Ctr, Matsuyama, Ehime 7910280, Japan; [Yagawa, Katsuro] AstraZeneca, Osaka, Japan	Iguchi, H (reprint author), Natl Hosp Org, Shikoku Canc Ctr, Clin Res Ctr, 160 Kou, Matsuyama, Ehime 7910280, Japan.	higuchi@shikoku-cc.go.jp			AstraZeneca	This study was sponsored by AstraZeneca. Writing assistance was provided by Claire Routley, PhD, from Mudskipper Business Ltd, funded by AstraZeneca.	Scagliotti GV, 2012, CANCER TREAT REV, V38, P292, DOI 10.1016/j.ctrv.2011.07.008; Gao J, 2011, CANCER RES, V71, P1029, DOI 10.1158/0008-5472.CAN-10-2274; Ryan PD, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.2007-0199; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Arnaldez FI, 2012, HEMATOL ONCOL CLIN N, V26, P527, DOI 10.1016/j.hoc.2012.01.004; Chen HX, 2013, CHIN J CANCER, V32, P242, DOI 10.5732/cjc.012.10263; Haluska P, 2014, CLIN CANC RES; Wu KD, 2007, CANCER IMMUNOL IMMUN, V56, P343, DOI 10.1007/s00262-006-0196-9; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI [10.1517/14728222.12.5.589 , 10.1517/14728220802062858]; Zha JP, 2010, CLIN CANCER RES, V16, P2512, DOI 10.1158/1078-0432.CCR-09-2232	10	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	FEB	2015	33	1					194	200		10.1007/s10637-014-0170-x		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AZ0QI	WOS:000347949400021		
J	Fujiwara, A; Maekawa, K; Tsuchida, T				Fujiwara, A.; Maekawa, K.; Tsuchida, T.			Genetic groups and endosymbiotic microbiota of the Bemisia tabaci species complex in Japanese agricultural sites	JOURNAL OF APPLIED ENTOMOLOGY			English	Article						Bemisia tabaci; endosymbiotic bacteria; genetic groups; mitochondrial COI gene	POLYMERASE-CHAIN-REACTION; MITOCHONDRIAL-DNA MARKERS; ALEYRODIDAE BIOTYPE-Q; LEAF CURL VIRUS; HEMIPTERA ALEYRODIDAE; SECONDARY ENDOSYMBIONTS; FACULTATIVE SYMBIONT; GENNADIUS HEMIPTERA; BACTERIAL SYMBIONT; REACTION PRIMERS	The whitefly Bemisia tabaci is a cryptic species complex of at least 24 genetically distinct species. Thus far, one obligate and seven facultative symbiotic bacteria have been reported from the B.tabaci species complex. Both genetic groups and infected symbionts are extremely important to estimate the pest status of B.tabaci. In this study, we collected 340 whiteflies from 39 agricultural sites, covering an entire region of the B.tabaci habitat in Japan, and examined the genotypes and symbiont community composition at subspecies level. Use of the cleaved amplified polymorphic sequence technique and mitochondrial cytochrome oxidase subunit I gene sequencing detected five genetic groups: indigenous species JpL and Asia II 6, invasive species Middle East-Asia Minor 1 (MEAM1) and Mediterranean Subclade Q1 (MED Q1), and a genetic group previously undetected in Asia, Mediterranean Subclade Q2 (MED Q2). The genetic groups exhibited characteristic infection statuses with regard to their facultative symbionts, as observed in other countries. The endosymbiotic microbiota of the Japanese MED Q1 was different from that in neighbouring countries, but similar to that in the French or Uruguayan MED Q1. These results may indicate that Japanese MED Q1 species have not invaded from neighbouring countries, but from distant countries by international transportation. All Japanese MED Q2 species were infected with Rickettsia, some of which are regarded as conferring a female-biased sex ratio and fitness benefit on B.tabaci. The results suggest that MED Q2 may be prevalent in Japan and neighbouring countries.	[Fujiwara, A.; Tsuchida, T.] Toyama Univ, Frontier Res Core Life Sci, Toyama 9308555, Japan; [Maekawa, K.] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan	Tsuchida, T (reprint author), Toyama Univ, Frontier Res Core Life Sci, 3190 Gofuku, Toyama 9308555, Japan.	tsuchida@ctg.u-toyama.ac.jp			KAKENHI [23681050]; Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science and Technology; JSPS Research Fellowship for Young Scientist [12J09071]	We thank M. Aizawa, A. Arakawa, X. L. Bing, S. Hagihara, N. Haruyama, H. Iida, T. Itabashi, T. Kijima, T. Kitamura, K. Kuwabara, K. Miura, T. Morikawa, A. Nakano, K. Namai, M. Nishino, J. Ohnishi, I. Ohta, T. Ohya, H. Oida, R. Sakai, K. Sugiyama, Y. Tagami, M. Takeda, S. Ueda and M. Yamashiro for whitefly samples; M. Watanabe, D. Hwang, K. Shinyashiki, M. Chokei, N. Maeda and K. Isobe for technical and secretarial assistance; H. Matsuzawa, A. Kurata, M. Oida, T. Sugimoto and K. Yamada for helpful discussions. This work was supported by KAKENHI (Grant Number 23681050). T. T. was supported by the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science and Technology. A.F. was supported by a JSPS Research Fellowship for Young Scientist (Grant Number 12J09071).	Ahmed MZ, 2009, J APPL ENTOMOL, V133, P733, DOI 10.1111/j.1439-0418.2009.01442.x; Ahmed MZ, 2009, J PEST SCI, V83, P135; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Nakamura Y, 2009, APPL ENVIRON MICROB, V75, P6757, DOI 10.1128/AEM.01583-09; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Tsuchida T, 2014, APPL ENVIRON MICROB, V80, P525, DOI 10.1128/AEM.03049-13; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.ento.40.1.511; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Park J, 2012, J ASIA-PAC ENTOMOL, V15, P186, DOI 10.1016/j.aspen.2011.10.005; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Tsagkarakou A, 2007, B ENTOMOL RES, V97, P29, DOI 10.1017/S000748530700466X; Fukatsu T, 1999, MOL ECOL, V8, P1935, DOI 10.1046/j.1365-294x.1999.00795.x; Tsagkarakou A, 2012, B ENTOMOL RES, V102, P353, DOI 10.1017/S0007485311000757; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Parrella G, 2012, J PEST SCI, V85, P227, DOI 10.1007/s10340-012-0417-2; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Shatters RG, 2009, J ECON ENTOMOL, V102, P750; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Elbert A, 2000, PEST MANAG SCI, V56, P60, DOI 10.1002/(SICI)1526-4998(200001)56:1<60::AID-PS88>3.0.CO;2-K; Khasdan V, 2005, B ENTOMOL RES, V95, P605, DOI 10.1079/BER2005390; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Horowitz AR, 2003, PHYTOPARASITICA, V31, P94, DOI 10.1007/BF02979772; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Ueda S, 2006, PHYTOPARASITICA, V34, P405, DOI 10.1007/BF02981027; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hosokawa T, 2007, P R SOC B, V274, P1979, DOI 10.1098/rspb.2007.0620; Guirao P, 1997, B ENTOMOL RES, V87, P587; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651; Tsuchida T, 2011, BIOL LETTERS, V7, P245, DOI 10.1098/rsbl.2010.0699; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Chu D, 2012, J ECON ENTOMOL, V105, P242, DOI 10.1603/EC11039; Chiel E, 2009, ANN ENTOMOL SOC AM, V102, P413, DOI 10.1603/008.102.0309; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Bing XL, 2013, INSECT SCI, V20, P194, DOI 10.1111/j.1744-7917.2012.01522.x; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Li M, 2010, INT J PEST MANAGE, V56, P275, DOI 10.1080/09670871003743428; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev2007.04.020; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Bing XL, 2013, APPL ENVIRON MICROB, V79, P569, DOI 10.1128/AEM.03030-12; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Chu D, 2006, FLOR ENTOMOL, V89, P169; Pan HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034817, 10.1371/journal.pone.0041314]; Chu D, 2008, INSECT SCI, V15, P115, DOI 10.1111/j.1744.7917.2008.00191.x; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Dennehy TJ, 2005, NEW CHALLENGES MANAG; DesBarro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29; DesBarro PJ, 2011, ANNU REV ENTOMOL, V56, P1; Gauthier N, 2014, PEST MANAG SCI, V70, P1477, DOI 10.1002/ps.3733; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Gnankine O, 2013, INSECT CONSERV DIVER, V6, P411, DOI 10.1111/j.1752-4598.2012.00206.x; Hsieh CH, 2007, ENVIRON ENTOMOL, V36, P952, DOI 10.1603/0046-225X(2007)36[952:EFMMAP]2.0.CO;2; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Kijima K, 2012, JPN J APPL ENTOMOL Z, V56, P9, DOI 10.1303/jjaez.2012.9; Lee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063817; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Martinez-Carrillo JL, 2007, PHYTOPARASITICA, V35, P282, DOI 10.1007/BF02981162; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670; Mouton L, 2012, BMC MICROBIOL, V12, P10; Moya A, 2001, MOL ECOL, V10, P891, DOI 10.1046/j.1365-294X.2001.01221.x; Nauen R, 2002, PEST MANAG SCI, V58, P868, DOI 10.1002/ps.557; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; Okazaki S., 2010, B OITA AGR RES CTR A, V4, P13; Parrella G, 2013, PEST MANAG SCI, V70, P1514; Rana VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042168; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Skaljac M, 2013, B ENTOMOL RES, V103, P48, DOI 10.1017/S0007485312000399; Su Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01367; Su Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089002; Swofford D. L., 2000, PAUP PHYLOGENETIC AN; Ueda S, 2009, J APPL ENTOMOL, V133, P355, DOI 10.1111/j.1439-0418.2008.01379.x	82	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0931-2048	1439-0418		J APPL ENTOMOL	J. Appl. Entomol.	FEB	2015	139	1-2					55	66		10.1111/jen.12171		12	Entomology	Entomology	AY6YS	WOS:000347709200006		
J	Nomano, FY; Mitsui, H; Kimura, MT				Nomano, F. Y.; Mitsui, H.; Kimura, M. T.			Capacity of Japanese Asobara species (Hymenoptera; Braconidae) to parasitize a fruit pest Drosophila suzukii (Diptera; Drosophilidae)	JOURNAL OF APPLIED ENTOMOLOGY			English	Article						biological control; host use; molecular phylogeny; parasitoids	LARVAL PARASITOIDS; HOST ASSOCIATIONS; FRUGIVOROUS DROSOPHILIDS; JAPONICA HYMENOPTERA; ABUNDANCE; FLIES; DISTRIBUTIONS; DIVERSITY; NORTHERN; TABIDA	Drosophila suzukii is a pest of soft fruit such as cherry, strawberry or blueberry and recently colonized North America and Europe from Asia. In this study, we assessed the utility of Japanese Asobara species as agents for the biological control of this pest species by examining their host use in nature and their capacity to parasitize this pest species. From Japan, eight Asobara species including putative three undescribed species were found; Asobara japonica was recorded from all over Japan, Asobaratabida from high altitude areas in central and northern Japan, Asobararossica and Asobara rufescens from central to northern Japan, three undescribed species from central to western or southern Japan and Asobarapleuralis from a subtropical island of Japan. Among them, an undescribed species Asobara sp. TK1 may be useful as an agent for the biological control because it was recorded only from D.suzukii. All of the remaining seven species were generalists mainly using drosophilid species associated with fermenting fruits, and four of them had no or very low abilities to parasitize D.suzukii, indicating that these seven species are not or less appropriate as agents for biological control.	[Nomano, F. Y.; Mitsui, H.; Kimura, M. T.] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan	Kimura, MT (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.	mtk@ees.hokudai.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [23370005]	We thank Y. Murata, B. Novkovic and N. Kasuya for their help in molecular studies. This work was partly supported by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (No. 23370005).	VET LEM, 1984, OECOLOGIA, V61, P182, DOI 10.1007/BF00396757; Kasuya N, 2013, APPL ENTOMOL ZOOL, V48, P87, DOI 10.1007/s13355-012-0156-0; Ideo S, 2008, ENTOMOL SCI, V11, P1, DOI 10.1111/j.1479-8298.2007.00244.x; Mitsui H, 2010, EUR J ENTOMOL, V107, P535; Yorozuya H, 2006, ENTOMOL SCI, V9, P13, DOI 10.1111/j.1479-8298.2006.00149.x; Kimura MT, 2012, J NAT HIST, V46, P1947, DOI 10.1080/00222933.2012.707239; Wharton RA, 2002, INVERTEBR SYST, V16, P7, DOI 10.1071/IT01012; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Novkovic B, 2012, EUR J ENTOMOL, V109, P517; Murata Y, 2009, EUR J ENTOMOL, V106, P171; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Mitsui H, 2010, ENTOMOL SCI, V13, P60, DOI 10.1111/j.1479-8298.2010.00372.x; Kraaijeveld AR, 1999, J EVOLUTION BIOL, V12, P129, DOI 10.1046/j.1420-9101.1999.00016.x; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Kasuya N, 2013, ENTOMOL SCI, V16, P227, DOI 10.1111/j.1479-8298.2012.00544.x; Mitsui H, 2006, POPUL ECOL, V48, P233, DOI 10.1007/s10144-006-0260-5; DRIESSEN G, 1990, NETH J ZOOL, V40, P409; VET LEM, 1985, OIKOS, V44, P487, DOI 10.2307/3565790; Poyet M, 2013, PHYSIOL ENTOMOL, V38, P45, DOI 10.1111/phen.12002; Stacconi M. V. Rossi, 2013, Entomologia, V1, P11, DOI 10.4081/entomologia.2013.e3; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Lemeunier F., 1986, P147; Belokobylskij S.A., 1998, KEY INSECTS RUSSIAN, V4, P163; Carton Y., 1986, Genetics and Biology of Drosophila, V3e, P347; Fischer M, 2003, Z ARBEITSGEMEINSCH O, V553, P73; Fischer Maximilian, 2007, Linzer Biologische Beitraege, V39, P857; Fischer M, 2008, ANN NATURHIST MUS WI, V109, P131; Fischer M., 1988, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V90, P93; Kacsoh BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034721; Kanzawa T, 1939, YAMANASHI AGR EXP ST; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIMURA M T, 1977, Kontyu, V45, P571; Nishiharu S, 1980, THESIS TOKYO METROPO; Nixon G. E. J., 1939, Proceedings of the Royal Entomological Society of London (B), V8, P61; Ovruski Sergio, 2000, Integrated Pest Management Reviews, V5, P81, DOI 10.1023/A:1009652431251; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; VansAlphen JJM, 1982, NETH J ZOOL, V32, P215; VansLenteren JC, 1998, INT J INSECT MORPHOL, V27, P263; Walsh D. B., 2011, Journal of Integrated Pest Management, V2, pG1	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0931-2048	1439-0418		J APPL ENTOMOL	J. Appl. Entomol.	FEB	2015	139	1-2					105	113		10.1111/jen.12141		9	Entomology	Entomology	AY6YS	WOS:000347709200011		
J	Toyoda, K; Teramoto, H; Yukawa, H; Inui, M				Toyoda, Koichi; Teramoto, Haruhiko; Yukawa, Hideaki; Inui, Masayuki			Expanding the Regulatory Network Governed by the Extracytoplasmic Function Sigma Factor sigma(H) in Corynebacterium glutamicum	JOURNAL OF BACTERIOLOGY			English	Article							OXYGEN-DEPRIVATION CONDITIONS; STREPTOMYCES-COELICOLOR A3(2); OXIDATIVE STRESS-RESPONSE; SURVIVAL FOLLOWING HEAT; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; GENE-EXPRESSION; RNA-POLYMERASE; AMINO-ACIDS	The extracytoplasmic function sigma factor sigma(H) is responsible for the heat and oxidative stress response in Corynebacterium glutamicum. Due to the hierarchical nature of the regulatory network, previous transcriptome analyses have not been able to discriminate between direct and indirect targets of sigma(H). Here, we determined the direct genome-wide targets of sigma(H) using chromatin immunoprecipitation with microarray technology (ChIP-chip) for analysis of a deletion mutant of rshA, encoding an anti-sigma factor of sigma(H). Seventy-five sigma(H)-dependent promoters, including 39 new ones, were identified. sigma(H)-dependent, heat-inducible transcripts for several of the new targets, including ilvD encoding a labile Fe-S cluster enzyme, dihydroxy-acid dehydratase, were detected, and their 5' ends were mapped to the sigma(H)-dependent promoters identified. Interestingly, functional internal sigma(H)-dependent promoters were found in operon-like gene clusters involved in the pentose phosphate pathway, riboflavin biosynthesis, and Zn uptake. Accordingly, deletion of rshA resulted in hyperproduction of riboflavin and affected expression of Zn-responsive genes, possibly through intracellular Zn overload, indicating new physiological roles of sigma(H). Furthermore, sigA encoding the primary sigma factor was identified as a new target of sigma(H). Reporter assays demonstrated that the sigma(H)-dependent promoter upstream of sigA was highly heat inducible but much weaker than the known sigma(A)-dependent one. Our ChIP-chip analysis also detected the sigma(H)-dependent promoters upstream of rshA within the sigH-rshA operon and of sigB encoding a group 2 sigma factor, supporting the previous findings of their sigma(H)-dependent expression. Taken together, these results reveal an additional layer of the sigma factor regulatory network in C. glutamicum.	[Toyoda, Koichi; Teramoto, Haruhiko; Yukawa, Hideaki; Inui, Masayuki] Res Inst Innovat Technol Earth, Kyoto, Japan; [Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth, Kyoto, Japan.	mmg-lab@rite.or.jp					Mimitsuka T, 2007, BIOSCI BIOTECH BIOCH, V71, P2130, DOI 10.1271/bbb.60699; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Inui M, 2007, MICROBIOL-SGM, V153, P2491, DOI 10.1099/mic.0.2006/005587-0; Yamamoto S, 2013, BIOTECHNOL BIOENG, V110, P2938, DOI 10.1002/bit.24961; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Wendisch VF, 2006, CURR OPIN MICROBIOL, V9, P268, DOI 10.1016/j.mib.2006.03.001; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Kumagai H, 2000, ADV BIOCHEM ENG BIOT, V69, P71; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Frunzke J, 2008, MOL MICROBIOL, V67, P305, DOI 10.1111/j.1365-2958.2007.06020.x; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Toyoda K, 2011, J BACTERIOL, V193, P4123, DOI 10.1128/JB.00384-11; Okino S, 2008, APPL MICROBIOL BIOT, V78, P449, DOI 10.1007/s00253-007-1336-7; Kallifidas D, 2010, MICROBIOL-SGM, V156, P1661, DOI 10.1099/mic.0.037804-0; Toyoda K, 2013, J BACTERIOL, V195, P1718, DOI 10.1128/JB.00016-13; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Novotna J, 2003, MOL MICROBIOL, V48, P1289, DOI 10.1046/j.1365-2958.2003.03529.x; Gaballa A, 2002, MOL MICROBIOL, V45, P997, DOI 10.1046/j.1365-2958.2002.03068.x; Takemoto N, 2014, APPL MICROBIOL BIOT, V98, P4159, DOI 10.1007/s00253-014-5570-5; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8; FLINT DH, 1993, J BIOL CHEM, V268, P14732; Ren BB, 2008, MOL MICROBIOL, V70, P953, DOI 10.1111/j.1365-2958.2008.06464.x; Koh YS, 1999, MOL GEN GENET, V261, P374; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Schneider J, 2010, APPL MICROBIOL BIOT, V88, P859, DOI 10.1007/s00253-010-2778-x; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Kim MS, 2012, MOL MICROBIOL, V85, P326, DOI 10.1111/j.1365-2958.2012.08115.x; LONETTO MA, 1994, P NATL ACAD SCI USA, V91, P7573, DOI 10.1073/pnas.91.16.7573; Paget MSB, 2001, MOL MICROBIOL, V39, P1036, DOI 10.1046/j.1365-2958.2001.02298.x; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Holatko J, 2009, J BIOTECHNOL, V139, P203, DOI 10.1016/j.jbiotec.2008.12.005; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BROWN OR, 1978, BIOCHEM BIOPH RES CO, V85, P1219, DOI 10.1016/0006-291X(78)90672-1; Busche T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-445; CARTER HL, 1988, J BACTERIOL, V170, P1617; Choi WW, 2009, FEMS MICROBIOL LETT, V290, P32, DOI 10.1111/j.1574-6968.2008.01398.x; Ehira S, 2009, J BACTERIOL, V191, P2964, DOI 10.1128/JB.00112-09; Fernandes ND, 1999, J BACTERIOL, V181, P4266; Gaballa A, 1998, J BACTERIOL, V180, P5815; Halgasova N, 2001, CURR MICROBIOL, V43, P249, DOI 10.1007/s002840010296; Halliwell B., 1989, FREE RADICALS BIOL M; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Jochmann N, 2009, MICROBIOL-SGM, V155, P1459, DOI 10.1099/mic.0.025841-0; Kim MS, 2009, MOL MICROBIOL, V73, P815, DOI 10.1111/j.1365-2958.2009.06824.x; Kim TH, 2005, BIOCHEM BIOPH RES CO, V331, P1542, DOI 10.1016/j.bbrc.2005.04.073; Kim TH, 2005, BIOCHEM BIOPH RES CO, V337, P757, DOI 10.1016/j.bbrc.2005.09.115; Miller J. H., 1972, EXPT MOL GENETICS; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; Nakunst D, 2007, J BACTERIOL, V189, P4696, DOI 10.1128/JB.00382-07; Ollagnier-de Choudens S, 1999, FEBS LETT, V453, P25, DOI 10.1016/S0014-5793(99)00694-8; Park JH, 2008, MOL MICROBIOL, V68, P861, DOI 10.1111/j.1365-2958.2008.06191.x; QI FX, 1991, J BACTERIOL, V173, P7050; QI FX, 1990, J BACTERIOL, V172, P5631; Schroder J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-12; SKLIAROVA SA, 2012, GENETIKA, V48, P967; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; TAYLOR WE, 1984, CELL, V38, P371, DOI 10.1016/0092-8674(84)90492-6; Teramoto H, 2010, APPL ENVIRON MICROB, V76, P5488, DOI 10.1128/AEM.00906-10; Teramoto H, 2012, FEBS J, V279, P4385, DOI 10.1111/febs.12028; Toyoda K, 2008, APPL MICROBIOL BIOT, V81, P291, DOI 10.1007/s00253-008-1682-0; Waldminghaus T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-414; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	77	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	FEB	2015	197	3					483	496		10.1128/JB.02248-14		14	Microbiology	Microbiology	AY6LD	WOS:000347676800009		
J	Ikeya, T; Shibutani, M; Maeda, K; Sugano, K; Nagahara, H; Ohtani, H; Hirakawa, K				Ikeya, Tetsuro; Shibutani, Masatsune; Maeda, Kiyoshi; Sugano, Kenji; Nagahara, Hisashi; Ohtani, Hiroshi; Hirakawa, Kosei			Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						Onodera's prognostic nutritional index; Unresectable metastatic colorectal cancer; Prognostic factor; Chemotherapy	SERUM-ALBUMIN; GASTRIC-CARCINOMA; TUMOR; CHEMOTHERAPY; SURGERY; SUPPORT; STAGE	Nutrition and immunity significantly affect the progression of cancer in cancer patients. Therefore, the evaluation of the nutritional and immune status would be useful as a prognostic factor and to determine the optimal treatment strategy for patients with unresectable metastatic colorectal cancer who are receiving chemotherapy. The aim of this retrospective study was to evaluate the prognostic significance of the nutritional and immune status in patients with unresectable metastatic colorectal cancer treated with chemotherapy. We retrospectively reviewed 80 patients with colorectal cancer. A total of 22 patients had metachronous unresectable cancer, and 58 patients had synchronous unresectable cancer. All patients underwent combination chemotherapy with oxaliplatin or irinotecan plus 5-fluorouracil/leucovorin as first-line chemotherapy. We then examined the correlations between the Onodera's prognostic nutritional index (OPNI) and the patients' clinicopathological features. The OPNI was calculated as follows: 10 x serum albumin (g/dl) + 0.005 x total lymphocyte count (per mm(3)). According to the receiver operating characteristic (ROC) curve analysis, the cutoff value for OPNI was 44.5. Patients with a pretreatment OPNI of a parts per thousand 44.5 demonstrated a longer OS than those with a pretreatment OPNI of < 44.5. Moreover, we categorized these patients into four groups according to the combination of the pre- and post-treatment OPNI. The patients in the group with both OPNIs a parts per thousand yen44.5 exhibited a better prognosis compared to the other group (p = 0.001). The OPNI is considered to be a useful marker for predicting the long-term outcome in patients who receive chemotherapy for unresectable metastatic colorectal cancer.	[Ikeya, Tetsuro; Shibutani, Masatsune; Maeda, Kiyoshi; Sugano, Kenji; Nagahara, Hisashi; Ohtani, Hiroshi; Hirakawa, Kosei] Osaka City Univ Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka, Japan	Shibutani, M (reprint author), Osaka City Univ Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka, Japan.	fbxbj429@ybb.ne.jp					Onate-Ocana LF, 2007, ANN SURG ONCOL, V14, P381, DOI 10.1245/s10434-006-9093-x; Feng JF, 2014, THER CLIN RISK MANAG, V10, P1, DOI 10.2147/TCRM.S56159; Maeda K, 2014, WORLD J SURG, V38, P1217, DOI 10.1007/s00268-013-2386-x; Mehrkhani F, 2009, COLORECTAL DIS, V11, P157, DOI 10.1111/j.1463-1318.2008.01556.x; Kuhry E, 2008, CANCER TREAT REV, V34, P498, DOI 10.1016/j.ctrv.2008.03.011; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Nozoe T, 2012, SURG TODAY, V42, P532, DOI 10.1007/s00595-011-0061-0; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; Ceze N, 2011, CANCER CHEMOTH PHARM, V68, P1305, DOI 10.1007/s00280-011-1610-3; Fearon KCH, 1998, ANN SURG, V227, P249, DOI 10.1097/00000658-199802000-00015; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hoffmann TK, 2002, CLIN CANCER RES, V8, P2553; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042; Nozoe T, 2010, SURG TODAY, V40, P440, DOI 10.1007/s00595-009-4065-y; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; BAUER J, 1991, ANN HEMATOL, V62, P203, DOI 10.1007/BF01729833; Chojkier M, 2005, J CLIN GASTROENTEROL, V39, pS143, DOI 10.1097/01.mcg.0000155514.17715.39; Ciccolallo L, 2005, GUT, V54, P268, DOI 10.1136/gut.2004.044214; Dintinjana RD, 2008, COLLEGIUM ANTROPOL, V32, P737; Dobrila-Dintinjana R, 2013, HEPATO-GASTROENTEROL, V60, P475, DOI 10.5754/hge12710; Forones NM, 2001, HEPATO-GASTROENTEROL, V48, P1199; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; Kayama T., 2011, CANC STAT JAPAN 2011; Klek S, 2014, WORLD J SURG, V38, P803, DOI 10.1007/s00268-013-2323-z; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Sobin LH, 2009, TNM CLASSIFICATION M, P73; Zhang S, 2010, COLORECTAL DIS, V12, P754, DOI 10.1111/j.1463-1318.2009.01911.x	30	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	FEB	2015	141	2					307	313		10.1007/s00432-014-1799-8		7	Oncology	Oncology	AY8UF	WOS:000347828100012		
J	Okuma, Y; Saito, M; Hosomi, Y; Sakuyama, T; Okamura, T				Okuma, Yusuke; Saito, Makoto; Hosomi, Yukio; Sakuyama, Toshikazu; Okamura, Tatsuru			Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Review						Thymic malignancies; Thymic carcinoma; Thymoma; Rare cancer; Chemotherapy	PHASE-II TRIAL; SINGLE-INSTITUTION EXPERIENCE; COMBINATION CHEMOTHERAPY; INTERGROUP TRIAL; INVASIVE THYMOMA; INDUCTION CHEMOTHERAPY; RADIATION-THERAPY; LUNG-CANCER; CARCINOMA; DOXORUBICIN	Thymic malignancies, comprising thymoma and thymic carcinoma, are rare. Consequently, optimal chemotherapy for advanced thymic malignancies remains controversial. Platinum-based chemotherapy is currently the consensus treatment based on the results of single-arm phase II trials and retrospective investigations. However, comparison of cisplatin-based and carboplatin-based chemotherapy has yet to be undertaken; the effectiveness of the addition of anthracycline also remains uncertain. In the present study, clinical trials and retrospective data regarding platinum-based chemotherapy were analyzed. The endpoint was the response rate to each chemotherapy. For advanced thymoma, we compared platinum with anthracycline-based chemotherapy and platinum with non-anthracycline-based chemotherapy. For advanced thymic carcinoma, anthracycline-based versus non-anthracycline-based chemotherapy and carboplatin-based versus cisplatin-based chemotherapy were compared. This analysis included a retrospective study of response of advanced thymic carcinoma to irinotecan and cisplatin in our institution. The response rate for the 314 patients from 15 studies with advanced thymoma, including both prospective and retrospective data, was 69.4 % [95 % confidence interval (CI) 63.1-75.0 %] for platinum with anthracycline-based chemotherapy and 37.8 % (95 % CI 28.1-48.6 %; p < 0.0001) for platinum with non-anthracycline-based chemotherapy. The response rates after anthracycline-based and non-anthracycline-based chemotherapy for advanced thymic carcinoma were similar (41.8 vs. 40.9 %; p < 0.91), whereas the response rates after cisplatin-based and carboplatin-based chemotherapy for advanced thymic carcinoma differed significantly (53.6 vs. 32.8 %; p = 0.0029) in 206 patients from 10 studies. Platinum with anthracycline-based chemotherapy is an optimal combination for advanced thymoma. For advanced thymic carcinoma, cisplatin-based chemotherapy may be superior to carboplatin-based chemotherapy.	[Okuma, Yusuke; Hosomi, Yukio; Okamura, Tatsuru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Bunkyo Ku, Tokyo 1138677, Japan; [Okuma, Yusuke; Sakuyama, Toshikazu] Jikei Univ, Sch Med, Div Oncol, Res Ctr Med Sci, Tokyo, Japan; [Saito, Makoto] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Clin Res Support, Tokyo 1138677, Japan	Okuma, Y (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	y-okuma@cick.jp					Kunitoh H, 2009, BRIT J CANCER, V101, P1549, DOI 10.1038/sj.bjc.6605347; Engels EA, 2010, J THORAC ONCOL, V5, pS260, DOI 10.1097/JTO.0b013e3181f1f62d; Giaccone G, 1996, J CLIN ONCOL, V14, P814; Park S, 2013, J THORAC ONCOL, V8, P959, DOI 10.1097/JTO.0b013e318292c41e; Agatsuma T, 2011, J THORAC ONCOL, V6, P2130, DOI 10.1097/JTO.0b013e31822e71c0; Loehrer PJ, 2001, CANCER, V91, P2010, DOI 10.1002/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2; de Jong WK, 2008, EUR J CANCER, V44, P123, DOI 10.1016/j.ejca.2007.11.004; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710; LEVINE GD, 1978, HUM PATHOL, V9, P495; Lemma GL, 2011, J CLIN ONCOL, V29, P2060, DOI 10.1200/JCO.2010.32.9607; Yokoi K, 2007, J THORAC ONCOL, V2, P73, DOI 10.1097/JTO.0b013e31802bafc8; Gao LT, 2013, J THORAC ONCOL, V8, P1329, DOI 10.1097/JTO.0b013e31829ceb50; Sugiura H, 2010, J ORTHOP SCI, V15, P654, DOI 10.1007/s00776-010-1506-9; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; FORNASIERO A, 1991, CANCER, V68, P30, DOI 10.1002/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4; Detterbeck FC, 2013, J THORAC ONCOL, V8, P1467, DOI 10.1097/JTO.0000000000000017; LOEHRER PJ, 1994, J CLIN ONCOL, V12, P1164; Weksler B, 2013, ANN THORAC SURG, V95, P299, DOI 10.1016/j.athoracsur.2012.09.006; Igawa S, 2010, LUNG CANCER, V67, P194, DOI 10.1016/j.lungcan.2009.03.031; Zucali PA, 2013, LUNG CANCER, V79, P236, DOI 10.1016/j.lungcan.2012.11.015; Loehrer PJ, 1997, J CLIN ONCOL, V15, P3093; BERNATZ PE, 1961, J THORAC CARDIOV SUR, V42, P424; Berruti A, 1999, BRIT J CANCER, V81, P841, DOI 10.1038/sj.bjc.6690773; Engel P, 1999, PATHOL RES PRACT, V195, P565; Furugen M, 2011, JPN J CLIN ONCOL, V41, P1013, DOI 10.1093/jjco/hyr089; Girard N, 2011, J THORAC ONCOL, V6, pS1749, DOI 10.1097/JTO.0b013e31821ea5f7; Grassin F, 2011, J THORAC ONCOL, V5, P893; Huang J, 2010, J THORAC ONCOL, V5, P2017, DOI 10.1097/JTO.0b013e3181f13682; Kawashima Y, 2013, ASCO M ABSTR S, V31, P7530; Kim ES, 2004, LUNG CANCER-J IASLC, V44, P369, DOI 10.1016/j.lungcan.2003.12.010; Lauriola L, 1998, AM J SURG PATHOL, V22, P1059, DOI 10.1097/00000478-199809000-00003; Lucchi M, 2006, J THORAC ONCOL, V1, P308, DOI 10.1097/01243894-200605000-00007; Masaoka A, 2010, J THORAC ONCOL, V5, pS304, DOI 10.1097/JTO.0b013e3181f20c05; Monica V, 2013, LUNG CANCER, V79, P228, DOI 10.1016/j.lungcan.2012.12.003; Müller-Hermelink H K, 1986, Curr Top Pathol, V75, P207; Noda Kazumasa, 2002, New England Journal of Medicine, V346, P85, DOI 10.1056/NEJMoa003034; Noguchi T, 2005, SUMITOMO KAGAKU, V2005-II, P1; Okuma Y, 2011, LUNG CANCER, V74, P492, DOI 10.1016/j.lungcan.2011.05.013; REA F, 1993, J THORAC CARDIOV SUR, V106, P543; Schmitt J, 2010, J THORAC ONCOL, V5, pS357, DOI 10.1097/JTO.0b013e3181f21129; Sobin LH, 1999, WHO INT HISTOLOGICAL, V2nd; Takeda K, 2013, ASCO M ABSTR S, V31, P7529; Travis W, 2004, WHO CLASSIFICATION T; Yoh K, 2003, CANCER, V98, P926, DOI 10.1002/cncr.11606	44	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	FEB	2015	141	2					323	331		10.1007/s00432-014-1800-6		9	Oncology	Oncology	AY8UF	WOS:000347828100014		
J	Denzer, UW; Rosch, T; Hoytat, B; Abdel-Hamid, M; Hebuterne, X; Vanbiervielt, G; Filippi, J; Ogata, H; Hosoe, N; Ohtsuka, K; Ogata, N; Ikeda, K; Aihara, H; Kudo, SE; Tajiri, H; Treszl, A; Wegscheider, K; Greff, M; Rey, JF				Denzer, Ulrike W.; Roesch, Thomas; Hoytat, Bilal; Abdel-Hamid, Mohammed; Hebuterne, Xavier; Vanbiervielt, Geoffroy; Filippi, Jerome; Ogata, Haruiko; Hosoe, Naoki; Ohtsuka, Kazuo; Ogata, Noriyuki; Ikeda, Keiichi; Aihara, Hiroyuki; Kudo, Shin-Ei; Tajiri, Hisao; Treszl, Andras; Wegscheider, Karl; Greff, Michel; Rey, Jean-Francois			Magnetically Guided Capsule Versus Conventional Gastroscopy for Upper Abdominal Complaints A Prospective Blinded Study	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						gastroscopy; capsule endoscopy; gastric cancer screening	GASTROINTESTINAL ENDOSCOPY; EUROPEAN-SOCIETY; HELICOBACTER-PYLORI; GASTRIC-CANCER; VIDEO CAPSULE; SMALL-BOWEL; ESOPHAGEAL; SEDATION; PROPOFOL	Objectives: Upper gastrointestinal endoscopy is mostly performed under sedation and has a low yield of relevant gastric lesions in patients without alarm symptoms. Simpler screening tests such as capsule endoscopy could be helpful, but gastric visualization is insufficient with the current passive capsules. A magnetically guided gastric capsule was prospectively evaluated in patients with routine indications for gastroscopy. Methods: A total of 189 symptomatic patients (105 male; mean age 53 y) from 2 French centers subsequently and blindly underwent capsule and conventional gastroscopy by 9 and 6 examiners, respectively. The final gold standard was unblinded conventional gastroscopy with biopsy under propofol sedation. Main outcome was accuracy (sensitivity/specificity) of capsule gastroscopy for diagnosis of major gastric lesions, defined as those lesions requiring conventional gastroscopy for biopsy or removal. Results: Twenty-three major lesions were found in 21 patients. Capsule accuracy was 90.5% [95% confidence interval (CI), 85.4%-94.3%] with a specificity of 94.1% (95% CI, 89.3%-97.1%) and a sensitivity of 61.9% (95% CI, 38%-82%). Accuracy did not correlate with lesion location, gastric luminal visibility, examiner case volume, or examination time. Of the remaining 168 patients, 94% had minor and mostly multiple lesions; the capsule made a correct diagnosis in 88.1% (95% CI, 82.2%-92.6%), with gastric visibility and lesion location in the proximal stomach having significant influence. All patients preferred capsule gastroscopy. Conclusions: In a prospective and strictly blinded study, magnetically guided capsule gastroscopy was shown to be feasible in clinical practice and was clearly preferred by patients. Improvements in capsule technology may render this technique a future alternative to gastroscopy.	[Denzer, Ulrike W.; Roesch, Thomas] Univ Hosp Hamburg Eppendorf, Dept Interdisciplinary Endoscopy, D-20246 Hamburg, Germany; [Treszl, Andras; Wegscheider, Karl] Univ Hosp Hamburg Eppendorf, Dept Med Biometry & Epidemiol, D-20246 Hamburg, Germany; [Hoytat, Bilal; Abdel-Hamid, Mohammed; Greff, Michel; Rey, Jean-Francois] Inst Arnault Tzanck, Dept Gastroenterol, St Laurent Du Var, France; [Hebuterne, Xavier; Vanbiervielt, Geoffroy; Filippi, Jerome] CHU Nice, Dept Gastroenterol, F-06202 Nice, France; [Hebuterne, Xavier; Vanbiervielt, Geoffroy; Filippi, Jerome] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Ogata, Haruiko; Hosoe, Naoki; Aihara, Hiroyuki] Keio Univ, Sch Med, Tokyo, Japan; [Ikeda, Keiichi; Tajiri, Hisao] Jikei Univ, Sch Med, Tokyo, Japan; [Ohtsuka, Kazuo; Ogata, Noriyuki; Kudo, Shin-Ei] Showa Univ, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan	Denzer, UW (reprint author), Univ Hosp Hamburg Eppendorf, Dept Interdisciplinary Endoscopy, Martinistr 52, D-20246 Hamburg, Germany.	u.denzer@uke.de			Siemens AG Healthcare sector, Germany; Japan Ministry of Health; Kings College London; MSD; Abbott; Nutricia; Fresenius-Kabi; Nestle	Supported by Olympus Co. (Hamburg, Germany) and Siemens Co. (Erlangen, Germany) by providing and maintaining equipment in St. Laurent du Var, covering the costs of ethical approval and study registration. Concerning the study, H.T., N.H., B.H., I.K., T.R., and U.W.D. received travel and hotel costs as participating physicians for study planning meetings and study performance in St. Laurent du Var. J.-F.R. and H.A. received a grant from Siemens AG Healthcare sector, Germany and financial support for consultancy for Olympus Medical Syst. Corp. Japan.; K.O. declared payment for consultancy and payment for lectures, S.-E.K. received a grant from the Japan Ministry of Health, payment for lectures from the Kings College London, and Royalties from Intestine, a Japanese journal. X.H. declares financial support due to board membership (companies: Abbott laboratories, Nestle, and Fresenius-Kabi), payment for lectures (MSD, Abbott, Nutricia, Fresenius-Kabi), and payment for development of educational presentations (MSD, Abbott, Nutricia, Nestle). J.F. received money for board membership (AbbVie, Astellas pharma) and payment for lectures (AbbVie, Ferring, Norgine, MSD). The remaining authors declare that they have nothing to disclose.	Koulaouzidis A, 2012, GASTROINTEST ENDOSC, V76, P983, DOI 10.1016/j.gie.2012.07.035; Keller J, 2011, GASTROINTEST ENDOSC, V73, P22, DOI 10.1016/j.gie.2010.08.053; Rey JF, 2012, GASTROINTEST ENDOSC, V75, P373, DOI 10.1016/j.gie.2011.09.030; Heuss LT, 2012, ENDOSCOPY, V44, P504, DOI 10.1055/s-0031-1291668; Spada C, 2012, ENDOSCOPY, V44, P527, DOI 10.1055/s-0031-1291717; Selgrad M, 2010, HELICOBACTER, V15, P40, DOI 10.1111/j.1523-5378.2010.00783.x; Ladas SD, 2010, ENDOSCOPY, V42, P220, DOI 10.1055/s-0029-1243968; Dumonceau JM, 2010, ENDOSCOPY, V42, P960, DOI 10.1055/s-0030-1255728; Miki K, 2011, P JPN ACAD B-PHYS, V87, P405, DOI 10.2183/pjab.87.405; Rey JF, 2010, ENDOSCOPY, V42, P541, DOI 10.1055/s-0030-1255521; Keller J, 2010, GASTROINTEST ENDOSC, V72, P941, DOI 10.1016/j.gie.2010.06.053; Agreus L, 2012, SCAND J GASTROENTERO, V47, P136, DOI 10.3109/00365521.2011.645501; Dumonceau JM, 2012, ENDOSCOPY, V44, P403, DOI 10.1055/s-0031-1291654; Eliakim R, 2004, ALIMENT PHARM THERAP, V20, P1083, DOI 10.1111/j-1365-2036.2004.02206.x; Neu B, 2003, ENDOSCOPY, V35, P957; Redondo-Cerezo E, 2005, GUT, V54, P309, DOI 10.1136/gut.2004.051318; Sharma VK, 2005, ENDOSCOPY, V37, P1060, DOI 10.1055/s-870311; Vargo JJ, 2012, GASTROENTEROLOGY, V143, pe18; Waterman M, 2009, J CLIN GASTROENTEROL, V43, P605, DOI 10.1097/MCG.0b013e3181aabd93	19	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	FEB	2015	49	2					101	107				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AY7DA	WOS:000347720300005		
J	Miyaki, R; Yoshida, S; Tanaka, S; Kominami, Y; Sanomura, Y; Matsuo, T; Oka, S; Raytchev, B; Tamaki, T; Koide, T; Kaneda, K; Yoshihara, M; Chayama, K				Miyaki, Rie; Yoshida, Shigeto; Tanaka, Shinji; Kominami, Yoko; Sanomura, Yoji; Matsuo, Taiji; Oka, Shiro; Raytchev, Bisser; Tamaki, Toru; Koide, Tetsushi; Kaneda, Kazufumi; Yoshihara, Masaharu; Chayama, Kazuaki			A Computer System To Be Used With Laser-based Endoscopy for Quantitative Diagnosis of Early Gastric Cancer	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						laser-based endoscopy; early gastric cancer; magnifying endoscopy; quantitative analysis	COLORECTAL TUMOR CLASSIFICATION; MAGNIFYING ENDOSCOPY; FEATURES	Goals: To evaluate the usefulness of a newly devised computer system for use with laser-based endoscopy in differentiating between early gastric cancer, reddened lesions, and surrounding tissue. Background: Narrow-band imaging based on laser light illumination has come into recent use. We devised a support vector machine (SVM)-based analysis system to be used with the newly devised endoscopy system to quantitatively identify gastric cancer on images obtained by magnifying endoscopy with blue-laser imaging (BLI). We evaluated the usefulness of the computer system in combination with the new endoscopy system. Study: We evaluated the system as applied to 100 consecutive early gastric cancers in 95 patients examined by BLI magnification at Hiroshima University Hospital. We produced a set of images from the 100 early gastric cancers; 40 flat or slightly depressed, small, reddened lesions; and surrounding tissues, and we attempted to identify gastric cancer, reddened lesions, and surrounding tissue quantitatively. Results: The average SVM output value was 0.846 +/- 0.220 for cancerous lesions, 0.381 +/- 0.349 for reddened lesions, and 0.219 +/- 0.277 for surrounding tissue, with the SVM output value for cancerous lesions being significantly greater than that for reddened lesions or surrounding tissue. The average SVM output value for differentiated-type cancer was 0.840 +/- 0.207 and for undifferentiated-type cancer was 0.865 +/- 0.259. Conclusions: Although further development is needed, we conclude that our computer-based analysis system used with BLI will identify gastric cancers quantitatively.	[Miyaki, Rie; Kominami, Yoko; Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Grad Sch Engn, Hiroshima 7348551, Japan; [Yoshida, Shigeto; Tanaka, Shinji; Sanomura, Yoji; Matsuo, Taiji; Oka, Shiro] Hiroshima Univ, Dept Endoscopy & Med, Grad Sch Engn, Hiroshima 7348551, Japan; [Raytchev, Bisser; Tamaki, Toru; Kaneda, Kazufumi] Hiroshima Univ, Dept Informat Engn, Grad Sch Engn, Hiroshima 7348551, Japan; [Koide, Tetsushi] Hiroshima Univ, Res Inst Nanodevice & Bio Syst, Hiroshima 7348551, Japan; [Yoshihara, Masaharu] Hiroshima Univ, Dept Hlth Serv Ctr, Hiroshima 7348551, Japan	Yoshida, S (reprint author), Hiroshima Univ, Dept Endoscopy & Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	yoshida7@hiroshima-u.ac.jp	Kaneda, Kazufumi/J-5562-2015; Tamaki, Toru/D-7091-2011	Kaneda, Kazufumi/0000-0002-5231-1826; Tamaki, Toru/0000-0001-9712-7777			Tamaki T, 2013, MED IMAGE ANAL, V17, P78, DOI 10.1016/j.media.2012.08.003; Nowak E, 2006, LECT NOTES COMPUT SC, V3954, P490; Ke Y, 2004, PROC CVPR IEEE, P506; Viola P, 2001, PROC CVPR IEEE, P511; Yao K, 2007, CLIN GASTROENTEROL H, V5, P869, DOI 10.1016/j.cgh.2007.02.034; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Yao K, 2009, ENDOSCOPY, V41, P462, DOI 10.1055/s-0029-1214594; Mian AS, 2008, INT J COMPUT VISION, V79, P1, DOI 10.1007/s11263-007-0085-5; Kato M, 2010, GASTROINTEST ENDOSC, V72, P523, DOI 10.1016/j.gie.2010.04.041; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Csurka G., 2004, WORKSH STAT LEARN CO, V1, P1, DOI DOI 10.1234/12345678; DaCosta R. S., 2003, DIGEST ENDOSC, V15, P153, DOI 10.1046/j.1443-1661.2003.00239.x; Jun L, 2007, P IEEE ICASSP2007, V2, P593; Lazebnik S, 2006, P IEEE C COMP VIS PA, V2, P264; Miyaki R, 2013, J GASTROEN HEPATOL, V28, P841, DOI 10.1111/jgh.12149; Muguruma N, 2008, DIGEST ENDOSC, V20, P101, DOI 10.1111/j.1443-1661.2008.00786.x; Tajiri H, 2001, CANCER DETECT PREV, V25, P166; Tajiri H, 2002, ENDOSCOPY, V34, P772, DOI 10.1055/s-2002-34267; Takemura Y, 2012, GASTROINTEST ENDOSC, V75, P179, DOI 10.1016/j.gie.2011.08.051; Tamaki T, 2011, LECT NOTES COMPUT SC, V6493, P452; Thakur M, 2005, RADIOLOGY, V236, P753, DOI 10.1148/radiol.236051160	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	FEB	2015	49	2					108	115				8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AY7DA	WOS:000347720300006		
J	Tanaka, Y; Sato, K; Tsuchida, H; Mizuide, M; Yasuoka, H; Ishida, K; Mori, M; Kusano, M; Yamada, M				Tanaka, Yoshiki; Sato, Ken; Tsuchida, Hiroyuki; Mizuide, Masafumi; Yasuoka, Hidetoshi; Ishida, Katsutoshi; Mori, Masatomo; Kusano, Motoyasu; Yamada, Masanobu			A Prospective Randomized Controlled Study of Endoscopic Sphincterotomy With the Endocut Mode or Conventional Blended Cut Mode	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						endoscopic sphincterotomy; Endocut mode; conventional blended cut mode; complication; efficacy	BILIARY SPHINCTEROTOMY; ELECTROSURGICAL CURRENT; PURE-CUT; COMPLICATIONS; CHOLEDOCHOLITHIASIS; PANCREATITIS; EXPERIENCE; TRIAL	Background: Although the potential advantages of the Endocut mode (E-mode) of endoscopic sphincterotomy (EST) over the conventional blended cut mode (C-mode) have been reported, the problems, including the small sample size and retrospective analysis, that occurred in previous studies make it difficult to conclude the advantage of the E-mode regarding the safety and efficacy. We performed a prospective randomized controlled study to compare these modes. Methods: A total of 360 patients with choledocholithiasis or stenosis of the bile duct were randomly assigned to one of the modes. To avoid the technical bias due to multiple operators or institutions, the main operator and the institution were restricted to only one experienced doctor and 3 institutions at his place of employment, respectively. We defined pancreatitis, bleeding, and perforation as complications of EST. Besides, bleeding includes endoscopically evident bleeding that was defined as visible during the procedure of sphincterotomy and temporary slight oozing. Results: The complications occurred in 20 (11.2%) patients from the E-mode group: pancreatitis in 6 (3.4%) and endoscopically evident bleeding in 14 (7.8%). In contrast, the complications occurred in 25 (13.8%) patients from the C-mode group: pancreatitis in 7 (3.9%) and endoscopically evident bleeding in 18 (9.9%), although these findings were not statistically significant. Overall, there were no severe complications. There were no significant differences in completion ratio of EST and the time taken for the sphincterotomy between both groups. Conclusions: The E-mode could not surpass the C-mode in safety and efficacy under the operation by a single endoscopist.	[Tanaka, Yoshiki] Saiseikai Maebashi Hosp, Dept Gastroenterol, Maebashi, Gunma, Japan; [Sato, Ken; Tsuchida, Hiroyuki; Mizuide, Masafumi; Mori, Masatomo; Yamada, Masanobu] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 3718511, Japan; [Yasuoka, Hidetoshi; Ishida, Katsutoshi] Tone Chuo Hosp, Dept Internal Med, Numata, Japan; [Kusano, Motoyasu] Gunma Univ Hosp, Dept Endoscopy & Endoscop Surg, Maebashi, Gunma, Japan	Sato, K (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	satoken@gunma-u.ac.jp			Japanese foundation for research and promotion of endoscopy	Supported by a grant from the Japanese foundation for research and promotion of endoscopy.	Akiho H, 2006, WORLD J GASTROENTERO, V12, P2086; Aliperti G, 1996, Gastrointest Endosc Clin N Am, V6, P379; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Perini RF, 2005, GASTROINTEST ENDOSC, V61, P53, DOI 10.1016/S0016-5107(04)02454-X; Freeman ML, 1997, ENDOSCOPY, V29, P288, DOI 10.1055/s-2007-1004193; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P845, DOI 10.1016/S0016-5107(04)00353-0; Rabenstein T, 1999, GASTROINTEST ENDOSC, V50, P628, DOI 10.1016/S0016-5107(99)80010-8; Katsinelos P, 2011, ENDOSCOPY, V43, P128, DOI 10.1055/s-0030-1255934; Verma D, 2007, GASTROINTEST ENDOSC, V66, P283, DOI 10.1016/j.gie.2007.01.018; Maydeo A, 2003, ENDOSCOPY, V35, pS19; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Elfant AB, 1996, AM J GASTROENTEROL, V91, P1499; Elta GH, 1998, GASTROINTEST ENDOSC, V47, P149, DOI 10.1016/S0016-5107(98)70348-7; Kohler A, 1998, ENDOSCOPY, V30, P351, DOI 10.1055/s-2007-1001281; Norton ID, 2005, CLIN GASTROENTEROL H, V3, P1029, DOI 10.1053/S1542-3565(05)00528-8; SHERMAN S, 1991, PANCREAS, V6, P350, DOI 10.1097/00006676-199105000-00013; SHERMAN S, 1991, GASTROENTEROLOGY, V101, P1068; Shinozuka N, 2001, NIHONGEKAKEIRENGOUGA, V26, P41; SIEGEL JH, 1994, AM J GASTROENTEROL, V89, P1827; Slivka A, 2003, GASTROINTEST ENDOSC, V58, P656; Stefanidis G, 2003, GASTROINTEST ENDOSC, V57, P192, DOI 10.1067/mge.2003.61; TAUNTON JC, 1981, J MED ENG TECHNOL, V5, P175, DOI 10.3109/03091908109064282	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	FEB	2015	49	2					127	131				5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AY7DA	WOS:000347720300009		
J	Kessoku, T; Yoneda, M; Sumida, Y; Eguchi, Y; Fujii, H; Hyogo, H; Ono, M; Kawaguchi, T; Nakajima, A				Kessoku, Takaomi; Yoneda, Masato; Sumida, Yoshio; Eguchi, Yuichiro; Fujii, Hideki; Hyogo, Hideyuki; Ono, Masafumi; Kawaguchi, Takumi; Nakajima, Atsushi		JSG-NAFLD	Insulin Resistance Correlated With the Severity of Liver Histology in Japanese NAFLD Patients: A Multicenter Retrospective Study	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Letter							SCORING SYSTEM; DISEASE; STEATOHEPATITIS		[Kessoku, Takaomi; Yoneda, Masato; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa 232, Japan; [Sumida, Yoshio] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan; [Eguchi, Yuichiro] Saga Med Sch, Dept Gen Med, Saga, Japan; [Fujii, Hideki] Osaka City Univ, Dept Hepatol, Osaka 558, Japan; [Hyogo, Hideyuki] Hiroshima Univ, Dept Gastroenterol & Metab, Hiroshima, Japan; [Ono, Masafumi] Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan; [Kawaguchi, Takumi] Kurume Univ, Sch Med, Dept Gastroenterol, Kurume, Fukuoka 830, Japan	Kessoku, T (reprint author), Yokohama City Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa 232, Japan.						Kessoku T, 2014, WORLD J GASTROENTERO, V20, P10108, DOI 10.3748/wjg.v20.i29.10108; Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Jung Kyong Yeun, 2014, J Clin Gastroenterol, V48, P883, DOI 10.1097/MCG.0000000000000065; Neuschwander-Tetri Brent A, 2010, Hepatology, V52, P913, DOI 10.1002/hep.23784	6	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	FEB	2015	49	2					169	170				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AY7DA	WOS:000347720300016		
J	Matsubayashi, H				Matsubayashi, Hiroyuki			Role of K-ras Mutation Analysis in EUS-FNA Samples Obtained From Pancreatic Solid Mass	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Letter							KRAS MUTATION; CARCINOMA; CANCER; SPECIMENS; DIAGNOSIS		Shizuoka Canc Ctr, Div Endoscopy, Shizuoka, Japan	Matsubayashi, H (reprint author), Shizuoka Canc Ctr, Div Endoscopy, Shizuoka, Japan.						Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Heinemann V, 2013, GUT, V62, P751, DOI 10.1136/gutjnl-2012-302759; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Fuccio L, 2013, GASTROINTEST ENDOSC, V78, P596, DOI 10.1016/j.gie.2013.04.162; Bournet B, 2015, J CLIN GASTROENTEROL, V49, P50, DOI 10.1097/MCG.0000000000000053; Matsubayashi H, 1998, CANCER, V82, P651, DOI 10.1002/(SICI)1097-0142(19980215)82:4<651::AID-CNCR6>3.0.CO;2-O; Matsubayashi H, 2000, PANCREAS, V21, P77, DOI 10.1097/00006676-200007000-00055; Moore PS, 2001, BRIT J CANCER, V84, P253, DOI 10.1054/bjoc.2000.1567	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	FEB	2015	49	2					173	173				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AY7DA	WOS:000347720300022		
J	Takahashi, M; Onozawa, S; Ogawa, R; Uesawa, Y; Echizen, H				Takahashi, M.; Onozawa, S.; Ogawa, R.; Uesawa, Y.; Echizen, H.			Predictive performance of three practical approaches for grapefruit juice-induced 2-fold or greater increases in AUC of concomitantly administered drugs	JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS			English	Article						area under curve; bioavailability; drug interactions; grapefruit juice; predictive value	PHARMACOKINETICS; INHIBITION; AMLODIPINE; TRANSPORT; EXTENT	What is known and objectiveClinical pharmacists have a challenging task when answering patients' question about whether they can take specific drugs with grapefruit juice (GFJ) without risk of drug interaction. To identify the most practicable method for predicting clinically relevant changes in plasma concentrations of orally administered drugs caused by the ingestion of GFJ, we compared the predictive performance of three methods using data obtained from the literature. MethodsWe undertook a systematic search of drug interactions associated with GFJ using MEDLINE and the Metabolism & Transport Drug Interaction Database (DIDB version 4.0). We considered an elevation of the area under the plasma concentrationtime curve (AUC) of 2 or greater relative to the control value [AUC ratio (AUCR)20] as a clinically significant interaction. Results and discussionThe data from 74 drugs (194 data sets) were analysed. When the reported information of CYP3A involvement in the metabolism of a drug of interest was adopted as a predictive criterion for GFJdrug interaction, the performance assessed by positive predictive value (PPV) was low (026), but that assessed by negative predictive value (NPV) and sensitivity was high (100 for both). When the reported oral bioavailability of 01 was used as a criterion, the PPV improved to 050 with an acceptable NPV of 081, but sensitivity was reduced to 021. When the reported AUCR was 10 after co-administration of a typical CYP3A inhibitor, the corresponding values were 064, 079 and 019, respectively. What is new and conclusionWe consider that an oral bioavailability of 01 or an AUCR of 10 caused by a CYP3A inhibitor of a drug of interest may be a practical prediction criterion for avoiding significant interactions with GFJ. Information about the involvement of CYP3A in their metabolism should also be taken into account for drugs with narrow therapeutic ranges.	[Takahashi, M.; Onozawa, S.; Ogawa, R.; Echizen, H.] Meiji Pharmaceut Univ, Dept Pharmacotherapy, Kiyose 2048588, Japan; [Uesawa, Y.] Meiji Pharmaceut Univ, Dept Clin Pharmaceut, Kiyose 2048588, Japan	Takahashi, M (reprint author), Meiji Pharmaceut Univ, Dept Pharmacotherapy, 2-522-1 Noshio, Kiyose 2048588, Japan.	t-masa@my-pharm.ac.jp					American Pharmacists Association, 2013, DRUG INF HDB COMPR R; Seden K, 2010, DRUGS, V70, P2373, DOI 10.2165/11585250-000000000-00000; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Lilja JJ, 1998, CLIN PHARMACOL THER, V64, P477, DOI 10.1016/S0009-9236(98)90130-8; Veronese ML, 2003, J CLIN PHARMACOL, V43, P831, DOI 10.1177/0091270003256059; Kato Y, 2009, J PHARM SCI-US, V98, P2529, DOI 10.1002/jps.21618; Shirasaka Y, 2010, J PHARMACOL EXP THER, V332, P181, DOI 10.1124/jpet.109.159756; Bailey DG, 2010, BRIT J CLIN PHARMACO, V70, P645, DOI 10.1111/j.1365-2125.2010.03722.x; Cupp M, 2013, 290101 PL; EDGAR B, 1992, EUR J CLIN PHARMACOL, V42, P313; Food and Drug Administration, 2012, GUID IND DR IN PRESS; Gertz M, 2008, CURR DRUG METAB, V9, P785, DOI 10.2174/138920008786049276; Josefsson M, 1996, EUR J CLIN PHARMACOL, V51, P189, DOI 10.1007/s002280050183; Ohnishi A, 2006, BRIT J CLIN PHARMACO, V62, P196, DOI 10.1111/j.1365-2125.2006.02636.x; Thummel KE, 2010, GOODMAN GILMANS PHAR, P1891; Uesawa Y, 2012, CURR PHARM BIOTECHNO, V13, P1705; Vincent J, 2000, BRIT J CLIN PHARMACO, V50, P455, DOI 10.1046/j.1365-2125.2000.00283.x	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-4727	1365-2710		J CLIN PHARM THER	J. Clin. Pharm. Ther.	FEB	2015	40	1					91	97		10.1111/jcpt.12231		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX9RR	WOS:000347240200014		
J	Akamine, Y; Miura, M; Yasui-Furukori, N; Ieiri, I; Uno, T				Akamine, Y.; Miura, M.; Yasui-Furukori, N.; Ieiri, I.; Uno, T.			Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers	JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS			English	Article						enantiomer; fexofenadine; organic anion-transporting polypeptides; pharmacokinetics; rifampicin; standard dose	HEALTHY-SUBJECTS; P-GLYCOPROTEIN; APPLE JUICE; TRANSPORTER INHIBITION; PLASMA-CONCENTRATIONS; OATP TRANSPORTERS; DRUG INTERACTION; HEPATIC-UPTAKE; ATORVASTATIN; DISPOSITION	What is known and objectiveRifampicin is a potent inducer of P-glycoprotein (P-gp) and inhibitor of organic anion-transporting polypeptides (OATPs), with fexofenadine acting as a substrate for both mechanisms. Simultaneous administration of single- or multiple-dose rifampicin 600mg significantly increases the concentrations of fexofenadine enantiomers by inhibiting OATP transporters. However, the effects of rifampicin 450mg are unknown. Here, we evaluated the effects of multiple doses of rifampicin 450mg on the pharmacokinetics of fexofenadine enantiomers in healthy Japanese volunteers. MethodsIn this randomized, two-phase, double-blind crossover study, 10 healthy volunteers received rifampicin 450mg/day or placebo for 7days. On day 7, fexofenadine 60mg was co-administered simultaneously. Results and discussionRifampicin significantly increased the mean area under the plasma concentration-time curve (AUC) of (R)- and (S)-fexofenadine (310-fold and 348-fold, respectively) and decreased the renal clearance of (R)- and (S)-fexofenadine (040-fold and 047-fold, respectively), causing marked differences in the mean amounts of these enantiomers excreted into the urine in the rifampicin phase (P<0001). These results indicated that multiple doses of rifampicin 450mg may be sufficient to inhibit the renal influx transporter and OATP-mediated hepatic uptake of both enantiomers. Moreover, these effects may be greater than the P-gp-inductive effects of rifampicin. Therefore, the interactive mechanism of multidose rifampicin may occur through a combination of OATP and P-gp transporters, thereby altering the pharmacokinetics of fexofenadine enantiomers. What is new and conclusionsIn this study of rifampicin 450mg, the interactive magnitude of the mean AUC values of fexofenadine enantiomers was higher than that observed in the previous study of rifampicin 600mg, and no dose-dependent inhibitory effects of rifampicin were observed. These effects may be clinically significant in patients receiving fexofenadine and rifampicin.	[Akamine, Y.; Uno, T.] Univ Ryukyus, Fac Med, Dept Hosp Pharm, Okinawa, Japan; [Akamine, Y.; Ieiri, I.] Kyushu Univ, Dept Clin Pharmacokinet, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Miura, M.] Akita Univ Hosp, Dept Pharm, Akita 0108543, Japan; [Yasui-Furukori, N.] Hirosaki Univ Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan	Miura, M (reprint author), Akita Univ Hosp, Dept Pharm, 1-1-1 Hondo, Akita 0108543, Japan.	m-miura@hos.akita-u.ac.jp					Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615; Vavricka SR, 2002, HEPATOLOGY, V36, P164, DOI 10.1053/jhep.2002.34133; Zheng HX, 2009, CLIN PHARMACOL THER, V85, P78, DOI 10.1038/clpt.2008.186; Tateishi T, 2008, BRIT J CLIN PHARMACO, V65, P693, DOI 10.1111/j.1365-2125.2008.03116.x; Kusuhara H, 2013, DRUG METAB DISPOS, V41, P206, DOI 10.1124/dmd.112.048330; Glaeser H, 2007, CLIN PHARMACOL THER, V81, P362, DOI 10.1038/sj.clpt.6100056; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Hamman MA, 2001, CLIN PHARMACOL THER, V69, P114, DOI 10.1067/mcp.2001.113697; Schuetz EG, 1996, MOL PHARMACOL, V49, P311; Miura M, 2007, CHIRALITY, V19, P223, DOI 10.1002/chir.20370; Nakanishi T, 2012, DRUG METAB PHARMACOK, V27, P106, DOI 10.2133/dmpk.DMPK-11-RV-099; Akamine Y, 2010, XENOBIOTICA, V40, P782, DOI 10.3109/00498254.2010.515318; Imanaga J, 2011, PHARMACOGENET GENOM, V21, P84, DOI 10.1097/FPC.0b013e32834300cc; Tapaninen T, 2011, BRIT J CLIN PHARMACO, V71, P718, DOI 10.1111/j.1365-2125.2010.03898.x; [Anonymous], 2009, PROD INF RIF; Lennernas H, 2003, CLIN PHARMACOKINET, V42, P1141, DOI 10.2165/00003088-200342130-00005; Sakugawa T, 2009, BRIT J CLIN PHARMACO, V67, P535, DOI 10.1111/j.1365-2125.2009.03396.x; Dresser GK, 2002, CLIN PHARMACOL THER, V71, P11, DOI 10.1067/mcp.2002.121152; Shitara Y, 2011, DRUG METAB PHARMACOK, V26, P220, DOI 10.2133/dmpk.DMPK-10-RV-094; ACOCELLA G, 1971, CHEMOTHERAPY, V16, P356; Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866; Bailey DG, 2010, BRIT J CLIN PHARMACO, V70, P645, DOI 10.1111/j.1365-2125.2010.03722.x; [Anonymous], 2003, PROD INF LIV; Miura M, 2007, J PHARMACEUT BIOMED, V43, P741, DOI 10.1016/j.jpba.2006.07.033; Akamine Y, 2012, BRIT J CLIN PHARMACO, V73, P478, DOI 10.1111/j.1365-2125.2011.04106.x; Matsushima S, 2008, DRUG METAB DISPOS, V36, P663, DOI 10.1124/dmd.107.017814; Yasui-Furukori N, 2005, CLIN PHARMACOL THER, V77, P17, DOI 10.1016/j.clpt.2004.08.026; Akamine Y, 2014, EUR J CLIN PHARMACOL, V70, P1087, DOI 10.1007/s00228-014-1705-y; Niemi M, 2003, CLIN PHARMACOKINET, V42, P819, DOI 10.2165/00003088-200342090-00003; Lau YY, 2007, CLIN PHARMACOL THER, V81, P194, DOI 10.1038/sj.clpt.6100038; Tahara H, 2006, DRUG METAB DISPOS, V34, P743, DOI 10.1124/dmd.105.008375; Backman JT, 2005, CLIN PHARMACOL THER, V78, P154, DOI 10.1016/j.clpt.2005.04.007; Robbins DK, 1998, BIOPHARM DRUG DISPOS, V19, P455, DOI 10.1002/(SICI)1099-081X(199810)19:7<455::AID-BDD130>3.3.CO;2-N; Baciewicz AM, 2008, AM J MED SCI, V335, P126, DOI 10.1097/MAJ.0b013e31814a586a; Bidstrup TB, 2004, EUR J CLIN PHARMACOL, V60, P109, DOI 10.1007/s00228-004-0746-z; Harrison B, 2010, CLIN DRUG INVEST, V30, P875, DOI 10.2165/11539110-000000000-00000; Komoto C, 2006, DRUG METAB PHARMACOK, V21, P126, DOI 10.2133/dmpk.21.126; Schwabedissen HEMZ, 2008, CANCER RES, V68, P9338, DOI 10.1158/0008-5472.CAN-08-0265; vansGiersbergen P L, 2007, CLIN PHARMACOL THER, V81, P414; Xiong H, 2007, J CLIN PHARMACOL, V47, P423, DOI 10.1177/0091270007299928	40	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-4727	1365-2710		J CLIN PHARM THER	J. Clin. Pharm. Ther.	FEB	2015	40	1					98	103		10.1111/jcpt.12213		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX9RR	WOS:000347240200015		
J	Yamashita, Y; Kato, J; Ueda, K; Nakamura, Y; Abe, H; Tamura, T; Itonaga, M; Yoshida, T; Maeda, H; Moribata, K; Niwa, T; Maekita, T; Iguchi, M; Tamai, H; Ichinose, M				Yamashita, Yasunobu; Kato, Jun; Ueda, Kazuki; Nakamura, Yasushi; Abe, Hiroko; Tamura, Takashi; Itonaga, Masahiro; Yoshida, Takeichi; Maeda, Hiroki; Moribata, Kosaku; Niwa, Toru; Maekita, Takao; Iguchi, Mikitaka; Tamai, Hideyuki; Ichinose, Masao			Contrast-Enhanced Endoscopic Ultrasonography Can Predict a Higher Malignant Potential of Gastrointestinal Stromal Tumors by Visualizing Large Newly Formed Vessels	JOURNAL OF CLINICAL ULTRASOUND			English	Article						GIST; angiogenesis; contrast-enhanced endoscopic ultrasonography; risk classification	ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HARMONIC EUS; ANGIOGENESIS; EXPRESSION; DIAGNOSIS; STOMACH; CANCER; GISTS; RISK	BackgroundThe aim of this study was to elucidate the histologic and clinical implications of detection of intratumoral vessels on contrast-enhanced endoscopic ultrasonography (CE-EUS) in gastrointestinal stromal tumors (GISTs). MethodsThirteen patients with a GIST, all of whom were referred for surgery, underwent presurgical CE-EUS. The malignant potential, assessed according to the modified Fletcher risk classification system, and the histologic degree of angiogenesis were compared with the presence or absence of intratumoral vessels on CE-EUS. ResultsOf the six tumors with intratumoral vessels observed on CE-EUS, five were intermediate- or high-risk GISTs, and the remaining seven negative cases were categorized as very low risk or low risk. The presence of intratumoral vessels on CE-EUS was significantly correlated with a higher-risk classification (p=0.005). On histologic examination, all GISTs having visualized vessels incorporated vessels of more than 500 m in diameter. The large intratumoral vessels of the five intermediate- or high-risk GISTs lacked elastic fibers, suggesting that they were neovascular in nature. These higher-risk tumors were also found, by immunohistochemical analysis, to have high expression of vascular endothelial growth factor. ConclusionsIntratumoral vessels observed in GISTs on CE-EUS are correlated with a higher degree of angiogenesis, resulting in higher malignant potential. (c) 2014 Wiley Periodicals, Inc. J Clin Ultrasound, 43:89-97, 2015	[Yamashita, Yasunobu; Kato, Jun; Ueda, Kazuki; Abe, Hiroko; Tamura, Takashi; Itonaga, Masahiro; Yoshida, Takeichi; Maeda, Hiroki; Moribata, Kosaku; Niwa, Toru; Maekita, Takao; Iguchi, Mikitaka; Tamai, Hideyuki; Ichinose, Masao] Wakayama Med Univ, Dept Internal Med 2, Wakayama 6410012, Japan; [Nakamura, Yasushi] Wakayama Med Univ, Div Pathol, Dept Clin Lab Med, Wakayama 6410012, Japan	Yamashita, Y (reprint author), Wakayama Med Univ, Dept Internal Med 2, 811-1 Kimiidera, Wakayama 6410012, Japan.						Hasegawa T, 2002, HUM PATHOL, V33, P669, DOI 10.1053/hupa.2002.124116; Demetri GD, 2009, CLIN CANCER RES, V15, P5902, DOI 10.1158/1078-0432.CCR-09-0482; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Kitano M, 2008, GASTROINTEST ENDOSC, V67, P141, DOI 10.1016/j.gie.2007.07.045; Sontum PC, 1999, INVEST RADIOL, V34, P268, DOI 10.1097/00004424-199904000-00003; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Takahashi R, 2003, ONCOLOGY-BASEL, V64, P266, DOI 10.1159/000069316; Nilsson B, 2005, CANCER, V103, P821, DOI 10.1002/cncr.20862; Palazzo L, 2000, GUT, V46, P88, DOI 10.1136/gut.46.1.88; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Chen WT, 2005, JPN J CLIN ONCOL, V35, P207, DOI 10.1093/jjco/hyi067; Kamiyama Y, 2005, WORLD J SURG, V29, P1429, DOI 10.1007/s00268-005-0045-6; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Cassier PA, 2010, BRIT J CANCER, V103, P165, DOI 10.1038/sj.bjc.6605743; Folkman J, 1990, JNCI-J NATL CANCER I, V3, P4, DOI DOI 10.1093/JNCI/82.1.4; Fukuta N, 2005, J GASTROENTEROL, V40, P247, DOI 10.1007/s00535-004-1531-6; Guang-Wu H, 2000, Laryngoscope, V110, P2066, DOI 10.1097/00005537-200012000-00017; Hasegawa S, 1998, RADIOLOGY, V208, P591; Hersh Marla R, 2005, Cancer Control, V12, P111; Hong T, 2001, INT J MOL MED, V8, P141; Hopkins TG, 2008, EJSO-EUR J SURG ONC, V34, P844, DOI 10.1016/j.ejso.2007.10.011; Izquierdo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008131; Kitano M, 2011, DIGEST ENDOSC, V23, P46, DOI 10.1111/j.1443-1661.2011.01146.x; Kudo M., 2003, CONTRAST HARMONIC IM, P22; Mastrangelo G, 2012, CANCER-AM CANCER SOC, V118, P5339, DOI 10.1002/cncr.27555; Monges G, 2010, B CANCER, V97, pE16, DOI 10.1684/bdc.2010.1041; Rammohan Ashwin, 2013, World J Gastrointest Oncol, V5, P102, DOI 10.4251/wjgo.v5.i6.102; Sakamoto H, 2008, ULTRASOUND MED BIOL, V34, P525, DOI 10.1016/j.ultrasmedbio.2007.09.018; Sakamoto H, 2011, GASTROINTEST ENDOSC, V73, P227, DOI 10.1016/j.gie.2010.10.011; Shah P, 2009, DIGEST DIS SCI, V54, P1265, DOI 10.1007/s10620-008-0484-7; Takahashi R, 2003, ONCOL REP, V10, P797; Yamashita Y, 2013, PANCREAS, V42, P990, DOI 10.1097/MPA.0b013e31827fe94c; Yamashita Y, 2013, J ULTRAS MED, V32, P61	36	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2751	1097-0096		J CLIN ULTRASOUND	J. Clin. Ultrasound	FEB	2015	43	2					89	97		10.1002/jcu.22195		9	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AY8YL	WOS:000347836500003		
J	Shahbakhti, M; Amini, MR; Li, J; Asami, S; Hedrick, JK				Shahbakhti, Mahdi; Amini, Mohammad Reza; Li, Jimmy; Asami, Satoshi; Hedrick, J. Karl			Early Model-Based Design and Verification of Automotive Control System Software Implementations	JOURNAL OF DYNAMIC SYSTEMS MEASUREMENT AND CONTROL-TRANSACTIONS OF THE ASME			English	Article								Verification and validation (V&V) are essential stages in the design cycle of automotive controllers to remove the gap between the designed and implemented controller. In this paper, an early model-based methodology is proposed to reduce the V&V time and improve the robustness of the designed controllers. The application of the proposed methodology is demonstrated on a cold start emission control problem in a midsize passenger car. A nonlinear reduced order model-based controller based on singular perturbation approximation (SPA) is designed to reduce cold start hydrocarbon (HC) emissions from a spark ignition (SI) combustion engine. A model-based simulation platform is created to verify the controller robustness against sampling, quantization, and fixed-point arithmetic imprecision. In addition, the results from early model-based verification are used to identify and remove sources of errors causing propagation of numerical imprecision in the controller structure. Thus the structure of the controller is modified to avoid or to reduce the level of numerical noise in the controller design. The performance of the final modified controller is validated in real-time by testing the control algorithm on a real engine control unit. The validation results indicate the modified controller is 17-63% more robust to different implementation imprecision while it requires lower implementation cost. The proposed methodology from this paper is expected to reduce typical V&V efforts in the development of automotive controllers.	[Shahbakhti, Mahdi; Amini, Mohammad Reza] Michigan Technol Univ, Dept Mech Engn & Engn Mech, Houghton, MI 49931 USA; [Li, Jimmy; Hedrick, J. Karl] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Asami, Satoshi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Shahbakhti, M (reprint author), Michigan Technol Univ, Dept Mech Engn & Engn Mech, Houghton, MI 49931 USA.	mahdish@mtu.edu; mamini@mtu.edu; jl2kx@berkeley.edu; asami-satoshi-nz@ynu.ac.jp; khedrick@me.berkeley.edu					Althoff M, 2011, HSCC 11: PROCEEDINGS OF THE 14TH INTERNATIONAL CONFERENCE ON HYBRID SYSTEMS: COMPUTATION AND CONTROL, P93; Althoff M., 2014, IEEE T ROB IN PRESS; Amini M. R., 2014, SAE INT J E IN PRESS, V7; Gray A, 2012, P AMER CONTR CONF, P4239; Anta A., 2010, 10 ACM INT C EMB SOF, P9; Asami S., 2011, DSCC20115965 ASME; Bielaczyc B., 1999, 1999011073 SAE; Dabney J. B., 2006, 10 IASTED INT C SOFT; Diewald R., 2009, 2009012837 SAE; Edelberg K, 2013, P AMER CONTR CONF, P2854; Edelberg K., 2013, DSCC20133900 ASME; Edelberg K., 2013, 52 IEEE C DEC CONTR, P6818; Eldib H., 2013, FORMAL METHODS COMPU; Eng J. A., 2005, 2005013867 SAE; Erkkinen T., 2008, 2008012709 SAE; Hansen A., 2012, ASME 5 ANN DYN SYST, P339; Hepburn J., 1994, 942072 SAE; Hrovat D, 1997, CONTROL ENG PRACT, V5, P1093, DOI 10.1016/S0967-0661(97)00101-9; Jaikamal V., 2009, 2009010153 SAE; Kapinski J, 2008, IEEE DECIS CONTR P, P4024; Khan A. H., 2014, EMBEDDED REAL TIME S, V520, P153; Lang K., 2010, 2010012323 SAE; Lee D., 2010, SAE INT J ENGINES, V3, P182; LIU Y, 1989, INT J CONTROL, V50, P1379, DOI 10.1080/00207178908953437; Lumsden G., 1995, 950412 SAE; Mitts K. J., 2009, 2009010520 SAE; MOORE BC, 1981, IEEE T AUTOMAT CONTR, V26, P17, DOI 10.1109/TAC.1981.1102568; Murphy B., 2008, 2008011469 SAE; Nakagawa S., 2003, 2003010567 SAE; Ohata A., 1995, 950075 SAE; Park J., 2014, UNMANNED SYST, V2, P101; Presti M., 2013, 2013240158 SAE; Saha I., 2013, THESIS UC BERKELEY B; Saikalis G., 1993, 930323 SAE; Salehi R., 2013, AM CONTR C WASH DC, P4417; Sanketi P. R., 2009, THESIS UC BERKELEY B; Sanketi P. R., 2006, 8 INT S ADV VEH CONT; Schweinsberg A., 2006, 2006013401 SAE; Shahbakhti M, 2012, P AMER CONTR CONF, P3587; Shaw II B. T., 2002, THESIS UC BERKELEY B; Taghavipour A., 2013, DETC201313489 ASME; Vora A., 2014, 2014011906 SAE; Waltner A., 1998, 980663 SAE; Weilenmann M, 2009, ATMOS ENVIRON, V43, P2419, DOI 10.1016/j.atmosenv.2009.02.005	44	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0022-0434	1528-9028		J DYN SYST-T ASME	J. Dyn. Syst. Meas. Control-Trans. ASME	FEB	2015	137	2							021006	10.1115/1.4027845		14	Automation & Control Systems; Instruments & Instrumentation	Automation & Control Systems; Instruments & Instrumentation	AZ2FR	WOS:000348050500006		
J	Nemoto, T; Kakinuma, Y; Shibasaki, T				Nemoto, Takahiro; Kakinuma, Yoshihiko; Shibasaki, Tamotsu			Impaired miR449a-induced downregulation of Crhr1 expression in low-birth-weight rats	JOURNAL OF ENDOCRINOLOGY			English	Article						low birth weight; psychopathology; stress; HPA axis; CRF receptor; miRNA	PITUITARY-ADRENAL AXIS; ADULT MALE RATS; PRENATAL STRESS; MESSENGER-RNA; HPA AXIS; CORTICOSTEROID RECEPTORS; PARAVENTRICULAR NUCLEUS; GENE-EXPRESSION; ALTERED CONTROL; BLOOD-PRESSURE	Low birth weight (LBW) is related to increased incidence of common cardiovascular and metabolic disorders, and psychopathologies later in life. Recent studies have suggested that maternal malnutrition affects fetal hypothalamic-pituitary-adrenal (HPA) axis programing although the mechanism is unknown. We demonstrated that LBW offspring delivered from malnourished dams showed prolonged elevated plasma corticosterone concentrations when compared with those of normal-birth-weight (NBW) offspring and impaired downregulation of corticotropin-releasing factor receptor type 1 (CRF-R1, Crhr1) in the anterior pituitary in restraint. Restraint increased expression of miR449a, which we had previously demonstrated to be involved in Crhr1 downregulation, in the anterior pituitary and serum exosomal miR449a contents through glucocorticoids in NBW offspring, but not in LBW offspring. Although plasma corticosterone concentrations were higher at 2000 h than at 0800 h in both LBW and NBW offspring, they were significantly higher in LBW offspring than in NBW offspring at 2000 and 0200 h. There were no significant diurnal changes in miR449a expression levels in the anterior pituitary of either NBW or LBW offspring, but the expression was significantly lower in LBW offspring than in NBW offspring at 1400, 2000, and 0200 h. The expression levels of GAS5, which inhibits glucocorticoid receptor (GR) binding to glucocorticoid-responsive element, in the anterior pituitary of LBW offspring were elevated when compared with those of NBW offspring. The downregulation of GR found in NBW offspring did not occur in restrained LBW offspring. These results indicate that impaired miR449a expression, probably induced by increased GAS5 expression, causes dysregulation of Crhr1 expression in the anterior pituitary, resulting in prolonged HPA axis activation in restrained LBW offspring.	[Nemoto, Takahiro; Kakinuma, Yoshihiko; Shibasaki, Tamotsu] Nippon Med Sch, Dept Physiol, Bunkyo Ku, Tokyo 1138602, Japan	Nemoto, T (reprint author), Nippon Med Sch, Dept Physiol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	taknemo@nms.ac.jp			Research on Measures for Intractable Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology (MEXT)-supported program for the Strategic Research Foundation at Private Universities; JSPS KAKENHI [23791238]	This study was supported in part by Research on Measures for Intractable Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, and Ministry of Education, Culture, Sports, Science and Technology (MEXT)-supported program for the Strategic Research Foundation at Private Universities, 2008-2012, and JSPS KAKENHI grant number 23791238.	Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P258, DOI 10.1111/j.1365-2826.2010.01969.x; Koehl M, 1999, J NEUROBIOL, V40, P302, DOI 10.1002/(SICI)1097-4695(19990905)40:3<302::AID-NEU3>3.0.CO;2-7; Bhatnagar S, 2005, HORM BEHAV, V47, P430, DOI 10.1016/j.yhbeh.2004.11.019; Ochedalski T, 1998, J NEUROENDOCRINOL, V10, P363, DOI 10.1046/j.1365-2826.1998.00212.x; Owen D, 2007, J NEUROENDOCRINOL, V19, P172, DOI 10.1111/j.1365-2826.2006.01517.x; Chadio SE, 2007, J ENDOCRINOL, V192, P495, DOI 10.1677/JOE-06-0172; Indredavik MS, 2004, ARCH DIS CHILD, V89, pF445, DOI 10.1136/adc.2003.038943; Raikkonen K, 2008, ARCH GEN PSYCHIAT, V65, P290, DOI 10.1001/archgenpsychiatry.2007.40; Reynolds RM, 2001, J CLIN ENDOCR METAB, V86, P245, DOI 10.1210/jc.86.1.245; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; CLARKE AS, 1994, DEV PSYCHOBIOL, V27, P257, DOI 10.1002/dev.420270502; Catalani A, 2002, PHARMACOL BIOCHEM BE, V73, P105, DOI 10.1016/S0091-3057(02)00755-4; Rumball CWH, 2008, ENDOCRINOLOGY, V149, P1163, DOI 10.1210/en.2007-1306; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Corbett BA, 2006, PSYCHONEUROENDOCRINO, V31, P59, DOI 10.1016/j.psyneuen.2005.05.011; Buhl ES, 2010, AM J PHYSIOL-ENDOC M, V298, pE920, DOI 10.1152/ajpendo.00606.2009; Schendel D, 2008, PEDIATRICS, V121, P1155, DOI 10.1542/peds.2007-1049; de Rooij SR, 2006, EUR J ENDOCRINOL, V155, P153, DOI 10.1530/eje.1.02193; Hempel RJ, 2010, PSYCHIAT CLIN NEUROS, V64, P548, DOI 10.1111/j.1440-1819.2010.02121.x; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Ward AMV, 2004, J CLIN ENDOCR METAB, V89, P1227, DOI 10.1210/jc.2003-030978; BIRNBERG NC, 1983, P NATL ACAD SCI-BIOL, V80, P6982, DOI 10.1073/pnas.80.22.6982; Buhl ES, 2007, AM J PHYSIOL-ENDOC M, V293, pE1451, DOI 10.1152/ajpendo.00356.2007; Davies AA, 2004, CIRCULATION, V110, P1258, DOI 10.1161/01.CIR.0000140980.61294.4D; Ehnvall A, 2004, EUR ARCH PSY CLIN N, V254, P349, DOI 10.1007/s00406-004-0512-3; HOLSBOERTRACHSLER E, 1987, ACTA PSYCHIAT SCAND, V75, P608, DOI 10.1111/j.1600-0447.1987.tb02844.x; HOSHINO Y, 1987, JPN J PSYCHIAT NEUR, V41, P227; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Irving RJ, 2004, HYPERTENSION, V43, P610, DOI 10.1161/01.HYP.0000116029.85706.5f; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; KOVACS KJ, 1987, NEUROENDOCRINOLOGY, V46, P365, DOI 10.1159/000124846; Lesage J, 2002, J NEUROENDOCRINOL, V14, P135, DOI 10.1046/j.0007-1331.2001.00753.x; Levitt NS, 2000, J CLIN ENDOCR METAB, V85, P4611, DOI 10.1210/jc.85.12.4611; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Meier I, 2010, HIPPOCAMPUS, V20, P1027, DOI 10.1002/hipo.20701; Nemoto T, 2010, AM J PHYSIOL-ENDOC M, V299, pE567, DOI 10.1152/ajpendo.00163.2010; Nemoto T, 2013, MOL ENDOCRINOL, V27, P1593, DOI 10.1210/me.2012-1357; Nemoto T, 2009, J ENDOCRINOL, V201, P105, DOI 10.1677/JOE-08-0467; REUS VI, 1985, BIOL PSYCHIAT, V20, P980, DOI 10.1016/0006-3223(85)90196-9; Sebaai N, 2002, NEUROENDOCRINOLOGY, V76, P243, DOI 10.1159/000065947; Sebaai N, 2004, NEUROENDOCRINOLOGY, V79, P163, DOI 10.1159/000078098; Viltart O, 2006, PSYCHONEUROENDOCRINO, V31, P769, DOI 10.1016/j.psyneuen.2006.02.007; Young EA, 2000, NEUROPSYCHOPHARMACOL, V23, P411, DOI 10.1016/S0893-133X(00)00129-9; Zhou Y, 1996, PEPTIDES, V17, P435, DOI 10.1016/0196-9781(96)00014-9	47	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0022-0795	1479-6805		J ENDOCRINOL	J. Endocrinol.	FEB	2015	224	2					195	203		10.1530/JOE-14-0537		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AY9OZ	WOS:000347881600012		
J	Ito, T; Oseko, N; Ototake, M				Ito, T.; Oseko, N.; Ototake, M.			Susceptibility of Amago trout, Oncorhynchus masou macrostomus (Gunther) to an isolate of infectious salmon anaemia virus	JOURNAL OF FISH DISEASES			English	Article						amago trout; infectious salmon anaemia virus; Oncorhynchus masou macrostomus (Gunther); susceptibility	ATLANTIC SALMON; RAINBOW-TROUT; ISAV; SALAR; MYKISS; TRUTTA; AGENT; CHILE		[Ito, T.] Fisheries Res Agcy, Natl Res Inst Aquaculture, Aquat Anim Hlth Div, Tamaki Lab, Tamaki, Mie 5190423, Japan; [Oseko, N.] Fisheries Res Agcy, Natl Res Inst Aquaculture, Diag & Training Ctr Fish Dis, Minamiise, Mie, Japan; [Ototake, M.] Fisheries Res Agcy, Natl Res Inst Aquaculture, Aquat Anim Hlth Div, Minamiise, Mie, Japan	Ito, T (reprint author), Fisheries Res Agcy, Natl Res Inst Aquaculture, Aquat Anim Hlth Div, Tamaki Lab, 224-1 Hiruta, Tamaki, Mie 5190423, Japan.	takafumi@fra.affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This work was mainly supported by a Grant-in-Aid from the Ministry of Agriculture, Forestry and Fisheries of Japan. The authors would like to acknowledge Dr B. Dannevig (National Veterinary Institute in Norway) and Professor Niels J. Olesen (National Veterinary Institute, Technical University of Denmark) for kindly providing the ISAV isolate (Glesvaer/2/90 isolate) and ASK cell line, respectively. We thank the Nanae Fresh-Water Laboratory Field Science Center for Northern Biosphere, Hokkaido University for providing the experimental Atlantic salmon.	Kibenge Frederick S. B., 2004, Animal Health Research Reviews, V5, P65, DOI 10.1079/AHRR200461; Kibenge FSB, 2001, DIS AQUAT ORGAN, V45, P9, DOI 10.3354/dao045009; Plarre H, 2005, DIS AQUAT ORGAN, V66, P71, DOI 10.3354/dao066071; Rolland JB, 2003, J FISH DIS, V26, P511, DOI 10.1046/j.1365-2761.2003.00473.x; Biacchesi S, 2007, J FISH DIS, V30, P631, DOI 10.1111/j.1365-2761.2007.00854.x; Rimstad E, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P143, DOI 10.1079/9781845935542.0143; Rimstad E, 1999, DIS AQUAT ORGAN, V36, P107, DOI 10.3354/dao036107; DANNEVIG BH, 1995, J GEN VIROL, V76, P1353, DOI 10.1099/0022-1317-76-6-1353; DANNEVIG BH, 1994, J FISH DIS, V17, P613, DOI 10.1111/j.1365-2761.1994.tb00259.x; Devold M, 2000, DIS AQUAT ORGAN, V40, P9, DOI 10.3354/dao040009; Geoghengen F., 2002, 6 ANN M EU NAT REF L, P23; Godoy MG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-28; Grove S, 2007, ARCH VIROL, V152, P1829, DOI 10.1007/s00705-007-1016-z; McCauly J. W., 2012, VIRUS TAXONOMY, P193; Nylund A, 2002, BULL EUR ASSN FISH P, V22, P311; OIE (WORLD ORGANIZATION FOR ANIMAL HEALTH), 2013, MAN DIAGN TESTS AQ A, P1; Snow M, 2001, AQUACULTURE, V196, P47, DOI 10.1016/S0044-8486(00)00588-3; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7775	1365-2761		J FISH DIS	J. Fish Dis.	FEB	2015	38	2					237	240		10.1111/jfd.12226		4	Fisheries; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Marine & Freshwater Biology; Veterinary Sciences	AY9SJ	WOS:000347890300012		
J	Kawada, T				Kawada, T.			Cardio-ankle vascular index and plasma lipids in patients with hypertension: causality of the association	JOURNAL OF HUMAN HYPERTENSION			English	Letter							CAVI		Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, 1-1-5 Sendagi, Tokyo 113, Japan.	kawada@nms.ac.jp					Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Kadota K, 2008, CIRC J, V72, P304, DOI 10.1253/circj.72.304; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Ibata Junko, 2008, Diabetes Res Clin Pract, V80, P265, DOI 10.1016/j.diabres.2007.12.016; Soska V, 2013, J ATHEROSCLER THROMB, V20, P443; Wang H, 2014, J HUM HYPERTENS, V29, P105	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9240	1476-5527		J HUM HYPERTENS	J. Hum. Hypertens.	FEB	2015	29	2					137	137		10.1038/jhh.2014.67		1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AY6KD	WOS:000347674300014		
J	Boubou, S; Suzuki, E				Boubou, Somar; Suzuki, Einoshin			Classifying actions based on histogram of oriented velocity vectors	JOURNAL OF INTELLIGENT INFORMATION SYSTEMS			English	Article						Human action recognition; Kinect; Skeletal data; Feature histogram; Feature extraction; HON4D; Conditional random fields; Extreme learning machines	HUMAN MOTION RECOGNITION; CONDITIONAL MODELS; CAMERAS; MACHINE	We present a new descriptor for activity recognition from skeleton data acquired by Kinect. Previous approaches tend to employ complex descriptors which require extensively long computation time. In this study, we present an efficient and effective descriptor which we name as Histogram-of-Oriented-Velocity-Vectors (HOVV). It is a scale-invariant, speed-invariant and length-invariant descriptor for human actions represented by 3D skeletons acquired by Kinect. We describe the skeleton sequence using 2D spatial histogram capturing the distribution of the orientations of velocity vectors of the joint in a spherical coordinate system. We make use of three methods to classify actions represented by HOVV descriptor. These are k-nearest neighbour classifier, Support Vector Machines classifier and Extreme Learning Machines. For the cases when HOVV descriptor is not sufficient, such as to differentiate actions which involve tiny movement of joints such as "sit-still", we also incorporate a simple skeleton descriptor as a prior to the action descriptor. Through extensive experiments, we test our system with different configurations. We also demonstrate that our HOVV descriptor outperforms the state-of-the-art methods. The results demonstrate that our descriptor has much shorter computational time due to the simpler computations needed for feature extraction. Moreover our descriptor shows a higher recognition accuracy compared with the state-of-the-art methods.	[Boubou, Somar] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Suzuki, Einoshin] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Dept Informat, Fukuoka 812, Japan	Boubou, S (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	somar.boubou@gmail.com; suzuki@inf.kyushu-u.ac.jp					Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; Ahmad M, 2006, INT C PATT RECOG, P263; Quattoni A, 2007, IEEE T PATTERN ANAL, V29, P1848, DOI 10.1109/TPAMI.2007.1124; Wang J, 2012, PROC CVPR IEEE, P1290, DOI 10.1109/CVPR.2012.6247813; Turaga P, 2008, IEEE T CIRC SYST VID, V18, P1473, DOI 10.1109/TCSVT.2008.2005594; Laptev I, 2005, INT J COMPUT VISION, V64, P107, DOI 10.1007/s11263-005-1838-7; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Sminchisescu C, 2005, IEEE I CONF COMP VIS, P1808; Han L, 2010, IMAGE VISION COMPUT, V28, P836, DOI 10.1016/j.imavis.2009.08.003; Junejo IN, 2011, IEEE T PATTERN ANAL, V33, P172, DOI 10.1109/TPAMI.2010.68; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; Ellis C, 2013, INT J COMPUT VISION, V101, P420, DOI 10.1007/s11263-012-0550-7; Oreifej O, 2013, PROC CVPR IEEE, P716, DOI 10.1109/CVPR.2013.98; Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381; Oliver N, 2004, COMPUT VIS IMAGE UND, V96, P163, DOI 10.1016/j.cviu.2004.02.004; Veeraraghavan A, 2009, IEEE T IMAGE PROCESS, V18, P1326, DOI 10.1109/TIP.2009.2017143; Huang P, 2010, INT J COMPUT VISION, V89, P362, DOI 10.1007/s11263-010-0319-9; Ryoo MS, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P1036, DOI 10.1109/ICCV.2011.6126349; Sminchisescu C, 2006, COMPUT VIS IMAGE UND, V104, P210, DOI 10.1016/j.cviu.2006.07.014; Chen X., 2013, P SCAND C IM AN, V7944, P640; Chen X., 2013, P 15 ACM INT C MULT, P467; Dollar P., 2005, VISUAL SURVEILLANCE, V2, P65, DOI DOI 10.1109/VSPETS.2005.1570899; Fengjun Lv., 2007, P IEEE C COMP VIS PA, P1; Ikizler N, 2009, IMAGE VISION COMPUT, V27, P1515, DOI 10.1016/j.imavis.2009.02.002; Karali A., 2012, P 1 INT C MULT PATT, P79; Kilner J., 2009, P INT C COMP VIS WOR, P1; Laptev I., 2008, CVPR, P1, DOI DOI 10.1109/CVPR.2008.4587756; Li W., 2010, CVPR WORKSH, V1, P9, DOI DOI 10.1109/CVPRW.2010.5543273; LUBLINERMAN R, 2006, P INT C PATT REC, P347; Martens J., 2011, P 28 INT C MACH LEAR, P1033; Oi F., 2013, P APPL COMP VIS WACV, P53; Oreifej O, 2013, HON4D CODE AND DATA; Pehlivan S, 2011, COMPUT VIS IMAGE UND, V115, P140, DOI 10.1016/j.cviu.2010.11.004; Song Y, 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), DOI 10.1109/FG.2011.5771431; Veeraraghavan A., 2006, P IEEE C COMP VIS PA, V1, P959; Wang H., 2009, BRIT MACH VIS C, V42, P1; Wang Yi, 2009, Proceedings of the 2009 9th International Conference on Electronic Measurement & Instruments (ICEMI 2009), DOI [10.1109/ICEMI.2009.5274660, 10.1109/ICEMI.2009.5274839]; Wang L, 2008, COMPUT VIS IMAGE UND, V110, P153, DOI 10.1016/j.cviu.2007.06.001; Wang Y., 2008, ADV NEURAL INFORM PR, V21, P1721; Weinland D., 2007, P INT C COMP VIS, P1; Xia L., 2012, P IEEE COMP SOC C CO, P20; Yang Y., 2008, P INT C MULT INF RET, P305, DOI 10.1145/1460096.1460146	42	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-9902	1573-7675		J INTELL INF SYST	J. Intell. Inf. Syst.	FEB	2015	44	1					49	65		10.1007/s10844-014-0329-0		17	Computer Science, Artificial Intelligence; Computer Science, Information Systems	Computer Science	AZ2GF	WOS:000348051800002		
J	Lin, QL; Liu, HC; Wang, DJ; Liu, L				Lin, Qing-Lian; Liu, Hu-Chen; Wang, Duo-Jin; Liu, Long			Integrating systematic layout planning with fuzzy constraint theory to design and optimize the facility layout for operating theatre in hospitals	JOURNAL OF INTELLIGENT MANUFACTURING			English	Article						Operating theatre management; Facility layout design; Systematic layout planning; Fuzzy constraint theory	ANT COLONY OPTIMIZATION; ROOM EFFICIENCY; LOCATION PROBLEM; SIMULATION; IMPROVE	Because of the competition of the medical market and the importance of the operaing theatre (OT), the OT process efficiency becomes a hot spot problem in hospital management. The OT facility layout is not only a problem about cost reduction, but also a great contribute to the efficiency of OT process. However, the facility layout optimization of OT was always ignored in the past decades. In order to become more competitive in the medical market, the facility layout of OT should be considered as an essential section in early design phase. To overcome these problems, this paper proposed a approach for designing and optimizing the facility layout of OT in hospitals. First, systematic layout planning (SLP) is applied to design the layout of OT based on the logistics and non-logistics relationships. The SLP is a tool which is used to arrange a workplace in a plant by locating two areas with high frequency and logical relationships close to each other. After that, fuzzy constraint theory is proposed for comprehensively evaluate the layout schemes. Fuzzy constraint theory uses objective function and constraint conditions for solving the problem which involves uncertainty. After designing and optimizing the facility layout of OT in Shanghai East Hospital, we can get the optimal layout plan. The aim of this study was development a new approach to design and optimize the facility layout for OT. This research results are able to help the hospital managers to adopt more modern management approaches in every day practise.	[Lin, Qing-Lian; Wang, Duo-Jin] Tech Univ Berlin, Dept Human Factors Engn & Prod Ergon, Sekr KWT 1, D-10623 Berlin, Germany; [Liu, Hu-Chen] Tokyo Inst Technol, Dept Ind Engn & Management, Meguro Ku, Tokyo 1528552, Japan; [Liu, Long] Tongji Univ, Coll Design & Innovat, Shanghai 200092, Peoples R China	Liu, L (reprint author), Tongji Univ, Coll Design & Innovat, 1239 Siping Rd, Shanghai 200092, Peoples R China.	qinglian.lin@awb.tu-berlin.de; huchenliu@foxmaill.com; duojin.wang@awb.tu-berlin.de; liulong@tongji.edu.cn					Allegri T. M., 1984, MAT HANDLING PRINCIP; Harders M, 2006, SURGERY, V140, P509, DOI 10.1016/j.surg.2006.06.018; Hahn PM, 2001, J INTELL MANUF, V12, P487, DOI 10.1023/A:1012252420779; Kulturel-Konak S, 2007, J INTELL MANUF, V18, P273, DOI [10.1007/s10845-007-0020-1, 10.1007/s10845-007-0020-10]; Jebali A, 2006, INT J PROD ECON, V99, P52, DOI 10.1016/j.ijpe.2004.12.006; Guerriero F, 2011, HEALTH CARE MANAG SC, V14, P89, DOI 10.1007/s10729-010-9143-6; van Tilburg CM, 2006, QUAL SAF HEALTH CARE, V15, P58, DOI 10.1136/qshc.2005.014902; Enea M, 2005, J INTELL MANUF, V16, P303, DOI 10.1007/s10845-005-7025-4; Astrop A, 1996, Curationis, V19, P2; Balakrishnan J, 2007, EUR J OPER RES, V177, P281, DOI 10.1016/j.ejor.2005.08.027; Barrett A., 2008, OPTIMIZATION FACILIT; Smith RS, 2011, J AM COLL SURGEONS, V213, P93; Davenport T.H., 1993, PROCESS INNOVATION R; Denton Brian, 2007, Health Care Manag Sci, V10, P13, DOI 10.1007/s10729-006-9005-4; Dexter F, 1999, ANESTHESIOLOGY, V91, P262, DOI 10.1097/00000542-199907000-00035; Dexter F, 2005, CURR OPIN ANESTHESIO, V18, P195, DOI 10.1097/01.aco.0000162840.02087.15; Dong H, 2005, FACILITIES PLANNING; Dwijayanti K, 2010, LECT NOTES ENG COMP, P1640; Esnaf S, 2009, J INTELL MANUF, V20, P259, DOI 10.1007/s10845-008-0233-y; Feyzollahi M., 2009, PAJOOHANDEH J, V14, P191; Friedman DM, 2006, ANN SURG, V243, P10, DOI 10.1097/01.sla.0000193600.97748.b1; Gilbert J.P., 2004, 2 WORLD C POM 15 ANN; Hammer M., 1993, REENGINEERING CORPOR; Hengst M., 2004, P 37 HAW INT C SYST, P1; Kleczkowski B. M., 1985, APPROACHES PLANNING; Koneczny S, 2009, WORK, V33, P145, DOI 10.3233/WOR-2009-0861; Lee HY, 2012, APPL MATH INFORM SCI, V6, p387S; Lee HY, 2012, J COMPUT CIVIL ENG, V26, P259, DOI 10.1061/(ASCE)CP.1943-5487.0000128; Maynard A, 1995, INT J HEALTH PLAN M, V10, P247, DOI 10.1002/hpm.4740100403; Motaghi M., 2011, INT J MANAGEMENT BUS, V1, P133; Nilsen Egil V, 2005, AORN J, V81, P349, DOI 10.1016/S0001-2092(06)60417-1; Nilsen E. V, 2005, AORN J, V81, P355; Ovretveit J, 2000, INT J HLTH CARE QUAL, V13, P74, DOI 10.1108/09526860010319523; Padgaonkar A. S., 2004, INT J HLTH CARE QUAL; Pasandideh SHR, 2012, J INTELL MANUF, V23, P651, DOI 10.1007/s10845-010-0416-1; Peponis J, 1996, J Healthc Des, V8, P109; RAOOT AD, 1993, INT J PROD RES, V31, P1735, DOI 10.1080/00207549308956820; Sandberg WS, 2005, ANESTHESIOLOGY, V103, P406, DOI 10.1097/00000542-200508000-00025; Tarkesh H, 2009, J INTELL MANUF, V20, P347, DOI 10.1007/s10845-008-0109-1; Tompkins J., 1996, FACILITIES PLANNING; Wang G. H., 2005, MODERN LOGISTICS ENG; Yang T., 2000, INT J OPER PROD MAN, V22, P1359	42	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0956-5515	1572-8145		J INTELL MANUF	J. Intell. Manuf.	FEB	2015	26	1					87	95		10.1007/s10845-013-0764-8		9	Computer Science, Artificial Intelligence; Engineering, Manufacturing	Computer Science; Engineering	AY9TP	WOS:000347893700007		
J	Shrestha, KC; Araki, Y; Yamakawa, M; Yoshida, N; Omori, T; Sutou, Y; Kainuma, R				Shrestha, Kshitij C.; Araki, Yoshikazu; Yamakawa, Makoto; Yoshida, Nobutoshi; Omori, Toshihiro; Sutou, Yuji; Kainuma, Ryosuke			Feasibility of Cu-Al-Mn superelastic alloy bar as a self-sensor material	JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES			English	Article						Cu-Al-Mn; superelastic alloy; shape memory alloy; self-sensor; electrical resistance feedback	SHAPE-MEMORY ALLOY; ELECTRICAL-RESISTANCE; NITI	This article examines the feasibility of Cu-Al-Mn superelastic alloy bars as possible self-sensor components, taking electrical resistance measurement as a feedback. Superelastic alloy bars change their crystallographic structure with phase transformation, as well as electrical resistance during loading-unloading process at ambient temperature. This work studies the relationship between strain and electrical resistance measurements of superelastic alloys at room temperature. Such relationship can be used in determining the state of a shape memory alloy-based structure effectively, without separate sensors, by appropriately measuring the changes in electrical resistance during and after structure's loading history. Quasi-static cyclic tensile tests are conducted in this article to investigate the relationship between electrical resistance and strain for a 4-mm-diameter Cu-Al-Mn superelastic alloy bar. It was demonstrated that linear relationship with little hysteresis can be achieved up to 10% strain. The test observations support the feasibility of newly developed Cu-Al-Mn superelastic alloy bars, characterized by low material cost and high machinability, as a multifunctional material for both structural and sensing elements.	[Shrestha, Kshitij C.; Araki, Yoshikazu; Yoshida, Nobutoshi] Kyoto Univ, Dept Architecture & Architectural Engn, Kyoto 6158540, Japan; [Shrestha, Kshitij C.] Univ Nevada, Dept Civil & Environm Engn, Coll Engn, Reno, NV 89557 USA; [Yamakawa, Makoto] Tokyo Denki Univ, Dept Architecture, Tokyo 101, Japan; [Omori, Toshihiro; Sutou, Yuji; Kainuma, Ryosuke] Tohoku Univ, Dept Mat Sci & Engn, Sendai, Miyagi 980, Japan	Araki, Y (reprint author), Kyoto Univ, Dept Architecture & Architectural Engn, Kyoto 6158540, Japan.	araki@archi.kyoto-u.ac.jp	Shrestha, Kshitij/K-3844-2015	Shrestha, Kshitij/0000-0001-9007-852X	A-STEP program, Japan Science and Technology Agency (JST) [AS2315014C]	This research was supported by the A-STEP program (#AS2315014C) provided by Japan Science and Technology Agency (JST).	Airoldi G, 1998, J PHYS IV, V7; Araki Y, 2011, EARTHQ ENG STRUCT D, V40, P107, DOI 10.1002/eqe.1029; Omori T, 2013, SCIENCE, V341, P1500, DOI 10.1126/science.1238017; Housner GW, 1997, J ENG MECH-ASCE, V123, P897, DOI 10.1061/(ASCE)0733-9399(1997)123:9(897); Dolce M, 2000, EARTHQUAKE ENG STRUC, V29, P945, DOI 10.1002/1096-9845(200007)29:7<945::AID-EQE958>3.3.CO;2-R; Ozbulut OE, 2011, J INTEL MAT SYST STR, V22, P1531, DOI 10.1177/1045389X11411220; Sutou Y, 2005, ACTA MATER, V53, P4121, DOI 10.1016/j.actamat.2005.05.013; Gedouin PA, 2010, INT J PLASTICITY, V26, P258, DOI 10.1016/j.ijplas.2009.06.004; Cui D, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/5/055019; KUCZYNSKI GC, 1954, PHYS REV, V94, P61, DOI 10.1103/PhysRev.94.61; Li H, 2005, J MATER CIVIL ENG, V17, P676, DOI 10.1061/(ASCE)0899-1561(2005)17:6(676); Murty DVS, 2008, TRANSDUCERS INSTRUME; Novak V, 2008, MAT SCI ENG A-STRUCT, V481, P127, DOI 10.1016/j.msea.2007.02.162; ONO N, 1990, MATER T JIM, V31, P381; PARKER RL, 1963, J APPL PHYS, V34, P2700, DOI 10.1063/1.1729795; Wu XD, 1999, SMART MATER STRUCT, V8, P574, DOI 10.1088/0964-1726/8/5/307	16	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1045-389X	1530-8138		J INTEL MAT SYST STR	J. Intell. Mater. Syst. Struct.	FEB	2015	26	3					364	370		10.1177/1045389X14529028		7	Materials Science, Multidisciplinary	Materials Science	AZ2LA	WOS:000348063900010		
J	Nakajima, Y; Masuda, N				Nakajima, Yohei; Masuda, Naoki			Evolutionary dynamics in finite populations with zealots	JOURNAL OF MATHEMATICAL BIOLOGY			English	Article							GAME DYNAMICS; COOPERATION; SELECTION	We investigate evolutionary dynamics of two-strategy matrix games with zealots in finite populations. Zealots are assumed to take either strategy regardless of the fitness. When the strategy selected by the zealots is the same, the fixation of the strategy selected by the zealots is a trivial outcome. We study fixation time in this scenario. We show that the fixation time is divided into three main regimes, in one of which the fixation time is short, and in the other two the fixation time is exponentially long in terms of the population size. Different from the case without zealots, there is a threshold selection intensity below which the fixation is fast for an arbitrary payoff matrix. We illustrate our results with examples of various social dilemma games.	[Nakajima, Yohei; Masuda, Naoki] Univ Tokyo, Dept Math Informat, Bunkyo Ku, Tokyo 1138656, Japan	Masuda, N (reprint author), Univ Tokyo, Dept Math Informat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	masuda@mist.i.u-tokyo.ac.jp			MEXT, Japan [23681033]; Nakajima Foundation; CREST JST; Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Council for Science and Technology Policy (CSTP)	We thank Bin Wu for carefully reading the manuscript. NM acknowledges the support provided through Grants-in-Aid for Scientific Research (No. 23681033) from MEXT, Japan, the Nakajima Foundation, CREST JST, and the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP).	Altrock PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002260; Singh P, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046104; Wu B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046106; Traulsen A, 2008, B MATH BIOL, V70, P1410, DOI 10.1007/s11538-008-9305-6; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Altrock PM, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013012; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Liu XT, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051132; Galam S, 2007, PHYSICA A, V381, P366, DOI 10.1016/j.physa.2007.03.034; Altrock PM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011925; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Antal T, 2006, B MATH BIOL, V68, P1923, DOI 10.1007/s11538-006-9061-4; Assaf M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.188701; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Taylor C, 2004, B MATH BIOL, V66, P1621, DOI 10.1016/j.bulm.2004.03.004; Assaf M, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/09/P09009; Ewens WJ, 2010, MATH POPULATION GENE, VI; Krapivsky P. L., 2010, KINETIC VIEW STAT PH; Kreindler GE, 2013, GAME ECON BEHAV, V80, P39, DOI 10.1016/j.geb.2013.02.004; Masuda N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00646; Maynard Smith J., 1982, EVOLUTION THEORY GAM; Mobilia M, 2003, PHYS REV LETT, V91; Mobilia M, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/08/P08029; Mobilia M, 2012, PHYS REV E, V86; Moran PAP, 1958, P CAMB PHILOS SOC, V54, P60, DOI [10.1017/s0305004100033193, DOI 10.1017/S0305004100033193)]; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Redner S., 2001, GUIDE 1 PASSAGE PROC; Sugden R., 1986, EC RIGHTS COOPERATIO; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Xie J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011130	30	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0303-6812	1432-1416		J MATH BIOL	J. Math. Biol.	FEB 1	2015	70	3					465	484		10.1007/s00285-014-0770-2		20	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	AY7ZE	WOS:000347773400003		
J	Saito, K; Tsukahara, A; Okabe, Y				Saito, Kazuya; Tsukahara, Akira; Okabe, Yoji			New Deployable Structures Based on an Elastic Origami Model	JOURNAL OF MECHANICAL DESIGN			English	Article							TRIANGULATED CYLINDERS	Traditionally, origami-based structures are designed on the premise of "rigid folding," However, every act of folding and unfolding is accompanied by elastic deformations in real structures. This study focuses on these elastic deformations in order to expand origami into a new method of designing morphing structures. The authors start by proposing a simple model for evaluating elastic deformation in nonrigid origami structures. Next, these methods are applied to deployable plate models. Initial strain is introduced into the elastic parts as actuators for deployment. Finally, by using the finite element method (FEM), it is confirmed that the proposed system can accomplish the complete deployment in 3 x 3 Miura-or model.	[Saito, Kazuya; Okabe, Yoji] Univ Tokyo, Inst Ind Sci, Dept Mech & Biofunct Syst, Tokyo 1538505, Japan; [Tsukahara, Akira] Univ Tokyo, Sch Engn, Dept Syst Innovat, Tokyo 1538505, Japan	Saito, K (reprint author), Univ Tokyo, Inst Ind Sci, Dept Mech & Biofunct Syst, 4-6-1 Komaba, Tokyo 1538505, Japan.	saito-k@iis.u-tokyo.ac.jp; tsuka-hr@iis.u-tokyo.ac.jp; okabey@iis.u-tokyo.ac.jp			Japan Society for the Promotion of Science [26870125]	This work has been supported by Grants-in-Aid for Young Scientists (B) (26870125) from the Japan Society for the Promotion of Science.	Hawkes E, 2010, P NATL ACAD SCI USA, V107, P12441, DOI 10.1073/pnas.0914069107; Wu WN, 2011, P ROY SOC A-MATH PHY, V467, P2561, DOI 10.1098/rspa.2011.0120; Kobayashi H, 2000, SOLID MECH APPL, V80, P211; Guest SD, 1996, J APPL MECH-T ASME, V63, P77, DOI 10.1115/1.2787212; Nojima T, 2002, JSME INT J C-MECH SY, V45, P364, DOI 10.1299/jsmec.45.364; Kobayashi H, 2003, SOLID MECH APPL, V106, P207; Liu Y, 2012, SOFT MATTER, V8, P1764, DOI 10.1039/c1sm06564e; Demaine E. D., 2009, GRAPHS COMBIN, V27, P377; GUEST SD, 1994, J APPL MECH-T ASME, V61, P778, DOI 10.1115/1.2901554; GUEST SD, 1994, J APPL MECH-T ASME, V61, P773, DOI 10.1115/1.2901553; Kobayashi H., 1998, BIOMIMETICS, V3, P105; Miura K., 2009, P INT ASS SHELL SPAT, P27; Nojima T., 2003, JSME INT C, V46, P154; Tachi T., 2009, P 4 INT M OR SCI MAT, P175; Tachi T, 2009, J INT ASS SHELL SPAT, V50, P173	15	1	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1050-0472			J MECH DESIGN	J. Mech. Des.	FEB	2015	137	2							021402	10.1115/1.4029228		5	Engineering, Mechanical	Engineering	AZ2NI	WOS:000348069800003		
J	Sasaki, T; Takeno, Y; Kirishima, A; Sato, N				Sasaki, Takayuki; Takeno, Yuu; Kirishima, Akira; Sato, Nobuaki			Leaching test of gamma-emitting Cs, Ru, Zr, and U from neutron-irradiated UO2/ZrO2 solid solutions in non-filtered surface seawater	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						Fukushima Dai-ichi NPS; fuel-debris; fission products; seawater; leaching; thermodynamics		The leaching behaviors of gamma-ray radionuclides, Cs-137, Ru-103, and Zr-95, produced by neutron irradiation of UO2/ZrO2 solid solutions, in real surface seawater were investigated under atmospheric conditions. The fraction of radionuclide inventory leached in the seawater was in the order of Cs > Ru (approximate to U) >> Zr, indicating that the fraction was significantly affected by the chemical state of the radionuclides. However, the amount of soluble nuclides was proportional to that of uranium regardless of whether the solid solutions were prepared under an oxidative or reductive environment. A tiny fraction of Ru was filtered out by a 3 kDa nominal molecular weight cut-off filter after the 160 d leaching test, suggesting a different behavior from its ionic form, but Cs and U did not form a colloid-like species in seawater.	[Sasaki, Takayuki; Takeno, Yuu] Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Kirishima, Akira; Sato, Nobuaki] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Sasaki, T (reprint author), Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158540, Japan.	sasaki@nucleng.kyoto-u.ac.jp			JSPS KAKENHI [24226021]	This work was supported by JSPS KAKENHI grant-in-aid for Scientific Research (S) [grant number 24226021].	COHEN I, 1963, J NUCL MATER, V9, P18, DOI 10.1016/0022-3115(63)90166-1; Shoesmith DW, 2000, J NUCL MATER, V282, P1, DOI 10.1016/S0022-3115(00)00392-5; Guillaumont R., 2003, CHEM THERMODYNAMICS, V5; Jensen SM, 1989, LOFTT3810 OECD ID NA, V1; Katayama YB, 1980, PNL3173; National Astronomical Observatory of Japan, 2004, CHRON SCI TABL 2005; Quinones J, 1996, J NUCL MATER, V238, P38, DOI 10.1016/S0022-3115(96)00339-X; Sasaki T, 2008, J NUCL SCI TECHNOL, V45, P735, DOI 10.3327/jnst.45.735; Serrano-Purroya D, 2012, J NUCL MATER, V427, P249, DOI 10.1016/j.jnucmat.2012.04.036	9	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					147	151		10.1080/00223131.2014.935511		5	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500001		
J	Kirishima, A; Sasaki, T; Sato, N				Kirishima, Akira; Sasaki, Takayuki; Sato, Nobuaki			Solution chemistry study of radioactive Sr on Fukushima Daiichi NPS site	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						solubility; strontium; contaminated water; thermodynamics; Fukushima Daiichi NPS; phase analysis; solution chemistry; seawater; Sr-90; speciation	25-DEGREES-C; SOLUBILITY; STRONTIUM; CELESTITE; SEAWATER; CALCITE; WATERS; COEFFICIENTS; SATURATION; BARITE	For the better understanding of chemical behavior of Sr-90 released from the damaged reactor cores of Fukushima Daiichi nuclear power station into the seawater system, the dissolution behavior of Sr(II) to the mixed seawater was experimentally investigated by the solubility measurement of Sr(II) under several solution conditions (mixing degree of seawater, pH, strontium concentration and temperature) and the microscopic analysis of the formed solid phase. The obtained results of the experiment were compared with thermodynamic equilibrium calculations for an interpretation of chemistry of Sr(II) in the targeted solution system. It was revealed that the Sr solubility became higher than the reported value in generic seawater system, while the solubility limiting solid was identified as SrSO4 which corresponded with the result of equilibrium calculation. Furthermore, under the unsaturated condition, about 6% of Sr(II) interacted with natural nano-size colloids existing in the Fukushima seawater and was captured by 3kDa filter.	[Kirishima, Akira; Sato, Nobuaki] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Sasaki, Takayuki] Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158530, Japan	Kirishima, A (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 1-1 Katahira,2 Chome, Sendai, Miyagi 9808577, Japan.	kiri@tagen.tohoku.ac.jp			JSPS KAKENHI [24226021]	This work was supported by JSPS KAKENHI grant-in-aid for Scientific Research (S) [grant number 24226021].	PINGITORE NE, 1986, GEOCHIM COSMOCHIM AC, V50, P2195, DOI 10.1016/0016-7037(86)90074-8; MORSE JW, 1990, CHEM GEOL, V82, P265, DOI 10.1016/0009-2541(90)90085-L; Rushdi AI, 2000, MAR CHEM, V69, P19, DOI 10.1016/S0304-4203(99)00089-4; MUCCI A, 1983, GEOCHIM COSMOCHIM AC, V47, P217, DOI 10.1016/0016-7037(83)90135-7; REARDON EJ, 1987, GEOCHIM COSMOCHIM AC, V51, P63, DOI 10.1016/0016-7037(87)90007-X; CULBERSON CH, 1978, J PHYS CHEM-US, V82, P2693, DOI 10.1021/j100514a012; Ilina SM, 2013, CHEM GEOL, V342, P63, DOI 10.1016/j.chemgeo.2013.01.019; Asano M, 2012, J ENV SCI ENG A, V1, P195; BERNSTEIN RE, 1987, SCIENCE, V237, P1490, DOI 10.1126/science.237.4821.1490; Dolin V, 2003, ROLE INTERFACES ENV, P135; Jones MT, 2012, EARTH PLANET SC LETT, V355, P51, DOI 10.1016/j.epsl.2012.08.040; MONNIN C, 1988, CHEM GEOL, V71, P283, DOI 10.1016/0009-2541(88)90055-1; Monnin C, 2006, GEOCHIM COSMOCHIM AC, V70, P3290, DOI 10.1016/j.gca.2006.04.002; National Astronomical Observatory of Japan, 2004, CHRON SCI TABL 2005; NORTH NA, 1974, GEOCHIM COSMOCHIM AC, V38, P1075, DOI 10.1016/0016-7037(74)90005-2; Puigdomenech I., 2009, HYDROCHEMICAL EQUILI; Puigdomenech I, 2009, MAKE EQUILIBRIUM DIA; Secretariat of the Team for Countermeasures for Decommissioning and Contaminated Water Treatment, 2014, PROGR STAT FUT CHALL; TATEDA Y, 1994, J RADIAT RES, V35, P213, DOI 10.1269/jrr.35.213; Tokyo Electric Power Company Inc, 2014, STAT FUK DAIICH NUCL	20	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					152	161		10.1080/00223131.2014.935510		10	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500002		
J	Fukano, Y				Fukano, Yoshitaka			Development of safety assessment methodology on fuel element failure propagation in SFR and its application to Monju	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						FBR; sodium-cooled fast reactor; Monju; safety; severe accident; LF; local subassembly fault	SODIUM; PINS; REACTORS; PRODUCT; BUNDLE; URANIA	Probabilistic and deterministic safety assessments and experimental studies on local fault (LF) propagation in sodium-cooled fast reactors (SFRs) have been performed in many countries because LFs have been historically considered as one of the possible causes of severe accidents. Adventitious fuel pin failures have been considered to be the most dominant initiators of LFs in these probabilistic assessments because of its high frequency of occurrence during reactor operation and possibility of subsequent pin-to-pin failure propagation. Four possible mechanisms of fuel element failure propagation from adventitious fuel pin failure (FEFPA) were identified from a state-of-the-art review of open papers. All the mechanisms for FEFPA analysis including thermal, mechanical and chemical propagation are modeled into a safety assessment code which is applicable to arbitrary SFRs by developing some needed but missing methods. Furthermore, an assessment on FEFPA of Japanese prototype fast breeder reactor (Monju) was performed using this methodology. It was clarified that FEFPA was highly unlikely and limited at most within one subassembly in Monju owing to its redundant and diverse detection and shutdown systems for FEFPA even assuming the propagation. These results also suggested future possibility of run-beyond-cladding-breach operation which would enhance the economic efficiency in Monju.	Japan Atom Energy Agcy, Tsuruga, Fukui 9191279, Japan	Fukano, Y (reprint author), Japan Atom Energy Agcy, 1 Shiraki, Tsuruga, Fukui 9191279, Japan.	fukano.yoshitaka@jaea.go.jp					BAKER RB, 1993, J NUCL MATER, V204, P109, DOI 10.1016/0022-3115(93)90206-E; MIGNANELLI MA, 1984, J NUCL MATER, V125, P182, DOI 10.1016/0022-3115(84)90545-2; Erp J.B., 1974, NUCL ENG DES, V31, P128; Fukano Y, 2013, J NUCL SCI TECHNOL, V50, P950, DOI 10.1080/00223131.2013.817319; Fukano Y., 2004, P 12 INT C NUCL ENG; HAGA K, 1985, NUCL TECHNOL, V70, P220; Japan Atomic Energy Agency, 1980, LIC DOC CONSTR PERM; Japan Nuclear Energy Safety Organization, 2005, STYD AN METH LOC SUB; Kleykamp H, 1997, J NUCL MATER, V248, P209, DOI 10.1016/S0022-3115(97)00120-7; LORENZELLI R, 1985, J NUCL MATER, V130, P298, DOI 10.1016/0022-3115(85)90319-8; MIGNANELLI MA, 1983, J NUCL MATER, V114, P168, DOI 10.1016/0022-3115(83)90254-4; Miyakawa S, 1994, T AT ENERGY SOC JPN, V36, P879; Nakai R, 1981, TN2418128 PNC JAP AT; PLITZ H, 1993, J NUCL MATER, V204, P238, DOI 10.1016/0022-3115(93)90222-K; Schleisiek K., 1985, P INT TOP M FAST REA, P141; STRAIN RV, 1993, J NUCL MATER, V204, P252, DOI 10.1016/0022-3115(93)90224-M; STRAIN RV, 1992, NUCL TECHNOL, V97, P227; Suzuki S., 2003, SUMMARY JOYO MK 3 UP; Vaughan GJ, 1985, P INT TOP M FAST REA, P457; Walter A. E., 2012, FAST SPECTRUM REACTO; WEIMAR P, 1982, NUCL TECHNOL, V57, P81; Wilson RE, 1973, ANL8036	22	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					178	192		10.1080/00223131.2014.939117		15	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500005		
J	Yanagi, C; Murase, M; Yoshida, Y; Kusunoki, T				Yanagi, Chihiro; Murase, Michio; Yoshida, Yoshitaka; Kusunoki, Takayoshi			Prediction of temperature and water level in a spent fuel pit during loss of all AC power supplies	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						spent fuel pit; loss of all AC power supplies; decay heat; evaporation; water temperature; water level; the Fukushima Daiichi Nuclear Power Station	CONTAINMENT COOLING SYSTEM	A prediction method for water temperature in a spent fuel pit of a pressurized water reactor (PWR) has been developed to calculate the increase in water temperature during the shutdown of cooling systems. In this study, the prediction method was extended to calculate the water level in a spent fuel pit during loss of all AC power supplies, and predicted results were compared with measured values of spent fuel pools in the Fukushima Daiichi Nuclear Power Station. The calculations gave reasonable results, but overestimated the decreasing rate of the water level and the water temperature. This indicated that decay heat was overestimated and evaporation heat transfer from the water surface was underestimated. Results of calculations with 80% decay heat and 155% (Unit 4 pool) or 230% (Unit 2 pool) evaporation heat flux were in good agreement with measured values. The data-fitted evaporation heat fluxes agreed rather well with the evaporation heat transfer correlation proposed by Fujii etal.	[Yanagi, Chihiro; Murase, Michio; Yoshida, Yoshitaka] Inst Nucl Safety Syst Inc, Tech Support Project, Inst Nucl Technol, Mihama, Fukui 9191205, Japan; [Kusunoki, Takayoshi] Kansai Elect Power Co Inc, Nucl Power Div, Mihama, Fukui 9191141, Japan	Yanagi, C (reprint author), Inst Nucl Safety Syst Inc, Tech Support Project, Inst Nucl Technol, 64 Sata, Mihama, Fukui 9191205, Japan.	yanagi.chihiro@inss.co.jp					American Nuclear Society, 1973, ANS5; Shibata K, 2002, J NUCL SCI TECHNOL, V39, P1125, DOI 10.3327/jnst.39.1125; [Anonymous], 2010, OV LIGHT WAT NUCL PO; Collins TE, 2001, NUREG1738 USNRC; Fujii T, 1996, J NUCL SCI TECHNOL, V33, P374; Katakura J, 2004, SET ORIGEN2 CROSS SE; KATAOKA Y, 1994, J NUCL SCI TECHNOL, V31, P1043; Ludwig S., 2002, CCC037117 OAK RIDG N; TEPCO, 2011, REP EFF EARTHQ NE JA; Yanagi C, 2011, 2011 FALL M AT EN SO, P41; Yanagi C, 2012, T JPN SOC MECH ENG-B, V78, P363; Yanagi Chihiro, 2012, Journal of Power and Energy Systems, V6, DOI 10.1299/jpes.6.51	12	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					193	203		10.1080/00223131.2014.939597		11	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500006		
J	Hata, K; Takeuchi, Y; Hama, K; Shiotsu, M				Hata, Koichi; Takeuchi, Yuto; Hama, Katsuhiko; Shiotsu, Masahiro			Natural convection heat transfer from horizontal rod bundles in liquid sodium. Part 1: Correlations for two parallel horizontal cylinders based on experimental and theoretical results	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						natural convection heat transfer; liquid sodium; horizontal rod bundle		Natural convection heat transfer coefficients on two parallel horizontal test cylinders in liquid sodium were obtained experimentally and theoretically for various setting angles, gamma, between vertical direction and the plane including both of these cylinders' axes, over the range of 0 degrees-90 degrees. Both test cylinders are 7.6mm in diameter and 50mm in heated length with the ratio of the distance between each cylinder axis to the cylinder diameter, S/D, of 2. Theoretical equations for laminar natural convection heat transfer from the two horizontal cylinders were numerically solved for the same conditions as the experimental ones. The average Nusselt numbers Nu on the cylinders obtained experimentally were compared with the corresponding theoretical values on the Nu versus modified Rayleigh number R-f [= Gr*Pr-2/(4 + 9Pr(1/2) + 10Pr)] graph. The experimental values of Nu for the upper cylinder are about 20% lower than those for the lower cylinder at gamma = 0 degrees for the range of R-f tested here. The value of Nu for the upper cylinder becomes higher and approaches that for the lower cylinder with the increase in gamma over the range of 0 degrees-90 degrees: the values for each cylinder agree with each other at gamma = 90 degrees. The values of Nu for the lower cylinder at each gamma are almost in agreement with those for a single cylinder. The theoretical values of Nu on two cylinders except those for R-f < 4 at gamma = 0 degrees are in agreement with the experimental data at each gamma with the deviations less than 15%. Correlations for two cylinders were obtained as functions of S/D and gamma based on the theoretical solutions. A combined correlation for multi-cylinders in a vertical array based on the correlations for two cylinders was developed. The values by the correlation agree with the theoretical solution for the multi-cylinders for R-f ranging from 4.7 to 63 within 10% difference.	[Hata, Koichi; Takeuchi, Yuto] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Hama, Katsuhiko; Shiotsu, Masahiro] Kyoto Univ, Dept Energy Sci & Technol, Sakyo Ku, Kyoto 6068501, Japan	Hata, K (reprint author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan.	hata@iae.kyoto-u.ac.jp			Ministry of Education, Science and Culture, Japan	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan.	CHURCHILL SW, 1975, INT J HEAT MASS TRAN, V18, P1049, DOI 10.1016/0017-9310(75)90222-7; LIEBERMA.J, 1969, INT J HEAT MASS TRAN, V12, P1385, DOI 10.1016/0017-9310(69)90023-4; MARSTERS GF, 1972, INT J HEAT MASS TRAN, V15, P921, DOI 10.1016/0017-9310(72)90231-1; Patankar S. V., 1980, NUMERICAL HEAT TRANS; Raithby GD, 1985, HDB HEAT TRANSFER FU; Spalding D. B., 1991, PHOENICS BEGINNERS G; Takeuchi Y, 1992, ASME HTD, V204, P183	7	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					214	227		10.1080/00223131.2014.943317		14	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500008		
J	Yamaki, T; Abe, Y; Kaneko, A; Segawa, T; Kawaguchi, K; Yamada, Y; Fujii, K				Yamaki, Tatsunori; Abe, Yutaka; Kaneko, Akiko; Segawa, Tomoomi; Kawaguchi, Koichi; Yamada, Yoshikazu; Fujii, Kan-ichi			The criteria of flushing phenomena under microwave heating	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						boiling transition; fuel cycle; MOX fuel; microwave heating; de-nitration; flushing		In the microwave heating (MH) de-nitration method developed in Japan, a mixed solution of uranyl nitrate and plutonium nitrate recovered from the spent fuel in the reprocessing plant is converted directly to mixed oxide (MH-MOX) powder. This MH-MOX powder is utilized to fabricate MOX fuel with UO2 powder for FBR. The MH method is accompanied with transient boiling phenomena such as overflow and flushing. Toward high-speed and high-capacity conversion by MH-method in the future, it is required to avoid overflow and flushing and to understand optimal conditions for design and operation. At the first step for these objectives, basic knowledge of transient boiling phenomena by the MH-method has been acquired with using distilled water. It is observed that generation of singular bubble triggers flushing and distilled water just before flushing is superheated by a temperature 10 degrees C higher than boiling temperature. Based on these results, it is clarified that the occurrence criteria of flushing correlate with absorbed power in the water and released power from the water surface.	[Yamaki, Tatsunori; Abe, Yutaka; Kaneko, Akiko] Univ Tsukuba, Grad Sch Syst & Informat Engn, Dept Engn Mech & Energy, Tsukuba, Ibaraki 3058573, Japan; [Segawa, Tomoomi; Kawaguchi, Koichi; Yamada, Yoshikazu] Japan Atom Energy Agcy, Tokai, Ibaraki 3191194, Japan; [Fujii, Kan-ichi] Ibaraki Univ, Hitachi, Ibaraki 3168511, Japan	Yamaki, T (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Dept Engn Mech & Energy, 1-1-1 Tennnoudai, Tsukuba, Ibaraki 3058573, Japan.	s1320967@u.tsukuba.ac.jp					MIKIC BB, 1970, INT J HEAT MASS TRAN, V13, P657, DOI 10.1016/0017-9310(70)90040-2; Federico ID, 1966, INT J HEAT MASS TRAN, V9, P1351; Katasaros KB, 1977, J FLUID MECH, V83, P311; NAVON U, 1971, AICHE J, V17, P131, DOI 10.1002/aic.690170127; Suzuki M, 2009, P GLOB 2009 SEP 6 11	5	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					241	250		10.1080/00223131.2014.946567		10	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500010		
J	Takao, K; Kawata, Y; Nogami, M; Harada, M; Morita, Y; Nishimura, K; Ikeda, Y				Takao, Koichiro; Kawata, Yoshinao; Nogami, Masanobu; Harada, Masayuki; Morita, Yasuji; Nishimura, Kenji; Ikeda, Yasuhisa			Precise determination of precipitation yield of uranyl nitrate with N-alkylated 2-pyrrolidone derivatives	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						analysis; actinides; fuel cycle; precipitation; uranium	PYRROLIDONE DERIVATIVES; SELECTIVE PRECIPITANT; COMPLEXES; ION	Yields of precipitated UO2(NO3)(2)(NRP)(2) (NRP = N-alkylated 2-pyrrolidone) were precisely determined by considering reduction of the solution volume through the precipitation, which can be estimated from difference in acid concentrations of the liquid phases before and after the precipitation. The studied NRPs were N-n-butyl (NBP) and N-n-propyl (NProP) derivatives. In both systems, the precipitation yields precisely determined were always higher than those simply calculated from the ratio of uranium concentrations before and after the precipitation. However, the differences between them are in the range of 0.6%-2.6%. If such a difference is practically negligible, the volume reduction through the precipitation does not have to be taken into account for simplicity of the analytical manipulation.	[Takao, Koichiro; Harada, Masayuki; Ikeda, Yasuhisa] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan; [Kawata, Yoshinao; Nishimura, Kenji] Mitsubishi Mat Corp, Naka, Ibaraki 3110102, Japan; [Nogami, Masanobu] Kinki Univ, Dept Elect & Elect Engn, Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan; [Morita, Yasuji] Japan Atom Energy Agcy, Naka, Ibaraki 3191195, Japan	Ikeda, Y (reprint author), Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528550, Japan.	yikeda@nr.titech.ac.jp					MOTOJIMA K, 1964, ANAL CHEM, V36, P733, DOI 10.1021/ac60210a011; Grenthe I., 1992, CHEM THERMODYNAMICS; Guillaumont R., 2003, UPDATE CHEM THERMODY; Ikeda Y, 2004, J ALLOY COMPD, V374, P420, DOI 10.1016/j.jallcom.2003.11.050; Koshino N, 2005, PROG NUCL ENERG, V47, P406, DOI 10.1016/j.pnucene.2005.05.040; Koshino N, 2005, INORG CHIM ACTA, V358, P1857, DOI 10.1016/j.ica.2004.12.036; Morita Y, 2009, J NUCL SCI TECHNOL, V46, P1129, DOI 10.3327/jnst.46.1129; Takao K, 2008, CRYST GROWTH DES, V8, P2364, DOI 10.1021/cg7012254; Takao K, 2009, J NUCL SCI TECHNOL, V46, P995; Varga TR, 2003, INORG CHIM ACTA, V342, P291, DOI 10.1016/S0020-1693(02)01162-3; Varga TR, 2000, INORG CHEM COMMUN, V3, P637, DOI 10.1016/S1387-7003(00)00123-4	11	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3131	1881-1248		J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	FEB 1	2015	52	2					294	298		10.1080/00223131.2014.937782		5	Nuclear Science & Technology	Nuclear Science & Technology	AY4FB	WOS:000347532500015		
J	Sugiura-Ogasawara, M; Lin, BL; Aoki, K; Maruyama, T; Nakatsuka, M; Ozawa, N; Sugi, T; Takeshita, T; Nishida, M				Sugiura-Ogasawara, M.; Lin, B. L.; Aoki, K.; Maruyama, T.; Nakatsuka, M.; Ozawa, N.; Sugi, T.; Takeshita, T.; Nishida, M.			Does surgery improve live birth rates in patients with recurrent miscarriage caused by uterine anomalies?	JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article						Bicornuate uterus; congenital uterine anomaly; metroplasty; recurrent pregnancy loss; septate uterus	MULLERIAN ANOMALIES; SEPTUM; UTERUS; MANAGEMENT; DIAGNOSIS; RESECTION; WOMEN	We found that congenital uterine anomalies have a negative impact on reproductive outcome in recurrent-miscarriage couples, being associated with further miscarriage with a normal embryonic karyotype. There has been no study comparing live birth rates between patients with and without surgery. We conducted a prospective study to prove that surgery for a bicornuate or septate uterus might improve the live birth rate. A total of 170 patients with congenital uterine anomalies suffering two or more miscarriages were examined. The live birth rate after ascertainment of anomalies, cumulative live birth rate and infertility rate, were compared between patients with and without surgery. In patients with a septate uterus, the live birth rate (81.3%) at the first pregnancy after ascertainment of anomalies with surgery tended to be higher than that (61.5%) in those without surgery. The infertility rates were similar in both groups, while the cumulative live birth rate (76.1%) tended to be higher than without surgery (60.0%). Surgery showed no benefit in patients with a bicornuate uterus for having a baby, but tended to decrease the preterm birth rate and the low birth weight. The possibility that surgery has benefits for having a baby in patients with a septate uterus suffering recurrent miscarriage could not be excluded.	[Sugiura-Ogasawara, M.] Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi 4678601, Japan; [Lin, B. L.] Kawasaki Municipal Hosp, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan; [Aoki, K.] Aoki Ladies Clin, Nagoya, Aichi, Japan; [Maruyama, T.] Keio Univ Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Nakatsuka, M.] Okayama Univ Med Sch, Fac Hlth Sci, Okayama, Japan; [Ozawa, N.] Natl Hosp Org Tokyo Med Ctr, Dept Obstet & Gynecol, Tokyo, Japan; [Sugi, T.] Sugi Womens Clin Lab Recurrent Pregnancy Loss, Yokohama, Kanagawa, Japan; [Takeshita, T.] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo 113, Japan; [Nishida, M.] Natl Hosp Org Kasumigaura Med Ctr, Dept Obstet & Gynecol, Ibaraki, Japan	Sugiura-Ogasawara, M (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Mizuho Ku, Nagoya, Aichi 4678601, Japan.	og.mym@med.nagoya-cu.ac.jp			Ministry of Health, Labour and Welfare of Japan	This study was supported by a grant-in-aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan.	FARQUHARSON RG, 1984, LANCET, V2, P228; Chan YY, 2011, HUM REPROD UPDATE, V17, P761, DOI 10.1093/humupd/dmr028; Woelfer B, 2001, OBSTET GYNECOL, V98, P1099, DOI 10.1016/S0029-7844(01)01599-X; PELLERITO JS, 1992, RADIOLOGY, V183, P795; Raga F, 1997, HUM REPROD, V12, P2277, DOI 10.1093/humrep/12.10.2277; Patton PE, 2004, AM J OBSTET GYNECOL, V190, P1669, DOI 10.1016/j.ajog.2004.02.046; Ogasawara M, 2000, FERTIL STERIL, V73, P300, DOI 10.1016/S0015-0282(99)00495-1; GOLDENBERG M, 1995, HUM REPROD, V10, P2663; Grimbizis G, 1998, HUM REPROD, V13, P1188, DOI 10.1093/humrep/13.5.1188; Hua M, 2011, AM J OBSTET GYNECOL, V205; Jacobsen LJ, 1997, HUM REPROD, V12, P1371; JONES HW, 1953, AM J OBSTET GYNECOL, V65, P325; Karande VC, 1999, HUM REPROD, V14, P1226, DOI 10.1093/humrep/14.5.1226; Kormanyos Z, 2006, HUM REPROD, V21, P1047, DOI 10.1093/humrep/dei438; Kowalik CR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008576.pub3; Lee R, 2000, AM J OBSTET GYNECOL, V182, P1414; STRASSMANN EO, 1961, CLIN OBSTET GYNECOL, V4, P240, DOI 10.1097/00003081-196104010-00020; Sugiura-Ogasawara M, 2010, FERTIL STERIL, V93, P1983, DOI 10.1016/j.fertnstert.2008.12.097; Sugiura-Ogasawara M, 2004, FERTIL STERIL, V81, P367, DOI 10.1016/j.fertnstert.2003.07.014; Sugiura-Ogasawara M, 2013, CURR OPIN OBSTET GYN, V25, P293, DOI 10.1097/GCO.0b013e3283632849; The American Fertility Society, 1988, FERTIL STERIL, V49, P944; TOMPKINS P, 1962, SURG CLIN N AM, V42, P1049	22	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0144-3615			J OBSTET GYNAECOL	J. Obstet. Gynaecol.	FEB	2015	35	2					155	158		10.3109/01443615.2014.936839		4	Obstetrics & Gynecology	Obstetrics & Gynecology	AY8II	WOS:000347797000012		
J	Oride, A; Kanasaki, H; Miyazaki, K				Oride, A.; Kanasaki, H.; Miyazaki, K.			Comparison of human menopausal gonadotropin stimulation with and without clomiphene for in-vitro fertilisation in poor-responders	JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article						Clomiphene; hMG; IVF; poor-responders	CONTROLLED OVARIAN STIMULATION; ANTAGONIST CETRORELIX; RANDOMIZED-TRIAL; GNRH ANTAGONIST; NATURAL CYCLE; IVF; CITRATE; PREGNANCY; AGONIST; DEHYDROEPIANDROSTERONE	This study aimed to determine the effectiveness of human menopausal gonadotropin (hMG) with and without clomiphene citrate (CC) for ovarian stimulation and oocyte retrieval in poor-responders. A total of 66 cycles in 13 patients met the inclusion criteria of 20 cycles of hMG stimulation and 46 cycles of CC + hMG stimulation. Mean total hMG dose per patient was significantly lower during the stimulation cycle with CC + hMG than with hMG alone. Mean oestradiol level at oocyte retrieval and mean number of oocytes retrieved per patient showed no significant differences between the two cycles. Four of the 13 patients achieved pregnancy with the CC + hMG cycles. The absence of a significant difference in oestradiol level at oocyte retrieval or in the number of oocytes retrieved between the two cycles, despite a significantly lower total hMG dose during the CC + hMG stimulation cycles, suggests a greater benefit of CC + hMG stimulation for poor-responders.	[Oride, A.; Kanasaki, H.; Miyazaki, K.] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan	Oride, A (reprint author), Shimane Univ, Sch Med, Dept Obstet & Gynecol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	oride@med.shimane-u.ac.jp					Pelinck MJ, 2002, HUM REPROD UPDATE, V8, P129, DOI 10.1093/humupd/8.2.129; Oudendijk JF, 2012, HUM REPROD UPDATE, V18, P1, DOI 10.1093/humupd/dmr037; VANHOOFF MHA, 1993, HUM REPROD, V8, P369; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Pu DH, 2011, HUM REPROD, V26, P2742, DOI 10.1093/humrep/der240; Keay SD, 1997, BRIT J OBSTET GYNAEC, V104, P521, DOI 10.1111/j.1471-0528.1997.tb11525.x; MARRS RP, 1984, FERTIL STERIL, V41, P682; Morgia F, 2004, FERTIL STERIL, V81, P1542, DOI 10.1016/j.fertnstert.2003.11.031; Karimzadeh MA, 2011, ARCH GYNECOL OBSTET, V283, P1159, DOI 10.1007/s00404-010-1828-z; Yong PYK, 2003, FERTIL STERIL, V79, P308, DOI 10.1016/S0015-0282(02)04583-1; Albano C, 1996, HUM REPROD, V11, P1632; Reynolds KA, 2013, HUM REPROD, V28, P2981, DOI 10.1093/humrep/det306; de Ziegler D, 2011, FERTIL STERIL, V96, P1069, DOI 10.1016/j.fertnstert.2011.09.049; Edwards RG, 1996, HUM REPROD, V11, P917; Wiser A, 2010, HUM REPROD, V25, P2496, DOI 10.1093/humrep/deq220; Ingerslev HJ, 2001, HUM REPROD, V16, P696, DOI 10.1093/humrep/16.4.696; Dickey RP, 1996, HUM REPROD UPDATE, V2, P483, DOI 10.1093/humupd/2.6.483; Gibreel A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008528.pub2; GLASIER AF, 1989, HUM REPROD, V4, P252; Lin YH, 2006, GYNECOL ENDOCRINOL, V22, P297, DOI 10.1080/09513590600702733; MACDOUGALL MJ, 1994, FERTIL STERIL, V61, P1052; Marci R, 2005, REPROD BIOMED ONLINE, V11, P189; Mohamed KA, 2006, GYNECOL ENDOCRINOL, V22, P57, DOI 10.1080/09513590500519260; Narkwichean A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-44; Olivennes F, 2000, FERTIL STERIL, V73, P314, DOI 10.1016/S0015-0282(99)00524-5; Rongieres-Bertrand C, 1999, HUM REPROD, V14, P683, DOI 10.1093/humrep/14.3.683	26	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0144-3615			J OBSTET GYNAECOL	J. Obstet. Gynaecol.	FEB	2015	35	2					163	167		10.3109/01443615.2014.940290		5	Obstetrics & Gynecology	Obstetrics & Gynecology	AY8II	WOS:000347797000014		
J	Shitsukawa, K; Shinomiya, S; Tanaka, Y; Okada, M; Kamada, M				Shitsukawa, K.; Shinomiya, S.; Tanaka, Y.; Okada, M.; Kamada, M.			Ovarian haemangioma with hyperandrogenism: a case report	JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Editorial Material									[Shitsukawa, K.; Tanaka, Y.; Okada, M.; Kamada, M.] Tokushima Prefecture Naruto Hosp, Dept Obstet & Gynecol, Naruto, Tokushima 7728503, Japan; [Shinomiya, S.] Tokushima Prefecture Naruto Hosp, Dept Pathol, Naruto, Tokushima 7728503, Japan	Shitsukawa, K (reprint author), Tokushima Prefecture Naruto Hosp, Dept Obstet & Gynecol, 32 Aza Kotani,Kurosaki Muya Cho, Naruto, Tokushima 7728503, Japan.	keiji_s@kde.biglobe.ne.jp					Gucer F, 2004, GYNECOL ONCOL, V94, P821, DOI 10.1016/j.ygyno.2004.06.021; Nezhat F, 2002, GYNECOL ONCOL, V84, P468, DOI 10.1006/gyno.2001.6542; Uppal Shweta, 2004, Archives of Gynecology and Obstetrics, V270, P1	3	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0144-3615			J OBSTET GYNAECOL	J. Obstet. Gynaecol.	FEB	2015	35	2					214	+		10.3109/01443615.2014.940288		2	Obstetrics & Gynecology	Obstetrics & Gynecology	AY8II	WOS:000347797000033		
J	Liu, WQ; Suzuki, K; Shibanuma, K				Liu, Weiqin; Suzuki, Katsuyuki; Shibanuma, Kazuki			Nonlinear Dynamic Response and Structural Evaluation of Container Ship in Large Freak Waves	JOURNAL OF OFFSHORE MECHANICS AND ARCTIC ENGINEERING-TRANSACTIONS OF THE ASME			English	Article								Many ship accidents and casualties are caused by large freak ocean waves. Traditionally, the strength of ships against freak waves is assessed by means of ultimate strength evaluation, assuming quasi-static conditions, but the nonlinear dynamic structural response of ships to freak waves should be considered as well. This paper describes how the strength of a ship can be evaluated in terms of its nonlinear vertical bending moment (VBM). Linear dynamic VBM of a ship, which is derived from hydrodynamics, is calculated using a time-domain strip theory code under freak wave conditions, and the nonlinear dynamic VBM, which is dependent on structural nonlinearity, is calculated using a combination of quasi-static and dynamic nonlinear analyses based on the finite element method (FEM). The nonlinear and linear VBMs are then compared to assess how they differ. Then, the influence of freak wave height and wave speed on the VBMs and deformation is studied.	[Liu, Weiqin; Suzuki, Katsuyuki; Shibanuma, Kazuki] Univ Tokyo, Sch Engn, Dept Syst Innovat, Tokyo 1138656, Japan	Liu, WQ (reprint author), Univ Tokyo, Sch Engn, Dept Syst Innovat, 7-3-1 Hongo, Tokyo 1138656, Japan.	liuweiqin_123@sina.com; katsu@race.u-tokyo.ac.jp; shibanuma@struct.t.u-tokyo.ac.jp					Iijima K, 2008, MAR STRUCT, V21, P420, DOI 10.1016/j.marstruc.2008.03.003; Kharif C, 2003, EUR J MECH B-FLUID, V22, P603, DOI 10.1016/j.euromechflu.2003.09.002; Haver S., 1990, P 10 INT SOC OFFSH P, V3, P123; Jiang L, 2012, P 6 INT C HYDR MAR T, P277; Minami M., 2006, P 16 INT OFFSH POL E; Pei Z., 2012, P 22 INT OFFSH POL E, P839; Shi J., 2007, P S HELD RES I APPL, V2, P1; Waseda T., 2005, P 15 ISOPE SEOUL KOR, V3, P1; Xia J, 1998, MARINE STRUCTURES, V11, P101, DOI 10.1016/S0951-8339(98)00008-2; Yamamoto Y., 1977, C SOC NAV ARCH JAP S, V145, P179	10	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0892-7219	1528-896X		J OFFSHORE MECH ARCT	J. Offshore Mech. Arct. Eng. Trans. ASME	FEB	2015	137	1							011601	10.1115/1.4028506		9	Engineering, Ocean; Engineering, Mechanical	Engineering	AZ2NO	WOS:000348070400008		
J	Falk, CF; Heine, SJ; Takemura, K; Zhang, CXJ; Hsu, CW				Falk, Carl F.; Heine, Steven J.; Takemura, Kosuke; Zhang, Cathy X. J.; Hsu, Chih-Wei			Are Implicit Self-Esteem Measures Valid for Assessing Individual and Cultural Differences?	JOURNAL OF PERSONALITY			English	Article						Implicit Attitudes; Self-Esteem; Cross-Cultural Psychology; Personality	ASSOCIATION TEST; SOCIAL COGNITION; METAANALYSIS; ENHANCEMENT; ATTITUDES; STEREOTYPES; BEHAVIOR	ObjectiveOur research utilized two popular theoretical conceptualizations of implicit self-esteem: 1) implicit self-esteem as a global automatic reaction to the self; and 2) implicit self-esteem as a context/domain specific construct. Under this framework, we present an extensive search for implicit self-esteem measure validity among different cultural groups (Study 1) and under several experimental manipulations (Study 2). MethodIn Study 1, Euro-Canadians (N=107), Asian-Canadians (N=187), and Japanese (N=112) completed a battery of implicit self-esteem, explicit self-esteem, and criterion measures. Included implicit self-esteem measures were either popular or provided methodological improvements upon older methods. Criterion measures were sampled from previous research on implicit self-esteem and included self-report and independent ratings. In Study 2, Americans (N=582) completed a shorter battery of these same types of measures under either a control condition, an explicit prime meant to activate the self-concept in a particular context, or prime meant to activate self-competence related implicit attitudes. ResultsAcross both studies, explicit self-esteem measures far outperformed implicit self-esteem measures in all cultural groups and under all experimental manipulations. ConclusionImplicit self-esteem measures are not valid for individual or cross-cultural comparisons. We speculate that individuals may not form implicit associations with the self as an attitudinal object.	[Falk, Carl F.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Heine, Steven J.; Zhang, Cathy X. J.; Hsu, Chih-Wei] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Takemura, Kosuke] Kyoto Univ, Kyoto 6068501, Japan; [Takemura, Kosuke] Japan Sci & Technol Agcy, RISTEX, Tokyo, Japan	Falk, CF (reprint author), Univ Calif Los Angeles, Grad Sch Educ & Informat Studies, Los Angeles, CA 90095 USA.	cffalk@gmail.com					Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; PELHAM BW, 1989, J PERS SOC PSYCHOL, V57, P672, DOI 10.1037//0022-3514.57.4.672; Spalding LR, 1999, PSYCHOL SCI, V10, P535, DOI 10.1111/1467-9280.00202; Rooke SE, 2008, ADDICT BEHAV, V33, P1314, DOI 10.1016/j.addbeh.2008.06.009; Yamaguchi S, 2007, PSYCHOL SCI, V18, P498, DOI 10.1111/j.1467-9280.2007.01928.x; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Hetts JJ, 1999, J EXP SOC PSYCHOL, V35, P512, DOI 10.1006/jesp.1999.1391; Heine SJ, 2007, PERS SOC PSYCHOL REV, V11, P4, DOI 10.1177/1088868306294587; Falk CF, 2009, EUR J PERSONALITY, V23, P183, DOI 10.1002/per.715; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; Thissen D, 2002, J EDUC BEHAV STAT, V27, P77, DOI 10.3102/10769986027001077; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Krizan Z, 2008, PERS INDIV DIFFER, V44, P521, DOI 10.1016/j.paid.2007.09.017; Heine SJ, 1997, J PERS SOC PSYCHOL, V72, P1268, DOI 10.1037//0022-3514.72.6.1268; Gawronski B, 2006, PSYCHOL BULL, V132, P692, DOI 10.1037/0033-2909.132.5.692; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Sedikides C, 2007, ASIAN J SOC PSYCHOL, V10, P201, DOI 10.1111/j.1467-839X.2007.00227.x; Rudolph A, 2008, EUR J PSYCHOL ASSESS, V24, P273, DOI 10.1027/1015-5759.24.4.273; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1; MARKUS H, 1987, ANNU REV PSYCHOL, V38, P299, DOI 10.1146/annurev.psych.38.1.299; DeHart T, 2006, J EXP SOC PSYCHOL, V42, P1, DOI 10.1016/j.jesp.2004.12.005; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037//0033-295X.102.1.4; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037//0033-295X.109.1.3; SWANN WB, 1992, J ABNORM PSYCHOL, V101, P293, DOI 10.1037//0021-843X.101.2.293; Tracy JL, 2009, SELF IDENTITY, V8, P196, DOI 10.1080/15298860802505053; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Tafarodi RW, 2001, PERS INDIV DIFFER, V31, P653, DOI 10.1016/S0191-8869(00)00169-0; Bosson J. K., 2006, SELF ESTEEM ISSUES A, P53; Bosson J. K., 2008, SOCIAL PERSONALITY P, V2, P1415, DOI [10.1111/j.1751-9004.2008.00089.x, DOI 10.1111/J.1751-9004.2008.00089.X]; Buhrmester MD, 2011, J PERS SOC PSYCHOL, V100, P365, DOI 10.1037/a0021341; Conner T, 2005, EMOTION, V5, P476, DOI 10.1037/1528-3542.5.4.476; Dijksterhuis A., 2009, ATTITUDES INSIGHTS N, P229; Epstein S., 2006, SELF ESTEEM ISSUES A, P69; Falk C. F., 2013, WHAT IS IMPLIC UNPUB; Hetts JJ, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P105; Karpinski A, 2004, PERS SOC PSYCHOL B, V30, P22, DOI 10.1177/0146167203258835; Kobayashi C, 2003, J CROSS CULT PSYCHOL, V34, P522, DOI 10.1177/0022022103257855; Koole S. L., 2007, SELF SOCIAL PSYCHOL, P36; Little R. J. A., 2002, STAT ANAL MISSING DA; Paulhus D. L., 1991, MEASURES PERSONALITY, V1, P17; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Pennebaker J. W., 2007, LINGUISTIC INQUIRY W; Peterson JL, 2013, J EXP SOC PSYCHOL, V49, P99, DOI 10.1016/j.jesp.2012.07.013; Rosenberg M., 1965, SOC ADOLESCENT SELF; Rudolph A, 2010, Z PSYCHOL, V218, P12, DOI 10.1027/0044-3409/a000003; Scheff TJ, 2004, J THEOR SOC BEHAV, V34, P73, DOI 10.1111/j.1468-5914.2004.00235.x; Tafarodi RW, 1998, J PERS SOC PSYCHOL, V74, P1181, DOI 10.1037/0022-3514.74.5.1181; Teige-Mocigemba S, 2008, EUR J PSYCHOL ASSESS, V24, P237, DOI 10.1027/1015-5759.24.4.237; Verplanken B, 2007, J PERS SOC PSYCHOL, V92, P526, DOI 10.1037/0022-3514.92.3.526; Whetstone M. R., 1992, CONV AM PSYCH SOC SA; Wicklund R. A., 1972, THEORY SELF AWARENES	54	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3506	1467-6494		J PERS	J. Pers.	FEB	2015	83	1					56	68		10.1111/jopy.12082		13	Psychology, Social	Psychology	AY4HS	WOS:000347539400005		
J	Maeda, H; Hirata, K; Watanabe, H; Ishima, Y; Chuang, VTG; Taguchi, K; Inatsu, A; Kinoshita, M; Tanaka, M; Sasaki, Y; Otagiri, M; Maruyama, T				Maeda, Hitoshi; Hirata, Kenshiro; Watanabe, Hiroshi; Ishima, Yu; Chuang, Victor Tuan Giam; Taguchi, Kazuaki; Inatsu, Akihito; Kinoshita, Manabu; Tanaka, Motohiko; Sasaki, Yutaka; Otagiri, Masaki; Maruyama, Toru			Polythiol-Containing, Recombinant Mannosylated-Albumin Is a Superior CD68(+)/CD206(+) Kupffer Cell-Targeted Nanoantioxidant for Treatment of Two Acute Hepatitis Models	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							HUMAN SERUM-ALBUMIN; INDUCED LIVER-INJURY; ACETAMINOPHEN HEPATOTOXICITY; REACTIVE OXYGEN; OXIDATIVE STRESS; MICE; TOXICITY; MECHANISMS; PROTEIN; ANTIOXIDANTS	Since reactive oxygen species (ROS) derived from Kupffer cells (KC), especially CD68(+) KC, play a key role in the induction of hepatic oxidative stress and injuries, we developed a polythiolated- and mannosylated human serum albumin (SH-Man-HSA), which functions as a novel nanoantioxidant for delivering thiol to CD68(+) KC. In vitro electron paramagnetic resonance coupled with pharmacokinetics and immunohistochemical studies showed that SH-Man-HSA possessed powerful radical-scavenging activity and rapidly and selectively delivered thiols to the liver via mannose receptor (CD206) on CD68(+) cells. SH-Man-HSA significantly improved the survival rate of concanavalin-A (Con-A)-treated mice. Moreover, SH-Man-HSA exhibited excellent hepatoprotective functions, not by decreasing tumor necrosis factor or interferon-gamma production that is closely associated with Con-A-induced hepatitis, but by suppressing ROS production. Interestingly, the protective effect of SH-Man-HSA was superior to N-acetyl cysteine (NAC). This could be attributed to the difference in the inhibition of hepatic oxidative stress between the two antioxidants depending on their potential for thiol delivery to the liver. Similar results were also observed for acetaminophen (APAP)-induced hepatopathy models. Flow cytometric data further confirmed that an increase in F4/80(+)/ROS+ cells was dramatically decreased by SH-Man-HSA. The administration of SH-Man-HSA at 4 hours following a Con-A or APAP injection also exhibited a profound hepatoprotective action against these hepatitis models, whereas this was not observed for NAC. It can be concluded therefore that SH-Man-HSA has great potential for use in a rescue therapy for hepatopathy as a nanoantioxidant because of its ability to efficiently and rapidly deliver thiols to CD68(+)/CD206(+) KC.	[Maeda, Hitoshi; Hirata, Kenshiro; Watanabe, Hiroshi; Ishima, Yu; Chuang, Victor Tuan Giam; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Watanabe, Hiroshi; Ishima, Yu; Maruyama, Toru] Kumamoto Univ, Sch Pharm, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan; [Tanaka, Motohiko; Sasaki, Yutaka] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol & Hepatol, Kumamoto 8620973, Japan; [Chuang, Victor Tuan Giam] Curtin Univ, Curtin Hlth Innovat Res Inst, Fac Hlth Sci, Sch Pharm, Perth, WA 6845, Australia; [Taguchi, Kazuaki; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan; [Otagiri, Masaki] Sojo Univ, DDS Res Inst, Kumamoto, Japan; [Inatsu, Akihito; Kinoshita, Manabu] Natl Def Med Coll, Dept Immunol & Microbiol, Saitama, Japan	Maruyama, T (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	tomaru@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [KAKENHI 21390177]	This research was supported, in part, by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) (KAKENHI 21390177).	Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Sun H, 2013, CELL IMMUNOL, V284, P60, DOI 10.1016/j.cellimm.2013.06.013; Katayama N, 2008, J PHARMACOL EXP THER, V325, P69, DOI 10.1124/jpet.107.132100; Kragh-Hansen U, 2001, BBA-PROTEIN STRUCT M, V1550, P20, DOI 10.1016/S0167-4838(01)00264-3; Nakashima H, 2008, HEPATOLOGY, V48, P1979, DOI 10.1002/hep.22561; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Hirata K, 2010, J CONTROL RELEASE, V145, P9, DOI 10.1016/j.jconrel.2010.03.010; Moreno-Otero R, 2013, DIGEST DIS SCI, V58, P1440, DOI 10.1007/s10620-013-2622-0; Saito C, 2010, HEPATOLOGY, V51, P246, DOI [10.1002/hep.23267, 10.1002/hep.2.3267]; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Botta D, 2006, J BIOL CHEM, V281, P28865, DOI 10.1074/jbc.M605143200; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; Laskin DL, 2001, TOXICOLOGY, V160, P111, DOI 10.1016/S0300-483X(00)00437-6; Sato K, 2002, FASEB J, V16, P1713, DOI 10.1096/fj.02-0331com; Ayoub SS, 2004, P NATL ACAD SCI USA, V101, P11165, DOI 10.1073/pnas.0404185101; Dobashi H, 1999, HEPATOLOGY, V30, P430, DOI 10.1002/hep.510300209; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Lewerenz V, 2003, TOXICOLOGY, V191, P179, DOI 10.1016/S0300-483X(03)00256-7; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; HNATOWICH DJ, 1982, INT J APPL RADIAT IS, V33, P327, DOI 10.1016/0020-708X(82)90144-2; Michael SL, 1999, HEPATOLOGY, V30, P186, DOI 10.1002/hep.510300104; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Kogelberg H, 2007, GLYCOBIOLOGY, V17, P36, DOI 10.1093/glycob/cwl053; LASKIN DL, 1995, HEPATOLOGY, V21, P1045, DOI 10.1016/0270-9139(95)90253-8; Chedid A, 2004, ARCH PATHOL LAB MED, V128, P1230; Hu WX, 2012, MOL MED REP, V6, P93, DOI 10.3892/mmr.2012.890; James LP, 2006, BIOCHEM BIOPH RES CO, V343, P171, DOI 10.1016/j.bbrc.2006.02.143; Lei XG, 2006, BIOCHEM J, V399, P455, DOI 10.1042/BJ20060784; Minchiotti L, 2001, EUR J BIOCHEM, V268, P344, DOI 10.1046/j.1432-1327.2001.01899.x; Singh R, 1996, ANAL BIOCHEM, V236, P114, DOI 10.1006/abio.1996.0139; Sparkenbaugh EM, 2011, J PHARMACOL EXP THER, V338, P492, DOI 10.1124/jpet.111.180521	35	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	2015	352	2					244	257		10.1124/jpet.114.219493		14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY8RY	WOS:000347822200006		
J	Xu, D; Wu, MH; Nishimura, S; Nishimura, T; Michie, SA; Zheng, M; Yang, ZC; Yates, AJ; Day, JS; Hillgren, KM; Takeda, ST; Guan, Y; Guo, YY; Peltz, G				Xu, Dan; Wu, Manhong; Nishimura, Sachiko; Nishimura, Toshihiko; Michie, Sara A.; Zheng, Ming; Yang, Zicheng; Yates, Alexander John; Day, Jeffrey S.; Hillgren, Kathleen M.; Takeda, Saori Takedai; Guan, Yuan; Guo, Yingying; Peltz, Gary			Chimeric TK-NOG Mice: A Predictive Model for Cholestatic Human Liver Toxicity	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							ENDOTHELIN ANTAGONIST BOSENTAN; BILE-ACID SYNTHESIS; SALT EXPORT PUMP; BILIARY-EXCRETION; DUCT LIGATION; RATS; HYPERTENSION; CHOLESTEROL; METABOLISM; FAILURE	Due to the substantial interspecies differences in drug metabolism and disposition, drug-induced liver injury (DILI) in humans is often not predicted by studies performed in animal species. For example, a drug (bosentan) used to treat pulmonary artery hypertension caused unexpected cholestatic liver toxicity in humans, which was not predicted by preclinical toxicology studies in multiple animal species. In this study, we demonstrate that NOG mice expressing a thymidine kinase transgene (TK-NOG) with humanized livers have a humanized profile of biliary excretion of a test (cefmetazole) drug, which was shown by an in situ perfusion study to result from interspecies differences in the rate of biliary transport and in liver retention of this drug. We also found that readily detectable cholestatic liver injury develops in TK-NOG mice with humanized livers after 1 week of treatment with bosentan (160, 32, or 6 mg/kg per day by mouth), whereas liver toxicity did not develop in control mice after 1 month of treatment. The laboratory and histologic features of bosentan-induced liver toxicity in humanized mice mirrored that of human subjects. Because DILI has become a significant public health problem, drug safety could be improved if preclinical toxicology studies were performed using humanized TK-NOG.	[Xu, Dan; Wu, Manhong; Nishimura, Toshihiko; Zheng, Ming; Guan, Yuan; Peltz, Gary] Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA; [Nishimura, Sachiko; Nishimura, Toshihiko] Ctr Adv Hlth & Biosci, Sunnyvale, CA USA; [Nishimura, Toshihiko] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Michie, Sara A.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Yang, Zicheng; Yates, Alexander John] Bruker CAM & LSC7, Fremont, CA USA; [Day, Jeffrey S.; Hillgren, Kathleen M.; Guo, Yingying] Eli Lilly & Co, Dept Drug Disposit, Indianapolis, IN 46285 USA; [Takeda, Saori Takedai] Vivo Sci Int, Sunnyvale, CA USA	Peltz, G (reprint author), Stanford Univ, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	gpeltz@stanford.edu			National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [1R01-DK0909921]; Eli Lilly and Company through the Lilly Research Award Program	This work was supported by a transformative R01 award from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grant 1R01-DK0909921]. This work was also partially supported by Eli Lilly and Company through the Lilly Research Award Program.	Humbert M, 2007, EUR RESPIR J, V30, P338, DOI 10.1183/09031936.00138706; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Williams JA, 2008, J CLIN PHARMACOL, V48, P849, DOI 10.1177/0091270008319329; Leclercq L, 2009, CHEM RES TOXICOL, V22, P280, DOI 10.1021/tx800432c; Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667; Ostapowicz G, 2002, ANN INTERN MED, V137, P947; Okumura H, 2007, TOXICOL SCI, V97, P533, DOI 10.1093/toxsci/kfm041; Anderson S, 2009, CHEM RES TOXICOL, V22, P243, DOI 10.1021/tx8004086; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Luo G, 2010, DRUG METAB DISPOS, V38, P422, DOI 10.1124/dmd.108.026260; DUELAND S, 1991, BIOCHEM J, V280, P373; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Fouassier L, 2002, J HEPATOL, V37, P184, DOI 10.1016/S0168-8278(02)00107-1; Hu YJ, 2013, PHARMACOGENET GENOM, V23, P78, DOI 10.1097/FPC.0b013e32835cb2c7; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Manning FJ, 1995, REV FIALURIDINE FIAU; Mano Y, 2007, BIOPHARM DRUG DISPOS, V28, P13, DOI 10.1002/bdd.527; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; Naito T, 1996, J SURG RES, V65, P70, DOI 10.1006/jsre.1996.0345; Nishimura T, 2013, J PHARMACOL EXP THER, V344, P388, DOI 10.1124/jpet.112.198697; Peltz G, 2013, TRENDS PHARMACOL SCI, V34, P255, DOI 10.1016/j.tips.2013.03.005; TAKITA M, 1988, J BIOCHEM-TOKYO, V103, P778; Walker D, 2009, CHEM RES TOXICOL, V22, P1653, DOI 10.1021/tx900213j; Watkins PB, 2006, HEPATOLOGY, V43, P618, DOI 10.1002/hep.21095; Xu D, 2014, PLOS MED, V11; Zamek-Gliszczynski MJ, 2006, MOL PHARMACOL, V70, P2127, DOI 10.1124/mol.106.026955	28	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	2015	352	2					274	280		10.1124/jpet.114.220798		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY8RY	WOS:000347822200009		
J	Takahashi, T; Yamamoto, M; Amikura, K; Kato, K; Serizawa, T; Serizawa, K; Akazawa, D; Aoki, T; Kawai, K; Ogasawara, E; Hayashi, JI; Nakada, K; Kainoh, M				Takahashi, Takehiro; Yamamoto, Masashi; Amikura, Kazutoshi; Kato, Kozue; Serizawa, Takashi; Serizawa, Kanako; Akazawa, Daisuke; Aoki, Takumi; Kawai, Koji; Ogasawara, Emi; Hayashi, Jun-Ichi; Nakada, Kazuto; Kainoh, Mie			A Novel MitoNEET Ligand, TT01001, Improves Diabetes and Ameliorates Mitochondrial Function in db/db Mice	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; PROTEIN MITONEET; OXIDATIVE CAPACITY; MEMBRANE PROTEIN; GAMMA AGONISTS; DNA CONTENT; IN-VIVO; THIAZOLIDINEDIONE; OBESITY	The mitochondrial outer membrane protein mitoNEET is a binding protein of the insulin sensitizer pioglitazone (5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione) and is considered a novel target for the treatment of type II diabetes. Several small-molecule compounds have been identified as mitoNEET ligands using structure-based design or virtual docking studies. However, there are no reports about their therapeutic potential in animal models. Recently, we synthesized a novel small molecule, TT01001 [ethyl-4-(3-(3,5-dichlorophenyl)thioureido)piperidine-1-carboxylate], designed on the basis of pioglitazone structure. In this study, we assessed the pharmacological properties of TT01001 in both in vitro and in vivo studies. We found that TT01001 bound to mitoNEET without peroxisome proliferator-activated receptor-gamma activation effect. In type II diabetes model db/db mice, TT01001 improved hyperglycemia, hyperlipidemia, and glucose intolerance, and its efficacy was equivalent to that of pioglitazone, without the pioglitazone-associated weight gain. Mitochondrial complex II 1 III activity of the skeletal muscle was significantly increased in db/db mice. We found that TT01001 significantly suppressed the elevated activity of the complex II 1 III. These results suggest that TT01001 improved type II diabetes without causing weight gain and ameliorated mitochondrial function of db/db mice. This is the first study that demonstrates the effects of a mitoNEET ligand on glucose metabolism and mitochondrial function in an animal disease model. These findings support targeting mitoNEET as a potential therapeutic approach for the treatment of type II diabetes.	[Takahashi, Takehiro; Yamamoto, Masashi; Amikura, Kazutoshi; Kato, Kozue; Serizawa, Takashi; Serizawa, Kanako; Akazawa, Daisuke; Aoki, Takumi; Kawai, Koji; Kainoh, Mie] Toray Industries Ltd, Pharmaceut Res Labs, Kamakura, Kanagawa 2488555, Japan; [Ogasawara, Emi; Hayashi, Jun-Ichi; Nakada, Kazuto] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	Takahashi, T (reprint author), Toray Industries Ltd, Pharmaceut Res Labs, 10-1,Tebiro 6 Chome, Kamakura, Kanagawa 2488555, Japan.	Takehiro_Takahashi@nts.toray.co.jp					Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Bieganski RM, 2011, J MOL GRAPH MODEL, V29, P965, DOI 10.1016/j.jmgm.2011.04.001; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Gillies PS, 2000, DRUGS, V60, P333, DOI 10.2165/00003495-200060020-00009; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953; Borsting E, 2012, AM J PHYSIOL-RENAL, V302, pF540, DOI 10.1152/ajprenal.00306.2011; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Geldenhuys WJ, 2010, BIOORG MED CHEM LETT, V20, P819, DOI 10.1016/j.bmcl.2009.12.088; Holmstrom MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011; Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pagel-Langenickel I, 2008, J BIOL CHEM, V283, P22464, DOI 10.1074/jbc.M800842200; Quinn CE, 2008, BRIT J PHARMACOL, V153, P636, DOI 10.1038/sj.bjp.0707452; Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865; Suzuki A, 2000, JPN J PHARMACOL, V84, P113, DOI 10.1254/jjp.84.113; Tang WHW, 2007, DIABETES OBES METAB, V9, P447, DOI 10.1111/j.1463-1326.2006.00616.x	33	1	2	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	2015	352	2					338	345		10.1124/jpet.114.220673		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY8RY	WOS:000347822200017		
J	Parada, RY; Mon-nai, W; Ueno, M; Kihara, J; Arase, S				Parada, Roxana Y.; Mon-nai, Wataru; Ueno, Makoto; Kihara, Junichi; Arase, Sakae			Red-Light-Induced Resistance to Brown Spot Disease Caused by Bipolaris oryzae in Rice	JOURNAL OF PHYTOPATHOLOGY			English	Article						Bipolaris oryzae; brown spot disease; disease resistance; phenylpropanoid; red light; rice; tryptophan	VICIA-FABA L.; BOTRYTIS-CINEREA; PRODUCTION SITUATIONS; PEST CONSTRAINTS; TROPICAL ASIA; LEAF-SPOT; ARABIDOPSIS; TOMATO; CRYPTOCHROMES; RESPONSES	In this study, the protective effect of red light against the brown spot disease caused by the fungus Bipolaris oryzae in rice was investigated. Lesion formation was significantly inhibited on detached leaves that were inoculated with B.oryzae and kept under red for 48h, but it was not inhibited when the leaves were kept under natural light or in the dark. The protective effect was also observed in intact rice plants inoculated with B.oryzae; the plants survived under red light, but most of them were killed by infection under natural light or dark condition. Red light did not affect fungal infection in onion epidermis cells or heat-shocked leaves of rice, and it did not affect cellulose digestion ability; this suggested that the protective effect is due to red-light-induced resistance. In addition, the degree of protection increased as the red light dosage increased, regardless of the order of the red light and natural light period, indicating that red-light-induced resistance is time dependent. Feeding of detached leaves with a tryptophan decarboxylase inhibitor, s--fluoromethyltryptophan (0.1mm), for 24h inhibited the development of resistance in response to red light irradiation. Suppression of resistance was also observed in leaves treated with a phenylalanine ammonia-lyase inhibitor, -aminooxy acetic acid (0.5mm). These results suggest that the tryptophan and phenylpropanoid pathways are involved in the red-light-induced resistance of rice to B.oryzae.	[Parada, Roxana Y.; Mon-nai, Wataru; Ueno, Makoto; Kihara, Junichi; Arase, Sakae] Shimane Univ, Plant Pathol Lab, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Arase, S (reprint author), Shimane Univ, Plant Pathol Lab, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan.	arase@life.shimane-u.ac.jp			Japan Society for the Promotion of Science (JSPS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	We thank to Dr. A. Ishihara of Tottori University, for providing the s-alpha-fluoromethyltryptophan (s-alpha-FMT). This research was supported by the Japan Society for the Promotion of Science (JSPS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Agrios G. N., 2005, PLANT PATHOL, P77; Akimitsu Kazuya, 1994, Journal of the Faculty of Agriculture Tottori University, V30, P17; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Islam SZ, 2008, J PHYTOPATHOL, V156, P708, DOI 10.1111/j.1439-0434.2008.01435.x; Inoue S, 2008, MOL PLANT, V1, P15, DOI 10.1093/mp/ssm001; Shirasawa H, 2012, CROP PROT, V39, P41, DOI 10.1016/j.cropro.2012.03.026; Ishihara A, 2008, PLANT J, V54, P481, DOI 10.1111/j.1365-313X.2008.03441.x; Rahman MZ, 2002, J PHYTOPATHOL, V150, P463, DOI 10.1046/j.1439-0434.2002.00781.x; Islam SZ, 2002, HORTSCIENCE, V37, P678; Rahman MZ, 2003, J PHYTOPATHOL, V151, P86, DOI 10.1046/j.1439-0434.2003.00685.x; Spalding EP, 2005, PLANT CELL ENVIRON, V28, P39, DOI 10.1111/j.1365-3040.2004.01282.x; Kang CY, 2009, PLANT CELL, V21, P2624, DOI 10.1105/tpc.109.069765; Savary S, 2000, PLANT DIS, V84, P341, DOI 10.1094/PDIS.2000.84.3.341; Islam SZ, 1999, J PHYTOPATHOL, V147, P65, DOI 10.1046/j.1439-0434.1999.147002065.x; Song FM, 2001, PHYSIOL MOL PLANT P, V59, P1, DOI 10.1006/pmpp.2001.0353; Islam SZ, 1998, J PHYTOPATHOL, V146, P479, DOI 10.1111/j.1439-0434.1998.tb04609.x; Savary S, 2000, PLANT DIS, V84, P357, DOI 10.1094/PDIS.2000.84.3.357; Rahman MZ, 2010, J PHYTOPATHOL, V158, P378, DOI 10.1111/j.1439-0434.2009.01632.x; ARASE S, 1985, Annals of the Phytopathological Society of Japan, V51, P490; ARASE S, 1982, Annals of the Phytopathological Society of Japan, V48, P578; Barnwal MK, 2013, EUR J PLANT PATHOL, V136, P443, DOI 10.1007/s10658-013-0195-6; Chakrabarti NK, 2001, MAJOR FUNGAL DISEASES OF RICE: RECENT ADVANCES, P293; Fernando PC, 2006, ENVIRON SCI POLICY, V9, P685; Gyula Peter, 2003, Current Opinion in Plant Biology, V6, P446, DOI 10.1016/S1369-5266(03)00082-7; HONDA Y, 1977, PLANT DIS REP, V61, P1036; Honda Y, 2000, P COE IGE INT S PLAN, P21; Khanam Nurun Nahar, 2005, Journal of General Plant Pathology, V71, P285, DOI 10.1007/s10327-005-0199-y; KIHARA J, 1994, PHYSIOL PLANTARUM, V92, P689; KUMAGAI T, 1988, PHOTOCHEM PHOTOBIOL, V47, P889, DOI 10.1111/j.1751-1097.1988.tb01672.x; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Rahman MZ, 2003, B FAC LIFE ENV SCI S, V8, P23; Reddy CS, 2011, FIELD CROP RES, V120, P241, DOI 10.1016/j.fcr.2010.10.005; Singh M., 1985, Oryza, V22, P134; Ueno M, 2003, PLANT J, V36, P215, DOI 10.1046/j.1365-313X.2003.01875.x; Ueno Makoto, 2009, Bulletin of the Faculty of Life and Environmental Science Shimane University, V14, P3; Umezu H, 1999, B ASS PLANT PROTECT, V24, P55; VAKALOUNAKIS DJ, 1991, PLANT DIS, V75, P795; VIDHYASEKARAN P, 1992, PHYSIOL MOL PLANT P, V41, P307, DOI 10.1016/0885-5765(92)90018-Q; XIAO JZ, 1991, PHYTOPATHOLOGY, V81, P58, DOI 10.1094/Phyto-81-58	39	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0931-1785	1439-0434		J PHYTOPATHOL	J. Phytopathol.	FEB	2015	163	2					116	123		10.1111/jph.12288		8	Plant Sciences	Plant Sciences	AY6YB	WOS:000347707500006		
J	Ben, HY; Zhao, YJ; Chai, AL; Shi, YX; Xie, XW; Li, BJ				Ben, Hai-Yan; Zhao, Yan-Jie; Chai, A-Li; Shi, Yan-Xia; Xie, Xue-Wen; Li, Bao-Ju			First Report of Myrothecium roridum Causing Leaf Spot on Anthurium andraeanum in China	JOURNAL OF PHYTOPATHOLOGY			English	Article						Anthurium andraeanum; leaf spot; Myrothecium roridum	UNITED-STATES	A new severe disease on Anthurium andraeanum Lind. was observed in the summer of 2011 in Beijing, China. The fungus was isolated from symptomatic leaves, and its pathogenicity was confirmed. Based on the morphological characteristics and molecular analysis, the pathogen was identified as Myrothecium roridum Tode ex Fr. This is the first report of M.roridum causing leaf spot on A.andraeanum in China.	[Ben, Hai-Yan; Li, Bao-Ju] Shenyang Agr Univ, Inst Plant Protect, Shenyang 110866, Peoples R China; [Ben, Hai-Yan; Chai, A-Li; Shi, Yan-Xia; Xie, Xue-Wen; Li, Bao-Ju] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China; [Zhao, Yan-Jie] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3050821, Japan	Li, BJ (reprint author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China.	libaoju@caas.cn			CAAS Science and Technology Innovation Program; Key Laboratory of Horticultural Crops Genetic Improvement, Ministry of Agriculture in China	This work was supported by CAAS Science and Technology Innovation Program and funded by Key Laboratory of Horticultural Crops Genetic Improvement, Ministry of Agriculture in China.	Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zhang YX, 2011, PLANT DIS, V95, P1030, DOI 10.1094/PDIS-02-11-0124; Ben HaiYan, 2009, Acta Horticulturae Sinica, V36, P553; Chase A. R., 1987, COMPENDIUM ORNAMENTA; Gantait S., 2008, Plant Tissue Culture & Biotechnology, V18, P113; Hong CF, 2013, PLANT DIS, V97, P1253, DOI 10.1094/PDIS-02-13-0177-PDN; Huang JD, 2012, GUANGDONG AGR SCI, V14, P45; Jouen E, 2007, PLANT DIS, V91, P462, DOI 10.1094/PDIS-91-4-0462B; KUEHNLE AR, 1992, PLANT CELL REP, V11, P438, DOI 10.1007/BF00232686; Lee SB, 1990, PCR PROTOCOLS GUIDE, P282; Mangandi JA, 2007, PLANT DIS, V91, P772, DOI 10.1094/PDIS-91-6-0772B; Mmbaga MT, 2010, PLANT DIS, V94, P1266, DOI 10.1094/PDIS-04-10-0264; Norman D. J., 1999, Plant Disease, V83, P300, DOI 10.1094/PDIS.1999.83.3.300A; Paim MCA, 2006, AUSTRALAS PLANT PATH, V35, P275, DOI 10.1071/AP06005; Seebold KW, 2005, PLANT DIS, V89, P342, DOI 10.1094/PD-89-0342A; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0931-1785	1439-0434		J PHYTOPATHOL	J. Phytopathol.	FEB	2015	163	2					144	147		10.1111/jph.12264		4	Plant Sciences	Plant Sciences	AY6YB	WOS:000347707500010		
J	Qian, SX; Kasahara, N				Qian, Shaoxiang; Kasahara, Naoto			Large Eddy Simulation Analysis of Fluid Temperature Fluctuations at a T-junction for Prediction of Thermal Loading	JOURNAL OF PRESSURE VESSEL TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article						large eddy simulation (LES); dynamic Smagorinsky model (DSM); hybrid scheme; fluid temperature fluctuation; tee junction; high cycle thermal fatigue	CROSS-FLOW; TRANSVERSE JET; LES; TEE	T-junctions are widely used for fluid mixing in power and process plants. Temperature fluctuations generated by the mixing of hot and cold fluids at a T-junction can cause high cycle thermal fatigue (HCTF) failure. The existing Japanese guideline for evaluating HCTF provides margin that varies greatly depending on the case for the evaluation result. Computational fluid dynamics (CFD)/finite element analysis (FEA) coupling analysis is expected to be a useful tool for the more accurate evaluation of HCTF. Precise temperature fluctuation histories are necessary to determine the thermal loads because fatigue damage prediction requires temperature fluctuation amplitudes and their cycle numbers. The present investigation was intended to discover the accurate prediction methods of fluid temperature fluctuations, prior to performing CFD/FEA coupling analysis. Large eddy simulation (LES) turbulence models suitable for the simulation of unsteady phenomena were investigated. The LES subgrid scale (SGS) models used included the standard Smagorinsky model (SSM) and the dynamic Smagorinsky model (DSM). The effects of numerical schemes for calculating the convective term in the energy equation on the simulation results were also investigated. LES analyses of the flow and temperature fields at a T-junction were carried out using these numerical methods. For comparison, the simulation conditions were the same as the experiment in literature. All of the simulation results show the flow pattern of a wall jet with strong flow and temperature fluctuations, as observed in the experiment. The simulation results indicate the numerical schemes have a great effect on the temperature distribution and the temperature fluctuation intensity (TFI). The first-order upwind difference scheme (1UD) significantly underestimates the TFI for each LES SGS model, although it exhibits good numerical stability. However, the hybrid scheme (HS), which is mainly the second-order central difference scheme (2CD) blended with a small fraction of 1UD, can better predict the TFI for each LES SGS model. Furthermore, the DSM model gives a prediction closer to the experimental results than the SSM model, while using the same numerical scheme. As a result, it was found through the systematic investigations of various turbulence models and numerical schemes that the approach using the DSM model and the HS with a large blending factor could provide accurate predictions of the fluid temperature fluctuations. Furthermore, it is considered that this approach is also applicable to the accurate prediction of any other scalar (e.g., concentration), based on the analogy of scalar transport phenomena.	[Qian, Shaoxiang] JGC Corp, EN Technol Ctr, Div Engn, Nishi Ku, Yokohama, Kanagawa 2206001, Japan; [Kasahara, Naoto] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Qian, SX (reprint author), JGC Corp, EN Technol Ctr, Div Engn, Nishi Ku, 2-3-1 Minato Mirai, Yokohama, Kanagawa 2206001, Japan.	qian.shaoxiang@jgc.com; kasahara@n.t.u-tokyo.ac.jp			Japanese government	The authors greatly acknowledge Dr. M. Suzuki of Graduate School of Engineering, The University of Tokyo in Japan, for his invaluable advice and comments on the present research. CFD simulations were carried out using the modified multiphysics CFD software FRONTFLOW/RED (FFR), which was developed as a part of the FSIS project granted by the Japanese government. Its source program is open and available from website.	Kamide H, 2009, NUCL ENG DES, V239, P58, DOI 10.1016/j.nucengdes.2008.09.005; FRIC TF, 1994, J FLUID MECH, V279, P1, DOI 10.1017/S0022112094003800; GERMANO M, 1991, PHYS FLUIDS A-FLUID, V3, P1760, DOI 10.1063/1.857955; Hu LW, 2006, INT J HEAT FLUID FL, V27, P54, DOI 10.1016/j.ijheatfluidflow.2005.08.001; Blanchard JN, 1999, EXP FLUIDS, V26, P63, DOI 10.1007/s003480050265; De Chant LJ, 2005, APPL MATH COMPUT, V161, P463, DOI 10.1016/j.amc.2003.12.109; Faidy C., 2000, INT C FAT REACT COMP; Gelineau O., 2001, T 16 INT C STRUCT ME, P1; Igarashi M., 2002, P 10 INT C NUCL ENG, P383; JNES (Japan Nuclear Energy Safety Organization), 2003, TROUBL NUCL POW PLAN; KELSO RM, 1995, PHYS FLUIDS, V7, P153, DOI 10.1063/1.868736; LANDMAN MJ, 1987, PHYS FLUIDS, V30, P2339, DOI 10.1063/1.866124; LILLY DK, 1992, PHYS FLUIDS A-FLUID, V4, P633, DOI 10.1063/1.858280; Maegawa M., 2006, P 19 S MAINT EQ JAP, P12; Majander P, 2006, INT J HEAT FLUID FL, V27, P402, DOI 10.1016/j.ijheatfluidflow.2006.01.004; Nakamura A., 2010, P 7 KOR JAP S NUCL T; Nakamura A., 2013, P JSME 2013 ANN M OK; Qian S., 2012, PVP201278159 ASME; Qian S., 2010, PVP201025611 ASME; Schluter JU, 2000, FLOW TURBUL COMBUST, V65, P177, DOI 10.1023/A:1011412810639; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Tanaka M., 2009, J POWER ENERGY SYSTE, V3, P237; The Japan Society of Mechanical Engineers (JSME), 2003, GUID EV HIGH CYCL TH, pS017; Wakamatsu M., 2003, P 11 INT C NUCL ENG	24	1	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0094-9930	1528-8978		J PRESS VESS-T ASME	J. Press. Vessel Technol.-Trans. ASME	FEB	2015	137	1							011303	10.1115/1.4028067		11	Engineering, Mechanical	Engineering	AZ2KZ	WOS:000348063800010		
J	Shibutani, T; Nakamura, I; Otani, A				Shibutani, Tadahiro; Nakamura, Izumi; Otani, Akihito			Failure Analysis of Piping Systems With Thinned Elbows on Tri-Axial Shake Table Tests	JOURNAL OF PRESSURE VESSEL TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article							CARBON-STEEL PIPE; BEHAVIOR	This paper presents a computational failure analysis of piping systems with and without thinned elbows on tri-axial shake table tests. In a previous experimental study, two piping models, a sound piping system and a degraded piping system with thinned elbows, were assessed. The sound piping system was found to fail at the elbow flank due to in-plane cyclic bending, whereas the degraded system failed at the end of the elbow due to excessive pipe ovalization. In the present study, finite element (FE) models of elbows were developed in order to carry out fracture analysis. The measured displacements of seismic motions were used as the boundary conditions for FE models. In the sound piping system, plastic strain concentrated at the flank of the elbow due to in-plane bending. The cumulative damage factor was calculated from the fatigue curve and Miner's rule. The effect of ratcheting was also considered. In the failed elbow, the calculated cumulative damage factor showed good agreement with experimental results. On the other hand, for the fracture analysis of the thinned elbow, the entire seismic loading history on the tri-axial shake table was considered, since the effect of pipe ovalization depends on loading history. The ovalization occurred at the elbow due to cumulative seismic loading. Consequently, the principal plastic strain began to concentrate at the end of the elbow. These FE results offer quantitative explanation for the observed failure modes in the degraded piping system.	[Shibutani, Tadahiro] Yokohama Natl Univ, Ctr Risk Management & Safety Sci, Yokohama, Kanagawa 2408501, Japan; [Nakamura, Izumi] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; [Otani, Akihito] IHI Corp, Yokohama, Kanagawa 2358501, Japan	Shibutani, T (reprint author), Yokohama Natl Univ, Ctr Risk Management & Safety Sci, Yokohama, Kanagawa 2408501, Japan.						Nakamura I, 2004, J PRESS VESS-T ASME, V126, P85, DOI 10.1115/1.1638787; Miyazaki K, 1999, NUCL ENG DES, V191, P195, DOI 10.1016/S0029-5493(99)00141-7; Kim JW, 2003, NUCL ENG DES, V220, P274, DOI 10.1016/S0029-5493(02)00386-2; Takahashi K, 2009, NUCL ENG DES, V239, P2719, DOI 10.1016/j.nucengdes.2009.09.011; Asada Y., 1985, P 3 GERM JAP JOINT S, P1; Eulitz K. - G., 2000, P MAT WEEK SEPT 2000, P25; Fujita S, 2004, J PRESS VESS-T ASME, V126, P115, DOI 10.1115/1.1637644; Hasegawa K., 2008, ASME J PRESSURE VESS, V130; Mikami A., 2004, P ASME PVP2004 SAN D, V473, P125; Nakamura I, 2010, PVP201025839 ASME; Nakamura I, 2010, J PRESS VESS-T ASME, V132, DOI 10.1115/1.4001517	11	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0094-9930	1528-8978		J PRESS VESS-T ASME	J. Press. Vessel Technol.-Trans. ASME	FEB	2015	137	1							011205	10.1115/1.4028422		5	Engineering, Mechanical	Engineering	AZ2KZ	WOS:000348063800006		
J	Takeshima, T; Yamauchi, T; Inagaki, M; Kodaka, M; Matsumoto, T; Kawano, K; Katsumata, Y; Fujimori, M; Hisanaga, A; Takahashi, Y				Takeshima, Tadashi; Yamauchi, Takashi; Inagaki, Masatoshi; Kodaka, Manami; Matsumoto, Toshihiko; Kawano, Kenji; Katsumata, Yotaro; Fujimori, Maiko; Hisanaga, Ayaka; Takahashi, Yoshitomo			Suicide prevention strategies in Japan: A 15-year review (1998-2013)	JOURNAL OF PUBLIC HEALTH POLICY			English	Article						suicide; suicide prevention; policy development; Basic Act for Suicide Prevention; Japan	NATIONS	Suicide is a global public health problem and solutions to it can be found only through a global dialog. The suicide rate in Japan has been alarming, but Japan has made substantial efforts to reduce this rate, making prevention a high priority. This report reviews the developmental stages of a comprehensive policy of suicide prevention in Japan from 1998 to 2013. Our review suggests that suicide prevention activities were facilitated by the 2006 Basic Act for Suicide Prevention and the 2007 General Principles of Suicide Prevention Policy. Along with the establishment of a Special Fund program for local governments, the Basic Act and General Principles led to the development of a comprehensive and multi-sector approach to suicide prevention. Suicide rates in Japan, especially among middle-aged men, decreased consistently after 2009, suggesting that the initiatives were effective. Continuous monitoring is needed to evaluate Japan's suicide prevention policy.	[Takeshima, Tadashi; Yamauchi, Takashi; Kodaka, Manami; Matsumoto, Toshihiko; Kawano, Kenji; Fujimori, Maiko; Hisanaga, Ayaka] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Ctr Suicide Prevent, Kodaira, Tokyo 1878553, Japan; [Inagaki, Masatoshi] Okayama Univ Hosp, Dept Neuropsychiat, Okayama, Japan; [Katsumata, Yotaro] Univ Niigata Prefecture, Dept Child Studies, Fac Human Life Studies, Niigata, Japan; [Takahashi, Yoshitomo] Univ Tsukuba, Sch Med, Dept Disaster Psychiat, Ibaraki, Japan	Takeshima, T (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Ctr Suicide Prevent, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878553, Japan.	ttake@ncnp.go.jp			Japan's Cabinet Office; Ministry of Health, Labour and Welfare of Japan	We extend our gratitude to Dr Shekhar Saxena, Dr Alexandra Fleischmann, and Dr Yutaro Setoya of the World Health Organization, and Dr Wang Xiangdung of the WHO Western Pacific Regional Office. We also would like to thank Japan's Cabinet Office and Ministry of Health, Labour and Welfare of Japan for their support.	Administrative Evaluation Bureau Ministry of Internal Affairs and Communications., 2012, JIS YOB TAIS KANS GY; Amagasa T., 2011, SUKUERU SHI; Matsubayashi T, 2011, SOC SCI MED, V73, P1395, DOI 10.1016/j.socscimed.2011.08.022; Andriessen K, 2009, CRISIS, V30, P43, DOI 10.1027/0227-5910.30.1.43; Cabinet Office Government of Japan, 2012, JIS SOUG TAIS TAIK D; Cabinet Office Government of Japan., 2012, 2012 WHIT PAP SUIC P; Cabinet Office Government of Japan, 2013, JIS TAIS HAK 2013; Cabinet Office Government of Japan., 2014, JIS TAIS HAK 2014; Cabinet Office Government of Japan, 2013, JIS TAIS; Center for Suicide Prevention, 2012, JIS TAIS TOR FUR CYO; Center for Suicide Prevention, 2012, TOD FUK SEIR SHIT OK; Fujita T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.08KD08; Fujiwara N., 2011, GAIKOKUNORIPPOU, V250, P193; Government of Canada, 2012, FED FRAM SUIC PREV A; Ishida T., 2010, J JAPANESE ASS PSYCH, V29, P234; Motohashi Y., 2012, LANCET, V379, P1282; National Center of Neurology and Psychiatry and the Working Group for Proposal of the Revision of General Principles of Suicide Prevention Policy, 2012, JIS SOUG TAIS TAIK M; Ono Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074902; Oyama H, 2006, CRISIS, V27, P58, DOI 10.1027/0227-5910.27.2.58; Sakurai H, 2003, JMAJ, V46, P47; Takeshima T, PSYCHAIT CL IN PRESS; Takeshima T., 2009, JISATSU YOBOU JISSAI, P16; Taylor SJ, 1997, ACTA PSYCHIAT SCAND, V95, P457, DOI 10.1111/j.1600-0447.1997.tb10132.x; United Nations, 1996, PREV SUIC GUID FORM; U.S. Government Printing Office, 2004, GL SMITH MEM ACT; World Health Organization, 2013, SUIC PREV SUPRE; World Health Organization, 2014, PREV SUIC GLOB IMP; World Health Organization, 2013, MENT HLTH ACT PLAN 2; World Health Organization, 2010, EV BAS SUIC PREV PRO; World Health Organization, 2012, WORLD HLTH ORG VIS J	30	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	0197-5897	1745-655X		J PUBLIC HEALTH POL	J. Public Health Policy	FEB	2015	36	1					52	66		10.1057/jphp.2014.42		15	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	AY4XJ	WOS:000347578100007		
J	Shiomi, A; Ito, M; Maeda, K; Kinugasa, Y; Ota, M; Yamaue, H; Shiozawa, M; Horie, H; Kuriu, Y; Saito, N				Shiomi, Akio; Ito, Masaaki; Maeda, Kotaro; Kinugasa, Yusuke; Ota, Mitsuyoshi; Yamaue, Hiroki; Shiozawa, Manabu; Horie, Hisanaga; Kuriu, Yoshiaki; Saito, Norio			Effects of a Diverting Stoma on Symptomatic Anastomotic Leakage after Low Anterior Resection for Rectal Cancer: A Propensity Score Matching Analysis of 1,014 Consecutive Patients	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							TOTAL MESORECTAL EXCISION; RISK-FACTORS; DEFUNCTIONING STOMA; COLORECTAL-SURGERY; METAANALYSIS; ILEOSTOMY	BACKGROUND: Routine creation of a diverting stoma (DS) in every patient who undergoes low anterior resection (LAR) remains controversial. We aimed to investigate the effect of DS on symptomatic anastomotic leakage (AL) after LAR. STUDY DESIGN: Patients with rectal cancer within 10 cm from the anal verge were eligible for this prospective, multicenter, cohort study (UMIN-CTR, number 000004017). Propensity score matching (PSM) was used to compare groups of patients with and without DS. RESULTS: One thousand fourteen consecutive patients were registered, of whom 936 patients who underwent LAR were analyzed. Before PSM, the overall rate of symptomatic AL was 13.2% (52 of 394) in patients with DS vs 12.7% (69 of 542) in cases without DS (p = 0.84). Symptomatic AL requiring re-laparotomy occurred in 4.7% (44 of 936) of all patients, occurring in 1.0% (4 of 394) of patients with DS vs 7.4% (40 of 542) of patients without DS (p < 0.001). After PSM, the 2 groups were nearly balanced, and the incidence rates of symptomatic AL in patients with and without DS were 10.9% and 15.8% (p = 0.26). The incidences of AL requiring re-laparotomy in patients with and without DS were 0.6% and 9.1% (p < 0.001). Multivariate analysis identified male sex (p < 0.001; odds ratio [OR] 3.2; 95% confidence interval [CI] 1.8 to 5.7) and tumor size (p < 0.001; OR 1.2; 95% CI 1.1 to 1.4) as independent risk factors of symptomatic AL. CONCLUSIONS: Diverting stoma did not have a significant relationship with symptomatic AL before and after PSM. However, DS does seem to mitigate the consequences of leakage, reducing the need for urgent abdominal reoperation. ((C) 2015 by the American College of Surgeons)	[Shiomi, Akio; Kinugasa, Yusuke] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan; [Ito, Masaaki; Saito, Norio] Natl Canc Ctr Hosp East, Div Colorectal Surg, Chiba, Japan; [Maeda, Kotaro] Fujita Hlth Univ, Sch Med, Dept Surg, Toyoake, Aichi, Japan; [Ota, Mitsuyoshi] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa, Japan; [Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan; [Shiozawa, Manabu] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan; [Horie, Hisanaga] Jichi Med Univ, Sch Med, Dept Surg, Shimotsuke, Tochigi, Japan; [Kuriu, Yoshiaki] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto 602, Japan	Shiomi, A (reprint author), 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	a.shiomi@scchr.jp					Tan WS, 2009, BRIT J SURG, V96, P462, DOI 10.1002/bjs.6594; Marusch F, 2002, DIS COLON RECTUM, V45, P1164, DOI 10.1097/01.DCR.0000027040.59190.12; Rahbari NN, 2010, SURGERY, V147, P339, DOI 10.1016/j.surg.2009.10.012; Eriksen MT, 2005, COLORECTAL DIS, V7, P51, DOI 10.1111/j.1463-1318.2004.00700.x; Matthiessen P, 2007, ANN SURG, V246, P207, DOI 10.1097/SLA.0b013e3180603024; Enker WE, 1999, ANN SURG, V230, P544, DOI 10.1097/00000658-199910000-00010; Akiyoshi T, 2011, AM J SURG, V202, P259, DOI 10.1016/j.amjsurg.2010.11.014; Rullier E, 2005, ANN SURG, V241, P465, DOI 10.1097/01.sla.0000154551.06768.e1; Law WL, 2000, AM J SURG, V179, P92, DOI 10.1016/S0002-9610(00)00252-X; Hallbook O, 1996, ANN SURG, V224, P58, DOI 10.1097/00000658-199607000-00009; Huser N, 2008, ANN SURG, V248, P52, DOI [10.1097/SLA.0b013e318176bf65, 10.1097/SLA.0b013e18176bf65]; Yeh CY, 2005, ANN SURG, V241, P9, DOI 10.1097/01.sla.0000150067.99651.6a; Peeters KCMJ, 2005, BRIT J SURG, V92, P211, DOI 10.1002/bjs.4806; Law WL, 2004, ANN SURG, V240, P260, DOI 10.1097/01.sla.0000133185.23514.32; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Chude GG, 2008, HEPATO-GASTROENTEROL, V55, P1562; Park JS, 2013, ANN SURG, V257, P665, DOI 10.1097/SLA.0b013e31827b8ed9; Branagan G, 2005, DIS COLON RECTUM, V48, P1021, DOI 10.1007/s10350-004-0869-4; Enker WE, 1999, ANN SURG, V230, P552; Matthiessen P, 2004, Colorectal Dis, V6, P462, DOI 10.1111/j.1463-1318.2004.00657.x; Merkel S, 2001, Colorectal Dis, V3, P154, DOI 10.1046/j.1463-1318.2001.00232.x; Mongin C, 2014, INT J COLORECTAL DIS, V29, P459, DOI 10.1007/s00384-014-1833-y; Poon RT, WORLD J SURG, p467e468; Poon RTP, 1999, WORLD J SURG, V23, P463; Rullier E, 1998, BRIT J SURG, V85, P355; Saito N, 2004, DIS COLON RECTUM, V47, P459, DOI 10.1007/s10350-003-0088-4; Trojano M, 2009, Int MS J, V16, P90; Wong NY, 2005, DIS COLON RECTUM, V48, P2076, DOI 10.1007/s10350-005-0146-1	28	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	FEB	2015	220	2					186	194		10.1016/j.jamcollsurg.2014.10.017		9	Surgery	Surgery	AY9XX	WOS:000347902000009		
J	Yoshida, N; Baba, Y; Watanabe, M; Hiyoshi, Y; Ishimoto, T; Iwagami, S; Kurashige, J; Sakamoto, Y; Miyamoto, Y; Baba, H				Yoshida, Naoya; Baba, Yoshifumi; Watanabe, Masayuki; Hiyoshi, Yukiharu; Ishimoto, Takatsugu; Iwagami, Shiro; Kurashige, Junji; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo			Triangulating Stapling Technique Covered with the Pedicled Omental Flap for Esophagogastric Anastomosis: A Safe Anastomosis with Fewer Complications	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							ESOPHAGECTOMY; LEAK		[Yoshida, Naoya; Baba, Yoshifumi; Hiyoshi, Yukiharu; Ishimoto, Takatsugu; Iwagami, Shiro; Kurashige, Junji; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Dai JG, 2011, SURGERY, V149, P404, DOI 10.1016/j.surg.2010.08.005; Takeuchi H, 2014, ANN SURG, V260, P259, DOI 10.1097/SLA.0000000000000644; Bhat MA, 2006, ANN THORAC SURG, V82, P1857, DOI 10.1016/j.athoracsur.2006.05.101; Sepesi B, 2012, J THORAC CARDIOV SUR, V144, P1146, DOI 10.1016/j.jtcvs.2012.07.085; Toh Y, 2009, SURG TODAY, V39, P201, DOI 10.1007/s00595-008-3827-2; VENKATESH KS, 1993, DIS COLON RECTUM, V36, P73, DOI 10.1007/BF02050306	6	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	FEB	2015	220	2					E13	E16		10.1016/j.jamcollsurg.2014.10.015		4	Surgery	Surgery	AY9XX	WOS:000347902000002		
J	Arii, J; Hirohata, Y; Kato, A; Kawaguchi, Y				Arii, Jun; Hirohata, Yoshitaka; Kato, Akihisa; Kawaguchi, Yasushi			Nonmuscle Myosin Heavy Chain IIB Mediates Herpes Simplex Virus 1 Entry	JOURNAL OF VIROLOGY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; GREEN FLUORESCENT PROTEIN; TYPE-2 RECEPTOR-ALPHA; CELL-FUSION; HEPARAN-SULFATE; GLYCOPROTEIN-B; EPITHELIAL-CELLS; VIRAL ENTRY; PILR-ALPHA; INTEGRIN ALPHA-V-BETA-3	Nonmuscle myosin heavy chain IIA (NMHC-IIA) has been reported to function as a herpes simplex virus 1 (HSV-1) entry coreceptor by interacting with viral envelope glycoprotein B (gB). Vertebrates have three genetically distinct isoforms of the NMHCII, designated NMHC-IIA, NMHC-IIB, and NMHC-IIC. COS cells, which are readily infected by HSV-1, do not express NMHC-IIA but do express NMHC-IIB. This observation prompted us to investigate whether NMHC-IIB might associate with HSV-1 gB and be involved in an HSV-1 entry like NMHC-IIA. In these studies, we show that (i) NMHC-IIB coprecipitated with gB in COS-1 cells upon HSV-1 entry; (ii) a specific inhibitor of myosin light chain kinase inhibited cell surface expression of NMHC-IIB in COS-1 cells upon HSV-1 entry as well as HSV-1 infection, as reported with NMHC-IIA; (iii) overexpression of mouse NMHC-IIB in IC21 cells significantly increased their susceptibility to HSV-1 infection; and (iv) knockdown of NMHC-IIB in COS-1 cells inhibited HSV-1 infection as well as cell-cell fusion mediated by HSV-1 envelope glycoproteins. These results supported the hypothesis that, like NMHC-IIA, NMHC-IIB associated with HSV-1 gB and mediated HSV-1 entry.	[Arii, Jun; Hirohata, Yoshitaka; Kato, Akihisa; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan; [Arii, Jun; Hirohata, Yoshitaka; Kato, Akihisa; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Dis Control, Tokyo, Japan	Kawaguchi, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan.	ykawagu@ims.u-tokyo.ac.jp			Funding Program for Next Generation World-Leading Researchers; Japan Society for the Promotion of Science (JSPS); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Sumitomo Foundation; Ichiro Kanehara Foundation	This study was supported in part by the Funding Program for Next Generation World-Leading Researchers and grants for scientific research from the Japan Society for the Promotion of Science (JSPS); a contract research fund for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and a grant for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan; and grants from the Takeda Science Foundation, Astellas Foundation for Research on Metabolic Disorders, the Sumitomo Foundation, and the Ichiro Kanehara Foundation.	Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Parry C, 2005, J GEN VIROL, V86, P7, DOI 10.1099/vir0.80567-0; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; Arii J, 2010, J VIROL, V84, P10773, DOI 10.1128/JVI.01166-10; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Cheshenko N, 2014, J VIROL, V88, P10026, DOI 10.1128/JVI.00725-14; Bender FC, 2005, J VIROL, V79, P11588, DOI 10.1128/JVI.79.18.11588-11597.2005; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Chesnokova LS, 2009, P NATL ACAD SCI USA, V106, P20464, DOI 10.1073/pnas.0907508106; Hahn AS, 2012, NAT MED, V18, P961, DOI 10.1038/nm.2805; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; HEROLD BC, 1991, J VIROL, V65, P1090; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Turner A, 1998, J VIROL, V72, P873; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Elliott G, 2005, J VIROL, V79, P9735, DOI 10.1128/JVI.79.15.9735-9745.2005; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Schelhaas M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000148; SARMIENTO M, 1979, J VIROL, V29, P1149; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Galdiero M, 1997, J VIROL, V71, P2163; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003; Roberts KL, 2010, J VIROL, V84, P9889, DOI 10.1128/JVI.00732-10; HEROLD BC, 1994, J GEN VIROL, V75, P1211, DOI 10.1099/0022-1317-75-6-1211; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Spear PG, 2006, VIROLOGY, V344, P17, DOI 10.1016/j.virol.2005.09.016; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Taylor JM, 2007, CELL HOST MICROBE, V2, P19, DOI 10.1016/j.chom.2007.06.005; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Arii J, 2009, J VIROL, V83, P4520, DOI 10.1128/JVI.02601-08; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Fournier N, 2000, J IMMUNOL, V165, P1197; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Gianni T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003806; Haan KM, 2000, J VIROL, V74, P2451, DOI 10.1128/JVI.74.5.2451-2454.2000; Haraguchi T, 2007, FEBS LETT, V581, P4949, DOI 10.1016/j.febslct.2007.09.028; Kanamori M, 2004, J VIROL, V78, P3984, DOI 10.1128/JVI.78.8.3984-3993.2004; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Mousseau DD, 2000, J BIOL CHEM, V275, P4467, DOI 10.1074/jbc.275.6.4467; MURAKAMI N, 1993, DEV BIOL, V157, P19, DOI 10.1006/dbio.1993.1108; OLDEN K, 1976, CELL, V8, P383, DOI 10.1016/0092-8674(76)90150-1; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; PAYNE LG, 1978, J VIROL, V27, P19; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Roizman B., 2007, FIELDS VIROLOGY; Veettil MV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001238; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Sun YY, 2014, J VIROL, V88, P237, DOI 10.1128/JVI.02141-13; Tanaka M, 2004, MICROBES INFECT, V6, P485, DOI 10.1016/j.micinf.2004.01.011; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Tullio AN, 2001, J COMP NEUROL, V433, P62, DOI 10.1002/cne.1125; van Leeuwen H, 2002, J VIROL, V76, P3471, DOI 10.1128/JVI.76.7.3471-3481.2002; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590	72	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	FEB	2015	89	3					1879	1888		10.1128/JVI.03079-14		10	Virology	Virology	AY8QJ	WOS:000347818100031		
J	Arimitsu, K; Oguri, A; Furutani, M				Arimitsu, Koji; Oguri, Ayaka; Furutani, Masahiro			365 nm-Light-sensitive photobase generators derived from trans-o-coumaric acid	MATERIALS LETTERS			English	Article						365 nm-light irradiation; Nitro group; Photobase generator; Photocyclization; Trans-o-coumaric acid	THERMAL CURING REACTION; PENDENT AMINO-GROUPS; CROSS-LINKING; PHOTOGENERATION; DERIVATIVES; CHEMISTRY; FILMS	We have developed a novel photobase generator (PBG) that generates primary or secondary amines via a photocyclization reaction without gas generation by using trans-o-coumaric acid as the molecular skeleton. To expand the absorption band to the long wavelength region, a chemical modification was performed to the PBG in which a nitro group was introduced to its aromatic ring. It was confirmed that the PBG absorbs 365 nm-light to change its chemical state in a methanol solution by UV vis spectral measurements. Anionic UV curing of poly(glycidyl methacrylate) films with 365 nm-light irradiation was accomplished by using the PBG instead of the prototype generator. (C) 2014 Elsevier B.V. All rights reserved.	[Arimitsu, Koji; Oguri, Ayaka; Furutani, Masahiro] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan	Arimitsu, K (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	arimitsu@rs.noda.tus.ac.jp					Arimitsu K, 2009, J PHOTOPOLYM SCI TEC, V22, P663, DOI 10.2494/photopolymer.22.663; FRECHET JMJ, 1992, PURE APPL CHEM, V64, P1239, DOI 10.1351/pac199264091239; Cameron JF, 1996, J AM CHEM SOC, V118, P12925, DOI 10.1021/ja954339a; CAMERON JF, 1991, J AM CHEM SOC, V113, P4303, DOI 10.1021/ja00011a038; Arimitsu K, 2013, CHEM MATER, V25, P4461, DOI 10.1021/cm4022485; Arimitsu K., 2007, POLYM PREPR JPN, V56, P4263; Chae KH, 2004, J POLYM SCI POL CHEM, V42, P975, DOI 10.1002/pola.11032; Chae KH, 2012, EUR POLYM J, V48, P1186, DOI 10.1016/j.eurpolymj.2012.05.006; Chae KH, 1998, MACROMOL RAPID COMM, V19, P1; Chae KH, 2011, POLYM ADVAN TECHNOL, V22, P1427, DOI 10.1002/pat.1628; ITO KI, 1994, J POLYM SCI POL CHEM, V32, P1793, DOI 10.1002/pola.1994.080320922; Mizouti K, 2007, J PHOTOPOLYM SCI TEC, V20, P181, DOI 10.2494/photopolymer.20.181; Nishikubo T, 1997, POLYM J, V29, P450, DOI 10.1295/polymj.29.450; Shirai M, 1998, B CHEM SOC JPN, V71, P2483, DOI 10.1246/bcsj.71.2483; Shirai M, 1996, PROG POLYM SCI, V21, P1, DOI 10.1016/0079-6700(95)00014-3; SONG KH, 1987, J POLYM SCI POL LETT, V25, P417, DOI 10.1002/pol.1987.140251003; SONG KH, 1988, MAKROMOL CHEM-RAPID, V9, P519; Wang BH, 1997, CHEM PHARM BULL, V45, P715	18	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-577X	1873-4979		MATER LETT	Mater. Lett.	FEB 1	2015	140						92	94		10.1016/j.matlet.2014.11.001		3	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AY7TF	WOS:000347761000024		
J	Okada, S; Takagi, K; Ozaki, K				Okada, Shusuke; Takagi, Kenta; Ozaki, Kimihiro			Synthesis of submicron plate-like hematite without organic additives and reduction to plate-like alpha-Fe	MATERIALS LETTERS			English	Article						Hematite; alpha-Fe; Plate-like particles; Hydrothermal synthesis	MORPHOLOGY-CONTROLLED SYNTHESIS; MAGNETIC-PROPERTIES; ALPHA-FE2O3; PARTICLES; PERFORMANCE; MECHANISM; SHAPE	Amorphous strontium hexaferrite (SrFe12O19) nanoparticles produced by co-precipitation were treated by a hydrothermal synthesis. The strontium in the hexaferrite leached from the structure during the hydrothermal treatment, producing uniform, submicron hexagonal plate-like hematite particles. The residual Sr to Fe ratio in the hematite particles was about 1 at%, which is lower than that of previously synthesized submicron plate-like hematite with inorganic ions as structure-directing agents. The plate-like hematite particles maintained their shape even after the hydrogen reduction, producing plate-like alpha-Fe particles having a saturation magnetization of 197 emu/g and a coercivity of 162 Oe. (C) 2014 Elsevier B.V. All rights reserved.	[Okada, Shusuke; Takagi, Kenta; Ozaki, Kimihiro] Natl Inst Adv Ind Sci & Technol, Green Innovat Magnet Mat Res Ctr GreIMM, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Okada, S (reprint author), Natl Inst Adv Ind Sci & Technol, Green Innovat Magnet Mat Res Ctr GreIMM, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	shusuke-okada@aist.go.jp					Qu J, 2013, CHEM-EUR J, V19, P11172, DOI 10.1002/chem.201301295; Sugimoto T, 1998, J COLLOID INTERF SCI, V207, P137, DOI 10.1006/jcis.1998.5741; Wang GH, 2009, APPL CATAL A-GEN, V364, P42, DOI 10.1016/j.apcata.2009.05.030; Han R, 2011, J ALLOY COMPD, V509, P2734, DOI 10.1016/j.jallcom.2010.11.074; Qiao L, 2008, J APPL PHYS, V103, DOI 10.1063/1.2891671; Peng DF, 2010, PARTICUOLOGY, V8, P386, DOI 10.1016/j.partic.2010.05.003; Ma J, 2013, J MATER CHEM A, V1, P5545, DOI 10.1039/c3ta10396j; Liu Y, 2010, J MAGN MAGN MATER, V322, P366, DOI 10.1016/j.jmmm.2009.09.062; Wen FS, 2009, PHYSICA B, V404, P3567, DOI 10.1016/j.physb.2009.06.001; Liu Z, 2013, J MATER CHEM A, V1, P3040, DOI 10.1039/c2ta00987k; Yang Y, 2011, INORG CHEM, V50, P10143, DOI 10.1021/ic201104w; Jean M, 2010, J ALLOY COMPD, V496, P306, DOI 10.1016/j.jallcom.2010.02.002; Liu XY, 1999, J MAGN MAGN MATER, V195, P452, DOI 10.1016/S0304-8853(99)00123-7; Barron V, 1996, J COLLOID INTERF SCI, V177, P407, DOI 10.1006/jcis.1996.0051; Chaudhari KN, 2012, CATAL SCI TECHNOL, V2, P119, DOI 10.1039/c1cy00124h; Iinuma H, 2012, Japan patent, Patent No. 5160129; Pourbaix M., 1966, ATLAS ELECTROCHEMICA; SHINDO D, 1993, MATER T JIM, V34, P580; Sugimoto T, 1996, COLLOID SURFACE A, V109, P155, DOI 10.1016/0927-7757(95)03454-4; Xia CH, 2009, J ALLOY COMPD, V480, P970, DOI 10.1016/j.jallcom.2009.02.106	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-577X	1873-4979		MATER LETT	Mater. Lett.	FEB 1	2015	140						135	139		10.1016/j.matlet.2014.11.002		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AY7TF	WOS:000347761000035		
J	Hirata, N; Tadanaga, K; Tatsumisago, M				Hirata, Naoya; Tadanaga, Kiyoharu; Tatsumisago, Masahiro			Photocatalytic O-2 evolution from water over Zn-Cr layered double hydroxides intercalated with inorganic anions	MATERIALS RESEARCH BULLETIN			English	Article						Inorganic compounds; Layered compounds; Intercalation reactions; Catalytic properties	HYDROTALCITE-LIKE COMPOUND; SODIUM DODECYL-SULFATE; AZO-DYE; DECARBONATION; PERFORMANCE; ADSORPTION; EXCHANGE; PHASE; FILMS; TIO2	Zn-Cr layered double hydroxides (LDHs) intercalated with inorganic anions (CO32-, Cl-, SO42- and NO3-) were synthesized by the co-precipitation method and the anion exchange process. The photocatalytic activity of the LDHs was studied by O-2 evolution from aqueous solution of AgNO3 as a sacrificial agent. All the prepared LDHs showed photocatalytic activity under either UV and/or visible light irradiation. Besides, the interlayer anions affected the photocatalytic activity of the LDHs. After irradiation, Ag particles were formed on the LDHs by accepting the electrons generated during the photocatalytic reaction. (C) 2014 Elsevier Ltd. All rights reserved.	[Hirata, Naoya; Tatsumisago, Masahiro] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Sakai, Osaka 5998531, Japan; [Tadanaga, Kiyoharu] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Tadanaga, K (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan.	tadanaga@eng.hokudai.ac.jp	Tadanaga, Kiyoharu/C-7260-2008	Tadanaga, Kiyoharu/0000-0002-3319-4353	Ministry of Education, Culture, Sports, Science and Technology of Japan; Nippon Sheet Glass Foundation for Materials Science and Engineering, Japan	This work was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant for research from Nippon Sheet Glass Foundation for Materials Science and Engineering, Japan.	Tadanaga K, 2010, ADV MATER, V22, P4401, DOI 10.1002/adma.201001766; Teramura K, 2012, ANGEW CHEM INT EDIT, V51, P8008, DOI 10.1002/anie.201201847; Katsumata K, 2013, MATER LETT, V107, P138, DOI 10.1016/j.matlet.2013.05.132; Behrens M, 2010, CHEM MATER, V22, P386, DOI 10.1021/cm9029165; Boclair JW, 1999, CHEM MATER, V11, P303, DOI 10.1021/cm980524m; Pavan PC, 1999, COLLOID SURFACE A, V154, P399, DOI 10.1016/S0927-7757(98)00847-4; Fan H, 2013, CHEM-EUR J, V19, P2523, DOI 10.1002/chem.201203408; Sokmen M, 2002, J PHOTOCH PHOTOBIO A, V147, P77, DOI 10.1016/S1010-6030(01)00627-X; Choy JH, 2004, BIOMATERIALS, V25, P3059, DOI 10.1016/j.biomaterials.2003.09.083; Naik B, 2010, J PHYS CHEM C, V114, P19473, DOI 10.1021/jp1083345; ABDULLAH M, 1990, J PHYS CHEM-US, V94, P6820, DOI 10.1021/j100380a051; Xi GC, 2011, CHEM-EUR J, V17, P5145, DOI 10.1002/chem.201002229; Tong H, 2012, ADV MATER, V24, P229, DOI 10.1002/adma.201102752; Iyi N, 2004, CHEM MATER, V16, P2926, DOI 10.1021/cm049579g; Silva CG, 2009, J AM CHEM SOC, V131, P13833, DOI 10.1021/ja905467v; Shao MF, 2011, CHEM ENG J, V168, P519, DOI 10.1016/j.cej.2011.01.016; Sun JC, 2014, J MOL CATAL A-CHEM, V382, P146, DOI 10.1016/j.molcata.2013.11.004; Daneshvar N, 2004, J PHOTOCH PHOTOBIO A, V162, P317, DOI 10.1016/s1010-6030(03)00378-2; Boclair JW, 1998, CHEM MATER, V10, P2050, DOI 10.1021/cm980298g; Fogg AM, 1999, ADV MATER, V11, P1466, DOI 10.1002/(SICI)1521-4095(199912)11:17<1466::AID-ADMA1466>3.0.CO;2-1; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Furukawa Y., 2012, SOLID STATE IONICS, V192, P185; Jiang R, 2011, COLOR TECHNOL, V127, P426, DOI 10.1111/j.1478-4408.2011.00341.x; Kubo D, 2012, J ELECTROANAL CHEM, V671, P102, DOI 10.1016/j.jelechem.2012.02.007; Okamoto K, 2006, J MATER CHEM, V16, P1608, DOI 10.1039/b601346e; Panda K.M., 2012, SEP PURIF TECHNOL, V91, P73; Pavan PC, 1998, MICROPOR MESOPOR MAT, V21, P659, DOI 10.1016/S1387-1811(98)00054-7; Roy A.D., 1991, SOLID STATE IONICS, V46, P95	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0025-5408	1873-4227		MATER RES BULL	Mater. Res. Bull.	FEB	2015	62						1	4		10.1016/j.materresbull.2014.11.013		4	Materials Science, Multidisciplinary	Materials Science	AY7TS	WOS:000347762300001		
J	Numata, Y; Sakata, T; Furukawa, H; Tajima, K				Numata, Yukari; Sakata, Tadanori; Furukawa, Hidemitsu; Tajima, Kenji			Bacterial cellulose gels with high mechanical strength	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Bacterial cellulose gels; Thermo-responsiveness; Composite gels	BIOSYNTHESIS; MICELLES; DELIVERY	A composite structure was formed between polyethylene glycol diacrylate (PEGDA) and bacterial cellulose (BC) gels swollen in polyethylene glycol (PEG) as a solvent (BC/PEG gel) to improve the mechanical strength of the gels. The mechanical strength under compression and the rheostatic properties of the gels were evaluated. The compression test results indicated that the mechanical strength of the gels depended on the weight percent of cross-linked PEGDA in the gel, the chain length between the cross-linking points, and the cross-linking density of PEGDA polymers. The PEGDA polymers around the cellulose fibers were resistant to pressure; thus, the BC/PEG-PEGDA gel was stronger than the BC/PEG gel under compression. The results of transmittance measurements and thermomechanical analysis showed that the rheostatic properties of the gels were retained even after composite structure formation. BC/PEG-PEGDA gels, which are expected to be biocompatible, may be useful for clinical applications as a soft material. (C) 2014 Elsevier B.V. All rights reserved.	[Numata, Yukari; Sakata, Tadanori] Asahikawa Natl Coll Technol, Dept Chem Mat, Asahikawa, Hokkaido 0718412, Japan; [Furukawa, Hidemitsu] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Tajima, Kenji] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan	Numata, Y (reprint author), Otaru Univ, Fac Commerce, Otaru, Hokkaido 0478501, Japan.	numata@res.otaru-uc.ac.jp			Northern Advancement Center for Science & Technology of Hokkaido, Japan	We are grateful to Shin-Nakamura Chemical Co., Ltd. for providing the PEGDA samples. This study was supported in part by Grants-in-Aid for Regional R&D Proposal-Based Program from the Northern Advancement Center for Science & Technology of Hokkaido, Japan (No.: T-Asahikawa).	Lin HQ, 2005, MACROMOLECULES, V38, P8381, DOI 10.1021/ma0510136; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Niidome T, 2009, J BIOMAT SCI-POLYM E, V20, P1203, DOI 10.1163/156856209X452953; Hagiwara Y, 2010, CELLULOSE, V17, P93, DOI 10.1007/s10570-009-9357-2; HESTRIN S, 1954, BIOCHEM J, V58, P345; Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149; ROSS P, 1991, MICROBIOL REV, V55, P35; Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570; Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197; Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Aliabadi HM, 2005, J CONTROL RELEASE, V104, P301, DOI 10.1016/j.jconrel.2005.02.015; Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018; OKIYAMA A, 1993, FOOD HYDROCOLLOID, V6, P493; Brown RM, 1996, J MACROMOL SCI PURE, VA33, P1345, DOI 10.1080/10601329608014912; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P2; Niidome T, 2010, BIOORGAN MED CHEM, V18, P4453, DOI 10.1016/j.bmc.2010.04.070; Numata Y, 2009, POLYM J, V41, P524, DOI 10.1295/polymj.PJ2009035; PRATTEN MK, 1985, MAKROMOL CHEM, V186, P725	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	FEB 1	2015	47						57	62		10.1016/j.msec.2014.11.026		6	Materials Science, Biomaterials	Materials Science	AY4YT	WOS:000347581600007		
J	Mochizuki, A; Kaneda, H				Mochizuki, Akira; Kaneda, Hideki			Study on the blood compatibility and biodegradation properties of magnesium alloys	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Magnesium alloy; Blood compatibility; Bio-degradation; Coagulation factor	IN-VITRO; CORROSION-RESISTANCE; ZN ALLOYS; BIOCOMPATIBILITY; SURFACE; DEGRADATION; THROMBIN; BEHAVIOR; IONS	Lately, several magnesium alloys have been investigated as a new class of biomaterials owing to their excellent biodegradability in living tissues. In this study, we considered AZ series of Mg alloy containing aluminum (3% to 9%) and zinc (1%) as a model magnesium alloy, and investigated their biodegradation in whole blood and blood compatibility in vitro. The results of the elution property of metal ions determined using chromogenic assay and the associated pH change show that the degradation resistance of the AZ series alloys in blood is improved by alloying aluminum. Furthermore, the blood compatibility of the alloys was investigated in terms of their hemolysis, factor Xa-like activity, using spectrophotometry and chromogenic assay, respectively, and coagulation time measurements (prothrombin time and activated partial thromboplastin time). The results indicated that the blood compatibility of the AZ series alloys is excellent, irrespective of the alloy composition. The excellent blood compatibility with the coagulation system could be attributed to the eluted Mg2+ ion, which suppresses the activation of certain coagulation factors in the intrinsic and/or extrinsic coagulation pathways. In terms of the degradation resistance of the AZ series alloys in blood, the results of pH change in blood and the amount of the eluted metal ions indicate that the performance is markedly improved with an increase in aluminum content. (C) 2014 Elsevier B.V. All rights reserved.	[Mochizuki, Akira; Kaneda, Hideki] Tokai Univ, Sch Engn, Dept Biomed Engn, Isehara, Kanagawa 2591292, Japan	Mochizuki, A (reprint author), Shimokasuya 143, Isehara, Kanagawa 2591292, Japan.	azmochi@wing.ncc.u-tokai.ac.jp			E.S.Q. Ltd., (Yabuki, Fukushima, Japan) under the subsidiary enterprise "Research and Development Programs for Medical and Welfare Apparatus" by Fukushima prefectural government	This work was sponsored by E.S.Q. Ltd., (Yabuki, Fukushima, Japan) under the subsidiary enterprise "Research and Development Programs for Medical and Welfare Apparatus" by Fukushima prefectural government.	ADAMS JH, 1979, THROMB HAEMOSTASIS, V42, P603; [Anonymous], 1999, WHO TECH REP SER, V889, P64; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; Ye SH, 2013, LANGMUIR, V29, P8320, DOI 10.1021/la401341y; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008; Wang J, 2013, ACTA BIOMATER, V9, P8678, DOI 10.1016/j.actbio.2013.02.041; [Anonymous], 2002, 109334 ISO; KIKUMOTO R, 1984, BIOCHEMISTRY-US, V23, P85, DOI 10.1021/bi00296a014; [Anonymous], 2005, B27505 ASTM; Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021; Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023; HERRING WB, 1960, AM J CLIN NUTR, V8, P846; Nordlien JH, 1996, J ELECTROCHEM SOC, V143, P2564, DOI 10.1149/1.1837048; Gu XN, 2011, MATER SCI ENG B-ADV, V176, P1778, DOI 10.1016/j.mseb.2011.05.032; Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273; Fan J, 2013, MAT SCI ENG C-MATER, V33, P2345, DOI 10.1016/j.msec.2013.01.063; Beutler E., 2006, WILLIAMS HEMATOLOGY, P555; Bodansky M, 1929, J BIOL CHEM, V82, P567; Geis-Gerstorfer J, 2011, MATER SCI ENG B-ADV, V176, P1761, DOI 10.1016/j.mseb.2011.06.006; Kita H, 2005, J JPN I MET, V69, P805, DOI 10.2320/jinstmet.69.805; Lu P, 2011, J BIOMED MATER RES B, V96B, P101, DOI 10.1002/jbm.b.31744; MORITA T, 1977, J BIOCHEM-TOKYO, V82, P1495; Roberts H.R., 2006, WILLIAMS HEMATOLOGY, P1665; Scheideler L, 2013, ACTA BIOMATER, V9, P8740, DOI 10.1016/j.actbio.2013.02.020; Schille C, 2011, MATER SCI ENG B-ADV, V176, P1797, DOI 10.1016/j.mseb.2011.04.007; Wan P, 2013, MAT SCI ENG C-MATER, V33, P2885, DOI 10.1016/j.msec.2013.03.017; Wang GX, 2012, MAT SCI ENG C-MATER, V32, P2190, DOI 10.1016/j.msec.2012.05.050; Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0; Zhu W.R., 2013, ACTA BIOMATER, V9, P8488	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	FEB 1	2015	47						204	210		10.1016/j.msec.2014.11.041		7	Materials Science, Biomaterials	Materials Science	AY4YT	WOS:000347581600025		
J	Suga, T; Osada, S; Narita, T; Oishi, Y; Kodama, H				Suga, Torao; Osada, Satoshi; Narita, Takayuki; Oishi, Yushi; Kodama, Hiroaki			Promotion of cell adhesion by low-molecular-weight hydrogel by Lys based amphiphile	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Cell attachment; Low-molecular hydrogel; Self-aggregation; Supramolecular hydrogelator	SUPRAMOLECULAR HYDROGELS; ALGINATE HYDROGELS; WATER; DERIVATIVES; RELEASE; GELATOR	Hydrogels formed by low-molecular hydrogelators have been used as anti-microbial agents and cell-attachment materials. However the biomedical application of low-molecular gelators is slowly progressing compared to the hydrogels formed by polymer hydrogelator that is applied to biomedical application such as tissue engineering and biomedical regions. To obtain a simple molecular model for potent and prospective usage of low-molecular hydrogelators, we designed a Lys-based hydrogelator which was mimic to the poly cationic poly-L-lysine that promotes cells to attach to a plastic plate nonspecifically. The gel-coating led to cause 10-fold cell attachment compared to no-coating well. Also five-time cells were attached to the well compared to the poly-L-lysine coating. From the competitive assay, these hydrogels could interact with cells through electrostatic interaction between positive charge from -NH3+ in the hydrogelator and negative charge from substances on the cell surface such as glycosaminoglycans. This strong adhesive ability can be useful for the tissue engineering and molecular glue regions using low-molecular hydrogels in the future. (C) 2014 Elsevier B.V. All rights reserved.	[Suga, Torao; Osada, Satoshi; Narita, Takayuki; Oishi, Yushi; Kodama, Hiroaki] Saga Univ, Grad Sch Sci & Engn, Dept Chem & Appl Chem, Saga 8408502, Japan	Kodama, H (reprint author), Saga Univ, Grad Sch Sci & Engn, Dept Chem & Appl Chem, 1 Honjo, Saga 8408502, Japan.	hiroaki@cc.saga-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [KAKENHI-23550194]; Japan Society for the Promotion of Science (JSPS) [23550194]	This work was supported by Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI-23550194) and the Japan Society for the Promotion of Science (JSPS) (23550194) through the JSPS Research Fellowship for Young Scientists.	Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; IMAE T, 1992, J AM CHEM SOC, V114, P3414, DOI 10.1021/ja00035a038; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Roy S, 2008, BIOTECHNOL BIOENG, V100, P756, DOI 10.1002/bit.21803; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049; Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340; Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K; Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Hanabusa K, 1999, CHEM MATER, V11, P649, DOI 10.1021/cm980528r; Salick DA, 2007, J AM CHEM SOC, V129, P14793, DOI 10.1021/ja076300z; Friggeri A, 2004, J CONTROL RELEASE, V97, P241, DOI 10.1016/j.jconrel.2004.03.012; Ajayaghosh A, 2008, CHEM SOC REV, V37, P109, DOI 10.1039/b704456a; AUMAILLEY M, 1989, EXP CELL RES, V181, P463, DOI 10.1016/0014-4827(89)90103-1; Ferrero C, 2008, J CONTROL RELEASE, V128, P71, DOI 10.1016/j.jconrel.2008.02.006; Fu XJ, 2010, HELV CHIM ACTA, V93, P158; Gao P, 2004, CHEM COMMUN, P1174, DOI 10.1039/b402956a; Yamazoe S, 2009, CHEM BIOL, V16, P773, DOI 10.1016/j.chembiol.2009.06.008	21	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	FEB 1	2015	47						345	350		10.1016/j.msec.2014.11.032		6	Materials Science, Biomaterials	Materials Science	AY4YT	WOS:000347581600041		
J	Iiduka, H				Iiduka, Hideaki			Acceleration method for convex optimization over the fixed point set of a nonexpansive mapping	MATHEMATICAL PROGRAMMING			English	Article						Convex optimization; Fixed point set; Nonexpansive mapping; Conjugate gradient method; Three-term conjugate gradient method; Fixed point optimization algorithm	CONJUGATE-GRADIENT METHOD; NETWORK BANDWIDTH ALLOCATION; GLOBAL CONVERGENCE; FEASIBILITY PROBLEMS; DESCENT METHOD; ALGORITHMS; PROPERTY; SEQUENCE	The existing algorithms for solving the convex minimization problem over the fixed point set of a nonexpansive mapping on a Hilbert space are based on algorithmic methods, such as the steepest descent method and conjugate gradient methods, for finding a minimizer of the objective function over the whole space, and attach importance to minimizing the objective function as quickly as possible. Meanwhile, it is of practical importance to devise algorithms which converge in the fixed point set quickly because the fixed point set is the set with the constraint conditions that must be satisfied in the problem. This paper proposes an algorithm which not only minimizes the objective function quickly but also converges in the fixed point set much faster than the existing algorithms and proves that the algorithm with diminishing step-size sequences strongly converges to the solution to the convex minimization problem. We also analyze the proposed algorithm with each of the Fletcher-Reeves, Polak-Ribi,re-Polyak, Hestenes-Stiefel, and Dai-Yuan formulas used in the conventional conjugate gradient methods, and show that there is an inconvenient possibility that their algorithms may not converge to the solution to the convex minimization problem. We numerically compare the proposed algorithm with the existing algorithms and show its effectiveness and fast convergence.	Meiji Univ, Dept Comp Sci, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Iiduka, H (reprint author), Meiji Univ, Dept Comp Sci, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.	iiduka@cs.meiji.ac.jp		Iiduka, Hideaki/0000-0001-9173-6723	Japan Society for the Promotion of Science [23760077, 22540175]	This work was supported by the Japan Society for the Promotion of Science through a Grant-in-Aid for Young Scientists (B) (23760077), and in part by the Japan Society for the Promotion of Science through a Grant-in-Aid for Scientific Research (C) (22540175).	Aoyama K, 2007, J NONLINEAR CONVEX A, V8, P471; OPIAL Z, 1967, B AM MATH SOC, V73, P591, DOI 10.1090/S0002-9904-1967-11761-0; Narushima Y, 2011, SIAM J OPTIMIZ, V21, P212, DOI 10.1137/080743573; Combettes PL, 2003, IEEE T SIGNAL PROCES, V51, P1771, DOI 10.1109/TSP.2003.812846; Iiduka H, 2012, MATH PROGRAM, V133, P227, DOI 10.1007/s10107-010-0427-x; Zhang L, 2007, OPTIM METHOD SOFTW, V22, P697, DOI 10.1080/10556780701223293; Zhang L, 2006, NUMER MATH, V104, P561, DOI 10.1007/s00211-006-0028-z; Cheng WY, 2007, NUMER FUNC ANAL OPT, V28, P1217, DOI 10.1080/01630560701749524; Zhang L, 2006, IMA J NUMER ANAL, V26, P629, DOI 10.1093/imanum/drl016; Bauschke HH, 1996, SIAM REV, V38, P367, DOI 10.1137/S0036144593251710; Slavakis K, 2007, IEEE T SIGNAL PROCES, V55, P4511, DOI 10.1109/TSP.2007.896252; Bakushinsky A., 1994, ILL POSED PROBLEMS T; Bauschke HH, 2011, CMS BOOKS MATH, P1, DOI 10.1007/978-1-4419-9467-7; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Combettes PL, 1999, IEEE T SIGNAL PROCES, V47, P2460, DOI 10.1109/78.782189; Dai YH, 1999, SIAM J OPTIMIZ, V10, P177, DOI 10.1137/S1052623497318992; Ekeland I., 1999, CLASSICS APPL MATH, V28; Goebel K., 1984, UNIFORM CONVEXITY HY; Goebel K., 1990, CAMBRIDGE STUDIES AD; Iiduka H, 2012, SIAM J OPTIMIZ, V22, P862, DOI 10.1137/110849456; Iiduka H, 2011, APPL MATH COMPUT, V217, P6315, DOI 10.1016/j.amc.2011.01.005; Iiduka H, 2009, SIAM J OPTIMIZ, V19, P1881, DOI 10.1137/070702497; Iiduka H, 2012, SIAM J CONTROL OPTIM, V50, P2173, DOI 10.1137/110850542; Iiduka H, 2011, IEEE COMMUN LETT, V15, P596, DOI 10.1109/LCOMM.2011.040711.101369; Iiduka H, 2011, J OPTIMIZ THEORY APP, V148, P580, DOI 10.1007/s10957-010-9769-z; Iiduka H, 2013, SIAM J OPTIMIZ, V23, P1, DOI 10.1137/120866877; Lewis A. S., 2000, CONVEX ANAL NONLINEA; Nesterov Yu. E., 1983, Doklady Akademii Nauk SSSR, V269; Nocedal J., 1999, SPRINGER SERIES OPER; Stampacchia G., 2000, CLASSICS APPL MATH, V31; Stark H., 1998, VECTOR SPACE PROJECT; Takahashi W., 2000, NONLINEAR FUNCTIONAL; WOLFE P, 1976, MATH PROGRAM, V11, P128, DOI 10.1007/BF01580381; Yamada I., 2001, INHERENTLY PARALLEL, P473; Yamada I., 2002, CONT MATH, V313, P269; Zeidler E., 1985, NONLINEAR FUNCTIONAL	36	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5610	1436-4646		MATH PROGRAM	Math. Program.	FEB	2015	149	1-2					131	165		10.1007/s10107-013-0741-1		35	Computer Science, Software Engineering; Operations Research & Management Science; Mathematics, Applied	Computer Science; Operations Research & Management Science; Mathematics	AY8WA	WOS:000347830300005		
J	Kawakami, E; Tokunaga, A; Ozawa, M; Sakamoto, R; Yoshida, N				Kawakami, Eri; Tokunaga, Akinori; Ozawa, Manabu; Sakamoto, Reiko; Yoshida, Nobuaki			The histone demethylase Fbxl11/Kdm2a plays an essential role in embryonic development by repressing cell-cycle regulators	MECHANISMS OF DEVELOPMENT			English	Article						Fbxl11; Kdm2a; Histone demethylase; p21; Embryogenesis	MOLECULAR-MECHANISMS; H2A UBIQUITYLATION; APICAL PAPILLA; STEM-CELLS; PROLIFERATION; METHYLATION; MOUSE; KDM2A; TRANSCRIPTION; DIFFERENTIATION	Methylation and de-methylation of histone lysine residues play pivotal roles in mammalian early development; these modifications influence chromatin architecture and regulate gene transcription. Fbxl11 (F-box and leucine-rich repeat 11)/Kdm2a is a histone demethylase that selectively removes mono-and di-methylation from histone H3K36. Previously, two other histone H3K36 demethylases (Jmjd5 or Fbxl10) were analyzed based on the phenotypes of the corresponding knockout (KO) mice; the results of those studies implicated H3K36 demethylases in cell proliferation, apoptosis, and senescence (Fukuda et al., 2011; Ishimura et al., 2012). To elucidate the physiological role of Fbxl11, we generated and examined Fbxl11 KO mice. Fbxl11 was expressed throughout the body during embryogenesis, and the Fbxl11 KO mice exhibited embryonic lethality at E10.5-12.5, accompanied with severe growth defects leading to reduced body size. Furthermore, knockout of Fbxl11 decreased cell proliferation and increased apoptosis. The lack of Fbxl11 resulted in downregulation of the Polycomb group protein (PcG) Ezh2, PcG mediated H2A ubiquitination and upregulation of the cyclin-dependent kinase inhibitor p21(Cip1). Taken together, our findings suggest that Fbxl11 plays an essential role in embryonic development and homeostasis by regulating cell proliferation and survival. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kawakami, Eri; Tokunaga, Akinori; Ozawa, Manabu; Sakamoto, Reiko; Yoshida, Nobuaki] Univ Tokyo, Ctr Expt Med & Syst Biol, Lab Dev Genet, Minato Ku, Tokyo 1088639, Japan; [Kawakami, Eri; Tokunaga, Akinori] Oita Univ, Fac Med, Tokunaga Lab, Yufu, Oita 8795593, Japan	Tokunaga, A (reprint author), Oita Univ, Fac Med, Tokunaga Lab, 1-1 Idaigaoka, Yufu, Oita 8795593, Japan.	aktoku@oita-u.ac.jp					Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667; Kottakis F, 2011, MOL CELL, V43, P285, DOI 10.1016/j.molcel.2011.06.020; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Gao RT, 2013, MOL CELL BIOCHEM, V379, P115, DOI 10.1007/s11010-013-1633-7; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Oh S, 2012, BIOCHEM BIOPH RES CO, V420, P61, DOI 10.1016/j.bbrc.2012.02.115; Du J, 2013, STEM CELLS, V31, P126, DOI 10.1002/stem.1255; Dhar SS, 2014, J BIOL CHEM, V289, P7483, DOI 10.1074/jbc.M113.521625; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Dong R, 2013, EXP CELL RES, V319, P2874, DOI 10.1016/j.yexcr.2013.07.008; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Ishimura A, 2012, DEVELOPMENT, V139, P749, DOI 10.1242/dev.074138; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Iwamori N, 2011, BIOL REPROD, V84, P1225, DOI 10.1095/biolreprod.110.088955; Baker RK, 1997, DEV BIOL, V185, P201, DOI 10.1006/dbio.1997.8541; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Takimoto R, 2001, P NATL ACAD SCI USA, V98, P781, DOI 10.1073/pnas.98.3.781; Wood A, 2006, GENE DEV, V20, P643, DOI 10.1101/gad.1414506	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4773	1872-6356		MECH DEVELOP	Mech. Dev.	FEB	2015	135						31	42		10.1016/j.mod.2014.10.001		12	Developmental Biology	Developmental Biology	AZ1ZM	WOS:000348033900003		
J	Nishimura, D; Sakai, H; Sato, T; Sato, F; Nishimura, S; Toyama-Sorimachi, N; Bartsch, JW; Sehara-Fujisawa, A				Nishimura, Daigo; Sakai, Hiroshi; Sato, Takahiko; Sato, Fuminori; Nishimura, Satoshi; Toyama-Sorimachi, Noriko; Bartsch, Joerg W.; Sehara-Fujisawa, Atsuko			Roles of ADAM8 in elimination of injured muscle fibers prior to skeletal muscle regeneration	MECHANISMS OF DEVELOPMENT			English	Article						ADAM8; Muscle regeneration; Neutrophil; PSGL-1	DUCHENNE MUSCULAR-DYSTROPHY; APOPTOTIC CELLS; MDX MICE; INFLAMMATION; MACROPHAGES; RECRUITMENT; NEUTROPHILS; ENGULFMENT; CONTRIBUTE; ADHESION	Skeletal muscle regeneration requires processes different from developmental myogenesis. One important difference is a requirement of inflammatory reactions prior to regenerative myogenesis, by which injured muscle fibers must be eliminated to make new myotubes. In this study, we show that efficient elimination of injured muscle fibers during regeneration requires ADAM8, a member of a disintegrin and metalloprotease (ADAM) family. Skeletal muscle of dystrophin-null mice, an animal model for Duchenne Muscular Dystrophy, deteriorates by the lack of ADAM8, which is characterized by increased area of muscle degeneration and increased number of necrotic and calcified muscle fibers. Adam8 is highly expressed in neutrophils. Upon cardiotoxin-induced skeletal muscle injury, neutrophils invade into muscle fibers through the basement membrane and form large clusters in wild type, but not in ADAM8-deficient mice, although neutrophils of the latter infiltrate into interstitial tissues similarly to those of wild type mice. Neutrophils lose their adhesiveness to blood vessels after infiltration, which includes an ectodomain shedding of P-Selectin Glycoprotein Ligand-1 (PSGL-1) on their surface. Expression of PSGL-1 on the surface of neutrophils remains higher in ADAM8-deficient than in wild type mice. These results suggest that ADAM8 mediates an enhanced invasiveness of neutrophils into injured muscle fibers by the removal of their adhesiveness to blood vessels after infiltration into interstitial tissues. (C) 2014 The Authors. Published by Elsevier Ireland	[Nishimura, Daigo; Sakai, Hiroshi; Sato, Takahiko; Sato, Fuminori; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto 6068507, Japan; [Nishimura, Satoshi] Jichi Med Univ, Ctr Mol Med, Dept Cell & Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Toyama-Sorimachi, Noriko] Natl Ctr Global Hlth & Med, Res Inst, Dept Mol Immunol & Inflammat, Shinjuku Ku, Tokyo 1628655, Japan; [Bartsch, Joerg W.] Univ Marburg, Dept Neurosurg Lab, D-35033 Marburg, Germany	Sehara-Fujisawa, A (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Sakyo Ku, Kawahara Cho 53, Kyoto 6068507, Japan.	asehara@frontier.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [MEXT KAKENHI 22122007]	We thank Drs. Takatoshi Matushita, Hitomi Karyu, Satoshi Toda, and Shigekazu Nagata, Tatsuki Sugiyama, and Takashi Nagasawa for technical advice and critical discussion. We also thank for Drs. Ikuya Nonaka and Ichizo Nishino for critical discussion. DMD-null mice were kindly provided by Dr. Kazunori Hanaoka. This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT KAKENHI 22122007).	Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Toda S, 2012, MOL CELL BIOL, V32, P118, DOI 10.1128/MCB.05993-11; Davenpeck KL, 2000, J IMMUNOL, V165, P2764; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Tidball JG, 2014, DEVELOPMENT, V141, P1184, DOI 10.1242/dev.098285; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Liang JJ, 2012, J BIOL CHEM, V287, P16510, DOI 10.1074/jbc.M112.360891; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; Naus Silvia, 2010, Am J Respir Crit Care Med, V181, P1318, DOI 10.1164/rccm.200909-1396OC; Dominguez-Luis M, 2011, EUR J IMMUNOL, V41, P3436, DOI 10.1002/eji.201141764; Iida A, 2010, CURR BIOL, V20, P1110, DOI 10.1016/j.cub.2010.04.052; Knolle MD, 2013, J IMMUNOL, V190, P6434, DOI 10.4049/jimmunol.1202329; Kudoh H, 2005, BIOCHEM BIOPH RES CO, V328, P507, DOI 10.1016/j.bbrc.2004.12.191; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Sakai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063016; Sasawatari S, 2010, IMMUNITY, V32, P200, DOI 10.1016/j.immuni.2010.01.012; Sato T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5597; Senf SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062687; Suelves M, 2007, J CELL BIOL, V178, P1039, DOI 10.1083/jcb.200705127; Teixeira CFP, 2003, MUSCLE NERVE, V28, P449, DOI 10.1002/mus.10453; Varga T., 2013, J IMMUNOL, V191, P701	35	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4773	1872-6356		MECH DEVELOP	Mech. Dev.	FEB	2015	135						58	67		10.1016/j.mod.2014.12.001		10	Developmental Biology	Developmental Biology	AZ1ZM	WOS:000348033900005		
J	Ajimizu, H; Kim, YH; Mishima, M				Ajimizu, Hitomi; Kim, Young Hak; Mishima, Michiaki			Rapid response of brain metastases to alectinib in a patient with non-small-cell lung cancer resistant to crizotinib	MEDICAL ONCOLOGY			English	Letter						Alectinib; Crizotinib; EML4-ALK; Brain metastases; NSCLC		Crizotinib is a potent and specific small-molecule inhibitor of both anaplastic lymphoma kinase (ALK) and c-MET tyrosine kinases, and patients with ALK rearrangement tumor benefit from crizotinib treatment; however, its penetration into calculated cerebrospinal fluid (CSF) is considered to be poor. Alectinib is a highly selective, next-generation ALK inhibitor, and both preclinical and clinical studies have indicated that alectinib is also effective in crizotinib-resistant tumors. A recent in vitro study demonstrated significant antitumor activity of alectinib for brain metastases using mouse models of ALK-positive non-small-cell lung cancer. In this paper, we report a first case alectinib was highly effective against brain metastases refractory to crizotinib. Further investigation of alectinib in this setting would be particularly valuable.	[Ajimizu, Hitomi; Kim, Young Hak; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, Kyoto 6068507, Japan	Kim, YH (reprint author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	ekim@kuhp.kyoto-u.ac.jp					Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Kim YH, 2013, J THORAC ONCOL, V8, pe85, DOI 10.1097/JTO.0b013e31829cebbb; Maillet D, 2013, J THORAC ONCOL, V8, pE30, DOI 10.1097/JTO.0b013e318288dc2d; Costa DB, 2011, J CLIN ONCOL, V29, pE443, DOI 10.1200/JCO.2010.34.1313; Kodama T, 2014, CANCER CHEMOTH PHARM, V74, P1023, DOI 10.1007/s00280-014-2578-6	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1357-0560	1559-131X		MED ONCOL	Med. Oncol.	FEB	2015	32	2							3	10.1007/s12032-014-0477-7		2	Oncology	Oncology	AY8AD	WOS:000347775900028		
J	Dewi, RT; Tachibana, S; Fajriah, S; Hanafi, M				Dewi, Rizna Triana; Tachibana, Sanro; Fajriah, Sofa; Hanafi, Muhammad			alpha-Glucosidase inhibitor compounds from Aspergillus terreus RCC1 and their antioxidant activity	MEDICINAL CHEMISTRY RESEARCH			English	Article						Aspergillus terreus RCC1; Isoaspulvinone E; alpha-Glucosidase inhibitor; Antioxidant	POSTPRANDIAL HYPERGLYCEMIA	As part of the search for naturally derived alpha-glucosidase inhibitors, the chemical components isolated from Aspergillus terreus RCC1 were evaluated. Three butenolides compounds were isolated and their structures were identified as isoaspulvinone E (1), aspulvinone E (2), and butyrolactone I (3). Compounds 1 and 2 exhibited high activity on alpha-glucosidase inhibitory with IC50 values of 8.92 and 2.70 mu M, respectively, lower than quercetin (IC50 = 10.92 mu M). However, these compounds exhibited moderate antioxidant activity with IC50 values of 167.82 and 114.86 mu M, respectively. To the best of our knowledge, this is the first report of both the alpha-glucosidase inhibitory and antioxidant activities of aspulvinone compounds. In particular, both the aspulvinone compounds could be employed as a lead compound for a new potential antidiabetic derived from terrestrial fungi.	[Dewi, Rizna Triana; Fajriah, Sofa; Hanafi, Muhammad] Kawasan PUSPIPTEK Serpong, Indonesian Inst Sci, Res Ctr Chem, Tangerang Selatan 15314, Banten, Indonesia; [Tachibana, Sanro] Ehime Univ, Dept Appl Biosci, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Hanafi, Muhammad] Pancasila Univ, Fac Pharm, Jakarta 12640, Indonesia	Dewi, RT (reprint author), Kawasan PUSPIPTEK Serpong, Indonesian Inst Sci, Res Ctr Chem, Tangerang Selatan 15314, Banten, Indonesia.	rtriana_dewi@yahoo.com					Kim KY, 2008, PHYTOCHEMISTRY, V69, P2820, DOI 10.1016/j.phytochem.2008.09.007; Kim YM, 2004, CARBOHYD RES, V339, P715, DOI 10.1016/j.carres.2003.11.005; Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149; Ramachandran A, 2014, DIABETES RES CLIN PR, V103, P231, DOI 10.1016/j.diabres.2013.11.011; Li YQ, 2009, J AGR FOOD CHEM, V57, P11463, DOI 10.1021/jf903083h; Du ZY, 2006, EUR J MED CHEM, V41, P213, DOI 10.1016/j.ejmech.2005.10.012; Kim YM, 2005, NUTRITION, V21, P756, DOI 10.1016/j.nut.2004.10.014; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001.0039; Gao HQ, 2013, BIOORG MED CHEM LETT, V23, P1776, DOI 10.1016/j.bmcl.2013.01.051; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Burla MC, 2007, J APPL CRYSTALLOGR, V40, P609, DOI 10.1107/S0021889807010941; Baron AD, 1998, DIABETES RES CLIN PR, V40, pS51; CAMPBELL AC, 1985, J CHEM SOC PERK T 1, P1567, DOI 10.1039/p19850001567; Cheng AYY, 2004, DRUG DISCOV TODAY, V192, P201; Choudhary MI, 2004, Z NATURFORSCH B, V59, P324; Creagh D. C., 1992, INT TABLES CRYSTALLO, VC, P200; Cromer D. T., 1974, INT TABLES XRAY CRYS, V4; Dewi Rizna T, 2007, Pak J Biol Sci, V10, P3131; Dewi RT, 2012, WASET, V70, P882; Dewi RT, 2014, MED CHEM RES, V23, P454, DOI 10.1007/s00044-013-0659-4; Ingavat N, 2009, J NAT PRODUCTS, V72, P2052; Jo SH, 2009, INT J APPL RES NAT P, V2, P52; Mayur B, 2010, J MED PLANTS RES, V4, P1547; Meng P, 2012, MED CHEM RES, V21, P4422, DOI 10.1007/s00044-012-9984-2; Nagia Mohamed Ms, 2012, Org Med Chem Lett, V2, P9, DOI 10.1186/2191-2858-2-9; OJIMA N, 1973, PHYTOCHEMISTRY, V12, P2527, DOI 10.1016/0031-9422(73)80469-8; Sancheti S, 2011, MED CHEM RES, V20, P1181, DOI 10.1007/s00044-010-9461-8; Shibano M, 2008, J NAT MED, V62, P349, DOI 10.1007/s11418-008-0244-1; Shihabudeen MS, 2011, NUTR METAB, V8, p[1, 11]; Takahashi T, 2012, MED CHEM RES, V21, P1762, DOI 10.1007/s00044-011-9699-9; Vertesy L, 2000, MEDLINE, V53, P677; Zhu PY, 2008, FOOD CHEM, V109, P737	32	0	0	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	1054-2523	1554-8120		MED CHEM RES	Med. Chem. Res.	FEB	2015	24	2					737	743		10.1007/s00044-014-1164-0		7	Chemistry, Medicinal	Pharmacology & Pharmacy	AY8WR	WOS:000347832000026		
J	Oshima, R; Yamada, M; Kurogi, E; Ogino, Y; Serizawa, Y; Tsuda, S; Ma, X; Egawa, T; Hayashi, T				Oshima, Rieko; Yamada, Mayumi; Kurogi, Eriko; Ogino, Yohei; Serizawa, Yasuhiro; Tsuda, Satoshi; Ma, Xiao; Egawa, Tatsuro; Hayashi, Tatsuya			Evidence for organic cation transporter-mediated metformin transport and 5 '-adenosine monophosphate-activated protein kinase activation in rat skeletal muscles	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						Metformin; 5 '-adenosine monophosphate-activated protein kinase; Organic cation transporter; Glucose transport; Skeletal muscle	ACETYL-COA CARBOXYLASE; GLUCOSE-TRANSPORT; DIABETES-MELLITUS; INSULIN; INCREASES; AMPK; PHOSPHORYLATION; ISOFORM; ALPHA-1-ISOFORM; INVOLVEMENT	Objective. 5'-adenosine monophosphate-activated protein kinase (AMPK) is a key molecule of metabolic enhancement in skeletal muscle. We investigated whether metformin (MET) acts directly on skeletal muscle, is transported into skeletal muscle via organic cation transporters (OCTs), and activates AMPK. Materials/Methods. Isolated rat epitrochlearis and soleus muscles were incubated in vitro either in the absence or in the presence of MET. The activation status of AMPK, the intracellular energy status, and glucose and MET transport activity were then evaluated. The effect of cimetidine, which is an OCT inhibitor, on AMPK activation was also examined. Results. MET (10 mmol/L, >= 60 min) increased the phosphorylation of Thr(172) at the catalytic alpha subunit of AMPK in both muscles. AMPK activity assays showed that both AMPK alpha 1 and AMPK alpha 2 activity increased significantly. The AMPK activation was associated with energy deprivation, which was estimated from the ATP, phosphocreatine (PCr), and glycogen content, and with increased rates of 3-O-methyl-D-glucose (3MG) transport. MET did not change the basal phosphorylation status of insulin receptor signaling molecules. MET was transported into the cytoplasm in a time-dependent manner, and cimetidine suppressed MET-induced AMPK phosphorylation and 3MG transport. Conclusion. These results suggest that MET is acutely transported into skeletal muscle by OCTs, and stimulates AMPK alpha 1 and alpha 2 activity in both fast- and slow-twitch muscle types, at least in part by reducing the energy state. (C) 2015 Elsevier Inc. All rights reserved.	[Oshima, Rieko; Yamada, Mayumi; Kurogi, Eriko; Ogino, Yohei; Serizawa, Yasuhiro; Tsuda, Satoshi; Hayashi, Tatsuya] Kyoto Univ, Lab Sports & Exercise Med, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Ma, Xiao] Yunnan Agr Univ, Key Lab Puer Tea Sci, Minist Educ, Kunming 650201, Yunnan Provice, Peoples R China; [Egawa, Tatsuro] Toyohashi SOZO Univ, Dept Physiol, Grad Sch Hlth Sci, Toyohashi, Aichi 4400016, Japan	Hayashi, T (reprint author), Kyoto Univ, Lab Sports & Exercise Med, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan.	tatsuya@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [23617009]; Urakami Foundation for Food and Food Culture; Foundation for Dietary Scientific Research; Asahi Group Foundation; Vascular Disease Research Foundation; Japan Society for the Promotion of Science for Young Scientists	This study was supported by research grants from the Japan Society for the Promotion of Science (TH, 23617009), Urakami Foundation for Food and Food Culture (TH), the Foundation for Dietary Scientific Research (TH), Asahi Group Foundation (TH), Vascular Disease Research Foundation (TH), and Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists (TE and ST).	Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Nakano M, 2006, METABOLISM, V55, P300, DOI 10.1016/j.metabol.2005.09.003; Ma X, 2009, J ETHNOPHARMACOL, V122, P54, DOI 10.1016/j.jep.2008.11.022; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Kristensen JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1099, DOI 10.1152/ajpendo.00417.2013; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Sogame Y, 2009, BIOPHARM DRUG DISPOS, V30, P476, DOI 10.1002/bdd.684; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001; DeFronzo RA, 1999, ANN INTERN MED, V131, P281; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Knowler WC, 2002, NEW ENGL J MED, V346, P393; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; Stapleton D, 1996, J BIOL CHEM, V271, P611; Egawa T, 2011, J APPL PHYSIOL, V111, P1629, DOI 10.1152/japplphysiol.00249.2011; Egawa T, 2009, METABOLISM, V58, P1609, DOI 10.1016/j.metabol.2009.05.013; Egawa T, 2011, ACTA PHYSIOL, V201, P227, DOI 10.1111/j.1748-1716.2010.02169.x; Koepsell H, 2007, PHARM RES, V24, P1227, DOI 10.1007/s11095-9254-z; Bikman BT, 2010, J OBES, V2010, P1, DOI DOI 10.1155/2010/970865; Egawa T, 2014, J PHYS FITNESS SPORT, V3, P55; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Jensen TE, 2008, PLOS ONE, V3; Lessard SJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE251, DOI 10.1152/ajpendo.00096.2005; Ma Xiao, 2011, Chinese Journal of Natural Medicines, V9, P215, DOI 10.3724/SP.J.1009.2011.00215; Ma XA, 2010, METABOLISM, V59, P1619, DOI 10.1016/j.metabol.2010.03.009; NESHER R, 1980, AM J PHYSIOL, V239, pE454; Owen MR, 2000, BIOCH J, P348; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Toyoda T, 2006, AM J PHYSIOL-ENDOC M, V290, pE583, DOI 10.1152/ajpendo.00395.2005; TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235; Umehara KI, 2007, XENOBIOTICA, V37, P818, DOI 10.1080/00498250701546012; YOUNG DA, 1986, J BIOL CHEM, V261, P6049	42	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	FEB	2015	64	2					296	304		10.1016/j.metabol.2014.10.037		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AY5CG	WOS:000347590300018		
J	Steur, PPM; Pavese, F; Fellmuth, B; Hermier, Y; Hill, KD; Kim, JS; Lipinski, L; Nagao, K; Nakano, T; Peruzzi, A; Sparasci, F; Szmyrka-Grzebyk, A; Tamura, O; Tew, WL; Valkiers, S; van Geel, J				Steur, Peter P. M.; Pavese, Franco; Fellmuth, Bernd; Hermier, Yves; Hill, Kenneth D.; Kim, Jin Seog; Lipinski, Leszek; Nagao, Keisuke; Nakano, Tohru; Peruzzi, Andrea; Sparasci, Fernando; Szmyrka-Grzebyk, Anna; Tamura, Osamu; Tew, Weston L.; Valkiers, Staf; van Geel, Jan			Isotopic effects in the neon fixed point: uncertainty of the calibration data correction	METROLOGIA			English	Article						neon; triple point; isotopic composition; uncertainty	TRIPLE-POINT; PURE NE-20; TEMPERATURE; ITS-90	The neon triple point is one of the defining fixed points of the International Temperature Scale of 1990 (ITS-90). Although recognizing that natural neon is a mixture of isotopes, the ITS-90 definition only states that the neon should be of 'natural isotopic composition', without any further requirements. A preliminary study in 2005 indicated that most of the observed variability in the realized neon triple point temperatures within a range of about 0.5 mK can be attributed to the variability in isotopic composition among different samples of 'natural' neon. Based on the results of an International Project (EUROMET Project No. 770), the Consultative Committee for Thermometry decided to improve the realization of the neon fixed point by assigning the ITS-90 temperature value 24.5561 K to neon with the isotopic composition recommended by IUPAC, accompanied by a quadratic equation to take the deviations from the reference composition into account. In this paper, the uncertainties of the equation are discussed and an uncertainty budget is presented. The resulting standard uncertainty due to the isotopic effect (k = 1) after correction of the calibration data is reduced to (4 to 40) mu K when using neon of 'natural' isotopic composition or to 30 mu K when using Ne-20. For comparison, an uncertainty component of 0.15 mK should be included in the uncertainty budget for the neon triple point if the isotopic composition is unknown, i.e. whenever the correction cannot be applied.	[Steur, Peter P. M.; Pavese, Franco] Ist Nazl Ric Metrol INRIM, Turin, Italy; [Fellmuth, Bernd] Phys Tech Bundesanstalt, Berlin, Germany; [Hermier, Yves; Sparasci, Fernando] Lab Commun Metrol LNE CNAM LCM, La Plaine St Denis, France; [Hill, Kenneth D.] Natl Res Council Canada, Ottawa, ON, Canada; [Kim, Jin Seog] Korean Res Inst Stand KRISS, Taejon, South Korea; [Lipinski, Leszek; Szmyrka-Grzebyk, Anna] Inst Niskich Temp & Badan Strukturalnych INTiBS, Wroclaw, Poland; [Nagao, Keisuke] Univ Tokyo, Grad Sch Sci, Geochem Res Ctr, Tokyo 113, Japan; [Nakano, Tohru; Tamura, Osamu] AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan; [Peruzzi, Andrea; van Geel, Jan] Van Swinden Lab, Delft, Netherlands; [Tew, Weston L.] NIST, Gaithersburg, MD 20899 USA; [Valkiers, Staf] EU JRC, Inst Reference Mat & Measurements, Geel, Belgium	Steur, PPM (reprint author), Ist Nazl Ric Metrol INRIM, Turin, Italy.	p.steur@inrim.it					White DR, 2010, INT J THERMOPHYS, V31, P1644, DOI 10.1007/s10765-010-0819-4; Wieser ME, 2011, PURE APPL CHEM, V83, P359, DOI 10.1351/PAC-REP-10-09-14; Bureau International des Poids et Mesures (BIPM), 2013, TECHN ANN MIS PRAT D; CLUSIUS K, 1960, Z NATURFORSCH PT A, V15, P1; Fellmuth B, 2005, METROLOGIA, V42, P171, DOI 10.1088/0026-1394/42/4/001; Hill K, 2011, FORBES, V187, P20; Pavese F, 2010, CCT1006 BIPM; Pavese F, 2014, INT J THERMOPHYS, V35, P1077, DOI 10.1007/s10765-014-1642-0; Pavese F, 2010, J CHEM THERMODYN, V42, P1222, DOI 10.1016/j.jct.2010.04.024; Pavese F, 2005, ANAL CHEM, V77, P5076, DOI 10.1021/ac048083f; Pavese F, 2011, J CHEM THERMODYN, V43, P1977, DOI 10.1016/j.jct.2011.07.011; Pavese F, 2013, AIP CONF PROC, V1552, P192, DOI 10.1063/1.4821378; Pavese F, 2008, INT J THERMOPHYS, V29, P57, DOI 10.1007/s10765-007-0329-1; Pavese F, 2008, CCT0806 BIPM; Ramirez R, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3023036; Ripple D C, 2005, CCT0507 BIPM AD HOC; Steur P P M, 2005, CCT0506 BIPM; Steur PPM, 2013, J CHEM THERMODYN, V60, P87, DOI 10.1016/j.jct.2013.01.011; Tew W L, 2010, COMMUNICATION	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0026-1394	1681-7575		METROLOGIA	Metrologia	FEB	2015	52	1								10.1088/0026-1394/52/1/104		7	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AZ3IC	WOS:000348119700014		
J	Takahashi, K; Matsuyama, S; Kinugasa, S; Ehara, K; Sakurai, H; Horikawa, Y; Kitazawa, H; Bounoshita, M				Takahashi, Kayori; Matsuyama, Shigetomo; Kinugasa, Shinichi; Ehara, Kensei; Sakurai, Hiromu; Horikawa, Yoshiteru; Kitazawa, Hideaki; Bounoshita, Masao			Molecularly uniform poly(ethylene glycol) certified reference material	METROLOGIA			English	Article						certified reference material; poly(ethylene glycol); degree of polymerization; supercritical fluid chromatography; polydispersity; uniform polymer	SUPERCRITICAL-FLUID CHROMATOGRAPHY; OLIGOMERS	A certified reference material (CRM) for poly(ethylene glycol) with no distribution in the degree of polymerization was developed. The degree of polymerization of the CRM was accurately determined to be 23. Supercritical fluid chromatography (SFC) was used to separate the molecularly uniform polymer from a standard commercial sample with wide polydispersity in its degree of polymerization. Through the use of a specific fractionation system coupled with SFC, we are able to obtain samples of poly(ethylene glycol) oligomer with exact degrees of polymerization, as required for a CRM produced by the National Metrology Institute of Japan.	[Takahashi, Kayori; Matsuyama, Shigetomo; Kinugasa, Shinichi; Ehara, Kensei; Sakurai, Hiromu] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Horikawa, Yoshiteru; Kitazawa, Hideaki; Bounoshita, Masao] JASCO Corp, Hachioji, Tokyo 1928537, Japan	Takahashi, K (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, 1-1-1 Umezono, Tsukuba, Ibaraki 3058563, Japan.	kayori.takahashi@ni.aist.go.jp					Wieser ME, 2013, PURE APPL CHEM, V85, P1047, DOI 10.1351/PAC-REP-13-03-02; Wieser ME, 2011, PURE APPL CHEM, V83, P359, DOI 10.1351/PAC-REP-10-09-14; Takahashi K, 2008, J CHROMATOGR A, V1193, P146, DOI 10.1016/j.chroma.2008.03.083; Berglund M, 2011, PURE APPL CHEM, V83, P397, DOI 10.1351/PAC-REP-10-06-02; Saito M, 2013, J BIOSCI BIOENG, V115, P590, DOI 10.1016/j.jbiosc.2012.12.008; [Anonymous], 2011, IUPAC TECHN REP; Bailey Jr F. E., 1976, POLYETHYLENE OXIDE; Berger T A, 1995, RSC CHROMATOGRAPHIC; Harris J. M., 1997, POLYETHYLENE GLYCOL; Harris JM., 1992, POLYETHYLENE GLYCOL; INTERNATIONAL ORGANIZATION FOR STANDARDIZATION (Geneva Switzerland), 1993, GUID EXPR UNC MEAS; International Organization of Standards, 1989, ISO GUID 35 CERT REF; JENTOFT RE, 1969, J POLYM SCI POL LETT, V7, P811, DOI 10.1002/pol.1969.110071110; Klesper K., 1962, J ORG CHEM, V27, P700; Saito M, 1994, FRACTIONATION PACKED; Shimada K, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1948378; Smith R M, 1998, SUPERCRITICAL FLUID; Takahashi K, 2013, J BIOSCI BIOENG, V116, P133, DOI 10.1016/j.jbiosc.2013.02.001; Takahashi K, 2008, ANAL BIOANAL CHEM, V391, P2079, DOI 10.1007/s00216-008-2075-z; UTE K, 1998, CHROMATOGR SCI SERIE, V75, P349; Ute K, 2000, ENCY ANAL CHEM, P8034	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0026-1394	1681-7575		METROLOGIA	Metrologia	FEB	2015	52	1								10.1088/0026-1394/52/1/8		9	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AZ3IC	WOS:000348119700004		
J	Yang, XS; Satur, JV; Sanematsu, K; Laukkanen, J; Saastamoinen, T				Yang, Xiaosheng; Satur, Jacqueline V.; Sanematsu, Kenzo; Laukkanen, Jukka; Saastamoinen, Tuula			Beneficiation studies of a complex REE ore	MINERALS ENGINEERING			English	Article						Rare earth minerals; Flotation; Modal mineralogy; Mineral recovery	FROTH FLOTATION; MINERALS; MONAZITE; XENOTIME; OLEATE	The beneficiations of a complex rare earth element (REE) ore containing REE minerals of carbonates, silicates and oxides and other REE bearing minerals (e.g. zircon and pyrochlore etc.) by flotation and high gradient magnetic separation (HGMS) were investigated. The recoveries of the different group of minerals in the flotation concentrates and their flotation kinetics were analyzed through the mineralogical studies by MLA. By flotation nearly 90% of La and Ce and 45% of Y were recovered in the final cumulative concentrate with the mass percentage of 11.5%. The mineralogical studies indicated that over 95% of carbonates were recovered in the final cumulative concentrate in which the recoveries of three major REE minerals bastnaesite, parisite and synchysite reached over 96%. The recoveries of silicate REE minerals such as cerite(Ce) and allanite were quite high and reached 86% and 65%, respectively. The recoveries of Nb mineral pyrochlore and Zr minerals zircon and elpidite were very low. HGMS was significantly less selective in recovering La and Ce but was effective in recovering Y. The flow sheet of rougher-cleaner flotation and the flow sheet of rougher flotation-cleaner HGMS were compared. The flow sheet of rougher flotation-cleaner HGMS was showed to be more effective in recovery of Y. (C) 2014 Elsevier Ltd. All rights reserved.	[Yang, Xiaosheng; Laukkanen, Jukka; Saastamoinen, Tuula] Geol Survey Finland, Mineral Proc Lab, Outokumpu, Finland; [Satur, Jacqueline V.; Sanematsu, Kenzo] Natl Inst Adv Ind Sci & Technol, Mineral Resources Res Grp, Inst Georesources & Environm, Tsukuba, Ibaraki, Japan	Yang, XS (reprint author), Tutkijankatu 1, Outokumpu 83500, Finland.	jason.yang@gtk.fi					Assis SM, 1996, MINER ENG, V9, P103, DOI 10.1016/0892-6875(95)00134-4; Jordens A, 2013, MINER ENG, V41, P97, DOI 10.1016/j.mineng.2012.10.017; Pavez O, 1996, MINER ENG, V9, P357, DOI 10.1016/0892-6875(96)00020-9; CHENG TW, 1994, MINER ENG, V7, P1085, DOI 10.1016/0892-6875(94)90001-9; CHENG TW, 1993, MINER ENG, V6, P341, DOI 10.1016/0892-6875(93)90014-E; [池汝安 Chi Ruan], 2007, [中国稀土学报, Journal of the Chinese Rare Earth Society], V25, P641; Gupta C.K., 2005, EXTRACTIVE METALLURG; Miyawaki R., 1996, RARE EARTH MINERALS, P21; PAVEZ O, 1993, MINER ENG, V6, P69, DOI 10.1016/0892-6875(93)90164-I; PRADIP, 1991, INT J MINER PROCESS, V32, P1, DOI 10.1016/0301-7516(91)90016-C; Yongfu Yu, 2000, W CHINA EXPLORATION, P1; Zhang J., 2012, 44 ANN M CAN MIN PRO, P79	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0892-6875			MINER ENG	Miner. Eng.	FEB	2015	71						55	64		10.1016/j.mineng.2014.10.005		10	Engineering, Chemical; Mineralogy; Mining & Mineral Processing	Engineering; Mineralogy; Mining & Mineral Processing	AZ2TU	WOS:000348086000009		
J	Hossain, E; Ota, A; Karnan, S; Takahashi, M; Mannan, SB; Konishi, H; Hosokawa, Y				Hossain, Ekhtear; Ota, Akinobu; Karnan, Sivasundaram; Takahashi, Miyuki; Mannan, Shahnewaj B.; Konishi, Hiroyuki; Hosokawa, Yoshitaka			Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						LPS; LOX-1; Atherosclerosis; Erk1/2; Molecular biology	LOW-DENSITY-LIPOPROTEIN; VASCULAR ENDOTHELIAL-CELLS; SCAVENGER RECEPTOR; LOX-1 DELETION; RAW 264.7; EXPRESSION; ATHEROSCLEROSIS; MICE; ACCUMULATION; GENE	There is a growing body of evidence supporting an intimate association of immune activation with the pathogenesis of cardiovascular diseases, including atherosclerosis. Uptake of oxidized low-density lipoprotein (oxLDL) through scavenging receptors promotes the formation of mature lipid-laden macrophages, which subsequently leads to exacerbation of regional inflammation and atherosclerotic plaque formation. In this study, we first examined changes in the mRNA level of the lectin-like oxLDL receptor-1 (LOX-1) in the mouse macrophage cell line RAW264.7 and the human PMA-induced macrophage cell line THP-1 after LPS stimulation. LPS significantly up-regulated LOX-1 mRNA in RAW264.7 cells; LOX-1 cell-surface protein expression was also increased. Flow cytometry and fluorescence microscopy analyses showed that cellular uptake of fluorescence (Dil)-labeled oxLDL was significantly augmented with LPS stimulation. The augmented uptake of Dil-oxLDL was almost completely abrogated by treatment with an anti-LOX-1 antibody. Of note, knockdown of Erk1/2 resulted in a significant reduction of LPS-induced LOX-1 up-regulation. Treatment with U0126, a specific inhibitor of MEK, significantly suppressed LPS-induced expression of LOX-1 at both the mRNA and protein levels. Furthermore, LOX-1 promoter activity was significantly augmented by LPS stimulation; this augmentation was prevented by U0126 treatment. Similar results were also observed in human PMA-induced THP-1 macrophages. Taken together, our results indicate that LPS up-regulates LOX-1, at least in part through activation of the Erk1/2 signaling pathway, followed by augmented cellular oxLDL uptake, thus highlighting a critical role of TLR4-mediated aberrant LOX-1 signaling in the pathogenesis of atherosclerosis.	[Hossain, Ekhtear; Ota, Akinobu; Karnan, Sivasundaram; Takahashi, Miyuki; Mannan, Shahnewaj B.; Konishi, Hiroyuki; Hosokawa, Yoshitaka] Aichi Med Univ Sch Med, Dept Biochem, Nagakute, Aichi, Japan; [Ota, Akinobu] Aichi Med Univ Sch Med, Dept Biochem, Nagakute, Aichi 4801195, Japan; [Takahashi, Miyuki] Aichi Med Univ Sch Med, Div Hematol, Dept Internal Med, Nagakute, Aichi, Japan	Ota, A (reprint author), Aichi Med Univ Sch Med, Dept Biochem, 1-1 Yazakokarimata,Bldg 2,Room 362, Nagakute, Aichi 4801195, Japan.	aota@aichi-med-u.ac.jp			Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [S1101027]; AIKEIKAI Foundation	This work was partly supported by a grant from the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [S1101027 to S. K., H. K., and Y. H.]; and the AIKEIKAI Foundation [to A. O.]. We would like to thank Dr. Takashi Yokochi and Dr. Hiroshi Miwa at Aichi Medical University (Aichi, Japan) for kindly providing the RAW264.7 mouse macrophage cell line and THP-1 human acute monocytic leukemia cell line, respectively.	Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Zernecke A, 2014, ARTERIOSCL THROM VAS, V34, P742, DOI 10.1161/ATVBAHA.113.301655; Hossain E, 2013, TOXICOL APPL PHARM, V273, P651, DOI 10.1016/j.taap.2013.10.012; Schaeffer DF, 2009, J LIPID RES, V50, P1676, DOI 10.1194/jlr.M900167-JLR200; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Ding ZF, 2013, BIOCHEM BIOPH RES CO, V440, P210, DOI 10.1016/j.bbrc.2013.09.020; Kume N, 1998, CIRC RES, V83, P322; Hossain E, 2013, TOXICOL LETT, V220, P70, DOI 10.1016/j.toxlet.2013.04.006; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Ueno T, 2009, J HYPERTENS, V27, P508, DOI 10.1097/HJH.0b013e3283207fe1; Takahashi M, 2013, CANCER SCI, V104, P165, DOI 10.1111/cas.12053; Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5; Martin-Fuentes P, 2007, J IMMUNOL, V179, P3242; Nagase M, 1998, J BIOL CHEM, V273, P33702, DOI 10.1074/jbc.273.50.33702; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Murase T, 1998, CIRC RES, V83, P328; Kataoka H, 1999, CIRCULATION, V99, P3110; Li DY, 2000, ARTERIOSCL THROM VAS, V20, P1116; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Goyal T, 2012, CURR ATHEROSCLER REP, V14, P150, DOI 10.1007/s11883-012-0228-1; Hu CP, 2008, CARDIOVASC RES, V79, P287, DOI 10.1093/cvr/cvn110; Chen JW, 2006, ARTERIOSCL THROM VAS, V26, P1163, DOI 10.1161/01.ATV.0000209998.73303.b5; El Fiky A, 2013, HUM IMMUNOL, V74, P1524, DOI 10.1016/j.humimm.2013.08.267; Fitzgerald ML, 2000, J IMMUNOL, V164, P2692; Hermonat PL, 2011, CARDIOVASC DRUG THER, V25, P393, DOI 10.1007/s10557-011-6322-8; Komura T, 2013, CELL IMMUNOL, V282, P44, DOI 10.1016/j.cellimm.2013.04.006; Taghavie-Moghadam PL, 2014, ANN NY ACAD SCI, V19, P19; Taront S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-9; Yesner LM, 1996, ARTERIOSCL THROM VAS, V16, P1019; Zhao WW, 2014, VASC PHARMACOL, V63, P162, DOI 10.1016/j.vph.2014.06.008	32	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	FEB	2015	400	1-2					29	40		10.1007/s11010-014-2259-0		12	Cell Biology	Cell Biology	AY4EE	WOS:000347530100004		
J	Ohtoyo, M; Tamura, M; Machinaga, N; Muro, F; Hashimoto, R				Ohtoyo, Mamoru; Tamura, Masakazu; Machinaga, Nobuo; Muro, Fumihito; Hashimoto, Ryuji			Sphingosine 1-phosphate lyase inhibition by 2-acetyl-4-(tetrahydroxybutyl)imidazole (THI) under conditions of vitamin B6 deficiency	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						2-Acetyl-4-(tetrahydroxybutyl)imidazole; Sphingosine 1-phosphate; S1P lyase; Vitamin B6; 4-Deoxypyridoxine	IONIZATION MASS-SPECTROMETRY; SPHINGOSINE-1-PHOSPHATE LYASE; LYMPHOCYTE SEQUESTRATION; AMMONIA CARAMEL; PYRIDOXINE; CELLS; RATS; LYMPHOPENIA; METABOLISM; KINASE	Caramel food colorant 2-acetyl-4-(tetrahydroxybutyl)imidazole (THI) causes lymphopenia in animals through sphingosine 1-phosphate lyase (SPL) inhibition. However, this mechanism of action is partly still controversial because THI did not inhibit SPL in vitro either in cell-free or in cell-based systems. It is thought that the in vitro experimental conditions which have been used so far were not suitable for the evaluation of SPL inhibition, especially in case of cell-based experiments. We speculated that the key factor might be the coenzyme pyridoxal 5'-phosphate (PLP), an active form of vitamin B6 (VB6), because media used in cell-based assays usually contain an excess amount of VB6 which leads to the activation of SPL. By the use of VB6-deficient culture medium, we could regulate apo- (without PLP) and holo- (with PLP) SPL enzyme in cultured cells, resulting in the successful detection of SPL inhibition by THI. Although the observed inhibitory effect was not as strong as that of 4-deoxypyridoxine (a VB6 analog SPL inhibitor), these findings may be useful for further understanding the mechanism of action of THI.	[Ohtoyo, Mamoru; Hashimoto, Ryuji] Daiichi Sankyo Co Ltd, New Modal Res Labs, R&D Div, Shinagawa Ku, Tokyo 1408710, Japan; [Tamura, Masakazu] Daiichi Sankyo Co Ltd, Biol Pharmacol Res Labs, R&D Div, Shinagawa Ku, Tokyo 1408710, Japan; [Machinaga, Nobuo] Daiichi Sankyo Co Ltd, Med Chem Res Labs, R&D Div, Shinagawa Ku, Tokyo 1408710, Japan; [Muro, Fumihito] Daiichi Sankyo Co Ltd, Vaccine Business Strategy Dept, Vaccine Business Intelligence Div, Chuo Ku, Tokyo 1038426, Japan	Ohtoyo, M (reprint author), Daiichi Sankyo Co Ltd, New Modal Res Labs, R&D Div, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	otoyo.mamoru.v7@daiichisankyo.co.jp					Said HM, 2003, AM J PHYSIOL-CELL PH, V285, pC1219, DOI 10.1152/ajpcell.00204.2003; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Billich A, 2013, ANAL BIOCHEM, V434, P247, DOI 10.1016/j.ab.2012.11.026; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Bagdanoff JT, 2010, J MED CHEM, V53, P8650, DOI 10.1021/jm101183p; Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Nussbaumer P, 2008, CHEMMEDCHEM, V3, P543, DOI 10.1002/cmdc.200700252; Wei IL, 1999, J AM COLL NUTR, V18, P144; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Sensken SC, 2010, J IMMUNOL, V184, P4133, DOI 10.4049/jimmunol.0903358; Bagdanoff JT, 2009, J MED CHEM, V52, P3941, DOI 10.1021/jm900278w; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Cliff MD, 1997, J ORG CHEM, V62, P1023, DOI 10.1021/jo961630f; GOBIN SJP, 1989, FOOD CHEM TOXICOL, V27, P627, DOI 10.1016/0278-6915(89)90116-6; GOBIN SJP, 1991, CLIN EXP IMMUNOL, V85, P335; Gugasyan R, 1998, IMMUNOLOGY, V93, P398; Hanna MC, 1997, J BIOL CHEM, V272, P10756; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P474, DOI 10.1016/j.bbrc.2005.02.014; ISCARO A, 1988, IMMUNOL CELL BIOL, V66, P395, DOI 10.1038/icb.1988.51; ITOH T, 1988, EUR J IMMUNOL, V18, P821, DOI 10.1002/eji.1830180525; LEKLEM JE, 1990, J NUTR, V120, P1503; Loetscher E, 2013, BIOCHEM BIOPH RES CO, V433, P345; LONG RF, 1954, J CHEM SOC, P3854, DOI 10.1039/jr9540003854; MEISTER A, 1954, J BIOL CHEM, V206, P89; Mukhopadhyay D, 2008, J BIOL CHEM, V283, P20159, DOI 10.1074/jbc.M709753200; Reina E, 2012, CHEM PHYS LIPIDS, V165, P225, DOI 10.1016/j.chemphyslip.2012.01.001; SHANE B, 1976, J BIOL CHEM, V251, P1042; SINKELDAM EJ, 1988, FOOD CHEM TOXICOL, V26, P195, DOI 10.1016/0278-6915(88)90119-6; Sugimoto M., 2009, METABOLOMICS, V6, P78; Trakatellis A, 1997, POSTGRAD MED J, V73, P617; VANDEKAMP JL, 1995, NUTR RES, V15, P415, DOI 10.1016/0271-5317(95)00009-7; Yu XQ, 2010, XENOBIOTICA, V40, P350, DOI 10.3109/00498251003611376	36	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	FEB	2015	400	1-2					125	133		10.1007/s11010-014-2268-z		9	Cell Biology	Cell Biology	AY4EE	WOS:000347530100013		
J	Ishii, S; Hirane, M; Kitamura, Y; Mori, S; Fukushima, N; Honoki, K; Tsujiuchi, T				Ishii, Shuhei; Hirane, Miku; Kitamura, Yuka; Mori, Shiori; Fukushima, Nobuyuki; Honoki, Kanya; Tsujiuchi, Toshifumi			Role of GPR120 in cell motile activity induced by 12-O-tetradecanoylphorbol-13-acetate in liver epithelial WB-F344 cells	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						GPR120; 12-O-tetradecanoylphorbol-13-acetate; Cell motility; Liver	LYSOPHOSPHATIDIC ACID RECEPTORS; METABOLIC COOPERATION; TUMOR PROMOTERS; INHIBITION; INDUCTION; MIGRATION; IDENTIFICATION; PROLIFERATION; EXPRESSION; SECRETION	G-protein-coupled receptor 120 (GPR120) is identified as a G-protein-coupled receptor for unsaturated long-chain free fatty acids that mediates insulin signaling and anti-inflammatory effects. Recently, it has been reported that GPR120 promotes the cell motile activity and angiogenesis in cancer cells. In this study, we assessed the role of GPR120 in the cell motile activity induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in rat liver epithelial WB-F344 cells. Cells were treated with TPA at a concentration of 5 nM for 72 h. The expression level of the Gpr120 gene was measured by quantitative real-time RT-PCR analysis. Cells treated with TPA showed the elevated Gpr120 expression, in comparison with untreated cells. In cell motility assays, the cell motile activity of cells treated with TPA was significantly higher than that of untreated cells. To confirm whether GPR120 is involved in the cell motile activity mediated by TPA, we generated GPR120 knockdown cells from WB-F344 cells. The cell motile activity induced by TPA was significantly suppressed by GPR120 knockdown. These results suggest that GPR120 plays an important role in the cell motile activity induced by TPA in WB-F344 cells.	[Ishii, Shuhei; Hirane, Miku; Kitamura, Yuka; Mori, Shiori; Tsujiuchi, Toshifumi] Kinki Univ, Div Canc Biol & Bioinformat, Dept Life Sci, Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan; [Fukushima, Nobuyuki] Kinki Univ, Div Mol Neurobiol, Dept Life Sci, Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan; [Honoki, Kanya] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 6348521, Japan	Tsujiuchi, T (reprint author), Kinki Univ, Div Canc Biol & Bioinformat, Dept Life Sci, Fac Sci & Engn, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	ttujiuch@life.kindai.ac.jp			Japan Society for the Promotion of Science [24590493]; Ministry of Health, Labor and Welfare of Japan; Faculty of Science and Engineering, Kinki University	This study was supported in part by a Grant-in-Aid (24590493) for Scientific Research (C) from Japan Society for the Promotion of Science, by Grants from the Ministry of Health, Labor and Welfare of Japan, and by Grants from the Faculty of Science and Engineering, Kinki University.	Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wu Q, 2013, ONCOGENE, V32, P5541, DOI 10.1038/onc.2013.264; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Lin CW, 2010, J CELL PHYSIOL, V225, P472, DOI 10.1002/jcp.22226; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Cornall LM, 2014, DRUG DISCOV TODAY, V19, P670, DOI 10.1016/j.drudis.2013.11.021; Yu SX, 2008, J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Tanabe E, 2012, BIOCHEM BIOPH RES CO, V428, P105, DOI 10.1016/j.bbrc.2012.10.015; Miyauchi S, 2010, J PHARMACOL SCI, V112, P19, DOI 10.1254/jphs.09R09FM; Lin CW, 2008, CARCINOGENESIS, V29, P1807, DOI 10.1093/carcin/bgn162; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; YOTTI LP, 1979, SCIENCE, V206, P1089, DOI 10.1126/science.493994; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.05; Hayashi M, 2012, CANCER LETT, V316, P91, DOI 10.1016/j.canlet.2011.10.030; Johnson MD, 1999, EXP CELL RES, V247, P105, DOI 10.1006/excr.1998.4336; KAVANAGH TJ, 1986, CANCER RES, V46, P1359; MURRAY AW, 1979, BIOCHEM BIOPH RES CO, V91, P395, DOI 10.1016/0006-291X(79)91535-3; OH SY, 1988, CARCINOGENESIS, V9, P135, DOI 10.1093/carcin/9.1.135; Okabe K, 2011, CANCER LETT, V309, P236, DOI 10.1016/j.canlet.2011.06.020; Okabe K, 2013, MOL CARCINOGEN, V52, P247, DOI 10.1002/mc.21851; Ren P, 1998, CARCINOGENESIS, V19, P169, DOI 10.1093/carcin/19.1.169; SLAGA TJ, 1976, J NATL CANCER I, V57, P1145; Tsujiuchi T, 2014, HISTOL HISTOPATHOL, V29, P313	25	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	FEB	2015	400	1-2					145	151		10.1007/s11010-014-2270-5		7	Cell Biology	Cell Biology	AY4EE	WOS:000347530100015		
J	Guan, JZ; Guan, WP; Maeda, T; Xie, GQ; Wan, GZ; Makino, N				Guan, Jing-Zhi; Guan, Wei-Ping; Maeda, Toyoki; Xie Guoqing; Wan GuangZhi; Makino, Naoki			Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Oxidative stress; Telomere; Multiple sclerosis	LOW-DENSITY-LIPOPROTEIN; NEURODEGENERATIVE DISEASES; CEREBROSPINAL-FLUID; PATHOGENESIS; ISOPROSTANES; ANTIOXIDANTS; CAPACITY; PLASMA; NEED	Lipid peroxidation due to oxidative stress (OS) may play an important role in the pathogenesis of chronic systemic inflammatory diseases such as multiple sclerosis (MS). Telomeres, repeated sequences that cap chromosome ends, undergo shortening with each cycle of cell division, resulting in cellular senescence. Research regarding telomere shortening has provided novel insight into the pathogenesis of various diseases. We hypothesized that OS damage leads to inflammatory reactions, which subsequently shortens the telomere length in MS. We enrolled 59 patients with MS, and age- and gender-matched 60 healthy controls. We divided MS subjects into three groups matched for age and gender according to the severity of disability: relatively benign course (BMS), secondary progressive MS, and primary progressive MS (PPMS). We analyzed the telomere length in peripheral blood mononuclear cells and the 8-iso-PGF2 alpha concentration in urine, a reliable and stable marker of lipid peroxidation in vivo. The data showed significant higher levels of urinary 8-iso-PGF2 alpha in MS subjects than in the controls. The lag-time, which represents the direct measurement of the resistance of low-density lipoprotein to oxidation, was shorter in the PPMS subjects than in the groups. Compared to that observed in the controls, the mean telomere length was significantly shorter in the PPMS group, whereas no significant telomere shortening was found between the controls and other subjects. Our data suggest that a decreased telomere length and enhanced lipid peroxidation reflects the severest stage of MS.	[Guan, Jing-Zhi; Xie Guoqing; Wan GuangZhi] Chinese Peoples Liberat Army, Hosp 309, Beijing, Peoples R China; [Guan, Wei-Ping] Chinese Peoples Liberat Army Gen Hosp, Nanlou Neurol Dept, Beijing, Peoples R China; [Maeda, Toyoki; Makino, Naoki] Kyushu Univ Beppu Hosp, Dept Cardiovasc Resp & Geriatr Med, Beppu, Oita 8740838, Japan	Maeda, T (reprint author), Kyushu Univ Beppu Hosp, Dept Cardiovasc Resp & Geriatr Med, Tsurumihara 4546, Beppu, Oita 8740838, Japan.	maedat@beppu.kyushu-u.ac.jp			National Natural. Science Fund (NSFC) [81170329/H2501]; Health and Labour Sciences Research Grants Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus; Ministry of Education, Science, and Culture of Japan [23590885]	This work was supported by grants from the National Natural. Science Fund (NSFC) (81170329/H2501), and 2012 Health and Labour Sciences Research Grants Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus, and the Ministry of Education, Science, and Culture of Japan (#23590885).	Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; Hug A, 2003, J IMMUNOL, V171, P432; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601; DELANGE T, 1990, MOL CELL BIOL, V10, P518; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Vladimirova O, 1999, INFLAMM RES, V48, P412, DOI 10.1007/s000110050480; Greco A, 2000, NEUROCHEM RES, V25, P1357, DOI 10.1023/A:1007608615682; Besler HT, 2003, NUTR NEUROSCI, V6, P189, DOI 10.1080/1028415031000115945; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; LeVine SM, 1998, FREE RADICAL BIO MED, V25, P33, DOI 10.1016/S0891-5849(98)00019-7; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, ppe43, DOI [DOI 10.1126/SAGEKE.2004.51.PE43, 10.1126/sageke.2004.51.pe43]; Bassett C N, 2003, J Nutr Health Aging, V7, P24; Dandona P, 2004, METAB SYNDR RELAT D, V2, P155, DOI 10.1089/met.2004.2.155; Ferretti G, 2005, MULT SCLER, V11, P677, DOI 10.1192/1352458505ms1240oa; Greco A, 1999, NEUROLOGY, V53, P1876; LEVINE SM, 1992, MED HYPOTHESES, V39, P271, DOI 10.1016/0306-9877(92)90121-R; NAIDOO R, 1992, CLIN CHEM, V38, P2449; NEWCOMBE J, 1994, NEUROPATH APPL NEURO, V20, P152, DOI 10.1111/j.1365-2990.1994.tb01174.x; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Rokach J, 1997, PROSTAG OTH LIPID M, V54, P823, DOI 10.1016/S0090-6980(97)00183-4	26	5	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	FEB	2015	400	1-2					183	187		10.1007/s11010-014-2274-1		5	Cell Biology	Cell Biology	AY4EE	WOS:000347530100019		
J	Sakai, H; Matsuura, K; Tanaka, Y; Honda, T; Nishida, T; Inui, M				Sakai, Hiroki; Matsuura, Kenji; Tanaka, Yoshie; Honda, Takeshi; Nishida, Teruo; Inui, Makoto			Signaling Mechanism Underlying the Promotion of Keratinocyte Migration by Angiotensin II	MOLECULAR PHARMACOLOGY			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; EGF RECEPTOR TRANSACTIVATION; AT(2) RECEPTORS; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; CARDIAC FIBROBLASTS; MESANGIAL CELLS; IN-VITRO; HB-EGF	Re-epithelialization begins early during skin wound healing and is regulated by various growth factors and cytokines. Angiotensin II promotes the migration of keratinocytes and thereby contributes to wound healing. We investigated the mechanism by which angiotensin II stimulates human keratinocyte migration. Angiotensin II-induced keratinocyte migration was inhibited by an angiotensin II type 1 receptor (AT(1)R) antagonist (candesartan) or an angiotensin II type 2 receptor (AT(2)R) antagonist (PD123319) as well as by depletion of AT(1)R or AT(2)R. A biased agonist for AT(1)R, [Sar(1), Ile(4), Ile(8)] angiotensin II, induced cell migration, whereas depletion of beta-arrestin2 inhibited angiotensin II-induced migration. Angiotensin II-induced migration was blocked by neutralizing antibodies to transforming growth factor-beta (TGF-beta) as well as by the TGF-beta receptor inhibitor SB431542. The amount of TGF-beta 1 was increased in the culture medium of angiotensin II-treated cells, and this effect was inhibited by candesartan or PD123319. Both angiotensin II-and TGF-beta-induced cell migration were inhibited by neutralizing antibodies to the epidermal growth factor (EGF) receptor but not by those to EGF receptor ligands. Angiotensin II-induced phosphorylation of the EGF receptor, and this effect was inhibited by candesartan, PD123319, SB431542, or depletion of beta-arrestin2, but not by neutralizing antibodies to heparin-binding EGF-like growth factor. Our results indicate that beta-arrestin-dependent signaling downstream of AT(1)R as well as AT(2)R signaling are necessary for angiotensin II-induced keratinocyte migration, and that such signaling promotes generation of the active form of TGF-beta, consequent activation of the TGF-beta receptor, and trans-activation of the EGF receptor by the TGF-beta receptor.	[Sakai, Hiroki; Matsuura, Kenji; Tanaka, Yoshie; Honda, Takeshi; Inui, Makoto] Yamaguchi Univ, Grad Sch Med, Dept Pharmacol, Ube, Yamaguchi 7558505, Japan; [Nishida, Teruo] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 7558505, Japan	Inui, M (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Pharmacol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	minui@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [25670128]; Yamaguchi University Research Project on Stress; Yamada Research Foundation	This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science [Grant #25670128], by a Yamaguchi University Research Project on Stress, and by a grant from Yamada Research Foundation.	Vinals F, 2001, MOL CELL BIOL, V21, P7218, DOI 10.1128/MCB.21.21.7218-7230.2001; AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; DUBEY RK, 1995, J CLIN INVEST, V96, P141, DOI 10.1172/JCI118014; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Campbell SE, 1997, J MOL CELL CARDIOL, V29, P1947, DOI 10.1006/jmcc.1997.0435; FISHER SA, 1995, AM J PHYSIOL-CELL PH, V268, pC910; Miura S, 1999, J HYPERTENS, V17, P397, DOI 10.1097/00004872-199917030-00013; Kurosaka M, 2009, BIOMED PHARMACOTHER, V63, P627, DOI 10.1016/j.biopha.2009.01.001; Kohno M, 1997, HYPERTENSION, V29, P1309; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Joo CK, 2008, ONCOGENE, V27, P614, DOI 10.1038/sj.onc.1210649; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002; Steckelings UM, 2004, EXP DERMATOL, V13, P148, DOI 10.1111/j.0906-6705.2004.0139.x; Yahata Y, 2006, J BIOL CHEM, V281, P13209, DOI 10.1074/jbc.M509771200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Ebi M, 2010, BIOCHEM BIOPH RES CO, V402, P449, DOI 10.1016/j.bbrc.2010.09.130; Takeda H, 2004, AM J PATHOL, V165, P1653, DOI 10.1016/S0002-9440(10)63422-0; WOLF G, 1993, J CLIN INVEST, V92, P1366, DOI 10.1172/JCI116710; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Steckelings UM, 2005, BRIT J DERMATOL, V153, P887, DOI 10.1111/j.1365-2133.2005.06806.x; VISWANATHAN M, 1992, PEPTIDES, V13, P783, DOI 10.1016/0196-9781(92)90187-8; Kintscher U, 2001, HYPERTENSION, V37, P587; Liu GB, 1997, ARTERIOSCL THROM VAS, V17, P1251; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; Chen JC, 2006, J AM SOC NEPHROL, V17, P1615, DOI 10.1681/ASN.2005111163; Dubey RK, 1998, INVEST OPHTH VIS SCI, V39, P2067; Ito J, 2011, BIOCHEM BIOPH RES CO, V412, P109, DOI 10.1016/j.bbrc.2011.07.054; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; KOIBUCHI Y, 1993, HYPERTENSION, V21, P1046; Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009; Louis S, 2011, AM J PHYSIOL-HEART C, V301, pH746, DOI 10.1152/ajpheart.00431.2010; Matsuura K, 2007, EUR J PHARMACOL, V563, P83, DOI 10.1016/j.ejphar.2007.02.014; Rodgers Kathleen, 1997, Wound Repair and Regeneration, V5, P175, DOI 10.1046/j.1524-475X.1997.50210.x; Simard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080532; Tang HT, 2009, BIOCHEM BIOPH RES CO, V385, P418, DOI 10.1016/j.bbrc.2009.05.081; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x	40	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	FEB	2015	87	2					277	285		10.1124/mol.114.096461		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY8NY	WOS:000347811600013		
J	Wada, E; Koyanagi, S; Kusunose, N; Akamine, T; Masui, H; Hashimoto, H; Matsunaga, N; Ohdo, S				Wada, Erika; Koyanagi, Satoru; Kusunose, Naoki; Akamine, Takahiro; Masui, Hiroaki; Hashimoto, Hana; Matsunaga, Naoya; Ohdo, Shigehiro			Modulation of Peroxisome Proliferator-Activated Receptor-alpha Activity by Bile Acids Causes Circadian Changes in the Intestinal Expression of Octn1/Slc22a4 in Mice	MOLECULAR PHARMACOLOGY			English	Article							ORGANIC CATION TRANSPORTER; PPAR-ALPHA; GENE-EXPRESSION; MOUSE-LIVER; CLOCK GENE; TRANSCRIPTION; REVEALS; FAMILY; TISSUE; CHRONOPHARMACOLOGY	In addition to their digestive actions, bile acids modulate gene expression by altering the activity of peroxisome proliferator-activated receptor-alpha (PPAR alpha). The modulatory effects of bile acids have been shown to affect the expression of genes responsible for lipid metabolism as well as membrane transporters. Bile acids are secreted in response to food intake and accumulate in intestinal epithelial cells. In the present study, we identified soluble carrier protein family 22 member 4 (Slc22a4), encoding organic cation transporter novel type-1 (Octn1), as a PPAR alpha-regulated gene and its intestinal expression exhibited circadian oscillations in a bile acid-dependent manner. Nocturnally active mice mainly consumed their food around the early dark phase, during which bile acids accumulated in intestinal epithelial cells. PPAR alpha activated the intestinal expression of Slc22a4 mRNA during the light period, and protein levels of Octn1 peaked before the start of the dark phase. The bile acids that accumulated in intestinal epithelial cells suppressed the PPAR alpha-mediated transactivation of Slc22a4 in the dark phase. The time-dependent suppression of PPAR alpha-mediated transactivation by bile acids regulated oscillations in the intestinal expression of Octn1/Slc22a4 during the daily feeding cycle. The results of a pharmacokinetic analysis also revealed that oscillations in the expression of Octn1 caused dosing time-dependent differences in the intestinal absorption of gabapentin (2-[1-(aminomethyl)cyclohexyl]acetic acid). These results suggest a molecular clock-independent mechanism by which bile acid-regulated PPAR alpha activity governs the circadian expression of intestinal organic cation transporters. This mechanism could also account for interindividual variations in the pharmacokinetics of drugs that are substrates of Octn1.	[Wada, Erika; Koyanagi, Satoru; Kusunose, Naoki; Akamine, Takahiro; Masui, Hiroaki; Hashimoto, Hana; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Dept Pharmaceut, Fac Pharmaceut Sci, Fukuoka 8128582, Japan	Ohdo, S (reprint author), Kyushu Univ, Dept Pharmaceut, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-ac.jp			Japan for the Promotion of Science [25136716, 25253038, 25670079, 26670317]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas [Grant 25136716] (to S.O.); a Grant-in-Aid for Scientific Research (A) [Grant 25253038] (to S.O.); and Grants-in-Aid for Challenging Exploratory Research [Grant 25670079] (to S.O.) and [Grant 26670317] (to S.K.) from the Japan for the Promotion of Science.	Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Hamdan AM, 2012, J BIOL CHEM, V287, P17224, DOI 10.1074/jbc.M111.333377; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Urban TJ, 2008, CLIN PHARMACOL THER, V83, P416, DOI 10.1038/sj.clpt.6100271; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Stearns AT, 2008, J PHARMACOL SCI, V108, P144, DOI 10.1254/jphs.08100SC; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; Hrushesky WJM, 2001, J CONTROL RELEASE, V74, P27, DOI 10.1016/S0168-3659(01)00307-8; Levi F, 1996, PATHOL BIOL, V44, P631; Lis Christopher G, 2003, Integr Cancer Ther, V2, P105, DOI 10.1177/1534735403002002002; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Ohdo S, 2007, DRUG METAB PHARMACOK, V22, P3, DOI 10.2133/dmpk.22.3; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Okamura A, 2014, J BIOL CHEM, V289, P25296, DOI 10.1074/jbc.M114.577023; Ripperger JA, 2000, GENE DEV, V14, P679; Ritskes-Hoitinga M., 2004, LAB MOUSE, P463, DOI 10.1016/B978-012336425-8/50081-9; Sinal CJ, 2001, J BIOL CHEM, V276, P47154, DOI 10.1074/jbc.M107000200; Tsuji A, 1996, PHARM RES-DORDR, V13, P963, DOI 10.1023/A:1016086003070; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	38	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	FEB	2015	87	2					314	322		10.1124/mol.114.094979		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY8NY	WOS:000347811600017		
J	Agbayani, B; Golston, C; Ishii, T				Agbayani, Brian; Golston, Chris; Ishii, Toru			Syntactic and prosodic scrambling in Japanese	NATURAL LANGUAGE & LINGUISTIC THEORY			English	Article						Japanese; Scrambling; Prosodic movement; Syntax-phonology interface; Prosodic phrasing	MOVEMENT	This paper presents evidence that Japanese has prosodic scrambling of phonological phrases (I center dot) in addition to the well-studied syntactic scrambling of XPs. All cases of scrambling in Japanese involve fronting constituents, be they syntactic XPs or phonological I center dot s. If the syntax cannot move XPs, the phonology is forced to move their prosodic equivalents: these I center dot s are fronted to the left edge of the intonational phrase (E (c)) that contains them and join to make a single recursive I center dot, the domain for tonal downstep (It and Mester 2012, 2013). Syntactic scrambling 'bleeds' prosodic scrambling, adding support for a uni-directional, feed-forward model of syntax-phonology interactions. Syntactic scrambling fronts XPs and obeys syntactic conditions on movement, and the scrambled XP exhibits interpretive effects in its surface position. Prosodic scrambling fronts I center dot s and is blind to syntactic conditions on movement, and the scrambled I center dot s are interpreted in situ, as expected.	[Agbayani, Brian; Golston, Chris] Calif State Univ Fresno, Fresno, CA 93740 USA; [Ishii, Toru] Meiji Univ, Tokyo 101, Japan	Agbayani, B (reprint author), Calif State Univ Fresno, Fresno, CA 93740 USA.	bagbayan@csufresno.edu					Agbayani B, 2010, LANGUAGE, V86, P133; Kratzer A, 2007, LINGUIST REV, V24, P93, DOI 10.1515/TLR.2007.005; Ito J, 2013, LINGUA, V124, P20, DOI 10.1016/j.lingua.2012.08.016; Sauerland U, 2002, LINGUIST INQ, V33, P283, DOI 10.1162/002438902317406722; Takano Y, 2002, J EAST ASIAN LINGUIS, V11, P243, DOI 10.1023/A:1016011311546; FUKUI N, 1993, LINGUIST INQ, V24, P399; Miyagawa S, 1997, LINGUIST INQ, V28, P1; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; Saito M, 2003, LINGUA, V113, P481, DOI 10.1016/S0024-3841(02)00083-9; Cheng LLS, 2009, LINGUIST REV, V26, P207, DOI 10.1515/tlir.2009.008; Ishihara S, 2007, LINGUIST REV, V24, P137, DOI 10.1515/TLR.2007.006; Boeckx Cedric, 1999, WCCFL, V18, P43; Chen Matthew, 1987, PHONOLOGY YB, V4, P109; Chomsky N., 2001, K HALE LIFE LANGUAGE, P1; Chomsky Noam, 1995, MINIMALIST PROGRAM; Chomsky Noam, 1993, VIEW BUILDING, V20, P1; Deguchi Masanori, 2002, NELS, V32.1, P73; Dobashi Yoshihito, 2003, THESIS CORNELL U; Fox Danny, 2000, EC SEMANTIC INTERPRE; FUKUI N, 2006, THEORETICAL COMPARAT, V13, P289; Fukui Naoki, 2004, LINGUISTIC VARIATION, V4, P109, DOI 10.1075/livy.4.04fuk; Golston Chris, 1995, PHONOLOGY, V21, P325; Golston Chris, 2011, W COAST C FORM LING, V28, P231; Harada Shin-ichi, 1977, GENGO, V6, P96; Harada S.-I., 1977, GENGO, V6, P88; Harford Carolyn, 1999, LINGUISTIC ANAL, V29, P47; Hayashishita J.-R., 2000, WCCFL, V19, P204; Hayes Bruce, 1989, RHYTHM METER, V1, P201; Hiraiwa K, 2010, SYNTAX-UK, V13, P133, DOI 10.1111/j.1467-9612.2009.00135.x; Hirotani Masako, 2005, U MASSACHUSETTS OCCA, P53; Hoji H, 2003, LINGUA, V113, P377, DOI 10.1016/S0024-3841(02)00081-5; Hoji Hajime, 2006, THEORETICAL EMPIRICA, P126; Inkelas Sharon, 1989, THESIS STANFORD U; Inoue Kazuko, 1978, NIHINGO BUNPOO KISOK; Ishihara Shinichiro, 2002, WCCFL, V21, P180; Ishihara Shinichiro, 2001, WORKING PAPERS LINGU, P142; Ito J, 2012, PROSODY MATTERS ESSA, P280; Kahnemuyipour Arsalan, 2009, SYNTAX SENTENTIAL ST; Koizumi M., 2000, J EAST ASIAN LINGUIS, V9, P227; Kubozono Haruo, 1988, THESIS U EDINBURGH T; Kuroda S.-Y., 1970, B RES I LOGOPEDICS P, V4, P127; Ladd D. R., 1986, PHONOLOGY YB, V3, P311, DOI [10.1017/S0952675700000671, DOI 10.1017/S0952675700000671]; Ladd D. Robert, 1992, OCCASIONAL PAPER; Lebeaux David, 1988, THESIS U MASSACHUSET; Lehmann Winfred, 1978, SYNTACTIC TYPOLOGY S, P57; Mahajan Anoop, 1990, THESIS MIT; Marantz Alec, 1988, THEORETICAL MORPHOLO, P253; Martin Samuel E., 1952, MORPHOPHONEMICS STAN; McCarthy John J., 1993, 3 RUTG CTR COGN SCI; MCCARTHY JOHN J., 1993, YB MORPHOLOGY, V1993, P79; McCawley James D., 1968, PHONOLOGICAL COMPONE; Miyagawa S, 2005, STUD GENERAT GRAMM, V69, P181; Miyagawa Shigeru, 2008, OPTIONALITY UNPUB; Miyagawa Shigeru, 2006, KOREAN ASS LANGIAGE, P3; Nespor M, 1986, PROSODIC PHONOLOGY; Nespor Marina, 1982, STRUCTURE PHONOLOGIC, P225; Nishigauchi Taisuke, 2002, GENGO KENKYU, V121, P49; Pak Marjorie, 2008, THESIS U PENNSYLVANI; Pesetsky David, 1989, THESIS MIT; Pierrehumbert Jane, 1988, LINGUISTIC INQUIRY M, V15; Poser William J., 1984, THESIS MIT; Richards N, 2010, LINGUIST INQ MONOGR, V56, P1; Ross, 1967, THESIS MIT; SAITO M, 1992, J EAST ASIAN LINGUIS, V1, P69, DOI 10.1007/BF00129574; SAITO M, 1989, ALTERNATIVE CONCEPTIONS OF PHRASE STRUCTURE, P182; Saito Mamuro, 1985, THESIS MIT; Selkirk E., 1986, PHONOLOGY YB, V3, P371, DOI DOI 10.1017/S0952675700000695; Selkirk Elisabeth, 1988, CLS 24, P316; Selkirk Elizabeth, 1995, U MASSACHUSETTS OCCA, V18, P439; Selkirk Elizabeth, 1991, INTERDISCIPLINARY AP, P519; Szendroi Kriszta, 2001, THESIS U COLLEGE LON; Tada Hiroaki, 1993, THESIS MIT; TAKAHASHI D, 1993, NAT LANG LINGUIST TH, V11, P655, DOI 10.1007/BF00993016; Teliga Viktoriia, 2011, THESIS CALIFORNIA ST; Tokizaki Hisao, 2006, THESIS U TSUKUBA; Uechi Akihiko, 1998, THESIS U BRIT COLUMB; Ueyama Ayumi, 1999, ANAPHORA REFER UNPUB, P23; van Gelderen Veronique, 2003, THESIS LEIDEN U; van Riemsdijk H., 1981, LINGUISTIC REV, V1, P171, DOI 10.1515/tlir.1981.1.2.171; ZEC D, 1990, PHONOLOGY-SYNTAX CONNECTION, P365; Zwicky Arnold, 1986, OHIO STATE U WORKING, V32, P92; Zwicky Arnold, 1986, OHIO STATE U WORKING, V32, P63	82	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-806X	1573-0859		NAT LANG LINGUIST TH	Nat. Lang. Linguist. Theory	FEB	2015	33	1					47	77		10.1007/s11049-014-9252-x		31	Linguistics; Language & Linguistics	Linguistics	AY4EA	WOS:000347529700002		
J	Ono, M; Yasuda, S; Shiono, Y; Furusawa, C; Inaba, S; Tanaka, T; Ikeda, T; Nohara, T				Ono, Masateru; Yasuda, Shin; Shiono, Yuki; Furusawa, Chisato; Inaba, Shinya; Tanaka, Takayuki; Ikeda, Tsuyoshi; Nohara, Toshihiro			A new hemiterpene glycoside from the ripe tomatoes	NATURAL PRODUCT RESEARCH			English	Article						Lycopersicon esculentum; tomato; Solanaceae; hemiterpene glycoside; radical-scavenging effect	STEROIDAL ALKALOID GLYCOSIDES; CHERRY TOMATO; ESCULEOSIDE; FRUITS; CONSTITUENTS; SAPONIN; LEAVES; SHIFTS; PLANTS	[GRAPHICS] A new hemiterpene glycoside (1) was isolated from ripe tomatoes (the fruit of Lycopersicon esculentum, Solanaceae) along with eight known compounds. The chemical structure of 1 was determined to be 2-methylbutan-1-ol beta-d-glucopyranosyl-(1 -> 6)-beta-d-glucopyranoside, based on spectroscopic data as well as chemical evidence. In addition, the radical-scavenging activities of the isolated compounds on the free radical of 1,1-diphenyl-2-picrylhydrazyl were examined. Among the tested compounds, tryptophan, 4-O-beta-d-glucopyranosyl caffeic acid and dihydro-p-coumaryl alcohol gamma-O-beta-d-glucopyranoside demonstrated 42.0%, 50.1% and 76.0% scavenging activities, respectively, at a concentration of 0.5mM.	[Ono, Masateru; Yasuda, Shin; Shiono, Yuki; Furusawa, Chisato; Inaba, Shinya; Tanaka, Takayuki] Tokai Univ, Sch Agr, Kumamoto 8691404, Japan; [Ikeda, Tsuyoshi; Nohara, Toshihiro] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto, Japan	Ono, M (reprint author), Tokai Univ, Sch Agr, Minamiaso 5435, Kumamoto 8691404, Japan.	mono@agri.u-tokai.ac.jp			JSPS KAKENHI from the Japan Society for the Promotion of Science [19590030, 24590022]; Tokai University Educational System General Research Organisation (Kanagawa, Japan)	This research was supported in part by a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI [grant numbers 19590030], [grant number 24590022]) from the Japan Society for the Promotion of Science. A part of this work was also supported by the Research and Study Project of Tokai University Educational System General Research Organisation (Kanagawa, Japan).	Yoshikawa M, 1997, CHEM PHARM BULL, V45, P464; Ikeda T, 2003, BIOL PHARM BULL, V26, P1198, DOI 10.1248/bpb.26.1198; Fujiwara Y, 2004, TETRAHEDRON, V60, P4915, DOI 10.1016/j.tet.2004.03.088; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; SEO S, 1978, J AM CHEM SOC, V100, P3331, DOI 10.1021/ja00479a014; Nohara T, 2010, J NAT PROD, V73, P1734, DOI 10.1021/np100311t; Fujiwara Y, 2003, CHEM PHARM BULL, V51, P234, DOI 10.1248/cpb.51.234; CUI CB, 1990, CHEM PHARM BULL, V38, P3218; Fujiwara Y, 2005, CHEM PHARM BULL, V53, P584, DOI 10.1248/cpb.53.584; HIGUCHI R, 1977, PHYTOCHEMISTRY, V16, P1007, DOI 10.1016/S0031-9422(00)86711-4; KASAI R, 1977, TETRAHEDRON LETT, P175; Ohno M, 2011, CHEM PHARM BULL, V59, P1403, DOI 10.1248/cpb.59.1403; Ono M, 2006, CHEM PHARM BULL, V54, P237, DOI 10.1248/cpb.54.237; Ono M, 2008, CHEM PHARM BULL, V56, P1499, DOI 10.1248/cpb.56.1499; Ono M, 2010, J NAT MED-TOKYO, V64, P500, DOI 10.1007/s11418-010-0436-3; Selenge E, 2013, J NAT MED-TOKYO, V67, P867, DOI 10.1007/s11418-013-0748-1; Tung HT, 2009, CHEM PHARM BULL, V57, P65; Zhou X, 2006, ZHONGCAOYAO, V37, P1618	18	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-6419	1478-6427		NAT PROD RES	Nat. Prod. Res.	FEB 1	2015	29	3					262	267		10.1080/14786419.2014.974053		6	Chemistry, Applied; Chemistry, Medicinal	Chemistry; Pharmacology & Pharmacy	AW9OE	WOS:000346586100009		
J	Garcia-Munoz, M; Lopez-Huerta, VG; Carrillo-Reid, L; Arbuthnott, GW				Garcia-Munoz, Marianela; Lopez-Huerta, Violeta G.; Carrillo-Reid, Luis; Arbuthnott, Gordon W.			Extrasynaptic glutamate NMDA receptors: Key players in striatal function	NEUROPHARMACOLOGY			English	Article						Memantine; Up-down states; Network; MEA	MEMBRANE-POTENTIAL FLUCTUATIONS; NEOSTRIATAL PROJECTION NEURONS; FAST-SPIKING INTERNEURONS; CA1 PYRAMIDAL NEURONS; D-ASPARTATE RECEPTORS; CELL ASSEMBLIES; IN-VIVO; ASTROCYTIC GLUTAMATE; VOLUME TRANSMISSION; HUNTINGTONS-DISEASE	N-methyl-D-aspartate receptors (NMDAR) are crucial for the function of excitatory neurotransmission and are present at the synapse and on the extrasynaptic membrane. The major nucleus of the basal ganglia, striatum, receives a large glutamatergic excitatory input carrying information about movements and associated sensory stimulation for its proper function. Such bombardment of glutamate synaptic release results in a large extracellular concentration of glutamate that can overcome the neuronal and glial uptake homeostatic systems therefore allowing the stimulation of extrasynaptic glutamate receptors. Here we have studied the participation of their extrasynaptic type in cortically evoked responses or in the presence of NMDARs stimulation. We report that extrasynaptic NMDAR blocker memantine, reduced in a dose-dependent manner cortically induced NMDA excitatory currents in striatal neurons (recorded in zero-Mg++ plus DNQX 10 mu M). Moreover, memantine (2-4 mu M) significantly reduced the NMDAR-dependent membrane potential oscillations called up and down states. Recordings of neuronal striatal networks with a fluorescent calcium indicator or with multielectrode arrays (MEA) also showed that memantine reduced in a dose-dependent manner, NMDA-induced excitatory currents and network behavior. We used multielectrode arrays (MEA) to grow segregated cortical and striatal neurons. Once synaptic contacts were developed (>21DIV) recordings of extracellular activity confirmed the cortical drive of spontaneous synchronous discharges in both compartments. After severing connections between compartments, active striatal neurons in the presence of memantine (1 mu M) and CNQX (10 mu M) were predominantly fast spiking interneurons (PSI). The significance of extrasynaptic receptors in the regulation of striatal function and neuronal network activity is evident. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).	[Garcia-Munoz, Marianela; Lopez-Huerta, Violeta G.; Carrillo-Reid, Luis; Arbuthnott, Gordon W.] Grad Univ, Okinawa Inst Sci & Technol, Brain Mech Behav Unit, Kunigami, Okinawa 9040412, Japan; [Carrillo-Reid, Luis] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Arbuthnott, GW (reprint author), Grad Univ, Okinawa Inst Sci & Technol, 1919-1 Tancha, Kunigami, Okinawa 9040412, Japan.	marianela@oist.jp; violeta@oist.jp; lc2998@columbia.edu; gordon@oist.jp	Arbuthnott, Gordon/A-4606-2015; Lopez Huerta, Violeta/G-3370-2015	Arbuthnott, Gordon/0000-0002-3386-8362; Lopez Huerta, Violeta/0000-0003-1906-3557	Okinawa Institute of Science and Technology Graduate University, Japan	This research was supported by the Okinawa Institute of Science and Technology Graduate University, Japan.	Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Goubard V, 2011, J PHYSIOL-LONDON, V589, P2301, DOI 10.1113/jphysiol.2010.203125; Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.050799; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Zoli M, 1996, PROG NEUROBIOL, V49, P363, DOI 10.1016/0301-0082(96)00020-2; Volman V, 2005, PHYS BIOL, V2, P98, DOI 10.1088/1478-3975/2/2/003; Chalifoux JR, 2011, J NEUROSCI, V31, P16435, DOI 10.1523/JNEUROSCI.2777-11.2011; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Koralek AC, 2013, NEURON, V79, P865, DOI 10.1016/j.neuron.2013.06.047; Lopez-Huerta VG, 2013, J NEUROSCI, V33, P4964, DOI 10.1523/JNEUROSCI.4721-12.2013; Koos T, 1999, NAT NEUROSCI, V2, P467; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Beatty JA, 2012, J NEUROPHYSIOL, V108, P771, DOI 10.1152/jn.00283.2012; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; Kaufman AM, 2012, J NEUROSCI, V32, P3992, DOI 10.1523/JNEUROSCI.4129-11.2012; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; Antic SD, 2010, J NEUROSCI RES, V88, P2991, DOI 10.1002/jnr.22444; Kreuz T, 2007, J NEUROSCI METH, V165, P151, DOI 10.1016/j.jneumeth.2007.05.031; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Sykova E, 2005, J NEURAL TRANSM, V112, P137, DOI 10.1007/s00702-004-0120-4; HAMMING RW, 1950, AT&T TECH J, V29, P147; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Carmignoto G, 2006, J PHYSIOLOGY-PARIS, V99, P98, DOI 10.1016/j.jphysparis.2005.12.008; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686; Plotkin JL, 2011, NAT NEUROSCI, V14, P881, DOI 10.1038/nn.2848; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Oda Y, 2014, EUR J NEUROSCI, V39, P1613, DOI 10.1111/ejn.12555; Schock SC, 2010, HISTOCHEM CELL BIOL, V134, P1, DOI 10.1007/s00418-010-0707-9; Morelli A, 2006, BIOSYSTEMS, V86, P100, DOI 10.1016/j.biosystems.2006.03.011; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; Parthasarathy HB, 1997, J NEUROSCI, V17, P2477; Bracci E, 2003, J PHYSIOL-LONDON, V549, P121, DOI 10.1113/jphysiol.2003.040857; Vicini S, 1998, J NEUROPHYSIOL, V79, P555; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Beggs JM, 2003, J NEUROSCI, V23, P11167; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Blackwell KT, 2003, J NEUROSCI, V23, P9123; Carrillo-Reid L, 2009, J NEUROPHYSIOL, V101, P737, DOI 10.1152/jn.90975.2008; Carrillo-Reid L, 2008, J NEUROPHYSIOL, V99, P1435, DOI 10.1152/jn.01131.2007; Carrillo-Reid L, 2011, J NEUROSCI, V31, P14972, DOI 10.1523/JNEUROSCI.3226-11.2011; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Hebb D., 1949, ORG BEHAV NEUROPSYCH; HERRLING PL, 1983, J PHYSIOL-LONDON, V339, P207; Jaidar O, 2010, J NEUROSCI, V30, P11326, DOI 10.1523/JNEUROSCI.1380-10.2010; Kohr G, 2007, J PHYSIOL-LONDON, V584, P367, DOI 10.1113/jphysiol.2007.144865; Levine MS, 2010, NEURON, V65, P145, DOI 10.1016/j.neuron.2010.01.010; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; Mitchell CS, 2007, J NEURAL ENG, V4, P276, DOI 10.1088/1741-2560/4/3/013; Oikonomou KD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00334; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1046/j.1460-9568.2003.03074.x; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Pomata PE, 2008, J NEUROSCI, V28, P13384, DOI 10.1523/JNEUROSCI.4343-08.2008; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Shi LH, 2004, EXP BRAIN RES, V157, P303, DOI 10.1007/s00221-004-1844-y; Strang G., 2009, INTRO LINEAR ALGEBRA; Suzuki T, 2008, EUR J NEUROSCI, V28, P521, DOI 10.1111/j.1460-9568.2008.06324.x; Wagenaar Daniel A, 2006, J Negat Results Biomed, V5, P16, DOI 10.1186/1477-5751-5-16; WILSON CJ, 1986, BRAIN RES, V367, P201, DOI 10.1016/0006-8993(86)91593-3	90	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	FEB	2015	89						54	63		10.1016/j.neuropharm.2014.09.013		10	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	AY5FE	WOS:000347597600006		
J	Yin, J; Sha, S; Chen, TT; Wang, CH; Hong, J; Jie, PH; Zhou, R; Li, L; Sokabe, M; Chen, L				Yin, Jun; Sha, Sha; Chen, Tingting; Wang, Conghui; Hong, Juan; Jie, Pinghui; Zhou, Rong; Li, Lin; Sokabe, Masahiro; Chen, Ling			Sigma-1 (sigma(1)) receptor deficiency reduces beta-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B	NEUROPHARMACOLOGY			English	Article						Alzheimer's disease (AD); Sigma-1 receptor (sigma R-1); Apoptosis; Spatial memory; beta-Amyloid (A beta); N-methyl-D-aspartate receptor (NMDAr)	ALZHEIMERS-DISEASE; PROTEIN-KINASE; DENTATE GYRUS; TYROSINE PHOSPHORYLATION; DEPRESSIVE-LIKE; BINDING-SITES; KNOCKOUT MICE; ACTIVATION; OLIGOMERS; NEUROPROTECTION	In early Alzheimer's disease (AD) brain, reduction of sigma-1 receptors (sigma R-1) is detected. In this study, we employed male heterozygous siR knockout (sigma R-1(+/-)) mice showing normal cognitive performance to investigate association of sigma R-1 deficiency with AD risk. Herein we report that a single injection (i.c.v.) of A beta(25-35) impaired spatial memory with approximately 25% death of pyramidal cells in the hippocampal CA1 region of WT mice (A beta(25-35)-WT mice), whereas it did not cause such impairments in sigma R-1(+/-) mice (A beta(25-35)-sigma R-1(+/-) mice). Compared with WT mice, A beta(25-35)-WT mice showed increased levels of NMDA-activated currents (INNIDA) and NR2B phosphorylation (phospho-NR2B) in the hippocampal CA1 region at 48 h after A beta(25-35)-injection (post-A beta(25-35)) followed by approximately 40% decline at 72 h post-A beta(-)(25-35) of their respective control levels, which was inhibited by the sigma R-1 antagonist NE100. In A beta 25-35WT mice, the administration of NR2B inhibitor Ro25-6981 or NE100 on day 1-4 post-A beta(25-35) attenuated the memory deficits and loss of pyramidal cells. By contrast, A beta(25-35)-sigma R-1(+/-) mice showed a slight increase in the INmDA density and the phosPho-NR2B at 48 h or 72 h post-AA beta 25-35 compared to sigma R-1(+/-) mice. Treatment with o-iR agonist PRE084 in A beta(25-35)-sigma R-1(+/-) mice caused the same changes in the I-NMDA density and the phospho-NR2B as those in A beta(25-35)-WT mice. Furthermore, A beta(25-35)-siR I- mice treated with the NMDA receptor agonist NMDA or PRE084 on day 1-4 post-A beta(25-35) showed a loss of neuronal cells and memory impairment. These results indicate that the aiR deficiency can reduce A beta(25-35)-induced neuronal cell death and cognitive deficits through suppressing A beta 25-35-enhanced NR2B phosphorylation. (C) 2014 Elsevier Ltd. All rights reserved.	[Yin, Jun; Sha, Sha; Chen, Ling] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yin, Jun; Sha, Sha; Chen, Tingting; Wang, Conghui; Hong, Juan; Jie, Pinghui; Zhou, Rong; Li, Lin; Chen, Ling] Nanjing Med Univ, Dept Physiol, Nanjing 210029, Jiangsu, Peoples R China; [Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Mech Lab, Nagoya, Aichi 4668550, Japan	Chen, L (reprint author), Nanjing Med Univ, Dept Physiol, Hanzhong Rd 140, Nanjing, Jiangsu, Peoples R China.	lingchen@njmu.edu.cn			National 973 Basic Research Program of China [2014CB943303]; National Natural Science Foundation of China [81071027, 31171440, 81361120247]; Graduate Students Scientific Research Innovation Project of Jiangsu Province [CXZZ13_0571]	We thank Dr. Zorrilla (Neurosciences Graduate Program, University of California) for providing us the sigma-1 receptor knockout mice. This work was supported by grants for National 973 Basic Research Program of China (2014CB943303); National Natural Science Foundation of China (81071027; 31171440; 81361120247) to Chen L and Graduate Students Scientific Research Innovation Project of Jiangsu Province (CXZZ13_0571) to Sha S.	Zemek F, 2014, EXPERT OPIN DRUG SAF, V13, P759, DOI 10.1517/14740338.2014.914168; Feher A, 2012, NEUROSCI LETT, V517, P136, DOI 10.1016/j.neulet.2012.04.046; Ramachandran S, 2009, EUR J PHARMACOL, V609, P19, DOI 10.1016/j.ejphar.2009.03.003; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x; Li LA, 2010, NEUROPHARMACOLOGY, V59, P323, DOI 10.1016/j.neuropharm.2010.02.009; BURDICK D, 1992, J BIOL CHEM, V267, P546; Chevallier N, 2011, J PSYCHOPHARMACOL, V25, P960, DOI 10.1177/0269881111400648; Grosshans DR, 2001, J NEUROCHEM, V76, P737, DOI 10.1046/j.1471-4159.2001.00034.x; Tackenberg C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.129; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; Francardo V, 2014, BRAIN, V137, P1998, DOI 10.1093/brain/awu107; Olivares D, 2012, CURR ALZHEIMER RES, V9, P746; Kaminsky YG, 2010, EXP NEUROL, V221, P26, DOI 10.1016/j.expneurol.2009.09.005; Sabino V, 2009, BEHAV BRAIN RES, V198, P472, DOI 10.1016/j.bbr.2008.11.036; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Li Z, 2009, J CEREBR BLOOD F MET, V29, P287, DOI 10.1038/jcbfm.2008.118; Miyatake R, 2004, BIOL PSYCHIAT, V55, P85, DOI 10.1016/j.biopsych.2003.07.008; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; Mishina M, 2008, ANN NUCL MED, V22, P151, DOI 10.1007/s12149-007-0094-z; Maurice T, 2001, BRAIN RES REV, V37, P116, DOI 10.1016/S0165-0173(01)00112-6; Chen L, 2007, J NEUROPHYSIOL, V98, P1538, DOI 10.1152/jn.01151.2006; Ronicke R, 2011, NEUROBIOL AGING, V32, P2219, DOI 10.1016/j.neurobiolaging.2010.01.011; Yang R, 2012, NEUROPHARMACOLOGY, V63, P1042, DOI 10.1016/j.neuropharm.2012.07.035; Noh MY, 2013, J NEUROCHEM, V127, P562, DOI 10.1111/jnc.12319; Kubo T, 2002, J NEUROSCI RES, V70, P474, DOI 10.1002/jnr.10391; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Zhang L, 2013, PROG NEURO-PSYCHOPH, V40, P12, DOI 10.1016/j.pnpbp.2012.08.017; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Sha S, 2013, CNS NEUROSCI THER, V19, P705, DOI 10.1111/cns.12129; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Huang Y, 2011, CURR ALZHEIMER RES, V8, P765; Hyrskyluoto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.170; JANSEN KLR, 1993, BRAIN RES, V623, P299, DOI 10.1016/0006-8993(93)91441-T; Maruszak A, 2007, DEMENT GERIATR COGN, V23, P432, DOI 10.1159/000101990; Maurice T, 1998, NEUROSCIENCE, V83, P413; Monnet FP, 2006, J PHARMACOL SCI, V100, P93, DOI 10.1254/jphs.CR0050032; Monnet FP, 2003, J PHARMACOL EXP THER, V307, P705, DOI 10.1124/jpet.103.053447; Nuwayhid SJ, 2003, J PHARMACOL EXP THER, V304, P364, DOI 10.1124/jpet.102.043398; Urn J. W., 2012, NAT NEUROSCI, V15, P1227; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O	44	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	FEB	2015	89						215	224		10.1016/j.neuropharm.2014.09.027		10	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	AY5FE	WOS:000347597600021		
J	Mochizuki, Y; Harada, H; Ikuta, M; Shimamoto, H; Tomioka, H; Tanaka, K; Hirai, H; Omura, K				Mochizuki, Yumi; Harada, Hiroyuki; Ikuta, Minoru; Shimamoto, Hiroaki; Tomioka, Hirofumi; Tanaka, Kae; Hirai, Hideaki; Omura, Ken			Clinical characteristics of multiple primary carcinomas of the oral cavity	ORAL ONCOLOGY			English	Article						Multiple primary carcinomas; Oral cavity; Survival rate; The cumulative incidence rate; Squamous cell carcinoma	SQUAMOUS-CELL CARCINOMA; 2ND PRIMARY TUMORS; PROLIFERATIVE VERRUCOUS LEUKOPLAKIA; NECK-CANCER PATIENTS; LARYNGEAL CARCINOMA; DIAGNOSTIC-CRITERIA; HEAD; SURVIVAL; NEOPLASMS; ADJACENT	Objectives: This study aimed to clarify the clinical characteristics of multiple primary carcinomas of the oral cavity. Materials and methods: We retrospectively reviewed the cases of 1015 patients who were treated during follow up for oral cancer at Tokyo Medical and Dental University between March 2001 and December 2012. We compared the clinical characteristics of 961 patients who developed single primary oral squamous cell carcinoma (SCC) during follow up and 54 patients who subsequently developed multiple primary carcinomas in the oral cavity. Results: Mean age at first diagnosis was significantly higher in patients with multiple primary carcinomas than single primary carcinoma. Multiple primary carcinomas showed a female predilection, were most prevalent in the gingiva, and tended to show earlier tumor and nodal stages than single primary carcinoma. The local recurrence rate was higher for multiple primary carcinomas than single primary carcinoma, and it increased with the number of multiple primary occurrences. The disease-specific survival rate at 10 years for patients with single primary carcinoma was 85.3% and that for patients with multiple primary carcinomas was 79.6%. The cumulative incidence rate for metachronous second multiple primary carcinomas after the onset of first carcinoma at 10 years was 8.0%. The recurrence of multiple primary carcinomas did not decrease the survival rate. Conclusion: Differences were found in the clinical characteristics between patients with single oral SCC and those with multiple primary oral carcinomas. Early diagnosis and treatment as well as close long-term follow up are needed for patients with multiple primary oral carcinomas. (C) 2014 Elsevier Ltd. All rights reserved.	[Mochizuki, Yumi; Harada, Hiroyuki; Ikuta, Minoru; Shimamoto, Hiroaki; Tomioka, Hirofumi; Tanaka, Kae; Hirai, Hideaki; Omura, Ken] Tokyo Med & Dent Univ, Grad Sch, Dept Oral & Maxillofacial Surg, Bunkyo Ku, Tokyo 1138549, Japan	Harada, H (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Oral & Maxillofacial Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	hiro-harada.osur@tmd.ac.jp					Kresty LA, 2008, CANCER EPIDEM BIOMAR, V17, P3179, DOI 10.1158/1055-9965.EPI-08-0574; [Anonymous], 2002, ACTA OTO-LARYNGOL; Thomson PJ, 2002, INT J ORAL MAX SURG, V31, P262, DOI 10.1054/ijom.2002.0220; HANSEN LS, 1985, ORAL SURG ORAL MED O, V60, P285, DOI 10.1016/0030-4220(85)90313-5; Qaisi M, 2014, J ORAL MAXIL SURG, V72, P1511, DOI 10.1016/j.joms.2014.03.012; van Houten VMM, 2004, CLIN CANCER RES, V10, P3614, DOI 10.1158/1078-0432.CCR-03-0631; Gonzalez-Garcia R, 2009, HEAD NECK-J SCI SPEC, V31, P1168, DOI 10.1002/hed.21088; DEVRIES N, 1986, INT J ORAL MAX SURG, V15, P85; Gabriel C, 2007, PHYS MED BIOL, V52, P4205, DOI 10.1088/0031-9155/52/14/012; Leon X, 2002, ACTA OTO-LARYNGOL, V122, P765, DOI 10.1080/003655402/000028048; Tabor MP, 2001, CLIN CANCER RES, V7, P1523; SCHWARTZ LH, 1994, CANCER, V74, P1933, DOI 10.1002/1097-0142(19941001)74:7<1933::AID-CNCR2820740718>3.0.CO;2-X; Petersen PE, 2005, COMMUNITY DENT ORAL, V33, P397, DOI 10.1111/j.1600-0528.2005.00251.x; Bagan JV, 2004, ORAL ONCOL, V40, P440, DOI 10.1016/j.oraloncology.2003.10.008; NG SKC, 1993, J NATL CANCER I, V85, P743, DOI 10.1093/jnci/85.9.743; Boudewijns M, 2003, CLIN MICROBIOL INFEC, V9, P222, DOI 10.1046/j.1469-0691.2003.00503.x; BOYSEN M, 1993, ACTA ONCOL, V32, P283, DOI 10.3109/02841869309093596; Cankovic M, 2013, J CANCER RES THER, V9, P240, DOI 10.4103/0973-1482.113365; CANNON CR, 1994, LARYNGOSCOPE, V104, P1, DOI 10.1288/00005537-199411001-00001; Carrard VC, 2013, MED ORAL PATOL ORAL, V18, pE411, DOI 10.4317/medoral.18912; Cerero-Lapiedra R, 2010, MED ORAL PATOL ORAL, V15, pE839, DOI 10.4317/medoral.15.e839; Cianfriglia F, 1999, ORAL ONCOL, V35, P157, DOI 10.1016/S1368-8375(98)00105-5; Esposito EDAVE, 2000, J SURG ONCOL, V74, P83, DOI 10.1002/1096-9098(200005)74:1<83::AID-JSO18>3.0.CO;2-Q; Fushimi Y, 2008, AJNR Am J Neuroradiol, V29, pE56, DOI 10.3174/ajnr.A1074; Hashibe M, 2005, CANCER LETT, V220, P185, DOI 10.1016/j.canlet.2004.10.023; Höckel Michael, 2005, Cancer Res, V65, P2997; Hsu SH, 2013, HEAD NECK-J SCI SPEC, V35, P1801, DOI 10.1002/hed.23242; Izumo T, 2012, JPN J CLIN ONCOL, V42, P1099, DOI 10.1093/jjco/hys141; JONES AS, 1995, CANCER, V75, P1343, DOI 10.1002/1097-0142(19950315)75:6<1343::AID-CNCR2820750617>3.0.CO;2-T; JOVANOVIC A, 1994, INT J CANCER, V56, P320, DOI 10.1002/ijc.2910560304; Kramer Franz-Josef, 2004, Clin Oral Investig, V8, P56; Lai WM, 2013, OR SURG OR MED OR PA, V116, P464, DOI 10.1016/j.oooo.2013.06.018; Liao CT, 2007, ORAL ONCOL, V43, P811, DOI 10.1016/j.oraloncology.2006.10.003; Nikolaou AC, 2000, LARYNGOSCOPE, V110, P58, DOI 10.1097/00005537-200001000-00012; REGUEIRO CA, 1994, EUR J CANCER, V30A, P2060, DOI 10.1016/0959-8049(94)00348-9; Rennemo E, 2008, LARYNGOSCOPE, V118, P1350, DOI 10.1097/MLG.0b013e318172ef9a; SHIKHANI AH, 1986, ARCH OTOLARYNGOL, V112, P1172; Shimamoto H, 2012, TOUKEIBUGAN, V38, P1; SLAUGHTER DP, 1946, SURGERY, V20, P133; Warren S, 1932, AM J CANCER, V16, P1358; Wiseman SM, 2003, ANN SURG ONCOL, V10, P551, DOI 10.1245/ASO.2003.09.010; WRIGHT A, 1985, J ORAL PATHOL MED, V14, P559, DOI 10.1111/j.1600-0714.1985.tb00529.x	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1368-8375	1879-0593		ORAL ONCOL	Oral Oncol.	FEB	2015	51	2					182	189		10.1016/j.oraloncology.2014.11.013		8	Oncology; Dentistry, Oral Surgery & Medicine	Oncology; Dentistry, Oral Surgery & Medicine	AY9XU	WOS:000347901800017		
J	Ariji, Y; Goto, M; Fukano, H; Sugita, Y; Izumi, M; Ariji, E				Ariji, Yoshiko; Goto, Mitsuo; Fukano, Hideo; Sugita, Yoshihiko; Izumi, Masahiro; Ariji, Eiichiro			Role of intraoral color Doppler sonography in predicting delayed cervical lymph node metastasis in patients with early-stage tongue cancer: a pilot study	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; ORAL TONGUE; TUMOR THICKNESS; PROGNOSTIC-FACTORS; INVASIVE FRONT; NECK METASTASIS; LINGUAL ARTERY; ULTRASONOGRAPHY; FLOOR; MICROVASCULATURE	Objective. To clarify the intraoral color Doppler sonographic features of tongue cancer in relation to cervical lymph node metastasis. Study Design. Thirty-one patients (24 men and 7 women; 32-87 years old; median 60.6 years) with T1-2 N0 squamous cell carcinoma of the tongue were enrolled. Preoperative clinical information and sonographic findings were collected. Patients were followed up for 2 years or more, and the presence of delayed lymph node metastasis was investigated. Significant clinical and sonographic factors were evaluated in relation to lymph node metastasis. Results. Significant differences in maximum and minimum tumor size, clinical type, tumor depth and thickness, shape of the invading front of the tumor, vascular index (VI) of the tumor area, and asymmetry of the VI of the deep lingual artery were observed between patients with cervical lymph node metastasis and those without. The areas under the curve (AUCs) of tumor thickness and the VI of the tumor area were 0.861 and 0.909, respectively, on receiver operating characteristic (ROC) curve analysis for predicting lymph node metastasis. The AUC for the VI showed a slightly higher value, although the difference was not significant (P = .532). Conclusions. Intraoral color Doppler sonography is recommended, as it may identify predictive factors of cervical lymph node metastasis.	[Ariji, Yoshiko; Izumi, Masahiro; Ariji, Eiichiro] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Nagoya, Aichi 4648651, Japan; [Goto, Mitsuo] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Chikusa Ku, Nagoya, Aichi 4648651, Japan; [Fukano, Hideo] Aichi Gakuin Univ, Sch Dent, Dept Maxillofacial Surg, Nagoya, Aichi 4648651, Japan; [Sugita, Yoshihiko] Aichi Gakuin Univ, Sch Dent, Dept Oral Pathol, Nagoya, Aichi 4648651, Japan	Ariji, Y (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chikusa Ku, 2-11 Suemori Dori, Nagoya, Aichi 4648651, Japan.	Yoshiko@dpc.agu.ac.jp					Amaral TMP, 2004, ORAL ONCOL, V40, P780, DOI 10.1016/j.oraloncology.2003.10.009; Byers RM, 1998, HEAD NECK-J SCI SPEC, V20, P138, DOI 10.1002/(SICI)1097-0347(199803)20:2<138::AID-HED7>3.0.CO;2-3; Taylor SM, 2010, ORAL ONCOL, V46, P38, DOI 10.1016/j.oraloncology.2009.10.005; Fukano H, 1997, HEAD NECK-J SCI SPEC, V19, P205, DOI 10.1002/(SICI)1097-0347(199705)19:3<205::AID-HED7>3.0.CO;2-6; O'Brien CJ, 2003, HEAD NECK-J SCI SPEC, V25, P937, DOI 10.1002/hed.10324; Kurokawa H, 2002, HEAD NECK-J SCI SPEC, V24, P731, DOI 10.1002/hed.10130; Lim SC, 2004, CLIN CANCER RES, V10, P166, DOI 10.1158/1078-0432.CCR-0533-3; Hayashi T, 2001, DENTOMAXILLOFAC RAD, V30, P242, DOI 10.1038/sj.dmfr.4600615; Alam F, 2008, AM J ROENTGENOL, V191, P604, DOI 10.2214/AJR.07.3401; Goto M, 2005, ORAL ONCOL, V41, P62, DOI 10.1016/j.oraloncology.2004.06.007; Al-Rajhi N, 2000, ORAL ONCOL, V36, P508, DOI 10.1016/S1368-8375(00)00042-7; Ariji Y, 1998, AM J NEURORADIOL, V19, P303; Kantola S, 2000, BRIT J CANCER, V83, P614, DOI 10.1054/bjoc.2000.1323; Shintani S, 1997, AM J SURG, V173, P345, DOI 10.1016/S0002-9610(96)00395-9; Okada Y, 2010, ODONTOLOGY, V98, P153, DOI 10.1007/s10266-010-0131-6; Kaneoya A, 2009, J ORAL MAXIL SURG, V67, P40, DOI 10.1016/j.joms.2007.08.006; Kawano K, 2006, HEAD NECK-J SCI SPEC, V28, P525, DOI 10.1002/hed.20349; Keski-Santti H, 2006, ORAL ONCOL, V42, P96, DOI 10.1016/j.oraloncology.2005.06.018; O-charoenrat P, 2003, ORAL ONCOL, V39, P386, DOI 10.1016/S1368-8375(02)00142-2; Dumitriu D, 2011, AM J ROENTGENOL, V197, pW924, DOI 10.2214/AJR.11.6529; Homze EJ, 1997, ORAL SURG ORAL MED O, V83, P321, DOI 10.1016/S1079-2104(97)90236-5; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; Ariji Y, 2013, OR SURG OR MED OR PA, V116, P354, DOI 10.1016/j.oooo.2013.05.017; Chikui T, 2004, EUR J RADIOL, V52, P246, DOI 10.1016/j.ejrad.2004.01.012; Eshghyar N, 2011, ARCH IRAN MED, V14, P276, DOI 0011144/AIM.0010; Furusawa J, 2008, ORAL ONCOL, V44, P793, DOI 10.1016/j.oraloncology.2007.10.004; Genden EM, 2003, ORAL ONCOL, V39, P207, DOI 10.1016/S1368-8375(02)00049-0; Hannen EJM, 2002, HEAD NECK-J SCI SPEC, V24, P643, DOI 10.1002/hed.10100; Helbig M, 2001, HEAD NECK-J SCI SPEC, V23, P233, DOI 10.1002/1097-0347(200103)23:3<233::AID-HED1024>3.0.CO;2-P; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Karakida Kazunari, 2002, Tokai J Exp Clin Med, V27, P65; Kimura Y, 2001, ACTA RADIOL, V42, P306; Kurokawa H, 2005, J ORAL PATHOL MED, V34, P329, DOI 10.1111/j.1600-0714.2005.00244.x; Okamoto M, 2002, J ORAL PATHOL MED, V31, P227, DOI 10.1034/j.1600-0714.2002.310406.x; Yuen APW, 2002, HEAD NECK-J SCI SPEC, V24, P513, DOI 10.1002/hed.10094; Shintani S, 2001, INT J ORAL MAX SURG, V30, P139, DOI 10.1054/ijom.2000.0035; Shpitzer T, 1996, ARCH OTOLARYNGOL, V122, P865; Songra AK, 2006, INT J ORAL MAX SURG, V35, P324, DOI 10.1016/j.ijom.2005.07.019; Takano JH, 2010, INT J ORAL MAX SURG, V39, P208, DOI 10.1016/j.ijom.2010.01.007; Woolgar JA, 1999, BRIT J ORAL MAX SURG, V37, P187, DOI 10.1054/bjom.1999.0034; Yamane M, 2007, HEAD NECK-J SCI SPEC, V29, P307, DOI 10.1002/hed.20523	41	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	FEB	2015	119	2					246	253		10.1016/j.oooo.2014.10.021		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY9EE	WOS:000347851800020		
J	Takai, Y; Yamamoto-Mitani, N; Kawakami, S; Abe, Y; Kamiyama, M; Saito, S				Takai, Yukari; Yamamoto-Mitani, Noriko; Kawakami, Saori; Abe, Yoshiki; Kamiyama, Manami; Saito, Shigeru			Differences between Nurses' and Care Workers' Estimations of Pain Prevalence among Older Residents	PAIN MANAGEMENT NURSING			English	Article							NURSING-HOME RESIDENTS; DEMENTIA; FACILITIES; VERSION; SCALE	A high prevalence of pain and difficulties with pain assessment has been widely reported among residents of long-term-care facilities. We explored nurses' and care workers' estimations of residents' pain (both general and chronic) and the number of residents with unknown pain status. We also examined the relationship between the prevalence of pain and assessment strategies undertaken by nurses and care workers. A cross-sectional design was used. Nurses and care workers across 750 long-term care facilities in four Japanese prefectures were asked to participate. Questionnaires were administered to one nurse and care worker at each facility. The questionnaires assessed the estimated numbers of residents who had pain in general, chronic pain, or unknown pain status on the day of data collection, and pain assessment strategies use by the health care professionals. In all, 263 (17.5%) questionnaires were returned from 147 nurses (55.9%) and 116 care workers (44.1%). The nurses' and care workers' median estimations of pain and chronic pain prevalence among residents were 11.6 and 9.4 and 29.4 and 15.5, respectively (p <. 001). Estimations of pain prevalence were significantly higher among nurses who had observed signs of pain among residents in the previous month (p = .04) and who applied a multidisciplinary approach to pain assessment and management (p = .007) than among nurses who did not do either. Nurses and care workers had relatively low estimations of the prevalence of pain among their residents. Staff should undertake appropriate and sufficient pain assessments in order to improve their understanding of residents' pain. (C) 2015 by the American Society for Pain Management Nursing	[Takai, Yukari; Yamamoto-Mitani, Noriko] Univ Tokyo, Grad Sch Med, Dept Adult Nursing Palliat Care Nursing, Tokyo 1130033, Japan; [Kawakami, Saori; Saito, Shigeru] Gunma Univ Hosp, Fac Med, Maebashi, Gumma, Japan; [Abe, Yoshiki] Univ Tsukuba, Sch Nursing, Tsukuba, Ibaraki, Japan; [Kamiyama, Manami] Gunma Univ Hosp, Grad Sch Hlth Sci, Maebashi, Gumma, Japan	Takai, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Adult Nursing Palliat Care Nursing, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	takaiyukari-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [23593428]	This research was funded by a Grant-in-Aid for Scientific Research (23593428) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The authors state they have no known conflicts of interest.	Abbey Jennifer, 2004, Int J Palliat Nurs, V10, P6; AGS Panel on Persistent Pain in Older Persons, 2002, J AM GERIATR SOC, V50, P205; Akamine I., 2002, J OKINAWA PREFECTURA, V3, P25; McAuliffe L, 2009, J ADV NURS, V65, P2, DOI 10.1111/j.1365-2648.2008.04861.x; Leong IYO, 2007, CLIN J PAIN, V23, P119, DOI 10.1097/01.ajp.0000210951.01503.3b; Boerlage AA, 2008, EUR J PAIN, V12, P910, DOI 10.1016/j.ejpain.2007.12.014; van Herk R, 2009, PAIN MANAG NURS, V10, P32, DOI 10.1016/j.pmn.2008.06.003; Kaasalainen S, 2007, J GERONTOL NURS, V33, P6; Won AB, 2004, J AM GERIATR SOC, V52, P867, DOI 10.1111/j.1532-5415.2004.52251.x; Zwakhalen SMG, 2009, EUR J PAIN, V13, P89, DOI 10.1016/j.ejpain.2008.02.009; Auret KA, 2008, J AM GERIATR SOC, V56, P301, DOI 10.1111/j.1532-5415.2007.01546.x; British Pain Society and British Geriatrics Society, 2007, ASS PAIN OLD PEOPL 2; Cadogan MP, 2008, J GERONTOL A-BIOL, V63, P969; Gariglio F., 2007, ARCH GERONTOL GERIAT, V47, P121; Gold G., 2006, GERIATRICS AGING, V9, P399; Hadjistavropoulos T, 2007, CLIN J PAIN, V23, pS1, DOI 10.1097/AJP.0b013e31802be869; Hadjistavropoulos T, 2010, PHYSIOTHER CAN, V62, P104, DOI 10.3138/physio.62.2.104; Institute for Clinical Systems Improvement, 2011, HLTH CAR GUID ASS MA; International Association for the Study of Pain, 2011, IASP TAX; Kasai K., 2001, J NURS SOC TOYAMA ME, V4, P13; Ko A., 2013, GERIATR GERONTOL INT, V14, P481; Mentes Janet C, 2004, Pain Manag Nurs, V5, P118, DOI 10.1016/j.pmn.2004.01.001; Ministry of Health Labour and Welfare, 2009, HEIS 19 NEN KAIG SA; Anzai Saori, 2012, Nihon Ronen Igakkai Zasshi, V49, P234; Smalbrugge Martin, 2007, BMC Geriatr, V7, P3, DOI 10.1186/1471-2318-7-3; Takai Yukari, 2013, Pain Manag Nurs, V14, pe1, DOI 10.1016/j.pmn.2011.01.005; Takai Y, 2010, GERIATR GERONTOL INT, V10, P145, DOI 10.1111/j.1447-0594.2009.00568.x; Takai Y, 2009, JPN J NURS SCI, V6, P111, DOI 10.1111/j.1742-7924.2009.00129.x; Welfare and Medical Service Agency, 2011, KAIG ROUJ HOK SIS KE; Wheeler Mary S, 2006, Home Healthc Nurse, V24, P354, DOI 10.1097/00004045-200606000-00003; Takemura Yukie, 2002, Nurs Health Sci, V4, P73, DOI 10.1046/j.1442-2018.2002.00107.x; Takai Yukari, 2013, Pain Manag Nurs, V14, pe59, DOI 10.1016/j.pmn.2011.04.004; Young JL, 2006, J ADV NURS, V53, P412	33	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1524-9042	1532-8635		PAIN MANAG NURS	Pain Manag. Nurs.	FEB	2015	16	1					20	32		10.1016/j.pmn.2014.03.005		13	Nursing	Nursing	AY9ZI	WOS:000347905800005		
J	Nagaya, K; Tsuchida, E; Nohara, F; Okamoto, T; Azuma, H				Nagaya, Ken; Tsuchida, Etsushi; Nohara, Fumikatsu; Okamoto, Toshio; Azuma, Hiroshi			The Temperature Change in an Endotracheal Tube During High Frequency Ventilation Using an Artificial Neonatal Lung Model With Babylog (R) 8000 Plus	PEDIATRIC PULMONOLOGY			English	Article						humidity; high-frequency ventilation; neonate; preterm infant; heated wire humidification; endotracheal tube	NECROTIZING TRACHEOBRONCHITIS; GAS TEMPERATURE; JET VENTILATION; HUMIDIFICATION; HUMIDITY; AIRWAY; WIRE	ObjectiveThere is little available data on airway humidity during high-frequency ventilation (HFV). The purpose of this study is to evaluate the temperature drop in an endotracheal tube (ETT) during HFV. MethodsWe examined the airway temperature in a neonatal HFV system using Babylog (R) 8000 plus. We measured the temperature change of inspired gases in the ETT under various oscillatory frequencies and oscillatory volumes with a fixed base flow. The temperatures in the ETT during HFV were compared with the temperatures during conventional intermittent positive pressure ventilation (IPPV). ResultsAs the oscillatory frequency was increased and the oscillatory volume (VThf) decreased, the difference in temperature between the Y piece and the inlet of an artificial lung in the ETT (ETT outside of body) increased. However, as the oscillatory frequency increased, there was no difference in the ETT temperature under constant oscillatory volume. In contrast, as the oscillatory volume was decreased, the difference in temperature in the ETT was greater under constant oscillatory frequency. Moreover, the temperature drop in the ETT with HFV was lower than that in the IPPV temperature with a similar respiratory volume. ConclusionsThe temperature change in the ETT was not dependent on the oscillatory frequency when the oscillatory volume was fixed; however, the temperature was dependent on the oscillatory volume when the oscillatory frequency was fixed. Pediatr Pulmonol. 2015; 50:173-178. (c) 2013 Wiley Periodicals, Inc.	[Nagaya, Ken; Tsuchida, Etsushi; Nohara, Fumikatsu; Okamoto, Toshio; Azuma, Hiroshi] Asahikawa Med Coll, Ctr Matern & Infant Care, Asahikawa, Hokkaido 0788510, Japan	Nagaya, K (reprint author), Asahikawa Med Coll, Ctr Matern & Infant Care, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	nagaya5p@asahikawa-med.ac.jp					Ryan SN, 2002, CRIT CARE MED, V30, P355, DOI 10.1097/00003246-200202000-00015; BOROS SJ, 1986, J PEDIATR-US, V109, P95, DOI 10.1016/S0022-3476(86)80585-6; CIRCEO LE, 1991, CHEST, V100, P268, DOI 10.1378/chest.100.1.268; Kilgour E, 2004, INTENS CARE MED, V30, P1491, DOI 10.1007/s00134-004-2235-3; LOMHOLT N, 1968, BRIT J ANAESTH, V40, P335, DOI 10.1093/bja/40.5.335; METLAY LA, 1983, NEW ENGL J MED, V309, P111; MIYAO H, 1992, CRIT CARE MED, V20, P674, DOI 10.1097/00003246-199205000-00021; Nagaya K, 2009, PEDIATR PULM, V44, P260, DOI 10.1002/ppul.20990; OPHOVEN JP, 1984, CRIT CARE MED, V12, P829, DOI 10.1097/00003246-198409000-00035; Schulze A, 2007, CLIN PERINATOL, V34, P19, DOI 10.1016/j.clp.2006.12.009; TARNOWMORDI WO, 1989, J PEDIATR-US, V114, P438, DOI 10.1016/S0022-3476(89)80567-0; Yamada Y, 2008, PEDIATR PULM, V43, P666, DOI 10.1002/ppul.20836	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-6863	1099-0496		PEDIATR PULM	Pediatr. Pulmonol.	FEB	2015	50	2					173	178		10.1002/ppul.22973		6	Pediatrics; Respiratory System	Pediatrics; Respiratory System	AY9MT	WOS:000347875900010		
J	Sakuma, K; Aoi, W; Yamaguchi, A				Sakuma, Kunihiro; Aoi, Wataru; Yamaguchi, Akihiko			Current understanding of sarcopenia: possible candidates modulating muscle mass	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Review						Skeletal muscle; Sarcopenia; Serum response factor; Autophagy; Myostatin	SERUM RESPONSE FACTOR; GROWTH-FACTOR-I; FACTOR-KAPPA-B; RING FINGER 1; UBIQUITIN-PROTEASOME PATHWAY; MYOGENIN PROTEIN EXPRESSION; SENESCENT SKELETAL-MUSCLE; FOCAL ADHESION KINASE; AGE-RELATED-CHANGES; AGING-RELATED LOSS	The world's elderly population is expanding rapidly, and we are now faced with the significant challenge of maintaining or improving physical activity, independence, and quality of life in the elderly. Sarcopenia, the age-related loss of skeletal muscle mass, is characterized by a deterioration of muscle quantity and quality leading to a gradual slowing of movement, a decline in strength and power, increased risk of fall-related injury, and often, frailty. Since sarcopenia is largely attributed to various molecular mediators affecting fiber size, mitochondrial homeostasis, and apoptosis, the mechanisms responsible for these deleterious changes present numerous therapeutic targets for drug discovery. Muscle loss has been linked with several proteolytic systems, including the ubuiquitin-proteasome, lysosome-autophagy, and tumor necrosis factor (TNF)-alpha/nuclear factor-kappaB (NF-kappa B) systems. Although many factors are considered to regulate age-dependent muscle loss, this gentle atrophy is not affected by factors known to enhance rapid atrophy (denervation, hindlimb suspension, etc.). In addition, defects in Akt-mammalian target of rapamycin (mTOR) and serum response factor (SRF)-dependent signaling have been found in sarcopenic muscle. Intriguingly, more recent studies indicated an apparent functional defect in autophagy- and myostatin-dependent signaling in sarcopenic muscle. In this review, we summarize the current understanding of the adaptation of many regulators in sarcopenia.	[Sakuma, Kunihiro] Toyohashi Univ Technol, Res Ctr Phys Fitness Sports & Hlth, Toyohashi, Aichi 4418580, Japan; [Aoi, Wataru] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Lab Hlth Sci, Sakyo Ku, Kyoto 6068522, Japan; [Yamaguchi, Akihiko] Hlth Sci Univ Hokkaido, Dept Phys Therapy, Ishikari, Hokkaido 0610293, Japan	Sakuma, K (reprint author), Toyohashi Univ Technol, Res Ctr Phys Fitness Sports & Hlth, 1-1 Hibarigaoka,Tenpaku Cho, Toyohashi, Aichi 4418580, Japan.	ksakuma@las.tut.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23500778]	This work was supported by a research Grant-in-Aid for Scientific Research C (No. 23500778) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Sakuma K, 2012, J CACHEXIA SARCOPENI, V3, P77, DOI 10.1007/s13539-011-0052-4; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Combaret L, 2009, CURR OPIN CLIN NUTR, V12, P37, DOI 10.1097/MCO.0b013e32831b9c31; Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; STARON RS, 1991, J APPL PHYSIOL, V70, P631; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Sakamoto K, 2002, J BIOL CHEM, V277, P11910, DOI 10.1074/jbc.M112410200; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Dodd SL, 2009, FASEB J, V23, P3415, DOI 10.1096/fj.08-124602; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Clavel S, 2006, MECH AGEING DEV, V127, P794, DOI 10.1016/j.mad.2006.07.005; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Cuervo AM, 2005, AUTOPHAGY, V1, P131; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Haddad F, 2006, J APPL PHYSIOL, V100, P1188, DOI 10.1152/japplphysiol.01227.2005; Kumar A, 2004, J MOL MED-JMM, V82, P434, DOI 10.1007/s00109-004-0555-y; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x; Kwak KS, 2004, CANCER RES, V64, P8193, DOI 10.1158/0008-5472.CAN-04-2102; McKay BR, 2012, FASEB J, V26, P2509, DOI 10.1096/fj.11-198663; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Allen DL, 2011, MED SCI SPORT EXER, V43, P1828, DOI 10.1249/MSS.0b013e3182178bb4; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bossola M, 2008, BIOGERONTOLOGY, V9, P261, DOI 10.1007/s10522-008-9135-9; Sakuma K, 2003, HISTOCHEM CELL BIOL, V119, P149, DOI 10.1007/s00418-003-0499-2; Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; Gaugler M, 2011, J APPL PHYSIOL, V111, P192, DOI 10.1152/japplphysiol.00175.2011; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109; Thomson DM, 2006, J PHYSIOL-LONDON, V574, P291, DOI 10.1113/jphysiol.2006.107490; Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509; Jogo M, 2009, FEBS LETT, V583, P2715, DOI 10.1016/j.febslet.2009.07.033; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Zhou JB, 2013, J CLIN INVEST, V123, P1821, DOI 10.1172/JCI64398; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Ratkevicius A, 2011, J GERONTOL A-BIOL, V66, P620, DOI 10.1093/gerona/glr025; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1171/JCI28721; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; McMullen CA, 2009, EXP GERONTOL, V44, P420, DOI 10.1016/j.exger.2009.03.006; Gan BY, 2006, J BIOL CHEM, V281, P37321, DOI 10.1074/jbc.M605241200; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Dedkov EI, 2003, CELL TISSUE RES, V311, P401, DOI 10.1007/s00441-002-0686-9; Wilkes EA, 2009, AM J CLIN NUTR, V90, P1343, DOI 10.3945/ajcn.2009.27543; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Dube J, 2006, CURR OPIN CLIN NUTR, V9, P553; Rieu I, 2009, J PHYSIOL-LONDON, V587, P5483, DOI 10.1113/jphysiol.2009.178319; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Bowser M, 2013, EXP GERONTOL, V48, P290, DOI 10.1016/j.exger.2012.11.004; Sandri M, 2010, AM J PHYSIOL-CELL PH, V298, pC1291, DOI 10.1152/ajpcell.00531.2009; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; Park C, 2013, CELL BIOCHEM BIOPHYS, V67, P3, DOI 10.1007/s12013-013-9623-7; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Deschenes MR, 2010, EXP GERONTOL, V45, P389, DOI 10.1016/j.exger.2010.03.007; Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; ROSENHEIMER JL, 1990, INT J DEV NEUROSCI, V8, P643, DOI 10.1016/0736-5748(90)90059-B; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Cong HL, 2011, HUM GENE THER, V22, P313, DOI 10.1089/hum.2010.057; LeBrasseur NK, 2012, DIABETOLOGIA, V55, P13, DOI 10.1007/s00125-011-2361-8; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lokireddy S, 2012, AM J PHYSIOL-CELL PH, V303, pC512, DOI 10.1152/ajpcell.00402.2011; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Bamman MM, 2004, J APPL PHYSIOL, V97, P1329, DOI 10.1152/japplphysiol.01387.2003; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Hyatt JPK, 2003, AM J PHYSIOL-CELL PH, V285, pC1161, DOI 10.1152/ajpcell.00128.2003; Arvat E, 2000, DRUG AGING, V16, P29, DOI 10.2165/00002512-200016010-00003; Butterfield GE, 1997, AM J PHYSIOL-ENDOC M, V272, pE94; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Wehling M, 2000, FASEB J, V14, P103; Joulia-Ekaza D, 2007, CURR OPIN PHARMACOL, V7, P310, DOI 10.1016/j.coph.2006.11.011; Melton LJ, 2000, J AM GERIATR SOC, V48, P625; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; TREISMAN R, 1987, EMBO J, V6, P2711; Donati A, 2001, J GERONTOL A-BIOL, V56, pB288; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Lamon S, 2009, J PHYSIOL-LONDON, V587, P1795, DOI 10.1113/jphysiol.2009.168674; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; FURUNO K, 1990, J BIOL CHEM, V265, P8550; Sakuma K, 2008, BBA-MOL BASIS DIS, V1782, P453, DOI 10.1016/j.bbadis.2008.03.008; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Gordon SE, 2001, J APPL PHYSIOL, V90, P1174; Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; Evans WJ, 2010, BIOGERONTOLOGY, V11, P527, DOI 10.1007/s10522-010-9297-0; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Edstrom E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x; Charvet C, 2006, MOL CELL BIOL, V26, P6664, DOI 10.1128/MCB.00138-06; Vainshtein A, 2014, J MOL MED, V92, P127, DOI 10.1007/s00109-013-1096-z; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Dodd S, 2009, BIOGERONTOLOGY, V10, P605, DOI 10.1007/s10522-008-9203-1; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JC131240; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Sandri M, 2011, CURR OPIN CLIN NUTR, V14, P223, DOI 10.1097/MCO.0b013e3283457a75; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; DeRuisseau KC, 2005, EXP GERONTOL, V40, P526, DOI 10.1016/j.exger.2005.04.005; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Edstrom E, 2006, J GERONTOL A-BIOL, V61, P663; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.253496100; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Parkington JD, 2004, J APPL PHYSIOL, V97, P243, DOI 10.1152/japplphysiol.01383.2003; Candow DG, 2005, J GERONTOL A-BIOL, V60, P148; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Aoi Wataru, 2011, Curr Aging Sci, V4, P101; Arnold HH, 1996, INT J DEV BIOL, V40, P345; Bar-Shai M, 2005, MECH AGEING DEV, V126, P289, DOI 10.1016/j.mad.2004.08.030; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Cao PR, 2005, INT J BIOCHEM CELL B, V37, P2088, DOI 10.1016/j.biocel.2004.11.010; Coffey Vernon G, 2006, FASEB J, V20, P190; DARDEVET D, 1994, ENDOCRINOLOGY, V134, P1475, DOI 10.1210/en.134.3.1475; Fernandez-Celemin L, 2002, AM J PHYSIOL-ENDOC M, V283, pE1279, DOI 10.1152/ajpendo.00054.2002; Funai K, 2006, AM J PHYSIOL-REG I, V290, pR1080, DOI 10.1152/ajpregu.00277.2005; GauthierRouviere C, 1996, MOL BIOL CELL, V7, P719; Hasselgren PO, 2007, J CELL PHYSIOL, V213, P679, DOI 10.1002/jcp.21190; Hornberger TA, 2003, J NUTR, V133, P3091; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kawabuchi M, 2011, AGEING RES REV, V10, P43, DOI 10.1016/j.arr.2010.10.003; Kimball SR, 2004, AM J PHYSIOL-ENDOC M, V287, pE772, DOI 10.1152/ajpendo.00535.2003; Kostrominova TY, 2000, AM J PHYSIOL-REG I, V279, pR179; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lahoute C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003910; LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91; Lexell, 1995, J GERONTOL A-BIOL, V50, P11; Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Ogata T, 2008, MECH AGEING DEV, V130, P328; Rahnert JA, 2011, EXP GERONTOL, V46, P282, DOI 10.1016/j.exger.2010.11.004; Sakuma K, 2013, FRONT PATHOL GENET, V1, P1; Sakuma K, 2012, RECENT RES DEV LIFE, P13; Sakuma Kunihiro, 2010, Curr Aging Sci, V3, P90; Sakuma K, 2011, CELL AGING, P93; Sakuma K, 2012, SKELETAL MUSCLE PHYS, P141; Sakuma K, 2011, RECENT PAT REGEN MED, V1, P284; Sakuma K, 2009, ACTA PHYSIOL, V197, P151, DOI 10.1111/j.1748-1716.2009.01995.x; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Siu PM, 2006, J APPL PHYSIOL, V100, P907, DOI 10.1152/japplphysiol.01012.2005; SMITH DO, 1987, J NEUROCHEM, V48, P1834, DOI 10.1111/j.1471-4159.1987.tb05744.x; Thomas MM, 2010, AM J PHYSIOL-REG I, V298, pR1269, DOI 10.1152/ajpregu.00663.2009; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; White TA, 2014, GERONTOLOGY IN PRESS; Yarasheski K E, 2002, J Nutr Health Aging, V6, P343	188	9	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	FEB	2015	467	2					213	229		10.1007/s00424-014-1527-x		17	Physiology	Physiology	AY8YA	WOS:000347835400002		
J	Xie, Y; Ding, WG; Matsuura, H				Xie, Yu; Ding, Wei-Guang; Matsuura, Hiroshi			Ca2+/calmodulin potentiates I (Ks) in sinoatrial node cells by activating Ca2+/calmodulin-dependent protein kinase II	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						Calmodulin; CaMKII; Sinoatrial node cells; Delayed rectifier K+ current; KCNQ1	RECTIFIER K+ CURRENT; PIG VENTRICULAR MYOCYTES; POTASSIUM CHANNEL; INTRACELLULAR CA2+; CALCIUM-CHANNELS; RABBIT HEART; CALMODULIN; PACEMAKER; MODULATION; K(V)LQT1	The slow component of the delayed rectifier K+ current (I (Ks)) plays an important role in the repolarization of action potentials in cardiac pacemaker cells and ventricular myocytes, and is regulated by various signaling pathways. Recent evidence has shown that calmodulin (CaM) is involved in modulation of diverse ion channels in cardiac myocytes under physiological and pathophysiological conditions. In the present study, we examined regulation of I (Ks) by Ca2+/CaM in guinea pig sinoatrial (SA) node cells using the whole-cell patch-clamp method. The density of I (Ks) was larger during intracellular dialysis with a higher Ca2+ concentration (pCa 7, Ca (+)) compared to that with a low Ca2+ concentration (pCa 10, Ca (-)). Intracellular application of CaM (400 nM) markedly potentiated I (Ks) with a Ca (+) pipette solution but not with a Ca (-) solution, thus showing that CaM potentiates I (Ks) in an intracellular Ca2+-dependent manner. Intracellular application of a specific Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor, autocamtide-2 inhibitory peptide (AIP, 500 nM), markedly reduced I (Ks) activity in the presence of higher intracellular Ca2+. Similarly, bath application of another inhibitor, KN-93 (1 mu M) also significantly suppressed I (Ks). Finally, the stimulatory action on I (Ks) of Ca2+/CaM was abolished by pretreatment with KN-93. Taken together, these observations suggest that Ca2+/CaM stimulates I (Ks) in guinea pig SA node cells through activation of CaMKII. This enhancement of I (Ks) by CaMKII may be involved in modulation of SA node automaticity under physiological or pathophysiological condition.	[Xie, Yu; Ding, Wei-Guang; Matsuura, Hiroshi] Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 5202192, Japan	Matsuura, H (reprint author), Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 5202192, Japan.	matuurah@belle.shiga-med.ac.jp					Aiba T, 2010, CARDIOVASC RES, V85, P454, DOI 10.1093/cvr/cvp324; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233; Ashpole NM, 2012, J BIOL CHEM, V287, P19856, DOI 10.1074/jbc.M111.322537; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Wen H, 2002, J NEUROSCI, V22, P7991; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Vinogradova TM, 2000, CIRC RES, V87, P760; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; IRISAWA H, 1993, PHYSIOL REV, V73, P197; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Bai CX, 2005, CIRC RES, V96, P64, DOI 10.1161/01.RES.0000151846.19788.E0; Boucherot A, 2001, J MEMBRANE BIOL, V182, P39; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61; Ding WG, 2002, BRIT J PHARMACOL, V137, P253, DOI 10.1038/sj.bjp.0704861; DOERR T, 1989, PFLUG ARCH EUR J PHY, V413, P599, DOI 10.1007/BF00581808; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; Kerst G, 2001, PFLUG ARCH EUR J PHY, V443, P146, DOI 10.1007/s004240100632; Lee A, 1999, NATURE, V399, P155; Li L, 1997, J PHYSIOL-LONDON, V501, P17, DOI 10.1111/j.1469-7793.1997.017bo.x; Maltsev VA, 2010, AM J PHYSIOL-HEART C, V298, pH2010, DOI 10.1152/ajpheart.00783.2009; Matsuura H, 2002, J PHYSIOL-LONDON, V540, P815; NITTA J, 1994, CIRC RES, V74, P96; Rigg L, 2003, CARDIOVASC RES, V57, P497, DOI 10.1016/S0008-6363(02)00668-5; TOHSE N, 1990, AM J PHYSIOL, V258, pH1200; Wang Z, 2002, J BIOL CHEM, V277, P24022, DOI 10.1074/jbc.M201949200; Yaniv Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057079; YUE DT, 1986, J GEN PHYSIOL, V87, P223, DOI 10.1085/jgp.87.2.223	39	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	FEB	2015	467	2					241	251		10.1007/s00424-014-1507-1		11	Physiology	Physiology	AY8YA	WOS:000347835400004		
J	Toyoda, H; Saito, M; Sato, H; Tanaka, T; Ogawa, T; Yatani, H; Kawano, T; Kanematsu, T; Hirata, M; Kang, Y				Toyoda, Hiroki; Saito, Mitsuru; Sato, Hajime; Tanaka, Takuma; Ogawa, Takeo; Yatani, Hirofumi; Kawano, Tsutomu; Kanematsu, Takashi; Hirata, Masato; Kang, Youngnam			Enhanced desensitization followed by unusual resensitization in GABA(A) receptors in phospholipase C-related catalytically inactive protein-1/2 double-knockout mice	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						PRIP; GABA(A) receptor; Desensitization; Calcineurin; Ca2+-induced Ca2+ release; Store-operated Ca2+ entry	GAMMA-AMINOBUTYRIC-ACID; FROG SENSORY NEURONS; GATED CHLORIDE CURRENTS; RAT HIPPOCAMPAL-NEURONS; CALCIUM-RELEASE; INTRACELLULAR CA2+; BINDING-PROTEIN; KINASE-II; RESPONSES; CALCINEURIN	Phospholipase C-related catalytically inactive proteins (PRIP-1/2) are previously reported to be involved in the membrane trafficking of GABA(A) receptor (GABA(A)R) and the regulation of intracellular Ca2+ stores. GABA(A)R-mediated currents can be regulated by the intracellular Ca2+. However, in PRIP-1/2 double-knockout (PRIP-DKO) mice, it remains unclear whether the kinetic properties of GABA(A)Rs are modulated by the altered regulation of intracellular Ca2+ stores. Here, we investigated whether GABA(A)R currents (I-GABA) evoked by GABA puff in layer 3 (L3) pyramidal cells (PCs) of the barrel cortex are altered in PRIP-DKO mice. The deletion of PRIP-1/2 enhanced the desensitization of I-GABA but induced a hump-like tail current (tail-I) at the GABA puff offset. I-GABA and the hump-like tail-I were suppressed by GABA(A)R antagonists. The enhanced desensitization of I-GABA and the hump-like tail-I in PRIP-DKO PCs were mediated by increases in the intracellular Ca2+ concentration and were largely abolished by a calcineurin inhibitor and ruthenium red. Calcium imaging revealed that Ca2+-induced Ca2+ release (CICR) and subsequent store-operated Ca2+ entry (SOCE) are more potent in PRIP-DKO PCs than in wild-type PCs. A mathematical model revealed that a slowdown of GABA-unbinding rate and an acceleration of fast desensitization rate by enhancing its GABA concentration dependency are involved in the generation of hump-like tail-Is. These results suggest that in L3 PCs of the barrel cortex in PRIP-DKO mice, the increased calcineurin activity due to the potentiated CICR and SOCE enhances the desensitization of GABA(A)Rs and slows the GABA-unbinding rate, resulting in their unusual resensitization following removal of GABA.	[Toyoda, Hiroki; Saito, Mitsuru; Sato, Hajime; Ogawa, Takeo; Kawano, Tsutomu; Kang, Youngnam] Osaka Univ, Grad Sch Dent, Dept Neurosci & Oral Physiol, Suita, Osaka 5650871, Japan; [Tanaka, Takuma] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 2268502, Japan; [Yatani, Hirofumi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka 5650871, Japan; [Kanematsu, Takashi] Hiroshima Univ, Div Integrated Med Sci, Dept Dent Pharmacol, Grad Sch Biomed Sci, Hiroshima 7348553, Japan; [Hirata, Masato] Kyushu Univ, Lab Mol & Cellular Biochem, Fac Dent Sci, Fukuoka 8128582, Japan	Kang, Y (reprint author), Osaka Univ, Grad Sch Dent, Dept Neurosci & Oral Physiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kang@dent.osaka-u.ac.jp			Japan Ministry of Education, Culture, Sports, Science and Technology [22300127, 24229009]	The authors thank Dr. N. Akaike for critically reviewing an earlier version of the manuscript. This study was supported by a Grant-in-Aid for Scientific Research to Y.K. (B; 22300127) and that to M.H. (S; 24229009) from Japan Ministry of Education, Culture, Sports, Science and Technology.	AKAIKE N, 1985, J PHYSIOL-LONDON, V360, P367; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; WANG RA, 1995, J NEUROPHYSIOL, V73, P2099; Muller MS, 2013, NEUROCHEM RES, V38, P1260, DOI 10.1007/s11064-013-1021-4; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Khodakhah K, 1997, BIOPHYS J, V73, P3349; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Mizokami A, 2010, J NEUROCHEM, V114, P302, DOI 10.1111/j.1471-4159.2010.06754.x; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; HENZI V, 1992, NEUROSCIENCE, V46, P251, DOI 10.1016/0306-4522(92)90049-8; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; AKAIKE N, 1987, J PHYSIOL-LONDON, V394, P85; Kanematsu T, 1996, BIOCHEM J, V313, P319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Houston CM, 2009, J PHYSIOL-LONDON, V587, P2115, DOI 10.1113/jphysiol.2009.171603; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243; Chang YC, 2002, J NEUROSCI, V22, P7982; CHEN QX, 1995, J PHYSIOL-LONDON, V482, P353; Cibulsky SM, 1999, J PHARMACOL EXP THER, V289, P1447; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Houston CM, 2008, J NEUROSCI, V28, P7574, DOI 10.1523/JNEUROSCI.5531-07.2008; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; Imanishi T, 1996, NEUROREPORT, V7, P1421, DOI 10.1097/00001756-199605310-00020; INOUE M, 1988, NEUROSCI RES, V5, P380, DOI 10.1016/0168-0102(88)90024-7; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; IRVING AJ, 1992, J PHYSIOL-LONDON, V456, P667; Jones MV, 1997, J NEUROSCI, V17, P7626; Jones MV, 1998, J NEUROSCI, V18, P8590; KINCAID RL, 1987, P NATL ACAD SCI USA, V84, P1118, DOI 10.1073/pnas.84.4.1118; KUNO T, 1992, J NEUROCHEM, V58, P1643, DOI 10.1111/j.1471-4159.1992.tb10036.x; Lalo UV, 1998, NEUROPHYSIOLOGY+, V30, P289, DOI 10.1007/BF02462840; Martina M, 1996, NEUROSCI LETT, V215, P95, DOI 10.1016/S0304-3940(96)12957-8; MOUGINOT D, 1991, J PHYSIOL-LONDON, V437, P109; Mozrzymas JW, 1998, J NEUROPHYSIOL, V79, P1321; NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191; ORSER BA, 1994, J NEUROSCI, V14, P7747; Ramakrishnan L, 2005, BIOCHEMISTRY-US, V44, P8523, DOI 10.1021/bi0477283; SHMIGOL A, 1994, NEUROREPORT, V5, P2073, DOI 10.1097/00001756-199410270-00021; Stelzer A, 1992, Ion Channels, V3, P83; Takenaka K, 2003, MOL CELL BIOL, V23, P7329, DOI 10.1128/MCB.23.20.7329-7338.2003; Vigh J, 2003, EUR J NEUROSCI, V17, P2237, DOI 10.1046/j.1460-9568.2003.02652.x	43	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	FEB	2015	467	2					267	284		10.1007/s00424-014-1511-5		18	Physiology	Physiology	AY8YA	WOS:000347835400006		
J	Wada, S; Kato, Y; Sawada, S; Aizawa, K; Park, JH; Russell, AP; Ushida, T; Akimoto, T				Wada, Shogo; Kato, Yoshio; Sawada, Shuji; Aizawa, Katsuji; Park, Jong-Hoon; Russell, Aaron P.; Ushida, Takashi; Akimoto, Takayuki			MicroRNA-23a has minimal effect on endurance exercise-induced adaptation of mouse skeletal muscle	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						MicroRNAs; Muscle fiber type; Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha; Endurance performance	TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; SYSTEMIC ENERGY HOMEOSTASIS; HEAVY-CHAIN ISOFORMS; FIBER-TYPE; EPITROCHLEARIS MUSCLE; RAT EPITROCHLEARIS; MICE; EXPRESSION; PGC-1; RNA	Skeletal muscles contain several subtypes of myofibers that differ in contractile and metabolic properties. Transcriptional control of fiber-type specification and adaptation has been intensively investigated over the past several decades. Recently, microRNA (miRNA)-mediated posttranscriptional gene regulation has attracted increasing attention. MiR-23a targets key molecules regulating contractile and metabolic properties of skeletal muscle, such as myosin heavy-chains and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1 alpha). In the present study, we analyzed the skeletal muscle phenotype of miR-23a transgenic (miR-23a Tg) mice to explore whether forced expression of miR-23a affects markers of mitochondrial content, muscle fiber composition, and muscle adaptations induced by 4 weeks of voluntary wheel running. When compared with wild-type mice, protein markers of mitochondrial content, including PGC-1 alpha, and cytochrome c oxidase complex IV (COX IV), were significantly decreased in the slow soleus muscle, but not the fast plantaris muscle of miR-23a Tg mice. There was a decrease in type IId/x fibers only in the soleus muscle of the Tg mice. Following 4 weeks of voluntary wheel running, there was no difference in the endurance exercise capacity as well as in several muscle adaptive responses including an increase in muscle mass, capillary density, or the protein content of myosin heavy-chain IIa, PGC-1 alpha, COX IV, and cytochrome c. These results show that miR-23a targets PGC-1 alpha and regulates basal metabolic properties of slow but not fast twitch muscles. Elevated levels of miR-23a did not impact on whole body endurance capacity or exercise-induced muscle adaptations in the fast plantaris muscle.	[Wada, Shogo; Aizawa, Katsuji; Park, Jong-Hoon; Ushida, Takashi; Akimoto, Takayuki] Univ Tokyo, Div Regenerat Med Engn, Ctr Dis Biol & Integrat Med, Grad Sch Med,Bunkyo Ku, Tokyo 1130033, Japan; [Kato, Yoshio] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Sawada, Shuji] Waseda Univ, Cooperat Major Adv Hlth Sci, Tokyo Univ Agr & Technol, Tokorozawa, Saitama 3591192, Japan; [Park, Jong-Hoon] Konkuk Univ, Dept Phys Educ, Seoul 143701, South Korea; [Russell, Aaron P.] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood 3125, Australia	Akimoto, T (reprint author), Univ Tokyo, Div Regenerat Med Engn, Ctr Dis Biol & Integrat Med, Grad Sch Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	akimoto@m.u-tokyo.ac.jp	Akimoto, Takayuki/H-6704-2012		Ministry of Education, Culture, Sports, Science and Technology, Japan [21680049, 25282198]; Takeda Science Foundation; Japan Society of the Promotion of Science (JSPS)	The authors thank Dr. Hiroshi Sagara (The University of Tokyo) and Akisa Tobimatsu for excellent technical support. The authors also thank Dr. Stefano Schiaffino (Venetian Institute for Molecular Medicine) for comments on EM images. This study was supported in part by Grants-in Aid for Young Investigators (A; 21680049 to T. A.) and for Scientific Research (B; 25282198 to T. A.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Takeda Science Foundation. S. W., K. A. and J. H. P. were supported by Japan Society of the Promotion of Science (JSPS).	NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Wang L, 2012, EXP CELL RES, V318, P2324, DOI 10.1016/j.yexcr.2012.06.018; Akimoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC541, DOI 10.1152/ajpcell.00243.2012; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Thyfault JP, 2007, AM J PHYSIOL-CELL PH, V292, pC729, DOI 10.1152/ajpcell.00311.2006; Li P, 2006, AM J PHYSIOL-CELL PH, V290, pC1461, DOI 10.1152/ajpcell.00532.2005; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Katzmarzyk PT, 2004, CAN J APPL PHYSIOL, V29, P90; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Kinugawa S, 2005, CIRCULATION, V111, P1480, DOI 10.1161/01.CIR.0000159261.11520.63; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; RODNICK KJ, 1992, AM J PHYSIOL, V262, pC9; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; BROWN M, 1992, MECH AGEING DEV, V63, P69, DOI 10.1016/0047-6374(92)90017-8; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Ikeda S, 2006, ACTA PHYSIOL, V188, P217, DOI 10.1111/j.1748-1716.2006.01623.x; NAUMANN K, 1994, DIFFERENTIATION, V55, P203, DOI 10.1046/j.1432-0436.1994.5530203.x; Nielsen S, 2010, J PHYSIOL-LONDON, V588, P4029, DOI 10.1113/jphysiol.2010.189860; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; RIEDY M, 1985, J APPL PHYSIOL, V59, P127; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Russell AP, 2012, NEUROBIOL DIS C, V49C, P107, DOI [10.1016/j.nbd.2012.08.015, DOI 10.1016/J.NBD.2012.08.015]; Russell AP, 2013, J PHYSL IN PRESS, V2013; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003	51	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	FEB	2015	467	2					389	398		10.1007/s00424-014-1517-z		10	Physiology	Physiology	AY8YA	WOS:000347835400015		
J	Hein, P				Hein, Patrick			Divided Nations and Transitional Justice: What Germany, Japan and South Korea Can Teach the World	POLITICAL STUDIES REVIEW			English	Book Review									[Hein, Patrick] Meiji Univ, Tokyo 101, Japan	Hein, P (reprint author), Meiji Univ, Tokyo 101, Japan.						HAN SJ, 2012, DIVIDED NATIONS TRAN	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-9299	1478-9302		POLIT STUD REV	Polit. Stud. Rev.	FEB	2015	13	1					113	113		10.1111/1478-9302.12073_33		1	Political Science	Government & Law	AY8BJ	WOS:000347779100060		
J	Hein, P				Hein, Patrick			The Psychology of Dictatorship	POLITICAL STUDIES REVIEW			English	Book Review									[Hein, Patrick] Meiji Univ, Tokyo 101, Japan	Hein, P (reprint author), Meiji Univ, Tokyo 101, Japan.						Moghaddam F. M., 2013, PSYCHOL DICTATORSHIP	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-9299	1478-9302		POLIT STUD REV	Polit. Stud. Rev.	FEB	2015	13	1					131	131		10.1111/1478-9302.12073_56		1	Political Science	Government & Law	AY8BJ	WOS:000347779100089		
J	Luo, CJ; Okubo, T; Nangrejo, M; Edirisinghe, M				Luo, C. J.; Okubo, Tomoyuki; Nangrejo, Muhammad; Edirisinghe, Mohan			Preparation of polymeric nanoparticles by novel electrospray nanoprecipitation	POLYMER INTERNATIONAL			English	Article						electrospray; nanoprecipitation; nanoparticles; polymethylsilsesquioxane	NANOCAPSULES; DISPLACEMENT; AGGREGATION; DELIVERY; SHAPE; JETS	Polymeric nanoparticles have important applications in drug delivery, biotechnology, diagnostics and energy harvesting. We report a new technique named electrospray nanoprecipitation, which combines electrospray with agitated solvent displacement. The process enables one-step formation of polymeric nanoparticles <100nm in size that are near-monodisperse with a diameter range significantly lower than could be obtained using either electrospray or agitated solvent displacement technique alone. Both reduction of polymer solution concentration and the addition of poly(vinyl alcohol) emulsifier in the water-non-solvent medium further reduce the average particle diameter. The technique provides an effective and straightforward method to further reduce the size range of near-monodisperse nanoparticles achievable in a single step, which can be readily adapted for reducing the achievable size range of core-shell structures using popular one-step encapsulation techniques such as coaxial electrospray. (c) 2014 The Authors. Polymer International published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.	[Luo, C. J.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 0FS, England; [Luo, C. J.; Okubo, Tomoyuki; Nangrejo, Muhammad; Edirisinghe, Mohan] UCL, Dept Mech Engn, London WC1E 7JE, England; [Okubo, Tomoyuki] Japan Patent Off, Patent Examinat Dept 3, Div Polymer, Chiyoda Ku, Tokyo, Japan	Edirisinghe, M (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.	m.edirisinghe@ucl.ac.uk			Japan Patent Office; EPSRC; UCL Knowledge Transfer & Enterprise Award	The authors thank the Japan Patent Office for funding a sabbatical period of training and research for TO that helped initiate this work. CJL and ME thank EPSRC and a UCL Knowledge Transfer & Enterprise Award for supporting their research. We also thank the Archaeology Department (UCL) for use of their microscope facilities.	Li D, 2007, J MATER CHEM, V17, P2279, DOI 10.1039/b700699c; Moinard-Checot D, 2008, J COLLOID INTERF SCI, V317, P458, DOI 10.1016/j.jcis.2007.09.081; Mishra B, 2010, NANOMED-NANOTECHNOL, V6, P9, DOI 10.1016/j.nano.2009.04.008; Lince F, 2008, J COLLOID INTERF SCI, V322, P505, DOI 10.1016/j.jcis.2008.03.033; Jung J, 2001, J SUPERCRIT FLUID, V20, P179, DOI 10.1016/S0896-8446(01)00064-X; Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595; Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987; Enayati M, 2010, J R SOC INTERFACE, V7, P667, DOI 10.1098/rsif.2009.0348; Nangrejo M, 2008, PHARM DEV TECHNOL, V13, P425, DOI 10.1080/10837450802247929 ; Zhuo R, 2005, ACTA BIOMATER, V1, P583, DOI 10.1016/j.actbio.2005.05.005; Hornig S, 2009, J MATER CHEM, V19, P3838, DOI 10.1039/b906556n; Lince F, 2009, CHEM ENG RES DES, V87, P543, DOI 10.1016/j.cherd.2008.11.009; Li D, 2006, J AM CHEM SOC, V128, P968, DOI 10.1021/ja056609n; MELCHER JR, 1969, ANNU REV FLUID MECH, V1, P111, DOI 10.1146/annurev.fl.01.010169.000551; Muller RH, 2004, J BIOTECHNOL, V113, P151, DOI 10.1016/j.jbiotec.2004.06.007; Barrero A, 2007, ANNU REV FLUID MECH, V39, P89, DOI 10.1146/annurev.fluid.39.050905.110245; Beck-Broichsitter M, 2010, EUR J PHARM SCI, V41, P244, DOI 10.1016/j.ejps.2010.06.007; FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Chang MW, 2013, J MATER CHEM B, V1, P3962, DOI 10.1039/c3tb20465k; Crespy D, 2007, MACROMOL CHEM PHYSIC, V208, P457, DOI 10.1002/macp.200600487; Drexler E, 1986, ENGINES OF CREATION; Enayati M, 2009, CURR PHARM BIOTECHNO, V10, P600; Feynman R. P., 1960, CALTECH ENG SCI, V23, P22; Ghanbar H, 2013, MAT SCI ENG C-MATER, V33, P2488, DOI 10.1016/j.msec.2012.12.098; Kenji S, 1993, US Patent, Patent No. 5204432; Ma J, 2002, J APPL POLYM SCI, V85, P1077, DOI 10.1002/app.10576; MESTEL AJ, 1994, J FLUID MECH, V274, P93, DOI 10.1017/S0022112094002053; NARAYANA.S, 1969, CHEM ENG SCI, V24, P223, DOI 10.1016/0009-2509(69)80031-X; Noriega-Pelaez EK, 2011, DRUG DEV IND PHARM, V37, P160, DOI 10.3109/03639045.2010.501800; Reis Catarina Pinto, 2006, Nanomedicine-Nanotechnology Biology and Medicine, V2, P8, DOI 10.1016/j.nano.2005.12.003; Quintanar-Guerrero D, 1998, DRUG DEV IND PHARM, V24, P1113, DOI 10.3109/03639049809108571; Taniguchi N, 1974, PROCEEDINGS OF THE I; TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205; Xu CJ, 2007, POLYM INT, V56, P821, DOI 10.1002/pi.2251; Zhang GZ, 2001, ACCOUNTS CHEM RES, V34, P249, DOI 10.1021/ar000011x	36	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-8103	1097-0126		POLYM INT	Polym. Int.	FEB	2015	64	2					183	187		10.1002/pi.4822		5	Polymer Science	Polymer Science	AY3CK	WOS:000347461900003		
J	Koike, K; Araki, T; Koike, Y				Koike, Kotaro; Araki, Toshimitsu; Koike, Yasuhiro			A highly transparent and thermally stable copolymer of 1-adamantyl methacrylate and styrene	POLYMER INTERNATIONAL			English	Article						1-adamantyl methacrylate; styrene; azeotropic copolymerizations; light scattering; optical fibers	PLASTIC OPTICAL-FIBERS; 193 NM PHOTORESIST; LIGHT-SCATTERING; REFRACTIVE-INDEX; POLY(1-ADAMANTYL METHACRYLATE); RADICAL POLYMERIZATION; POLYMERS; ADAMANTANE; GLASSES; ION	Thermal and optical properties of copolymers of 1-adamantyl methacrylate (AdMA) and styrene (St) prepared by free radical polymerization in the bulk are investigated. The copolymer forms an azeotrope when the composition is AdMA/St=55/45mol%. The glass transition temperature and decomposition temperature of the azeotropic copolymer are 170 and ca 340 degrees C, respectively. The refractive index increases nonlinearly with St content from 1.522 to 1.591. The light scattering loss at 633nm is 28.1dBkm(-1), which is less than half of that of polystyrene. The total optical loss including molecular vibrational absorption, which is evaluated using a copolymer-based optical fiber, is 292-645dBkm(-1) at 500-700nm. These values correspond to transmittances of 86-93% for a 1m optical path length. (c) 2014 Society of Chemical Industry	[Koike, Kotaro; Araki, Toshimitsu; Koike, Yasuhiro] Keio Univ, Yasuhiro Koike Keio Photon Res Inst, Saiwai Ku, Kawasaki, Kanagawa 2120032, Japan	Koike, K (reprint author), Keio Univ, Yasuhiro Koike Keio Photon Res Inst, Saiwai Ku, 7-1 Shinkawasaki, Kawasaki, Kanagawa 2120032, Japan.	kotarokoike@kpri.keio.ac.jp	Koike, Yasuhiro /G-2104-2014		Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Abe N, 1995, J PHOTOPOLYM SCI TEC, V8, P637, DOI 10.2494/photopolymer.8.637; FORT RC, 1964, CHEM REV, V64, P277, DOI 10.1021/cr60229a004; BAMFORD CH, 1969, POLYMER, V10, P885, DOI 10.1016/0032-3861(69)90120-7; MATSUMOTO A, 1991, MACROMOLECULES, V24, P4017, DOI 10.1021/ma00014a008; Akimoto Y, 2012, OPT LETT, V37, P1853, DOI 10.1364/OL.37.001853; KOIKE Y, 1991, POLYMER, V32, P1737, DOI 10.1016/0032-3861(91)90356-N; DEBYE P, 1957, J APPL PHYS, V28, P679, DOI 10.1063/1.1722830; Engelmann S, 2007, J VAC SCI TECHNOL B, V25, P1353, DOI 10.1116/1.2759935; Chung TY, 2011, PLASMA PROCESS POLYM, V8, P1068, DOI 10.1002/ppap.201100071; Koike K, 2014, POLYM ADVAN TECHNOL, V25, P204, DOI 10.1002/pat.3224; DEBYE P, 1949, J APPL PHYS, V20, P518, DOI 10.1063/1.1698419; KAINO T, 1981, J APPL PHYS, V52, P7061, DOI 10.1063/1.328702; Koike Y, 2011, J POLYM SCI POL PHYS, V49, P2, DOI 10.1002/polb.22170; BONTA G, 1976, POLYMER, V17, P217, DOI 10.1016/0032-3861(76)90103-8; Acar HY, 2000, MACROMOLECULES, V33, P3855, DOI 10.1021/ma991621j; Robello DR, 2013, J APPL POLYM SCI, V127, P96, DOI 10.1002/app.37802; Nest D, 2009, PLASMA PROCESS POLYM, V6, P649, DOI 10.1002/ppap.200900039; Robertson CG, 1998, POLYMER, V39, P2129, DOI 10.1016/S0032-3861(97)00508-9; Briers D, 2004, POLYMER, V45, P19, DOI 10.1016/j.polymer.2003.11.002; ECKL M, 1995, MACROMOL CHEM PHYSIC, V196, P315, DOI 10.1002/macp.1995.021960122; Fleischmann S, 2010, J POLYM SCI POL CHEM, V48, P2251, DOI 10.1002/pola.24007; Fuchise K, 2010, POLYM J, V42, P626, DOI 10.1038/pj.2010.55; GROH W, 1988, MAKROMOL CHEM, V189, P2861; Huang Y, 2006, MACROMOLECULES, V39, P1544; Ishizone T, 2002, MACROMOL CHEM PHYSIC, V203, P2375, DOI 10.1002/macp.200290018; Iwata S, 1997, APPL OPTICS, V36, P4549, DOI 10.1364/AO.36.004549; Iwata S, 1996, JPN J APPL PHYS 1, V35, P3896, DOI 10.1143/JJAP.35.3896; KAINO T, 1987, J POLYM SCI POL CHEM, V25, P37, DOI 10.1002/pola.1987.080250105; KHARDIN AP, 1982, USP KHIM+, V51, P480; Koike K, 2014, POLYMER, V55, P2697, DOI 10.1016/j.polymer.2014.04.009; Koike K, 2010, POLYMER, V51, P1377, DOI 10.1016/j.polymer.2010.01.043; Koike K, 2008, POLYM ADVAN TECHNOL, V19, P516, DOI 10.1002/pat.1091; Koike K, 2014, POLYMER, V55, P878, DOI 10.1016/j.polymer.2013.12.058; KOIKE Y, 1989, MACROMOLECULES, V22, P1367, DOI 10.1021/ma00193a060; KOIKE Y, 1992, MACROMOLECULES, V25, P4807, DOI 10.1021/ma00044a049; Kuzyk MG, 2006, POLYM FIBER OPTICS M, P146; Lorentz H. A., 1880, ANN PHYS, V9, P641; LORENZ L, 1880, ANN PHYS, V11, P70; MATSUMOTO A, 1992, COLLOID POLYM SCI, V270, P17, DOI 10.1007/BF00656924; MAYO FR, 1951, J AM CHEM SOC, V73, P1691, DOI 10.1021/ja01148a081; MEYER VE, 1965, J POLYM SCI PART A, V3, P2843, DOI 10.1002/pol.1965.100030811; Momose H, 2001, P SOC PHOTO-OPT INS, V4345, P695, DOI 10.1117/12.436903; NOF Corporation, 2014, FUNCT CHEM POL PROD; OTSU T, 1991, CHEM LETT, P1145, DOI 10.1246/cl.1991.1145; Takahashi M, 1994, J PHOTOPOLYM SCI TEC, V7, P31, DOI 10.2494/photopolymer.7.31; TAKAHASHI M, 1995, P SOC PHOTO-OPT INS, V2438, P422, DOI 10.1117/12.210352; Tanio N, 2009, KOBUNSHI RONBUNSHU, V66, P1; TANIO N, 1989, POLYM J, V21, P119, DOI 10.1295/polymj.21.119; Tanio N, 2006, POLYM J, V38, P814, DOI 10.1295/polymk.PJ2005192; Tatsukami Y, 1985, Japanese Patent, Patent No. [JP 60125807, 60125807]; Tatsukami Y, 1988, Japanese Patent, Patent No. [JP 63195609, 63195609]; Tatsukami Y, 1986, US Patent, Patent No. 4576438; Uozu Y, 1994, Japanese Patent, Patent No. [JP 06256433, 06256433]; Wang MX, 2007, J MATER CHEM, V17, P1699, DOI 10.1039/b617133h; Yamaki Y, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.071601	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-8103	1097-0126		POLYM INT	Polym. Int.	FEB	2015	64	2					188	195		10.1002/pi.4794		8	Polymer Science	Polymer Science	AY3CK	WOS:000347461900004		
J	Carli, LN; Daitx, TS; Guegan, R; Giovanela, M; Crespo, JS; Mauler, RS				Carli, Larissa N.; Daitx, Tales S.; Guegan, Regis; Giovanela, Marcelo; Crespo, Janaina S.; Mauler, Raquel S.			Biopolymer nanocomposites based on poly(hydroxybutyrate-co-hydroxyvalerate) reinforced by a non-ionic organoclay	POLYMER INTERNATIONAL			English	Article						biodegradable polymer; nanocomposites; non-ionic organoclay; thermomechanical properties; impact strength	MECHANICAL-PROPERTIES; POLY(ETHYLENE OXIDE); THERMAL-DEGRADATION; MELT INTERCALATION; MONTMORILLONITE; SMECTITE; CLAY; SURFACTANTS; ADSORPTION; MORPHOLOGY	In this study, a nanocomposite based on a biodegradable polymer poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) reinforced by triethylene glycol mono-n-decyl ether (C10E3) non-ionic organoclay (C10E3-Mt) was prepared. The morphology and the thermal and mechanical properties of PHBV/C10E3-Mt were compared with those of PHBV nanocomposites prepared using commercial organically modified montmorillonite Cloisite((R)) 30B (OMt) and raw montmorillonite (Mt). Nanocomposites with 3wt% nanoparticles were obtained by melt processing. The high level of dispersion with improved interfacial interactions between OMt and polymer led to an increase in the thermal stability and modulus of PHBV. However, this nanocomposite presented a lower strain before fracture, typical of brittle behavior. The transmission electron microscopy and wide angle X-ray diffraction results revealed a significant increase in the interlayer spacing of clay for the PHBV/C10E3-Mt nanocomposite, which was favored by the wide expansion of the platelets of the starting non-ionic organoclay. This characteristic of C10E3-Mt, together with its hydrophobic behavior, allowed its easy incorporation in the PHBV matrix, thus improving the processing and maintaining a high modulus with increased material toughness. (c) 2014 Society of Chemical Industry	[Carli, Larissa N.; Giovanela, Marcelo; Crespo, Janaina S.] Univ Caxias Sul, Ctr Ciencias Exatas & Tecnol, BR-95070560 Caxias Do Sul, RS, Brazil; [Daitx, Tales S.; Mauler, Raquel S.] Univ Fed Rio Grande do Sul, Inst Quim, BR-91501970 Porto Alegre, RS, Brazil; [Guegan, Regis] Univ Orleans, CNRS, UMR 7327, Inst Sci Terre Orleans, F-45071 Orleans, France; [Guegan, Regis] Waseda Univ, Grad Sch Creat Sci & Engn, Shinjuku Ku, Tokyo 1698050, Japan	Carli, LN (reprint author), Univ Fed Santa Catarina, Campus Blumenau,Rua Pomerode 710, BR-89065300 Blumenau, SC, Brazil.	larissa.carli@ufsc.br; regis.guegan@univ-orleans.fr; raquel.mauler@ufrgs.br	Giovanela, Marcelo/C-4407-2012; Carli, Larissa/B-1055-2015; Mauler, Raquel/L-6614-2014	Giovanela, Marcelo/0000-0003-0874-383X; 	Secretaria da Ciencia e Tecnologia do Estado do Rio Grande do Sul (SCT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Pronex (FAPERGS/CNPq); UFRGS (Edital PROPG) [001/2011]	The authors are grateful to Secretaria da Ciencia e Tecnologia do Estado do Rio Grande do Sul (SCT), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Pronex (FAPERGS/CNPq) and UFRGS (Edital PROPG no 001/2011) for financial support. Moreover, Regis Guegan is grateful to the Canon Foundation in Europe for their support in this research allowing him to be hosted at the University of Waseda.	Beall GW, 2004, APPL CLAY SCI, V27, P179, DOI 10.1016/j.clay.2004.06.006; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Carli LN, 2013, MAT SCI ENG C-MATER, V33, P932, DOI 10.1016/j.msec.2012.11.023; Lai MD, 2004, POLYM INT, V53, P1479, DOI 10.1002/pi.1566; Carli LN, 2011, COMPOS PART A-APPL S, V42, P1601, DOI 10.1016/j.compositesa.2011.07.007; Carli LN, 2014, APPL CLAY SCI, V87, P311, DOI 10.1016/j.clay.2013.11.032; Hablot E, 2008, POLYM DEGRAD STABIL, V93, P413, DOI 10.1016/j.polymdegradstab.2007.11.018; Botana A, 2010, APPL CLAY SCI, V47, P263, DOI 10.1016/j.clay.2009.11.001; Bordes P, 2009, POLYM DEGRAD STABIL, V94, P789, DOI 10.1016/j.polymdegradstab.2009.01.027; Mathur S, 1997, J COLLOID INTERF SCI, V196, P92, DOI 10.1006/jcis.1997.5192; Ferrage E, 2005, AM MINERAL, V90, P1358, DOI 10.2138/am.2005.1776; Bordes P, 2008, MACROMOL CHEM PHYSIC, V209, P1473, DOI 10.1002/macp.200800022; Vaia RA, 1997, MACROMOLECULES, V30, P8000, DOI 10.1021/ma9603488; Alexandre M, 2002, POLYMER, V43, P2123, DOI 10.1016/S0032-3861(02)00036-8; Deng YJ, 2006, COLLOID POLYM SCI, V284, P347, DOI 10.1007/s00396-005-1388-0; Xie W, 2001, CHEM MATER, V13, P2979, DOI 10.1021/cm010305s; Wang SF, 2005, POLYM DEGRAD STABIL, V87, P69, DOI 10.1016/j.polymdegradstab.2004.07.008; Su CC, 2009, J COLLOID INTERF SCI, V332, P11, DOI 10.1016/j.jcis.2008.12.024; Abe H, 2006, MACROMOL BIOSCI, V6, P469, DOI 10.1002/mabi.200600070; Shen YH, 2001, CHEMOSPHERE, V44, P989, DOI 10.1016/S0045-6535(00)00564-6; BURCHILL S, 1983, CLAY MINER, V18, P373, DOI 10.1180/claymin.1983.018.4.04; Chen DZ, 2007, COMPOS SCI TECHNOL, V67, P1617, DOI 10.1016/j.compscitech.2006.07.034; Dagnon KL, 2009, POLYM INT, V58, P133, DOI 10.1002/pi.2503; Deng YJ, 2003, CLAY CLAY MINER, V51, P150, DOI 10.1346/CCMN.2003.0510204; Dubnikova I. L., 2007, Journal of Applied Polymer Science, V105, DOI 10.1002/app.26665; Fukushima K, 2009, MAT SCI ENG C-BIO S, V29, P1433, DOI 10.1016/j.msec.2008.11.005; GOGOLEWSKI S, 1993, POLYM DEGRAD STABIL, V40, P313, DOI 10.1016/0141-3910(93)90137-8; Guegan R, 2009, CLAY CLAY MINER, V57, P502, DOI 10.1346/CCMN.2009.0570411; Guegan R, 2010, LANGMUIR, V26, P19175, DOI 10.1021/la1039267; Guegan R, 2013, SOFT MATTER, V9, P10913, DOI 10.1039/c3sm52337c; Hristov VN, 2004, POLYM TEST, V23, P581, DOI 10.1016/j.polymertesting.2003.10.011; Ireland DR, 1981, INSTRUMENTED IMPACT; Karaborni S, 1996, SCIENCE, V271, P1102, DOI 10.1126/science.271.5252.1102; Menard K. P., 1999, DYNAMIC MECH ANAL PR; Choi WM, 2003, J APPL POLYM SCI, V90, P525, DOI 10.1002/app.12702; Sarier N, 2010, THERMOCHIM ACTA, V510, P113, DOI 10.1016/j.tca.2010.07.004; Song CJ, 2001, APPL BIOCHEM BIOTECH, V94, P169, DOI 10.1385/ABAB:94:2:169; Su CC, 2008, COLLOID SURFACE A, V312, P1, DOI 10.1016/j.colsurfa.2007.06.019; Theng BKG, 2013, FORMATION PROPERTIES; Yang J, 2011, J APPL POLYM SCI, V121, P2458, DOI 10.1002/app.33773; Zhang YQ, 2004, COMPOS SCI TECHNOL, V64, P1383, DOI 10.1016/j.compscitech.2003.10.014	41	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-8103	1097-0126		POLYM INT	Polym. Int.	FEB	2015	64	2					235	241		10.1002/pi.4781		7	Polymer Science	Polymer Science	AY3CK	WOS:000347461900010		
J	Wang, X; Arai, M				Wang, Xin; Arai, Makoto			A numerical study on coupled sloshing and ship motions of a liquefied natural gas carrier in regular and irregular waves	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART M-JOURNAL OF ENGINEERING FOR THE MARITIME ENVIRONMENT			English	Article						Sloshing; ship motions; coupling effect; liquefied natural gas; irregular wave		This article presents a numerical study of the coupled ship motions and tank sloshing of a liquefied natural gas carrier. To solve this coupled problem, we have developed a time-domain numerical method. The method combines a ship motion solver based on strip theory and a computational fluid dynamics sloshing solver. The method has been applied to a liquefied natural gas carrier model to investigate the coupling effect in regular waves. Simulations for four different loading conditions were carried out, and the results of ship motion response amplitude operators and free surface movement amplitudes were presented in frequency domain. The coupling effect on ship motions and sloshing has been discussed. Based on the assumption of linearity of ship motions and wave, the authors used the ship motion response amplitude operators (with coupling effect) obtained in regular wave conditions to generate ship motion time histories in irregular waves. Sloshing in tanks was then simulated by using the ship motion time histories in irregular wave conditions. The calculated impact pressure time histories were analyzed by using the exceedance probability function.	[Wang, Xin] Osaka Univ, Dept Naval Architecture & Ocean Engn, Suita, Osaka 5650871, Japan; [Arai, Makoto] Yokohama Natl Univ, Dept Syst Designs Ocean Space, Yokohama, Kanagawa 240, Japan	Wang, X (reprint author), Osaka Univ, Dept Naval Architecture & Ocean Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	wang@naoe.eng.osaka-u.ac.jp					Hirdaris SE, 2010, SHIPS OFFSHORE STRUC, V5, P307, DOI 10.1080/17445301003626263; Kim Y, 2007, OCEAN ENG, V34, P2176, DOI 10.1016/j.oceaneng.2007.03.008; Kim Y, 2002, J SHIP RES, V46, P52; Rognebakke OF, 2003, J SHIP RES, V47, P208; Arai M., 1992, J SOC NAV ARCH JAPAN, V1992, P177; Arai M., 2002, J SOC NAVAL ARCHITEC, V2002, P299; Faltinsen OM, 1993, SEA LOADS SHIPS OFFS; Faltinsen O.M., 2009, SLOSHING; Faltinsen OM, 2009, INT MAR ASS MED 12 1; Hurt CW, 1975, LA5852; Malenica S., 2003, 13 INT OFFSH POL ENG; Molin B, 2002, INT MAR ASS MED MAY; Motora S, 1977, T W JPN SOC NAV ARCH, V167, P23; Salvesen N., 1970, T SNAME, V78, P250; Wang X, 2011, J JAPAN SOC NAVAL AR, V14, P97; Wang X, 2011, INT J OFFSHORE POLAR, V21, P256; Welch JE, 1966, LA3425; Yoshioka I, 1976, J SOC NAV ARCHIT JPN, V140, P152	18	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1475-0902	2041-3084		P I MECH ENG M-J ENG	Proc. Inst. Mech. Eng. Part M- J. Eng. Marit. Environ.	FEB	2015	229	1					3	13		10.1177/1475090213493771		11	Engineering, Marine	Engineering	AY8GP	WOS:000347792700001		
J	Maeyama, T; Fukunishi, N; Ishikawa, KL; Furuta, T; Fukasaku, K; Takagi, S; Noda, S; Himeno, R; Fukuda, S				Maeyama, T.; Fukunishi, N.; Ishikawa, K. L.; Furuta, T.; Fukasaku, K.; Takagi, S.; Noda, S.; Himeno, R.; Fukuda, S.			Radiological characteristics of MRI-based VIP polymer gel under carbon beam irradiation	RADIATION PHYSICS AND CHEMISTRY			English	Article						PHITS; Gel dosimeter; Dose-averaged LET; Three-dimensional dose distribution; LET dependence; Dose verification	PROFILE MEASUREMENTS; ION RADIOTHERAPY; DOSE MEASUREMENTS; PHOTON BEAMS; X-RAY; DOSIMETRY; DETECTOR; PROTON	We study the radiological characteristics of VIP polymer gel dosimeters under carbon beam irradiation with energy of 135 and 290 AMeV. To evaluate dose response of VIP polymer gels, the transverse (or spin-spin) relaxation rate R-2 of the dosimeters measured by magnetic resonance imaging (MRI) as a function of linear energy transfer (LET), rather than penetration depth, as is usually done in previous reports. LET is evaluated by use of the particle transport simulation code PHITS. Our results reveal that the dose response decreases with increasing dose-averaged LET and that the dose response-LET relation also varies with incident carbon beam energy. The latter can be explained by taking into account the contribution from fragmentation products. (C) 2014 Elsevier Ltd. All rights reserved.	[Maeyama, T.; Fukunishi, N.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Ishikawa, K. L.; Fukasaku, K.; Takagi, S.; Noda, S.; Himeno, R.] RIKEN, Adv Ctr Comp & Commun, Wako, Saitama 3510198, Japan; [Ishikawa, K. L.] Univ Tokyo, Grad Sch Engn, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo 1138656, Japan; [Furuta, T.] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan; [Fukasaku, K.] Himonya Hosp, Dept Neurosurg, Meguro Ku, Tokyo 1520013, Japan; [Takagi, S.] Univ Tokyo, Grad Sch Engn, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Fukuda, S.] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan	Maeyama, T (reprint author), RIKEN, Nishina Ctr Accelerator Based Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	maeyama@riken.jp			MEXT, Japan; RIKEN;  [B-16310036]	This research has been carried out as a Research Project with Heavy Ions at NIRS-HIMAC. This research was supported by Research and Development of the Next-Generation Integrated Simulation of Living Matter, which is a part of the development and use of the Next-Generation Supercomputer Project of MEXT, Japan, as well as by RIKEN President's Discretionary Fund (Strategic Programs for R&D). TF and TM gratefully acknowledge support by the RIKEN Special Postdoctoral Researchers Program. TM also acknowledges support by The Grant-in-Aid for Young Scientists (B-16310036).	Pappas E, 1999, PHYS MED BIOL, V44, P2677, DOI 10.1088/0031-9155/44/10/320; Baldock C, 2010, PHYS MED BIOL, V55, pR1, DOI 10.1088/0031-9155/55/5/R01; Matsufuji N, 2003, PHYS MED BIOL, V48, P1605, DOI 10.1088/0031-9155/48/11/309; MacDougall N, 2002, PHYS MED BIOL, V47, pR107, DOI 10.1088/0031-9155/47/20/201; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Pappas E, 2008, MED PHYS, V35, P4640, DOI 10.1118/1.2977829; Minohara S, 2010, J RADIAT RES, V51, P385, DOI 10.1269/jrr.10028; Armstrong T.W., 1973, ORNL4869; Baker CR, 2009, APPL RADIAT ISOTOPES, V67, P402, DOI 10.1016/j.apradiso.2008.06.031; DENKLEEF JJEI, 1987, MAGNET RESON MED, V5, P513; Jensen JLWV, 1906, ACTA MATH-DJURSHOLM, V30, P175, DOI 10.1007/BF02418571; Kanai T, 2004, PHYS MED BIOL, V49, P771, DOI 10.1088/0031-9155/49/5/008; Kantemiris I, 2009, Journal of Physics: Conference Series, V164, DOI 10.1088/1742-6596/164/1/012055; Karaiskos P, 2005, PHYS MED BIOL, V50, P1235, DOI 10.1088/0031-9155/50/6/013; Kennan R.P., 1992, P INT SOC MAGN RES M; Kipouros P, 2001, PHYS MED BIOL, V46, P2143, DOI 10.1088/0031-9155/46/8/308; Kozicki M, 2007, MACROMOL SYMP, V254, P345, DOI 10.1002/masy.200750850; Linz U., 2012, ION BEAM THERAPY FUN; Maeyama T., 2014, HOUSYASENKAGAKU, V98, P11; Maeyama T, 2014, RADIAT PHYS CHEM, V96, P92, DOI 10.1016/j.radphyschem.2013.09.004; Maryanski M.J., 1992, P INT SOC MAGN RES M; Pantelis E, 2008, MED PHYS, V35, P2312, DOI 10.1118/1.2919099; Papagiannis P, 2001, MED PHYS, V28, P1416, DOI 10.1118/1.1382603; Papoutsaki MV, 2013, PHYS MEDICA, V29, P453, DOI 10.1016/j.ejmp.2013.01.003; Papoutsaki MV, 2013, J PHYS CONF SER, V444, DOI 10.1088/1742-6596/444/1/012088; Pappas E, 2003, PHYS MED BIOL, V48, pN65, DOI 10.1088/0031-9155/48/5/401; Pappas E, 2001, PHYS MED BIOL, V46, P783, DOI 10.1088/0031-9155/46/3/313; Pappas E, 2005, MED PHYS, V32, P1513, DOI 10.1118/1.1916048; Pappas E, 2006, MED PHYS, V33, P3700, DOI [10.1118/1.2349691, 10.1118/1.234969]; Petrokokkinos L, 2009, J INSTRUM, V4, DOI 10.1088/1748-0221/4/06/P06018; Ramm U, 2004, RADIOTHER ONCOL, V73, pS99, DOI 10.1016/S0167-8140(04)80025-2; Ramm U, 2000, PHYS MED BIOL, V45, pN95, DOI 10.1088/0031-9155/45/9/401; Ryuto H, 2008, PLANT BIOTECHNOL, V25, P119, DOI 10.5511/plantbiotechnology.25.119; Vandecasteele J, 2013, PHYS MED BIOL, V58, P19, DOI 10.1088/0031-9155/58/1/19	34	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-806X			RADIAT PHYS CHEM	Radiat. Phys. Chem.	FEB	2015	107						7	11		10.1016/j.radphyschem.2014.09.001		5	Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical	Chemistry; Nuclear Science & Technology; Physics	AY4XN	WOS:000347578500002		
J	Rammah, YS; Ashraf, O; Abdalla, AM; Eisa, M; Ashry, AH; Tsuruta, T				Rammah, Y. S.; Ashraf, O.; Abdalla, A. M.; Eisa, M.; Ashry, A. H.; Tsuruta, T.			Fast detection of alpha particles in DAM-ADC nuclear track detectors	RADIATION PHYSICS AND CHEMISTRY			English	Article						Fission fragments; Alpha particles; DAM-ADC; Etching efficiency	ALLYL DIGLYCOL CARBONATE; DIALLYL PHTHALATE RESIN; CR-39; COPOLYMERS	Fast detection of alpha particles in DAM-ADC nuclear track detectors using a new chemical etchant was investigated. Cf-252 and Am-241 sources were used for irradiating samples of DAM-ADC SSNTDs with fission fragments and alpha particles in air at normal temperature and pressure. A series of experimental chemical etching are carried out using new etching solution (8 ml of 10 N NaOH+ 1 ml CH3OH) at 60 degrees C to detect alpha particle in short time in DAM-ADC detectors. Suitable analyzing software has been used to analyze experimental data. From fission and alpha track diameters, the value of bulk etching rate is equal to 8.52 mu m/h. Both of the sensitivity and etching efficiency were found to vary with the amount of methanol in the etching solution and etching time. The DAM-ADC detectors represent the best efficiency applicable in detectors in the entire range of alpha energies (from 1 to 5 MeV). The activation energies of this etchant have been calculated; track activation energy, E-T, has been found to be lower than the bulk activation energy, E-B, for the DAM-ADC nuclear track detectors. These results are in more agreement with the previous work. (C) 2014 Elsevier Ltd. All rights reserved.	[Rammah, Y. S.] Menoufia Univ, Fac Sci, Dept Phys, Shibin Al Kawm, Egypt; [Rammah, Y. S.] TU Berlin, Ctr Astron & Astrophys, Berlin, Germany; [Rammah, Y. S.] British Univ Egypt, Ctr Theoret Phys, Sherouk City 11837, Egypt; [Ashraf, O.; Abdalla, A. M.; Eisa, M.; Ashry, A. H.] Ain Shams Univ, Fac Educ, Dept Phys, Cairo, Egypt; [Abdalla, A. M.] Najran Univ, Fac Sci & Arts, Dept Phys, Najran, Saudi Arabia; [Abdalla, A. M.] Najran Univ, Fac Sci & Arts, Promising Ctr Sensors & Elect Devices, Najran, Saudi Arabia; [Tsuruta, T.] Kinki Univ, Atom Energy Res Inst, Higashiosaka, Osaka 5778502, Japan	Rammah, YS (reprint author), Menoufia Univ, Fac Sci, Dept Phys, Shibin Al Kawm, Egypt.	dr_yasser1974@yahoo.com					Nikezic D, 2004, MAT SCI ENG R, V46, P51, DOI 10.1016/j.mser.2004.07.003; Price PB, 2005, RADIAT MEAS, V40, P146, DOI 10.1016/j.radmeas.2005.05.003; Szydlowski A, 2013, RADIAT MEAS, V50, P258, DOI 10.1016/j.radmeas.2012.03.013; Yu KN, 2005, RADIAT MEAS, V40, P380, DOI 10.1016/j.radmeas.2005.03.011; Ashry AH, 2012, NUCL INSTRUM METH B, V290, P39, DOI 10.1016/j.nimb.2012.08.021; Ashry AH, 2014, RADIAT PHYS CHEM, V101, P41, DOI 10.1016/j.radphyschem.2014.03.037; Durrani S. A., 1987, SOLID STATE NUCL TRA; El-Badry BA, 2007, PRAMANA-J PHYS, V69, P669, DOI 10.1007/s12043-007-0165-7; El-Hawary MM, 1999, RADIAT PHYS CHEM, V54, P547, DOI 10.1016/S0969-806X(98)00292-8; El-Samman H, 2014, RADIAT PHYS CHEM, V102, P79, DOI 10.1016/j.radphyschem.2014.04.022; Fleischer R. L., 1975, NUCL TRACKS SOLID; Gaillard S, 2005, RADIAT RES, V163, P343, DOI 10.1667/RR3307; Matiullah, 2005, RADIAT MEAS, V39, P551, DOI 10.1016/j.radmeas.2004.10.009; Neerja, 2007, RADIAT MEAS, V42, P135, DOI 10.1016/j.radmeas.2006.08.007; PORTWOOD T, 1986, NUCL TRACKS RAD MEAS, V12, P109; Price P. B., 2008, RADIAT MEAS, V43, P13; SADOWSKI M, 1994, NUCL INSTRUM METH B, V86, P311, DOI 10.1016/0168-583X(94)95295-7; Tse KCC, 2007, NUCL INSTRUM METH B, V263, P300, DOI 10.1016/j.nimb.2007.04.307; Tsuruta T, 1999, RADIAT MEAS, V31, P99, DOI 10.1016/S1350-4487(99)00108-0; Tsuruta T, 2011, RADIAT MEAS, V46, P59, DOI 10.1016/j.radmeas.2010.07.033; Tsuruta T, 2000, RADIAT MEAS, V32, P289, DOI 10.1016/S1350-4487(00)00037-8; Yu K.N., 2009, NUCL TRACK DETECTORS, P133	22	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-806X			RADIAT PHYS CHEM	Radiat. Phys. Chem.	FEB	2015	107						183	188		10.1016/j.radphyschem.2014.10.013		6	Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical	Chemistry; Nuclear Science & Technology; Physics	AY4XN	WOS:000347578500029		
J	Tsuyama, I; Higa, M; Nakao, K; Matsui, T; Horikawa, M; Tanaka, N				Tsuyama, Ikutaro; Higa, Motoki; Nakao, Katsuhiro; Matsui, Tetsuya; Horikawa, Masahiro; Tanaka, Nobuyuki			How will subalpine conifer distributions be affected by climate change? Impact assessment for spatial conservation planning	REGIONAL ENVIRONMENTAL CHANGE			English	Article						Tsuga diversifolia; Abies veitchii; Potential habitat; Adaptation measures; Natural parks and reserves; Gap analysis	SPECIES DISTRIBUTION; JAPAN; DIVERSITY; CANADA; SCENARIOS; FORESTS; SYSTEMS; EUROPE	The objective of this study was to assess the impact of climate change on keystone subalpine conifers, Tsuga diversifolia and Abies veitchii, incorporating the uncertainties of general circulation models (GCMs) for spatial conservation planning in Japan. Potential habitats for T. diversifolia and A. veitchii under current and 20 GCMs in 2080-2100 were predicted using generalized additive models. We counted the number of GCMs under which current potential habitat was predicted to lose by a spatial unit and used them as indices of vulnerability and prediction uncertainty. Gaps between protected areas and potential habitats under the future climates were identified. Reasonably accurate models revealed that T. diversifolia and A. veitchii require cool and wet summers with low winter precipitation. Only less than 1 % of current potential habitats for the species were predicted to be sustainable with low GCMs-related uncertainties. Most of these certainly sustainable habitats were designated as protected areas. Of current potential habitats for T. diversifolia and A. veitchii, 88 and 97 % were predicted to be non-habitats under future climates with low GCMs-related uncertainties. These certainly vulnerable habitats included the southern and low elevated northern range limits of the species, of which 70 % were designated as protected areas. These results suggest that subalpine conifers are vulnerable to the climate change irrespective of GCMs variation. Strengthening of monitoring may be necessary, especially at unprotected and certainly vulnerable habitats in lower subalpine areas where influences of the climate change will appear first. Active management including assisted regeneration may be necessary for preserving the vulnerable and genetically endemic populations.	[Tsuyama, Ikutaro; Tanaka, Nobuyuki] Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Toyohira Ku, Sapporo, Hokkaido 0628516, Japan; [Higa, Motoki] Kochi Univ, Plant Ecol Lab, Fac Sci, Kochi 7808520, Japan; [Nakao, Katsuhiro; Matsui, Tetsuya] Forestry & Forest Prod Res Inst, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan; [Horikawa, Masahiro] Toyota Motor Co Ltd, Toyota Biotechnol & Afforestat Lab, Miyosi, Aichi 4700201, Japan	Tsuyama, I (reprint author), Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Toyohira Ku, 7 Hitsujigaoka, Sapporo, Hokkaido 0628516, Japan.	itsuyama@affrc.go.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-8]	We thank Mr Hiromu Daimaru, Dr Masatsugu Yasuda, and Ms Etsuko Nakazono for their valuable comments on this study. We also thank anonymous reviewers and editors for their useful comments. This research was supported by the Environment Research and Technology Development Fund (S-8) of the Ministry of the Environment, Japan.	Aizawa M, 2005, J PHYTOGEOGR TAXON, V53, P13; Chape S, 2005, PHILOS T ROY SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Iverson LR, 1998, ECOL MONOGR, V68, P465, DOI 10.1890/0012-9615(1998)068[0465:PAOTSF]2.0.CO;2; Hannah L, 2002, GLOBAL ECOL BIOGEOGR, V11, P485, DOI 10.1046/j.1466-822X.2002.00306.x; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Lepage BA, 2003, BOT J LINN SOC, V141, P257, DOI 10.1046/j.1095-8339.2003.00131.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Begon M, 1996, ECOLOGY INDIVIDUALS; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE; Burnham K. P., 1998, MODEL SELECTION MULT; Caro T., 2010, CONSERVATION PROXY I; Fujii S, 2012, GENETIC STRUCTURE PO; Hayashi Y, 1951, B GOV FOR EXP STA, V47, P1; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; IPCC, 2001, CLIMATE CHANGE 2001; Japan Meteorological Agency, 1996, CLIM NORM JAP; KANZAKI M, 1984, BOT MAG TOKYO, V97, P297, DOI 10.1007/BF02488663; Kira T., 1948, KANTI NOGAKU, V2, P143; Lemieux CJ, 2005, CAN GEOGR-GEOGR CAN, V49, P384, DOI 10.1111/j.0008-3658.2005.00103.x; Matsui T, 2009, APPL VEG SCI, V12, P328, DOI 10.1111/j.1654-109X.2009.01027.x; R Development Core Team, 2011, R VERS 2 12 2; Saruki S, 2004, B KYUSHU U FOR, V85, P47; Scott D, 2005, FOREST CHRON, V81, P696; Sohma K, 1987, EXPLANATORY TEXT QUA, P80; Sugita H, 2002, SNOW ENV PLANT ECOLO, P74; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tanaka N, 2009, GLOB ENV RES, V14, P153; Tanaka N, 2012, BIODIVERS ECOL, V4, P308, DOI [10.7809/b-e.00104, DOI 10.7809/B-E.00104]; Tatewaki M, 1964, RES B COLL EXP HOKKA, V23, P83; Tsuyama I, 2014, J FOREST RES-JPN, V19, P154, DOI 10.1007/s10310-013-0399-9; Tsuyama I, 2011, ANN FOREST SCI, V68, P689, DOI 10.1007/s13595-011-0086-y; Tsuyama I, 2012, J FOREST RES-JPN, V17, P137, DOI 10.1007/s10310-011-0283-4; Wood S. N, 2006, GEN ADDITIVE MODELS; Woodward FI, 1996, CLIMATE PLANT DISTRI; Yokoyama Shotaro, 2001, Forest Ecology and Management, V140, P93, DOI 10.1016/S0378-1127(00)00279-6	47	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-3798	1436-378X		REG ENVIRON CHANGE	Reg. Envir. Chang.	FEB	2015	15	2					393	404		10.1007/s10113-014-0641-9		12	Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology	AY6XE	WOS:000347705300015		
J	Tareque, MI; Islam, TM; Koshio, A; Kawahara, K				Tareque, Md. Ismail; Islam, Towfiqua Mahfuza; Koshio, Atsushi; Kawahara, Kazuo			Economic Well-Being and Elder Abuse in Rajshahi District of Bangladesh	RESEARCH ON AGING			English	Article						elder abuse and neglect; inequality; Bangladesh	QUALITY-OF-LIFE; SELF-RATED HEALTH; RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; MORTALITY; POPULATION; PREVALENCE; NEGLECT; CHILDHOOD; MORBIDITY	This article examines the distribution of wealth and then tests associations between elder abuse and wealth in Rajshahi district of Bangladesh. Data from 896 respondents (60 years old and over) were collected in April 2009. Principal component analysis was used to construct a wealth index, and logistic regressions were performed to test the associations between wealth and elder abuse. Results reveal that about 62% of individuals from poor households face abuse of some kind, whereas only 6% of individuals from rich households do. The test of the relationship between elder abuse and wealth also suggests that individuals from rich households were more likely not to be abused than individuals from poor households. Results of this study may be useful to policy makers developing policies and programs aimed at preventing elder abuse and reducing inequalities in elder abuse in Rajshahi district as well as in the whole of Bangladesh.	[Tareque, Md. Ismail] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Islam, Towfiqua Mahfuza; Kawahara, Kazuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hlth Policy Sci, Tokyo, Japan; [Koshio, Atsushi] Nippon Med Sch, Dept Hlth Policy & Management, Tokyo 113, Japan	Tareque, MI (reprint author), Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh.	tareque_pshd@yahoo.com					Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Amstadter AB, 2010, AM J GERIAT PSYCHIAT, V18, P615, DOI 10.1097/JGP.0b013e3181ca7ef2; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Bauldry S, 2012, SOC SCI MED, V75, P1311, DOI 10.1016/j.socscimed.2012.05.017; Rahman MO, 2003, GERONTOLOGIST, V43, P856; Corso PS, 2008, AM J PUBLIC HEALTH, V98, P1094, DOI 10.2105/AJPH.2007.119826; Lachs MS, 1997, GERONTOLOGIST, V37, P469; Post L, 2010, RES AGING, V32, P323, DOI 10.1177/0164027509357705; Dong XQ, 2009, JAMA-J AM MED ASSOC, V302, P517, DOI 10.1001/jama.2009.1109; ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839; Zimmer Z, 2008, SOC SCI MED, V66, P57, DOI 10.1016/j.socscimed.2007.08.032; PILLEMER K, 1988, GERONTOLOGIST, V28, P51; Lloyd-Sherlock P, 2000, SOC SCI MED, V51, P887, DOI 10.1016/S0277-9536(00)00068-X; Lachs MS, 2004, LANCET, V364, P1263, DOI 10.1016/S0140-6736(04)17144-4; Kabir ZN, 2000, INT J GERIATR PSYCH, V15, P441, DOI 10.1002/(SICI)1099-1166(200005)15:5<441::AID-GPS142>3.0.CO;2-O; Kendall-Tackett K, 2002, CHILD ABUSE NEGLECT, V26, P715, DOI 10.1016/S0145-2134(02)00343-5; Bollen KA, 2002, POP STUD-J DEMOG, V56, P81, DOI 10.1080/00324720213796; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9; KOSBERG JI, 1988, GERONTOLOGIST, V28, P43; Bangladesh Bureau of Statistics, 2011, REP HOUS INC EXP SUR; Bangladesh Bureau of Statistics, 2011, BANGL POP HOUS CENS; Buri H, 2006, RES AGING, V28, P562, DOI 10.1177/0164027506289722; Chokkanathan Srinivasan, 2005, J Elder Abuse Negl, V17, P45; Fox J., 1989, HLTH INEQUALITIES EU; Geriatric Center Nepal, 2010, BAS STUD REP CAS ELD; Gunnsteinsson S, 2010, J HEALTH POPUL NUTR, V28, P509; Halder AK, 2008, J HEALTH POPUL NUTR, V26, P64; HelpAge International, 2006, SOC PENS BANGL; Houweling TAJ, 2003, INT J EQUITY HEALTH, V2, P8, DOI [10.1186/1475-9276-2-8, DOI 10.1186/1475-9276-2-8]; Jamuna D, 2003, J Aging Soc Policy, V15, P125, DOI 10.1300/J031v15n02_08; Kabir M. H., 1996, ASIAN POPULATION STU, V145; Kabir M. H., 1994, AGEING ASIAN POPULAT, P52; LAHIRI DB, 1958, B INT STATIST INST, V36, P144; Lasheras C, 2001, EXP AGING RES, V27, P257; National Center on Elder Abuse, 2008, FREQ ASK QUEST WHAT; Neno Rebecca, 2005, Nurs Stand, V20, P43; Paranitharan P, 2009, Ceylon Med J, V54, P1; Parker T, 2004, AM INDIAN ALASKA NAT, V11, P1; Rahman K. M. M., 2010, Journal of Population and Social Studies, V19, P25; Rahman K. M. M., 2010, J INT WOMENS STUDIES, V11, P162; Rutstein S, 2004, DHS WEALTH INDEX; Schiamberg LB, 2000, INT J AGING HUM DEV, V50, P329; Tareque M. I., 2013, APPL DEMOGRAPHY PUBL, P257; Tareque M. I., 2009, SOCIODEMOGRAPHIC STA; Tareque M. I., 2008, INDIAN J GERONTOL, V22, P411; United Nations Population Division, 2010, WORLD POP PROSP 2010; World Health Organization, 2008, GLOB RESP ELD AB NEG; World Health Organization, 2002, ACT AG POL FRAM; World Health Organization, 2002, TOR DECL GLOB PREV E; Yan E, 2001, J INTERPERS VIOLENCE, V16, P1158, DOI 10.1177/088626001016011004; Yanagisawa S., 2012, J INT HLTH, V27, P141	52	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0164-0275	1552-7573		RES AGING	Res. Aging	FEB	2015	37	2					200	224		10.1177/0164027514527833		25	Gerontology	Geriatrics & Gerontology	AZ0UD	WOS:000347959400004		
J	Matsushima, N; Zhao, LX				Matsushima, Noriaki; Zhao, Laixun			Multimarket Linkages, Trade and the Productivity Puzzle	REVIEW OF INTERNATIONAL ECONOMICS			English	Article							INCENTIVES; MERGER; POWER	This paper examines the relationship between firms' productivity improvement and the volume of exports, and shows that it can be sometimes negative, which seems to be an empirical puzzle. The key lies in that we simultaneously take into account intermediate retailers (i.e. vertically) and multimarket linkages (i.e. horizontally). With convex cost functions, when market conditions worsen, the manufacturer increases supply to the retailer who is larger or more efficient in trade cost.	[Matsushima, Noriaki] Osaka Univ, Inst Social & Econ Res, Ibaraki, Osaka 5670047, Japan; [Zhao, Laixun] Kobe Univ, Res Inst Econ & Business, Kobe, Hyogo, Japan	Matsushima, N (reprint author), Osaka Univ, Inst Social & Econ Res, Mihogaoka 6-1, Ibaraki, Osaka 5670047, Japan.	nmatsush@iser.osaka-u.ac.jp	Matsushima, Noriaki/D-1819-2012	Matsushima, Noriaki/0000-0002-7865-3875			Ahn JaeBin, 2013, CAPACITY CONSTRAINED; Helpman E, 2004, AM ECON REV, V94, P300, DOI 10.1257/000282804322970814; Bernard AB, 2003, AM ECON REV, V93, P1268, DOI 10.1257/000282803769206296; Wagner J, 2007, WORLD ECON, V30, P60, DOI 10.1111/j.1467-9701.2007.00872.x; Lommerud KE, 2005, EUR ECON REV, V49, P717, DOI 10.1016/S0014-2921(03)00068-0; Melitz MJ, 2003, ECONOMETRICA, V71, P1695, DOI 10.1111/1468-0262.00467; Melitz MJ, 2008, REV ECON STUD, V75, P295, DOI 10.1111/j.1467-937X.2007.00463.x; RUBINSTEIN A, 1982, ECONOMETRICA, V50, P97, DOI 10.2307/1912531; HWANG H, 1990, AM ECON REV, V80, P567; Iyer G, 2003, J MARKETING RES, V40, P80, DOI 10.1509/jmkr.40.1.80.19134; BINMORE K, 1986, RAND J ECON, V17, P176, DOI 10.2307/2555382; DOBSON PW, 1994, EUR ECON REV, V38, P87, DOI 10.1016/0014-2921(94)90007-8; Ghemawat P, 2010, INT J IND ORGAN, V28, P415, DOI 10.1016/j.ijindorg.2010.03.013; HORN H, 1988, RAND J ECON, V19, P408, DOI 10.2307/2555664; Inderst R, 2007, EUR ECON REV, V51, P647, DOI 10.1016/j.euroecorev.2006.02.002; Marshall RC, 2004, INT ECON REV, V45, P239, DOI 10.1111/j.1468-2354.2004.00124.x; Matsushima N, 2014, J ECON BEHAV ORGAN, V106, P428, DOI 10.1016/j.jebo.2014.07.014; Soderbery Anson, 2013, MARKET SIZE STRUCTUR; Symeonidis G, 2010, INT J IND ORGAN, V28, P230, DOI 10.1016/j.ijindorg.2009.08.004	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0965-7576	1467-9396		REV INT ECON	Rev. Int. Econ.	FEB	2015	23	1					1	13		10.1111/roie.12155		13	Economics	Business & Economics	AZ2IM	WOS:000348057500001		
J	Ikeda, KT; Hirose, Y; Hiraoka, K; Noro, E; Fujishima, K; Tomita, M; Kanai, A				Ikeda, Kahori T.; Hirose, Yuka; Hiraoka, Kiriko; Noro, Emiko; Fujishima, Kosuke; Tomita, Masaru; Kanai, Akio			Identification, expression, and molecular evolution of microRNAs in the "living fossil" Triops cancriformis (tadpole shrimp)	RNA-A PUBLICATION OF THE RNA SOCIETY			English	Article						microRNA; deep sequencing; development; evolution; T. cancriformis	ARGONAUTE PROTEINS; SEQUENCE ALIGNMENT; ANIMAL DEVELOPMENT; SMALL RNAS; PREDICTION; GENOME; GENES; ANNOTATION; BIOGENESIS; ALGORITHMS	MicroRNAs have been identified and analyzed in various model species, but an investigation of miRNAs in nonmodel species is required for a more complete understanding of miRNA evolution. In this study, we investigated the miRNAs of the nonmodel species Triops cancriformis (tadpole shrimp), a "living fossil," whose morphological form has not changed in almost 200 million years. Dramatic ontogenetic changes occur during its development. To clarify the evolution of miRNAs, we comparatively analyzed its miRNAs and the components of its RNAi machinery. We used deep sequencing to analyze small RNA libraries from the six different developmental stages of T. cancriformis (egg, first-fourth instars, and adult), and also analyzed its genomic DNA with deep sequencing. We identified 180 miRNAs (87 conserved miRNAs and 93 novel candidate miRNAs), and deduced the components of its RNAi machinery: the DICER1, AGO1-3, PIWI, and AUB proteins. A comparative miRNA analysis of T. cancriformis and Drosophila melanogaster showed inconsistencies in the expression patterns of four conserved miRNAs. This suggests that although the miRNA sequences of the two species are very similar, their roles differ across the species. An miRNA conservation analysis revealed that most of the conserved T. cancriformis miRNAs share sequence similarities with those of arthropods, although T. cancriformis is called a "living fossil." However, we found that let-7 and DICER1 of T. cancriformis are more similar to those of the vertebrates than to those of the arthropods. These results suggest that miRNA systems of T. cancriformis have evolved in a unique fashion.	[Ikeda, Kahori T.; Hirose, Yuka; Hiraoka, Kiriko; Noro, Emiko; Fujishima, Kosuke; Tomita, Masaru; Kanai, Akio] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan; [Ikeda, Kahori T.; Hirose, Yuka; Tomita, Masaru; Kanai, Akio] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2520882, Japan; [Fujishima, Kosuke] NASA, Ames Res Ctr, Univ Affiliated Res Ctr, Moffett Field, CA 94043 USA; [Tomita, Masaru; Kanai, Akio] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa 2520882, Japan	Kanai, A (reprint author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan.	akio@sfc.keio.ac.jp			Yamagata Prefectural Government; Tsuruoka City, Japan; Japan Society for the Promotion of Science (JSPS)	We thank Keiji Igarashi (Tohoku University of Community Service and Science, Japan) for sharing his extensive knowledge of the tadpole shrimp. We also thank Dr. Yoshiki Ikeda (Institute for Advanced Biosciences, Keio University, Japan) for valuable discussions and technical assistance, and all the members of the RNA group at the Institute for Advanced Biosciences, Keio University, Japan, for their insightful discussions. This research was supported, in part, by research funds from the Yamagata Prefectural Government and Tsuruoka City, Japan, and a research grant from the Japan Society for the Promotion of Science (JSPS).	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ruan LW, 2011, FISH SHELLFISH IMMUN, V31, P334, DOI 10.1016/j.fsi.2011.05.023; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Mukherjee K, 2013, MOL BIOL EVOL, V30, P627, DOI 10.1093/molbev/mss263; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Marco A, 2013, NUCLEIC ACIDS RES, V41, P7745, DOI 10.1093/nar/gkt534; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; Nahvi A, 2009, RNA, V15, P814, DOI 10.1261/rna.1565109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Huang TZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-159; Igarashi K, 1971, J YAGAMATA AGR FORES, V28, P4; Korn M, 2013, MOL PHYLOGENET EVOL, V69, P1159, DOI 10.1016/j.ympev.2013.08.006; Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581; Mathers TC, 2013, PEERJ, V1, DOI 10.7717/peerj.62; Pfeffer S., 2005, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB2604S72; Schurko AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-78; Sempere Lorenzo F., 2003, Developmental Biology, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Takahashi F., 1975, ENV CONTROL BIOL, V13, P29; Takane K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-101; Wang Zhiguo, 2010, World J Biol Chem, V1, P41, DOI 10.4331/wjbc.v1.i4.41; Watanabe Y, 2008, PROG THEOR PHYS SUPP, P219, DOI 10.1143/PTPS.173.219	52	2	2	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA-Publ. RNA Soc.	FEB	2015	21	2					230	242		10.1261/rna.045799.114		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ2AG	WOS:000348036400008		
J	Mu, SC; Lyu, YH; Morihata, A				Mu, Shin-Cheng; Lyu, Yu-Han; Morihata, Akimasa			Approximate by thinning: Deriving fully polynomial-time approximation schemes	SCIENCE OF COMPUTER PROGRAMMING			English	Article						Approximation algorithms; Program derivation	OPTIMIZATION PROBLEMS; ALGORITHMS; MAXIMUM	The fully polynomial-time approximation scheme (FPTAS) is a class of approximation algorithms for optimisation problems that is able to deliver an approximate solution within any chosen ratio in polynomial time. By generalising Bird and de Moor's Thinning Theorem to a property between three orderings, we come up with a datatype-generic strategy for constructing fold-based FPTASs. Greedy, thinning, and approximation algorithms can thus be seen as a series of generalisations. Components needed in constructing an FPTAS are often natural extensions of those in the thinning algorithm, Design of complex FPTASs is thus made easier, and some of the resulting algorithms turn out to be simpler than those in previous works. (C) 2014 Elsevier B.V. All rights reserved.	[Mu, Shin-Cheng] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Lyu, Yu-Han] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA; [Morihata, Akimasa] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1138654, Japan	Mu, SC (reprint author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	scm@iis.sinica.edu.tw; yuhanlyu@cs.dartmouth.edu; morihata@graco.c.u-tokyo.ac.jp					AUSIELLO G, 1995, THEOR COMPUT SCI, V150, P1, DOI 10.1016/0304-3975(94)00291-P; IBARRA OH, 1975, J ACM, V22, P463, DOI 10.1145/321906.321909; GAREY MR, 1978, J ACM, V25, P499, DOI 10.1145/322077.322090; Woeginger GJ, 2000, INFORMS J COMPUT, V12, P57, DOI 10.1287/ijoc.12.1.57.11901; Mcbride C, 2008, J FUNCT PROGRAM, V18, P1, DOI 10.1017/S0956796807006326; NEMHAUSER GL, 1969, MANAGE SCI, V15, P494, DOI 10.1287/mnsc.15.9.494; HOROWITZ E, 1976, J ACM, V23, P317, DOI 10.1145/321941.321951; AUSIELLO G., 1999, COMPLEXITY APPROXIMA; Backhouse R.C., 1991, ALG METH SOFTW TECHN, P303; Backhouse R.C., 1991, P IFIP TC2 WG2 1 WOR, P287; Backhouse R.C., 1992, LECT NOTES COMPUTER, V755, P7; Bird R, 2002, LECT NOTES COMPUT SC, V2297, P281; Bird R, 2005, J FUNCT PROGRAM, V15, P679, DOI 10.1017/S0956796805005642; Bird RS, 2001, J FUNCT PROGRAM, V11, P411; Bird R.S, 1997, INT SER COMPUT SCI; Bird R.S., 1990, RES TOPICS FUNCTIONA, P287; Curtis S., 1997, IFIP TC2 WORK C ALG, P1; Curtis S., 1995, THESIS OXFORD U; deMoor O, 1995, LECT NOTES COMPUT SC, V982, P1; Doerr B., 2009, GECCO 09, P771; Escoffier B., 2010, COMPUT SCI REV, V4, P19; Gries D., 1993, LOGICAL APPROACH DIS; Halman N, 2008, PROCEEDINGS OF THE NINETEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P700; Halman N, 2009, OPER RES LETT, V37, P239, DOI 10.1016/j.orl.2009.03.002; Hinze R., 2000, S PRINC PROGR LANG B, P119; Ito T, 2005, INT J FOUND COMPUT S, V16, P803, DOI 10.1142/S0129054105003303; Jansson P., 1997, S PRINC PROGR LANG; Kleinberg J., 2005, ALGORITHM DESIGN; Korte B., 1981, NONLINEAR PROGRAMMIN, V4, P415; Morihata A, 2011, NEW GENERAT COMPUT, V29, P31, DOI 10.1007/s00354-010-0098-4; Mu SC, 2010, WGP 2010: PROCEEDINGS OF THE 2010 ACM SIGPLAN WORKSHOP ON GENERIC PROGRAMMING, P97; Sasano I., 2001, LECT NOTES COMPUTER, V2196, P72; Sasano I, 2000, ACM SIGPLAN NOTICES, V35, P137, DOI 10.1145/357766.351254; Williamson D.P., 2011, DESIGN APPROXIMATION	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6423	1872-7964		SCI COMPUT PROGRAM	Sci. Comput. Program.	FEB 1	2015	98		4				484	515		10.1016/j.scico.2014.07.001		32	Computer Science, Software Engineering	Computer Science	AY7LJ	WOS:000347741400003		
J	Miyabe, S; Ono, N; Makino, S				Miyabe, Shigeki; Ono, Nobutaka; Makino, Shoji			Blind compensation of interchannel sampling frequency mismatch for ad hoc microphone array based on maximum likelihood estimation	SIGNAL PROCESSING			English	Article						Ad hoc microphone array; Drift; Sampling frequency; Maximum likelihood estimation; Blind source separation		In this paper, we propose a novel method for the blind compensation of drift for the asynchronous recording of an ad hoc microphone array. Digital signals simultaneously observed by different recording devices have drift of the time differences between the observation channels because of the sampling frequency mismatch among the devices. On the basis of a model in which the time difference is constant within each short time frame but varies in proportion to the central time of the frame, the effect of the sampling frequency mismatch can be compensated in the short-time Fourier transform (STFT) domain by a linear phase shift. By assuming that the sources are motionless and have stationary amplitudes, the observation is regarded as being stationary when drift does not occur. Thus, we formulate a likelihood to evaluate the stationarity in the STFT domain to evaluate the compensation of drift. The maximum likelihood estimation is obtained effectively by a golden section search. Using the estimated parameters, we compensate the drift by STFT analysis with a noninteger frame shift. The effectiveness of the proposed blind drift compensation method is evaluated in an experiment in which artificial drift is generated. (C) 2014 The Authors. Published by Elsevier B.V.	[Miyabe, Shigeki; Makino, Shoji] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki 3058573, Japan; [Ono, Nobutaka] Grad Univ Adv Studies SOKENDAI, Dept Informat,Sch Multidisciplinary Sci, Principles Informat Res Div,Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan	Miyabe, S (reprint author), Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	miyabe@tara.tsukuba.ac.jp					Ono N, 2011, 2011 IEEE WORKSHOP ON APPLICATIONS OF SIGNAL PROCESSING TO AUDIO AND ACOUSTICS (WASPAA), P189, DOI 10.1109/ASPAA.2011.6082320; Vincent E, 2006, IEEE T AUDIO SPEECH, V14, P1462, DOI 10.1109/TSA.2005.858005; KUREMATSU A, 1990, SPEECH COMMUN, V9, P357, DOI 10.1016/0167-6393(90)90011-W; Raykar VC, 2005, IEEE T SPEECH AUDI P, V13, P70, DOI 10.1109/TSA.2004.838540; Bertrand A., 2011, P SCVT 2011; Brandstein References M., 2001, MICROPHONE ARRAYS SI; Hasegawa K, 2010, LECT NOTES COMPUT SC, V6365, P57, DOI 10.1007/978-3-642-15995-4_8; Hoflinger F, 2012, P IPIN 2012; Janson T., 2012, P IPIN 2012; Javidi S., 2011, FRONT NEUROSCI, V5, P25; Lienhart R., 2003, P ICASSP, P840; Liu Z., 2007, P IWAENC 2007; Liu ZC, 2007, INT CONF ACOUST SPEE, P761; Makino S, 2007, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-1-4020-6479-1; Markovich-Golan S., 2012, P IWAENC; Miyabe S., 2013, P WASPAA 2013; MIYABE S, 2013, P ICASSP, P674; Ono N., 2009, P IEEE WORKSH APPL S, P161; Robledo-Arnuncio E., 2007, P WASPAA, P21; Roy O, 2009, IEEE T SIGNAL PROCES, V57, P645, DOI 10.1109/TSP.2008.2009267; Schmalenstroeer J., 2013, P EUSIPCO 2013; Souden M., 2012, P MLSP 2012	22	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-1684	1879-2677		SIGNAL PROCESS	Signal Process.	FEB	2015	107				SI		185	196		10.1016/j.sigpro.2014.09.015		12	Engineering, Electrical & Electronic	Engineering	AY7SP	WOS:000347759500016		
J	Minemoto, T; Murata, M				Minemoto, Takashi; Murata, Masashi			Theoretical analysis on effect of band offsets in perovskite solar cells	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Solar cells; Perovskite; Device simulation; Band offset; Buffer layer; Hole transport material	HOLE-TRANSPORT; EFFICIENT; DEPOSITION; COMPOUND; ELECTRON; LAYERS; PERFORMANCE; ZN1-XMGXO; LENGTHS; FILMS	The effect of band offsets in CH3NH3PbI3-xClx perovskite-based solar cells with planar junction configuration was analyzed using one-dimensional device simulator. As widely known in thin-film compound solar cells, the band offset between buffer/absorber layers is a decisive factor for carrier recombination at the interface, determining open-circuit voltage (V-oc). In this study, the impact of two kinds of band offsets, i.e., the conduction band offset of buffer (or blocking layer)/absorber layers and the valence band offset of absorber/hole transport material (HTM) were examined. When the conduction band of the buffer was lower than that of the absorber, the interface recombination became prominent and V-oc decreased. In contrast when the conduction band of the buffer was higher than that of the absorber by more than 0.3 eV, the collection of photo-generated carriers, i.e. electron in this case, was impeded by the spike formed by the conduction band offset. Thus, the optimum position of the conduction band of the buffer was 0.0 similar to 0.3 eV higher than that of the absorber. Also, the optimum position of the valence band of the HTM was derived to be 0.0 similar to 0.2 eV lower than that of the absorber. These findings will be useful for new material choice and optimization of buffers and HTMs. (C) 2014 Elsevier B.V. All rights reserved.	[Minemoto, Takashi; Murata, Masashi] Ritsumeikan Univ, Dept Elect & Elect Engn, Shiga 5258577, Japan	Minemoto, T (reprint author), Ritsumeikan Univ, Dept Elect & Elect Engn, 1-1-1 Nojihigashi, Shiga 5258577, Japan.	minemoto@se.ritsumei.ac.jp; ro0009he@ed.ritsumei.ac.jp	Minemoto, Takashi/F-9342-2011				Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Minemoto T, 2003, SOL ENERG MAT SOL C, V75, P121, DOI 10.1016/S0927-0248(02)00120-4; You JB, 2014, ACS NANO, V8, P1674, DOI 10.1021/nn406020d; Snaith HJ, 2007, ADV MATER, V19, P3643, DOI 10.1002/adma.200602085; Altermatt PP, 2011, J COMPUT ELECTRON, V10, P314, DOI 10.1007/s10825-011-0367-6; Gloeckler M, 2005, THIN SOLID FILMS, V480, P241, DOI 10.1016/j.tsf.2004.11.018; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Minemoto T, 2013, CURR APPL PHYS, V13, P103, DOI 10.1016/j.cap.2012.06.019; Minemoto T, 2001, SOL ENERG MAT SOL C, V67, P83, DOI 10.1016/S0927-0248(00)00266-X; Dullweber T, 2001, THIN SOLID FILMS, V387, P11, DOI 10.1016/S0040-6090(00)01726-0; Poplavskyy D, 2003, J APPL PHYS, V93, P341, DOI 10.1063/1.1525866; Ball JM, 2013, ENERG ENVIRON SCI, V6, P1739, DOI 10.1039/c3ee40810h; Chirila A, 2011, NAT MATER, V10, P857, DOI [10.1038/nmat3122, 10.1038/NMAT3122]; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Burgelman M, 2000, THIN SOLID FILMS, V361, P527, DOI 10.1016/S0040-6090(99)00825-1; HIRASAWA M, 1994, PHYSICA B, V201, P427, DOI 10.1016/0921-4526(94)91130-4; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Rau U, 1999, APPL PHYS A-MATER, V69, P131, DOI 10.1007/s003390050984; Torndahl T, 2007, PROG PHOTOVOLTAICS, V15, P225, DOI 10.1002/pip.733; Klenk R, 2001, THIN SOLID FILMS, V387, P135, DOI 10.1016/S0040-6090(00)01736-3; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Minemoto T, 2001, J APPL PHYS, V89, P8327, DOI 10.1063/1.1366655; BASORE PA, 1990, IEEE T ELECTRON DEV, V37, P337, DOI 10.1109/16.46362; Edri E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4461; Hamazaki R, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC10; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI 10.1038/NPHOTON.2013.80; Hironiwa D., 2014, JPN J APPL PHYS, V53; Ikuno T., 2013, APPL PHYS LETT, V102; Liu D., 2013, NAT PHOTONICS, V8, P133, DOI DOI 10.1038/NPHOTON.2013.342; Minemoto T., 2014, J APPL PHYS, V116; Murata M., 2014, JPN J APPL PHYS, V53; Niemegeers A, 1997, J APPL PHYS, V81, P2881, DOI 10.1063/1.363946; Nollet P, 2003, THIN SOLID FILMS, V431, P414, DOI 10.1016/S0040-6090(03)00201-3; Repins I, 2008, PROG PHOTOVOLTAICS, V16, P235, DOI 10.1002/pip.822; Sinsermsuksakul P., 2013, APPL PHYS LETT, V102; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Tanaka K, 2009, SOL ENERGY, V83, P477, DOI 10.1016/j.solener.2008.09.003; Turcu M, 2003, J PHYS CHEM SOLIDS, V64, P1591, DOI 10.1016/S0022-3697(03)00137-9; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167; Yuan H.C., 2009, APPL PHYS LETT, V95	41	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	FEB	2015	133						8	14		10.1016/j.solmat.2014.10.036		7	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AZ1RH	WOS:000348015100003		
J	Moriwaki, K; Nomoto, M; Ishizuka, S; Mukai, A; Sato, K; Kobayashi, H; Niki, S				Moriwaki, Kenichi; Nomoto, Maki; Ishizuka, Shogo; Mukai, Atsushi; Sato, Keigo; Kobayashi, Hiroyuki; Niki, Shigeru			Effects of alkali-metal block layer to enhance Na diffusion into Cu(in,Ga)Se-2 absorber on flexible solar cells	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Cu(InxGa1-x)Se-2; Sodium diffusion mechanism; Alkali-metal block; High efficiency	THIN-FILMS	An alkali-metal containing (AC) layer, specifically sodium (Na), is necessary for improving Cu(InxGa1-x) Se-2 (CIGS) solar cell performance on an alkali-free flexible substrate. However, we found that Na from the AC precursor layer diffused not only into the CIGS absorber layer but also into our flexible metal foil substrate, the surface of which was covered with an Al2O3 layer, and thus creating Na depletion in the CIGS layer. In this work, newly developed alkali-metal block (AB) layers are introduced between the AC layers and the metal foil substrates in order to suppress Na diffusion into the substrates and enhance Na diffusion into the CIGS layers. Using different AB layer materials-Ti, TiO2, and TiN-and AC layers with systematically-varied thickness, Na concentrations in the CIGS layers and the solar cell efficiencies are investigated. Ti and TiN AB layers efficiently enhance the Na diffusion into the CIGS absorber layers. As a result, a high efficiency of 17.6% is obtained on the metal foil substrate using optimally prepared AC and AB layer of TiN. The AB layer controls the Na diffusion from the AC layer in one direction, and thus contributes to the precise control of Na concentrations in the CIGS layer. Hence, high efficiency solar cells on a variety of flexible substrates will be achieved comparable to those on soda-lime glass substrates. (C) 2014 Elsevier B.V. All rights reserved.	[Moriwaki, Kenichi; Nomoto, Maki; Mukai, Atsushi; Sato, Keigo; Kobayashi, Hiroyuki] FUJIFILM Corp, Frontier Core Technol Lab, Ashigarakami, Kanagawa 2588577, Japan; [Ishizuka, Shogo; Niki, Shigeru] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Moriwaki, K (reprint author), FUJIFILM Corp, Frontier Core Technol Lab, 577 Ushijima, Ashigarakami, Kanagawa 2588577, Japan.	kenichi.moriwaki@fujifilm.com			New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI)	The authors would like to thank A. Yamada, A. Obara, and S. Kimura (AIST) for help with experiments, and Dr. H. Komaki (AIST) for fruitful discussions. This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI).	Rudmann D, 2004, APPL PHYS LETT, V84, P1129, DOI 10.1063/1.1646758; Chirila A, 2011, NAT MATER, V10, P857, DOI [10.1038/nmat3122, 10.1038/NMAT3122]; Moriwaki K, 2013, SOL ENERG MAT SOL C, V112, P106, DOI 10.1016/j.solmat.2013.01.016; Contreras MA, 1997, IEEE PHOT SPEC CONF, P359, DOI 10.1109/PVSC.1997.654102; Niki S, 2010, PROG PHOTOVOLTAICS, V18, P453, DOI 10.1002/pip.969; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Ard MB, 2000, THIN SOLID FILMS, V361, P9; Ishizuka S., 2009, J APPL PHYS, V106, P1; Ishizuka S., 2008, APPL PHYS LETT, V93, P1; Kimura R, 1999, JPN J APPL PHYS 2, V38, pL899, DOI 10.1143/JJAP.38.L899; Kohara N, 1997, APPL PHYS LETT, V71, P835, DOI 10.1063/1.119661; Minoura S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4790174; Moriwaki Kenichi, 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Murakami N., 2011, P 37 IEEE PHOT SPEC, P402; Nomoto M., 2011, P 21 PVSEC FUK	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	FEB	2015	133						21	25		10.1016/j.solmat.2014.10.039		5	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AZ1RH	WOS:000348015100005		
J	Kumagai, A				Kumagai, Akira			Texturization using metal catalyst wet chemical etching for multicrystalline diamond wire sawn wafer	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Texture; Acidic texture; Metal catalyst texture (MCT); Slurry wire sawn wafer; Diamond wire sawn wafer	SILICON-WAFERS; SOLAR-CELLS	Acidic solution texture by HF/HNO3 has been wildly used for the multicrystalline-Si (mc-Si) solar cell mass production. But, acidic texturing is difficult for the diamond wire sawn wafer, because the damage layer does not homogeneously distribute on the diamond wire sawn wafer. Metal catalyst texture (MCT) using silver nitrate (AgNO3) is effective method even though the diamond wire sawn wafer. The texture with metal catalyst reaction is spontaneously formed irrespective of the wafer surface condition. In this article, fine texture structure is demonstrated for the diamond wire sawn wafer by the MCT method, texture structure is possible to control easily by changing the immersion time in the reaction container. The cell conversion efficiency for the diamond wire sawn wafer by the MCT is as high as that for the slurry wire sawn wafer by the acidic texture. The MCT is effective method for both the slurry and diamond wire sawn wafer. The MCT method will especially become most possible alternative candidate for the diamond wire sawn wafer. (C) 2014 Elsevier B.V. All rights reserved.	JET CO LTD, Dev Technol Dept, Proc Engn Sect, Satosho Cho, Okayama 7190302, Japan	Kumagai, A (reprint author), JET CO LTD, Dev Technol Dept, Proc Engn Sect, 6078 Kanayama, Satosho Cho, Okayama 7190302, Japan.	akira_kumagai@jetcoltd.co.jp					Ruby DS, 2002, SOL ENERG MAT SOL C, V74, P133, DOI 10.1016/S0927-0248(02)00057-0; Watanabe N, 2010, PROG PHOTOVOLTAICS, V18, P485, DOI 10.1002/pip.923; Basore P.A., 1996, P 25 PHOT SPEC C WAS, P449; Chou Y.C., 2011, THIRTY SEVENTH PHOTO, P19; Chuck Hsul W., 2013, INT J PHOTOENERGY, V2012, P7; De Wolf S., 2000, P 16 EUR PHOT SOL EN; Junghanel M., 2010, TWENTY FIFTH EUROPEA, p2637 ; Lippold M, 2014, SOL ENERG MAT SOL C, V127, P104, DOI 10.1016/j.solmat.2014.04.006; Nishimoto Y., 2009, TWENTY FOURTH EUROPE, P21; Shirasawa K., 1997, FOURTEENTH EUROPEAN, P384; Watanabe R, 2013, INT J PHOTOENERGY, DOI 10.1155/2013/951303	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	FEB	2015	133						216	222		10.1016/j.solmat.2014.11.008		7	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AZ1RH	WOS:000348015100031		
J	Chantana, J; Hironiwa, D; Watanabe, T; Teraji, S; Kawamura, K; Minemoto, T				Chantana, Jakapan; Hironiwa, Daisuke; Watanabe, Taichi; Teraji, Seiki; Kawamura, Kazunori; Minemoto, Takashi			Controlled back slope of Ga/(In plus Ga) profile in Cu(In,Ga)Se-2 absorber fabricated by multi layer precursor method for improvement of its photovoltaic performance	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Cu(In,Ga)Se-2; Thin-film solar cells; Ga/(In plus Ga) profile; Average Ga/(In plus Ga); Space charge region; Multi layer precursor method	SOLAR-CELLS; THIN-FILMS	Cu(In,Ga)Se-2 (CIGS) absorbers with several Ga/III, Ga/(In+Ga) ratio, profiles were deposited by the so called "multi layer precursor method" consisting of Ga-Se/In-Se/Cu-Se stacks. The effects of average Ga/ III ratios and back slopes of the Ga/III profiles on the photovoltaic performance were investigated. The optimum average Ga/III ratio of approximately 0.36 leads to the appropriate average band-gap energy as well as sufficiently long carrier lifetime in CIGS absorber, thus enhancing open-circuit voltage. In addition, the back slope of 0.50 mu m(-1), defined as the ratio of the change in Ga/III ratio to the change in the depth range from 1 to 2 mu m from CIGS surface, induces back surface field of 0.34 V/mu m, thereby increasing short-circuit current density. Ultimately, the CIGS absorber on flexible stainless steel substrate with the double graded Ga/III profile (the average Ga/III of 0.36 and the back slope of 0.50 mu m(-1)) was fabricated by the multi layer precursor method. This results in the 14.36%-efficient CIGS solar cell on the flexible substrate without an anti-reflective layer. (C) 2014 Elsevier B.V. All rights reserved.	[Chantana, Jakapan; Hironiwa, Daisuke; Minemoto, Takashi] Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan; [Watanabe, Taichi; Teraji, Seiki; Kawamura, Kazunori] Nitto Denko Corp, Environm & Energy Res Ctr, Suita, Osaka 5650871, Japan	Chantana, J (reprint author), Ritsumeikan Univ, Dept Elect & Elect Engn, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	jakapan@fc.ritsumei.ac.jp; hironiwa@fc.ritsumetac.jp; taichi_watanabe@gg.nitto.co.jp; seiki_teraji@gg.nitto.co.jp; kazunori_kawamura@gg.nitto.co.jp; minemoto@se.ritsumei.ac.jp	Minemoto, Takashi/F-9342-2011; Chantana, Jakapan/O-5110-2015	Chantana, Jakapan/0000-0002-5711-4979	NEDO (New Energy and Industrial Technology Development Organization) in Japan	This work is supported by the NEDO (New Energy and Industrial Technology Development Organization) in Japan.	Ogawa Y, 1996, APPL SURF SCI, V92, P232, DOI 10.1016/0169-4332(95)00236-7; Heath JT, 2002, APPL PHYS LETT, V80, P4540, DOI 10.1063/1.1485301; Hsieh TP, 2011, SOLID STATE ELECTRON, V56, P175, DOI 10.1016/j.sse.2010.11.019; Rudmann D, 2004, APPL PHYS LETT, V84, P1129, DOI 10.1063/1.1646758; Minemoto T, 2001, SOL ENERG MAT SOL C, V67, P83, DOI 10.1016/S0927-0248(00)00266-X; Chantana J, 2014, SOL ENERG MAT SOL C, V130, P567, DOI 10.1016/j.solmat.2014.08.012; Chirila A, 2011, NAT MATER, V10, P857, DOI [10.1038/nmat3122, 10.1038/NMAT3122]; Rudmann D, 2003, THIN SOLID FILMS, V431, P37, DOI 10.1016/S0040-6090(03)00246-3; Hashimoto Y, 1996, JPN J APPL PHYS 1, V35, P4760, DOI 10.1143/JJAP.35.4760; Pianezzi F, 2012, PROG PHOTOVOLTAICS, V20, P253, DOI 10.1002/pip.1247; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; Powalla M, 2013, SOL ENERG MAT SOL C, V119, P51, DOI 10.1016/j.solmat.2013.05.002; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Chantana J., 2014, JPN J APPL PHYS, V53; Chantana J., 2013, PHYS LETT, V103; Chantana J, 2013, J APPL PHYS, V114; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/nmat3789, 10.1038/NMAT3789]; Hasoon E.S., 2005, APPL PHYS LETT, V87; Salome P.M., 2014, PROG PHOTOV RES APPL; Vallat-Sauvain E., 2006, THIN FILM SOLAR CELL, P1	21	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	FEB	2015	133						223	228		10.1016/j.solmat.2014.11.023		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AZ1RH	WOS:000348015100032		
J	Zheng, HJ; Tsukahara, M; Liu, E; Ye, LY; Xiong, H; Noguchi, S; Suzuki, K; Ji, ZS				Zheng, Hua-Jun; Tsukahara, Masatoshi; Liu, Enuo; Ye, Luyi; Xiong, Hui; Noguchi, Shigeru; Suzuki, Koichi; Ji, Zai-Si			The Novel Helicase helG (DHX30) Is Expressed During Gastrulation in Mice and Has a Structure Similar to a Human DExH Box Helicase	STEM CELLS AND DEVELOPMENT			English	Article							PRE-MESSENGER-RNA; TRANSLATION INITIATION; ENCEPHALOMYOCARDITIS VIRUS; MOUSE DEVELOPMENT; MALELESS PROTEIN; GENE; DISRUPTION; DROSOPHILA; SEQUENCE; MUTATION	The gene trap method for embryonic stem cells is an efficient method for identifying new genes that are involved in development. Using this method, we identified a novel gene called helicase family gene related to gastrulation (helG). Helicase family proteins regulate many systems in the body that are related to cell survival. HelG encodes a protein of 137 kDa, which contains a DExH helicase motif that is now named DHX30. HelG is strongly expressed in neural cells (ie, in the headfold, neural plate, neural tube, and brain) and somites during embryogenesis. Growing homozygous mutant embryos have neither differentiated somites nor brains. In these mutants, development was retarded by embryonic day 7.5 (E7.5), and the mutants died at E9.5. After the purification of HelG, an untwisting experiment was performed to confirm the helicase activity of HelG for DNA in vitro. We report for the first time that a helicase family gene is required for differentiation during embryogenesis; this gene might interact with polynucleotides to regulate some genes that are important for early development and has a structure similar to that of a human DExH box helicase.	[Zheng, Hua-Jun; Liu, Enuo; Ye, Luyi; Ji, Zai-Si] Shanghai Inst Planned Parenthood Res, Lab Med Food, Shanghai 200032, Peoples R China; [Zheng, Hua-Jun; Xiong, Hui] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Tsukahara, Masatoshi] Trop Technol Ctr Ltd, Div Res & Dev, Uruma, Okinawa, Japan; [Noguchi, Shigeru; Ji, Zai-Si] Meiji Dairies Corp, Div Res & Dev, Odawara, Kanagawa, Japan; [Suzuki, Koichi] Nihon Univ, Coll Bioresource Sci, Dept Food BioSci & BioTechnol, Fujisawa, Kanagawa, Japan	Ji, ZS (reprint author), Shanghai Inst Planned Parenthood Res, Lab Med Food, 2140 Xie Tu Rd, Shanghai 200032, Peoples R China.	zai-si_ji@kta.biglobe.ne.jp					Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; NIELSEN PJ, 1988, EMBO J, V7, P2097; Minabe-Saegusa C, 1998, DEV GROWTH DIFFER, V40, P343; Lee CG, 1998, P NATL ACAD SCI USA, V95, P13709, DOI 10.1073/pnas.95.23.13709; TOONE WM, 1991, J BACTERIOL, V173, P3291; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; KIM DG, 1992, MOL CELL BIOL, V12, P3636; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; LEE CG, 1993, J BIOL CHEM, V268, P16822; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; FAUST C, 1995, DEVELOPMENT, V121, P273; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0; Varlet I, 1997, DEVELOPMENT, V124, P1033; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; JANG SK, 1988, J VIROL, V62, P2636; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Guenther UP, 2009, HUM MOL GENET, V18, P1288, DOI 10.1093/hmg/ddp028; Parsyan A, 2009, P NATL ACAD SCI USA, V106, P22217, DOI 10.1073/pnas.0909773106; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Zhang SS, 1997, J BIOL CHEM, V272, P11487; SUEMORI H, 1995, MECH DEVELOP, V51, P265, DOI 10.1016/0925-4773(95)00371-1; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; BALLYCUIF L, 1993, DEVELOPMENT, V117, P543; CHEN JH, 1990, NUCLEIC ACIDS RES, V18, P6447, DOI 10.1093/nar/18.21.6447; de Boer J, 1998, CANCER RES, V58, P89; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Kanaar R, 1996, CURR BIOL, V6, P828, DOI 10.1016/S0960-9822(02)00606-1; Kaneko H, 1997, BIOCHEM BIOPH RES CO, V240, P348, DOI 10.1006/bbrc.1997.7648; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; Kudlinzki D, 2012, BIOL CHEM, V393, P1131, DOI 10.1515/hsz-2012-0158; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; LEE JJ, 1992, DEVELOPMENT, V115, P277; Morgan R, 1997, DEVELOPMENT, V124, P2751; PAUSE A, 1993, MOL CELL BIOL, V13, P6789; Saegusa H, 1996, DEV BIOL, V174, P55, DOI 10.1006/dbio.1996.0051; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; TEIGELKAMP S, 1994, EMBO J, V13, P888; Tsukahara M, 2000, GENE, V254, P45, DOI 10.1016/S0378-1119(00)00259-6; Tsukahara M, 2001, DEV GROWTH DIFFER, V43, P285; Wang X, 1996, DEV BIOL, V177, P274, DOI 10.1006/dbio.1996.0162; ZHANG SS, 1995, J BIOL CHEM, V270, P16422; Zhou YD, 2008, VIROLOGY, V372, P97, DOI 10.1016/j.virol.2007.10.027	52	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	FEB 1	2015	24	3					372	383		10.1089/scd.2014.0077		12	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	AZ9CO	WOS:000348509100009		
J	Hata, M; Shiono, M; Akiyama, K; Sezai, A; Wakui, S; Kimura, H; Sekino, H				Hata, Mitsumasa; Shiono, Motomi; Akiyama, Kenji; Sezai, Akira; Wakui, Shinji; Kimura, Haruka; Sekino, Hisakuni			Incidence of Drug Interaction When Using Proton Pump Inhibitor and Warfarin According to Cytochrome P450 2C19 (CYP2C19) Genotype in Japanese	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						open heart surgery; anticoagulant therapy; proton pump inhibitor	OPEN-HEART-SURGERY; S-MEPHENYTOIN 4'-HYDROXYLATION; RANDOMIZED-TRIAL; COMPLICATIONS; METABOLISM; OMEPRAZOLE; ANTICOAGULATION	Objectives The US Food and Drug Administration has suggested that proton pump inhibitors (PPIs) increase the international normalized ratio (INR) when used concomitantly with warfarin (WF) because of being metabolized by cytochrome P450 2C19 (CYP2C19). We assessed whether CYP2C19 genotypes and type of PPI accentuated the drug interaction. Methods and Results The study group was 82 patients who needed WF after surgery and had their CYP2C19 genotypes analyzed in advance. We randomly divided them into two groups: group I (n = 41) included patients who had lansoprazole 15 mg/day and group II (n = 41) included patients who had rabeprazole 10 mg/day. The dose of WF was controlled by the doctor in charge as a target INR of 1.6 to 2.6 during the 2 months after surgery. The maximum INR was significantly higher in group I (3.36 +/- 0.98) than in group II (2.29 +/- 0.55, p < 0.0001). The incidence of over-INR (> 3.5) was significantly higher in group I (15 cases) than in group II (2 cases, p = 0.0001). Several bleeding events complicated 10 patients in group I, but none in group II (p = 0.015). Logistic regression analysis revealed that over-INR (odds ratio [OR] 3.58, 95% confidence interval [CI]: 3.48-368.25, p < 0.0001), and pair of lansoprazole and CYP2C19 intermediate metabolizer (OR 2.39, 95% CI: 1.108-29.491, p = 0.0009) were independent predictors of bleeding events. Conclusion If a patient has had the intermediate metabolizer CYP2C19 genotype and concomitant use of WF and a PPI after open heart surgery, lansoprazole intensifies the effects of WF and is associated with bleeding events.	[Hata, Mitsumasa; Shiono, Motomi; Akiyama, Kenji; Sezai, Akira; Wakui, Shinji; Kimura, Haruka] Nihon Univ, Dept Cardiovasc Surg, Sch Med, Tokyo 1738610, Japan; [Sekino, Hisakuni] Sekino Res Inst Clin Pharmacol, Dept Clin Pharmacol, Tokyo, Japan	Hata, M (reprint author), Nihon Univ, Dept Cardiovasc Surg, Sch Med, Itabashi Ku, 30-1 Ooyaguchi Kamimachi, Tokyo 1738610, Japan.	hata.mitsumasa@nihon-u.ne.jp					ANDERSSON T, 1993, BRIT J CLIN PHARMACO, V36, P521; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Kubota T, 1996, CLIN PHARMACOL THER, V60, P661, DOI 10.1016/S0009-9236(96)90214-3; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Ishizaki T, 1999, ALIMENT PHARM THERAP, V13, P27; Takahashi H, 2001, CLIN PHARMACOKINET, V40, P587, DOI 10.2165/00003088-200140080-00003; Hata M, 2008, THORAC CARDIOV SURG, V56, P274, DOI 10.1055/s-2008-1038378; Limdi NA, 2009, BLOOD CELL MOL DIS, V43, P119, DOI 10.1016/j.bcmd.2009.01.019; Glance LG, 2007, J THORAC CARDIOV SUR, V134, P53, DOI 10.1016/j.jtcvs.2007.02.037; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Lindh JD, 2009, EUR J CLIN PHARMACOL, V65, P365, DOI 10.1007/s00228-008-0584-5; YASUDA S, 1995, CLIN PHARMACOL THER, V58, P143, DOI 10.1016/0009-9236(95)90192-2; Hata M, 2006, SURG TODAY, V36, P131, DOI 10.1007/s00595-005-3108-2; Hata M, 2005, CIRC J, V69, P331, DOI 10.1253/circj.69.331; Levine MN, 2004, CHEST, V126, p287S, DOI 10.1378/chest.126.3_suppl.287S; McCarthy Denis M, 2003, Am J Ther, V10, P330, DOI 10.1097/00045391-200309000-00005; Meyer UA, 1996, EUR J GASTROEN HEPAT, V8, pS21, DOI 10.1097/00042737-199610001-00005; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609	18	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	FEB	2015	63	1					45	50		10.1055/s-0034-1383814		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AZ0RX	WOS:000347953300008		
J	Niu, XY; de Graaf, IAM; van de Vegte, D; Langelaar-Makkinje, M; Sekine, S; Groothuis, GMM				Niu, Xiaoyu; de Graaf, Inge A. M.; van de Vegte, Dennis; Langelaar-Makkinje, Miriam; Sekine, Shuichi; Groothuis, Geny M. M.			Consequences of Mrp2 deficiency for diclofenac toxicity in the rat intestine ex vivo	TOXICOLOGY IN VITRO			English	Article						Diclofenac; Mrp2; Toxicity; Transporter; Metabolism; Disposition	RESISTANCE-ASSOCIATED PROTEIN-2; P-GLYCOPROTEIN EFFLUX; PRECISION-CUT LIVER; INDUCED ENTEROPATHY; PEROXIDIZED LIPIDS; DRUG DISPOSITION; IN-VIVO; GLUTATHIONE; TRANSPORT; EXPRESSION	The non-steroidal anti-inflammatory drug diclofenac (DCF) has a high prevalence of intestinal side effects in humans and rats. It has been reported that Mrp2 transporter deficient rats (Mrp2(-)) are more resistant to DCF induced intestinal toxicity. This was explained in vivo by impaired Mrp2-dependent biliary transport of DCF-acylglucuronide (DAG), leading to decreased intestinal exposure to DAG and DCF. However, it is not known to what extent adaptive changes in the Mrp2(-) intestine itself influence its sensitivity to DCF toxicity without the influence of liver metabolites. To investigate this, DCF toxicity and disposition were studied ex vivo by precision-cut intestinal slices and Ussing chamber using intestines from wild type (WT) and Mrp2(-) rats. The results show that adaptive changes due to Mrp2 deficiency concerning Mrp2, Mrp3 and BCRP gene expression, GSH content and DAG formation were different between liver and intestine. Furthermore, Mrp2(-) intestine was intrinsically more resistant to DCF toxicity than its WT counterpart ex vivo. This can at least partly be explained by a reduced DCF uptake by the Mrp2(-) intestine, but is not related to the other adaptive changes in the intestine. The extrapolation of this data to humans with MRP2 deficiency is uncertain due to species differences in activity and regulation of transporters. (C) 2014 Elsevier Ltd. All rights reserved.	[Niu, Xiaoyu; de Graaf, Inge A. M.; van de Vegte, Dennis; Langelaar-Makkinje, Miriam; Groothuis, Geny M. M.] Univ Groningen, Dept Pharm, Div Pharmacokinet Toxicol & Targeting, NL-9713 AV Groningen, Netherlands; [Sekine, Shuichi] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan	de Graaf, IAM (reprint author), Univ Groningen, Dept Pharm, Div Pharmacokinet Toxicol & Targeting, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	I.A.M.de.Graaf@rug.nl					Suzuki H, 2002, ADV DRUG DELIVER REV, V54, P1311, DOI 10.1016/S0169-409X(02)00075-3; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; Jedlitschky G, 2006, EXPERT OPIN DRUG MET, V2, P351, DOI 10.1517/17425255.2.3.351; Keppler D, 1997, ADV ENZYME REGUL, V37, P321, DOI 10.1016/S0065-2571(96)00013-1; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P1715, DOI 10.1073/pnas.87.5.1715; Davies NM, 2000, J PHARM PHARM SCI, V3, P137; Lagas JS, 2009, DRUG METAB DISPOS, V37, P129, DOI 10.1124/dmd.108.023200; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; LoGuidice A, 2012, J PHARMACOL EXP THER, V341, P447, DOI 10.1124/jpet.111.191122; Lagas JS, 2010, MOL PHARMACOL, V77, P687, DOI 10.1124/mol.109.062364; Kruh GD, 2007, CANCER METAST REV, V26, P5, DOI 10.1007/s10555-007-9039-1; Xiong H, 2002, DRUG METAB DISPOS, V30, P962, DOI 10.1124/dmd.30.9.962; Seitz S, 1998, GASTROENTEROLOGY, V115, P1476, DOI 10.1016/S0016-5085(98)70026-5; SMALL RE, 1989, CLIN PHARMACY, V8, P545; AW TY, 1992, AM J PHYSIOL, V263, pG665; AW TY, 1994, J CLIN INVEST, V94, P1218, DOI 10.1172/JCI117439; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; ELFERINK RPJ, 1989, J CLIN INVEST, V84, P476, DOI 10.1172/JCI114189; Fortuna A, 2012, EPILEPSIA, V53, P529, DOI 10.1111/j.1528-1167.2012.03409.x; Goncalves I, 2012, ACTA CIR BRAS, V27, P131, DOI 10.1590/S0102-86502012000200006; Gotoh Y, 2000, J PHARMACOL EXP THER, V292, P433; Hadi M, 2012, CHEM RES TOXICOL, V25, P1938, DOI 10.1021/tx300248j; Ito K, 1997, AM J PHYSIOL-GASTR L, V272, pG16; Johnson BM, 2006, DRUG METAB DISPOS, V34, P556, DOI 10.1124/dmd.105.005793; Lu SC, 1996, HEPATOLOGY, V24, P253, DOI 10.1002/hep.510240140; Mottino AD, 2000, J PHARMACOL EXP THER, V293, P717; Newton DJ, 2005, LIFE SCI, V77, P1106, DOI 10.1016/j.lfs.2005.01.020; Nishino A, 2000, Drug Metab Dispos, V28, P1146; Niu X., 2014, ARCH TOXICO IN PRESS; Niu XY, 2014, TOXICOL IN VITRO, V28, P1296, DOI 10.1016/j.tiv.2014.06.010; Oga EF, 2013, DRUG METAB PHARMACOK, V28, P314, DOI 10.2133/dmpk.DMPK-12-RG-117; Oguro T, 1996, J PHARMACOL EXP THER, V277, P1676; Rost D, 2002, AM J PHYSIOL-GASTR L, V282, pG720, DOI 10.1152/ajpgi.00318.2001; Seitz S, 1998, CHEM RES TOXICOL, V11, P513, DOI 10.1021/tx970203+; Treinen-Moslen M, 2006, PHARMACOL THERAPEUT, V112, P649, DOI 10.1016/j.pharmathera.2006.05.007; van de Kerkhof EG, 2006, DRUG METAB DISPOS, V34, P1893, DOI 10.1124/dmd.106.011148	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-2333			TOXICOL IN VITRO	Toxicol. Vitro	FEB	2015	29	1					168	175		10.1016/j.tiv.2014.10.004		8	Toxicology	Toxicology	AY7NL	WOS:000347746600022		
J	Reisinger, K; Hoffmann, S; Alepee, N; Ashikaga, T; Barroso, J; Elcombe, C; Gellatly, N; Galbiati, V; Gibbs, S; Groux, H; Hibatallah, J; Keller, D; Kern, P; Klaric, M; Kolle, S; Kuehnl, J; Lambrechts, N; Lindstedt, M; Millet, M; Martinozzi-Teissier, S; Natsch, A; Petersohn, D; Pike, I; Sakaguchi, H; Schepky, A; Tailhardat, M; Templier, M; van Vliet, E; Maxwell, G				Reisinger, Kerstin; Hoffmann, Sebastian; Alepee, Nathalie; Ashikaga, Takao; Barroso, Joao; Elcombe, Cliff; Gellatly, Nicola; Galbiati, Valentina; Gibbs, Susan; Groux, Herve; Hibatallah, Jalila; Keller, Donald; Kern, Petra; Klaric, Martina; Kolle, Susanne; Kuehnl, Jochen; Lambrechts, Nathalie; Lindstedt, Malin; Millet, Marion; Martinozzi-Teissier, Silvia; Natsch, Andreas; Petersohn, Dirk; Pike, Ian; Sakaguchi, Hitoshi; Schepky, Andreas; Tailhardat, Magalie; Templier, Marie; van Vliet, Erwin; Maxwell, Gavin			Systematic evaluation of non-animal test methods for skin sensitisation safety assessment	TOXICOLOGY IN VITRO			English	Article						Skin sensitisation; Testing strategy; Safety assessment; Non-animal test methods; Adverse Outcome Pathways	EPIDERMAL EQUIVALENT ASSAY; SCREENING CONTACT ALLERGENS; PEPTIDE REACTIVITY; DENDRITIC CELLS; IL-18 PRODUCTION; RISK-ASSESSMENT; POTENCY; LINE; REPRODUCIBILITY; ACTIVATION	The need for non-animal data to assess skin sensitisation properties of substances, especially cosmetics ingredients, has spawned the development of many in vitro methods. As it is widely believed that no single method can provide a solution, the Cosmetics Europe Skin Tolerance Task Force has defined a three-phase framework for the development of a non-animal testing strategy for skin sensitisation potency prediction. The results of the first phase systematic evaluation of 16 test methods are presented here. This evaluation involved generation of data on a common set of ten substances in all methods and systematic collation of information including the level of standardisation, existing test data, potential for throughput, transferability and accessibility in cooperation with the test method developers. A workshop was held with the test method developers to review the outcome of this evaluation and to discuss the results. The evaluation informed the prioritisation of test methods for the next phase of the non-animal testing strategy development framework. Ultimately, the testing strategy combined with bioavailability and skin metabolism data and exposure consideration is envisaged to allow establishment of a data integration approach for skin sensitisation safety assessment of cosmetic ingredients. (C) 2014 The Authors. Published by Elsevier Ltd.	[Reisinger, Kerstin; Petersohn, Dirk] Henkel AG & CO KGaA, D-40191 Dusseldorf, Germany; [Hoffmann, Sebastian] Seh Consulting Serv, D-33098 Paderborn, Germany; [Alepee, Nathalie; Martinozzi-Teissier, Silvia] LOreal Res Ea Innovat, F-93600 Aulnay Sous Bois, France; [Ashikaga, Takao] Shiseido Co Ltd, Qual Assurance Ctr, Kanagawa, Japan; [Barroso, Joao; Klaric, Martina] Cosmet Europe, B-1160 Brussels, Belgium; [Elcombe, Cliff] OCR Biosci Ltd, Dundee DD1 5JJ, Scotland; [Gellatly, Nicola; Maxwell, Gavin] Unilever Safety & Environm Assurance Ctr, Sharnbrook MK44 1LQ, Beds, England; [Galbiati, Valentina] Univ Milan, Toxicol Lab, I-20133 Milan, Italy; [Gibbs, Susan] Vrije Univ Amsterdam, Med Ctr, Dept Dermatol, NL-1081 HV Amsterdam, Netherlands; [Groux, Herve] ImmunoSearch, F-06130 Le Plan De Grasse, France; [Hibatallah, Jalila] Chanel, F-92521 Neuilly Sur Seine, France; [Keller, Donald] Cyprotex LLC, Kalamazoo, MI USA; [Kern, Petra] Procter & Gamble Technol Beijing Co Ltd, Global Product Stewardship, KongGang Dev Area Area B, Beijing 101312, Peoples R China; [Kolle, Susanne] BASF SE, Expt Toxicol & Ecol, D-67056 Ludwigshafen, Germany; [Kuehnl, Jochen; Schepky, Andreas] Beiersdorf AG, D-20245 Hamburg, Germany; [Lambrechts, Nathalie] VITO NV, B-2400 Mol, Belgium; [Lindstedt, Malin] Lund Univ, Dept Immunotechnol, S-22381 Lund, Sweden; [Millet, Marion; Templier, Marie] Inst Rech Pierre Fabre, CEPC, F-81106 Castres, France; [Natsch, Andreas] Givaudan Schweiz AG, CH-8600 Dubendorf, Switzerland; [Pike, Ian] Proteome Sci Plc, Cobham KT11 3EP, England; [Sakaguchi, Hitoshi] Kao Corp, Ichikai, Tochigi, Japan; [Tailhardat, Magalie] LVMH Rech, F-45804 St Jean De Braye, France; [van Vliet, Erwin] SeCAM, CH-6982 Agno, Switzerland	Reisinger, K (reprint author), Henkel AG & CO KGaA, Henkelstr 67, D-40191 Dusseldorf, Germany.	kerstin.reisinger@henkel.com; sebastian.hoffmann@seh-cs.com; nalepee@rd.loreal.com; takao.ashikaga@to.shiseido.cojp; Joao.BARROSO@ec.europa.eu; CliffElcombe@cxrbiosciences.com; Nichola.Gellatly@unilever.com; valentine.galbiati@unimi.it; S.Gibbs@vumc.nl; hgroux@immunosearch.fr; jalila.hibatallah@chanel-corp.com; dkeller@ceetox.com; kern.ps@pg.com; mklaric@cosmeticseurope.eu; susanne.kolle@basf.com; jochen.kuehnl@beiersdorf.com; nathalie.lambrechts@vito.be; malinlindstedt@immunith.se; marion.millet@pierre-fabre.com; steissier@rdloreal.com; andreas.natsch@givaudan.com; ian.pike@proteomics.com; sakaguchi.hitoshi@kao.cojp; andreas.schepky@beiersdorf.com; mtailhardat@research.lvmh-pc.com; marie.templier@pierre-fabre.com; erwin.vanvliet@secam-ce.eu; Gavin.Maxwell@unilever.com					Ade Nadege, 2006, J Immunotoxicol, V3, P189, DOI 10.1080/15476910600978038; Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014; Hooyberghs J, 2008, TOXICOL APPL PHARM, V231, P103, DOI 10.1016/j.taap.2008.03.014; Ainscough JS, 2013, J IMMUNOTOXICOL, V10, P223, DOI 10.3109/1547691X.2012.711782; Reuter H, 2011, TOXICOL IN VITRO, V25, P315, DOI 10.1016/j.tiv.2010.09.016; Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259; Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x; Jowsey IR, 2006, J APPL TOXICOL, V26, P341, DOI 10.1002/jat.1146; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013; Galbiati V, 2011, TOXICOL IN VITRO, V25, P724, DOI 10.1016/j.tiv.2010.12.011; Corsini E, 2009, TOXICOL IN VITRO, V23, P789, DOI 10.1016/j.tiv.2009.04.005; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; Goebel C, 2012, REGUL TOXICOL PHARM, V63, P40, DOI 10.1016/j.yrtph.2012.02.007; Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064; Ashikaga T, 2010, ATLA-ALTERN LAB ANIM, V38, P275; Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2; Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019; MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473; Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399; McKim JM, 2012, CUTAN OCUL TOXICOL, V31, P292, DOI 10.3109/15569527.2012.667031; Gerberick GF, 2009, TOXICOL SCI, V112, P164, DOI 10.1093/toxsci/kfp192; Maxwell G, 2011, ALTEX-ALTERN ANIM EX, V28, P50; Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211; Gibbs S, 2013, TOXICOL APPL PHARM, V272, P529, DOI 10.1016/j.taap.2013.07.003; Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009; Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213; Cottrez F., 2011, 8 WORLD C ALT MONTR; dos Santos GG, 2011, TOXICOL IN VITRO, V25, P347, DOI 10.1016/j.tiv.2010.10.008; Gomes C., 2012, COMPSTAT 20 INT C CO, P271; Jaworska J., 2013, J APPL TOXICOL; Jaworska Joanna, 2010, ALTEX, V27, P231; Kimber I, 2012, CONTACT DERMATITIS, V67, P179, DOI 10.1111/j.1600-0536.2012.02148.x; Lambrechts N, 2011, TOXICOL LETT, V203, P106, DOI 10.1016/j.toxlet.2011.02.015; Lambrechts N, 2010, TOXICOL SCI, V116, P122, DOI 10.1093/toxsci/kfq108; Natsch A., 2013, J APPL TOXICOL; Nukada Y., 2012, TOXICOL IN VITRO, V27, P609; OECD, 2012, SER TEST ASS, V168; Teunis M, 2013, TOXICOL IN VITRO, V27, P1135, DOI 10.1016/j.tiv.2012.06.004; Teunis MAT, 2014, ALTEX-ALTERN ANIM EX, V31, P251, DOI http://dx.doi.org/10.14573/altex.1308021; Thierse H.J., 2011, PROGR NOVEL TESTING, P145; van der Veen JWD, 2015, TOXICOL IN VITRO, V29, P81, DOI 10.1016/j.tiv.2014.08.010	44	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-2333			TOXICOL IN VITRO	Toxicol. Vitro	FEB	2015	29	1					259	270		10.1016/j.tiv.2014.10.018		12	Toxicology	Toxicology	AY7NL	WOS:000347746600034		
J	Loehle, S; Matta, C; Minfray, C; Le Mogne, T; Iovine, R; Obara, Y; Miyamoto, A; Martin, JM				Loehle, S.; Matta, C.; Minfray, C.; Le Mogne, T.; Iovine, R.; Obara, Y.; Miyamoto, A.; Martin, J. M.			Mixed lubrication of steel by C18 fatty acids revisited. Part I: Toward the formation of carboxylate	TRIBOLOGY INTERNATIONAL			English	Article						Organic friction modifiers; Computer simulation; Adsorption; Friction	MOLECULAR-DYNAMICS; STEARIC-ACID; FRICTION; SURFACE; ADSORPTION; MONOLAYER; TRIBOCHEMISTRY; MECHANISMS; SIMULATION; ADDITIVES	The requirements in automotive lubrication impose more complex lubricant formulation. For environmental issues, it is important to reduce additives containing sulfur and phosphorous compounds. We propose to revisit the lubrication of steel by stearic acid with a new approach combining experimental and molecular simulation techniques. The adsorption mechanism of stearic acid on iron oxide surface is investigated by ultra-accelerated quantum chemistry molecular dynamics simulations. Adsorption experiments are performed followed by in-situ XPS and ex-situ PMIRRAS analyses. The adsorption mechanism occurred through the acid group mainly by chemisorption. Friction behavior of stearic acid with iron oxide is studied. Results suggest that the friction process favors the formation of carboxylate function. The low friction behavior seems to be related to the generation of a SAM strongly bonded to the surface. (C) 2014 Elsevier Ltd. All rights reserved.	[Loehle, S.; Iovine, R.] TOTAL, Solaize Res Ctr, F-69360 Solaize, France; [Matta, C.; Minfray, C.; Le Mogne, T.; Martin, J. M.] Ecole Cent Lyon, Lab Tribol & Dynam Syst, F-69134 Ecully, France; [Obara, Y.; Miyamoto, A.] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808579, Japan	Loehle, S (reprint author), TOTAL, Solaize Res Ctr, BP 22, F-69360 Solaize, France.	sophie.loehle@total.com; clotilde.minfray@ec-lyon.fr					Ahmed F, 2011, CATAL TODAY, V164, P16, DOI 10.1016/j.cattod.2010.10.009; Alam K, 2011, CATAL TODAY, V164, P9; Anghel V, 1996, TRIBOL SER, V32, P459; Sahoo RR, 2009, J COLLOID INTERF SCI, V333, P707, DOI 10.1016/j.jcis.2009.01.046; Hsu SM, 2002, TRIBOL LETT, V13, P131, DOI 10.1023/A:1020112901674; Ratoi M, 2000, TRIBOL INT, V33, P241, DOI 10.1016/S0301-679X(00)00037-2; Onodera T, 2009, J PHYS CHEM B, V113, P16526, DOI 10.1021/jp9069866; JAHANMIR S, 1985, WEAR, V102, P331, DOI 10.1016/0043-1648(85)90176-0; WOODCOCK LV, 1971, CHEM PHYS LETT, V10, P257, DOI 10.1016/0009-2614(71)80281-6; Przedlacki M, 2006, TRIBOL T, V49, P202, DOI 10.1080/05698190500544676; Wu CD, 2007, COMP MATER SCI, V39, P808, DOI 10.1016/j.commatsci.2006.10.004; ALLEN CM, 1969, WEAR, V14, P363, DOI 10.1016/0043-1648(69)90017-9; Kajdas CK, 2005, TRIBOL INT, V38, P337, DOI 10.1016/j.triboint.2004.08.017; Harrison JA, 2008, PHILOS T R SOC A, V366, P1469, DOI 10.1098/rsta.2007.2169; Simic R, 2013, APPL SURF SCI, V283, P460, DOI 10.1016/j.apsusc.2013.06.131; Cheng HF, 2012, ADV COLLOID INTERFAC, V171, P53, DOI 10.1016/j.cis.2012.01.003; Mikulski PT, 2011, TRIBOL LETT, V42, P37, DOI 10.1007/s11249-010-9740-z; Bowden FP, FRICTION LUBRICATION; Buckley DH, 1981, TRIBOL SER, V5; Buehler MJ, 2008, ATOMISTIC MODELING M, P38; CROWELL JE, 1986, J CHEM PHYS, V85, P3111, DOI 10.1063/1.451020; Davidson JE, 2006, J MOL GRAPH MODEL, V25, P495, DOI 10.1016/j.jmgm.2006.03.006; Fischer DA, 1997, TRIBOL LETT, V3, P41, DOI 10.1023/A:1019148131061; Fischer DA, 1997, TRIBOL LETT, V3, P35, DOI 10.1023/A:1019109407863; Greenfield ML, 1999, TRIBOL LETT, V7, P137, DOI 10.1023/A:1019133723193; Harrison JA, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/35/354009; Islam MM, 2011, CATAL TODAY, V177, P39, DOI 10.1016/j.cattod.2011.06.007; KAJDAS C, 1987, WEAR, V116, P167, DOI 10.1016/0043-1648(87)90231-6; Loehle, 2014, TRIBOL LETT, V53, P319; Loehle S, 2014, THESIS; Majzner M, 2003, TRIBOLOGIA, V34, P63; Miyamoto A., 2012011292 SAE; Miyamoto A., 2013, WTC TOR; Morita Y, 2008, JPN J APPL PHYS, V47, P3032, DOI 10.1143/JJAP.47.3032; Onodera T, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/3/034009; Onodera Tasuku, 2010, Tribology Online, V5, DOI 10.2474/trol.5.173; Tabor D, 1991, COLLOIDAL STATE MATT	37	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-679X	1879-2464		TRIBOL INT	Tribol. Int.	FEB	2015	82		A				218	227		10.1016/j.triboint.2014.10.020		10	Engineering, Mechanical	Engineering	AY7QC	WOS:000347753200023		
J	Mino, K; Imura, M; Koyama, D; Omori, M; Kawarabata, S; Sato, M; Watanabe, Y				Mino, Koji; Imura, Masato; Koyama, Daisuke; Omori, Masayoshi; Kawarabata, Shigeki; Sato, Masafumi; Watanabe, Yoshiaki			MESHLESS BUBBLE FILTER USING ULTRASOUND FOR EXTRACORPOREAL CIRCULATION AND ITS EFFECT ON BLOOD	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Article						Bubble filter; Extracorporeal circulation; Acoustic radiation force; Hemolysis; Free hemoglobin	STANDING-WAVE FIELD; CARDIOPULMONARY BYPASS; SMALL OBJECTS; AIR; HEMOLYSIS; TRANSPORTATION; MANIPULATION; TEMPERATURE; MICROEMBOLI; VIBRATION	A bubble filter with no mesh structure for extracorporeal circulation using ultrasound was developed. Hemolysis was evaluated by measuring free hemoglobin (FHb). FHb in 120 mL of bovine blood was measured in acoustic standing-wave fields. With a sound pressure amplitude of 60 kPa at driving frequencies of 1 MHz, 500 kHz and 27 kHz for 15 min. FHb values were 641.6, 2575 and 8903 mg/dL, respectively. Thus, hemolysis was inhibited with higher driving frequencies when the same sound pressure amplitude was applied. An ultrasound bubble filter with a resonance frequency of 1 MHz was designed. The filtering characteristics of the flowing microbubbles were investigated with a circulation system using bovine blood with a flow rate of 5.0 L/min. Approximately 99.1% of microbubbles were filtered with 250 kPa and a flow of 5.0 L/min. Hemolysis decreased as the sound pressure decreased; FHb values were 225.8 and 490.7 mg/dL when using 150 and 200 kPa, respectively. (C) 2015 World Federation for Ultrasound in Medicine & Biology.	[Mino, Koji; Watanabe, Yoshiaki] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Kyoto 6100321, Japan; [Imura, Masato; Koyama, Daisuke] Doshisha Univ, Fac Sci & Engn, Kyotanabe, Kyoto 6100321, Japan; [Omori, Masayoshi; Kawarabata, Shigeki; Sato, Masafumi] JMS Co Ltd, Cent Res Lab, Naka Ku, Hiroshima, Japan	Koyama, D (reprint author), Doshisha Univ, Fac Sci & Engn, 1-3 Tataramiyakodani, Kyotanabe, Kyoto 6100321, Japan.	dkoyama@mail.doshisha.ac.jp			MEXT-Supported program for the Strategic Research Foundation at Private Universities	This work was partially supported by a research grant (grant S1311037) from MEXT-Supported program for the Strategic Research Foundation at Private Universities.	Benes E, 2001, ULTRASON, P649, DOI 10.1109/ULTSYM.2001.991812; Ding MJ, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.097301; Kozuka T, 2008, JPN J APPL PHYS, V47, P4336, DOI 10.1143/JJAP.47.4336; Koyama D, 2010, IEEE T ULTRASON FERR, V57, P1152, DOI 10.1109/TUFFC.2010.1527; Hatanaka S, 2002, ULTRASONICS, V40, P655, DOI 10.1016/S0041-624X(02)00193-2; WHYMARK RR, 1975, ULTRASONICS, V13, P251, DOI 10.1016/0041-624X(75)90072-4; Paul R, 2003, ARTIF ORGANS, V27, P517, DOI 10.1046/j.1525-1594.2003.07103.x; Kozuka T, 2007, JPN J APPL PHYS 1, V46, P4948, DOI 10.1143/JJAP.46.4948; Koyama D, 2010, IEEE T ULTRASON FERR, V57, P1434, DOI [10.1109/TUFFC .2010.1562, 10.1109/TUFFC.2010.1562]; Schellman JA, 1997, BIOPHYS J, V73, P2960; Hammon JW, 1997, ANN THORAC SURG, V63, P1613, DOI 10.1016/S0003-4975(97)00261-0; Koyama D, 2011, IEEE T ULTRASON FERR, V58, P737, DOI 10.1109/TUFFC.2011.1866; OSHIRO I, 1982, CLIN BIOCHEM, V15, P83, DOI 10.1016/S0009-9120(82)91069-4; Friend JR, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/14/145301; CLARK RE, 1995, J THORAC CARDIOV SUR, V109, P249, DOI 10.1016/S0022-5223(95)70386-1; Fearn SJ, 2001, J THORAC CARDIOV SUR, V121, P1150, DOI 10.1067/mtc.2001.114099; GERSHFELD NL, 1988, J MEMBRANE BIOL, V101, P67, DOI 10.1007/BF01872821; Hatano H., 1991, Journal of the Acoustical Society of Japan, V47; Ito Yu, 2010, Acoustical Science and Technology, V31, DOI 10.1250/ast.31.420; LEPOCK JR, 1989, BIOCHIM BIOPHYS ACTA, V980, P191, DOI 10.1016/0005-2736(89)90399-4; Mason T. J., 1989, SONOCHEMISTRY THEORY; Masuda K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.07HF11; MILLER DL, 1991, ULTRASOUND MED BIOL, V17, P171, DOI 10.1016/0301-5629(91)90124-F; Minnaert M, 1933, PHILOS MAG, V16, P235; Mino K, 2013, SENSOR ACTUAT A-PHYS, V199, P202, DOI 10.1016/j.sna.2013.06.003; MOUSSA NA, 1979, J BIOMECH ENG-T ASME, V101, P213; PUGSLEY W, 1994, STROKE, V25, P1393; Rabaud D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.134501; REINHART WH, 1987, MICROVASC RES, V34, P1, DOI 10.1016/0026-2862(87)90075-6	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-5629	1879-291X		ULTRASOUND MED BIOL	Ultrasound Med. Biol.	FEB	2015	41	2					465	471		10.1016/j.ultrasmedbio.2014.09.011		7	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AY9WW	WOS:000347899300013		
J	Nakasato, T; Morita, J; Ogawa, Y				Nakasato, Takehiko; Morita, Jun; Ogawa, Yoshio			Evaluation of Hounsfield Units as a predictive factor for the outcome of extracorporeal shock wave lithotripsy and stone composition	UROLITHIASIS			English	Article						Computed tomography; Extracorporeal shock wave lithotripsy; Hounsfield Unit; Stone composition; Urinary stone	HELICAL COMPUTED-TOMOGRAPHY; URINARY CALCULI; MULTIVARIATE-ANALYSIS; CHEMICAL-COMPOSITION; ATTENUATION VALUE; URETERAL CALCULI; CT; MANAGEMENT; DENSITY; SUCCESS	The objective of this study was to evaluate the utility of the Hounsfield Unit (HU) values as a predictive factor of extracorporeal shock wave lithotripsy outcome for ureteral and renal stones. We also assessed the possibility that HU values could be used to predict stone composition. A retrospective study was performed to measure stone HU values in 260 patients who underwent extracorporeal shock wave lithotripsy (ESWL) for solitary renal and ureteral stones from July 2007 to January 2012. Stone volume, location, skin-to-stone distance, stone HU values, and stone composition were assessed. Success of ESWL was defined as: (1) being stone-free or (2) residual stone fragments < 4 mm after 3 months by radiography. Of the 260 assessed patients, 141 (54.2 %) were stone-free, 32 (12.3 %) had residual stone fragments < 4 mm (clinically insignificant stone fragments), and 87 (33.5 %) had residual stone fragments a parts per thousand yen4 mm after one round of ESWL. Multivariate analysis revealed that stone location and mean HU were significant predictors of ESWL success. Receiver operating characteristic curves defined cutoff values for predicting treatment outcome. Treatment success rates were significantly higher for stones < 815 HU than with stones > 815 HU (P < 0.0265). HU of calcium oxalate and calcium phosphate stones were higher than those of uric acid stones, but we could not differentiate between calcium oxalate monohydrate and calcium oxalate dihydrate stones. Evaluation of stone HU values prior to ESWL can predict treatment outcome and aid in the development of treatment strategies.	[Nakasato, Takehiko; Morita, Jun; Ogawa, Yoshio] Showa Univ, Sch Med, Dept Urol, Shinagawa Ku, Tokyo 1428666, Japan	Nakasato, T (reprint author), Showa Univ, Sch Med, Dept Urol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	take_nkst@yahoo.co.jp					Preminger GM, 2007, J UROLOGY, V178, P2418, DOI 10.1016/j.juro.2007.09.107; Arac M, 2005, EUR RADIOL, V15, P65, DOI 10.1007/s00330-004-2511-1; Bandi G, 2009, BJU INT, V103, P524, DOI 10.1111/j.1464-410X.2008.08069.x; Gupta NP, 2005, BJU INT, V95, P1285, DOI 10.1111/j.1464-410X.2005.05520.x; Joseph P, 2002, J UROLOGY, V167, P1968, DOI 10.1016/S0022-5347(05)65064-1; Weld KJ, 2007, UROLOGY, V70, P1043, DOI 10.1016/j.urology.2007.07.074; Ouzaid I, 2012, BJU INT, V110, pE438, DOI 10.1111/j.1464-410X.2012.10964.x; CHAUSSY C, 1980, LANCET, V2, P1265; Nakada SY, 2000, UROLOGY, V55, P816, DOI 10.1016/S0090-4295(00)00518-5; Pareek G, 2005, UROLOGY, V65, P33, DOI 10.1016/j.urology.2004.08.004; Mostafavi MR, 1998, J UROLOGY, V159, P673, DOI 10.1016/S0022-5347(01)63698-X; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; Motley G, 2001, UROLOGY, V58, P170, DOI 10.1016/S0090-4295(01)01115-3; Pearle MS, 2005, J UROLOGY, V173, P2005, DOI 10.1097/01.ju.0000158458.51706.56; Deveci S, 2004, UROLOGY, V64, P237, DOI 10.1016/j.urology.2004.03.029; MITCHESON HD, 1983, J UROLOGY, V130, P814; Ng CF, 2009, J UROLOGY, V181, P1151, DOI 10.1016/j.juro.2008.10.161; Bourdoumis A, 2014, PANMINERVA MED, V56, P1; Demirel A, 2003, J INT MED RES, V31, P1; Imamura Y, 2013, INT J UROL, V20, P616, DOI 10.1111/j.1442-2042.2012.03229.x; Katz DS, 1997, EUR RADIOL, V7, P680, DOI 10.1007/BF02742925; Park Yong Il, 2010, Korean J Urol, V51, P713, DOI 10.4111/kju.2010.51.10.713; Patel SR, 2009, UROL INT, V83, P175, DOI 10.1159/000230020; PSIHRAMIS KE, 1992, J UROLOGY, V147, P1006; Wang LJ, 2004, EUR RADIOL, V14, P1634, DOI 10.1007/s00330-004-2309-1; Wang LJ, 2005, EUR RADIOL, V15, P2238, DOI 10.1007/s00330-005-2742-9; Yoshida S, 2006, UROLOGY, V68, P33, DOI 10.1016/j.urology.2006.01.052	28	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2194-7228	2194-7236		UROLITHIASIS	Urolithiasis	FEB	2015	43	1					69	75		10.1007/s00240-014-0712-x		7	Urology & Nephrology	Urology & Nephrology	AY8ZX	WOS:000347840200011		
J	Kawahara, T; Ito, H; Terao, H; Uemura, H; Kubota, Y; Matsuzaki, J				Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Uemura, Hiroji; Kubota, Yoshinobu; Matsuzaki, Junichi			Double ureteral access sheath (UAS) technique for complicated distal ureteral stone	UROLITHIASIS			English	Letter									[Kawahara, Takashi; Ito, Hiroki; Uemura, Hiroji; Kubota, Yoshinobu] Univ Grad Sch Med, Dept Urol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Matsuzaki, Junichi] Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan	Kawahara, T (reprint author), Univ Grad Sch Med, Dept Urol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	takashi_tk2001@yahoo.co.jp					BODDY SAM, 1988, BRIT J UROL, V61, P27, DOI 10.1111/j.1464-410X.1988.tb09156.x; Kawahara T, 2013, UROLITHIASIS, V41, P31, DOI 10.1007/s00240-012-0518-7	2	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2194-7228	2194-7236		UROLITHIASIS	Urolithiasis	FEB	2015	43	1					99	100		10.1007/s00240-014-0735-3		2	Urology & Nephrology	Urology & Nephrology	AY8ZX	WOS:000347840200017		
J	Konuma, T; Kato, S; Ooi, J; Oiwa-Monna, M; Tojo, A; Takahashi, S				Konuma, Takaaki; Kato, Seiko; Ooi, Jun; Oiwa-Monna, Maki; Tojo, Arinobu; Takahashi, Satoshi			Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors	ANNALS OF HEMATOLOGY			English	Article						Philadelphia chromosome; Acute lymphoblastic leukemia; Cord blood transplantation; Bone marrow transplantation; Peripheral blood stem cell transplantation; Myeloablative conditioning	STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; TOTAL-BODY IRRADIATION; ADULT PATIENTS; BONE-MARROW; ALLOGENEIC TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; COMPLETE REMISSION; REDUCED-INTENSITY; IMATINIB	Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) is a distinct clinical entity among ALL and is associated with adverse outcomes and higher rates of relapse when conventional chemotherapy is used alone. Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for patients with Ph+ALL, the impact of graft sources, particularly cord blood transplantation (CBT), on allo-HSCT for patients with Ph+ALL has yet to be clarified. We retrospectively compared clinical outcomes after unrelated CBT (n = 20), unrelated bone marrow transplantation (n = 7), and related bone marrow and peripheral blood stem cell transplantations (n = 13) following myeloablative conditioning in 40 patients with Ph+ALL. Although graft source had no significant impact on survival or relapse, disease status at transplantation did significantly affect outcomes. These data suggest that unrelated CBT is feasible and should be considered early in the course of patients with Ph+ALL when HLA-compatible related and unrelated donors are not available.	[Konuma, Takaaki; Kato, Seiko; Oiwa-Monna, Maki; Tojo, Arinobu; Takahashi, Satoshi] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, Tokyo 1088639, Japan; [Ooi, Jun] Teikyo Univ, Sch Med, Dept Hematol Oncol, Tokyo 173, Japan	Konuma, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tkonuma@ims.u-tokyo.ac.jp			Kobayashi Foundation	The authors thank all of the physicians and staff at the hospitals and the cord blood banks in Japan for their help in this study. This work was supported in part by The Kobayashi Foundation.	Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; Marks DI, 2014, HAEMATOLOGICA, V99, P322, DOI 10.3324/haematol.2013.094193; Lee S, 2005, BLOOD, V105, P3449, DOI 10.1182/blood-2004-09-3785; Fielding AK, 2009, BLOOD, V113, P4489, DOI 10.1182/blood-2009-01-199380; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Mizuta S, 2014, BLOOD, V123, P2325, DOI 10.1182/blood-2013-11-538728; Bassan R, 2010, J CLIN ONCOL, V28, P3644, DOI 10.1200/JCO.2010.28.1287; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Kumar P, 2008, BIOL BLOOD MARROW TR, V14, P1394, DOI 10.1016/j.bbmt.2008.09.021; Pfeifer H, 2013, LEUKEMIA, V27, P1254, DOI 10.1038/leu.2012.352; Bachanova V, 2014, LEUKEMIA, V28, P658, DOI 10.1038/leu.2013.253; Fielding AK, 2014, BLOOD, V123, P843, DOI 10.1182/blood-2013-09-529008; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Mizuta S, 2011, LEUKEMIA, V25, P41, DOI 10.1038/leu.2010.228; Burke MJ, 2009, BONE MARROW TRANSPL, V43, P107, DOI 10.1038/bmt.2008.296; Cutler C, 2009, BONE MARROW TRANSPL, V44, P667, DOI 10.1038/bmt.2009.283; Fielding AK, 2010, BLOOD, V116, P3409, DOI 10.1182/blood-2010-01-242750; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kebriaei P, 2012, BIOL BLOOD MARROW TR, V18, P584, DOI 10.1016/j.bbmt.2011.08.011; Laport GG, 2008, BLOOD, V112, P903, DOI 10.1182/blood-2008-03-143115; Onishi Y, 2011, BIOL BLOOD MARROW TR, V17, P1093, DOI 10.1016/j.bbmt.2011.01.010; Ooi J, 2009, BONE MARROW TRANSPL, V43, P455, DOI 10.1038/bmt.2008.347; Pinana JL, 2014, HAEMATOLOGICA, V99, P378, DOI 10.3324/haematol.2013.091009; Tomblyn MB, 2009, J CLIN ONCOL, V27, P3634, DOI 10.1200/JCO.2008.20.2960; Yanada M, 2005, BONE MARROW TRANSPL, V36, P867, DOI 10.1038/sj.bmt.1705148	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	FEB	2015	94	2					289	296		10.1007/s00277-014-2195-9		8	Hematology	Hematology	AY6ML	WOS:000347680200014		
J	Kolodziejczyk, LA; Yokoyama, K				Kolodziejczyk, Leszek Aleksander; Yokoyama, Keita			Categorical characterizations of the natural numbers require primitive recursion	ANNALS OF PURE AND APPLIED LOGIC			English	Article						Reverse mathematics; Nonstandard models; Second-order logic; Peano system; Categorical sentences		Simpson and Yokoyama (2013) [9] asked whether there exists a characterization of the natural numbers by a second-order sentence which is provably categorical in the theory RCA(0)*. We answer in the negative, showing that for any characterization of the natural numbers which is provably true in WKL0*, the categoricity theorem implies Sigma(0)(1) induction. On the other hand, we show that RCA(0)* does make it possible to characterize the natural numbers categorically by means of a set of second-order sentences. We also show that a certain Pi(1)(2)-conservative extension of RCA(0)* admits a provably categorical single-sentence characterization of the naturals, but each such characterization has to be inconsistent with WKL0* + superexp. (C) 2014 Elsevier B.V. All rights reserved.	[Kolodziejczyk, Leszek Aleksander] Univ Warsaw, Inst Math, PL-02097 Warsaw, Poland; [Yokoyama, Keita] Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi, Ishikawa, Japan	Yokoyama, K (reprint author), Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi, Ishikawa, Japan.	lak@mimuw.edu.pl; y-keita@jaist.ac.jp			Polish National Science Centre [2013/09/B/ST1/04390]; JSPS [25887026]	Supported in part by Polish National Science Centre Grant No. 2013/09/B/ST1/04390.; Supported in part by JSPS Grant-in-Aid for Research Activity Start-up Grant No. 25887026.	PUDLAK P, 1985, J SYMBOLIC LOGIC, V50, P423, DOI 10.2307/2274231; Vaananen J, 2012, B SYMB LOG, V18, P91, DOI 10.2178/bsl/1327328440; Simpson SG, 2013, ANN PURE APPL LOGIC, V164, P284, DOI 10.1016/j.apal.2012.10.014; Enayat A., 2014, MODEL THEOR IN PRESS; Enayat A., 2013, CSLI LECT NOTES, V211, P93; Enderton H.B., 2009, STANFORD ENCY PHILOS; Gaifman H., 1982, MONOGRAPHIE ENSEIGNE, V30, P187; HAJEK P, 1993, METAMATHEMATICS 1 OR; Simpson SG, 2009, PERSPECT LOGIC, P1, DOI 10.1017/CBO9780511581007; SIMPSON SG, 1986, ANN PURE APPL LOGIC, V31, P289, DOI 10.1016/0168-0072(86)90074-6; Tanaka K, 1997, ANN PURE APPL LOGIC, V84, P41, DOI 10.1016/S0168-0072(95)00058-5; Yokoyama K., 2009, P 10 AS LOG C WORLD, P375	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-0072	1873-2461		ANN PURE APPL LOGIC	Ann. Pure Appl. Log.	FEB	2015	166	2					219	231		10.1016/j.apal.2014.10.003		13	Mathematics, Applied; Mathematics; Logic	Mathematics; Science & Technology - Other Topics	AY3PL	WOS:000347495200004		
J	Akashi, K; Kunitomo, N				Akashi, Kentaro; Kunitomo, Naoto			The limited information maximum likelihood approach to dynamic panel structural equation models	ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS			English	Article						Dynamic panel structural equation; LIML; Many orthogonal conditions; Forward and backward filters; Optimality	INSTRUMENTAL-VARIABLE ESTIMATION; ERROR-COMPONENTS; ESTIMATORS	We develop the panel-limited information maximum likelihood approach for estimating dynamic panel structural equation models. When there are dynamic effects and endogenous variables with individual effects at the same time, the LIML method for the filtered data does give not only a consistent estimator and asymptotic normality, but also attains the asymptotic bound when the number of orthogonal conditions is large. Our formulation includes Alvarez and Arellano (Econometrica 71:1121-1159, 2003), Blundell and Bond (Econ Rev 19-3:321-340, 2000) and other linear dynamic panel models as special cases.	[Akashi, Kentaro] Gakushuin Univ, Fac Econ, Toshima Ku, Tokyo 1130033, Japan; [Kunitomo, Naoto] Univ Tokyo, Grad Sch Econ, Bunkyo Ku, Tokyo 1130033, Japan	Kunitomo, N (reprint author), Univ Tokyo, Grad Sch Econ, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	kentaro.akashi@gakushuin.ac.jp; kunitomo@e.u-tokyo.ac.jp					Akashi K., 2008, T TEST DYNAMIC UNPUB; Anderson T. W., 2005, CIRJEF321 U TOK GRAD; ANDERSON TW, 1981, J AM STAT ASSOC, V76, P598, DOI 10.2307/2287517; ANDERSON TW, 1982, J ECONOMETRICS, V18, P47, DOI 10.1016/0304-4076(82)90095-1; Anderson TW, 2011, J ECONOMETRICS, V165, P58, DOI 10.1016/j.jeconom.2011.05.006; Anderson TW, 2010, J ECONOMETRICS, V157, P191, DOI 10.1016/j.jeconom.2009.12.001; Akashi K, 2012, J ECONOMETRICS, V166, P167, DOI 10.1016/j.jeconom.2011.08.005; Hahn JY, 2002, ECONOMETRICA, V70, P1639, DOI 10.1111/1468-0262.00344; Hayakawa K, 2009, ECONOMET THEOR, V25, P873, DOI 10.1017/S0266466609090707; ANDERSON TW, 1950, ANN MATH STAT, V21, P570, DOI 10.1214/aoms/1177729752; Alvarez J, 2003, ECONOMETRICA, V71, P1121, DOI 10.1111/1468-0262.00441; HOLTZEAKIN D, 1988, ECONOMETRICA, V56, P1371, DOI 10.2307/1913103; ANDERSON TW, 1949, ANN MATH STAT, V20, P46, DOI 10.1214/aoms/1177730090; Alonso-Borrego C, 1999, J BUS ECON STAT, V17, P36, DOI 10.2307/1392237; Arellano M., 2003, PANEL DATA ECONOMETR; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Baltagi B. H., 2005, ECONOMETRIC ANAL PAN; Blundell R., 2000, ECONOMET REV, V19, P321, DOI DOI 10.1080/07474930008800475.ACCESSED; Hayakawa K., 2006, 130 HIT U HIST; Hsiao C., 2003, ANAL PANEL DATA; Kunitomo N, 2012, ANN I STAT MATH, V64, P881, DOI 10.1007/s10463-011-0336-7; Kunitomo N., 2010, CIRJEF780 U TOK GRAD; KUNITOMO N, 1980, J AM STAT ASSOC, V75, P693	23	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-3157	1572-9052		ANN I STAT MATH	Ann. Inst. Stat. Math.	FEB	2015	67	1					39	73		10.1007/s10463-013-0438-5		35	Statistics & Probability	Mathematics	AY6RA	WOS:000347692100003		
J	Kawanago, M; Takemura, S; Ishizuka, R; Shioya, I				Kawanago, M.; Takemura, S.; Ishizuka, R.; Shioya, I.			Dietary branched-chain amino acid supplementation affects growth and hepatic insulin-like growth factor gene expression in yellowtail, Seriola quinqueradiata	AQUACULTURE NUTRITION			English	Article						branched-chain amino acid; feed efficiency ratio; gene expression; insulin-like growth factor; Seriola quinqueradiata; yellowtail	TROUT ONCORHYNCHUS-MYKISS; CATFISH ICTALURUS-PUNCTATUS; MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE REGULATION; BREAM SPARUS-AURATA; FACTOR-I IGF-1; PROTEIN-SYNTHESIS; RAINBOW-TROUT; CHANNEL CATFISH	We investigated the effect of dietary supplementation with a branched-chain amino acid (BCAA) mixture (valine, leucine and isoleucine) on juvenile yellowtail (Seriola quinqueradiata) growth and hepatic insulin-like growth factor (IGF) gene expression. Total dietary BCAA content was 8.1, 8.5, 9.0 and 9.8gkg(-1) for the control, 0.4%, 1.0% and 2.0% BCAA experimental groups, respectively. Body weight was measured on day 77, after which fish were fasted for 3days and refed; the livers were then removed 3 or 9h later for analysis of hepatic gene expression. Body weight significantly increased in the BCAA-supplemented groups. Hepatic expression of IGF1 and IGF2 significantly increased in the 2% BCAA group at 3 and 9h after refeeding. In the 1% BCAA group, hepatic IGF1 expression tended to be higher at 9h than in the control group after refeeding. Also, hepatic IGF2 significantly increased at only 9h after refeeding in the 1% BCAA group. In conclusion, dietary supplementation with crystalline BCAAs increased growth and hepatic expression of IGF1 and IGF2. These results suggest that dietary crystalline BCAA supplementation would be a valuable addition to yellowtail aquaculture practices.	[Kawanago, M.; Ishizuka, R.; Shioya, I.] Nippon Suisan Kaisha Ltd, Aquaculture Fundamental Res Grp, Cent Res Lab, Hachioji, Tokyo 1920991, Japan; [Takemura, S.] Nippon Suisan Kaisha Ltd, Res Support & Adm Sect, Cent Res Lab, Hachioji, Tokyo 1920991, Japan	Kawanago, M (reprint author), Nippon Suisan Kaisha Ltd, Aquaculture Fundamental Res Grp, Cent Res Lab, 1-32-3 Nanakuni, Hachioji, Tokyo 1920991, Japan.	mako-k@nissui.co.jp					Anderson S., 2005, MEDITERRANEAN FISH N, P73; Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Cruz EMV, 2006, AQUACULTURE, V251, P585, DOI 10.1016/j.aquaculture.2005.06.039; Fukada H, 2012, DOMEST ANIM ENDOCRIN, V42, P220, DOI 10.1016/j.domaniend.2011.12.005; Ayson FG, 2007, GEN COMP ENDOCR, V150, P196, DOI 10.1016/j.ygcen.2006.08.001; THISSEN JP, 1994, ENDOCRINOLOGY, V134, P1570, DOI 10.1210/en.134.3.1570; Benedito-Palos L, 2007, AQUACULTURE, V267, P199, DOI 10.1016/j.aquaculture.2007.01.011; Crozier SJ, 2005, J NUTR, V135, P376; MONIER S, 1983, DIABETES, V32, P392, DOI 10.2337/diabetes.32.5.392; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Han B, 2008, MOL REPROD DEV, V75, P810, DOI 10.1002/mrd.20832; Espe M, 2007, AQUACULTURE, V263, P168, DOI 10.1016/j.aquaculture.2006.10.018; FULLER SJ, 1992, BIOCHEM J, V282, P85; Andoh T, 2007, GEN COMP ENDOCR, V151, P308, DOI 10.1016/j.ygcen.2007.01.015; Brameld JM, 1999, J NUTR, V129, P1298; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; GARLICK PJ, 1988, BIOCHEM J, V254, P579; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Peterson BC, 2004, COMP BIOCHEM PHYS A, V139, P317, DOI 10.1016/j.cbpb.2004.09.015; Zhao J, 2012, AQUACULTURE, V368, P117, DOI 10.1016/j.aquaculture.2012.09.019; Ahmed I, 2006, BRIT J NUTR, V96, P450, DOI 10.1079/BJN20061845; Schwartz MW, 2000, NATURE, V404, P661; FERNSTROM JD, 1990, J NUTR BIOCHEM, V1, P508, DOI 10.1016/0955-2863(90)90033-H; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; LOUARD RJ, 1995, METABOLISM, V44, P424, DOI 10.1016/0026-0495(95)90047-0; Hevroy EM, 2007, GEN COMP ENDOCR, V152, P39, DOI 10.1016/j.ygcen.2007.02.015; Anthony T, 2007, GEN COMP ENDOCR, V151, P308; Anthony TG, 2001, AM J PHYSIOL-ENDOC M, V281, pE430; AOAC, 1990, OFFICIAL METHODS ANA; Ballesteros M, 2000, J CLIN ENDOCR METAB, V85, P2865, DOI 10.1210/jc.85.8.2865; Brosnan JT, 2006, J NUTR, V136, p207S; CHOO PS, 1991, J NUTR, V121, P1932; Clay LA, 2005, BBA-GENE STRUCT EXPR, V1731, P139, DOI 10.1016/j.bbaexp.2005.10.001; D'Mello J.F., 2003, AMINO ACIDS ANIMAL N; Fernstrom JD, 2005, J NUTR, V135, p1539S; FRYBURG DA, 1994, AM J PHYSIOL, V267, pE331; Jousse C, 1998, BIOCHEM J, V334, P147; MCCORMICK SD, 1992, GEN COMP ENDOCR, V86, P398, DOI 10.1016/0016-6480(92)90064-Q; Meton I, 2000, J NUTR, V130, P757; Meyuhas Oded, 1996, V30, P363; Ministry of Agriculture Forestry and Fisheries Japan, 2010, WHIT PAP FISH; Moriyama S, 1995, GROWTH REGULAT, V5, P64; NRC (National Research Council), 1993, NUTR REQ FISH; Pedroso FL, 2009, FISHERIES SCI, V75, P887, DOI 10.1007/s12562-009-0107-z; PENG Y, 1973, J NUTR, V103, P608; RAMANAMU.PS, 1970, J NEUROCHEM, V17, P27, DOI 10.1111/j.1471-4159.1970.tb00498.x; Rodehutscord M, 1997, J NUTR, V127, P1166; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Silverstein JT, 2000, AQUACULTURE, V190, P77, DOI 10.1016/S0044-8486(00)00387-2; SMITH TK, 1978, J NUTR, V108, P1180; STRAUS DS, 1988, J BIOL CHEM, V263, P18404; Wacyk J, 2012, AQUACULTURE, V356, P223, DOI 10.1016/j.aquaculture.2012.05.013; Yoshitomi A., 2006, AQUACULTURE, V261, P440	53	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1353-5773	1365-2095		AQUACULT NUTR	Aquac. Nutr.	FEB	2015	21	1					63	72		10.1111/anu.12141		10	Fisheries	Fisheries	AY2WC	WOS:000347446000007		
J	Okada, T; Nakatani, M; Sawada, Y; Miyashita, S; Kumai, H; Ishibashi, Y				Okada, Tokihiko; Nakatani, Masahiro; Sawada, Yoshifumi; Miyashita, Shigeru; Kumai, Hidemi; Ishibashi, Yasunori			Effect of tank wall colour and pattern on the survival rate of juvenile Pacific bluefin tuna Thunnus orientalis (Temminck and Schlegel) during ship transportation	AQUACULTURE RESEARCH			English	Article						Pacific bluefin tuna; Thunnus orientalis; fish transportation; collision death; patterned wall; fingerling production	RESPONSES; VISION	Juvenile Pacific bluefin tuna (Thunnus orientalis; PBT) often experience high mortality during ship transportation. This study investigated whether the addition of colours or patterns to the walls of tanks affected survival rate. In the first experiment, three colours and lattice patterns were tested: dark blue single-colour, red single-colour, and red-blue lattice pattern. Fish in all tanks exhibited abnormal behaviours when sunlight entered the tanks between 0800 and 1000hours, but mortality only increased in the single-coloured tanks as a result of collision with the tank walls. In the second experiment, four colours and patterns were tested: dark blue single-colour, red-blue lattice pattern, red-blue lattice pattern with shade sheet and red-green lattice pattern with shade sheet. Again, we visually observed that fish in all treatment groups exhibited abnormal behaviour when sunlight entered the tanks, but there were no collision deaths in the lattice-patterned tanks and survival in this group was significantly higher than in the single-coloured tanks. Thus, the use of a high-contrast colour pattern can prevent mass death of juvenile PBT during ship transportation.	[Okada, Tokihiko; Nakatani, Masahiro] Kinki Univ, Fish Nursery Ctr, Ohshima Stn, Kushimoto, Japan; [Sawada, Yoshifumi] Kinki Univ, Fisheries Lab, Ohshima Expt Stn, Kushimoto, Japan; [Miyashita, Shigeru] Kinki Univ, Shirahama Expt Stn, Fisheries Lab, Shirahama, Japan; [Kumai, Hidemi] Kinki Univ, Fisheries Lab, Uragami Expt Stn, Nachikatsuura, Japan; [Ishibashi, Yasunori] Kinki Univ, Fac Agr, Dept Fisheries, Nara 6318505, Japan	Ishibashi, Y (reprint author), Kinki Univ, Fac Agr, Dept Fisheries, Nakamachi, Nara 6318505, Japan.	isibasi@nara.kindai.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	We are grateful to the staff of Kinki University Fish Nursery Center, Shirahama, Sumami, Ohshima and Amami Stations, and the ship's captain, all sailors, and the president of Sumihomaru Katsugyo Unpan Ltd for their assistance during the experiment. The authors thank Mr. Tomoki Honryo for his constructive suggestions, which improved the manuscript. This study was supported in part by the 21st Century and Global COE programmes from the Ministry of Education, Science, Sports and Culture of Japan.	Altinok I, 2004, AQUACULTURE, V239, P47, DOI 10.1016/j.aquaculture.2004.05.035; Torisawa S, 2007, J FISH BIOL, V71, P411, DOI 10.1111/j.1095-8649.2007.01498.x; Matsumoto T, 2009, BIOL BULL-US, V217, P142; Matsumoto T, 2011, FISH PHYSIOL BIOCHEM, V37, P693, DOI 10.1007/s10695-011-9469-0; Sawada Y, 2005, AQUAC RES, V36, P413, DOI 10.1111/j.1365-2109.2005.01222.x; Honryo T, 2013, AQUAC RES, V44, P1058, DOI 10.1111/j.1365-2109.2012.03109.x; Miyazaki T, 2008, FISHERIES SCI, V74, P314, DOI 10.1111/j.1444-2906.2008.01527.x; Matsumoto T, 2012, FISH PHYSIOL BIOCHEM, V38, P911, DOI 10.1007/s10695-011-9574-0; Ishibashi Y, 2009, AQUACULTURE, V293, P157, DOI 10.1016/j.aquaculture.2009.04.029; Fukuda H, 2010, AQUACULTURE, V305, P73, DOI 10.1016/j.aquaculture.2010.04.014; Harada T., 1971, MEM FAC AGR KINKI U, V4, P153; Ishibashi Y, 2006, NIPPON SUISAN GAKK, V72, P949, DOI 10.2331/suisan.72.949; Ishibashi Y., 2011, AQUACULTURE IND PACI, P53; Ishibashi Y, 2013, AQUACULT ENG, V56, P13, DOI 10.1016/j.aquaeng.2013.03.004; Kumai H., 1997, SUISANZOSHOKU, V45, P293; Masuma S, 2001, FISHERIES SCI, V67, P228, DOI 10.1046/j.1444-2906.2001.00244.x; Safina C., 2001, TUNA PHYSL ECOLOGY E, P413; Williams N, 2007, CURR BIOL, V17, pR108, DOI 10.1016/j.cub.2007.01.066; Yoshikawa A., 1980, TEICHI, V57, P1	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-557X	1365-2109		AQUAC RES	Aquac. Res.	FEB	2015	46	2					446	452		10.1111/are.12196		7	Fisheries	Fisheries	AY1UG	WOS:000347377000017		
J	Esposito, G; Valenzi, S; Islam, T; Mash, C; Bornstein, MH				Esposito, G.; Valenzi, S.; Islam, T.; Mash, C.; Bornstein, M. H.			Immediate and selective maternal brain responses to own infant faces	BEHAVIOURAL BRAIN RESEARCH			English	Article						Mother-infant interaction; Infant face	EVENT-RELATED POTENTIALS; GAMMA-BAND ACTIVITY; OSCILLATIONS; PERCEPTION; MOTHERS; CORTEX; MEMORY	Infant faces elicit caregiving in adults. In previous research on brain responses to images of infant faces, the faces were unknown to participants. This study investigated EEG in primiparous mothers of 3- to 6-month-old infants viewing their own infant's face compared to an unfamiliar but appearance-matched infant's face. Spectral power was calculated and compared, and power at three EEG bands (delta, theta, and gamma) was found to differ between faces. Brain responses among primiparous mothers distinguish images of their own versus unfamiliar infants. (C) 2014 Elsevier B.V. All rights reserved.	[Esposito, G.] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, TN, Italy; [Esposito, G.] Nanyang Technol Univ, Div Psychol, Singapore 639798, Singapore; [Valenzi, S.] RIKEN, Brain Sci Inst, Lab Adv Brain Signal Proc, Saitama, Japan; [Islam, T.] RIKEN, Brain Sci Inst, Lab Dev Gene Regulat, Saitama, Japan; [Mash, C.; Bornstein, M. H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	Esposito, G (reprint author), Univ Trento, Dept Psychol & Cognit Sci, Rovereto, TN, Italy.	gianluca.esposito@unitn.it; Marc_H_Bornstein@nih.gov	Esposito, Gianluca/K-9353-2013	Esposito, Gianluca/0000-0002-9442-0254	Japan Society for the Promotion of Science [24730563, 2402747, JSPS PE09064]; FPR Program (RIKEN Brain Science Institute); Intramural Research Program of the NIH-NICHD (USA)	All participants in this study are gratefully acknowledged. This research was supported by the ST fellowship from Japan Society for the Promotion of Science (JSPS PE09064), Grant-in-aid for Scientific Research from Japan Society for the Promotion of Science (Projects #24730563 and #2402747), the FPR Program (RIKEN Brain Science Institute), and the Intramural Research Program of the NIH-NICHD (USA).	Knyazev GG, 2009, NEUROSCIENCE, V164, P1588, DOI 10.1016/j.neuroscience.2009.09.057; Esposito G, 2013, CURR BIOL, V23, P739, DOI 10.1016/j.cub.2013.03.041; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Grabowski TJ, 2001, HUM BRAIN MAPP, V13, P199, DOI 10.1002/hbm.1033; Glosser G, 2003, NEUROLOGY, V61, P81; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Kirmizi-Alsan E, 2006, BRAIN RES, V1104, P114, DOI 10.1016/j.brainres.2006.03.010; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Nakamura K, 2000, BRAIN, V123, P1903, DOI 10.1093/brain/123.9.1903; Ross LA, 2010, NEUROIMAGE, V49, P3452, DOI 10.1016/j.neuroimage.2009.11.012; Kanayama N, 2007, PSYCHOPHYSIOLOGY, V44, P392, DOI 10.1111/j.1469-8986.2007.00511.x; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Doi H, 2012, BRAIN COGNITION, V80, P266, DOI 10.1016/j.bandc.2012.07.009; Caharel S, 2014, J COGNITIVE NEUROSCI, V26, P81, DOI 10.1162/jocn_a_00451; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Caria A, 2012, NEUROIMAGE, V60, P884, DOI 10.1016/j.neuroimage.2011.12.068; Meador KJ, 2002, NEUROLOGY, V59, P847; Doi H, 2012, NEUROPSYCHOLOGIA, V50, P1297, DOI 10.1016/j.neuropsychologia.2012.02.013; Bornstein M. H., 2013, INFANT MIND ORIGINS, P266; Bornstein MH, 2014, DEV INFANCY CONT INT, P93; Dobel C, 2011, PLOS ONE, V6, P5; Esposito G, 2014, PLOS ONE; Esposito G, 2014, EARLY CHILD DEV CARE; Fukatsu R, 1999, NEUROLOGY, V52, P1096; Hollingshead A. B., 1975, 4 FACTOR INDEX UNPUB; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021	28	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 1	2015	278						40	43		10.1016/j.bbr.2014.09.018		4	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AY5AQ	WOS:000347586300005		
J	Kawaura, K; Koike, H; Kinoshita, K; Kambe, D; Kaku, A; Karasawa, J; Chaki, S; Hikichi, H				Kawaura, Kazuaki; Koike, Hiroyuki; Kinoshita, Kohnosuke; Kambe, Daiji; Kaku, Ayaka; Karasawa, Jun-ichi; Chaki, Shigeyuki; Hikichi, Hirohiko			Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Forced swimming test; MK-801; Glycine transporter-1 inhibitor; D-serine; Schizophrenia	TREATMENT-REFRACTORY SCHIZOPHRENICS; NEGATIVE SYMPTOMS; SELECTIVE INHIBITOR; RECEPTOR ANTAGONIST; NMDA RECEPTORS; ANIMAL-MODEL; IN-VIVO; ANTIPSYCHOTICS; PHENCYCLIDINE; RISPERIDONE	Glutamatergic dysfunction, particularly the hypofunction of N-methyl-D-aspartate (NMDA) receptors, is involved in the pathophysiology of schizophrenia. The positive modulation of the glycine site on the NMDA receptor has been proposed as a novel therapeutic approach for schizophrenia. However, its efficacy against negative symptoms, which are poorly managed by current medications, has not been fully addressed. In the present study, the effects of the positive modulation of the glycine site on the NMDA receptor were investigated in an animal model of negative symptoms of schizophrenia. The subchronic administration of MK-801 increased immobility in the forced swimming test in rats without affecting spontaneous locomotor activity. The increased immobility induced by MK-801 was attenuated by the atypical antipsychotic clozapine but not by either the typical antipsychotic haloperidol or the antidepressant imipramine, indicating that the increased immobility induced by subchronic treatment with MK-801 in the forced swimming test may represent a negative symptom of schizophrenia. Likewise, positive modulation of the glycine sites on the NMDA receptor using an agonist for the glycine site, D-serine, and a glycine transporter-1 inhibitor, N-[(3R)-3-([1,1'-biphenyl]-4-yloxy)-3-(4-fluorophenyl)propyll-N-methylglycine hydrochloride (NFPS), significantly reversed the increase in immobility in MK-801-treated rats without reducing the immobility time in vehicle-treated rats. The present results show that the stimulation of the NMDA receptor through the glycine site on the receptor either directly with D-serine or by blocking glycine transporter-1 attenuates the immobility elicited by the subchronic administration of MK-801 and may be potentially useful for the treatment of negative symptoms of schizophrenia. (C) 2014 Elsevier B.V. All rights reserved.	[Kawaura, Kazuaki; Koike, Hiroyuki; Kambe, Daiji; Kaku, Ayaka; Karasawa, Jun-ichi; Chaki, Shigeyuki; Hikichi, Hirohiko] Taisho Pharmaceut Co Ltd, Pharmacol Labs, Kita Ku, Saitama 3319530, Japan; [Kinoshita, Kohnosuke] Taisho Pharmaceut Co Ltd, Drug Safety & Pharmacokinet Labs, Kita Ku, Saitama 3319530, Japan	Hikichi, H (reprint author), Taisho Pharmaceut Co Ltd, Pharmacol Labs, Kita Ku, 1-403 Yoshino Cho, Saitama 3319530, Japan.	h-hikichi@so.taisho.co.jp					Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Chiusaroli R, 2010, PHARMACOL RES, V61, P430, DOI 10.1016/j.phrs.2009.12.010; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Chen L, 2003, J NEUROPHYSIOL, V89, P691, DOI 10.1152/jn.00680.2002; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Schoemaker JH, 2014, J CLIN PSYCHOPHARM, V34, P190, DOI 10.1097/JCP.0000000000000073; Kinoshita K, 2013, ANAL BIOCHEM, V432, P124, DOI 10.1016/j.ab.2012.09.035; Murai R, 2007, BEHAV BRAIN RES, V180, P152, DOI 10.1016/j.bbr.2007.03.003; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Tsai GC, 2004, BIOL PSYCHIAT, V55, P452, DOI 10.1016/j.biopsych.2003.09.012; Heresco-Levy U, 2004, BIOL PSYCHIAT, V55, P165, DOI 10.1016/S0006-3223(03)00707-8; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Black MD, 2009, PSYCHOPHARMACOLOGY, V202, P385, DOI 10.1007/s00213-008-1289-2; Karasawa JI, 2008, BEHAV BRAIN RES, V186, P78, DOI 10.1016/j.bbr.2007.07.033; Umbricht D, 2014, JAMA PSYCHIAT, V71, P637, DOI 10.1001/jamapsychiatry.2014.163; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; Chindo BA, 2012, PROG NEURO-PSYCHOPH, V38, P310, DOI 10.1016/j.pnpbp.2012.04.018; Seillier A, 2009, BEHAV BRAIN RES, V204, P410, DOI 10.1016/j.bbr.2009.02.007; NODA Y, 1995, BRIT J PHARMACOL, V116, P2531; Coyle JT, 2004, PSYCHOPHARMACOLOGY, V174, P32, DOI 10.1007/s00213-003-1709-2; Boulay D, 2008, PHARMACOL BIOCHEM BE, V91, P47, DOI 10.1016/j.pbb.2008.06.009; PITKANEN M, 1994, EUR J PHARMACOL, V253, P125, DOI 10.1016/0014-2999(94)90766-8; Krystal JH, 1999, HARVARD REV PSYCHIAT, V7, P125, DOI 10.1093/hrp/7.3.125; Depoortere R, 2005, NEUROPSYCHOPHARMACOL, V30, P1963, DOI 10.1038/sj.npp.1300772; Boyer P, 1990, Mod Probl Pharmacopsychiatry, V24, P152; Brar J S, 1997, Ann Clin Psychiatry, V9, P227, DOI 10.3109/10401239709147802; Crow TJ., 1986, BRIT J PSYCHIAT, V137, P379; Hons J, 2010, PSYCHIAT RES, V176, P103, DOI 10.1016/j.psychres.2009.11.008; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Langen B, 2012, PSYCHOPHARMACOLOGY, V221, P249, DOI 10.1007/s00213-011-2567-y; LINDENMAYER JP, 1994, J CLIN PSYCHOPHARM, V14, P201; MILLER DD, 1994, COMPR PSYCHIAT, V35, P8, DOI 10.1016/0010-440X(94)90164-3; Okuyama S, 1997, BRIT J PHARMACOL, V121, P515, DOI 10.1038/sj.bjp.0701164; Paxinos G., 1997, RAT BRAIN STEREOTAXI; Pozzi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083879; SCHOOLER NR, 1994, J CLIN PSYCHIAT, V55, P22; Shimazaki T, 2010, PSYCHOPHARMACOLOGY, V209, P263, DOI 10.1007/s00213-010-1794-y; Takamori K, 2001, LIFE SCI, V69, P1891, DOI 10.1016/S0024-3205(01)01262-0; Weiser Mark, 2012, J Clin Psychiatry, V73, pe728, DOI 10.4088/JCP.11m07031; Wilcox KS, 1996, J NEUROPHYSIOL, V76, P3415	41	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 1	2015	278						186	192		10.1016/j.bbr.2014.09.046		7	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AY5AQ	WOS:000347586300021		
J	Nejime, M; Inoue, M; Saruwatari, M; Mikami, A; Nakamura, K; Miyachi, S				Nejime, Masafumi; Inoue, Masato; Saruwatari, Masanori; Mikami, Akichika; Nakamura, Katsuki; Miyachi, Shigehiro			Responses of monkey prefrontal neurons during the execution of transverse patterning	BEHAVIOURAL BRAIN RESEARCH			English	Article						Single neuronal activity; Nonhuman primate; Medial prefrontal cortex; Configural discrimination; Nonlinear association; Long-term memory	HIPPOCAMPAL-FORMATION; PARAHIPPOCAMPAL CORTEX; CONFIGURAL TASKS; MACAQUE MONKEYS; LOCATION MEMORY; RHESUS MACAQUES; OLFACTORY CUES; DAMAGE; CONNECTIONS; RATS	Recent functional imaging studies have suggested that the prefrontal cortex (PF) is engaged in the performance of transverse patterning (TP), which consists of 3 conflicting discriminations (A+/B-, B+/C-, C+/A-). However, the roles of PF in TP are still unclear. To address this issue, we examined the neuronal responses in 3 regions [the principal sulcus (PS), dorsal convexity (DC), and medial prefrontal cortex (MPF)] of the macaque PF during the performance of an oculomotor version of TP. A delayed matching-to-sample (DMS) task was used as a control task. The TP task-responsive neurons were most abundant in MPF. We analyzed the dependency of each neuronal response on the task type (TP or DMS), target shape (A, B, or C), and target location (left or right). Immediately after the choice cue presentation, many MPF neurons showed task dependency. Interestingly, some of them already exhibited differential activity between the 2 tasks before the choice cue presentation. Immediately before the saccade, the number of target location-dependent neurons increased in MPF and PS. Among them, many MPF neurons were also influenced by the task type, whereas PS neurons tended to show location dependency without task dependency. These results suggest that MPF and PS are involved in the execution of TP: MPF appears to be more important in the target selection based on the TP rule, whereas PS is apparently more related to the response preparation. In addition, some neurons showed a postsaccadic response, which may be related to the feedback mechanism. (C) 2014 Elsevier B.V. All rights reserved.	[Nejime, Masafumi; Inoue, Masato; Saruwatari, Masanori; Mikami, Akichika; Nakamura, Katsuki; Miyachi, Shigehiro] Kyoto Univ, Primate Res Inst, Cognit Neurosci Sect, Inuyama, Aichi 4848506, Japan; [Mikami, Akichika] Chubu Gakuin Univ, Fac Nursing & Rehabil, Gifu 5013993, Japan	Miyachi, S (reprint author), Kyoto Univ, Primate Res Inst, Cognit Neurosci Sect, Inuyama, Aichi 4848506, Japan.	miyachi.shigehiro.8e@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20019021, A06]	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (20019021 to S.M.), and by Global COE program A06 (to M.N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors would like to thank Enago (www.enago.jp) for the English language review.	Alvarado MC, 2000, LEARN MEMORY, V7, P244, DOI 10.1101/lm.35100; Alvarado MC, 2002, HIPPOCAMPUS, V12, P421, DOI 10.1002/hipo.1115; ALVARADO MC, 1995, PSYCHOBIOLOGY, V23, P178; Alvarado MC, 1995, BEHAV NEUROSCI, V109, P1052, DOI 10.1037/0735-7044.109.6.1052; Alvarado MC, 2005, J NEUROSCI, V25, P1599, DOI 10.1523/JNEUROSCI.4457-04.2005; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Kondo H, 2005, J COMP NEUROL, V493, P479, DOI 10.1002/cne.20796; Rudy JW, 1995, HIPPOCAMPUS, V5, P375, DOI 10.1002/hipo.450050502; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; RUDY JW, 1992, J COGNITIVE NEUROSCI, V4, P208, DOI 10.1162/jocn.1992.4.3.208; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814; Mills T, 2012, BRAIN TOPOGR, V25, P248, DOI 10.1007/s10548-012-0217-2; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; McDonald RJ, 1997, HIPPOCAMPUS, V7, P371, DOI 10.1002/(SICI)1098-1063(1997)7:4<371::AID-HIPO3>3.0.CO;2-M; RUDY JW, 1993, DEV PSYCHOBIOL, V26, P171, DOI 10.1002/dev.420260304; Rickard TC, 1998, J COGNITIVE NEUROSCI, V10, P509, DOI 10.1162/089892998562915; ALVARADO MC, 1995, BEHAV NEUROSCI, V109, P204, DOI 10.1037//0735-7044.109.2.204; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; SPENCE KW, 1952, PSYCHOL REV, V59, P89, DOI 10.1037/h0063067; Rickard TC, 2006, J COGNITIVE NEUROSCI, V18, P1723, DOI 10.1162/jocn.2006.18.10.1723; FUSTER JM, 1982, EXP NEUROL, V77, P679, DOI 10.1016/0014-4886(82)90238-2; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355; Alvarado MC, 2005, HIPPOCAMPUS, V15, P118, DOI 10.1002/hipo.20037; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714; Dusek JA, 1998, BEHAV NEUROSCI, V112, P762, DOI 10.1037/0735-7044.112.4.762; Hasegawa I, 1998, SCIENCE, V281, P818; Inoue M, 2010, EUR J NEUROSCI, V31, P938, DOI 10.1111/j.1460-9568.2010.07123.x; Meltzer JA, 2008, HUM BRAIN MAPP, V29, P385, DOI 10.1002/hbm.20391; Meltzer JA, 2009, PSYCHOPHYSIOLOGY, V46, P153, DOI 10.1111/j.1469-8986.2008.00719.x; RUDY JW, 1991, DEV PSYCHOBIOL, V24, P221, DOI 10.1002/dev.420240404; Tsujimoto S, 2004, CEREB CORTEX, V14, P47, DOI 10.1093/cercor/bhg090; Tsujimoto S, 2005, CEREB CORTEX, V15, P888, DOI 10.1093/cercor/bhh188; WHISHAW IQ, 1991, BEHAV NEUROSCI, V105, P787, DOI 10.1037/0735-7044.105.6.787	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 1	2015	278						293	302		10.1016/j.bbr.2014.10.015		10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AY5AQ	WOS:000347586300034		
J	Ushimura, A; Tsuji, T; Tanaka, S; Kogo, M; Yamamoto, T				Ushimura, Ayako; Tsuji, Tadataka; Tanaka, Susumu; Kogo, Mikihiko; Yamamoto, Takashi			Neuropeptide-Y modulates eating patterns and masticatory muscle activity in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Feeding; Neuropeptide-Y; Orexin; Behavioral analysis; Electrophysiology; Mastication	MELANIN-CONCENTRATING HORMONE; IMMUNOHISTOCHEMICAL ANALYSIS; PANCREATIC-POLYPEPTIDE; FEEDING-BEHAVIOR; BRAIN; OREXIN; STIMULATION; RECEPTORS; RESPONSES; NEURONS	Neuropeptide Y (NPY) is a powerful orexigenic peptide secreted by hypothalamic neurons. The present study investigates how NPY injection into the lateral ventricle modulates masticatory movements and eating behavior. Behavioral experiments showed that cumulative food intake over a 4-h period and latency to eating were increased and decreased, respectively, in NPY-injected rats compared to saline-injected control rats. The feeding time for 2 g pellets was shorter in NPY-injected rats and resulted in an increased feeding rate, with more potent effects observed at 1 mu g compared to 10 mu g NPY. After injection of 10 mu g NPY, a greater number of bouts with shorter average bout duration for eating 2 g, compared to 1 mu g NPY, were observed. Furthermore, 10 mu g NPY injection resulted in prolonged periods of moving and shortened sleep and grooming. Electromyography recordings from the digastric and masseter muscles showed two distinct patterns of bursts corresponding to the gnawing and chewing phases. After the injection of 1 mu g NPY, the burst magnitude of masseter muscle during the gnawing phase increased, reflecting strong jaw-closing muscle activity. The relative integrated EMG of masseter muscle in both phases was smaller following injection of 10 mu g NPY in comparison with that of 1 mu g NPY. The present study indicates that 1 mu g NPY administration promotes feeding behavior together with increased feeding rate and powerful jaw-closing muscle activity; whereas 10 mu g NPY administration lowers jaw-closing muscle activity during biting and produces mastication with shorter and more frequent feeding bouts than 1 mu g NPY. (C) 2014 Elsevier B.V. All rights reserved.	[Ushimura, Ayako; Tsuji, Tadataka; Tanaka, Susumu; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka 5650871, Japan; [Yamamoto, Takashi] Kio Univ, Dept Hlth & Nutr, Fac Hlth Sci, Koryo, Nara 6350832, Japan	Tsuji, T (reprint author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	g2787b@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [21390535, 25293409, 21791988]	This work was supported by Grants-in-Aid for Scientific Research (B) (21390535 and 25293409 to M.K) and a Grant-in-Aid for Young Scientists (B) (21791988 to T.T.) from the Japan Society for the Promotion of Science. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; MORGANE PJ, 1961, SCIENCE, V133, P887, DOI 10.1126/science.133.3456.887; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; MORLEY JE, 1987, AM J PHYSIOL, V252, pR599; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ehlers CL, 1997, NEUROPSYCHOPHARMACOL, V17, P34; Yamanaka A, 2000, BRAIN RES, V859, P404, DOI 10.1016/S0006-8993(00)02043-6; JOLICOEUR FB, 1995, BRAIN RES BULL, V37, P1, DOI 10.1016/0361-9230(94)00172-3; GRILL HJ, 1978, BRAIN RES, V143, P263, DOI 10.1016/0006-8993(78)90568-1; CHRONWALL BM, 1985, NEUROSCIENCE, V15, P1159, DOI 10.1016/0306-4522(85)90260-X; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; STANLEY BG, 1984, LIFE SCI, V35, P2635, DOI 10.1016/0024-3205(84)90032-8; ANAND BK, 1951, YALE J BIOL MED, V24, P123; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427; CLARK JT, 1985, ENDOCRINOLOGY, V117, P2435; Cooper SJ, 2006, EUR J PHARMACOL, V532, P253, DOI 10.1016/j.ejphar.2005.11.046; CURRIE PJ, 1995, PEPTIDES, V16, P599, DOI 10.1016/0196-9781(95)00020-K; DEQUIDT ME, 1986, NEUROSCIENCE, V18, P545, DOI 10.1016/0306-4522(86)90057-6; Hu YG, 1997, BRAIN RES BULL, V44, P97, DOI 10.1016/S0361-9230(97)00101-9; Sahu A, 2002, BRAIN RES, V944, P232, DOI 10.1016/S0006-8993(02)02941-4; Sakurai T, 1998, CELL, V92, DOI DOI 10.1016/S0092-8674(00)80949-6; STANLEY BG, 1989, PHYSIOL BEHAV, V46, P173, DOI 10.1016/0031-9384(89)90251-5; Toth A, 2007, BRAIN RES BULL, V72, P293, DOI 10.1016/j.brainresbull.2007.01.006; Tsuji T, 2011, J NEUROPHYSIOL, V106, P3129, DOI 10.1152/jn.01108.2010; Ulman EA, 2008, ALN MAG          OCT, P17; Westberg KG, 2011, INT REV NEUROBIOL, V97, P77, DOI 10.1016/B978-0-12-385198-7.00004-7; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; YAMAZOE M, 1985, BRAIN RES, V335, P109, DOI 10.1016/0006-8993(85)90281-1; Yannielli PC, 2001, PEPTIDES, V22, P547, DOI 10.1016/S0196-9781(01)00356-4	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 1	2015	278						520	526		10.1016/j.bbr.2014.10.031		7	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AY5AQ	WOS:000347586300064		
J	Mizuta, Y; Ohno, T				Mizuta, Yoshihiro; Ohno, Takao			Herz-Morrey spaces of variable exponent, Riesz potential operator and duality	COMPLEX VARIABLES AND ELLIPTIC EQUATIONS			English	Article						Primary: 31B15; 46E35; Riesz potentials; Herz-Morrey spaces of variable exponent; maximal functions; Sobolev's inequality; Trudinger's inequality; duality	LIPSCHITZ SPACES; GENERALIZED LEBESGUE; SOBOLEV EMBEDDINGS; SINGULAR-OPERATORS; FOURIER-TRANSFORMS; BOUNDEDNESS; INTEGRALS; THEOREM	Our aim in this paper is to deal with the boundedness of the Hardy-Littlewood maximal operator on Herz-Morrey spaces and to establish Sobolev's inequalities for Riesz potentials of functions in Herz-Morrey spaces. Further, we discuss the associate spaces among Herz-Morrey spaces.	[Mizuta, Yoshihiro] Hiroshima Inst Technol, Dept Mech Syst Engn, Saeki Ku, Hiroshima, Higashi Hiroshi 7315193, Japan; [Ohno, Takao] Oita Univ, Fac Educ & Welf Sci, Oita 8701192, Japan	Mizuta, Y (reprint author), Hiroshima Inst Technol, Dept Mech Syst Engn, Saeki Ku, 2-1-1 Miyake, Hiroshima, Higashi Hiroshi 7315193, Japan.	y.mizuta.5x@it-hiroshima.ac.jp					Adams DR, 1981, REPORTS, V2; Burenkov VI, 2011, POTENTIAL ANAL, V35, P67, DOI 10.1007/s11118-010-9205-x; Adams DR, 2012, ARK MAT, V50, P201, DOI 10.1007/s11512-010-0134-0; Guliyev VS, 2013, J MATH ANAL APPL, V401, P72, DOI 10.1016/j.jmaa.2012.03.041; Diening L, 2004, MATH INEQUAL APPL, V7, P245; Almeida A, 2008, GEORGIAN MATH J, V15, P195; Gogatishvili A, 2013, J MATH ANAL APPL, V397, P678, DOI 10.1016/j.jmaa.2012.08.025; Burenkov VI, 2010, COMPLEX VAR ELLIPTIC, V55, P739, DOI 10.1080/17476930903394697; HERZ CS, 1968, J MATH MECH, V18, P283; Izuki M, 2010, HIROSHIMA MATH J, V40, P343; Gogatishvili A, 2011, CZECH MATH J, V61, P609; Guliyev VS, 2010, MATH SCAND, V107, P285; Almeida A, 2012, J MATH ANAL APPL, V394, P781, DOI 10.1016/j.jmaa.2012.04.043; Di Fratta G, 2009, NONLINEAR ANAL-THEOR, V70, P2582, DOI 10.1016/j.na.2008.03.044; Capone C., 2005, J FUNCT SPACE APPL, V3, P73; Chiarenza F., 1987, REND MAT, V7, P273; Diening L, 2011, LECT NOTES MATH, V2017, P1, DOI 10.1007/978-3-642-18363-8; Diening L, 2004, MATH NACHR, V268, P31, DOI 10.1002/mana.200310157; FLETT TM, 1974, P LOND MATH SOC, V29, P538; Guliyev V. S., 2010, J MATH SCI, V170, P423, DOI DOI 10.1007/S10958-010-0095-7; Guliyev VS, 2013, J MATH SCI, V193, P228; JOHNSON R, 1974, P LOND MATH SOC, V29, P127; JOHNSON R, 1973, P LOND MATH SOC, V27, P290; Mizuta Y, 2011, COMPLEX VAR ELLIPTIC, V56, P671, DOI 10.1080/17476933.2010.504837; Mizuta Y, 2014, ANN ACAD SCI FENN-M, V39, P389, DOI 10.5186/aasfm.2014.3913; Mizuta Y, 2010, B SCI MATH, V134, P12, DOI 10.1016/j.bulsci.2009.09.004; Mizuta Y, 2008, J MATH SOC JPN, V60, P583, DOI 10.2969/jmsj/06020583; Peetre J., 1969, J FUNCT ANAL, V4, P71, DOI 10.1016/0022-1236(69)90022-6; Rika M., 2000, ELECTRORHEOLOGICAL F; Samko S, 2013, MEDITERRANIAN J MATH, V10, P2005	30	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-6933	1747-6941		COMPLEX VAR ELLIPTIC	Complex Var. Elliptic Equ.	FEB 1	2015	60	2					211	240		10.1080/17476933.2014.908857		30	Mathematics	Mathematics	AY4GM	WOS:000347536300005		
J	Tokuda, M; Fujisawa, M; Miyashita, K; Kawakami, Y; Morimoto-Yamashita, Y; Torii, M				Tokuda, M.; Fujisawa, M.; Miyashita, K.; Kawakami, Y.; Morimoto-Yamashita, Y.; Torii, M.			Involvement of TRPV1 and AQP2 in hypertonic stress by xylitol in odontoblast cells	CONNECTIVE TISSUE RESEARCH			English	Article						AQP2; hypertonic stress; odontoblast cells; TRPV1; xylitol	POTENTIAL VANILLOID CHANNELS; EPITHELIAL-CELLS; STREPTOCOCCUS-MUTANS; DENTINAL PAIN; INHIBITION; EXPRESSION; CARIES; LINE	Aim: To examine the responses of mouse odontoblast-lineage cell line (OLC) cultures to xylitol-induced hypertonic stress. Methodology: OLCs were treated with xylitol, sucrose, sorbitol, mannitol, arabinose and lyxose. Cell viability was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium assay. The expression of transient receptor potential vanilloids (TRPV) 1, 3 and 4 was detected using a reverse transcriptase-polymerase chain reaction (RT-PCR) assay. The expression of aquaporin (AQP) 2 was detected using immunofluorescence and Western blotting analysis. The expression of interleukin-6 (IL-6) under xylitol-induced hypertonic stress was assessed using an enzyme-linked immunosorbent assay (ELISA). Small interfering ribonucleic acid (siRNA) for AQP2 was used to inhibition assay. Results: Xylitol-induced hypertonic stress did not decrease OLC viability, unlike the other sugars tested. OLCs expressed TRPV1, 3 and 4 as well as AQP2. Xylitol inhibited lipopolysaccharide (LPS)-induced IL-6 expression after 3 h of hypertonic stress. TRPV1 mRNA expression was upregulated by xylitol. Costimulation with HgCl2 (AQP inhibitor) and Ruthenium red (TRPV1 inhibitor) decreased cell viability with xylitol stimulation. OLCs treated with siRNA against TRPV1 exhibited decreased cell viability with xylitol stimulation. Conclusion: OLCs have high-cell viability under xylitol-induced hypertonic stress, which may be associated with TRPV1 and AQP2 expressions.	[Tokuda, M.; Fujisawa, M.; Miyashita, K.; Kawakami, Y.; Morimoto-Yamashita, Y.; Torii, M.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Restorat Dent & Endodontol, Kagoshima 890, Japan	Tokuda, M (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Restorat Dent & Endodontol, Kagoshima 890, Japan.	mas-tok@dent.kagoshima-u.ac.jp					Amaral LFB, 2011, INT J COSMETIC SCI, V33, P391, DOI 10.1111/j.1468-2494.2010.00633.x; Mergler S, 2012, HISTOCHEM CELL BIOL, V137, P743, DOI 10.1007/s00418-012-0924-5; Forssten SD, 2010, NUTRIENTS, V2, P290, DOI 10.3390/nu2030290; Magloire H, 2010, J OROFAC PAIN, V24, P335; Galizia L, 2012, J CELL BIOCHEM, V113, P580, DOI 10.1002/jcb.23382; Son AR, 2009, J DENT RES, V88, P1014, DOI 10.1177/0022034509343413; Fujisawa M, 2012, J ENDODONT, V38, P931, DOI 10.1016/j.joen.2012.03.023; Pan Z, 2011, INVEST OPHTH VIS SCI, V52, P485, DOI 10.1167/iovs.10-5801; Gresz V, 2004, AM J PHYSIOL-GASTR L, V287, pG151, DOI 10.1152/ajpgi.00480.2003; Yang M, 2013, J CELL BIOCHEM, V114, P111, DOI 10.1002/jcb.24308; Chung G, 2013, J DENT RES, V92, P948, DOI 10.1177/0022034513501877; El Karim IA, 2011, PAIN, V152, P2211, DOI 10.1016/j.pain.2010.10.016; Arany S, 2006, BIOCHEM BIOPH RES CO, V342, P718, DOI 10.1016/j.bbrc.2006.02.020; Day RE, 2014, BBA-GEN SUBJECTS, V1840, P1492, DOI 10.1016/j.bbagen.2013.09.033; Sato M, 2013, J ENDODONT, V39, P779, DOI 10.1016/j.joen.2013.01.012; Arsenijevic T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.189; BRANNSTROM M, 1986, J ENDODONT, V12, P453, DOI 10.1016/S0099-2399(86)80198-4; Brocker C., 2012, BIOMOL CONCEPTS, V3, P345, DOI DOI 10.1515/BMC-2012-0001; Han SJ, 2005, CLIN DIAGN LAB IMMUN, V12, P1285, DOI 10.1128/CDLI.12.11.1285-1291.2005; Islam MS, 2012, ANN NUTR METAB, V61, P57, DOI 10.1159/000338440; Maurin JC, 2013, M S-MED SCI, V29, P293, DOI 10.1051/medsci/2013293016; Soderling EM, 2008, CURR MICROBIOL, V56, P382, DOI 10.1007/s00284-007-9076-6	22	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0300-8207	1607-8438		CONNECT TISSUE RES	Connect. Tissue Res.	FEB	2015	56	1					44	49		10.3109/03008207.2014.984804		6	Cell Biology; Orthopedics	Cell Biology; Orthopedics	AY2LD	WOS:000347420900006		
J	Kohmura, H; Hirayama, H; Ueno, T				Kohmura, Hiroaki; Hirayama, Hiroyuki; Ueno, Takatoshi			Diving Into The Water: Cues Related to the Decision-Making by an Egg Parasitoid Attacking Underwater Hosts	ETHOLOGY			English	Article						Aquarius paludum insularis; cost; foraging strategy; scelionidae; Tiphodytes gerriphagus; water strider	GERRIPHAGUS MARCHAL HYMENOPTERA; SUBMERGED OVIPOSITION; INFOCHEMICAL USE; HELIOTHIS-ZEA; SEX-PHEROMONE; LOCATION; HETEROPTERA; PLANT; TRICHOGRAMMA; SCELIONIDAE	Although adult parasitoids spend a majority of their lives above ground, females of several species must search for their host in the water or on the soil. Adult parasitoids above ground can use a variety of sensory cues to detect their hosts from a distance. However, their sensory cues can be impaired from volatile chemicals, and their visual stimuli can be decreased while submerging or burrowing in the water of soil during their search for their hosts. Searching underwater or underground would incur high foraging costs, that is, time and energy consumption and increase risk of drowning. Therefore, to reduce such costs and increase searching efficiency, the decision on where to start submerging or burrowing for attacking hosts is important for parasitoids. Furthermore, there are no studies that have examined the cues of submerging or burrowing parasitoids on their exploit for the decision to attack their hosts. We have examined the cues used by the egg parasitoid Tiphodytes gerriphagus attacking underwater hosts. We compared the searching behaviors of T.gerriphagus among four oviposition site conditions. The four sites investigated were oviposition site with both host adult chemical residues and presence of eggs, with only the presence of eggs, with only the host adult chemical residues, and without any cue. Our results indicated that T.gerriphagus more frequently contacted and submerged at oviposition sites with the adult residues rather than at oviposition sites without them. Nonetheless, the presence of underwater host eggs did not affect the host-searching behavior. This suggests that T.gerriphagus decided to submerge at the oviposition site in response to the adult residues. Furthermore, our observation also suggested that T.gerriphagus has already detected that the adult residues might be volatile before contacting the oviposition site. Finally, we will discuss the exploitation patterns of host-searching cue by parasitoids that need to submerge from the context of its reliability and detectability problems.	[Kohmura, Hiroaki; Ueno, Takatoshi] Kyushu Univ, Inst Biol Control, Fac Agr, Fukuoka 8128581, Japan; [Hirayama, Hiroyuki] Kyushu Univ, Fac Sci, Dept Biol, Lab Ecol Sci, Fukuoka 8128581, Japan	Hirayama, H (reprint author), Kyushu Univ, Fac Sci, Dept Biol, Lab Ecol Sci,Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	hirohirayama@kyudai.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9]	The authors thank Whelma Villaester for editing the manuscript. This work was supported in part by the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan.	Amano H, 2008, ECOL ENTOMOL, V33, P560, DOI 10.1111/j.1365-2311.2008.00988.x; Yong TH, 2007, BIOCONTROL SCI TECHN, V17, P135, DOI 10.1080/09583150600937352; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Fatouros NE, 2008, BEHAV ECOL, V19, P677, DOI 10.1093/beheco/arn011; WACKERS FL, 1994, BIOL CONTROL, V4, P105, DOI 10.1006/bcon.1994.1018; HOLM S, 1979, SCAND J STAT, V6, P65; Steidle JLM, 2003, ENTOMOL EXP APPL, V108, P133, DOI 10.1046/j.1570-7458.2003.00080.x; VET LEM, 1991, NETH J ZOOL, V41, P202; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; DICKE M, 1999, P 38 S BRIT EC SOC 1, P483; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Godfray H.C.J., 1994, PARASITOIDS BEHAV EV; HENRIQUEZ NP, 1993, J INSECT BEHAV, V6, P455, DOI 10.1007/BF01049525; Hirayama H, 2009, ANIM BEHAV, V78, P935, DOI 10.1016/j.anbehav.2009.07.019; Hirayama H, 2008, ANIM BEHAV, V76, P1919, DOI 10.1016/j.anbehav.2008.08.013; Hoffmeister TS, 1999, ETHOLOGY, V105, P223, DOI 10.1046/j.1439-0310.1999.00361.x; Inoue M, 2008, J ETHOL, V26, P43, DOI 10.1007/s10164-006-0028-6; LEWIS WJ, 1982, J CHEM ECOL, V8, P1323, DOI 10.1007/BF00987765; MCAUSLANE HJ, 1990, ENVIRON ENTOMOL, V19, P26; McCullagh P., 1989, GEN LINEAR MODEL; NOLDUS LPJJ, 1988, ENTOMOL EXP APPL, V48, P293; NUMMELIN M, 1988, ANN ZOOL FENN, V25, P299; Querino RB, 2009, NEOTROP ENTOMOL, V38, P346, DOI 10.1590/S1519-566X2009000300008; R Development Core Team, 2009, R LANG ENV STAT COMP; SPENCE JR, 1986, CAN J ZOOL, V64, P2728, DOI 10.1139/z86-397; Turlings Ted C. J., 2002, P148, DOI 10.1017/CBO9780511542190.007	26	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0179-1613	1439-0310		ETHOLOGY	Ethology	FEB	2015	121	2					168	175		10.1111/eth.12326		8	Psychology, Biological; Behavioral Sciences; Zoology	Psychology; Behavioral Sciences; Zoology	AY4KE	WOS:000347545900007		
J	Sato, Y; Yoneyama, O; Azumaya, M; Takeuchi, M; Sasaki, S; Yokoyama, J; Shioji, K; Kawauchi, Y; Hashimoto, S; Nishigaki, Y; Kobayashi, M; Sugimura, K; Honma, T; Narisawa, R; Aoyagi, Y				Sato, Yuichi; Yoneyama, Osamu; Azumaya, Masaki; Takeuchi, Manabu; Sasaki, Syun-ya; Yokoyama, Junji; Shioji, Kazuhiko; Kawauchi, Yusuke; Hashimoto, Satoru; Nishigaki, Yuuki; Kobayashi, Masaaki; Sugimura, Kazuhito; Honma, Terasu; Narisawa, Rintaro; Aoyagi, Yutaka			The Relationship Between Iron Deficiency in Patients with Helicobacter Pylori-Infected Nodular Gastritis and the Serum Prohepcidin Level	HELICOBACTER			English	Article						Hepcidin; HP-related iron-deficiency anemia; hyperplastic polyp; hypochlorhydria; nodular gastritis	HYPERPLASTIC POLYPS; ACID-SECRETION; PEPSINOGEN-I; ANEMIA; METAANALYSIS; CHILDREN; HEPCIDIN; JAPANESE; ADOLESCENTS; GUIDELINES	Background and aimsHelicobacter pylori (H. pylori) is recognized as a causative agent for unexplained iron-deficiency anemia (IDA). We evaluated many background factors influencing an iron-deficiency state in adult patients with various H.pylori-infected upper gastrointestinal tract diseases. MethodStudy 1: H.pylori-infected 121 patients (nodular gastritis (NG) (n=19), duodenal ulcer (DU) (n=30), or gastric ulcer (GU) (n=47), or gastric hyperplastic polyp (GHP) (n=25)) were enrolled. The RBC count and hemoglobin, iron, ferritin, pepsinogen (PG) I, PG II, gastrin, and anti-H. pylori antibody (Ab) levels in the serum were measured. Study 2: H.pylori-infected 105 patients (NG, n=19; DU, n=43; GU, n=32; GHP, n=11) and non-H.pylori-infected individuals (n=35) were examined for the levels of prohepcidin, ferritin, and iron in the serum. In addition, we measured the data before and after the H.pylori eradication. ResultsIn the patients with GHP and NG, hypoferritinemia was observed in comparison with the GU and DU patients. In the GHP patients, low levels of PG I, a decreased PG I/II ratio, and hypergastrinemia were observed. The levels of serum prohepcidin in the patients with H.pylori-associated disease were higher than those in the uninfected adults. In the patients with NG, the serum prohepcidin levels were higher than those in the other H.pylori-infected patient groups and decreased after the eradication. ConclusionH.pylori-related iron-deficiency state might be associated with several factors, such as hypochlorhydria and hepcidin, in patients with GHP or NG.	[Sato, Yuichi; Yoneyama, Osamu; Azumaya, Masaki; Takeuchi, Manabu; Sasaki, Syun-ya; Yokoyama, Junji; Shioji, Kazuhiko; Kawauchi, Yusuke; Hashimoto, Satoru; Nishigaki, Yuuki; Sugimura, Kazuhito; Honma, Terasu; Aoyagi, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol, Niigata 9518121, Japan; [Kobayashi, Masaaki; Narisawa, Rintaro] Niigata Univ, Med & Dent Hosp, Div Endoscopy, Niigata 9518121, Japan	Sato, Y (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol, Niigata 9518121, Japan.	yuichi@med.niigata-u.ac.jp					Cardamone M, 2008, J PAEDIATR CHILD H, V44, P647, DOI 10.1111/j.1440-1754.2008.01374.x; Jain R, 2009, DIGEST DIS SCI, V54, P1839, DOI 10.1007/s10620-008-0572-8; SAMLOFF IM, 1982, GASTROENTEROLOGY, V83, P204; Qu XH, 2010, WORLD J GASTROENTERO, V16, P886, DOI 10.3748/wjg.v16.i7.886; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Yuan WZ, 2010, SCAND J GASTROENTERO, V45, P665, DOI 10.3109/00365521003663670; Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Barabino A, 2002, HELICOBACTER, V7, P71, DOI 10.1046/j.1083-4389.2002.00073.x; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Schwarz P, 2012, GUT, V61, P193, DOI 10.1136/gut.2011.241208; ASAKA M, 1992, GASTROENTEROLOGY, V102, P760; Al-Haddad M, 2007, DIGEST DIS SCI, V52, P105, DOI 10.1007/s10620-006-9182-5; Kido M, 2010, INFECT IMMUN, V78, P108, DOI 10.1128/IAI.00762-09; Annibale B, 2003, DIGEST LIVER DIS, V35, P288, DOI 10.1016/S1590-8658(03)00067-7; Muhsen K, 2008, HELICOBACTER, V13, P323, DOI 10.1111/j.1523-5378.2008.00617.x; Azab SFA, 2013, ANN HEMATOL, V92, P1477, DOI 10.1007/s00277-013-1813-2; Bonilla Palacios JJ, 1994, ACTA GASTROENTEROL L, V24, P77; BUJANOVER Y, 1990, J PEDIATR GASTR NUTR, V11, P41, DOI 10.1097/00005176-199007000-00008; Cherian S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004030; Ciacci C, 2004, DIGEST LIVER DIS, V36, P455, DOI 10.1016/j.dld.2004.02.008; Ganz T, 2012, BIOCHIM BIOPHYS ACTA, V9, P26; Gulen H, 2011, PEDIATR HEMAT ONCOL, V28, P694, DOI 10.3109/08880018.2011.572145; HARUMA K, 1993, SCAND J GASTROENTERO, V28, P633, DOI 10.3109/00365529309096102; Huang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088408; Kim HK, 2013, GASTROENT RES PRACT, V201810, P28; Kitamura S, 2013, J GASTROEN HEPATOL, V28, P1154, DOI 10.1111/jgh.12180; Lee JH, 2009, HELICOBACTER, V14, P36, DOI 10.1111/j.1523-5378.2009.00658.x; Lee Sun-Young, 2010, Korean Journal of Internal Medicine, V25, P195, DOI 10.3904/kjim.2010.25.2.195; Miyamoto M, 2003, DIGEST DIS SCI, V48, P968, DOI 10.1023/A:1023016000096; Nakamura S, 2007, DIGEST ENDOSC, V19, P74, DOI 10.1111/j.1443-1661.2007.00693.x; Nakashima R, 2011, J DIGEST DIS, V12, P436, DOI 10.1111/j.1751-2980.2011.00532.x; Ozkasap S, 2013, PEDIATR HEMAT ONCOL, V30, P425, DOI 10.3109/08880018.2013.783144; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Yokota S, 2008, CLIN INFECT DIS, V46, pE31, DOI 10.1086/526784	38	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	FEB	2015	20	1					11	18		10.1111/hel.12170		8	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	AY4HZ	WOS:000347540000002		
J	Li, F; Yan, JG; Xu, LY; Jin, SG; Rodriguez, JAP; Dohm, JH				Li, Fei; Yan, Jianguo; Xu, Luyuan; Jin, Shuanggen; Rodriguez, J. Alexis P.; Dohm, James H.			A 10 km-resolution synthetic Venus gravity field model based on topography	ICARUS			English	Article						Venus; Interior; Geophysics	ISOSTATIC COMPENSATION; ORDER MODEL; SUPPORT	A high resolution gravity field model is extremely important in the exploration of Venus. In this paper, we present a 3-dimensional Venus gravity field VGM2014 constructed by using the latest gravity and topography models, residual terrain model (RTM) and the Airy-Heiskanen isostatic compensation model. The VGM2014 is the first 10 km scale Venus gravity field model; the final results are representations of the 3-dimensional surface gravity accelerations and gravity disturbances for Venus. We found that the optimal global compensation depth of Venus is about 60 km, and the crustal density is potentially less than the commonly accepted value of 2700-2900 kg m(-3). This model will be potentially beneficial for the precise orbit determination and landing navigation of spacecraft around Venus, and may be utilized as a priori model for Venus gravity field simulation and inversion studies. The VGM2014 does not incorporate direct gravity information beyond degree 70 and it is not recommended for small-scale geophysical interpretation. (C) 2014 Elsevier Inc. All rights reserved.	[Li, Fei; Yan, Jianguo] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430070, Peoples R China; [Yan, Jianguo] Natl Astron Observ Japan, RISE Project, Oshu 0230861, Japan; [Xu, Luyuan] Wuhan Univ, Chinese Antarctic Ctr Surveying & Mapping, Wuhan 430070, Peoples R China; [Jin, Shuanggen] Chinese Acad Sci, Shanghai Astron Observ, Shanghai 20030, Peoples R China; [Rodriguez, J. Alexis P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Dohm, James H.] Univ Tokyo, Univ Museum, Tokyo 1130033, Japan	Yan, JG (reprint author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430070, Peoples R China.		Jin, Shuanggen/B-8094-2008	Jin, Shuanggen/0000-0002-5108-4828	National Natural Science Foundation of China [41174019, 41374024]; National Keystone Basic Research Program [2012CB72000]	We used the Generic Mapping Tools (GMT) software for drawing the figures. Our spherical harmonic analyses were performed using the freely available software archive SHTOOLS (http://www.ipgp.fr/similar to wieczor/SH/SH.html). Dr. Stephen McClure is appreciated for his discussion on the manuscript. This research is supported by Grant of the National Natural Science Foundation of China (41174019, 41374024) and the National Keystone Basic Research Program (2012CB72000).	Hirt C, 2012, PLANET SPACE SCI, V67, P147, DOI 10.1016/j.pss.2012.02.006; Hirt C, 2012, EARTH PLANET SC LETT, V329, P22, DOI 10.1016/j.epsl.2012.02.012; Mazarico E, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003472; Rappaport NJ, 1999, ICARUS, V139, P19, DOI 10.1006/icar.1999.6081; KUCINSKAS AB, 1994, ICARUS, V112, P104, DOI 10.1006/icar.1994.1172; Hirt C, 2010, J GEODESY, V84, P179, DOI 10.1007/s00190-009-0354-x; James PB, 2013, J GEOPHYS RES-PLANET, V118, P859, DOI 10.1029/2012JE004237; BANERDT WB, 1986, J GEOPHYS RES-SOLID, V91, P403, DOI 10.1029/JB091iB01p00403; Basilevsky AT, 2007, ICARUS, V192, P167, DOI 10.1016/j.icarus.2007.07.007; FORSBERG R, 1981, J GEOPHYS RES, V86, P7843, DOI 10.1029/JB086iB09p07843; Forsberg R., 1984, OSUDGSS355; Grimm R.E., 1997, VENUS; Konopliv A.S., 1996, VENUS 120 DEGREE ORD; Konopliv AS, 1999, ICARUS, V139, P3, DOI 10.1006/icar.1999.6086; Kucinskas AB, 1996, J GEOPHYS RES-PLANET, V101, P4725, DOI 10.1029/95JE02979; Lawson C.L., 1995, SOC IND APPL MATH, V15; Nagy D, 2000, J GEODESY, V74, P552, DOI 10.1007/s001900000116; Rummel R., 1988, COMP GLOBAL TOPOGRAP; Senske D.A., 1992, LUNAR PLANET SCI, V789, P107; Torge W., 2001, GEODESY; Watts A.B., 2001, ISOSTASY FLEXURE LIT; Wessel P., 1998, EOS T AM GEOL UNION; Wieczorek M. A., 2007, TREATISE GEOPHYS, V10, P165, DOI DOI 10.1016/B978-044452748-6/00156-5; Zolotov M.Y., 1992, VENUS GEOLOGY GEOCHE	24	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	FEB	2015	247						103	111		10.1016/j.icarus.2014.09.052		9	Astronomy & Astrophysics	Astronomy & Astrophysics	AX1ER	WOS:000346691400009		
J	Ito, K; Matsuoka, K; Matsuzaka, K; Morinaga, K; Inoue, T				Ito, K.; Matsuoka, K.; Matsuzaka, K.; Morinaga, K.; Inoue, T.			Hypoxic condition promotes differentiation and mineralization of dental pulp cells in vivo	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						dental pulp; differentiation; DSPP; hypoxia; in vivo; rat	HEMATOPOIETIC STEM-CELLS; OXYGEN-TENSION; TISSUE; DENTINOGENESIS; EXPRESSION; INDUCTION; RESPONSES; MARKERS; VITRO	AimTo investigate the behaviour of dental pulp cells under hypoxic conditions in vivo using an experimental animal model. MethodologyA mini-screw was inserted into the inferior dental nerve canal of rats to arrest the blood supply, which resulted in a reduced oxygen level in the dental pulps of molar teeth used for the experimental group. The decrease in blood supply was evaluated by injected India ink in transparent specimens. The hypoxia marker hypoxyprobe-1 was investigated by immunohistochemical staining. The mRNA expressions of ATP-binding cassette transporter (ABC) G2 (ABCG2) which is a marker for the capacity to excrete metabolites and for stem-like cells as well as dentine sialophosphoprotein (DSPP) and osteocalcin (OCN) which are markers for mineralization were evaluated by RT-PCR. Protein was evaluated by immunohistochemical staining using ABCG2, dentine sialoprotein (DSP) and OCN. ResultsThe evaluation of India ink indicated a decreased blood supply in the transparent specimens, and hypoxyprobe-1 immunohistochemical staining showed positive expression. ABCG2, DSPP and OCN mRNA expressions increased at 7 and 14days. Immunohistochemically, ABCG2, DSP and OCN-positive cells were localized in the odontoblastic layer. ConclusionsHypoxic conditions promoted mineralization and differentiation of dental pulp cells of the odontoblastic layer.	[Ito, K.; Morinaga, K.] Tokyo Dent Coll, Dept Endodont & Clin Cariol, Chiba 2618502, Japan; [Matsuoka, K.; Matsuzaka, K.; Inoue, T.] Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiba 2618502, Japan; [Matsuzaka, K.; Inoue, T.] Tokyo Dent Coll, Dept Clin Pathophysiol, Chiba 2618502, Japan	Inoue, T (reprint author), Tokyo Dent Coll, Dept Clin Pathophysiol, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	inoue@tdc.ac.jp					Amemiya H, 2008, J PERIODONTAL RES, V43, P322, DOI 10.1111/j.1600-0765.2007.01032.x; Wei X, 2007, J ENDODONT, V33, P703, DOI 10.1016/j.joen.2007.02.009; Li LF, 2011, J ENDODONT, V37, P799, DOI 10.1016/j.joen.2011.02.028; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013; KIM S, 1984, J DENT RES, V63, P650, DOI 10.1177/00220345840630050801; Amemiya K, 2003, EUR J ORAL SCI, V111, P332, DOI 10.1034/j.1600-0722.2003.00047.x; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Dean M, 2001, J LIPID RES, V42, P1007; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Pear WS, 2005, CANCER CELL, V8, P435, DOI 10.1016/j.ccr.2005.11.016; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; GAZELIUS B, 1986, Endodontics and Dental Traumatology, V2, P219; GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422; Holger KE, 2011, NEW ENGL J MED, V364, P656; Honda MJ, 2007, INT ENDOD J, V40, P949, DOI 10.1111/j.1365-2591.2007.01301.x; Kato H, 1991, J MEIKAI U SCH DENT, V20, P224; Kenmotsu M, 2010, INT ENDOD J, V43, P1132, DOI 10.1111/j.1365-2591.2010.01789.x; Kim HKW, 2009, BONE, V45, P280, DOI 10.1016/j.bone.2009.03.665; Michel G, 2008, PHARM RES, V58, P137; OHZEHI H, 1980, Bulletin of Tokyo Dental College, V21, P21; Sakdee JB, 2009, J ENDODONT, V35, P818, DOI 10.1016/j.joen.2009.03.001; Sawada F, 1992, J MEIKAI U SCH DENT, V21, P37; Senzui S, 2010, ORAL MED PATHOL, V14, P107; Wakatsuki E, 1980, Bull Tokyo Dent Coll, V21, P111; Wang JM, 2010, J ENDODONT, V36, P453, DOI 10.1016/j.joen.2009.11.018; Yu CY, 2002, ARCH ORAL BIOL, V47, P25; Zahm AM, 2008, BONE, V43, P25, DOI 10.1016/j.bone.2008.03.010	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	FEB	2015	48	2					115	123		10.1111/iej.12288		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY0UT	WOS:000347313200001		
J	Han, L; Kodama, S; Okiji, T				Han, L.; Kodama, S.; Okiji, T.			Evaluation of calcium-releasing and apatite-forming abilities of fast-setting calcium silicate-based endodontic materials	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						apatite-forming ability; bioactivity; calcium ion release; endodontic; fast-setting calcium silicate-based cement; mineral trioxide aggregate	MINERAL TRIOXIDE AGGREGATE; WHITE PORTLAND-CEMENT; PHOSPHATE-CONTAINING FLUID; END FILLING MATERIALS; MECHANICAL-PROPERTIES; NATURAL POZZOLANS; BLENDED CEMENTS; ION RELEASE; PROROOT MTA; SURFACE	AimTo evaluate two fast-setting calcium silicate-based endodontic materials (Endocem mineral trioxide aggregate (MTA) and Endocem Zr) with regard to their ability to release calcium ions (Ca2+) and produce apatite-like precipitates after immersion in phosphate-buffered saline (PBS). MethodologyEndocem MTA, Endocem Zr and white ProRoot MTA (WMTA) were used. Chemical composition of the powder of each material was analysed with a wavelength-dispersive X-ray spectroscopy electron probe microanalyser with image observation function (SEM-EPMA). The amount of Ca2+ released from water-immersed set cements was measured with an EDTA titration method. Morphology and chemical composition of surface precipitates formed on the surface of PBS-immersed cements were analysed with the SEM-EPMA. Data obtained were analysed using one-way analysis of variance and Tukey's honestly significant difference test with a significance level of 5%. ResultsEndocem MTA and WMTA contained calcium (Ca), silicon (Si) and bismuth as the major elemental constituents, whereas Endocem Zr contained zirconium as the most abundant element, followed by Ca and Si. The amount of Ca2+ release was WMTA >Endocem MTA Endocem Zr. After immersion in PBS for 14days, the three materials produced Ca- and phosphorus (P)-containing apatite-like surface precipitates. WMTA showed higher Ca/P ratio of the precipitates compared with the other cements, with statistical significance between WMTA and Endocem Zr (P<0.05). ConclusionCompared with WMTA, Endocem MTA and Endocem Zr were associated with significantly less Ca ions release and, when immersed in PBS, produced apatite-like crystalline precipitates of significantly lower Ca/P ratios.	[Han, L.; Kodama, S.; Okiji, T.] Niigata Univ, Grad Sch Med & Dent Sci, Div Cariol Operat Dent & Endodont, Dept Oral Hlth Sci, Niigata 9518514, Japan	Han, L (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Cariol Operat Dent & Endodont, Dept Oral Hlth Sci,Chuo Ku, 5274 Gakkocho Dori 2 Bancho, Niigata 9518514, Japan.	han@dent.niigata-u.ac.jp			Japan Society for the Promotion of Sciences [22592118]; Pentron Japan Inc.	This work was supported in part by a grant-in-aid for Scientific Research (No. 22592118) from the Japan Society for the Promotion of Sciences. Dr. Okiji reports a grant from Pentron Japan Inc. during the conduct of the study.	Han LL, 2010, DENT MATER J, V29, P512, DOI 10.4012/dmj.2009-133; Askarinejad A, 2012, ULTRASON SONOCHEM, V19, P119, DOI 10.1016/j.ultsonch.2011.05.005; Gandolfi MG, 2010, INT ENDOD J, V43, P917, DOI 10.1111/j.1365-2591.2010.01768.x; Gandolfi MG, 2009, ORAL SURG ORAL MED O, V108, pE39, DOI 10.1016/j.tripleo.2009.07.039; Reyes-Carmona JF, 2009, J ENDODONT, V35, P731, DOI 10.1016/j.joen.2009.02.011; Bortoluzzi EA, 2009, J ENDODONT, V35, P550, DOI 10.1016/j.joen.2008.12.018; Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010; Camilleri J, 2011, DENT MATER, V27, P845, DOI 10.1016/j.dental.2011.04.011; Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41; Nekoofar MH, 2010, INT ENDOD J, V43, P782, DOI 10.1111/j.1365-2591.2010.01745.x; Dammaschke T, 2005, DENT MATER, V21, P731, DOI 10.1016/j.dental.2005.01.019; Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7; Coomaraswamy KS, 2007, J ENDODONT, V33, P295, DOI 10.1016/j.joen.2006.11.018; Mente J, 2013, J ENDODONT, V39, P20, DOI 10.1016/j.joen.2012.10.007; Kogan P, 2006, J ENDODONT, V32, P569, DOI 10.1016/j.joen.2005.08.006; Viapiana R, 2014, INT ENDOD J, V47, P437, DOI 10.1111/iej.12167; Krupp C, 2013, J ENDODONT, V39, P1364, DOI 10.1016/j.joen.2013.06.030; Duarte MAH, 2003, ORAL SURG ORAL MED O, V95, P345, DOI 10.1067/moe.2003.12; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Han L, 2011, INT ENDOD J, V44, P1081, DOI 10.1111/j.1365-2591.2011.01924.x; Bozeman TB, 2006, J ENDODONT, V32, P425, DOI 10.1016/j.joen.2005.08.009; Snellings R, 2012, REV MINERAL GEOCHEM, V74, P211, DOI 10.2138/rmg.2012.74.6; Choi Y, 2013, J ENDODONT, V39, P467, DOI 10.1016/j.joen.2012.11.023; Kasuga T, 2005, ACTA BIOMATER, V1, P55, DOI 10.1016/j.actbio.2004.08.001; Huang TH, 2008, J ENDODONT, V34, P590, DOI 10.1016/j.joen.2008.02.002; Tingey MC, 2008, J ENDODONT, V34, P45, DOI 10.1016/j.joen.2007.09.013; Han L, 2013, INT ENDOD J, V46, P808, DOI 10.1111/iej.12062; Gandolfi MG, 2012, INT ENDOD J, V45, P571, DOI 10.1111/j.1365-2591.2012.02013.x; Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008; Turanli L, 2004, CEMENT CONCRETE RES, V34, P2277, DOI 10.1016/j.cemconres.2004.04.011; Baek SH, 2010, J ENDODONT, V36, P1323, DOI 10.1016/j.joen.2010.04.008; Camilleri J, 2008, INT ENDOD J, V41, P843, DOI 10.1111/j.1365-2591.2008.01435.x; Hsieh SC, 2009, J ENDODONT, V35, P1292, DOI 10.1016/j.joen.2009.06.007; ITOH A, 1970, ANALYST, V95, P583, DOI 10.1039/an9709500583; Jang JH, 2013, J ENDODONT, V39, P1598, DOI 10.1016/j.joen.2013.08.035; Kang JS, 2012, SCANNING, V34, P207, DOI 10.1002/sca.20295; Li Q, 2013, DENT MATER J, V32, P808, DOI 10.4012/dmj.2013-113; Mostafa NY, 2010, CEMENT CONCRETE COMP, V32, P386, DOI 10.1016/j.cemconcomp.2010.02.003; Nazari A, 2010, MATER RES-IBERO-AM J, V13, P551, DOI 10.1590/S1516-14392010000400019; Okiji T, 2009, INT J DENT, V2009, P1, DOI DOI 10.1155/2009/464280; Oliveira IR, 2010, INT ENDOD J, V43, P1069, DOI 10.1111/j.1365-2591.2010.01770.x; Rodriguez-Camacho RE, 2002, CEMENT CONCRETE RES, V32, P1851, DOI 10.1016/S0008-8846(01)00714-1; Tanomaru M, 2009, J ENDODONT, V35, P1418, DOI 10.1016/j.joen.2009.07.009; TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2	44	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	FEB	2015	48	2					124	130		10.1111/iej.12290		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY0UT	WOS:000347313200002		
J	Yamaguchi, T; Ikeda, O; Oda, Y; Hata, S; Kuroki, K; Kuroda, H; Hirose, A				Yamaguchi, T.; Ikeda, O.; Oda, Y.; Hata, S.; Kuroki, K.; Kuroda, H.; Hirose, A.			Three-Layer Zn/Al/Zn Clad Solder for Die Attachment	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Zn-Al solder; Pb-free; clad material; eutectic melting; die attachment		Three-layer Zn/Al/Zn clad solders have been developed for high-temperature die attachment. The clad structure is used to improve the wettability and bondability of Zn-Al eutectic solder by preventing oxidation of the Al. The materials were produced by clad-rolling Zn and Al strips. TEM observations revealed that the Zn/Al clad interface was metallurgically bonded and that the Al oxide was almost entirely removed. The melting behavior of Zn/Al/Zn clad solder was examined. Eutectic melting began at the Zn/Al clad interface at 382A degrees C, and all of the material melted within approximately 10 s. Unlike conventional Zn-Al solders, Zn/Al/Zn clad solders were successfully bonded without flux. The shear strength of a Zn/Al/Zn clad solder joint was three times that of a Pb-based solder joint. The bondability of Zn/Al/Zn clad solder was superior because the Al oxide films, which prevent bonding between chip and substrate, were fragmented by clad-rolling, and the outer Zn layers prevented Al oxidation during the bonding process.	[Yamaguchi, T.; Ikeda, O.] Hitachi Ltd, Mfg Technol Res Ctr, Yokohama Res Lab, Totsuka Ku, Yokohama, Kanagawa 2440817, Japan; [Oda, Y.] NEOMAX MAT Co Ltd, Dept Engn, Suita, Osaka 5640043, Japan; [Hata, S.; Kuroki, K.; Kuroda, H.] Hitachi Met Ltd, Elect Mat Business Unit, Cable Mat Co, Hitachi, Ibaraki 3191411, Japan; [Yamaguchi, T.; Hirose, A.] Osaka Univ, Div Mat & Mfg Sci, Grad Sch Engn, Suita, Osaka, Japan	Yamaguchi, T (reprint author), Hitachi Ltd, Mfg Technol Res Ctr, Yokohama Res Lab, Totsuka Ku, 292 Yoshida Cho, Yokohama, Kanagawa 2440817, Japan.	takuto.yamaguchi.xu@hitachi.com; ODA.YU@neomax.co.jp					Akada Y., 2008, MAT T, V49; Japan Institute of Metals, 2004, MET DAT BOOK; Kim S.J., 2008, MAT T, V49; Lang F., 2011, J ELECT MAT, V40, P7; Lee J.E., 2005, MAT T, V46; Rettenmayr M., 2002, J ELECT MAT, V31; Shimizu T., 1999, J ELECT MAT, V28, P11; Suganuma K., 2010, IEEE ELECT DEVICE LE; Takaku Y., 2009, J ELECT MAT, V38; Tanimoto S., 2012, IMAPS HITEC; Ueshima M., 2012, 4 EL SYST INT TECHN; Yamada Y., 2009, T JPN I ELECT PACKAG, V2, P1; Yamada Y., 2007, MICROELECTRON RELIAB, V47, P12; Yoon S.W., 2012, APEC	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	FEB	2015	44	2					751	760		10.1007/s11664-014-3538-y		10	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AY6WX	WOS:000347704600019		
J	Roush, GC; Fagard, RH; Salles, GF; Pierdomenico, SD; Reboldi, G; Verdecchia, P; Eguchi, K; Kario, K; Hoshide, S; Polonia, J; de la Sierra, A; Hermida, RC; Dolan, E; Fapohunda, J				Roush, George C.; Fagard, Robert H.; Salles, Gil F.; Pierdomenico, Sante D.; Reboldi, Gianpaolo; Verdecchia, Paolo; Eguchi, Kazuo; Kario, Kazuomi; Hoshide, Satoshi; Polonia, Jorge; de la Sierra, Alejandro; Hermida, Ramon C.; Dolan, Eamon; Fapohunda, Jadesola		ABC-H Investigators	Prognostic impact of sex-ambulatory blood pressure interactions in 10 cohorts of 17 312 patients diagnosed with hypertension: systematic review and meta-analysis	JOURNAL OF HYPERTENSION			English	Article						blood pressure determination; blood pressure monitoring/ambulatory; cardiovascular diseases; cohort studies; prospective studies; stroke; survival analysis	PREDICTS CARDIOVASCULAR EVENTS; CORONARY-ARTERY-DISEASE; WHITE-COAT; MICROVASCULAR DYSFUNCTION; SUSTAINED HYPERTENSION; EUROPEAN-SOCIETY; WOMEN; RISK; OUTCOMES; VARIABILITY	Background: Whether ambulatory blood pressure (BP) among hypertensive patients better predicts cardiovascular events (CVEs) in women relative to men is unclear. Methods: We searched PUBMED and OVID databases. Cohorts were required to have hypertension, 1+ years of follow-up, with stroke and coronary artery disease as outcomes. Lead investigators for these cohorts provided ad hoc analyses. Random-effect meta-analyses gave hazard ratios for CVEs from a 1 standard deviation (SD) mmHg increase and a 10mmHg increase in SBP. Subgroup and meta-regression analyses quantified the relative increase in risk in women versus men. Results: Patients were from Europe, Brazil, and Japan (10 cohorts, n = 17 312, CVEs = 1892). One cohort lacked sex-specific hazard ratios from 24 h and clinic SBP. Compared with men, women tended to have greater SDs and coefficients of variation of SBP. Subgroup analyses showed higher hazard ratios in women than in men from increases in ambulatory but not clinic SBPs. For women relative to men, a 1 SD increase in night-time, daytime, 24 h, and clinic SBP gave hazard ratios (95% confidence limits) of 1.17 (1.06-1.30), 1.24 (1.10-1.39), 1.21 (1.08-1.36), and 0.94 (0.84-1.05), respectively, whereas a 10mmHg increase in SBP, gave hazard ratios of 1.06 (0.99-1.14), 1.13 (1.03-1.23), 1.10 (1.01-1.21), and 0.96 (0.89-1.03), respectively. Conclusion: In patients with hypertension, increases in ambulatory, but not clinic, SBP predict higher risks for CVEs in women than in men. Although women tended to have greater variability in SBP, this did not entirely explain the sex-ambulatory BP interactions.	[Roush, George C.] UCONN Sch Med, ABC H, St Vincents Med Ctr, Bridgeport, CT 06604 USA; [Fagard, Robert H.] Univ Leuven, UZ, Hypertens Unit, Leuven, Belgium; [Salles, Gil F.] Univ Hosp Clementino Fraga Filho, Rio De Janeiro, Brazil; [Pierdomenico, Sante D.] Univ Gabriele dAnnunzio, Dipartimento Med & Sci Invecchiamento, Chieti, Italy; [Reboldi, Gianpaolo] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy; [Verdecchia, Paolo] Osped Assisi, Assisi, Italy; [Eguchi, Kazuo; Kario, Kazuomi; Hoshide, Satoshi] Jichi Univ, Sch Med, Shimotsuke, Tochigi, Japan; [Polonia, Jorge] Fac Med Porto, Oporto, Portugal; [de la Sierra, Alejandro] Univ Barcelona, Hosp Mutua Terrassa, Dept Internal Med, Terrassa, Spain; [Hermida, Ramon C.] Univ Vigo, Bioengn & Chronobiol Labs, Vigo 36310, Spain; [Dolan, Eamon] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England; [Fapohunda, Jadesola] UCONN Sch Med, St Vincents Med Ctr, Bridgeport, CT USA	Roush, GC (reprint author), UCONN Sch Med, ABC H, St Vincents Med Ctr, Bridgeport, CT 06604 USA.	groush@gcr0.com					Alwan A, 2010, WHO GLOBAL STATUS RE, P22; Head GA, 2012, J HYPERTENS, V30, P253, DOI 10.1097/HJH.0b013e32834de621; Pierdomenico SD, 2011, AM J HYPERTENS, V24, P52, DOI 10.1038/ajh.2010.203; Boggia J, 2011, HYPERTENSION, V57, P397, DOI 10.1161/HYPERTENSIONAHA.110.156828; Vermeltfoort IAC, 2010, CLIN RES CARDIOL, V99, P475, DOI 10.1007/s00392-010-0159-1; Hermida RC, 2013, CHRONOBIOL INT, V30, P355, DOI 10.3109/07420528.2013.750490; Fagard RH, 2007, J HYPERTENS, V25, P2193; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Conen D, 2008, J HYPERTENS, V26, P1290, DOI 10.1097/HJH.0b013e3282f97854; Tsioufis C, 2011, J HUM HYPERTENS, V25, P281, DOI 10.1038/jhh.2010.113; Rossi P, 2011, J HYPERTENS, V29, P1023, DOI 10.1097/HJH.0b013e328344da5e; Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; Salles GF, 2008, ARCH INTERN MED, V168, P2340, DOI 10.1001/archinte.168.21.2340; Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; Dolan E, 2009, J HYPERTENS, V27, P876, DOI 10.1097/HJH.0b013e328322cd62; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Serne EH, 2007, HYPERTENSION, V50, P204, DOI 10.1161/HYPERTENSIONAHA.107.089680; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Mesquita-Bastos J, 2010, BLOOD PRESS MONIT, V15, P240, DOI 10.1097/MBP.0b013e32833c8b08; Hermida RC, 2013, CHRONOBIOL INT, V30, P55, DOI 10.3109/07420528.2012.701457; de la Sierra A, 2012, J HYPERTENS, V30, P713, DOI 10.1097/HJH.0b013e328350bb40; Kario K, 2001, J AM COLL CARDIOL, V38, P238, DOI 10.1016/S0735-1097(01)01325-0; Manios ED, 2008, AM J HYPERTENS, V21, P153, DOI 10.1038/ajh.2007.43; Namasivayam M, 2011, HYPERTENSION, V57, P193, DOI 10.1161/HYPERTENSIONAHA.110.160200; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Franklin SS, 2012, HYPERTENSION, V59, P564, DOI 10.1161/HYPERTENSIONAHA.111.180653; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Chester R, 2013, J AM SOC HYPERTENS, V7, P379, DOI 10.1016/j.jash.2013.05.007; Borenstein M, 2009, INTRO METAANALYSIS; Dzielinska Z, 2009, BLOOD PRESS MONIT, V14, P99, DOI 10.1097/MBP.0b013e32832b9df3; Eguchi K, 2009, J HYPERTENS, V27, P2265, DOI 10.1097/HJH.0b013e328330a938; Gordis L, 2004, EPIDEMIOLOGY, P156; Hermida RC, 2013, CHRONOBIOL INT, V30, P221, DOI 10.3109/07420528.2012.701487; Jacobs AK, 2003, CIRCULATION, V107, P375, DOI 10.1161/01.CIR.0000048895.18974.6B; National Institute for Health and Clinical Excellence, 2011, HYP CLIN MAN PRIM HY; Reh W, 1996, COMPUT STAT DATA AN, V22, P449, DOI 10.1016/0167-9473(96)83707-8; Schwartz GL, 2000, AM J HYPERTENS, V13, P1203, DOI 10.1016/S0895-7061(00)01198-5	42	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	FEB	2015	33	2					212	220		10.1097/HJH.0000000000000435		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AY2CM	WOS:000347396100002		
J	Ohara, M; Kohara, K; Tabara, Y; Igase, M; Miki, T				Ohara, Maya; Kohara, Katsuhiko; Tabara, Yasuharu; Igase, Michiya; Miki, Tetsuro			Portable indices for sarcopenia are associated with pressure wave reflection and central pulse pressure: the J-SHIPP study	JOURNAL OF HYPERTENSION			English	Article						arterial stiffness; central blood pressure; obesity; pressure wave reflection; sarcopenia	SYSTOLIC BLOOD-PRESSURE; ARTERIAL STIFFNESS; MUSCLE MASS; OBESITY; MORTALITY; VELOCITY; DIAGNOSIS; STRENGTH; THERAPY; DISEASE	Objective: We recently reported that thigh muscle sarcopenia measured by computed tomography is related to arterial stiffness, pressure wave reflection, and central pulse pressure (PP). However, it remains to be determined whether more straightforward and simple techniques such as hand grip strength and the bio-impedance method are also useful for the clinical evaluation of sarcopenia. Methods: A total of 1593 middle-aged to older patients participated in this cross-sectional study. Brachial-to-ankle pulse wave velocity (baPWV) was measured as an index of arterial stiffness. Second PP (PP2) at the second peak of radial SBP was used to estimate central PP. Radial augmentation index was calculated as PP2/PP. Thigh muscle cross-sectional area and abdominal visceral fat area were quantified by computed tomography. Patients were classified as sarcopenic if their hand grip strength or skeletal muscle mass (measured by bioelectrical impedance) was more than 1 SD lower than the mean of those in a reference group aged below 50 years, or in the lowest 20% of the studied population. Visceral obesity was defined as visceral fat area greater than 100 cm(2). Results: Antidyslipidemia drug and antidiabetic drug were significantly associated with lower hand grip strength. Both sarcopenic indices were significantly and independently associated with baPWV, radial augmentation index, and PP2. Sarcopenia defined by either criterion was significantly associated with higher baPWV, radial augmentation index, and PP2. Visceral obesity was significantly associated only with baPWV. Conclusion: These findings indicate the clinical usefulness of noninvasive methods for assessment of sarcopenia, which is a risk factor for cardiovascular disease.	[Ohara, Maya; Kohara, Katsuhiko; Igase, Michiya; Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med & Neurol, Toon, Ehime 7910295, Japan; [Tabara, Yasuharu] Kyoto Univ, Grad Sch Med, Dept Clin Genet, Kyoto, Japan	Kohara, K (reprint author), Ehime Univ, Grad Sch Med, Dept Geriatr Med & Neurol, Toon, Ehime 7910295, Japan.	koharak@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23390188, 25670353]; Mitsui Sumitomo Insurance Welfare Foundation in Japan	Source of support: This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (#23390188, #25670353) and research funding from the Mitsui Sumitomo Insurance Welfare Foundation in Japan.	Abbatecola AM, 2012, AGE, V34, P469, DOI 10.1007/s11357-011-9238-0; Anker MS, 2013, INT J CARDIOL, V162, P73, DOI 10.1016/j.ijcard.2012.10.018; Pierce GL, 2013, AM J HYPERTENS, V26, P20, DOI 10.1093/ajh/hps014; Pietilainen KH, 2013, BRIT J NUTR, V109, P1910, DOI 10.1017/S0007114512003698; Ohara M, 2014, INT J CARDIOL, V174, P214, DOI 10.1016/j.ijcard.2014.03.194; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Roman MJ, 2010, J HYPERTENS, V28, P384, DOI 10.1097/HJH.0b013e328333d228; Williams B, 2009, CIRCULATION, V119, P53, DOI 10.1161/CIRCULATIONAHA.108.785915; Lurbe E, 2012, HYPERTENSION, V60, P550, DOI 10.1161/HYPERTENSIONAHA.112.194746; Kohara K, 2014, ENDOCRINE, V45, P15, DOI 10.1007/s12020-013-9992-0; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Wang KL, 2009, J HYPERTENS, V27, P461, DOI 10.1097/HJH.0b013e3283220ea4; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Sayer AA, 2013, AGE AGEING, V42, P145, DOI 10.1093/ageing/afs191; Ochi M, 2010, ATHEROSCLEROSIS, V212, P327, DOI 10.1016/j.atherosclerosis.2010.05.026; Teoh WL, 2013, J HYPERTENS, V31, P1010, DOI 10.1097/HJH.0b013e32835f7ecf; Maple-Brown LJ, 2005, J HYPERTENS, V23, P1403, DOI 10.1097/01.hjh.0000173524.80802.5a; Scuteri A, 2012, ATHEROSCLEROSIS, V221, P189, DOI 10.1016/j.atherosclerosis.2011.11.045; Tabara Y, 2011, J HYPERTENS, V29, P1948, DOI 10.1097/HJH.0b013e32834abd06; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Kohara K, 2012, INT J CARDIOL, V158, P146, DOI 10.1016/j.ijcard.2012.04.033; Kohara K, 2009, J HUM HYPERTENS, V23, P538, DOI 10.1038/jhh.2008.154; Kohara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024633; Kohara K, 2005, AM J HYPERTENS, V18, p11S, DOI 10.1016/j.amjhyper.2004.10.010; Kohara K, 2012, CURR HYPERTENS REV, V8, P100; Kuo HK, 2010, INT J CARDIOL, V143, P184, DOI 10.1016/j.ijcard.2009.02.005; Nichols WW, 2011, MCDONALDS BLOOD FLOW, P225; Ochi N, 2010, AM J HYPERTENS, V23, P889, DOI 10.1038/ajh.2010.60; Takazawa K, 2012, J HYPERTENS, V30, P908, DOI 10.1097/HJH.0b013e3283524910; Matsuzawa Y, 2002, CIRC J, V66, P987; Wohlfahrt P, 2014, AM J HYPERTENS, V27, P162, DOI 10.1093/ajh/hpt166	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	FEB	2015	33	2					314	322		10.1097/HJH.0000000000000394		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AY2CM	WOS:000347396100017		
J	Kumagai, K; Tabara, Y; Yamashiro, K; Miyake, M; Akagi-Kurashige, Y; Oishi, M; Yoshikawa, M; Kimura, Y; Tsujikawa, A; Takahashi, Y; Setoh, K; Kawaguchi, T; Terao, C; Yamada, R; Kosugi, S; Sekine, A; Nakayama, T; Matsuda, F; Yoshimura, N				Kumagai, Kyoko; Tabara, Yasuharu; Yamashiro, Kenji; Miyake, Masahiro; Akagi-Kurashige, Yumiko; Oishi, Maho; Yoshikawa, Munemitsu; Kimura, Yugo; Tsujikawa, Akitaka; Takahashi, Yoshimitsu; Setoh, Kazuya; Kawaguchi, Takahisa; Terao, Chikashi; Yamada, Ryo; Kosugi, Shinji; Sekine, Akihiro; Nakayama, Takeo; Matsuda, Fumihiko; Yoshimura, Nagahisa		Nagahama Study Grp	Central blood pressure relatesmore strongly to retinal arteriolar narrowing than brachial blood pressure: the Nagahama Study	JOURNAL OF HYPERTENSION			English	Article						central blood pressure; retinal vessel caliber; small artery narrowing	CARDIOVASCULAR RISK-FACTORS; CENTRAL PULSE PRESSURE; VESSEL DIAMETERS; MICROVASCULAR ABNORMALITIES; VASCULAR CALIBER; ASIAN POPULATION; DISEASE; STROKE; INFLAMMATION; VALIDATION	Objectives: Although central blood pressure (BP) is considered to be more closely associated with large arterial remodeling and cardiovascular outcomes than brachial BP, few studies have investigated these associations with changes in small arteries. As morphological changes in retinal vessels might be associated with cardiovascular outcomes, we conducted a cross-sectional study to investigate the association of central BP with retinal vessel caliber. Methods: The study included 8054 Japanese participants. Central BP was estimated by the radial arterial waveform by calibrating brachial BP. Central retinal arteriolar equivalent (CRAE) was computationally measured using fundus photography. Results: CRAE was most strongly associated with central SBP (r = -0.324, P < 0.001), followed by DBP (r = -0.292, P < 0.001) and central pulse pressure (PP; r = -0.226, P < 0.001). The correlation coefficient between SBP and CRAE was significantly greater in central SBP than in brachial SBP (r = -0.300, P < 0.001). After adjustment for possible covariates, brachial SBP (beta = -0.221, P < 0.001) and central SBP (beta = -0.239, P < 0.001) were independently associated with CRAE. Further, higher brachial SBP (beta = -0.226, P < 0.001) and smaller PP amplification (beta = -0.092, P < 0.001) were identified as independent determinants of narrowing of CRAE in the same equation, which indicated the superiority of central BP. Central BP-determined hypertensive individuals had a significantly narrower CRAE independent of brachial BP (central/brachial: hypertension/hypertension 121.4 +/- 11.5, hypertension/normotension 120.9 +/- 11.2, normotension/ hypertension 125.1 +/- 11.9, normotension/normotension 128.1 +/- 11.5 mu m). Conclusion: Central BP was more closely associated with the narrowing of CRAE than brachial BP. Slight increases in central BP might be involved in the morphological changes in small retinal arteries, even in individuals with optimal brachial BP.	[Kumagai, Kyoko; Yamashiro, Kenji; Miyake, Masahiro; Akagi-Kurashige, Yumiko; Oishi, Maho; Yoshikawa, Munemitsu; Kimura, Yugo; Tsujikawa, Akitaka; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan; [Tabara, Yasuharu; Setoh, Kazuya; Kawaguchi, Takahisa; Terao, Chikashi; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan; [Takahashi, Yoshimitsu; Nakayama, Takeo] Kyoto Univ, Dept Hlth Informat, Sch Publ Hlth, Kyoto 6068507, Japan; [Kosugi, Shinji] Kyoto Univ, Dept Med Eth & Med Genet, Sch Publ Hlth, Kyoto 6068507, Japan; [Sekine, Akihiro] Kyoto Univ, Med Res Support Ctr, Kyoto 6068507, Japan	Tabara, Y (reprint author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Sakyo Ku, Shogoin Kawaramachi, Kyoto 6068507, Japan.	tabara@genome.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science & Technology in Japan; Takeda Science Foundation	Financial support: This study was supported by a University Grant, and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science & Technology in Japan, and a research grant from the Takeda Science Foundation.	Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Muiesan ML, 2013, HYPERTENSION, V61, P130, DOI 10.1161/HYPERTENSIONAHA.111.00006; Izzard AS, 2005, J HYPERTENS, V23, P247, DOI 10.1097/00004872-200502000-00002; Boutouyrie P, 1999, CIRCULATION, V100, P1387; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Cheng HM, 2013, J AM COLL CARDIOL, V62, P1780, DOI 10.1016/j.jacc.2013.06.029; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Ott C, 2013, HYPERTENSION, V61, P1340, DOI 10.1161/HYPERTENSIONAHA.111.00617; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Sabanayagam C, 2009, AM J EPIDEMIOL, V169, P625, DOI 10.1093/aje/kwn367; Ikram MK, 2013, OPHTHALMOLOGICA, V229, P125, DOI 10.1159/000342158; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Takase H, 2013, HYPERTENS RES, V36, P50, DOI 10.1038/hr.2012.122; Liew G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1404, DOI 10.1001/archopht.126.10.1404; Doubal FN, 2009, J NEUROL NEUROSUR PS, V80, P158, DOI 10.1136/jnnp.2008.153460; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; Waddell TK, 2001, HYPERTENSION, V38, P927, DOI 10.1161/hy1001.096107; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; MURGO JP, 1980, CIRCULATION, V62, P105; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Salvetti M, 2014, HYPERTENSION, V63, P1110, DOI 10.1161/HYPERTENSIONAHA.113.03004; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; de Jong FJ, 2007, ANN NEUROL, V61, P491, DOI 10.1002/ana.21129; Hirata K, 2013, J HYPERTENS, V31, P508, DOI 10.1097/HJH.0b013e32835c1d45; Ikram MK, 2006, DIABETES, V55, P506, DOI 10.2337/diabetes.55.02.06.db05-0546; Lin MM, 2012, J HYPERTENS, V30, P581, DOI 10.1097/HJH.0b013e3283501354; Sun C, 2008, INVEST OPHTH VIS SCI, V49, P1784, DOI 10.1167/iovs.07-1450; Wong TY, 2004, LANCET NEUROL, V3, P179	30	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	FEB	2015	33	2					323	329		10.1097/HJH.0000000000000391		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AY2CM	WOS:000347396100018		
J	Kawada, T				Kawada, Tomoyuki			Effect of serum C-reactive protein and plasma fibrinogen levels on recurrent preeclampsia	JOURNAL OF HYPERTENSION			English	Letter							EVENTS; REGRESSION		[Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					van Rijn BB, 2014, J HYPERTENS, V32, P408, DOI 10.1097/HJH.0000000000000027; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	FEB	2015	33	2					421	421		10.1097/HJH.0000000000000456		1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AY2CM	WOS:000347396100029		
J	Nakamura, N; Tamagawa-Mineoka, R; Ueta, M; Kinoshita, S; Katoh, N				Nakamura, Naomi; Tamagawa-Mineoka, Risa; Ueta, Mayumi; Kinoshita, Shigeru; Katoh, Norito			Toll-Like Receptor 3 Increases Allergic and Irritant Contact Dermatitis	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							ADAPTIVE IMMUNE-RESPONSES; EPITHELIAL-CELLS; INNATE IMMUNITY; HYPERSENSITIVITY; LIGANDS; TLR3; INFLAMMATION; RECRUITMENT; ELICITATION; SUPPRESSION	There is increasing recognition of the role of Toll-like receptor 3 (TLR3) in noninfectious inflammatory diseases, but the function of TLR3 in inflammatory skin diseases is unclear. We investigated the functions of TLR3 in allergic and irritant contact dermatitis (ICD). The contact hypersensitivity (CHS) response was lower in Toll-like receptor 3 knockout (Tlr3 KO) mice, and was greater in TLR3 transgenic (Tg) mice than in wild-type (WT) mice after challenge with 2,4,6-trinitro-1-chlorobenzene. Adoptive transfer of immunized lymph node cells from Tlr3 KO mice induced CHS in WT recipients. In contrast, adoptive transfer of those from WT mice did not fully induce CHS in Tlr3 KO recipients. The ICD reaction following croton oil application was lower in Tlr3 KO mice, and was greater in TLR3 Tg mice than in WT mice. Maturation, migration, and antigen presentation of dendritic cells and proliferation of lymphocytes between WT mice and Tlr3 KO mice were comparable. These results show that TLR3 enhances antigen-independent skin inflammation in the elicitation phase of allergic contact dermatitis and in ICD.	[Nakamura, Naomi; Tamagawa-Mineoka, Risa; Katoh, Norito] Kyoto Prefectural Univ Med, Dept Dermatol, Grad Sch Med Sci, Kyoto 6028566, Japan; [Ueta, Mayumi; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Grad Sch Med Sci, Kyoto 6028566, Japan	Tamagawa-Mineoka, R (reprint author), Kyoto Prefectural Univ Med, Dept Dermatol, Grad Sch Med Sci, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	risat@koto.kpu-m.ac.jp			Japanese Ministry of Education, Science, Sports, and Culture; Ministry of Education, Culture, Sports, Science and Technology of the Japanese government	We thank Professor Tadatsugu Taniguchi and Hideo Negishi for TLR3 Tg mice, Professor Shizuo Akira for Tlr3 KO mice, and Tsunao Kishida and Osam Mazda for NOD/Shijic-scid JCI mice. This work was supported in part by a grant from the Japanese Ministry of Education, Science, Sports, and Culture to RT-M, MU, and NK. This work also was conducted as a part of the BioBank Japan Project supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang SJ, 2011, ARCH DERMATOL RES, V303, P771, DOI 10.1007/s00403-011-1170-8; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; Dufour JH, 2002, J IMMUNOL, V168, P3195; Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kato A, 2007, J IMMUNOL, V179, P1080; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Scheibner KA, 2006, J IMMUNOL, V177, P1272; Sebastiani S, 2002, ARCH DERMATOL RES, V293, P552, DOI 10.1007/s00403-001-0276-9; Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105; WILLIS CM, 1989, J INVEST DERMATOL, V93, P695, DOI 10.1111/1523-1747.ep12319895; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Dilulio NA, 1999, EUR J IMMUNOL, V29, P3485, DOI 10.1002/(SICI)1521-4141(199911)29:11<3485::AID-IMMU3485>3.0.CO;2-B; Yokoi S, 2009, J DERMATOL SCI, V53, P120, DOI 10.1016/j.jdermsci.2008.08.009; Farina GA, 2010, J INVEST DERMATOL, V130, P2583, DOI 10.1038/jid.2010.200; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Askenase PW, 2005, J IMMUNOL, V175, P6390; Canavese M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008725; Corsini Emanuela, 1998, Toxicology Letters (Shannon), V102-103, P277, DOI 10.1016/S0378-4274(98)00323-3; Freudenberg MA, 2009, GIORN ITAL DERMAT V, V144, P173; Ishii KJ, 2008, CLIN IMMUNOLOGY PRIN, P39, DOI 10.1016/B978-0-323-04404-2.10003-X; Majewska M, 2009, PHARMACOL REP, V61, P539; Martin SF, 2008, CURR OPIN ALLERGY CL, V8, P289, DOI 10.1097/ACI.0b013e3283088cf9; Nuolivirta K, 2012, PEDIATR INFECT DIS J, V31, P920, DOI 10.1097/INF.0b013e31825aff25; Prescott SL, 2008, J ALLERGY CLIN IMMUN, V122, P391, DOI [10.1016/j.jaci.2008.04.042, 10.1016/j.jaci.2008.04.0422]; Ptak W, 2006, INT ARCH ALLERGY IMM, V139, P188, DOI 10.1159/000091164; Ueta M, 2010, BRIT J OPHTHALMOL, V94, P1528, DOI 10.1136/bjo.2010.180554; Ueta M, 2009, J ALLERGY CLIN IMMUN, V123, P1187, DOI 10.1016/j.jaci.2009.03.008; WILLIS CM, 1986, BRIT J DERMATOL, V115, P305, DOI 10.1111/j.1365-2133.1986.tb05745.x	45	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	FEB	2015	135	2					411	417		10.1038/jid.2014.402		7	Dermatology	Dermatology	AY6JI	WOS:000347672300014		
J	Yamamoto, M; Nakajima, K; Takaishi, M; Kitaba, S; Magata, Y; Kataoka, S; Sano, S				Yamamoto, Mayuko; Nakajima, Kimiko; Takaishi, Mikiro; Kitaba, Shun; Magata, Yasuhiro; Kataoka, Sayo; Sano, Shigetoshi			Psoriatic Inflammation Facilitates the Onset of Arthritis in a Mouse Model	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							AUTOIMMUNE ARTHRITIS; CLINICAL-FEATURES; INNATE IMMUNITY; IN-VITRO; DISEASE; SKIN; RECEPTOR; CELLS; GP130; NAIL	Psoriatic arthritis (PsA) is a seronegative, inflammatory joint disease associated with psoriasis. In most patients with PsA, skin lesions precede arthritis; however, the causality of skin inflammation for the development of arthritis remains unclear. Gp130(F759/F759) knock-in (F759) mice develop autoimmune arthritis after 1 year of age through persistent signal transducer and activator of transcription 3 (Stat3) activation due to impairment in SOCS3-dependent negative regulation. Here, we crossed F759 mice with K5.Stat3C transgenic mice, in which keratinocytes express constitutive active Stat3 (Stat3C), leading to generation of psoriasis-like skin change. F759 mice harboring the K5.Stat3C transgene not only had aggravated skin lesions but also spontaneously developed arthritis with high penetrance in adjacent paws as early as 3 weeks of age. The joint lesions included swelling of the peripheral paws and nail deformities contiguous with the skin lesions, closely resembling PsA. Histopathologic study revealed enthesitis and bone erosions, with mononuclear cell infiltrates. Quantitative reverse transcriptase PCR (RT-PCR), immunohistochemical analyses, and flow cytometry showed upregulation of the IL-23/T helper type 17 (Th17) pathway in affected joints. Furthermore, enforced generation of psoriasis-like skin inflammation by topical treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) in F759 mice induced swelling of the underlying joints. This animal model renders psoriatic inflammation as the driver of arthritis and helps to further understand the pathogenesis of PsA.	[Yamamoto, Mayuko; Nakajima, Kimiko; Takaishi, Mikiro; Sano, Shigetoshi] Kochi Univ, Dept Dermatol, Kochi Med Sch, Nankoku, Kochi 7838505, Japan; [Kitaba, Shun] Osaka Univ, Dept Dermatol, Grad Sch Med, Suita, Osaka, Japan; [Magata, Yasuhiro] Hamamatsu Univ Sch Med, Dept Mol Imaging, Appl Med Photon Lab, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Kataoka, Sayo] Kochi Univ, Sci Res Ctr, Nankoku, Kochi 7838505, Japan	Sano, S (reprint author), Kochi Univ, Dept Dermatol, Kochi Med Sch, Nankoku, Kochi 7838505, Japan.	sano.derma@kochi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Drs T Hirano, M Murakami, and K Ishihara for kindly providing gp130F759 mice and for helpful discussions and Ms R Kamijima for technical assistance. This work was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Colucci S, 2007, J PATHOL, V212, P47, DOI 10.1002/path.2153; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Tan EST, 2012, AM J CLIN DERMATOL, V13, P375, DOI 10.2165/11597000-000000000-00000; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; McGonagle D, 2007, ARTHRITIS RHEUM, V56, P2482, DOI 10.1002/art.22758; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Ritchlin C, 1998, J RHEUMATOL, V25, P1544; McGonagle D, 2011, ANN RHEUM DIS, V70, pI71, DOI 10.1136/ard.2010.144097; Tan AL, 2007, RHEUMATOLOGY, V46, P253, DOI 10.1093/rheumatology/kel214; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Takata T, 2011, J DERMATOL SCI, V64, P144, DOI 10.1016/j.jdermsci.2011.08.002; Raychaudhuri SP, 2012, MOL CELL BIOCHEM, V359, P419, DOI 10.1007/s11010-011-1036-6; Radtke MA, 2009, J EUR ACAD DERMATOL, V23, P683, DOI 10.1111/j.1468-3083.2009.03159.x; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Lubberts E, 2010, SEMIN IMMUNOPATHOL, V32, P43, DOI 10.1007/s00281-009-0189-9; Cenit MC, 2013, HUM IMMUNOL, V74, P230, DOI 10.1016/j.humimm.2012.10.019; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Nograles KE, 2009, NAT CLIN PRACT RHEUM, V5, P83, DOI 10.1038/ncprheum0987; Tan AL, 2006, ARTHRITIS RHEUM, V54, P1328, DOI 10.1002/art.21736; Spuls PI, 2012, BRIT J DERMATOL, V167, P710, DOI 10.1111/bjd.12025; Murakami M, 2012, INT J BIOL SCI, V8, P1267, DOI 10.7150/ijbs.4828; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Boehncke WH, 2014, J EUR ACAD DERMATOL, V28, P264, DOI 10.1111/jdv.12222; Sawa S, 2006, J EXP MED, V203, P1459, DOI 10.1084/jem.20052187; Murakami M, 2011, J EXP MED, V208, P103, DOI 10.1084/jem.20100900; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Bonifati C, 1997, CLIN IMMUNOL IMMUNOP, V83, P41, DOI 10.1006/clin.1996.4313; Nakajima K, 2011, J IMMUNOL, V186, P4481, DOI 10.4049/jimmunol.1000148; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Hwang J, 2011, P NATL ACAD SCI USA, V108, P11566, DOI 10.1073/pnas.1019658108; Lloyd P, 2012, ARTHRITIS, V2012; Lories RJ, 2012, CURR RHEUMATOL REP, V14, P375, DOI 10.1007/s11926-012-0257-3; McGonagle D, 2009, DERMATOLOGY, V218, P97, DOI 10.1159/000182250; Nograles KE, 2011, EXP CELL RES, V317, P1293, DOI 10.1016/j.yexcr.2011.01.024; Punzi L, 1998, CLIN EXP RHEUMATOL, V16, P277; Rahman Proton, 2012, J Rheumatol, V39, P431, DOI 10.3899/jrheum.111242	45	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	FEB	2015	135	2					445	453		10.1038/jid.2014.426		9	Dermatology	Dermatology	AY6JI	WOS:000347672300018		
J	Tsuchisaka, A; Ohara, K; Ishii, N; Nguyen, NT; Marinkovich, MP; Hashimoto, T				Tsuchisaka, Atsunari; Ohara, Koji; Ishii, Norito; Nguyen, Ngon T.; Marinkovich, M. Peter; Hashimoto, Takashi			Type VII Collagen Is the Major Autoantigen for Sub lamina Densa-Type Linear IgA Bullous Dermatosis	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Letter							BASEMENT-MEMBRANE; ANTIGEN; AUTOANTIBODIES; SKIN; IMMUNOFLUORESCENCE; DOMAIN		[Tsuchisaka, Atsunari; Ohara, Koji; Ishii, Norito; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Fukuoka, Japan; [Tsuchisaka, Atsunari; Ohara, Koji; Ishii, Norito; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Fukuoka, Japan; [Nguyen, Ngon T.; Marinkovich, M. Peter] Stanford Univ, Sch Med, Ctr Clin Sci Res, Dept Dermatol, Stanford, CA USA; [Marinkovich, M. Peter] Palo Alto Vet Affairs Med Ctr, Div Dermatol, Palo Alto, CA USA	Tsuchisaka, A (reprint author), Kurume Univ, Sch Med, Dept Dermatol, Fukuoka, Japan.	hashimot@med.kurume-u.ac.jp					Siprashvili Z, 2010, HUM GENE THER, V21, P1299, DOI 10.1089/hum.2010.023; ZONE JJ, 1990, J CLIN INVEST, V85, P812, DOI 10.1172/JCI114508; Guide SV, 2001, CLIN DERMATOL, V19, P719, DOI 10.1016/S0738-081X(00)00185-1; Hashimoto T, 1996, BRIT J DERMATOL, V134, P336; Ishii N, 2008, BRIT J DERMATOL, V158, P1151, DOI 10.1111/j.1365-2133.2008.08492.x; Ishii N, 2004, BRIT J DERMATOL, V150, P843, DOI 10.1111/j.1365-2133.2004.05933.x; Ishiko A, 1996, J INVEST DERMATOL, V106, P739, DOI 10.1111/1523-1747.ep12345793; Liu YL, 2003, J DERMATOL SCI, V32, P125, DOI 10.1016/S0923-1811(03)00092-6; RUSENKO KW, 1989, J INVEST DERMATOL, V92, P510; WILLSTEED E, 1990, J CUTAN PATHOL, V17, P144, DOI 10.1111/j.1600-0560.1990.tb00073.x; ZAMBRUNO G, 1994, J AM ACAD DERMATOL, V31, P884, DOI 10.1016/S0190-9622(94)70252-7	11	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	FEB	2015	135	2					626	629		10.1038/jid.2014.381		4	Dermatology	Dermatology	AY6JI	WOS:000347672300042		
J	Louzguine-Luzgin, DV; Chen, N; Churymov, AY; Louzguina-Luzgina, LV; Polkin, VI; Battezzati, L; Yavari, AR				Louzguine-Luzgin, D. V.; Chen, N.; Churymov, A. Yu.; Louzguina-Luzgina, L. V.; Polkin, V. I.; Battezzati, L.; Yavari, A. R.			Role of different factors in the glass-forming ability of binary alloys	JOURNAL OF MATERIALS SCIENCE			English	Article							BULK METALLIC GLASSES; SOLID-SOLUTION PHASE; THERMAL-STABILITY; SUPERCOOLED LIQUID; AMORPHOUS-ALLOYS; INTERMETALLIC COMPOUNDS; MULTICOMPONENT ALLOYS; CRYSTAL-STRUCTURE; STRUCTURAL MODEL; ATOMIC PACKING	In the present work, we discuss the glass-forming ability of various binary alloys in which the glassy phase was not formed even by melt spinning technique with high cooling rate of the melt up to 1 MK/s (some consisted of partly glassy phase), though by commonly accepted guidelines, these alloys could be as good glass-formers as many other binary glasses. The alloys studied belong to binary systems with multiple eutectics; the constituent elements have a negative enthalpy of mixing, and a significant variability of atomic size differences is observed from system to system. The results indicate the necessity of taking into account simultaneously various factors influencing the glass-forming ability including melt fragility.	[Louzguine-Luzgin, D. V.; Yavari, A. R.] Tohoku Univ, WPI Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Chen, N.] Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China; [Churymov, A. Yu.; Louzguina-Luzgina, L. V.; Polkin, V. I.] Natl Univ Sci & Technol MISiS, Moscow 119049, Russia; [Battezzati, L.] IFM Univ Torino, Dipartimento Chim, Turin, Italy; [Yavari, A. R.] Inst Natl Polytech Grenoble, CNRS, SIMAP, F-38402 St Martin Dheres, France	Louzguine-Luzgin, DV (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.	dml@wpi-aimr.tohoku.ac.jp	LOUZGUINE, Dmitri/D-2492-2010; Chen, Na/A-4120-2010	LOUZGUINE, Dmitri/0000-0001-5716-4987; 	World Premier International Research Center Initiative (WPI), MEXT, Japan; Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST "MISiS" [K2-2014-013]	This work was supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan and by the Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST "MISiS" (No K2-2014-013). The authors sincerely thank Daniel Miracle and Kevin Laws for their critical comments.	Zhou DW, 2008, MATER LETT, V62, P206, DOI 10.1016/j.matlet.2007.04.110; Egami T, 1997, MAT SCI ENG A-STRUCT, V226, P261, DOI 10.1016/S0921-5093(97)80041-X; CARVALHO EM, 1980, J MATER SCI, V15, P1224, DOI 10.1007/BF00551811; Yao KF, 2008, SCI CHINA SER G, V51, P414, DOI 10.1007/s11433-008-0051-4; NAGEL SR, 1975, PHYS REV LETT, V35, P380, DOI 10.1103/PhysRevLett.35.380; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; Senkov ON, 2001, MATER RES BULL, V36, P2183, DOI 10.1016/S0025-5408(01)00715-2; Guo FQ, 2004, APPL PHYS LETT, V84, P37, DOI 10.1063/1.1637940; Miracle DB, 2006, ACTA MATER, V54, P4317, DOI 10.1016/j.actamat.2006.06.002; Miracle DB, 2006, MATER TRANS, V47, P1737, DOI 10.2320/matertrans.47.1737; Johnson WL, 1999, MRS BULL, V24, P42; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; Xia L, 2006, J APPL PHYS, V99, DOI 10.1063/1.2158130; Miracle DB, 2003, PHILOS MAG, V83, P2409, DOI 10.1080/1478643031000098828; Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219; INOUE A, 1995, MATER T JIM, V36, P866; TURNBULL D, 1961, J CHEM PHYS, V34, P120, DOI 10.1063/1.1731549; Guo S, 2011, PROG NAT SCI-MATER, V21, P433; Chen N, 2011, J MATER SCI, V46, P2091, DOI 10.1007/s10853-010-5043-x; Suryanarayana C, 2009, J NON-CRYST SOLIDS, V355, P355, DOI 10.1016/j.jnoncrysol.2008.12.009; Egami T, 2012, PHILOS MAG, V92, P655, DOI 10.1080/14786435.2011.630692; Takeuchi A, 2005, MATER TRANS, V46, P2817, DOI 10.2320/matertrans.46.2817; Miracle DB, 2010, INT MATER REV, V55, P218, DOI 10.1179/095066010X12646898728200; Louzguine-Luzgin DV, 2014, J MATER SCI, V49, P6716, DOI 10.1007/s10853-014-8276-2; YAVARI AR, 1983, PHYS LETT A, V95, P165, DOI 10.1016/0375-9601(83)90825-3; Lu ZP, 2002, ACTA MATER, V50, P3501, DOI 10.1016/S1359-6454(02)00166-0; Louzguine DV, 2002, SCRIPTA MATER, V47, P887, DOI 10.1016/S1359-6462(02)00268-3; Fang SS, 2003, J NON-CRYST SOLIDS, V321, P120, DOI 10.1016/S0022-3093(03)00155-8; Ojovan MI, 2013, J NON-CRYST SOLIDS, V382, P79, DOI 10.1016/j.jnoncrysol.2013.10.016; GLIMOIS JL, 1981, J LESS-COMMON MET, V78, P45, DOI 10.1016/0022-5088(81)90112-0; EGAMI T, 1984, J NON-CRYST SOLIDS, V64, P113, DOI 10.1016/0022-3093(84)90210-2; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; Mattern N, 2008, J NON-CRYST SOLIDS, V354, P1054, DOI 10.1016/j.jnoncrysol.2007.08.035; Zhang Y, 2008, ADV ENG MATER, V10, P534, DOI 10.1002/adem.200700240; Senkov ON, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.104202; PAULING L, 1947, J AM CHEM SOC, V69, P542, DOI 10.1021/ja01195a024; BATSANOV SS, 1994, RUSS CHEM B+, V43, P199, DOI 10.1007/BF00695809; BATTEZZATI L, 1988, J LESS-COMMON MET, V145, P31, DOI 10.1016/0022-5088(88)90259-7; Bergman C, 1980, J PHYSIQUE, V41, P591, DOI 10.1051/jphyscol:19808150; BLATTER A, 1985, PHYS REV LETT, V54, P2103, DOI 10.1103/PhysRevLett.54.2103; Botta WJ, 2008, PHIL MAG LETT, V88, P785, DOI 10.1080/09500830802375622; BSENKO L, 1976, ACTA CRYSTALLOGR B, V32, P2220, DOI 10.1107/S0567740876007413; Burlington MA, 2004, ASM INT METALS REFER, P4; Burlington MA, 2004, ASM INT METALS REFER; BUSCHOW KHJ, 1971, ACTA CRYSTALL B-STRU, VB 27, P1085, DOI 10.1107/S0567740871003558; Davies H. A., 1983, Amorphous metallic alloys; EGAMI T, 1996, J NONCRYST SOLIDS, V205, P575, DOI 10.1016/S0022-3093(96)00277-3; EIBLER R, 1987, J PHYS F MET PHYS, V17, P1533, DOI 10.1088/0305-4608/17/7/011; FANG T, 1992, J PHYS-CONDENS MAT, V4, P2405, DOI 10.1088/0953-8984/4/10/007; GABATHULER JP, 1975, ACTA CRYSTALLOGR B, V31, P608, DOI 10.1107/S0567740875003378; Gale WF, 2004, SMITHELLS METALS REF; Gebhardt E, 1964, IMD SPEC REP SER, V10, P303; Goldschmidt VM, 1928, Z PHYS CHEM-STOCH VE, V133, P397; GRATZ E, 1993, J PHYS-CONDENS MAT, V5, P7955, DOI 10.1088/0953-8984/5/43/009; Hiiussler P, 1983, Z PHYS B, V53, P15; Hobbs D, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.014407; Huang ZH, 2008, J ALLOY COMPD, V463, P328, DOI 10.1016/j.jallcom.2007.09.005; KADOMATSU H, 1988, J LESS-COMMON MET, V141, P29, DOI 10.1016/0022-5088(88)90207-X; KIM YW, 1989, ACTA METALL MATER, V37, P247, DOI 10.1016/0001-6160(89)90283-6; Louzguine DV, 2002, APPL PHYS LETT, V80, P1556, DOI 10.1063/1.1457522; Louzguine DV, 1999, J PHYS SOC JPN, V68, P2298, DOI 10.1143/JPSJ.68.2298; Louzguine DV, 2001, APPL PHYS LETT, V79, P3410, DOI 10.1063/1.1420781; Louzguine DV, 1999, MATER RES BULL, V34, P1165, DOI 10.1016/S0025-5408(99)00099-9; Louzguine-Luzgin DV, 2005, J ALLOY COMPD, V399, P78, DOI 10.1016/j.jallcom.2005.02.018; Louzguine DV, 2002, J MATER RES, V17, P1014, DOI 10.1557/JMR.2002.0149; Louzguine-Luzgin D. V., 2013, HDB MAGNETIC MAT, V21, P131; Louzguine-Luzgin Dmitri V, 2008, Advanced Engineering Materials, V10, DOI 10.1002/adem.200800134; Louzguine-Luzgin DV, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2159420; Louzguine-Luzgin DV, 2014, J ALLOY COMPD, V586, pS2, DOI 10.1016/j.jallcom.2012.09.057; Louzguine-Luzgin DV, 2010, METALL MATER TRANS A, V41A, P1664, DOI 10.1007/s11661-009-0087-8; Louzguine-Luzgin DV, 2007, PHILOS MAG, V87, P1845, DOI 10.1080/14786430601096928; Louzguine-Luzgin DV, 2008, J APPL PHYS, V104; Louzguine-Luzgin DV, 2011, J APPL PHYS, V110, DOI 10.1063/1.3624745; Louzguine-Luzgin DV, 2010, J APPL PHYS, V108, DOI 10.1063/1.3506687; Louzguine-Luzgin DV, 2009, INTERMETALLICS, V17, P477, DOI 10.1016/j.intermet.2008.12.008; MCMASTER.OD, 1970, ACTA CRYSTALL B-STRU, VB 26, P1224, DOI 10.1107/S0567740870003928; Mendeleev D. I., 1889, J CHEM SOC, V55, P634; Miracle DB, 2003, MAT SCI ENG A-STRUCT, V347, P50, DOI 10.1016/S0921-5093(02)00579-8; Nurgayanov PP, 2000, GLASS PHYS CHEM+, V26, P335; Park ES, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862790; Perepezko JH, 2010, J ALLOY COMPD, V495, P360, DOI 10.1016/j.jallcom.2009.10.051; Perepezko JH, 2008, MATER SCI ENG B-ADV, V148, P171, DOI 10.1016/j.mseb.2007.09.058; Satta M, 2009, J ALLOY COMPD, V483, P50, DOI 10.1016/j.jallcom.2008.07.148; Senkov ON, 2005, J APPL PHYS, V97, DOI 10.1063/1.1896434; STEEB S, 1968, J LESS-COMMON MET, V15, P137, DOI 10.1016/0022-5088(68)90047-7; Sudavtsova VS, 2009, POWDER METALL MET C+, V48, P582; Suryanarayana C, 2011, BULK METALLIC GLASSES, P1, DOI 10.1201/9781420085976-1; TAMURA K, 1969, PHYS LETT A, VA 29, P52, DOI 10.1016/0375-9601(69)91025-1; Tkatch VI, 2011, J NONCRYST SOLIDS, V357, P163; Uhlmann D. R., 1972, Journal of Non-Crystalline Solids, V7, DOI 10.1016/0022-3093(72)90269-4; WANG H, 1993, J AM CHEM SOC, V115, P2357, DOI 10.1021/ja00059a034; Winter M, 2008, WEBELEMENTS PERIODIC, V2007; Yavari AR, 2005, NAT MATER, V4, P1	93	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2461	1573-4803		J MATER SCI	J. Mater. Sci.	FEB	2015	50	4					1783	1793		10.1007/s10853-014-8741-y		11	Materials Science, Multidisciplinary	Materials Science	AX4JJ	WOS:000346898800028		
J	Monzen, R; Kawai, R; Watanabe, C				Monzen, Ryoichi; Kawai, Ryutaro; Watanabe, Chihiro			Effect of external stress on nucleation of ellipsoidal omega precipitates in a Ti-20 wt% Mo alloy	JOURNAL OF MATERIALS SCIENCE			English	Article							CU; PHASE; DEFECTS; GROWTH; ZONES	The effects of an external stress on the formation of ellipsoidal omega phase precipitates have been examined for a Ti-20 wt% Mo alloy aged at 300 A degrees C. Application of a tensile stress accelerates the nucleation of omega precipitates but a compressive stress does not significantly affect it. Estimates of the average misfit strains along the loading and the transverse directions, based on the misfit strains of omega precipitates, from measurements of the length change and the lattice parameter reveal preferential formation of specific omega variants among crystallographically equivalent four ones, which depends on the sense of the applied stress. This is supported by the result of the dependence of the number density of an omega variant on its misfit strain along the loading direction. This result, together with the dependence of the formation of omega precipitates on the sense of the applied stress, can be well understood through the interaction energy due to the presence of misfit strains between the applied stress and omega precipitate.	[Monzen, Ryoichi; Kawai, Ryutaro; Watanabe, Chihiro] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mech Sci & Engn, Kanazawa, Ishikawa 9201192, Japan	Monzen, R (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mech Sci & Engn, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	monzen@se.kanazawa-u.ac.jp	WATANABE, Chihiro/L-3531-2015				HICKMAN BS, 1969, T METALL SOC AIME, V245, P1329; Monzen R, 2012, PHILOS MAG, V92, P1826, DOI 10.1080/14786435.2012.658878; Volmer M, 1926, Z PHYS CHEM-STOCH VE, V119, P277; HOSFORD WF, 1975, METALL TRANS, VA  6, P487, DOI 10.1007/BF02658406; Pond RC, 2003, ACTA MATER, V51, P5385, DOI 10.1016/S1359-6454(03)00395-1; Skrotzki B, 1996, METALL MATER TRANS A, V27, P3431, DOI 10.1007/BF02595436; Zhu AW, 2001, ACTA MATER, V49, P2285, DOI 10.1016/S1359-6454(01)00119-7; ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133; ETO T, 1978, ACTA METALL MATER, V26, P499, DOI 10.1016/0001-6160(78)90175-X; Fontaine DD, 1988, METALL T A, V19A, P169, DOI 10.1007/BF02652523; Fontaine D.D., 1971, ACTA METALL, V19, P1153; Kun S, 2006, PHYS B, V385-386, P141; Miyazawa T, 2011, J MATER SCI, V46, P4228, DOI 10.1007/s10853-010-5239-0; Monzen R, 2010, METALL MATER TRANS A, V41A, P1936, DOI 10.1007/s11661-010-0244-0; Monzen R, 2005, PHIL MAG LETT, V85, P603, DOI 10.1080/09500830500421488; Nishizawa H, 1998, MATER T JIM, V39, P609; Pond RC, 1994, SOLID STATE PHYS, V47, P287, DOI 10.1016/S0081-1947(08)60641-4; SILCOCK JM, 1958, ACTA METALL MATER, V6, P481, DOI 10.1016/0001-6160(58)90111-1; Watanabe C, 2008, PHILOS MAG, V88, P1401, DOI 10.1080/14786430802178087	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2461	1573-4803		J MATER SCI	J. Mater. Sci.	FEB	2015	50	4					1876	1882		10.1007/s10853-014-8750-x		7	Materials Science, Multidisciplinary	Materials Science	AX4JJ	WOS:000346898800037		
J	Ning, HM; Iijima, T; Hu, N; Liu, YL; Wu, LK; Liu, F; Arai, M				Ning, Huiming; Iijima, Takeharu; Hu, Ning; Liu, Yaolu; Wu, Liangke; Liu, Feng; Arai, Masahiro			Investigation on mode-II interface fracture toughness of CFRP/Al laminates toughened by VGCF interleaves	JOURNAL OF MATERIALS SCIENCE			English	Article							TRANSVERSE LOADS; COMPOSITES; DELAMINATION	Mode-II interlaminar mechanical properties of CFRP/Al(aluminum) laminates were improved by acid treatment to an Al plate and adding vapor-grown carbon fiber (VGCF) between the Al plate and a CFRP layer. The influence of VGCF addition on the Mode-II interlaminar mechanical properties was explored by end-notched flexure tests. The experimental results demonstrated that the critical load and Mode-II fracture toughness of the specimen with acid treatment and 10 g/m(2) addition of VGCF increase by 73.66 and 175.76 %, respectively, compared to those of the specimen with acid treatment only. The improvement mechanisms were investigated by the observation of crack propagation path and fracture surface under laser scanning and scanning electron microscopies. Moreover, finite element analyses were undertaken based on the cohesive zone model to verify the experimental fracture toughness and to predict the interfacial shear strength between the Al plate and the CFRP layer.	[Ning, Huiming; Hu, Ning; Liu, Yaolu; Wu, Liangke] Chongqing Univ, Chongqing Key Lab Heterogeneous Mat Mech, Dept Engn Mech, Coll Aerosp Engn, Chongqing 400044, Peoples R China; [Iijima, Takeharu; Hu, Ning] Chiba Univ, Dept Mech Engn, Inage Ku, Chiba 2638522, Japan; [Liu, Feng] Hunan Univ, Coll Mech & Vehicle Engn, Changsha 412008, Hunan, Peoples R China; [Arai, Masahiro] Shinshu Univ, Dept Mech Engn, Nagano 3808553, Japan	Hu, N (reprint author), Chongqing Univ, Chongqing Key Lab Heterogeneous Mat Mech, Dept Engn Mech, Coll Aerosp Engn, Chongqing 400044, Peoples R China.	huning@faculty.chiba-u.jp			Research Funds from the NSF of China [11372104, 11332013]	This study is supported by the Research Funds from the NSF of China (Nos. 11372104 and 11332013).	Almuhammadi K, 2014, MATER DESIGN, V53, P921, DOI 10.1016/j.matdes.2013.07.081; Alfano M, 2011, INT J FRACTURE, V171, P139, DOI 10.1007/s10704-011-9636-4; Critchlow GW, 2006, INT J ADHES ADHES, V26, P419, DOI 10.1016/j.ijadhadh.2005.07.001; Hu N, 2008, MECH MATER, V40, P920, DOI 10.1016/j.mechmat.2008.05.003; Arai M, 2008, COMPOS SCI TECHNOL, V68, P516, DOI 10.1016/j.compscitech.2007.06.007; Alfano M, 2011, PROCEDIA ENGINEER, V10, P1760, DOI 10.1016/j.proeng.2011.04.293; Hu N, 2007, COMPOS SCI TECHNOL, V67, P752, DOI 10.1016/j.compscitech.2006.04.014; Khan SU, 2012, CARBON, V50, P5265, DOI 10.1016/j.carbon.2012.07.011; Lee SH, 2012, COMPOS SCI TECHNOL, V73, P1, DOI 10.1016/j.compscitech.2012.09.011; Kim WS, 2010, INT J ADHES ADHES, V30, P408, DOI 10.1016/j.ijadhadh.2010.05.004; Vogelesang LB, 2000, J MATER PROCESS TECH, V103, P1, DOI 10.1016/S0924-0136(00)00411-8; Botelho EC, 2007, APPL COMPOS MATER, V14, P209, DOI 10.1007/s10443-007-9041-3; Cho DH, 1998, J COMPOS MATER, V32, P1221; Jen MHR, 2005, COMPOS SCI TECHNOL, V65, P775, DOI 10.1016/j.compscitech.2004.10.010; Kim HS, 2006, COMPOS PART A-APPL S, V37, P1708, DOI 10.1016/j.compositesa.2005.09.015; Lee SH, 2002, J COMPOS MATER, V36, P2153, DOI 10.1106/002199802026981; Li Y, 2009, COMPOS PART A-APPL S, V40, P2004, DOI 10.1016/j.compositesa.2009.09.002; Ning HM, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/3/035004; Park SY, 2010, J MATER PROCESS TECH, V210, P1008, DOI 10.1016/j.jmatprotec.2010.01.017; Rhee KY, 2003, MAT SCI ENG A-STRUCT, V357, P270, DOI 10.1016/S0921-5093(03)00207-7; Russell A, 1982, PROGR SCI ENG COMPSI, V1, P279; Sekine H, 2000, J COMPOS MATER, V34, P551, DOI 10.1106/0AMC-AUMX-WB3H-95BY; Vlot A., 2001, FIBRE METAL LAMINATE; Yasaee M, 2012, COMPOS PART A-APPL S, V43, P121, DOI 10.1016/j.compositesa.2011.09.026	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2461	1573-4803		J MATER SCI	J. Mater. Sci.	FEB	2015	50	4					1915	1923		10.1007/s10853-014-8755-5		9	Materials Science, Multidisciplinary	Materials Science	AX4JJ	WOS:000346898800042		
J	Nakayama, K				Nakayama, K.			Porphyromonas gingivalis and related bacteria: from colonial pigmentation to the type IX secretion system and gliding motility	JOURNAL OF PERIODONTAL RESEARCH			English	Review						gliding motility; Porphyromonas gingivalis; protease; protein secretion system; review; virulence factors	OUTER-MEMBRANE PROTEIN; TERMINAL SIGNAL PEPTIDASE; BACTEROIDES-GINGIVALIS; TANNERELLA-FORSYTHIA; ANIONIC POLYSACCHARIDE; CYSTEINE PROTEINASE; PROTOPORPHYRIN-IX; VIRULENCE FACTORS; GENOME SEQUENCE; ARG-GINGIPAIN	Porphyromonas gingivalis is a gram-negative, non-motile, anaerobic bacterium implicated as a major pathogen in periodontal disease. P. gingivalis grows as black-pigmented colonies on blood agar, and many bacteriologists have shown interest in this property. Studies of colonial pigmentation have revealed a number of important findings, including an association with the highly active extracellular and surface proteinases called gingipains that are found in P.gingivalis. The Por secretion system, a novel type IX secretion system (T9SS), has been implicated in gingipain secretion in studies using non-pigmented mutants. In addition, many potent virulence proteins, including the metallocarboxypeptidase CPG70, 35kDa hemin-binding protein HBP35, peptidylarginine deiminase PAD and Lys-specific serine endopeptidase PepK, are secreted through the T9SS. These findings have not been limited to P.gingivalis but have been extended to other bacteria belonging to the phylum Bacteroidetes. Many Bacteroidetes species possess the T9SS, which is associated with gliding motility for some of these bacteria.	Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 8528588, Japan	Nakayama, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 8528588, Japan.	knak@nagasaki-u.ac.jp					Abaibou H, 2001, INFECT IMMUN, V69, P325, DOI 10.1128/IAI.69.1.325-335.2001; POTEMPA J, 1995, INFECT IMMUN, V63, P1176; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; McGraw WT, 1999, INFECT IMMUN, V67, P3248; Shibata Y, 2003, BIOCHEM BIOPH RES CO, V300, P351, DOI 10.1016/S0006-291X(02)02826-7; MCDERMID AS, 1988, INFECT IMMUN, V56, P1096; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Okamoto K, 1998, J BIOL CHEM, V273, P21225, DOI 10.1074/jbc.273.33.21225; Smalley JW, 1998, BIOCHEM J, V331, P681; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105; Liao F, 2009, MED HYPOTHESES, V72, P732, DOI 10.1016/j.mehy.2008.12.040; Smalley JW, 2002, BIOCHEM J, V362, P239, DOI 10.1042/0264-6021:3620239; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Kadowaki T, 2000, J BIOCHEM-TOKYO, V128, P153; Smalley JW, 2003, MICROBIOL-SGM, V149, P1711, DOI 10.1099/mic.0.26258-0; Sato K, 2009, MICROBIOL-SGM, V155, P1282, DOI 10.1099/mic.0.025163-0; Kondo Y, 2010, INFECT IMMUN, V78, P2846, DOI 10.1128/IAI.01448-09; Kharade SS, 2014, J BACTERIOL, V196, P961, DOI 10.1128/JB.01170-13; SHAH HN, 1987, CURR MICROBIOL, V15, P241, DOI 10.1007/BF01589374; Saiki K, 2007, MICROBIOL IMMUNOL, V51, P483; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; GENCO CA, 1995, INFECT IMMUN, V63, P2459; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Ishiguro I, 2009, FEMS MICROBIOL LETT, V292, P261, DOI 10.1111/j.1574-6968.2009.01489.x; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Shoji M, 2002, MICROBIOL-SGM, V148, P1183; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Chen T, 2000, MICROB PATHOGENESIS, V28, P235, DOI 10.1006/mpat.1999.0338; Smalley JW, 2004, BIOCHEM J, V379, P833, DOI 10.1042/BJ20031221; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Narita Y, 2014, MICROBIOL-SGM, V160, P2295, DOI 10.1099/mic.0.080192-0; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; ABIKO Y, 1990, ARCH ORAL BIOL, V35, P689, DOI 10.1016/0003-9969(90)90091-N; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Yoshimura M, 2008, ORAL MICROBIOL IMMUN, V23, P413, DOI 10.1111/j.1399-302X.2008.00444.x; Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028; Glew MD, 2012, J BIOL CHEM, V287, P24605, DOI 10.1074/jbc.M112.369223; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Chen YY, 2002, J BIOL CHEM, V277, P23433, DOI 10.1074/jbc.M200811200; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Collinson LM, 1998, MICROBIOL-UK, V144, P2487; desPablo P., 2009, NAT REV RHEUMATOL, V5, P218; Furusho H, 2013, J GASTROENTEROL, V48, P1259, DOI 10.1007/s00535-012-0738-1; Glew MD, 2014, J PROTEOMICS, V110, P72, DOI 10.1016/j.jprot.2014.07.033; Gully N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100838; Haffajee AD, 2000, PERIODONTOL, V5, P78; Madianos P N, 2001, Ann Periodontol, V6, P175, DOI 10.1902/annals.2001.6.1.175; Maresz KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003627; Maruyama M, 2009, HYBRIDOMA, V28, P431, DOI 10.1089/hyb.2009.0055; MCKEE AS, 1988, J MED MICROBIOL, V27, P59; Nakane D, 2013, P NATL ACAD SCI USA, V110, P11145, DOI 10.1073/pnas.1219753110; Nakayama K, 1995, DENT JPN, V32, P25; Nguyen KA, 2009, MICROBIOL-SGM, V155, P328, DOI 10.1099/mic.0.024323-0; Nonaka M, 2014, FEMS MICROBIOL LETT, V354, P60, DOI 10.1111/1574-6968.12426; Pussinen PJ, 2004, CURR OPIN LIPIDOL, V15, P583, DOI 10.1097/00041433-200410000-00013; Saiki K, 2014, MOL ORAL MICROBIOL, V29, P32, DOI 10.1111/omi.12043; SHAH HN, 1976, J APPL BACTERIOL, V41, P473, DOI 10.1111/j.1365-2672.1976.tb00660.x; SHAH HN, 1989, ORAL MICROBIOL IMMUN, V4, P19, DOI 10.1111/j.1399-302X.1989.tb00401.x; Shoji M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05056; Shoji M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-152; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Shoji M, 2013, MICROBIOLOGYOPEN, V2, P383, DOI 10.1002/mbo3.84; Simpson W, 1999, INFECT IMMUN, V67, P5012; Smalley JW, 2007, ARCH BIOCHEM BIOPHYS, V465, P44, DOI 10.1016/j.abb.2007.05.011; Tomek MB, 2014, MOL ORAL MICROBIOL, V29, P307, DOI 10.1111/omi.12062; Veith PD, 2004, INFECT IMMUN, V72, P3655, DOI 10.1128/IAI.72.6.3655-3657.2004; Wang Y, 2014, APPL ENVIRON MICROB, V80, P6037, DOI 10.1128/AEM.01785-14; Yoneda M., 2012, BMC GASTROENTEROL, V16, P12, DOI DOI 10.1186/1471-230X-12-16	77	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	FEB	2015	50	1					1	8		10.1111/jre.12255		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY3EO	WOS:000347467600001		
J	Mizutani, S; Ekuni, D; Tomofuji, T; Azuma, T; Kataoka, K; Yamane, M; Iwasaki, Y; Morita, M				Mizutani, S.; Ekuni, D.; Tomofuji, T.; Azuma, T.; Kataoka, K.; Yamane, M.; Iwasaki, Y.; Morita, M.			Relationship between xerostomia and gingival condition in young adults	JOURNAL OF PERIODONTAL RESEARCH			English	Article						cross-sectional studies; gingival diseases; xerostomia; young adult	DRY MOUTH; ORAL-HEALTH; ELDERLY-PEOPLE; SYMPTOMS; DIAGNOSIS; JAPANESE; RADIOTHERAPY; MEDICATIONS; POPULATION; PREVALENCE	Background and ObjectiveXerostomia is a subjective symptom of dryness in the mouth. Although a correlation between xerostomia and oral conditions in the elderly has been reported, there are few such studies in the young adults. The aim of this study was to examine the relationship of xerostomia with the gingival condition in university students. Material and MethodsA total of 2077 students (1202 male subjects and 875 female subjects), 18-24years of age, were examined. The disease activity and severity of the gingival condition were assessed as the percentage of teeth with bleeding on probing (%BOP) and the presence of teeth with probing pocket depth of 4mm, respectively. Additional information on xerostomia, oral health behaviors, coffee/tea intake and nasal congestion was collected via a questionnaire. Path analysis was used to test pathways from xerostomia to the gingival condition. ResultsOne-hundred and eighty-three (8.8%) students responded that their mouths frequently or always felt dry. Xerostomia was related to %BOP and dental plaque formation, but was not related to the presence of probing pocket depth 4mm. In the structural model, xerostomia was related to dental plaque formation (p<0.01), and a lower level of dental plaque formation was associated with a lower %BOP. Xerostomia was associated with coffee/tea intake (p<0.01) and nasal congestion (p<0.001). ConclusionXerostomia was indirectly related to gingival disease activity through the accumulation of dental plaque. Nasal congestion and coffee/tea intake also affected xerostomia. These findings suggest that xerostomia should be considered in screening for gingivitis risk in young adults.	[Mizutani, S.; Ekuni, D.; Tomofuji, T.; Azuma, T.; Kataoka, K.; Yamane, M.; Morita, M.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Kita Ku, Okayama 7008558, Japan; [Iwasaki, Y.] Okayama Univ, Hlth Serv Ctr, Kita Ku, Okayama 7008558, Japan	Ekuni, D (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	dekuni7@md.okayama-u.ac.jp			FUTOKU foundation, Tokyo, Japan	We are grateful to Ms Chie Omori (Okayama University, Okayama, Japan) for helping oral examination. The authors declare that they have no conflicts of interest. This work was supported by FUTOKU foundation, Tokyo, Japan.	Ciancio SG, 2004, J AM DENT ASSOC, V135, P1440; Ekuni D, 2008, J PERIODONTAL RES, V43, P417, DOI 10.1111/j.1600-0765.2007.01063.x; Shimazu T, 2005, INT J CANCER, V116, P150, DOI 10.1002/ijc.20989; Dirix P, 2010, LANCET ONCOL, V11, P85, DOI 10.1016/S1470-2045(09)70231-1; WAGAIYU EG, 1991, J CLIN PERIODONTOL, V18, P698, DOI 10.1111/j.1600-051X.1991.tb00112.x; Thomson WM, 1999, COMMUNITY DENT HLTH, V16, P12; Nederfors T, 1997, COMMUNITY DENT ORAL, V25, P211, DOI 10.1111/j.1600-0528.1997.tb00928.x; Hopcraft MS, 2010, AUST DENT J, V55, P238, DOI 10.1111/j.1834-7819.2010.01229.x; Armitage GC, 1996, J PERIODONTOL, V67, P57; ATKINSON JC, 1994, J AM DENT ASSOC, V125, P409; Browne MW, 1993, SAGE FOCUS EDITIONS, V154, P136, DOI DOI 10.1080/10705511.2012.687671; Carsons S, 2001, AM J MANAG CARE, V7, pS433; Dawes C, 2008, J AM DENT ASSOC, V139, p18S; de lasRosa-Garcia E, 2006, MED ORAL PATOL ORAL, V11, P467; Deasy JO, 2010, INT J RADIAT ONCOL, V76, pS58, DOI 10.1016/j.ijrobp.2009.06.090; FOX PC, 1987, J AM DENT ASSOC, V115, P581; Frutos R, 2002, MED ORAL, V7, P31; Furuta M, 2011, J PERIODONTOL, V82, P558, DOI 10.1902/jop.2010.100444; Gileva Olga S, 2004, Med Oral, V9, P212; GREENE JC, 1964, J AM DENT ASSOC, V68, P7; Greenspan D, 1996, Oncology (Williston Park), V10, P7; GREENSTEIN G, 1984, J PERIODONTOL, V55, P684; Hirotomi T, 2006, J DENT, V34, P692, DOI 10.1016/j.jdent.2006.01.001; Hochberg MC, 1998, J RHEUMATOL, V25, P486; Ikebe K, 2007, ORAL SURG ORAL MED O, V103, P216, DOI 10.1016/j.tripleo.2005.12.001; Kojima A, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-62; Korn GP, 2002, REV BRAS OTORRINOLAR, V68, P1; Li-Tze Hu, 1999, STRUCTURAL EQUATION, V6, P1; Maughan RJ, 2003, J HUM NUTR DIET, V16, P411, DOI 10.1046/j.1365-277X.2003.00477.x; Modéer T, 2000, Dent Clin North Am, V44, P633; Moore Paul A, 2008, Compend Contin Educ Dent, V29, P50; Napenas JJ, 2009, ODONTOLOGY, V97, P76, DOI 10.1007/s10266-008-0099-7; Nasri C, 2007, CLINICS, V62, P561, DOI 10.1590/S1807-59322007000500005; Quandt SA, 2011, J AM GERIATR SOC, V59, P439, DOI 10.1111/j.1532-5415.2010.03309.x; Schwartz M, 1995, CLIN GUIDE PERIODONT, P132; Slade GD, 1997, COMMUNITY DENT ORAL, V25, P429, DOI 10.1111/j.1600-0528.1997.tb01734.x; THOMSON WM, 1993, NEW ZEAL MED J, V106, P219; Thomson WM, 2006, ACTA ODONTOL SCAND, V64, P249, DOI 10.1080/00016350600633243; Thomson WM, 2000, ORAL SURG ORAL MED O, V89, P46, DOI 10.1016/S1079-2104(00)80013-X; Thomson W M, 1999, Spec Care Dentist, V19, P20, DOI 10.1111/j.1754-4505.1999.tb01363.x; Turner MD, 2007, J AM DENT ASSOC, V138, p15S	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	FEB	2015	50	1					74	79		10.1111/jre.12183		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY3EO	WOS:000347467600009		
J	Mitani, A; Takasu, H; Horibe, T; Furuta, H; Nagasaka, T; Aino, M; Fukuda, M; Fujimura, T; Mogi, M; Noguchi, T				Mitani, A.; Takasu, H.; Horibe, T.; Furuta, H.; Nagasaka, T.; Aino, M.; Fukuda, M.; Fujimura, T.; Mogi, M.; Noguchi, T.			Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series	JOURNAL OF PERIODONTAL RESEARCH			English	Article						enamel matrix protein; guided tissue regeneration; intrabony defect; long-term care	ENAMEL-MATRIX-PROTEINS; PERIODONTAL DEFECTS; INFRABONY DEFECTS; DERIVATIVE EMDOGAIN(R); BIOABSORBABLE BARRIERS; HISTOLOGIC EVALUATION; BONY DEFECTS; TRIAL; THERAPY; MEMBRANES	Background and ObjectiveAlthough regenerative periodontal surgery with EMD or guided tissue regeneration (GTR) has been shown to enhance periodontal regeneration, there are limited data on the long-term results following these treatment modalities. The purpose of the present study was to investigate the long-term clinical outcomes in intrabony defects following regenerative periodontal surgery with EMD or GTR compared with open-flap debridement (OFD). Material and MethodsData from 40 subjects (44 teeth), with no history of smoking or systemic diseases that could interfere with periodontal disease and who received one of three surgical procedures (EMD, GTR or OFD) for two- or three-wall intrabony defects, were analyzed. Postoperative reduction in probing pocket depth, gain in clinical attachment level, gingival recession and percentage bone fill were compared at 1, 3 and 5years. ResultsReduction in probing pocket depth after GTR was significantly higher than after OFD at 1 and 3years postoperatively, but there was no difference between the groups at 5years. The gains in clinical attachment level for EMD (at 3 and 5years) and for GTR (at 1, 3 and 5years) were significantly greater than for OFD. Gingival recession after treatment with EMD and GTR showed a tendency toward positive results, whereas no such tendency was observed for OFD. Postoperative percentage bone fill for EMD and GTR was significantly greater than for OFD at 3 and 5years. ConclusionsThis is a retrospective study and an exploratory report with a high risk of bias. Within the limits of the current study, it may be concluded that superior gains in clinical attachment level and improved percentage bone fill can be obtained with EMD and GTR when compared with OFD, and these can be maintained over a period of 5years.	[Mitani, A.; Takasu, H.; Horibe, T.; Furuta, H.; Nagasaka, T.; Aino, M.; Fukuda, M.; Fujimura, T.; Noguchi, T.] Aichi Gakuin Univ, Sch Dent, Dept Periodontol, Nagoya, Aichi 4648651, Japan; [Mogi, M.] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Nagoya, Aichi 4648651, Japan	Mitani, A (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Periodontol, Chikusa Ku, 2-11 Suemori Dori, Nagoya, Aichi 4648651, Japan.	minita@dpc.agu.ac.jp					Heijl L, 1997, J CLIN PERIODONTOL, V24, P693, DOI 10.1111/j.1600-051X.1997.tb00251.x; Mayfield L, 1998, J CLIN PERIODONTOL, V25, P585, DOI 10.1111/j.1600-051X.1998.tb02492.x; Stavropoulos A, 2010, J CLIN PERIODONTOL, V37, P200, DOI 10.1111/j.1600-051X.2009.01520.x; Siciliano VI, 2011, J PERIODONTOL, V82, P62, DOI 10.1902/jop.2010.100144; Esposito M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub3; Tonetti MS, 2002, J CLIN PERIODONTOL, V29, P317, DOI 10.1034/j.1600-051X.2002.290407.x; Sculean A, 1999, J PERIODONTAL RES, V34, P310, DOI 10.1111/j.1600-0765.1999.tb02259.x; Tonetti MS, 1996, J CLIN PERIODONTOL, V23, P548, DOI 10.1111/j.1600-051X.1996.tb01823.x; Cortellini P, 1996, J PERIODONTOL, V67, P217, DOI 10.1902/jop.1996.67.3.217; Cortellini P, 2007, J CLIN PERIODONTOL, V34, P87, DOI 10.1111/j.1600-051X.2006.01020.x; NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x; Tonetti MS, 1998, J PERIODONTOL, V69, P1183; Sculean A, 2008, J CLIN PERIODONTOL, V35, P817, DOI 10.1111/j.1600-051X.2008.01295.x; BASSIOUNY MA, 1975, J PERIODONTOL, V46, P748; Caffesse RG, 1997, J CLIN PERIODONTOL, V24, P747, DOI 10.1111/j.1600-051X.1997.tb00192.x; Carinci F, 2006, ORAL DIS, V12, P329, DOI 10.1111/j.1601-0825.2005.01204.x; Cortellini P, 2004, J PERIODONTOL, V75, P672, DOI 10.1902/jop.2004.75.5.672; Cosyn J, 2012, J CLIN PERIODONTOL, V39, P979, DOI 10.1111/j.1600-051X.2012.01924.x; Crea A, 2008, J PERIODONTOL, V79, P2281, DOI 10.1902/jop.2008.080135 ; Eickholz P, 2006, J PERIODONTOL, V77, P88, DOI 10.1902/jop.2006.77.1.88; Froum SJ, 2001, J PERIODONTOL, V72, P25, DOI 10.1902/jop.2001.72.1.25; Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x; Okuda K, 2000, J PERIODONTOL, V71, P1821, DOI 10.1902/jop.2000.71.12.1821; Pontoriero R, 1999, J CLIN PERIODONTOL, V26, P833; Pretzl B, 2008, J PERIODONTOL, V79, P1491, DOI 10.1902/jop.2008.070571 ; Sculean A, 2004, J CLIN PERIODONTOL, V31, P545, DOI 10.1111/j.1600-051X.2004.00518.x; Sculean A, 2001, J CLIN PERIODONTOL, V28, P397, DOI 10.1034/j.1600-051x.2001.028005397.x; Sculean A, 1999, INT J PERIODONT REST, V19, P157; Sculean A, 1999, J PERIODONTOL, V70, P255, DOI 10.1902/jop.1999.70.3.255; Sculean A, 2008, J PERIODONTOL, V79, P1991, DOI 10.1902/jop.2008.080009 ; Sculean A, 2000, J CLIN PERIODONTOL, V27, P466, DOI 10.1034/j.1600-051x.2000.027007466.x; Silvestri M, 2000, J CLIN PERIODONTOL, V27, P603, DOI 10.1034/j.1600-051x.2000.027008603.x; Yukna RA, 2000, J PERIODONTOL, V71, P752, DOI 10.1902/jop.2000.71.5.752; Zetterstrom O, 1997, J CLIN PERIODONTOL, V24, P697, DOI 10.1111/j.1600-051X.1997.tb00252.x; Zucchelli G, 2002, J PERIODONTOL, V73, P3, DOI 10.1902/jop.2002.73.1.3	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	FEB	2015	50	1					123	130		10.1111/jre.12188		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY3EO	WOS:000347467600014		
J	Nakada, T; Kato, T; Numabe, Y				Nakada, T.; Kato, T.; Numabe, Y.			Effects of fatigue from sleep deprivation on experimental periodontitis in rats	JOURNAL OF PERIODONTAL RESEARCH			English	Article						alveolar bone loss; modifying factor; periodontitis; partial sleep deprivation	ALVEOLAR BONE LOSS; SERUM-ALBUMIN; DISEASE; STRESS; MODEL; DISTURBANCES; METAANALYSIS; PREDICTORS; APNEA	Background and ObjectiveFactors such as vascularization of the periodontium, inflammatory reactions and immune response affect the oral environment and ecology, decreasing host resistance and promoting the development of symptoms and the advancement of periodontal disease. Fatigue also influences the hypothalamic-pituitary-adrenal axis and reports relate it to systemic resistance. The aim of this study was to evaluate whether fatigue is a modifying factor for periodontal disease in rats. Material and MethodsWe divided 24 3-wk-old male Sprague-Dawley rats randomly into the following four groups: control; fatigue (deep sleep deprivation for 7d); infection (rats inoculated with carboxymethyl cellulose containing periodontopathic bacteria); and compound (combined fatigue and infection conditions). Weight, serum corticosterone levels, serum albumin levels, interleukin-1 and tumor necrosis factor- expression levels and distance from the cement-enamel junction to the alveolar bone crest were measured at baseline, and on the 36th (before sleep deprivation), 43rd (immediately after sleep deprivation) and 57th d (end of experiment). ResultsImmediately after sleep deprivation and at the end of the experiment, weight gain in the fatigue and compound groups was significantly lower than in controls (p<0.05). Immediately after sleep deprivation, serum corticosterone levels were significantly higher in the fatigue and compound groups than in controls (p<0.05). Moreover, serum albumin levels were significantly lower in the fatigue and compound groups than in controls (p<0.05). Immediately after sleep deprivation, gene expression of interleukin-1 was significantly higher in the infection and compound groups than in controls (p<0.05). Moreover, gene expression of tumor necrosis factor- was significantly higher in the compound group than in controls (p<0.05). At the end of the experiment, the distance from the cement-enamel junction to the alveolar bone crest was significantly higher in the infection and compound groups than in controls (p<0.05). Moreover, the distance was significantly higher in the compound group than in the infection group. ConclusionsFatigue worsened systemic health in rats and increased gingival inflammation and alveolar bone loss in experimental periodontitis. In conclusion, our results suggest that fatigue is a modifying factor for periodontal disease in rats.	[Nakada, T.; Kato, T.; Numabe, Y.] Nippon Dent Univ Tokyo, Dept Periodontol, Sch Life Dent Tokyo, Tokyo 1028159, Japan	Nakada, T (reprint author), Nippon Dent Univ Tokyo, Dept Periodontol, Sch Life Dent Tokyo, Chiyoda Ku, 1-9-20 Fujimi, Tokyo 1028159, Japan.	nakadato@tky.ndu.ac.jp			Research Center for Odontology [11-21]; Department of Periodontology; School of Life Dentistry at Tokyo; Nippon Dental University at Tokyo, Japan	This study was carried out in accordance with the Guidelines of Nippon Dental University, the School of Life Dentistry at Tokyo, the Section of Biological Sciences, and the Research Center for Odontology (grant 11-21 to T. Nakada).; All funding was obtained through the Department of Periodontology, the School of Life Dentistry at Tokyo, and the Nippon Dental University at Tokyo, Japan.	LEWIS G, 1992, J EPIDEMIOL COMMUN H, V46, P92, DOI 10.1136/jech.46.2.92; Shahid A, 2010, J PSYCHOSOM RES, V69, P81, DOI 10.1016/j.jpsychores.2010.04.001; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Nakajima K, 2006, J PERIODONTAL RES, V41, P527, DOI 10.1111/j.1600-0765.2006.00901.x; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chambrone L, 2013, J CLIN PERIODONTOL, V40, P607, DOI 10.1111/jcpe.12106; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Tanaka M, 2003, NEUROSCI LETT, V352, P159, DOI 10.1016/S0304-3940(03)01044-9; Akazawa KH, 2010, NEUROSCI RES, V66, P372, DOI 10.1016/j.neures.2009.12.009; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Iwasaki M, 2008, J CLIN PERIODONTOL, V35, P291, DOI 10.1111/j.1600-051X.2008.01215.x; Bultmann U, 2013, EUR J PUBLIC HEALTH, V23, P123, DOI 10.1093/eurpub/ckr207; Yehuda S, 2009, J INTERF CYTOK RES, V29, P393, DOI 10.1089/jir.2008.0080; Peruzzo DC, 2007, J PERIODONTOL, V78, P1491, DOI 10.1902/jop.2007.060371; Genco RJ, 1999, J PERIODONTOL, V70, P711, DOI 10.1902/jop.1999.70.7.711; Graves DT, 2008, J CLIN PERIODONTOL, V35, P89, DOI 10.1111/j.1600-051X.2007.01172.x; Peruzzo DC, 2008, J PERIODONTOL, V79, P697, DOI 10.1902/jop.2008.070369 ; Baker PJ, 2005, J PERIODONTOL, V76, P2042, DOI 10.1902/jop.2005.76.11-S.2042; dasSilva AM, 1995, J CLIN PERIODONTOL, V22, P516; Ferentinos P, 2009, J PSYCHOSOM RES, V66, P37, DOI 10.1016/j.jpsychores.2008.07.009; Koban M., 2005, AM J PHYSIOL-ENDOC M, V289, P68; Li CH, 2007, J PERIODONTOL, V78, P1120, DOI 10.1902/jop.2007.060320; Mills PJ, 2008, SLEEP BREATH, V12, P397, DOI 10.1007/s11325-008-0192-8; Nicola NA, 1994, GUIDEBOOK CYTOKINES, P17; Ogawa H, 2006, J CLIN PERIODONTOL, V33, P312, DOI 10.1111/j.1600-051X.2005.00901.x; Schreiner H, 2011, J PERIODONTOL, V82, P142, DOI 10.1902/jop.2010.100250; Sharma S, 2010, INT J ENDOCRINOL, DOI 10.1155/2010/270832; Sharpe M, 2002, BRIT MED J, V325, P480, DOI 10.1136/bmj.325.7362.480; Stepnowsky CJ, 2011, SLEEP MED, V12, P832, DOI 10.1016/j.sleep.2011.07.004; Van Sluyters RC, 2003, GUIDELINES CARE USE, P120; vansLeeuwen W. M., 2009, PLOS ONE, V4, pe4589; Watanabe Y., 2002, 1 TERM RESULT REPORT, P131; Wilensky A, 2005, J PERIODONTOL, V76, P1282, DOI 10.1902/jop.2005.76.8.1282	33	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	FEB	2015	50	1					131	137		10.1111/jre.12189		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY3EO	WOS:000347467600015		
J	Poapolathep, S; Klangkaew, N; Arreesrisom, P; Isariyodom, S; Sugita-Konishi, Y; Kumagai, S; Poapolathep, A				Poapolathep, S.; Klangkaew, N.; Arreesrisom, P.; Isariyodom, S.; Sugita-Konishi, Y.; Kumagai, S.; Poapolathep, A.			Toxicokinetics and absolute oral bioavailability of melamine in broiler chickens	JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS			English	Article							CYANURIC ACID; RATS; DEPLETION; RESIDUES; TISSUES; DIETS; MILK; PIGS	The objective of this study was to investigate the toxicokinetic characteristics of melamine in broilers due to the limited information available for livestock. Melamine was then administered to broiler chickens at an intravenous (i.v.) or oral (p.o.) dosage of 5.5mg/kg of body weight, and plasma samples were collected up to 48h. The concentration of melamine in each plasma sample was analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Melamine was measurable up to 24h after i.v. and p.o. administration. A one-compartment model was developed to describe the toxicokinetics of melamine in broilers. Following i.v. administration, the values for the elimination half-life (t(1/2)), the volume of distribution (V-d), and the clearance (CL) were 4.42 +/- 1.02h, 00.52 +/- 0.18L/kg, and 0.08 +/- 0.01L/h/kg, respectively. The absolute oral bioavailability (F) was 95.63 +/- 3.54%. The results suggest that most of the administered melamine is favorably absorbed from the alimentary tract and rapidly cleared by the kidneys in broiler chickens.	[Poapolathep, S.; Klangkaew, N.; Poapolathep, A.] Kasetsart Univ, Fac Vet Med, Dept Pharmacol, Bangkok 10900, Thailand; [Arreesrisom, P.] Kasetsart Univ, Fac Vet Technol, Bangkok 10900, Thailand; [Isariyodom, S.] Kasetsart Univ, Fac Agr, Dept Anim Husb, Bangkok 10900, Thailand; [Sugita-Konishi, Y.] Azabu Univ, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan; [Kumagai, S.] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan	Poapolathep, A (reprint author), Kasetsart Univ, Fac Vet Med, Dept Pharmacol, Bangkok 10900, Thailand.	fvetamp@ku.ac.th			University of Tokyo, Japan	This study was supported by the University of Tokyo, Japan.	Reimschuessel R, 2008, AM J VET RES, V69, P1217, DOI 10.2460/ajvr.69.9.1217; Lam CW, 2009, CLIN CHIM ACTA, V402, P150, DOI 10.1016/j.cca.2008.12.035; Brown CA, 2007, J VET DIAGN INVEST, V19, P525; Mitchell AD, 2011, POULTRY SCI, V90, P1712, DOI 10.3382/ps.2010-01156; Chan EYY, 2008, LANCET, V372, P1444, DOI 10.1016/S0140-6736(08)61604-9; Bai X, 2010, J AGR FOOD CHEM, V58, P5414, DOI 10.1021/jf904026n; Baynes R. E., 2010, ENV HLTH THREAT J, V3, P1; Baynes RE, 2008, FOOD CHEM TOXICOL, V46, P1196, DOI 10.1016/j.fct.2007.11.013; Burns Katie, 2007, J Am Vet Med Assoc, V230, P1600; FDA, 2007, INT MEL AN SAF RISK; IARC, 1987, IARC MONOGR EVAL C S, V7, P65; Lu MB, 2009, POULTRY SCI, V88, P2167, DOI 10.3382/ps.2009-00087; Lv XW, 2010, J AGR FOOD CHEM, V58, P943, DOI 10.1021/jf9026316; MAST RW, 1983, FOOD CHEM TOXICOL, V21, P807, DOI 10.1016/0278-6915(83)90216-8; NTP, 2008, NTP RES CONC MEL CYA; OKUMURA M, 1992, CARCINOGENESIS, V13, P1043, DOI 10.1093/carcin/13.6.1043; Reddy MB, 2005, PHYSIOLOGICALLY BASED PHARMACOKINETICS MODELING: SCIENCE AND APPLICATIONS, P1, DOI 10.1002/0471478768; Reimschuessel R., 2009, J VET PHARMACOL THER, V33, P172, DOI DOI 10.1111/J.1365-2885.2009.01111.X; Riviere J. E, 2000, COMP PHARAMACOKINETI; Stine CB, 2012, FOOD CHEM TOXICOL, V50, P3426, DOI 10.1016/j.fct.2012.07.055; Sun P, 2011, J DAIRY SCI, V94, P3575, DOI 10.3168/jds.2010-4018; Thompson M. E., 2008, VET PATHOL, V45, P7417; World Health Organization, 2008, TOX HLTH ASP MEL CYA; Wu U. T., 2010, J AGR FOOD CHEM, V58, P108; Yang F, 2009, J SEP SCI, V32, P2974, DOI 10.1002/jssc.200900201	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7783	1365-2885		J VET PHARMACOL THER	J. Vet. Pharmacol. Ther.	FEB	2015	38	1					101	104		10.1111/jvp.12145		4	Pharmacology & Pharmacy; Veterinary Sciences	Pharmacology & Pharmacy; Veterinary Sciences	AY3DA	WOS:000347463500014		
J	Nishino, A; Ogushi, K; Ueda, K				Nishino, Atsuhiro; Ogushi, Koji; Ueda, Kazunaga			Calibration of reference torque wrenches using a 10 N m deadweight torque standard machine	MEASUREMENT			English	Article						Torque; Calibration; Torque wrench; Torque standard; Small-rated-capacity; Reference torque wrench		Within the torque traceability system in Japan, there are two processes, one for "pure torque" loading without any parasitic components, and the other for "torque wrench" loading with unavoidable transverse force and bending moment. The torque standard for reference torque wrenches (RTWs), which is a reference standard for first-grade accredited laboratories, has been disseminated in the range from 5 N m to 5 kN m using other torque standard machines at the National Metrology Institute of Japan (NMIJ). In this study, in order to expand the range of the torque standard for RTWs, we designed new holders allowing small-rated-capacity RTWs to be calibrated using the 10 N m deadweight torque standard machine (10-N m-DWTSM). We also studied the calibration method for small-rated-capacity RTWs according to the guidelines that have been adopted for medium and large RTWs. Experiments conducted using two kinds of small-rated-capacity RTWs showed that the 10-N m-DWTSM equipped with new holders can calibrate small-rated-capacity RTWs, and the calibration procedure ordinarily adopted for medium to large capacity RTWs is also applicable to the calibration of small-rated-capacity RTWs. The newly designed holder with an aerostatic shaft resulted in a smaller relative standard uncertainty due to reproducibility with a change in mounting position compared with that obtained using the conventional holder with a solid shaft. (C) 2014 Elsevier Ltd. All rights reserved.	[Nishino, Atsuhiro; Ogushi, Koji; Ueda, Kazunaga] AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan	Nishino, A (reprint author), AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan.	a.nishino@aist.go.jp					[Anonymous], 2012, JCG209S1105; Nishino A, 2014, MEASUREMENT, V49, P77, DOI 10.1016/j.measurement.2013.11.033; Nishino A., 2014, P SICE ANN C 2014 HO; Nishino A., 2013, P SICE ANN C 2013 AI; Ogushi K, 2012, MEASUREMENT, V45, P1200, DOI 10.1016/j.measurement.2012.01.016; Ogushi K., 2005, P SICE 22 SENS FOR O, P267; Peschel D., 1996, P 15 TC3 C IMEKO MAD, P251; Torque Traceability Study Group, 2004, JMIF016	8	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-2241	1873-412X		MEASUREMENT	Measurement	FEB	2015	61						1	8		10.1016/j.measurement.2014.09.081		8	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AY3UB	WOS:000347506700001		
J	Mironov, S; Inagaki, K; Sato, YS; Kokawa, H				Mironov, Sergey; Inagaki, Kosuke; Sato, Yutaka S.; Kokawa, Hiroyuki			Effect of Welding Temperature on Microstructure of Friction-stir Welded Aluminum Alloy 1050	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							GRAIN-STRUCTURE; CRYSTALLOGRAPHIC TEXTURE; EVOLUTION; DEFORMATION; STRAINS; TORSION	High-resolution electron-backscatter diffraction was used to study the effect of welding temperature on the microstructure, texture, and strength of friction-stir welded aluminum. In all cases, the grain structure development was shown to be primarily governed by continuous recrystallization, although discontinuous recrystallization may also play a role at relatively high temperatures. An increase in welding temperature was shown to lead to transformation of the morphology of the deformation-induced substructure from lamellar type to equiaxed type. This was deduced to alter strain compatibility requirements and thus change the texture from C{001}< 110 > to B/(B) over bar {112}< 110 >. (C) The Minerals, Metals & Materials Society and ASM International 2014	[Mironov, Sergey; Inagaki, Kosuke; Sato, Yutaka S.; Kokawa, Hiroyuki] Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Sendai, Miyagi 9808579, Japan	Mironov, S (reprint author), Tohoku Univ, Grad Sch Engn, Dept Mat Proc, 6-6-02 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	smironov@material.tohoku.ac.jp	Kokawa, Hiroyuki/B-2655-2014	Kokawa, Hiroyuki/0000-0003-3255-7180	Tohoku University	The authors are grateful to Mr. A. Honda for technical assistance. One of the authors (S. Mironov) would like to express his hearty thanks to Tohoku University for providing a scientific fellowship.	Ahmed MMZ, 2008, SCRIPTA MATER, V59, P507, DOI 10.1016/j.scriptamat.2008.04.047; MONTHEILLET F, 1985, ACTA METALL MATER, V33, P705, DOI 10.1016/0001-6160(85)90035-5; MCQUEEN HJ, 1985, SCRIPTA METALL MATER, V19, P73, DOI 10.1016/0036-9748(85)90268-6; Fonda RW, 2007, SCRIPTA MATER, V57, P1052, DOI 10.1016/j.scriptamat.2007.06.068; Prangnell PB, 2005, ACTA MATER, V53, P3179, DOI 10.1016/j.actamat.2005.03.044; Fonda RW, 2006, METALL MATER TRANS A, V37A, P3593, DOI 10.1007/s11661-006-1054-2; Nandan R, 2008, PROG MATER SCI, V53, P980, DOI 10.1016/j.pmatsci.2008.05.001; Fonda RW, 2011, SCI TECHNOL WELD JOI, V16, P288, DOI 10.1179/1362171811Y.0000000010; Mishra RS, 2005, MAT SCI ENG R, V50, P1, DOI 10.1016/j.mser.2005.07.001; Hughes DA, 1997, ACTA MATER, V45, P3871, DOI 10.1016/S1359-6454(97)00027-X; Field DP, 2001, METALL MATER TRANS A, V32, P2869, DOI 10.1007/s11661-001-1037-2; Fonda RW, 2004, SCRIPTA MATER, V51, P243, DOI 10.1016/j.scriptamat.2004.04.017; Jeon J, 2011, ACTA MATER, V59, P7439, DOI 10.1016/j.actamat.2011.09.013; Mironov S, 2008, ACTA MATER, V56, P2602, DOI 10.1016/j.actamat.2008.01.040; Suhuddin UFHR, 2010, MAT SCI ENG A-STRUCT, V527, P1962, DOI 10.1016/j.msea.2009.11.029; Sato YS, 2001, METALL MATER TRANS A, V32, P3033, DOI 10.1007/s11661-001-0178-7; FUJITA H, 1973, ACTA METALL MATER, V21, P355, DOI 10.1016/0001-6160(73)90191-0; Kocks U.F., 1981, DEFORMATION POLYCRYS, P35; Pettersen T, 2003, METALL MATER TRANS A, V34A, P2727, DOI 10.1007/s11661-003-0174-1	19	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	FEB	2015	46A	2					783	790		10.1007/s11661-014-2651-0		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AY0RD	WOS:000347303400022		
J	Somekawa, H; Mukai, T				Somekawa, Hidetoshi; Mukai, Toshiji			Hall-Petch Breakdown in Fine-Grained Pure Magnesium at Low Strain Rates	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							ROOM-TEMPERATURE; POLYCRYSTALLINE MAGNESIUM; NANOCRYSTALLINE MATERIALS; NANOINDENTATION BEHAVIOR; DEFORMATION MECHANISMS; PLASTIC-DEFORMATION; ACTIVATION VOLUME; RATE SENSITIVITY; SIZE DEPENDENCE; NONBASAL SLIP	The effects of grain size and strain rate on tension behavior at ambient temperature were investigated for several extruded magnesium with an average grain size in the range between 1 and 20 mu m. In quasi-static strain rate regimes (1 x 10(-2) to 10(-4) s(-1)), the activation volume was similar to 20b (3) (b is the Burgers vector), which suggested that the major contribution of deformation was cross-slip and/or multiple slips. In contrast, in low strain rate regimes (< 1 x 10(-4) s(-1)), the ductility increased with grain refinement, and the maximum elongation-to-failure was 230 pct for a grain size of 1.2 mu m and a strain rate of 1 x 10(-5) s(-1); such ductility was never observed in magnesium at room temperature. In addition, the activation volume was also reduced to similar to 5b (3). Observations of the deformed surface revealed plentiful traces of grain boundary sliding. This mechanism played an important role in deformation. As a result, while the yield strength was aligned on the Hall-Petch relation in quasi-static strain rate regimes, an inverse Hall-Petch effect was observed in low strain rate regimes.	[Somekawa, Hidetoshi] Natl Inst Mat Sci, Res Ctr Strateg Mat, Tsukuba, Ibaraki 3050047, Japan; [Mukai, Toshiji] Kobe Univ, Dept Mech Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Somekawa, H (reprint author), Natl Inst Mat Sci, Res Ctr Strateg Mat, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	somekawa.hidetoshi@nims.go.jp	Mukai, Toshiji/F-9570-2014	Mukai, Toshiji/0000-0002-9628-5762	JSPS [25102712]; MEXT	The authors are grateful to Ms. R. Komatsu (National Institute for Materials Science) for her technical help and Dr. A. Singh for his TEM observation. This work was partially supported by the JSPS Grant-in-Aid for Scientific Research on Innovation Area "Bulk Nanocrystructured Metals" in No. 25102712 and "Nanotechnology Network Project" of the MEXT.	Somekawa H, 2012, J MATER RES, V27, P1295, DOI 10.1557/jmr.2012.52; Kawasaki M, 2008, MATER TRANS, V49, P84, DOI 10.2320/matertrans.ME200720; Koike J, 2003, MATER TRANS, V44, P445, DOI 10.2320/matertrans.44.445; ZEHETBAUER M, 1993, ACTA METALL MATER, V41, P577, DOI 10.1016/0956-7151(93)90088-A; CONRAD H, 1961, ACTA METALL MATER, V9, P367, DOI 10.1016/0001-6160(61)90230-9; MUSSOT P, 1985, RES MECH, V14, P69; Somekawa H, 2005, SCRIPTA MATER, V53, P1059, DOI 10.1016/j.scriptamat.2005.07.001; Rodriguez P, 2004, METALL MATER TRANS A, V35A, P2697, DOI 10.1007/s11661-004-0215-4; Meyers MA, 2001, ACTA MATER, V49, P4025, DOI 10.1016/S1359-6454(01)00300-7; Li YP, 2007, MATER TRANS, V48, P1215, DOI 10.2320/matertrans.I-MRA2007849; Agnew SR, 2005, INT J PLASTICITY, V21, P1161, DOI 10.1016/j.ijplas.2004.05.018; Somekawa H, 2010, PHIL MAG LETT, V90, P883, DOI 10.1080/09500839.2010.514577; Barnett MR, 2004, ACTA MATER, V52, P5093, DOI 10.1016/j.actamat.2004.07.015; Asaro RJ, 2005, ACTA MATER, V53, P3369, DOI 10.1016/j.actamat.2005.03.047; Caceres CH, 2007, MAT SCI ENG A-STRUCT, V462, P193, DOI 10.1016/j.msea.2005.12.113; Argon AS, 2006, PHIL MAG LETT, V86, P713, DOI 10.1080/09500830600986091; Wang YM, 2006, ACTA MATER, V54, P2715, DOI 10.1016/j.actamat.2006.02.013; WILSON DV, 1963, PHILOS MAG, V8, P1543, DOI 10.1080/14786436308207317; Sharon JA, 2014, SCRIPTA MATER, V75, P10, DOI 10.1016/j.scriptamat.2013.10.016; Koike J, 2005, METALL MATER TRANS A, V36A, P1689, DOI 10.1007/s11661-005-0032-4; Zhu YT, 2005, MAT SCI ENG A-STRUCT, V409, P234, DOI 10.1016/j.msea.2005.05.111; SHERBY OD, 1989, PROG MATER SCI, V33, P169, DOI 10.1016/0079-6425(89)90004-2; Hirsch J, 2013, ACTA MATER, V61, P818, DOI 10.1016/j.actamat.2012.10.044; Koike J, 2003, ACTA MATER, V51, P2055, DOI 10.1016/S1359-6454(03)00005-3; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/S1359-6454(02)00421-4; CHAPMAN JA, 1962, J I MET, V91, P39; CHRISTIAN JW, 1995, PROG MATER SCI, V39, P1, DOI 10.1016/0079-6425(94)00007-7; Wang CL, 2009, J MATER RES, V24, P1615, DOI 10.1557/JMR.2009.0187; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Caceres CH, 2011, METALL MATER TRANS A, V42A, P1950, DOI 10.1007/s11661-010-0599-2; Somekawa H, 2013, SCRIPTA MATER, V68, P416, DOI 10.1016/j.scriptamat.2012.11.010; RAO GS, 1982, METALL TRANS A, V13, P2219, DOI 10.1007/BF02648393; LANGDON TG, 1972, METALL TRANS, V3, P797, DOI 10.1007/BF02647651; ARMSTRON.RW, 1970, METALL TRANS, V1, P1169; Ashby M.F., 1982, DEFORMATION MECH MAP; Barnett MR, 2008, SCRIPTA MATER, V59, P696, DOI 10.1016/j.scriptamat.2008.05.027; Choi HJ, 2010, MAT SCI ENG A-STRUCT, V527, P1565, DOI 10.1016/j.msea.2009.10.035; HAUSER FE, 1956, T AM I MIN MET ENG, V206, P589; Hwang S, 2001, SCRIPTA MATER, V44, P1507, DOI 10.1016/S1359-6462(01)00716-3; *JAP IND STAND COM, 2002, JISH7501; *JAP IND STAND COM, 2002, JISH7007; LIVINGSTON JD, 1957, ACTA METALL MATER, V5, P322, DOI 10.1016/0001-6160(57)90044-5; MARGOLIN H, 1975, ACTA METALL MATER, V23, P1411, DOI 10.1016/0001-6160(75)90150-9; MARUYAMA K, 1981, T JPN I MET, V22, P723; Matsunaga T, 2010, PHILOS MAG, V90, P4041, DOI 10.1080/14786435.2010.502883; Milligan W. W., 1993, Nanostructured Materials, V2, DOI 10.1016/0965-9773(93)90153-3; MISHRA RS, 1995, ACTA METALL MATER, V43, P877, DOI 10.1016/0956-7151(94)00323-A; MUKAI T, UNPUB; Ono N., 2003, MATER LETT, V58, P39, DOI DOI 10.1016/S0167-577X(03)00410-5; REEDHILL RE, 1968, INHOMOGENEITY PLASTI; REY C, 1982, ACTA METALL MATER, V30, P523, DOI 10.1016/0001-6160(82)90233-4; Sergueeva AV, 2007, MAT SCI ENG A-STRUCT, V463, P8, DOI 10.1016/j.msea.2006.07.152; SHNTHI M, 2012, J ALLOY COMPD, V513, P202; SOMEKAWA H, 2011, ACTA MAT, V59, P7559; VALIEV RZ, 1977, PHYS STATUS SOLIDI A, V44, P477, DOI 10.1002/pssa.2210440209; VANSWYGENHOVEN H, 2003, PHYS REV B, V64; WILSON DV, 1970, J I MET, V98, P133; ZHAGN X, 2002, APPL PHYS LETT, V81, P823	58	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	FEB	2015	46A	2					894	902		10.1007/s11661-014-2641-2		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AY0RD	WOS:000347303400032		
J	Vajpai, SK; Ota, M; Watanabe, T; Maeda, R; Sekiguchi, T; Kusaka, T; Ameyama, K				Vajpai, Sanjay Kumar; Ota, Mie; Watanabe, Tomoyuki; Maeda, Ryo; Sekiguchi, Tatsuya; Kusaka, Takayuki; Ameyama, Kei			The Development of High Performance Ti-6Al-4V Alloy via a Unique Microstructural Design with Bimodal Grain Size Distribution	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							SEVERE PLASTIC-DEFORMATION; HARMONIC STRUCTURE DESIGN; AL-MG ALLOY; MECHANICAL-PROPERTIES; HIGH-STRENGTH; NANOSTRUCTURED METALS; TENSILE DUCTILITY; BEHAVIOR; SUPERPLASTICITY; TITANIUM	The present work deals with the strengthening of Ti-6Al-4V alloy by creating a unique microstructure with bimodal grain size distribution, termed as "harmonic structure." The Ti-6Al-4V compacts with harmonic structure design were successfully prepared via a powder metallurgy approach consisting of controlled mechanical milling and spark plasma sintering of the pre-alloyed Ti-6Al-4V powders. The microstructural evolution at each stage of processing has been investigated to establish a correlation between the processing conditions and the microstructural evolution. The Ti-6Al-4V compacts with heterogeneous harmonic structure exhibited better mechanical properties as compared to their homogeneous fine/coarse-grained counterparts. An attempt has also been made to explain the deformation mechanism of the harmonic-structured Ti-6Al-4V specimens with the help of the experimental evidences. The superior mechanical properties of the harmonic structure Ti-6Al-4V were found to be related to the peculiar topological distribution of strong fine-grained and ductile coarse-grained regions, which promotes uniform distribution of strain during plastic deformation and results in improved mechanical properties by avoiding the localized plastic deformation in the early stages of deformation.	[Vajpai, Sanjay Kumar; Ota, Mie] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Japan; [Watanabe, Tomoyuki; Maeda, Ryo; Sekiguchi, Tatsuya] Ritsumeikan Univ, Grad Sch, Kusatsu, Japan; [Sekiguchi, Tatsuya] IHI Corp, Tokyo, Japan; [Kusaka, Takayuki; Ameyama, Kei] Ritsumeikan Univ, Dept Mech Engn, Kusatsu, Japan	Vajpai, SK (reprint author), Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Japan.	vajpaisk@gmail.com			Japan Science and Technology Agency (JST); MEXT, Japan [22102004]	This research was supported by the Japan Science and Technology Agency (JST) under Collaborative Research Based on Industrial Demand "Heterogeneous Structure Control: Toward Innovative Development of Metallic Structural Materials," and by the Grant-in-Aid for Scientific Research on Innovative Area, "Bulk Nanostructured Metals," through MEXT, Japan (contract No. 22102004). These supports are gratefully appreciated.	Zherebtsov S, 2012, MAT SCI ENG A-STRUCT, V536, P190, DOI 10.1016/j.msea.2011.12.102; Witkin D, 2003, SCRIPTA MATER, V49, P297, DOI 10.1016/S1359-6462(03)00283-5; Ko YG, 2006, METALL MATER TRANS A, V37A, P381, DOI 10.1007/s11661-006-0008-z; Wang YM, 2004, ACTA MATER, V52, P1699, DOI 10.1016/j.actamat.2003.12.022; Joshi SP, 2006, METALL MATER TRANS A, V37A, P2397, DOI 10.1007/BF02586214; Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2; Orlov D, 2013, MATER TRANS, V54, P1549, DOI 10.2320/matertrans.MH201320; Murty SVSN, 2014, MAT SCI ENG A-STRUCT, V589, P174, DOI 10.1016/j.msea.2013.09.087; Ciuca OP, 2013, MATER TRANS, V54, P1629, DOI 10.2320/matertrans.MH201321; Fujiwara H, 2008, MATER TRANS, V49, P90, DOI 10.2320/matertrans.ME200703; Boyer RR, 1996, MAT SCI ENG A-STRUCT, V213, P103, DOI 10.1016/0921-5093(96)10233-1; Chao Q, 2014, METALL MATER TRANS A, V45A, P2659, DOI 10.1007/s11661-014-2205-5; Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133; Fan GJ, 2006, ACTA MATER, V54, P1759, DOI 10.1016/j.actamat.2005.11.044; Sekiguchi T, 2010, MATER TRANS, V51, P39, DOI [10.2320/matertrans.MB2009131, 10.2320/matertrans.MB200913]; Zherebtsov SV, 2004, SCRIPTA MATER, V51, P1147, DOI 10.1016/j.scriptamat.2004.08.018; Dirras G, 2010, MAT SCI ENG A-STRUCT, V527, P1206, DOI 10.1016/j.msea.2009.09.050; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/S1359-6454(02)00421-4; Wang YM, 2004, MAT SCI ENG A-STRUCT, V375, P46, DOI 10.1016/j.msea.2003.10.214; Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9; Salishchev GA, 2001, J MATER PROCESS TECH, V116, P265, DOI 10.1016/S0924-0136(01)01037-8; Jin H, 2004, SCRIPTA MATER, V50, P1319, DOI 10.1016/j.scriptamat.2004.02.021; Warwick JLW, 2013, ACTA MATER, V61, P1603, DOI 10.1016/j.actamat.2012.11.037; Mishra RS, 2001, MAT SCI ENG A-STRUCT, V298, P44, DOI 10.1016/S0921-5093(00)01338-1; Sergueeva AV, 2000, SCRIPTA MATER, V43, P819, DOI 10.1016/S1359-6462(00)00496-6; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; WEISS I, 1986, METALL TRANS A, V17, P1935, DOI 10.1007/BF02644991; Nalla RK, 2002, METALL MATER TRANS A, V33, P899, DOI 10.1007/s11661-002-1023-3; Boyer R., 1994, MAT PROPERTIES HDB T, P483; BRODERICK TF, 1985, METALL TRANS A, V16, P1951, DOI 10.1007/BF02662396; Grosdidier T, 2010, J ALLOY COMPD, V504, pS456, DOI 10.1016/j.jallcom.2010.03.035; Kim JY, 2008, MATER TRANS, V49, P215, DOI 10.2320/matertrans.MER2007224; Long Y, 2014, MAT SCI ENG A-STRUCT, V608, P82, DOI 10.1016/j.msea.2014.04.057; Long Y, 2013, MAT SCI ENG A-STRUCT, V585, P408, DOI 10.1016/j.msea.2013.07.078; Peters M., 2003, TITANIUM TITANIUM AL, P1; Sawangrat C, 2014, MATER TRANS, V55, P99, DOI 10.2320/matertrans.MA201303; Sergueeva AV, 2002, MAT SCI ENG A-STRUCT, V323, P318, DOI 10.1016/S0921-5093(01)01384-3; Srinivasarao B, 2008, SCRIPTA MATER, V58, P759, DOI 10.1016/j.scriptamat.2007.12.016; Sutton M. A., 2009, IMAGE CORRELATION SH, P1; Tamirisakandala S, 2004, JOM-US, V56, P60, DOI 10.1007/s11837-004-0131-5; Yamanoglu R, 2011, POWDER METALL, V54, P604, DOI 10.1179/1743290110Y.0000000006; Zgerebtsov S., 2011, ACTA MAT, V59, P4138; Zhang W, 2006, INT J MATER RES, V97, P1143; Zhang Z, 2014, MAT SCI ENG A-STRUCT, V598, P106, DOI 10.1016/j.msea.2014.01.023	44	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	FEB	2015	46A	2					903	914		10.1007/s11661-014-2649-7		12	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AY0RD	WOS:000347303400033		
J	Sato, D; Ohno, M; Matsuura, K				Sato, Daisuke; Ohno, Munekazu; Matsuura, Kiyotaka			Phase-Field Simulations and Analysis of Effect of Dispersed Particles on Migration of Delta to Gamma Transformation Interface	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							PERCENT CARBON-STEEL; GRAIN-GROWTH; PERITECTIC REACTION; DIFFUSION; SOLIDIFICATION; ALLOYS; SYSTEM	Retardation effect of dispersed inert particles on delta-gamma interface migration in carbon steels during isothermal delta to gamma transformation is analyzed by two-dimensional phase-field simulations. The effect is systematically investigated for different values of particle radius, r, particle spacing, l, and initial carbon concentration of delta phase. The retardation effect becomes stronger when the pinning parameter described by r/l (2) is larger and the carbon concentration of delta phase is higher, indicating that delta to gamma transformation kinetics can be retarded in a similar way to the pinning effect on grain growth kinetics.	[Sato, Daisuke] Hokkaido Univ, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Ohno, Munekazu; Matsuura, Kiyotaka] Hokkaido Univ, Fac Engn, Div Mat Sci & Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Ohno, M (reprint author), Hokkaido Univ, Fac Engn, Div Mat Sci & Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	mohno@eng.hokudai.ac.jp	Ohno, Munekazu/A-5222-2012	Ohno, Munekazu/0000-0001-5383-412X			GUSTAFSON P, 1985, SCAND J METALL, V14, P259; MAEHARA Y, 1985, T IRON STEEL I JPN, V25, P1045; Kim SG, 1999, PHYS REV E, V60, P7186, DOI 10.1103/PhysRevE.60.7186; Kim SG, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061605; Steinbach I, 1999, PHYSICA D, V134, P385, DOI 10.1016/S0167-2789(99)00129-3; Suwa Y, 2007, ACTA MATER, V55, P6881, DOI 10.1016/j.actamat.2007.08.045; ZENER C, 1949, J APPL PHYS, V20, P950, DOI 10.1063/1.1698258; Ohno M, 2010, ACTA MATER, V58, P6134, DOI 10.1016/j.actamat.2010.07.031; Ohno M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031603; Ohno M, 2010, ACTA MATER, V58, P5749, DOI 10.1016/j.actamat.2010.06.050; Manohar PA, 1998, ISIJ INT, V38, P913, DOI 10.2355/isijinternational.38.913; Chen L, 2012, ISIJ INT, V52, P434; ELST R, 1988, ACTA METALL MATER, V36, P1723, DOI 10.1016/0001-6160(88)90240-4; Fredriksson H., 1976, Metal Science, V10; Kerr HW, 1996, INT MATER REV, V41, P129; Mastuura K., 1995, ISIJ INT, V35, P183; MATSUURA K, 1993, ISIJ INT, V33, P583, DOI 10.2355/isijinternational.33.583; Ohno M, 2012, ISIJ INT, V52, P1832, DOI 10.2355/isijinternational.52.1832; Schmidt L., 1974, SCAND J METALL, V3, P193; SMITH CS, 1948, T AM I MIN MET ENG, V175, P15; Tsuchiya S, 2010, ISIJ INT, V50, P1959, DOI 10.2355/isijinternational.50.1959; Yin H, 1999, ACTA MATER, V47, P1523, DOI 10.1016/S1359-6454(99)00022-1; Yoshida N., 2004, TETSU HAGANE, V90, P198	23	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	FEB	2015	46A	2					981	988		10.1007/s11661-014-2650-1		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AY0RD	WOS:000347303400039		
J	Shima, Y; Nakanishi, K; Hama, T; Sato, M; Mukaiyama, H; Togawa, H; Tanaka, R; Kaito, H; Nozu, K; Iijima, K; Yoshikawa, N				Shima, Yuko; Nakanishi, Koichi; Hama, Taketsugu; Sato, Masashi; Mukaiyama, Hironobu; Togawa, Hiroko; Tanaka, Ryojiro; Kaito, Hiroshi; Nozu, Kandai; Iijima, Kazumoto; Yoshikawa, Norishige			Biopsy timing and Oxford classification variables in Childhood/Adolescent IgA nephropathy	PEDIATRIC NEPHROLOGY			English	Article						Glomerulosclerosis; Crescents; Correlation; Onset; Diagnosis	CHILDREN	Although the Oxford classification of IgA nephropathy appears valid, we found crescents were significantly related to renal outcome in our cohort, whereas segmental glomerulosclerosis (S) was not. The timing of renal biopsy may significantly affect the variables in the Oxford classification. The relationship between biopsy timing and pathological variables (mesangial hypercellularity score [M], endocapillary hypercellularity [E], S, tubular atrophy/interstitial fibrosis [T], crescents, and global glomerulosclerosis [G]) was analyzed retrospectively in 250 children with IgA nephropathy. The median time from disease onset to renal biopsy was 5.1 months (interquartile range, 2.7-15.4). M (rho = -0.26, P < 0.0001), E (rho = -0.34, P < 0.0001), and crescents (rho = -0.14, P = 0.023) showed significant negative correlations, and S (rho = 0.15, P = 0.018) and G (rho = 0.25, P < 0.0001) showed significant positive correlations with time to biopsy (Spearman test). M, E, and crescents differed significantly in renal biopsies obtained before and after 3 years from onset (Wilcoxon test). Most crescents (92.9 %) were cellular/fibrocellular and were acute lesions. As crescents formed early after disease onset and decreased over time, they may be prognostic for acute phase, but not for chronic phase disease. Renal biopsy timing may alter the significance of variables used in the Oxford classification.	[Shima, Yuko; Nakanishi, Koichi; Hama, Taketsugu; Sato, Masashi; Mukaiyama, Hironobu; Togawa, Hiroko; Yoshikawa, Norishige] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Tanaka, Ryojiro] Kobe Childrens Hosp, Dept Nephrol, Kobe, Hyogo, Japan; [Kaito, Hiroshi; Nozu, Kandai; Iijima, Kazumoto] Kobe Univ, Dept Pediat, Grad Sch Med, Kobe, Hyogo 657, Japan	Nakanishi, K (reprint author), Wakayama Med Univ, Dept Pediat, Wakayama, Japan.	knakanis@wakayama-med.ac.jp					Shima Y, 2012, PEDIATR NEPHROL, V27, P783, DOI 10.1007/s00467-011-2061-0; MURAKAMI M, 1991, PEDIATR NEPHROL, V5, P50; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Katafuchi R, 2011, CLIN J AM SOC NEPHRO, V6, P2806, DOI 10.2215/CJN.02890311; Coppo R, 2010, KIDNEY INT, V77, P921, DOI 10.1038/ki.2010.43; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; YOSHIKAWA N, 1992, NEPHRON, V60, P60; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Alexopoulos E, 2004, KIDNEY INT, V65, P341, DOI 10.1111/j.1523-1755.2004.00437.x; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Murakami M, 2005, KIDNEY INT, V67, pS23, DOI 10.1111/j.1523-1755.2005.09406.x; YOSHIKAWA N, 1987, KIDNEY INT, V32, P585, DOI 10.1038/ki.1987.248; YOSHIKAWA N, 1987, J PEDIATR-US, V110, P555, DOI 10.1016/S0022-3476(87)80547-4	14	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-041X	1432-198X		PEDIATR NEPHROL	Pediatr. Nephrol.	FEB	2015	30	2					293	299		10.1007/s00467-014-2862-z		7	Pediatrics; Urology & Nephrology	Pediatrics; Urology & Nephrology	AY0OG	WOS:000347295200013		
J	Hibino, S; Sasaki, H; Abe, Y; Hojo, A; Uematsu, M; Sekine, T; Itabashi, K				Hibino, Satoshi; Sasaki, Hiroshi; Abe, Yoshifusa; Hojo, Akira; Uematsu, Mitsugu; Sekine, Takashi; Itabashi, Kazuo			Renal function in angiotensinogen gene-mutated renal tubular dysgenesis with glomerular cysts	PEDIATRIC NEPHROLOGY			English	Article						Renal tubular dysgenesis; Angiotensinogen; Rennin-angiotensin system; Nephrogenic diabetes insipidus; Glomerular cysts	CONCENTRATING ABILITY; NEONATAL-PERIOD; MUTATIONS; FETOPATHY; EXPOSURE; SYSTEM; CELL	Inherited renal tubular dysgenesis (RTD) is caused by mutations in the genes encoding the components of the renin-angiotensin system (RAS). RTD is characterized by oligohydramnios, renal failure, neonatal hypocalvaria, and severe hypotension. The histological characteristics, underlying mechanism, and long-term prognosis remain poorly known. We describe here a 4-year-old female with RTD. Endocrinologic analysis showed a discrepancy between low plasma renin activity and high active renin concentration, suggesting a loss of the renin substrate, angiotensinogen (AGT). Direct sequencing revealed a frameshift deletion at nucleotide 1,355 in exon 5 in the AGT gene. Although a histological hallmark is regarded to be the absence or poor development of the proximal tubule, the patient does have minimally impaired function of the proximal tubule. Glomerular cysts without glomerular tufts were noted in approximately half of the glomeruli. The urinary concentrating ability and sodium reabsorption and potassium excretion in the distal nephron were severely affected. The patient has an impaired function of the distal nephron despite minimally affected function of the proximal tubule, probably attributed to renal tubular dysgenesis and fetal hypoperfusion. The renal tubular maturity and the severity of ischemic injury may be key determinants of the clinical symptoms and pathological findings in RTD, in which the RAS plays an important role.	[Hibino, Satoshi; Sasaki, Hiroshi; Abe, Yoshifusa; Hojo, Akira; Itabashi, Kazuo] Showa Univ, Dept Pediat, Sch Med, Shinagawa Ku, Tokyo 1428666, Japan; [Uematsu, Mitsugu] Tohoku Univ, Dept Pediat, Grad Sch Med, Sendai, Miyagi 980, Japan; [Sekine, Takashi] Toho Univ, Dept Pediat, Ohashi Med Ctr, Tokyo, Japan	Hibino, S (reprint author), Showa Univ, Dept Pediat, Sch Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	satohibino@yahoo.co.jp					Chen Y, 2004, J AM SOC NEPHROL, V15, P1232, DOI 10.1097/01.ASN.0000123690.75026.3F; Gubler MC, 2010, KIDNEY INT, V77, P400, DOI 10.1038/ki.2009.423; Gribouval O, 2012, HUM MUTAT, V33, P316, DOI 10.1002/humu.21661; Miura K, 2009, PEDIATR NEPHROL, V24, P1235, DOI 10.1007/s00467-008-1091-8; Quan A, 2006, EARLY HUM DEV, V82, P23, DOI 10.1016/j.earlhumdev.2005.11.001; Tsuchida S, 1998, J CLIN INVEST, V101, P755, DOI 10.1172/JCI1899; Gribouval O, 2005, NAT GENET, V37, P964, DOI 10.1038/ng1623; Danilov SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010438; Guron G, 1999, ACTA PHYSIOL SCAND, V165, P103; Kihara M, 1998, KIDNEY INT, V53, P548, DOI 10.1046/j.1523-1755.1998.00801.x; Laube GF, 2007, ARCH DIS CHILD-FETAL, V92, P402, DOI 10.1136/adc.2006.101717; Martignoni G, 2004, MODERN PATHOL, V17, P1455, DOI 10.1038/modpathol.3800236; Schreiber R, 2010, PEDIATR NEPHROL, V25, P2531, DOI 10.1007/s00467-010-1584-0; Uematsu M, 2006, AM J MED GENET A, V140A, P2355, DOI 10.1002/ajmg.a.31448; Uematsu M, 2009, EUR J PEDIATR, V168, P207, DOI 10.1007/s00431-008-0743-9; Zingg-Schenk A, 2008, EUR J PEDIATR, V167, P311, DOI 10.1007/s00431-007-0492-1	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-041X	1432-198X		PEDIATR NEPHROL	Pediatr. Nephrol.	FEB	2015	30	2					357	360		10.1007/s00467-014-3007-0		4	Pediatrics; Urology & Nephrology	Pediatrics; Urology & Nephrology	AY0OG	WOS:000347295200022		
J	Kikuchi, S; Aosaki, T; Bito, K; Naito, S; Katayama, Y				Kikuchi, S.; Aosaki, T.; Bito, K.; Naito, S.; Katayama, Y.			In vivo evaluation of lateral lipid chain packing in human stratum corneum	SKIN RESEARCH AND TECHNOLOGY			English	Article						Raman spectroscopy; in vivo; intercellular lipids; stratum corneum; lateral lipid chain packing	X-RAY-DIFFRACTION; ELECTRON-DIFFRACTION; ORGANIZATION; SKIN; SPECTROSCOPY; TEMPERATURE; CORNEOCYTE; BARRIER; DOMAINS; MATRIX	Background/aimsThe matrix of intercellular lipids (ICL) of stratum corneum (SC) plays an important role in the barrier function of SC. It is important to understand the structure of the ICL matrix for dermatology and cosmetic science. Several methods exist for the analysis of the structure; however, it is difficult to conduct these analyses noninvasively. MethodsWe have developed a method for the analysis of the lateral packing of ICL using Raman spectroscopy. As a proof-of-principle experiment, we prepared a human SC sheet sample and analyzed its structure by the proposed method and by a conventional method involving X-ray diffraction. We compared the results of both methods. In addition, we applied the proposed method to living human skin, and we analyzed the lateral packing of ICL of SC taken from three separate body sites. ResultsThe results of our method corresponded to those of the conventional method. We detected regional differences of ICL lateral packing using our method in vivo. The results indicated that the packing of ICL in SC taken from the forearm and upper arm are more ordered than that taken from the cheek. ConclusionThe results verify that our developed method allows the evaluation of the lateral packing of ICL inside the SC layer of the skin in vivo. Using this method, we can detect regional differences of SC samples taken from various body sites.	[Aosaki, T.; Katayama, Y.] Kao Corp, Skin Beauty Res Labs, Tokyo, Japan		kikuchi.shou@kao.co.jp					Forster M, 2011, PHARM RES-DORDR, V28, P858, DOI 10.1007/s11095-010-0342-0; WERTZ PW, 1985, J INVEST DERMATOL, V84, P410, DOI 10.1111/1523-1747.ep12265510; Damien F, 2010, J INVEST DERMATOL, V130, P611, DOI 10.1038/jid.2009.272; Vyumvuhore R, 2013, J RAMAN SPECTROSC, V44, P1077, DOI 10.1002/jrs.4334; BOUWSTRA JA, 1992, INT J PHARM, V84, P205, DOI 10.1016/0378-5173(92)90158-X; Caspers PJ, 2001, J INVEST DERMATOL, V116, P434, DOI 10.1046/j.1523-1747.2001.01258.x; KLIGMAN AM, 1963, ARCH DERMATOL, V88, P702; Janssens M, 2013, BBA-BIOMEMBRANES, V1828, P1814, DOI 10.1016/j.bbamem.2013.04.001; ANIGBOGU ANC, 1995, INT J PHARMACEUT, V125, P265, DOI 10.1016/0378-5173(95)00141-5; BOUWSTRA JA, 1991, J INVEST DERMATOL, V97, P1005, DOI 10.1111/1523-1747.ep12492217; Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010; Boncheva M, 2008, BBA-BIOMEMBRANES, V1778, P1344, DOI 10.1016/j.bbamem.2008.01.022; Babita Kumar, 2006, Current Drug Delivery, V3, P95, DOI 10.2174/156720106775197466; ELIAS PM, 1975, J CELL BIOL, V65, P180, DOI 10.1083/jcb.65.1.180; Elias P.M., 1983, J INVEST DERMATOL, V80, P44, DOI DOI 10.1038/JID.1983.12); Hatta I, 2006, BBA-BIOMEMBRANES, V1758, P1830, DOI 10.1016/j.bbamem.2006.08.014; Nakazawa H, 2009, CHEM PHYS LIPIDS, V160, pS47, DOI 10.1016/j.chemphyslip.2009.06.087; Nakazawa H, 2013, BBA-BIOMEMBRANES, V1828, P1424, DOI 10.1016/j.bbamem.2013.02.001; Pilgram GSK, 1999, J INVEST DERMATOL, V113, P403, DOI 10.1046/j.1523-1747.1999.00706.x; Watanabe H, 2010, CHEM PHARM BULL, V58, P312; WERTZ PW, 1987, J INVEST DERMATOL, V89, P419, DOI 10.1111/1523-1747.ep12471781; WHITE SH, 1988, BIOCHEMISTRY-US, V27, P3725, DOI 10.1021/bi00410a031	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-752X	1600-0846		SKIN RES TECHNOL	Skin Res. Technol.	FEB	2015	21	1					76	83		10.1111/srt.12159		8	Dermatology	Dermatology	AY3DS	WOS:000347465300012		
J	Arimoto, H; Egawa, M				Arimoto, H.; Egawa, M.			Imaging wavelength and light penetration depth for water content distribution measurement of skin	SKIN RESEARCH AND TECHNOLOGY			English	Article						stratum corneum; water content; near-infrared; Monte Carlo simulation	NEAR-INFRARED SPECTROSCOPY; HYDRATION; RANGE	Background/purposeWe investigate the measurement sensitivity for the water content distribution in Near-infrared (NIR) imaging ranging up to 2m. MethodsTo evaluate the sensitivity, our attention is focused to the light penetration depth in the skin tissue because the thickness of a layer where the water content can be varied is very thin and deep light penetration decreases the signal variation. The light penetration depths in the wavelengths of 1300, 1450, and 1920nm are calculated theoretically based on the Monte Carlo light transport simulation. ResultsIt is clarified that the wavelength of 1920nm gives the smallest penetration depth. A NIR imaging experiment is demonstrated to verify the difference of imaging sensitivity. The experiment result shows that the NIR image taken at 1920nm gives the most sensitive measurement of the water content distribution in skin.	[Arimoto, H.] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki, Japan; [Egawa, M.] Shiseido Res Ctr, Yokohama, Kanagawa, Japan	Arimoto, H (reprint author), Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, AIST Cent 2, Tsukuba, Ibaraki 3058568, Japan.	arimoto-h@aist.go.jp					Egawa M, 2011, APPL SPECTROSC, V65, P924, DOI 10.1366/11-06251; Arimoto H, 2005, SKIN RES TECHNOL, V11, P27, DOI 10.1111/j.1600-0846.2005.00093.x; Egawa M, 2006, APPL SPECTROSC, V60, P24, DOI 10.1366/000370206775382866; Troy TL, 2001, J BIOMED OPT, V6, P167, DOI 10.1117/1.1344191; Attas EM, 2002, P SOC PHOTO-OPT INS, V4614, P79, DOI 10.1117/12.460783; Attas M, 2002, VIB SPECTROSC, V28, P37, DOI 10.1016/S0924-2031(01)00143-6; Fluhr JW, 1999, SKIN RES TECHNOL, V5, P161, DOI DOI 10.1111/J.1600-0846.1999.TB00126.X); WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Zhang SL, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922347	9	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-752X	1600-0846		SKIN RES TECHNOL	Skin Res. Technol.	FEB	2015	21	1					94	100		10.1111/srt.12163		7	Dermatology	Dermatology	AY3DS	WOS:000347465300015		
J	Ponhong, K; Teshima, N; Grudpan, K; Vichapong, J; Motomizu, S; Sakai, T				Ponhong, Kraingkrai; Teshima, Norio; Grudpan, Kate; Vichapong, Jitlada; Motomizu, Shoji; Sakai, Tadao			Successive determination of urinary bilirubin and creatinine employing simultaneous injection effective mixing flow analysis	TALANTA			English	Article						Simultaneous injection effective mixing; flow analysis; Bilirubin; Creatinine; Urinalysis	SPECTROPHOTOMETRIC DETERMINATION; ANALYSIS SYSTEM; JAFFE REACTION; SAMPLES; SERUM; CHEMILUMINESCENCE; EXTRACTION	A novel four-channel simultaneous injection effective mixing flow analysis (SIEMA) system has been assembled for successive determination of bilirubin and creatinine in urinary samples. The chemical variables and physical parameters in the flow system were optimized for the enhancement of successive analytical performances. The interferences from urine matrices on the determination of bilirubin and creatinine were eliminated to dilute urine samples. The calibration graphs with the optimum conditions were achieved to be in 0.024-5.0 mg L-1 for bilirubin and 2-100 mg L-1 for creatinine. The relative standard deviations (RSDs) at 3 mg L-1 of bilirubin and at 50 mg L-1 of creatinine for 11 runs were 1.5 and 1.0%, respectively. The limits of detections (3 sigma of blank) for bilirubin and creatinine were 714 L-1 and 0.6 mg L-1, respectively. The sample throughput for stepwise detection was 22h(-1). The proposed method was applied to the successive determination of bilirubin and creatinine in urine samples. (C) 2014 Elsevier B.V. All rights reserved.	[Ponhong, Kraingkrai; Teshima, Norio; Vichapong, Jitlada; Sakai, Tadao] Aichi Inst Technol, Dept Appl Chem, Toyota 4700392, Japan; [Ponhong, Kraingkrai; Grudpan, Kate] Chiang Mai Univ, Fac Sci, Dept Chem, Chiang Mai 50200, Thailand; [Ponhong, Kraingkrai; Grudpan, Kate] Chiang Mai Univ, Ctr Excellence Innovat Analyt Sci & Technol, Chiang Mai 50200, Thailand; [Vichapong, Jitlada] Khon Kaen Univ, Dept Chem, Fac Sci, Khon Kaen 4002, Thailand; [Motomizu, Shoji] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Teshima, N (reprint author), Aichi Inst Technol, Dept Appl Chem, 1247 Yachigusa,Yakusa Cho, Toyota 4700392, Japan.	teshima@aitech.ac.jp			Japan Society for the Promotion of Science [26288072]	K.P. and K.G. acknowledge The Thailand Research Found (TRF) for the Royal Golden Jubilee Ph.D. program and Chiang Mai University through the Center of Excellence for Innovation in Analytical Science and Technology. N.T. acknowledges the financial support of this study by Grants-in-Aid for Scientific Research (KAKENHI) No. 26288072 from Japan Society for the Promotion of Science.	Ando S, 2012, BUNSEKI KAGAKU, V61, P115, DOI 10.2116/bunsekikagaku.61.115; Teshima N, 2010, ANAL SCI, V26, P143; Lu C, 2007, ANAL CHIM ACTA, V590, P159, DOI 10.1016/j.aca.2007.03.028; Simerville JA, 2005, AM FAM PHYSICIAN, V71, P1153; DELANGHE J, 1989, CLIN CHEM, V35, P1802; Siangproh W, 2009, TALANTA, V79, P1111, DOI 10.1016/j.talanta.2008.12.068; Ohira SI, 2009, ANAL BIOCHEM, V384, P238, DOI 10.1016/j.ab.2008.10.015; Watla-Iad K, 2007, ANAL CHIM ACTA, V604, P139, DOI 10.1016/j.aca.2007.10.010; HUSDAN H, 1968, CLIN CHEM, V14, P222; NARAYANAN S, 1980, CLIN CHEM, V26, P1119; Ponhong K, 2011, TALANTA, V87, P113, DOI 10.1016/j.talanta.2011.09.048; Falco PC, 2001, TALANTA, V55, P1079; Lee HS, 2007, LUMINESCENCE, V22, P331, DOI 10.1002/bio.967; FERNANDEZROMERO JM, 1993, ANAL CHIM ACTA, V276, P271, DOI 10.1016/0003-2670(93)80394-Z; Grabowska I, 2005, ANAL CHIM ACTA, V540, P181, DOI 10.1016/j.aca.2004.09.021; Jaffe M, 1886, Z PHYSL CHEM, V10, P391; Jendrassik L, 1938, BIOCHEM Z, V297, P81; Kutter D, 2000, CLIN CHIM ACTA, V297, P297, DOI 10.1016/S0009-8981(00)00255-2; Lu C, 2004, TALANTA, V63, P333, DOI [10.1016/j.talanta.2003.10.049, 10.1016/j.talunta.2003.12.049]; Matsudo T, 2001, YAKUGAKU ZASSHI, V121, P191, DOI 10.1248/yakushi.121.191; Parviainen MT, 1997, SCAND J CLIN LAB INV, V57, P275, DOI 10.3109/00365519709060037; Putnam D. F., 1971, CR1802 NASA; Ratanawimarnwong N, 2012, TALANTA, V96, P50, DOI 10.1016/j.talanta.2012.02.027; Ryan D, 2011, ANAL CHIM ACTA, V684, P17, DOI 10.1016/j.aca.2010.10.035; SAKAI T, 1995, ANAL CHIM ACTA, V308, P446, DOI 10.1016/0003-2670(94)00516-O; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Suzuki Y, 1998, ANAL SCI, V14, P609, DOI 10.2116/analsci.14.609; Suzuki Y., 1994, JPN J CLIN CHEM, V23, P158; Tokuda K., 1993, JPN J CLIN CHEM, V22, P116; Tymecki T., 2013, ANAL CHIM ACTA, V787, P118; van Staden J.F., 1983, ANAL CHEM, V315, P141; Vichapong J, 2013, ANAL METHODS-UK, V5, P2419, DOI 10.1039/c3ay40192h; Wang X, 2006, CURR PAEDIAT, V16, P70, DOI 10.1016/j.cupe.2005.10.002; Young J L, 2001, Infect Dis Obstet Gynecol, V9, P249, DOI 10.1155/S1064744901000412	34	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	FEB	2015	133				SI		71	76		10.1016/j.talanta.2014.05.065		6	Chemistry, Analytical	Chemistry	AY6CX	WOS:000347656200012		
J	Guo, S; Ishimatsu, R; Nakano, K; Imato, T				Guo, Shuai; Ishimatsu, Ryoichi; Nakano, Koji; Imato, Toshihiko			Automated chemiluminescence immunoassay for a nonionic surfactant using a recycled spinning-pausing controlled washing procedure on a compact disc-type microfluidic platform	TALANTA			English	Article						Compact disc (CD)-type microfluidic platform; Chemiluminescence immunoassay; Nonionic surfactant; Recycled spinning-pausing washing procedure	PERFORMANCE LIQUID-CHROMATOGRAPHY; LINKED-IMMUNOSORBENT-ASSAY; ALKYLPHENOL POLYETHOXYLATES; PROTEIN ADSORPTION; MASS SPECTROMETRY; POLY(ETHYLENE GLYCOL); WASTE-WATER; LINEAR ALKYLBENZENESULFONATES; POLY(DIMETHYLSILOXANE); POLYDIMETHYLSILOXANE	A fully automated and integrated chemiluminescence immunoassay, carried out on a compact disc (CD)type microfluidic platform, for the detection of alkylphenol polyethoxylates (APnEOs) is described. The pattern of the CD-type microchip was designed so as to permit the sequential solution delivery of the sample solution, the washing solution and the luminol solution, which are required in the chemiluminescence immunoassay process, along with a designed rotation program for spinning the CD-type microchip. The procedure for flowing the washing solution, the volume of which was limited on the CD-type microchip, was optimized by using a recycled spinning-pausing rotation program to overcome the non-specific adsorption of the horseradish peroxidase labeled APnEO5 at the detection area. The detection limit of the immunoassay is about 10 ppb. (C) 2014 Elsevier B.V. All rights reserved.	[Guo, Shuai; Ishimatsu, Ryoichi; Nakano, Koji; Imato, Toshihiko] Kyushu Univ, Dept Appl Chem, Grad Sch Engn, Fukuoka 812, Japan	Imato, T (reprint author), Kyushu Univ, Dept Appl Chem, Grad Sch Engn, Fukuoka 812, Japan.	imato@cstf.kyush-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society of Promotion of the Science (ISPS) [25288065]	The authors wish to acknowledge financial supports from the Global CUE Program "Science for Future Molecular Systems" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and from the Japan Society of Promotion of the Science (ISPS, Grant no. 25288065).	Andreu V, 2007, SCI TOTAL ENVIRON, V378, P124, DOI 10.1016/j.scitotenv.2007.01.024; Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068; Zhang Q, 2008, LAB CHIP, V8, P352, DOI 10.1039/b716295m; Alauzun JG, 2010, BIOMATERIALS, V31, P3471, DOI 10.1016/j.biomaterials.2010.01.069; Morais S, 2007, ANAL CHEM, V79, P7628, DOI 10.1021/ac070328b; Zhang RQ, 2007, ANAL CHIM ACTA, V600, P105, DOI 10.1016/j.aca.2007.02.052; Tu Q, 2013, COLLOID SURFACE B, V102, P361, DOI 10.1016/j.colsurfb.2012.08.033; Sugiura S, 2008, COLLOID SURFACE B, V63, P301, DOI 10.1016/j.colsurfb.2007.12.013; SCHEMBRI CT, 1995, J AUTOM CHEM, V17, P99, DOI 10.1155/S1463924695000174; Yeh PY, 2012, LANGMUIR, V28, P16227, DOI 10.1021/la303196m; Goda T, 2008, COLLOID SURFACE B, V63, P64, DOI 10.1016/j.colsurfb.2007.11.014; Lara-Martin PA, 2006, J CHROMATOGR A, V1137, P188, DOI 10.1016/j.chroma.2006.10.009; Lai S, 2004, ANAL CHEM, V76, P1832, DOI 10.1021/ac0348322; Carneiro LB, 2011, APPL SURF SCI, V257, P10514, DOI 10.1016/j.apsusc.2011.07.031; Zilio C, 2014, BIOMED MICRODEVICES, V16, P107, DOI 10.1007/s10544-013-9810-8; Bhushan B, 2006, J VAC SCI TECHNOL A, V24, P1197, DOI 10.1116/1.2167077; Badr IHA, 2002, ANAL CHEM, V74, P5569, DOI 10.1021/ac025690z; Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046; Zhou JH, 2009, ANAL CHEM, V81, P6627, DOI 10.1021/ac900551m; Wu ZG, 2009, LAB CHIP, V9, P1500, DOI 10.1039/b901651a; Chen H, 2004, BIOMATERIALS, V25, P2273, DOI 10.1016/j.biomaterials.2003.09.023; Zhao XT, 2014, J MEMBRANE SCI, V450, P111, DOI 10.1016/j.memsci.2013.08.044; Wu ZQ, 2012, COLLOID SURFACE B, V96, P37, DOI 10.1016/j.colsurfb.2012.03.016; Farrell M, 2010, COLLOID SURFACE B, V81, P468, DOI 10.1016/j.colsurfb.2010.07.059; Espejo R, 2002, J CHROMATOGR A, V976, P335, DOI 10.1016/S0021-9673(02)01229-3; Bai HJ, 2009, LANGMUIR, V25, P10402, DOI 10.1021/la900944c; BANERJEE S, 1985, ANAL CHEM, V57, P2590, DOI 10.1021/ac00290a036; Cantero M, 2004, J CHROMATOGR A, V1046, P147, DOI 10.1016/j.chroma.2004.06.073; Cheng CY, 2006, J CHROMATOGR A, V1127, P246, DOI 10.1016/j.chroma.2006.05.096; Fan DH, 2010, COLLOID SURFACE B, V75, P608, DOI 10.1016/j.colsurfb.2009.10.015; Geissler A, 2010, PLASMA PROCESS POLYM, V7, P64, DOI 10.1002/ppap.200900098; Goda Y, 2004, WATER RES, V38, P4323, DOI 10.1016/j.watres.2004.07.030; Guo S, 2012, PURE APPL CHEM, V84, P2027, DOI 10.1351/PAC-CON-11-10-10; Holczer E, 2013, MATER SCI FORUM, V729, P361, DOI 10.4028/www.scientific.net/MSF.729.361; Ishihara K., 2007, NANOBIOTECHNOLOGY, V3, P83, DOI 10.1007/s12030-008-9006-0; Koh YKK, 2008, CHEMOSPHERE, V73, P551, DOI 10.1016/j.chemosphere.2008.06.016; Lin WF, 2011, ACTA BIOMATER, V7, P2053, DOI 10.1016/j.actbio.2011.02.001; Liu JF, 2003, J SEP SCI, V26, P823, DOI 10.1002/jssc.200301455; Madou M, 2000, CHEM REV, V100, P2679, DOI 10.1021/cr980098o; MARCOMINI A, 1987, ANAL CHEM, V59, P1709, DOI 10.1021/ac00140a027; MARCOMINI A, 1987, J CHROMATOGR, V403, P243, DOI 10.1016/S0021-9673(00)96358-1; Puckett LG, 2004, ANAL CHEM, V76, P7263, DOI 10.1021/ac049758h; Smet N. D., 2009, J BIOMAT SCI-POLYM E, V20, P2039; Takasu T, 2002, ANAL BIOANAL CHEM, V372, P554, DOI 10.1007/s00216-001-1135-4; Tugulu T., 2009, MACROMOL S, V279, P103; Wang AJ, 2007, J CHROMATOGR A, V1147, P120, DOI 10.1016/j.chroma.2007.02.030; Yang LY, 2010, ANAL CHEM, V82, P6430, DOI 10.1021/ac100544x; Zhang ZW, 2013, ANAL METHODS-UK, V5, P4694, DOI 10.1039/c3ay40494c	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	FEB	2015	133				SI		100	106		10.1016/j.talanta.2014.06.075		7	Chemistry, Analytical	Chemistry	AY6CX	WOS:000347656200017		
J	Matsuda, O; Larciprete, MC; Li Voti, R; Wright, OB				Matsuda, Osamu; Larciprete, Maria Cristina; Li Voti, Roberto; Wright, Oliver B.			Fundamentals of picosecond laser ultrasonics	ULTRASONICS			English	Article						Optical pump-probe technique; Gigahertz and terahertz acoustic waves; Longitudinal and shear acoustic waves; Interferometer; Green's function	COHERENT ACOUSTIC PHONONS; OPTICAL-GENERATION; TRANSPARENT FILMS; QUANTUM-WELLS; LIGHT; INTERFEROMETRY; WAVES; TRANSMISSION; PROPAGATION; PULSES	The aim of this article is to provide an introduction to picosecond laser ultrasonics, a means by which gigahertz-terahertz ultrasonic waves can be generated and detected by ultrashort light pulses. This method can be used to characterize materials with nanometer spatial resolution. With reference to key experiments, we first review the theoretical background for normal-incidence optical detection of longitudinal acoustic waves in opaque single-layer isotropic thin films. The theory is extended to handle isotropic multilayer samples, and is again compared to experiment. We then review applications to anisotropic samples, including oblique-incidence optical probing, and treat the generation and detection of shear waves. Solids including metals and semiconductors are mainly discussed, although liquids are briefly mentioned. (C) 2014 Elsevier B.V. All rights reserved.	[Matsuda, Osamu; Wright, Oliver B.] Hokkaido Univ, Fac Engn, Div Appl Phys, Sapporo, Hokkaido 0608628, Japan; [Larciprete, Maria Cristina; Li Voti, Roberto] Univ Roma La Sapienza, Dipartimento Sci Base & Appl Ingn, I-00161 Rome, Italy	Matsuda, O (reprint author), Hokkaido Univ, Fac Engn, Div Appl Phys, Sapporo, Hokkaido 0608628, Japan.	omatsuda@eng.hokudai.ac.jp	Li Voti, Roberto/P-5265-2014; 	Li Voti, Roberto/0000-0002-1849-2950; Larciprete, Maria Cristina/0000-0002-7876-628X			Abeles F., 1967, Advanced Optical Techniques; Akimov AV, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.033902; Akimov AV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.037401; Akmanov S.A., 1992, SOV PHYS USP, V35, P153; WRIGHT OB, 1992, PHYS REV LETT, V69, P1668, DOI 10.1103/PhysRevLett.69.1668; MARADUDIN AA, 1975, PHYS REV B, V11, P1392, DOI 10.1103/PhysRevB.11.1392; Tachizaki T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194518; Matsuda O, 2002, J OPT SOC AM B, V19, P3028, DOI 10.1364/JOSAB.19.003028; Wright OB, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024303; Saito T, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.205421; Scalora M, 1998, J APPL PHYS, V83, P2377, DOI 10.1063/1.366996; Sun CK, 2000, PHYS REV LETT, V84, P179, DOI 10.1103/PhysRevLett.84.179; Chigarev NV, 2000, PHYS REV B, V61, P15837, DOI 10.1103/PhysRevB.61.15837; THOMSEN C, 1986, PHYS REV B, V34, P4129, DOI 10.1103/PhysRevB.34.4129; WRIGHT OB, 1995, APPL PHYS LETT, V66, P1190, DOI 10.1063/1.113853; Singhsomroje W, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.174303; Muskens OL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.035503; LIN HN, 1991, J APPL PHYS, V69, P3816, DOI 10.1063/1.348958; WRIGHT OB, 1994, PHYS REV B, V49, P9985, DOI 10.1103/PhysRevB.49.9985; van Capel PJS, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2195098; Hurley DH, 1999, OPT LETT, V24, P1305, DOI 10.1364/OL.24.001305; TAS G, 1994, PHYS REV B, V49, P15046, DOI 10.1103/PhysRevB.49.15046; Rossignol C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.166106; Daly BC, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214307; Sarto MS, 2005, IEEE T ELECTROMAGN C, V47, P602, DOI 10.1109/TEMC.2005.853214; Matsuda O, 2013, J OPT SOC AM B, V30, P1911, DOI 10.1364/JOSAB.30.001911; Hao HY, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.064302; Mizoguchi K, 1999, PHYS REV B, V60, P8262, DOI 10.1103/PhysRevB.60.8262; Audoin B, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.214304; Babilotte P, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3501125; BASSERAS P, 1994, J APPL PHYS, V75, P2761; Born M., 1999, PRINCIPLES OPTICS; Chern GW, 2004, J APPL PHYS, V95, P1114, DOI 10.1063/1.1637957; Dehoux T, 2010, ULTRASONICS, V50, P197, DOI 10.1016/j.ultras.2009.08.008; Dehoux T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235409; FELDMAN A, 1982, J APPL PHYS, V53, P1477, DOI 10.1063/1.330645; Grimsditch M., 2001, HDB ELASTIC PROPERTI, VI, P331; Gusev V. E., 1993, LASER OPTOACOUSTICS; Gusev V, 1996, ACUSTICA, V82, pS37; Kashiwada S, 2006, J APPL PHYS, V100, DOI 10.1063/1.2353125; Kent AJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.215504; Landau L., 1982, MECHANICS, V1; Lin KH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358321; Lin KH, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.073307; Matsuda O, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224110; Matsuda O., 2000, ANAL SCI, V17, ps216; Matsuda O, 2003, REV SCI INSTRUM, V74, P895, DOI 10.1063/1.1519679; Mechri C, 2007, J PHYS CONF SER, V92, DOI 10.1088/1742-6596/92/1/012030; Mizunuma E., 2005, THESIS HOKKAIDO U; Mounier D, 2010, OPT EXPRESS, V18, P6767, DOI 10.1364/OE.18.006767; Nowacki W., 1962, THERMOELASTICITY; Nye J. F., 1957, PHYS PROPERTIES CRYS; Ozgur U, 2001, PHYS REV LETT, V86, P5604, DOI 10.1103/PhysRevLett.86.5604; Perrin B., 1996, PROG NATURAL SCI S, VS6, P444; Perrin B, 2007, TOP APPL PHYS, V107, P333; Pezeril T, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.174307; Pezeril T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.132301; Pezeril T, 2005, J PHYS D APPL PHYS, V38, P1421, DOI 10.1088/0022-3727/38/9/015; Pu NW, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115428; Tomoda M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2432238; Wen YC, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2731441; Winter MFP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.265501; Wright O. B., 2001, PHYS REV B, V64; WRIGHT OB, 1992, JPN J APPL PHYS 1, V31, P85; WRIGHT OB, 1995, OPT LETT, V20, P632, DOI 10.1364/OL.20.000632; WRIGHT OB, 1992, J APPL PHYS, V71, P1617, DOI 10.1063/1.351218; WRIGHT OB, 1995, IEEE T ULTRASON FERR, V42, P331, DOI 10.1109/58.384440; Yahng JS, 2002, APPL PHYS LETT, V80, P4723, DOI 10.1063/1.1488693; YAMAMOTO A, 1994, PHYS REV LETT, V73, P740, DOI 10.1103/PhysRevLett.73.740; Yariv A., 1984, OPTICAL WAVES CRYSTA	70	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0041-624X	1874-9968		ULTRASONICS	Ultrasonics	FEB	2015	56						3	20		10.1016/j.ultras.2014.06.005		18	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AU1MY	WOS:000345386000002		
J	Kundu, T; Yang, X; Nakatani, H; Takeda, N				Kundu, T.; Yang, X.; Nakatani, H.; Takeda, N.			A two-step hybrid technique for accurately localizing acoustic source in anisotropic structures without knowing their material properties	ULTRASONICS			English	Article						Acoustic source localization; Acoustic emission; Anisotropic plate	SOURCE LOCALIZATION; LOCATING POINT; IMPACT; PLATES; EMISSION	Acoustic source localization techniques generally assume straight line propagation of waves from the acoustic source to the sensor. However, it is well-known that in anisotropic plates the acoustic energy does not always propagate in straight lines. Even for isotropic plates containing a cavity or an inclusion between the acoustic source and the sensor the straight line propagation assumption is violated. In such cases only options available in localizing acoustic source is to use relatively expensive distributed sensor systems, or to follow time reversal techniques based on the impulse response functions which is labor intensive and computationally demanding. A two-step hybrid technique is proposed in this paper for predicting acoustic source in anisotropic plates. During the first step it was assumed that the waves propagated along straight lines from the acoustic source to the sensor. The source was localized with this simplifying assumption. Then this first prediction was improved in the second step by solving an optimization problem. Experimental results showed that the second step always moved the estimates towards the actual source location. Thus it always reduced the prediction error irrespective of whether the final prediction coincided with the actual source location or not. (C) 2014 Elsevier B.V. All rights reserved.	[Kundu, T.] Univ Arizona, Dept Civil Engn & Engn Mech, Tucson, AZ 85721 USA; [Yang, X.] Sichuan Univ, Coll Water Resource & Hydropower, State Key Lab Hydraul & Mt River Engn, Chengdu 610065, Peoples R China; [Nakatani, H.] Osaka City Univ, Grad Sch Engn, Dept Mech & Phys Engn, Osaka 5588585, Japan; [Takeda, N.] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan	Kundu, T (reprint author), Univ Arizona, Dept Civil Engn & Engn Mech, Tucson, AZ 85721 USA.	tkundu@email.arizona.edu; sherryjjscu@gmail.com; hayatonakatani@imat.eng.osaka-cu.ac.jp; takeda@smart.k.u-tokyo.ac.jp			National Science Foundation [CMMI 1044018]	Authors are thankful to Dr. Ito of the University of Tokyo for letting them use his acoustic emission equipment. Partial financial support from the National Science Foundation (Grant Number CMMI 1044018) to the first author is also gratefully acknowledged.	Ciampa F, 2010, COMPOS PART A-APPL S, V41, P1777, DOI 10.1016/j.compositesa.2010.08.013; Kundu T, 2014, ULTRASONICS, V54, P25, DOI 10.1016/j.ultras.2013.06.009; Hajzargerbashi T, 2011, ULTRASONICS, V51, P317, DOI 10.1016/j.ultras.2010.10.005; NELDER JA, 1965, COMPUT J, V7, P308; Kundu T, 2008, ULTRASONICS, V48, P193, DOI 10.1016/j.ultras.2007.12.001; Nakatani H, 2014, ULTRASONICS, V54, P1776, DOI 10.1016/j.ultras.2014.03.001; Kundu T, 2012, ULTRASONICS, V52, P740, DOI 10.1016/j.ultras.2012.01.017; Baxter MG, 2007, MECH SYST SIGNAL PR, V21, P1512, DOI 10.1016/j.ymssp.2006.05.003; Ciampa F, 2012, STRUCT HEALTH MONIT, V11, P643, DOI 10.1177/1475921712451951; Barricelli N. A., 1957, METHODS, V9, P143; Fraser A., 1970, COMPUTER MODELS GENE; Koabaz M, 2012, STRUCT HEALTH MONIT, V11, P315, DOI 10.1177/1475921711419991; Kundu T, 2007, J ACOUST SOC AM, V122, P2057, DOI 10.1121/1.2775322; Kundu T., 2012, 6 EUR WORKSH STRUCT; Kundu T, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/3/035006; Nakatani H., 2013, P 9 INT WORKSH STRUC; Nakatani H, 2013, KEY ENG MATER, V558, P331, DOI 10.4028/www.scientific.net/KEM.558.331; Xiao DH, 2014, ULTRASONICS, V54, P737, DOI 10.1016/j.ultras.2013.09.020	18	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0041-624X	1874-9968		ULTRASONICS	Ultrasonics	FEB	2015	56						271	278		10.1016/j.ultras.2014.08.009		8	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AU1MY	WOS:000345386000030		
J	Islam, MN; Arai, Y; Araki, W				Islam, Md Nurul; Arai, Yoshio; Araki, Wakako			Use of ultrasonic back-reflection intensity for predicting the onset of crack growth due to low-cycle fatigue in stainless steel under block loading	ULTRASONICS			English	Article						Block load; Ultrasonic attenuation; Crack growth; Prediction method	ELECTROMAGNETIC ACOUSTIC-RESONANCE; ROTATING BENDING FATIGUE; INTERNAL-FRICTION; ATTENUATION PEAK; DAMAGE; DISLOCATIONS; CONSTANT; SPECTRA	The present study proposes the use of ultrasonic back-reflected waves for evaluating low cycle fatigue crack growth from persistent slip bands (PSBs) of stainless steel under block loading. Fatigue under high-low block loading changes the back-reflected intensity of the ultrasonic wave that emanates from the surface. Measuring the change in ultrasonic intensity can predict the start of crack growth with reasonable accuracy. The present study also proposes a modified constant cumulative plastic strain method and a PSB damage evolution model to predict the onset of crack growth under block loads. (C) 2014 Elsevier B.V. All rights reserved.	[Islam, Md Nurul] Rajshahi Univ Engn & Technol, Dept Mech Engn, Rajshahi 6204, Bangladesh; [Arai, Yoshio; Araki, Wakako] Saitama Univ, Dept Mech Engn, Saitama, Japan	Islam, MN (reprint author), Rajshahi Univ Engn & Technol, Dept Mech Engn, Rajshahi 6204, Bangladesh.	nurul93213@yahoo.com			Ministry of Education, Science, Sports, and Culture, of the Government of Japan; Tokyo Electric Power Company; Hokkaido Electric Power Co., Inc.; Tohoku Electric Power Co., Inc.; Chubu Electric Power Co., Inc.; Hokuriku Electric Power Company; Kansai Electric Power Co., Inc.; Chugoku Electric Power Co., Inc.; Shikoku Electric Power Co., Inc.; Kyusyu Electric Power Co., Inc.; Japan Atomic Power Company; Electric Power Development Co., Ltd.	The authors express gratitude to the Ministry of Education, Science, Sports, and Culture, of the Government of Japan for providing financial support during this research work and also to the LCF committee in The Japan Welding Engineering Society supported by Tokyo Electric Power Company, Hokkaido Electric Power Co., Inc., Tohoku Electric Power Co., Inc., Chubu Electric Power Co., Inc., Hokuriku Electric Power Company, The Kansai Electric Power Co., Inc., The Chugoku Electric Power Co., Inc., Shikoku Electric Power Co., Inc., Kyusyu Electric Power Co., Inc., The Japan Atomic Power Company and Electric Power Development Co., Ltd.	[Anonymous], 2002, G4304 JIS; GRANATO A, 1956, J APPL PHYS, V27, P583, DOI 10.1063/1.1722436; Taheri F, 2003, MAR STRUCT, V16, P69, DOI 10.1016/S0951-8339(02)00004-7; Zhang YH, 2009, INT J FATIGUE, V31, P138, DOI 10.1016/j.ijfatigue.2008.04.006; Schijve J, 2003, INT J FATIGUE, V25, P679, DOI 10.1016/S0142-1123(03)00051-3; Hirao M, 2000, ACTA MATER, V48, P517, DOI 10.1016/S1359-6454(99)00346-8; GRANATO A, 1956, J APPL PHYS, V27, P789, DOI 10.1063/1.1722485; Ohtani T, 2000, J ALLOY COMPD, V310, P440, DOI 10.1016/S0925-8388(00)00956-7; Mikheevskiy S, 2009, INT J FATIGUE, V31, P1828, DOI 10.1016/j.ijfatigue.2009.02.035; Bailat C, 2000, J NUCL MATER, V276, P283, DOI 10.1016/S0022-3115(99)00222-6; CHRIST HJ, 1995, MAT SCI ENG A-STRUCT, V201, P1, DOI 10.1016/0921-5093(95)09782-1; Freudenthal A.M., 1956, INT C FAT AIRCR STRU, P146; Hirao M, 1997, ULTRASONICS, V35, P413, DOI 10.1016/S0041-624X(97)00030-9; Islam M.N., 2012, MAT SCI ENG A-STRUCT, V556, P309; Islam MN, 2009, MAT SCI ENG A-STRUCT, V520, P49, DOI 10.1016/j.msea.2009.05.016; Islam M.N., 2010, J SOLID MECH MAT ENG, V4, P376; Jono M, 2005, INT J FATIGUE, V27, P1006, DOI 10.1016/j.ijfatigue.2004.09.011; Kenderian S, 2003, MAT SCI ENG A-STRUCT, V348, P90, DOI 10.1016/S0921-5093(02)00636-6; Koehler J. S., 1952, IMPERFECTIONS NEARLY, P197; McEvily AJ, 2005, INT J FATIGUE, V27, P862, DOI 10.1016/j.ijfatigue.2005.04.001; Miner MA, 1945, J APPL MECH, V12, P159; Obrtlik K, 2005, J NUCL MATER, V342, P35, DOI 10.1016/j.jnucmat.2005.03.010; Ogi H, 2000, METALL MATER TRANS A, V31, P1121, DOI 10.1007/s11661-000-0107-1; Ogi H, 2000, J ALLOY COMPD, V310, P436, DOI 10.1016/S0925-8388(00)01020-3; Ohtani T., 2001, T JAPANESE SOC MEC A, V67, P454; WOLFENDEN A, 1983, SCRIPTA METALL MATER, V17, P321, DOI 10.1016/0036-9748(83)90166-7	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0041-624X	1874-9968		ULTRASONICS	Ultrasonics	FEB	2015	56						354	360		10.1016/j.ultras.2014.09.001		7	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AU1MY	WOS:000345386000041		
J	Pavuluri, CM; Kawamura, K; Swaminathan, T				Pavuluri, Chandra Mouli; Kawamura, Kimitaka; Swaminathan, T.			Time-resolved distributions of bulk parameters, diacids, ketoacids and alpha-dicarbonyls and stable carbon and nitrogen isotope ratios of TC and TN in tropical Indian aerosols: Influence of land/sea breeze and secondary processes	ATMOSPHERIC RESEARCH			English	Article						Bulk parameters; Diacids; Stable isotope ratios; Time-resolved distributions; Tropical coastal Indian aerosols	SULFUR-DIOXIDE EMISSIONS; DICARBOXYLIC-ACIDS; ATMOSPHERIC AEROSOLS; ORGANIC AEROSOL; SOUTHEAST-ASIA; AIR-POLLUTION; SEA-BREEZE; COMBUSTION; PARTICLES; INVENTORY	To better understand the photochemical production and diurnal distributions of organic and inorganic aerosols in the tropical coastal Indian atmosphere, the aerosol (TSP) samples were collected every 3 h during 30-31 January, 14-15 February and 28-29 May 2007 from Chennai and studied for total carbon (TC) and nitrogen (TN) and their stable isotope ratios (delta C-13(TC) and delta N-15(TN)), carbonaceous components, inorganic ions, diacids, ketoacids and alpha-dicarbonyls. Time-resolved distributions of bulk parameters, inorganic ions, and diacids and related compounds, except for few species, did not show any clear diurnal trend but showed peaks at 6-9 h during all the study periods, except for the peak at 15-18 h on 28 May. SO42-, C-2 - C-6 diacids, ketoacids and alpha-dicarbonyls in February and on 29 May showed a diurnal trend. delta C-13(TC) and delta N-15(TN) stayed relatively constant during the study periods but showed C-13 depletion (in January) and N-15 enrichment when TC and TN peaked. Based on these results together with air mass trajectories, we found that the diurnal distributions of Chennai aerosols are mainly influenced by land/sea breeze and the aged (photochemically processed) air masses, although in situ photochemical production and nighttime chemistry of secondary aerosol species, particularly C-2-C-4 diacids and SO42-, are significant. The characteristics of seasonal variations of carbonaceous components, and diacids and related compounds and comparisons of delta C-13(TC) and delta N-15(TN) of Chennai aerosols with the isotopic signatures of the point sources inferred that biofuel/biomass burning in South and Southeast Asia are the major sources of aerosols (TSP). (C) 2014 Elsevier B.V. All rights reserved.	[Pavuluri, Chandra Mouli; Kawamura, Kimitaka] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Swaminathan, T.] Indian Inst Technol, Dept Chem Engn, Madras 600036, Tamil Nadu, India	Pavuluri, CM (reprint author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	cmpavuluri@pop.lowtem.hokudai.ac.jp	Kawamura, Kimitaka/B-3839-2011		Japan Society for the Promotion of Science (JSPS) [19204055, 24221001]; Ministry of the Environment, Japan [B903]	This study was partly supported by Grant-in-aid Nos. 19204055 and 24221001 from the Japan Society for the Promotion of Science (JSPS), Japan and the Environment and Technology Development fund (B903) of the Ministry of the Environment, Japan. We appreciate the financial support of a JSPS Fellowship to C. M. P. We also thank R. A. Damodar and K. Jagannathan for their support in the sample collection, and E. Tachibana for isotope analysis. The authors acknowledge the NOAA Air Resources Laboratory (ARL) for the provision of the HYSPLIT transport and dispersion model and/or READY website (http://www.ready.noaa.gov) used in this publication.	Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Rudich Y, 2007, ANNU REV PHYS CHEM, V58, P321, DOI 10.1146/annurev.physchem.58.032806.104432; Bardouki H, 2003, ATMOS ENVIRON, V37, P195, DOI 10.1016/S1352-2310(02)00859-2; LU R, 1994, J ATMOS SCI, V51, P2285, DOI 10.1175/1520-0469(1994)051<2285:APTIAC>2.0.CO;2; Poschl U, 2005, ANGEW CHEM INT EDIT, V44, P7520, DOI 10.1002/anie.200501122; Lim YB, 2010, ATMOS CHEM PHYS, V10, P10521, DOI 10.5194/acp-10-10521-2010; Lelieveld J, 2001, SCIENCE, V291, P1031, DOI 10.1126/science.1057103; Kawamura K, 1996, ATMOS ENVIRON, V30, P1709, DOI 10.1016/1352-2310(95)00395-9; Kawamura K, 2005, ATMOS ENVIRON, V39, P1945, DOI 10.1016/j.atmosenv.2004.12.014; Reddy MS, 2002, ATMOS ENVIRON, V36, P677, DOI 10.1016/S1352-2310(01)00463-0; Simoneit BRT, 2002, APPL GEOCHEM, V17, P129, DOI 10.1016/S0883-2927(01)00061-0; Rengarajan R, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008150; KAWAMURA K, 1993, ANAL CHEM, V65, P3505, DOI 10.1021/ac00071a030; Fu PQ, 2010, ATMOS CHEM PHYS, V10, P2663; Kawamura K, 1999, J GEOPHYS RES-ATMOS, V104, P3501, DOI 10.1029/1998JD100041; KAWAMURA K, 1993, ENVIRON SCI TECHNOL, V27, P2227, DOI 10.1021/es00047a033; KAWAMURA K, 1987, ENVIRON SCI TECHNOL, V21, P105, DOI 10.1021/es00155a014; Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; Pulikesi M, 2006, J HAZARD MATER, V137, P1554, DOI 10.1016/j.jhazmat.2006.04.040; Turpin BJ, 2000, ATMOS ENVIRON, V34, P2983, DOI 10.1016/S1352-2310(99)00501-4; Chowdhury Z, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008386; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Aggarwal SG, 2013, ATMOS CHEM PHYS, V13, P4667, DOI 10.5194/acp-13-4667-2013; Pavuluri CM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012661; Reddy MS, 2002, ATMOS ENVIRON, V36, P699, DOI 10.1016/S1352-2310(01)00464-2; Turekian VC, 1998, CHEM GEOL, V152, P181, DOI 10.1016/S0009-2541(98)00105-3; Carrico CM, 2003, ATMOS ENVIRON, V37, P2811, DOI 10.1016/S1352-2310(03)00197-3; Widory D, 2007, ATMOS ENVIRON, V41, P2382, DOI 10.1016/j.atmosenv.2006.11.009; Srimuruganandam B, 2011, ATMOS ENVIRON, V45, P3091, DOI 10.1016/j.atmosenv.2011.03.014; Pavuluri CM, 2010, ATMOS ENVIRON, V44, P3597, DOI 10.1016/j.atmosenv.2010.05.039; Martinelli LA, 2002, ATMOS ENVIRON, V36, P2427, DOI 10.1016/S1352-2310(01)00454-X; Draxler R. R., 2012, HYSPLIT HYBRID SINGL; Garg A, 2001, ATMOS ENVIRON, V35, P2679, DOI 10.1016/S1352-2310(00)00414-3; Kawamura K, 2010, ATMOS ENVIRON, V44, P5320, DOI 10.1016/j.atmosenv.2010.09.016; Kundu S., 2010, J GEOPHYS RES ATMOS, V115; Miller S.T.K., 2003, REV GEOPHYS, V41; Miyazaki Y, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011790; Pavuluri CM, 2012, ATMOS ENVIRON, V62, P622, DOI 10.1016/j.atmosenv.2012.08.063; Pavuluri CM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015617; Srinivas CV, 2006, J EARTH SYST SCI, V115, P557, DOI 10.1007/BF02702909; Streets DG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003093; Venkatesan R, 2009, ATMOS RES, V92, P505, DOI 10.1016/j.atmosres.2009.02.005; Widory D, 2004, ATMOS ENVIRON, V38, P953, DOI 10.1016/j.atmosenv.2003.11.001; Yang H, 2004, ENVIRON CHEM, V1, P13, DOI 10.1071/EN04006	44	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0169-8095	1873-2895		ATMOS RES	Atmos. Res.	FEB	2015	153						188	199		10.1016/j.atmosres.2014.08.011		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AY0CD	WOS:000347264600015		
J	Lu, SL; Liu, DY; Zhang, WC; Liu, PW; Fei, Y; Gu, Y; Wu, MH; Yu, S; Yonemochi, S; Wang, XJ; Wang, QY				Lu, Senlin; Liu, Dingyu; Zhang, Wenchao; Liu, Pinwei; Fei, Yi; Gu, Yan; Wu, Minghong; Yu, Shang; Yonemochi, Shinich; Wang, Xiaoju; Wang, Qingyue			Physico-chemical characterization of PM2.5 in the microenvironment of Shanghai subway	ATMOSPHERIC RESEARCH			English	Article						Shanghai subway system; PM2.5; Physicochemcial characterization	ATMOSPHERIC PARTICULATE MATTER; AEROSOL-PARTICLES; IRON; SPECIATION; AIRBORNE; FINE; STATIONS; SYSTEM; XANES; DUST	The Shanghai subway metro system has brought great convenience to the city's travelling public, although passengers are exposed to airborne particles in this built micro-environment. However, investigations on the physicochemical characterization of PM2.5 air pollution in the Shanghai subway system are to date very limited. Three subway stations along the No. 7 line were selected as subway PM2.5 monitoring sites: Pan'guang, Shanghai University (SHU), and Jing'an, which are located in an outer suburban area, a suburban area and the urban area, respectively, airborne PM2.5 on the subway station platforms and in the ambient atmosphere above-ground was synchronously collected from 19th March to 4th, May, 2012. Cutting-edge techniques, including scanning electronic microscopy coupled with energy dispersive X-ray (SEM/EDX), inductively coupled plasma mass spectrometry (ICP-MS) and X-ray absorption near-edge structure (XANES) were employed to investigate microscopic characterization, chemical elements and speciation of the main heavy metals in subway PM2.5. Our results demonstrated that mass levels of PM2.5 in the subway stations were higher than that in ambient air. Mass levels of PM 25 in the subway stations and in ambient air ranged from 49.17 +/- 19.7 mu g/m(3) to 66.15 +/- 25.20 mu g/m(3), and 24.52 +/- 3.3 mu g/m(3) to 65.60 +/- 5.6 mu g/m(3), respectively. The microscopic characterization of PM2.5 in ambient air and in subway stations showed marked differences. The PM2.5 in the subway stations was mainly composed of iron-containing particles and mineral particles, while the PM2.5 in ambient air largely consisted of mineral particles and soot aggregates. Fe was the most abundant element in subway PM2.5, followed by: major elements (mass level > 100 ng/m(3)) including Na, Mg, Al, K, Ca, Zn, Mn, Ba; sub-major elements (10 ng/m(3) < mass level < 100 ng/m(3)) including Li, Cr, Ni,Cu, Ga, Sr, Pb; and minor elements (mass level < 10 ng/m(3)), Be, V, As, Se, Rb, Ag, Cd, Tl, Bi. The mass levels of Ca, Al and Zn in ambient PM2.5 were higher than those in subway PM2.5, however those of the remaining 26 measured elements in subway PM2.5 were higher than in ambient PM2.5. The speciation of Fe in PM2.5 was in the form of Fe2+, while for Cu, that in the finer fractions (<0.25,0.5 and 1.0 mu m) was in the form Cu2+, but in the PM2.5 fraction itself, was as Cu1+ (C) 2014 Elsevier B.V. All rights reserved.	[Lu, Senlin; Liu, Dingyu; Zhang, Wenchao; Liu, Pinwei; Fei, Yi; Gu, Yan; Wu, Minghong] Shanghai Univ, Sch Environm & Chem Engn, Shanghai 200444, Peoples R China; [Yu, Shang] Shanghai Univ, Inst Environm Pollut & Hlth, Shanghai 200444, Peoples R China; [Yonemochi, Shinich; Wang, Xiaoju] Ctr Environm Sci Saitama, Saitama 3740115, Japan; [Wang, Qingyue] Saitama Univ, Sch Sci & Engn, Saitama 3388570, Japan	Lu, SL (reprint author), Shanghai Univ, Sch Environm & Chem Engn, Shanghai 200444, Peoples R China.	senlinlv@staff.shu.edu.cn			Natural Science Foundation of China (NSFC Grant) [41273127, 21477073]; Innovation Program of Shanghai Municipal Education Commission; Program for Innovative Research Team in the University [IRT13078]	The research was supported by the Natural Science Foundation of China (NSFC Grant No. 41273127, 21477073), the Innovation Program of Shanghai Municipal Education Commission, and the Program for Innovative Research Team in the University (No. IRT13078). The authors thank the two anonymous reviewers for their insightful and detailed comments on the manuscript, and Professor Margaret Burchett for her most careful revision.	Donaldson K, 1997, ENVIRON HEALTH PERSP, V105, P1285, DOI 10.2307/3433548; Karlsson HL, 2005, CHEM RES TOXICOL, V18, P19, DOI 10.1021/tx049723c; Jung HJ, 2012, J HAZARD MATER, V213, P331, DOI 10.1016/j.jhazmat.2012.02.006; Aarnio P, 2005, ATMOS ENVIRON, V39, P5059, DOI 10.1016/j.atmosenv.2005.05.012; Furuya K, 2001, J TRACE MICROPROBE T, V19, P469, DOI 10.1081/TMA-100107583; Kam W, 2013, ENVIRON SCI-PROC IMP, V15, P234, DOI 10.1039/c2em30495c; Adams HS, 2001, ATMOS ENVIRON, V35, P4557, DOI 10.1016/S1352-2310(01)00194-7; Calvo AI, 2013, ATMOS RES, V120, P1, DOI 10.1016/j.atmosres.2012.09.021; Salma I, 2007, ATMOS ENVIRON, V41, P8391, DOI 10.1016/j.atmosenv.2007.06.017; Fubini B, 1995, TOXICOL LETT, V82-3, P951, DOI 10.1016/0378-4274(95)03531-1; Ripanucci G, 2006, J OCCUP ENVIRON HYG, V3, P16, DOI 10.1080/15459620500444004; Mbengue S, 2014, ATMOS RES, V135, P35, DOI 10.1016/j.atmosres.2013.08.010; Chillrud SN, 2004, ENVIRON SCI TECHNOL, V38, P732, DOI 10.1021/es034734y; Mugica-Alvarez V, 2012, ATMOS ENVIRON, V49, P284, DOI 10.1016/j.atmosenv.2011.11.038; Kam W, 2011, ATMOS ENVIRON, V45, P1506, DOI 10.1016/j.atmosenv.2010.12.049; Feng YL, 2009, ATMOS RES, V92, P434, DOI 10.1016/j.atmosres.2009.01.003; Midander K, 2012, SCI TOTAL ENVIRON, V427, P390, DOI 10.1016/j.scitotenv.2012.04.014; Johansson C, 2003, ATMOS ENVIRON, V37, P3, DOI 10.1016/S1352-2310(02)00833-6; Feng YL, 2010, J HAZARD MATER, V183, P574, DOI 10.1016/j.jhazmat.2010.07.062; Song XY, 2014, ATMOS RES, V143, P462, DOI 10.1016/j.atmosres.2014.03.015; Nieuwenhuijsen MJ, 2007, ATMOS ENVIRON, V41, P7995, DOI 10.1016/j.atmosenv.2007.08.002; Seaton A, 2005, OCCUP ENVIRON MED, V62, P355, DOI 10.1136/oem.2004.014332; Bao Liangman, 2009, THESIS CHINESE ACAD; Brains M., 2006, ATMOS ENVIRON, V40, P348; Chan L., 2000, ATMOS ENVIRON, V36, P3363; Gustafsson M, 2012, TRANSPORT RES D-TR E, V17, P277, DOI 10.1016/j.trd.2011.12.006; Li G., 2006, SPEC STEEL, V27, P23; Lin J, 2009, CHINESE PHYS C, V33, P965, DOI 10.1088/1674-1137/33/11/007; Lu SL, 2008, ATMOS ENVIRON, V42, P7205, DOI 10.1016/j.atmosenv.2008.07.030; Ministry of Environmental Protection, 2012, AMB AIR QUAL STAND; Newyille, 2001, J SYNCHROTRON RADIAT, V8, P322; Oakes M, 2012, ATMOS CHEM PHYS, V12, P745, DOI 10.5194/acp-12-745-2012; Osan J, 2010, SPECTROCHIM ACTA B, V65, P1008, DOI 10.1016/j.sab.2010.11.002; Shi CZ, 2015, ATMOS RES, V153, P235, DOI 10.1016/j.atmosres.2014.09.002; Vasconcellos E. A., 2001, URBAN TRANSPORT ENV; Wang Youjun, 2012, THESIS DONGHUA U; Wang YS, 2007, J RADIOANAL NUCL CH, V273, P247, DOI 10.1007/s10967-007-0743-7; Wang YS, 2006, CHINESE SCI BULL, V51, P2275, DOI 10.1007/s11434-006-2103-3; [夏志新 XIA Zhixin], 2008, [钢铁, Iron and Steel], V43, P41; Zhang WG, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003524	40	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0169-8095	1873-2895		ATMOS RES	Atmos. Res.	FEB	2015	153						543	552		10.1016/j.atmosres.2014.10.006		10	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AY0CD	WOS:000347264600044		
J	Wang, HH; Ohnuki, H; Endo, H; Izumi, M				Wang, Huihui; Ohnuki, Hitoshi; Endo, Hideaki; Izumi, Mitsuru			Impedimetric and amperometric bifunctional glucose biosensor based on hybrid organic-inorganic thin films	BIOELECTROCHEMISTRY			English	Article						Glucose biosensor; Self-assembled monolayer; Amperometcy; Impedance spectroscopy; Langmuir-Blodgett films	LANGMUIR-BLODGETT-FILMS; BLUE MODIFIED ELECTRODE; IMPEDANCE SPECTROSCOPY EIS; GLASSY-CARBON ELECTRODE; PRUSSIAN-BLUE; HYDROGEN-PEROXIDE; ELECTROCHEMICAL CHARACTERIZATION; CHOLESTEROL BIOSENSOR; OPERATIONAL STABILITY; HUMAN SERUM	A novel glucose biosensor with an immobilized mediator was studied using electrochemical impedance spectroscopy (EIS) and amperometry measurements. The biosensor has a characteristic ultrathin form and is composed of a self-assembled monolayer anchoring glucose oxidase (GOx) covered with Langmuir-Blodgett (LB) films of Prussian blue (PB). The immobilized PB in the LB films acts as a mediator and enables the biosensor to work under a low potential (0.0 V vs. Ag/AgCI). In the EIS measurements, a dramatic decrease in charge transfer resistance (R-ct) was observed with sequential addition of glucose, which can be attributed to enzymatic activity. The linearity of the biosensor response was observed by the variation of the sensor response (1/R-ct) as a function of glucose concentration in the range 0 to 25 mM. The sensor also showed linear amperometric response below 130 mM glucose. The organic-inorganic system of GOx and PB nanodusters demonstrated bifunctional sensing action, both amperometry and EIS modes, as well as long sensing stability for 4 days. (C) 2014 Elsevier B.V. All rights reserved.	[Wang, Huihui; Ohnuki, Hitoshi; Izumi, Mitsuru] Tokyo Univ Marine Sci & Technol, Div Marine Technol, Tokyo 1358533, Japan; [Endo, Hideaki] Tokyo Univ Marine Sci & Technol, Div Marine Sci, Tokyo 1088477, Japan	Ohnuki, H (reprint author), Tokyo Univ Marine Sci & Technol, Div Marine Technol, 2-1-6 Etchujima Koto Ku, Tokyo 1358533, Japan.	ohnuki@kaiyodai.ac.jp	ENDO, Hideaki/O-1893-2014; Ohnuki, Hitoshi/O-2050-2014		Japan Society for the Promotion of Science (ISPS) [2136006]; Faculty of Marine Technology, Tokyo University of Marine Science and Technology	This research was supported by a Grant-in-Aid for Scientific Research (B) (No. 2136006) from the Japan Society for the Promotion of Science (ISPS) and by a Grant-in-Aid from the Faculty of Marine Technology, Tokyo University of Marine Science and Technology.	KARYAKIN AA, 1994, ANAL LETT, V27, P2861; Zayats M, 2002, J AM CHEM SOC, V124, P14724, DOI 10.1021/ja027919y; Forzani ES, 2004, NANO LETT, V4, P1785, DOI [10.1021/nl049080l, 10.1021/nl049080I]; Chen W, 2007, J PHYS CHEM C, V111, P13452, DOI [10.1021/jp072385e, 10.1021/j0072385e]; Shervedani RK, 2006, BIOELECTROCHEMISTRY, V69, P201, DOI 10.1016/j.bioelechem.2006.01.003; JUTTNER K, 1990, ELECTROCHIM ACTA, V35, P1501, DOI 10.1016/0013-4686(90)80004-8; Wang HH, 2012, SENSOR ACTUAT B-CHEM, V168, P249, DOI 10.1016/j.snb.2012.04.018; Zhai YL, 2011, J ELECTROANAL CHEM, V656, P198, DOI 10.1016/j.jelechem.2010.11.020; Katz E, 2003, ELECTROANAL, V15, P913, DOI 10.1002/elan.200390114; Malinauskas A, 2004, MAT SCI ENG C-BIO S, V24, P513, DOI 10.1016/j.msec.2004.01.002; Jung SK, 1996, ANAL CHEM, V68, P591, DOI 10.1021/ac950424p; Yoo EH, 2010, SENSORS-BASEL, V10, P4558, DOI 10.3390/s100504558; Zhang L, 2005, BIOSENS BIOELECTRON, V21, P337, DOI 10.1016/j.bios.2004.10.021; Ohnuki H, 2007, LANGMUIR, V23, P4675, DOI 10.1021/la063175g; Daniels JS, 2007, ELECTROANAL, V19, P1239, DOI 10.1002/elan.200603855; Solanki PR, 2007, LANGMUIR, V23, P7398, DOI 10.1021/la700350x; Kohma T, 2007, B CHEM SOC JPN, V80, P158, DOI 10.1246/bcsj.80.158; Xiao Y, 1999, ANAL CHIM ACTA, V391, P73, DOI 10.1016/S0003-2670(99)00196-8; Dharuman V, 2005, BIOSENS BIOELECTRON, V21, P645, DOI 10.1016/j.bios.2004.12.020; Karyakin AA, 1999, ELECTROCHEM COMMUN, V1, P78, DOI 10.1016/S1388-2481(99)00010-7; Maalouf R, 2007, BIOSENS BIOELECTRON, V22, P2682, DOI 10.1016/j.bios.2006.11.003; CHI QJ, 1995, ANAL CHIM ACTA, V310, P429, DOI 10.1016/0003-2670(95)00152-P; Gao Q, 2011, BIOELECTROCHEMISTRY, V81, P109, DOI 10.1016/j.bioelechem.2011.04.003; Zhao W, 2005, LANGMUIR, V21, P9630, DOI 10.1021/la051370+; Liu HY, 2010, ANAL CHEM, V82, P5865, DOI 10.1021/ac101110q; Wagner N, 2002, J APPL ELECTROCHEM, V32, P859, DOI 10.1023/A:1020551609230; Zhang D, 2004, LANGMUIR, V20, P7303, DOI 10.1021/la049667f; Che X, 2010, ELECTROCHIM ACTA, V55, P5420, DOI 10.1016/j.electacta.2010.04.091; Chen HL, 2009, SCI CHINA SER B, V52, P1128, DOI 10.1007/s11426-009-0146-4; de Mattos IL, 2000, ANAL SCI, V16, P795; Eggins B.R., 2002, CHEM SENSORS BIOSENS, P111; Gonzalez-Fernandez E, 2011, BIOSENS BIOELECTRON, V26, P2354, DOI 10.1016/j.bios.2010.10.011; Guadagnini L, 2010, ELECTROANAL, V22, P1695, DOI 10.1002/elan.200900569; Haghighi B, 2009, ELECTROANAL, V21, P1862, DOI 10.1002/elan.200904647; Kafi AKM, 2008, THIN SOLID FILMS, V516, P3641, DOI 10.1016/j.tsf.2007.08.040; Martinez CCM, 2010, BIOSENS BIOELECTRON, V26, P1239, DOI 10.1016/j.bios.2010.06.033; Marzouk SAM, 2011, SENSOR ACTUAT B-CHEM, V157, P647, DOI 10.1016/j.snb.2011.05.045; Matharu Z, 2007, LANGMUIR, V23, P13188, DOI 10.1021/la702123a; MUSIANI MM, 1990, ELECTROCHIM ACTA, V35, P1665, DOI 10.1016/0013-4686(90)80023-H; Ramanavicius A, 2014, J ELECTROCHEM SOC, V161, pB31, DOI 10.1149/2.021403jes; Ravaine S, 1998, LANGMUIR, V14, P6347, DOI 10.1021/la9808014; Shervedani RK, 2009, SENSOR ACTUAT B-CHEM, V137, P195, DOI 10.1016/j.snb.2008.10.018; Singhal R, 2002, SENSOR ACTUAT B-CHEM, V86, P42, DOI 10.1016/S0925-4005(02)00145-4; Tsuji H, 1997, ELECTROANAL, V9, P161, DOI 10.1002/elan.1140090215; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; YU PG, 1995, ANAL CHIM ACTA, V300, P91, DOI 10.1016/0003-2670(94)00396-4; Zuo SH, 2010, ADV SCI LETT, V3, P476, DOI 10.1166/asl.2010.1155	47	7	7	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1567-5394	1521-186X		BIOELECTROCHEMISTRY	Bioelectrochemistry	FEB	2015	101						1	7		10.1016/j.bioelechem.2014.06.007		7	Biochemistry & Molecular Biology; Biology; Biophysics; Electrochemistry	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Biophysics; Electrochemistry	AX8BM	WOS:000347135600001		
J	Li, DL; Tamura, M; Nakagawa, Y; Tomishige, K				Li, Dalin; Tamura, Masazumi; Nakagawa, Yoshinao; Tomishige, Keiichi			Metal catalysts for steam reforming of tar derived from the gasification of lignocellulosic biomass	BIORESOURCE TECHNOLOGY			English	Article						Biomass gasification; Tar; Steam reforming; Metal catalysts; Synthesis gas	SUPPORTED-RH CATALYSTS; NI-OLIVINE CATALYSTS; HYDROTALCITE-LIKE PRECURSORS; IRON ALLOY NANOPARTICLES; SOLID-SOLUTION CATALYSTS; HYDROGEN-PRODUCTION; MODEL-COMPOUND; HOT-GAS; FLUIDIZED-BED; NI/LA0.7SR0.3ALO3-DELTA CATALYST	Biomass gasification is one of the most important technologies for the conversion of biomass to electricity, fuels, and chemicals. The main obstacle preventing the commercial application of this technology is the presence of tar in the product gas. Catalytic reforming of tar appears a promising approach to remove tar and supported metal catalysts are among the most effective catalysts. Nevertheless, improvement of catalytic performances including activity, stability, resistance to coke deposition and aggregation of metal particles, as well as catalyst regenerability is greatly needed. This review focuses on the design and catalysis of supported metal catalysts for the removal of tar in the gasification of biomass. The recent development of metal catalysts including Rh, Ni, Co, and their alloys for steam reforming of biomass tar and tar model compounds is introduced. The role of metal species, support materials, promoters, and their interfaces is described. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Dalin] Fuzhou Univ, NERC CFC, Sch Chem Engn, Fuzhou 350002, Fujian, Peoples R China; [Tamura, Masazumi; Nakagawa, Yoshinao; Tomishige, Keiichi] Tohoku Univ, Dept Appl Chem, Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Li, DL (reprint author), Fuzhou Univ, NERC CFC, Sch Chem Engn, Gongye Rd 523, Fuzhou 350002, Fujian, Peoples R China.	dalinli@fzu.edu.cn					Mukai D, 2013, APPL CATAL A-GEN, V453, P60, DOI 10.1016/j.apcata.2012.11.040; Miyazawa T, 2006, CATAL TODAY, V115, P254, DOI 10.1016/j.cattod.2006.02.055; Furusawa T, 2013, FUEL, V103, P111, DOI 10.1016/j.fuel.2011.09.026; Li DL, 2014, INT J HYDROGEN ENERG, V39, P10959, DOI 10.1016/j.ijhydene.2014.05.062; Swierczynski D, 2006, CHEM MATER, V18, P4025, DOI 10.1021/cm0613511; Li DL, 2011, APPL CATAL A-GEN, V408, P1, DOI 10.1016/j.apcata.2011.09.018; Li DL, 2011, APPL CATAL B-ENVIRON, V102, P528, DOI 10.1016/j.apcatb.2010.12.035; Coll R, 2001, FUEL PROCESS TECHNOL, V74, P19, DOI 10.1016/S0378-3820(01)00214-4; Nakamura K, 2009, APPL CATAL B-ENVIRON, V86, P36, DOI 10.1016/j.apcatb.2008.07.016; Koike M, 2013, APPL CATAL B-ENVIRON, V140, P652, DOI 10.1016/j.apcatb.2013.04.065; Yung MM, 2009, ENERG FUEL, V23, P1874, DOI 10.1021/ef800830n; Yamazaki O, 1996, APPL CATAL A-GEN, V136, P49, DOI 10.1016/0926-860X(95)00268-5; Nishikawa J, 2008, CATAL TODAY, V131, P146, DOI 10.1016/j.cattod.2007.10.066; Nishikawa J, 2008, CATAL COMMUN, V9, P195, DOI 10.1016/j.catcom.2007.05.045; Xiao XB, 2011, BIORESOURCE TECHNOL, V102, P1975, DOI 10.1016/j.biortech.2010.09.016; Wang L, 2013, FUEL, V112, P654, DOI 10.1016/j.fuel.2012.01.073; Koike M, 2013, FUEL, V103, P122, DOI 10.1016/j.fuel.2011.04.009; Tomishige K, 2007, CATAL COMMUN, V8, P1074, DOI 10.1016/j.catcom.2006.05.051; Pfeifer C, 2004, IND ENG CHEM RES, V43, P1634, DOI 10.1021/ie030742b; Wang L, 2014, APPL CATAL B-ENVIRON, V160, P701, DOI 10.1016/j.apcatb.2014.06.021; Nacken M, 2012, APPL CATAL B-ENVIRON, V125, P111, DOI 10.1016/j.apcatb.2012.05.027; Kuhn JN, 2008, APPL CATAL A-GEN, V341, P43, DOI 10.1016/j.apcata.2007.12.037; Bampenrat A, 2010, APPL CATAL A-GEN, V373, P154, DOI 10.1016/j.apcata.2009.11.008; Wang D, 2011, APPL ENERG, V88, P1656, DOI 10.1016/j.apenergy.2010.11.041; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Constantinou DA, 2012, APPL CATAL B-ENVIRON, V117, P81, DOI 10.1016/j.apcatb.2012.01.005; Nacken M, 2007, IND ENG CHEM RES, V46, P1945, DOI 10.1021/ie060887t; Quitete CPB, 2014, APPL CATAL A-GEN, V478, P234, DOI 10.1016/j.apcata.2014.04.019; Abu El-Rub Z, 2004, IND ENG CHEM RES, V43, P6911, DOI 10.1021/ie0498403; Mei DH, 2013, ACS CATAL, V3, P1133, DOI 10.1021/cs4000427; Constantinou DA, 2010, APPL CATAL B-ENVIRON, V96, P276, DOI 10.1016/j.apcatb.2010.02.007; Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K; Koike M, 2012, CHEMSUSCHEM, V5, P2312, DOI 10.1002/cssc.201200507; Basile F, 2011, BIOMASS BIOENERG, V35, pS116, DOI 10.1016/j.biombioe.2011.06.047; Li CS, 2009, APPL CATAL B-ENVIRON, V88, P351, DOI 10.1016/j.apcatb.2008.11.004; Ma L, 2005, CATAL TODAY, V105, P729, DOI 10.1016/j.cattod.2005.06.022; Xu CB, 2010, FUEL, V89, P1784, DOI 10.1016/j.fuel.2010.02.014; Oemar U, 2013, INT J HYDROGEN ENERG, V38, P5525, DOI 10.1016/j.ijhydene.2013.02.083; Sekine Y, 2013, APPL CATAL A-GEN, V451, P160, DOI 10.1016/j.apcata.2012.11.005; Wang L, 2012, APPL CATAL B-ENVIRON, V121, P95, DOI 10.1016/j.apcatb.2012.03.025; Li DL, 2014, CHEMSUSCHEM, V7, P510, DOI 10.1002/cssc.201300855; Park HJ, 2010, BIORESOURCE TECHNOL, V101, pS101, DOI 10.1016/j.biortech.2009.03.036; Zhao HB, 2000, IND ENG CHEM RES, V39, P3195, DOI 10.1021/ie000213x; Wang L, 2014, APPL CATAL B-ENVIRON, V150, P82, DOI 10.1016/j.apcatb.2013.12.002; Furusawa T, 2005, APPL CATAL A-GEN, V278, P207, DOI 10.1016/j.apcata.2004.09.035; Li DL, 2013, INT J HYDROGEN ENERG, V38, P3572, DOI 10.1016/j.ijhydene.2013.01.057; Asadullah M, 2002, ENVIRON SCI TECHNOL, V36, P4476, DOI 10.1021/es020575r; Ashok J., 2013, ACS CATAL, V4, P289; Colby J.L., 2009, ENERGY FUEL, V24, P1341; Corujo A, 2010, BIOMASS BIOENERG, V34, P1695, DOI 10.1016/j.biombioe.2010.06.010; Draelants DJ, 2001, IND ENG CHEM RES, V40, P3309, DOI 10.1021/ie0009785; Engelen K, 2003, CHEM ENG SCI, V58, P665, DOI 10.1016/S0009-2509(02)00593-6; Furusawa T, 2005, APPL CATAL A-GEN, V278, P195, DOI 10.1016/j.apcata.2004.09.034; Guell BM, 2011, APPL CATAL B-ENVIRON, V106, P280, DOI DOI 10.1016/J.APCATB.2011.05.012; Hofbauer H., 2002, 12 EUR C TECHN EXH B; Kimura T, 2006, APPL CATAL B-ENVIRON, V68, P160, DOI 10.1016/j.apcatb.2006.08.007; Lasa H, 2011, CHEM REV, V111, P5404; Li BT, 2005, CATAL TODAY, V104, P7, DOI 10.1016/j.cattod.2005.03.037; Li JF, 2008, ENVIRON SCI TECHNOL, V42, P6224, DOI 10.1021/es800138r; Ma L, 2008, POWDER TECHNOL, V180, P21, DOI 10.1016/j.powtec.2007.02.035; Mukai D, 2014, APPL CATAL A-GEN, V471, P157, DOI 10.1016/j.apcata.2013.11.032; Oemar U, 2014, APPL CATAL B-ENVIRON, V148, P231, DOI 10.1016/j.apcatb.2013.10.001; Peter M., 2002, BIOSOURCE TECHNOLOGY, V83, P55; Polychronopoulou K, 2004, APPL CATAL A-GEN, V272, P37, DOI 10.1016/j.apcata.2004.05.002; Polychronopoulou K, 2012, APPL CATAL B-ENVIRON, V111, P360, DOI 10.1016/j.apcatb.2011.10.019; Polychronopoulou K, 2004, J CATAL, V228, P417, DOI 10.1016/j.jcat.2004.09.016; Polychronopoulou K, 2006, J CATAL, V241, P132, DOI 10.1016/j.jcat.2006.04.015; Reed T. B., 1971, FREE ENERGY FORMATIO, P66; Swierczynski D, 2007, APPL CATAL B-ENVIRON, V74, P211, DOI 10.1016/j.apcatb.2007.01.017; Tomishige K, 1999, J CATAL, V181, P91, DOI 10.1006/jcat.1998.2286; Wang L, 2011, APPL CATAL A-GEN, V392, P248, DOI 10.1016/j.apcata.2010.11.013; Wang TJ, 2006, FUEL PROCESS TECHNOL, V87, P421, DOI 10.1016/j.fuproc.2005.10.006; Zhao HB, 2000, CATAL TODAY, V56, P229, DOI 10.1016/S0920-5861(99)00280-1; Zhao ZK, 2009, APPL CATAL A-GEN, V363, P64, DOI 10.1016/j.apcata.2009.04.042; Zhao ZK, 2008, IND ENG CHEM RES, V47, P717, DOI 10.1021/ie0710891	75	10	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	FEB	2015	178						53	64		10.1016/j.biortech.2014.10.010		12	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AX8HM	WOS:000347150700007		
J	Kumagai, S; Matsuno, R; Grause, G; Kameda, T; Yoshioka, T				Kumagai, Shogo; Matsuno, Ryo; Grause, Guido; Kameda, Tomohito; Yoshioka, Toshiaki			Enhancement of bio-oil production via pyrolysis of wood biomass by pretreatment with H2SO4	BIORESOURCE TECHNOLOGY			English	Article						Japanese cedar wood; Thermal decomposition; Thermogravimetry-mass spectroscopy; Hydrolysis; Levoglucosan	HYDROTHERMAL LIQUEFACTION; CLEAVAGE MECHANISMS; LIQUID BIOFUELS; LIGNIN; CELLULOSE; GASIFICATION; DIMERS; TEMPERATURE; COMPONENTS; KINETICS	In this work, a Japanese cedar wood sample was treated during the first step at ambient temperature and atmospheric pressure using several concentrations of sulfuric acid (H2SO4) in a stirred flask. During this pretreatment C-O bonds of cellulose, hemicellulose, and lignin were cleaved. The second step involved the pyrolysis of the pretreated wood sample at 550 degrees C in a quartz glass tube reactor. A maximum oil yield of 46.8 wt% with the minimum char yield of 10.1 wt% was obtained by the treatment with 3 M H2SO4, whereas untreated wood samples resulted in a 30.1 wt% yield of oil. The main components in the oils were levoglucosan and tar. These results suggest that moderate acid pretreatment produced shorter chain units of cellulose, hemicellulose, and lignin, thereby facilitating the conversion into oil by pyrolysis. The results of thermogravimetry-mass spectroscopy supported the presence of shorter chain units in the pretreated wood samples. (C) 2014 Elsevier Ltd. All rights reserved.	[Kumagai, Shogo; Matsuno, Ryo; Grause, Guido; Kameda, Tomohito; Yoshioka, Toshiaki] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kumagai, Shogo] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan	Yoshioka, T (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.	yoshioka@env.che.tohoku.ac.jp			Tohoku University [45300120]	The authors thank Tohoku University for financial support # 45300120.	Demirbas A, 2011, APPL ENERG, V88, P17, DOI 10.1016/j.apenergy.2010.07.016; Lv GJ, 2013, J ANAL APPL PYROL, V104, P185, DOI 10.1016/j.jaap.2013.08.005; Kotake T, 2014, J ANAL APPL PYROL, V105, P309, DOI 10.1016/j.jaap.2013.11.018; Wang H, 2012, APPL BIOCHEM BIOTECH, V167, P285, DOI 10.1007/s12010-012-9678-8; Shen DK, 2010, BIORESOURCE TECHNOL, V101, P6136, DOI 10.1016/j.biortech.2010.02.078; Carlson TR, 2011, ENERG ENVIRON SCI, V4, P145, DOI 10.1039/c0ee00341g; Kawamoto H, 2008, J ANAL APPL PYROL, V81, P88, DOI 10.1016/j.jaap.2007.09.006; Kawamoto H, 2007, J WOOD SCI, V53, P268, DOI 10.1007/s10086-006-0839-7; EVANS RJ, 1987, ENERG FUEL, V1, P123, DOI 10.1021/ef00002a001; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; JORGENSEN AD, 1990, ANAL CHEM, V62, P683, DOI 10.1021/ac00206a007; Yorgun S, 2009, MICROPOR MESOPOR MAT, V122, P189, DOI 10.1016/j.micromeso.2009.02.032; Kobayashi T, 2011, ENERG FUEL, V25, P1790, DOI 10.1021/ef1017219; Shen DK, 2010, J ANAL APPL PYROL, V87, P199, DOI 10.1016/j.jaap.2009.12.001; Kirkels AF, 2011, RENEW SUST ENERG REV, V15, P471, DOI 10.1016/j.rser.2010.09.046; Akhtar J, 2011, RENEW SUST ENERG REV, V15, P1615, DOI 10.1016/j.rser.2010.11.054; Nigam PS, 2011, PROG ENERG COMBUST, V37, P52, DOI 10.1016/j.pecs.2010.01.003; Amen-Chen C, 2001, BIORESOURCE TECHNOL, V79, P277, DOI 10.1016/S0960-8524(00)00180-2; Toor SS, 2011, ENERGY, V36, P2328, DOI 10.1016/j.energy.2011.03.013; Alvarez J, 2014, INT J HYDROGEN ENERG, V39, P10883, DOI 10.1016/j.ijhydene.2014.04.189; Branca C, 2013, IND ENG CHEM RES, V52, P5030, DOI 10.1021/ie400155x; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Shen DK, 2009, BIORESOURCE TECHNOL, V100, P6496, DOI 10.1016/j.biortech.2009.06.095; EMSLEY AM, 1994, CELLULOSE, V1, P26, DOI 10.1007/BF00818797; Kawamoto H, 2008, HOLZFORSCHUNG, V62, P50, DOI 10.1515/HF.2008.007; Asmadi M, 2010, J WOOD SCI, V56, P319, DOI 10.1007/s10086-009-1097-2; Fukutome A, 2014, J ANAL APPL PYROL, V108, P98, DOI 10.1016/j.jaap.2014.05.012; Grause G, 2009, POLYM DEGRAD STABIL, V94, P1119, DOI 10.1016/j.polymdegradstab.2009.03.014; Hassan El-Barbary M, 2009, Appl Biochem Biotechnol, V154, P3, DOI 10.1007/s12010-008-8445-3; Hosoya T, 2007, J WOOD SCI, V53, P351, DOI 10.1007/s10086-006-0854-8; Li S, 2001, FUEL, V80, P1809, DOI 10.1016/S0016-2361(01)00064-3; Nakamura T, 2008, J ANAL APPL PYROL, V81, P173, DOI 10.1016/j.jaap.2007.11.002; Thangalazhy-Gopakumar S, 2012, ENERG FUEL, V26, P5300, DOI 10.1021/ef3008213; Zhang B, 2012, APPL BIOCHEM BIOTECH, V168, P37, DOI 10.1007/s12010-011-9284-1	34	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	FEB	2015	178						76	82		10.1016/j.biortech.2014.09.146		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AX8HM	WOS:000347150700010		
J	Iwase, SI; Nakahira, K; Tuda, M; Kagoshima, K; Takagi, M				Iwase, S. -I.; Nakahira, K.; Tuda, M.; Kagoshima, K.; Takagi, M.			Host-plant dependent population genetics of the invading weevil Hypera postica	BULLETIN OF ENTOMOLOGICAL RESEARCH			English	Article						Hypera postica; Chinese milk vetch; extended Bayesian skyline plot; statistical parsimony network; narrow-leaved vetch; hairy vetch	ALFALFA WEEVIL; MITOCHONDRIAL-DNA; CYTOPLASMIC INCOMPATIBILITY; COLEOPTERA-CURCULIONIDAE; MOLECULAR CLOCK; WESTERN STRAINS; BEMISIA-TABACI; SEQUENCES; GROWTH; DROSOPHILA	Population genetics of invading pests can be informative for understanding their ecology. In this study, we investigated population genetics of the invasive alfalfa weevil Hypera postica in Fukuoka Prefecture, Japan. We analyzed mitochondrial tRNA(Leu)-COII, nuclear EF-1 alpha gene fragments, and Wolbachia infection in relation to three leguminous host plants: Vicia angustifolia, Vicia villosa, and a new host Astragalus sinicus cultivated as a honey source and green manure crop. A parsimony network generated from mitochondrial gene sequences uncovered two major haplotypic groups, Western and Egyptian. In contrast to reported Wolbachia infection of the Western strain in the United States, none of our analyzed individuals were infected. The absence of Wolbachia may contribute to the stable coexistence of mitochondrial strains through inter-strain reproductive compatibility. Hypera postica genetic variants for the mitochondrial and nuclear genes were associated neither with host plant species nor with two geographic regions (Hisayama and Kama) within Fukuoka. Mitochondrial haplogroups were incongruent with nuclear genetic variants. Genetic diversity at the nuclear locus was the highest for the populations feeding on V. angustifolia. The nuclear data for A. sinicus-feeding populations indicated past sudden population growth and extended Bayesian skyline plot analysis based on the mitochondrial and nuclear data showed that the growth of A. sinicus-feeding population took place within the past 1000 years. These results suggest a shorter history of A. sinicus as a host plant compared with V. angustifolia and a recent rapid growth of H. postica population using the new host A. sinicus.	[Iwase, S. -I.; Nakahira, K.; Tuda, M.; Kagoshima, K.; Takagi, M.] Kyushu Univ, Fac Agr, Inst Biol Control, Fukuoka 8128581, Japan; [Tuda, M.; Takagi, M.] Kyushu Univ, Div Agr Bioresource Sci, Dept Bioresource Sci, Lab Insect Nat Enemies, Fukuoka 8128581, Japan	Iwase, SI (reprint author), Kyushu Univ, Fac Agr, Inst Biol Control, Fukuoka 8128581, Japan.	siwase@grt.kyushu-u.ac.jp; tuda@grt.kyushu-u.ac.jp			JSPS [22570215, 23405008, 25430194]; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development [25412]	This study was done in part as a PhD study of SI and was supported by a Grant-in-Aid from JSPS (22570215, 23405008 and 25430194) and by Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (25412) to MT.	Kuwata R, 2005, J APPL ENTOMOL, V129, P191, DOI 10.1111/j.1439-0418.2005.00954.191-197; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Gomez-Zurita J, 2000, MOL PHYLOGENET EVOL, V14, P304, DOI 10.1006/mpev.1999.0712; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; MAUND CM, 1991, CAN ENTOMOL, V123, P197; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.2307/2410314; Haran J, 2013, MOL PHYLOGENET EVOL, V67, P156, DOI 10.1016/j.ympev.2012.12.022; Fu YX, 1997, GENETICS, V147, P915; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1046/j.1570-7458.1998.00261.x; Bottger JAA, 2013, J ECON ENTOMOL, V106, P426, DOI 10.1603/EC12262; TEMPLETON AR, 1992, GENETICS, V132, P619; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Tuda M, 2004, B ENTOMOL RES, V94, P75, DOI 10.1079/BER2003277; Kauwe JSK, 2004, J N AM BENTHOL SOC, V23, P824, DOI 10.1899/0887-3593(2004)023<0824:PANCAO>2.0.CO;2; HOLDEN PR, 1993, MOL GEN GENET, V240, P213, DOI 10.1007/BF00277059; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Tuda M, 2006, MOL ECOL, V15, P3541, DOI 10.1111/j.1365-294X.2006.03030.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; HSIAO TH, 1985, ENTOMOL EXP APPL, V37, P155; Kondo NI, 2011, ZOOL SCI, V28, P501, DOI 10.2108/zsj.28.501; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; BLICKENSTAFF C. C., 1965, ANN ENTOMOL SOC AMER, V58, P523; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayashikawa S., 1999, PL PROT, V53, P419; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hsiao Ting H., 1993, P311; Hsiao TH, 1996, ECOLOGY AGR PESTS BI, P57; Kato K., 1989, KYUSHU PLANT CONTROL, V505, P7; Kimura H., 1991, HYPERA POSTICA PLANT, V45, P50; Kimura H., 1988, PLANT PROTECTION, V42, P498; MANGLITZ GR, 1981, J ECON ENTOMOL, V74, P581; Mardulyn P, 2011, MOL PHYLOGENET EVOL, V61, P686, DOI 10.1016/j.ympev.2011.09.001; Morimoto K., 1987, KANKYO KANRI GIJUTSU, V5, P1; Newton J.H., 1933, COLORADO AGR EXPT ST, V399, P19; Nylander J.A.A., 2004, MRAICPL PROGRAM DIST; Okumura M., 2002, PL PROT, V56, P329; Okumura M., 1991, Honeybee Science, V12, P145; PIENKOWS.RL, 1969, ANN ENTOMOL SOC AM, V62, P1268; Radcliffe E. B., 1998, Integrated Pest Management Reviews, V3, P225, DOI 10.1023/A:1009611219360; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubidge EM, 2012, NAT CLIM CHANGE, V2, P285, DOI 10.1038/NCLIMATE1415; Sakurai Hironori, 1997, Research Bulletin of the Faculty of Agriculture Gifu University, V62, P23; Shoubu M, 2005, BIOL CONTROL, V34, P144, DOI 10.1016/j.biocontrol.2005.04.009; TAJIMA F, 1983, GENETICS, V105, P437; Utsumi K., 1989, KOBE PLANT PROTECTIO, V854, P44; WHITE CE, 1972, J ECON ENTOMOL, V65, P85; Wood K.A., 1978, ILLINOIS AGR EXPT ST, V54; Yamaguchi Daisuke, 2006, Science Bulletin of the Faculty of Agriculture Kyushu University, V61, P77	58	1	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0007-4853	1475-2670		B ENTOMOL RES	Bull. Entomol. Res.	FEB	2015	105	1					92	100		10.1017/S0007485314000728		9	Entomology	Entomology	AX9PJ	WOS:000347234000010		
J	Terai, N				Terai, Nobuhiro			ON EXPONENTIAL DIOPHANTINE EQUATIONS CONTAINING THE EULER QUOTIENT	BULLETIN OF THE AUSTRALIAN MATHEMATICAL SOCIETY			English	Article						exponential Diophantine equations; Fermat quotient; Euler quotient; integer solutions		Let a and m be relatively prime positive integers with a > 1 and m > 2. Let phi (m) be Euler's totient function. The quotient E-m(a) = (a(phi(m)) - 1) = m is called the Euler quotient of m with base a. By Euler's theorem, E-m(a) is an integer. In this paper, we consider the Diophantine equation E-m(a) = x(l) in integers x > 1; l > 1. We conjecture that this equation has exactly five solutions (a; m; x; l) except for (l; m) = (2; 3); (2; 6), and show that if the equation has solutions, then m = p(s) or m = 2p(s) with p an odd prime and s >= 1.	Oita Univ, Fac Engn, Dept Comp Sci & Intelligent Syst, Oita 8701192, Japan	Terai, N (reprint author), Oita Univ, Fac Engn, Dept Comp Sci & Intelligent Syst, 700 Dannoharu, Oita 8701192, Japan.	terai-nobuhiro@oita-u.ac.jp					Agoh T, 1997, J NUMBER THEORY, V66, P29, DOI 10.1006/jnth.1997.2162; Bennett MA, 2004, CAN J MATH, V56, P23, DOI 10.4153/CJM-2004-002-2; Bennett MA, 2004, COMPOS MATH, V140, P1399, DOI 10.1112/s0010437x04000983; Bosma W., HDB MAGMA FUNCTIONS; Cao Z., 1999, C R MATH REP ACAD SC, V21, P23; Cohn JHE, 1997, ACTA ARITH, V78, P401; Dickson L.E, 1971, HIST THEORY NUMBERS, VI; Kihel O, 2002, CAN MATH BULL, V45, P247, DOI 10.4153/CMB-2002-028-1; Le M. H., 1993, C R MATH REP ACAD SC, V15, P121; Ljunggren W., 1942, AVH NORSKE VID AKAD, V5, P1; Lucas E., 1891, THEORIE NOMBRES; Mihilescu P., 2004, J REINE ANGEW MATH, V572, P167; NAGELL T., 1964, INTRO NUMBER THEORY; Osada H., 1989, C R MATH REP ACAD SC, V11, P115; Stormer C., 1899, B SOC MATH FRANCE, V27, P160; Terai N., 1990, TOKYO J MATH, V13, P277	16	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0004-9727	1755-1633		B AUST MATH SOC	Bull. Aust. Math. Soc.	FEB	2015	91	1					11	18		10.1017/S0004972714000719		8	Mathematics	Mathematics	AX8LX	WOS:000347162000002		
J	Engel, A; Glyk, A; Hulsewig, A; Gross, J; Dillert, R; Bahnemann, DW				Engel, Astrid; Glyk, Anna; Huelsewig, Anja; Gross, Julia; Dillert, Ralf; Bahnemann, Detlef W.			Determination of the photocatalytic deposition velocity	CHEMICAL ENGINEERING JOURNAL			English	Article						Heterogeneous photocatalysis; Deposition velocity; Nitrogen oxide; Titanium dioxide; Air purification	TITANIUM-DIOXIDE; ATMOSPHERIC CHEMISTRY; NITROGEN(II) OXIDE; LIGHT-INTENSITY; NITROUS-ACID; NOX; DEGRADATION; OXIDATION; SURFACES; ENVIRONMENT	Microscale atmospheric dispersion models have been employed recently to predict the possible effect of photocatalytically active surfaces on the air pollution in urban areas. These simulations use the photocatalytic deposition velocity as an input value. However, no generally accepted experimental method for the determination of the photocatalytic deposition velocity is available. Here a method to determine the photocatalytic deposition velocity is proposed which is based on ISO 22179-1 et seqq. specifying test methods for the determination of the air-purification performance of materials that contain a photocatalyst or have photocatalytic films on the surface. It is assumed that the rate of the photocatalytic surface reaction of a species i, R-A(i), is given by an expression having the mathematical form R-A(i) = (A)k(i)K(i)c(i)/(1 + KiCi) where the kinetic parameters (A)k(i) and K-i are variables depending on the photon flux, the temperature, the humidity and the concentration of other pollutants. Under steady state conditions the mole balance of a differential volume of a fluid element inside the plug flow reactor described in the cited ISO standards reads Y=(A)k(i)K(i)X - const(i). This equation is a linear equation of the two variables Y=ln(C-in,C-i/C-out,C-i)/(C-in,C-i - C-out,C-i) and X = A(r)/q(V)(c(in,i)-c(out,i)) where c(in,i), c(out,i), A(r), and q(v) are the inlet and outlet concentration of the pollutant i under consideration, the irradiated photocatalytically active surface, and the volumetric flow rate through the photocatalytic reactor, respectively. It is argued that the slope (A)k(i)K(i) of this equation is the demanded' photocatalytic deposition velocity V-pc,V-i. Thus, the measurement of C-out,C-i at varying C-in,C-i makes the photocatalytic deposition velocity accessible. (C) 2014 Elsevier B.V. All rights reserved.	[Engel, Astrid; Glyk, Anna; Gross, Julia; Dillert, Ralf; Bahnemann, Detlef W.] Leibniz Univ Hannover, Inst Tech Chem, D-30167 Hannover, Germany; [Engel, Astrid; Dillert, Ralf] Leibniz Univ Hannover, Lab Nano & Quantenengn, D-30167 Hannover, Germany; [Huelsewig, Anja] D Tox, D-30167 Hannover, Germany	Dillert, R (reprint author), Sophia Univ, Chiyoda Ku, 7-1 Kioicho, Tokyo 1028554, Japan.	dillert@iftc.uni-hannover.de	Bahnemann, Detlef/G-3375-2012		German Federal Ministry of Education and Research [03X0069F]	This work which was funded in part by the German Federal Ministry of Education and Research (contract no. 03X0069F, HelioClean - Nanotechnologisch funktionalisierte Baustoffe zur solarkatalytischen Luft- und Oberflachenreinigung") was presented in part by R.D. at the 2nd International Conference on Photocatalytic and Advanced Oxidation Technologies for Treatment of Water, Air, Soil and Surfaces (PAOT-2), September 9-12, 2013, Gdansk, Poland, and the 3rd European Symposium on Photocatalysis (JEP 2013), September 25-27, 2013, Portoroz, Slovenia. The authors thank Dr. Gerald Burgeth, Sto AG, for the cession of the paint samples. R.D. thanks the Leibniz University Hannover and Prof. Dr. D. Bahnemann for granting him a leave of absence.	WESELY ML, 1977, JAPCA J AIR WASTE MA, V27, P1110; Hunger M, 2010, CEMENT CONCRETE RES, V40, P313, DOI 10.1016/j.cemconres.2009.09.013; Dunlea EJ, 2007, ATMOS CHEM PHYS, V7, P2691; Maggos T, 2007, J HAZARD MATER, V146, P668, DOI 10.1016/j.jhazmat.2007.04.079; Maggos T, 2007, APPL PHYS A-MATER, V89, P81, DOI 10.1007/s00339-007-4033-6; Villena G, 2012, ATMOS MEAS TECH, V5, P149, DOI 10.5194/amt-5-149-2012; Yu QL, 2009, APPL CATAL B-ENVIRON, V92, P454, DOI 10.1016/j.apcatb.2009.09.004; Ballari MM, 2010, APPL CATAL B-ENVIRON, V95, P245, DOI 10.1016/j.apcatb.2010.01.002; Dillert R, 2013, PHYS CHEM CHEM PHYS, V15, P20876, DOI 10.1039/c3cp54469a; HICKS BB, 1987, WATER AIR SOIL POLL, V36, P311, DOI 10.1007/BF00229675; Kontos AG, 2012, CHEM ENG J, V179, P151, DOI 10.1016/j.cej.2011.10.072; Wang SB, 2007, ENVIRON INT, V33, P694, DOI 10.1016/j.envint.2007.02.011; [Anonymous], 2007, 2219712007 ISO; Yang R, 2007, ATMOS ENVIRON, V41, P1221, DOI 10.1016/j.atmosenv.2006.09.043; Maggos T, 2008, ENVIRON MONIT ASSESS, V136, P35, DOI 10.1007/s10661-007-9722-2; Langridge JM, 2009, ATMOS ENVIRON, V43, P5128, DOI 10.1016/j.atmosenv.2009.06.046; Mo JH, 2009, ATMOS ENVIRON, V43, P2229, DOI 10.1016/j.atmosenv.2009.01.034; Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001; Dillert R, 2012, J HAZARD MATER, V211, P240, DOI 10.1016/j.jhazmat.2011.11.041; Behlen A., 1996, P 8 INT C DET CONS S, P377; Behlen A., 1996, THESIS U HAMBURG HAM; Bolte G., 2012, SAUBERE LUFT DANK PH, P54; Brunner J., 1998, MESSUNSICHERHEITEN S; Bruse M., 2011, K LUFTQ STRASS 2011, P236; Flassak T., 2011, K LUFTQ STRASS 2011, P214; Fogler H.S., 2006, ELEMENTS CHEM REACTI; Gustafsson RJ, 2006, CHEM COMMUN, P3936, DOI 10.1039/b609005b; CALVERT JG, 1990, PURE APPL CHEM, V62, P2167, DOI 10.1351/pac199062112167; JUDEIKIS HS, 1978, ATMOS ENVIRON, V12, P2315, DOI 10.1016/0004-6981(78)90272-X; MCMAHON TA, 1979, ATMOS ENVIRON, V13, P571, DOI 10.1016/0004-6981(79)90186-0; Monge ME, 2010, PHYS CHEM CHEM PHYS, V12, P8992, DOI 10.1039/b925785c; Moussiopoulos N, 2008, ENVIRON MODEL ASSESS, V13, P357, DOI 10.1007/s10666-007-9098-2; Neunhauserer L., 2011, K LUFTQ STRASS 2011, P259; Yu QL, 2009, NANOTECHNOLOGY IN CONSTRUCTION 3, PROCEEDINGS, P389, DOI 10.1007/978-3-642-00980-8_53	34	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1385-8947	1873-3212		CHEM ENG J	Chem. Eng. J.	FEB 1	2015	261						88	94		10.1016/j.cej.2014.03.040		7	Engineering, Environmental; Engineering, Chemical	Engineering	AX8AA	WOS:000347131500013		
J	Tahara, M; Kondo, Y; Yokosawa, M; Tsuboi, H; Takahashi, S; Shibayama, S; Matsumoto, I; Sumida, T				Tahara, M.; Kondo, Y.; Yokosawa, M.; Tsuboi, H.; Takahashi, S.; Shibayama, S.; Matsumoto, I.; Sumida, T.			T-bet regulates differentiation of forkhead box protein 3(+) regulatory T cells in programmed cell death-1-deficient mice	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						FoxP3(+) regulatory T cells; helper T cell subsets; programmed cell death-1; T cell tolerance; Th1 cells	SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSCRIPTION FACTOR; CONTACT-DERMATITIS; EXPERIMENTAL COLITIS; INHIBITORY RECEPTOR; MURINE MODEL; SCURFY MICE; PD-1; MOUSE; EXPRESSION	Programmed cell death-1 (PD-1) plays an important role in peripheral T cell tolerance, but whether or not it affects the differentiation of helper T cell subsets remains elusive. Here we describe the importance of PD-1 in the control of T helper type 1 (Th1) cell activation and development of forkhead box protein 3 (FoxP3(+)) regulatory T cells (T-regs). PD-1-deficient T cell-specific T-bet transgenic (P/T) mice showed growth retardation, and the majority died within 10 weeks. P/T mice showed T-bet over-expression, increased interferon (IFN)- production by CD4(+) T cells and significantly low FoxP3(+) T-reg cell percentage. P/T mice developed systemic inflammation, which was probably induced by augmented Th1 response and low FoxP3(+) T-reg count. The study identified a unique, previously undescribed role for PD-1 in Th1 and T-reg differentiation, with potential implication in the development of Th1 cell-targeted therapy.	[Tahara, M.; Kondo, Y.; Yokosawa, M.; Tsuboi, H.; Matsumoto, I.; Sumida, T.] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; [Takahashi, S.] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Takahashi, S.] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058575, Japan; [Shibayama, S.] Tsukuba Inst ONO Pharmaceut Co LTD, Tsukuba, Ibaraki, Japan	Sumida, T (reprint author), Univ Tsukuba, Div Clin Immunol, Doctoral Programs Clin Sci, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tsumida@md.tsukuba.ac.jp			Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology	We thank Dr F. G. Issa for the critical reading of the manuscript. This work was supported by the Research Program for Intractable Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan and the Ministry of Education, Culture, Sports, Science and Technology.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Kido M, 2008, GASTROENTEROLOGY, V135, P1333, DOI 10.1053/j.gastro.2008.06.042; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Zheng LJ, 2007, J IMMUNOL, V179, P8035; ISHIDA Y, 1992, EMBO J, V11, P3887; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Kondo Y, 2012, ARTHRITIS RHEUM-US, V64, P162, DOI 10.1002/art.33335; Ishizaki K, 2007, J IMMUNOL, V178, P605; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Bamias G, 2005, GASTROENTEROLOGY, V128, P654, DOI 10.1053/j.gastro.2004.11.053; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Bertsias GK, 2009, ARTHRITIS RHEUM, V60, P207, DOI 10.1002/art.24227; Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773; Kondo S, 1996, J INVEST DERMATOL, V106, P993, DOI 10.1111/1523-1747.ep12338505; Fantini MC, 2007, EUR J IMMUNOL, V37, P3155, DOI 10.1002/eji.200737766; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; Chemnitz JM, 2004, J IMMUNOL, V173, P945; Chang JH, 2009, EUR J IMMUNOL, V39, P1241, DOI 10.1002/eji.200838913; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Chen J, 2009, CELL IMMUNOL, V6, P1123; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277; HAUSER C, 1990, J INVEST DERMATOL, V95, P436, DOI 10.1111/1523-1747.ep12555587; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; Kuchroo VK, 1993, J IMMUNOL, V151, P4271; Lan RY, 2007, J AUTOIMMUN, V29, P272, DOI 10.1016/j.jaut.2007.07.021; Li C, 2012, J CLIN CELL IMMUNOL, VA12, DOI [10.4172/2155-9899.S12-010, DOI 10.4172/2155-9899.S12-010]; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Sharma R, 2007, J AUTOIMMUN, V29, P10, DOI 10.1016/j.jaut.2007.04.001; Traidl C, 2000, SKIN PHARMACOL APPL, V13, P300, DOI 10.1159/000029938; Yoshida T, 2008, P NATL ACAD SCI USA, V105, P3533, DOI 10.1073/pnas.0710951105	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	FEB	2015	179	2					197	209		10.1111/cei.12455		13	Immunology	Immunology	AX9PH	WOS:000347233800006		
J	Sato, H; Onozuka, M; Hagiya, A; Hoshino, S; Narita, I; Uchiumi, T				Sato, H.; Onozuka, M.; Hagiya, A.; Hoshino, S.; Narita, I.; Uchiumi, T.			Characterization of anti-P monoclonal antibodies directed against the ribosomal protein-RNA complex antigen and produced using Murphy Roths large autoimmune-prone mice	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						autoantibody; monoclonal anti-P; ribosomal antigenic complex; SLE	SYSTEMIC-LUPUS-ERYTHEMATOSUS; GTPASE-ASSOCIATED CENTER; B-CELL-RECEPTOR; SACCHAROMYCES-CEREVISIAE; EPITOPE RECOGNITION; FACTOR-II; AUTOANTIBODIES; DOMAIN; STALK; ASSOCIATION	Autoantibodies, including anti-ribosomal P proteins (anti-P), are thought to be produced by an antigen-driven immune response in systemic lupus erythematosus (SLE). To test this hypothesis, we reconstituted the ribosomal antigenic complex in vitro using human P0, phosphorylated P1 and P2 and a 28S rRNA fragment covering the P0 binding site, and immunized Murphy Roths large (MRL)/lrp lupus mice with this complex without any added adjuvant to generate anti-P antibodies. Using hybridoma technology, we subsequently obtained 34 clones, each producing an anti-P monoclonal antibody (mAb) that recognized the conserved C-terminal tail sequence common to all three P proteins. We also obtained two P0-specific monoclonal antibodies, but no antibody specific to P1, P2 or rRNA fragment. Two types of mAbs were found among these anti-P antibodies: one type (e.g. 9D5) reacted more strongly with the phosphorylated P1 and P2 than that with their non-phosphorylated forms, whereas the other type (e.g. 4H11) reacted equally with both phosphorylated and non-phosphorylated forms of P1/P2. Both 9D5 and 4H11 inhibited the ribosome/eukaryotic elongation factor-2 (eEF-2)-coupled guanosine triphosphate (GTP)ase activity. However, preincubation with a synthetic peptide corresponding to the C-terminal sequence common to all three P proteins, but not the peptide that lacked the last three C-terminal amino acids, mostly prevented the mAb-induced inhibition of GTPase activity. Thus, at least two types of anti-P were produced preferentially following the immunization of MRL mice with the reconstituted antigenic complex. Presence of multiple copies of the C-termini, particularly that of the last three C-terminal amino acid residues, in the antigenic complex appears to contribute to the immunogenic stimulus.	[Sato, H.; Narita, I.] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata 9502181, Japan; [Onozuka, M.; Hoshino, S.; Uchiumi, T.] Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan; [Hagiya, A.] Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 386, Japan	Uchiumi, T (reprint author), Niigata Univ, Fac Sci, Dept Biol, Nishi Ku, Ikarashi 2-8050, Niigata 9502181, Japan.	uchiumi@bio.sc.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23657087, 24370073]	We thank Drs Maki Touma, Kosuke Ito and Tomohiro Miyoshi (all from Niigata University) for their valuable comments and discussions on the present study. This work was supported by a Grant-in-Aid for Scientific Research (no. 23657087 and no. 24370073 to T. U.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Nomura N, 2012, P NATL ACAD SCI USA, V109, P3748, DOI 10.1073/pnas.1112934109; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Toubi E, 2007, AUTOIMMUN REV, V6, P119, DOI 10.1016/j.autrev.2006.07.004; Frolova L, 1996, RNA, V2, P334; Katzav A, 2007, ARTHRITIS RHEUM, V56, P938, DOI 10.1002/art.22419; Naganuma T, 2007, GENES CELLS, V12, P501, DOI 10.1111/j.1365-2443.2007.01067.x; HASLER P, 1991, J BIOL CHEM, V266, P13815; BONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503; SATO T, 1994, CLIN EXP IMMUNOL, V98, P35; ELKON K, 1986, P NATL ACAD SCI USA, V83, P7419, DOI 10.1073/pnas.83.19.7419; TAN EM, 1991, CELL, V67, P841, DOI 10.1016/0092-8674(91)90356-4; Baba K, 2013, NUCLEIC ACIDS RES, V41, P3635, DOI 10.1093/nar/gkt044; BONFA E, 1988, J IMMUNOL, V140, P3434; Carmona-Fernandes D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-98; Chen M, 2005, AUTOIMMUN REV, V4, P117, DOI 10.1016/j.autrev.2004.08.038; Chindalore V, 1998, CLIN IMMUNOL IMMUNOP, V87, P292, DOI 10.1006/clin.1998.4541; CHU JL, 1991, J EXP MED, V174, P507, DOI 10.1084/jem.174.3.507; COSTA O, 1986, J RHEUMATOL, V13, P722; EISENBERG RA, 1978, J EXP MED, V147, P582, DOI 10.1084/jem.147.2.582; ELKON KB, 1994, ADV EXP MED BIOL, V347, P81; Engvall E, 1980, Methods Enzymol, V70, P419; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; HINES JJ, 1991, J IMMUNOL, V146, P3386; Iwasaki K, 1979, Methods Enzymol, V60, P657; Kessenbrock K, 2007, J MOL MED-JMM, V85, P953, DOI 10.1007/s00109-007-0239-5; Lee KM, 2013, NUCLEIC ACIDS RES, V41, P8776, DOI 10.1093/nar/gkt636; Nagai T, 2005, ARTHRITIS RHEUM, V52, P847, DOI 10.1002/art.20869; Naganuma T, 2010, J BIOL CHEM, V285, P4747, DOI 10.1074/jbc.M109.068098; NAIRN AC, 1982, NATURE, V299, P734, DOI 10.1038/299734a0; Santos C, 2005, MOL MICROBIOL, V58, P217, DOI 10.1111/j.1365-2958.2005.04816.x; Shimizu T, 2002, NUCLEIC ACIDS RES, V30, P2620, DOI 10.1093/nar/gkf379; STCLAIR EW, 1990, J CLIN INVEST, V85, P515, DOI 10.1172/JCI114467; Treanor B, 2012, IMMUNOLOGY, V136, P21, DOI 10.1111/j.1365-2567.2012.03564.x; Uchiumi T, 1997, J BIOL CHEM, V272, P3302; UCHIUMI T, 1991, J BIOL CHEM, V266, P2054; UCHIUMI T, 1990, J BIOL CHEM, V265, P89; UCHIUMI T, 1986, EUR J BIOCHEM, V156, P37, DOI 10.1111/j.1432-1033.1986.tb09545.x; Uchiumi T, 2000, J BIOL CHEM, V275, P35116, DOI 10.1074/jbc.M004596200; UCHIUMI T, 1994, EMBO J, V13, P3389; VIDALES FJ, 1984, BIOCHEMISTRY-US, V23, P390, DOI 10.1021/bi00297a032; Zampieri S, 2003, CELL MOL LIFE SCI, V60, P588, DOI 10.1007/s000180300050; Zieve GW, 2003, AUTOIMMUN REV, V2, P235, DOI 10.1016/S1568-9972(03)00018-1	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	FEB	2015	179	2					236	244		10.1111/cei.12460		9	Immunology	Immunology	AX9PH	WOS:000347233800010		
J	Gabr, MH; Okumura, W; Ueda, H; Kuriyama, W; Uzawa, K; Kimpara, I				Gabr, Mohamed H.; Okumura, Wataru; Ueda, Hisai; Kuriyama, Wataru; Uzawa, Kiyoshi; Kimpara, Isao			Mechanical and thermal properties of carbon fiber/polypropylene composite filled with nano-clay	COMPOSITES PART B-ENGINEERING			English	Article						Carbon fiber; Fracture toughness; Thermal properties; Thermoplastic resin	FRACTURE-TOUGHNESS; SILICATE NANOCOMPOSITES; FIBER COMPOSITES; FATIGUE BEHAVIOR; REINFORCED EPOXY; NANOPARTICLES; PERFORMANCE; NANOFIBERS; ORGANOCLAY; CELLULOSE	The effect of organoclay on the mechanical and thermal properties of woven carbon fiber (CF)/compatibilized polypropylene (PPc) composites is investigated. Polypropylene-organoclay hybrids nanocomposites were prepared using a maleic anhydride-modified PP oligomer (PP-g-MA) as a compatibilizer. Different weight percentages of Nanomer (R) I-30E nanoclay were dispersed in PP/PP-g-MA (PPc) using a melt mixing method. The PPc/organoclay nanocomposite was then used to manufacture plain woven CF/PPc nanocomposites using molding compression process. CF/PPc/organoclay composites were characterized by different techniques, namely; dynamic mechanical analysis (DMA), fracture toughness and scanning electron microscope. The results revealed that at filler content 3% of organoclay, initiation and propagation interlaminar fracture toughness in mode I were improved significantly by 64% and 67% respectively, which could be explained by SEM at given weight as well; SEM images showed that in front of the tip, fibers pull out during initiation delamination accounting for fracture toughness improvement. Dynamic mechanical analysis showed enhancement in thermomechanical properties. With addition 3 wt.% of organoclay, the glass transition temperature increased by about 6 degrees C compared to neat CF/PPc composite indicating better heat resistance with addition of organoclay. (C) 2014 Elsevier Ltd. All rights reserved.	[Gabr, Mohamed H.; Uzawa, Kiyoshi; Kimpara, Isao] Kanazawa Inst Technol, Lab Integrated Technol Syst, Kanazawa, Ishikawa 9240838, Japan; [Gabr, Mohamed H.] Sohag Univ, Fac Ind Educ, Sohag 611111, Egypt; [Okumura, Wataru; Ueda, Hisai; Kuriyama, Wataru] Ind Res Inst Ishikawa, Kanazawa, Ishikawa 9208203, Japan	Gabr, MH (reprint author), Kanazawa Inst Technol, Lab Integrated Technol Syst, Kanazawa, Ishikawa 9240838, Japan.	mgabr@neptune.kanazawa-it.ac.jp			Regional Innovation Strategy Support Program (The Ministry of Education, Culture, Sports, Science and Technology (MEXT))	This work is a part of the Ishikawa Carbon Fiber Cluster Project supported by Regional Innovation Strategy Support Program (The Ministry of Education, Culture, Sports, Science and Technology (MEXT)).	Gardea F, 2014, COMPOS PART B-ENG, V56, P611, DOI 10.1016/j.compositesb.2013.08.032; Lee JH, 2005, COMPOS SCI TECHNOL, V65, P1996, DOI 10.1016/j.compscitech.2005.03.015; Jiang Q, 2014, COMPOS PART B-ENG, V56, P408, DOI 10.1016/j.compositesb.2013.08.064; Pandey JK, 2005, STARCH-STARKE, V57, P8, DOI 10.1002/star.200400313; Suin S, 2014, MATER DESIGN, V54, P553, DOI 10.1016/j.matdes.2013.08.091; Wetzel B, 2003, COMPOS SCI TECHNOL, V63, P2055, DOI 10.1016/S0266-3538(03)00115-5; Parija S, 2004, POLYM COMPOSITE, V25, P646, DOI 10.1002/pc.20059; Velmurugan R, 2007, COMPOS SCI TECHNOL, V67, P61, DOI 10.1016/j.compscitech.2006.03.032; Khan MZS, 1996, COMPOS SCI TECHNOL, V56, P695, DOI 10.1016/0266-3538(96)00052-8; CHARLESWORTH JM, 1988, POLYM ENG SCI, V28, P230, DOI 10.1002/pen.760280406; Shiu SC, 2014, COMPOS PART B-ENG, V56, P691, DOI 10.1016/j.compositesb.2013.09.007; Phong NT, 2013, MATER DESIGN, V47, P624, DOI 10.1016/j.matdes.2012.12.057; KIM JK, 1991, COMPOS SCI TECHNOL, V41, P333, DOI 10.1016/0266-3538(91)90072-W; Gabr MH, 2013, CELLULOSE, V20, P819, DOI 10.1007/s10570-013-9876-8; Shen ZQ, 2009, COMPOS SCI TECHNOL, V69, P239, DOI 10.1016/j.compscitech.2008.10.017; Silva RV, 2006, COMPOS SCI TECHNOL, V66, P1328, DOI 10.1016/j.compscitech.2005.10.012; Barakat NAM, 2009, J PHYS CHEM C, V113, P19452, DOI 10.1021/jp905667s; Gabr MH, 2010, COMPOS STRUCT, V92, P1999, DOI 10.1016/j.compstruct.2009.12.009; Becker O, 2003, J MATER SCI LETT, V22, P1411, DOI 10.1023/A:1025703212174; Chen Q, 2014, COMPOS PART B-ENG, V58, P43, DOI 10.1016/j.compositesb.2013.10.048; Diaz J, 2003, J MATER PROCESS TECH, V143, P342, DOI 10.1016/S0924-0136(03)00450-3; Gabr MH, 2010, COMPOS PART A-APPL S, V41, P1263, DOI 10.1016/j.compositesa.2010.05.010; Gabr MH, 2010, J MATER SCI, V45, P3841, DOI 10.1007/s10853-010-4439-y; Ge ML, 2009, J REINF PLAST COMP, V28, P5, DOI 10.1177/0731684407079493; HARISMENDY MR, 1997, POLYMER, V38, P5573; Jeencham R, 2014, COMPOS PART B-ENG, V56, P249, DOI 10.1016/j.compositesb.2013.08.012; MOHAMED HGA, 2014, POLYM TEST, V37, P51; Parlevliet PP, 2006, COMPOS PART A-APPL S, V37, P1847, DOI 10.1016/j.compositesa.2005.12.025; Phong NT, 2013, COMPOS STRUCT, V99, P380, DOI 10.1016/j.compstruct.2012.12.018; Phong NT, 2013, J MATER SCI, V48, P6039, DOI 10.1007/s10853-013-7400-z; Phonthammachai N, 2011, COMPOS PART A-APPL S, V42, P881, DOI 10.1016/j.compositesa.2011.02.014; Ramsaroop A, 2010, MAT SCI APPL, V01, P301, DOI 10.4236/msa.2010.15044; Ray D, 2002, COMPOS PART A-APPL S, V33, P233, DOI 10.1016/S1359-835X(01)00096-3; Shokrieh MM, 2012, MATER DESIGN, V40, P443, DOI 10.1016/j.matdes.2012.03.008; Takagi H, 2013, J REINF PLAST COMP, V32, P1542, DOI 10.1177/0731684413494109	35	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-8368	1879-1069		COMPOS PART B-ENG	Compos. Pt. B-Eng.	FEB	2015	69						94	100		10.1016/j.compositesb.2014.09.033		7	Engineering, Multidisciplinary; Materials Science, Composites	Engineering; Materials Science	AY0CY	WOS:000347266600012		
J	Piotrowski, LW; Casolino, M; Ebisuzaki, T; Higashide, K				Piotrowski, Lech Wiktor; Casolino, Marco; Ebisuzaki, Toshikazu; Higashide, Kazuhiro			The simulation of the LANFOS-H food radiation contamination detector using Geant4 package	COMPUTER PHYSICS COMMUNICATIONS			English	Article						LANFOS; Fukushima; Cs-137; Food radiation contamination; Scintillator		Recent incident in the Fukushima power plant caused a growing concern about the radiation contamination and resulted in lowering the Japanese limits for the permitted amount of Cs-137 in food to 100 Bq/kg. To increase safety and ease the concern we are developing LANFOS (Large Food Non-destructive Area Sampler) a compact, easy to use detector for assessment of radiation in food. Described in this paper LANFOS-H has a 4 pi coverage to assess the amount of Cs-137 present, separating it from the possible K-40 food contamination. Therefore, food samples do not have to be pre-processed prior to a test and can be consumed after measurements. It is designed for use by non-professionals in homes and small institutions such as schools, showing safety of the samples, but can be also utilized by specialists providing radiation spectrum. Proper assessment of radiation in food in the apparatus requires estimation of the gamma conversion factor of the detectors how many gamma photons will produce a signal. In this paper we show results of the Monte Carlo estimation of this factor for various approximated shapes of fish, vegetables and amounts of rice, performed with Geant4 package. We find that the conversion factor combined from all the detectors is similar for all food types and is around 37%, varying maximally by 5% with sample length, much less than for individual detectors. The different inclinations and positions of samples in the detector introduce uncertainty of 1.4%. This small uncertainty validates the concept of a 4 pi non-destructive apparatus. (C) 2014 Elsevier B.V. All rights reserved.	[Piotrowski, Lech Wiktor; Casolino, Marco; Ebisuzaki, Toshikazu; Higashide, Kazuhiro] RIKEN, Wako, Saitama, Japan; [Casolino, Marco] Ist Nazl Fis Nucl, Milan, Italy; [Casolino, Marco] Univ Roma Tor Vergata, I-00173 Rome, Italy	Piotrowski, LW (reprint author), RIKEN, 2-1 Hirosawa, Wako, Saitama, Japan.	lech.piotrowski@riken.jp		casolino, marco/0000-0001-6067-5104	Japanese Science and Technology Agency; JSPS	The authors would like to thank the Japanese Science and Technology Agency for its support. LWP acknowledges the support from JSPS Postdoctoral Fellowship for Foreign Researchers. Part of the Monte Carlo simulations were performed using the RIKEN Integrated Cluster of Clusters (RICC) facility.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0010-4655	1879-2944		COMPUT PHYS COMMUN	Comput. Phys. Commun.	FEB	2015	187						49	54		10.1016/j.cpc.2014.10.010		6	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	AX5GH	WOS:000346954200006		
J	Minoshima, T; Matsumoto, Y; Amano, T				Minoshima, Takashi; Matsumoto, Yosuke; Amano, Takanobu			A finite volume formulation of the multi-moment advection scheme for Vlasov simulations of magnetized plasma	COMPUTER PHYSICS COMMUNICATIONS			English	Article						Advection equation; Conservative form; Multi-moment; Vlasov simulations; Magnetized plasmas; Magnetic reconnection	MAXWELL SYSTEM; RECONNECTION; EQUATION; INTEGRATION; SPACE; CODE	We present a finite volume version of the multi-moment advection scheme (Minoshima et al., 2011, 2013). The scheme advances zeroth to second order piecewise moments at cell centers through their numerical fluxes obtained from one-dimensional high order interpolation. The modification simplifies the scheme without losing its high performance. We apply the scheme to two-dimensional electromagnetic Vlasov simulations of linear wave propagation and nonlinear magnetic reconnection problems. Our Vlasov simulation resolves microscopic structure of the non-Maxwellian plasma velocity distribution around the magnetic reconnection site as well as macroscopic structure of fluid quantities within the energy error of 2%, and is in good agreement with previous studies. (C) 2014 The Authors. Published by Elsevier B.V.	[Minoshima, Takashi] Japan Agcy Marine Earth Sci & Technol, Math Sci & Adv Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Matsumoto, Yosuke] Chiba Univ, Dept Phys, Inage Ku, Chiba 2638522, Japan; [Amano, Takanobu] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	Minoshima, T (reprint author), Japan Agcy Marine Earth Sci & Technol, Math Sci & Adv Technol, Kanazawa Ku, 3173-25 Syowa Machi, Yokohama, Kanagawa 2360001, Japan.	minoshim@jamstec.go.jp			JSPS [24740338]; Research Institute for Information Technology, Kyushu University	We thank an anonymous referee for careful review and insightful comments to improve our manuscript. This work was supported by JSPS Grant-in-Aid for Young Scientists (B) #24740338, and "Advanced Computational Scientific Program" of Research Institute for Information Technology, Kyushu University. T.M. thanks K. Fukazawa for technical supports on the use of the Fujitsu PRIMERGY CX400 system.	Sircombe NJ, 2009, J COMPUT PHYS, V228, P4773, DOI 10.1016/j.jcp.2009.03.029; Hoshino M, 2001, EARTH PLANETS SPACE, V53, P627; SAITO Y, 1995, J GEOPHYS RES, V100, P23567, DOI 10.1029/95JA01675; Zenitani S, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3662430; GODFREY BB, 1974, J COMPUT PHYS, V15, P504, DOI 10.1016/0021-9991(74)90076-X; EVANS CR, 1988, ASTROPHYS J, V332, P659, DOI 10.1086/166684; Crouseilles N, 2009, COMPUT PHYS COMMUN, V180, P1730, DOI 10.1016/j.cpc.2009.04.024; Shay MA, 2001, J GEOPHYS RES-SPACE, V106, P3759, DOI 10.1029/1999JA001007; Tsuneta S, 1996, ASTROPHYS J, V456, P840, DOI 10.1086/176701; Kuznetsova MM, 2001, J GEOPHYS RES-SPACE, V106, P3799, DOI 10.1029/1999JA001003; CHENG CZ, 1976, J COMPUT PHYS, V22, P330, DOI 10.1016/0021-9991(76)90053-X; Filbet F, 2001, J COMPUT PHYS, V172, P166, DOI 10.1006/jcph.2001.6818; Hoshino M, 2001, J GEOPHYS RES-SPACE, V106, P25979, DOI 10.1029/2001JA900052; Hesse M, 1999, PHYS PLASMAS, V6, P1781, DOI 10.1063/1.873436; Mangeney A, 2002, J COMPUT PHYS, V179, P495, DOI 10.1006/jcph.2002.7071; TERASAWA T, 1983, GEOPHYS RES LETT, V10, P475, DOI 10.1029/GL010i006p00475; Birdsall C. K., 1991, PLASMA PHYS VIA COMP; Ghizzo A, 2003, J COMPUT PHYS, V186, P47, DOI 10.1016/S0021-9991(03)00010-X; Higashimori K., 2012, J GEOPHYS RES, V117, P1220; Minoshima T, 2011, ASTR SOC P, V459, P277; Minoshima T, 2011, J COMPUT PHYS, V230, P6800, DOI 10.1016/j.jcp.2011.05.010; Minoshima T, 2013, J COMPUT PHYS, V236, P81, DOI 10.1016/j.jcp.2012.11.024; Nakamura T, 1999, COMPUT PHYS COMMUN, V120, P122, DOI 10.1016/S0010-4655(99)00247-7; Petschek H, 1964, PHYS SOLAR FLARES, P425; Pritchett PL, 2001, J GEOPHYS RES-SPACE, V106, P3783, DOI 10.1029/1999JA001006; Schmitz H, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2347101; Schmitz H, 2006, COMPUT PHYS COMMUN, V175, P86, DOI 10.1016/j.cpc.2006.02.007; Umeda T, 2009, COMPUT PHYS COMMUN, V180, P365, DOI 10.1016/j.cpc.2008.11.001	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0010-4655	1879-2944		COMPUT PHYS COMMUN	Comput. Phys. Commun.	FEB	2015	187						137	151		10.1016/j.cpc.2014.10.023		15	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	AX5GH	WOS:000346954200016		
J	Miyatake, Y				Miyatake, Yuto			A derivation of energy-preserving exponentially-fitted integrators for Poisson systems	COMPUTER PHYSICS COMMUNICATIONS			English	Article						Poisson systems; Energy-preserving method; Exponentially-fitted method	RUNGE-KUTTA METHODS; NUMERICAL-INTEGRATION; OSCILLATORY PROBLEMS; HAMILTONIAN-SYSTEMS; NYSTROM METHODS; GAUSS TYPE	Exponentially-fitted (EF) methods are special methods for ordinary differential equations that better compute periodic/oscillatory solutions. Such solutions often appear in Hamiltonian systems, and in view of this, symplectic or energy-preserving variants of EF methods have been intensively studied recently. In these studies, the symplectic variants have been further applied to Poisson systems, while such a challenge has not ever been done for the energy-preserving variants. In this paper, we propose an energy-preserving EF method for Poisson systems, with special emphasis on the second- and fourth-order schemes. (C) 2014 Elsevier B.V. All rights reserved.	Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Bunkyo Ku, Tokyo 1138656, Japan	Miyatake, Y (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	yuto_miyatake@mist.i.u-tokyo.ac.jp			Japan Society for the Promotion of Science	The author is thankful for various comments by the reviewers. The author is grateful to Takayasu Matsuo for his careful reading of this manuscript and helpful suggestions. The author is supported by the Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists.	Vanden Berghe G, 2001, J COMPUT APPL MATH, V132, P95, DOI 10.1016/S0377-0427(00)00602-6; Brugnano L, 2012, J COMPUT APPL MATH, V236, P3890, DOI 10.1016/j.cam.2012.02.033; Quispel GRW, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/4/045206; Cohen D, 2011, BIT, V51, P91, DOI 10.1007/s10543-011-0310-z; Vanden Berghe G, 2003, J COMPUT APPL MATH, V159, P217, DOI 10.1016/S0377-0427(03)00450-3; Franco JM, 2004, J COMPUT APPL MATH, V167, P1, DOI 10.1016/j.cam.2003.09.042; Ozawa K, 2005, JPN J IND APPL MATH, V22, P403; Franco JM, 2002, J COMPUT APPL MATH, V149, P407, DOI 10.1016/S0377-0427(02)00485-5; Paternoster B, 1998, APPL NUMER MATH, V28, P401, DOI 10.1016/S0168-9274(98)00056-7; McLachlan RI, 1999, PHILOS T R SOC A, V357, P1021, DOI 10.1098/rsta.1999.0363; D'Ambrosio R, 2014, J COMPUT APPL MATH, V263, P277, DOI 10.1016/j.cam.2013.12.022; Hollevoet D, 2012, J COMPUT APPL MATH, V236, P4006, DOI 10.1016/j.cam.2012.02.016; Ozawa K, 2001, JPN J IND APPL MATH, V18, P107; Simos TE, 1998, COMPUT PHYS COMMUN, V115, P1, DOI 10.1016/S0010-4655(98)00088-5; Brugnano L., 2010, J NUMER ANAL IND APP, V5, P17; Calvo M, 2010, COMPUT PHYS COMMUN, V181, P2044, DOI 10.1016/j.cpc.2010.08.019; Calvo M, 2008, COMPUT PHYS COMMUN, V178, P732, DOI 10.1016/j.cpc.2008.01.046; Calvo M, 2008, J COMPUT APPL MATH, V218, P421, DOI 10.1016/j.cam.2007.05.016; Calvo M, 2010, BIT, V50, P3, DOI 10.1007/s10543-010-0250-z; Calvo M., 2009, J COMPUT APPL MATH, V178, P387; D'Ambrosio R, 2012, APPL MATH COMPUT, V218, P7468, DOI 10.1016/j.amc.2012.01.014; Franco JM, 2004, APPL NUMER MATH, V50, P427, DOI 10.1016/j.apnum.2004.01.005; Franco JM, 2007, COMPUT PHYS COMMUN, V177, P479, DOI 10.1016/j.cpc.2007.05.003; Gonzalez O, 1996, J NONLINEAR SCI, V6, P449, DOI 10.1007/BF02440162; Hairer E., 2010, J NUMER ANAL IND APP, V5, P73; Hairer E., 2006, GEOMETRIC NUMERICAL; ITOH T, 1988, J COMPUT PHYS, V76, P85, DOI 10.1016/0021-9991(88)90132-5; Ixtru L.G., 2004, EXPONENTIAL FITTING; Miyatake Y., 2014, P ICNAAM 20 IN PRESS; Miyatake Y, 2014, BIT, V54, P777, DOI 10.1007/s10543-014-0474-4; Vanden Berghe G, 2011, NUMER ALGORITHMS, V56, P591, DOI 10.1007/s11075-010-9407-8; Vanden Berghe G, 1999, COMPUT PHYS COMMUN, V123, P7, DOI 10.1016/S0010-4655(99)00365-3; Vanden Berghe G, 2000, J COMPUT APPL MATH, V125, P107, DOI 10.1016/S0377-0427(00)00462-3; Van de Vyver H, 2005, NEW ASTRON, V10, P261, DOI 10.1016/j.newast.2004.12.004; Van De Vyver H, 2006, COMPUT PHYS COMMUN, V174, P255, DOI 10.1016/j.cpc.2005.10.007; You X, 2013, MATH COMPUT SIMULAT, V94, P76, DOI 10.1016/j.matcom.2013.05.010	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0010-4655	1879-2944		COMPUT PHYS COMMUN	Comput. Phys. Commun.	FEB	2015	187						156	161		10.1016/j.cpc.2014.11.003		6	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	AX5GH	WOS:000346954200018		
J	Pawankar, R; Hayashi, M; Yamanishi, S; Igarashi, T				Pawankar, Ruby; Hayashi, Miyuki; Yamanishi, Shingo; Igarashi, Toru			The paradigm of cytokine networks in allergic airway inflammation	CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						allergic rhinitis; asthma; IL-31; IL-33; Th17; Th2 cytokines; thymic stromal lymphopoietin	THYMIC STROMAL LYMPHOPOIETIN; INNATE LYMPHOID-CELLS; FC-EPSILON-RI; CHRONIC RHINOSINUSITIS; MAST-CELLS; INCREASED EXPRESSION; NASAL POLYPS; DISEASE SEVERITY; RHINITIS RISK; IGE SYNTHESIS	Purpose of review Cytokines are immunomodulatory proteins important in cell signaling. Complex interactions of innate and adaptive immune cells, as well as structural cells and their cytokines, play crucial roles in regulating allergic airway inflammation. Here, we summarize current knowledge about the potential roles of known and newly identified helper T cells and epithelial cell-derived cytokines [interleukin (IL)-9, IL-17, IL-22, IL-25, and IL-33] in allergic rhinitis and asthma. Recent findings Although T-helper (Th)2 cells were considered to be the main orchestrators of allergic airway inflammation, recent studies have revealed the potential interaction of other helper T cells and their cytokines in this process. Th17 cells may have a role in allergic rhinitis and asthma, and chronic rhinosinusitis with nasal polyps. An IL-9-producing subset called Th9 cells, Th22 cells which primarily secrete IL-22, IL-13, tumor necrosis factor-a, Th25 cells via producing IL-25 and epithelial cell-derived thymic stromal lymphopoietin, IL-33, IL-31, and IL-25 are believed to be important for the initiation of allergic reactions and inducing airway inflammation. Summary A new paradigm of an interplay of cytokines is important in allergic rhinitis and asthma in orchestrating the allergic inflammatory response. Potential therapeutic applications emerging from the roles of these cytokines are promising, but need further research.	[Pawankar, Ruby; Hayashi, Miyuki; Yamanishi, Shingo; Igarashi, Toru] Nippon Med Sch, Dept Pediat, Tokyo 1138603, Japan	Pawankar, R (reprint author), Nippon Med Sch, Dept Pediat, Div Allergy, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	pawankar.ruby@gmail.com					Amin K, 2001, J ALLERGY CLIN IMMUN, V107, P249, DOI 10.1067/mai.2001.112266; Erin EM, 2005, CLIN EXP ALLERGY, V35, P1608, DOI 10.1111/j.1365-2222.2005.02381.x; Onbasi K, 2005, CLIN EXP ALLERGY, V35, P1423, DOI 10.1111/j.1365-2222.2005.02351.x; Erin EM, 2005, ALLERGY, V60, P1524, DOI 10.1111/j.1398-9995.2005.00928.x; Kobayashi H, 2002, BLOOD, V99, P2214, DOI 10.1182/blood.V99.6.2214; Baumann R, 2013, CLIN EXP ALLERGY, V43, P1134, DOI 10.1111/cea.12148; Scadding GW, 2012, J IMMUNOL METHODS, V384, P25, DOI 10.1016/j.jim.2012.06.013; Pene J, 2008, J IMMUNOL, V180, P7423; Pawankar R, 2005, CHEM IMMUNOL ALLERGY, V87, P111; Okayama Y, 2009, EUR RESPIR J, V34, P425, DOI 10.1183/09031936.00121008; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Suto H, 2006, J IMMUNOL, V176, P4102; Baumann R, 2013, AM J RHINOL ALLERGY, V27, P266, DOI 10.2500/ajra.2013.27.3913; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Kamekura R, 2009, CELL TISSUE RES, V338, P283, DOI 10.1007/s00441-009-0855-1; Pawankar R, 2000, AM J RHINOL, V14, P309, DOI 10.2500/105065800781329582; Movahedi M, 2013, AM J OTOLARYNG, V34, P676, DOI 10.1016/j.amjoto.2013.05.002; Ying S, 2008, J IMMUNOL, V181, P2790; Ota K, 2014, J IMMUNOL RES, DOI 10.1155/2014/602846; Okano M, 2011, J ALLERGY CLIN IMMUN, V127, P277, DOI 10.1016/j.jaci.2010.09.029; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720; Nonaka M, 2004, CLIN EXP ALLERGY, V34, P804, DOI 10.1111/j.1365-2222.2004.01954.x; Otto BA, 2008, CURR OPIN OTOLARYNGO, V16, P270, DOI 10.1097/MOO.0b013e3282fb2885; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Pilette C, 2013, ALLERGY, V68, P312, DOI 10.1111/all.12090; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; Ying XJ, 2013, GENE, V521, P222, DOI 10.1016/j.gene.2013.03.088; Pawankar R, 1997, J CLIN INVEST, V99, P1492, DOI 10.1172/JCI119311; Kamekura R, 2012, CLIN EXP ALLERGY, V42, P218, DOI 10.1111/j.1365-2222.2011.03867.x; Figueroa DJ, 2003, CLIN EXP ALLERGY, V33, P1380, DOI 10.1046/j.1365-2222.2003.01786.x; Nouri-Aria KT, 2005, J ALLERGY CLIN IMMUN, V116, P73, DOI 10.1016/j.jaci.2005.03.011; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Van Zele T, 2014, AM J RHINOL ALLERGY, V28, P192, DOI 10.2500/ajra.2014.28.4033; Gluck J, 2012, INFLAMM RES, V61, P547, DOI 10.1007/s00011-012-0443-9; Ciprandi G, 2008, J ALLERGY CLIN IMMUN, V122, P650, DOI 10.1016/j.jaci.2008.06.005; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nakamaru Y, 2004, ANN OTO RHINOL LARYN, V113, P205; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Ishida A, 2012, ALLERGOL INT, V61, P589, DOI 10.2332/allergolint.11-OA-0370; Asaka D, 2012, INT ARCH ALLERGY IMM, V158, P47, DOI 10.1159/000337764; Bajoriuniene I, 2012, LUNG, V190, P487, DOI 10.1007/s00408-012-9411-y; Baumann Ralf, 2012, Clin Transl Allergy, V2, P13, DOI 10.1186/2045-7022-2-13; Bradding P, 1996, ANN NY ACAD SCI, V796, P272, DOI 10.1111/j.1749-6632.1996.tb32589.x; Casale TB, 2008, J ALLERGY CLIN IMMUN, V121, P288, DOI 10.1016/j.jaci.2007.11.040; Cheng D, 2014, AM J RESP CRIT CARE; Ciprandi G, 2010, ANN ALLERG ASTHMA IM, V104, P180, DOI 10.1016/j.anai.2009.11.043; Han DM, 2010, CLIN IMMUNOL, V136, P292, DOI 10.1016/j.clim.2010.03.006; Kimura S, 2011, ALLERGY ASTHMA IMMUN, V3, P186, DOI 10.4168/aair.2011.3.3.186; Klemens C, 2007, ALLERGY ASTHMA PROC, V28, P434, DOI 10.2500/aap.2007.28.3017; Liu W, 2014, PEDIAT RES; Liu Y, 2013, J ALLERGY CLIN IMMUN, V131, P387, DOI 10.1016/j.jaci.2012.11.027; Loza MJ, 2007, J ALLERGY CLIN IMMUN, V120, P578, DOI 10.1016/j.jaci.2007.05.019; Moore WC, 2014, J ALLERGY CLIN IMMUN, V6, P1557; Pawankar R, 2007, CURR OPIN ALLERGY CL, V7, P1, DOI 10.1097/ACI.0b013e3280145347; PAWANKAR RU, 1995, AM J RESP CRIT CARE, V152, P2059; Powe DG, 2000, CLIN OTOLARYNGOL, V25, P570, DOI 10.1046/j.1365-2273.2000.00422-2.x; Scadding GW, 2013, EAACI SERIN M LEUV M; Shah SA, 2013, PHARMACOLOGY, V91, P158, DOI 10.1159/000346609; SIM TC, 1995, AM J RESP CRIT CARE, V152, P927; Smurthwaite Lyn, 2002, Curr Allergy Asthma Rep, V2, P231, DOI 10.1007/s11882-002-0024-z; Terada N, 2001, AM J RESP CRIT CARE, V164, P575; Wang H, 2010, CLIN EXP ALLERGY, V40, P1194, DOI 10.1111/j.1365-2222.2010.03542.x; Wilson AM, 2005, CLIN EXP ALLERGY, V35, P39, DOI 10.1111/j.1365-2222.2004.02072.x; Ying XJ, 2012, GENE, V506, P179, DOI 10.1016/j.gene.2012.06.066; Zhang Y, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-79; Zhang Y, 2013, HUM IMMUNOL, V74, P241, DOI 10.1016/j.humimm.2012.11.004	72	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1528-4050	1473-6322		CURR OPIN ALLERGY CL	Curr. Opin. Allergy Clin. Immunol.	FEB	2015	15	1					41	48		10.1097/ACI.0000000000000129		8	Allergy; Immunology	Allergy; Immunology	AX9ZX	WOS:000347258500006		
J	Braido, F; Baiardini, I; Blasi, F; Pawankar, R; Canonica, GW				Braido, Fulvio; Baiardini, Ilaria; Blasi, Francesco; Pawankar, Ruby; Canonica, Giorgio W.			Adherence to asthma treatments: 'we know, we intend, we advocate'	CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						adherence; asthma; control; cost; manifesto	INHALED CORTICOSTEROIDS; MEDICATION ADHERENCE; ELECTRONIC MONITOR; DISEASE MANAGEMENT; OUTCOMES; PROGRAM; CARE; COMMUNITY	Purpose of review To highlight the state of the art and the current outlook on the adherence to treatment in asthma, starting from the `Manifesto on Adherence to asthma treatment in respiratory allergy' endorsed by the World Allergy Organization, Allergic Rhinitis and Its Impact on Asthma and Global Allergy, Asthma European Network, and Interasma. Recent findings Adherence to the pharmacological treatments of asthma is known to be low: about 50% of those who had been prescribed long-term treatment are nonadherent, at least part of the time. Nonadherence is associated with lack of asthma control, poor health outcomes, and increased costs. The reasons for suboptimal adherence are multifaceted and may be related to the patients, the treatment and asthma features, the physician-patient relationship, and the healthcare resources and facilities. Summary Taking into account the multidimensional nature of adherence, no single intervention or strategy is per se able to enhance it, but all players involved in the process (government authorities, patient organizations, scientific societies, stakeholders, and others) are called to work together to develop a combined action plan based on the patient's complexity.	[Braido, Fulvio; Baiardini, Ilaria; Canonica, Giorgio W.] Azienda Osped Univ IRCCS San Martino, Allergy & Resp Dis Dept, Genoa, Italy; [Blasi, Francesco] Univ Milan, IRCCS Fdn Ca Granda Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy; [Pawankar, Ruby] Nippon Med Sch, Dept Pediat, Div Allergy, Tokyo 113, Japan	Braido, F (reprint author), Azienda Osped Univ IRCCS San Martino, Allergy & Resp Dis Dept, Genoa, Italy.	fulvio.braido@unige.it			Associazione Ricerca Malattie Immunologiche e Allergiche (ARMIA); Associazione Pazienti Disturbi Respiratori nel Sonno (ASPADIRES)	This work was supported by the Associazione Ricerca Malattie Immunologiche e Allergiche (ARMIA) and Associazione Pazienti Disturbi Respiratori nel Sonno (ASPADIRES).	Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Gordon K, 2007, PATIENT EDUC COUNS, V65, P407, DOI 10.1016/j.pec.2006.09.012; Jentzsch NS, 2012, RESP MED, V106, P338, DOI 10.1016/j.rmed.2011.12.001; Desai M, 2011, CURR ALLERGY ASTHM R, V11, P454, DOI 10.1007/s11882-011-0227-2; Drotar D, 2009, J DEV BEHAV PEDIATR, V30, P574, DOI 10.1097/DBP.0b013e3181c3c3bb; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Armour C, 2007, THORAX, V62, P496, DOI 10.1136/thx.2006.064709; Tran N, 2014, J ASTHMA, V51, P536, DOI 10.3109/02770903.2014.888572; Baiardini I, 2009, CURR OPIN ALLERGY CL, V9, P228, DOI 10.1097/ACI.0b013e32832b4651; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Patel M, 2013, RESPIROLOGY, V18, P546, DOI 10.1111/resp.12059; AUGER KA, 2014, J PEDIAT; Barnes CB, 2014, RESP CARE; BATEMAN ED, 2014, ALLERGY CLIN IMMUNOL; BENDER BG, 2013, CHEST, V144, P428; BENDER DG, 2002, J ALLERGY CLIN IMM S, V109, pS554; Berg J, 1998, ANN BEHAV MED, V20, P36, DOI 10.1007/BF02893807; Braido F, 2011, J ASTHMA, V48, P266, DOI 10.3109/02770903.2011.555040; Braido F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-94; Brooks TL, 2014, J GEN INTERN MED, V29, P1506, DOI 10.1007/s11606-014-2940-8; Clatworthy Jane, 2009, Prim Care Respir J, V18, P300, DOI 10.4104/pcrj.2009.00037; Foster JM, 2012, J ASTHMA, V49, P657, DOI 10.3109/02770903.2012.684253; Foster JM, 2014, J ALLERGY CLIN IMMUN; GAUDE GS, 2014, FAMILY MED PRIM CARE, V3, P33; Hall RL, 2014, PATIENT PREFER ADHER, V8, P775, DOI 10.2147/PPA.S61248; Haynes RB, 2008, COCHRANE DB SYST REV, V2, P2, DOI DOI 10.1002/14651858.CD000011.PUB3; Kritikos V, 2007, J ASTHMA, V44, P57, DOI 10.1080/02770900601125755; Latry P, 2008, CLIN THER, V30, P1058, DOI 10.1016/j.clinthera.2008.06.011; Lindner Paul S, 2014, Conn Med, V78, P207; LINDNER PS, 2014, J MANAGE CARE PHARM, V20, P786; Morisky DE, 2009, HEALTH EDUC BEHAV, V36, P505, DOI 10.1177/1090198107311279; OCONOR R, 2014, CHEST, DOI DOI 10.1378/CHEST.14-0914; Sabate E, 2003, ADHERENCE LONG TERM; Sadatsafavi M, 2013, CHEST, V144, P428, DOI 10.1378/chest.12-2773; van Dulmen S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6363-7-55; Van Steenis MNA, 2014, PATIENT PREFER ADHER, V8, P83, DOI 10.2147/PPA.S44185; van Boven JFM, 2014, J MANAGE CARE PHARM, V20, P786; Wang KY, 2010, PHARM WORLD SCI, V32, P721, DOI 10.1007/s11096-010-9427-4; World Health Organization (WHO), 2003, ADHERENCE LONG TERM	39	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1528-4050	1473-6322		CURR OPIN ALLERGY CL	Curr. Opin. Allergy Clin. Immunol.	FEB	2015	15	1					49	55		10.1097/ACI.0000000000000132		7	Allergy; Immunology	Allergy; Immunology	AX9ZX	WOS:000347258500007		
J	Hraiech, S; Yoshida, T; Papazian, L				Hraiech, Sami; Yoshida, Takeshi; Papazian, Laurent			Balancing neuromuscular blockade versus preserved muscle activity	CURRENT OPINION IN CRITICAL CARE			English	Review						acute respiratory distress syndrome; mechanical ventilation; neuromuscular blockers; spontaneous breathing	RESPIRATORY-DISTRESS-SYNDROME; PRESSURE RELEASE VENTILATION; ACUTE LUNG INJURY; INTENSIVE-CARE-UNIT; CRITICAL ILLNESS POLYNEUROPATHY; PLEURAL SURFACE PRESSURE; MECHANICAL VENTILATION; BLOCKING-AGENTS; ESOPHAGEAL PRESSURE; PARALYSIS	Purpose of reviewAcute respiratory distress syndrome (ARDS) is still associated with a high mortality. The best way to ensure mechanical ventilation in ARDS patients is still debated, recent data arguing for a muscle paralysis and a controlled ventilation whereas other elements being in favor of a preserved spontaneous breathing. The purpose of this review is to discuss the benefits and the disadvantages of both strategies.Recent findingsRandomized controlled trials have brought the evidence that at the acute phase of ARDS, a 48-h administration of cisatracurium is associated with a decrease in mortality for the most severe hypoxemic patients. Other studies suggest that spontaneous breathing could be deleterious at this period. In the less severe patients (mild ARDS), however, a few studies have demonstrated the benefits of preserving spontaneous breathing with an improvement in oxygenation and a decrease in the length of mechanical ventilation.SummaryIn ARDS patients, the ventilator strategy should be a balance between muscle paralysis in the most hypoxemic patients and preserved spontaneous breathing after improvement or from the acute phase in less severe forms. However, monitoring plateau pressure, tidal volume and perhaps also transpulmonary pressure seems crucial to limit the occurrence of ventilator-induced lung injury.	[Hraiech, Sami; Papazian, Laurent] Hop Nord Marseille, Assistance Publ Hop Marseille, F-13015 Marseille, France; [Hraiech, Sami; Papazian, Laurent] Aix Marseille Univ, Fac Med, Marseille, France; [Yoshida, Takeshi] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, Osaka, Japan	Hraiech, S (reprint author), Hop Nord Marseille, Assistance Publ Hop Marseille, Chemin Bourrely, F-13015 Marseille, France.	sami.hraiech@ap-hm.fr					Akoumianaki E, 2014, AM J RESP CRIT CARE, V189, P520, DOI 10.1164/rccm.201312-2193CI; Alhazzani W, 2013, CRIT CARE, V17, DOI 10.1186/cc12557; Keenan JC, 2014, CURR OPIN CRIT CARE, V20, P63, DOI 10.1097/MCC.0000000000000054; Murray MJ, 2002, CRIT CARE MED, V30, P142, DOI 10.1097/00003246-200201000-00021; Hering R, 2002, INTENS CARE MED, V28, P1426, DOI 10.1007/s00134-002-1442-z; [Anonymous], 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Griffiths RD, 2010, CRIT CARE MED, V38, P779, DOI 10.1097/CCM.0b013e3181cc4b53; Hubmayr RD, 2002, AM J RESP CRIT CARE, V165, P1647, DOI 10.1164/rccm.2001080-01CP; Bolton CF, 2010, CAN J NEUROL SCI, V37, P431; Forel JM, 2006, CRIT CARE MED, V34, P2749, DOI 10.1097/01.CCM.0000239435.87433.0D; Sharshar T, 2009, CRIT CARE MED, V37, P3047, DOI 10.1097/CCM.0b013e3181b027e9; Talmor D, 2006, CRIT CARE MED, V34, P1389, DOI 10.1097/01.CCM.0000215515.49001.A2; Steingrub JS, 2014, CRIT CARE MED, V42, P90, DOI 10.1097/CCM.0b013e31829eb7c9; Gainnier M, 2004, CRIT CARE MED, V32, P113, DOI 10.1097/01.CCM.0000104114.72614.BC; Latronico N, 2005, CURR OPIN CRIT CARE, V11, P126, DOI 10.1097/01.ccx.0000155357.24360.89; Yoshida T, 2013, AM J RESP CRIT CARE, V188, P1420, DOI 10.1164/rccm.201303-0539OC; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Putensen C, 2001, AM J RESP CRIT CARE, V164, P43; Richard JCM, 2013, INTENS CARE MED, V39, P2003, DOI 10.1007/s00134-013-3032-7; HANSENFLASCHEN J, 1993, AM REV RESPIR DIS, V147, P234; Kaplan LJ, 2001, CRIT CARE, V5, P221, DOI 10.1186/cc1027; Putensen C, 2006, CURR OPIN CRIT CARE, V12, P13, DOI 10.1097/01.ccx.0000198994.37319.60; Slutsky AS, 2010, NEW ENGL J MED, V363, P1176, DOI 10.1056/NEJMe1007136; STOCK MC, 1987, CRIT CARE MED, V15, P462, DOI 10.1097/00003246-198705000-00002; Van den Berghe G, 2005, NEUROLOGY, V64, P1348; Guldner A, 2014, CURR OPIN CRIT CARE, V20, P69, DOI 10.1097/MCC.0000000000000055; Hedenstierna G, 2005, INTENS CARE MED, V31, P1327, DOI 10.1007/s00134-005-2761-7; Putensen C, 1999, AM J RESP CRIT CARE, V159, P1241; WITT NJ, 1991, CHEST, V99, P176, DOI 10.1378/chest.99.1.176; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Wrigge H, 2003, ANESTHESIOLOGY, V99, P376, DOI 10.1097/00000542-200308000-00019; Yoshida T, 2013, CRIT CARE MED, V41, P536, DOI 10.1097/CCM.0b013e3182711972; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Mehta S, 2006, CRIT CARE MED, V34, P374, DOI 10.1097/01.CCM.0000196830.61965.F1; Wrigge H, 2005, CRIT CARE, V9, pR780, DOI 10.1186/cc3908; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; BRISMAR B, 1985, ANESTHESIOLOGY, V62, P422, DOI 10.1097/00000542-198504000-00009; COGGESHALL JW, 1985, ARCH INTERN MED, V145, P1718, DOI 10.1001/archinte.145.9.1718; DANGELO E, 1974, J APPL PHYSIOL, V37, P311; DANGELO E, 1973, RESP PHYSIOL, V19, P356, DOI 10.1016/0034-5687(73)90039-X; De JB, 2002, JAMA-J AM MED ASSOC, V288, P2859; Gama de AM, 2012, CURR OPIN ANESTHESIO, V25, P148; HEDENSTIERNA G, 1985, ANESTHESIOLOGY, V62, P247, DOI 10.1097/00000542-198503000-00007; HOPPIN FG, 1969, J APPL PHYSIOL, V27, P863; KRUEGER JJ, 1961, J APPL PHYSIOL, V16, P465; Marini JJ, 2012, CURR OPIN CRIT CARE, V18, P1, DOI 10.1097/MCC.0b013e32834ef425; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Testelmans D, 2007, INTENS CARE MED, V33, P872, DOI 10.1007/s00134-007-0584-4; Weber-Carstens S, 2010, CRIT CARE, V14, DOI 10.1186/cc9074; Yoshida T, 2012, CRIT CARE MED, V40, P1578, DOI 10.1097/CCM.0b013e3182451c40	52	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-5295	1531-7072		CURR OPIN CRIT CARE	Curr. Opin. Crit. Care	FEB	2015	21	1					26	33		10.1097/MCC.0000000000000175		8	Critical Care Medicine	General & Internal Medicine	AX5OU	WOS:000346977300006		
J	Kamae, T; Widmer, S; Zamboni, LQ				Kamae, Teturo; Widmer, Steven; Zamboni, Luca Q.			Abelian maximal pattern complexity of words	ERGODIC THEORY AND DYNAMICAL SYSTEMS			English	Article								In this paper, we study the maximal pattern complexity of infinite words up to Abelian equivalence. We compute a lower bound for the Abelian maximal pattern complexity of infinite words which are both recurrent and aperiodic by projection. We show that in the case of binary words, the bound is actually achieved and gives a characterization of recurrent aperiodic words.	[Kamae, Teturo] Osaka City Univ, Adv Math Inst, Osaka 5588585, Japan; [Widmer, Steven] Univ N Texas, Dept Math, Denton, TX 76203 USA; [Zamboni, Luca Q.] Univ Lyon 1, Inst Camille Jordan, F-69622 Villeurbanne, France; [Zamboni, Luca Q.] Univ Turku, Dept Math, Turku 20014, Finland; [Zamboni, Luca Q.] Univ Turku, Turku Ctr Comp Sci, Turku 20014, Finland	Kamae, T (reprint author), Osaka City Univ, Adv Math Inst, Osaka 5588585, Japan.	kamae@apost.plala.or.jp; s.widmer1@gmail.com; lupastis@gmail.com			Academy of Finland	The third author is supported by a FiDiPro grant from the Academy of Finland.	Kamae T, 2002, ERGOD THEOR DYN SYST, V22, P1191, DOI 10.1017/S014338570200055X; Richomme G, 2011, J LOND MATH SOC, V83, P79, DOI 10.1112/jlms/jdq063; Coven E., 1973, MATH SYST THEORY, V7, P138, DOI 10.1007/BF01762232; Morse M, 1940, AM J MATH, V62, P1, DOI 10.2307/2371431; Kamae T, 2011, ERGOD THEOR DYN SYST, V31, P1445, DOI 10.1017/S014338571000074X; Kamae T, 2006, EUR J COMBIN, V27, P125, DOI 10.1016/j.ejc.2004.07.006; McCutcheon R., 1999, LECT NOTES MATH, V1722	7	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0143-3857	1469-4417		ERGOD THEOR DYN SYST	Ergod. Theory Dyn. Syst.	FEB	2015	35		1				142	151		10.1017/etds.2013.51		10	Mathematics, Applied; Mathematics	Mathematics	AX8MA	WOS:000347162300006		
J	Tsuda, Y; Nakamura, R; Osajima, S; Matsuda, T				Tsuda, Yusuke; Nakamura, Ryuichi; Osajima, Syouko; Matsuda, Takaaki			Surface wettability controllable polyimides bearing long-chain alkyl groups via phenyl ester linkages by ultraviolet light irradiation	HIGH PERFORMANCE POLYMERS			English	Article						Polyimide; long-chain alkyl group; UV irradiation; surface wettability; printed electronics	DESIGN	The novel polyimides and copolyimides are synthesized from the diamines having three long-chain alkyl groups connected by phenyl ester linkages, 5-(2,5-dioxotetrahydrofuryl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride or diphenylsulfonetetracarboxylic dianhydride as a tetracarboxylic dianhydride, and 4,4'-diaminodiphenylether as a diamine comonomer. These polyimides show good film-forming ability and good thermal properties. The thin films of obtained polyimides were irradiated by ultraviolet (UV) light ((max) = 254 nm), and the contact angles for the water decreased from near 100 degrees (hydrophobicity) to near 20 degrees (hydrophilicity) in proportion to irradiated UV light energy. From the result of attenuated total reflectance analysis, it is recognized that the hydrophobic long-chain alkyl groups on the polyimide surface decrease and the hydrophilic groups such as carboxyl groups and hydroxyl groups generate on their surface. Thus, the surface wettability of these polyimides can be controlled by UV light irradiation, and this method is expected to be applied in the field of printed electronics.	[Tsuda, Yusuke; Nakamura, Ryuichi; Osajima, Syouko; Matsuda, Takaaki] Kurume Natl Coll Technol, Dept Biochem & Appl Chem, Kurume, Fukuoka 8308555, Japan	Tsuda, Y (reprint author), Kurume Natl Coll Technol, Dept Biochem & Appl Chem, Komorino 1-1-1, Kurume, Fukuoka 8308555, Japan.	tsuda@kurume-nct.ac.jp			RICOH Co. Ltd; Toyohashi University of Technology	Financial supports from RICOH Co. Ltd and Toyohashi University of Technology are gratefully acknowledged.	Tsuda Y, 2000, POLYM J, V32, P594, DOI 10.1295/polymj.32.594; Balagurusamy VSK, 1997, J AM CHEM SOC, V119, P1539, DOI 10.1021/ja963295i; Tsuda Y, 2008, POLYM J, V40, P354, DOI 10.1295/polymj.PJ2007169; Ghosh M. K., 1996, POLYIMIDES FUNDAMENT; Hasegawa M, 2001, PROG POLYM SCI, V26, P259, DOI DOI 10.1016/S0079-6700(00)00042-3; HOYLE CE, 1992, POLYMER, V33, P3162, DOI 10.1016/0032-3861(92)90229-P; Kim C, 2012, ACS APPL MATER INTER, V4, P2168, DOI 10.1021/am300160s; Klan P, 2009, PHOTOCHEMISTRY ORGAN, P386; Miital KL, 2009, POLYIMIDES OTHER HIG, V5; Percec V, 2000, J AM CHEM SOC, V122, P4249, DOI 10.1021/ja9943400; Suzuki K, 2011, JOURNAL OF THE IMAGI, V50, P142; Tsuda Y., 2011, FEATURES LIQUID CRYS, P3; Tsuda Y, 2009, POLYIMIDES AND OTHER HIGH-TEMPERATURE POLYMERS: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS, VOL 5, P17; Tsuda Y, 2009, INT J MOL SCI, V10, P5031, DOI 10.3390/ijms10115031; Tsuda Y, 2000, POLYM J, V32, P941, DOI 10.1295/polymj.32.941; Tsuda Y, 2006, POLYM J, V38, P1043, DOI 10.1295/polymj.PJ2005257; Tsuda Y, 2011, KOBUNSHI RONBUNSHU, V68, P24, DOI 10.1295/koron.68.24	17	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-0083	1361-6412		HIGH PERFORM POLYM	High Perform. Polym.	FEB	2015	27	1					46	58		10.1177/0954008314538466		13	Polymer Science	Polymer Science	AX8JL	WOS:000347155800006		
J	Tsukamoto, K; Koba, S; Tsuru, M; Oie, Y				Tsukamoto, Kazuya; Koba, Shun; Tsuru, Masato; Oie, Yuji			Cognitive Radio-Aware Transport Protocol for Mobile Ad Hoc Networks	IEEE TRANSACTIONS ON MOBILE COMPUTING			English	Article						Transport protocol; cognitive radio; mobile ad hoc network; multi-hop communication	CONGESTION CONTROL; PERFORMANCE; TCP	With the proliferation of new wireless service, scarce wireless resources is expected to become a critical issue. For this reason, cognitive radio mobile ad hoc networks (CogMANET) are being developed as a promising solution to this problem. However, in CogMANET, channel switching is inherently necessary whenever a primary user with a license appears on the channel. Allowing secondary users to choose an available channel from among a wide spectrum range thus enables reliable communication in this context, but communication characteristics such as bottleneck bandwidth and RTT will change with channel switch. In response to this change, TCP has to adaptively update its congestion window (cwnd) to make an efficient use of the available resources. For this purpose, TCP CRAHN was proposed for CogMANET. In this paper, TCP CRAHN is first evaluated in cases where bottleneck bandwidth and RTT drastically change. Based on these results, TCP CoBA is proposed to further improve the throughput of the above use cases. TCP CoBA updates the cwnd based upon the available buffer space in the relay node upon channel switch, as well as other communication characteristics. Through simulations, we show that compared with TCP CRAHN, TCP CoBA improves the throughput by up to 200 percent.	[Tsukamoto, Kazuya; Koba, Shun; Tsuru, Masato; Oie, Yuji] Kyushu Inst Technol, Dept Comp Sci & Elect, Iizuka, Fukuoka 8208502, Japan	Tsukamoto, K (reprint author), Kyushu Inst Technol, Dept Comp Sci & Elect, Iizuka, Fukuoka 8208502, Japan.	tsukamoto@cse.kyutech.ac.jp	Oie, Yuji/C-8885-2009		JSPS KAKENHI [25330107]	This study was supported in part by the JSPS KAKENHI (25330107).	Lee WY, 2008, IEEE T WIREL COMMUN, V7, P3845, DOI 10.1109/T-WC.2008.070391; Katabi D, 2002, ACM SIGCOMM COMP COM, V32, P89, DOI 10.1145/964725.633035; Liu J, 2001, IEEE J SEL AREA COMM, V19, P1300, DOI 10.1109/49.932698; Al-Ali AK, 2013, AD HOC NETW, V11, P1836, DOI 10.1016/j.adhoc.2013.04.007; Lim WS, 2009, COMPUT COMMUN, V32, P134, DOI 10.1016/j.comcom.2008.09.034; Sundaresan K, 2005, IEEE T MOBILE COMPUT, V4, P588, DOI 10.1109/TMC.2005.81; Chowdhury KR, 2013, IEEE T MOBILE COMPUT, V12, P790, DOI 10.1109/TMC.2012.59; Chen K., 2003, P IEEE ICC MAY, P1080; Felice M. D., 2011, ELSEVIER PERFORM EVA, V68, P859; Grieco LA, 2004, ACM SIGCOMM COMP COM, V34, P25, DOI 10.1145/997150.997155; Jain R., 1984, DECTR301; Kim W., 2011, P 4 INT C COGN RAD A, P44; Kondareddy Y. R., 2009, P IEEE GLOBECOM, P1; Li F, 2007, 2007 FOURTH INTERNATIONAL CONFERENCE ON BROADBAND COMMUNICATIONS, NETWORKS & SYSTEMS, VOLS 1 AND 2, P846; Luo CQ, 2011, WIREL NETW, V17, P479, DOI 10.1007/s11276-010-0292-9; Mascolo S., 2001, P 7 ANN INT C MOB CO, P287, DOI 10.1145/381677.381704; Sarkar D., 2010, P IEEE INFOCOM COMP, P1; Slingerland A., 2007, P 2 IEEE INT S NEW F, P486; Tsukamoto K., 2008, P INT C WIR ACC VEH; Wellens M, 2008, IET COMMUN, V2, P772, DOI 10.1049/iet-com:20070480	20	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1536-1233	1558-0660		IEEE T MOBILE COMPUT	IEEE. Trans. Mob. Comput.	FEB	2015	14	2					288	301		10.1109/TMC.2014.2320267		14	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AX7LS	WOS:000347098100005		
J	Odkhuu, E; Koide, N; Tsolmongyn, B; Jambalganiin, U; Naiki, Y; Komatsu, T; Yoshida, T; Yokochi, T				Odkhuu, Erdenezaya; Koide, Naoki; Tsolmongyn, Bilegtsaikhan; Jambalganiin, Ulziisaikhan; Naiki, Yoshikazu; Komatsu, Takayuki; Yoshida, Tomoaki; Yokochi, Takashi			Involvement of redox balance in in vitro osteoclast formation of RAW 264.7 macrophage cells in response to LPS	INNATE IMMUNITY			English	Article						Glutathione; lipopolysaccharide; osteoclastogenesis; reactive oxygen species; redox state	COLONY-STIMULATING FACTOR; NUCLEAR-FACTOR; RECEPTOR ACTIVATOR; GENE-EXPRESSION; DIFFERENTIATION; LIPOPOLYSACCHARIDE; BONE; MODULATION; LIGAND; IMPAIRMENT	Here we report that LPS induces osteoclast (OC) formation in murine RAW 264.7 macrophage cells in RPMI-1640 medium but not in -minimum essential medium (-MEM) as the original culture medium. LPS-induced OC formation in both media was examined to clarify the differential response. Receptor activator of NF-B ligand induced OC formation in either -MEM or RPMI-1640 medium. However, LPS-induced OC formation in RAW 264.7 cells maintained in RPMI-1640 medium, but not -MEM, which was also supported by mouse bone marrow-derived macrophages, although they were less sensitive to LPS than RAW 264.7 cells. LPS augmented the expression of nuclear factor of activated T-cells (NFATc1) as a key transcription factor of osteoclastogenesis in cells maintained in RPMI-1640 medium, but reduced it in cells maintained in -MEM. A high concentration of LPS was cytotoxic against cells maintained in -MEM. Glutathione exclusively present in RPMI-1640 medium prevented LPS-induced cell death in -MEM and augmented LPS-induced NFATc1 expression, followed by enhanced LPS-induced OC formation. LPS induced higher generation of reactive oxygen species in -MEM than RPMI-1640 medium. An antioxidant enhanced LPS-induced OC formation, whereas a pro-oxidant reduced it. Taken together, redox balance in the culture condition was suggested to regulate invitro LPS-induced OC formation.	[Odkhuu, Erdenezaya; Koide, Naoki; Tsolmongyn, Bilegtsaikhan; Jambalganiin, Ulziisaikhan; Naiki, Yoshikazu; Komatsu, Takayuki; Yoshida, Tomoaki; Yokochi, Takashi] Aichi Med Univ, Sch Med, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan; [Odkhuu, Erdenezaya] Hlth Sci Univ Mongolia, Dept Anat, Ulaanbaatar, Mongol Peo Rep	Yokochi, T (reprint author), Aichi Med Univ, Sch Med, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan.	yokochi@aichi-med-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [S1101027]	This work was supported, in part, by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, and a grant of Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2011-2015 (S1101027).	Noman ASM, 2010, IMMUNOL LETT, V131, P166, DOI 10.1016/j.imlet.2010.04.006; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Nason R, 2009, JARO-J ASSOC RES OTO, V10, P151, DOI 10.1007/s10162-008-0153-8; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Takami M, 2002, J IMMUNOL, V169, P1516; Takahashi Naoyuki, 2007, V135, P285; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Nair SP, 1996, INFECT IMMUN, V64, P2371; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Le Nihouannen D, 2010, BONE, V46, P1336, DOI 10.1016/j.bone.2009.11.021; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Islam S, 2007, BIOCHEM BIOPH RES CO, V360, P346, DOI 10.1016/j.bbrc.2007.06.023; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Tumurkhuu G, 2007, FEMS IMMUNOL MED MIC, V49, P304, DOI 10.1111/j.1574-695X.2006.00203.x; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; FELIX R, 1990, J BONE MINER RES, V5, P781; FERNBACH SK, 1983, SKELETAL RADIOL, V10, P43; Huh YJ, 2006, CELL DEATH DIFFER, V13, P1138, DOI 10.1038/sj.cdd.4401793; Ishii J, 2008, J CELL BIOCHEM, V105, P896, DOI 10.1002/jcb.21886; Islam S, 2008, MICROBIOL IMMUNOL, V52, P585, DOI 10.1111/j.1348-0421.2008.00076.x; Kim H, 2006, FEBS LETT, V580, P5661, DOI 10.1016/j.febslet.2006.09.015; Mendjargal A, 2013, INT IMMUNOPHARMACOL, V15, P671, DOI 10.1016/j.intimp.2013.02.014; Odkhuu E, 2012, IMMUNOL LETT, V142, P34, DOI 10.1016/j.imlet.2011.12.001; Sigma-Aldrich, CLASS MED SALTS; Silva MJB, 2011, J DENT RES, V90, P495, DOI 10.1177/0022034510391792; Wilson Michael, 1995, Science Progress, V78, P19; Zhuang L, 2007, LARYNGOSCOPE, V117, P841, DOI 10.1097/MLG.0b013e318033783a	33	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-4259	1753-4267		INNATE IMMUN-LONDON	Innate Immun.	FEB	2015	21	2					194	202		10.1177/1753425914524242		9	Biochemistry & Molecular Biology; Immunology; Medicine, Research & Experimental; Microbiology	Biochemistry & Molecular Biology; Immunology; Research & Experimental Medicine; Microbiology	AX7AI	WOS:000347068800008		
J	El-Sharkavvy, II; Uddin, K; Miyazaki, T; Saha, BB; Koyama, S; Kil, HS; Yoon, SH; Miyawaki, J				El-Sharkavvy, Ibrahim I.; Uddin, Kutub; Miyazaki, Takahiko; Saha, Bidyut Baran; Koyama, Shigeru; Kil, Hyun-Sig; Yoon, Seong-Ho; Miyawaki, Jin			Adsorption of ethanol onto phenol resin based adsorbents for developing next generation cooling systems	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Adsorption cooling; Adsorption isotherms; Ethanol; Kinetics; Phenol resin	CARBON MOLECULAR-SIEVE; ACTIVATED CARBON; WATER-ADSORPTION; METHANOL; DIOXIDE; PAIRS	Adsorption characteristics of ethanol onto two promising adsorbents have been investigated for developing high performance adsorption chillers. These new adsorbents are based on spherical phenol resin treated with different mass ratios of KOH named as KOH4-PR and KOH6-PR. Experimental adsorption isotherm measurements show that the adsorption capacity of KOH4-PR/ethanol is as high as 1.43 kg kg(-1) whilst one kg of KOH6-PR able to adsorb nearly about 2 kg of ethanol. To the best of our knowledge, the studied adsorbents possess the highest ethanol uptake. Moreover, it is found that the KOH4-PR/ethanol pair has notably high adsorption kinetics at the lower range of adsorption temperatures. Experimental measurements of adsorption uptake and adsorption uptake rate of the studied pairs have been analyzed and isosteric heats of adsorption have also been extracted. (C) 2014 Elsevier Ltd. All rights reserved.	[El-Sharkavvy, Ibrahim I.; Miyazaki, Takahiko; Koyama, Shigeru] Kyushu Univ, Fac Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Uddin, Kutub; Saha, Bidyut Baran; Koyama, Shigeru; Yoon, Seong-Ho; Miyawaki, Jin] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [El-Sharkavvy, Ibrahim I.] Mansoura Univ, Fac Engn, Dept Power Mech Engn, Mansoura, Egypt; [Kil, Hyun-Sig; Yoon, Seong-Ho; Miyawaki, Jin] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan; [El-Sharkavvy, Ibrahim I.; Uddin, Kutub; Miyazaki, Takahiko; Saha, Bidyut Baran; Koyama, Shigeru] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan; [Miyawaki, Jin] Kyushu Univ, Res & Educ Ctr Adv Energy Mat Devices & Syst, Kasuga, Fukuoka 8190395, Japan	Saha, BB (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga Koen 6-1, Kasuga, Fukuoka 8168580, Japan.	saha.baran.bidyut.213@m.kyushu-u.ac.jp		El-Sharkawy, Ibrahim I./0000-0003-2690-9661	Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST)	This work was financially supported by Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST). Authors also thank to Asahi Organic Chemicals Industry Co., Ltd., Japan for providing BEAPS (R) samples.	Wang RZ, 1997, J SOL ENERG-T ASME, V119, P214, DOI 10.1115/1.2888021; Aristov YI, 2002, APPL THERM ENG, V22, P191, DOI 10.1016/S1359-4311(01)00072-2; Gordeeva L, 2014, APPL ENERG, V117, P127, DOI 10.1016/j.apenergy.2013.11.073; El-Sharkawy II, 2006, APPL THERM ENG, V26, P859, DOI 10.1016/j.applthermaleng.2005.10.010; Choudhury B, 2010, RENEW SUST ENERG REV, V14, P2189, DOI 10.1016/j.rser.2010.03.025; Saha BB, 2011, J CHEM ENG DATA, V56, P1974, DOI 10.1021/je100973t; El-Sharkawy II, 2014, INT J HEAT MASS TRAN, V73, P445, DOI 10.1016/j.ijheatmasstransfer.2014.02.046; El-Sharkawy II, 2009, INT J REFRIG, V32, P1579, DOI 10.1016/j.ijrefrig.2009.06.011; Henninger SK, 2012, INT J REFRIG, V35, P543, DOI 10.1016/j.ijrefrig.2011.10.004; Solmus I, 2010, APPL ENERG, V87, P2062, DOI 10.1016/j.apenergy.2009.11.027; Henninger SK, 2010, APPL THERM ENG, V30, P1692, DOI 10.1016/j.applthermaleng.2010.03.028; Aristov YI, 2012, APPL THERM ENG, V42, P18, DOI 10.1016/j.applthermaleng.2011.02.024; Chua HT, 2002, J CHEM ENG DATA, V47, P1177, DOI 10.1021/je0255067; Crank J., 1956, MATH DIFFUSION; Tamainot-Telto Z, 2009, INT J REFRIG, V32, P1212, DOI 10.1016/j.ijrefrig.2009.01.008; El-Sharkawy II, 2014, APPL ENERG, V126, P235, DOI 10.1016/j.apenergy.2014.03.092; Oliveira RG, 2010, CHEM ENG TECHNOL, V33, P1679, DOI 10.1002/ceat.201000075; PASSOS E, 1986, J HEAT RECOV SYST, V6, P259, DOI 10.1016/0198-7593(86)90010-X; Rutherford SW, 2004, LANGMUIR, V20, P8681, DOI 10.1021/la049330d; Rutherford SW, 2003, CARBON, V41, P405, DOI 10.1016/S0008-6223(02)00318-4; Ruthven D. M., 1984, PRINCIPLES ADSORPTIO; RUTHVEN DM, 1992, CHEM ENG SCI, V47, P4305, DOI 10.1016/0009-2509(92)85108-N; Saha BB, 2012, INT J REFRIG, V35, P499, DOI 10.1016/j.ijrefrig.2011.05.002; Saha BB, 2009, INT J REFRIG, V32, P1563, DOI 10.1016/j.ijrefrig.2009.03.010; Uddin K., APPL THERM ENG	25	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	FEB	2015	81						171	178		10.1016/j.ijheatmasstransfer.2014.10.012		8	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	AX5FE	WOS:000346951400020		
J	Chen, ZH; Utaka, Y				Chen, Zhihao; Utaka, Yoshio			On heat transfer and evaporation characteristics in the growth process of a bubble with microlayer structure during nucleate boiling	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Numerical simulation; VOF; Nucleate pool boiling; Phase change heat transfer; Microlayer evaporation	SIMULATION; ETHANOL; VOLUME; FLOWS; WATER	We have previously observed and experimentally measured a microlayer formed beneath a growing bubble during nucleate pool boiling. The initial microlayer thickness was of micrometer order and increased linearly with distance from the bubble inception site. The quantitative degree of contribution of the microlayer evaporation to bubble growth was still not elucidated, although a large number of experimental studies have been conducted on the distribution and evaporation characteristics of the microlayer. To clarify the heat transfer characteristics, especially the contribution of microlayer evaporation in nucleate pool boiling, numerical simulations are performed here for two phase vapor-liquid flow induced by the growth of a single bubble using the volume of fluid method. Furthermore, a special model is proposed to combine the microlayer and bulk liquid regions, the scales of which are extremely different in the simulations. The microlayer was neglected in the volume fraction calculation, while the evaporation from the microlayer was included by applying the source terms of the basic equations for the presence of a virtual microlayer. Similar tendencies were observed between the calculated and experimental results on the variations in the microlayer radius and bubble volume. The proportion of microlayer evaporation to total bubble volume was generally in agreement with the previous results, and the ratio of microlayer evaporation to the change in the total bubble volume was approximately 40 percent. (C) 2014 Elsevier Ltd. All rights reserved.	[Chen, Zhihao; Utaka, Yoshio] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2408501, Japan	Utaka, Y (reprint author), Yokohama Natl Univ, Fac Engn, Tokiwadai 79-5, Yokohama, Kanagawa 2408501, Japan.	utaka@ynu.ac.jp					Utaka Y, 2013, INT J HEAT MASS TRAN, V57, P222, DOI 10.1016/j.ijheatmasstransfer.2012.10.031; ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Utaka Y, 2014, INT J HEAT MASS TRAN, V68, P479, DOI 10.1016/j.ijheatmasstransfer.2013.09.063; Kunkelmann C, 2009, NUMER HEAT TR A-APPL, V56, P631, DOI 10.1080/10407780903423908; Haelssig JB, 2010, INT J HEAT MASS TRAN, V53, P3947, DOI 10.1016/j.ijheatmasstransfer.2010.05.013; KOFFMAN LD, 1983, J HEAT TRANS-T ASME, V105, P625; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; Fluent Inc, 2006, FLUENT 6 3 US GUID; Fujita Y., 1977, T JPN SOC MECH ENG, V43, P4586; Jiang YY, 2013, INT J HEAT MASS TRAN, V56, P640, DOI 10.1016/j.ijheatmasstransfer.2012.09.006; Nakamura K., 2008, T JPN SOC MECH ENG-B, V74, P2560; Ohnaka I., 1985, INTRO COMPUTATIONAL, V202; Ose Y., 2009, PROG MULTIPHASE FLOW, V4, P29; Sanna A, 2009, APPL THERM ENG, V29, P1327, DOI 10.1016/j.applthermaleng.2008.05.021; Sharp R., 1964, D1997 NASA TN; STEPHAN P, 1994, WARME STOFFUBERTRAG, V30, P119; Utaka Y., 2008, T JAPAN SOC MECH E B, V74, P2358; Yabuki T., 2010, T JPN SOC MECH ENG-B, V76, P1932; Youngs D.L., 1982, NUMERICAL METHODS FL, P273	20	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	FEB	2015	81						750	759		10.1016/j.ijheatmasstransfer.2014.10.058		10	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	AX5FE	WOS:000346951400071		
J	Horiuchi, K; Nishihara, A; Sugimura, K				Horiuchi, Keisuke; Nishihara, Atsuo; Sugimura, Kazuyuki			Multi-objective optimization of water-cooled pinfin heatsinks	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Optimization; Pinfin heatsink; Pareto ranking method	HEAT-TRANSFER; CROSS-FLOW; FIN ARRAYS; CONVECTION	This paper presents the multi-objective optimization of water-cooled pinfin heatsinks. The heat transfer rate and pressure drop were the objective functions, and four parameters (height, diameter, longitudinal pitch, and transverse pitch) of pinfin geometry were the design variables. The relationship between the objective functions and the design variables for pinfin heatsink was calculated by using our own semi-analytical equations. We applied two kinds of constraints. One is the clearance distance between the tip of the pins and the flow channel wall, and the other is the minimum gap between pins considering cost-effectiveness and manufacturability. The best trade-off curves between the pressure drop and the heat transfer rate were calculated using genetic algorithm. We found the similarity of the best trade-off curves under two different constraint conditions when the multiplication of the pin height and the minimum gap between pins were the same. We also showed that the small clearance causes the reduction of pressure drop while maintaining high heat transfer performance. Our calculated solutions were validated by comparing with experimental results. The pressure drops could be predicted within an error of 30%, and the effective heat transfer rates agreed within an error of 10%. (C) 2014 Elsevier Ltd. All rights reserved.	[Horiuchi, Keisuke; Nishihara, Atsuo; Sugimura, Kazuyuki] Hitachi Ltd, Hitachi Res Lab, Hitachinaka, Ibaraki 3120034, Japan	Horiuchi, K (reprint author), Hitachi Ltd, Hitachi Res Lab, 832-2 Horiguchi, Hitachinaka, Ibaraki 3120034, Japan.	keisuke.horiuchi.oa@hitachi.com					Khan WA, 2006, INT J HEAT MASS TRAN, V49, P4831, DOI 10.1016/j.ijheatmasstransfer.2006.05.042; Li P, 2008, NUMER HEAT TR A-APPL, V53, P418, DOI 10.1080/10407780701632759; METZGER DE, 1982, J HEAT TRANS-T ASME, V104, P700; Chiang KT, 2006, INT COMMUN HEAT MASS, V33, P836, DOI 10.1016/j.icheatmasstransfer.2006.04.011; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Matos RS, 2001, INT J HEAT MASS TRAN, V44, P3953, DOI 10.1016/S0017-9310(01)00006-0; Simpson TW, 2001, AIAA J, V39, P2233, DOI 10.2514/2.1234; Dogruoz MB, 2005, INT J HEAT MASS TRAN, V48, P5058, DOI 10.1016/j.ijheatmasstransfer.2005.07.004; BRIGHAM BA, 1984, J ENG GAS TURB POWER, V106, P241; Haley S. W., 1982, 82GT138 ASME; Horiuchi K., 2010, 21 INT S TRANSP PHEN, VIS01-04; Horiuchi K., 2009, ASME INT MECH ENG C; Horiuchi K., 2013, J ENERGY POWER ENG, V7, P1487; Khan W. A., 2006, 44 AIAA AER SCI M EX; Kraus A. D., 1983, THERMAL ANAL CONTROL, P76; Lee TH, 2007, INT J OFFSHORE POLAR, V17, P132; METZGER DE, 1984, J ENG GAS TURB POWER, V106, P252; Metzger D. E., 1986, 86GT132 ASME; Metzger D.E., 1982, PRESSURE LOSS HEAT T, V3, P137; SIMONEAU RJ, 1984, J HEAT TRANS-T ASME, V106, P42; VanFossen G.J., 1982, ASME, V104, P268; Zapach T., 2000, 7 INT C THERM THERM, P63; Zukauskas A., 1972, ADV HEAT TRANSFER, V8, P93, DOI 10.1016/S0065-2717(08)70038-8	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	FEB	2015	81						760	766		10.1016/j.ijheatmasstransfer.2014.10.057		7	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	AX5FE	WOS:000346951400072		
J	Yaji, K; Yamada, T; Kubo, S; Izui, K; Nishiwaki, S				Yaji, Kentaro; Yamada, Takayuki; Kubo, Seiji; Izui, Kazuhiro; Nishiwaki, Shinji			A topology optimization method for a coupled thermal-fluid problem using level set boundary expressions	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Topology optimization; Level set method; Phase field method; Thermal-fluid; Heat sink	MICROCHANNEL HEAT SINKS; NAVIER-STOKES FLOW; STRUCTURAL OPTIMIZATION; DESIGN; SHAPE; CONDUCTION	This paper presents a topology optimization method for a coupled thermal-fluid problem based on the two- and three-dimensional steady-state Navier-Stokes and energy equations. In this research, the optimization problem is formulated as a heat exchange maximization problem to obtain structures that function as high-performance cooling devices. Such devices, for example, liquid-cooled heat sinks, have recently attracted considerable attention as an engineering application for thermal cooling devices. The proposed optimization method employs level set boundary expressions and a Tikhonov-based regularization scheme enables qualitative control of the geometric complexity of the optimal configurations. Using the developed methodology, we provide two- and three-dimensional numerical examples that confirm the applicability, from an engineering standpoint, of the optimization method for the design of cooling devices. (C) 2014 Elsevier Ltd. All rights reserved.	[Yaji, Kentaro; Yamada, Takayuki; Izui, Kazuhiro; Nishiwaki, Shinji] Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan; [Kubo, Seiji] IHI Corp, R&D Technol Ctr, Numer Engn Dept, Isogo Ku, Yokohama, Kanagawa 2358501, Japan	Yaji, K (reprint author), Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan.	yaji.kentarou.74v@st.kyoto-u.ac.jp	Yamada, Takayuki/C-9652-2010	Yamada, Takayuki/0000-0002-5349-6690	Grant for Environmental Research Projects from The Sumitomo Foundation; JSPS KAKENHI [24760119]	This work was supported in part by a Grant for Environmental Research Projects from The Sumitomo Foundation, and JSPS KAKENHI Grant No. 24760119. In addition, we would like to thank Tsuguo Kondoh for his valuable comments and advice on the theory of computational fluid dynamics.	Anflor CTM, 2009, INT J HEAT MASS TRAN, V52, P4604, DOI 10.1016/j.ijheatmasstransfer.2009.02.048; TUCKERMAN DB, 1981, ELECTRON DEVIC LETT, V2, P126; MALLADI R, 1995, IEEE T PATTERN ANAL, V17, P158, DOI 10.1109/34.368173; Li Q, 2004, INT J HEAT MASS TRAN, V47, P5071, DOI 10.1016/j.ijheatmasstransfer.2004.06.010; Allaire G, 2004, J COMPUT PHYS, V194, P363, DOI 10.1016/j.jcp.2003.09.032; Otomori M, 2012, COMPUT METHOD APPL M, V237, P192, DOI 10.1016/j.cma.2012.04.022; Kim SJ, 2000, INT J HEAT MASS TRAN, V43, P1735, DOI 10.1016/S0017-9310(99)00259-8; Li Q, 1999, INT J HEAT MASS TRAN, V42, P3361, DOI 10.1016/S0017-9310(99)00008-3; Qu WL, 2002, INT J HEAT MASS TRAN, V45, P3973, DOI 10.1016/S0017-9310(02)00101-1; Wang MY, 2003, COMPUT METHOD APPL M, V192, P227, DOI 10.1016/S0045-7825(02)00559-5; Kim SJ, 2004, HEAT TRANSFER ENG, V25, P37, DOI 10.1080/01457630490248359; Yaji K, 2014, J COMPUT PHYS, V274, P158, DOI 10.1016/j.jcp.2014.06.004; Borrvall T, 2003, INT J NUMER METH FL, V41, P77, DOI 10.1002/fld.426; Sokolowski J, 1999, SIAM J CONTROL OPTIM, V37, P1251, DOI 10.1137/S0363012997323230; Bruns TE, 2007, INT J HEAT MASS TRAN, V50, P2859, DOI 10.1016/j.ijheatmasstransfer.2007.01.039; Husain A, 2008, APPL THERM ENG, V28, P1101, DOI 10.1016/j.applthermaleng.2007.12.001; Koo J, 2005, INT J HEAT MASS TRAN, V48, P2652, DOI 10.1016/j.ijheatmasstransfer.2005.01.029; Zhou SW, 2008, J COMPUT PHYS, V227, P10178, DOI 10.1016/j.jcp.2008.08.022; BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2; Errico RM, 1997, B AM METEOROL SOC, V78, P2577, DOI 10.1175/1520-0477(1997)078<2577:WIAAM>2.0.CO;2; Morini GL, 2004, INT J THERM SCI, V43, P631, DOI 10.1016/j.ijthermalsci.2004.01.003; Koga AA, 2013, INT J HEAT MASS TRAN, V64, P759, DOI [10.1016/j.ijheatmasstransfer.2013.05.007, 10.1016/ijheatmasstransfer.2013.05.007]; Gersborg-Hansen A, 2005, STRUCT MULTIDISCIP O, V30, P181, DOI 10.1007/s00158-004-0508-7; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Yamada T, 2010, COMPUT METHOD APPL M, V199, P2876, DOI 10.1016/j.cma.2010.05.013; Deng YB, 2011, J COMPUT PHYS, V230, P6688, DOI 10.1016/j.jcp.2011.05.004; Matsumori T, 2013, STRUCT MULTIDISCIP O, V47, P571, DOI 10.1007/s00158-013-0887-8; Sigmund O, 2013, STRUCT MULTIDISCIP O, V48, P1031, DOI 10.1007/s00158-013-0978-6; MISSAGGIA LJ, 1989, IEEE J QUANTUM ELECT, V25, P1988, DOI 10.1109/3.35223; Olesen LH, 2006, INT J NUMER METH ENG, V65, P975, DOI 10.1002/nme.1468; WHITAKER S, 1986, TRANSPORT POROUS MED, V1, P3, DOI 10.1007/BF01036523; Yamada T, 2011, J COMPUT INF SCI ENG, V11, DOI 10.1115/1.3563049; Yoon GH, 2012, COMPUT METHOD APPL M, V209, P28, DOI 10.1016/j.cma.2011.11.005; Zhuang CG, 2007, COMPUT METHOD APPL M, V196, P1074, DOI 10.1016/j.cma.2006.08.005	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	FEB	2015	81						878	888		10.1016/j.ijheatmasstransfer.2014.11.005		11	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	AX5FE	WOS:000346951400083		
J	Ijioma, ER; Muntean, A; Ogawa, T				Ijioma, Ekeoma Rowland; Muntean, Adrian; Ogawa, Toshiyuki			Effect of material anisotropy on the fingering instability in reverse smoldering combustion	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Review						Reverse smoldering; Anisotropy; Homogenization; Combustion instability; Fingering pattern	POWER-LAW FLUIDS; FILTRATION COMBUSTION; POROUS-MEDIA; PATTERN-FORMATION; PREMIXED FLAMES; MACROSCOPIC DESCRIPTION; PROPAGATION; HOMOGENIZATION; DIFFUSION; TRANSPORT	It is well known from experiments that a sample of thin porous material burning against an oxidizing air under microgravity exhibits various finger-like char patterns. The patterns are classified into three distinct types depending on the oxidizer flow rate. (I) Sparse fingers; (II) tip-splitting fingers; (III) connected front. We presently extend our modeling strategy based on the homogenization approach, which has been applied for the case of isotropic porous media, to analyze the pattern behavior on anisotropic porous media. In order to understand the characteristic features of the patterns based on the influence of the local structure, we simply rely on fixed anisotropic two-dimensional geometries representative of the microstructure of interest. Thus, we illustrate numerically the consequence of the material anisotropy on the fingering patterns based on effective diffusion tensors calculated using the homogenization method and the mechanism of thermal-diffusion instability. Besides revealing new insights on the experimental observations, our numerical results show that material anisotropy can influence the uniformity on the patterns, but the distinct fingering regimes are independent of the local microstructure of materials. This effect is consistent with the qualitative experimental findings from Zik and Moses (1999). (C) 2014 Elsevier Ltd. All rights reserved.	[Ijioma, Ekeoma Rowland; Ogawa, Toshiyuki] Meiji Univ, Meiji Inst Adv Study Math Sci MIMS, Nakano Ku, Tokyo 1648525, Japan; [Ogawa, Toshiyuki] Meiji Univ, Grad Sch Adv Math Sci, Nakano Ku, Tokyo 1648525, Japan; [Muntean, Adrian] Eindhoven Univ Technol, Dept Math & Comp Sci, Ctr Analysis Sci Comp & Applicat CASA, ICMS, NL-5600 MB Eindhoven, Netherlands	Ijioma, ER (reprint author), Meiji Univ, Meiji Inst Adv Study Math Sci MIMS, Nakano Ku, 4-21-1 Nakano, Tokyo 1648525, Japan.	e.r.ijioma@gmail.com; a.muntean@tue.nl; tshogw@gmail.com		Ijioma, Ekeoma/0000-0002-5631-2500	Meiji Institute for Advanced Study of Mathematical Sciences (MIMS)	This work is supported by the Meiji Institute for Advanced Study of Mathematical Sciences (MIMS). E. R. Ijioma thanks Professor Elisha Moses (Weizmann Institute of Science) for insightful discussion.	Aldushin AP, 2009, DOKL PHYS CHEM, V427, P125, DOI 10.1134/S0012501609070033; Aldushin AP, 1998, COMBUST SCI TECHNOL, V133, P293, DOI 10.1080/00102209808952038; Allaire G., 2002, CHEM ENG SCI, V65, P2292; ALLAIRE G, 1992, SIAM J MATH ANAL, V23, P1482, DOI 10.1137/0523084; AURIAULT JL, 1983, INT J HEAT MASS TRAN, V26, P861; Kagan L, 2008, COMBUST THEOR MODEL, V12, P269, DOI 10.1080/13647830701639462; OHLEMILLER TJ, 1983, COMBUST FLAME, V54, P131, DOI 10.1016/0010-2180(83)90027-5; Kim JS, 1996, J FLUID MECH, V327, P273, DOI 10.1017/S0022112096008543; SCHULT DA, 1995, COMBUST FLAME, V101, P471, DOI 10.1016/0010-2180(94)00239-O; Ijioma ER, 2013, COMBUST THEOR MODEL, V17, P185, DOI 10.1080/13647830.2012.734860; Zik O, 1998, PHYS REV LETT, V81, P3868, DOI 10.1103/PhysRevLett.81.3868; Yazdchi K, 2011, INT J MULTIPHAS FLOW, V37, P956, DOI 10.1016/j.ijmultiphaseflow.2011.05.003; MATKOWSKY BJ, 1978, SIAM J APPL MATH, V35, P465, DOI 10.1137/0135038; SIVASHINSKY GI, 1983, ANNU REV FLUID MECH, V15, P179, DOI 10.1146/annurev.fl.15.010183.001143; Orgeas L, 2006, CHEM ENG SCI, V61, P4490, DOI 10.1016/j.ces.2006.01.046; QUINTARD M, 1994, ADV WATER RESOUR, V17, P221, DOI 10.1016/0309-1708(94)90002-7; Ikeda K, 2008, HIROSHIMA MATH J, V38, P349; Wahle CW, 2003, COMBUST SCI TECHNOL, V175, P1389, DOI 10.1080/00102200390218921; Auriault J. -L., 2009, HOMOGENIZATION COUPL; AURIAULT JL, 1991, INT J ENG SCI, V29, P785, DOI 10.1016/0020-7225(91)90001-J; Auriault JL, 2002, INT J ENG SCI, V40, P1151, DOI 10.1016/S0020-7225(02)00007-1; Bakhvalov N., 1989, MATH ITS APPL SOVIET, V36; Bensoussan A., 1978, STUDIES MATH ITS APP, V5; Chen R.-H., 1992, S INT COMBUSTION, V24, P213, DOI 10.1016/S0082-0784(06)80030-5; Cheng P, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011939; Donato P., 1999, INTRO HOMOGENIZATION; Fasano A., 2009, MATH METHOD APPL SCI, P1; Fatima T., 2014, 00042201402181 MEIJ; Gan F., 2013, APPL MATH MECH, V2013, P1; Hashin Z., 1983, J APPL MECH, V50, P483; Hu L., 2013, MODELING SIMULATION; Ijioma E.R., 2014, THESIS MEIJI U TOKYO; Kadowaki S, 2005, COMBUST FLAME, V143, P174, DOI 10.1016/j.combustflame.2005.05.012; Kagan L, 1996, PHYS REV E, V53, P6021, DOI 10.1103/PhysRevE.53.6021; Kang SH, 2003, COMBUST THEOR MODEL, V7, P343, DOI 10.1088/1364-7830/7/2/308; Kechagia PE, 2002, CHEM ENG SCI, V57, P2565, DOI 10.1016/S0009-2509(02)00124-0; Lu CA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036201; Lu ZB, 2011, COMBUST THEOR MODEL, V15, P795, DOI 10.1080/13647830.2011.564658; Muntean A., 2011, LECT NOTES I MATH IN, V34; OHLEMILLER TJ, 1985, PROG ENERG COMBUST, V11, P277, DOI 10.1016/0360-1285(85)90004-8; Olson SL, 1998, TWENTY-SEVENTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P2525; Ozerkovskaya NI, 2010, COMBUST EXPLO SHOCK+, V46, P515, DOI 10.1007/s10573-010-0067-8; PELCE P, 1982, J FLUID MECH, V124, P219, DOI 10.1017/S002211208200247X; Sanchez-Palencia E., 1985, LECT NOTES PHYS, V272; Shkadinskii KG, 1996, COMBUST EXPLO SHOCK+, V32, P667, DOI 10.1007/BF02111568; Szymkiewicz A., 2004, THESIS GDANSK U TECH; Whitaker S., 1998, THEORY APPL TRANSPOR, V13; Zik O., 1999, AM PHYS SOC, V60, P518; Zik O., 1998, P COMBUST INST, V27, P2815	49	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	FEB	2015	81						924	938		10.1016/j.ijheatmasstransfer.2014.11.021		15	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	AX5FE	WOS:000346951400087		
J	Bessho, S; Hayashi, M				Bessho, Shun-ichiro; Hayashi, Masayoshi			Should the Japanese tax system be more progressive? An evaluation using the simulated SMCFs based on the discrete choice model of labor supply	INTERNATIONAL TAX AND PUBLIC FINANCE			English	Article						Social marginal cost of public funds; Discrete choice model; Household labor supply; Japan	COST-BENEFIT-ANALYSIS; MARGINAL COST; PUBLIC FUNDS; UNITED-KINGDOM; INCOME; WORK; TAXATION; REFORM; PARTICIPATION; ELASTICITIES	This study proposes a method to obtain the social marginal costs of public funds (SMCF) that allows for heterogeneity on a household basis as well as labor supply responses along both the extensive and the intensive margins. To demonstrate our methodology, we take the example of the 1999 national income tax reform in Japan and evaluate it by estimating the SMCFs for changing marginal tax rates in different income brackets. We estimate the discrete choice model (DCM) of labor supply using a 1997 data set of Japanese households, and we use the estimates to generate the SMCFs with a DCM micro-simulation. We evaluate the simulated SMCFs with various distributional weights and find that the value of the SMCF for a 1 % increase in the marginal tax rate in any given income bracket decreases as we move across brackets from the bottom to the top. This finding suggests that the national government should have made the Japanese income tax system more progressive rather than less progressive as carried out in the 1999 reform. Our method is readily transferrable to tax reforms in other countries as well.	[Bessho, Shun-ichiro] Keio Univ, Fac Econ, Minato Ku, Tokyo 1088345, Japan; [Hayashi, Masayoshi] Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan	Bessho, S (reprint author), Keio Univ, Fac Econ, Minato Ku, 2-15-45 Mita, Tokyo 1088345, Japan.	bessho@econ.keio.ac.jp; hayashim@e.u-tokyo.ac.jp					Aaberge R, 2004, J POPUL ECON, V17, P767; Aaberge R, 2013, SCAND J ECON, V115, P449, DOI 10.1111/sjoe.12015; Kimmel J, 1998, J MONETARY ECON, V42, P289, DOI 10.1016/S0304-3932(98)00023-3; Hoynes HW, 1996, ECONOMETRICA, V64, P295, DOI 10.2307/2171784; Creedy J, 2005, J ECON SURV, V19, P697, DOI 10.1111/j.0950-0804.2005.00265.x; Fleurbaey M, 2013, HEALTH ECON, V22, P711, DOI 10.1002/hec.2859; VANSOEST A, 1995, J HUM RESOUR, V30, P63, DOI 10.2307/146191; Brewer M, 2006, LABOUR ECON, V13, P699, DOI 10.1016/j.labeco.2005.11.002; Peichl A, 2012, LABOUR ECON, V19, P129, DOI 10.1016/j.labeco.2011.09.007; Kleven HJ, 2006, J PUBLIC ECON, V90, P1955, DOI 10.1016/j.jpubeco.2006.03.006; Haan P, 2006, APPL ECON LETT, V13, P251, DOI 10.1080/13504850500396348; Pacifico D, 2013, EMPIR ECON, V45, P929, DOI 10.1007/s00181-012-0637-6; Bargain O, 2006, LABOUR ECON, V13, P667, DOI 10.1016/j.labeco.2005.10.007; Baldini M., 2009, RIV ITALIANA EC, V14, P191; Bargain O., 2011, IZA DISCUSSION PAPER, V5820; Bargain O., 2012, J HUMAN RES IN PRESS, V6753; Bargain O, 2009, ECON LETT, V105, P103, DOI 10.1016/j.econlet.2009.06.019; Bessho S., 2005, J ASIAN EC, V16, P956, DOI 10.1016/j.asieco.2005.10.008; Bessho S., 2013, PUBLIC FINANC REV, V41, P360; Bessho Shun-ichiro, 2011, Journal of Asian Economics, V22, DOI 10.1016/j.asieco.2011.05.007; Blundell R, 1999, HDB LABOR EC A, P1559, DOI 10.1016/S1573-4463(99)03008-4; Blundell R., 2000, FISCAL STUDIES, V21, P75, DOI 10.1111/j.1475-5890.2000.tb00581.x; Blundell R., 1999, JOINT CTR POV RES C; BRENT RJ, 1984, PUBLIC FINANC QUART, V12, P213, DOI 10.1177/109114218401200206; Brewer M., 2005, DID WORKING FAMILIES; Brink A, 2007, INT TAX PUBLIC FINAN, V14, P457, DOI 10.1007/s10797-007-9030-3; Callan Tim, 2009, LABOUR, V23, P1; Creedy J., 2011, J APPL EC, V14, P2; Creedy J., 2006, LABOR SUPPLY MICROSI; Dagsvik JK, 2011, EMPIR ECON, V40, P779, DOI 10.1007/s00181-010-0367-6; Dahlby B., 2008, MARGINAL COST PUBLIC; Dahlby B, 1998, J PUBLIC ECON, V67, P105, DOI 10.1016/S0047-2727(97)00049-2; Decoster A., 2010, CTR EC STUDIES DISCU, V10.30; DODGSON JS, 1980, MANCH SCH ECON SOC, V48, P1, DOI 10.1111/j.1467-9957.1980.tb00708.x; DODGSON JS, 1983, EUR ECON REV, V20, P59, DOI 10.1016/0014-2921(83)90057-0; Duncan A, 2002, ECON REC, V78, P264, DOI 10.1111/1475-4932.00056; Ericson P., 2009, 4379 IZA; FELDSTEIN M, 1976, J PUBLIC ECON, V6, P77, DOI 10.1016/0047-2727(76)90042-6; Fleurbaey M., 2006, INEQUALITY EC INTEGR, P225; Fleurbaey M., 2008, 25 OPHI; Fuest C, 2008, CESIFO ECON STUD, V54, P73, DOI 10.1093/cesifo/ifn003; Gerfin M, 2007, GER ECON REV, V8, P447, DOI 10.1111/j.1468-0475.2007.00414.x; Gong XD, 2002, J HUM RESOUR, V37, P163, DOI 10.2307/3069607; Haan P, 2010, GER ECON REV, V11, P278; Hayashi M., 2010, SOCIAL PROTECTION E, P19; Hayashi M., 2009, JPN EC, V36, P106; Liu L., 2006, PUB FIN REV, V34, P60, DOI 10.1177/1091142105278152; Mych M., 2006, REV ECON HOUSEHOLD, V4, P129; Poapongsakorn N, 2000, INT TAX PUBLIC FINAN, V7, P63, DOI 10.1023/A:1008706113216; Preston I., 1999, J POPUL ECON, V12, P243; Sandmo A, 1998, J PUBLIC ECON, V70, P365, DOI 10.1016/S0047-2727(98)00040-1; Shalhoub M., 2011, AM J MATH MODELING, V1, P1; Steiner V., 2005, EMPIRICA, V32, P91, DOI 10.1007/s10663-005-1982-x; Steiner V., 2004, CESIFO ECON STUD, V50, P541, DOI 10.1093/cesifo/50.3.541; van Soest A, 2001, ECONOMIST-NETHL, V149, P191, DOI 10.1023/A:1017531304601; Vermeulen F, 2006, J POPUL ECON, V19, P99, DOI 10.1007/s00148-005-0007-1	56	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0927-5940	1573-6970		INT TAX PUBLIC FINAN	Int. Tax Public Financ.	FEB	2015	22	1					144	175		10.1007/s10797-014-9303-6		32	Economics	Business & Economics	AY0JP	WOS:000347283300006		
J	Inoue, T; Kohno, K; Baba, H; Takeshima, M; Honma, H; Nakai, Y; Suzuki, T; Hatano, K; Arai, H; Matsubara, S; Kusumi, I; Terao, T				Inoue, Takeshi; Kohno, Kentaro; Baba, Hajime; Takeshima, Minoru; Honma, Hiroshi; Nakai, Yukiei; Suzuki, Toshihito; Hatano, Koji; Arai, Heii; Matsubara, Shigehiro; Kusumi, Ichiro; Terao, Takeshi			Does temperature or sunshine mediate the effect of latitude on affective temperaments? A study of 5 regions in Japan	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Latitude; Temperature; Sunshine; Hyperthymic temperament	TEMPS-A; HYPERTHYMIC TEMPERAMENT; POPULATION	Background: Previously, we compared the hyperthymic scores of residents in Sapporo, Koshigaya, and Oita (which are located at latitudes of 43 degrees N, 36 degrees N, and 33 degrees N in Japan, respectively) using the Temperament Evaluation of Memphis, Pisa, Paris and San Diego-auto questionnaire version (TEMPS-A). We found that residents who lived at lower latitudes had higher hyperthymic temperament scores; however, the mechanism of the effect of latitude on hyperthymic temperament remained unclear. The current study examined the mediators of the latitude effect in additional regions with different annual temperatures and amounts of ambient sunshine. Methods: The Japanese archipelago stretches over 4000 km from north to south and has four large islands: Hokkaido, Honshu, Shikoku, and Kyushu. In addition to the TEMPS-A previously reported data collected at Sapporo (latitude 43 degrees N), Koshigaya (36 degrees N), and Oita (33 degrees N), we collected the TEMPS-A data of 189 and 106 residents from Takaoka (36 degrees N) and Obihiro (42 degrees N), respectively. Taken together, these five regions have different patterns (i.e., highs and lows) of annual ambient total sunshine (hours) and mean temperature (degrees C). The effect of latitude, sunshine, and temperature on affective temperaments was analyzed for five Japanese regions. Results: Multiple regression analyses revealed that latitude predicted significant variance in hyperthymic temperament. Ambient temperature, but not sunshine, significantly affected hyperthymic temperament. Limitations: The light exposure that residents actually received was not measured. The number of regions studied was limited. The findings might not generalize to residents across Japan or other countries. Conclusions: The present findings suggest that latitude affects hyperthymic temperament, and ambient temperature might mediate this effect. (C) 2014 Elsevier B.V. All rights reserved	[Inoue, Takeshi; Nakai, Yukiei; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kohno, Kentaro; Hatano, Koji; Terao, Takeshi] Oita Univ, Fac Med, Dept Neuropsychiat, Oita, Japan; [Baba, Hajime; Suzuki, Toshihito; Arai, Heii] Juntendo Univ, Sch Med, Dept Psychiat, Chiba, Japan; [Baba, Hajime; Suzuki, Toshihito; Arai, Heii] Juntendo Koshigaya Hosp, Dept Psychiat, Saitama, Japan; [Takeshima, Minoru] Kouseiren Takaoka Hosp, Dept Psychiat, Takaoka, Toyama, Japan; [Takeshima, Minoru] J Clin, Kanazawa, Ishikawa 9200024, Japan; [Honma, Hiroshi; Matsubara, Shigehiro] Obihiro Natl Hosp, Dept Psychiat, Obihiro, Hokkaido, Japan	Inoue, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	tinoue@med.hokudai.ac.jp; terao@oita-u.ac.jp			Japanese Society for the Promotion of Science [24591723]	A Grant-in-Aid for Scientific Research (C) (24591723) from the Japanese Society for the Promotion of Science, the "Integrated research on neuropsychiatric disorders" program conducted under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and a grant from the Interdisciplinary Project for Psychosomatological Research at Hokkaido University supported this work. We greatly appreciate Dr. Tsuyoshi Akiyama for Isis permission to use the TEMPS-A Japanese version.	Akiyama T, 2005, J AFFECT DISORDERS, V85, P93, DOI 10.1016/j.jad.2004.01.011; Matsumoto S, 2005, J AFFECT DISORDERS, V85, P85, DOI 10.1016/j.jad.2003.10.001; Nakai Y, 2014, J AFFECT DISORDERS, V158, P101, DOI 10.1016/j.jad.2014.02.004; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Rovai L, 2013, EUR REV MED PHARMACO, V17, P2065; Gonda X, 2011, J AFFECT DISORDERS, V131, P45, DOI 10.1016/j.jad.2010.12.003; Harada M, 2013, J AFFECT DISORDERS, V151, P763, DOI 10.1016/j.jad.2013.06.017; Hoaki N, 2011, PSYCHOPHARMACOLOGY, V213, P633, DOI 10.1007/s00213-010-1999-0; Kawamura Y, 2010, PSYCHOPATHOLOGY, V43, P240, DOI 10.1159/000313522; Kohno K, 2012, J AFFECT DISORDERS, V142, P53, DOI 10.1016/j.jad.2012.03.052; Kohno K, 2014, J AFFECT DISORDERS, V162, P26, DOI 10.1016/j.jad.2014.03.029; Sakai Y, 2005, J AFFECT DISORDERS, V85, P101, DOI 10.1016/j.jad.2004.03.012	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	FEB 1	2015	172						141	145		10.1016/j.jad.2014.09.049		5	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	AX0LD	WOS:000346643000021		
J	Nan-ya, K; Kajihara, M; Kojima, N; Degawa, M				Nan-ya, Ken-ichiro; Kajihara, Masatomo; Kojima, Natsuki; Degawa, Masakuni			Usefulness of urinary kidney injury molecule-1 (Kim-1) as a biomarker for cisplatin-induced sub-chronic kidney injury	JOURNAL OF APPLIED TOXICOLOGY			English	Article						Kim-1; urinary biomarkers; sub-chronic kidney injury; cisplatin; rat	TUBULAR INJURY; 2 STRAINS; NEPHROTOXICITY; CLUSTERIN; RATS; EXPRESSION; QUALIFICATION; TOXICITY; DISEASE; CELLS	We explored biomarkers suitable for monitoring sub-chronic kidney injury using the three rat models of cisplatin (CDDP)-induced kidney injury, which were designed to extend the current knowledge beyond the sub-acute exposure period. In the pilot study, a single intravenous administration of 1.5 mg kg(-1) CDDP to rats was confirmed to result in no histopathological changes. Subsequently, CDDP was intravenously administered to rats at a dose of 1.5 mg kg(-1) for 4 days at 24-h intervals (Experimental model 1) and for up to 10 weeks at weekly intervals (Experimental models 2 and 3), and the changes in blood and urine components, such as recently recommended urinary biomarkers (Kim-1, clusterin and so on) and traditional blood biomarkers (blood urea nitrogen and serum creatinine), were examined together with the histopathological changes in renal tissues during the development of the kidney injury in each model. In these experimental models, a significant increase in urinary Kim-1 was observed prior to the histopathological changes in renal tissues, and these changes were retained after the adverse histopathological changes. Significant changes in all of the other urinary biomarkers examined occurred along with the histopathological changes. In addition, the increase in urinary Kim-1 after weekly treatment with CDDP for 4 weeks was reduced in a time-dependent manner after cessation of the drug. The present findings indicate that urinary Kim-1 is the most useful biomarker for CDDP-induced rat sub-chronic kidney injury among the biomarkers examined. Copyright (c) 2014 John Wiley & Sons, Ltd. We explored biomarkers suitable for monitoring sub-chronic kidney injury using rat models of kidney injury induced by cisplatin (CDDP). CDDP was intravenously administered to rats at 1.5 mg kg(-1) for 4 days at 24-h intervals and for up to 10 weeks at weekly intervals, and the changes in blood and urine components were examined together with the histopathological changes in renal tissues. The present findings indicate that urinary kidney injury molecule-1 (Kim-1) is the most useful biomarker for CDDP-induced rat sub-chronic kidney injury.	[Nan-ya, Ken-ichiro] Kyowa Hakko Kirin Co Ltd, Drug Discovery Res Labs, Nagaizumi, Shizuoka 4118731, Japan; [Nan-ya, Ken-ichiro; Degawa, Masakuni] Univ Shizuoka, Sch Pharmaceut Sci, Dept Mol Toxicol, Suruga Ku, Shizuoka 4228526, Japan; [Kajihara, Masatomo] Kyowa Hakko Kirin Co Ltd, Dev Res Labs, Nagaizumi, Shizuoka 4118731, Japan; [Kojima, Natsuki] Kyowa Hakko Kirin Co Ltd, Discovery & Dev Res Promot Labs, Nagaizumi, Shizuoka 4118731, Japan	Nan-ya, K (reprint author), Kyowa Hakko Kirin Co Ltd, Drug Discovery Res Labs, 1188 Shimotogari, Nagaizumi, Shizuoka 4118731, Japan.	kenichiro.nanya@kyowa-kirin.co.jp					Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Harpur E, 2011, TOXICOL SCI, V122, P235, DOI 10.1093/toxsci/kfr112; Pfaller W, 1998, ENVIRON HEALTH PERSP, V106, P559, DOI 10.2307/3433806; Fuchs TC, 2011, BIOMARK MED, V5, P763, DOI [10.2217/bmm.11.86, 10.2217/BMM.11.86]; Sasaki D, 2011, BIOMARKERS, V16, P553, DOI 10.3109/1354750X.2011.613123; Rouse RL, 2011, KIDNEY INT, V79, P1186, DOI 10.1038/ki.2010.463; Hoffmann D, 2010, TOXICOLOGY, V277, P49, DOI 10.1016/j.tox.2010.08.013; Zhou Y, 2008, TOXICOL SCI, V101, P159, DOI 10.1093/toxsci/kfm60; Davis JW, 2004, TOXICOL APPL PHARM, V200, P16, DOI 10.1016/j.taap.2004.02.001; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Proulx NL, 2005, NEPHROL DIAL TRANSPL, V20, P1617, DOI 10.1093/ndt/gfh839; Marrer E, 2010, TOXICOL APPL PHARM, V243, P167, DOI 10.1016/j.taap.2009.12.015; Pinches M, 2012, TOXICOL PATHOL, V40, P522, DOI 10.1177/0192623311432438; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Hoffmann D, 2010, TOXICOL SCI, V116, P8, DOI 10.1093/toxsci/kfq029; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Kuhlmann MK, 1997, NEPHROL DIAL TRANSPL, V12, P2478, DOI 10.1093/ndt/12.12.2478; Yu Y, 2010, NAT BIOTECHNOL, V28, P470, DOI 10.1038/nbt.1624; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Prozialeck WC, 2007, KIDNEY INT, V72, P985, DOI 10.1038/sj.ki.5002467; Huo WQ, 2010, TRANSPLANT REV-ORLAN, V24, P143, DOI 10.1016/j.trre.2010.02.002; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Correa-Rotter R, 1998, J AM SOC NEPHROL, V9, P33; Dieterle F, 2010, NAT BIOTECHNOL, V28, P455, DOI 10.1038/nbt.1625; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Tonomura Y, 2010, TOXICOLOGY, V273, P53, DOI 10.1016/j.tox.2010.04.015; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Chevalier RL, 1996, J AM SOC NEPHROL, V7, P1098; Hart Susan G. Emeigh, 2005, Journal of Pharmacological and Toxicological Methods, V52, P30; Fenoglio C, 2005, ANTICANCER RES, V25, P4123; Fuchs TC, 2012, TOXICOL PATHOL, V540, P1031; Gautier JC, 2010, TOXICOL PATHOL, V38, P943, DOI 10.1177/0192623310379139; Gonzalez R, 2005, MEDIAT INFLAMM, P139, DOI 10.1155/MI.2005.139; HARDING MA, 1991, DEV BIOL, V146, P483, DOI 10.1016/0012-1606(91)90249-3; Hosohata K, 2012, J PHARMACOL EXP THER, V341, P656, DOI 10.1124/jpet.112.192807; Kharasch ED, 2006, TOXICOL SCI, V90, P419, DOI 10.1093/toxsci/kfj088; Kramer AB, 2009, AM J PHYSIOL-RENAL, V296, pF1136, DOI 10.1152/ajprenal.00541.2007; Kuehn EW, 2002, AM J PHYSIOL-RENAL, V283, pF1326, DOI 10.1152/ajprenal.00166.2002; Swain A, 2011, J APPL TOXICOL, V32, P417; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Vinken P, 2012, TOXICOL PATHOL, V40, P1049, DOI 10.1177/0192623312444765	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0260-437X	1099-1263		J APPL TOXICOL	J. Appl. Toxicol.	FEB	2015	35	2					124	132		10.1002/jat.2999		9	Toxicology	Toxicology	AX1TP	WOS:000346729200002		
J	Takai, S; Higuchi, S; Yano, A; Tsuneyama, K; Fukami, T; Nakajima, M; Yokoi, T				Takai, Shohei; Higuchi, Satonori; Yano, Azusa; Tsuneyama, Koichi; Fukami, Tatsuki; Nakajima, Miki; Yokoi, Tsuyoshi			Involvement of immune- and inflammatory-related factors in flucloxacillin-induced liver injury in mice	JOURNAL OF APPLIED TOXICOLOGY			English	Article						flucloxacillin; inflammatory; toll-like receptor 4 (TLR4); IL-17	HEPATIC-INJURY; MOUSE MODEL; ACTIVATION; RECEPTOR; DISEASE; CANCER; INTERLEUKIN-17; HEPATOTOXICITY; HEPATOCYTES; DAMAGE	Drug-induced liver injury (DILI) is a serious problem in pre-clinical stages of drug development and clinical pharmacotherapy, but the pathogenesis of DILI has not been elucidated. Flucloxacillin (FLX), which is a -lactam antibiotic of the penicillin class that is used widely in Europe and Australia, rarely causes DILI. Clinical features suggest that FLX-induced liver injury is caused by immune- and inflammatory-related factors, but the mechanism of FLX-induced liver injury is unknown. The purpose of this study was to elucidate the mechanisms of FLX-induced liver injury in vivo. Plasma alanine aminotransferase, aspartate aminotransferase and total-bilirubin levels were significantly elevated in FLX-administered mice [1000mgkg(-1), intraperitoneally (i.p.)]. Toll-like receptor 4 (TLR4) ligands, such as high-mobility group box1 (HMGB1) and S100A8/A9, were significantly increased in FLX-administered mice, and inflammatory factors, such as interleukin (IL)-1, tumor necrosis factor-alpha (TNF-), macrophage inflammatory protein (MIP)-2, CXC chemokine-ligand-1 (CXCL1) and monocyte chemoattractant protein (MCP)-1, were also significantly elevated. IL-17-related transcriptional factors and cytokines were increased, and the administration of recombinant IL-17 (2mg per body weight, i.p.) resulted in an exacerbation of the FLX-induced liver injury. TLR4-associated-signal transduction may be involved in FLX-induced liver injury, and IL-17 is an exacerbating factor. Copyright (c) 2014 John Wiley & Sons, Ltd. Flucloxacillin (FLX), which is a -lactam antibiotic of the penicillin class, rarely causes drug-induced liver injury. The purpose of this study was to elucidate the mechanisms of FLX-induced liver injury in vivo. Toll-like receptor 4 (TLR4) ligands and inflammatory factors were significantly increased in FLX-administered mice. IL-17-related transcriptional factors and cytokines were increased, and the administration of recombinant IL-17 resulted in an exacerbation of the FLX-induced liver injury.TLR4-associated-signal transduction and IL-17 may be involved in FLX-induced liver injury.	[Takai, Shohei; Higuchi, Satonori; Yano, Azusa; Fukami, Tatsuki; Nakajima, Miki; Yokoi, Tsuyoshi] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan; [Tsuneyama, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Diagnost Pathol, Toyama 9300194, Japan; [Yokoi, Tsuyoshi] Nagoya Univ, Dept Drug Safety Sci, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Yokoi, T (reprint author), Kanazawa Univ, Fac Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tyokoi@med.nagoya-u.ac.jp	Fukami, Tatsuki/C-8907-2015; Nakajima, Miki/C-3990-2015		Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan [H23-BIO-G001]	This study was supported by Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (H23-BIO-G001)	Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Yano A, 2012, TOXICOLOGY, V293, P107, DOI 10.1016/j.tox.2012.01.008; Kobayashi E, 2009, TOXICOL SCI, V111, P302, DOI 10.1093/toxsci/kfp165; Wuillemin N, 2013, J IMMUNOL, V190, P4956, DOI 10.4049/jimmunol.1202949; Monshi MM, 2013, HEPATOLOGY, V57, P727, DOI 10.1002/hep.26077; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Carey MA, 2005, TOXICOLOGY, V216, P41, DOI 10.1016/j.tox.2005.07.015; Kobayashi M, 2012, J APPL TOXICOL, V32, P823, DOI 10.1002/jat.2731; Sasaki E, 2013, TOXICOL SCI, V136, P250, DOI 10.1093/toxsci/kft184; Li L, 2011, HEPATOLOGY, V54, P1620, DOI 10.1002/hep.24552; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Asehnoune K, 2004, J IMMUNOL, V172, P2522; Andrade RJ, 2011, J ANTIMICROB CHEMOTH, V66, P1431, DOI 10.1093/jac/dkr159; Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Russmann S, 2005, BRIT J CLIN PHARMACO, V60, P76, DOI 10.1111/j.1365-2125.2005.02370.x; Higuchi S, 2011, TOXICOL LETT, V200, P139, DOI 10.1016/j.toxlet.2010.11.006; OLSSON R, 1992, J HEPATOL, V15, P154, DOI 10.1016/0168-8278(92)90029-O; Verma S, 2009, GUT, V58, P1555, DOI 10.1136/gut.2008.163675; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Dugan CM, 2011, TOXICOL SCI, V120, P507, DOI 10.1093/toxsci/kfr005; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Roche JK, 2008, LAB INVEST, V88, P1178, DOI 10.1038/labinvest.2008.83; De Filippo K, 2008, J IMMUNOL, V180, P4308; Stachulski AV, 2013, MED RES REV, V33, P985, DOI 10.1002/med.21273; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Ishida Y, 2002, FASEB J, V16, DOI 10.1096/fj.02-0046com; Antoine DJ, 2009, TOXICOL SCI, V112, P521, DOI 10.1093/toxsci/kfp235; Higuchi S, 2012, TOXICOL SCI, V130, P4, DOI 10.1093/toxsci/kfs222; DEVEREAUX BM, 1995, EUR J CLIN PHARMACOL, V49, P81; Kobayashi M, 2010, TOXICOLOGY, V275, P50, DOI 10.1016/j.tox.2010.05.011; Kumada T, 2004, MODERN PATHOL, V17, P1141, DOI 10.1038/modpathol.3800165; Lakehal F, 2001, CHEM RES TOXICOL, V14, P694, DOI 10.1021/tx0002435; Malhis H, 2006, HEPATOLOGY, V43, P31; Ranganath S, 1998, J IMMUNOL, V161, P3822; Törnhage C-J, 2009, Drug Healthc Patient Saf, V1, P17; Yohes HC, 2006, AM J PHYSIOL-GASTR L, V290, P1269	44	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0260-437X	1099-1263		J APPL TOXICOL	J. Appl. Toxicol.	FEB	2015	35	2					142	151		10.1002/jat.3002		10	Toxicology	Toxicology	AX1TP	WOS:000346729200004		
J	Tonomura, Y; Kato, Y; Hanafusa, H; Morikawa, Y; Matsuyama, K; Uehara, T; Ueno, M; Torii, M				Tonomura, Yutaka; Kato, Yuki; Hanafusa, Hiroyuki; Morikawa, Yuji; Matsuyama, Keigo; Uehara, Takeki; Ueno, Motonobu; Torii, Mikinori			Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats	JOURNAL OF APPLIED TOXICOLOGY			English	Article						drug-induced liver injury; traditional biomarker; standardized diagnostic threshold; diagnostic performance; predictive performance; receiver-operating characteristic curve	IN-VITRO INHIBITION; HEPATIC SECRETION; MUSCLE; SERUM; HEPATOTOXICITY; FENOFIBRATE; CIRRHOSIS; TOXICITY; PATTERNS; SKELETAL	Traditional biomarkers such as alanine and aspartate aminotransferase (ALT, AST) and total bilirubin (TBIL) have been widely used for detecting drug-induced liver injury (DILI). Although the Food and Drug Administration (FDA) proposed standardized thresholds for human as Hy's law, those for animals have not been determined, and predictability of these biomarkers for future onset of hepatic lesions remains unclear. In this study, we investigated these diagnostic and predictive performance of 10 traditional biomarkers for liver injury by receiver-operating characteristic (ROC) curve, using a free-access database where 142 hepatotoxic or non-hepatotoxic compounds were administrated to male rats (n=5253). Standardization of each biomarker value was achieved by calculating the ratio to control mean value, and the thresholds were determined under the condition of permitting 5% false positive. Of these 10 biomarkers, AST showed the best diagnostic performance. Furthermore, ALT and TBIL also showed high performance under the situation of hepatocellular necrosis and bile duct injury, respectively. Additionally, the availability of the diagnostic thresholds in difference testing facility was confirmed by the application of these thresholds to in-house prepared dataset. Meanwhile, incorrect diagnosis by the thresholds was also observed. Regarding prediction, all 10 biomarkers showed insufficient performance for future onset of hepatic lesions. In conclusion, the standardized diagnostic thresholds enable consistent evaluation of traditional biomarkers among different facilities, whereas it was suggested that novel biomarker is required for more accurate diagnosis and prediction of DILI. Copyright (c) 2014 John Wiley & Sons, Ltd. Traditional biomarkers for liver injury have been used in drug development, whereas the standardized thresholds and performance have not been established in preclinical toxicity study. Therefore, we determined the thresholds using large-scale rat database, and validated the availability of the thresholds in different facility using in-house dataset. However, all biomarkers analyzed showed insufficient predictability for future onset of hepatic lesion. Collectively, the standardized thresholds enable consistent evaluation of the biomarkers among different facilities, whereas a more useful biomarker is required.	[Tonomura, Yutaka; Kato, Yuki; Hanafusa, Hiroyuki; Morikawa, Yuji; Matsuyama, Keigo; Ueno, Motonobu; Torii, Mikinori] Shionogi & Co Ltd, Res Lab Dev, Drug Safety Evaluat, Toyonaka, Osaka 5610825, Japan; [Uehara, Takeki] Shionogi & Co Ltd, Global Project Management, Kita Ku, Osaka 5300012, Japan	Tonomura, Y (reprint author), Shionogi & Co Ltd, Res Lab Dev, Drug Safety Evaluat, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan.	yutaka.tonomura@shionogi.co.jp					Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; BULLE F, 1990, HEPATOLOGY, V11, P545, DOI 10.1002/hep.1840110404; Tonomura Y, 2012, TOXICOLOGY, V302, P179, DOI 10.1016/j.tox.2012.07.012; GORES GJ, 1990, HEPATOLOGY, V11, P690, DOI 10.1002/hep.1840110425; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; Senior JR, 2012, CLIN PHARMACOL THER, V92, P332, DOI 10.1038/clpt.2012.108; Chang JH, 2013, MOL PHARMACEUT, V10, P3067, DOI 10.1021/mp4001348; Zhang DL, 2005, DRUG METAB DISPOS, V33, P1729, DOI 10.1124/dmd.105.005447; Pettersen JC, 2012, TOXICOL PATHOL, V40, P435, DOI 10.1177/0192623311431945; Keppler D, 2000, SEMIN LIVER DIS, V20, P265, DOI 10.1055/s-2000-9391; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; LEMASTERS JJ, 1983, J CELL BIOL, V97, P778, DOI 10.1083/jcb.97.3.778; Temple R, 2006, PHARMACOEPIDEM DR S, V15, P241, DOI 10.1002/pds.1211; Amacher DE, 1998, FOOD CHEM TOXICOL, V36, P831, DOI 10.1016/S0278-6915(98)00066-0; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; Ballmer PE, 2001, CLIN NUTR, V20, P271, DOI 10.1054/clnu.2001.0439; Ennulat D, 2010, TOXICOL SCI, V116, P397, DOI 10.1093/toxsci/kfq144; Westwood FR, 2005, TOXICOL PATHOL, V33, P246, DOI 10.1080/01926230590908213; Crawford AR, 1997, J CLIN INVEST, V100, P2562, DOI 10.1172/JCI119799; Bailey WJ, 2012, TOXICOL SCI, V130, P229, DOI 10.1093/toxsci/kfs243; Ennulat D, 2010, TOXICOL PATHOL, V38, P810, DOI 10.1177/0192623310374332; FDA, 2009, GUID IND DRUG IND LI; FDA, 1987, 018936 FDA NDA; Hoffman WE, 1999, CLIN CHEM LAB ANIMAL, P399; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708; KAMIIKE W, 1989, CLIN CHIM ACTA, V185, P265, DOI 10.1016/0009-8981(89)90216-7; KAPLAN M M, 1970, Journal of Clinical Investigation, V49, P508, DOI 10.1172/JCI106260; Mendez Christian M, 2005, Nutr Clin Pract, V20, P314, DOI 10.1177/0115426505020003314; Okada M, 2009, TOXICOL PATHOL, V37, P517, DOI 10.1177/0192623309336151; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; SPECTOR AA, 1984, CLIN PHYSIOL BIOCH, V2, P123; Tietge UJF, 1998, HEPATO-GASTROENTEROL, V45, P2255; Uhing MR, 2004, CLIN PERINATOL, V31, P475, DOI 10.1016/j.clp.2004.03.018	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0260-437X	1099-1263		J APPL TOXICOL	J. Appl. Toxicol.	FEB	2015	35	2					165	172		10.1002/jat.3053		8	Toxicology	Toxicology	AX1TP	WOS:000346729200006		
J	Nishimura, Y; Kondo, C; Morikawa, Y; Tonomura, Y; Torii, M; Yamate, J; Uehara, T				Nishimura, Yoko; Kondo, Chiaki; Morikawa, Yuji; Tonomura, Yutaka; Torii, Mikinori; Yamate, Jyoji; Uehara, Takeki			Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats	JOURNAL OF APPLIED TOXICOLOGY			English	Article						miRNA; miR-208; biomarker; cardiotoxicity; troponin	ACUTE MYOCARDIAL-INFARCTION; GENOMIC BIOMARKERS; MICRORNAS; DIAGNOSIS; TROPONINS; TOXICITY	Cardiotoxicity is one of the major safety concerns in drug development. Therefore, detecting and monitoring cardiotoxicity throughout preclinical and clinical studies is important for pharmaceutical companies. The present study was conducted in order to explore a plasma miRNA biomarker for cardiotoxicity in rats. As organ specificity is an important factor for a biomarker, we analyzed the miRNA microarray dataset in 55 organs/tissues in normal male rats. Based on this analysis, 5 miRNAs consisting of miR-208 (heart-specific), miR-1, miR-133a, miR-133b (heart and skeletal muscle-specific) and miR-206 (skeletal muscle-specific) were selected. Next, we evaluated the usefulness of those 5 miRNAs as circulating biomarkers in rats administered with single-dose isoproterenol or doxorubicin. Plasma miR-208 was consistently increased through 24 h after dosing in rats administered with isoproterenol, whereas plasma concentrations of cardiac troponin (cTn) showed transient elevation. In contrast, the plasma levels of miR-1, miR-133a, miR-133a and miR-206 were elevated after treatment with doxorubicin, probably as a result of skeletal muscle toxicity. Additionally, the plasma miR-208 level was elevated even after repeat-dose administration (once daily for 7 days) of isoproterenol under which the pathological condition proceeded to the sub-chronic phase such as fibrosis. Thus, our data suggest that miR-208 is a promising plasma biomarker for cardiotoxicity in rats. Monitoring of plasma miR-208 levels in rats may lead to more accurate evaluation of cardiotoxicity in preclinical studies. Copyright (c) 2014 John Wiley & Sons, Ltd. The present study was conducted in order to explore a plasma miRNA biomarker for cardiotoxicity in rats. We selected candidate miRNAs by the analysis of the miRNA microarray dataset derived from comprehensive organs/tissues in normal rats, and confirmed their usefulness in drug-induced rat cardiotoxicity. From the analysis, plasma miR-208 showed the most sensitive and sustainable increase and it appears to be a promising biomarker for drug-induced cardiotoxicity in rats.	[Nishimura, Yoko; Kondo, Chiaki; Tonomura, Yutaka; Torii, Mikinori] Shionogi & Co Ltd, Res Lab Dev, Toyonaka, Osaka 5610825, Japan; [Morikawa, Yuji] Shionogi & Co Ltd, Discovery Res Lab Innovat Frontier Med, Toyonaka, Osaka 5610825, Japan; [Yamate, Jyoji] Osaka Prefecture Univ, Lab Vet Pathol Life & Environm Sci, Izumisano, Osaka 5988531, Japan; [Uehara, Takeki] Shionogi & Co Ltd, Global Project Management, Kita Ku, Osaka 5300012, Japan	Nishimura, Y (reprint author), Shionogi & Co Ltd, Res Lab Dev, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan.	youko.nishimura@shionogi.co.jp					Ahmadi F, 2014, IRAN J KIDNEY DIS, V8, P31; Tonomura Y, 2012, TOXICOLOGY, V302, P179, DOI 10.1016/j.tox.2012.07.012; Qureshi ZP, 2011, PHARMACOEPIDEM DR S, V20, P772, DOI 10.1002/pds.2155; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Broder H, 2008, REV CARDIOVASC MED, V9, P75; Reagan WJ, 2010, TOXICOL PATHOL, V38, P1134, DOI 10.1177/0192623310382438; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Cheng YH, 2012, J MOL CELL CARDIOL, V53, P668, DOI 10.1016/j.yjmcc.2012.08.010; O'Brien PJ, 2008, TOXICOLOGY, V245, P206, DOI 10.1016/j.tox.2007.12.006; Mori Y, 2010, TOXICOLOGY, V271, P36, DOI 10.1016/j.tox.2010.02.015; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Jis X, 2009, CLIN CHEM, V55, P1944; Lis C, 2013, BMC MED GENOMICS, V6, P16; McNaughton R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004221; Minamis K, 2014, SCI DATA, V1; Nishimura Y, 2013, J APPL TOXICOL, V33, P1120, DOI 10.1002/jat.2867; Oliveira-Carvalho V, 2013, MOL BIOL REP, V40, P2663, DOI 10.1007/s11033-012-2352-y; vans Empels VP, 2012, CURR HYPERTENS REP, V14, P498	20	7	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0260-437X	1099-1263		J APPL TOXICOL	J. Appl. Toxicol.	FEB	2015	35	2					173	180		10.1002/jat.3044		8	Toxicology	Toxicology	AX1TP	WOS:000346729200007		
J	Wakui, S; Mutou, T; Takahashi, H; Ikegami, M; Wanibuchi, H; Fukushima, S				Wakui, Shin; Mutou, Tomoko; Takahashi, Hiroyuki; Ikegami, Masahiro; Wanibuchi, Hideki; Fukushima, Shoji			Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay	JOURNAL OF APPLIED TOXICOLOGY			English	Article						VEGF mRNA; VEGF; rats; BBN; short-term bladder carcinogenesis assay	URINARY-BLADDER; CANCER; EXPRESSION; ANGIOGENESIS; ALPHA; ACID; BETA; VEGF	Generically, carcinogenic effects of chemicals in bladder carcinogenesis are judged by induction of papillary or nodular (PN) hyperplasia in rats given N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) for 4weeks and the test chemical for 22-28 weeks. However, upregulation of vascular endothelial growth factor (VEGF) begins early in rat BBN bladder carcinogenesis. To establish a short-term rat bladder carcinogenic bioassay, we analyzed the correlations between VEGF, VEGF mRNA and bladder lesions inductions at 10 and 26weeks after BBN treatment. Six-week-old male Wistar (slc) rats were given 0.05% BBN for 4, 10 or 26weeks. To avoid individual rat bias, the bladders were investigated by partial cystectomy at 10weeks and total cystectomy at 26weeks. After induction, PN hyperplasia and carcinoma in rats increased with the length of BBN treatment and immunohistochemical VEGF expression also increased following carcinogenesis, but the immunoreactivity of individual lesions was quite variable. Moreover, induction of PN hyperplasia at 10weeks' BBN treatment was not significantly correlated with that at 26weeks' treatment; thus, it was not possible to predict the carcinogenic effect due to the induction of PN hyperplasia at 26weeks' BBN treatment by that at 10weeks' treatment. However, VEGF mRNA levels of rat bladders at 10weeks' BBN treatment revealed a strong significant correlation with the incidence of bladder lesions at 26weeks' treatment. Here, we suggest that quantitative VEGF mRNA levels are a good biomarker for a short-term BBN-induced bioassay for rat bladder carcinogenesis. Copyright (c) 2014 John Wiley & Sons, Ltd. To establish a short-term rat bladder carcinogenic bioassay, the correlations analyzed between VEGF, VEGF mRNA, and bladder lesions inductions after BBN treatment. Wistar rats were given 0.05% BBN for 4, 10, or 26 weeks. VEGF mRNA levels of rat bladders at 10 weeks BBN treatment revealed a strong significant correlation with the incidence of bladder lesions at 26 weeks treatment. we suggest that quantitative VEGF mRNA levels are a good biomarker for a short-term BBN-induced rat bladder carcinogenesis bioassay.	[Wakui, Shin] Azabu Univ, Sch Vet Med, Dept Toxicol, Sagamihara, Kanagawa 2525201, Japan; [Mutou, Tomoko] Drug Safety Testing Ctr, Saitama 3350116, Japan; [Takahashi, Hiroyuki; Ikegami, Masahiro] Jikei Univ, Dept Pathol, Sch Med, Tokyo 1058461, Japan; [Wanibuchi, Hideki] Osaka City Univ, Dept Pathol, Sch Med, Osaka 5458585, Japan; [Fukushima, Shoji] Japan Ind Safety & Hlth Assoc, Japan Bioassay Res Ctr, Kawasaki, Kanagawa 2570015, Japan	Wakui, S (reprint author), Azabu Univ, Sch Vet Med, Dept Toxicol, 1-17-71 Chuo, Sagamihara, Kanagawa 2525201, Japan.	Wakui@azabu-u.ac.jp			Azabu University Research Services Division; Promotion and Mutual Aid Corporation for Private Schools of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [25450473]	This study was partially supported by a grant award for this research project by the Azabu University Research Services Division, and the Promotion and Mutual Aid Corporation for Private Schools of Japan, Grant-in-Aid for Matching Fund Subsidy for Private Universities provided funding for this project. This study was supported by Grants-in-Aid (C) #25450473 (S.W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	TOI M, 1994, JPN J CANCER RES, V85, P1045; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Salim EI, 2000, CARCINOGENESIS, V21, P195, DOI 10.1093/carcin/21.2.195; Wakui S, 2006, LAB INVEST, V86, P1172, DOI 10.1038/labinvest.3700476; Wanibuchi H, 1996, CARCINOGENESIS, V17, P2435, DOI 10.1093/carcin/17.11.2435; Marone PA, 2014, REGUL TOXICOL PHARM, V68, P108, DOI [10.1016/j.yrtph.2013.11.011, 10.1016/j.yrtph.201.3.11.011]; BERTRAM JS, 1972, EUR J CANCER, V8, P587, DOI 10.1016/0014-2964(72)90137-5; COHEN SM, 1990, SCANNING MICROSCOPY, V4, P135; Filders JJ, 2000, CANC J S3, V6, pS225; FUKUSHIMA S, 1991, PROG EXP TUMOR RES, V33, P154; FUKUSHIMA S, 1983, CANCER RES, V43, P4454; FUKUSHIMA S, 1982, ACTA PATHOL JAPON, V32, P243; Hameed DA, 2008, CANCER BIOL THER, V7, P92; ITO N, 1983, ENVIRON HEALTH PERSP, V50, P61, DOI 10.2307/3429535; ITO N, 1969, GANN, V60, P401; ITO N, 1989, EXP PATHOL-JENA, V36, P1; Kogevinas M, 2003, CANCER CAUSE CONTROL, V14, P907, DOI 10.1023/B:CACO.0000007962.19066.9c; KUNZE E, 1976, Z KREBSFORSCH KLIN O, V87, P139; Lees JW, 2009, BIOANALYSIS, V1, P1464; Motohashi M, 2011, J TOXICOL SCI, V36, P373; Murata T, 1996, LAB INVEST, V74, P819; OBRIEN T, 1995, CANCER RES, V55, P510; Okajima E, 1997, JPN J CANCER RES, V88, P543; Squires RA, 1986, MONOGRAPHS PATHOLOGY, P311; Urquidis V, 2012, J UROLOGY, V79; Wakui S, 1999, VET PATHOL, V36, P111, DOI 10.1354/vp.36-2-111; Wanibuchis H, 1997, J TOXICOL PATHOL, V10, P31; Wanibuchi Hideki, 2006, Asian Pac J Cancer Prev, V7, P122; Zeegerss MP, 2000, CANCER, V66, P4	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0260-437X	1099-1263		J APPL TOXICOL	J. Appl. Toxicol.	FEB	2015	35	2					181	190		10.1002/jat.3021		10	Toxicology	Toxicology	AX1TP	WOS:000346729200008		
J	Ikeda, M; Yoshimura, R; Hashimoto, R; Kondo, K; Saito, T; Shimasaki, A; Ohi, K; Tochigi, M; Kawamura, Y; Nishida, N; Miyagawa, T; Sasaki, T; Tokunaga, K; Kasai, K; Takeda, M; Nakamura, J; Ozaki, N; Iwata, N				Ikeda, Masashi; Yoshimura, Reiji; Hashimoto, Ryota; Kondo, Kenji; Saito, Takeo; Shimasaki, Ayu; Ohi, Kazutaka; Tochigi, Mamoru; Kawamura, Yoshiya; Nishida, Nao; Miyagawa, Taku; Sasaki, Tsukasa; Tokunaga, Katsushi; Kasai, Kiyoto; Takeda, Masatoshi; Nakamura, Jun; Ozaki, Norio; Iwata, Nakao			Genetic Overlap Between Antipsychotic Response and Susceptibility to Schizophrenia	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Letter							GENOME-WIDE ASSOCIATION; JAPANESE POPULATION; DISORDER		[Ikeda, Masashi; Kondo, Kenji; Saito, Takeo; Shimasaki, Ayu; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Yoshimura, Reiji; Nakamura, Jun] Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan; [Hashimoto, Ryota] Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Osaka, Japan; [Hashimoto, Ryota; Ohi, Kazutaka; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Tochigi, Mamoru] Teikyo Univ, Sch Med, Dept Psychiat, Tokyo 173, Japan; [Kawamura, Yoshiya] Sake Seijinkai Hosp, Dept Psychiat, Yokohama, Kanagawa, Japan; [Nishida, Nao; Miyagawa, Taku; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo, Japan; [Nishida, Nao] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Lab Hlth Educ, Bunkyo Ku, Tokyo, Japan; [Kasai, Kiyoto] Univ Tokyo, Dept Psychiat, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan	Ikeda, M (reprint author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan.	ikeda-ma@fujita-hu.ac.jp	Ozaki, Norio/M-8908-2014	Ozaki, Norio/0000-0002-7360-4898			Ikeda M, 2010, BIOL PSYCHIAT, V67, P263, DOI 10.1016/j.biopsych.2009.08.030; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Iovieno N, 2012, J CLIN PSYCHIAT, V73, P1300, DOI 10.4088/JCP.11r07485; Otowa T, 2009, J HUM GENET, V54, P122, DOI 10.1038/jhg.2008.17; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Salari K, 2012, EUR HEART J, V33, P1564, DOI 10.1093/eurheartj/ehs112; The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, 2011, NAT GENET, V43, P969	10	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	FEB	2015	35	1					85	88				5	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	AX5QY	WOS:000346983200016		
J	Takaki, M; Okabe, N				Takaki, Manabu; Okabe, Nobuyuki			Aripiprazole May Be Effective as an Add-on Treatment in Bulimic Symptoms of Eating Disorders	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Letter							ANOREXIA-NERVOSA; EFFICACY; TOLERABILITY; PHARMACOLOGY; RECEPTOR		[Takaki, Manabu; Okabe, Nobuyuki] Okayama Univ, Dept Neuropsychiat, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Takaki, M (reprint author), Okayama Univ, Dept Neuropsychiat, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	manabuta@cc.okayama-u.ac.jp					DeLeon A, 2004, CLIN THER, V26, P649, DOI 10.1016/S0149-2918(04)90066-5; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Connor KM, 2005, J CLIN PSYCHIAT, V66, P49; Muscatello MRA, 2011, J CLIN PSYCHOPHARM, V31, P174, DOI 10.1097/JCP.0b013e31820e3db6; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Brewerton TD, 2012, CURR PSYCHIAT REP, V14, P398, DOI 10.1007/s11920-012-0287-6; Marcus RN, 2008, J CLIN PSYCHOPHARM, V28, P156, DOI [10.1097/JCP.0b013e31816774f9, 10.1097/JCP.0b13e318677489]; Flament MF, 2012, INT J NEUROPSYCHOPH, V15, P189, DOI 10.1017/S1461145711000381; He M, 2013, CNS DRUGS, V27, P423, DOI 10.1007/s40263-013-0062-1; Murotani T, 2011, NEUROPHARMACOLOGY, V61, P228, DOI 10.1016/j.neuropharm.2011.04.003; Trunko ME, 2011, INT J EAT DISORDER, V44, P269, DOI 10.1002/eat.20807; Yoshimatsu H, 2008, NUTRITION, V24, P27	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	FEB	2015	35	1					93	95				4	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	AX5QY	WOS:000346983200020		
J	Hashimoto, N; Maeda, T; Okubo, R; Narita, H; Kusumi, I				Hashimoto, Naoki; Maeda, Tamaki; Okubo, Ryo; Narita, Hisashi; Kusumi, Ichiro			Simple Pulmonary Eosinophilia Associated With Clozapine Treatment	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Letter							PNEUMONIAS; REASONS		[Hashimoto, Naoki; Okubo, Ryo; Narita, Hisashi; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Hashimoto, Naoki] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Maeda, Tamaki] Koyogaoka Hosp, Abashiri, Hokkaido, Japan	Hashimoto, N (reprint author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.	hashinao@vega.ocn.ne.jp					Abdelmawla N, 2009, BRIT J PSYCHIAT, V194, P468, DOI 10.1192/bjp.194.5.468a; Roberts CE, 2011, AM J PSYCHIAT, V168, P1147, DOI [10.1176/appi.ajp.2010.10040519, 10.1176/appi.ajp.2011.10040519]; Cottin V, 2005, ALLERGY, V60, P841, DOI 10.1111/j.1398-9995.2005.00812.x; Taylor DM, 2009, BRIT J PSYCHIAT, V194, P165, DOI 10.1192/bjp.bp.108.051979; Nielsen J, 2013, J CLIN PSYCHIAT, V74, P603, DOI 10.4088/JCP.12r08064; Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096; LIEBOW AA, 1969, MEDICINE, V48, P251, DOI 10.1097/00005792-196907000-00001; Loffler W, 1932, BEITR KLIN TUBERK, V79, P368, DOI 10.1007/BF02079221; Solomon J, 2006, SEM RESP CRIT CARE M, V27, P192, DOI 10.1055/s-2006-939522	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	FEB	2015	35	1					99	101				4	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	AX5QY	WOS:000346983200023		
J	Mizuki, Y; Takaki, M				Mizuki, Yutaka; Takaki, Manabu			Blonanserin Ameliorated the Tendency Toward QTc Prolongation Associated With Risperidone in a Patient With Schizophrenia	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Letter							DOUBLE-BLIND; EFFICACY; TOLERABILITY; HALOPERIDOL		[Mizuki, Yutaka; Takaki, Manabu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama, Japan	Mizuki, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama, Japan.	manabuta@cc.okayama-u.ac.jp					Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Garcia E, 2009, CNS DRUGS, V23, P615, DOI 10.2165/00023210-200923070-00006; Harrigan EP, 2004, J CLIN PSYCHOPHARM, V24, P62, DOI 10.1097/01.jcp.0000104913.75206.62; Crumb WJ, 2006, PHARM RES, V23, P1133, DOI 10.1007/s11095-006-0070-7; Yang J, 2010, CLIN NEUROPHARMACOL, V33, P169, DOI 10.1097/WNF.0b013e3181dcda50; NODA Y, 1993, J PHARMACOL EXP THER, V265, P745; Deeks ED, 2010, CNS DRUGS, V24, P65, DOI 10.2165/11202620-000000000-00000; Vieweg WVR, 2013, PSYCHOPHARMACOLOGY, V228, P515, DOI 10.1007/s00213-013-3192-8; Killeen MJ, 2009, EXPERT OPIN DRUG SAF, V8, P249, DOI 10.1517/14740330902936846; Kishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088049; Takaki M, 2012, ACTA NEUROPSYCHIATR, V24, P380, DOI 10.1111/j.1601-5215.2012.00663.x; US Food and Drug Administration Advisory Committee, 2000, ZELD CAPS ZIPR SUMM; Vieweg WV, 2003, PRIM CARE COMPANION, V5, P205	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	FEB	2015	35	1					101	102				3	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	AX5QY	WOS:000346983200024		
J	Kurman, J; Liem, GA; Ivancovsky, T; Morio, H; Lee, J				Kurman, Jenny; Liem, Gregory Arief; Ivancovsky, Tal; Morio, Hiroaki; Lee, Joo			Regulatory Focus as an Explanatory Variable for Cross-Cultural Differences in Achievement-Related Behavior	JOURNAL OF CROSS-CULTURAL PSYCHOLOGY			English	Article						regulatory focus; culture; individualism-collectivism; initiation; creativity; mastery goals; achievement	NEGATIVE ROLE-MODELS; INDIVIDUALISM-COLLECTIVISM; CREATIVE-THINKING; SCHOOL-STUDENTS; SOCIAL AXIOMS; MOTIVATION; SELF; PREVENTION; PROMOTION; ARAB	The main claim of the present study is that regulatory focus (i.e., promotion vs. prevention orientations) is an important explanatory variable of cross-cultural differences in actual and self-reported achievement-related behaviors and preferences, which include a component of autonomy. It adds explained variance in behavior above and beyond that of individualism/collectivism (I/C), and mediates the relations between I/C and behavior. Three studies are reported. The first compared Israeli Jews and Arabs on minimal initiation (n = 255), the second compared Israeli Jews and Japanese on creativity (n = 92), and the third compared Swiss, Mexican, and Indonesian samples on preference for mastery goals in education (n = 488). All three studies demonstrated the ability of regulatory focus scales to distinguish between cultures and to serve as meaningful predictors of actual and self-reported achievement-related behaviors. The measured I/C scales were found to be less relevant to behavior prediction than was regulatory focus. In most studies, regulatory focus scales mediated the relations between some of the I/C scales and behavior. The diversity of the measured behaviors and cultures supports the ecological validity of the findings.	[Kurman, Jenny; Ivancovsky, Tal] Univ Haifa, IL-31905 Haifa, Israel; [Liem, Gregory Arief] Natl Inst Educ, Singapore, Singapore; [Morio, Hiroaki] Kansai Univ, Suita, Osaka, Japan; [Lee, Joo] Yonsei Univ, Seoul 120749, South Korea	Kurman, J (reprint author), Univ Haifa, IL-31905 Haifa, Israel.	jennyk@psy.haifa.ac.il					Allen R. E., 1991, CONCISE OXFORD DICT; Frese M, 1996, ACAD MANAGE J, V39, P37, DOI 10.2307/256630; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Higgins ET, 2001, EUR J SOC PSYCHOL, V31, P3, DOI 10.1002/ejsp.27; Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854; Elliot AJ, 2002, J PERS SOC PSYCHOL, V82, P804, DOI 10.1037/0022-3514.82.5.804; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; SCHWARTZ SH, 1990, J PERS SOC PSYCHOL, V58, P878, DOI 10.1037//0022-3514.58.5.878; DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037//0033-295X.95.2.256; Vissa B, 2012, ORGAN SCI, V23, P492, DOI 10.1287/orsc.1100.0567; HUNT SD, 1994, ACAD MANAGE J, V37, P1568, DOI 10.2307/256799; Dwairy M, 1996, CLIN PSYCHOL REV, V16, P231, DOI 10.1016/S0272-7358(96)00011-6; Higgins ET, 2008, HANDBOOK OF MOTIVATION AND COGNITION ACROSS CULTURES, P161, DOI 10.1016/B978-0-12-373694-9.00008-8; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037//0033-2909.128.1.3; Salili F, 2001, SPR SER HUM EX, P221; Brewer MB, 2007, PSYCHOL REV, V114, P133, DOI 10.1037/0033-295X.114.1.133; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Higgins ET, 1997, J PERS SOC PSYCHOL, V72, P515, DOI 10.1037/0022-3514.72.3.515; Shavitt S, 2006, J CONSUM PSYCHOL, V16, P325, DOI 10.1207/s15327663jcp1604_3; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1; Lockwood P, 2005, PERS SOC PSYCHOL B, V31, P379, DOI 10.1177/0146167204271598; Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037//0022-3514.81.6.1001; Kagitcibasi C, 2005, J CROSS CULT PSYCHOL, V36, P403, DOI 10.1177/0022022105275959; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Heine SJ, 2001, J PERS SOC PSYCHOL, V81, P599, DOI 10.1037//0022-3514.81.4.599; Leung K, 2007, EUR J PERSONALITY, V21, P91, DOI 10.1002/per.615; Liberman N, 1999, J PERS SOC PSYCHOL, V77, P1135, DOI 10.1037//0022-3514.77.6.1135; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; Lee AY, 2000, J PERS SOC PSYCHOL, V78, P1122, DOI 10.1037//0022-3514.78.6.1122; Fulmer CA, 2010, PSYCHOL SCI, V21, P1563, DOI 10.1177/0956797610384742; Leung K, 2004, ADV EXP SOC PSYCHOL, V36, P119, DOI 10.1016/S0065-2601(04)36003-X; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rank J, 2004, APPL PSYCHOL-INT REV, V53, P518, DOI 10.1111/j.1464-0597.2004.00185.x; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; Elliot AJ, 2001, PSYCHOL SCI, V12, P505, DOI 10.1111/1467-9280.00393; Liberman N, 2001, J PERS SOC PSYCHOL, V80, P5, DOI 10.1037//0022-3514.80.1.5; Saeki N, 2001, J CREATIVE BEHAV, V35, P24; Haws KL, 2010, J MARKETING RES, V47, P967; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037//0033-295X.96.3.506; Arimoto A, 2009, ASIA PAC EDUC REV, V10, P29, DOI 10.1007/s12564-009-9008-1; Cox MV, 1998, PSYCHOLOGIA, V41, P171; Crowe E, 1997, ORGAN BEHAV HUM DEC, V69, P117, DOI 10.1006/obhd.1996.2675; Csikszentmlhalyi M., 1999, HDB CREATIVITY, P313; El-haj M., 1996, JEWISH ARAB ENCOUNTE; FLORIAN V, 1993, J COMP FAM STUD, V24, P189; Forster J, 2003, ORGAN BEHAV HUM DEC, V90, P148, DOI 10.1016/S0749-5978(02)00509-5; Guilford J. P., 1986, CREATIVE TALENTS THE; Gyorkos C, 2013, CROSS-CULT RES, V47, P310, DOI 10.1177/1069397112470371; Heydenfeldt JAG, 2000, INT J INTERCULT REL, V24, P383, DOI 10.1016/S0147-1767(00)00007-9; Hofstede G, 1983, EXPISCATIONS CROSS C, P335; Hofstede G., 2001, CULTURES CONSEQUENCE; Hofstede G. H., 1980, CULTURES CONSEQUENCE; Jaquish G A, 1984, Int J Aging Hum Dev, V20, P1, DOI 10.2190/RNJJ-NBD0-4A3K-0XPA; JOSEPH S, 1993, ETHOS, V21, P452, DOI 10.1525/eth.1993.21.4.02a00040; Kagitcibasi C., 1997, HDB CROSS CULTURAL P, V3, P1; Komarraju M, 2008, INT J CONFL MANAGE, V19, P20, DOI 10.1108/10444060810849164; Kurman J, 2012, EUR J SOC PSYCHOL, V42, P482, DOI 10.1002/ejsp.1838; Kurman J, 2007, J CROSS CULT PSYCHOL, V38, P581, DOI 10.1177/0022022107305240; Kurman J., 2013, C INT ASS CROSS CULT; Liem AD, 2008, INT J PSYCHOL, V43, P898, DOI 10.1080/00207590701838097; Maehr M. L., 1980, STUDIES CROSS CULTUR, V2, P221; McClelland D. C., 1953, ACHIEVEMENT MOTIVE; Morris M, 2010, TLS-TIMES LIT SUPPL, P6; Ng A. K., 2004, LIBERATING CREATIVE; Perlmutter R., 2013, C INT ASS CROSS CULT; Pierro A, 2006, EUR J PERSONALITY, V20, P355, DOI 10.1002/per.600; RAPOPORT T, 1989, SEX ROLES, V20, P255, DOI 10.1007/BF00287723; Realo A, 2002, EUR J PERSONALITY, V16, P163, DOI 10.1002/per.437; RUDOWICZ E, 1995, INT J PSYCHOL, V30, P417, DOI 10.1080/00207599508246577; Sagy S, 2001, YOUTH SOC, V33, P3, DOI 10.1177/0044118X01033001001; Schwartz S. H., 1994, INDIVIDUALISM COLLEC, P85; Singelis T. M., 1995, CROSS-CULT RES, V29, P240, DOI DOI 10.1177/106939719502900302; Smooha S., 1989, ARABS JEWS ISRAEL CO; Sternberg RJ, 1999, HDB CREAT, V1, P3, DOI DOI 10.1017/CB09780511807916.003; Stevenson H. W., 1996, HDB CHINESE PSYCHOL, P124; Tan A. -G., 2000, KOREAN J PROBLEM SOL, V10, P79; Thomsen L, 2007, EUR J SOC PSYCHOL, V37, P445, DOI 10.1002/ejsp.366; Torrance E.P., 1974, TORRANCE TEST CREATI; Triandis Harry C., 1995, INDIVIDUALISM COLLEC; TZURIEL D, 1992, J YOUTH ADOLESCENCE, V21, P551, DOI 10.1007/BF01537395; Verkuyten M, 2001, GENET SOC GEN PSYCH, V127, P378; Volkema RJ, 2012, INT J CONFL MANAGE, V23, P266, DOI 10.1108/10444061211248976; Yamaguchi S, 1994, INDIVIDUALISM COLLEC, P175; Zha P, 2006, CREATIVITY RES J, V18, P355, DOI 10.1207/s15326934crj1803_10	84	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0221	1552-5422		J CROSS CULT PSYCHOL	J. Cross-Cult. Psychol.	FEB	2015	46	2					171	190		10.1177/0022022114558090		20	Psychology, Social	Psychology	AX4QO	WOS:000346916800001		
J	Vauclair, CM; Fischer, R; Ferreira, MC; Guerra, V; Hossler, U; Karabati, S; de Carvalho, MK; Porto, JB; Reyes, ML; Rytkonen, J; Spiess, E				Vauclair, Christin-Melanie; Fischer, Ronald; Ferreira, Maria Cristina; Guerra, Valeschka; Hoessler, Ulrich; Karabati, Serdar; de Carvalho Filho, Moises Kirk; Porto, Juliana B.; Lopez Reyes, Melissa; Rytkonen, Jenni; Spiess, Erika			What Kinds of Value Motives Guide People in Their Moral Attitudes? The Role of Personal and Prescriptive Values at the Culture Level and Individual Level	JOURNAL OF CROSS-CULTURAL PSYCHOLOGY			English	Article						personal values; prescriptive values; cultural values; moral attitudes; cross-cultural comparisons	BEHAVIOR; CONVICTION; STRENGTH; SELF; FIT	Opinions about moralized issues are arguably one of the most difficult issues in interpersonal dialogues given that they can result in intolerance and prejudicial behavior toward those with divergent moral beliefs. Recent research has shown that moral attitudes vary not only depending on the individual's characteristics but also as a function of culture. Individuals from individualistic-oriented cultures exhibit more lenient judgments toward moralized issues than those from collectivistic-oriented cultures. What is unclear to date is what kinds of cultural value motives underlie these attitudesAre they driven only by intrinsic value motives (personal values) or also by extrinsic value motives (prescriptive values in the form of societal expectations about what should be valued)? The cultural press to conform is arguably stronger if moral attitudes are predicted by the latter. Participants from eight countries (N = 1,456) responded to a questionnaire containing a modified version of the Schwartz Value Survey assessing personal and prescriptive values. The results showed that personal value ratings of openness-to-change versus conservation at the culture and individual levels were predictive of individuals' moral attitudes consistent with previous findings. Prescriptive value ratings of openness-to-change versus conservation also predicted individuals' moral attitudes, but only at the aggregated culture level. This suggests that the prescriptive values concept is a truly group-level phenomenon and that attitudes toward moralized issues are guided by cultural values with normative qualities. We discuss the implications for intercultural contact situations.	[Vauclair, Christin-Melanie] Inst Univ Lisboa ISCTE IUL, CIS, P-1649026 Lisbon, Portugal; [Fischer, Ronald] Victoria Univ Wellington, Wellington, New Zealand; [Ferreira, Maria Cristina] Univ Salgado de Oliveira, Rio De Janeiro, Brazil; [Guerra, Valeschka] Univ Fed Espirito Santo, Vitoria, Brazil; [Hoessler, Ulrich] Regensburg Univ Appl Sci, Regensburg, Germany; [Karabati, Serdar] Bilgi Univ, Istanbul, Turkey; [de Carvalho Filho, Moises Kirk] Kyoto Univ Foreign Studies, Kyoto, Japan; [Porto, Juliana B.] Univ Brasilia, BR-70910900 Brasilia, DF, Brazil; [Lopez Reyes, Melissa] De La Salle Univ, Manila 1004, Philippines; [Rytkonen, Jenni] Univ Helsinki, FIN-00014 Helsinki, Finland; [Spiess, Erika] Univ Munich, Munich, Germany	Vauclair, CM (reprint author), Inst Univ Lisboa ISCTE IUL, CIS IUL, Edificio ISCTE,Ave Forcas Armadas, P-1649026 Lisbon, Portugal.	melanie.vauclair@iscte.pt	Porto, Juliana/G-8280-2015; 	Porto, Juliana/0000-0001-9164-2719; Fischer, Ronald/0000-0002-3055-3955			Aijzen I., 1991, ORG BEHAV HUMAN DECI, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Lievens F, 2008, J APPL PSYCHOL, V93, P268, DOI 10.1037/0021-9010.93.2.268; Higgins ET, 2006, PSYCHOL REV, V113, P439, DOI 10.1037/0033-295X.113.3.439; Schwartz SH, 2014, J CROSS CULT PSYCHOL, V45, P5, DOI 10.1177/0022022113490830; Vauclair CM, 2011, EUR J SOC PSYCHOL, V41, P645, DOI 10.1002/ejsp.794; Fischer R, 2006, PERS SOC PSYCHOL B, V32, P1419, DOI 10.1177/0146167206291425; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Wright JC, 2008, PERS SOC PSYCHOL B, V34, P1461, DOI 10.1177/0146167208322557; Gelfand MJ, 2006, J APPL PSYCHOL, V91, P1225, DOI 10.1037/0021-9010.91.6.1225; MILLER JG, 1990, J PERS SOC PSYCHOL, V58, P33, DOI 10.1037/0022-3514.58.1.33; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037//0003-066X.55.1.68; Skitka LJ, 2005, J PERS SOC PSYCHOL, V88, P895, DOI 10.1037/0022-3514.88.6.895; SCHWARTZ SH, 1972, J PERS SOC PSYCHOL, V24, P225, DOI 10.1037/h0033365; Bardi A, 2003, PERS SOC PSYCHOL B, V29, P1207, DOI 10.1177/0146167203254602; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/S0065-2601(08)60281-6; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879; Fischer R, 2010, J CROSS CULT PSYCHOL, V41, P135, DOI 10.1177/0022022109354377; BENTLER PM, 1992, PSYCHOL BULL, V112, P400, DOI 10.1037/0033-2909.112.3.400; Byrne D, 1971, ATTRACTION PARADIGM; Cialdini R. B., 2012, HDB THEORIES SOCIAL, V2, P295; Crissman P, 1942, J SOC PSYCHOL, V16, P29; Cushner K., 1996, INTERCULTURAL INTERA; De Waal F, 1996, GOOD NATURED ORIGINS; Earley P. C., 2002, RES MULTILEVEL ISSUE, V1, P279; Feather N. T., 1999, VALUES ACHIEVEMENT J; Fischer R, 2008, J SOC PSYCHOL, V148, P167, DOI 10.3200/SOCP.148.2.167-186; Fischer R., 2012, INT J CROSS CULTURAL, V12, P157, DOI [10.1177/1470595812439867, DOI 10.1177/1470595812439867]; Goodwin L. D., 2006, J EXPT ED, V74, P249, DOI [10.3200/JEXE.74.3.249-266, DOI 10.3200/JEXE.74.3.249-266]; Hair J.F., 2006, MULTIVARIATE DATA AN; Harding S, 1986, CONTRASTING VALUES W; Harkness J. A., 2003, CROSS CULTURAL SURVE, P35; Hofstede G., 2001, CULTURES CONSEQUENCE; James L. R., 2000, MULTILEVEL THEORY RE, P349; Katcba C., 1997, HDB CROSS CULTURAL P, P1; Kluckhohn C, 1952, GEN THEORY ACTION, P388; Kristiansen CM, 1996, ONT SYMP P, V8, P77; LISKA AE, 1990, SOC PSYCHOL QUART, V53, P292, DOI 10.2307/2786735; Rokeach M., 1973, NATURE HUMAN VALUES; Ross L., 1977, ADV EXPT SOCIAL PSYC, P173, DOI [DOI 10.1016/S0065-2601(08)60357-3, 10.1016/S00652601(08)60357-3]; Schwartz S. H., 2007, MEASURING ATTITUDES, P161, DOI DOI 10.4135/9781849209458.N9; Schwartz S. H., 2007, DRAFT USERS MANUAL P; Schwartz SH, 1997, BRIT J SOC PSYCHOL, V36, P3; Schwartz S. H., 2006, REV FRANCAISE SOCIOL, V47, P249; Shweder R. A., 1997, MORALITY HLTH, P119; Simms L.J., 2007, HDB RES METHODS PERS, P240; Smith P. B., 2008, INDIVIDUALS CULTURES, P283; Triandis H. C., 2001, HDB CULTURE PSYCHOL, P35; Turiel E., 1983, DEV SOCIAL KNOWLEDGE	52	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0221	1552-5422		J CROSS CULT PSYCHOL	J. Cross-Cult. Psychol.	FEB	2015	46	2					211	228		10.1177/0022022114557487		18	Psychology, Social	Psychology	AX4QO	WOS:000346916800003		
J	Sawaumi, T; Yamaguchi, S; Park, J; Robinson, AR				Sawaumi, Takafumi; Yamaguchi, Susumu; Park, Joonha; Robinson, Angela R.			Japanese Control Strategies Regulated by Urgency and Interpersonal Harmony: Evidence Based on Extended Conceptual Framework	JOURNAL OF CROSS-CULTURAL PSYCHOLOGY			English	Article						primary control; secondary control; cultural difference; harmony	LIFE-SPAN THEORY; SECONDARY CONTROL STRATEGIES; CULTURE; SELF; CRITIQUE; HEALTH; WORLD	People use control strategies to improve their physical as well as interpersonal situations. Previous research has maintained that Japanese, compared with North Americans, are more oriented toward secondary control (changing oneself) than primary control (changing one's circumstances). However, Heckhausen and Schulz's work suggests dominance of primary control over secondary control across cultures. The conflicting views regarding Japanese control orientations are reconciled by considering situational variation. Based on an extended framework of primary control, two empirical studies examined the alternative hypothesis that control orientation would be affected by perceived urgency and concern about harmony maintenance. Study 1 used open-ended questions (n = 171) to validate the extended primary control taxonomy, and revealed that participants' control orientations were influenced by their subjective urgency of control and perceived difficulty in maintaining interpersonal harmony. Study 2 (n = 246) replicated the latter results with Likert-type scale ratings. These results support the extended framework of primary control and identify two situational predictors of control orientation.	[Sawaumi, Takafumi; Yamaguchi, Susumu; Park, Joonha] Univ Tokyo, Tokyo 1130033, Japan; [Robinson, Angela R.] Victoria Univ Wellington, Wellington, New Zealand	Sawaumi, T (reprint author), Univ Tokyo, Grad Sch Humanities & Sociol, Dept Social Psychol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	t.sawaumi@gmail.com		Robinson, Angela/0000-0002-9946-6470			ROTHBAUM F, 1982, J PERS SOC PSYCHOL, V42, P5, DOI 10.1037/0022-3514.42.1.5; Endo Y, 2000, PERS SOC PSYCHOL B, V26, P1571, DOI 10.1177/01461672002612011; Ohbuchi K, 1996, PERS SOC PSYCHOL B, V22, P1035, DOI 10.1177/01461672962210007; Haynes TL, 2009, J SOC CLIN PSYCHOL, V28, P165; HECKHAUSEN J, 1995, PSYCHOL REV, V102, P284, DOI 10.1037//0033-295X.102.2.284; Morling B, 2006, PSYCHOL BULL, V132, P269, DOI 10.1037/0033-2909.132.2.269; Wrosch C, 2000, PSYCHOL AGING, V15, P387, DOI 10.1037//0882-7974.15.3.387; Ashman O, 2006, INT J AGING HUM DEV, V62, P143, DOI 10.2190/9LXU-WLYP-NC22-98MJ; Bandura A., 1997, SELF EFFICACY EXERCI; Brown P., 1987, POLITENESS SOME UNIV; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Gibbs Jr R. W., 2000, METAPHOR SYMBOL, V15, P5, DOI DOI 10.1080/10926488.2000.9678862; Gould SJ, 1999, PSYCHOL REV, V106, P597, DOI 10.1037/0033-295X.106.3.597; Heckhausen J, 1999, PSYCHOL REV, V106, P605, DOI 10.1037/0033-295X.106.3.605; Heine S. J., 2007, HDB CULTURAL PSYCHOL, P714; Kurman J, 2012, J CROSS CULT PSYCHOL, V43, P15, DOI 10.1177/0022022110388565; Lin CC, 2011, EUR J SOC PSYCHOL, V41, P446, DOI 10.1002/ejsp.817; Morling B, 2007, PSYCHOL BULL, V133, P917, DOI 10.1037/0033-2909.133.6.917; Morling B., 2000, ASIAN J SOC PSYCHOL, V3, P73, DOI 10.1111/1467-839X.00055; Oerter R, 1996, CULT PSYCHOL, V2, P9, DOI 10.1177/1354067X9621002; Skinner EA, 2007, PSYCHOL BULL, V133, P911, DOI 10.1037/0033-2909.133.6.911; Tobin SJ, 2010, PERS SOC PSYCHOL B, V36, P371, DOI 10.1177/0146167209359701; Tsukahara T., 2008, JAPANESE PSYCHOL REV, V51, P396; Tsukahara T, 2010, JPN J EDUC PSYCHOL, V58, P186; WEISZ JR, 1984, AM PSYCHOL, V39, P974, DOI 10.1037//0003-066X.39.9.974; Yamaguchi S, 2001, HDB CULTURE PSYCHOL, P223	26	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0221	1552-5422		J CROSS CULT PSYCHOL	J. Cross-Cult. Psychol.	FEB	2015	46	2					252	268		10.1177/0022022114563749		17	Psychology, Social	Psychology	AX4QO	WOS:000346916800005		
J	Hayashi, N; Naumkin, PI				Hayashi, Nakao; Naumkin, Pavel I.			Large time asymptotics for the fourth-order nonlinear Schrodinger equation	JOURNAL OF DIFFERENTIAL EQUATIONS			English	Article						Fourth-order nonlinear Schrodinger equation; Large time asymptotics	GLOBAL WELL-POSEDNESS; VORTEX FILAMENT; DIMENSIONS; DISPERSION	We consider the Cauchy problem for the fourth-order nonlinear Schrodinger equation in the super critical case i partial derivative(t)u + 1/4 partial derivative(4)(x)u = lambda partial derivative(x)(vertical bar u vertical bar(rho-1)u), where rho > 4, lambda is an element of C. We prove the global existence and the large time asymptotics of solutions for small initial data u(0) is an element of H-1 boolean AND H-1/2,H-1, when the order of the nonliuearity rho >4. (C) 2014 Elsevier Inc. All rights reserved.	[Hayashi, Nakao] Osaka Univ, Grad Sch Sci, Dept Math, Osaka, Tokyonaka 5600043, Japan; [Naumkin, Pavel I.] Ctr Ciencias Matemat, Morelia 58089, Michoacan, Mexico	Hayashi, N (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, Osaka, Tokyonaka 5600043, Japan.	nhayashi@math.sci.osaka-u.ac.jp; pavelni@matmor.unam.mx			JSPS KAKENHI [24654034, 25220702]; CONACYT; PAPIIT [IN100113]	We would like to thank the unknown referee for useful comments and careful reading the first draft. The work of N.H. is supported by JSPS KAKENHI Grant Numbers 24654034, 25220702. The work of P.I.N. is partially supported by CONACYT and PAPIIT project IN100113.	Ben-Artzi M, 2000, CR ACAD SCI I-MATH, V330, P87, DOI 10.1016/S0764-4442(00)00120-8; Guo CH, 2006, APPL MATH LETT, V19, P706, DOI 10.1016/j.aml.2005.10.002; Fukumoto Y, 2001, FLUID MEC A, V59, P211; Huo ZH, 2005, J DIFFER EQUATIONS, V214, P1, DOI 10.1016/j.jde.2004.09.005; Karpman VI, 1996, PHYS REV E, V53, pR1336; Hao CC, 2006, J MATH ANAL APPL, V320, P246, DOI 10.1016/j.jmaa.2005.06.091; Karpman VI, 2000, PHYSICA D, V144, P194, DOI 10.1016/S0167-2789(00)00078-6; Pausader B, 2007, DYNAM PART DIFFER EQ, V4, P197; Pausader B, 2013, NONLINEARITY, V26, P2175, DOI 10.1088/0951-7715/26/8/2175; KENIG CE, 1991, INDIANA U MATH J, V40, P33, DOI 10.1512/iumj.1991.40.40003; Wang YZ, 2012, NONLINEAR ANAL-THEOR, V75, P2534, DOI 10.1016/j.na.2011.10.047; Wang YZ, 2012, B AUST MATH SOC, V85, P371, DOI 10.1017/S0004972711003327; DYSTHE KB, 1979, P ROY SOC LOND A MAT, V369, P105, DOI 10.1098/rspa.1979.0154; KENIG CE, 1993, COMMUN PUR APPL MATH, V46, P527, DOI 10.1002/cpa.3160460405; Pausader B, 2010, J HYPERBOL DIFFER EQ, V7, P651, DOI 10.1142/S0219891610002256; Segata J., 2003, DIFFERENTIAL INTEGRA, V16, P841; Segata J, 2006, MATH METHOD APPL SCI, V29, P1785, DOI [10.1002/mma.751, 10.1002/mms.751]; Stein E., 1993, HARMONIC ANAL REAL V	18	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-0396	1090-2732		J DIFFER EQUATIONS	J. Differ. Equ.	FEB 1	2015	258	3					880	905		10.1016/j.jde.2014.10.007		26	Mathematics	Mathematics	AY0DN	WOS:000347268100009		
J	Kijima, H				Kijima, Hideo			Influence of lubrication on roughness crushing in skin-pass rolling of steel strip	JOURNAL OF MATERIALS PROCESSING TECHNOLOGY			English	Article						Skin-pass rolling; Temper rolling; Finite element analysis; Lubrication; Roll radius; Roughness; Yield-point phenomena	CONTACT CONDITIONS; RADIUS	Skin-pass rolling (or temper rolling) is usually the final process in the production of cold-rolled steel sheets. In operation, skin-pass rolling is performed with a lubricant with very low lubricating ability. However, relatively few studies have been reported in the literature regarding the effect of lubrication in skin-pass rolling. In this paper, the influence of lubrication on roughness crushing in skin-pass rolling is investigated by experimental rolling tests as well as numerical analysis by elastic-plastic FEM, especially focusing on differences in lubrication behavior depending on roll radius. The results with a large, operational size roll are well explained by the height characterization parameters and are considered to be reasonable from the viewpoint of classical knowledge in deep drawing tests and plane strain upsetting. It was found that some characteristics of skin-pass rolling related to lubrication are not properly simulated using small radius, laboratory size rolls due to insufficient contact length. (C) 2014 Elsevier B.V. All rights reserved.	JFE Steel Corp, Rolling & Proc Res Dept, Fukuyama, Hiroshima, Japan	Kijima, H (reprint author), JFE Steel Corp, Rolling & Proc Res Dept, 1 Kokan Cho, Fukuyama, Hiroshima, Japan.	h-kijima@jfe-steel.co.jp					Yoshida F, 2008, INT J PLASTICITY, V24, P1792, DOI 10.1016/j.ijplas.2008.05.004; Aoki A., 2008, TETSU TO HAGANE, V94, P438; Dixon A., 2006, P 9 INT STEEL ROLL C; Hill R., 1950, MATH THEORY PLASTICI; Imai I., 1980, P MIN WAST UT S, V2, P1203; Kasuga Y., 1968, B JSME, V11, P344; Kijima H, 2014, J MATER PROCESS TECH, V214, P1111, DOI 10.1016/j.jmatprotec.2013.12.019; Kijima H., 2014, P 167 ISIJ M CURR AD, V27, P350; Kijima H., 2014, P JPN SPRING C TECHN, P215; Kijima H., 2013, P 165 ISIJ M CURR AD, V26, P278; Kijima H., 2013, P JPN SPRING C TECHN, P215; Kijima H, 2013, J MATER PROCESS TECH, V213, P1764, DOI 10.1016/j.jmatprotec.2013.04.011; Kijima H, 2009, J MATER PROCESS TECH, V209, P4835, DOI 10.1016/j.jmatprotec.2009.01.004; Kijima H, 2007, CIRP ANN-MANUF TECHN, V56, P301, DOI 10.1016/j.cirp.2007.05.070; Kimura Y., 1999, INT J MECH SCI, V41, P207; Pawelski O., 1993, P 1 INT C MET ROLL P, P475; Santino A., 1994, 6 INT ROLL C DUSS, P422; Schwab R, 2013, ACTA MATER, V61, P1798, DOI 10.1016/j.actamat.2012.12.003; Sun JN, 2009, J IRON STEEL RES INT, V16, P27, DOI 10.1016/S1006-706X(09)60056-X	19	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-0136			J MATER PROCESS TECH	J. Mater. Process. Technol.	FEB	2015	216						1	9		10.1016/j.jmatprotec.2014.08.010		9	Engineering, Industrial; Engineering, Manufacturing; Materials Science, Multidisciplinary	Engineering; Materials Science	AX6GJ	WOS:000347020800001		
J	Ning, HM; Li, Y; Hu, N; Arai, M; Takizawa, N; Liu, YL; Wu, L; Li, JH; Mo, FH				Ning, Huiming; Li, Yuan; Hu, Ning; Arai, Masahiro; Takizawa, Naoya; Liu, Yaolu; Wu, Liangke; Li, Jinhua; Mo, Fuhao			Experimental and numerical study on the improvement of interlaminar mechanical properties of Al/CFRP laminates	JOURNAL OF MATERIALS PROCESSING TECHNOLOGY			English	Article						Al/CFRP laminates; Vapor grown carbon fiber (VGCF); Fracture toughness; Interlaminar mechanical properties; Finite element analysis	TRANSVERSE LOADS; COMPOSITES	Improvement of interlaminar mechanical properties in Al/CFRP laminates, fabricated by carbon fiber reinforced plastic (CFRP) prepregs combined with Al alloy sheets, was studied experimentally and numerically. Three toughening methods including acid etching and mechanical patterning for surface treatment of Al alloy sheet, as well as addition of nanofiller (i.e., vapor grown carbon fiber (VGCF)) to the interface of CFRP and Al sheet, were investigated. Experimental results of double cantilever beam tests show the improvement on the interlaminar mechanical properties of Mode-I fracture in terms of much higher critical load Pc and fracture toughness G(IC). The highest Gic was obtained in the specimens with the combination of acid etching on Al sheet and 10 g/m(2) VGCF addition, which was 41 and 6.5 times higher than those of the pristine samples without any treatment and the samples with only acid etching, respectively. Although further mechanical patterning had a positive effect for the case without VGCF addition, the minor effect was observed for the case of VGCF addition because of difficult dispersion of VGCF. Crack propagation and fracture surface were also observed to interpret the improvement mechanism. Moreover, by using the above experimental Gic, finite element analyses were carried out based on cohesive zone model to numerically simulate delamination propagation. The numerically predicted interlaminar tensile strength of Al/CFRP laminates also shows great improvement of interlaminar mechanical properties using the above toughening methods. (C) 2014 Elsevier B.V. All rights reserved.	[Ning, Huiming; Hu, Ning; Liu, Yaolu; Wu, Liangke] Chongqing Univ, Coll Aerosp Engn, Chongqing 400044, Peoples R China; [Li, Yuan] Tohoku Univ, Dept Nanomech, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Hu, Ning; Takizawa, Naoya; Li, Jinhua] Chiba Univ, Dept Mech Engn, Inage Ku, Chiba 2638522, Japan; [Arai, Masahiro] Shinshu Univ, Dept Mech Syst Engn, Nagano 3808553, Japan; [Mo, Fuhao] Hunan Univ, Coll Mech & Vehicle Engn, Changsha 410082, Hunan, Peoples R China	Hu, N (reprint author), Chiba Univ, Dept Mech Engn, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	ninghu@cqu.edu.cn			National Natural Science Foundation of China [11372104]	This work is partly supported by the Research Funds from National Natural Science Foundation of China (No. 11372104) to NH.	Li YA, 2011, COMP MATER SCI, V50, P1854, DOI 10.1016/j.commatsci.2011.01.029; Chang PY, 2008, MAT SCI ENG A-STRUCT, V496, P273, DOI 10.1016/j.msea.2008.07.041; Hu N, 2008, MECH MATER, V40, P920, DOI 10.1016/j.mechmat.2008.05.003; Arai M, 2008, COMPOS SCI TECHNOL, V68, P516, DOI 10.1016/j.compscitech.2007.06.007; Hu N, 2007, COMPOS SCI TECHNOL, V67, P752, DOI 10.1016/j.compscitech.2006.04.014; Karapappas P, 2009, J COMPOS MATER, V43, P977, DOI 10.1177/0021998308097735; Khan SU, 2012, CARBON, V50, P5265, DOI 10.1016/j.carbon.2012.07.011; Kim WS, 2010, INT J ADHES ADHES, V30, P408, DOI 10.1016/j.ijadhadh.2010.05.004; [Anonymous], 1993, K7086 JIS; Cho DH, 1998, J COMPOS MATER, V32, P1221; Janarthanan V, 1997, POLYMER, V38, P105, DOI 10.1016/S0032-3861(96)00447-8; Jen R.M.H., 2005, COMPOS SCI TECHNOL, V65, P775; Kim HS, 2006, COMPOS PART A-APPL S, V37, P1708, DOI 10.1016/j.compositesa.2005.09.015; Li Y, 2009, COMPOS PART A-APPL S, V40, P2004, DOI 10.1016/j.compositesa.2009.09.002; Molitor P, 2002, INT J ADHES ADHES, V22, P101, DOI 10.1016/S0143-7496(01)00041-0; Reyes G, 2009, COMPOS PART A-APPL S, V40, P176, DOI 10.1016/j.compositesa.2008.10.016; Vlot A., 2001, FIBRE METAL LAMINATE	17	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-0136			J MATER PROCESS TECH	J. Mater. Process. Technol.	FEB	2015	216						79	88		10.1016/j.jmatprotec.2014.08.031		10	Engineering, Industrial; Engineering, Manufacturing; Materials Science, Multidisciplinary	Engineering; Materials Science	AX6GJ	WOS:000347020800009		
J	Miura, T; Ueji, R; Fujii, H				Miura, Takuya; Ueji, Rintaro; Fujii, Hidetoshi			Enhanced tensile properties of Fe-Ni-C steel resulting from stabilization of austenite by friction stir welding	JOURNAL OF MATERIALS PROCESSING TECHNOLOGY			English	Article						Friction stir welding; Electron backscatten diffraction; Fe-Ni-C steel; Phase transformation; Retained austenite; Tensile property	MICROSTRUCTURAL EVOLUTION; STAINLESS-STEEL; CARBON-STEEL; STRAIN-RATE; DEFORMATION; BEHAVIOR	The austenite in the stir zone (SZ) of Fe-24wt%Ni-0.1%C alloy fabricated by friction stir welding (FSW) was successfully stabilized. The volume fraction of austenite increases with decreasing rotation speed of the FSW tool, Electron backscatter diffraction (EBSD) measurements clarified the Kurdjumov-Sachs orientation relationship between the retained austenite and the martensite phase; this orientation relationship indicated that a phase transformation occurs after stirring and that austenite is plastically deformed during this transformation. Additional EBSD measurements clarified that more dislocations remain and that the austenite grain is refined when the rotation speed is decreased. These lattice defects provide a barrier to the martensite transformation. The retained austenite exhibited the transformation-induced plasticity (TRIP) effect when the SZ was evaluated using tensile tests. As a result, SZs with a substantial amount of retained austenite exhibit both high strength and ductility. (C) 2014 Elsevier B.V. All rights reserved.	[Miura, Takuya; Ueji, Rintaro; Fujii, Hidetoshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan; [Miura, Takuya] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan	Miura, T (reprint author), Osaka Univ, Joining & Welding Res Inst, Suita, Osaka 565, Japan.	miura@jwri.osaka-u.ac.jp		Miura, Takuya/0000-0002-8991-5412	Japan Science and Technology Agency (JST); Ministry of Education, Sports, Culture, Science; Japan Society for Promotion of Science and Technology of Japan, ISIJ	This study was supported by the Japan Science and Technology Agency (JST) under Collaborative Research Based on Industrial Demand "Heterogeneous Structure Control: Towards Innovative Development of Metallic Structural Materials"; the Global COE Programs from the Ministry of Education, Sports, Culture, Science; and a Grant-in-Aid for Science Research from the Japan Society for Promotion of Science and Technology of Japan, ISIJ Research Promotion Grant.	Cui L, 2007, SCRIPTA MATER, V56, P637, DOI 10.1016/j.scriptamat.2006.12.004; Park WS, 2010, MATER DESIGN, V31, P3630, DOI 10.1016/j.matdes.2010.02.041; Fujii H, 2006, MAT SCI ENG A-STRUCT, V429, P50, DOI 10.1016/j.msea.2006.04.118; Mironov S, 2011, ACTA MATER, V59, P5472, DOI 10.1016/j.actamat.2011.05.021; Sato YS, 2007, SCRIPTA MATER, V57, P557, DOI 10.1016/j.scriptamat.2007.04.050; TSUZAKI K, 1991, MATER T JIM, V32, P222; Ghosh M, 2010, SCRIPTA MATER, V63, P851, DOI 10.1016/j.scriptamat.2010.06.032; Chatterjee S, 2006, MATER SCI TECH-LOND, V22, P641, DOI 10.1179/174328406X86128; Fujii H, 2014, SCRIPTA MATER, V70, P39, DOI 10.1016/j.scriptamat.2013.09.012; He ZP, 2012, J MATER PROCESS TECH, V212, P2141, DOI 10.1016/j.jmatprotec.2012.05.020; KAJIWARA S, 1986, METALL TRANS A, V17, P1693, DOI 10.1007/BF02817268; Miura T., 2012, P INT S VIS JOIN WEL, V1, P137; Saeid T., 2008, MAT SCI ENG A-STRUCT, V496A, P252; Thomas W.M., 1991, Int. patent Appl. No, Patent No. [PCT/GB92/02203, 9202203]	14	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-0136			J MATER PROCESS TECH	J. Mater. Process. Technol.	FEB	2015	216						216	222		10.1016/j.jmatprotec.2014.09.014		7	Engineering, Industrial; Engineering, Manufacturing; Materials Science, Multidisciplinary	Engineering; Materials Science	AX6GJ	WOS:000347020800023		
J	Hirota, K; Michitsuji, K				Hirota, Kenji; Michitsuji, Kota			Deformation behavior in boss forming with small punch/die diameter ratio	JOURNAL OF MATERIALS PROCESSING TECHNOLOGY			English	Article						Half blanking; Extrusion; Boss; Pin; Sheet metal; Negative clearance	SHEET-METAL; EXTRUSION	Sheet metal parts with bosses or small pins can be manufactured by half blanking. This paper focuses on deformation in small boss forming on a sheet metal by half blanking at small punch/die diameter ratios of 1-1.8. In the case that the boss diameter is less than the sheet thickness, the boss height became lower than the depth of punch penetration at a punch/die diameter ratio of 1. The mechanism of decrease in the boss height and countermeasures to the problem were investigated through the FE analysis. The results showed that the boss height was improved up to the same level as the depth of punch penetration by both increasing punch/die diameter ratio and applying an appropriate blank holding force. The boss height was also affected by the material ductility and a higher boss was formed for the not-annealed sheet under the same forming conditions. The punch/die diameter ratio did not make a big difference in the mean punch pressure although a larger force was needed by using a larger diameter punch. (C) 2014 Elsevier B.V. All rights reserved.	[Hirota, Kenji; Michitsuji, Kota] Kyushu Inst Technol, Dept Mat Sci & Engn, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan	Hirota, K (reprint author), Kyushu Inst Technol, Dept Mat Sci & Engn, Tobata Ku, 1-1 Sensui Cho, Kitakyushu, Fukuoka 8048550, Japan.	hirota@post.matsc.kyutech.ac.jp					Hirota K, 2007, J MATER PROCESS TECH, V191, P283, DOI 10.1016/j.jmatprotec.2007.03.024; Fu MW, 2013, MATER DESIGN, V49, P774, DOI 10.1016/j.matdes.2013.02.045; Merklein M, 2012, CIRP ANN-MANUF TECHN, V61, P725, DOI 10.1016/j.cirp.2012.05.007; Zheng PF, 2005, FINITE ELEM ANAL DES, V42, P189, DOI 10.1016/j.finel.2005.06.002; Chan WL, 2013, MATER DESIGN, V43, P249, DOI 10.1016/j.matdes.2012.07.004; Ghassemali E., 2011, STEEL RES INT SPECIA, P1014; Hirota K, 2010, STEEL RES INT, V81, P414; Lim S.C.V., 2010, P INT FORUM MICRO MA, V2010, P11; Murakami H., 2005, P 8 INT C TECHN PLAS; Wang ZG, 2013, CIRP ANN-MANUF TECHN, V62, P291, DOI 10.1016/j.cirp.2013.03.057; Zhang S., 2008, T NONFERR METAL SOC, V18, P269	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-0136			J MATER PROCESS TECH	J. Mater. Process. Technol.	FEB	2015	216						294	301		10.1016/j.jmatprotec.2014.09.012		8	Engineering, Industrial; Engineering, Manufacturing; Materials Science, Multidisciplinary	Engineering; Materials Science	AX6GJ	WOS:000347020800030		
J	Kimura, Y; Fujita, N; Matsubara, Y; Kobayashi, K; Amanuma, Y; Yoshioka, O; Sodani, Y				Kimura, Yukio; Fujita, Noriki; Matsubara, Yukihiro; Kobayashi, Koji; Amanuma, Yosuke; Yoshioka, Osami; Sodani, Yasuhiro			High-speed rolling by hybrid-lubrication system in tandem cold rolling mills	JOURNAL OF MATERIALS PROCESSING TECHNOLOGY			English	Article						Lubrication; Emulsion; Cold rolling; Plate-out; Hybrid-lubrication system; Chatter	IN-WATER EMULSIONS; OIL	Lubrication is one of the most important factors for improving the productivity of tandem cold rolling mills, as it is possible to increase the rolling speed of thin gauge steel strips and prevent chatter when rolling materials with high deformation resistance. In this study, a new hybrid lubrication system is proposed and its effectiveness is clarified. The system is based on a lubricant recirculation system combined with a system for flexible lubrication control. The key to realizing the new lubricant system is control of plate-out oil film formation on the strip surface under high-speed rolling conditions. The plate-out oil film formation of emulsions is investigated, and the conditions for achieving a sufficient plate-out oil film are clarified. The time-dependent property, oil droplet size, and emulsion concentration are found to have significant effects on plate-out behavior. In addition, the conditions for practical application of hybrid lubrication systems are discussed from the viewpoint of realizing effective plate-out control. A new hybrid lubrication system was investigated, and it successfully enabled flexible controllability of lubrication conditions and achieved the high-speed stable rolling, while maintaining an oil consumption rate equal to that of recirculation systems. (C) 2014 Elsevier B.V. All rights reserved.	[Kimura, Yukio; Fujita, Noriki; Matsubara, Yukihiro; Sodani, Yasuhiro] JFE Steel Corp, Steel Res Lab, Chiba 2600835, Japan; [Kobayashi, Koji; Amanuma, Yosuke] JFE Steel Corp, West Japan Works, Fukuyama, Hiroshima, Japan; [Yoshioka, Osami] JFE Steel Corp, Tin Mill Prod Business Planning Dept, Chiba 2600835, Japan	Kimura, Y (reprint author), JFE Steel Corp, Rolling & Proc Res Dept, Steel Res Lab, Chuo Ku, 1 Kawasaki Cho, Chiba 2600835, Japan.	yu-kimura@jfe-steel.co.jp					WILSON WRD, 1993, WEAR, V161, P207, DOI 10.1016/0043-1648(93)90471-W; Fujita N, 2012, ISIJ INT, V52, P850; Kimura Y, 2009, TETSU TO HAGANE, V95, P340; Laugier M, 2011, P I MECH ENG J-J ENG, V225, P949, DOI 10.1177/1350650111414514; Fujita N, 2013, P I MECH ENG J-J ENG, V227, P413, DOI 10.1177/1350650112467873; Azushima A, 2011, TRIBOL T, V54, P275, DOI 10.1080/10402004.2010.542275; Lo SW, 2010, J TRIBOL-T ASME, V132, DOI 10.1115/1.4000274; Kimura Y, 2003, ISIJ INT, V43, P77, DOI 10.2355/isijinternational.43.77; Reich R, 2004, TRIBOL T, V47, P489, DOI 10.1080/05698190490493427; Azushima A., 1998, JPN J SOC TECHNOL PL, V39, P1238; Ford H., 1948, P I MECH ENG, V159, P144; Fujita N., 2012, P 63 JPN JOINT C TEC, P451; Furukawa K, 1976, KAWASAKI STEEL GIHO, V8, P60; Guillaument R, 2011, P I MECH ENG J-J ENG, V225, P905, DOI 10.1177/1350650111411245; Iwadoh S, 1996, TETSU TO HAGANE, V82, P220; Kaneko T., 2000, CAMP ISIJ, V13, P318; Kimura Y., 2012, P JPN SPRING C TECHN, V2012, P157; KIMURA Y, 1989, TRIBOL T, V32, P524, DOI 10.1080/10402008908981921; Kimura Y., 2012, P JPN SPRING C TECHN, V2012, P159; Mase T., 1977, P 28 JAP JOINT C TEC, P114; Muramoto H., 1982, TETSU TO HAGANE, V68, pS370; Orowan E., 1943, Proceedings of the Institution of Mechanical Engineers, V150; Roberts W.L., 1966, FRICTION LUBRICATION, P103; Semoto S., 1992, J JPN SOC TECHNOL PL, V33, P790; Soda N., 1966, J JPN SOC TECHNOL PL, V7, P249	25	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-0136			J MATER PROCESS TECH	J. Mater. Process. Technol.	FEB	2015	216						357	368		10.1016/j.jmatprotec.2014.10.002		12	Engineering, Industrial; Engineering, Manufacturing; Materials Science, Multidisciplinary	Engineering; Materials Science	AX6GJ	WOS:000347020800036		
J	Jee, D; Zako, M; La, TY				Jee, Donghyun; Zako, Masahiro; La, Tae Yoon			Serum D-Dimer Levels to Evaluate the Risk for Arterial Thromboembolism After Intravitreal Injection of Bevacizumab and Ranibizumab	JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article							MACULAR DEGENERATION; VENOUS THROMBOEMBOLISM; ELEVATED LEVELS; THROMBOSIS; VEGF; PHARMACOKINETICS; DIAGNOSIS; LUCENTIS; THERAPY; AVASTIN	Purpose: There are concerns about arterial thromboembolic event after intravitreal injection of bevacizumab or ranibizumab. Motivated by the fact that D-dimer was a sensitive biomarker for thromboembolism, we evaluated serum D-dimer levels in patients with age-related macular degeneration (AMD) after intravitreal injection of bevacizumab and ranibizumab. Methods: In this prospective, nonrandomized, uncontrolled study, 122 patients (122 eyes) with AMD were enrolled. Sixty-two eyes received intravitreal injections of bevacizumab and 60 eyes received intravitreal injections of ranibizumab monthly for 3 months. Serum D-dimer levels were measured in patients before intravitreal injection and 1 day, 1 week, 1 month, and 3 months thereafter. Results: Serum D-dimer levels were not significantly altered following injection of either bevacizumab or ranibizumab. Subgroup analysis for patients at risk for thromboembolic events revealed that serum D-dimer levels showed no significant change after injection of ranibizumab. However, D-dimer levels significantly increased at 1 day (P=0.041) and 1 week (P=0.022) after injection of bevacizumab. Conclusions: Serum D-dimer levels were not changed after injection with either bevacizumab or ranibizumab. In subgroup analysis, bevacizumab injection in patients at risk of thromboembolism increased serum D-dimer levels.	[Jee, Donghyun; La, Tae Yoon] St Vincent Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Jee, Donghyun; La, Tae Yoon] Catholic Univ Korea, Coll Med, Seoul 137701, South Korea; [Zako, Masahiro] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi, Japan	La, TY (reprint author), Catholic Univ Korea, Coll Med, Seoul 137701, South Korea.	laty@catholic.ac.kr					Verhovsek M, 2008, ANN INTERN MED, V149, P481; Wada H, 2006, J THROMB HAEMOST, V4, P1253, DOI 10.1111/j.1538-7836.2006.01942.x; Kilickap S, 2003, J CLIN ONCOL, V21, P3542, DOI 10.1200/JCO.2003.99.046; Sun C, 2009, OPHTHALMOLOGY, V116, P1913, DOI 10.1016/j.ophtha.2009.03.046; Lippi G, 2010, J THROMB THROMBOLYS, V30, P459, DOI 10.1007/s11239-010-0460-x; Nomoto H, 2009, INVEST OPHTH VIS SCI, V50, P4807, DOI 10.1167/iovs.08-3148; Tripodi A, 2011, CLIN CHEM, V57, P1256, DOI 10.1373/clinchem.2011.166249; Hu CC, 2010, STROKE, V41, P613, DOI 10.1161/STROKEAHA.109.571000; Tolentino M, 2011, SURV OPHTHALMOL, V56, P95, DOI 10.1016/j.survophthal.2010.08.006; Tseng CS, 2005, FEMS IMMUNOL MED MIC, V43, P99, DOI 10.1016/j.femism.2004.10.004; Wong TY, 2006, ANN INTERN MED, V145, P98; Schmidt-Erfurth U, 2010, EXPERT OPIN DRUG SAF, V9, P149, DOI 10.1517/14740330903418422; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P2179, DOI 10.1016/j.ophtha.2007.09.012; Ueta T, 2009, OPHTHALMOLOGY, V116, P362, DOI 10.1016/j.ophtha.2008.09.046; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Matsuyama W, 2000, CHEST, V118, P948, DOI 10.1378/chest.118.4.948; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Mannucci PM, 2002, PATHOPHYSIOL HAEMO T, V32, P209, DOI 10.1159/000073567; Schmucker C, 2010, CURR OPIN OPHTHALMOL, V21, P218, DOI 10.1097/ICU.0b013e3283386783; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Schouten JSAG, 2009, GRAEF ARCH CLIN EXP, V247, P1, DOI 10.1007/s00417-008-0952-y; Meyer CH, 2011, EYE, V25, P661, DOI 10.1038/eye.2011.66; Alexander SL, 2007, OPHTHALMOLOGY, V114, P2174, DOI 10.1016/j.ophtha.2007.09.017; Brill-Edwards P, 1999, THROMB HAEMOSTASIS, V82, P688; Carneiro A. M., 2011, ACTA OPHTHALMOL, V90, pe25; Cosmi B, 2010, THROMB RES, V125, pS62, DOI 10.1016/S0049-3848(10)70016-5; Csaky K, 2009, AM J OPHTHALMOL, V148, P647, DOI 10.1016/j.ajo.2009.06.014; Hargett CW, 2008, SEMIN RESP CRIT CARE, V29, P15, DOI 10.1055/s-2008-1047559; Kim Hyuncheol, 2009, Mol Vis, V15, P2803; Lowe GDO, 2006, BRIT J HAEMATOL, V133, P232, DOI 10.1111/j.1365-2141.2006.06021.x; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Schmucker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042701; Thorneycroft IH, 2003, J REPROD MED, V48, P911	36	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1080-7683	1557-7732		J OCUL PHARMACOL TH	J. Ocular Pharmacol. Ther.	FEB 1	2015	31	1					32	36		10.1089/jop.2013.0234		5	Ophthalmology; Pharmacology & Pharmacy	Ophthalmology; Pharmacology & Pharmacy	AY2AR	WOS:000347391500006		
J	Fukuda, M; Sasaki, H				Fukuda, Masamichi; Sasaki, Hiroshi			The Transcorneal Penetration of Commercial Ophthalmic Formulations Containing Timolol Maleate in Rabbit Eyes	JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article							CORNEAL PENETRATION; PIGMENTED RABBIT; IN-VITRO; SURFACE; EPITHELIUM; EYEDROPS; BLOCKERS; BARRIER	Purpose: We investigated the transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes. Methods: One drop (30 mu L) of each ophthalmic solution (Xalacom((R)), DuoTrav((R)), Cosopt((R)), and Timoptol((R))) was administered to the conjunctival sac of the rabbits' eyes and the timolol maleate aqueous humor concentration was measured by high-performance liquid chromatography 15, 60, 120, and 240 min after the completion of administration. The effect of timolol ophthalmic solution pH (5.7-6.8) on ocular penetration was also examined. Results: The concentration [Cmax (mu g/mL)] of timolol maleate, found in each of the 4 ophthalmic solutions, penetrated to the aqueous humor was as follows: DuoTrav>Cosopt>Timoptol>Xalacom. The concentration of timolol maleate penetrated to the aqueous humor was highest with solutions in the vicinity of pH 6.8. Conclusions: The concentration of timolol maleate penetrated to the aqueous humor was highest in DuoTrav followed by Cosopt, Timoptol, and Xalacom, and the pH and Benzalkonium chloride (BAK) concentration of the ophthalmic solution were believed to be factors that influenced this phenomena.	[Fukuda, Masamichi; Sasaki, Hiroshi] Kanazawa Med Univ, Dept Ophthalmol, Kahoku, Ishikawa 9200293, Japan	Fukuda, M (reprint author), Kanazawa Med Univ, Dept Ophthalmol, 1-1 Daigaku, Kahoku, Ishikawa 9200293, Japan.	fukuda@kanazawa-med.ac.jp					ASHTON P, 1991, PHARMACEUT RES, V8, P1166, DOI 10.1023/A:1015810619869; Ishibashi T, 2003, J GLAUCOMA, V12, P486, DOI 10.1097/00061198-200312000-00008; Becquet F, 1998, CURR EYE RES, V17, P419, DOI 10.1080/02713689808951223; Shimazaki J, 2000, BRIT J OPHTHALMOL, V84, P1250, DOI 10.1136/bjo.84.11.1250; De Saint Jean M, 2000, CURR EYE RES, V20, P85, DOI 10.1076/0271-3683(200002)20:2;1-D;FT085; Pisella PJ, 2004, INVEST OPHTH VIS SCI, V45, P1360, DOI 10.1167/iovs.03-1067; CHANG SC, 1987, INVEST OPHTH VIS SCI, V28, P487; ARAIE M, 1980, Nippon Ganka Gakkai Zasshi, V84, P2085; Fukuda M., 2012, IGAKU TO YAKUGAKU, V68, P283; Fukuda Masamichi, 2013, Clin Ophthalmol, V7, P515, DOI 10.2147/OPTH.S40147; Fukuda M., 2009, ATARASHII GANKA, V26, P977; Fukuda M, 2004, JPN J OPHTHALMOL, V48, P93, DOI 10.1007/S10384-003-0033-z; Fukuda Masamichi, 2012, Clin Ophthalmol, V6, P585, DOI 10.2147/OPTH.S30935; Fukuda M, 2008, CURR MED RES OPIN, V24, P3479, DOI 10.1185/03007990802480091 ; Jong C., 1994, GRAEFES ARCH CLIN EX, V232, P221, DOI 10.1007/BF00184009; Niiya A, 2000, OPHTHALMOLOGICA, V214, P332, DOI 10.1159/000027515; SHIH RL, 1990, J OCUL PHARMACOL, V6, P329, DOI 10.1089/jop.1990.6.329	17	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1080-7683	1557-7732		J OCUL PHARMACOL TH	J. Ocular Pharmacol. Ther.	FEB 1	2015	31	1					57	60		10.1089/jop.2014.0015		4	Ophthalmology; Pharmacology & Pharmacy	Ophthalmology; Pharmacology & Pharmacy	AY2AR	WOS:000347391500010		
J	Ohkubo, T; Iwadate, Y; Deguchi, K; Ohki, S; Shimizu, T				Ohkubo, Takahiro; Iwadate, Yasuhiko; Deguchi, Kenzo; Ohki, Shinobu; Shimizu, Tadashi			Changes in surface structure of sodium aluminoborosilicate glasses during aqueous corrosion analyzed by using NMR	JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS			English	Article						Non-crystalline materials; Nuclear magnetic resonance; Oxides	SOLID-STATE NMR; HIGH-RESOLUTION B-11; NUCLEAR-WASTE GLASSES; BOROSILICATE GLASSES; X-RAY; DISSOLUTION; INTERDIFFUSION; INFORMATION; CHEMISTRY; RESONANCE	Aqueous corrosion tests were performed for aluminoborosilicate glasses with different Na contents at 90 degrees C for 20 days. Multi-nuclear solid-state nuclear magnetic resonance (NMR) techniques were employed to characterize the structures of the pristine and altered glasses. B-11 magic-angle spinning (MAS) NMR spectra showed the same line shape for the pristine and altered glasses, indicating that B species such as BO3 and BO4 were released into the solution congruently with the same fraction during the static dissolution experiments. The reconstruction of Si on the glass surface as hydrated phases was confirmed by the Si-29 MAS and H-1 -> Si-29 cross-polarization magic-angle spinning NMR spectra of the altered glasses. Na-23 MAS and triple-quantum magic-angle spinning NMR spectra showed that part of the Na released from pristine glasses was incorporated in the hydrated phases, which can be identified by a Na-23 chemical shift at delta(iso) = - 3.3 ppm. The availability of these structural data by employing solid-state NMR techniques can provide a better understanding of the formation of the hydrated phases and the effect of dissolution behavior on the glass composition. (c) 2014 Elsevier Ltd. All rights reserved.	[Ohkubo, Takahiro; Iwadate, Yasuhiko] Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan; [Deguchi, Kenzo; Ohki, Shinobu; Shimizu, Tadashi] Natl Inst Mat Sci, Tsukuba Magnet Lab, Tsukuba, Ibaraki 3050003, Japan	Ohkubo, T (reprint author), Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	ohkubo.takahiro@faculty.chiba-u.jp			Radioactive Waste Management Funding and Research Center (RWMC) in Japan	This research is supported by the Radioactive Waste Management Funding and Research Center (RWMC) in Japan.	Angeli F, 2006, GEOCHIM COSMOCHIM AC, V70, P2577, DOI 10.1016/j.gca.2006.02.023; Stebbins JF, 1998, SOLID STATE IONICS, V112, P137, DOI 10.1016/S0167-2738(98)00224-0; Pierce EM, 2010, GEOCHIM COSMOCHIM AC, V74, P2634, DOI 10.1016/j.gca.2009.09.006; Zeng Q, 2000, GEOCHIM COSMOCHIM AC, V64, P883, DOI 10.1016/S0016-7037(99)00352-X; Du LS, 2003, J PHYS CHEM B, V107, P10063, DOI 10.1021/jp0340481; Du LS, 2005, J NON-CRYST SOLIDS, V351, P3508, DOI 10.1016/j.jnoncrysol.2005.08.033; PLODINEC MJ, 1986, J NON-CRYST SOLIDS, V84, P206, DOI 10.1016/0022-3093(86)90779-9; GULLION T, 1991, J MAGN RESON, V92, P439, DOI 10.1016/0022-2364(91)90286-3; Geisler T, 2010, J NON-CRYST SOLIDS, V356, P1458, DOI 10.1016/j.jnoncrysol.2010.04.033; Tsomaia N, 2003, AM MINERAL, V88, P54; Epping JD, 2005, PHYS CHEM CHEM PHYS, V7, P2384, DOI 10.1039/b502265g; Gin S, 2011, J PHYS CHEM C, V115, P18696, DOI 10.1021/jp205477q; Hellmann R, 2012, CHEM GEOL, V294, P203, DOI 10.1016/j.chemgeo.2011.12.002; Ledieu A, 2004, J NON-CRYST SOLIDS, V343, P3, DOI 10.1016/j.jnoncrysol.2004.06.006; DOREMUS RH, 1975, J NON-CRYST SOLIDS, V19, P137, DOI 10.1016/0022-3093(75)90079-4; Chan JCC, 2000, J MAGN RESON, V147, P170, DOI 10.1006/jmre.2000.2191; McKeown DA, 2010, J NUCL MATER, V399, P13, DOI 10.1016/j.jnucmat.2009.12.007; LANFORD WA, 1979, J NON-CRYST SOLIDS, V33, P249, DOI 10.1016/0022-3093(79)90053-X; Dohmen L, 2013, INT J APPL GLASS SCI, V4, P357, DOI 10.1111/ijag.12046; CZJZEK G, 1981, PHYS REV B, V23, P2513, DOI 10.1103/PhysRevB.23.2513; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; DELL WJ, 1983, J NON-CRYST SOLIDS, V58, P1, DOI 10.1016/0022-3093(83)90097-2; LUTZE W, 1985, NATURE, V314, P252, DOI 10.1038/314252a0; Angeli F, 2001, CHEM PHYS LETT, V341, P23, DOI 10.1016/S0009-2614(01)00423-7; Banba T., 1993, BUNSEKIKAGAKU, Vin Japanese, P317; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Du LS, 2003, CHEM MATER, V15, P3913, DOI 10.1021/cm034427r; Egan JM, 2000, J PHYS CHEM B, V104, P9580, DOI 10.1021/jp992999m; Amoureux JP, 1996, J MAGN RESON SER A, V123, P116, DOI 10.1006/jmra.1996.0221; Geneste G, 2006, J NON-CRYST SOLIDS, V352, P3147, DOI 10.1016/j.noncrysol.2006.04.023; Gin S., 2012, J NONCRYST SOLIDS; Grambow B., 1985, MATER RES SOC S P, V44, P15; Houston JR, 2008, GEOCHIM COSMOCHIM AC, V72, P3326, DOI 10.1016/j.gca.2008.04.028; Icenhower JP, 2008, GEOCHIM COSMOCHIM AC, V72, P2767, DOI 10.1016/j.gca.2008.02.026; Iseghem P.V., 1988, MATER RES SOC S P, V112, P631; MacKenzie K., 2002, MULTINUCLEAR SOLID S, P206; MacKenzie K.J.D., 2002, MULTINUCLEAR SOLID S, P272; Masui H, 2002, Z NATURFORSCH A, V57, P473; Mendel J., 1981, PNL3802; Murphy KA, 2013, J NON-CRYST SOLIDS, V369, P44, DOI 10.1016/j.jnoncrysol.2013.03.021; Rebiscoul D, 2007, J NON-CRYST SOLIDS, V353, P2221, DOI 10.1016/j.jnoncrysol.2007.03.002; Rong C, 1998, J NON-CRYST SOLIDS, V223, P32, DOI 10.1016/S0022-3093(97)00436-5; Pletnev RN, 1999, GLASS PHYS CHEM+, V25, P342	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3697	1879-2553		J PHYS CHEM SOLIDS	J. Phys. Chem. Solids	FEB	2015	77						164	171		10.1016/j.jpcs.2014.10.018		8	Chemistry, Multidisciplinary; Physics, Condensed Matter	Chemistry; Physics	AX5FQ	WOS:000346952600024		
J	Soejima, K; Kashimura, T; Asami, T; Kazama, T; Matsumoto, T; Nakazawa, H				Soejima, Kazutaka; Kashimura, Tsutomu; Asami, Takashi; Kazama, Tomohiko; Matsumoto, Taro; Nakazawa, Hiroaki			Effects of mature adipocyte-derived dedifferentiated fat (DFAT) cells on generation and vascularisation of dermis-like tissue after artificial dermis grafting	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Trauma; plastic surgery; artificial dermis; dedifferentiated fat cells; angiogenesis	FIBROBLAST-GROWTH-FACTOR; STEM-CELLS; SKIN RECONSTRUCTION; WOUND CONTRACTION; ADIPOSE-TISSUE; LEG ULCERS; REGENERATION; SUBSTITUTE; DIFFERENTIATION; PROLIFERATION	Although artificial dermis (AD) is effective for skin reconstruction, it requires two separate procedures, because the AD must be vascularised before skin grafts. To shorten the period of the dermis-like tissue generation before the secondary skin grafting must be beneficial. Dedifferentiated fat (DFAT) cells are isolated from mature adipose cell suspensions and have potential to differentiate into multiple cell types including endothelial cells. This study aimed to investigate effects of DFAT cells on dermal regeneration after AD grafts in rats. The effects of combination use of DFAT cells and basic fibroblast growth factor (bFGF) were also tested to mimic clinical situations. DFAT cells were isolated from SD rats. Full-thickness wounds were created on the back of rats followed by AD grafting. Five groups were established; Group I: control, Group II: treated with DFAT cells, Group III: treated with bFGF, Group IV: treated with both of DFAT cells and bFGF, and Group V: treated with Green fluorescent protein (GFP)-labelled DFAT cells and bFGF. Histological evaluation was serially performed. Group IV showed markedly promoted vascularisation of dermis-like tissue. In particular, capillary infiltration into the dermis was obtained within 2 days. Immunohistochemical examination revealed that the transplanted DFAT cells had differentiated into endothelial cells and participated in angiogenesis. Group IV also showed a marked increase in the thickness of the dermis like tissue. The present results suggest that the use of DFAT cells under bFGF treatment could be beneficial to shorten the period required for dermal regeneration and vascularisation and contribute to use AD more effectively and safely.	[Soejima, Kazutaka; Kashimura, Tsutomu; Asami, Takashi; Nakazawa, Hiroaki] Nihon Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 1738610, Japan; [Kazama, Tomohiko; Matsumoto, Taro] Nihon Univ, Adv Med Res Ctr, Tokyo 1738610, Japan	Soejima, K (reprint author), Nihon Univ, Sch Med, Dept Plast & Reconstruct Surg, Itabashi Ku, 30-1 Kamicho, Tokyo 1738610, Japan.	soejima.kazutaka@nihon-u.ac.jp			JSPS KAKENHI Grant [24592721]	This work was supported by JSPS KAKENHI Grant Number 24592721.	Akasaka Y, 2007, WOUND REPAIR REGEN, V15, P378, DOI 10.1111/j.1524-475X.2007.00240.x; BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005; Jumabay M, 2012, J MOL CELL CARDIOL, V53, P790, DOI 10.1016/j.yjmcc.2012.09.005; HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008; Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Agren MS, 1999, J INVEST DERMATOL, V112, P463, DOI 10.1046/j.1523-1747.1999.00549.x; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Akita S, 2008, J TRAUMA, V64, P809, DOI 10.1097/TA.0b013e31802c8247; Mizuno H, 2011, METHODS MOL BIOL, V702, P453, DOI 10.1007/978-1-61737-960-4_33; Mendez MV, 1998, J VASC SURG, V28, P1040, DOI 10.1016/S0741-5214(98)70030-8; Moiemen NS, 2001, PLAST RECONSTR SURG, V108, P93, DOI 10.1097/00006534-200107000-00015; Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403; DAVIDSON JM, 1985, J CELL BIOL, V100, P1219, DOI 10.1083/jcb.100.4.1219; Jumabay M, 2009, J MOL CELL CARDIOL, V47, P565, DOI 10.1016/j.yjmcc.2009.08.004; Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1; YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; SUZUKI S, 1990, BRIT J PLAST SURG, V43, P47, DOI 10.1016/0007-1226(90)90044-Z; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Behr B, 2010, PLAST RECONSTR SURG, V126, P1163, DOI 10.1097/PRS.0b013e3181ea42bb; Campitiello E, 2005, Acta Biomed, V76 Suppl 1, P69; Canonico S, 2009, DERMATOL SURG, V35, P195, DOI 10.1111/j.1524-4725.2008.34409.x; GOSPODAROWICZ D, 1986, MOL CELL ENDOCRINOL, V46, P187, DOI 10.1016/0303-7207(86)90001-8; Mustoe T, 2006, PLAST RECONSTR SURG, V117, P35; Nobusue H, 2008, CELL TISSUE RES, V332, P435, DOI 10.1007/s00441-008-0593-9; Oki Y, 2008, CELL STRUCT FUNCT, V33, P211; Prystowsky JH, 2001, DERMATOL SURG, V27, P653; Prystowsky JH, 2001, DERMATOL SURG, V27, P648, DOI 10.1046/j.1524-4725.2001.00340.x; Przybylski M, 2009, J Wound Care, V18, P516; SCHWEIGERER L, 1988, TRENDS PHARMACOL SCI, V9, P427, DOI 10.1016/0165-6147(88)90125-3; Shen T, 2013, CHINESE MED J-PEKING, V126, P1498, DOI 10.3760/cma.j.issn.0366-6999.20123284; Soejima K, 1997, BURNS, V23, P501, DOI 10.1016/S0305-4179(97)88485-9; Soejima K, 2006, BURNS, V32, P312, DOI 10.1016/j.burns.2005.10.013; STERN R, 1990, Journal of Burn Care and Rehabilitation, V11, P7, DOI 10.1097/00004630-199001000-00003; Tsuji-Saso Y, 2007, SCAND J PLAST RECONS, V41, P228, DOI 10.1080/02844310701384041; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055; Yannas IV, 2011, PLAST RECONSTR SURG, V127, p60S, DOI 10.1097/PRS.0b013e318200a44d; Yeong EK, 2013, J BURN CARE RES, V34, P161, DOI 10.1097/BCR.0b013e3182685f0a	41	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	FEB	2015	49	1					25	31		10.3109/2000656X.2014.920712		7	Orthopedics; Surgery	Orthopedics; Surgery	AY0PB	WOS:000347297600005		
J	Mitsukawa, N; Saiga, A; Satoh, K				Mitsukawa, Nobuyuki; Saiga, Atsuomi; Satoh, Kaneshige			Protocol of surgical indications for scar contracture release before childbirth: Women with severe abdominal scars after burn injuries	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Burn; severe abdominal scar contracture; childbirth; surgical indications	CHILDHOOD; EXPANSION; PREGNANCY	It is difficult to determine if women with severe abdominal burn scar contractures can have uneventful pregnancies and births. There are few reports involving the relationship between severe abdominal scar contractures and pregnancy/ childbirth. Furthermore, all of these reports are based on retrospective studies. The present study focused on women with severe abdominal burn scar contractures with desired fertility. This study investigated whether or not normal childbirth is possible, the necessity of scar contracture release, and the delivery method. In addition, a protocol developed by this hospital was prospectively evaluated. Surgery was indicated in women with scars covering >= 75% of the total abdominal area. The scarred area in the upper abdomen, superior to the navel, was considered particularly important. The protocol of this study serves merely as a reference, and future studies are needed with an increased number of cases.	[Mitsukawa, Nobuyuki; Satoh, Kaneshige] Chiba Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Chiba 2608670, Japan; [Saiga, Atsuomi] St Marys Hosp, Dept Plast & Reconstruct Surg, Fukuoka, Japan	Mitsukawa, N (reprint author), Chiba Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nmitsu@air.linkclub.or.jp					Clark JA, 1996, BURNS, V22, P443, DOI 10.1016/0305-4179(96)00038-1; HAESEKER B, 1981, BRIT J PLAST SURG, V34, P102, DOI 10.1016/0007-1226(81)90111-9; Kakagia D, 2012, J BURN CARE RES, V33, pE166, DOI 10.1097/BCR.0b013e318239ca90; Kitzmiller WJ, 1998, ANN PLAS SURG, V40, P111, DOI 10.1097/00000637-199802000-00001; MCCAULEY R L, 1991, Journal of Burn Care and Rehabilitation, V12, P51, DOI 10.1097/00004630-199101000-00013; Rai YS, 1976, BURNS, V1, P167; Takeda K, 2013, ANN PLAS SURG, V70, P643, DOI 10.1097/SAP.0b013e318285885c; Verhaegen PDHM, 2011, PLAST RECONSTR SURG, V127, P1958, DOI 10.1097/PRS.0b013e31820cf4be; WIDGEROW AD, 1991, ANN PLAS SURG, V27, P269, DOI 10.1097/00000637-199109000-00012	9	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	FEB	2015	49	1					32	35		10.3109/2000656X.2014.942314		4	Orthopedics; Surgery	Orthopedics; Surgery	AY0PB	WOS:000347297600006		
J	Yamamura, E				Yamamura, Eiji			Wage Disparity and Team Performance in the Process of Industry Development: Evidence From Japan's Professional Football League	JOURNAL OF SPORTS ECONOMICS			English	Article						wage disparity; team performance; industry development	PRODUCTIVITY; TOURNAMENTS; DISPERSION; BASEBALL	The changing effects of wage disparity on team performance during the process of industry development are examined using data sourced from the Japanese professional football league. The results show that wage disparity leads to a reduction in team performance during the developing stage but does not influence performance during the developed stage. Unobserved fixed team effects and endogeneity bias were controlled in the study.	Seinan Gakuin Univ, Dept Econ, Fukuoka 8148511, Japan	Yamamura, E (reprint author), Seinan Gakuin Univ, Dept Econ, 6-2-92 Sawaraku Nishijin, Fukuoka 8148511, Japan.	yamaei@seinan-gu.ac.jp					Richards DG, 1998, APPL ECON LETT, V5, P291, DOI 10.1080/758524403; Idson TL, 2000, ECON INQ, V38, P345, DOI 10.1093/ei/38.2.345; LAZEAR EP, 1981, J POLIT ECON, V89, P841, DOI 10.1086/261010; Depken CA, 2000, ECON LETT, V67, P87, DOI 10.1016/S0165-1765(99)00249-9; Arellano M., 2003, PANEL DATA ECONOMETR; Avrutin BM, 2007, ATLANTIC ECON J, V35, P509, DOI 10.1007/s11293-007-9084-8; Berri DJ, 2004, ATLANTIC ECON J, V32, P130, DOI 10.1007/BF02298830; Chatterjee S., 2003, EC B, V1, P1; LEVINE DI, 1991, J ECON BEHAV ORGAN, V15, P237, DOI 10.1016/0167-2681(91)90031-R; Nikkan Sports, 1994, J LEAG PLAY MEIK; RAMASWAMY R, 1991, ECONOMICA, V58, P501, DOI 10.2307/2554695; ROSEN S, 1986, AM ECON REV, V76, P701; Sommers P., 1998, ATLANTIC ECON J, V26, P119, DOI 10.1007/BF02298378; Yamamura E, 2009, APPL ECON LETT, V16, P261, DOI 10.1080/13504850601018361	14	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1527-0025	1552-7794		J SPORT ECON	J. Sport. Econ.	FEB	2015	16	2					214	223		10.1177/1527002512471539		10	Economics; Hospitality, Leisure, Sport & Tourism	Business & Economics; Social Sciences - Other Topics	AY1DZ	WOS:000347335100005		
J	Gavrilyuk, AL; Koolen, JH				Gavrilyuk, Alexander L.; Koolen, Jack H.			The Terwilliger polynomial of a Q-polynomial distance-regular graph and its application to pseudo-partition graphs	LINEAR ALGEBRA AND ITS APPLICATIONS			English	Article						Distance-regular graph; Terwilliger algebra; Folded halved cube; Folded Johnson graph; Q-polynomial	FOLDED JOHNSON GRAPHS; INTERSECTION ARRAYS; SUBCONSTITUENT ALGEBRA; HALVED CUBES	Let Gamma be a Q-polynomial distance-regular graph with diameter at least 3. Terwilliger (1993) implicitly showed that there exists a polynomial, say T(lambda) is an element of R[lambda], of degree 4 depending only on the intersection numbers of Gamma and its Q-polynomial ordering and such that T(eta) >= 0 holds for any non-principal eigenvalue eta of the local graph Gamma(x) for any vertex x is an element of V(Gamma). We call T(lambda) the Terwilliger polynomial off. In this paper, we give an explicit formula for T(lambda) in terms of the intersection numbers of Gamma and the dual eigenvalues of Gamma with respect to the first primitive idempotent in its Q-polynomial ordering. We then apply this polynomial to show that all pseudo-partition graphs with diameter at least 3 are known. (C) 2014 Elsevier Inc. All rights reserved.	[Gavrilyuk, Alexander L.] Tohoku Univ, Grad Sch Informat Sci, Res Ctr Pure & Appl Math, Sendai, Miyagi 9808579, Japan; [Gavrilyuk, Alexander L.] UB RAS, Krasovsky Inst Math & Mech, Ekaterinburg 620990, Russia; [Koolen, Jack H.] Univ Sci & Technol China, Sch Math Sci, Wentsun Wu Key Lab CAS, Hefei 280026, Anhui, Peoples R China	Gavrilyuk, AL (reprint author), UB RAS, Krasovsky Inst Math & Mech, Kovalevskaya Str 16, Ekaterinburg 620990, Russia.	alexander.gavriliouk@gmail.com; koolen@ustc.edu.cn		Koolen, Jack/0000-0002-8623-5681	Russian Federation for young scientists [MK-1719.2013.1]; RFBR [12-01-31098]; '100 talents program' of the Chinese Academy of Sciences	Part of the work was done while this author was visiting Tohoku University as a JSPS Postdoctoral Fellow (PE13018). The author was also supported by the Grant of the President of Russian Federation for young scientists (MK-1719.2013.1) and RFBR (12-01-31098).; Supported by the '100 talents program' of the Chinese Academy of Sciences.	Bang S, 2009, EUR J COMBIN, V30, P638, DOI 10.1016/j.ejc.2008.07.016; BANNAI E., 1984, ALGEBRAIC COMBINATOR, VI; BLOKHUIS A, 1989, J GRAPH THEOR, V13, P229, DOI 10.1002/jgt.3190130209; Brouwer A.E., 1989, ERGEB MATH GRENZGEB, V18; BUSSEMAKER FC, 1992, MATH COMPUT, V59, P583, DOI 10.2307/2153076; Coolsaet K, 2008, J COMB THEORY A, V115, P1086, DOI 10.1016/j.jcta.2007.12.001; Dickie GA, 1996, J COMB THEORY B, V68, P161, DOI 10.1006/jctb.1996.0061; Go JT, 2002, EUR J COMBIN, V23, P793, DOI 10.1006/eujc.2002.0597; Hobart S, 1998, J ALGEBR COMB, V7, P53, DOI 10.1023/A:1008619211978; Ito T., 2001, DIMACS SER DISCRETE, V56, P167; Jurisic A, 2012, DESIGN CODE CRYPTOGR, V65, P29, DOI 10.1007/s10623-012-9651-0; Makhnev AA, 1998, SIBERIAN MATH J+, V39, P936, DOI 10.1007/BF02672915; Metsch K, 1997, EUR J COMBIN, V18, P65, DOI 10.1006/eujc.1995.0082; Metsch K, 1997, EUR J COMBIN, V18, P901, DOI 10.1006/eujc.1997.0143; Metsch K, 2003, DESIGN CODE CRYPTOGR, V29, P215, DOI 10.1023/A:1024116811689; NEUMAIER A, 1985, J REINE ANGEW MATH, V357, P182; Seidel J. J., 1968, LINEAR ALGEBRA APPL, V1, P281, DOI DOI 10.1016/0024-3795(68)90008-6; Terwilliger P., 1993, LECT NOTE TERWILLIGE; TERWILLIGER P, 1993, J ALGEBR COMB, V2, P73, DOI 10.1023/A:1022480715311; Terwilliger P., 1992, J ALGEBR COMB, V1, P363, DOI 10.1023/A:1022494701663; TERWILLIGER P, 1985, J COMB THEORY B, V39, P265, DOI 10.1016/0095-8956(85)90054-1; TERWILLIGER P, 1986, J COMB THEORY B, V40, P213, DOI 10.1016/0095-8956(86)90078-X; TERWILLIGER P, 1995, EUR J COMBIN, V16, P405, DOI 10.1016/0195-6698(95)90020-9; Urlep M, 2012, EUR J COMBIN, V33, P1246, DOI 10.1016/j.ejc.2012.02.005; van Dam E. R., 2014, PREPRINT	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0024-3795	1873-1856		LINEAR ALGEBRA APPL	Linear Alg. Appl.	FEB 1	2015	466						117	140		10.1016/j.laa.2014.09.048		24	Mathematics, Applied; Mathematics	Mathematics	AX6HU	WOS:000347024400009		
J	Shimabukuro, O; Yoshikawa, M				Shimabukuro, Osamu; Yoshikawa, Masayoshi			Modular adjacency algebras of Grassmann graphs	LINEAR ALGEBRA AND ITS APPLICATIONS			English	Article						Association schemes; P-polynomial schemes; Modular adjacency algebras; Grassmann graphs; Dual polar graphs	ASSOCIATION SCHEMES	The adjacency algebra of an association scheme is defined over an arbitrary field. In general, it is always semisimple over a field of characteristic zero but not always semisimple over a field of positive characteristic. The structures of adjacency algebras over fields of positive characteristic have not been sufficiently studied. In this paper, we consider the structures of adjacency algebras of some P-polynomial schemes of class d with intersection numbers c(i) not equivalent to 0 modulo p for 1 <= i <= d over fields of positive characteristic p. The classes of these P-polynomial schemes include association schemes originating from Grassmann graphs, double Grassmann graphs, and all types of dual polar graphs. We discuss the structures of the modular adjacency algebras of Grassmann graphs. (C) 2014 Elsevier Inc. All rights reserved.	[Shimabukuro, Osamu] Nagasaki Univ, Fac Educ, Dept Math, Nagasaki 8528521, Japan; [Yoshikawa, Masayoshi] Nagano Prefecture Azusagawa Senior High Sch, Matsumoto, Nagano 3901401, Japan	Shimabukuro, O (reprint author), Nagasaki Univ, Fac Educ, Dept Math, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	shimabukuro@nagasaki-u.ac.jp; yosikawa@nagano-c.ed.jp					Shimabukuro O, 2007, EUR J COMBIN, V28, P145, DOI 10.1016/j.ejc.2005.07.010; Hanaki A, 2005, J ALGEBR COMB, V21, P269, DOI 10.1007/s10801-005-6911-3; Shimabukuro O, 2011, DISCRETE MATH, V311, P978, DOI 10.1016/j.disc.2011.02.030; Yoshikawa M, 2004, J ALGEBR COMB, V20, P331, DOI 10.1023/B:JACO.0000048521.68503.2b; Bannai E., 1984, ALGEBRAIC COMBINATOR, VI; Brouwer A.E., 1989, DISTANCE REGULAR GRA; Ceccherini-Silverstein T., 2008, HARMONIC ANAL FINITE; DELSARTE P, 1976, J COMB THEORY A, V20, P230, DOI 10.1016/0097-3165(76)90017-0; Delsarte P., 1973, PHILIPS RES REP S, V10; Nagao H., 1897, REPRESENTATIONS FINI; Van Lint J.H., 2001, COURSE COMBINATORICS; Yoshikawa M., 2006, J FAC SCI SHINSHU U, V40, P27	12	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0024-3795	1873-1856		LINEAR ALGEBRA APPL	Linear Alg. Appl.	FEB 1	2015	466						208	217		10.1016/j.laa.2014.10.013		10	Mathematics, Applied; Mathematics	Mathematics	AX6HU	WOS:000347024400013		
J	Munemasa, A; Sano, Y; Taniguchi, T				Munemasa, Akihiro; Sano, Yoshio; Taniguchi, Tetsuji			On the smallest eigenvalues of the line graphs of some trees	LINEAR ALGEBRA AND ITS APPLICATIONS			English	Article						Graph eigenvalue; Line graph; Tree; Generalized Bethe tree		In this paper, we study the characteristic polynomials of the line graphs of generalized Bathe trees. We give an infinite family of such graphs sharing the same smallest eigenvalue. Our family generalizes the family of coronas of complete graphs discovered by Cvetkovic and Stevanovic. (C) 2014 Elsevier Inc. All rights reserved.	[Munemasa, Akihiro] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan; [Sano, Yoshio] Univ Tsukuba, Fac Engn Informat & Syst, Div Informat Engn, Ibaraki 3058573, Japan; [Taniguchi, Tetsuji] Hiroshima Inst Technol, Dept Elect & Comp Engn, Hiroshima 7315193, Japan	Sano, Y (reprint author), Univ Tsukuba, Fac Engn Informat & Syst, Div Informat Engn, Ibaraki 3058573, Japan.	munemasa@math.is.tohoku.ac.jp; sano@cs.tsukuba.ac.jp; t.taniguchi.t3@cc.it-hiroshima.ac.jp		Munemasa, Akihiro/0000-0002-2635-0733	JSPS KAKENHI [25887007, 25400217]	This work was supported by JSPS KAKENHI grant number 25887007.; This work was supported by JSPS KAKENHI grant number 25400217.	Barik S, 2007, SIAM J DISCRETE MATH, V21, P47, DOI 10.1137/050624029; Chihara T.S., 1978, MATH ITS APPL, V13; Cvetkovic D., 2003, PUBL I MATH-BEOGRAD, V73, P39, DOI 10.2298/PIM0373039C; Cvetkovic D. M., 1988, ANN DISCRETE MATH, V36; DOOB M, 1979, LINEAR ALGEBRA APPL, V27, P17, DOI 10.1016/0024-3795(79)90028-4; Godsil C. D., 1978, B AUST MATH SOC, V18, P21; Greaves G., 2014, J COMBIN THEORY B; Rojo O, 2005, LINEAR ALGEBRA APPL, V403, P97, DOI 10.1016/j.laa.2005.01.011; Rojo O, 2011, LINEAR ALGEBRA APPL, V435, P2402, DOI 10.1016/j.laa.2010.10.008; Schwenk A. J., 1974, LECT NOTES MATH, V406, P153	10	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0024-3795	1873-1856		LINEAR ALGEBRA APPL	Linear Alg. Appl.	FEB 1	2015	466						501	511		10.1016/j.laa.2014.10.037		11	Mathematics, Applied; Mathematics	Mathematics	AX6HU	WOS:000347024400031		
J	Lu, Y; Kobayashi, K; Guan, SJ; Hao, L; Yoshida, H; Asanuma, H; Chen, JX				Lu, Yun; Kobayashi, Kouta; Guan, Sujun; Hao, Liang; Yoshida, Hiroyuki; Asanuma, Hiroshi; Chen, Jinxiang			Influence of oxidation process on photocatalytic activity of photocatalyst coatings by mechanical coating technique	MATERIALS SCIENCE IN SEMICONDUCTOR PROCESSING			English	Article						Mechanical coating technique; Heat oxidation; TiO2; Composite coatings; Photocatalytic activity	THIN-FILMS; ALUMINA BALLS; RUTILE; DEGRADATION; TITANIA; ANATASE	Titanium (Ti) coatings on alumina (Al2O3) balls fabricated by mechanical coating technique (MCT) were oxidized in air at a series of relatively low temperatures with the oxidation time of 3 h and 50 h. Crystal structure and microstructure of the coatings were investigated. Photocatalytic activity of the coatings was evaluated and discussed. The results showed that titanium dioxide (TiO2) films on Ti or Ti/TiO2 coatings were fabricated by the MCT and subsequent heat oxidation. The oxidized coatings started to show the mixed-phase of anatase and rutile, at the temperature of 873 K for 3 h and 773 K for 50 h. With extending the oxidation time from 3 h to 50 h, the oxidative effect of relatively lower temperatures of 773 K to 973 K almost reached to that of higher temperatures, which is similar to the time-temperature equivalence principle. Photocatalytic activity of anatase TiO2 at 673 K is higher than that of mixed-phase or rutile TiO2 under UV irradiation. (C) 2014 Elsevier Ltd. All rights reserved.	[Lu, Yun; Kobayashi, Kouta; Guan, Sujun; Asanuma, Hiroshi] Chiba Univ, Grad Sch, Inage Ku, Chiba 2638522, Japan; [Lu, Yun; Asanuma, Hiroshi] Chiba Univ, Fac Engn, Inage Ku, Chiba 2638522, Japan; [Hao, Liang] Tianjin Univ Sci & Technol, Coll Mech Engn, Tianjin 300222, Peoples R China; [Yoshida, Hiroyuki] Chiba Inductrial Technol Res Inst, Wakaba Ku, Chiba 2640017, Japan; [Chen, Jinxiang] Southeast Univ, Int Inst Urban Syst Engn, Nanjing 210096, Jiangsu, Peoples R China	Lu, Y (reprint author), Chiba Univ, Grad Sch, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	luyun@faculty.chiba-u.jp; haoliang@tust.edu.cn					Lu Y, 2012, ADV MATER RES-SWITZ, V415-417, P1942, DOI 10.4028/www.scientific.net/AMR.415-417.1942; Arabatzis IM, 2003, J CATAL, V220, P127, DOI 10.1016/S0021-9517(03)00241-0; Kumar SG, 2011, J PHYS CHEM A, V115, P13211, DOI 10.1021/jp204364a; Yan MC, 2005, J PHYS CHEM B, V109, P8673, DOI 10.1021/jp046087i; Neubert S, 2014, CATAL TODAY, V230, P97, DOI 10.1016/j.cattod.2013.11.046; Fujishima A, 2006, CR CHIM, V9, P750, DOI 10.1016/j.crci.2005.02.055; Miyauchi M, 2002, CHEM MATER, V14, P2812, DOI 10.1021/cm020076p; Gao YN, 2014, APPL SURF SCI, V294, P36, DOI 10.1016/j.apsusc.2013.12.107; Kakiuchi K, 2006, J CRYST GROWTH, V293, P541, DOI 10.1016/j.jcrysgro.2006.06.004; Emelius H.J., 1973, COMPREHENSIVE INORGA; Ferry JD, 1980, VISCOELASTIC PROPERT; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Hao L, 2012, POWDER TECHNOL, V228, P377, DOI 10.1016/j.powtec.2012.05.056; Hao L, 2012, J MATER PROCESS TECH, V212, P1169, DOI 10.1016/j.jmatprotec.2012.01.001; Li YL, 2002, J CRYST GROWTH, V242, P511, DOI 10.1016/S0022-0248(02)01438-0; Liu XL, 2014, CATAL TODAY, V224, P77, DOI 10.1016/j.cattod.2013.09.041; Lu Y, 2013, MAT SCI SEMICON PROC, V16, P1949, DOI 10.1016/j.mssp.2013.07.024; Lu Y., 2011, MATER SCI FORUM, P1229; Luttrell T., 2014, SCI REP, V4, P1; Mills A, 2002, J PHOTOCH PHOTOBIO A, V151, P171, DOI 10.1016/S1010-6030(02)00190-9; Muir J.M.R., 2014, SURF SCI, V617, P60; Nakaruk A, 2010, THIN SOLID FILMS, V518, P3735, DOI 10.1016/j.tsf.2009.10.109; Nishimura T., 2011, J APPL PHYS, V50, P1; Ozawa K, 2014, J PHYS CHEM LETT, V5, P1953, DOI 10.1021/jz500770c; Spuur R.A., 1957, ANAL CHEM, V29, P760; The Japan Titanium Society, 1992, PROC TECHN TIT; Trapalis C, 2009, THIN SOLID FILMS, V517, P6243, DOI 10.1016/j.tsf.2009.02.070; Zhang XW, 2008, MATER LETT, V62, P895, DOI 10.1016/j.matlet.2007.07.007	28	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-8001	1873-4081		MAT SCI SEMICON PROC	Mater. Sci. Semicond. Process	FEB	2015	30						128	134		10.1016/j.mssp.2014.10.004		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	AY0DB	WOS:000347266900018		
J	Ravidhas, C; Josephine, AJ; Sudhagar, P; Devadoss, A; Terashima, C; Nakata, K; Fujishima, A; Raj, AME; Sanjeeviraja, C				Ravidhas, C.; Josephine, A. Juliat; Sudhagar, P.; Devadoss, Anitha; Terashima, C.; Nakata, K.; Fujishima, Akira; Raj, A. Moses Ezhil; Sanjeeviraja, C.			Facile synthesis of nanostructured monoclinic bismuth vanadate by a co-precipitation method: Structural, optical and photocatalytic properties	MATERIALS SCIENCE IN SEMICONDUCTOR PROCESSING			English	Article						Photocatalyst; BiVO4; Oxygen evolution; Raman spectroscopy; Visible light semiconductor; Co-precipitation	VISIBLE-LIGHT IRRADIATION; ARTIFICIAL PHOTOSYNTHESIS; HYDROTHERMAL SYNTHESIS; CONTROLLABLE SYNTHESIS; GLUCOSE-OXIDATION; WATER OXIDATION; BIVO4; OXYGEN; PERFORMANCE; EVOLUTION	We report the synthesis of bismuth vanadate (BiVO4) nanostructure by atoxic-free, inexpensive co-precipitation method. The BiVO4 nanostructures were derived from bismuth nitrate and ammonia metavanadate as starting precursors and sodium hydroxide (NaOH) were used as stabilizers for tuning the morphology (nanorod, nanospheriod and nanoparticulate). The influence of post-calcination treatment (450, 550 and 650 degrees C) on structural, optical and photocatalytic properties of BiVO4 was studied. The post-calcination treatment strongly induces the crystallization process and produce monoclinic BiVO4 structure with predominant (112) crystallite phases. The absorbance of BiVO4 shows broad coverage of visible light wavelength region up to 550 nm, which is appreciable for solar light driven photocatalysis. Among the different calcinated samples, anisotropy rod-shape BiVO4 (calcinated at 450 degrees C) shows high optical absorbance than other treated (550 and 650 degrees C) samples. The monotonic shift in characteristic Raman vibration mode at 824 cm(-1) with increasing calcination temperature indicates that the V-O bond length is affected by Bi3+ diffusivity. The PL spectra of these samples explore the intrinsic defects present in BlVO4, and found to be high in high temperature calcinated samples. The photocatalytic property of resultant BiVO4 samples was evaluated in oxygen generation with Ag+ donors. As a result of reduced defects and high optical absorbance, the BiVO4 calcinated at 450 degrees C showed high photocatalytic oxygen yield (1.02 mmol) compared with high temperature calcinated samples (0.48 mmol). The appreciable quantity of solar fuel O-2 generation from the low-cost co-precipitation method can be widely implemented in other visible light metal oxide nanostructures. (C) 2014 Elsevier Ltd. All rights reserved.	[Ravidhas, C.] Bishop Heber Coll Autonomous, Dept Phys, Tiruchchirappalli 620017, Tamil Nadu, India; [Josephine, A. Juliat] Holy Cross Coll Autonomous, Dept Phys, Tiruchchirappalli 620002, Tamil Nadu, India; [Sudhagar, P.; Devadoss, Anitha; Terashima, C.; Nakata, K.; Fujishima, Akira] Tokyo Univ Sci, Res Inst Sci & Technol, PIRC, Noda, Chiba 2788510, Japan; [Raj, A. Moses Ezhil] Scott Christian Coll Autonomous, Dept Phys, Nagercoil 629003, Tamil Nadu, India; [Sanjeeviraja, C.] Alagappa Chettiar Coll Engn & Technol, Dept Phys, Karaikkudi 630004, Tamil Nadu, India	Ravidhas, C (reprint author), Bishop Heber Coll Autonomous, Dept Phys, Tiruchchirappalli 620017, Tamil Nadu, India.	cravidhas@gmail.com; vedichi@gmail.com	PITCHAIMUTHU, SUDHAGAR/C-9842-2012; Nakata, Kazuya/D-7633-2011	Nakata, Kazuya/0000-0002-6648-8534	University Grants Commission, NewDelhi, India [42-903/2013 (SR)]	This work was financially supported by University Grants Commission, NewDelhi, India [F.no. 42-903/2013 (SR)] under Major Research Project Scheme (MRP).	Abdi F.F., 2013, NAT COMMUN, P4; Xu HL, 2006, J PHYS CHEM B, V110, P13829, DOI 10.1021/jp061934y; Obregon S, 2014, RSC ADV, V4, P6920, DOI 10.1039/c3ra46603e; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; LANGFORD JI, 1978, J APPL CRYSTALLOGR, V11, P10, DOI 10.1107/S0021889878012601; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Pilli SK, 2011, ENERG ENVIRON SCI, V4, P5028, DOI 10.1039/c1ee02444b; Lu Y, 2014, CRYSTENGCOMM, V16, P6059, DOI 10.1039/c4ce00379a; Luo WJ, 2013, PHYS CHEM CHEM PHYS, V15, P1006, DOI 10.1039/c2cp43408c; Wang DE, 2012, J PHYS CHEM C, V116, P5082, DOI 10.1021/jp210584b; Liu W, 2010, ULTRASON SONOCHEM, V17, P669, DOI 10.1016/j.ultsonch.2009.12.012; Tachibana Y, 2012, NAT PHOTONICS, V6, P511, DOI 10.1038/nphoton.2012.175; Park JJ, 2012, ENVIRON SCI TECHNOL, V46, P12510, DOI 10.1021/es3037252; Myung N, 2011, J PHYS CHEM C, V115, P7793, DOI 10.1021/jp200632f; FUJIHIRA M, 1981, NATURE, V293, P206, DOI 10.1038/293206a0; Obregon S, 2013, J MOL CATAL A-CHEM, V376, P40, DOI 10.1016/j.molcata.2013.04.012; Gotic M, 2005, J MOL STRUCT, V744, P535, DOI 10.1016/j.molstruc.2004.10.075; Zhong DK, 2011, J AM CHEM SOC, V133, P18370, DOI 10.1021/ja207348x; Kamegawa T, 2012, ADV MATER, V24, P3697, DOI 10.1002/adma.201201037; Liang YQ, 2011, J PHYS CHEM C, V115, P17594, DOI 10.1021/jp203004v; Chong MN, 2010, WATER RES, V44, P2997, DOI 10.1016/j.watres.2010.02.039; Zhang L, 2006, J PHYS CHEM B, V110, P2668, DOI 10.1021/jp056367d; Sudhagar P, 2014, PHYS CHEM CHEM PHYS, V16, P17748, DOI 10.1039/c4cp02009j; Madhusudan P, 2013, ENVIRON SCI POLLUT R, V20, P6638, DOI 10.1007/s11356-013-1694-x; Yin WZ, 2010, J HAZARD MATER, V173, P194, DOI 10.1016/j.jhazmat.2009.08.068; Wang M, 2013, J ALLOY COMPD, V548, P70, DOI 10.1016/j.jallcom.2012.08.140; Tokunaga S, 2001, CHEM MATER, V13, P4624, DOI 10.1021/cm0103390; Kho YK, 2011, ACS APPL MATER INTER, V3, P1997, DOI 10.1021/am200247y; Devadoss A, 2014, ACS APPL MATER INTER, V6, P4864, DOI 10.1021/am4058925; Jia QX, 2012, P NATL ACAD SCI USA, V109, P11564, DOI 10.1073/pnas.1204623109; HARDCASTLE FD, 1991, J PHYS CHEM-US, V95, P5031, DOI 10.1021/j100166a025; Chen L, 2012, CRYSTENGCOMM, V14, P4217, DOI 10.1039/c2ce06684j; Huang CM, 2010, J MOL CATAL A-CHEM, V327, P38, DOI 10.1016/j.molcata.2010.05.009; Karunakaran C, 2014, MAT SCI SEMICON PROC, V21, P122, DOI 10.1016/j.mssp.2014.01.040; Ma JZ, 2014, J PHYS CHEM C, V118, P7434, DOI 10.1021/jp500116n; Gouvea D, 2011, APPL SURF SCI, V257, P4219, DOI 10.1016/j.apsusc.2010.12.023; Rajeshwar K, 2009, CHEM SOC REV, V38, P1984, DOI 10.1039/b811238j; BROWN ID, 1976, ACTA CRYSTALLOGR B, V32, P1957, DOI 10.1107/S0567740876006869; Iwase A, 2010, J MATER CHEM, V20, P7536, DOI 10.1039/c0jm00961j; Kudo A, 1999, J AM CHEM SOC, V121, P11459, DOI 10.1021/ja992541y; Ding CM, 2013, PHYS CHEM CHEM PHYS, V15, P4589, DOI 10.1039/c3cp50295c; Abdi FF, 2012, J PHYS CHEM C, V116, P9398, DOI 10.1021/jp3007552; Dong PY, 2013, J MATER CHEM A, V1, P4651, DOI 10.1039/c3ta00130j; Zhao ZY, 2011, PHYS CHEM CHEM PHYS, V13, P4746, DOI 10.1039/c0cp01871f; Jia QX, 2014, CHEM SCI, V5, P1513, DOI 10.1039/c3sc52810c; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Yu JQ, 2006, ADV FUNCT MATER, V16, P2163, DOI 10.1002/adfm.200500799; Seabold JA, 2012, J AM CHEM SOC, V134, P2186, DOI 10.1021/ja209001d; Stoltzfus MW, 2007, INORG CHEM, V46, P3839, DOI 10.1021/ic061157g; Pelaez M, 2012, APPL CATAL B-ENVIRON, V125, P331, DOI 10.1016/j.apcatb.2012.05.036; FUJISHIMA A, 1975, J ELECTROCHEM SOC, V122, P1487, DOI 10.1149/1.2134048; Li R, 2013, CRYSTENGCOMM, V15, P10049, DOI 10.1039/c3ce41470a; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; Daly R, 2006, PHYS STATUS SOLIDI C, V3, P3325, DOI 10.1002/pssc.200567112; DAVID WIF, 1983, J PHYS C SOLID STATE, V16, P5127, DOI 10.1088/0022-3719/16/26/008; Devadoss A, 2014, PHYS CHEM CHEM PHYS, V16, P21237, DOI 10.1039/c4cp03262d; Fan H., 2011, J PHYS CHEM C, V116, P2425; Haider N.C., 1966, ACTA CRYSTALLOGR, V20, P312; Martinez-de la Cruz A, 2010, MATER RES BULL, V45, P135, DOI 10.1016/j.materresbull.2009.09.029; Stoughton S., 2013, APL MAT, V1; Wu X., 2013, SCI REP, P3; Yao W, 2008, DALTON T, P1426, DOI 10.1039/b713338c; Yu JQ, 2005, CHEM LETT, V34, P850, DOI 10.1246/cl.2005.850	63	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-8001	1873-4081		MAT SCI SEMICON PROC	Mater. Sci. Semicond. Process	FEB	2015	30						343	351		10.1016/j.mssp.2014.10.026		9	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	AY0DB	WOS:000347266900047		
